<SEC-DOCUMENT>0000927066-21-000008.txt : 20210212
<SEC-HEADER>0000927066-21-000008.hdr.sgml : 20210212
<ACCEPTANCE-DATETIME>20210212160727
ACCESSION NUMBER:		0000927066-21-000008
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		145
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210212
DATE AS OF CHANGE:		20210212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAVITA INC.
		CENTRAL INDEX KEY:			0000927066
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				510354549
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14106
		FILM NUMBER:		21627271

	BUSINESS ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		310-536-2668

	MAIL ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA HEALTHCARE PARTNERS INC.
		DATE OF NAME CHANGE:	20121107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA INC
		DATE OF NAME CHANGE:	20001005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TOTAL RENAL CARE HOLDINGS INC
		DATE OF NAME CHANGE:	19950524
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dva-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:cb65dee0-3538-408a-90c8-cfac27791e84,g:bb413262-db44-4a11-afdc-c2a9f72b9180,d:878840fee65247deaca27d2dd6a8246f--><html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dva="http://www.davita.com/20201231" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dva-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl8yLTEtMS0xLTA_72dd95eb-2ac2-4ecc-a7bc-8e09e1be563d">false</ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl8zLTEtMS0xLTA_c52b91be-3f3b-4a54-8274-50cb4f278a13">2020</ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl80LTEtMS0xLTA_4ab362bc-2efa-4b9b-902d-cfc442774a19">FY</ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl81LTEtMS0xLTA_424921f3-c8c0-4151-b771-c3f7622d7403">0000927066</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzItMS0xLTEtMA_e50a0205-c338-4f55-a4ec-d11fc849e665">0.001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzItMi0xLTEtMA_74a0261a-897b-49a0-ac0e-bb5587951820">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzMtMS0xLTEtMA_1ecd2763-dccb-4023-afbe-4604992a49aa">5,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzMtMi0xLTEtMA_f2ebf2a9-0589-4eb5-9ae3-1c0a3f767f89">5,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzQtMS0xLTEtMA_f3ff6b6d-2c19-47dd-a0f7-040fae50a277">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzQtMi0xLTEtMA_47618c40-92c2-4a6f-b780-0225a500fc8b">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzUtMS0xLTEtMA_5d4374f6-c3da-40cf-9cc7-cd71dada6476">0.001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzUtMi0xLTEtMA_62f0c6ff-ab85-4b08-8ade-f61b13a995d4">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzYtMS0xLTEtMA_83508764-974e-4d2a-9281-056fcf7a0c9c">450,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzYtMi0xLTEtMA_a8ee7a56-f658-404c-b3df-b2764771e255">450,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzctMS0xLTEtMA_f9ac3b11-daa3-4aae-9c8f-726e8aee76c6">109,933</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzctMi0xLTEtMA_2fa68549-ae15-4097-bcaa-25f1e1309cb7">125,843</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzgtMS0xLTEtMA_a8f70893-4fca-4182-ba19-db3156751702">109,933</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzgtMi0xLTEtMA_c230f8f6-d776-468c-bf5b-d357643d57ac">125,843</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="dva:NumberOfConcentrationRiskCustomers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzI4MDM3NTQ2NTA4NjEx_9fb1f867-3bab-4615-a9e8-112a820166c8">no</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzI4MDM3NTQ2NTA4NjMy_d32bd530-8401-4070-9fee-1cb69ce68159">10</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i0827e76d53914466af9eff1dc6c5d343_I20191231" decimals="INF" name="dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzIw_618662da-8833-4cbb-bb7c-c46087f22d38">18</ix:nonFraction><ix:nonNumeric contextRef="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231" format="ixt-sec:durwordsen" name="dva:AccountsReceivablePeriodOutstanding" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzEyNw_89a83a49-0c54-4a32-9bb7-0cfa3a7c8c36">six months</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjAvZnJhZzo1YjBmY2FkYTJmZDM0NjNhOTljMWVlMjYzMjllMjUwMS90ZXh0cmVnaW9uOjViMGZjYWRhMmZkMzQ2M2E5OWMxZWUyNjMyOWUyNTAxXzY2_b1b5a29e-23cc-4f75-b645-caccc19d8508">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjAvZnJhZzo1YjBmY2FkYTJmZDM0NjNhOTljMWVlMjYzMjllMjUwMS90ZXh0cmVnaW9uOjViMGZjYWRhMmZkMzQ2M2E5OWMxZWUyNjMyOWUyNTAxXzE5Ng_be7fdb06-e4cd-489e-acf3-708360283b60">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjYvZnJhZzo1NWQzM2IwOTUzMGE0ODU3YjhkOWEzZGRkYjkzOGFhOC90ZXh0cmVnaW9uOjU1ZDMzYjA5NTMwYTQ4NTdiOGQ5YTNkZGRiOTM4YWE4XzE2_bb2c8c94-270f-4f30-bc59-1961ab09af0a">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjYvZnJhZzo1NWQzM2IwOTUzMGE0ODU3YjhkOWEzZGRkYjkzOGFhOC90ZXh0cmVnaW9uOjU1ZDMzYjA5NTMwYTQ4NTdiOGQ5YTNkZGRiOTM4YWE4XzI4NTg3MzAyMzIyNDU1_b36e9656-f29f-4e24-98d1-061c31fdd65a">no</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="4" name="dva:PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzIvZnJhZzo2YjcyZTcyNDUyYWE0OWJlOGUyNzlkOWJjN2E5MWYzNS90ZXh0cmVnaW9uOjZiNzJlNzI0NTJhYTQ5YmU4ZTI3OWQ5YmM3YTkxZjM1Xzgz_9baeebc2-79fb-47f4-8a20-40a75a558e9c">1.00</ix:nonFraction><ix:nonNumeric contextRef="i8ed3cefb5e264fc19465d2168eeb14b6_D20200101-20201231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNDky_16edd235-5259-4498-82b0-f1d0de7d36e2">2036-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i3faf499aa9a748f1954b1f5b2998f2f7_D20200101-20201231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4MDM3NTQ2NTA4NTk0_fae82ee4-1e77-4f7e-8680-c3bd76ee6399">2029-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i46cc1be6f24843f99366871f9141b719_D20200101-20201231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNDk2_1186c4b4-02cb-42f2-97ab-82019426e967">2040-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i7242eb9d60a04733a2c41990205ffce0_D20200101-20201231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNTAw_626e597d-7fd6-478f-b67d-3f5d7a25eca3">2021-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i48f1c17b32af4699bc7a441a7ef30448_D20200101-20201231" name="us-gaap:TaxCreditCarryforwardExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNTA0_1d01f9ac-b49d-4a9c-8733-287cb9ec4afc">2024-12-31</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i7e335188f31c48569623a8cbca6e9598_I20200213" decimals="-3" format="ixt-sec:numwordsen" name="dva:ProceedsFromRepricingAgreementOnSecuredDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDcvZnJhZzoyNjZhMzQ2YjMzNDM0NTVhYTkxOWExZDJhZjAzNmJlNy90ZXh0cmVnaW9uOjI2NmEzNDZiMzM0MzQ1NWFhOTE5YTFkMmFmMDM2YmU3XzI4MDM3NTQ2NTA5MzI3_6b067d1a-4b79-4ca6-bb38-adb0dc75cfc2">no</ix:nonFraction><ix:nonNumeric contextRef="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231" format="ixt-sec:duryear" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzky_dfd5b969-8e00-45e6-8179-c401433cd25b">1</ix:nonNumeric><ix:nonNumeric contextRef="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231" format="ixt-sec:duryear" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzk4_d7248c68-dea9-430e-9c5a-594570a18d4e">2</ix:nonNumeric><ix:nonNumeric contextRef="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231" format="ixt-sec:duryear" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzE2Mw_5554c2e8-966b-4b2e-95f3-9be46728114b">3</ix:nonNumeric><ix:nonNumeric contextRef="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231" format="ixt-sec:duryear" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzE2OQ_59f1b6ff-0077-4e82-b754-de010bc6576c">4</ix:nonNumeric><ix:nonNumeric contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" format="ixt-sec:duryear" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzk4_0db614d5-71f6-46db-8d97-cccc8db7d1c5">0</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="ifd91e8a803cd4443a8f9187ba2180bb8_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzMtMS0xLTEtMA_9d40663e-7e91-4a14-b2ae-3ce4c1c230eb">50.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ifd91e8a803cd4443a8f9187ba2180bb8_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzMtMi0xLTEtMA_77bd4666-aa44-4b0e-85b2-66e4e00b4143">60.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i5225de491d414cc396c96583c06b3790_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzQtMS0xLTEtMA_439e3a79-2bd2-4944-a5bd-9fda1ff84a2d">60.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i5225de491d414cc396c96583c06b3790_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzQtMi0xLTEtMA_c961c681-7502-44ff-9d53-f64b69bcca20">70.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i4869c0e869c345499d845df4d1726074_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzUtMS0xLTEtMA_84570900-e65c-4117-814a-1d444edffedc">70.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i4869c0e869c345499d845df4d1726074_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzUtMi0xLTEtMA_2b64b0b7-fd68-487b-b0f1-ddda565937e0">80.00</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib5d81d4cfd9b4d3a90277b4e0ba77a2f_D20191104-20191104" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzI2Ng_f5ad62a1-3a96-4f0e-80cf-572681e71412">50</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ibbd08d038cf54271ba04c5bae7ea2247_D20200701-20200701" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzM3NQ_a020ed18-fa21-467e-962a-610068a54adf">100</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzU2MA_b8da859f-e29c-4f01-a147-d2bc298d9298">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzcxNQ_e98e87f0-78e8-4715-84a3-d6a88354c575">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PaymentsOfDividendsCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzI4NTg3MzAyMzIzMTQ1_9ce0257b-fcf0-4f65-9712-274e8590df13">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PaymentsOfDividendsCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzc2Mw_5c80e3b5-93f9-4f07-b7d7-b8d9e88c71c6">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PaymentsOfDividendsCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzc3OA_cb12741f-b57c-410d-895a-becc3f079b7b">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i76ba37986e6d4a12be3157c80c387fc9_I20191104" decimals="-3" format="ixt:numdotdecimal" name="dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4NTg3MzAyMzIyODgz_d78fc656-e24a-47d4-a254-50290adde1c7">246,373</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i105b8a0db46c4b329658833071e7f412_I20201210" decimals="-3" format="ixt:numdotdecimal" name="dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4NTg3MzAyMzIyOTE2_070de8e5-d436-4fdf-87d1-3e23111239d4">329,302</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4MDM3NTQ2NTA5MTU1_19d544e4-9081-421d-84ef-440f44a9dc3e">16,477</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4MDM3NTQ2NTA5MjQ1_75a697ab-4316-41bc-8234-cf7ae2261dcc">41,020</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dva-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i455090d9ae6c4bde8821c7170863d88e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1de112d305e94047b9078f3339c24026_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808f8139875c457e969c8ed421c88028_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7411005e6a69450f90e334cbe2a78126_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fac62eb6d9e438d9cffedfad9480206_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f9f0f6c1854cc2b831462ed14ee61e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea92518235484ea8bf5f60c37164f758_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i339c0adb944141beb35f1f190097beba_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aed65b31414464481f45589046dd452_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee29f3075d90411e97da80cfb155be40_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i821341ce571140c0813c92a7b329684f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7a7ef37ab494bd3867be9a034c8ae17_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i036278cf7d8347788f7fcdf25acbf8b5_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9adcf1b689594ff49c7827e7c45a99ba_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11909335cca546ad85c586bcfb13dce1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6e22f6f3f724a35bed885f82b31bb8a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d06c26940f24e1fbe98edcd4bba0d49_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b135446f5334d709fef3456c13e371b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie32a7f3467e74c40b5ee59a7db8b3af9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a10dd7b6f72489798f395a4ba7d5774_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2999225279c547bb86d45264eed0b5a9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if64308cbce6e4abe90bdf552304e7cbe_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b5d1183ea1e473eaec3e4b8f2b2518b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66313af05c484394a3714b810b898338_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5b8c698b4f44d7b880f261b5acd9515_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ade1676d7ef4cda9e4d3f1b875b9feb_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc34c3096bcb4003b347988f2fb970ad_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa5780e8d82a48b59708a1ff1276a66c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3387e99cd35649b49ab4860ac21de1b2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d247586e6c4138a61320064b0c31f7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib825ca1aa06a4e079d3c844ba6177f19_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4c874d135ae405b86b7b38ebcf9f62c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecd4fd2059754cc49cb4f8aac8c883f1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f880539ba04aa6bf3a2d7cf33b0b29_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice9f2467e9a64adeaff985f8e4c19438_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e915932320b4ae6acd3fbb11411779a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5bb9dfef3744514a0f063432ab36168_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84b966e5887040ab818abe14226ea392_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5495b245d279498ba671db088b9cd741_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a96a317245446879f226ad58e296daa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id00ebe3d20f44469990e8c005164fa4a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d1c51a49e14e6280972be024b74db0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d5e9b53ace74efe9eed270c48169e97_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42fa656b3e574210b01ef1b7211cc59f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce9502863624611b7b5cfc59cc39ee9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1759c41f6f1649ea99256fdf926d649e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90c222c41994c9798b61036606e41ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c39adcdfcd42309a9115c0d0fdcc55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0e12f9281dc4d0f9e7d785149a69a88_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b232edb6214093a0c5d7e31595d14d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47223b014646447aac32d557643104a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fc62187afaa4e38b48175be5f574c2c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a37cb5f5593422481356f9dc98a3f3b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94bfac29df0345ed80042412796b3ada_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27b1a608e9d425fb9716950917809df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe1d0c26345f4dd988fa30758fc01afe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6922cd861e2a48a59394b6ef51aaff96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3fd3e2a7d3d4e1a85627c011b215e0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i392918f6cd454f4482fe89cf50ebc86f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54db2eb8f1ec40a89ceed1e1d8b4f241_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>dva:clinic</xbrli:measure></xbrli:unit><xbrli:context id="i2dc41b2293ce4a6a80887886af6405df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>dva:state</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>dva:patient</xbrli:measure></xbrli:unit><xbrli:context id="i4902d542b6e047d884a728d3dcf0e573_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1bbb20c229b4a6d8445cfaf1ad7307a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05384b4fdc8c489886da60a656894693_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>dva:country</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>dva:entity</xbrli:measure></xbrli:unit><xbrli:context id="i317edbea3c674863a4195c7cc9cb635b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf248d771016450592bc55285a8f1c42_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a5d338ecdd42329c520f41a32fe9c4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80c5922bf87c4c29a6121290f1760795_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ae27697d58642a8a39741ac5b46b72d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1f7687b20c34347a978c801bcbfd456_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide1f2f90b0234c6386c95ee837e0334b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb582b032e9d46908fb473a5d0de200f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie70348b0c0a94bb5b0ed3de0b4debc07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id59d792b2bf74f6e9847d2fd9f3bbca7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ab540b60374ad4aad5a23a7bf8dddd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i867730cbcf0748fcb37173e698317b23_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44562b75ffb5414b8b4eb109b9499d54_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i254282fb16c34ab2945f3c18a75f8323_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4206fb8a521a438eadb170f4aaec89d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0914af09be91438c9bdd1e22b951a0df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41625250859e40bda54bf40e92bd1151_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i635c2eebb9e64938a68735ae6c593657_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6ed05dcee04d00b0acebc6f9646492_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfbe0a9a2b6e487387fc940140536289_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9039b41e698646108961d8438f298065_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29a5025fe7d546f59cb2d4b2ffb19b92_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic73e85c3fcad4252b56e5ca71804381f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68577d74812348348e7271f689002b75_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10176a49705641908ef22710eb3ceb0f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90161d3cc08b4d05b4c9a4bc96f77638_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafc956536376499ca4f18116e1a28156_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd1d128a80ca4c31ab1a4b08899c3bee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i331cb12a3bc84e9dbd3524df3c61c1e5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9225d7ed664b4437a955e3239e2d4672_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad6e19bfd204637ac41e31412365fde_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57e64e40c6c949a4a0c172e586effb9e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbdb192b5cd84c0aa25e94fee7bff238_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i164e3c5e63494e49a4973e32ed991ff5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia940e3b4e9754716a7d35abf7b1359f0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f9b9ab0e8584df69e653fc61911e0cc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaf2fdbccba5422e8e3b2a15008e502e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14af6fc05fe24609a9ef1d172b06d3ed_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bfe5b640ee64eca89b909864373b865_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i799a2b20a00e45e0b3f08db269fa3736_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39bda8f256e44c4884a542b1ea607df5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c528d2849c2446c8b9fb3e906e29ece_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc14ea5b25b54be1945bb52726f391c6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74881d974a934edab7eb395774d2e72a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie830c422acbf447b830d5ba05d456555_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie092dc1a9f334a2d8959b7937c63b6da_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e35707e465473fb9d209c48d673e9c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b2c11e9409a4ebfb1af5af31c5eec06_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib57b9bde3eb844b8825af8894f08bd19_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47790222420f478db2f7ad17705accb2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21697e32a0ec4bf1904f2fc73b9dbbad_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if961d3964d254d87be469310f7624b7c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72f27d9ed3464afea1d79fe17c36cc36_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a04f4ad256b450eb154971edb661d29_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10d8743c3594411698541aa578ec2aff_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a90a56c3c54abe92e41788859d9e6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59029b4957e44e428f8a80a0cb5a4790_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0da31cd8a6a4e4a97290ebfc52869b0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib87a97e373bd46c89dac120c212a644a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibabc1893044f4e66a6479c0d43899227_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i884b650f6da14ccebfbdcc5a5e3c9c2a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i444084475ebc4fe2ad288f8829a0542f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0827e76d53914466af9eff1dc6c5d343_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8497a3de1675439ca2a3f1871e38384e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d4d7d40de954bc4a8f5ba7ec06c8900_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if18749a859234cf7b23652f60c460caf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ab2d52784864cf6ac6e10794af391d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf901af366f34dbaa56ecfe998516c0a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb978d08cfeb4642bd53e53555d6f21e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccf23c460b304d34975ca6b21fa9b648_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8314d71719804d359b9983c38b6897ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6369add7b9a341bbb8a486c2b65be42f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica2929163ca34ad6b905be96f45d01d4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e82366908fc411981946281d867f868_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51c7cd9eeaa64c0a91528e12f2172af6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2be35772674635818cdd631d499246_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f29353214f44b529f3e84fdb2acc7f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39149e895b2b4e0593f509dcaf83e78f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b4634b59f749b0b5c6631027941142_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a1bfddc39c4a169c47e840741f335c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied88af0a7c524bc3999fdbfa994108b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3063267a01f94e3fb4a375c1970717cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b89299a9bfd462b8e5b3a7023ed6334_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51925e49d034403085e491018c02d26d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">naics:ZZ446110</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie087c1d3f9974f219511b176db8eda1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie16ddbc3f61d4fdd876789fdb7485e3f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaaf284806a9483fb5c0391481bc7d0d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b74ed9100c4ce592923a9de27931be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e26a206867842e28cae11fb48c778d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie28a01afc63f4186886299ee6dea4de7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if835180905f04b80823ceda1bcf614db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaa907c146d64b698d6ea801e89b4f89_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida6bf19e541046eb93c237e38a4905bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1023bb732b9148d293570ccb2f49efc1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6f1bc577e6248d9aea0e2a4190a616a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8edd1564071a44ce9689f85e2562bf1d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieee6b2ebaa1a4e44884eb99babde1e22_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee2cd9df79914869b9cacc76ab090369_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i176abd0dfd064576a6fca693618a4d85_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i743f6eba826d4df9965c6fe5e996c814_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff2c6d1977b942e7a9758284e817d55c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a1644379314e62bdaab27a9dfd42f2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadefb36dac0a43168cf91c594bc2b46d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8d3af328249451ea7b48056f3f531e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5952bbd67214b9a90b15f0edf9153a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5831886c34dd408a8ed406190748f295_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic54da9f2132a4f749e030ac9e3e0c618_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if638379c314e4e40a080f1df9bc6d4eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5c4935b96bc45d599d29d673dc708b8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3604fec36844df58062ea76e02219c2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2f082dee6464c25915568ecfd2d5672_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bf9f1c0751e45cb82db545fe4859306_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dva:segment</xbrli:measure></xbrli:unit><xbrli:context id="i910ed57bdfbe40edaf7a7ec74018eace_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62f30525c6a45a4b19b99409e8b6a62_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93e30cc7514476e83496bdfc4e18ffb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if485fd70c4f140e5a792e18f8695f7b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec8d246ff474a11befdb8bf8dc561ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ed3cefb5e264fc19465d2168eeb14b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3faf499aa9a748f1954b1f5b2998f2f7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">dva:TaxYear2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46cc1be6f24843f99366871f9141b719_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7242eb9d60a04733a2c41990205ffce0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f1c17b32af4699bc7a441a7ef30448_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286706e9b0964d8cbb75adb2d5340592_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i250b8e686fbb4a0eb1114ccbc4b5e9c3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52324c1dc24d4d8b859c1369fb83eb5d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dcd17ac6da84bfca13be11407dd097e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if381450d87824e869bf60a18db4c6586_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a345c6e30c94176b6d3453a7fbf6e28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70dcb1ea14854f37b5aeb6d646b2e0f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14df805acc674d20a7c5aa1dba69bf55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10592b24a7d94ae2bbaa1ef42f4ed1a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f85fe5578d64f21b789dbb1d9ab19ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b049dd4b914f4ea5123c565a84fdeb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a809ec49865440ca9f74653e3e59525_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7394d13923fd428d9c2578d297562554_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f4adb73272a42f5b8ce1b57a5c7617c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe49a72ad734e399a94074a044ba38e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37d9e5736a9a43eea92eece9c7a70156_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f563c4e28454aeb9d6c1ab26ac542f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c63e5480b1f427bae9d35c3d385319a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513c7b56b1594745a1ebb8321dbbfc57_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7040636942049efaf5dd11457035dfc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4bef0b2f7a346219d36e58e1f35f48d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacef66fccbd84dedacbd5a8f1b5e7b10_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aa636c18275409199f124f364f5e504_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18932cd78584f0cb719262f3f8eab08_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6706bd8a691e4f01b5d9b858653eb878_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic69633efe6f54a5fa84fd43f264fe79d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i856ad81a7b084214953762fad3fc3894_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4f6b88319747d09864ee3399753c01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06b84976de74f0aa4c9de71c05d9548_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94c16909492241318308c8c001933088_D20210106-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-06</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida75c1b36c22493e8c7e9267cf54a7aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8033f3e1736c4c5b95b3f8eefbe1406a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbb4bf191ef14070a5362746d88603e0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f522b31ed94ee9a22ac5be8888a7a7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i045e4836b7c044119912cf78d7ff47a9_D20200213-20200213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-13</xbrli:startDate><xbrli:endDate>2020-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7314edaaf4ba4f878c3576d48795f7e4_D20200213-20200213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-13</xbrli:startDate><xbrli:endDate>2020-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e335188f31c48569623a8cbca6e9598_I20200213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic72d397e0f3e4b2891c3e57dbe084568_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e1759fea1d4fe6be3ee89fad61189a_I20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-09</xbrli:startDate><xbrli:endDate>2020-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60afbcc7ed1f4c10bc730c4a41fd1553_I20200715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-15</xbrli:startDate><xbrli:endDate>2020-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4577c6d1bfd84e039d738058c80d0d6f_I20200811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-11</xbrli:startDate><xbrli:endDate>2020-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c9ee24fbe9340239ddc070e034d80e0_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-21</xbrli:startDate><xbrli:endDate>2020-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8da420e4fe43e3abe44f58b0f0c849_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad2e96f61d94f8eaade51037ef306a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed9f709bc0e4ef09c4f9e055ef04e86_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f29329fa0a24761880b3da66bfea3f0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifff59c8376d84505bcb4b4231e5bd78f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff41e1baf8154d9d8e160378c8afe9a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19164efdfc254d9a849e3b6592273062_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife085c5fc53a464ba6234e3b54b5902b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a62382e0e04fc6a6d5db83d4b94e8d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie19cd8d5f7704699a59ba60718cf6759_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib88f0f66836c4e39b167ed6b9e1eab25_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4253a297c545feae0bc83b8afdfbac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4a73b09375643e2b9ad54bdb2776bab_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4f6eb4a12be4460b4491ec67bbeb914_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaadc39011cd34e719eb41ca937a418b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf49515840e487e8f2fffe6cb4b0d22_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb973ffc2bf49c1b23aebcc238a4c6c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e3ddb19c4b4f45ab14958866d7c43d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7008e4c2d54ce6862f4b7e5e90c295_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96fe2a0d86c443a28c19325250d8c04e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia424f1cb12ad4530b4ccca1a7530e070_I20190812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f14d1dd6ac4677890feb6e64809282_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a37e07755da4c969e25d18ca6f25243_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62132ed6d58b423cba1f3c99ca102a0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic824c560585f40d3a9cd728889fd74f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ef674119c2b4d74aa417195d2c6c430_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41cd8e78e8344b3ebb08e9406b65619d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f16999941ed40e69576042281e8c119_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31bf166ca5d4a4da3dc6b7a74d31624_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21a3c92cde084cf8b5352300822f8a32_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6750de267f4090baf50a854a1011e0_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65d88e830460478cba6dc77e5492cad1_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9df1ffed4d1a4507989270b5f5b4cad0_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48eb570e320e4ce9a013b7d5c8f0f816_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if29e4c04bf37468ebe8740252e6f04c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4528caebac5945689bef0ffaf6291d30_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09a03f944078404d9b7042cd462b1e45_I20200611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic29f0bcf68804559a9cb68580986a3d1_I20200611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56347587ed084168beda32c60aeec406_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40641a42352446a9899eac8cf4b67998_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefce2246983a490cbf7573fdfb4284f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec9363113cab4f59bd24f4201b13c82a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50aab727700a46ef9be399f0944d2e80_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ecc951facbe48a0a302ba1044295757_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia83bbff9dda64502a7fbedbbc8a8a4d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6b7c8b669444401a9a4b4002e230983_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26848a1a0f5d41bb9f8750c93c848335_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ccc591606cc4e39942d003b9bd1727c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60a53b9f954142e297133141bab808dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2584bc113b24dca93703a2c83984853_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c8fd716e0254f41a042164ecba35111_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a79748b304b4708bba0c7e5287e2026_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e22cdd25e2e4d95989b353987e285c8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24385aeb87a94f68874b67e43b0ac293_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93d09393df004ac29505b1eca4c5d9f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i398441769aa34ea5b548ab2875ab7937_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib34487485c5647c193bb709cf8e7c4cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockOptionProgramAndStockAppreciationRightProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockOptionProgramAndStockAppreciationRightProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockOptionProgramAndStockAppreciationRightProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-04</xbrli:startDate><xbrli:endDate>2019-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icebe77b40956462b9ff854742673e44a_I20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb4d386a219415092cadf2a89fb4b27_D20191104-20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-04</xbrli:startDate><xbrli:endDate>2019-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d81d4cfd9b4d3a90277b4e0ba77a2f_D20191104-20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-04</xbrli:startDate><xbrli:endDate>2019-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e9613618454126afe7f679892ff495_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide5fa201da08419d8480005b0941c2ef_D20200101-20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13cf2d394c7d46048c99aed94e7a3468_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i428a7bb3ffa14fe5895e9f5a7c269bed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f3ec9369a584177b5460514179d0117_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b178e933b3b47e2ac8bbe854a99a0bb_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7def829c92e542139bac66fe336262de_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4ea773d13594e1e9feb21e2fab910b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f4222a3b2941c78d4c11684f04bb29_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i127cf2093ba342448f4db553c0454a5d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd91e8a803cd4443a8f9187ba2180bb8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5225de491d414cc396c96583c06b3790_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4869c0e869c345499d845df4d1726074_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbd08d038cf54271ba04c5bae7ea2247_D20200701-20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib743729442954729b874209aa3b7ad4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-02</xbrli:startDate><xbrli:endDate>2021-02-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76ba37986e6d4a12be3157c80c387fc9_I20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i105b8a0db46c4b329658833071e7f412_I20201210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7083b873e21941ca8755a4ceb7aeeac8_I20210210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib85e3af4c76943dfb45faef356b1edb8_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia09cc0ebe548468cb11bfb4a15f51203_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e4cffaa726b44c38a7415a3a0c9e4a9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aee781d32fe49c2bb5de5584a9e35d2_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id982bc2b303943b3a1f13e6fa0132c37_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id91bd7812fa548a7aeaa626e95f390fa_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc3a6ff6bb04c1e93904bc9ac788525_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2676db50d104876ba6149c180d0549c_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d0662ace310459d8294892cb68ab800_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3eda312133844699a6a4a94669d3aa9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7b5073da4b446ea0318c702a7868ed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e862399f5a48ab8399e8f0cdb32c64_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i400ae66383684fca86f44ab51c352938_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie318599ad486430586f67152fedcd6e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c60b527bad44f338d70eaf4c922c693_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4353b1da6dea495987a98903f6f24d81_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa528156b4734e65b6f4086215f035cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41c844e403784223aaf6cd1848e6ab04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i121893f4c40449a89e600dbe09cccfb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f863d3dd90b4b01b6b02423feddcd8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa2af9b4b56d4ea9bd2ee38a1c474653_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i211344fc537744f5a1e5ca5d7a509101_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34eb33d6da174197975f748888e130fa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5bdaf5b8e324f16af4b2af8e8b5cea5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife8b48f4488041a98b5163ddacda7b3d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42771298d95c4449aba8f0b634283f8a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbedb04193324daca88f65acd841b435_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffcc4ae070e4183aea32935e65560e6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe2c2378655447c9ff1bb02277688af_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19715ea7c0d44a94b2cc8fb506d311dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a352df164304776a46c85b682e9ab80_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13fc6ded13df4a0880a140b68e18899f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8030b65740034eaa9eae02d95f2133a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if04951c8b4f5456da29bb184a415e56e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id643d82f1c0c49a58e67abb271a5f89b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61c7d20749714b578bd03a14636c3b75_D20200501-20200501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:RMSLifelineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd580bc9f0ce4f48a42dcff947bb8c76_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if69af729580f4423a3ac3716ba3c2db6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i786a553c52f743c5b1b4a38214be1b9b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e92165fc1424a7ba5419b7bb4e85b10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i707d83d1d9eb45bbaa369393203a03a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab59816d75634fd58eaaa890c090532b_D20190619-20190619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-19</xbrli:startDate><xbrli:endDate>2019-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2343e73177c4a59a625d97fd537e0a2_D20171205-20171205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-05</xbrli:startDate><xbrli:endDate>2017-12-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9577f3ef1df845c38e9359052401de77_D20190619-20190619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-19</xbrli:startDate><xbrli:endDate>2019-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4ad841931d5470f881644ba3f00c2c2_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id64a66f74d0f4ecba8a1a1be356f290d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dva:CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a0c036d197423599d73e88e5341015_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DMGAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4eac1171b5341d8b967522bcb813373_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DMGAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65a17e126ac34461a4fca6925ed519bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36352b7df66948dba0eacf04441040eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i692b9792fba94d658bf1614514353578_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8204d20559346598ff50ef21663702d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic360e4e817a54ccbb56e6288ed0b1685_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie862d7ef0c1343e2a506a5ff72228d56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd4732a8e3d41d984f5f16deb38d1b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i757c9663b761453cad7e8ec5f01cb559_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i045ff3fd899a407682817e4edb66922f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68711243663d45cd9878789705596fad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b5178b3f27148099f8931545f27730d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d92344999cf4f04aef6369cc712a589_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8733faebf4f497296ada527a7cd8acd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3feefe9b7e3f4d1e8e1438498a7ed0e0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i250b1181003d40a3ab8cd67db23630ae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7ace566871432e8e4240927f2bf074_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c3be00a520d4ae2958de6ed78743b3f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5de5994570ca4c2d88f909bc24fd0c06_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0baec8c73f084f299738f9079b65dd67_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0420ed82e7024d998b6589e8747f9f7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd8fa94d190c4eed9526f7bfc49e982b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6be2ddd91d4f4088ed90946f8137ab_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee1168a88cd84c8194c82fee58056484_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i338ebbb235e94664b8762945904b8e65_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d0245cc46dc4065a8942a8b290f03b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i250b62935f564b88b9b115cc2724bca5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15645add5fe64f3da803a62328e47752_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d063b2501144da199dc74e77efdc1c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50bc107b4f0a4837842f4727bce2675b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326bc266ccc04e9085736f4e63bfcd54_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60ede493ecc1446dacb46d6cfbf3cac9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5953439c8d14af49838fde6e6488453_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6163ef4be0a465f90685726ac832a2b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3d2a102026c4112b723366408486f2d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa612087266445208d57b0d501856183_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if32f22662e54432da57bda5635cea91f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b594af4c5946d799a66354ffb0bb8e_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa4aa6d5d9f647368ce987a4ceb5e733_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:RMSLifelineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640e3c80e07c4131ab855012b2ae413d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5a13855d6745d88e71a8dbda06352e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib323764e090d434bbb21570c9e96b6b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffbc38c3d5d4d4fad2bd3d8db1d28bd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea338e77f4034e17a9b6e514cff7d6d3_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40704e0cd419424eaece0c344ca47892_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i878840fee65247deaca27d2dd6a8246f_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.138%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjU1_a147bd0d-d13b-4fb3-9014-4163ddd17099">10-K</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6OTM4ZmFkMGRlNWFjNDhhNzgzNjZlNTI3OTlkNjdiYTkvdGFibGVyYW5nZTo5MzhmYWQwZGU1YWM0OGE3ODM2NmU1Mjc5OWQ2N2JhOV8wLTAtMS0xLTA_b599f04a-8dff-4be6-99d4-322c0cc80b47">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the Fiscal Year Ended <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8xMjI_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8xMjI_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MDYyNGU2ZmYxZmE3NDczM2FmNThiNGJmODQ1NGNlYjcvdGFibGVyYW5nZTowNjI0ZTZmZjFmYTc0NzMzYWY1OGI0YmY4NDU0Y2ViN18wLTAtMS0xLTA_c569c7cb-fc99-46eb-94f1-0e9290518988">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from ___________ to ___________</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUw_4ed09732-a129-4c8d-ad11-0f8ce5730122">1-14106</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><img src="dva-20201231_g1.gif" alt="dva-20201231_g1.gif" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:112px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUx_bb79ca2e-aa95-43f2-99ca-67088d997507">DAVITA INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:244.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:244.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MTk3MTcxYzBhZDM5NDcwNmJhODUzYWJlMDNmNjlkMmYvdGFibGVyYW5nZToxOTcxNzFjMGFkMzk0NzA2YmE4NTNhYmUwM2Y2OWQyZl8wLTAtMS0xLTA_40852495-e607-4252-9852-1825ba3be7b5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MTk3MTcxYzBhZDM5NDcwNmJhODUzYWJlMDNmNjlkMmYvdGFibGVyYW5nZToxOTcxNzFjMGFkMzk0NzA2YmE4NTNhYmUwM2Y2OWQyZl8wLTItMS0xLTA_e10ab564-b8ac-480f-b491-7f8edceacbeb">51-0354549</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.50pt"><tr><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:19.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:30.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8wLTAtMS0xLTA_5d7e26d4-184b-46b6-9ce7-458d885c66d0">2000 16th Street</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8xLTAtMS0xLTA_bccf0fa6-bc9a-4e0d-a874-ac1855454e91">Denver,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8xLTEtMS0xLTA_58d07dd4-5695-4bc9-9821-e50f96a4e92f">CO</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8xLTItMS0xLTA_3f276071-0d2f-4977-9311-15e8bdc95847">80202</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Telephone number (<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjU2_1650924d-e040-40a4-929b-49b24e1b7690">720</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjQ3_df44821a-7d0c-45d0-aade-d8e6a588b937">631-2100</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:159.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:30.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:115.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:6.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:190.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading symbol(s):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZGVlMTA1ZjQ0NTRhNDAwMmI3YmQxM2NjZTllMzQ2M2IvdGFibGVyYW5nZTpkZWUxMDVmNDQ1NGE0MDAyYjdiZDEzY2NlOWUzNDYzYl8xLTAtMS0xLTA_3c18376e-0c4d-456f-a148-09e6e2e8c871">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZGVlMTA1ZjQ0NTRhNDAwMmI3YmQxM2NjZTllMzQ2M2IvdGFibGVyYW5nZTpkZWUxMDVmNDQ1NGE0MDAyYjdiZDEzY2NlOWUzNDYzYl8xLTItMS0xLTA_63c9401c-dd2a-4444-a320-601719c180cd">DVA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZGVlMTA1ZjQ0NTRhNDAwMmI3YmQxM2NjZTllMzQ2M2IvdGFibGVyYW5nZTpkZWUxMDVmNDQ1NGE0MDAyYjdiZDEzY2NlOWUzNDYzYl8xLTQtMS0xLTA_3e773b5f-fc5e-4942-be53-394400698790">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjQ4_2f7bb62d-6e25-411b-855c-6dfc0f078912">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUy_43daf786-89cd-414e-acda-b1e3159de68a">No</ix:nonNumeric>&#160;&#160;&#9746;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUz_d08d3ffb-de7e-4e2b-9352-9f97a7e79543">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjQ5_541532a3-490b-4f72-bca1-c90245ba7e1d">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.00pt"><tr><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:102.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:145.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:127.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZDVhMjZhZmQ1OGM2NGU2YjgwOWM3Y2IzMDkxNGQyNTcvdGFibGVyYW5nZTpkNWEyNmFmZDU4YzY0ZTZiODA5YzdjYjMwOTE0ZDI1N18wLTAtMS0xLTA_e0162893-43bd-456a-9ac3-92c49a78f4ab">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZDVhMjZhZmQ1OGM2NGU2YjgwOWM3Y2IzMDkxNGQyNTcvdGFibGVyYW5nZTpkNWEyNmFmZDU4YzY0ZTZiODA5YzdjYjMwOTE0ZDI1N18xLTUtMS0xLTA_17979017-83d3-41ee-b26b-9aa47453ecd8">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZDVhMjZhZmQ1OGM2NGU2YjgwOWM3Y2IzMDkxNGQyNTcvdGFibGVyYW5nZTpkNWEyNmFmZDU4YzY0ZTZiODA5YzdjYjMwOTE0ZDI1N18yLTUtMS0xLTA_15a27251-5759-4032-989b-31ae172912f5">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#9744;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its final report.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yODAzNzU0NjUxMTM3NQ_2ef490e6-b50d-4593-a485-0c5f561dce96">&#9746;</ix:nonNumeric></span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:booleanfalse" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjU0_7c10106c-5b36-4721-9a9b-6c6414ae6f90">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of June&#160;30, 2020, the aggregate market value of the Registrant's common stock outstanding held by non-affiliates based upon the closing price on the New York Stock Exchange was approximately $<ix:nonFraction unitRef="usd" contextRef="i455090d9ae6c4bde8821c7170863d88e_I20200630" decimals="-8" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yMzU2_ad3b5600-0e0a-45d2-b671-71748a460fc6">9.7</ix:nonFraction> billion.</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of January&#160;29, 2021, the number of shares of the Registrant&#8217;s common stock outstanding was approximately <ix:nonFraction unitRef="shares" contextRef="i1de112d305e94047b9078f3339c24026_I20210129" decimals="-5" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNDU0_4253c2bf-f5d3-40ad-91aa-108a490ab8e7">109.4</ix:nonFraction> million shares.</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Documents incorporated by reference</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Portions of the Registrant&#8217;s proxy statement for its 2021 annual meeting of stockholders are incorporated by reference in Part III of this Form 10-K.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.230%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.248%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_13">Business</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_55">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_55">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_58">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_58">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_61">Properties</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_61">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_64">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_64">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_67">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_67">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_73">Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_73">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_76">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_76">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_79">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_79">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_121">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_121">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_124">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_124">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_127">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_127">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_130">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_130">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_133">Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_133">79</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART III.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_139">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_139">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_142">Executive Compensation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_142">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_145">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_145">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_148">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_148">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_151">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_151">81</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART IV.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_157">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_157">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_160">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_160">82</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_313">Exhibit Index</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_313">1 of </a>5</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_316">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_316">S-1</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i878840fee65247deaca27d2dd6a8246f_13"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated in this Annual Report on Form 10-K &#8220;DaVita&#8221;, &#8220;the Company&#8221; &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; and other similar terms refer to DaVita Inc. and its consolidated subsidiaries. Our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are made available free of charge through our website, located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, as soon as reasonably practicable after the reports are filed with or furnished to the Securities and Exchange Commission (SEC). The SEC also maintains a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">http://www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> where these reports and other information about us can be obtained. The contents of our website are not incorporated by reference into this report.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_16"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of DaVita Inc.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita is a leading healthcare provider focused on transforming care delivery to improve quality of life for patients globally. We are one of the largest providers of kidney care services in the U.S. and have been a leader in clinical quality and innovation for over 20 years. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings. Over the years, we have established a value-based culture with a philosophy of caring that is focused on both our patients and teammates. This culture and philosophy fuel our continuous drive toward achieving our mission to be the provider, partner and employer of choice and fulfilling our vision to "build the greatest healthcare community the world has ever seen."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of kidney function is normally irreversible. Kidney failure is typically caused by Type I and Type II diabetes, hypertension, polycystic kidney disease, long-term autoimmune attack on the kidneys and prolonged urinary tract obstruction. End stage renal disease or end stage kidney disease (ESRD or ESKD) is the stage of advanced kidney impairment that requires continued dialysis treatments or a kidney transplant to sustain life. Dialysis is the removal of toxins, fluids and salt from the blood of patients by artificial means. Patients suffering from ESRD generally require dialysis at least three times a week for the rest of their lives.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure and ESRD in the United States, and is our largest line of business. As of December&#160;31, 2020, we provided dialysis and administrative services and related laboratory services throughout the U.S. via a network of 2,816 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 204,200 patients and provided hospital inpatient dialysis services in approximately 900 hospitals. Our robust platform to deliver kidney care services also includes established nephrology and payor relationships as well as home programs. In addition, as of December&#160;31, 2020, we provided dialysis and administrative services to a total of 321 outpatient dialysis centers located in ten countries outside of the U.S., serving approximately 36,200 patients. The Company also consists of our ancillary services and strategic initiatives, which include the aforementioned international operations (collectively, our ancillary services), as well as our corporate administrative support.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patient-centric care model leverages our platform of kidney care services to maximize patient choice in both models and modalities of care. We believe that the flexibility we offer coupled with a focus on comprehensive kidney care supports our commitments to help improve clinical outcomes and quality of life for our patients. For the eighth consecutive year, we are an industry leader in the Centers for Medicare &amp; Medicaid Services&#8217; (CMS) Quality Incentive Program (QIP), which promotes high quality services in outpatient dialysis facilities treating patients with ESRD. We are also an industry leader for the seventh consecutive year under CMS&#8217; Five-Star Quality Rating system, which rates eligible dialysis centers based on the quality of outcomes to help patients, their families, and caregivers make more informed decisions about where patients receive care. According to the most recently collected data, we are an industry leader for the total number of patients in home-based dialysis services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quality clinical outcomes are driven by our experienced and knowledgeable teammates. We employ registered nurses, licensed practical or vocational nurses, patient care technicians, social workers, registered dietitians, biomedical technicians and other administrative and support teammates who strive to achieve superior clinical outcomes at our dialysis facilities. In addition to our teammates at our dialysis facilities, as of December&#160;31, 2020, our domestic Chief Medical Officer leads a team of 18 senior nephrologists in our physician leadership team as part of our domestic Office of the Chief Medical Officer (OCMO). Our international Chief Medical Officer leads a team of 11 senior nephrologists in our physician leadership team as part of our international OCMO. Our OCMO teammates represent a variety of academic, clinical practice, and clinical research backgrounds. We also have a Physician Counsel that serves as an advisory body to senior management, which is composed of nine physicians with extensive experience in clinical practice and have seven Group Medical Directors as of December&#160;31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, we completed the sale of our DaVita Medical Group (DMG) business, a patient and physician-focused integrated healthcare delivery and management company, to Collaborative Care Holdings, LLC, a subsidiary of UnitedHealth Group Inc. As a result, the DMG business has been classified as discontinued operations and its results of operations are reported as discontinued operations for all periods presented in the consolidated financial statements included in this report. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial information about DMG, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Note 22 to the consolidated financial statements included in this report.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_2828"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 and its impact on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a caregiving organization, we are exposed to and will continue to be impacted by the effects of the novel coronavirus (COVID-19) pandemic. DaVita&#8217;s teammates include, among others, dialysis nurses, patient care technicians, social workers, dieticians and other caregivers who are on the front lines of the ongoing COVID-19 pandemic providing critical, life-sustaining care for our patients. We are closely monitoring the impact on our business of the pandemic and the resulting economic environment, including the impact on our patients, teammates, physician partners, suppliers, vendors and business partners.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this time of great challenge, our top priorities continue to be the health, safety and well-being of our patients, teammates and physician partners and helping to ensure that our patients have the ability to maintain continuity of care throughout this crisis, whether in the hospital, outpatient or home setting. To that end, we have dedicated and continue to dedicate substantial resources in response to COVID-19, including the implementation of additional protocols in coordination with the Centers for Disease Control and Prevention (CDC) on infection control and clinical best practices to help safely maintain continuity of care for our patients and help protect our caregivers. We also have been collaborating with the CDC, the U.S. Department of Health and Human Services (HHS), CMS, the American Society of Nephrology, and dialysis providers nationwide to help ensure that the dialysis community is able to support patients nationwide during this global health crisis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The protocols and initiatives we have implemented in response to COVID-19 include steps designed to implement dedicated care shifts for patients with confirmed or suspected COVID-19 and other enhanced clinical practices, including procuring additional equipment and clinical supplies, including personal protective equipment (PPE) and providing financial support to our teammates associated with relief reimbursement. These efforts are part of a wider Prepare, Prevent, Respond and Recover protocol that we have implemented in connection with the pandemic, which also includes operational protocols such as the redistribution of teammates, machines and supplies across the country as needed and increased investment in and utilization of telehealth capabilities. We also have maintained business process continuity during the pandemic by enabling most back office teammates to work remotely. Our response protocol generally has allowed us to maintain continuity of care for our patients and we carefully monitor the efficacy of these protocols and their impact on our operations and strategic priorities as the pandemic continues. If we are required to maintain certain restrictive operational initiatives for an extended period of time, it may adversely impact our strategic initiatives, such as our strategy to continue to build on our abilities to offer home dialysis options. Certain temporary changes made in response to the COVID-19 pandemic could become permanent, which could have an adverse impact on our business. In addition, any staffing shortages or disruptions, or any equipment or clinical supply shortages, disruptions or delays or associated price increases, could impact our ability to provide dialysis services or the cost of providing those services. Due in part to the protocols and initiatives described above, we have incurred significant costs related to COVID-19 in 2020, and we expect to continue to incur extended and significant additional costs in connection with our response to COVID-19. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have worked with certain government agencies to respond to the COVID-19 pandemic, and in certain cases have sought waivers of regulatory requirements. We also are working to help make COVID-19 vaccines available to our patients and teammates, including through coordination with state and federal governments on direct vaccine distribution so that we can administer vaccines to our patients and teammates. These vaccines are currently available under emergency use authorizations, and there can be no assurance that our patients and caregivers will choose to receive a COVID-19 vaccine or that the vaccines will prove to be as safe and effective as currently understood by the scientific community. In addition, we may encounter difficulties with the availability and storage of the vaccines, or administration of the vaccines, some of which have multiple dose requirements. We operate in a complex and highly regulated environment, and the novel nature of our COVID-19 response, including, for example, with respect to regulatory waivers and our administration of the newly developed COVID-19 vaccines, may increase our exposure to legal, regulatory and clinical risks.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Coronavirus Aid, Relief, and Economic Security (CARES) Act and subsequent COVID-19 relief legislation temporarily suspended Medicare&#8217;s 2% sequestration from May 1, 2020 through December 31, 2020, and the Consolidated Appropriations Act subsequently extended this sequestration suspension until March 31, 2021. While in effect, this legislation, has increased, and will continue to increase, our revenues. Furthermore, a significant initial part of the federal government response to the COVID-19 pandemic was the CARES Act's authorization of $100 billion in funding to be distributed to healthcare providers through the federal Public Health and Social Services Emergency Fund (Provider Relief Fund). While we declined approximately $250 million of government funding received in the second quarter of 2020 from the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provider Relief Fund, certain of our competitors accepted such funds. There can be no assurance that financial or other assistance will be available from the government if we have a need for such assistance in the future.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the ultimate impact of this public health crisis on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; its impact on the CKD patient population and our patient population; the availability, acceptance, impact and efficacy of COVID-19 vaccines and other treatments or therapies; the pandemic&#8217;s continuing impact on the U.S. and global economies and unemployment; the responses of our competitors to the pandemic and related changes in the marketplace; and the timing, scope and effectiveness of federal, state and local governmental responses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion of the COVID-19 pandemic and our response, including its impact on us and related risks and uncertainties, please see the discussion below under the heading "Human Capital Management", as well as the risk factor in Item 1A Risk Factors under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_19"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis business is a leading provider of kidney dialysis services for patients suffering from ESRD. As of December&#160;31, 2020, we provided dialysis and administrative services in the U.S. through a network of 2,816 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 204,200 patients. We also provide hospital inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the U.S. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the United States Renal Data System (USRDS), there were over 555,000 ESRD dialysis patients in the U.S. in 2018. Based on the most recent 2020 annual data report from the USRDS, the underlying ESRD dialysis patient population has grown at an approximate compound rate of 3.7% from 2008 to 2018 and a compound rate of 3.5% from 2013 to 2018, which suggests that the rate of growth of the ESRD patient population is declining relative to long term trends. A number of factors may impact ESRD growth rates, including, among others, the aging of the U.S. population, transplant rates, incidence rates for diseases that cause kidney failure such as diabetes and hypertension, mortality rates for dialysis patients and growth rates of minority populations with higher than average incidence rates of ESRD. Certain of these factors, in particular mortality rates for dialysis patients, have been impacted by the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 1972, the federal government has provided healthcare coverage for ESRD patients under the Medicare ESRD program regardless of age or financial circumstances. ESRD is the first and only disease state eligible for Medicare coverage both for dialysis and dialysis-related services and for all benefits available under the Medicare program. For patients with Medicare coverage, all ESRD payments for dialysis treatments are made under a single bundled payment rate. See page 7 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Medicare reimbursement limits the allowable charge per treatment, it provides industry participants with a relatively predictable and recurring revenue stream for dialysis services provided to patients without commercial insurance. For the year ended December&#160;31, 2020, approximately 90% of our total dialysis patients were covered under some form of government-based program, with approximately 74% of our dialysis patients covered under Medicare and Medicare Advantage plans.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatment options for ESRD</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treatment options for ESRD are dialysis and kidney transplantation.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis options</span></div><div style="margin-top:9pt;padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hemodialysis</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hemodialysis, the most common form of ESRD treatment, is usually performed at a freestanding outpatient dialysis center, at a hospital-based outpatient center, or at the patient&#8217;s home. The hemodialysis machine uses an artificial kidney, called a dialyzer, to remove toxins, fluids and salt from the patient&#8217;s blood. The dialysis process occurs across a semi-permeable membrane that divides the dialyzer into two distinct chambers. While blood is circulated through one chamber, a pre-mixed fluid is circulated through the other chamber. The toxins, salt and excess fluids from the blood cross the membrane into the fluid, allowing cleansed blood to return back into the patient&#8217;s body. Each hemodialysis treatment that occurs in the outpatient dialysis centers typically lasts approximately three and one-half hours and is usually performed three times per week.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospital inpatient hemodialysis services are required for patients with acute kidney failure primarily resulting from trauma, patients in early stages of ESRD and ESRD patients who require hospitalization for other reasons. Hospital inpatient hemodialysis is generally performed at the patient&#8217;s bedside or in a dedicated treatment room in the hospital, as needed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some ESRD patients who are healthier and more independent may perform home hemodialysis in their home or residence through the use of a hemodialysis machine designed specifically for home therapy that is portable, smaller and easier to use. Patients receive training, support and monitoring from registered nurses, usually in our outpatient dialysis centers, in connection with their home hemodialysis treatment. Home hemodialysis is typically performed with greater frequency than dialysis treatments performed in outpatient dialysis centers and on varying schedules.</span></div><div style="margin-top:9pt;padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Peritoneal dialysis</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peritoneal dialysis uses the patient&#8217;s peritoneal or abdominal cavity to eliminate fluid and toxins and is typically performed at home. The most common methods of peritoneal dialysis are continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD). Because it does not involve going to an outpatient dialysis center three times a week for treatment, peritoneal dialysis is generally an alternative to hemodialysis for patients who are healthier, more independent and desire more flexibility in their lifestyle. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAPD introduces dialysis solution into the patient&#8217;s peritoneal cavity through a surgically placed catheter. Toxins in the blood continuously cross the peritoneal membrane into the dialysis solution. After several hours, the patient drains the used dialysis solution and replaces it with fresh solution. This procedure is usually repeated four times per day.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CCPD is performed in a manner similar to CAPD, but uses a mechanical device to cycle dialysis solution through the patient&#8217;s peritoneal cavity while the patient is sleeping or at rest.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kidney transplantation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although kidney transplantation, when successful, is generally the most desirable form of therapeutic intervention, the shortage of suitable donors, side effects of immunosuppressive pharmaceuticals given to transplant recipients and dangers associated with transplant surgery for some patient populations have generally limited the use of this treatment option. An executive order signed in July 2019 (the 2019 Executive Order) directed the HHS to develop policies addressing, among other things, the goal of making more kidneys available for transplant. As directed by the 2019 Executive Order, the CMS, through its Center for Medicare and Medicaid Innovation (CMMI), subsequently released the framework for certain proposed voluntary payment models that would adjust payment incentives to encourage kidney transplants. For more information regarding the 2019 Executive Order and these payment models, please see the discussion below under the heading &#8220;-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New models of care and Medicare and Medicaid program reforms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i878840fee65247deaca27d2dd6a8246f_22"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. dialysis services we provide</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outpatient hemodialysis services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we operated or provided administrative services through a network of 2,816 outpatient dialysis centers in the U.S. that are designed specifically for outpatient hemodialysis. In 2020, our overall network of U.S. outpatient dialysis centers increased by 63 primarily as a result of the opening of new dialysis centers and acquisitions, net of center closures, representing a total increase of approximately 2.3% from 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of our enrollment in Medicare for the provision of dialysis services, we contract with a nephrologist or a group of associated nephrologists to provide medical director services at each of our dialysis centers. In addition, other nephrologists may apply for practice privileges to treat their patients at our centers. Each center has an administrator, typically a registered nurse, who supervises the day-to-day operations of the center and its staff. The staff of each center typically consists of registered nurses, licensed practical or vocational nurses, patient care technicians, a social worker, a registered dietician, biomedical technician support and other administrative and support personnel.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare regulations, we cannot promote, develop or maintain any kind of contractual relationship with our patients that would directly or indirectly obligate a patient to use or continue to use our dialysis services, or that would give us any preferential rights other than those related to collecting payments for our dialysis services. Our total patient turnover, which is based upon all causes, averaged approximately 25% in 2020 and 24% in 2019. The overall number of patients to whom we provided services in the U.S. in 2020 decreased by approximately 1.3% from 2019, primarily due to an increase in mortality rates, which have been impacted by the COVID-19 pandemic, and a decline in new admissions. This was partially offset by new dialysis patients who started treating at our centers during the year from acquisitions and non-acquired growth.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hospital inpatient hemodialysis services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we provided hospital inpatient hemodialysis services, excluding physician services, to patients in approximately 900 hospitals throughout the U.S. We render these services based on a contracted per-treatment fee that is individually negotiated with each hospital. When a hospital requests our services, we typically administer the dialysis treatment at the patient&#8217;s bedside or in a dedicated treatment room in the hospital, as needed. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Home-based dialysis services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Home-based dialysis services includes home hemodialysis and peritoneal dialysis. Many of our outpatient dialysis centers offer certain support services for dialysis patients who prefer and are able to perform either home hemodialysis or peritoneal dialysis in their homes. Home-based hemodialysis support services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance. Registered nurses train patients and their families or other caregivers to perform either home hemodialysis or peritoneal dialysis. The 2019 Executive Order and related HHS guidance described above also included a stated goal of increasing the relative number of new ESRD patients that receive dialysis at home as compared to those receiving dialysis in center or at a hospital.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the most recent 2020 annual data report from the USRDS, in 2018 approximately 12% of ESRD dialysis patients in the U.S. perform home-based dialysis.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatments and revenues by modality:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph summarizes our U.S. dialysis treatments by modality and U.S. dialysis patient services revenues by modality for the year ended December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><img src="dva-20201231_g2.jpg" alt="dva-20201231_g2.jpg" style="height:172px;margin-bottom:5pt;vertical-align:text-bottom;width:625px"/></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ESRD laboratory services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate one separately licensed and highly automated clinical laboratory which specializes in ESRD patient testing. This specialized laboratory provides routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients which are integral components of the overall dialysis services that we provide. Our laboratory provides these tests predominantly for our network of ESRD patients throughout the U.S. These tests are performed to monitor a patient&#8217;s ESRD condition, including the adequacy of dialysis, as well as other medical conditions of the patient. Our laboratory utilizes information systems which provide information to certain members of the dialysis centers&#8217; staff and medical directors regarding critical outcome indicators. </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate or provide management and administrative services pursuant to management and administrative services agreements to 53 outpatient dialysis centers located in the U.S. in which we either own a noncontrolling interest or which are wholly-owned by third parties. Management fees are established by contract and are recognized as earned typically based on a percentage of revenues or cash collections generated by the outpatient dialysis centers.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_25"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of revenue&#8212;concentrations and risks</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis revenues represent approximately 91% of our consolidated revenues for the year ended December&#160;31, 2020. Our U.S. dialysis revenues are derived primarily from our core business of providing dialysis services and related laboratory services and, to a lesser extent, the administration of pharmaceuticals and management fees generated from providing management and administrative services to certain outpatient dialysis centers, as discussed above.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of our U.S. dialysis revenues are principally from government-based programs, including Medicare and Medicare Advantage plans, Medicaid and managed Medicaid plans and commercial insurance plans. Our largest source of revenue is from Medicare and Medicare Advantage plans which accounted for 57% of our overall U.S. dialysis patient services revenues for the year ended December&#160;31, 2020. Other sources of our U.S. dialysis patient services revenues for the year ended December&#160;31, 2020, were from commercial payors (including hospital inpatient dialysis services) accounting for 32% of revenues, Medicaid and managed Medicaid plans accounting for 7% of our revenues and other government programs accounting for 4% of our revenues. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare revenue</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare ESRD revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government dialysis related payment rates in the U.S. are principally determined by federal Medicare and state Medicaid policy. For patients with Medicare coverage, all ESRD payments for dialysis treatments are made under a single bundled payment rate which provides a fixed payment rate to encompass all goods and services provided during the dialysis treatment that are related to the dialysis treatment, including certain pharmaceuticals, such as Epogen&#174; (EPO), vitamin D analogs and iron supplements, irrespective of the level of pharmaceuticals administered to the patient or additional services performed. Prior to January 2021, calcimimetics, a drug class taken by many patients with ESRD to treat mineral bone disorder, was separately billable through a transitional drug add-on payment adjustment (TDAPA); however, since January 1, 2021 and as described more fully below, calcimimetics has been included in the ESRD bundled payment. Most lab services are also included in the bundled payment.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this ESRD Prospective Payment System (PPS), the bundled payments to a dialysis facility may be reduced by as much as 2% based on the facility&#8217;s performance in specified quality measures set annually by CMS through its QIP. CMS established QIP through the Medicare Improvements for Patients and Providers Act of 2008 to promote high quality services in outpatient dialysis facilities treating patients with ESRD. QIP associates a portion of Medicare reimbursement directly with a facility&#8217;s performance on quality of care measures. Reductions in Medicare reimbursement result when a facility&#8217;s overall score on applicable measures does not meet established standards. The bundled payment rate is also adjusted for certain patient characteristics, a geographic usage index and certain other factors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertainty about future payment rates remains a material risk to our business, as well as the potential implementation of or changes in coverage determinations or other rules or regulations by CMS or Medicare Administrative Contractors that may impact reimbursement. An important provision in the Medicare ESRD statute is an annual adjustment, or market basket update, to the ESRD PPS base rate. Absent action by Congress, the ESRD PPS base rate is automatically updated annually by a formulaic inflation adjustment. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, pursuant to the 2019 Executive Order, CMS, through CMMI, published the final ESRD Treatment Choices mandatory payment model (ETC). The ETC launched on January 1, 2021, and will be administered through CMMI and in approximately 30% of dialysis clinics across the country.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2020, CMS issued a final rule to update the ESRD PPS payment rate and policies. Among other things, the rule provided for the inclusion of calcimimetics in the ESRD bundled payment as described above; specified TDAPAs for certain new renal dialysis drugs and biological products; and amended the reporting measures in the ESRD QIP. CMS estimates that the overall impact of the final rule will increase ESRD facilities&#8217; average reimbursement by 1.6% in 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Budget Control Act of 2011 (BCA) and subsequent activity in Congress, a $1.2 trillion sequester (across-the-board spending cuts) in discretionary programs took effect in 2013 reducing Medicare payments by 2%, which was subsequently extended through fiscal year 2027. The CARES Act that was signed into law on March 27, 2020 included a provision that suspended the 2% Medicare sequestration from May 1, 2020 through December 31, 2020, and the Consolidated Appropriations Act, 2021 signed into law on December 27, 2020 extended the suspension of the 2% Medicare sequestration until March 31, 2021. In the year ended December 31, 2020, our revenues increased due to this suspension and we estimate that this suspension will increase our revenues while it remains in effect. When the temporary suspension is no longer in effect the across-the-board spending cuts of the BCA will continue to adversely affect our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESRD patients receiving dialysis services become eligible for primary Medicare coverage at various times, depending on their age or disability status, as well as whether they are covered by a commercial insurance plan. Generally, for a patient not covered by a commercial insurance plan, Medicare becomes the primary payor for ESRD patients receiving dialysis services either immediately or after a three-month waiting period. For a patient covered by a commercial insurance plan, Medicare generally becomes the primary payor after 33 months, which includes the three-month waiting period, or earlier if the patient&#8217;s commercial insurance plan coverage terminates. When Medicare becomes the primary payor, the payment rates we receive for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that patient shift from the commercial insurance plan rates to Medicare payment rates, which are on average significantly lower than commercial insurance rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare pays 80% of the amount set by the Medicare system for each covered dialysis treatment. The patient is responsible for the remaining 20%. In most cases, a secondary payor, such as Medicare supplemental insurance, a state Medicaid program or a commercial health plan, covers all or part of these balances. Some patients who do not qualify for Medicaid, but otherwise cannot afford secondary insurance in the form of a Medicare Supplement Plan, can apply for premium payment assistance from charitable organizations to obtain secondary coverage. If a patient does not have secondary insurance coverage, we are generally unsuccessful in our efforts to collect from the patient the remaining 20% portion of the ESRD composite rate that Medicare does not pay. However, we are able to recover some portion of this unpaid patient balance from Medicare through an established cost reporting process by identifying these Medicare bad debts on each center&#8217;s Medicare cost report.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, federal legislative and executive action has been focused on developing new models of kidney care for Medicare beneficiaries. For additional detail on these and other developments in models of care, see the discussion below under the heading &#8220;&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New models of care and Medicare and Medicaid program reforms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Advantage revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage (MA, managed Medicare or Medicare Part C) plans are offered by private health insurers who contract with CMS to provide their members with Medicare Part A, Part B and/or Part D benefits. These MA plans include health maintenance organizations, preferred provider organizations, private fee-for-service organizations, special needs plans (SNPs) or Medicare medical savings account plans. The 21st Century Cures Act (the Cures Act) included a provision that, effective January 1, 2021, allows Medicare-eligible beneficiaries with ESRD to choose coverage under an MA plan. Prior to the Cures Act, MA plans were only available to ESRD patients if the patient was remaining on an MA plan that they had enrolled in prior to being diagnosed with ESRD, or in certain other limited situations such as a SNP. As a result, this provision under the Cures Act could broaden access for Medicare ESRD patients to certain enhanced benefits offered by MA plans. MA plans usually provide reimbursement to us at a negotiated rate that is generally higher than Medicare FFS rates.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicaid revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid programs are state-administered programs partially funded by the federal government. These programs are intended to provide health coverage for patients whose income and assets fall below state-defined levels and who are otherwise uninsured. These programs also serve as supplemental insurance programs for co-insurance payments due from Medicaid-eligible patients with primary coverage under the Medicare program. Some Medicaid programs also pay for additional services, including some oral medications that are not covered by Medicare. We are enrolled in the Medicaid programs in the states in which we conduct our business.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before a patient becomes eligible to elect to have Medicare as their primary payor for dialysis services, a patient&#8217;s commercial insurance plan, if any, is generally responsible for payment of such dialysis services for up to the first 33 months, as discussed above. Although commercial payment rates vary, average commercial payment rates established under commercial contracts are generally significantly higher than Medicare rates. The payments we receive from commercial payors generate nearly all of our profits and all of our non-hospital dialysis profits come from commercial payors. Payment methods from commercial payors can include a single lump-sum per treatment, referred to as bundled rates, or in other cases separate payments for dialysis treatments and pharmaceuticals, if used as part of the treatment, referred to as FFS rates. Commercial payment rates are the result of negotiations between us and insurers or third-party administrators. Our out-of-network payment rates are on average higher than in-network commercial contract payment rates. Some of our commercial contracts pay us under a single bundled payment rate for all dialysis services provided to covered patients. However, some of our commercial contracts also pay us for certain other services and pharmaceuticals in addition to the bundled payment. Our commercial contracts typically contain annual price escalator provisions. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 25% of our U.S. dialysis patient services revenues and approximately 10% of our U.S. dialysis patients are associated with non-hospital commercial payors for the year ended December&#160;31, 2020. Non-hospital commercial patients as a percentage of our total U.S. dialysis patients for 2020 were relatively flat compared to 2019. Less than 1% of our U.S. dialysis revenues are due directly from patients. There is no single commercial payor that accounted for more than 10% of total U.S. dialysis revenues for the year ended December&#160;31, 2020. See Note 2 to the consolidated financial statements included in this report for disclosure on our concentration related to our commercial payors on a total consolidated revenue basis.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the number of our patients under commercial plans and the rates under these commercial plans are subject to change based on a number of factors. These factors include, among others, a highly competitive rate environment that shapes our ongoing negotiations with commercial payors; changes in commercial plan design; and the health of the U.S. economy including the continuing impact of COVID-19 and efforts to contain the virus. In addition, changes in state and federal legislation, regulations, rules, laws, guidance or other requirements may impact the availability and scope of commercial insurance, including, among others, developments that impact the healthcare exchanges introduced by the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (Affordable Care Act (ACA)) and commercial payor participation in that marketplace as well as developments that impact the availability of charitable premium assistance. For additional detail on the potential impact of these factors on our commercial revenue, see the risk factors in Item 1A Risk Factors under the headings "</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex series of governmental laws, regulations and requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation"; "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows"; "</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We continuously have ongoing negotiations with commercial payors, and if the average rates that commercial payors pay us decline significantly, if patients in commercial plans are subject to restriction in plan designs or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it would have a material adverse effect on our business, results of operations, financial condition and cash flows"; "If the number or percentage of patients with higher-paying commercial insurance declines, it could have a material adverse effect on our business, results of operations, financial condition and cash flows"; and "We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us."</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from other pharmaceuticals</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2018, both oral and intravenous forms of calcimimetics became the financial responsibility of our U.S. dialysis business for our Medicare patients and are reimbursed under Medicare Part B. Since the effective date through December 31, 2020, the oral and intravenous forms of calcimimetics were separately reimbursed through a TDAPA and not as part of the ESRD PPS bundled payment. These separate reimbursement payments for calcimimetics were subject to change on an annual basis. During the initial pass-through TDAPA period, Medicare payments were based on a pass-through rate of the average sales price plus approximately 6% before sequestration (or 4% adjusted for sequestration), and in 2020 they were based on a pass-through rate of the average sales price plus 0%, before sequestration. As expected, as of January 1, 2021, calcimimetics was entered into the ESRD PPS bundled payment.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_28"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician relationships</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint venture partners</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and operate certain of our dialysis centers through entities that are structured as joint ventures. We generally hold controlling interests in these joint ventures, with certain nephrologists, hospitals, management services organizations, and/or other healthcare providers holding minority equity interests. These joint ventures are typically formed as limited liability companies. For the year ended December&#160;31, 2020, revenues from joint ventures in which we have a controlling interest represented approximately 27% of our net U.S. dialysis revenues. We expect to continue to enter into new U.S. dialysis-related joint ventures in the ordinary course of business.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Community physicians</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An ESRD patient generally seeks treatment at an outpatient dialysis center near their home where their treating nephrologist has practice privileges. Our relationships with local nephrologists and our ability to provide quality dialysis services and to meet the needs of their patients are key factors in the success of our dialysis operations. Over 5,400 nephrologists currently refer patients to our outpatient dialysis centers.&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical directors</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participation in the Medicare ESRD program requires that dialysis services at an outpatient dialysis center be under the general supervision of a medical director.&#160;Per these requirements, this individual is usually a board certified nephrologist. We have engaged physicians or groups of physicians to serve as medical directors for each of our outpatient dialysis centers. At some outpatient dialysis centers, we also separately contract with one or more other physicians or groups to serve as assistant or associate medical directors over other modalities such as home dialysis. We have over 1,000 individual physicians and physician groups under contract to provide medical director services.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical directors for our dialysis centers enter into written contracts with us that specify their duties and fix their compensation generally for periods of ten years. The compensation of our medical directors is the result of arm&#8217;s length negotiations, consistent with fair market value, and generally depends upon an analysis of various factors such as the physician&#8217;s duties, responsibilities, professional qualifications and experience, as well as the time and effort required to provide such services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical director contracts and joint venture operating agreements generally include covenants not to compete or own interests in other competing outpatient dialysis centers within a defined geographic area for various time periods, as applicable. These non-compete agreements do not restrict or limit the physicians from practicing medicine or prohibit the physicians from referring patients to any outpatient dialysis center, including competing centers. </span></div><div id="i878840fee65247deaca27d2dd6a8246f_31"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Location of our U.S. dialysis centers</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we operated or provided administrative services to a total of 2,816 U.S. outpatient dialysis centers. A total of 2,763 of such centers are consolidated in our financial statements. Of the remaining 53 non-consolidated U.S. outpatient dialysis centers, we own a noncontrolling interest in 50 centers and provide management and administrative services to three centers that are wholly-owned by third parties. The locations of the 2,763 U.S. outpatient dialysis centers consolidated in our financial statements at December&#160;31, 2020, were as follows:</span></div><div style="margin-top:9pt"><img src="dva-20201231_g3.gif" alt="dva-20201231_g3.gif" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ancillary services and strategic initiatives, including our international operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our ancillary services and strategic initiatives relate primarily to our core business of providing kidney care services and, as of December&#160;31, 2020, consisted primarily of integrated kidney care, physician services, ESCO joint ventures (ESCO JVs), and clinical research programs, as well as our international operations.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ancillary Services and Strategic Initiatives</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made and continue to make investments in building our integrated care capabilities, including the operation of certain strategic business initiatives that are intended to integrate care amongst healthcare participants across the renal care continuum from chronic kidney disease (CKD) to ESRD to kidney transplant. Through improved technology and data sharing, as well as an increasing focus on value-based contracting and care, these initiatives seek to bring together physicians, nurses, dieticians, pharmacists, hospitals, dialysis clinics, transplant centers and payors with a view towards improving clinical outcomes for our patients and reducing the overall cost of comprehensive kidney care.</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:12.53pt">Integrated Kidney Care services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;VillageHealth DM, LLC, also doing business as DaVita Integrated Kidney Care (DaVita IKC), provides advanced integrated care management services to health plans and government programs for members/beneficiaries diagnosed with ESRD, chronic kidney disease, and/or poly-comorbid conditions. Through a combination of clinical coordination, innovative interventions, predictive analytics, medical claims analysis and information technology, we endeavor to assist our customers and patients in obtaining superior renal healthcare and improved clinical outcomes, as well as helping to reduce overall medical costs. Integrated kidney care management revenues from commercial and Medicare Advantage insurers can be based upon either an established contract fee recognized as earned over the contract period, or related to the operation of value-based programs, including pay for performance, shared savings, and capitation contracts. DaVita IKC also contracts with payors to operate Medicare Advantage ESRD Special Needs Plans to provide ESRD patients full service healthcare. We are at risk for all medical costs of the program in excess of the capitation payments. DaVita IKC supports our ESCO joint ventures, and more recently has been provisionally accepted to participate in one of the voluntary payment models administered by CMMI.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Physician services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Nephrology Practice Solutions (NPS) is an independent business that partners with physicians committed to providing outstanding clinical and integrated care to patients. NPS provides nephrologist recruitment and staffing services in select markets which are billed on a per search basis. NPS also offers physician practice management services to nephrologists under administrative services agreements. These services include physician practice management, billing and collections, credentialing, coding, and other support services that enable physician practices to increase efficiency and manage their administrative needs. Additionally, NPS owns and operates nephrology practices in multiple states. Fees generated from these services are recognized as earned typically based upon flat fees or cash collections generated by the physician practice.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ESCO JVs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our dialysis clinics have entered into partnerships with various nephrology practices, health systems, and other providers to establish three ESCO JVs in Phoenix-Tucson Arizona, South Florida, and Philadelphia Pennsylvania-Camden, New Jersey. The ESCO JVs were formed under the CMS Innovation Center&#8217;s CEC Model, a demonstration to assess the impact of care coordination for ESRD patients in a dialysis-center oriented ACO setting. Each ESCO JV has a shared risk arrangement with CMS and the programs are evaluated on a performance year basis.&#160;The delivery of improved quality outcomes for patients and program savings depend on the contributions of the dialysis center teammates, nephrologists, health system and hospital partners, pharmacy providers, other primary care and specialty care providers and facilities, and integrated care management support from DaVita IKC, which is also the manager of the ESCO JVs. The CEC Model ended the South Florida ESCO JV program on December 31, 2020, while the Phoenix-Tucson Arizona and Philadelphia Pennsylvania-Camden, New Jersey programs are scheduled to end on March 31, 2021.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Clinical research programs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;DaVita Clinical Research (DCR) is a provider-based specialty clinical research organization with a full spectrum of services for clinical drug research and device development. DCR uses its extensive, applied database and real-world healthcare experience to assist in the design, recruitment and completion of retrospective and prospective pragmatic and clinical trials. Revenues are based upon an established fee per study, as determined by contract with drug companies and other sponsors and are recognized as earned according to the contract terms.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion of our ancillary services and strategic initiatives, see Item 7, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">". </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International dialysis operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we operated or provided administrative services to a total of 321 outpatient dialysis centers, which includes consolidated and nonconsolidated centers located in ten countries outside of the U.S., serving approximately 36,200 patients. Our international dialysis operations have continued to grow steadily and expand as a result of acquiring and developing outpatient dialysis centers in various strategic markets. Our international operations are included as part of our ancillary services and strategic initiatives. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The locations of our international outpatient dialysis centers are as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.409%"><tr><td style="width:1.0%"></td><td style="width:67.237%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saudi Arabia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes centers that are operated or managed by our Asia Pacific joint venture (APAC JV).</span></div><div id="i878840fee65247deaca27d2dd6a8246f_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate administrative support</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support consists primarily of labor, benefits and long-term incentive compensation costs for departments which provide support to all of our different operating lines of business. These expenses are included in our consolidated general and administrative expenses.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_40"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government regulation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex regulatory environment with an extensive and evolving set of federal, state and local governmental laws, regulations and other requirements. These laws, regulations and other requirements are promulgated and overseen by a number of different legislative, regulatory, administrative and quasi-regulatory bodies, each of which may have varying interpretations, judgments or related guidance. As such, we utilize considerable resources on an ongoing basis to monitor, assess and respond to applicable legislative, regulatory and administrative requirements, but there is no guarantee that we will be successful in our efforts to adhere to all of these requirements. Additional discussion on certain of these laws, regulations and other requirements is set forth below in this section.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing are each themselves comprised of numerous associated regulations or other requirements that have varying levels of impact on our business. If any of our personnel, representatives or operations are found to violate these laws, regulations or other requirements, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation and stock price, including, among others:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of required certifications, suspension or exclusion from or termination of our participation in government programs (including Medicare, Medicaid and CMMI demonstration programs);</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Refunds of amounts received in violation of law or applicable payment program requirements dating back to the applicable statute of limitation periods;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of licenses required to operate healthcare facilities or administer pharmaceuticals in the states in which we operate;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reductions in payment rates or coverage for dialysis and ancillary services and pharmaceuticals;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Criminal or civil liability, fines, damages or monetary penalties, which could be material and/or could materially harm our reputation or stock price;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposition of corporate integrity agreements or consent agreements;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enforcement actions, investigations, or audits by governmental agencies and/or state law claims for monetary damages by patients who believe their protected health information (PHI) has been used, disclosed or not properly safeguarded in violation of federal or state patient privacy laws, including, among others, the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Privacy Act of 1974;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandated changes to our practices or procedures that significantly increase operating expenses that could subject us to ongoing audits and reporting requirements as well as increased scrutiny of our billing and business practices, which could lead to potential fines, among other things;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Termination of various relationships and/or contracts related to our business, such as joint venture arrangements, medical director agreements, real estate leases and consulting agreements with physicians; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Harm to our reputation which could negatively impact our business relationships and stock price, affect our ability to attract and retain patients, physicians and teammates, affect our ability to obtain financing and decrease access to new business opportunities, among other things.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our industry will continue to be subject to extensive and complex regulation, the scope and effect of which are difficult to predict. We are currently subject to various legal proceedings, such as lawsuits, investigations, audits and inquiries by various government and regulatory agencies, as further described in Note 16 to the consolidated financial statements, and our operations and activities could be reviewed or challenged by regulatory authorities at any time in the future. For additional detail on risks related to each of the foregoing, see the discussion in Item 1A. Risk Factors under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm stock price, and in some circumstances, could materially harm our reputation"; and "We are, and may in the future be, a party to various lawsuits, demands, claims, qui tam suits, governmental investigations and audits and other legal matters, any of which could result in, among other things, substantial financial penalties or awards against us, mandated refunds, substantial payments made by us, required changes to our business practices, exclusion from future participation in Medicare, Medicaid and other healthcare programs and possible criminal penalties, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price."</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensure and Certification</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our dialysis centers are certified by CMS, as required for the receipt of Medicare payments. Certain of our payor contracts also condition payment on Medicare certification. In some states, our outpatient dialysis centers also are required to secure additional state licenses and permits. Governmental authorities, primarily state departments of health, periodically inspect our centers to determine if we satisfy applicable federal and state standards and requirements, including the conditions for coverage in the Medicare ESRD program.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced some delays in obtaining Medicare certifications from CMS, though recent changes by CMS in the prioritizing of dialysis providers as well as legislation allowing private entities to perform initial dialysis facility surveys for certification has helped to decrease or limit certain delays.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2019, CMS finalized updates to the Provider Enrollment Rule creating onerous disclosure obligations for all providers enrolled in Medicare, Medicaid and the Children&#8217;s Health Insurance Plan (CHIP). The final rule implements greater revocation authority and increases the bar for re-enrollment for providers who are terminated from the Medicare program. It also institutes penalties for providers who submit incomplete or inaccurate information or who have affiliations with other providers that CMS has determined pose undue risk of fraud, waste or abuse. If we fail to comply with these and other applicable requirements on our licensure and certification programs, particularly in light of increased penalties that include a 10-year bar to re-enrollment, under certain circumstances it could have a material adverse impact on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Anti-Kickback Statute</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, in cash or kind, to induce or reward either the referral of an individual for, or the purchase, or order or recommendation of, any good or service, for which payment may be made under federal and state healthcare programs such as Medicare and Medicaid.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal criminal penalties for the violation of the federal Anti-Kickback Statute include imprisonment, fines and exclusion of the provider from future participation in the federal healthcare programs, including Medicare and Medicaid. Violations of the federal Anti-Kickback Statute are punishable by imprisonment for up to ten years and fines of up to $100,000 or both. Larger fines can be imposed upon corporations under the provisions of the U.S. Sentencing Guidelines and the Alternate Fines Statute. Individuals and entities convicted of violating the federal Anti-Kickback Statute are subject to mandatory exclusion from participation in Medicare, Medicaid and other federal healthcare programs for a minimum of five years. Civil penalties for violation of this law include up to $100,000 in monetary penalties per violation, repayments of up to three times the total payments between the parties to the arrangement and suspension from future participation in Medicare and Medicaid. Court decisions have held that the statute may be violated even if only one purpose of remuneration is to induce referrals. The ACA amended the federal Anti-Kickback Statute to clarify the intent that is required to prove a violation. Under the statute as amended, the defendant may not need to have actual knowledge of the federal Anti-Kickback Statute or have the specific intent to violate it. In addition, the ACA amended the federal Anti-Kickback Statute to provide that any claims for items or services resulting from a violation of the federal Anti-Kickback Statute are considered false or fraudulent for purposes of the False Claims Act (FCA).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute includes statutory exceptions and regulatory safe harbors that protect certain arrangements. Business transactions and arrangements that are structured to comply fully with an applicable safe harbor do not violate the federal Anti-Kickback Statute. Transactions and arrangements that do not satisfy all elements of a relevant safe harbor do not necessarily violate the law. When an arrangement does not satisfy a safe harbor, the arrangement must be evaluated on a case-by-case basis in light of the parties&#8217; intent and the arrangement&#8217;s potential for abuse. Arrangements that do not satisfy a safe harbor may be subject to greater scrutiny by enforcement agencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2020, HHS' Office of Inspector General (OIG) and CMS released a final rule implementing modifications to the Federal Anti-Kickback Statute and Civil Monetary Penalties Statute that are intended to promote value-based and coordinated care arrangements as well as reduce other regulatory burdens. The changes implemented by the final rules went into effect on January 19, 2021. We continue to assess the anticipated impact of these modifications on our business, results of operations and financial condition.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita and its subsidiaries enter into several arrangements with physicians and other potential referral sources, that potentially implicate the Anti-Kickback Statute, such as:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical director agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Because our medical directors may refer patients to our dialysis centers, our arrangements with these physicians are designed to substantially comply with the safe harbor for personal service arrangements. Although we endeavor to structure the Medical Director Agreements we enter into with physicians to substantially comply with the safe harbor for personal service arrangements, including the requirement that compensation be consistent with fair market value, the safe harbor requires that when services are provided on a part-time basis, the agreement must specify the schedule of intervals of services, and their precise length and the exact charge for such services. Because of the nature of our medical directors&#8217; duties, it is impossible to fully satisfy this technical element of the safe harbor. As a result, these arrangements could be subject to scrutiny since they do not expressly describe the schedule of part-time services to be provided under the arrangement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As noted above, we own a controlling interest in numerous U.S. dialysis related joint ventures. Our internal policies, procedures, and template agreements were developed and are utilized for compliance with the Anti-Kickback Statute. However, we recognize that at times these joint ventures do not fully satisfy all of the requirements of the safe harbor for investments in small entities. Although failure to comply with a safe harbor does not render an arrangement illegal under the federal Anti-Kickback Statute, an arrangement that does not operate within a safe harbor may be subject to scrutiny by both federal and state government enforcement agencies including the OIG and the Department of Justice (DOJ). Joint ventures that fall outside the safe harbors are evaluated on a case-by-case basis under the federal Anti-Kickback Statute.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We lease space from entities in which physicians, hospitals or medical groups hold ownership interests, and we sublease space to referring physicians. We endeavor to structure these arrangements to comply with the federal Anti-Kickback Statute safe harbor for space rentals in all material respects.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consulting agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, we enter into consulting agreements with physicians. Engaged physicians provide services including providing input on processes, services and protocols as well as providing education on assorted topics. We endeavor to structure these arrangements to comply with the federal Anti-Kickback Statute safe harbor for personal services in all material respects.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment and coverage agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our subsidiary Nephrology Practice Solutions and its affiliated entities employs and contracts with physicians and Advanced Practice Providers to provide administrative and clinical services. We endeavor to structure these arrangements to comply with the federal Anti-Kickback Statute safe harbor for employment and personal services in all material respects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Some referring physicians may own our common stock. We believe that these interests materially satisfy the requirements of the Anti-Kickback Statute safe harbor for investments in large publicly traded companies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our dialysis centers and subsidiaries sometimes acquire certain items and services at a discount that may be reimbursed by a federal healthcare program. We endeavor to structure our vendor contracts that include discount or rebate provisions to comply with the federal Anti-Kickback Statute safe harbor for discounts.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our business transactions or arrangements, including those described above, were found to violate the federal Anti-Kickback Statute, we, among other things, could face criminal, civil or administrative sanctions, including possible exclusion from participation in Medicare, Medicaid and other state and federal healthcare programs. Any findings that we have violated these laws could have a material adverse impact on our business, results of operations, financial condition, cash flows, reputation and stock price.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stark Law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stark Law prohibits a physician who has a financial relationship, or who has an immediate family member who has a financial relationship, with entities providing Designated Health Services (DHS), from referring Medicare and Medicaid patients to such entities for the furnishing of DHS, unless an exception applies. DHS is defined to mean any of the following enumerated items or services; clinical laboratory services; physical therapy services; occupational therapy services; radiology services, including magnetic resonance imaging, computerized axial tomography scans, and ultrasound services; radiation therapy services and supplies; durable medical equipment and supplies; parenteral and enteral nutrients, equipment, and supplies; prosthetics, orthotics and prosthetic devices and supplies; home health services; outpatient prescription drugs; inpatient and outpatient hospital services; and outpatient speech-language pathology services. The types of financial arrangements between a physician and a DHS entity that trigger the self-referral prohibitions of the Stark Law are broad and include direct and indirect ownership and investment interests and compensation arrangements. The Stark Law also prohibits the DHS entity receiving a prohibited referral from presenting, or causing to be presented, a claim or billing for the services arising out of the prohibited referral. The prohibition applies regardless of the reasons for the financial relationship and the referral; unlike the federal Anti-Kickback Statute, intent to induce referrals is not required. If the Stark Law is implicated, the financial relationship must fully satisfy a Stark Law exception. If an exception is not satisfied, then the parties to the arrangement could be subject to sanctions. Sanctions for violation of the Stark Law include denial of payment for claims for services provided in violation of the prohibition, refunds of amounts collected in violation of the prohibition, a civil penalty of up to $15,000 for each service arising out of the prohibited referral, a civil penalty of up to $100,000 against parties that enter into a scheme to circumvent the Stark Law prohibition, civil assessment of up to three times the amount claimed, and potential exclusion from the federal healthcare programs, including Medicare and Medicaid. Amounts collected for prohibited claims must be reported and refunded generally within 60 days after the date on which the overpayment was identified. Furthermore, Stark Law violations and failure to return overpayments timely can form the basis for FCA liability as discussed below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definition of DHS under the Stark Law excludes services paid under a composite rate, even if some of the components bundled in the composite rate are DHS. Although the ESRD bundled payment system is no longer titled a composite rate, we believe that the former composite rate payment system and the current bundled system are both composite systems excluded from the Stark Law. Since most services furnished to Medicare beneficiaries provided in our dialysis centers are reimbursed through a bundled rate, the services performed in our facilities generally are not DHS, and the Stark Law referral prohibition does not apply to those services. Certain separately billable drugs (drugs furnished to an ESRD patient that are not for the treatment of ESRD that CMS allows our centers to bill for using the so-called AY modifier) may be considered DHS. However, we have implemented certain billing controls designed to limit DHS being billed out of our dialysis clinics. Likewise, the definition of inpatient hospital services, for purposes of the Stark Law, also excludes inpatient dialysis performed in hospitals that are not certified to provide ESRD services. Consequently, our arrangements with such hospitals for the provision of dialysis services to hospital inpatients do not trigger the Stark Law referral prohibition.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although prescription drugs are DHS, there is an exception in the Stark Law for calcimimetics, EPO and other specifically enumerated dialysis drugs when furnished in or by an ESRD facility such that the arrangement for the furnishing of the drugs does not violate the Stark Law. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into several types of financial relationships with referring physicians, including compensation arrangements. If our dialysis centers were to bill for a non-exempted drug and the financial relationships with the referring physician did not satisfy an exception, we could be required to change our practices, face civil penalties, pay substantial fines, return certain payments received from Medicare and beneficiaries or otherwise experience a material adverse effect as a result of a challenge to payments made pursuant to referrals from these physicians under the Stark Law. Additionally, certain of our subsidiaries, were they to bill DHS, would implicate the Stark Law. As such we endeavor to structure arrangements with relevant physicians to fit within the existing exceptions to the Stark Law. If we were to fail to satisfy an applicable exception, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we could similarly be required to change practices, face penalties and fines, return certain payments or otherwise face adverse consequences.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2020, CMS released a final rule implementing modifications to the Stark Law. The purpose of these modifications is to promote value-based and coordinated care arrangements as well as reduce other regulatory burdens. The changes implemented by the final rules went into effect on January 19, 2021. We continue to assess the anticipated impact of these modifications on our business, results of operations and financial condition.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical director agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We endeavor to structure our medical director agreements to satisfy the personal services arrangement exception to the Stark Law. While we believe that the compensation provisions included in our medical director agreements are the result of arm&#8217;s length negotiations and result in fair market value payments for medical director services, an enforcement agency could nevertheless challenge the level of compensation that we pay our medical directors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We lease space from entities in which referring physicians hold interests and we sublease space to referring physicians at some of our dialysis centers. The Stark Law provides an exception for lease arrangements if specific requirements are met. We endeavor to structure our leases and subleases with referring physicians to satisfy the requirements for this exception.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consulting agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, we enter into consulting agreements with physicians. Engaged physicians provide services including providing input on processes, services and protocols as well as providing education on assorted topics. We endeavor to structure these arrangements to comply with the Stark Law exception for personal services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We employ physicians to provide administrative and clinical services. We endeavor to structure these arrangements to comply with the relevant Stark Law exceptions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Some referring physicians may own our common stock. We believe that these interests satisfy the Stark Law exception for investments in large publicly traded companies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Some of our referring physicians also own equity interests in entities that operate our dialysis centers and subsidiaries. We believe that none of the Stark Law exceptions applicable to physician ownership interests in entities to which they make DHS referrals apply to the kinds of ownership arrangements that referring physicians hold in several of our subsidiaries that operate dialysis centers. Accordingly, these dialysis centers do not bill Medicare for DHS, if any, when provided based on the referral from any physician owners. If the dialysis centers bill for DHS referred by physician owners, the dialysis centers or subsidiaries could be subject to the Stark Law penalties described above unless a relevant exception to the Stark Law applies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The operations of our ancillary and subsidiary businesses are also subject to compliance with the Stark Law, and any failure to comply with these requirements, particularly in light of the strict liability nature of the Stark Law, could subject these operations to the Stark Law penalties and sanctions described above. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If CMS or other regulatory or enforcement authorities determined that we have submitted claims in violation of the Stark Law, or otherwise violated the Stark Law, we would be subject to the penalties described above. In addition, it might be necessary to restructure existing compensation agreements with our medical directors and to repurchase or to request the sale of ownership interests in subsidiaries and partnerships held by referring physicians or, alternatively, to refuse to accept referrals for DHS from these physicians, or take other actions to modify our operations. Any such penalties and restructuring or other required actions could have a material adverse effect on our business, results of operations, financial condition, cash flows, stock price and reputation.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fraud and abuse under state law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states in which we operate dialysis centers have laws prohibiting physicians from holding financial interests in various types of medical facilities to which they refer patients. Some of these laws could potentially be interpreted broadly as prohibiting physicians who hold shares of our publicly traded stock or are physician owners from referring patients to our dialysis centers if the centers use our laboratory subsidiary to perform laboratory services for their patients or do not otherwise satisfy an exception to the law. States also have laws similar to or stricter than the federal Anti-Kickback Statute that may affect our ability to receive referrals from physicians with whom we have financial relationships, such as our medical directors. Some state anti-kickback laws also include civil and criminal penalties. Some of these laws include exemptions that may be applicable to our medical directors and other physician relationships or for financial interests limited to shares of publicly traded stock. Some, however, may include no explicit exemption for certain types of agreements and/or relationships entered into with physicians. If these laws are interpreted to apply to referring physicians with whom we contract for medical director and similar services, to referring physicians with whom we hold joint ownership interests or to referring physicians who hold interests in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita Inc. limited solely to our publicly traded stock, and for which no applicable exception exists, we may be required to terminate or restructure our relationships with or refuse referrals from these referring physicians and could be subject to criminal, civil and administrative sanctions, refund requirements and exclusions from government healthcare programs, including Medicare and Medicaid, which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Practice of Medicine and Fee-Splitting</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are states in which we operate that have laws that prohibit business entities, such as our Company and our subsidiaries, from practicing medicine, employing physicians to practice medicine or exercising control over medical decisions by physicians (known collectively as the corporate practice of medicine). These states also prohibit entities from engaging in certain financial arrangements, such as fee-splitting, with physicians. In some states these prohibitions are expressly stated in a statute or regulation, while in other states the prohibition is a matter of judicial or regulatory interpretation. Violations of the corporate practice of medicine vary by state and may result in physicians being subject to disciplinary action, as well as to forfeiture of revenues from payors for services rendered. For lay entities, violations may also bring both civil and, in more extreme cases, criminal liability for engaging in medical practice without a license. Some of the relevant laws, regulations, and agency interpretations in states with corporate practice of medicine restrictions have been subject to limited judicial and regulatory interpretation. Moreover, state laws are subject to change.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">False Claims Act</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal FCA is a means of policing false bills or false requests for payment in the healthcare delivery system. In part, the FCA authorizes the imposition of up to three times the government&#8217;s damages and civil penalties on any person who, among other acts:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Knowingly presents or causes to be presented to the federal government, a false or fraudulent claim for payment or approval;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Knowingly makes, uses or causes to be made or used, a false record or statement material to a false or fraudulent claim;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Knowingly makes, uses, or causes to be made or used, a false record or statement material to an obligation to pay the government, or knowingly conceals or knowingly and improperly, avoids or decreases an obligation to pay or transmit money or property to the federal government; or</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conspires to commit the above acts.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, amendments to the FCA impose severe penalties for the knowing and improper retention of overpayments collected from government payors. Under these provisions, within 60 days of identifying and quantifying an overpayment, a provider is required to follow certain notification and repayment processes. An overpayment impermissibly retained could subject us to liability under the FCA, exclusion from government healthcare programs, and penalties under the federal Civil Monetary Penalty statute. As a result of these provisions, our procedures for identifying and processing overpayments may be subject to greater scrutiny.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2020, the DOJ issued a final rule announcing penalties for a violation of the FCA ranging from $11,665 to $23,331 for each false claim, plus up to three times the amount of damages caused by each false claim, which can be as much as the amounts received directly or indirectly from the government for each such false claim. The federal government has used the FCA to prosecute a wide variety of alleged false claims and fraud allegedly perpetrated against Medicare and state healthcare programs, including coding errors, billing for services not rendered, the submission of false cost reports, billing for services at a higher payment rate than appropriate, billing under a comprehensive code as well as under one or more component codes included in the comprehensive code and billing for care that is not considered medically necessary. The ACA provides that claims tainted by a violation of the federal Anti-Kickback Statute are false for purposes of the FCA. Some courts have held that filing claims or failing to refund amounts collected in violation of the Stark Law can form the basis for liability under the FCA. In addition to the provisions of the FCA, which provide for civil enforcement, the federal government can use several criminal statutes to prosecute persons who are alleged to have submitted false or fraudulent claims for payment to the federal government. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Monetary Penalties Statute</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Civil Monetary Penalties Statute, 42 U.S.C. &#167; 1320a-7a, authorizes the imposition of civil money penalties, assessments, and exclusion against an individual or entity based on a variety of prohibited conduct, including, but not limited to:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Presenting, or causing to be presented, claims for payment to Medicare, Medicaid, or other third-party payors that the individual or entity knows or should know are for an item or service that was not provided as claimed or is false or fraudulent; </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Offering remuneration to a Federal healthcare program beneficiary that the individual or entity knows or should know is likely to influence the beneficiary to order or receive healthcare items or services form a particular provider;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Arranging contracts with an entity or individual excluded from participation in the Federal healthcare programs;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Violating the federal Anti-Kickback Statute;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Making, using, or causing to be made or used, a false record or statement material to a false or fraudulent claim for payment for items and services furnished under a Federal healthcare program;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Making, using, or causing to be made any false statement, omission, or misrepresentation of a material fact in any application, bid, or contract to participate or enroll as a provider of services or a supplier under a Federal healthcare program; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failing to report and return an overpayment owed to the federal government.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantial civil monetary penalties may be imposed under the federal Civil Monetary Penalty Statute and vary, depending on the underlying violation. In addition, an assessment of not more than three times the total amount claimed for each item or service may also apply, and a violator may be subject to exclusion from Federal and state healthcare programs.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Corrupt Practices Act</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the provisions of the Foreign Corrupt Practices Act (FCPA) in the United States and similar laws in other countries, which generally prohibit companies and those acting on their behalf from making improper payments to foreign government officials for the purpose of obtaining or retaining business. A violation of the FCPA by us and/or our agents or representatives could result in, among other things, the imposition of fines and penalties, changes to our business practices, the termination of our contracts or debarment from bidding on contracts, and/or harm to our reputation, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Privacy and Security</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Portability and Accountability Act of 1996 and its implementing privacy and security regulations, as amended by the federal Health Information Technology for Economic and Clinical Health Act (HITECH Act), (collectively referred to as HIPAA), require us to provide certain protections to patients and their health information. The HIPAA privacy and security regulations extensively regulate the use and disclosure of PHI and require covered entities, which include healthcare providers, to implement and maintain administrative, physical and technical safeguards to protect the security of such information. Additional security requirements apply to electronic PHI. These regulations also provide patients with substantive rights with respect to their health information.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HIPAA privacy and security regulations also require us to enter into written agreements with certain contractors, known as business associates, to whom we disclose PHI. Covered entities may be subject to penalties for, among other activities, failing to enter into a business associate agreement where required by law or as a result of a business associate violating HIPAA if the business associate is found to be an agent of the covered entity and acting within the scope of the agency. Business associates are also directly subject to liability under the HIPAA privacy and security regulations. In instances where we act as a business associate to a covered entity, there is the potential for additional liability beyond our status as a covered entity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covered entities must report breaches of unsecured PHI to affected individuals without unreasonable delay but not to exceed 60 days of discovery of the breach by a covered entity or its agents. Notification must also be made to the HHS, and, for breaches of unsecured PHI involving more than 500 residents of a state or jurisdiction, to the media. All non-permitted uses or disclosures of unsecured PHI are presumed to be breaches unless the covered entity or business associate establishes that there is a low probability the information has been compromised. Various state laws and regulations may also require us to notify affected individuals in the event of a data breach involving individually identifiable information without regard to whether there is a low probability of the information being compromised.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Penalties for impermissible use or disclosure of PHI were increased by the HITECH Act by imposing tiered penalties of more than $50,000 per violation and up to $1.5&#160;million per year for identical violations. In addition, HIPAA provides for criminal penalties of up to $250,000 and ten years in prison, with the severest penalties for obtaining and disclosing PHI with </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the intent to sell, transfer or use such information for commercial advantage, personal gain or malicious harm. Further, state attorneys general may bring civil actions seeking either injunction or damages in response to violations of the HIPAA privacy and security regulations that threaten the privacy of state residents.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the protection of PHI, healthcare companies must meet privacy and security requirements applicable to other categories of personal information. Companies may process consumer information in conjunction with website and corporate operations. They may also handle employee information, including Social Security Numbers, payroll information, and other categories of sensitive information, to further their employment practices. In processing this additional information, companies must comply with the privacy and security requirements of consumer protection laws, labor and employment laws, and its publicly-available notices.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Data protection laws are evolving globally, and may add additional compliance costs and legal risks to our international operations. In Europe, the General Data Protection Regulation (GDPR) became effective on May 25, 2018. The GDPR applies to entities that are established in the European Union (EU), as well as extends the scope of EU data protection laws to foreign companies processing data of individuals in the EU. The GDPR imposes a comprehensive data protection regime with the potential for regulatory fines as well as data breach litigation by impacted data subjects. Under GDPR, regulatory penalties may be passed by data protection authorities for up to the greater of 4% of worldwide turnover or &#8364;20 million. The costs of compliance with, and other burdens imposed by, the GDPR and other new laws, regulations and policies implementing the GDPR may impact our European operations and/or limit the ways in which we can provide services or use personal data collected while providing services. In July 2020, the Court of Justice of the European Union issued an opinion in the Schrems II case that invalidated the E.U.-U.S. Privacy Shield as a basis for transferring EU personal data to the U.S. The Court upheld European Commission-approved Standard Contractual Clauses (SCCs) as a basis for transfers of EU personal data to the United States, but imposed additional compliance burdens on companies to ensure their ability to comply with such contractual obligations. In October 2020, the U.S. government has issued guidance to companies on how to assess their ability to comply with transfer obligations, and in November 2020, the European Data Protection Board (EDPB), tasked with overseeing compliance with the GDPR, published, further to its initial guidance, its recommendations on measures to supplement data transfer rules to ensure compliance with EEA data protection law. In addition, the European Commission has also published a draft implementing a decision on new SCCs for the transfer of personal data to third countries which may be a significant task to put into place given its requirements. These developments add a layer of complexity to compliance efforts around international data transfers and compliance with the GDPR. If we fail to comply with the requirements of GDPR, we could be subject to penalties that would have a material adverse impact on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data protection laws are also evolving nationally, and may add additional compliance costs and legal risks to our U.S. operations. For example, the California Consumer Protection Act (CCPA) became effective January 1, 2020 and enforceable by the California Attorney General on July 1, 2020. The CCPA is a privacy law that requires certain companies doing business in California to enhance privacy disclosures regarding the collection, use and sharing of a consumer's personal data. The CCPA grants consumers additional privacy rights that are broader than current Federal privacy rights. The CCPA also permits the imposition of civil penalties, grants enforcement authority to the state Attorney General and provides a private right of action for consumers where certain personal information is breached due to unreasonable information security practices. Since its passage, several other states, including Nevada and Maine, have expanded their state data protection laws, and other states are considering similar legislation. These laws impose organizational requirements and grant individual rights that are comparable to those established in the CCPA. Additionally, in November 2020, California voters passed the California Privacy Rights Act (CPRA). The CPRA, which is expected to take effect on January 2023, significantly expands the data protection obligations imposed by the CCPA on companies doing business in California, including additional consumer rights processes, limitations on data uses, and opt outs for certain uses of sensitive data. It also will create a new California data protection agency to enforce the law, and require certain businesses with higher risk privacy and security practices to submit annual audits to the agency on a regular basis. The CPRA will likely result in broader increased regulatory scrutiny in California of businesses&#8217; privacy and security practices, could lead to a further rise in data protection litigation, and will require additional compliance investment and potential business process changes in the meantime.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the breach reporting requirements under HIPAA, companies are subject to state breach notification laws. Each state enforces a law requiring companies to provide notice of a breach of certain categories of sensitive personal information, e.g. Social Security Number, financial account information, or username and password. A company impacted by a breach must notify affected individuals, attorney&#8217;s general or other agencies within a certain time frame. If a company does not provide timely notice with the required content, it may be subject to civil penalties brought by attorney&#8217;s generals or affected individuals. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies must also safeguard personal information in accordance with federal and state data security laws and requirements. These requirements are akin to the HIPAA requirements to safeguard PHI, described above. The Federal Trade Commission, for example, requires companies to implement reasonable data security measures relative to its operations and the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">volume and complexity of the information it processes. Also, various state data security laws require companies to safeguard data with technical security controls and underlying policies and processes. Due to the constant changes in the data security space, companies must continuously review and update data security practices to mitigate any potential operational or legal liabilities stemming from data security risks.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare reform</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2010, broad healthcare reform legislation was enacted in the U.S. through the ACA, but the ACA&#8217;s regulatory framework and other healthcare reforms continue to evolve as a result of executive, legislative, regulatory and administrative developments and judicial proceedings. There have been multiple attempts to repeal or amend the ACA through legislative action and legal challenges, and the most recent challenge is currently before the U.S. Supreme Court. A repeal or other significant change to the ACA could have a material impact on our business if, for example, programs under the ACA were cancelled, including, among others, Medicaid expansion, CMMI models or the health insurance exchanges. Our revenue and operating income levels are highly sensitive to the percentage of our patients with higher-paying commercial health insurance and any legislative, regulatory or other changes that decrease the accessibility and availability, including the duration, of commercial insurance may have a material adverse impact on our business. In the event the health insurance exchange markets are significantly impaired as a result of legislative developments or other changes, it may adversely impact the percentage of our patients with higher-paying commercial health insurance, particularly if patients become unemployed due to factors related to the COVID-19 pandemic or otherwise and are unable to turn to the exchanges as an alternative to employer-based coverage.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in legislation, regulation or market conditions in connection with or resulting from the recent elections, could also impact our business in a number of ways, some of which may be material. For example, proposed legislative developments or administrative decisions, such as the creation of a public health insurance option similar to Medicare, government programs that impact access to Medicaid expansion or funding to families to purchase plans through health insurance exchanges or changes to the eligibility age for Medicare beneficiaries, eliminating the eligibility cap for the advance premium tax credit (APTC) and enhancing activities aimed at enrolling eligible individuals in Medicaid could impact the percentage of our patients with higher-paying commercial health insurance, impact the scope of coverage under commercial health plans and increase our expenses, among other things. Particularly in light of the ongoing COVID-19 pandemic, considerable uncertainty exists surrounding the continued development of the ACA and related regulations, programs and models, as well as similar healthcare reform measures and/or other potential changes at the federal and/or state level to laws, regulations and other requirements that govern our business.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New models of care and Medicare and Medicaid program reforms</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the 2019 Executive Order directed CMS to create payment models to evaluate the effects of creating payment incentives for the greater use of home dialysis and kidney transplants for those already on dialysis. CMS, through CMMI, published the final ETC mandatory payment model on September 18, 2020. The ETC will be administered through CMMI and launched in approximately 30% of dialysis clinics across the country on January 1, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, CMS also announced the implementation of four voluntary kidney care payment models with the stated goal of helping healthcare providers reduce the cost and improve the quality of care for patients with late-stage chronic kidney disease and ESRD. CMS has stated these payment models are aimed to prevent or delay the need for dialysis and encourage kidney transplantation. These payment models have a scheduled commencement date of April 2021, though applicants now have the option to delay implementation until January 2022. Though we have applied for, and been provisionally accepted to participate in certain of these voluntary models, we continue to assess these models and their viability for us and the industry. These voluntary models continue CMMI&#8217;s prior work with various healthcare providers to develop, refine and implement ACOs and other innovative models of care for Medicare and Medicaid beneficiaries, including, without limitation, the CEC Model (which includes the development of ESRD Seamless Care Organizations), the Duals Demonstration, and other models. We participated in the CEC Model with CMMI, including with organizations in Arizona, Florida, and adjacent markets in New Jersey and Pennsylvania. The CEC ESCOs Model overall ended in Florida in December 2020, while the Arizona and adjacent markets in New Jersey and Pennsylvania are scheduled to end in March 2021. We may choose to participate in additional models either as a partner with other providers or independently. Even in areas where we are not directly participating in these or other CMMI models, some of our patients may be assigned to an ACO, another ESRD Care Model, or another program, in which case the quality and cost of care that we furnish will be included in an ACO's, another ESRD Care Model's, or other program's calculations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as to the aforementioned new models of care, federal bipartisan legislation related to full capitation demonstration for ESRD was introduced in Congress in September 2020 as the BETTER Kidney Care Act. This proposed legislation, which has not secured introduction in the current Congress, would build on prior coordinated care models, such as the CEC Model, and would establish a demonstration program for the provision of integrated care to Medicare fee-for-service </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dialysis and transplant patients. We have made and continue to make investments in building our integrated care capabilities, but there can be no assurances that initiatives such as this or similar legislation will be introduced or passed into law, and the ongoing COVID-19 pandemic may delay the progress of any such initiatives. If such legislation is passed, there can be no assurances that we will be able to successfully execute on the required strategic initiatives that would allow us to provide a competitive and successful integrated care program on the broader scale contemplated by legislation like this, and in the desired time frame. Additionally, the ultimate terms and conditions of any such potential legislation remain unclear. For example, our costs of care could exceed our associated reimbursement rates under such legislation. For additional detail on the evolving health care landscape and associated developments in our competitive environment, see the risk factor in Item 1A Risk Factors under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors, it could materially adversely affect our business, results of operations, financial condition and cash flows." </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has also issued final rules related to the Cures Act. The Cures Act included a provision that, effective January 1, 2021, allows Medicare eligible beneficiaries with ESRD to choose coverage under a Medicare Part C MA managed care plan. This provision could broaden access to certain enhanced benefits offered by MA plans. MA plans usually provide reimbursement to us at a negotiated rate that is generally higher than Medicare FFS rates. We continue to evaluate the potential impact of this change in benefit eligibility, as there remains significant uncertainty as to how many or which newly eligible ESRD patients will seek to enroll in MA plans for their ESRD benefits and how quickly any such changes would occur. This uncertainty may be heightened by components of the aforementioned final rules, which include a provision that, among other things, removes the objective time and distance standards relating to network adequacy for outpatient dialysis centers for MA plans. The removal of these standards could result in MA plans seeking to limit provider networks available to dialysis patients. If MA plans attempt to use this revision to the rules to limit or restrict their networks, this may adversely impact the number of ESRD patients that select MA plans and also may result in the Company not being an in-network provider for significant MA plans. For details on the risks associated with these changes, see the risk factors in Item 1A Risk Factors under the headings,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "We continuously have ongoing negotiations with commercial payors, and if the average rates that commercial payors pay us decline significantly, if patients in commercial plans are subject to restriction in plan designs or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it would have a material adverse effect on our business, results of operations, financial condition and cash flows". </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cures Act also includes provisions related to data interoperability, information blocking, and patient access. CMS and the Office of the National Coordinator for Health Information Technology (ONC) recently issued final rules related to these provisions, which include, among other things, requirements surrounding information blocking, changes to ONC's Health IT Certification Program and requirements that CMS-regulated payors make relevant claims/care data and provider directory information available through standardized patient access and provider directory application programming interfaces (APIs) that connect to provider electronic health records. We have made and continue to make investments in building data interoperability capabilities, including as part of building on our integrated care capabilities as noted above, and continue to evaluate the potential impact of the CMS and ONC final rules. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, recent price and patient responsibility transparency regulations require health plans to make certain pricing and patient responsibility information publicly available. Certain of the requirements went into effect January 1, 2021 while others will go into effect January 1, 2024. There is a possibility that any changes by health plans resulting from these regulations could impact our revenue and results of operations.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other regulations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis and related lab services operations are subject to various state hazardous waste and non-hazardous medical waste disposal laws. These laws do not classify as hazardous most of the waste produced from dialysis services. Occupational Safety and Health Administration regulations require employers to provide workers who are occupationally subject to blood or other potentially infectious materials with prescribed protections. These regulatory requirements apply to all healthcare facilities, including dialysis centers, and require employers to make a determination as to which employees may be exposed to blood or other potentially infectious materials and to have in effect a written exposure control plan. In addition, employers are required to provide or employ hepatitis B vaccinations, personal protective equipment and other safety devices, infection control training, post-exposure evaluation and follow-up, waste disposal techniques and procedures and work practice controls. Employers are also required to comply with various record-keeping requirements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a few states in which we do business have certificate of need programs regulating the establishment or expansion of healthcare facilities, including dialysis centers.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State initiatives</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been several state initiatives to limit payments to dialysis providers or impose other burdensome operational requirements, which, if passed, could have a material adverse impact on our business, results of operation, financial condition and cash flows. For example, on October 24, 2019, the Service Employees International Union - United Healthcare Workers West (SEIU) proposed a California statewide ballot initiative (Proposition 23) that sought to impose certain regulatory requirements on dialysis clinics, including requirements related to physician staffing levels, clinical reporting, clinical treatment options and limitations on the ability to make decisions on closing or reducing services for dialysis clinics. While this ballot initiative was rejected by voters in 2020, we incurred substantial costs to oppose it. We may face ballot initiatives or other proposed regulations or legislation in California or other states in future years, which may require us to incur further substantial costs and which, if passed, could have a material adverse impact on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolving proposed or issued laws, requirements, rules and guidance that impact our business, including as may be described above, and any failure on our part to adequately adjust to any resulting marketplace developments could have a material adverse effect on our business, results of operations, financial condition and cash flows. For additional discussion on the risks associated with the evolving payment and regulatory landscape for kidney care, see the discussion in Item 1A Risk Factors, including the discussion under the heading,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Our business is subject to a complex series of governmental laws, regulations and requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation" and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows".</span></div><div id="i878840fee65247deaca27d2dd6a8246f_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate compliance program</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are subject to extensive regulations. Management has designed and implemented a corporate compliance program as part of our commitment to comply fully with applicable criminal, civil and administrative laws and regulations and to maintain the high standards of conduct we expect from all of our teammates. We continuously review this program and work to enhance it as appropriate. The primary purposes of the program include:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessing and identifying risks for existing and new businesses;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Training and educating our teammates and affiliated professionals to promote awareness of legal and regulatory requirements, a culture of compliance, and the necessity of complying with all applicable laws, regulations and requirements;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developing and implementing compliance policies and procedures and creating controls to support compliance with applicable laws, regulations and requirements and our policies and procedures;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Auditing and monitoring the activities of our operating units and business support functions to identify and mitigate risks and potential instances of noncompliance in a timely manner; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ensuring that we promptly take steps to resolve any instances of noncompliance and address areas of weakness or potential noncompliance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a code of conduct that each of our teammates, members of our Board of Directors, affiliated professionals and certain third parties must follow, and we have an anonymous compliance hotline for teammates and patients to report potential instances of noncompliance that is managed by a third party. Our Chief Compliance Officer administers the compliance program. The Chief Compliance Officer reports directly to our Chief Executive Officer and the Chair of the Compliance and Quality Committee of our Board of Directors (Board Compliance and Quality Committee). Previously, we were subject to a five-year Corporate Integrity Agreement (CIA) with OIG. The term of the CIA expired on October 22, 2019, and we were notified on May 20, 2020 that the OIG had closed out its review. The CIA (i) required that we maintain certain elements of our compliance programs; (ii) imposed certain expanded compliance-related requirements during the term of the CIA; (iii) required ongoing monitoring and reporting by an independent monitor, imposed certain reporting, certification, records retention and training obligations, allocated certain oversight responsibility to the Board&#8217;s Compliance and Quality Committee, and necessitated the creation of a Management Compliance Committee and the retention of an independent compliance advisor to the Board; and (iv) contained certain business restrictions related to a subset of our joint venture arrangements. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future penalties, sanctions or other consequences could be more severe in certain circumstances if the OIG or a similar regulatory authority determines that we knowingly and repeatedly failed to comply with applicable laws, regulations or requirements that apply to our business, including substantial penalties and exclusion from participation in federal healthcare programs that could have a material adverse effect on our business, results of operations, financial condition and cash flows, reputation and stock price.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. dialysis industry has experienced consolidation over the last 20 years, but remains highly competitive. Patient retention and the continued referrals of patients from referral sources such as hospitals and nephrologists, as well as acquiring or developing new outpatient dialysis centers are some of the important parts of our growth strategy. In our U.S. dialysis business, we continue to face intense competition from large and medium-sized providers, among others, which compete directly with us for limited acquisition targets, for individual patients who may choose to dialyze with us and for physicians qualified to provide required medical director services. Competition for growth in existing and expanding geographies or areas is intense and is not limited to large competitors with substantial financial resources or established participants in the dialysis space. We also compete with individual nephrologists, former medical directors or physicians that have opened their own dialysis units or facilities. Moreover, as we continue our international dialysis expansion into various international markets, we face competition from large and medium-sized providers, among others, for acquisition targets as well as physician relationships. We also experience competitive pressures from other dialysis providers in recruiting and retaining qualified skilled clinical personnel as well as in connection with negotiating contracts with commercial healthcare payors and inpatient dialysis service agreements with hospitals. Acquisitions, developing new outpatient dialysis centers, patient retention and physician relationships are significant components of our growth strategy and our business could be adversely affected if we are not able to continue to make dialysis acquisitions on reasonable and acceptable terms, continue to develop new outpatient dialysis centers, maintain or establish new relationships with physicians or if we experience significant patient attrition relative to our competitors. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Together with our largest competitor, Fresenius Medical Group (FMC), we account for approximately 73% of outpatient dialysis centers in the U.S. Many of the centers not owned by us, FMC or other large for profit dialysis providers are owned or controlled by hospitals or non-profit organizations. Hospital-based and non-profit dialysis units typically are more difficult to acquire than physician-owned dialysis centers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FMC also manufactures a full line of dialysis supplies and equipment in addition to owning and operating outpatient dialysis centers worldwide. This may, among other things, give FMC cost advantages over us because of its ability to manufacture its own products. Additionally, FMC has been one of our largest suppliers of dialysis products and equipment over the last several years. In January 2021, upon the expiration of our prior agreement with FMC on December 31, 2020, we entered into and subsequently extended a new agreement with FMC to purchase a certain amount of dialysis equipment, parts and supplies from FMC which extends through December&#160;31, 2024. The amount of purchases from FMC over the remaining term of this agreement will depend upon a number of factors, including the operating requirements of our centers, the number of centers we acquire, and growth of our existing centers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been a number of announcements by non-traditional dialysis providers and others, which relate to entry into the dialysis and pre-dialysis space, the development of innovative technologies, or the commencement of new business activities that could be disruptive to the industry. These developments over time may shift the competitive landscape in which we operate. For additional discussion on these developments and associated risks, see the risk factor in Item 1A Risk Factors under the heading, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors, it could materially adversely affect our business, results of operations, financial condition and cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i878840fee65247deaca27d2dd6a8246f_49"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are predominantly self-insured with respect to professional and general liability and workers' compensation risks through wholly-owned captive insurance companies.&#160;We are also predominantly self-insured with respect to employee medical and other health benefits. We also maintain insurance, excess coverage, or reinsurance for property and general liability, professional liability, directors&#8217; and officers&#8217; liability, workers' compensation, cybersecurity and other coverage in amounts and on terms deemed appropriate by management, based on our actual claims experience and expectations for future claims. Future claims could, however, exceed our applicable insurance coverage. Physicians practicing at our dialysis centers are required to maintain their own malpractice insurance, and our medical directors are required to maintain coverage for their individual private medical practices. Our liability policies cover our medical directors for the performance of their duties as medical directors at our outpatient dialysis centers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human capital management</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At DaVita, we are guided by our Mission&#8212;to be the provider, partner and employer of choice&#8212;and a set of Core Values&#8212;Service Excellence, Integrity, Team, Continuous Improvement, Accountability, Fulfillment and Fun&#8212;which are reinforced at all levels of the organization. Our teammates share a common passion for improving patients' lives and are the cornerstone for the health of DaVita.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to be a community first and a company second, and affectionately call ourselves a Village. To be a healthy Village, we need to attract, retain and motivate highly qualified and diverse teammates. To do so, we have implemented strategies that support our mission to be the employer of choice, such as: </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Designing programs and processes to cultivate a diverse talent pipeline that allows us to hire ahead of needs;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing development and professional growth opportunities; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Offering a robust total rewards program. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These efforts are underpinned by a foundational focus on diversity and belonging that starts at the top with our Board of Directors and executive leadership and permeates through our Village as further described below. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that this intentional investment of time and resources fosters a special community of teammates that, in turn, inspires the Village to take better care of our patients and better care of the communities in which we live.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oversight &amp; Management</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors provides oversight on human capital matters, receiving regular updates from our Chief People Officer about People Services&#8217; activities, strategies and initiatives, and through the Board&#8217;s annual work with our Chief Executive Officer on management development and succession planning. Among other things, our Board of Directors and/or its committees also receive reports related to pay equity, risks and trends related to labor and human capital management issues and general issues pertaining to our teammates. The Board also oversees the Company's activities, policies and programs related to corporate environmental and social responsibility, including considering the impact of such activities, policies and programs on the Company, teammates and communities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These reports and recommendations to the Board and its committees are part of our broader People Services leadership and oversight framework, which includes guidance from various stakeholders across the business and benefits from the full participation of senior leadership. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity &amp; Belonging</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in our teammates is underscored by our commitment to Diversity &amp; Belonging (D&amp;B). Our D&amp;B vision is "a diverse Village where everyone belongs." Our 3,137 dialysis centers operate in communities large and small, in nearly every state in the U.S. as well as ten other countries: Brazil, China, Columbia, Germany, Malaysia, Poland, Portugal, Saudi Arabia, Singapore, and the United Kingdom. Our Village's diversity is inherent in the teammates who work in our centers, the patients we care for, the physicians with whom we partner, and the communities where we serve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help achieve this vision, we empower all leaders and teammates to cultivate D&amp;B in their centers and on their teams. One way we do this is by sharing tools and resources like our Belonging Teammate and Belonging Leader Guides, which encourage teammates to connect with each other to learn about individual experiences with belonging and better understand the impact of unconscious bias. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take a collaborative, leader-led approach to building our D&amp;B program. Everyone from our front-line patient care technicians (PCTs) and nurses to our divisional vice presidents, our CEO and our Board of Directors has a role in implementing our strategy. It truly does take a Village to bring our vision to life. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past several years, our D&amp;B efforts have focused primarily on supporting strong representation of women and people of color and ensuring that we are creating a welcoming, open environment where all teammates, patients, physicians and care partners belong.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, our Village in the U.S. was comprised of 78% women and 54% people of color. We are proud of the fact that in the U.S. as of December 31, 2020, 74% of our managers and 54% of our directors are women and that leaders with profit and loss responsibility are 52% women and 27% people of color. We also are proud of the fact that our Board of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors is comprised of 44% women and 33% people of color. With respect to Board leadership positions, we are one of the few companies in the S&amp;P 500 to have a woman serving as the Chair of the Board of Directors, and 75% of our Board committees are led by women or people of color.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Talent Pipeline and Career Development</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We understand that a key component of developing strong representation of women and people of color in leadership is to have recruiting practices focused on diversity. Some of our practices include: </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Diverse Sourcing: Our recruiters are trained on how to source for diverse candidates to ensure we have a robust pipeline at all levels of the organization.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diverse Partnerships: We have external partnerships with organizations like Forte Foundation and Management Leadership for Tomorrow to help create equal opportunities for diverse candidates.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Redwoods Leadership: We partner closely with diverse student body organizations at colleges and universities to source applicants for our Redwoods leadership development programs. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helping teammates reach the next stage in their career and increasing their earnings potential is one of our passions. We have several career development programs that support teammates to further their careers. To help ensure that teammates have the support needed to succeed in their current roles, and grow their careers, we have invested in an end-to-end career development pipeline that includes programs and initiatives that provide financial, academic and social support to our clinical and operations personnel to help achieve their higher education and leadership goals. For example, approximately 86% of our teammates are clinical field/operations personnel, and we have programs in place to help guide their potential journey at DaVita. Beginning with programs that cover certification fees for PCTs to coaching and tuition programs that help guide PCTs to becoming registered nurses (RNs) to programs that help develop high potential nurses, clinical coordinators and clinic nurse managers into operational managers and ultimately to programs that prepare and coach operational managers for potential regional operations director roles, our goal is to make resources available to teammates at each step of a possible career path.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Rewards Program and Pay Equity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pay philosophy and practices are designed to be competitive in the local market and to reward strong team and individual performance. We believe merit-driven pay encourages teammates to do their best work, including in caring for our patients, and we strive to link pay to performance so we can continue to incentivize the provision of extraordinary care to our patients and grow our Village.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help our teammates reach their full potential, we offer a total rewards package. More than just pay, our comprehensive compensation package connects teammates to robust health care coverage, resources for retirement planning and savings, opportunities for career development, and well-being resources for every stage of life.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support our teammates in maintaining strong physical and mental health, we offer a variety of physical and mental health benefits programs, including, among other things:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Teammate Assistance Program that offers counseling sessions annually to all teammates and their household members, along with work/life resources and tools that include telephonic or face to face legal consultation and expert financial planning/consultation.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Free access to Headspace application for digital meditation and mindfulness and referrals/consultations on everyday issues such as dependent care, auto repair, pet care and home improvement.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vitality Points, a voluntary wellness incentive program that allows participating teammates and spouses/domestic partners to earn credits toward their medical premium for getting a biometric screening and engaging in healthy actions should they not meet certain targets.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short &amp; Long term disability for full time teammates and Life/AD&amp;D coverage at both the basic and supplemental levels.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our DaVita Village Network, which provides financial support to eligible teammates experiencing a specific tragedy or hardship and helps cover additional costs that local fundraising and insurance do not fully cover.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In support of our teammates and their families, we also offer family support programs that include family care programs for back-up child and elder care, parental support and parental leave programs. We also offer a number of scholarships for teammates' children and grandchildren.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer a robust suite of financial well-being programs for eligible teammates including, among others, a 401(k) program with company match, an employee stock purchase plan, health savings account funding for certain high deductible health plans and a deferred compensation plan. We also offer DailyPay, a service that provides teammates with financial flexibility by allowing them to access earned but unpaid wages before payday for a nominal fee. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pay Equity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At DaVita, we are committed to equal pay for equal work; meaning, teammates in the same position, performing at the same level, and in similar geographies, are paid fairly relative to one another, regardless of their gender, race or ethnicity. We believe that equitable pay is a critical component of establishing a fair work environment where all teammates are valued and feel like they belong. Fair pay is essential to our ability to attract and motivate the highly qualified, and diverse, teammates who are at the center of our current and future success.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Agile Response, Teammate Feedback and Responding to the Public Health Crisis</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic tested our ability to respond to external developments and care for our teammates in real time. In response to the hardship imposed by the pandemic on our teammates, and in recognition of their dedication and commitment to our patients&#8217; health, DaVita provided financial relief to over 50,000 teammates, such as a &#8220;Village Lives&#8221; award of $100 per week from March through May 2020, as well as other relief payments during the pandemic. In addition, we did not furlough, layoff or reduce pay for any teammates due to the pandemic. One of our key goals during the pandemic was to maintain frequent communication and engagement with teammates, including &#8220;town hall&#8221; calls, emails and more. As the pandemic has persisted, we continue to provide essential relief programs to support these teammates, including backup childcare, modified sick policies and certain increased overtime pay for front-line positions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most importantly, the health and safety of our teammates in the Village and their families remains a top priority throughout this ongoing pandemic. We implemented guidance early in the pandemic to help mitigate health and safety risks imposed by COVID-19, including, among other things:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Securing necessary supplies of personal protective equipment;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting visitors to our centers;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Screening teammates, patients and visitors for signs and symptoms of, or exposure to, COVID-19, before allowing entry into our clinics or business offices;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementing an early universal masking policy; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing guidance on staying safe outside of our centers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also converted our live, in-person teammate and leadership development programs to virtual delivery, to help ensure that our teammates across our global Village could continue to grow personally and professionally and have access to career development resources despite the ongoing pandemic.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our ability to engage with teammates and respond to these developments has helped us to better care for them. By caring for our teammates, we were generally able to maintain continuity of care for our patients and support the broader healthcare community throughout this unprecedented public health crisis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we employed approximately 67,000 teammates, including our international teammates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about certain risks associated with our human capital management, see the risk factor in Item 1A Risk Factors under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If our labor costs continue to rise, including due to shortages, changes in certification requirements and/or higher than normal turnover rates in skilled clinical personnel; or currently pending or future governmental laws, rules, regulations or initiatives impose additional requirements or limitations on our operations or profitability; or, if we are unable to attract and retain key leadership talent, we may experience disruptions in our business operations and increases in operating expenses, among other things, which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also encourage you to visit our website at www.davita.com for more detailed information regarding certain of the human capital related programs and initiatives described herein, including our Policy on Fair and Equitable Pay, as well as our efforts to care for our patients, our community and our world. Nothing on our website, sections thereof or documents linked thereto, shall be deemed incorporated by reference into this Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws. Please read the cautionary notice regarding forward-looking statements in Item 7 of Part II of this Annual Report on Form 10-K under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; These forward-looking statements involve risks and uncertainties, including those discussed below, which could have a material adverse effect on our business, cash flows, financial condition, results of operations and/or reputation. The risks and uncertainties discussed below are not the only ones facing our business. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial could also have a material adverse effect on our business, cash flows, financial condition, results of operations and/or reputation.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_2869"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the principal risks and uncertainties that could adversely affect our business, cash flows, financial condition and/or results of operations, and these adverse impacts may be material. This summary is qualified in its entirety by reference to the more detailed descriptions of the risks and uncertainties included in this Item 1A below and you should read this summary together with those more detailed descriptions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These principal risk and uncertainties relate to, among other things: </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to the Operation of our Business</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the dynamic and evolving novel coronavirus pandemic;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the complex set of governmental laws, regulations and other requirements that impact us, including potential changes thereto;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations and audits and other legal matters that we may be subject to from time to time;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with complex privacy and information security laws that impact us and/or our ability to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our negotiations and arrangements with commercial payors, including with respect to value-based care and Medicare Advantage plans, the average rates that commercial payors pay us, any restrictions in plan designs or other contractual terms, including, without limitation, the scope and duration of coverage and in-network benefits;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number or percentage of our patients with higher-paying commercial insurance;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement our strategy with respect to home-based dialysis;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of and payment rates under government-based programs; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in clinical practices, payment rates or regulations impacting pharmaceuticals;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our acquisitions, mergers, joint ventures or dispositions;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain supply relationships that meet our needs at cost-effective prices or at prices that allow for adequate reimbursement as applicable, as well as our ability to access new technology or superior products in a cost-effective manner;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ancillary services and strategic initiatives, including without limitation, our international operations and our ability to expand within markets or to new markets, or invest in new products or services; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to appropriately estimate the amount of dialysis revenues and related refund liabilities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in physician referrals to our dialysis centers, whether due to governmental laws, regulations or other requirements, new competition, a perceived decrease in the quality of service levels at our centers or other reasons;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in labor costs, including, without limitation, due to shortages, changes in certification requirements and/or higher than normal turnover rates in skilled clinical personnel; or currently pending or future governmental laws, rules, regulations or initiatives;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain key leadership talent;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain employees or our ability to manage operating cost increase or productivity decreases whether due to union organizing activities or legislative or other changes;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to effectively maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely, including, without limitation, our clinical, billing and collections systems;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Risks</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our current or future level of indebtedness, including, without limitation, our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenants;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax laws, regulations and interpretations or challenges to our tax positions;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liability claims for damages and other expenses that are not covered by insurance or exceed our existing insurance coverage;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully maintain an effective internal control over financial reporting;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deterioration in economic conditions, disruptions in the financial markets or the effects of natural or other disasters, political instability, public health crises or adverse weather events such as hurricanes, earthquakes, fires or flooding, including as such events may be impacted by the effects of climate change; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provisions in our organizational documents, our compensation programs and policies and certain requirements under Delaware law that may deter changes of control or make it more difficult for our stockholders to change the composition of our Board of Directors and take other corporate actions that our stockholders would otherwise determine to be in their best interests.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_2875"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Operation of our Business</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disease caused by the novel coronavirus (COVID-19) is impacting the world and our business in many different ways. The ultimate impact of COVID-19 on us will depend on future developments that are highly uncertain and difficult to predict, including among other things, the severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; its impact on the chronic kidney disease (CKD) population and our patient population; the availability, acceptance, impact and efficacy of COVID-19 treatments, therapies and vaccines; the pandemic&#8217;s continuing impact on the U.S. and global economies and unemployment; the responses of our competitors to the pandemic and related changes in the marketplace; and the timing, scope and effectiveness of federal, state and local governmental responses. The impact could come in many forms, including but not limited to those described below.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;We have experienced and expect to continue to experience a negative impact on revenue and non-acquired growth from COVID-19 due to lower treatment volumes, including from the negative impact on our patient census that is the result of changes in rates of mortality. Because ESRD patients may be older and generally have comorbidities, several of which are risk factors for COVID-19, we believe the mortality rate of infected patients is, and will continue to be, higher in the dialysis population than in the general population, and COVID-19 also could impact the CKD population differentially. Over the longer term, we believe that changes in mortality in both the CKD and ESRD populations due to COVID-19 will depend primarily on the infection rate, case fatality rate, the age and health status of affected patients, the access to and efficacy of vaccinations as well as willingness to be vaccinated. We expect that these changes are likely to continue to negatively impact our revenue and non-acquired growth even as the pandemic subsides. However, determining the extent to which these impacts should be directly attributable to COVID-19 is difficult due to testing and reporting limitations, and other factors may drive treatment volumes and new admissions over time, such as the number of transplants or deferred admissions. The magnitude of these cumulative impacts has been substantial and, depending on the ultimate severity and duration of the pandemic could be material.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226; &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and efforts to contain the virus have led to global economic deterioration and rapid and sharp increases in unemployment levels, which ultimately could result in a materially reduced share of our patients being covered by commercial insurance plans, with more patients being covered by lower-paying government insurance programs or being uninsured. These effects may persist after the pandemic subsides as, among other things, our patients could experience permanent changes in their insurance coverage as a result of changes to their employment status. In the event such a material reduction occurs in the share of our patients covered by commercial insurance plans, it would have a material adverse impact on our business, results of operations, financial condition and cash flows. The extent of these effects will depend upon, among other things, the extent and duration of the increased unemployment levels for our patient population, economic deterioration and potential recession; the timing and scope of federal, state and local governmental responses to the ongoing pandemic; and patients&#8217; ability to retain existing insurance and their individual choices with respect to their coverage.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;We have dedicated and continue to dedicate substantial resources in response to COVID-19 and have had, and expect to continue to have, extended and significant additional costs in connection with our response to COVID-19. The steps we have taken designed to help safely maintain continuity of care for our patients and help protect our caregivers, such as our policies to implement dedicated care shifts for patients with confirmed or suspected COVID-19 and other enhanced clinical practices, have increased, and are expected to continue to increase, our expenses and use of personal protective equipment (PPE). Our response to COVID-19 also has resulted in higher salary and wage expense, and we have provided, and may provide in the future, substantial financial support associated with relief reimbursement to our teammates. Furthermore, the effort and cost needed to procure certain of our equipment and clinical supplies, including PPE, have increased, and we expect these increased costs will continue while the pandemic persists. These efforts are part of a wider Prepare, Prevent, Respond and Recover protocol that we have implemented in connection with the pandemic, which also includes operational initiatives such as the redistribution of teammates, machines and supplies across the country as needed and increased investment in and utilization of telehealth capabilities. Our response protocol generally has allowed us to maintain continuity of care for our patients. If the pandemic requires us to maintain certain restrictive operational protocols for an extended period of time, it may adversely impact our strategic initiatives, such as our strategy to continue to build o our abilities to offer home dialysis options. Certain temporary changes made in response to the COVID-19 pandemic could become permanent, which could have an adverse impact on our business. In addition, any equipment or clinical supply shortages, disruptions or delays or associated price increases could impact our ability to provide dialysis services or the cost of providing those services.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;We have had, and expect to continue to have, increased costs and risk associated with a high demand for our skilled clinical personnel. Historically we have faced costs and difficulties in hiring and retaining nurses and other caregivers due to a nationwide shortage of skilled clinical personnel, and these challenges have been heightened by the increased demand for and demand upon such personnel by the ongoing pandemic, particularly the more recent resurgence of the virus that is more widespread geographically, which, among other things, makes it more difficult for us to reallocate our resources to affected geographies. Any staffing shortages or disruptions could impact our ability to provide dialysis services or the cost of providing those services. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;If we experience a failure of the fitness of our clinical laboratory, dialysis centers and related operations and/or other facilities as a result of the COVID-19 pandemic, or another event or occurrence adversely impacts the safety of our caregivers or patients, we could face adverse consequences, including without limitation, material negative impact on our brand, increased litigation, compliance or regulatory investigations, teammate unrest, work stoppages or other workforce disruptions. Any legal actions brought by patients, teammates, caregivers or others allegedly exposed to COVID-19 at our facilities or by our caregivers may involve significant demands and require substantial legal defense costs, which may not be adequately covered by our professional and general liability insurance.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;If general economic conditions continue to deteriorate or remain uncertain for an extended period of time, we may incur future charges to recognize impairment in the carrying amount of our goodwill and other intangible assets. We may experience an increased need for additional liquidity funded by accessing existing credit facilities, raising new debt in the capital markets, or other sources, and we may seek to refinance existing debt, which may be more difficult or costly as a result of the pandemic&#8217;s impact on capital markets or on us. Furthermore, any extended billing or collection cycles, or deterioration in collectability of accounts receivable, will adversely impact our results of operations and cash flows. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;In our value-based care and other programs where we assume financial accountability for total patient cost, an increase in COVID-19 rates among patients could have an impact on total cost of care. This increase may in turn impact the profitability of those programs relative to their respective funding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;The global nature of the pandemic may have varying impacts on our ongoing operations outside the United States, and may impact our ability to expand our operations into other parts of the world.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government response to the pandemic has been wide-ranging and will continue to develop over time, particularly in light of the new federal administration. As a result, we may not be able to accurately predict the nature, timing or extent of resulting changes to the markets in which we conduct business or on the other participants that operate in those markets, or any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern our business. We believe that these changes may impact our business in a variety of ways, including but not limited to those described below.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226; &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our need, ability and willingness to use and retain any provider relief or other funds or assistance from the government, the consequences of our decisions with respect thereto, our ability to operate within any restrictions on our business or operations that may be imposed as a condition to participation in any government assistance programs, and the impact of any such programs on our competitors, all will depend, among other things, on the magnitude, timing and nature of COVID-19&#8217;s impact on the Company as well as the requirements of any such programs, which are uncertain. There can be no assurance that financial or other assistance will be available from the government if we have a need for such assistance in the future.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;State and local shelter in place and social distancing restrictions and guidance have required us to significantly increase the use of remote arrangements for our teammates and telehealth technology for our dialysis patients, which broadens our technology footprint for where and how protected health information is used or disclosed, and in turn increases our exposure to the various privacy and information security risks we face, such as the risk of "phishing" and other cybersecurity attacks and the risk of unauthorized dissemination of sensitive personal, proprietary or confidential information. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;We have worked with certain government agencies and other kidney care providers to respond to the COVID-19 pandemic, and in certain cases have sought waivers of regulatory requirements. For example, as part of our efforts to help cohort patients in line with guidance from the CDC, we have sought waivers of certain regulatory requirements related to the survey and acceleration of new clinics and entered into agreements with other kidney care providers to help ensure that patients can receive dialysis in an outpatient setting rather than a hospital. In addition, we are also working to help make COVID-19 vaccines available to patients and teammates, including through coordination with state and federal governments on direct vaccine distribution so that we can administer vaccines to our patients and teammates. These vaccines are currently available under emergency use authorizations and there can be no assurance that our patients and caregivers will choose to receive a COVID-19 vaccine or that the vaccines will prove to be as safe and effective as currently understood by the scientific community. In addition, we may encounter difficulties with the availability, storage of the vaccine, or administration of the vaccines, some of which have multiple dose requirements. We operate in a complex and highly regulated environment, and the novel nature of our COVID-19 response, including, for example, with respect to regulatory waivers and our administration of the newly developed COVID-19 vaccines, may increase our exposure to legal, regulatory and clinical risks.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing and other continued impacts and disruptions to our business as a result of the COVID-19 pandemic could have a material adverse impact on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition, results of operations, cash flows and/or liquidity. In addition, the COVID-19 pandemic heightens many of the other risks and uncertainties discussed herein. For additional information related to COVID-19 and its impact on our business, see the discussion in Part I, Item 1. Business under the headings, "COVID-19 and its impact on our business" and "Human Capital Management" and Part II, Item 7, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex regulatory environment with an extensive and evolving set of federal, state and local governmental laws, regulations and other requirements that apply to us. These laws, regulations and other requirements are promulgated and overseen by a number of different legislative, regulatory, administrative, and quasi-regulatory bodies, each of which may have varying interpretations, judgments or related guidance. As such, we utilize considerable resources on an ongoing basis to monitor, assess and respond to applicable legislative, regulatory and administrative requirements, but there is no guarantee that we will be successful in our efforts to adhere to all of these requirements. Laws, regulations and other requirements that apply to or impact our business include, but are not limited to:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare and Medicaid reimbursement statutes, rules and regulations (including, but not limited to, manual provisions, local coverage determinations, national coverage determinations, payment schedules and agency guidance); </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare and Medicaid provider requirements, including requirements associated with providing and updating certain information about the Medicare or Medicaid entity, as applicable, and its direct and indirect affiliates;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal fraud waste and abuse laws and analogous state laws;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the 21st Century Cures Act (the Cures Act);</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal Acquisition Regulations;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Foreign Corrupt Practices Act (FCPA); </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal and state antitrust and competition laws and regulations; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws related to the corporate practice of medicine;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">individualized state law requirements associated with the operation of our business; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state laws regarding the collection, use and disclosure of patient health information (e.g., Health Insurance Portability and Accountability Act of 1996 (HIPAA)) and the storage, handling, shipment, disposal and/or dispensing of pharmaceuticals and blood products and other biological materials.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have been subject to a five-year Corporate Integrity Agreement (CIA) with Office of Inspector General (OIG) for the U.S. Department of Health and Human Services (HHS). The term of the CIA expired on October 22, 2019, and we were notified on May 20, 2020 that the OIG had closed out its review. Any future penalties, sanctions or other consequences imposed on us could be more severe in certain circumstances if the OIG or a similar regulatory authority determines that we knowingly and repeatedly failed to comply with applicable laws, regulations or other requirements, and could adversely impact our results of operations or financial condition or could have a negative impact on our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing are each themselves comprised of numerous associated regulations or other requirements that have varying levels of impact on our business. If any of our personnel, representatives or operations are found to violate these or other laws, regulations or requirements, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation and stock price, including, among others:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of required certifications or suspension or exclusion from or termination of our participation in government programs (including, without limitation, Medicare, Medicaid and Center for Medicare and Medicaid Innovation (CMMI) demonstration programs); </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Refunds of amounts received in violation of law or applicable payment program requirements dating back to the applicable statute of limitation periods; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of licenses required to operate healthcare facilities or administer pharmaceuticals in the states in which we operate; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reductions in payment rates or coverage for dialysis and ancillary services and pharmaceuticals; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Criminal or civil liability, fines, damages or monetary penalties, which could be material and/or could materially harm our reputation or stock price; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposition of corporate integrity agreements or consent agreements; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enforcement actions, investigations, or audits by governmental agencies and/or state law claims for monetary damages by patients who believe their protected health information (PHI) has been used, disclosed or not properly safeguarded in violation of federal or state patient privacy laws, including, among others, HIPAA and the Privacy Act of 1974; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandated changes to our practices or procedures that significantly increase operating expenses that could subject us to ongoing audits and reporting requirements as well as increased scrutiny of our billing and business practices which could lead to potential fines, among other things;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Termination of various relationships and/or contracts related to our business, such as joint venture arrangements, medical director agreements, real estate leases and consulting agreements with physicians; and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Harm to our reputation which could negatively impact our business relationships and stock price, affect our ability to attract and retain patients, physicians and teammates, affect our ability to obtain financing and decrease access to new business opportunities, among other things. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the healthcare sector, including the dialysis industry, is also regularly subject to negative publicity, including as a result of governmental investigations, adverse media coverage and political debate surrounding industry regulation. Negative publicity, regardless of merit, regarding the dialysis industry generally, the U.S. healthcare system or DaVita in particular may adversely affect us. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16 to the consolidated financial statements included in this report for further details regarding certain pending legal proceedings and regulatory matters to which we are or may be subject from time to time, any of which may include allegations of violations of applicable laws, regulations and requirements</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the laws, regulations and other requirements that govern our business may continue to change over time, and there is no assurance that we will be able to accurately predict the nature, timing or extent of such changes or the impact of such changes on the markets in which we conduct business or on the other participants that operate in those markets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, the regulatory framework of the Patient Protection and Affordable Care Act and the Health Care Reconciliation Act of 2010, as amended (collectively, the ACA), and other healthcare reforms continue to evolve as a result of executive, legislative, regulatory and administrative developments and judicial proceedings. These changes shape the landscape for our current dialysis business as well as for emerging comprehensive and integrated kidney care markets. For example, an executive order issued in July 2019 (the 2019 Executive Order) directed CMS to create payment models through CMMI to evaluate the effects of creating payment incentives for the greater use of home-based dialysis and kidney transplants for those already on dialysis, improve quality of care for kidney patients and reduce expenditures. In addition, future legislative action related to, among other things, full capitation demonstration for ESRD may ultimately impact our ability to provide a competitive and successful integrated care program at scale. We have made and continue to make investments in building our integrated care capabilities, but there can be no assurances that initiatives such as this or similar legislation will be passed into law, and the ongoing COVID-19 pandemic may delay the progress of such initiatives. If such legislation is passed, there can be no assurances that we will be able to successfully execute on the required strategic initiatives that would allow us to provide a competitive and successful integrated care program on the broader scale contemplated by this legislation, and in the desired time frame. Additionally, the ultimate terms and conditions of any such potential legislation remain unclear. For example, our costs of care could exceed our associated reimbursement rates under such legislation. Any failure on our part to adequately implement strategic initiatives to adjust to any marketplace developments resulting from executive, legislative, regulatory or administrative changes such as these could have a material adverse impact on our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been multiple attempts to repeal or amend the ACA through legislative action and legal challenges, and the most recent challenge is currently before the U.S. Supreme Court. In the event the ACA is repealed or significantly altered, it would impact our business in a number of ways, some of which may be material. The outcome of this U.S. Supreme Court proceeding will likely impact the future viability of ACA policies and programs that impact our business, including, among others, Medicaid expansion, CMMI and the health insurance exchanges. For example, if an ACA repeal ends Medicaid expansion it could have an adverse impact on coverage available to our patients and if such a repeal impacts CMMI&#8217;s authority to implement innovative payment models, we may lose the investment of the resources we have dedicated to those programs. In addition, our revenue and operating income levels are highly sensitive to the percentage of our patients with higher-paying commercial health insurance and any legislative, regulatory or other changes that decrease the accessibility and availability, including the duration, of commercial insurance may have a material adverse impact on our business. The ACA's health insurance exchanges, which provide a marketplace for eligible individuals and small employers to purchase health insurance, initially increased the accessibility and availability of commercial insurance. In the event the exchange markets are significantly impaired as a result of legislative developments or other changes, it may adversely impact the percentage of our patients with higher-paying commercial health insurance, particularly if patients become unemployed due to factors related to the COVID-19 pandemic or otherwise and are unable to turn to the exchanges as an alternative to employer-based coverage. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the political environment resulting from the most recent election cycle may increase the likelihood of changes that would impact us, such as changes to the healthcare regulatory landscape or to the federal corporate tax rate. Examples of such potential changes could include, among other things, legislative developments or administrative decisions such as moving to a universal health insurance or "single payor" system whereby health insurance is provided to all Americans by the government, the availability of a &#8220;public health insurance option&#8221; similar to Medicare, government programs that impact access to Medicaid expansion or impact funding provided to families to purchase plans through the health insurance exchanges </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or changes to the eligibility age for Medicare beneficiaries. Some of these and other related changes could in turn impact the percentage of our patients with higher-paying commercial health insurance, impact the scope or terms of coverage under commercial health plans and increase our expenses, among other things. The timing of any legislative or executive action related to these potential initiatives remains uncertain, particularly in light of the ongoing COVID-19 pandemic, and as such, considerable uncertainty exists surrounding the continued development of the ACA and related regulations, programs and models, as well as similar healthcare reform measures and/or other changes that may be enacted at the federal and/or state level to laws, regulations and other requirements that govern our business.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we cannot predict the short- or long-term effects of legislative or regulatory changes, we believe that future market changes could result in, among other things, more restrictive commercial plans with lower reimbursement rates or higher deductibles and co-payments that patients may not be able to pay. To the extent that changes in statutes, regulations or related guidance or changes in other market conditions result in a reduction in the percentage of our patients with commercial insurance, limit the scope or nature of coverage through the exchanges or other health insurance programs or otherwise reduce reimbursement rates for our services from commercial and/or government payors, it could have a material adverse effect on our business, results of operations, financial condition and cash flows. For additional information on the impact of legislative or regulatory changes on the coverage and rates for our services and the percentage of our patients with commercial insurance, see the risk factors under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We continuously have ongoing negotiations with commercial payors, and if the average rates that commercial payors pay us decline significantly, if patients in commercial plans are subject to restriction in plan designs or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it would have a material adverse effect on our business, results of operations, financial condition and cash flows,"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If the number or percentage of patients with higher-paying commercial insurance declines, it could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The introduction of new or modified rules and regulations also generates continuous risks related to appropriate compliance. Changes to the continuously evolving healthcare regulatory landscape may also have the potential to generate opportunities with relative ease of entry for certain smaller and/or non-traditional providers and we may be competing with them for patients in an asymmetrical environment with respect to data and/or regulatory requirements given our status as an ESRD service provider. These opportunities may be enhanced by disruptions or changes to the healthcare regulatory landscape resulting from the ongoing global health crisis. For additional detail on our evolving competitive environment, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors, it could materially adversely affect our business, results of operations, financial condition and cash flows." </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, if we are unable to efficiently and effectively adjust to new or modified rules and regulations, including with respect to regulatory compliance, it may, among other things, erode our patient base or reimbursement rates and could otherwise have a material adverse impact on our business, results of operation, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have also been several state initiatives to limit payments to dialysis providers or impose other burdensome operational requirements, which, if passed, could have a material adverse impact on our business, results of operation, financial condition and cash flow. For instance, in 2020, voters in California considered a statewide ballot initiative that sought to impose certain regulatory requirements on dialysis clinics, including requirements related to physician staffing levels, clinical reporting, clinical treatment options and limitations on the ability to make decisions on closing or reducing services for dialysis clinics. While this ballot initiative was rejected by voters in 2020, we incurred substantial costs to oppose it. We may face ballot initiatives or other proposed regulations or legislation in California or other states in future years, which may require us to incur further substantial costs and which, if passed, could have a material adverse impact on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, there have also been rule making and legislative efforts at both the federal and state level regarding the use of charitable premium assistance for ESRD patients and may establish new conditions for coverage standards for dialysis facilities. For example, on October 13, 2019, a California bill (AB 290) was signed into law that limits the amount of reimbursement paid to certain providers for services provided to patients with commercial insurance who receive charitable premium assistance. The American Kidney Fund (AKF), an organization that provides charitable premium assistance, announced that it would be withdrawing from California as a result of AB 290. The implementation of AB 290 has been stayed pending resolution of legal challenges, but in the event AB 290 becomes effective and the AKF withdraws from California, it may cause other organizations that provide charitable premium assistance to withdraw from California, and we would expect an adverse impact on the ability of patients to afford Medicare premiums and Medicare supplemental and commercial coverage. We expect that such an adverse impact will in turn adversely impact our business, results of operations, financial condition and cash flows. Bills similar to AB 290 were introduced in Illinois (SB 600) and Oregon (SB 900) in 2019, but have not been successfully passed to date. If these or similar bills are introduced and implemented in other jurisdictions, and organizations that provide charitable premium assistance in those jurisdictions are similarly impacted, it could in the aggregate have a material adverse impact on our business, results of operations, financial condition and cash flows. For additional information on the impact of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreases to the percentage of our patients with commercial insurance, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If the number or percentage of patients with higher-paying commercial insurance declines, it could have a material adverse effect on our business, results of operations, financial condition and cash flows".</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, regulatory guidance, proposed legislation and ballot initiatives and any similar initiatives could restrict or prohibit the ability of patients with access to alternative coverage from selecting a marketplace plan on or off exchange, limit the amount of revenue that a dialysis provider can retain for caring for patients with commercial insurance, impose burdensome operational requirements, affect payments made to providers for services provided to patients who receive charitable premium assistance and/or otherwise restrict or prohibit the use of charitable premium assistance, or reduce the standards for network adequacy. In turn, these potential impacts could cause us to incur substantial costs to oppose any such proposed requirements or measures, impact our dialysis center development plans, and if passed and/or implemented, could materially reduce our revenues and increase our operating and other costs, adversely impact dialysis centers across the U.S. making certain centers economically unviable, lead to the closure of certain centers, restrict the ability of dialysis patients to obtain and maintain optimal insurance coverage and reduce the number of patients that select commercial insurance plans or MA plans for their dialysis care, among other things. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolving proposed or issued laws, requirements, rules and guidance that impact our business, including as may be described above, and any failure on our part to adequately adjust to any resulting marketplace developments, could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the information above describes statutory and regulatory provisions, it is qualified in its entirety by reference to the particular statutory and regulatory provisions that are referenced. For additional information related to the laws, rules and other regulations described above, please see Part I, Item 1 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business&#8211;Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of this Form 10-K. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are, and may in the future be, a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> suits, governmental investigations and audits and other legal matters, any of which could result in, among other things, substantial financial penalties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or awards against us, mandated refunds, substantial payments made by us, required changes to our business practices, exclusion from future participation in Medicare, Medicaid and other healthcare programs and possible criminal penalties, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, and may in the future be, subject to investigations and audits by governmental agencies and/or private civil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators and other lawsuits, demands, claims and legal proceedings, including, without limitation, investigations or other actions resulting from our obligation to self-report suspected violations of law.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responding to subpoenas, investigations and other lawsuits, claims and legal proceedings as well as defending ourselves in such matters will continue to require management's attention and cause us to incur significant legal expense. Negative findings or terms and conditions that we might agree to accept as part of a negotiated resolution of pending or future legal or regulatory matters could result in, among other things, substantial financial penalties or awards against us, substantial payments made by us, harm to our reputation, required changes to our business practices, exclusion from future participation in Medicare, Medicaid and other healthcare programs and, in certain cases, criminal penalties, any of which could have a material adverse effect on us. It is possible that criminal proceedings may be initiated against us and/or individuals in our business in connection with governmental investigations. Other than as may be described in Note 16 to the consolidated financial statements included in this report, we cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which we are or may be subject from time to time, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price. See Note 16 to the consolidated financial statements included in this report for further details regarding these and other legal proceedings and regulatory matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privacy and information security laws are complex, and if we fail to comply with applicable laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, or if we fail to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks, we may be subject to government or private actions due to privacy and security breaches or suffer losses to our data and information technology assets, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must comply with numerous federal and state laws and regulations in both the U.S. and the foreign jurisdictions in which we operate governing the collection, dissemination, access, use, security and privacy of PHI, including, without limitation, HIPAA and its implementing privacy, security, and related regulations, as amended by the federal Health Information Technology for Economic and Clinical Health Act (HITECH) and collectively referred to as HIPAA. We are also required to report known breaches of PHI and other certain personal information consistent with applicable breach reporting </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements set forth in applicable laws and regulations. From time to time, we may be subject to both federal and state inquiries or audits related to HIPAA, HITECH and other state privacy laws associated with complaints, desk audits, and data breaches. If we fail to comply with applicable privacy and security laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information, including PHI, on our behalf, properly maintain the integrity of our data, protect our proprietary rights, or defend against cybersecurity attacks, it could materially harm our reputation and/or have a material adverse effect on our business, results of operations, financial condition and cash flows. These risks may be intensified to the extent that the laws change or to the extent that we increase our use of third-party service providers that utilize sensitive personal information, including PHI, on our behalf.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data protection laws are evolving globally, and may continue to add additional compliance costs and legal risks to our international operations. In Europe, the General Data Protection Regulation (GDPR) imposes a comprehensive data protection regime with the potential for regulatory fines as well as data breach litigation by impacted data subjects. Under the GDPR, regulatory penalties may be assessed by data protection authorities for up to the greater of 4% of worldwide turnover or &#8364;20 million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data protection laws are also evolving nationally, and may add additional compliance costs and legal risks to our U.S. operations. For example, the California Consumer Privacy Act (CCPA) and California Privacy Rights Act (CPRA) have been passed into law in the past several years, and they collectively expand our obligations related to the collection, use and sharing of consumer data and also permit additional penalties, grant additional enforcement authority and authorize private rights of action. The costs of compliance with, and the burdens imposed by, the GDPR, the CCPA, the CPRA or other new laws, regulations or policies may impact our operations and/or limit the ways in which we can provide services or use personal data collected while providing services. If we fail to comply with the requirements of GDPR, the CCPA, the CPRA or other new laws, regulations or policies, we could be subject to penalties that, in some cases, would have a material adverse impact on our business, results of operations, financial condition and cash flows. For more information on regulations affecting our business, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business&#8211;Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Part I, Item 1 of this Form 10-K.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scrutiny over cybersecurity standards in the health sector is also increasing. In particular, the HHS Office for Civil Rights, in partnership with the Healthcare and Public Health Sector Coordinating Council (HSCC), recently issued cybersecurity guidelines for healthcare organizations that reflect consensus-based, voluntary practices to cost-effectively reduce cybersecurity risks for organizations of varying sizes. Although these HHS-backed guidelines, entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Health Industry Cybersecurity Practices: Managing Threats and Protecting Patients,"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are voluntary, they are likely to serve as an important reference point for the healthcare industry, and may cause us to invest additional resources in technology, personnel and programmatic cybersecurity controls as the cybersecurity risks we face continue to evolve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, the use of the Internet and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including, among others, foreign state agents. Our business and operations rely on the secure and continuous processing, transmission and storage of confidential, proprietary and other information in our computer systems and networks, including sensitive personal information, such as PHI, social security numbers, and/or credit card information of our patients, teammates, physicians, business partners and others. Our business and operations also rely on certain critical IT vendors that support such processing, transmission and storage (which have become more relevant and important given the information security issues and risks that are intensified through remote work arrangements).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review, monitor and implement multiple layers of security measures through technology, processes and our people. We utilize security technologies designed to protect and maintain the integrity of our information systems and data, and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, our facilities and systems and those of our third-party service providers may be vulnerable to privacy and security incidents; security attacks and breaches; acts of vandalism or theft; computer viruses and other malicious code; coordinated attacks by a variety of actors, including, among others, activist entities or state sponsored cyberattacks; emerging cybersecurity risks; cyber risk related to connected devices; misplaced or lost data; programming and/or human errors; or other similar events that could impact the security, reliability and availability of our systems. Internal or external parties may attempt to circumvent our security systems, and we have in the past, and expect that we will in the future, experience attacks on our network including, without limitation, reconnaissance probes, denial of service attempts, malicious software attacks including ransomware or other attacks intended to render our internal operating systems or data unavailable, and phishing attacks or business email compromise. Cybersecurity requires ongoing investment and diligence against evolving threats. Emerging and advanced security threats, including, without limitation, coordinated attacks, require additional layers of security which may disrupt or impact efficiency of operations. As with any security program, there always exists the risk that employees will violate our policies despite our compliance efforts or that certain attacks may be beyond the ability of our security and other systems to detect. There can be no assurance that investments, diligence and/or our internal controls will be sufficient to prevent or timely discover an attack.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any security breach involving the misappropriation, loss or other unauthorized disclosure or use of confidential information, including, among others, PHI, financial data, competitively sensitive information, or other proprietary data, whether by us or a third party, could have a material adverse effect on our business, results of operations, financial condition, cash flows and materially harm our reputation. We may be required to expend significant additional resources to modify our protective measures, to investigate and remediate vulnerabilities or other exposures, or to make required notifications. The occurrence of any of these events could, among other things, result in interruptions, delays, the loss or corruption of data, cessations in the availability of systems and liability under privacy and security laws, all of which could have a material adverse effect on our business, results of operations, financial condition and cash flows, or materially harm our reputation and trigger regulatory actions and private party litigation. If we are unable to protect the physical and electronic security and privacy of our databases and transactions, we could be subject to potential liability and regulatory action, our reputation and relationships with our patients, physicians, vendors and other business partners would be harmed, and our business, results of operations, financial condition and cash flows could be materially and adversely affected. Failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or to defend against cybersecurity attacks, could subject us to monetary fines, civil suits, civil penalties or criminal sanctions and requirements to disclose the breach publicly, and could further result in a material adverse effect on our business, results of operations, financial condition and cash flows or harm our reputation. As malicious cyber activity escalates, including activity that originates outside of the U.S., and as our COVID-19 response increases our remote work arrangements and broadens our technology footprint, the risks we face relating to transmission of data and our use of service providers outside of our network, as well as the storing or processing of data within our network, intensify. There have been increased international, federal and state and other privacy, data protection and security enforcement efforts and we expect this trend to continue. While we plan to maintain cyber liability insurance, there can be no assurance that we will successfully be able to obtain such insurance on terms and conditions that are favorable to us or at all. Additionally, any cyber liability insurance may not cover us for all types of losses and may not be sufficient to protect us against the amount of all losses.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We continuously have ongoing negotiations with commercial payors, and if the average rates that commercial payors pay us decline significantly, if patients in commercial plans are subject to restriction in plan designs or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it would have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our U.S. dialysis net patient services revenues for the year ended December 31, 2020 was generated from patients who have commercial payors (including hospital dialysis services) as their primary payor. The majority of these patients have insurance policies that pay us on terms and at rates that are generally significantly higher than Medicare rates. The payments we receive from commercial payors generate nearly all of our profit and all of our nonacute dialysis profits come from commercial payors. We continue to experience downward pressure on some of our commercial payment rates as a result of general conditions in the market, including as employers shift to less expensive options for medical services, as a result of consolidations among commercial payors, increased focus on dialysis services and other factors. Commercial payment rates could be materially lower in the future due to these or other factors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continuously are in the process of negotiating existing and potential new agreements with commercial payors who aggressively negotiate terms with us, and we can make no assurances about the ultimate results of these negotiations or the timing of any potential rate changes resulting from these negotiations. Sometimes many significant agreements are being renegotiated at the same time. In the event that our ongoing negotiations result in overall commercial rate reductions in excess of overall commercial rate increases, the cumulative effect could have a material adverse effect on our business, results of operations, financial condition and cash flows. We believe payor consolidations have significantly increased the negotiating leverage of commercial payors, and ongoing consolidations may continue to increase this leverage in the future. Our negotiations with payors occur in a highly competitive environment and are also influenced by these marketplace dynamics, and we may experience decreased contracted rates with commercial payors or experience decreases in patient volume, including in instances where we are unable to come to agreement with commercial payors on rates, as our negotiations with commercial payors continue. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our negotiations with commercial payors may relate to commercial fee-for-service contracts, value-based care (VBC) contracts in which we share risk with commercial payors, as well as contracts to provide dialysis services to Medicare Part C Medicare Advantage (MA) patients. If we fail to maintain contracts with payors and other healthcare providers with competitive or favorable terms, either with respect to commercial plans, commercial VBC contracts, MA plans or otherwise, including, without limitation, with respect to reimbursement rates, scope and duration of coverage and in-network benefits, or if we fail to accurately estimate the price for and manage our medical costs in an effective manner such that the profitability of our value-based products is negatively impacted, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These negotiations may also be impacted by legislative or regulatory developments and associated legal rulings. For example, the final rules for the Cures Act included a provision that, effective January 1, 2021, allows Medicare-eligible beneficiaries with ESRD to choose coverage under a MA managed care plan. This provision could broaden patient access to certain enhanced benefits offered by MA plans. MA plans usually provide reimbursement to us at a negotiated rate that is generally higher than Medicare fee-for-service rates. We continue to evaluate the potential ultimate impact of this change in benefit eligibility, as there is significant uncertainty as to how many or which newly eligible ESRD patients will seek to enroll in MA plans for their ESRD benefits and how quickly any such changes would occur. This uncertainty may be heightened by components of the aforementioned final rules, which include a provision that, among other things, removes the objective time and distance standards relating to network adequacy for outpatient dialysis centers for MA plans. If MA plans attempt to use this revision to the rules to limit or restrict their networks, this may adversely impact the number of ESRD patients that select MA plans and also may result in the Company not being an in-network provider for significant MA plans. If kidney patients choose not to enroll in MA plans or choose to leave MA plans, whether due to network adequacy standards or otherwise, or if we fail to provide education to kidney patients in the manner specified by CMS, we could be subject to certain clinical, operational, financial and legal risks, which could have a material adverse effect on our business, results of operations, financial condition and cash flows. In addition, recent price and patient responsibility transparency regulations require health plans to make certain pricing and patient responsibility information publicly available. Certain of the requirements went into effect January 1, 2021 while others will go into effect January 1, 2024. There is a possibility that any changes by health plans resulting from these regulations could impact our revenue and results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain payors have also been attempting to design and implement plans that restrict access to ESRD coverage both in the commercial and individual market. Among other things, these restrictive plan designs seek to limit the duration and/or the breadth of ESRD benefits, limit the number of in-network providers, set arbitrary provider reimbursement rates, or otherwise restrict access to care, all of which may result in a decrease in the number of patients covered by commercial insurance. Payors have also disputed the scope and duration of ESRD benefit coverage under their plans. Any of the foregoing, including developments in plan design or new business activities of commercial payors, may lead to a significant decrease in the number of patients with commercial plans, the duration of benefits for patients under commercial plans and/or a significant decrease in the payment rates we receive, any of which would have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some commercial payors are pursuing or have incorporated policies into their provider manuals limiting or refusing to accept charitable premium assistance from non-profit organizations, such as the American Kidney Fund, which may impact the number of patients who are able to afford commercial plans. Paying for coverage is a significant financial burden for many patients, and ESRD disproportionately affects the low-income population. Charitable premium assistance supports continuity of coverage and access to care for patients, many of whom are unable to continue working full-time as a result of their severe condition. A material restriction in patients' ability to access charitable premium assistance may restrict the ability of dialysis patients to obtain and maintain optimal insurance coverage, and may have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional details regarding the impact of a decline in our patients under commercial plans, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If the number or percentage of patients with higher-paying commercial insurance declines, it could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For additional details regarding specific risks we face regarding potential legislative or regulatory changes that, among other things, could result in fewer patients covered under commercial plans or an increase of patients covered under more restrictive commercial plans with lower reimbursement rates, see the discussion in the risk factor under the headings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" and "Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If the number or percentage of patients with higher-paying commercial insurance declines, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue levels are sensitive to the number of our patients with higher-paying commercial insurance coverage and the percentage of our patients under higher-paying commercial plans relative to government-based programs. A patient's insurance coverage may change for a number of reasons, including changes in the patient's or a family member's employment status. A material portion of our commercial revenue is concentrated with a limited number of commercial payors, and any changes impacting our highest paying commercial payors will have a disproportionate impact on us. In addition, many patients with commercial and government insurance rely on financial assistance from charitable organizations, such as the American Kidney Fund. Certain payors have challenged our patients' and other providers' patients' ability to utilize assistance from charitable organizations for the payment of premiums, including, without limitation, through litigation and other legal proceedings. The </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">use of charitable premium assistance for ESRD patients has also faced challenges and inquiries from legislators, regulators and other governmental authorities, and this may continue. In addition, CMS or another regulatory agency or legislative authority may issue a new rule or guidance that challenges or restricts charitable premium assistance. For additional details, see the risk factor under the headings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" and "Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these challenges to kidney patients' use of premium assistance is successful or restrictions are imposed on the use of financial assistance from such charitable organizations or if organizations providing such assistance are no longer available such that kidney patients are unable to obtain, or continue to receive or receive for a limited duration, such financial assistance, it could have a material adverse effect on our business, results of operations, financial condition and cash flows. In addition, if our assumptions about how kidney patients will respond to any change in financial assistance from charitable organizations are incorrect, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Medicare becomes the primary payor for a patient, the payment rate we receive for that patient decreases from the employer group health plan or commercial plan rate to the lower Medicare payment rate. If the number of our patients who have Medicare or another government-based program as their primary payor increases, it could negatively impact the percentage of our patients covered under commercial insurance plans. There are a number of factors that could drive a decline in the percentage of our patients covered under commercial insurance plans, including, among others, a continued decline in the rate of growth of the ESRD patient population, continued improved mortality or the reduced availability of commercial health plans or reduced coverage by such plans through the ACA exchanges or otherwise due to changes to the marketplace, healthcare regulatory system or otherwise. Commercial payors could also cease paying in the primary position after providing 30 months of coverage resulting in potentially material reductions in payment as the patient moves to Medicare primary. Moreover, declining macroeconomic conditions, such as, for example, those resulting from the ongoing COVID-19 pandemic, could also negatively impact the percentage of our patients covered under commercial insurance plans. To the extent there are sustained or increased job losses in the U.S., we could experience a decrease in the number of patients covered under commercial plans and/or an increase in uninsured and underinsured patients independent of whether general economic conditions improve. If we experience higher numbers of uninsured or underinsured patients, it also would result in an increase in uncollectible accounts. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the ultimate results of our continual negotiations with commercial payors under existing and potential new agreements cannot be predicted and, among other things, could result in a decrease in the number of our patients covered by commercial plans to the extent that we cannot reach agreement with commercial payors on rates and other terms, resulting in termination or non-renewals of existing agreements and our inability to enter into new agreements. Our agreements and rates with commercial payors may be impacted by new business activities of these commercial payors as well as steps that these commercial payors have taken and may continue to take to control the cost of and/or the eligibility for access to the services that we provide, including, without limitation, relative to products on and off the healthcare exchanges. These efforts could impact the number of our patients who are eligible to enroll in commercial insurance plans, and remain on the plans, including plans offered through healthcare exchanges. For additional detail on the risks related to commercial payor activity, including restrictive plan design, see the discussion under the headin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We continuously have ongoing negotiations with commercial payors, and if the average rates that commercial payors pay us decline significantly, if patients in commercial plans are subject to restriction in plan designs or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it would have a material adverse effect on our business, results of operations, financial condition and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" We could also experience a further decrease in the payments we receive for services if changes to the marketplace or the healthcare regulatory system result in fewer patients covered under commercial plans or an increase of patients covered under more restrictive commercial plans with lower reimbursement rates, among other things.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there is a significant reduction in the number of patients under higher-paying commercial plans relative to government-based programs that pay at lower rates or a significant increase in the number of patients that are uninsured and underinsured, it would have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not able to successfully implement our strategy with respect to home-based dialysis, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, it could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our home-based dialysis services, which include home hemodialysis and peritoneal dialysis (PD), represented approximately 17% of our U.S. dialysis patient services revenues for the year ended December 31, 2020, and have increasingly </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">become an important part of our overall strategy. In addition, home-based dialysis recently has been the subject of increased political and industry focus. For example, in connection with the 2019 Executive Order, HHS set out specific goals related to home dialysis and CMMI&#8217;s ESRD Treatment Choices mandatory payment model (ETC) included new incentives to encourage dialysis at home. We are a leader in home-based dialysis and have made investments in processes and infrastructure to continue to grow this modality. There are, however, risks associated with this growth, including, among other things, financial, legal and operational risks related to our ability to design and develop infrastructure and to plan for capacity in a modality that is part of an evolving marketplace. We may also be subject to associated risks related to our ability to successfully manage related operational initiatives, find, train and retain appropriate staff, contract with payors for appropriate reimbursement, and maintain processes to adhere to the complex regulatory and legal requirements, including without limitation those associated with billing Medicare. For additional detail on risks associated with operating in a highly regulated environment, see "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to the above risks, certain risks inherent to home-based dialysis will increase as we expand our home-based dialysis offerings, including risks related to managing transitions between in-center and home-based dialysis, billing and telehealth systems, among others. For additional detail on risks associated with information systems and new technology generally, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Failing to effectively maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely, including, without limitation, our clinical, billing and collections systems could materially adversely affect our business, results of operations, financial condition and cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increased focus on home-based dialysis is also indicative of the generally evolving market for kidney care. This developing market may create additional opportunities for competition with relative ease of entry, and if we are unable to successfully adapt to these marketplace developments in a timely and compliant manner, we may see a reduction in our overall number of patients, among other things. Our response to the COVID-19 pandemic has also required us to impose certain operational restrictions that may adversely impact certain home-based dialysis initiatives, and the extent of this impact may depend on the severity or duration of the pandemic, among other things. For additional detail on the competitive landscape in kidney care, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors, it could materially adversely affect our business, results of operations, financial condition and cash flows,"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and for additional detail on the impact of COVID-19 on our home-based dialysis business, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us."</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to successfully implement our strategy with respect to home-based dialysis, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, it could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in the structure of and payment rates under the Medicare ESRD program could have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our dialysis revenues are generated from patients who have Medicare as their primary payor. For patients with Medicare coverage, all ESRD payments for dialysis treatments are currently made under a single bundled payment rate which provides a fixed payment rate to encompass all goods and services provided during the dialysis treatment that are related to the treatment of dialysis, subject to certain adjustments as described below. Most lab services are also included in the bundled payment. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the ESRD Prospective Payment System (PPS), bundled payments to a dialysis facility may be reduced by as much as 2% based on the facility's performance in specified quality measures set annually by CMS through the ESRD Quality Incentive Program, which was established by the Medicare Improvements for Patients and Providers Act of 2008. The bundled payment rate is also adjusted for certain patient characteristics, a geographic usage index and certain other factors. In addition, the ESRD PPS is subject to rebasing, which can have a positive financial effect, or a negative one if the government fails to rebase in a manner that adequately addresses the costs borne by dialysis facilities. Similarly, as new drugs, services or labs are added to the ESRD bundle, CMS' failure to adequately calculate the costs associated with the drugs, services or labs could have a material adverse effect on our business, results of operations, financial condition and cash flows. In certain instances, new injectable, intravenous or oral products may be reimbursed separately from the bundled payment through a transitional drug add-on payment adjustment (TDAPA). For a discussion of certain risks associated with this transitional pricing process, see the risk factor under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in clinical practices, payment rates or regulations impacting pharmaceuticals could have a material adverse effect on our business, results of operations, financial condition, and cash flows and negatively impact our ability to care for patients."</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current bundled payment system presents certain operating, clinical and financial risks, which include, without limitation:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that our rates are reduced by CMS. CMS publishes a final rule for the ESRD PPS each year and uncertainty about future payment rates remains a material risk to our business.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that CMS, on its own or through its contracted Medicare Administrative Contractors (MACs) or otherwise, implements Local Coverage Determinations (LCDs) or implements payment provisions, policy or regulatory mandates, including changes to the existing or future PPS, that limit our ability to either be paid for covered dialysis services or bill for treatments or other drugs and services or other rules that may impact reimbursement. Such payment rules and regulations and coverage determinations or related decisions could have an adverse impact on our operations and revenue. There is also risk commercial insurers could seek to incorporate the requirements or limitations associated with such LCDs or CMS guidance into their contracted terms with dialysis providers, which could have an adverse impact on our revenue. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that a MAC, or multiple MACs, change their interpretations of existing regulations, manual provisions and/or guidance, or seek to implement or enforce new interpretations that are inconsistent with how we have interpreted existing regulations, manual provisions and/or guidance.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that CMS implements data and related reporting requirements that result in decreased reimbursement and/or increased technology and operational costs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that increases in our operating costs will outpace the Medicare rate increases we receive. We expect operating costs to continue to increase due to inflationary factors, such as increases in labor and supply costs, including, without limitation, increases in maintenance costs and capital expenditures to improve, renovate and maintain our facilities, equipment and information technology to meet changing regulatory requirements and business needs, regardless of whether there is a compensating inflation-based increase in Medicare payment rates or in payments under the bundled payment rate system. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of continued federal budget sequestration cuts or other disruptions in federal government operations and funding. As a result of the Budget Control Act of 2011, the Bipartisan Budget Act (BBA) and the CARES Act, an annual 2% reduction to Medicare payments took effect on April 1, 2013, and has been extended through 2030 (though the reduction was temporarily suspended from May 1, 2020 through March 31, 2021 in connection with COVID-19 relief related legislation). These across-the-board spending cuts have affected and will continue to adversely affect our business, results of operations, financial condition and cash flows. Any extended disruption in federal government operations and funding, including an extended government shutdown, U.S. government debt default and/or failure of the U.S. government to enact annual appropriations could have a material adverse effect on our business, results of operations, financial condition and cash flows. Additionally, disruptions in federal government operations may delay or negatively impact regulatory approvals and guidance that are important to our operations, and create uncertainty about the pace of upcoming regulatory developments.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that failure to adequately develop and maintain our clinical systems or failure of our clinical systems to operate effectively could have a material adverse effect on our business, results of operations, financial condition and cash flows. For example, in connection with claims for which at least part of the government's payments to us is based on clinical performance or patient outcomes or co-morbidities, if our clinical systems fail to accurately capture the data we report to CMS or we otherwise have data integrity issues with respect to the reported information, we might be over-reimbursed by the government, which could, among other things, subject us to liability exclusion from participation in federal healthcare programs, and penalties under the federal Civil Monetary Penalty statute and could adversely impact our reputation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to similar risks for services billed separately from the ESRD bundled payment, including, without limitation, the risk that a MAC, or multiple MACs, change their interpretations of existing regulations, manual provisions and/or guidance; or seek to implement or enforce new interpretations that are inconsistent with how we have interpreted existing regulations, manual provisions and/or guidance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above risks under the current Medicare ESRD program, changing legislation and other regulatory and executive developments have led and may continue to lead to the emergence of new models of care and other initiatives in both the government and private sector that, among other things, may impact the structure of, and payment rates under, the Medicare ESRD program. Moreover, the number of our patients with primary Medicare coverage may be subject to change, particularly with the effectiveness of the Cures Act, which allows Medicare-eligible individuals with ESRD to enroll in Medicare Part C MA managed care plans. For additional details regarding the risks we face for failing to adhere to our Medicare and Medicaid </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory compliance obligations or failing to adequately implement strategic initiatives to adjust to marketplace developments, see the risk factor above under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" and "Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in clinical practices, payment rates or regulations impacting pharmaceuticals could have a material adverse effect on our business, results of operations, financial condition, and cash flows and negatively impact our ability to care for patients.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare bundles certain pharmaceuticals into the ESRD PPS payment rate at industry average doses and prices. Variations above the industry average may be subject to partial reimbursement through the PPS outlier reimbursement policy.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to industry averages, which can be caused by, among other things, changes in physician prescribing practices, including in response to the introduction of new drugs, treatments or technologies, changes in best and/or accepted clinical practice, changes in private or governmental payment criteria regarding pharmaceuticals, or the introduction of administration policies may negatively impact our ability to obtain sufficient reimbursement levels for the care we provide, which could have a material adverse effect on our business, results of operations, financial condition and cash flows. Physician practice patterns, including their independent determinations as to appropriate pharmaceuticals and dosing, are subject to change, including, for example, as a result of changes in labeling of pharmaceuticals or the introduction of new pharmaceuticals. Additionally, commercial payors have increasingly examined their administration policies for pharmaceuticals and, in some cases, have modified those policies. If such policy and practice trends or other changes to private and governmental payment criteria make it more difficult to preserve our margins per treatment, it could have a material adverse effect on our business, results of operations, financial condition and cash flows. Further, increased utilization of certain pharmaceuticals whose costs are included in a bundled reimbursement rate, or decreases in reimbursement for pharmaceuticals whose costs are not included in a bundled reimbursement rate, could also have a material adverse effect on our business, results of operation, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations and processes impacting reimbursement for pharmaceuticals and any changes thereto could similarly affect our operating results. For example, from January 1, 2018 to December 31, 2020, calcimimetics was part of the Medicare Part B payment and was subject to a TDAPA period prior to being incorporated into the payment bundle on January 1, 2021. During this transitional period, the wider availability of generic supplies of oral calcimimetics drove the acquisition cost of that drug down, which in turn lowered associated reimbursement rates and led to significant fluctuations in our levels of operating income. In addition, we anticipate that a hypoxia-inducible factor (HIF) product could be approved by the FDA and available to the market during 2021, but as of the date hereof, the timing and details of such an approval, including the contents of the applicable FDA label, remain uncertain. We expect that HIF products will be subject to a TDAPA period prior to being incorporated into the payment bundle. We are developing operational and clinical processes designed to provide the drug as may be required under the applicable regulations and as may be prescribed by physicians and also are working to contract with manufacturers of drug(s) to establish terms and access to the product, as well as payors, as applicable, for reimbursement and/or administration of the drug. If HIF products are approved, we could experience significant fluctuations in our associated levels of operating income and could be subject to material financial, operational and/or legal risk if we are not adequately reimbursed for the cost of the drug, if we are unable to implement effective and appropriate operational measures to distribute the drug, if we fail to implement appropriate storage and diversion controls or if we cannot obtain competitive pricing for the HIF, the aggregate impact of these risks could have a material adverse effect on our business, results of operation, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar operating and clinical rigor and appropriate processes will be needed for other potential new drugs, treatments or technologies that are approved and come onto the market. Any failure to successfully contract with manufacturers for competitive pricing, failure to successfully contract with the government or other payors for appropriate reimbursement, or failure to prepare, develop and implement processes that provide for appropriate availability and use in our clinics could have a material adverse impact on our business, results of operations, financial condition and cash flows. Additionally, as new kidney care drugs, treatments or technologies are introduced over time, we expect that the use of transitional payment adjustments to incorporate certain of these new drugs, treatments or technologies as defined by the CMS policy into the bundled Medicare Part B ESRD payment may lead to fluctuations in associated levels of operating income and risk that the reimbursement levels of such drugs, treatments or technologies may not adequately cover our cost to obtain the drug or other associated costs. Drivers of these risks include, among other things, the risk that CMS may not provide adequate funding in the Medicare Part B ESRD payment in the post-transitional period or such items are not covered by transitional add on pricing, in which case there may be </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">less clarity on the reimbursement, either of which may in turn materially adversely impact our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be subject to increased inquiries or audits from a variety of governmental bodies or claims by third parties related to pharmaceuticals, which would require management's attention and could result in significant legal expense. Any negative findings could result in, among other things, substantial financial penalties or repayment obligations, the imposition of certain obligations on and changes to our practices and procedures as well as the attendant financial burden on us to comply with the obligations, or exclusion from future participation in the Medicare and Medicaid programs, and could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation. For additional details, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in state Medicaid or other non-Medicare government-based programs or payment rates could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primary coverage for a significant number of our patients comes from state Medicaid programs partially funded by the federal government as well as other non-Medicare government-based programs, such as coverage through the Department of Veterans Affairs (VA). As state governments and other governmental organizations face increasing financial hardship and budgetary pressure, including as a result of the COVID-19 pandemic, we may in turn face reductions in payment rates, delays in the receipt of payments, limitations on enrollee eligibility or other changes to the applicable programs. For example, certain state Medicaid programs and the VA have recently considered, proposed or implemented payment rate reductions. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The VA adopted Medicare's bundled PPS pricing methodology for any veterans receiving treatment from non-VA providers under a national contracting initiative. Since we are a non-VA provider, these reimbursements are tied to a percentage of Medicare reimbursement, and we have exposure to any dialysis reimbursement changes made by CMS. Approximately 3% of our U.S. dialysis net patient services revenues for the year ended December 31, 2020 were generated by the VA.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we entered into a Nationwide Dialysis Services contract with the VA that includes five separate one-year renewal periods throughout the term of the contract. The term structure is similar to our prior five-year agreement with the VA, and is consistent with VA practice for similar provider agreements. With this contract award, the VA has agreed to keep our percentage of Medicare reimbursement consistent with that under our prior agreement with the VA during the term of the contract. As with that prior agreement, this agreement provides the VA with the right to terminate the agreements without cause on short notice, among other things. Should the VA renegotiate, not renew or cancel these agreements for any reason, we may cease accepting patients under this program and may be forced to close centers or experience lower reimbursement rates, which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Medicaid programs are increasingly adopting Medicare-like bundled payment systems, but sometimes these payment systems are poorly defined and are implemented without any claims processing infrastructure, or patient or facility adjusters. If these payment systems are implemented without any adjusters and claims processing infrastructure, Medicaid payments will be substantially reduced and the costs to submit such claims may increase, which will have a negative impact on our business, results of operations, financial condition and cash flows. In addition, some state Medicaid program eligibility requirements mandate that citizen enrollees in such programs provide documented proof of citizenship. If our patients cannot meet these proof of citizenship documentation requirements, they may be denied coverage under these programs, resulting in decreased patient volumes and revenue. These Medicaid payment and enrollment changes, along with similar changes to other non-Medicare government programs, could reduce the rates paid by these programs for dialysis and related services, delay the receipt of payment for services provided and further limit eligibility for coverage which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors, it could materially adversely affect our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient retention and the continued referrals of patients from referral sources such as hospitals and nephrologists, as well as acquisitions, are some of the important parts of our growth strategy. In our U.S. dialysis business, we continue to face intense competition from large and medium-sized providers, among others, which compete directly with us for the limited acquisition targets as well as for individual patients and physicians qualified to serve as medical directors. U.S. regulations require medical directors for each center. As we and our competitors continue to grow and open new dialysis centers, we may not be able to retain an adequate number of nephrologists to serve as medical directors. Competition in existing and expanding geographies or areas is intense, and is not limited to large competitors with substantial financial resources or to established participants in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dialysis space. We also compete with individual nephrologists who have opened their own dialysis units or facilities. Moreover, as we continue our expansion into various international markets, we will continue to face competition from large and medium-sized providers, among others, for acquisition targets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Fresenius Medical Group, our largest competitor, manufactures a full line of dialysis supplies and equipment in addition to owning and operating dialysis centers. This may, among other things, give it cost advantages over us because of its ability to manufacture its own products. See further discussion regarding risks associated with our suppliers and new technologies under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If certain of our suppliers do not meet our needs, if there are material price increases on supplies, if we are not reimbursed or adequately reimbursed for drugs we purchase or if we are unable to effectively access new technology or superior products, it could negatively impact our ability to effectively provide the services we offer and could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to traditional dialysis providers, there have been a number of announcements by non-traditional dialysis providers and others, which relate to entry into the dialysis and pre-dialysis space, the development of innovative technologies, or the commencement of new business activities that could be disruptive to the industry. Some of these new entrants have considerable financial resources. Although these and other potential competitors may face operational or financial challenges, the highly-competitive and evolving dialysis and pre-dialysis marketplaces have presented some opportunities for relative ease of entry for these and other potential competitors. As a result, we may compete with these smaller or non-traditional providers or others in an asymmetrical environment with respect to data and regulatory requirements that we face as an ESRD service provider, thereby negatively impacting our ability to effectively compete. These and other factors have continued to drive change in the dialysis and pre-dialysis space, and if we are unable to successfully adapt to these dynamics, it could have a material adverse impact on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, each of the aforementioned competitive pressures and related risks may be impacted by a continued decline in the rate of growth of the ESRD patient population, higher mortality rates for dialysis patients or other reductions in demand for dialysis treatments. The recent 2020 annual data report from the United States Renal Data System (USRDS) suggests that the rate of growth of the ESRD patient population is declining relative to long term trends. A number of factors may impact ESRD growth rates, including, without limitation, the aging of the U.S. population, incidence rates for diseases that cause kidney failure such as diabetes and hypertension, transplant rates, mortality rates for dialysis patients and growth rates of minority populations with higher than average incidence rates of ESRD. Certain of these factors, in particular the mortality rates for dialysis patients, have been impacted by the COVID-19 pandemic. The magnitude of these cumulative COVID-19 related impacts on our patient census and treatment volumes has been substantial and depending on the ultimate severity and duration of the pandemic, could be material. For additional information, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Changes in the structure of and payment rates under the Medicare ESRD program could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to effectively implement our growth strategy, including by making acquisitions at the desired pace or at all; if we are not able to continue to maintain the expected or desired level of non-acquired growth; or if we experience significant patient attrition either as a result of new business activities in the dialysis or pre-dialysis space by our existing competitors, other market participants, new entrants, new technology or other forms of competition, or as a result of reductions in demand for dialysis treatments, including, without limitation, due to increased mortality rates for dialysis patients resulting from COVID-19 or otherwise, reduced prevalence of ESRD or an increase in the number of kidney transplants, it could materially adversely affect our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may engage in acquisitions, mergers, joint ventures or dispositions, which may materially affect our results of operations, debt-to-capital ratio, capital expenditures or other aspects of our business, and, under certain circumstances, could have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy includes growth through acquisitions of dialysis centers and other businesses, as well as through entry into joint ventures. We may engage in acquisitions, mergers, joint ventures or dispositions or expand into new business lines or models, which may affect our results of operations, debt-to-capital ratio, capital expenditures or other aspects of our business. There can be no assurance that we will be able to identify suitable acquisition targets or merger partners or buyers for dispositions or that, if identified, we will be able to agree to terms with merger partners, acquire these targets or make these dispositions on acceptable terms or on the desired timetable. There can also be no assurance that we will be successful in completing any acquisitions, mergers or dispositions that we announce, executing new business lines or models or integrating any acquired business into our overall operations. There is no guarantee that we will be able to operate acquired businesses successfully as stand-alone businesses, or that any such acquired business will operate profitably or will not otherwise have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation. In addition, acquisition, merger or joint venture activity conducted as part of our overall growth strategy is subject to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">antitrust and competition laws, and antitrust regulators can investigate future (or pending) and consummated transactions. These laws could impact our ability to pursue these transactions, and under certain circumstances, could result in mandated divestitures, among other things. If a proposed transaction or series of transactions is subject to challenge under antitrust or competition laws, we may incur substantial legal costs, management&#8217;s attention and resources may be diverted, and if we are found to have violated these or other related laws, regulations or requirements, we could suffer severe consequences that could have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation and stock price. For additional detail, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Further, we cannot be certain that key talented individuals at the business being acquired will continue to work for us after the acquisition or that they will be able to continue to successfully manage or have adequate resources to successfully operate any acquired business. In addition, certain of our acquired dialysis centers and facilities have been in service for many years, which may result in a higher level of maintenance costs. Further, our facilities, equipment and information technology may need to be improved or renovated to maintain or increase operational efficiency, compete for patients and medical directors, or meet changing regulatory requirements. Increases in maintenance costs and/or capital expenditures could have, under certain circumstances, a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Businesses we acquire may have unknown or contingent liabilities or liabilities that are in excess of the amounts that we originally estimated, and may have other issues, including, without limitation, those related to internal controls over financial reporting or issues that could affect our ability to comply with healthcare laws and regulations and other laws applicable to our expanded business, which could harm our reputation. As a result, we cannot make any assurances that the acquisitions we consummate will be successful. Although we generally seek indemnification from the sellers of businesses we acquire for matters that are not properly disclosed to us, we are not always successful. In addition, even in cases where we are able to obtain indemnification, we may discover liabilities greater than the contractual limits, the amounts held in escrow for our benefit (if any), or the financial resources of the indemnifying party. In the event that we are responsible for liabilities substantially in excess of any amounts recovered through rights to indemnification or alternative remedies that might be available to us, or any applicable insurance, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the terms of the equity purchase agreement for the DMG sale (the DMG sale agreement), we agreed to certain indemnification obligations, including with respect to claims for breaches of our representations and warranties regarding compliance with law, litigation, absence of undisclosed liabilities, employee benefit matters, labor matters, or taxes, among others, and other claims for which we provided the buyer with a special indemnity. As a result, we may become obligated to make payments to the buyer relating to our previous ownership and operation of the DMG business. Any such post-closing liabilities and required payments under the DMG sale agreement, or otherwise, or in connection with any other past or future disposition of material assets or businesses could individually or in the aggregate have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, joint ventures, including, without limitation, our Asia Pacific joint venture, and minority investments inherently involve a lesser degree of control over business operations, thereby potentially increasing the financial, legal, operational and/or compliance risks associated with the joint venture or minority investment. In addition, we may be dependent on joint venture partners, controlling shareholders or management who may have business interests, strategies or goals that are inconsistent with ours. Business decisions or other actions or omissions of the joint venture partner, controlling shareholders or management may require us to make capital contributions or necessitate other payments, result in litigation or regulatory action against us, result in reputational harm to us or adversely affect the value of our investment or partnership, among other things. In addition, we have potential obligations to purchase the interests held by third parties in many of our joint ventures as a result of put provisions that are exercisable at the third party's discretion within specified time periods, pursuant to the applicable agreement. If these put provisions were exercised, we would be required to purchase the third party owner's equity interest, generally at the appraised market value. There can be no assurances that these joint ventures and/or minority investments, including, without limitation, our Asia Pacific joint venture, ultimately will be successful.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If certain of our suppliers do not meet our needs, if there are material price increases on supplies, if we are not reimbursed or adequately reimbursed for drugs we purchase or if we are unable to effectively access new technology or superior products, it could negatively impact our ability to effectively provide the services we offer and could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant suppliers, with a substantial portion of our total vendor spend concentrated with a limited number of third party suppliers. These third party suppliers include, without limitation, suppliers of pharmaceuticals that may be the primary source of products critical to the services we provide, or to which we have committed obligations to make purchases, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sometimes at particular prices. If any of these suppliers do not meet our needs for the products they supply, including, without limitation, in the event of a product recall, shortage or dispute, and we are not able to find adequate alternative sources, if we experience material price increases from these suppliers that we are unable to mitigate, or if some of the drugs that we purchase from our suppliers are not reimbursed or not adequately reimbursed by commercial or government payors, or if we are unable to secure products, including pharmaceuticals at competitive rates and within the desired time frame, it could have a material adverse impact on our business, results of operations, financial condition and cash flows. In addition, the technology related to the products critical to the services we provide is subject to new developments which may result in superior products. If we are not able to access superior products on a cost-effective basis, either due to competitive conditions in the marketplace or otherwise, or if suppliers are not able to fulfill our requirements for such products, we could face patient attrition and other negative consequences which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expansion of our operations to and offering our services in markets outside of the U.S. subjects us to political, economic, legal, operational and other risks that could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to expand our operations by offering our services and entering new lines of business in certain markets outside of the U.S., which increases our exposure to the inherent risks of doing business in international markets. Depending on the market, these risks include those relating to:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the local economic environment;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political instability, armed conflicts or terrorism;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public health crises, such as pandemics or epidemics, including the COVID-19 pandemic;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">social changes;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intellectual property legal protections and remedies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade regulations;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">procedures and actions affecting approval, production, pricing, reimbursement and marketing of products and services;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign currency;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional U.S. and foreign taxes;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">export controls;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">antitrust and competition laws and regulations;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of reliable legal systems which may affect our ability to enforce contractual rights;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in local laws or regulations, or interpretation or enforcement thereof;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially longer ramp-up times for starting up new operations and for payment and collection cycles;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial and operational, and information technology systems integration;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with U.S. laws, such as the FCPA, or local laws that prohibit us, our partners, or our partners' or our agents or intermediaries from making improper payments to foreign officials or any third party for the purpose of obtaining or retaining business; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">data and privacy restrictions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issues relating to the failure to comply with applicable non-U.S. laws, requirements or restrictions may also impact our domestic business and/or raise scrutiny on our domestic practices.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some factors that will be critical to the success of our international business and operations will be different than those affecting our domestic business and operations. For example, conducting international operations requires us to devote significant management resources to implement our controls and systems in new markets, to comply with local laws and regulations, including to fulfill financial reporting and records retention requirements among other things, and to overcome the numerous new challenges inherent in managing international operations, including, without limitation, challenges based on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">differing languages and cultures, challenges related to establishing clinical operations in differing regulatory and compliance environments, and challenges related to the timely hiring, integration and retention of a sufficient number of skilled personnel to carry out operations in an environment with which we are not familiar.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any expansion of our international operations through acquisitions or through organic growth could increase these risks. Additionally, while we may invest material amounts of capital and incur significant costs in connection with the growth and development of our international operations, including to start up or acquire new operations, we may not be able to operate them profitably on the anticipated timeline, or at all.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks could have a material adverse effect on our business, results of operations, financial condition, cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If our joint ventures were found to violate the law, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we owned a controlling interest in numerous dialysis-related joint ventures, which represented approximately 27% of our U.S. dialysis revenues for the year ended December 31, 2020. In addition, we also owned noncontrolling equity investments in several other dialysis related joint ventures. We expect to continue to increase the number of our joint ventures. Many of our joint ventures with physicians or physician groups also have certain physician owners providing medical director services to centers we own and operate. Because our relationships with physicians are governed by the federal and state anti-kickback statutes, we have sought to structure our joint venture arrangements to satisfy as many federal safe harbor requirements as we believe are commercially reasonable. Our joint venture arrangements do not satisfy all of the elements of any safe harbor under the federal Anti-Kickback Statute, however, and therefore are susceptible to government scrutiny. Additionally, our joint ventures and minority investments inherently involve a lesser degree of control over business operations, thereby potentially increasing the financial, legal, operational and/or compliance risks associated with the joint venture or minority investment. If our joint ventures are found to violate applicable laws or regulations, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation. For additional information on these risks, see the risk factors under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may engage in acquisitions, mergers, joint ventures or dispositions, which may materially affect our results of operations, debt-to-capital ratio, capital expenditures or other aspects of our business, and, under certain circumstances, could have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation."</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">There are significant risks associated with estimating the amount of dialysis revenues and related refund liabilities that we recognize, and if our estimates of revenues and related refund liabilities are materially inaccurate, it could impact the timing and the amount of our revenues recognition or have a material adverse effect on our business,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant risks associated with estimating the amount of U.S. dialysis net patient services revenues and related refund liabilities that we recognize in a reporting period. The billing and collection process is complex due to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, such as ensuring appropriate documentation. Determining applicable primary and secondary coverage for approximately 204,200 U.S. patients at any point in time, together with the changes in patient coverage that occur each month, requires complex, resource-intensive processes. Errors in determining the correct coordination of benefits may result in refunds to payors. Revenues associated with Medicare and Medicaid programs are also subject to estimating risk related to the amounts not paid by the primary government payor that will ultimately be collectible from other government programs paying secondary coverage, the patient's commercial health plan secondary coverage or the patient. Collections, refunds and payor retractions typically continue to occur for up to three years and longer after services are provided. We generally expect our range of U.S. dialysis net patient services revenues estimating risk to be within 1% of net revenues for the segment. If our estimates of U.S. dialysis net patient services revenues and related refund liabilities are materially inaccurate, it could impact the timing and the amount of our revenues recognition and have a material adverse impact on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ancillary services and strategic initiatives, including, without limitation, our international operations, that we operate or invest in now or in the future may generate losses and may ultimately be unsuccessful. In the event that one </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or more of these activities is unsuccessful, our business, results of operations, financial condition and cash flows may be negatively impacted and we may have to write off our investment and incur other exit costs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ancillary services and strategic initiatives are subject to many of the same risks, regulations and laws, as described in the risk factors related to our dialysis business set forth in this Part I, Item 1A, and are also subject to additional risks, regulations and laws specific to the nature of the particular strategic initiative. We expect to add additional service offerings to our business and pursue additional strategic initiatives in the future as circumstances warrant, which could include healthcare services not related to dialysis. Many of these initiatives require or would require investments of both management and financial resources and can generate significant losses for a substantial period of time and may not become profitable in the expected timeframe or at all. There can be no assurance that any such strategic initiative will ultimately be successful. Any significant change in market conditions or business performance, including, without limitation, as a result of the COVID-19 pandemic, or in the political, legislative or regulatory environment, may impact the performance or economic viability of any of these strategic initiatives. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our ancillary services or strategic initiatives, including our international operations, are unsuccessful, it would have a negative impact on our business, results of operations, financial condition and cash flows, and we may determine to exit that line of business. We could incur significant termination costs if we were to exit certain of these lines of business. In addition, we may incur a material write-off or an impairment of our investment, including, without limitation, goodwill or other assets, in one or more of our ancillary services or strategic initiatives. In that regard, we have taken, and may in the future take, impairment and restructuring charges in addition to those described above related to our ancillary services and strategic initiatives, including, without limitation, in our international and pharmacy businesses.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If a significant number of physicians were to cease referring patients to our dialysis centers, whether due to law, rule or regulation, new competition, a perceived decrease in the quality of service levels at our centers or other reasons, it would have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physicians, including medical directors, choose where they refer their patients. Some physicians prefer to have their patients treated at dialysis centers where they or other members of their practice supervise the overall care provided as medical director of the center. As a result, referral sources for many of our centers include the physician or physician group providing medical director services to the center.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical director contracts are for fixed periods, generally ten years, and at any given time a large number of them could be up for renewal at the same time. Medical directors have no obligation to extend their agreements with us and, under certain circumstances, our former medical directors may choose to provide medical director services for competing providers or establish their own dialysis centers in competition with ours. Neither our current nor former medical directors have an obligation to refer their patients to our centers. In addition, there are a number of new entrants into the dialysis space, and physicians, including medical directors, may refer patients to these new entrants rather than the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aging of the nephrologist population and opportunities presented by our competitors may negatively impact a medical director's decision to enter into or extend his or her agreement with us. Moreover, a perceived decrease in the quality of service levels at our centers or different affiliation models in the changing healthcare environment that limit a nephrologist's choice in where he or she can refer patients, such as an increase in the number of physicians becoming employed by hospitals, may limit a nephrologist's ability or desire to refer patients to our centers or otherwise negatively impact treatment volumes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if the terms of any existing agreement are found to violate applicable laws, there can be no assurances that we would be successful in restructuring the relationship, which would lead to the early termination of the agreement. If we are unable to obtain qualified medical directors to provide supervision of the operations and care provided at our dialysis centers, it could affect physicians' desire to refer patients to our dialysis centers. If a significant number of physicians were to cease referring patients to our dialysis centers, it would have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If our labor costs continue to rise, including due to shortages, changes in certification requirements and/or higher than normal turnover rates in skilled clinical personnel; or currently pending or future governmental laws, rules, regulations or initiatives impose additional requirements or limitations on our operations or profitability; or, if we are unable to attract and retain key leadership talent, we may experience disruptions in our business operations and increases in operating expenses, among other things, which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face increasing labor costs generally, and in particular, we continue to face increased labor costs and difficulties in hiring nurses due to a nationwide shortage of skilled clinical personnel that has been exacerbated by the ongoing COVID-19 pandemic. We have incurred and expect to continue to incur increased labor costs and experience staffing challenges related to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 while the pandemic persists, the extent of which will depend on the severity and duration of the pandemic, among other things. For additional discussion of the risks facing us related to COVID-19, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for nurses with hospitals and other healthcare providers. This nursing shortage may limit our ability to expand our operations. Furthermore, changes in certification requirements can impact our ability to maintain sufficient staff levels, including to the extent our teammates are not able to meet new requirements, among other things. In addition, if we experience a higher than normal turnover rate for our skilled clinical personnel, our operations and treatment growth may be negatively impacted, which could adversely affect our business, results of operations, financial condition and cash flows. We also face competition in attracting and retaining talent for key leadership positions. If we are unable to attract and retain qualified individuals, we may experience disruptions in our business operations, including, without limitation, our ability to achieve strategic goals, which could have a material adverse effect on our business, results of operations, financial condition and cash flows. For additional information on these risks, see the risk factors under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" and "Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is labor intensive and could be materially adversely affected if we are unable to attract and retain employees or if union organizing activities or legislative or other changes result in significant increases in our operating costs or decreases in productivity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is labor intensive, and our financial and operating results have been and continue to be subject to variations in labor-related costs, productivity and the number of pending or potential claims against us related to labor and employment practices. Political or other efforts at the national or local level could result in actions or proposals that increase the likelihood of success of union organizing activities at our facilities and ongoing union organizing activities at our facilities could continue or increase for other reasons. We could experience an upward trend in wages and benefits and labor and employment claims, including, without limitation, the filing of class action suits, or adverse outcomes of such claims, or face work stoppages. In addition, we are and may continue to be subject to targeted corporate campaigns by union organizers in response to which we have been and may continue to be required to expend substantial resources, both time and financial. Any of these events or circumstances could have a material adverse effect on our employee relations, treatment growth, productivity, business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failing to effectively maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely, including, without limitation, our clinical, billing and collections systems could materially adversely affect our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends significantly on effective information systems. Our information systems require an ongoing commitment of significant resources to maintain, upgrade and enhance existing systems and develop or contract for new systems in order to keep pace with continuing changes in information processing technology, emerging cybersecurity risks and threats, evolving industry, legal and regulatory standards and requirements, new models of care, and other changes in our business, among other things. For example, the provisions related to data interoperability, information blocking, and patient access in the Cures Act include, among other things, changes to the Office of the National Coordinator for Health Information Technology&#8217;s (ONC's) Health IT Certification Program and requirements that CMS-regulated payors make relevant claims/care data and provider directory information available through standardized patient access and provider directory application programming interfaces (APIs) that connect to provider electronic health records. We have made and continue to make investments in building data interoperability capabilities, including as part of building on our integrated care capabilities as noted above, and continue to evaluate the potential impact of the CMS and ONC final rules. Any failure to adequately comply with these rules may adversely impact our Medicare business, our ability to scale our integrated care business and our ability to compete with certain smaller and/or non-traditional providers taking advantage of an asymmetrical environment with respect to data and/or regulatory requirements given our status as an ESRD service provider. There can be no assurances that the implementation of planned enhancements to our systems, such as our implementation of these data interoperability provisions or our other efforts that are currently ongoing to upgrade and better integrate our clinical systems, will be successful or that we will ultimately realize anticipated benefits from investments in new or existing information systems. In addition, we may from time to time obtain significant portions of our systems-related support, technology or other services from independent third parties, which may make our operations vulnerable if such third parties fail to perform adequately.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to successfully implement, operate and maintain effective and efficient information systems with adequate technological capabilities, deficiencies or defects in the systems and related technology, or our failure to efficiently and effectively consolidate our information systems to eliminate redundant or obsolete applications, could result in competitive </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disadvantages, which could have a material adverse effect on our business, financial condition and results of operations. For additional information on the risks we face in a highly competitive market, see the risk factor under the heading, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors, it could materially adversely affect our business, results of operations, financial condition and cash flows." </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the information we rely upon to run our business was found to be inaccurate or unreliable or if we or third parties on which we rely fail to adequately maintain information systems and data integrity effectively, whether due to software deficiencies, human coding or implementation error or otherwise, we could experience difficulty meeting clinical outcome goals, face regulatory problems, including sanctions and penalties, incur increases in operating expenses or suffer other adverse consequences, any of which could be material. Moreover, failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or information systems and data hosted by third parties upon which we rely, could subject us to severe consequences as described in the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Privacy and information security laws are complex, and if we fail to comply with applicable laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, or if we fail to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks, we may be subject to government or private actions due to privacy and security breaches or suffer losses to our data and information technology assets, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our billing system, among others, is critical to our billing operations. If there are defects in the billing system, or billing systems or services of third parties upon which we rely, we may experience difficulties in our ability to successfully bill and collect for services rendered, including, without limitation, a delay in collections, a reduction in the amounts collected, increased risk of retractions from and refunds to commercial and government payors, an increase in our provision for uncollectible accounts receivable and noncompliance with reimbursement laws and related requirements, any or all of which could materially adversely affect our results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the clinical environment, a failure of our clinical systems, or the systems of our third-party service providers, to operate effectively could have a material adverse effect on our business, the clinical care provided to patients, results of operations, financial condition and cash flows. For example, in connection with claims for which at least part of the government's payments to us is based on clinical performance or patient outcomes or co-morbidities, if relevant clinical systems fail to accurately capture the data we report to CMS or we otherwise have data integrity issues with respect to the reported information, this could impact our payments from government payors as well as our ability to retain funds paid to us based on the inaccurate information.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we expect the highly competitive environment in which we operate to become increasingly more competitive as the market evolves and new technologies are introduced. This dynamic environment requires continuous investment in new technologies and clinical applications. Machine learning and artificial intelligence are increasingly driving innovations in technology, and parts of our operations may employ robotics. If these technologies or applications fail to operate as anticipated or do not perform as specified, including due to potential design defects and defects in the development of algorithms or other technologies, human error or otherwise, our clinical operations, business and reputation may be harmed. If we are unable to successfully maintain, enhance or operate our information systems, including through the implementation of such technologies or applications in our clinical operations and laboratory, we may be, among other things, unable to efficiently adapt to evolving laws and requirements, unable to remain competitive with others who successfully implement and advance this technology, subject to increased risk under existing laws, regulations and requirements that apply to our business, and our patients' safety may be adversely impacted, any of which could have a material adverse impact on our business, results of operations and financial condition and could materially harm our reputation. For additional detail, see the discussion in the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation.&#8221;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The level of our current and future debt could have an adverse impact on our business, and our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenants depends on many factors beyond our control.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a substantial amount of indebtedness outstanding and we may incur substantial additional indebtedness in the future, including indebtedness incurred to finance repurchases of our common stock pursuant to our share repurchase authorization discussed under "Stock Repurchases" in Part II, Item 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As described in Note 13 to the consolidated financial statements included in this report, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we are party to a senior secured credit agreement (the Credit Agreement), which consists of a secured term loan A facility, a secured term loan B-1 facility and a secured revolving line of credit in the aggregate principal amount of $1 billion. Our long-term indebtedness also includes $3.250 billion aggregate principal amount of senior notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to generate sufficient cash to service our indebtedness and for other intended purposes, it could, for example:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it difficult for us to make payments on our debt;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to general adverse economic and industry conditions;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flows from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and investments, repurchases of stock at the levels intended or announced, or at all, and other general corporate purposes;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we operate;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expose us to interest rate volatility that could adversely affect our business, results of operations, financial condition and cash flows, and our ability to service our indebtedness;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds, or to refinance existing debt on favorable terms when otherwise available or at all.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior secured credit facilities bear, and other indebtedness we may incur in the future may bear, interest at a variable rate. As a result, at any given time interest rates on the senior secured credit facilities and any other variable rate debt could be higher or lower than current levels. If interest rates increase, our debt service obligations on our variable rate indebtedness will increase even though the amount borrowed remains the same, and therefore net income and associated cash flows, including cash available for servicing our indebtedness, will correspondingly decrease.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indebtedness levels and the required payments on such indebtedness may also be impacted by expected reforms related to LIBOR. The variable interest rates payable under our senior secured credit facilities are linked to LIBOR as the benchmark for establishing such rates. The LIBOR benchmark has been the subject of recent national, international and other regulatory guidance and reform proposals. The reforms may cause LIBOR to perform differently from the past and LIBOR may ultimately cease to exist after 2023. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of, among other entities, large U.S. financial institutions, is considering replacing U.S. dollar LIBOR with a new index that measures the cost of borrowing cash overnight, backed by U.S. Treasury securities (SOFR). Whether or not SOFR or any other potential alternative reference rate attains market traction as a LIBOR replacement rate remains in question</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our senior secured credit facilities include mechanics to facilitate the adoption by us and our lenders of an alternative benchmark rate for use in place of LIBOR; however, no assurance can be made that we and our lenders will agree on such an alternative rate and, even if agreed upon, such alternative rate may not perform in a manner similar to LIBOR and may result in interest rates that are higher or lower than those that would have resulted had LIBOR remained in effect.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make payments on our indebtedness, to fund planned capital expenditures and expansion efforts, including, without limitation, any strategic acquisitions we may make in the future, to repurchase our stock at the levels intended or announced and to meet our other liquidity needs, will depend on our ability to generate cash. This depends not only on the success of our business but is also subject to economic, financial, competitive, regulatory and other factors that are beyond our control. We cannot provide assurances that our business will generate sufficient cash flows from operations in the future or that future borrowings will be available to us in amounts sufficient to enable us to service our indebtedness or to fund our working capital and other liquidity needs, including those described above. If we are unable to generate sufficient funds to service our outstanding indebtedness or to meet our working capital or other liquidity needs, including those described above, we would be required to refinance, restructure, or otherwise amend some or all of such indebtedness, sell assets, change or reduce our intended or announced uses or strategy for capital deployment, including, without limitation, for stock repurchases, reduce capital expenditures, planned expansions or other strategic initiatives, or raise additional cash through the sale of our equity or equity-related securities. We cannot make any assurances that any such refinancing, restructurings, amendments, sales of assets, or issuances of equity or equity-related securities can be accomplished or, if accomplished, will be on favorable terms or would raise sufficient funds to meet these obligations or our other liquidity needs. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may continue to incur indebtedness in the future, and the amount of that additional indebtedness may be substantial. Although the Credit Agreement includes covenants that could limit our indebtedness, we currently have, and expect to continue to have, the ability to incur substantial additional debt. The risks described in this risk factor could intensify as new </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt is added to current debt levels or if we incur any new debt obligations that subject us to restrictive covenants that limit our financial and operational flexibility. Any breach or failure to comply with any of these covenants could result in a default under our indebtedness. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to pay any of our indebtedness when due or any other default under our credit facilities or our other indebtedness could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could trigger cross default or cross acceleration provisions in our other debt instruments, thereby permitting the holders of that other indebtedness to demand immediate repayment or cease to make future extensions of credit, and, in the case of secured indebtedness, to take possession of and sell the collateral securing such indebtedness to satisfy our obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings under our senior secured credit facilities and senior indentures are guaranteed by certain of our domestic subsidiaries, and borrowings under our senior secured credit facilities are secured by substantially all of our and certain of our domestic subsidiaries' assets. Such guarantees and the fact that we have pledged such assets may make it more difficult and expensive for us to make, or under certain circumstances could effectively prevent us from making, additional secured and unsecured borrowings.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could be subject to adverse changes in tax laws, regulations and interpretations or challenges to our tax positions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to tax laws and regulations of the U.S. federal, state and local governments as well as various foreign jurisdictions. We compute our income tax provision based on enacted tax rates in the jurisdictions in which we operate. As the tax rates vary among jurisdictions, a change in earnings attributable to the various jurisdictions in which we operate could result in an unfavorable or favorable change in our overall tax provision.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws or regulations may be proposed or enacted that could adversely affect our overall tax liability. There can be no assurance that changes in tax laws or regulations, both within the U.S. and the other jurisdictions in which we operate, will not materially and adversely affect our effective tax rate, tax payments, results of operations, financial condition and cash flows. For example, changes to the political environment related to the most recent U.S. election cycle increase the likelihood that changes in taxation and related regulations could have a material adverse impact on our results of operations and financial condition. Similarly, changes in tax laws and regulations that impact our patients, business partners and counterparties or the economy generally may also impact our results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, tax laws and regulations are complex and subject to varying interpretations, and any significant failure to comply with applicable tax laws and regulations in all relevant jurisdictions could give rise to material penalties and liabilities. We are regularly subject to audits by various tax authorities. For example, our current audits include an audit by the Internal Revenue Service for the years 2014&#8211;2017, and it is possible that the final determination of this and any other tax audits and any related litigation could be materially different from our historical income tax provisions and accruals. Any changes in enacted tax laws, rules or regulatory or judicial interpretations; any adverse development or outcome in connection with tax audits in any jurisdiction; or any change in the pronouncements relating to accounting for income taxes could materially and adversely impact our effective tax rate, tax payments, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be subject to liability claims for damages and other expenses that are not covered by insurance or exceed our existing insurance coverage that could have a material adverse effect on our business, results of operations, financial condition, cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and how we manage our business may subject us, as well as our officers and directors to whom we owe certain defense and indemnity obligations, to litigation and liability. Our business, profitability and growth prospects could suffer if we face negative publicity or we pay damages or defense costs in connection with a claim that is outside the scope or limits of coverage of any applicable insurance coverage, including, without limitation, claims related to adverse patient events, cybersecurity incidents, contractual disputes, antitrust and competition laws and regulations, professional and general liability and directors' and officers' duties. In addition, we have received notices of claims from commercial payors and other third parties, as well as subpoenas and CIDs from the federal government, related to our business practices, including, without limitation, our historical billing practices and the historical billing practices of acquired businesses. Although the ultimate outcome of these claims cannot be predicted, an adverse result with respect to one or more of these claims could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation. We maintain insurance coverage for those risks we deem are appropriate to insure against and make determinations about whether to self-insure as to other risks or layers of coverage. However, a successful claim, including, without limitation, a professional liability, malpractice or negligence claim or a claim related to a cybersecurity incident, which is in excess of any applicable insurance coverage, that is outside the scope or limits of any applicable insurance coverage, or that is subject to our self-insurance retentions, could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if our costs of insurance and claims increase, then our earnings could decline. Market rates for insurance premiums and deductibles have been steadily increasing. Our business, results of operations, financial condition and cash flows could be materially and adversely affected by any of the following:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the collapse or insolvency of our insurance carriers;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further increases in premiums and deductibles;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in the number of liability claims against us or the cost of settling or trying cases related to those claims; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining insurance with exclusions for things such as communicable diseases; or</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an inability to obtain one or more types of insurance on acceptable terms, if at all.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to successfully maintain an effective internal control over financial reporting, the integrity of our financial reporting could be compromised, which could have a material adverse effect on our ability to accurately report our financial results, the market's perception of our business and our stock price.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The integration of acquisitions and addition of new business lines into our internal control over financial reporting has required and will continue to require significant time and resources from our management and other personnel and has increased, and is expected to continue to increase our compliance costs. Failure to maintain an effective internal control environment could have a material adverse effect on our ability to accurately report our financial results, the market's perception of our business and our stock price. In addition, we could be required to restate our financial results in the event of a significant failure of our internal control over financial reporting or in the event of inappropriate application of accounting principles.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deterioration in economic conditions, disruptions in the financial markets or the effects of natural or other disasters, political instability, public health crises or adverse weather events such as hurricanes, earthquakes, fires or flooding could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deterioration in economic conditions, whether in connection with the COVID-19 pandemic or otherwise, could have a material adverse effect on our business, results of operations, financial condition and cash flows. Among other things, the potential decline in federal and state revenues that may result from such conditions may create additional pressures to contain or reduce reimbursements for our services from Medicare, Medicaid and other government sponsored programs. Increases in job losses in the U.S. as a result of adverse economic conditions, including economic deterioration due to the ongoing COVID-19 pandemic, could result in a smaller percentage of our patients being covered by an employer group health plan and a larger percentage being covered by lower paying Medicare and Medicaid programs. Employers may also select more restrictive commercial plans with lower reimbursement rates. To the extent that payors are negatively impacted by a decline in the economy, we may experience further pressure on commercial rates, a slowdown in collections and a reduction in the amounts we expect to collect. In addition, uncertainty in the financial markets could adversely affect the variable interest rates payable under our credit facilities or could make it more difficult to obtain or renew such facilities or to obtain other forms of financing in the future, if at all. For additional information regarding the risks presented by the COVID-19 pandemic, see the discussion in the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" For additional information regarding the risks related to our indebtedness, see the discussion in the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"The level of our current and future debt could have an adverse impact on our business, and our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenants depends on many factors beyond our control."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, as of December 31, 2020, we had approximately $6.919 billion of goodwill recorded on our consolidated balance sheet. We account for impairments of goodwill in accordance with the provisions of applicable accounting guidance, and record impairment charges when and to the extent a reporting unit's carrying amount is determined to exceed its estimated fair value. We use a variety of factors to assess changes in the financial condition, future prospects and other circumstances concerning our businesses and to estimate their fair value when applicable. These assessments and the related valuations can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should our revenues and financial results be materially, unfavorably impacted due to, among other things, a worsening of the economic and employment conditions in the United States that negatively impacts reimbursement rates or the availability of insurance coverage for our patients, we may incur future charges to recognize impairment in the carrying amount of our goodwill and other intangible assets, which could have a material adverse effect on our business, results of operation and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, some of our operations, including our clinical laboratory, dialysis centers and other facilities, may be adversely impacted by the effects of natural or other disasters, political instability, public health crises such as global pandemics or epidemics, including the COVID-19 pandemic, or adverse weather events such as hurricanes, earthquakes, fires or flooding. Each of these effects and risks may be further intensified by the increasing impact of climate change on a global scale. In addition, these risks are particularly heightened for our patients in part because individuals with chronic illness may be more susceptible to the adverse effects of epidemics or other public health crises and also because any natural or other disaster, political instability or adverse weather event that disrupts or limits the operation of any of our centers or other facilities or services may delay or otherwise impact the critical services we provide to dialysis patients. Further, any such event or other occurrence that results in a failure of the fitness of our clinical laboratory, dialysis centers and related operations and/or other facilities or otherwise adversely impacts the safety of our teammates or patients at any of those locations could lead us to face adverse consequences, including, without limitation, the potential loss of data, including PHI or PII, compliance or regulatory investigations, any of which could materially impact our business, results of operation and financial condition, and could materially harm our reputation. For example, our clinical laboratory is located in Florida, a state that has in the past experienced and may in the future experience hurricanes. Natural or other disasters or adverse weather events could significantly damage or destroy our facilities, disrupt operations, increase our costs to maintain operations and require substantial expenditures and recovery time to fully resume operations. In addition, as the effects of climate change progressively surface, such as through potential increases in the frequency and intensity of natural or other disasters or adverse weather events or through laws or regulations adopted in response, we may face increased costs associated with operating our clinics, including, without limitation, with respect to supplies of water or energy costs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our presence in markets outside the U.S. may increase our exposure to these and similar risks related to natural disasters, public health crises, political instability, climate change or other catastrophic events outside our control. For additional information regarding the risks related to our international business, see the discussion in the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expansion of our operations to and offering our services in markets outside of the U.S. subjects us to political, economic, legal, operational and other risks that could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any or all of these factors, as well as other consequences of these events, none of which we can currently predict, could have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provisions in our organizational documents, our compensation programs and policies and certain requirements under Delaware law may deter changes of control and may make it more difficult for our stockholders to change the composition of our Board of Directors and take other corporate actions that our stockholders would otherwise determine to be in their best interests.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our organizational documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in our management, or limit the ability of our stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting our stockholders from acting by written consent, advance notice requirements for director nominations and stockholder proposals and granting our Board of Directors the authority to issue preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our outstanding employee stock-based compensation awards include a provision accelerating the vesting of the awards in the event of a change of control. These and any other change of control provisions may affect the price an acquirer would be willing to pay for our Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to Section 203 of the Delaware General Corporation Law that, subject to exceptions, prohibits us from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions described above may discourage, delay or prevent an acquisition of our Company at a price that our stockholders may find attractive. These provisions could also make it more difficult for our stockholders to elect directors and take other corporate actions and could limit the price that investors might be willing to pay for shares of our common stock.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_58"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Properties.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in Denver, Colorado, consisting of one owned 240,000 square foot building and one leased 345,900 square foot location. Our headquarters are occupied by teammates engaged in management, finance, marketing, strategy, legal, compliance and other administrative functions. We lease five business offices located in California, Pennsylvania, Tennessee and Washington, as well as own one business office in Washington for our U.S. dialysis business. Our laboratory is based in Florida where we operate our lab services out of one leased building. We also lease other administrative offices in the U.S. and worldwide. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our U.S. dialysis business we own the land and buildings for six outpatient dialysis centers. We also own 21 properties for development, including operating outpatient dialysis centers and properties we hold for sale. In addition, we lease a total of four owned properties to third-party tenants. Our remaining outpatient dialysis centers are located on premises that we lease.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our leases for our U.S. dialysis business cover periods from five years to 20 years and typically contain renewal options of five years to ten years at the fair rental value at the time of renewal. Our leases are generally subject to periodic consumer price index increases, or contain fixed escalation clauses. Our outpatient dialysis centers range in size from approximately 1,000 to 33,000 square feet, with an average size of approximately 7,800 square feet. Our international leases generally range from one to ten years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our outpatient dialysis centers are operating at or near capacity. However, we believe that we have adequate capacity within most of our existing dialysis centers to accommodate additional patient volume through increased hours and/or days of operation, or, if additional space is available within an existing facility, by adding dialysis stations. We can usually relocate existing centers to larger facilities or open new centers if existing centers reach capacity. With respect to relocating centers or building new centers, we believe that we can generally lease space at economically reasonable rates in the areas planned for each of these centers, although there can be no assurances in this regard. Expansion of existing centers or relocation of our dialysis centers is subject to review for compliance with conditions relating to participation in the Medicare ESRD program, among other things. In states that require a certificate of need or center license, additional approvals would generally be necessary for expansion or relocation.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_64"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Part I, Item&#160;3&#160;is incorporated herein by reference to the information set forth under the caption &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Note 16 to the consolidated financial statements included in this report.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_67"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i878840fee65247deaca27d2dd6a8246f_73"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange under the symbol DVA. The closing price of our common stock on January&#160;29, 2021 was $117.37 per share. According to Computershare, our registrar and transfer agent, as of January&#160;29, 2021, there were 7,594 holders of record of our common stock. This figure does not include the indeterminate number of beneficial holders whose shares are held of record by brokerage firms and clearing agencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our initial public offering was in 1994, and we have not declared or paid cash dividends to holders of our common stock since going public. We have no current plans to pay cash dividends and there are certain limitations on our ability to pay dividends under the terms of our senior secured credit facilities. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and capital resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; under Item 7. "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and the notes to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our repurchases of our common stock during the fourth quarter of 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:500.25pt"><tr><td style="width:1.0pt"></td><td style="width:156.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:93.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average price<br/>paid per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares purchased as part of publicly announced plans or programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate dollar value<br/>of shares that may yet be purchased under the plans or programs</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars and shares in thousands, except per share data)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1-31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1-30, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1-31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our repurchases of our common stock during 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:30.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average price<br/>paid per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares purchased as part of publicly announced plans or programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate dollar value<br/>of shares that may yet be purchased under the plans or programs</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars and shares in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 - March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - September 30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 - December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The total number of shares purchased and the aggregate amount paid for shares repurchased include shares repurchased pursuant to our modified Dutch auction tender offer at a clearing price of $88.00 per share plus related fees and expenses of $2.5 million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of the close of business on November 4, 2019, the Board terminated all remaining prior share repurchase authorizations available to us and approved a new share repurchase authorization of $2.0 billion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to us under the aforementioned November 4, 2019 authorization and approved a new share repurchase authorization of $2.0 billion. We are authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;10, 2021, we have a total of $1.807 billion available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, we remain subject to share repurchase limitations, including under the terms of our senior secured credit facilities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selected Financial Data.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial and operating data should be read in conjunction with Item 7. "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and our consolidated financial statements filed as part of this report. The following table presents selected consolidated financial and operating data for the periods indicated: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars and shares in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income statement data:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,404,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,876,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,707,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses and charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,855,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,745,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,879,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,063,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,677,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,694,636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,812,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,029,710&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(304,111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(443,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(487,435)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(430,634)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(414,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,048,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,399,786&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">431,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">915,811&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">790,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,075,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,191,344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (loss) income from discontinued operations, net</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(457,038)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(245,372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(158,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">994,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,021,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">830,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,033,082&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(221,035)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(210,313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(173,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(166,937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(153,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">663,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.60&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.62&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.71&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.04&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares for earnings per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,623&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,812&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,365&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,349&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,905&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet data (as of period end):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,532,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,703,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,283,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,988,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,311,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,110,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,974,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,755,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,917,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,977,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,172,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,158,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,944,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total DaVita Inc. shareholders' equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,383,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,133,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,703,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,690,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,648,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">On January 1, 2018, we adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (Topic 606) using the cumulative effect method for those contracts that were not substantially completed as of January 1, 2018. See Notes 1 and 2 of the consolidated financial statements for further discussion of our adoption of Topic 606. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The following table summarizes losses (gains) on changes in ownership interest, net, accruals for legal matters, impairment charges, restructuring charges and gain on settlement included in operating expenses and charges:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:44.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certain operating expenses and charges:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on changes in ownership interests, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(374,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accruals for legal matters</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on settlement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(529,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Tax expense for 2017 included a net tax benefit of $251,510 related to U.S. tax legislation passed in December 2017. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">On June&#160;19, 2019, we completed the sale of our DMG business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. Accordingly, DMG's results of operations are reported as net income (loss) from discontinued operations, net of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">tax for all periods presented and its assets and liabilities were classified as held for sale for the periods reported prior to close of the transaction.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The following table summarizes our common stock activity:</span></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:43.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(dollars and shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,446,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,402,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,153,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,072,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_82"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Annual Report on Form 10-K, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains statements that are forward-looking statements within the meaning of the federal securities laws and as such are intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements could include, among other things, DaVita's response to and the expected future impacts of the novel coronavirus (COVID-19), including statements about our balance sheet and liquidity, our expenses and expense offsets, revenues, billings and collections, potential need, ability or willingness to use any funds under government relief programs, availability or cost of supplies, treatment volumes, mix expectation, such as the percentage or number of patients under commercial insurance, the availability and administration of COVID-19 vaccines, and overall impact on our patients and teammates, as well as other statements regarding our future operations, financial condition and prospects, expenses, strategic initiatives, government and commercial payment rates, expectations related to value-based care and Medicare Advantage plan enrollment and our ongoing stock repurchase program. All statements in this report, other than statements of historical fact, are forward-looking statements. Without limiting the foregoing, statements including the words "expect," "intend," "will," "could," "plan," "anticipate," "believe," "forecast," "guidance," "outlook," "goals," and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on DaVita's current expectations and are based solely on information available as of the date of this report. DaVita undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may be required by law. Actual future events and results could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the continuing impact of the dynamic and evolving COVID-19 pandemic, including, without limitation, on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition and results of operations; the government&#8217;s response to the COVID-19 pandemic; the availability, acceptance, impact and efficacy of COVID-19 treatments, therapies and vaccines; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; the continuing impact of the pandemic on our revenue and non-acquired growth due to lower treatment volumes; the consequences of an extended economic downturn resulting from the impacts of COVID-19, such as a potential negative impact on our commercial mix, which may persist even after the pandemic subsides; and continuing COVID-19-related costs, such as costs to procure equipment and clinical supplies and higher salary and wage expense. The aforementioned risks and uncertainties may also have the effect of heightening many of the other risks and uncertainties discussed below; </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the concentration of profits generated by higher-paying commercial payor plans for which there is continued downward pressure on average realized payment rates, and a reduction in the number or percentage of our patients under such plans, including, without limitation, as a result of restrictions or prohibitions on the use and/or availability of charitable premium assistance, which may result in the loss of revenues or patients, or our making incorrect assumptions about how our patients will respond to any change in financial assistance from charitable organizations;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">noncompliance by us or our business associates with any privacy or security laws or any security breach by us or a third party involving the misappropriation, loss or other unauthorized use or disclosure of confidential information;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the ongoing implementation of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof or related litigation result in a reduction in coverage or reimbursement rates for our services, a reduction in the number of patients enrolled in higher-paying commercial plans or that are enrolled in or select Medicare Advantage plans or other material impacts to our business; or our making incorrect assumptions about how our patients will respond to any such developments;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction in government payment rates under the Medicare End Stage Renal Disease program or other government-based programs and the impact of the Medicare Advantage benchmark structure;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">risks arising from potential changes in laws, regulations or requirements applicable to us, such as potential and proposed federal and/or state legislation, regulation, ballot, executive action or other initiatives, including those related to healthcare and/or labor matters, such as AB 290 in California;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the political environment and related developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act, the exchanges and many other core aspects </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of the current healthcare marketplace, as well as the composition of the U.S. Supreme Court and the new presidential administration and congressional majority;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement our strategies with respect to home-based dialysis, value-based care and/or integrated kidney care, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">changes in pharmaceutical practice patterns, reimbursement and payment policies and processes, or pharmaceutical pricing, including with respect to hypoxia inducible factors;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">legal and compliance risks, such as our continued compliance with complex government regulations;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">continued increased competition from dialysis providers and others, and other potential marketplace changes;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain contracts with physician medical directors, changing affiliation models for physicians, and the emergence of new models of care introduced by the government or private sector that may erode our patient base and reimbursement rates, such as accountable care organizations, independent practice associations and integrated delivery systems;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete acquisitions, mergers or dispositions that we might announce or be considering, on terms favorable to us or at all, or to integrate and successfully operate any business we may acquire or have acquired, or to successfully expand our operations and services in markets outside&#160;the United States, or to businesses outside of dialysis;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the variability of our cash flows, including without limitation any extended billing or collections cycles; the risk that we may not be able to generate or access sufficient cash in the future to service our indebtedness or to fund our other liquidity needs; and the risk that we may not be able to refinance our indebtedness as it becomes due, on terms favorable to us or at all;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">factors that may impact our ability to repurchase stock under our stock repurchase program and the timing of any such stock repurchases, as well as our use of a considerable amount of available funds to repurchase stock;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">risks arising from the use of accounting estimates, judgments and interpretations in our financial statements;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">impairment of our goodwill, investments or other assets; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties associated with the other risk factors set forth in Part I, Item 1A. of this Annual Report on Form 10-K, and the other risks and uncertainties discussed in any subsequent reports that we file or furnish with the SEC from time to time.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following should be read in conjunction with our consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal business is to provide dialysis and related lab services to patients in the United States, which we refer to as our U.S. dialysis business. We also operate various ancillary services and strategic initiatives including our international operations, which we collectively refer to as our ancillary services, as well as our corporate administrative support. Our U.S. dialysis business is a leading provider of kidney dialysis services in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;19, 2019, we completed the sale of our DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC, a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented and DMG is not included below in this Management's Discussion and Analysis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the challenges of responding to the novel coronavirus pandemic (COVID-19), our year-over-year overall financial performance in 2020 benefited from increased revenue, which was primarily due to higher average revenue per treatment in our U.S. dialysis business as well as acquired growth in our international business. This was partially offset by increases in labor costs (both operating and overhead), lower margin on calcimimetics, increases in advocacy costs, and increased costs driven by the emergence of COVID-19, including increased costs related to compensation and medical supplies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drivers of our financial performance in 2020 included the following:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improved key clinical outcomes in our U.S. dialysis business, including our recognition as an industry leader for the eighth consecutive year in CMS&#8217; Quality Incentive Program and for the last seven years under the CMS Five-Star Quality Rating system;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenue growth of 0.9% in U.S. dialysis, 5.3% in U.S. ancillary services, and 11.0% in international operations;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net increase of 63 U.S. and 62 international dialysis centers, including entering a new country, the United Kingdom;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating cash flows of $1.979 billion from continuing operations;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">repurchase of 16,477,378 shares of our common stock for aggregate consideration of $1.447 billion, and reduction of our share count by 12.6% year-over-year;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refinancing transactions, including the redemption of our 5.125% and 5.0% senior notes, the issuance of our new 4.625% and 3.75% senior notes and the repricing of our Term Loan B-1 resulting in lower debt expense; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of COVID-19 as further discussed in Part I. Item 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Business&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 and its impact on our business" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we expect that COVID-19 will continue to impact our business and financial performance, as described in further detail below, though the magnitude of these impacts remains difficult to predict and subject to significant uncertainty due to a number of factors, including, among others, the severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; its impact on the CKD patient population and our patient population; the availability, acceptance, impact and efficacy of COVID-19 treatments, therapies and vaccines; the pandemics' continuing impact on the U.S. and global economies and unemployment; the responses of our competitors to the pandemic and related changes in the marketplace; and the timing, scope and effectiveness of federal, state and local government responses. The continued impacts and disruptions to our business as a result of the COVID-19 pandemic could have a material adverse impact on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition, results of operations, cash flows and/or liquidity. On treatment volume, we continue to face pressure primarily driven by the impact of COVID-19 on mortality rates for dialysis patients. This pressure is also influenced by slowing industry growth and competitive activity. On reimbursement rate, we expect modest growth in aggregate, primarily due to the expected net market basket update for Medicare treatments as well as an increase in Medicare Advantage enrollment due to the 21st Century Cures Act, partially offset by the scheduled resumption of Medicare sequestration in 2021. On cost, we continue to expect inflationary pressure on wage rates and other costs, partially offset by continued savings on pharmaceutical costs. We expect to incur significantly less advocacy costs in 2021 than we experienced in 2020. We also expect to continue making investments to expand our ability to offer home-based dialysis service options and further advance our integrated care and value-based care initiatives in 2021. Finally, the timing and scope of any potential changes to the regulatory landscape remain uncertain, particularly in light of the ongoing COVID-19 pandemic and the incoming new federal administration, and as such, considerable uncertainty exists surrounding the continued development of the various governmental laws, regulations and other requirements that impact our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below includes analysis of our financial condition and results of operations for the years ended December&#160;31, 2020 compared to December&#160;31, 2019. Our Annual Report on Form 10-K for the year ended December&#160;31, 2019, includes a discussion and analysis of our financial condition and results of operations for the year ended December&#160;31, 2018, in its Part II Item 7, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">".</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to the "Notes" in the discussion below refer to the notes to the Company's consolidated financial statements included in this Annual Report on Form 10-K at Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as referred from Part II Item 8, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements and Supplementary Data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div id="i878840fee65247deaca27d2dd6a8246f_2820"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 and its impact on our business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above and described in further detail in Part I Item 1, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," we continue to closely monitor the impact on our business of the pandemic and the resulting economic environment, including the impact on our patients, teammates, physician partners, suppliers, vendors and business partners. We have dedicated and continue to dedicate substantial resources in response to COVID-19, to help safely maintain continuity of care for our patients throughout this crisis, whether in the hospital, outpatient or home setting, and to help protect our caregivers. Our COVID-19 response has included, among other things, the implementation of additional protocols and operational initiatives related to infection control and clinical best practices, redistribution of resources across geographies and increased investment in and utilization of telehealth capabilities. We also have maintained business process continuity during the pandemic by enabling most back office teammates to work remotely and implemented guidance early in the pandemic to help mitigate health and safety risks to our teammates imposed by COVID-19. Our response protocol generally has allowed us to maintain continuity of care for our patients and we carefully monitor the efficacy of these protocols and their impact on our operations and strategic initiatives as the pandemic continues. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in part to the protocols and initiatives described above, we incurred significant costs related to COVID-19 in 2020, and we expect to continue to incur extended and significant additional costs in connection with our response to COVID-19. For example, we have had, and expect to continue to have, increased costs associated with a high demand for our skilled clinical personnel. Additionally, the steps we have taken designed to help safely maintain continuity of care for our patients and help protect our caregivers, such as our policies to implement dedicated care shifts for patients with confirmed or suspected COVID-19 and other enhanced clinical practices, have increased, and are expected to continue to increase, our expenses and use of personal protective equipment (PPE). Our response to COVID-19 also has resulted in higher salary and wage expense, and we have provided, and may provide in the future, substantial financial support associated with relief reimbursement to our teammates. Furthermore, the effort and cost needed to procure certain of our equipment and clinical supplies, including PPE, have increased, and we expect that these increased costs will continue while the pandemic persists. However, our COVID-19 response reduced certain other expenses in 2020, such as those related to teammate travel, though it remains uncertain how much of these reductions, if any, will persist after the pandemic subsides.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced and expect to continue to experience a negative impact on revenue and non-acquired growth from COVID-19 due to lower treatment volumes, including from the negative impact on our patient census that is the result of changes in rates of mortality. Because ESRD patients may be older and generally have comorbidities, several of which are risk factors for COVID-19, we believe the mortality rate of infected patients is, and will continue to be, higher in the dialysis population than in the general population, and COVID-19 also could impact the CKD population differently. Over the longer term, we believe that changes in mortality in both the CKD and ESRD populations due to COVID-19 will depend primarily on the infection rate, case fatality rate, the age and health status of affected patients, the access to and efficacy of vaccinations as well as willingness to be vaccinated. We expect that these changes are likely to continue to negatively impact our revenue and non-acquired growth even as the pandemic subsides. However, determining the extent to which these impacts should be directly attributable to COVID-19 is difficult due to testing and reporting limitations, and other factors that may drive treatment volumes and new admissions over time, such as the number of transplants or deferred admissions. The magnitude of these cumulative impacts has been substantial, and depending on the ultimate severity and duration of the pandemic, could be material.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the COVID-19 pandemic and efforts to contain the virus have led to global economic deterioration and rapid and sharp increases in unemployment levels, which ultimately could result in a materially reduced share of our patients being covered by commercial insurance plans, with more patients being covered by lower-paying government insurance programs or being uninsured. These effects may persist after the pandemic subsides as, among other things, our patients could experience permanent changes in their insurance coverage as a result of changes to their employment status. In the event such a material reduction occurs in the share of our patients covered by commercial insurance plans, it would have a material adverse impact on our business, results of operations, financial condition and cash flows. The extent of these effects will be dependent upon, among other things, the extent and duration of the increased unemployment levels for our patient population, economic deterioration and potential recession; the timing and scope of federal, state and local governmental responses to the ongoing pandemic; and patients&#8217; ability to retain existing insurance and their individual choices with respect to their coverage. Despite </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the broader economic conditions in the U.S. in 2020, our commercial mix in 2020 was relatively flat as compared to our commercial mix in 2019, which we believe was largely due to the fact that older, higher-risk patients who tend to disproportionately have government health insurance coverage, have been more adversely impacted by COVID-19 to date, but the ultimate impact of COVID-19 on our commercial mix will depend on future developments that are highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government response to COVID-19 has been wide-ranging and will continue to develop over time, particularly in light of the new federal administration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may not be able to accurately predict the nature, timing or extent of the impact of such changes on the markets in which we conduct business or on the other participants that operate in those markets, or any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern our business. We have worked with certain government agencies to respond to the COVID-19 pandemic, and in certain cases have sought waivers of regulatory requirements. We also are working to help make COVID-19 vaccines available to our patients and teammates, including through coordination with state and federal governments on direct vaccine distribution so that we can administer vaccines to our patients and teammates. These vaccines are currently available under emergency use authorizations, and there can be no assurance that our patients and caregivers will choose to receive a COVID-19 vaccine or that the vaccines will prove to be as safe and effective as currently understood by the scientific community. In addition, we may encounter difficulties with the availability and storage of the vaccines, or experience other complications related to administering the vaccines, some of which have multiple dose requirements. We operate in a complex and highly regulated environment, and the novel nature of our COVID-19 response, including, for example, with respect to regulatory waivers and our administration of the newly developed COVID-19 vaccines, may increase our exposure to legal, regulatory and clinical risks.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, a significant initial part of the federal government response to the COVID-19 pandemic was the Coronavirus Aid, Relief, and Economic Security (CARES) Act, a $2 trillion economic stimulus package that was signed into law on March 27, 2020. The CARES Act included a provision that suspended the 2% Medicare sequestration from May 1, 2020 through December 31, 2020, and in the year ended December 31, 2020 our revenues increased due to this suspension as further described below. The Consolidated Appropriations Act 2021, signed into law on December 27, 2020, extended the suspension of the 2% Medicare sequestration until March 31, 2021. While in effect, this legislation has increased, and will continue to increase our revenues. In addition, the CARES Act authorized $100 billion in funding to be distributed to healthcare providers through the federal Public Health and Social Services Emergency Fund (Provider Relief Fund). While we declined approximately $250 million of government funding received in the second quarter of 2020 from the Provider Relief Fund, certain of our competitors accepted such funds. There can be no assurance that financial or other assistance will be available from the government if we have a need for such assistance in the future. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the ultimate impact of this public health crisis on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic; further spread or resurgence of the virus including as a result of the emergence of new strains of the virus; its impact on the CKD patient population and our patient population; the availability, acceptance, impact and efficacy of COVID-19 treatments, therapies and vaccines; the pandemic&#8217;s continuing impact on the U.S. and global economies and unemployment; the responses of our competitors to the pandemic and related changes in the marketplace; and the timing, scope and effectiveness of federal, state and local governmental responses. At this time, we cannot reasonably estimate the ultimate impact the COVID-19 pandemic will have on us, but the adverse impact could be material.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion of the COVID-19 pandemic and our response, including its impact on us and related risks and uncertainties, please see the discussion in Part I Item 1 "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" under the headings, "COVID-19 and its impact on our business" and "Human Capital Management", as well as the risk factor in Part I Item 1A. Risk Factors under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_2834"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated results of operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenues, operating income and adjusted operating income by line of business. See the discussion of our results for each line of business following this table: </span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"></td><td style="width:46.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted operating income (loss):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income (loss) by reportable segment, see the "Reconciliations of non-GAAP measures" section below. </span></div><div id="i878840fee65247deaca27d2dd6a8246f_88"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis business is a leading provider of kidney dialysis services, operating 2,816 outpatient dialysis centers and serving a total of approximately 204,200 patients. We also provide hospital inpatient dialysis services in approximately 900 hospitals. We estimate that we have approximately a 36% share of the U.S. dialysis market based upon the number of patients we serve. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 91% of our 2020 consolidated revenues were derived directly from our U.S. dialysis business. The principal drivers of our U.S. dialysis revenues include&#160;&#160;&#160;&#160;:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our number of treatments, which is primarily a function of the number of chronic patients requiring approximately three in-center treatments per week as well as, to a lesser extent, the number of treatments for home-based dialysis and hospital inpatient dialysis; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our average dialysis patient service revenue per treatment, including the mix of patients with commercial plans and government programs as primary payor.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our U.S. dialysis business, our home-based dialysis and hospital inpatient dialysis services are operationally integrated with our outpatient dialysis centers and related laboratory services. Our outpatient, home-based, and hospital inpatient dialysis services comprise approximately 77%, 17% and 6% of our U.S. dialysis revenues, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., government dialysis-related payment rates are principally determined by federal Medicare and state Medicaid policy. For 2020, approximately 68% of our total U.S. dialysis patient services revenues were generated from government-based programs for services to approximately 90% of our total U.S. patients. These government-based programs are principally Medicare and Medicare Advantage, Medicaid and managed Medicaid plans, and other government plans, representing approximately 57%, 7% and 4% of our U.S. dialysis patient services revenues, respectively. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialysis payment rates from commercial payors vary and a major portion of our commercial rates are set at contracted amounts with payors and are subject to intense negotiation pressure. On average, dialysis-related payment rates from contracted commercial payors are significantly higher than Medicare, Medicaid and other government program payment rates, and therefore the percentage of commercial patients in relation to total patients represents a significant driver of our total average dialysis patient service revenue per treatment. Commercial payors (including hospital dialysis services) represent approximately 32% of U.S. dialysis patient services revenues.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For discussion of government reimbursement, the Medicare ESRD bundled payment system, Medicare Advantage and commercial reimbursement, see the discussion in Part I. Item 1. Business under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. dialysis business &#8211; Sources of revenue-concentrations and risks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; For a discussion of operational, clinical and financial risks and uncertainties that we face in connection with the Medicare ESRD bundled payment system, see the risk factor in Part I. Item 1A. Risk Factors under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; For a discussion of operational, clinical and financial risks and uncertainties that we face in connection with commercial payors, see the risk factors in Item 1A. Risk Factors under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We continuously have ongoing negotiations with commercial payors, and if the average rates that commercial payors pay us decline significantly, if patients in commercial plans are subject to restriction in plan designs or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it would have a material adverse effect on our business, results of operations, financial condition and cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"; and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If the number of patients with higher-paying commercial insurance declines, it could have a material adverse effect on our business, results of operations, financial condition and cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2018, both oral and intravenous forms of calcimimetics became the financial responsibility of our U.S. dialysis business for our Medicare patients and are reimbursed under Medicare Part B. Since the effective date through December 31, 2020, the oral and intravenous forms of calcimimetics were separately reimbursed through a transitional drug add-on payment adjustment (TDAPA) and not as part of the ESRD PPS bundled payment. These separate reimbursement payments for calcimimetics were subject to change on an annual basis. During the initial TDAPA period, Medicare payments were based on a pass-through rate of the average sales price plus approximately 6% before sequestration (or 4% adjusted for sequestration), and in 2020 they were based on a pass-through rate of the average sales price plus 0%, before sequestration. As expected, as of January 1, 2021, calcimimetics was added to the ESRD PPS bundled payment. We therefore expect our operating income from calcimimetics to be more stable in the future as compared to the past three years under the TDAPA model.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 4% and 6% of our total U.S. dialysis patient services revenues for the years 2020 and 2019, respectively, are associated with the administration of separately-billable physician-prescribed pharmaceuticals, of which approximately 3% and 4% relate to the administration of calcimimetics, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to experience increases in our operating costs in 2021 that may outpace any net Medicare rate increases that we may receive, which could significantly impact our operating results.&#160;In particular, we expect to continue experiencing increases in operating costs that are subject to inflation, such as labor and supply costs, including increases in maintenance costs, regardless of whether there is a compensating inflation-based increase in Medicare payment rates or in payments under the ESRD bundled payment rate system. We also continue to expect to incur additional COVID-19-related costs while the pandemic continues. In addition, we expect to continue to incur capital expenditures to improve, renovate and maintain our facilities, equipment and information technology to meet evolving regulatory requirements and otherwise.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs are those costs directly associated with operating and supporting our dialysis centers, home-based dialysis programs and hospital inpatient dialysis programs, and consist principally of labor, benefits, pharmaceuticals, medical supplies and other operating costs of the dialysis centers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal drivers of our U.S. dialysis patient care costs include:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical hours per treatment, labor rates and benefit costs;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">vendor pricing and utilization levels of pharmaceuticals;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business infrastructure costs, which include the operating costs of our dialysis centers; and </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain professional fees. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other cost categories that can present significant variability include employee benefit costs, insurance costs and medical supply costs. In addition, proposed ballot initiatives or referendums, legislation, regulations or policy changes could cause us to incur substantial costs to prepare for, or implement changes required. Any such changes could result in, among other things, increases in our labor costs or limitations on the amount of revenue that we can retain. For additional information on risks associated with potential and proposed ballot initiatives, referendums, legislation, regulations or policy changes, see the risk factor in Item 1A. Risk Factors under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our average clinical hours per treatment decreased in 2020 compared to 2019. We are always striving for improved productivity levels, however, changes in things such as federal and state policies or regulatory billing requirements can lead to increased labor costs. In 2020, the demand for skilled clinical personnel increased due to the demand of the pandemic on these resources, intensifying these competitive pressures; however, we managed to increase our overall clinical teammate retention in 2020. In 2020 and 2019, we experienced an increase in our clinical labor rates of approximately 3.0% and 2.0%, respectively, consistent with general industry trends. We also continue to experience increases in the infrastructure and operating costs of our dialysis centers, primarily due to the number of new dialysis centers opened, and general increases in rent, utilities and repairs and maintenance. In 2020, we continued to implement certain cost control initiatives to help manage our overall operating costs, including labor productivity, and we expect to continue these initiatives in 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis general and administrative expenses represented 9.0% and 8.1% of our U.S. dialysis revenues in 2020 and 2019, respectively. Increases in general and administrative expenses over the last several years were primarily related to strengthening our dialysis business and related compliance and operational processes, responding to certain legal and compliance matters, professional fees associated with enhancing our information technology systems and more recent advocacy costs in 2020 related to countering union policy efforts. We expect that these levels of general and administrative expenses will be impacted by lower advocacy costs in 2021 compared to 2020, offset by continued investment in developing our capabilities and executing on our strategic priorities, among other things.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis results of operations</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:47.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dialysis treatments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30,314,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30,172,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Average treatments per day</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">96,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">96,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treatment days</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Average patient service revenue per treatment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">350.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">349.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Normalized non-acquired treatment growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Normalized non-acquired treatment growth reflects year over year growth in treatment volume, adjusted to exclude acquisitions and other similar transactions, and further adjusted to normalize for the number and mix of treatment days in a given period versus the prior period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis revenues in 2020 increased primarily due to an increase in dialysis treatments and an increase in our average patient service revenue per treatment. The increase in our U.S. dialysis treatments was driven by approximately one additional treatment day in 2020 compared to 2019 and an increase in acquired and non-acquired treatments, partially offset by the deconsolidation of two dialysis partnerships, as described below under the heading "Equity investment income". Treatments were negatively impacted by higher mortality than experienced historically as well as a decline in new admissions. We believe the increased mortality rate is largely attributable to the impact of COVID-19 on our patient population. Our U.S. dialysis revenues were positively impacted by an increase in our average patient service revenue per treatment driven by favorable changes in government rate, including an increase in Medicare rates due to a base rate increase in 2020 and the temporary suspension of Medicare sequestration as well as an increase in hospital inpatient dialysis services revenue per treatment, partially offset by a decline in calcimimetics reimbursement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses and charges:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:47.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs per treatment</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.27&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.03)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">General and administrative expenses for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included advocacy costs of approximately $67 million incurred to counter union policy efforts, including a California ballot initiative.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient care costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs are those costs directly associated with operating and supporting our dialysis centers and consist principally of compensation expenses including labor and benefits, pharmaceuticals, medical supplies and other operating costs of the dialysis centers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs per treatment decreased primarily due to decreases in pharmaceutical unit costs, as well as decreased travel expenses due to COVID-19. These decreases were partially offset by an increase in labor costs and COVID-19-related costs, including compensation, medical supplies and teammate relief reimbursement and benefit program expenses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses in 2020 increased primarily due to an increase in advocacy costs incurred to counter union policy efforts, including those related to a California ballot initiative. These increases were also driven by contributions to our charitable foundation, labor costs and COVID-19-related costs, including compensation expenses. These increases were partially offset by a decrease in travel expenses due to COVID-19 and a decrease in long-term incentive compensation expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense is directly impacted by the number of dialysis centers we develop and acquire. U.S. dialysis depreciation and amortization expense increased primarily due to growth in the number of dialysis centers we operate.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity investment income. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis equity investment income increased primarily due to the deconsolidation of two of our near 50%-owned dialysis partnerships at year-end 2019, based on a reassessment of relative rights and powers over these partnerships. Our portion of these partnerships' earnings are now recognized in equity investment income.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.017%"><tr><td style="width:1.0%"></td><td style="width:46.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see the "Reconciliations of non-GAAP measures" section below. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income and adjusted operating income in 2020 decreased compared to 2019 primarily due to a decrease in calcimimetics margin, increases in labor costs, advocacy costs and charitable contributions; and an increase in COVID-19-related expenses, including compensation, medical supplies, and reimbursement and benefit program expenses, as described above. These decreases to operating income were partially offset by volume growth from approximately one additional treatment day in the year and an increase in our average dialysis patient service revenue per treatment, as described above, as well as decreases in pharmaceutical unit costs, travel expenses and long-term incentive compensation expense.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other - Ancillary services</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other operations include ancillary services that are primarily aligned with our core business of providing dialysis services to our network of patients. As of December&#160;31, 2020, these consisted primarily of integrated care (DaVita IKC), ESRD seamless care organizations (ESCOs), clinical research programs (DaVita Clinical Research), and physician services, as well as our international operations. These ancillary services, including our international operations, generated revenues of approximately $1.053 billion in 2020, representing approximately 9% of our consolidated revenues. As further described in the risk factor in Item 1A. Risk Factors under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our ancillary services and strategic initiatives, including, without limitation, our international operations, that we operate or invest in now or in the future may generate losses and may ultimately be unsuccessful. In the event that one or more of these activities is unsuccessful, our business, results of operations, financial condition and cash flows may be negatively impacted and we may have to write off our investment and incur other exit costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," if any of our ancillary services or strategic initiatives, such as our international operations, are unsuccessful, it could have a negative impact on our business, results of operations, financial condition and cash flows, and we may determine to exit that line of business, which could result in significant termination costs. In addition, we have in the past and may in the future incur material write-offs or impairments of our investments, including goodwill, in one or more of these ancillary services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to add additional service offerings to our business and pursue additional strategic initiatives in the future as circumstances warrant, which could include, among other things, healthcare services not related to dialysis. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, our international dialysis operations provided dialysis and administrative services through a total of 321 outpatient dialysis centers located in ten countries outside of the U.S. For 2020, total revenues generated from our international operations were approximately 5% of our consolidated revenues.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ancillary services results of operations</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"></td><td style="width:45.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating (loss) income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjusted operating loss:</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The reported operating income (loss) and adjusted operating income for the years ended December&#160;31, 2020 and December&#160;31, 2019, include approximately $3 million and $2 million, respectively, of foreign currency losses.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating (loss) income by reportable segment, see the "Reconciliations of non-GAAP measures" section below. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. ancillary services revenues in 2020 increased due to an increase in revenues at our integrated care business, primarily due to revenue increases in our special needs plans, as well as an increase in revenues in our ESCO and physician services businesses. These increases were partially offset by a decrease in revenue in our clinical research programs, as well as due to the sale of Lifeline, as described below. Our international revenues increased primarily as a result of acquired treatment growth as we continue to expand our international business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charges impacting operating income: </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on changes in ownership interests, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We sold 100% of the stock of Lifeline, our vascular access business, effective May 1, 2020 and recognized a loss of approximately $16 million on this transaction.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During 2019, we recognized goodwill impairment charges of $125 million in our international reporting units. See further discussion of these impairment charges and our reporting units that remain at risk of goodwill impairment in Note 10 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating loss and adjusted operating loss:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. ancillary services operating loss in 2020 was negatively impacted by the loss on sale of Lifeline, as described above, and both U.S. ancillary operating loss and adjusted operating loss were negatively impacted by an increase in medical costs due to COVID-19 in our integrated care business and a decrease in revenue in our clinical research programs, partially offset by increases in revenues in our integrated care and ESCO businesses. International operating results and adjusted operating results increased in 2020 compared to 2019. International operating results in 2019 were negatively impacted by goodwill impairment charges, as described above, and both international operating results and adjusted operating results benefited in 2020 primarily from acquisition-related growth and the reduction of certain other periodic expenses, partially offset by increased medical supplies costs and higher mortality due to COVID-19.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_94"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate administrative support</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support consists primarily of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">labor, benefits and long-term incentive compensation expense, as well as professional fees for departments which provide support to all of our various operating lines of business. In 2020, corporate support also included an accrual for legal matters. Corporate administrative support expenses are included in general and administrative expenses on our consolidated income statement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accruals for legal matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During 2020, we recorded a net charge for legal matters of $35 million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support expenses increased $54 million in 2020 primarily driven by accruals for legal matters, as described above. In addition, both corporate administrative support and adjusted corporate administrative support expenses increased in 2020 due to an increase in severance accruals recorded in the second quarter of 2020 associated with our senior executive leadership transition and an increase in long-term compensation expense.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_97"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate-level charges</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:53.459%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Debt expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(44.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effective income tax rate from continuing operations attributable to </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;DaVita Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our effective income tax rate from continuing operations attributable to DaVita Inc., see the "Reconciliations of non-GAAP measures" section below. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense decreased primarily due to a decrease in our outstanding debt balances and a decrease in the overall weighted average effective interest rate on our debt in 2020. Our overall weighted average effective interest rate in 2020 was 3.59% compared to 5.01% in 2019. See Note 13 to the consolidated financial statements for further information on the components of our debt and changes in them since 2019. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt prepayment, refinancing and redemption charges</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt prepayment, refinancing and redemption charges were $89 million in 2020 as a result of the redemption in full of both our $1.75 billion aggregate principal amount outstanding of 5.125% senior notes and our $1.50 billion aggregate principal amount outstanding of 5.0% senior notes. These 2020 charges represented debt redemption premium charges and deferred financing cost write-offs associated with our prior senior note debt that was paid in full. These charges recognized in 2020 also included $3 million of refinancing charges comprised partially of fees incurred on the repricing of our Term Loan B and partially of deferred financing costs written off for the portion of this debt considered extinguished and reborrowed. In 2019, we incurred debt prepayment, refinancing and redemption charges of $33 million as a result of the repayment of all principal balances outstanding under our prior senior secured credit facilities and the redemption of our $1.25 billion aggregate principal amount outstanding of 5.75% senior notes. See further discussion of our 2020 debt prepayment, refinancing and redemption charges in Note 13 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income consists primarily of interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses. Other income decreased in 2020 primarily due to a decrease in interest income on our holdings of cash and cash equivalents in 2020 and a decrease in foreign currency transaction gains. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for income taxes&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate and effective income tax rate from continuing operations attributable to DaVita Inc. increased in 2020 primarily due to an increase in nondeductible advocacy costs and the impact of a discrete benefit included in the 2019 tax rate from a reduction in the blended state rate. This increase was partially offset by a reduction in accruals associated with uncertain tax positions in 2020.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in income attributable to noncontrolling interests in 2020 compared to 2019 was due to improved earnings at certain U.S. dialysis partnerships, including, among other things, reimbursements we made to certain of our U.S. dialysis partnerships for certain COVID-19-related expenses, partially offset by the deconsolidation of two dialysis partnerships at year-end 2019.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_103"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our consolidated accounts receivable balances at December&#160;31, 2020 and December&#160;31, 2019, were $1.824 billion and $1.796 billion, respectively, representing approximately 59 days and 58 days of revenue (DSO), respectively, net of allowances for uncollectible accounts. The increase in consolidated DSO was primarily due to an increase of one day of DSO in our U.S. dialysis business primarily due to held claims for COVID-19-related cohort arrangement billings as well as claims from centers impacted by hurricanes in the fourth quarter of 2020.&#160;Our DSO calculation is based on the current quarter&#8217;s average revenues per day. There were no significant changes during 2020 from 2019 in the amount of unreserved accounts receivable over one year old or the amounts pending approval from third-party payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and 2019, our net patient services accounts receivable balances that are more than six months old represents approximately 17% and 18%, respectively of our total net accounts receivable balances outstanding. Substantially all revenue realized is from government and commercial payors, as discussed above. There were no significant unreserved balances over one year old. Less than 1% of our revenues are classified as patient pay.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts pending approval from third-party payors associated with Medicare bad debt claims as of December&#160;31, 2020 and 2019, other than the standard monthly billing, consisted of approximately $154 million and $138 million, respectively, and are classified as other receivables. A significant portion of our Medicare bad debt claims are typically paid to us before the Medicare fiscal intermediary audits the claims but are subject to subsequent adjustment based upon the actual results of those audits. Such audits typically occur one to four years after the claims are filed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our major sources and uses of cash, cash equivalents and restricted cash:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:53.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash items in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other working capital changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in) provided by investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine maintenance/IT/other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and relocations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG net sale proceeds received, net of DMG cash sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,821)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (payments) issuances, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,995)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing and debt redemption costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award exercises and other share issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,847)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,696)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,850&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,477,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,020,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,542,854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents consolidated cash flow activity, including cash flows related to discontinued operations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our free cash flow from continuing operations, see the "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated cash flows</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated cash flows from operating activities for 2020 were $1,979 million, all of which was from continuing operations, compared with consolidated operating cash flows for the same period in 2019 of $2,072 million, of which $1,973 million was from continuing operations. The increase in cash flow from continuing operations was primarily driven by a decrease in cash interest paid partially offset by COVID-19-related expenses in 2020, and increases in labor and advocacy costs, as well as an increase in DSO of approximately one day in 2020 compared to 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from investing activities in 2020 decreased $3,821 million compared to 2019 primarily due to the net cash proceeds received from the DMG sale, which closed in June 2019, as well as an increase in acquisition expenditures partially offset by a decrease in capital expenditures. We developed 31 fewer centers and acquired 51 additional centers in 2020 compared to 2019. See below for additional information regarding the growth in our dialysis centers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from financing activities improved $2,850 million in 2020 compared to 2019. Significant sources of cash during 2020 included issuances of $1,500 million in aggregate principal amount of 3.75% senior notes due 2031 in August 2020 and $1,750 million in aggregate principal amount of 4.625% senior notes due 2030 in June 2020, as well as a net draw of $75 million on our revolving line of credit. Significant uses of cash during 2020 included the subsequent redemptions in full of $1,500 million in aggregate principal amount of 5.0% senior notes due 2025 in August 2020 and $1,750 million in aggregate principal amount of 5.125% senior notes due 2024 in July 2020. Other net payments during 2020 primarily consisted of regularly scheduled mandatory principal payments under our senior secured credit facilities totaling approximately $55 million on Term Loan A and $27 million on Term Loan B-1 and additional required principal payments under other debt arrangements. In addition, we incurred bond issuance costs of approximately $38 million, debt redemption premium charges related to the redemption of our senior notes due in 2024 and 2025 of approximately $67 million and costs of repricing our Term Loan B of approximately $3 million. See further discussion in Note 13 to the consolidated financial statements related to debt financing activities. By comparison, in 2019 debt payments primarily consisted of principal prepayments totaling $5,142 million on our term debt under our prior senior secured credit facility funded primarily by the net proceeds from the DMG sale and the redemption of all of our outstanding 5.75% senior notes due in 2022 for an aggregate cash payment consisting of principal and redemption premium of $1,262 million, partially offset by funding of our term debt of $4,500 million under our new senior credit facility. Cash flows used for share repurchases also decreased in 2020 as compared to 2019. See below for further information on our share repurchases. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis center capacity and growth</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are typically able to increase our capacity by extending hours at our existing dialysis centers, expanding our existing dialysis centers, relocating our dialysis centers, developing new dialysis centers and by acquiring dialysis centers. The development of a typical new outpatient dialysis center generally requires approximately $2.4 million for leasehold improvements and other capital expenditures. Based on our experience, a new outpatient dialysis center typically opens within a year after the property lease is signed, normally achieves operating profitability in the second year after Medicare certification, and normally reaches maturity within three to five years. Acquiring an existing outpatient dialysis center requires a substantially greater initial investment, but profitability and cash flows are generally accelerated and more predictable. To a limited extent, we enter into agreements to provide management and administrative services to outpatient dialysis centers in which we own a noncontrolling interest or which are wholly-owned by third parties in return for management fees.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the growth in our dialysis operations by number of dialysis centers owned or operated:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of centers operated at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired centers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed centers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in non-owned managed or administered centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sold and closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of centers operated at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.181%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers which we manage or provide administrative services to but in which we own a noncontrolling equity interest or which are wholly-owned by third parties, including our Asia Pacific joint venture centers.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were sold and/or closed for which the majority of patients were not retained.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were closed for which the majority of patients were retained and transferred to one of our other existing outpatient dialysis centers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our common stock repurchases during the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"><tr><td style="width:1.0%"></td><td style="width:45.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions and shares in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tender offers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The aggregate amounts paid for shares repurchased pursuant to our 2020 and 2019 tender offers for our shares during the years ended December&#160;31, 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of $2.5 million and $2.3 million, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2020, we have repurchased 1,063,000 shares of our common stock for $123 million at an average cost of $115.98 per share from January 1, 2021 through February&#160;10, 2021. We retired all shares of common stock held in treasury effective December&#160;31, 2020 and December&#160;31, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion of our share repurchase activity and authorizations in Note 19 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available liquidity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, our cash balance was $325 million and we held approximately $20 million in short-term investments. At that time we also had $925 million available and $75 million drawn on our $1.0 billion revolving line of credit under our senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding under this facility, but we had no such letters of credit outstanding as of December&#160;31, 2020. As of December&#160;31, 2020 we also separately had approximately $65 million in letters of credit outstanding under a separate bilateral secured letter of credit facility.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 to the consolidated financial statements for components of our long-term debt and their interest rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and efforts to prevent its spread have dramatically reduced global economic activity and driven increased volatility in the financial markets. We have maintained business process continuity during the COVID-19 pandemic by enabling most back office teammates to work remotely, and as of the date of this report, we have not experienced a material deterioration in our liquidity position as a result of the COVID-19 crisis. In addition, we elected not to accept approximately $250 million in funds available to us through the CARES Act Provider Relief Fund and returned the funds we received in May 2020. There can be no assurance that we will be able to continue to forgo financial or other assistance available under the CARES Act or similar subsequent legislation or that similar assistance will be available from the government if we have a need for such assistance in the future. The ultimate impact of the pandemic will depend on future developments that are highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash flow from operations and other sources of liquidity, including from amounts available under our senior secured credit facilities and our access to the capital markets, will be sufficient to fund our scheduled debt service under the terms of our debt agreements and other obligations for the foreseeable future, including the next 12 months. Our primary recurrent sources of liquidity are cash from operations and cash from borrowings, which are subject to general, economic, financial, competitive, regulatory and other factors that are beyond our control, as described in Item 1A Risk Factors under the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The level of our current and future debt could have an adverse impact on our business, and our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenants depends on many factors beyond our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div id="i878840fee65247deaca27d2dd6a8246f_100"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliations of non-GAAP measures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide reconciliations of adjusted operating income (loss) to operating income (loss) as presented on a U.S. generally accepted accounting principles (GAAP) basis for our U.S. dialysis reportable segment as well as for our U.S. ancillary services, our international business, and for our total ancillary services which combines them and is disclosed as our other segments category. These non-GAAP or &#8220;adjusted&#8221; measures are presented because management believes these measures are useful adjuncts to, but not alternatives for, our GAAP results.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, management uses adjusted operating income (loss) to compare and evaluate our performance period over period and relative to competitors, to analyze the underlying trends in our business, to establish operational budgets and forecasts and for incentive compensation purposes. We believe this non-GAAP measure is also useful to investors and analysts in evaluating our performance over time and relative to competitors, as well as in analyzing the underlying trends in our business. We also believe this presentation enhances a user's understanding of our normal operating income by excluding certain items which we do not believe are indicative of our ordinary results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our effective income tax rate on income from continuing operations attributable to DaVita Inc. excludes noncontrolling owners' income, which primarily relates to non-tax paying entities. We believe this adjusted effective income tax rate is useful to management, investors and analysts in evaluating our performance and establishing expectations for income taxes incurred on our ordinary results attributable to DaVita Inc.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, our free cash flow from continuing operations represents net cash provided by operating activities from continuing operations less distributions to noncontrolling interests and all capital expenditures (including development capital expenditures, routine maintenance and information technology), plus contributions from noncontrolling interests and proceeds from the sale of self-developed properties. Management uses this measure to assess our ability to fund acquisitions and meet our debt service obligations and we believe this measure is equally useful to investors and analysts as an adjunct to cash flows from operating activities from continuing operations and other measures under GAAP.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important to bear in mind that these non-GAAP &#8220;adjusted&#8221; measures are not measures of financial performance under GAAP and should not be considered in isolation from, nor as substitutes for, their most comparable GAAP measures.</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate <br/>administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on changes in ownership interests, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for legal matters</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate <br/>administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:74.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling owners&#8217; income primarily attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense for continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Income tax attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from continuing operations attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate on income from continuing operations attributable to DaVita Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:65.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by continuing operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by continuing operating activities attributable to DaVita Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,769&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,797&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Expenditures for routine maintenance and information technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(399)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Expenditures for development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_109"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-balance sheet arrangements and aggregate contractual obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the debt obligations and operating lease liabilities reflected on our balance sheet, we have commitments associated with letters of credit, as well as certain working capital funding obligations associated with our equity investments in nonconsolidated dialysis ventures that we manage and some we manage that are wholly-owned by third parties.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have potential obligations to purchase the noncontrolling interests held by third parties in many of our majority-owned dialysis partnerships and other nonconsolidated entities. These obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods as outlined in each specific put provision. For additional information see Note 17 to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of these contractual obligations and commitments as of December&#160;31, 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:50.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022-2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024-2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scheduled payments under contractual obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments on credit facilities and senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases, including imputed interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential cash requirements under other commitments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-owned and minority owned put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating capital advances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase commitments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">See Note 13 to the consolidated financial statements for components of our long-term debt and related interest rates. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">See Note 14 to the consolidated financial statements for components of our leases and related interest rates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on December&#160;31, 2022. Under the terms of the agreement, the Company will purchase EPO from Amgen in amounts necessary to meet no less than 90% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that we will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that we serve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase commitments in the table above represent our agreements with various suppliers to purchase set amounts of dialysis equipment, parts, and supplies. If we fail to meet the minimum purchase commitments under these contracts during any year, it is required to pay the difference to the supplier.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements of approximately $88 million of existing income tax liabilities for unrecognized tax benefits, including interest, penalties and other long-term tax liabilities, are excluded from the table above as reasonably reliable estimates of their timing cannot be made.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_112"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Note 16 to the consolidated financial statements included in this report is incorporated by reference in response to this item.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_115"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies, estimates and judgments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements and accompanying notes are prepared in accordance with United States generally accepted accounting principles. These accounting principles require us to make estimates, judgments and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions (redeemable equity interests). All significant estimates, judgments and assumptions are developed based on the best information available to us at the time made and are regularly reviewed and updated when necessary. Actual results will generally differ from these estimates, and such differences may be material. Changes in estimates are reflected in our financial statements in the period of change based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Certain accounting estimates, including those concerning revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates, and loss contingencies are considered to be critical to evaluating and understanding our financial results because they involve inherently uncertain matters and their application requires the most difficult and complex judgments and estimates. For additional information, see Part II Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules" &#8211; Note 1 &#8211; "Organization and summary of significant accounting policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as referred from Part II Item 8, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements and Supplementary Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. dialysis revenue recognition and accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There are significant estimating risks associated with the amount of U.S. dialysis revenue that we recognize in a given reporting period. Payment rates are often subject to significant uncertainties related to wide variations in the coverage terms of the commercial healthcare plans under which we receive payments. In addition, ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage, and other payor issues complicate the billing and collection process. Net revenue recognition and allowances for uncollectible billings require the use of estimates of the amounts that will ultimately be realized considering, among other items, retroactive adjustments that may be associated with regulatory reviews, audits, billing reviews and other matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are recognized based on (a)&#160;the payment rates that are established by statute or regulation for the portion of the payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b)&#160;for the portion not paid by the primary government payor, the estimated amounts that will ultimately be collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient. Our dialysis related reimbursements from Medicare are subject to certain variations under Medicare&#8217;s single bundled payment rate system whereby our reimbursements can be adjusted for certain patient characteristics and other variable factors. Our revenue recognition depends upon our ability to effectively capture, document and bill for Medicare&#8217;s base payment rate and these other factors. In addition, as a result of the potential range of variations that can occur in our dialysis-related reimbursements from Medicare under the single bundled payment rate system, our revenue recognition is subject to a greater degree of estimating risk.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial healthcare plans, including contracted managed-care payors, are billed at our usual and customary rates; however, revenue is recognized based on estimated net realizable revenue for the services provided. Net realizable revenue is estimated based on contractual terms for the patients covered under commercial healthcare plans with which we have formal agreements, non-contracted commercial healthcare plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in our billing and collection processes that can result in denied claims for payments, the estimated timing of collections, changes in our expectations of the amounts that we expect to collect and regulatory compliance matters. Determining applicable primary and secondary coverage for our approximately 204,200 U.S. dialysis patients at any point in time, together with the changes in patient coverages that occur each month, requires complex, resource-intensive processes. Collections, refunds and payor retractions typically continue to occur for up to three years or longer after services are provided.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expect the range of our U.S. dialysis revenue estimating risk to be within 1% of revenue, which can represent as much as approximately 5% of our U.S. dialysis business&#8217;s adjusted operating income. Changes in estimates are reflected in the then-current financial statements based on on-going actual experience trends, or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Changes in revenue estimates for prior periods are separately disclosed and reported if material to the current reporting period and longer term trend analyses, and have not been significant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for laboratory services, which are integrally related to our dialysis services, are recognized in the period services are provided at the estimated net realizable amounts to be received.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairments of goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We account for impairments of goodwill in accordance with the provisions of applicable accounting guidance. Goodwill is not amortized, but is assessed for impairment when changes in circumstances warrant and at least annually. An impairment charge is recorded when and to the extent a reporting unit's carrying amount is determined to exceed its estimated fair value.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in circumstance that may trigger a goodwill impairment assessment for one of our business units can include, among others, changes in the legal environment, addressable market, business strategy, development or business plans, reimbursement structure, operating performance, future prospects, relationships with partners, and/or market value indications for the subject business. We use a variety of factors to assess changes in the financial condition, future prospects and other circumstances concerning the subject businesses and to estimate their fair value when applicable. Any change in the factors, assessments or assumptions involved could affect a determination of whether and when to assess goodwill for impairment as well as the outcome of such an assessment. These assessments and the related valuations can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our income tax expense, deferred tax assets and liabilities, and liabilities for unrecognized tax benefits reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We are subject to income taxes in the United States and numerous state and foreign jurisdictions, and changes in tax laws or regulations may be proposed or enacted that could adversely affect our overall tax liability. The actual impact of any such laws or regulations could be materially different from our current estimates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgments and estimates are required in determining our consolidated income tax expense. Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, which will result in taxable or deductible amounts in the future. In evaluating our ability to recover our deferred tax assets within the jurisdictions from which they arise, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, results of recent operations, and assumptions about the amount of future federal, state, and foreign pre-tax operating income adjusted for items that do not have tax consequences. The assumptions about future taxable income require significant judgments and are consistent with the plans and estimates we use to manage the underlying businesses. To the extent that recovery is not likely, a valuation allowance is established. The allowance is regularly reviewed and updated for changes in circumstances that would cause a change in judgment about the realizability of the related deferred tax assets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The FASB defines fair value generally as the amount at which an asset (or liability) could be bought (or assumed) or sold (or settled) in a current transaction between willing parties, that is, other than in a forced or liquidation sale. It also defines fair value more specifically for most purposes as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests). These purposes can include purchase accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, and other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based compensation, among others. The criticality of a particular fair value estimate to our consolidated financial statements depends upon the nature and size of the item being measured, the extent of uncertainties involved and the nature and magnitude or potential effect of assumptions and judgments required. Critical fair value estimates can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss contingencies.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Notes 1 and 16 to the consolidated financial statements, we operate in a highly regulated industry and are party to various lawsuits, claims, qui tam suits, governmental investigations and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law), contract disputes and other legal proceedings.&#160;Assessments of such matters can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. We record accruals for loss contingencies on such matters to the extent that we determine an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. See Note 16 to the consolidated financial statements included in this report for further discussion.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_118"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant new accounting standards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 to the consolidated financial statements included in this report for information regarding certain recent financial accounting standards that have been issued by the FASB.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate sensitivity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide information about our financial instruments that are sensitive to changes in interest rates. The first table below presents principal repayments and current weighted average interest rates on our debt obligations as of December&#160;31, 2020. The variable rates presented reflect the weighted average LIBOR rates in effect for all debt tranches plus interest rate margins in effect as of December&#160;31, 2020. The Term Loan A interest rate margin in effect at December&#160;31, 2020, was 1.50%. At December&#160;31, 2020, the Term Loan B-1 interest rate margin in effect was 1.75%. At December&#160;31, 2020, we had an outstanding balance on our revolving line of credit bearing interest at an Alternate Base Rate (the Prime Rate) plus 0.50%. On January 6, 2021 our revolving line of credit rate was converted to a LIBOR-based rate of LIBOR plus 1.50%. The interest rates in effect on our Term Loan A and revolving line of credit are subject to adjustment depending upon changes in our leverage ratio.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.974%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>interest<br/>rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="51" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents the fair value of our long-term debt excluding financing leases.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.970%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receive variable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR above 2.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a further discussion of our debt, see Note 13 to our consolidated financial statements at Part II Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules" &#8211; Note 13 &#8211; "Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as referred from Part II Item 8, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements and Supplementary Data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash flow from operations and other sources of liquidity, including from amounts available under our current credit facilities and our access to the capital markets, will be sufficient to fund our scheduled debt service under the terms of our debt agreements and other obligations for the foreseeable future, including the next 12 months. Our primary recurrent sources of liquidity are cash from operations and cash from borrowings.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One means of assessing exposure to debt-related interest rate changes is a duration-based analysis that measures the potential loss in net income resulting from a hypothetical increase in interest rates of 100 basis points across all variable rate maturities (referred to as a parallel shift in the yield curve). Under this model, with all else constant, it is estimated that such an increase would have reduced net income by approximately $34.8 million, $32.4 million, and $37.8 million, net of tax, for the years ended December&#160;31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exchange rate sensitivity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our business is predominantly conducted in the U.S., we have developing operations in ten other countries as well. For financial reporting purposes, the U.S. dollar is our reporting currency. However, the functional currencies of our operating businesses in other countries are typically those of the countries in which they operate. Therefore, changes in the rate of exchange between the U.S. dollar and the local currencies in which our international operations are conducted affect our results of operations and financial position as reported in our consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have consolidated the balance sheets of our non-U.S. dollar denominated operations into U.S. dollars at the exchange rates prevailing at the balance sheet dates and have translated their revenues and expense at average exchange rates during each period.&#160;Additionally, our individual subsidiaries are exposed to transactional risks mainly resulting from intercompany transactions between and among subsidiaries with different functional currencies. This exposes the subsidiaries to fluctuations in the rate of exchange between the invoicing or obligation currencies and the currency in which their local operations are conducted.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our exposure to foreign exchange risk through the judgment of our international and corporate management teams.&#160;Through 2020, our international operations have remained fairly small relative to the size of our consolidated financial statements, constituting approximately 9% of our consolidated assets as of December&#160;31, 2020, with no single country constituting more than 3% of consolidated assets, and approximately 5% of our consolidated revenues for the year ended December&#160;31, 2020.&#160;In addition, our foreign currency translation (losses) gains were approximately (0.4)%, (1)%, and (3)% of our consolidated operating income for the years ended December&#160;31, 2020, 2019 and 2018.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the relatively small size of our international operations, management does not consider our exposure to foreign exchange risk to be significant to the consolidated enterprise.&#160;As such, through December&#160;31, 2020, we have not engaged in transactions to hedge the exposure of our international transactions or net investments to foreign currency risk.&#160;</span></div><div id="i878840fee65247deaca27d2dd6a8246f_124"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the Index to Financial Statements and Index to Financial Statement Schedules included at Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div id="i878840fee65247deaca27d2dd6a8246f_127"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_130"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9A.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has established and maintains disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that it files or submits pursuant to the Securities Exchange Act of 1934 (Exchange Act) as amended is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") as appropriate to allow for timely decisions regarding required disclosures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our CEO and CFO, of the effectiveness of the design and operation of the Company's disclosure controls and procedures in accordance with the Exchange Act requirements as of December 31, 2020. Based upon that evaluation, the CEO and CFO concluded that the Company's disclosure controls and procedures were effective as required by the Exchange Act as of such date for our Exchange Act reports, including this report. Management recognizes that these controls and procedures can provide only reasonable assurance of desired outcomes, and that estimates and judgments are still inherent in the process of maintaining effective controls and procedures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in the Company's internal control over financial reporting that was identified during the evaluation that occurred during the fourth fiscal quarter of 2020 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_133"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9B.&#160;&#160;&#160;&#160;Other Information.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i878840fee65247deaca27d2dd6a8246f_139"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to disclose any amendments or waivers to the Code of Ethics applicable to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions, on our website located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In 2002, we adopted a Corporate Governance Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, and to all of our financial accounting and legal professionals who are directly or indirectly involved in the preparation, reporting and fair presentation of our financial statements and Exchange Act reports. The Code of Ethics is posted on our website, located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We also maintain a Corporate Code of Conduct that applies to all of our employees, officers and directors, which is posted on our website.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Corporate Governance Guidelines all Board Committees including the Audit Committee, Nominating and Governance Committee and the Compensation Committee, which are comprised solely of independent directors as defined within the listing standards of the New York Stock Exchange, have written charters that outline the committee&#8217;s purpose, goals, membership requirements and responsibilities. These charters are regularly reviewed and updated as necessary by our Board of Directors. All Board Committee charters as well as the Corporate Governance Guidelines are posted on our website located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information required to be disclosed by this item will appear in, and is incorporated by reference from, the sections entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal 1 Election of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to be included in our definitive proxy statement relating to our 2021 annual stockholder meeting.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_142"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Executive Compensation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will appear in, and is incorporated by reference from, the sections entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pay Ratio Disclosure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee Interlocks and Insider Participation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" included in our definitive proxy statement relating to our 2021 annual stockholder meeting. The information required by Item&#160;407(e)(5) of Regulation S-K will appear in and is incorporated by reference from the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to be included in our definitive proxy statement relating to our 2021 annual stockholder meeting; however, this information shall not be deemed to be filed.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_145"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about our common stock that may be issued upon the exercise of stock-settled stock appreciation rights, restricted stock units and other rights under all of our existing equity compensation plans as of December&#160;31, 2020, which consist of our 2020 Incentive Award Plan, 2011 Incentive Award Plan and our Employee Stock Purchase Plan. The material terms of these plans are described in Note 18 to the consolidated financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan category (shares in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">shares&#160;to&#160;be issued upon&#160;exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of outstanding options, warrants and rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price of outstanding options, warrants and rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares remaining<br/>available&#160;for future issuance under&#160;equity<br/>compensation plans&#160;(excluding securities reflected&#160;in<br/>column&#160;(a))</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of shares reflected in columns (a) and (c)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(d)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not requiring shareholder<br/> approval</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Includes 1,092 shares of common stock reserved for issuance in connection with performance share units at the maximum number of shares issuable thereunder.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">This weighted average excludes full value awards such as restricted stock units and performance share units.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information required to be disclosed by Item&#160;12 will appear in, and is incorporated by reference from, the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to be included in our definitive proxy statement relating to our 2021 annual stockholder meeting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will appear in, and is incorporated by reference from, the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Relationships and Related Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to be included in our definitive proxy statement relating to our 2021 annual stockholder meeting.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_151"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Principal Accounting Fees and Services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will appear in, and is incorporated by reference from, the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal 2 Ratification of the Appointment of our Independent Registered Public Accounting Firm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to be included in our definitive proxy statement relating to our 2021 annual stockholder meeting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i878840fee65247deaca27d2dd6a8246f_157"></div><div style="-sec-extract:summary;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits, Financial Statement Schedules.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) Documents filed as part of this Report:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)&#160;Index to Financial Statements:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:87.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_163">Management&#8217;s Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_163">F-1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_166">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_166">F-2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_169">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_169">F-5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_172">Consolidated Statements of Income for the years ended December&#160;31, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_172">F-6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_175">Consolidated Statements of Comprehensive Income for the years ended December&#160;31, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_175">F-7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_178">Consolidated Balance Sheets as of December&#160;31, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_178">F-8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_184">Consolidated Statements of Cash Flow for the years ended December&#160;31, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_184">F-9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_187">Consolidated Statements of Equity for the years ended December&#160;31, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_187">F-10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_190">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_190">F-12</a></span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(2)&#160;Index to Financial Statement Schedules:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:87.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_319">Schedule II&#8212;Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i878840fee65247deaca27d2dd6a8246f_319">S-</a>3</span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(3)&#160;Exhibits</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in the Exhibit Index that precedes the signature pages of this Annual Report on Form 10-K.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_160"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form 10-K Summary.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and which includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last fiscal year, the Company conducted an evaluation, under the oversight of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company&#8217;s internal control over financial reporting. This evaluation was completed based on the criteria established in the report titled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon our evaluation under the COSO framework, we have concluded that the Company&#8217;s internal control over financial reporting was effective as of December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent registered public accounting firm, KPMG LLP, has issued an attestation report on the Company&#8217;s internal control over financial reporting, which report is included in this Annual Report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita Inc.:</span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of DaVita Inc. and subsidiaries (the Company) as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income, equity, and cash flow for each of the years in the three-year period ended December 31, 2020, and the related notes and financial statement Schedule II &#8211; Valuation and Qualifying Accounts (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2020, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 12, 2021 expressed an unqualified opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Accounting Principle </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 14 to the consolidated financial statements, the Company has changed its method of accounting for leases as of January 1, 2019 due to the adoption of the Financial Accounting Standards Board&#8217;s Accounting Standards Codification Topic 842 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. dialysis patient service revenue recognition</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Notes 1 and 2 to the consolidated financial statements, the Company recognized $10,619 million in U.S. dialysis patient service revenue for the year ended December&#160;31, 2020. There are uncertainties associated with estimating U.S. dialysis patient service revenue, which generally take several years to resolve. As these estimates are refined over time, both positive and negative adjustments are recognized in the current period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of the recognition of the transaction price the Company expects to collect as a result of satisfying its performance obligations related to U.S. dialysis patient service revenue as a critical audit matter because it involves estimation that requires complex auditor judgment. The key assumptions and inputs used to estimate the transaction price relate to ongoing insurance coverage changes, differing interpretations of contract coverage, determination of applicable primary and secondary coverage, coordination of benefits, and varying patient characteristics impacting Medicare reimbursements. Changes to the key assumptions and inputs used in the application of the methodology may have a significant effect on the Company&#8217;s determination of the estimate.</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company&#8217;s U.S. dialysis patient service revenue recognition process, including controls related to the application of the methodology used to estimate the transaction price, and the key assumptions and inputs. We evaluated the Company&#8217;s key assumptions and inputs to estimate the transaction price the Company expects to collect as a result of satisfying its performance obligations by comparing key assumptions to historical collection experience, trends of refunds and payor payment adjustments, delays in the Company&#8217;s billing and collection process and regulatory compliance matters. Additionally, we compared U.S. dialysis patient service revenue related to the transaction price estimates recognized in prior periods to actual cash collections related to performance obligations satisfied in prior periods to analyze the Company&#8217;s ability to estimate the transaction price the Company expects to collect as a result of satisfying its performance obligations. We developed an estimate of U.S. dialysis patient service revenue based on actual and expected cash collections and compared to U.S. dialysis patient service revenue recorded by the Company for the year-ended December 31, 2020.</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of the goodwill impairment analyses for the Germany kidney care reporting unit</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 10 to the consolidated financial statements, the Company performed annual and other impairment assessments for their reporting units throughout 2020. As a result of these assessments, the Company has not recognized any goodwill impairment charges in the current year. The goodwill balance for the Germany kidney care reporting unit as of December&#160;31, 2020 was $323 million.</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified the evaluation of the goodwill impairment analyses for the Germany kidney care reporting unit as a critical audit matter. The evaluations involved assessing the key assumptions used in estimating the fair value of the reporting unit, including non-acquired patient growth rate, projected number of treatments, projected revenue growth rate, discount rates, and revenue and clinical earnings before interest, taxes, depreciation, and amortization (EBITDA) multiples. Evaluation of these key assumptions involved a high degree of subjectivity and auditor judgment as changes to these assumptions could have a significant impact on any goodwill impairment charges recognized.</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company&#8217;s goodwill impairment assessment process, including controls over the development of key assumptions as described above. We assessed the Company&#8217;s ability to forecast by comparing prior year actual results of the reporting unit to previously forecasted amounts for the reporting unit. We evaluated the Company&#8217;s non-acquired patient growth rate, projected number of treatments, and projected revenue growth rate, for the reporting unit by comparing the projections to the Company&#8217;s underlying business strategies and operating plans for the reporting unit, and other industry and market data. In addition, we involved valuation professionals with specialized skills and knowledge, who assisted in:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">evaluating the projected revenue growth rate for the reporting unit by comparing projected rates with comparable companies</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">evaluating the discount rate for the reporting unit, by comparing the inputs used to develop the discount rate to publicly available market data for comparable companies to assess whether the inputs used in the development of the discount rate are reasonable</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">evaluating the revenue and clinical EBITDA multiples utilized in the Company&#8217;s valuation of the reporting unit by comparing the multiples selected to a range of multiples from comparable transactions.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Evaluation of legal proceedings and regulatory matters</span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Notes 1 and 16 to the consolidated financial statements, the Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> suits, governmental investigations and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings. The Company records accruals for certain legal proceedings and regulatory matters to the extent an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We identified the evaluation of legal proceedings and regulatory matters as a critical audit matter. Due to the nature of the legal proceedings and regulatory matters, a high degree of subjectivity was required in evaluating the completeness of the Company&#8217;s population of legal proceedings and regulatory matters. Additionally, complex auditor judgment was required in evaluating the Company&#8217;s probability of outcome assessment, and related disclosures. </span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company&#8217;s legal proceedings and regulatory matters process. This includes controls over the Company&#8217;s determination of the completeness of the population of legal proceedings and regulatory matters, as well as controls over the Company&#8217;s probability of outcome assessment, and related disclosures. We tested existing legal proceedings and regulatory matters by reading certain written correspondence received from outside parties as well as reading certain written responses provided to outside parties. We read letters received directly from the Company&#8217;s external and internal legal counsel that described certain legal proceedings and regulatory matters. We involved forensic professionals with specialized skills and knowledge who inspected the Company&#8217;s compliance case log. Additionally, we assessed the completeness of the population of legal proceedings and regulatory matters and related disclosures by 1) inquiring of certain key executives and directors and 2) evaluating information received through procedures described above and through publicly available information about the Company, its competitors, and the industry.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-bottom:10pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2000. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;12, 2021</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita Inc.:</span></div><div style="margin-bottom:5pt"><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on Internal Control Over Financial Reporting </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited DaVita Inc. and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsidiaries&#8217; (the Company) internal control over financial reporting as of December 31, 2020, based on criteria established in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income, equity, and cash flow for each of the years in the three-year period ended December 31, 2020, and the related notes and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II &#8211; Valuation and Qualifying Accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(collectively, the consolidated financial statements), and our report dated February 12, 2021 expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;12, 2021</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues before provision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzItMS0xLTEtMA_b97480dd-ab0a-4a50-982e-453aa74a2ebe">11,039,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzItMy0xLTEtMA_b5fcd6b5-ec37-44b2-8652-04a89da2de5e">10,918,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzItNS0xLTEtMA_53aa4821-d6e0-4229-9983-fa7cf295d90c">10,709,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for uncollectible accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:ProvisionForExpectedCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMtMS0xLTEtMA_d7102ad5-4f1c-42d3-9bc2-ab425b160665">13,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:ProvisionForExpectedCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMtMy0xLTEtMA_a84b1968-db99-4139-a6a5-ba6ec6e65db5">21,715</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:ProvisionForExpectedCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMtNS0xLTEtMA_65e9f676-3793-42a6-8bc0-4b915f709f30">49,587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQtMS0xLTEtMA_0db97280-4b65-4ee8-969c-1c9645ef901a">11,026,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQtMy0xLTEtMA_4f66473a-f297-4df7-9932-e61dfa2dc794">10,896,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQtNS0xLTEtMA_d46fbffe-338b-49bd-b50c-cc5add77d2e1">10,660,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzUtMS0xLTEtMA_51db0ae3-6906-4753-8504-a1878a74e4b6">524,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzUtMy0xLTEtMA_582e1350-3c49-43ca-8c1b-c1141925ba1b">491,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzUtNS0xLTEtMA_5c98630a-32c8-47f3-afeb-631bab755057">744,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzYtMS0xLTEtMA_33b8f4cc-6938-4747-a0b0-366bf92cfdb0">11,550,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzYtMy0xLTEtMA_a3e80159-7bd7-404b-b525-40b6668321ef">11,388,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzYtNS0xLTEtMA_0a5748b5-236c-4967-b938-92a96ba37446">11,404,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses and charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:PatientCareCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzgtMS0xLTEtMA_103df5a9-a4f7-4f4f-9517-884e7f064046">7,988,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:PatientCareCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzgtMy0xLTEtMA_4f6e8093-7976-4604-b85b-cfd6ff486c06">7,914,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:PatientCareCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzgtNS0xLTEtMA_f2fa94a5-6bbd-4dc5-819b-1c82a5dc718d">8,195,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzktMS0xLTEtMA_4b652ac0-8a64-4f81-b97e-55b620ef1b6d">1,247,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzktMy0xLTEtMA_0795ac8e-be89-4204-abce-26dfa3965ff7">1,103,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzktNS0xLTEtMA_92df231c-cf8f-4962-8f25-87023c25c2af">1,135,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEwLTEtMS0xLTA_3f21f16c-b756-418d-8ad3-8d44a04922f5">630,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEwLTMtMS0xLTA_a3c5297a-666b-47f8-b7f4-479136d78fed">615,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEwLTUtMS0xLTA_580996f7-b7f3-497b-aa42-26a7f3ef58f6">591,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for uncollectible accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzExLTEtMS0xLTA_4b4376bf-62a3-44ae-a85b-1554b8f67bd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzExLTMtMS0xLTA_1c6987a6-bb65-4792-8d7f-1c8ee4f162cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzExLTUtMS0xLTA_fad79436-abbc-4af4-b134-63a651e34315">7,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment (income) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEyLTEtMS0xLTA_45bff8dc-e8b1-4d3a-83f6-5da6ea93d3fd">26,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEyLTMtMS0xLTA_0d51151d-15f4-4c36-83e6-04690be69bf5">12,679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEyLTUtMS0xLTA_526cff40-963b-4dcd-bfb4-b527b58a248c">4,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEzLTEtMS0xLTA_9f850db0-4477-4b89-8dfa-7e66412536a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEzLTMtMS0xLTA_c69b2aa8-45df-479b-8093-9a17efb9e73e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEzLTUtMS0xLTA_90070bb0-bf15-424e-858c-abd4de85a3ac">17,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE0LTEtMS0xLTA_469413c9-ef64-47d3-8c66-5fca7f5340aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE0LTMtMS0xLTA_0f63e7c4-d009-4ce6-8d93-7c83ecf4f5c2">124,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE0LTUtMS0xLTA_a1260521-e84d-4cd5-9c08-543a6547c27c">3,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on changes in ownership interest, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE1LTEtMS0xLTA_41af6b61-be3e-4b77-beb1-3617d7b4e5b8">16,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE1LTMtMS0xLTA_5e7b0901-08e3-4fa6-812b-11eaf8d0224c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE1LTUtMS0xLTA_cd5d2937-e7ac-4328-8aa0-44abde42ae6b">60,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE3LTEtMS0xLTA_e8adffce-956c-46b7-83db-9b0ae6b9e355">9,855,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE3LTMtMS0xLTA_3041c3c1-4bf0-4bbf-a12d-887fee9018cb">9,745,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE3LTUtMS0xLTA_42f9c29f-8bf8-4f2d-8212-9f2e93bc0cfe">9,879,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE4LTEtMS0xLTA_0ae702be-2bbf-4d10-98bc-f1e2381a4b7f">1,694,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE4LTMtMS0xLTA_4bb55b28-8b48-4f17-91ed-34d01bc739e2">1,643,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE4LTUtMS0xLTA_5cd12cc6-2bdc-44b1-a0d8-82caad150a01">1,525,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE5LTEtMS0xLTA_a47e7cd2-0a4c-4527-bcdc-11d9131d093b">304,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE5LTMtMS0xLTA_9194548f-eab6-4c4f-9aca-09bf577ca656">443,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE5LTUtMS0xLTA_87c3cab9-e9f1-4799-a473-e0f41b8554c8">487,435</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIwLTEtMS0xLTA_3292df5e-4ff5-4532-8074-18bde157cc89">89,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIwLTMtMS0xLTA_8985fb03-73a3-425b-881d-8aeee9931c8f">33,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIwLTUtMS0xLTA_250da049-6ff3-43d5-a260-6afc82e23ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIxLTEtMS0xLTA_6402c34a-0213-42d0-a972-c6b4cfa134f0">16,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIxLTMtMS0xLTA_a827941b-62c9-4046-9add-1d4b709bce20">29,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIxLTUtMS0xLTA_121cca0c-61fb-43a9-81b4-00542ed6a142">10,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIyLTEtMS0xLTA_2593fbd9-f679-4de3-8ca8-3b7f85f4e14d">1,318,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIyLTMtMS0xLTA_b891f00e-06e0-43bf-8905-939a1d95998f">1,195,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIyLTUtMS0xLTA_730d54ac-6d91-4e45-b587-1fca427173e7">1,048,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIzLTEtMS0xLTA_3f04e2a3-2011-4506-8aa8-cc6a74a3f1da">313,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIzLTMtMS0xLTA_1b32508f-0a9d-46b4-b803-b471ded6b53b">279,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIzLTUtMS0xLTA_7d355790-c3d1-4b88-9d29-dac0afe7d933">258,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI0LTEtMS0xLTA_7e471ce0-3f79-49d5-992a-f7c69ede4176">1,004,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI0LTMtMS0xLTA_3cf9ac8f-d664-4772-afd9-6ef36637e082">915,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI0LTUtMS0xLTA_e528f2a8-7dcb-46c5-859a-032366557af3">790,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI1LTEtMS0xLTA_6a2be20e-e8fc-4618-9d1c-87c7dacf271d">9,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI1LTMtMS0xLTA_feea139f-188d-4b7a-bfd8-472db311f745">105,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI1LTUtMS0xLTA_075a0a76-ca71-4d39-952b-145fa220b6dd">457,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI2LTEtMS0xLTA_6a01009f-a959-4417-885a-95046efebfeb">994,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI2LTMtMS0xLTA_65e53e36-4143-44c2-b8f0-23e2d91132c8">1,021,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI2LTUtMS0xLTA_b004a6be-2fa0-4dbd-be21-a19e1b3e75e0">333,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI3LTEtMS0xLTA_889f2d86-378e-4cc2-a058-9206931c9776">221,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI3LTMtMS0xLTA_57589928-4698-485c-be73-97b7bbc1d3a1">210,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI3LTUtMS0xLTA_698028dd-c87b-4b1e-8865-47891e996579">173,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI4LTEtMS0xLTA_dfb5763e-d267-405c-925b-f0447e6e9700">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI4LTMtMS0xLTA_9e311d3e-1fc4-41ac-9443-6885c493cb30">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI4LTUtMS0xLTA_b8e265dd-d330-4bdb-9ab6-ff10ca4c1a5b">159,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMwLTEtMS0xLTA_2d900bda-22af-435c-ae02-37439754f585">6.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMwLTMtMS0xLTA_a183d623-941d-47d4-a90e-99c41a21d2ca">4.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMwLTUtMS0xLTA_4706b716-ec96-420b-8500-b4dfffeff1cf">3.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMxLTEtMS0xLTA_c899f3b7-ae77-401b-9c5f-770a8d1f49ac">6.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMxLTMtMS0xLTA_d6432bdf-6c51-4a38-8611-4febf3b6c6e2">5.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMxLTUtMS0xLTA_db01ae63-9640-45a3-a194-8ad676165f33">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMyLTEtMS0xLTA_4aa53c23-1947-46ca-8f54-76163ea1f320">6.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMyLTMtMS0xLTA_313fa9d4-ff9b-4584-ab52-ab9aeaef08f9">4.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMyLTUtMS0xLTA_caa69b59-6aaa-4d6e-9ef3-6a4192be8796">3.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMzLTEtMS0xLTA_dae41f19-f822-4c2e-9101-c3aad588a365">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMzLTMtMS0xLTA_f3211d91-0d72-4221-b0c6-d4b0552226af">5.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMzLTUtMS0xLTA_9694e0fa-9d90-4209-931f-4d2ba3b7c76b">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares for earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM1LTEtMS0xLTA_bbc6921f-e374-48c0-aec3-90a9bb6ebf60">119,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM1LTMtMS0xLTA_4f61be2c-608c-428b-9007-0241eaf2cace">153,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM1LTUtMS0xLTA_cb501814-795d-4c7a-9c2c-e1b9335a9003">170,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM2LTEtMS0xLTA_9f2670eb-5b6e-4cae-9754-7146d950ebf5">122,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM2LTMtMS0xLTA_373a3ab4-9498-4a3f-850c-ac100f2a671b">153,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM2LTUtMS0xLTA_3e668ea5-ad25-41c0-9aba-0220a17338e0">172,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM4LTEtMS0xLTA_92471df0-e307-4e68-9920-4d957959b742">783,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM4LTMtMS0xLTA_28372998-f966-4989-a285-9b4b54f9ce73">706,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM4LTUtMS0xLTA_804ebe7c-7772-43f2-9cb6-721b818546e9">624,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM5LTEtMS0xLTA_a1860ae4-c4c4-4d28-9092-20a98f5b5b42">9,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM5LTMtMS0xLTA_cd4c689c-6874-4ac3-b135-fa220b2ceafa">104,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM5LTUtMS0xLTA_859c8bc6-2cfe-4ddd-b314-a13328cf6973">464,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQwLTEtMS0xLTA_49b3f939-8a4e-49e0-8c33-015cd43da6dd">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQwLTMtMS0xLTA_da85b60e-970d-4c64-b2c8-90f1de7a8e3e">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQwLTUtMS0xLTA_c031532e-8ec8-445a-9e55-ade6a86c5321">159,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzItMS0xLTEtMA_6a01009f-a959-4417-885a-95046efebfeb">994,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzItMy0xLTEtMA_65e53e36-4143-44c2-b8f0-23e2d91132c8">1,021,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzItNS0xLTEtMA_b004a6be-2fa0-4dbd-be21-a19e1b3e75e0">333,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains on interest rate cap agreements:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzUtMS0xLTEtMA_1fbe6015-7736-43f3-a2ef-32697305e38a">16,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzUtMy0xLTEtMA_a9cd0128-10e0-4f68-bf62-da8e0f601a89">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzUtNS0xLTEtMA_d3ba7c6c-720d-4255-bd3c-e521527ef680">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzYtMS0xLTEtMA_f07b0575-e5b9-499d-b65f-cee712c290b7">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzYtMy0xLTEtMA_bf511a16-4344-4fa6-b432-10d01c04d802">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzYtNS0xLTEtMA_1a5a2a7b-24b2-4b9f-80d7-f481a6572828">6,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzExLTEtMS0xLTA_3453fdee-eb94-417a-be0e-77d23fcdd930">7,623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzExLTMtMS0xLTA_c5bf6361-c249-4578-8c78-4bbb46399ac7">20,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzExLTUtMS0xLTA_892e06c1-b3b2-4379-a684-1fd8e2df7191">45,944</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEyLTEtMS0xLTA_40b5f3e5-977b-4a29-943a-db97f5c0e1d6">18,656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEyLTMtMS0xLTA_8cac647d-08c9-4ec0-bbd8-423c2bb907f4">12,574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEyLTUtMS0xLTA_d2f0eea8-2b94-4897-b2ad-5239c4496d12">39,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEzLTEtMS0xLTA_c0021bed-7274-425b-8f6e-cdeb6528c16e">976,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEzLTMtMS0xLTA_ab313328-0669-4661-a62d-81933e5b5940">1,008,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEzLTUtMS0xLTA_69c8aeeb-560d-43c6-8dec-33c4b6836398">293,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE0LTEtMS0xLTA_9c63403d-0380-4b40-8d89-30b9f1312aa7">221,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE0LTMtMS0xLTA_98d99ea4-1cc9-4b67-a854-5c43e0371cf1">210,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE0LTUtMS0xLTA_70ca9960-721d-40e6-baeb-b3fac0a75639">173,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE1LTEtMS0xLTA_a02e7ff7-2a1b-4b84-b3d9-89e16caa11f6">754,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE1LTMtMS0xLTA_294aea12-53c1-429c-9661-e5a5888f150c">798,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE1LTUtMS0xLTA_78f16e4f-3ba2-4636-9700-d525e81c37d7">119,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:74.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.760%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzItMS0xLTEtMA_8dacf3be-31e3-4147-90ef-430d7c64ca52">324,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzItMy0xLTEtMA_ed558ee5-cf6c-40c8-82bd-bad1d3e66ed2">1,102,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMtMS0xLTEtMA_9049bc08-5920-4200-829e-830f2261cd36">176,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMtMy0xLTEtMA_a539cf2d-d397-4787-838d-86f52294d3fb">106,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQtMS0xLTEtMA_23a8af23-650d-4f2c-9b01-bd73b8f9db2a">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQtMy0xLTEtMA_0a35fc01-bee0-4ea8-b1f4-452690a8cff4">11,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzUtMS0xLTEtMA_a5c39b39-902b-4f02-82f3-ab06a75a424f">1,824,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzUtMy0xLTEtMA_5c38cee6-9f0e-4024-bf4b-840a85c11083">1,795,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzYtMS0xLTEtMA_e30be2f5-c02e-4d7c-bfe8-314ed39596b8">111,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzYtMy0xLTEtMA_aff07628-10fd-4d6e-8c6c-71116bd9c841">97,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzctMS0xLTEtMA_cade24f1-a16d-4397-bb3f-7a6884267769">544,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzctMy0xLTEtMA_3abf4746-819e-417d-a8d1-0b7068e15f83">489,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzgtMS0xLTEtMA_28bbd5d3-cb52-4022-8b38-2db984600019">76,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzgtMy0xLTEtMA_a3a38611-ba99-4111-9957-630df6af5b04">66,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzktMS0xLTEtMA_aab97d70-5e92-4391-b9ca-c16d2c5b037b">70,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzktMy0xLTEtMA_e974f129-ddc7-4031-b6d5-9f3ec8bf0f78">19,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzExLTEtMS0xLTA_75fbb017-2f94-4a6b-b2a6-6d9b3041b12f">3,148,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzExLTMtMS0xLTA_95817cc3-c5fc-4362-817a-3fcaad30e394">3,690,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEyLTEtMS0xLTA_a1d581eb-1360-4208-9827-a7dd9919a96f">3,521,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEyLTMtMS0xLTA_1df75261-64e6-4013-a021-50beb62bcd21">3,473,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEzLTEtMS0xLTA_c7d1bce1-0b00-4133-8967-59e40810fd53">2,863,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEzLTMtMS0xLTA_548ef30a-1f8e-4f33-9e9e-afe65bf9811b">2,830,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net of accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE0LTEtMS0xLTA_8998b340-ef51-4728-9916-cb94249c12bb">166,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE0LTMtMS0xLTA_6c4aec50-b83c-436a-b9ef-654d80e86335">135,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE1LTEtMS0xLTA_021e7148-2740-422d-9a10-7f5cb1d0bc8c">257,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE1LTMtMS0xLTA_81f94ce5-2348-41cd-83b5-6c8a2a7ca221">241,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE2LTEtMS0xLTA_2407ce5b-a1ed-492b-a1d4-bd6277e9ebe0">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE2LTMtMS0xLTA_7c66d2da-fae8-48ca-8646-3f28a3610f40">36,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE3LTEtMS0xLTA_44f56d7d-82c7-42ab-ac21-9b1e1d083667">79,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE3LTMtMS0xLTA_e3332d95-6bdb-4d36-bd3d-634f589090a7">115,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE4LTEtMS0xLTA_dc9efe79-96f1-48e0-b8f1-e06983205bc1">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE4LTMtMS0xLTA_cf23b16b-cea4-47bf-b4c9-aeba50c57ab0">6,787,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE5LTEtMS0xLTA_9a2caf59-8d98-4669-932f-44b175894359">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE5LTMtMS0xLTA_416b910b-cc99-4650-abf1-b12d8161787e">17,311,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIxLTEtMS0xLTA_3124b846-9dc7-4eb2-874d-eff87614b9b3">434,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIxLTMtMS0xLTA_c35be31d-b850-4e76-9ee7-6ffda143e9cb">403,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIyLTEtMS0xLTA_3d1654b4-71b4-41fa-bf56-e7c17d1663aa">810,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIyLTMtMS0xLTA_457084a3-286c-4c5c-8f31-551519b964ee">756,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIzLTEtMS0xLTA_37bb064e-99d4-4030-a5ba-b2f92b20b2b4">685,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIzLTMtMS0xLTA_106d3736-e155-4ec0-82ae-c8299ff97c50">695,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI0LTEtMS0xLTA_7801376b-17b8-4b21-921f-7d650f5d9ff0">369,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI0LTMtMS0xLTA_e767a0ea-76c6-45ed-9744-23594d1b9cfb">343,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI1LTEtMS0xLTA_fda79bb0-8a10-4ada-b88b-ba83048d7ed8">168,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI1LTMtMS0xLTA_966ef7d1-577c-423f-938e-0c35f99dc5dc">130,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI2LTEtMS0xLTA_63c056e6-0a6d-4c95-aa68-d983aa515a8d">7,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI2LTMtMS0xLTA_5691b098-5351-43a6-a808-2726cc24bec7">42,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI4LTEtMS0xLTA_b0558c0f-5f47-46c4-9e38-16709a2056d7">2,476,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI4LTMtMS0xLTA_af42ca63-d3c8-4830-a384-732195098a4b">2,372,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI5LTEtMS0xLTA_e0736ace-3b2b-4fa0-96ae-dcc8b5342752">2,738,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI5LTMtMS0xLTA_e571dc37-6713-47eb-ac0b-514bacfef522">2,723,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMwLTEtMS0xLTA_206f8289-13c2-4188-862b-8e2c3d9548c8">7,917,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMwLTMtMS0xLTA_21293b24-0b3f-4021-b74e-e03705463d59">7,977,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMxLTEtMS0xLTA_069a4b43-9c77-4748-b819-662a1932b9c2">150,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMxLTMtMS0xLTA_5ed26443-88b2-4302-a604-ac880c621ce3">160,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMyLTEtMS0xLTA_c54e264f-cb92-42f0-ae36-7989028f463d">809,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMyLTMtMS0xLTA_9fd7744b-4dc8-4679-a070-e52c7dec2f62">577,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMzLTEtMS0xLTA_f7309b69-6e1c-497c-b0c9-5f81f3f97a36">14,091,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMzLTMtMS0xLTA_067bde58-7ae9-4897-a4c5-f369912a372a">13,811,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM1LTEtMS0xLTA_ad6dec72-6716-4a1e-affe-9fc98ed90e05">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM1LTMtMS0xLTA_2e3829c5-9eea-4361-8c36-1dcb09e0c775">1,180,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock ($0.001 par value, 5,000 shares authorized; none issued)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM3LTEtMS0xLTA_313aa742-85d1-490e-9d8e-4e4d004e58d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM3LTMtMS0xLTA_a326ee6d-1735-4a41-b1b1-a506d6c27330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock ($0.001 par value, 450,000 shares authorized; 109,933 and<br/> 125,843 shares issued and outstanding at December 31, 2020 and 2019, respectively)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM4LTEtMS0xLTA_422e394e-4223-4ec7-981a-e3399902f1fb">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM4LTMtMS0xLTA_495e5c74-4563-4c57-b501-219403faaab7">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM5LTEtMS0xLTA_7dabc8d5-5f1a-4c90-a3f4-c265ef3d6158">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM5LTMtMS0xLTA_10822e9e-fff5-4cbd-ac07-402800987558">749,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQwLTEtMS0xLTA_5785a804-21fa-46e6-a755-34206c1260a5">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQwLTMtMS0xLTA_0075d03a-6048-4b73-b131-009867c6b31e">1,431,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQxLTEtMS0xLTA_3e83edae-ef6c-4e81-a192-6362b30bb9b7">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQxLTMtMS0xLTA_524b0f3e-3aa8-4549-a725-d2d55450c4e7">47,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DaVita Inc. shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQyLTEtMS0xLTA_967f0175-5463-42e6-bcf0-dac682d79ea4">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQyLTMtMS0xLTA_215643ed-3fd3-4aff-965b-49b9fa6e775b">2,133,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests not subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQzLTEtMS0xLTA_32ec4848-9f16-4eac-9d5a-a521588ce80f">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQzLTMtMS0xLTA_851ef53b-9f83-4722-b568-b278cd75bdd4">185,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ0LTEtMS0xLTA_0c3c838a-ae4f-4e1c-9353-39f0b8bcf4cb">1,566,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ0LTMtMS0xLTA_b64ce50b-9ccc-4164-9af1-84d7e648d230">2,319,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ1LTEtMS0xLTA_51342596-0910-447c-ae27-c29d36ea1465">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ1LTMtMS0xLTA_e68b0dfa-876e-4fcc-9bfa-be82576e2986">17,311,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMtMS0xLTEtMA_80f65fc3-8294-4357-9f37-bb8032c6128e">994,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMtMy0xLTEtMA_8b6816dc-a5c7-4884-99f7-362895aac005">1,021,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMtNS0xLTEtMA_3a20d1cc-7ad5-4719-a1ae-0729c6606fff">333,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUtMS0xLTEtMA_edc4c3e1-94ea-402d-b7ed-08133a778aca">630,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUtMy0xLTEtMA_63c84d76-462f-41ef-a107-2b3ff22ca0c2">615,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUtNS0xLTEtMA_caf7603b-558c-4720-b779-2e9c0e598b8f">591,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzYtMS0xLTEtMA_60b9be5e-a801-4cd8-ba39-a954ae66ae81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzYtMy0xLTEtMA_c82377ba-5af3-4cdc-8145-cf99065cd87a">124,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzYtNS0xLTEtMA_3d70c106-581a-4308-9e56-b088c205ea00">61,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation adjustment on disposal group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzctMS0xLTEtMA_05d2bb0f-47f2-4078-bac2-c7653c530af4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzctMy0xLTEtMA_38970846-92d2-4532-827c-f47376b4abea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzctNS0xLTEtMA_2f57c177-cbb9-41ff-81d5-66ec9b0a0b05">316,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtRefinancingCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzgtMS0xLTEtMA_e9994244-d9c5-4072-9bb0-325f295bd93a">86,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtRefinancingCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzgtMy0xLTEtMA_895b7bc3-24dd-45cb-baa5-486c97b3b286">33,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="dva:DebtRefinancingCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzgtNS0xLTEtMA_8604a393-13c9-4fe9-9c2f-4f399b392d9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzktMS0xLTEtMA_125c9075-3d86-4fa0-982e-db85eacd9b62">91,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzktMy0xLTEtMA_2eb37ee7-9d1e-4076-95bf-92222fa0e287">67,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzktNS0xLTEtMA_0af9115d-7c8d-4b70-9454-41c145beb6b1">73,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEwLTEtMS0xLTA_fd5c4fb0-f622-4f10-bfec-e9ced3866bfd">240,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEwLTMtMS0xLTA_4f4fd27a-a821-4929-a03a-2c162ec8339c">41,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEwLTUtMS0xLTA_7e467b51-b21e-40d4-8a09-4af5f657003f">273,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzExLTEtMS0xLTA_e1c52525-b1af-4d94-af30-926829501f7d">13,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzExLTMtMS0xLTA_2dcee004-1384-4419-88f7-1a38931bf359">8,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzExLTUtMS0xLTA_527fe4c7-fa42-4f02-91a2-48eabcea4eb3">26,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on sales of business interests, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEyLTEtMS0xLTA_720d3a9f-67c0-4910-bdd3-687e6835da2f">24,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEyLTMtMS0xLTA_c18ea45a-57c1-4ff7-a902-22fb1e8d138e">23,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetLossGainOnDispositionOfBusinessInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEyLTUtMS0xLTA_ce713d59-65d7-4767-8e28-3ba5bfb82163">85,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEzLTEtMS0xLTA_03e624e4-a74c-464c-ad3b-ed1d88f91e68">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEzLTMtMS0xLTA_8eab4c5a-dd2d-4f3f-8472-409fa937e563">49,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEzLTUtMS0xLTA_23abaa6e-cc21-4dae-a909-b7d97b61a78e">82,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE1LTEtMS0xLTA_f47c4b35-0703-4e5e-8427-c9c01ee5dde4">21,087</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE1LTMtMS0xLTA_5d9accf2-e2df-4ec2-9373-398c6bb196f1">79,957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE1LTUtMS0xLTA_7cc38df2-84b9-4a5b-a0a3-5f6f0102d756">81,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE2LTEtMS0xLTA_e01fed9f-d62e-4d80-804b-73a9e196deff">12,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE2LTMtMS0xLTA_87140f2d-03dc-493a-8820-1619718cfb3f">10,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE2LTUtMS0xLTA_3f9afbbe-8090-4743-bd6a-3eab47afbab8">73,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE3LTEtMS0xLTA_8abc2ead-1464-46f4-ace9-81924e549c80">79,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE3LTMtMS0xLTA_f29adb7f-56d6-48e3-abf6-22ce5056c8b9">2,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE3LTUtMS0xLTA_bfcc02f3-55a2-4fe7-ae0c-9c3c7685438b">236,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE4LTEtMS0xLTA_46b4e91b-91c6-4e2d-8216-36a20666b174">6,123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE4LTMtMS0xLTA_3aee5e6b-4d02-40ea-ae46-86676256a781">6,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE4LTUtMS0xLTA_a09e5671-8fb0-4181-8d77-c682b888b774">3,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE5LTEtMS0xLTA_dd2037e3-935e-4b28-be29-65a22a52a764">37,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE5LTMtMS0xLTA_577a388f-e2cc-49ae-a0f8-51d6ee0090e0">84,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE5LTUtMS0xLTA_b312d6c2-aaad-4e14-afc3-1bed37553b55">35,959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIwLTEtMS0xLTA_29166071-dbcc-4c7d-a6b3-1323015f4401">20,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIwLTMtMS0xLTA_1ffe2053-f0ce-414a-8083-47e05aa8518e">14,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIwLTUtMS0xLTA_bc543e95-0257-4780-baa9-0c3f99c58d11">84,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIxLTEtMS0xLTA_01f2f658-0d67-4b0b-8328-7dd49afb65bb">105,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIxLTMtMS0xLTA_e4d22172-7122-40b6-bbe8-eba4b9262b88">181,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIxLTUtMS0xLTA_347ee363-8e56-4c95-affa-9189f905e66f">157,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIyLTEtMS0xLTA_2b9a71fd-c981-4cd9-904a-10fd23347aa7">87,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIyLTMtMS0xLTA_da78e4c2-6f61-4873-a7ce-629fc80f51c8">95,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIyLTUtMS0xLTA_9b016315-ae2b-452c-a85e-0d963dcd96de">23,635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIzLTEtMS0xLTA_8bc5d620-e4b3-4c9c-9fb3-b177eb647ee4">19,851</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIzLTMtMS0xLTA_86f556f3-d8d8-412f-9cc4-0593111aee5c">31,446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIzLTUtMS0xLTA_5ebc14b5-1169-4ae2-87ff-8dd4a723b8f8">1,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI0LTEtMS0xLTA_e45c6b9b-a699-40e0-9fe4-1574294d0c84">1,979,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI0LTMtMS0xLTA_773662dd-f4f0-4f04-85d2-ad1af5d0c40b">2,072,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI0LTUtMS0xLTA_a2d0df79-3457-4b6c-afc1-fabab40343f7">1,771,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI2LTEtMS0xLTA_9cf5bef1-e389-4b02-89d3-00e04bdd0411">674,541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI2LTMtMS0xLTA_75e7d8c6-cbb6-4c08-8f99-0c74076762f9">766,546</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI2LTUtMS0xLTA_36a87438-2cae-4c72-91be-cd985c33b16d">987,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI3LTEtMS0xLTA_f1227ccd-18cb-4503-a3fa-1b6f157c0075">182,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI3LTMtMS0xLTA_82ae734f-d509-4880-ab36-20643209124c">100,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI3LTUtMS0xLTA_87460e77-414b-4cd1-a9b7-6f1a781af6da">183,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from asset and business sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI4LTEtMS0xLTA_4908fb23-1009-408a-b0e0-7a2e6d55e397">50,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI4LTMtMS0xLTA_4f2b1359-f717-4f37-8c3e-b62cab8a3f72">3,877,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI4LTUtMS0xLTA_b2cc74ae-6123-48f1-8364-d1cb0667161f">150,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTEtMS0xLTYyNQ_57b3a8a8-8bcc-4621-bde8-cc5b5bdfab75">150,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTMtMS0xLTYyNQ_a4d28908-1668-4600-a930-85a663a406f4">101,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTUtMS0xLTYyNQ_d282d432-0f7f-42ef-b562-dde1aa2bf99f">5,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of other debt and equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTEtMS0xLTA_462fbd54-b581-49a6-b600-1e207bc0309f">3,757</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTMtMS0xLTA_334f6e80-1990-4c09-a4c8-a06fe9daa071">5,458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTUtMS0xLTA_df46c8e3-42b7-4a07-9308-fecf633edcad">8,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTEtMS0xLTYzMQ_64d46774-6bb0-402a-b516-e62949c154e1">151,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTMtMS0xLTYzMQ_ee4117b3-a658-49c6-b37b-496059270712">95,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTUtMS0xLTYzMQ_3b7de801-8ede-4423-8e55-256f1b89948e">34,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of other debt and equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTEtMS0xLTA_8047f9c2-6b77-471e-99d5-20c1a28dd54e">3,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTMtMS0xLTA_664ee3d8-6f0d-4e48-8550-95f38e60ae01">3,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTUtMS0xLTA_6fb916f1-5ca0-461c-b869-dcab87353ecb">9,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMzLTEtMS0xLTA_e8f4f883-da20-4c1e-ac10-92303804c3a0">22,341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMzLTMtMS0xLTA_7e33f004-4539-4bc4-a79d-86d65fbeaf34">9,366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMzLTUtMS0xLTA_dac441f0-1187-440b-9eb1-3013f4bb39dd">19,177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM0LTEtMS0xLTA_94aac866-1bc6-4744-8432-2012f1b7492b">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM0LTMtMS0xLTA_c08f5c2a-a9b2-4a30-9481-4847c00bc4d5">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM0LTUtMS0xLTA_2cabb512-e338-49f6-ab36-4dcf2dfbef48">3,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM1LTEtMS0xLTA_bf50187a-c90e-4a24-9b50-557b79cdd485">825,371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM1LTMtMS0xLTA_ca7b3172-3efe-43cf-b588-af7c03c9854c">2,995,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM1LTUtMS0xLTA_1cb55d14-55d7-42bc-a7a6-32a691c5f41a">1,005,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM3LTEtMS0xLTA_d5b50b5f-9259-4da2-b399-b4c42c88eaf3">4,046,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM3LTMtMS0xLTA_322a1fcf-e54c-49e9-963d-1aa328627fda">38,525,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM3LTUtMS0xLTA_4c09bc36-1c82-44ee-9d24-4a39968161f8">59,934,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM4LTEtMS0xLTA_e246b81f-68c6-4b10-9c30-1de27e67359e">4,110,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM4LTMtMS0xLTA_f16d7c9d-a403-49e3-8492-717a4496792e">40,520,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM4LTUtMS0xLTA_204af097-842f-4087-a3df-5066b7bb0667">59,234,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing and debt redemption costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtFinancingAndDebtRedemptionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTEtMS0xLTY3Mw_88c05d69-778b-4ce9-a1b0-0215dbcc58ea">105,848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtFinancingAndDebtRedemptionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTMtMS0xLTY3Mw_3b59cda0-824d-4aee-9e74-17721cd4b9c1">85,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtFinancingAndDebtRedemptionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTUtMS0xLTY3Mw_c9c7b0c0-7a9f-483f-bfd8-d9b09e4f8146">5,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTEtMS0xLTA_fc205cde-02d1-476a-adcb-3c73642018b7">1,458,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTMtMS0xLTA_6f2c1b9f-5fd9-4faf-8f6d-98df3eaf1497">2,383,816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTUtMS0xLTA_64b528da-c9dd-4364-bea2-e16d6e353523">1,161,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDistributionsToAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQwLTEtMS0xLTA_a05906cc-c7ed-4492-8678-b00481b4409d">253,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDistributionsToAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQwLTMtMS0xLTA_d3799ea7-9d1d-4285-8317-a58788e73449">233,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDistributionsToAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQwLTUtMS0xLTA_4827cbee-25a1-4344-992b-94e4ebcda21d">196,441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (payments) receipts related to stock purchases and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" name="dva:PaymentsRelatedToStockPurchasesAndAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQxLTEtMS0xLTA_6239f210-681e-4351-9552-dd8d9ddc3733">975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQxLTMtMS0xLTA_e21a5546-8655-4a06-bf31-2fccb1673fc7">11,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQxLTUtMS0xLTA_3e5e62fb-b8be-4eab-a2a7-72839eb4bbb5">13,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQyLTEtMS0xLTA_c2ba8ef2-9d61-48b6-a81e-a8358a656bd2">42,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQyLTMtMS0xLTA_d2e95edd-5a2b-4c94-936f-6d434ad323f5">57,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQyLTUtMS0xLTA_e87624ab-c486-43d6-954a-883d5ccf3594">52,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of additional noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQzLTEtMS0xLTA_6394b55d-7abc-4b88-9b1a-79e103f0eaf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQzLTMtMS0xLTA_38194a1f-7b2c-4792-8730-04fa1b7dc2f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQzLTUtMS0xLTA_fb5dadf9-8dff-493c-a0b7-5ba0fd8ba6c1">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ0LTEtMS0xLTA_edd0b099-c966-4180-b494-449da3cbd1bc">7,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ0LTMtMS0xLTA_bfb04f25-3594-4826-accc-93e1141ee84d">68,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ0LTUtMS0xLTA_e1860bbb-d269-4641-8708-6f73e41e4d13">28,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ1LTEtMS0xLTA_cfccfa1b-a379-4e89-b449-f37af898f8cd">1,846,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ1LTMtMS0xLTA_c90777d0-9f9a-4542-8044-7dd9392de2ca">4,696,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ1LTUtMS0xLTA_ea28b7e9-22b7-4b24-b2ee-0e1ea8e686b9">625,354</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ2LTEtMS0xLTA_e3b7eae2-a0c9-4626-8f12-c5450004b5a6">13,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ2LTMtMS0xLTA_c1553335-dc58-4027-82e9-a891ec209c87">1,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ2LTUtMS0xLTA_b8835e8d-2d7d-4d5d-8dee-95c447c5def4">3,350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ3LTEtMS0xLTA_d005edc0-041e-4d9a-ae98-5c98fb750470">706,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ3LTMtMS0xLTA_9560055f-3063-4af4-ab59-a4a5c37c9a11">369,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ3LTUtMS0xLTA_ef57651a-f404-4bc2-bb2a-6bafc9831eb2">137,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net (decrease) increase in cash, cash equivalents and restricted cash from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7411005e6a69450f90e334cbe2a78126_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ4LTEtMS0xLTA_c9f1e791-2d91-4bf3-bd04-16045a4bc654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac62eb6d9e438d9cffedfad9480206_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ4LTMtMS0xLTA_5b703ffe-0d61-4dcc-842a-3e2f378df496">423,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f9f0f6c1854cc2b831462ed14ee61e_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ4LTUtMS0xLTA_a4b362e3-99d3-413a-8b49-4e7efadb34e2">240,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea92518235484ea8bf5f60c37164f758_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ5LTEtMS0xLTA_035e381e-2b1b-495f-834c-78621106693d">706,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339c0adb944141beb35f1f190097beba_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ5LTMtMS0xLTA_11c71b01-b6e1-4ab7-92c7-7ede86190957">793,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aed65b31414464481f45589046dd452_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ5LTUtMS0xLTA_a9613723-6b31-4772-8b52-c83b722a261b">103,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUwLTEtMS0xLTA_65c77ae4-8f81-4e50-96d8-da0c8db6826a">1,208,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUwLTMtMS0xLTA_a5b41010-cd8f-46b1-9acd-ae2a531edb4f">415,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee29f3075d90411e97da80cfb155be40_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUwLTUtMS0xLTA_e1b35b04-692e-4449-9030-a3bd30788ad8">518,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash of continuing operations at end of the year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUxLTEtMS0xLTA_44b49fad-ead4-4553-ad60-adf064a2c330">501,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUxLTMtMS0xLTA_3f614174-a436-407b-92e3-853a39e5a467">1,208,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUxLTUtMS0xLTA_bab47018-a180-4acf-acab-c919b4727bb1">415,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_187"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.049%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling<br/>interests<br/>subject to put<br/>provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders' Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i821341ce571140c0813c92a7b329684f_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMS0xLTEtMA_4dca24bb-bcbd-4e45-af4b-3332d878b4c3">1,011,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7a7ef37ab494bd3867be9a034c8ae17_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMy0xLTEtMA_78922e78-054a-433a-acab-8c10bc5d5654">182,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7a7ef37ab494bd3867be9a034c8ae17_I20171231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtNS0xLTEtMA_9b1ef53b-4e25-4780-bd03-0ec22157f60f">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036278cf7d8347788f7fcdf25acbf8b5_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtNy0xLTEtMA_8090e9bc-63c4-4e80-ae6b-7d43513ee558">1,042,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adcf1b689594ff49c7827e7c45a99ba_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtOS0xLTEtMA_96c8a8e9-35c2-438f-8a31-6e8c30e6e7ef">3,633,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11909335cca546ad85c586bcfb13dce1_I20171231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTEtMS0xLTA_f3f94710-ae0a-4eb4-924d-c95545af5ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11909335cca546ad85c586bcfb13dce1_I20171231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTMtMS0xLTA_121805f2-e054-4cd5-862f-55b28903ac37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6e22f6f3f724a35bed885f82b31bb8a_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTUtMS0xLTA_56c91e74-583b-4b48-a3d2-07d868c9efe8">13,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d06c26940f24e1fbe98edcd4bba0d49_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTctMS0xLTA_7b58f27c-1609-4748-9029-d7b50b2b556f">4,690,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b135446f5334d709fef3456c13e371b_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTktMS0xLTA_a3cb07e7-4370-4fce-9a7d-ce12da773984">196,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of change<br/> in accounting principle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32a7f3467e74c40b5ee59a7db8b3af9_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzQtOS0xLTEtNDc1_44ef360f-777c-4c7c-b478-868cc8b950e7">8,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a10dd7b6f72489798f395a4ba7d5774_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzQtMTUtMS0xLTQ3NQ_52c487dd-4a90-4c66-9941-32da227a6698">8,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2999225279c547bb86d45264eed0b5a9_I20171231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzQtMTctMS0xLTQ3NQ_299a259a-36e3-49ca-8bc6-bbddc3bea0de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtMS0xLTEtMA_e7a25000-66a9-442a-b129-5ead5eb26425">105,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64308cbce6e4abe90bdf552304e7cbe_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtOS0xLTEtMA_07015395-8673-4e33-88b0-cdedd53ce334">159,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtMTctMS0xLTA_2250109d-ca62-4c53-adac-30d0528c2ae7">159,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtMTktMS0xLTA_64a3a08e-0d10-43c1-9864-12a66352ecee">68,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b5d1183ea1e473eaec3e4b8f2b2518b_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzYtMTUtMS0xLTA_2108ccd3-6968-4642-9409-53be55439e67">39,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzYtMTctMS0xLTA_8829e80a-d405-4f88-8b07-883874c25ded">39,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzctMy0xLTEtMA_3fe9f502-9d4a-4675-9069-d759b80ee00d">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktNS0xLTEtMjEzMjU_f85ba4d8-3f65-46b6-adb9-884d0fda57a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzctNy0xLTEtMA_f7449a49-cef2-47b4-83f5-561496774af5">17,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzctMTctMS0xLTA_3b3439c4-731e-4ebf-a474-367e2c1e6ecb">17,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktMy0xLTEtMzc0NA_cf46c30d-3ce4-48ae-a904-0f24484ab370">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktNS0xLTEtMzc0OQ_4ed89f1f-fc2e-44a4-822b-3303f30fe1d6">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktNy0xLTEtMzc0OQ_5cddeb62-bb50-465c-b285-49250dee1ffb">5,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktMTctMS0xLTM3NTE_82dbf58d-19b4-4a7d-b005-8d2a46383499">5,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/> compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEwLTctMS0xLTA_38836730-2670-415f-bf12-65b4b0857fb1">73,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEwLTE3LTEtMS0w_5ab06084-fb9a-4e4e-a738-ffb6b174f02c">73,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/> interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEyLTEtMS0xLTA_6a9ceeea-9c5a-47df-86b1-5f62a8cec2ea">119,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEyLTE5LTEtMS0w_46897c3f-3e60-41c1-9996-91fa4ff60ef6">77,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEzLTEtMS0xLTA_8fddf151-8951-48da-94e7-c7bb8abb1578">32,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:NoncontrollingInterestIncreaseFromContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEzLTE5LTEtMS0w_bd400df4-73c5-4d5b-9cc6-f553efaa1905">19,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTEtMS0xLTA_237316e4-2749-4af1-8538-0d35d5546d04">79,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTctMS0xLTA_f34a72a2-a78c-4e59-b1a3-02178e3cbe66">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTE3LTEtMS0w_580e13cc-1790-4016-a75d-2bb14c1ce703">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTE5LTEtMS0w_7646787a-1d1c-44fb-82d1-3d3425d2f0c8">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTEtMS0xLTA_3e4412ff-8479-4ade-86b4-01f4216a69a8">8,546</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTctMS0xLTA_aea80f45-1cb2-49ca-ba15-1124b2861fce">17,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTE3LTEtMS0w_8ede897b-8407-4480-9095-fcdb3b56c4d0">17,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTE5LTEtMS0w_efb1e076-03ec-4809-94e8-1b5bd7f74523">1,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE2LTEtMS0xLTA_cacd8530-af3f-4f39-b328-6becbb78e8b1">23,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE2LTctMS0xLTA_7943cd85-8896-4a34-afbb-c4df35e14b55">23,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE2LTE3LTEtMS0w_0bb632d0-4bf1-4f0d-8b9d-014c92c67013">23,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE3LTExLTEtMS0w_b117c01a-c128-40ee-b0a4-0e25ca506dac">16,844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE3LTEzLTEtMS0w_c42730c6-e3d0-41f6-8dcd-38dca646a876">1,153,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE3LTE3LTEtMS0w_1541b736-64c1-4bec-93b3-4bbcd3337a50">1,153,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTMtMS0xLTA_65cdaa69-46d4-4ed5-9918-c06d6cc9b182">16,844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTUtMS0xLTA_a48db9c1-db0f-4dfd-baf2-77160277ea65">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTctMS0xLTA_2900ff3c-697e-4db8-a6db-b948144a60fa">95,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if64308cbce6e4abe90bdf552304e7cbe_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTktMS0xLTA_453d9239-5a37-48ee-b48c-48b4656ebf8a">1,058,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTExLTEtMS0w_6d4721a0-7df0-4679-9447-99283f9c912c">16,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTEzLTEtMS0w_5905890f-499e-4ad7-89c1-baf37b8259c5">1,153,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE3LTEtMS01MDU_c5eb19d8-0d3f-46a8-8cbd-5e503edb8de8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5b8c698b4f44d7b880f261b5acd9515_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTEtMS0xLTA_c95a7165-107c-4deb-9165-adb0004b59b0">1,124,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ade1676d7ef4cda9e4d3f1b875b9feb_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTMtMS0xLTA_b1543c13-e330-4771-8dac-fa7ab8d565a2">166,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ade1676d7ef4cda9e4d3f1b875b9feb_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTUtMS0xLTA_d12d337a-e1c6-4a26-a1aa-8f7f6a0920a6">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc34c3096bcb4003b347988f2fb970ad_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTctMS0xLTA_788a97ce-6a93-4a5a-bda6-a9cbade1fd30">995,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa5780e8d82a48b59708a1ff1276a66c_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTktMS0xLTA_4fd69c5f-5ccb-4534-9406-887ec9529dbf">2,743,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3387e99cd35649b49ab4860ac21de1b2_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTExLTEtMS0w_541dafa6-b90e-48d8-8b58-390730cdce65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3387e99cd35649b49ab4860ac21de1b2_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTEzLTEtMS0w_17607759-d601-44f6-bdc2-3631f1309562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9d247586e6c4138a61320064b0c31f7_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE1LTEtMS0w_74957ece-4d82-4ddd-9109-bc2e64dec59c">34,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib825ca1aa06a4e079d3c844ba6177f19_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE3LTEtMS0w_a8cdfe93-7e82-42ac-bcdc-7a6a43c90809">3,703,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4c874d135ae405b86b7b38ebcf9f62c_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE5LTEtMS0w_542b6ed9-a6f0-4504-aab9-57d83ad5ebe6">204,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of change<br/> in accounting principle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecd4fd2059754cc49cb4f8aac8c883f1_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIxLTEtMS0xLTUxMg_15bf8df9-45e2-4e41-8c13-5453bb22a88c">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f880539ba04aa6bf3a2d7cf33b0b29_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIwLTktMS0xLTA_93b0bb5a-e5e3-4a3a-aac5-72c39524a240">39,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ice9f2467e9a64adeaff985f8e4c19438_I20181231" xsi:nil="true" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIwLTE1LTEtMS0w_09620955-574c-4c3f-902f-e77a78162b24"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e915932320b4ae6acd3fbb11411779a_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIwLTE3LTEtMS0w_679c35b0-7bd2-40e1-8a2d-4648ae94c4c6">39,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5bb9dfef3744514a0f063432ab36168_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIxLTE5LTEtMS01MjQ_321bd97c-605f-425c-bce3-389192b4e677">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTEtMS0xLTA_48251a48-ebd2-437d-b518-5069cb103dfa">143,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5495b245d279498ba671db088b9cd741_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTktMS0xLTA_16ac8d7b-190e-45d1-ac48-61e0d5a262b7">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTE3LTEtMS0w_1363ecb2-f389-46f2-9a36-f13abf00c1ee">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTE5LTEtMS0w_42826e86-495d-4db3-a2ac-41d68baaaab8">66,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id00ebe3d20f44469990e8c005164fa4a_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIzLTE1LTEtMS0w_953934d5-f934-4af4-a623-dc6c57e1f698">12,574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIzLTE3LTEtMS0w_d6df895d-1429-4056-857a-ce17ae4075c2">12,574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI0LTMtMS0xLTA_8e95b92b-4dc5-499b-8c34-84cb28918e58">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTUtMS0xLTUxOQ_c077fa3f-6066-4a35-9c8b-3c46850c25b4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI0LTctMS0xLTA_9bf18429-92d8-4ca7-b474-95cec58b0fde">16,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI0LTE3LTEtMS0w_61b19670-fc31-431f-ac15-e9e6f369ef2a">16,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTMtMS0xLTM3NzE_811163a8-028e-44b8-b5a1-c17694790096">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI2LTUtMS0xLTIxMzMx_7c74baf2-91a3-47b4-b95a-af61feea9b5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTctMS0xLTM3NzE_71c966f4-aa48-4a4b-9bda-f723fdc59308">3,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTE3LTEtMS0zNzcx_241c7e3e-0e92-4f2e-b572-009bac85fa1a">3,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/> compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI3LTctMS0xLTA_b54bcbe9-d5c8-4a6c-b517-64cbe1e8ff5c">67,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI3LTE3LTEtMS0w_14ace259-988f-4e5e-abd0-20069ac5337a">67,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/> interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI5LTEtMS0xLTA_dbf47415-0ac8-467d-8793-dc417b40388e">155,011</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI5LTE5LTEtMS0w_58b0d79d-412d-4bf5-8ac4-6532b45f7f7c">78,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMwLTEtMS0xLTA_1a2f0af6-78b5-4592-9e64-5154fc36ff2f">35,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:NoncontrollingInterestIncreaseFromContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMwLTE5LTEtMS0w_83f1d03d-7fe8-473a-a52a-32c4422590a9">21,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMxLTEtMS0xLTA_e0cb866a-73e1-480d-9712-d0dc5663c387">6,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMxLTE5LTEtMS0w_a3dce628-04ce-4dfd-81df-5f12b304be2f">10,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTEtMS0xLTA_f181936d-ee4f-4bda-a8ba-cb0ba59db2ff">11,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTctMS0xLTA_166882d3-fde8-4516-8a9c-2e6a51d19f88">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTE3LTEtMS0w_ab91eba9-2a05-489b-aca3-6c44b7e1d7a0">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTE5LTEtMS0w_f7fa6000-eaf3-4132-b9dd-c4c5fe9deae7">19,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMzLTEtMS0xLTA_79fc7662-c27f-4bb5-ba63-d65b244cafa7">49,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMzLTctMS0xLTA_8d051844-9e36-483b-b69b-19a0d9831662">49,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMzLTE3LTEtMS0w_7609f785-a946-4ce5-9485-86d876fdfae4">49,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM0LTExLTEtMS0w_5e5ae116-3854-4f55-98cd-ab6830cb8494">41,020</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM0LTEzLTEtMS0w_fab24964-49ba-4d29-b859-9a794cb3eef9">2,402,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM0LTE3LTEtMS0w_fd6bc099-5eab-4718-a5b8-1b9c25aa9761">2,402,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTMtMS0xLTA_d86ff850-16fd-48eb-a2b6-2f3541985ccd">41,020</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTUtMS0xLTA_7c5d8e4c-0016-4fcb-a018-8891dfe5f1d2">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTctMS0xLTA_add8c05a-def7-4406-b292-9b361869a110">240,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5495b245d279498ba671db088b9cd741_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTktMS0xLTA_bfca850c-ab2f-41b6-b7eb-272f22392796">2,162,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTExLTEtMS0w_793d41de-bc0d-44ae-9867-a58e196b675b">41,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTEzLTEtMS0w_be16b6be-4cba-4374-8a7a-0f65e607007a">2,402,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTE3LTEtMS0w_8e512243-01b9-4de8-b7e4-11e63dacfb01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d1c51a49e14e6280972be024b74db0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTEtMS0xLTA_fe99618a-ae31-421f-ba30-482d58bd7a85">1,180,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTMtMS0xLTA_43a12928-5677-4326-9ba4-0866e43f21a1">125,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTUtMS0xLTA_2be81d5d-ac8b-4aa2-9fab-d44b4d7e6feb">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42fa656b3e574210b01ef1b7211cc59f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTctMS0xLTA_1bd00f4f-a420-4a07-863c-a49de330ee3f">749,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce9502863624611b7b5cfc59cc39ee9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTktMS0xLTA_191d37d2-7ad3-48f4-995a-bcd4896c2a6f">1,431,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTExLTEtMS0w_b6f0e8cd-f560-478d-999c-5928957671ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTEzLTEtMS0w_b5fe7c26-592a-41f2-a824-f1586201e7e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if90c222c41994c9798b61036606e41ed_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTE1LTEtMS0w_6eff05b0-f70a-4d79-8514-cf137769a394">47,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c39adcdfcd42309a9115c0d0fdcc55_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTE3LTEtMS0w_4484e9bc-e30a-4fcf-8a60-a1eb20b9542d">2,133,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e12f9281dc4d0f9e7d785149a69a88_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTE5LTEtMS0w_3e3a1058-a827-4232-9904-b3529a944fbc">185,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY - continued</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.439%"><tr><td style="width:1.0%"></td><td style="width:19.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.928%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.089%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling<br/>interests<br/>subject to put<br/>provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders' Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d1c51a49e14e6280972be024b74db0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMS0xLTEtMA_fe99618a-ae31-421f-ba30-482d58bd7a85">1,180,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMy0xLTEtMA_43a12928-5677-4326-9ba4-0866e43f21a1">125,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtNS0xLTEtMA_2be81d5d-ac8b-4aa2-9fab-d44b4d7e6feb">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42fa656b3e574210b01ef1b7211cc59f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtNy0xLTEtMA_1bd00f4f-a420-4a07-863c-a49de330ee3f">749,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce9502863624611b7b5cfc59cc39ee9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtOS0xLTEtMA_191d37d2-7ad3-48f4-995a-bcd4896c2a6f">1,431,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTEtMS0xLTA_b6f0e8cd-f560-478d-999c-5928957671ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTMtMS0xLTA_b5fe7c26-592a-41f2-a824-f1586201e7e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if90c222c41994c9798b61036606e41ed_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTUtMS0xLTA_6eff05b0-f70a-4d79-8514-cf137769a394">47,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c39adcdfcd42309a9115c0d0fdcc55_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTctMS0xLTA_4484e9bc-e30a-4fcf-8a60-a1eb20b9542d">2,133,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e12f9281dc4d0f9e7d785149a69a88_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTktMS0xLTA_3e3a1058-a827-4232-9904-b3529a944fbc">185,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtMS0xLTEtMA_0d7c781a-0a91-4e6b-bb04-861d87d333a1">141,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b232edb6214093a0c5d7e31595d14d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtOS0xLTEtMA_7d93289d-2836-4b0e-80e8-303c09456cbc">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtMTctMS0xLTA_aba02c1b-e315-41e3-83a3-50e4118339c9">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtMTktMS0xLTA_67a31b01-16f5-448b-b1a6-1555be60eea9">79,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fc62187afaa4e38b48175be5f574c2c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzctMTUtMS0xLTA_a908abbd-a03c-4792-9fc1-47e6af7c1637">18,656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzctMTctMS0xLTA_bccb3d8d-19a3-4321-a85c-de12aab02a15">18,656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtMy0xLTEtMA_a3c98aa0-7e21-4daa-85c5-c40a04c6eab6">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtNS0xLTEtMA_05a2f63d-a7ed-413a-8de2-a7f79a0ab7f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtNy0xLTEtMA_8ef94532-5b03-49a7-b13e-a4fb4e4a0f06">17,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtMTctMS0xLTA_a7cc9c38-a724-45bb-aa3f-7f9577acd009">17,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktMy0xLTEtMzc5NA_bb083494-3ca9-4f35-8d1a-2977c75ec785">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktNS0xLTEtMzc5NA_00e17b39-912f-4892-b812-3da20eccb018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktNy0xLTEtMzc5NA_deb899c1-8fda-4d9d-b0bf-dfb2aa5dfe61">17,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktMTctMS0xLTM3OTQ_d056c3c3-afc9-4009-ac91-a6328642df18">17,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/> compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzExLTctMS0xLTA_137283c2-1fd1-45f6-bc60-587ccd032a45">90,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzExLTE3LTEtMS0w_0f9148a1-203c-461e-8a84-ea4d5540dcab">90,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/> interest from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzEzLTEtMS0xLTA_23ac0053-516e-46f7-a50d-ebd2442b466c">163,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzEzLTE5LTEtMS0w_4270c22b-0859-4362-b9d9-ca19b240b0eb">89,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE0LTEtMS0xLTA_bcfb0ca1-4124-4c60-97dc-210998aeda06">30,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:NoncontrollingInterestIncreaseFromContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE0LTE5LTEtMS0w_7c77ce16-0d6f-48a8-9717-9f8799d8bea2">12,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE1LTEtMS0xLTA_e6d13e35-b1b8-4073-b899-dc3a209d1daa">3,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE1LTE5LTEtMS0w_d6958961-0f44-4a20-9dc9-9cc0b89d8a9c">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTEtMS0xLTA_be4f7356-7914-4320-89ca-e83c0a52ef63">7,771</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTctMS0xLTA_626de235-3886-4860-ac3d-a554f2c9a785">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTE3LTEtMS0w_8cd9d8a1-0d98-4c84-9d00-997eb64638d9">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTE5LTEtMS0w_2f1027f2-0cca-43a3-9867-bfbcc744b747">4,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE3LTEtMS0xLTA_615fb34f-639f-47cd-bfd2-6565dc4ad27d">151,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE3LTctMS0xLTA_6ca7ee09-6591-42b6-8f6e-b3f3e4b76d97">151,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE3LTE3LTEtMS0w_8a190b4f-ad43-481f-8dc9-613edf661a49">151,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE4LTExLTEtMS0w_23ecc71c-57e9-45bf-8916-e92b422a736c">16,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE4LTEzLTEtMS0w_1e2d8c20-700d-4860-9ae0-d5ae841715c3">1,446,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE4LTE3LTEtMS0w_02634b76-39d1-4e82-8f47-df6673818f98">1,446,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTMtMS0xLTA_83d8e8cf-ab25-43e8-8a57-27326e25e990">16,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTUtMS0xLTA_46209425-dcff-4ca8-b567-9d077f0f80dc">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTctMS0xLTA_d28be41e-3eed-4ee8-8c3e-deb98ef9bff3">93,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b232edb6214093a0c5d7e31595d14d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTktMS0xLTA_469bf25c-008f-4037-a1f1-420562c6d41f">1,352,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTExLTEtMS0w_20d8730b-c34a-4bd5-ae52-9776f9400ce4">16,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTEzLTEtMS0w_7762dbb1-1221-4fe1-a2bf-d98656cfb1a3">1,446,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTE3LTEtMS0w_a5bd9fc2-3d26-46a5-9c43-c6bb3832b062">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a37cb5f5593422481356f9dc98a3f3b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTEtMS0xLTA_c71b7d2d-0c04-4d10-b74c-6c13d676892a">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94bfac29df0345ed80042412796b3ada_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTMtMS0xLTA_1d55d4a7-b165-4f88-a538-15ae04533421">109,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94bfac29df0345ed80042412796b3ada_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTUtMS0xLTA_c5431c87-8439-4133-8330-9375e4cbb9ab">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27b1a608e9d425fb9716950917809df_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTctMS0xLTA_8f13897f-b441-4b70-a22f-023acf732c65">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe1d0c26345f4dd988fa30758fc01afe_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTktMS0xLTA_4876d000-8ffe-402a-82f6-fe6715acae7f">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6922cd861e2a48a59394b6ef51aaff96_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTExLTEtMS0w_9ba634a8-859a-4370-8612-5368a4d2dad9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6922cd861e2a48a59394b6ef51aaff96_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTEzLTEtMS0w_1745fa47-71cf-4597-b6db-e50a6f72d95f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3fd3e2a7d3d4e1a85627c011b215e0c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTE1LTEtMS0w_3ea6b2c4-e338-4608-b7aa-6b08aab97840">66,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i392918f6cd454f4482fe89cf50ebc86f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTE3LTEtMS0w_ec69a3ec-68f7-457d-ace8-7329f27d59e7">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db2eb8f1ec40a89ceed1e1d8b4f241_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTE5LTEtMS0w_ca184e0d-0322-4789-a81c-cc3a0e33aaa1">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_190"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i878840fee65247deaca27d2dd6a8246f_193"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDI4_ab41fd96-8540-4143-8331-6450c915c161" continuedAt="ia061ff5fcf454d95b93900d32f194e61" escape="true">Organization and summary of significant accounting policies</ix:nonNumeric></span></div><ix:continuation id="ia061ff5fcf454d95b93900d32f194e61" continuedAt="i370538abf2394ba0951be61dacaf7727"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its dialysis and related lab services to patients in the United States (its U.S. dialysis business), its ancillary services and strategic initiatives including its international operations (collectively, its ancillary services), and its corporate administrative support.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s largest line of business is its U.S. dialysis business, which operates kidney dialysis centers in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December&#160;31, 2020, the Company operated or provided administrative services through a network of <ix:nonFraction unitRef="clinic" contextRef="i2dc41b2293ce4a6a80887886af6405df_I20201231" decimals="INF" format="ixt:numdotdecimal" name="dva:NumberOfSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzcwMg_95ede915-1471-406d-8e0d-e7cc12aa0188">2,816</ix:nonFraction> U.S. outpatient dialysis centers in <ix:nonFraction unitRef="state" contextRef="i2dc41b2293ce4a6a80887886af6405df_I20201231" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2Xzc0MQ_1f9684e5-159b-44b0-b12b-4b16ba18ce5e">46</ix:nonFraction> states and the District of Columbia, serving a total of approximately <ix:nonFraction unitRef="patient" contextRef="i4902d542b6e047d884a728d3dcf0e573_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="dva:NumberOfCustomers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzgxNA_6c7ae56f-39b0-4cab-87aa-4139759259c6">204,200</ix:nonFraction> patients. In addition, as of December&#160;31, 2020, the Company operated or provided administrative services to a total of <ix:nonFraction unitRef="clinic" contextRef="ie1bbb20c229b4a6d8445cfaf1ad7307a_I20201231" decimals="INF" name="dva:NumberOfSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzkyMQ_2c7ee1e6-ff6c-4567-8d3f-0e921cdd0598">321</ix:nonFraction> outpatient dialysis centers serving approximately <ix:nonFraction unitRef="patient" contextRef="i05384b4fdc8c489886da60a656894693_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="dva:NumberOfCustomers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2Xzk3NA_b297dda1-08cd-4727-bb13-1016ade66656">36,200</ix:nonFraction> patients located in <ix:nonFraction unitRef="country" contextRef="ie1bbb20c229b4a6d8445cfaf1ad7307a_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2Xzk5Nw_1e580cac-a869-43a2-b8f7-ea42862fc104">ten</ix:nonFraction> countries outside of the U.S.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented in these consolidated financial statements. For financial information about the DMG business, see Note 22.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. dialysis business qualifies as a separately reportable segment and the Company&#8217;s ancillary services, including its international operations, have been combined and disclosed in the other segments category.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDQ4_573646fe-276d-4559-a0c1-69c5cc6d900b" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of presentation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company only has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#8217;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#8217;s international subsidiaries from their functional currencies into the Company&#8217;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTY0_7b15d4b1-933d-41bd-b69b-aeacef56a2e1" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#8217;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDQ5_203ee8ce-6896-44cf-b8f1-526e62268087" continuedAt="ifd49d695c07f430490e981dccf0ae426" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, the Company adopted Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 606) using the cumulative effect method for those contracts that were not substantially completed as of January 1, 2018. Results for reporting periods beginning on and after January 1, 2018 are presented under Topic 606.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i370538abf2394ba0951be61dacaf7727" continuedAt="i80596e0e8b3f4c6c94e5eacb0f3b4c6b"><ix:continuation id="ifd49d695c07f430490e981dccf0ae426"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:AllowanceForUncollectibleAccountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDM1_9d3c1756-3a0e-4a5a-a1a2-c29e27ab367a" escape="true">The adoption of this new standard primarily changed the Company&#8217;s presentation of revenues, provision for uncollectible accounts and allowance for doubtful accounts. Topic 606 requires revenue to be recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Accordingly, for performance obligations satisfied after the adoption of Topic 606, the Company no longer separately presents a provision for uncollectible accounts on the consolidated income statement and no longer presents the related allowance for doubtful accounts on the consolidated balance sheet. However, as a result of the Company&#8217;s election to apply Topic 606 only to contracts not substantially completed as of January 1, 2018, the Company continued to maintain an allowance for doubtful accounts related to performance obligations satisfied prior to the adoption of Topic 606. Net collections or write-offs of accounts receivable generated prior to January 1, 2018, beyond amounts previously reserved thereon, are presented in the provision for uncollectible accounts on the consolidated income statement in accordance with Topic 605.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., <ix:nonFraction unitRef="number" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" name="dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI4MDM3NTQ2NTQ3OTgw_55cea711-49da-4dd0-afd2-f04ed4d1b770">80</ix:nonFraction>% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare&#8217;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#8217;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#8217;s base payment rate as well as these other variable factors.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#8217;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#8217;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#8217;s usual and customary rates.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services and strategic initiatives. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and ESRD seamless care organizations are estimated in the period services are provided. Revenues associated with pharmacy services until that business was closed in 2018 were estimated as prescriptions were filled and shipped to patients. Revenues associated with direct primary care until that business was sold in 2018 were estimated over the membership period.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i80596e0e8b3f4c6c94e5eacb0f3b4c6b" continuedAt="i75d8002366154e41841bdd15886f6123"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:OtherNonoperatingIncomeExpensePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDM5_0eb5389b-ec53-4b65-a872-f008fa3cb700" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTky_2e87968a-7792-460d-896f-bd2d1a1d811a" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTgz_ebfd13b6-368d-4e81-b5a8-07e510cc3d55" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted cash and equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow for certain legal settlements pending finalization.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDUw_34a0039e-1e6d-4e6a-b443-b6c2c166e42b" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in debt and equity securities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#8217;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within "Other income, net". These debt and equity investments are classified as "short-term investments" or "long-term investments" on the Company's consolidated balance sheet. See Note 5 for further details.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTkz_6e4f3091-fefa-4081-b79a-e8a92d01301e" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels from the manufacturer and related data submission.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTg2_3a2e18c7-b4af-4584-ab42-c30752dd0df5" continuedAt="i254bd8b706bb4f69b9b63241e49ccf5b" escape="true">Property and equipment</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i254bd8b706bb4f69b9b63241e49ccf5b">Property and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDI0_d39cb0ea-4ebb-436f-b3e2-eb710cc2f703" continuedAt="icf981a14002342db9e1781826cad68b2" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i75d8002366154e41841bdd15886f6123" continuedAt="i4c16c387456b4fc6a9d6609b9434944b"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icf981a14002342db9e1781826cad68b2">Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.</ix:continuation></span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDE5_c3a1a265-6404-4ebc-a40a-9c5a9159d0ab" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortizable intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: non-competition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDQx_b6d84988-1f54-42b2-b8ff-1273472f1714" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indefinite-lived intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDEy_1d5b54f7-10a6-43e7-8eba-59d02aeb64db" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity method and other investments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as &#8220;Equity method and other investments&#8221; on the Company's consolidated balance sheet.&#160;See Note 9 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDEz_ef59bd22-93a0-44dc-9675-e883626c054e" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:InsuranceAndSelfInsurancePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDA3_5d988889-6458-4c59-b8ba-690ed233dad3" continuedAt="i2a39f2b0ae464ad387f4d9c95cf2380f" escape="true">Self-insurance</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2a39f2b0ae464ad387f4d9c95cf2380f">The Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#8217; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims.</ix:continuation> </span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTc0_95a8352a-1dbe-4f4a-b5e6-4e4cb8af39b3" continuedAt="i1d3561d062fd46e6a48568bb93bb4f1d" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4c16c387456b4fc6a9d6609b9434944b" continuedAt="if3ef0726612d4c23965d5550909bdb49"><ix:continuation id="i1d3561d062fd46e6a48568bb93bb4f1d" continuedAt="i42b820e0c9454b70856426af70a2e5ab"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.</span></div></ix:continuation><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTk1_b84746e1-0e6e-43e8-912a-f963689b26f0" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDIw_15954a84-2e39-4509-bec8-4335a590c1fb" continuedAt="i7675ee0a47ab4b8da390e29a3c58a8a0" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate cap agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTk4_bf82b3b4-c268-498c-a841-89c4aebd0046" continuedAt="i2a53cf63408c46dbb2e2b45ee0799523" escape="true">Noncontrolling interests</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2a53cf63408c46dbb2e2b45ee0799523" continuedAt="i9ca2a0cbdb70489da182a802c1426d67">Noncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes.</ix:continuation> As of December&#160;31, 2020, third parties held noncontrolling equity interests in <ix:nonFraction unitRef="entity" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" name="dva:NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzIwMTI0_5b24326b-df91-45ac-b736-6da0122b8283">688</ix:nonFraction> consolidated legal entities.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTYz_279b529a-0d16-4a5a-8295-d701481e8da3" continuedAt="i2044d514e7cb4026b64ea84d4cbb5ada" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2044d514e7cb4026b64ea84d4cbb5ada">The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based compensation, as applicable. The Company has also classified its assets, liabilities and temporary equity into the appropriate fair value hierarchy levels as defined by the FASB.</ix:continuation> See Note 24 for further details.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDIx_78a53dc6-43a0-4531-b8ec-44cfc46d7e05" continuedAt="ia34fb6cbe2c64d709686c9d4c280dceb" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New accounting standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this ASU amend the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments and off-balance sheet credit exposures. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied using a modified retrospective basis. The adoption of ASU No. 2016-13 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework -Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The applicable amendments in this ASU remove requirements for disclosures concerning transfers between fair value measurement levels 1, 2 and 3 and disclosures concerning </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if3ef0726612d4c23965d5550909bdb49"><ix:continuation id="ia34fb6cbe2c64d709686c9d4c280dceb"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation processes for level 3 fair value measurements. The applicable amendments in this ASU also add a requirement to separately disclose the changes in unrealized gains and losses included in other comprehensive income for the reporting period for level 3 items measured at fair value on a recurring basis, and require disclosure of the range and weighted average of significant unobservable inputs used to develop level 3 fair value measurements.&#160;The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied on a prospective basis.&#160;The adoption of this ASU did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2018-15 aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted this ASU as of January 1, 2020, using the prospective transition approach, which allows the Company to change the accounting method without restating prior periods or booking cumulative adjustments. The adoption of ASU No. 2018-15 did not have a material impact on the Company's consolidated financial statements. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The Company has evaluated the impact of this standard on its consolidated financial statements, including accounting policies, processes, and systems, and does not expect the impact to be material.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_196"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI4MDM3NTQ2NTE1MTQ0_5b40c1c2-770f-4da7-92d9-b3fbc2068cbc" continuedAt="i5851a9a6542f49f3bb2acddb52fdf688" escape="true">Revenue recognition and accounts receivable</ix:nonNumeric></span></div><ix:continuation id="i5851a9a6542f49f3bb2acddb52fdf688" continuedAt="icbde3d6cd54a42b1946aa7d6f576f826"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI4NTc_8d06c243-d08b-4078-a918-5265b44edc71" continuedAt="iac4613d4f7f041f098ac30869e19fdc6" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and primary payor source were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:37.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317edbea3c674863a4195c7cc9cb635b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzMtMS0xLTEtMA_2728b2e5-9c52-4206-a6ea-54a6b953f7a7">6,048,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf248d771016450592bc55285a8f1c42_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzMtNS0xLTEtMA_6cac2cfa-f33b-456c-98f0-bca8cd8dc0c8">6,048,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a5d338ecdd42329c520f41a32fe9c4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzQtMS0xLTEtMA_7e99e4ff-f825-4769-ab1d-02ee039d9160">744,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80c5922bf87c4c29a6121290f1760795_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzQtNS0xLTEtMA_17463540-102e-4cc6-97e3-25df530ac5b2">744,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae27697d58642a8a39741ac5b46b72d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzUtMS0xLTEtMA_cc35b0f1-d508-48a4-9a76-89fb1fd5d540">455,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f7687b20c34347a978c801bcbfd456_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzUtMy0xLTEtMA_c9c821ad-6b37-42b0-b1b3-efd4b36dee21">380,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1f2f90b0234c6386c95ee837e0334b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzUtNS0xLTEtMA_bf84a2f6-e5cf-4adb-91ce-cb737ab43e92">836,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb582b032e9d46908fb473a5d0de200f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzYtMS0xLTEtMA_f272fe8e-7bcf-47b7-9528-61c1abf76372">3,370,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70348b0c0a94bb5b0ed3de0b4debc07_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzYtMy0xLTEtMA_18ce8f59-d471-4532-93ed-e3e325f83d7f">170,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59d792b2bf74f6e9847d2fd9f3bbca7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzYtNS0xLTEtMA_281cc82a-23a7-4e9d-9829-4119b7b4d60c">3,540,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ab540b60374ad4aad5a23a7bf8dddd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzgtMy0xLTEtMA_040ac17a-dff7-4e7d-9bd6-358d40cdb26e">419,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf248d771016450592bc55285a8f1c42_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzgtNS0xLTEtMA_201527b4-cf2b-4cda-b20a-b9148bb849be">419,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867730cbcf0748fcb37173e698317b23_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzktMy0xLTEtMA_0123a1db-acc1-4d23-91e9-4a2afbedc3d8">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80c5922bf87c4c29a6121290f1760795_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzktNS0xLTEtMA_401909b1-9d7a-42c3-8ffd-40ff74b205e3">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70348b0c0a94bb5b0ed3de0b4debc07_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEwLTMtMS0xLTA_fe982f60-aa6b-4dc2-b9f6-9e4e676efe44">33,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59d792b2bf74f6e9847d2fd9f3bbca7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEwLTUtMS0xLTA_ff9371f7-0708-4120-a81f-ccabca6d6fe1">33,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44562b75ffb5414b8b4eb109b9499d54_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzExLTEtMS0xLTA_c1e5d2ac-31bc-400a-ac84-027e4f1d0986">40,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254282fb16c34ab2945f3c18a75f8323_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzExLTMtMS0xLTA_caba969e-fd15-43aa-a808-1eeb322d33fa">47,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4206fb8a521a438eadb170f4aaec89d1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzExLTUtMS0xLTA_817aed46-5fb8-44c7-a8f6-b73c74d67a33">88,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0914af09be91438c9bdd1e22b951a0df_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEyLTEtMS0xLTA_a464dc05-84cd-4376-b908-41de0684c820">145,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41625250859e40bda54bf40e92bd1151_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEyLTMtMS0xLTA_dc814c28-fe19-4e25-9ae3-9b50ba88a718">16,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635c2eebb9e64938a68735ae6c593657_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEyLTUtMS0xLTA_afb806da-9cf0-4ed7-b2dd-c67c73e39467">162,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEzLTEtMS0xLTA_d7380342-8472-499e-a4b7-4214853ab405">10,514,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEzLTMtMS0xLTA_d8ed19cb-40c5-4197-ab7b-3b95460bc8c7">1,035,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEzLTUtMS0xLTA_6c1e4bc5-64fe-4809-8498-d5490eb90811">11,550,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="icbde3d6cd54a42b1946aa7d6f576f826" continuedAt="ic3951fcc7fb946318d3b9f5f574b1bca"><ix:continuation id="iac4613d4f7f041f098ac30869e19fdc6"><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:37.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a6ed05dcee04d00b0acebc6f9646492_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzMtMS0xLTEtMA_ea8e89cc-3e26-40e4-a57c-6aa16d8df886">6,129,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbe0a9a2b6e487387fc940140536289_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzMtNS0xLTEtMA_a3e714bf-b876-4965-8d74-f0896a5988a8">6,129,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9039b41e698646108961d8438f298065_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzQtMS0xLTEtMA_b48ccd72-8f91-4613-b2d5-c772c5beb7de">669,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a5025fe7d546f59cb2d4b2ffb19b92_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzQtNS0xLTEtMA_ee50b436-54e6-43c1-817b-78c4f3b96f69">669,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73e85c3fcad4252b56e5ca71804381f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzUtMS0xLTEtMA_15bb26ac-a410-4886-bba0-28f0bc6876b8">446,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68577d74812348348e7271f689002b75_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzUtMy0xLTEtMA_7700d91c-8156-47e5-b3d0-dfd97b6b9c1c">352,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10176a49705641908ef22710eb3ceb0f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzUtNS0xLTEtMA_adcbc897-d5e4-4463-835f-93304fbdc5f6">798,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90161d3cc08b4d05b4c9a4bc96f77638_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzYtMS0xLTEtMA_eac06e95-2b96-43ef-a93e-a8d2117af3ae">3,286,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc956536376499ca4f18116e1a28156_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzYtMy0xLTEtMA_6997bf5b-68d6-4899-a376-7e1e46ed38d5">144,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1d128a80ca4c31ab1a4b08899c3bee_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzYtNS0xLTEtMA_e5e36cf2-0e23-4648-89f7-537775f9645d">3,430,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i331cb12a3bc84e9dbd3524df3c61c1e5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzgtMy0xLTEtMA_623058f4-a5a5-41b9-a600-62605ac661ae">264,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbe0a9a2b6e487387fc940140536289_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzgtNS0xLTEtMA_e162b7e1-1495-4608-a63a-a34977f2e95f">264,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9225d7ed664b4437a955e3239e2d4672_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzktMy0xLTEtMA_f9bdde4a-8685-45dc-8ab1-a9a7b2181fba">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a5025fe7d546f59cb2d4b2ffb19b92_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzktNS0xLTEtMA_227f7d19-3827-4e9f-99d1-0b604dfebfff">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc956536376499ca4f18116e1a28156_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEwLTMtMS0xLTA_e3c92db1-e6ce-4f97-b8a8-612a01ed9d55">130,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1d128a80ca4c31ab1a4b08899c3bee_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEwLTUtMS0xLTA_52e81e2f-a6cb-4294-bc34-7a18ab3a0e28">130,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ad6e19bfd204637ac41e31412365fde_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzExLTEtMS0xLTA_bb96f3cf-1f82-427c-885c-1ec1ef406d2f">32,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57e64e40c6c949a4a0c172e586effb9e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzExLTMtMS0xLTA_2a7b328f-6633-48b3-a9ce-847fc6f5316c">78,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbdb192b5cd84c0aa25e94fee7bff238_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzExLTUtMS0xLTA_a2fa4db1-9259-44eb-9ef7-bb66aa7f405e">110,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i164e3c5e63494e49a4973e32ed991ff5_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEyLTEtMS0xLTA_99c611d6-0516-4276-b83d-1e427bc745cc">132,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia940e3b4e9754716a7d35abf7b1359f0_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEyLTMtMS0xLTA_3ab2e852-83e5-4599-8c31-5eccb7b0ad50">14,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9b9ab0e8584df69e653fc61911e0cc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEyLTUtMS0xLTA_d05773fd-d952-4caf-acfb-becc99fcc56f">146,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEzLTEtMS0xLTA_1d2f007b-c5fb-406a-a8a3-faf9058f30a6">10,430,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEzLTMtMS0xLTA_3e73c845-6afa-4719-86ec-c87e53c89e74">957,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEzLTUtMS0xLTA_19f5f65d-5a67-4e6f-b32f-31657d3ace49">11,388,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:37.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf2fdbccba5422e8e3b2a15008e502e_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzMtMS0xLTEtMA_cbeb49e6-103a-4b30-9514-2f7033d76de6">6,063,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14af6fc05fe24609a9ef1d172b06d3ed_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzMtNS0xLTEtMA_c86d787f-9ff7-4c90-97a2-20e1daa2f624">6,063,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bfe5b640ee64eca89b909864373b865_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzQtMS0xLTEtMA_2eebf8bf-d247-40ec-bc9b-d07e40516103">628,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799a2b20a00e45e0b3f08db269fa3736_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzQtNS0xLTEtMA_d55202a8-ed97-4905-b1ec-286a2504b1ca">628,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bda8f256e44c4884a542b1ea607df5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzUtMS0xLTEtMA_1bf0682b-1af6-40fa-a506-a04e7b1f8c42">446,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c528d2849c2446c8b9fb3e906e29ece_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzUtMy0xLTEtMA_e91d351d-e91b-48fd-8c13-d8762ceaac18">335,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc14ea5b25b54be1945bb52726f391c6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzUtNS0xLTEtMA_0c8e3faa-4ef8-4e35-845a-93d5430fbd94">782,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74881d974a934edab7eb395774d2e72a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzYtMS0xLTEtMA_1da0c28f-bae1-42f8-946b-c8381b66e384">3,176,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie830c422acbf447b830d5ba05d456555_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzYtMy0xLTEtMA_92449004-6e37-49e2-9953-d3449b510b64">101,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie092dc1a9f334a2d8959b7937c63b6da_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzYtNS0xLTEtMA_109e7e52-50f2-423d-904c-e7fda82c85ca">3,278,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e35707e465473fb9d209c48d673e9c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzgtMy0xLTEtMA_77a373fe-7c4d-4715-8b8e-6811302690f0">492,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14af6fc05fe24609a9ef1d172b06d3ed_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzgtNS0xLTEtMA_963ec812-eaeb-4c6a-beea-751c0af02e88">492,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2c11e9409a4ebfb1af5af31c5eec06_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzktMy0xLTEtMA_b32fa382-1c11-462f-a103-b9611041bdc9">44,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799a2b20a00e45e0b3f08db269fa3736_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzktNS0xLTEtMA_2ed54281-0887-43cf-9073-71e0c1b41c85">44,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie830c422acbf447b830d5ba05d456555_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEwLTMtMS0xLTA_5f27a09e-1994-4034-b687-51e498a49c37">90,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie092dc1a9f334a2d8959b7937c63b6da_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEwLTUtMS0xLTA_ab301777-a762-4d00-9c55-7b1f120be125">90,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57b9bde3eb844b8825af8894f08bd19_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzExLTEtMS0xLTA_3778989d-ef69-45d6-b3ae-c3c47779c93c">19,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47790222420f478db2f7ad17705accb2_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzExLTMtMS0xLTA_4c063570-cafa-4236-bfe6-97c69f4bd079">130,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21697e32a0ec4bf1904f2fc73b9dbbad_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzExLTUtMS0xLTA_12966822-9bcb-4d9f-a7e6-a29add9e2aa5">150,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if961d3964d254d87be469310f7624b7c_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEyLTEtMS0xLTA_a9412edd-5bbc-44a3-b795-0a438c881b6a">92,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f27d9ed3464afea1d79fe17c36cc36_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEyLTMtMS0xLTA_2f1efc52-6c35-4f9c-b3af-0c272cffaca1">34,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a04f4ad256b450eb154971edb661d29_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEyLTUtMS0xLTA_452e40c8-5a2d-43a7-8aa1-c4375a14ff83">127,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEzLTEtMS0xLTA_4b58f97d-bc2d-42fc-a056-f528436c0221">10,242,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d8743c3594411698541aa578ec2aff_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEzLTMtMS0xLTA_b87f55ba-c1cf-4e39-b971-7f233f1a4d51">1,161,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEzLTUtMS0xLTA_05bc69e4-2524-4815-8012-9290e4b56425">11,404,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="usd" contextRef="i33a90a56c3c54abe92e41788859d9e6c_I20201231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzEwNTg_f01fbc0e-504b-4835-a3ac-4c086d3d3564">no</ix:nonFraction> allowance for doubtful accounts related to performance obligations satisfied in years prior to January 1, 2018 as of December&#160;31, 2020 and such allowance was $<ix:nonFraction unitRef="usd" contextRef="i59029b4957e44e428f8a80a0cb5a4790_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzEwNjU_1fb33cca-b87d-4a2d-8de0-aae5796af4d6">8,328</ix:nonFraction> as of December&#160;31, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 1, there are significant risks associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues including determining applicable primary and secondary coverage, changes in patient coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period. As a result of these changes in estimates, <ix:nonFraction unitRef="usd" contextRef="ie0da31cd8a6a4e4a97290ebfc52869b0_D20200101-20201231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI4MDM3NTQ2NTE1MTYx_75616f0c-21c3-4f12-946e-0243b98d114c">no</ix:nonFraction> additional revenue was recognized during the year ended December&#160;31, 2020 associated with performance obligations satisfied prior to January 1, 2018 and additional revenue of $<ix:nonFraction unitRef="usd" contextRef="ib87a97e373bd46c89dac120c212a644a_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzE4ODk_c4ebcad5-995e-4137-86d1-408620dc790e">37,274</ix:nonFraction> was recognized during the year ended December&#160;31, 2019 associated with performance obligations satisfied in years prior to January 1, 2018.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is <ix:nonFraction unitRef="number" contextRef="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="dva:NumberOfConcentrationRiskCustomers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzIxNjc_aacc69c3-3a0c-4270-9d45-726dc29d1249">no</ix:nonFraction> single commercial payor that accounted for more than <ix:nonFraction unitRef="number" contextRef="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzIyMjM_feb9d9a6-efdd-48b3-820d-e09825b8532d">10</ix:nonFraction>% of total consolidated accounts receivable or consolidated revenues at or for the years ended December&#160;31, 2020 or 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3951fcc7fb946318d3b9f5f574b1bca">Net dialysis services accounts receivable and other receivables from Medicare, including Medicare Advantage plans, and Medicaid, including managed Medicaid plans, were approximately $<ix:nonFraction unitRef="usd" contextRef="ibabc1893044f4e66a6479c0d43899227_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI1MTE_84075dfa-69a3-48cf-8de5-e5c0013776af">1,101,837</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i884b650f6da14ccebfbdcc5a5e3c9c2a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI1MTg_690a2251-f123-4fe1-9361-6ffa117a51c9">1,038,248</ix:nonFraction> as of December&#160;31, 2020 and 2019, respectively. Approximately <ix:nonFraction unitRef="number" contextRef="i444084475ebc4fe2ad288f8829a0542f_I20201231" decimals="INF" name="dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI1NjY_25b73a4f-855e-48d3-9031-58556001be0e">17</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0827e76d53914466af9eff1dc6c5d343_I20191231" decimals="INF" name="dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzM4NDgyOTA3MDQwMjI_618662da-8833-4cbb-bb7c-c46087f22d38">18</ix:nonFraction>% of the Company&#8217;s net patient services accounts receivable balances as of December&#160;31, 2020 and 2019, respectively, were more than <ix:nonNumeric contextRef="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231" format="ixt-sec:durwordsen" name="dva:AccountsReceivablePeriodOutstanding" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI2NzM_2f873a5b-4e65-4f6c-a8ed-0ba61b73311c">six months</ix:nonNumeric> old. There were <ix:nonFraction unitRef="usd" contextRef="i444084475ebc4fe2ad288f8829a0542f_I20201231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:AccountsReceivableNetCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI2OTI_03b0df94-1b71-4d36-8aae-aa7db0c065b4">no</ix:nonFraction> significant balances over <ix:nonNumeric contextRef="i8497a3de1675439ca2a3f1871e38384e_D20200101-20201231" format="ixt-sec:durwordsen" name="dva:AccountsReceivablePeriodOutstanding" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI3MjE_a314884f-9cf7-4739-a4e9-9d974a8dc3d6">one year</ix:nonNumeric> old at December&#160;31, 2020. The Company's accounts receivable are principally due from Medicare and Medicaid programs and commercial insurance plans.</ix:continuation></span></div><div id="i878840fee65247deaca27d2dd6a8246f_202"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90ZXh0cmVnaW9uOjU3YTM5OTY3N2ZmOTRjNDk5MjAyYjVjMGQxYzllNDYzXzEyNjE_78a86f5e-2d63-4a62-a62e-d462e0d8b169" continuedAt="idf6855d1d5094a4bbfc3b287c4b6579c" escape="true">Earnings&#160;per share</ix:nonNumeric></span></div><ix:continuation id="idf6855d1d5094a4bbfc3b287c4b6579c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90ZXh0cmVnaW9uOjU3YTM5OTY3N2ZmOTRjNDk5MjAyYjVjMGQxYzllNDYzXzEyNjU_a1662d9d-b58b-4a8d-86c3-36da2319e3c7" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding, reduced for 2018 by the weighted average shares held in escrow that under certain circumstances may have been returned to the Company. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units (under the treasury stock method) and, for 2018, the weighted average contingently returnable shares held in escrow that were outstanding during the period.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90ZXh0cmVnaW9uOjU3YTM5OTY3N2ZmOTRjNDk5MjAyYjVjMGQxYzllNDYzXzEyNjc_b2f670e0-faeb-4304-b184-b4ffd6331922" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzMtMS0xLTEtMA_92471df0-e307-4e68-9920-4d957959b742">783,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzMtMy0xLTEtMA_28372998-f966-4989-a285-9b4b54f9ce73">706,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzMtNS0xLTEtMA_804ebe7c-7772-43f2-9cb6-721b818546e9">624,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzQtMS0xLTEtMA_a1860ae4-c4c4-4d28-9092-20a98f5b5b42">9,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzQtMy0xLTEtMA_cd4c689c-6874-4ac3-b135-fa220b2ceafa">104,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzQtNS0xLTEtMA_859c8bc6-2cfe-4ddd-b314-a13328cf6973">464,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzUtMS0xLTEtMA_49b3f939-8a4e-49e0-8c33-015cd43da6dd">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzUtMy0xLTEtMA_da85b60e-970d-4c64-b2c8-90f1de7a8e3e">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzUtNS0xLTEtMA_c031532e-8ec8-445a-9e55-ade6a86c5321">159,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzgtMS0xLTEtMA_6dc3092a-2dc1-4b39-942e-0dfa2de98589">119,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzgtMy0xLTEtMA_44d72f5a-e52a-4be3-ae52-e50e90bd47de">153,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzgtNS0xLTEtMA_18732573-7a92-41e4-b9ea-a5f1005c173e">171,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently returnable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzktMS0xLTEtMA_813bd04e-4b61-4448-9689-0819630c07bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzktMy0xLTEtMA_183c7450-475a-4e10-b063-e894990a45d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzktNS0xLTEtMA_e426aa3c-04ca-40cb-b952-1e9669d8f39b">1,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTEtMS0xLTA_3be29fec-261c-4bc9-9a2d-6e83559b2626">119,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTMtMS0xLTA_e0618ddf-e433-42d5-8906-4429d882326a">153,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTUtMS0xLTA_465ba5c4-38e8-4cdf-a5e0-3402b302df74">170,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently returnable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTEtMS0xLTY4MTg_c1f7d0f6-5d5b-4aa9-9415-c482749fb916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTMtMS0xLTY4MTg_7b0dc701-6b5b-42d5-a89e-0698613da982">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTUtMS0xLTY4MTg_72c967fc-1cd3-4c66-8a27-c4f0bf05c38d">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzExLTEtMS0xLTY4MTg_6bfc0f25-1079-470a-a4c8-394f40569a4b">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzExLTMtMS0xLTY4MTg_84ac4a4e-0ee8-482b-a3eb-5c308a806348">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzExLTUtMS0xLTY4MTg_4f067a40-c3db-4137-83c5-b3deed90998e">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEyLTEtMS0xLTY4MTg_3f4c40ae-6616-488b-8ab6-225d7d1d321e">122,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEyLTMtMS0xLTY4MTg_a5c2b875-feb3-4a81-8862-8e4252d57246">153,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEyLTUtMS0xLTY4MTg_3c70b8e1-eb1e-4907-992c-b79ea58b0446">172,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEzLTEtMS0xLTA_2d900bda-22af-435c-ae02-37439754f585">6.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEzLTMtMS0xLTA_a183d623-941d-47d4-a90e-99c41a21d2ca">4.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEzLTUtMS0xLTA_4706b716-ec96-420b-8500-b4dfffeff1cf">3.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE0LTEtMS0xLTA_b7756e80-94fe-43d0-94d8-1f73e0877b32">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE0LTMtMS0xLTA_b5ab02a4-255d-45b6-81ec-16c4ba77f7b7">0.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE0LTUtMS0xLTA_c5bfdfd6-7045-4178-bb7b-bac2538d41f3">2.73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE1LTEtMS0xLTA_c899f3b7-ae77-401b-9c5f-770a8d1f49ac">6.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE1LTMtMS0xLTA_d6432bdf-6c51-4a38-8611-4febf3b6c6e2">5.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE1LTUtMS0xLTA_db01ae63-9640-45a3-a194-8ad676165f33">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzIzLTEtMS0xLTA_4aa53c23-1947-46ca-8f54-76163ea1f320">6.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzIzLTMtMS0xLTA_313fa9d4-ff9b-4584-ab52-ab9aeaef08f9">4.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzIzLTUtMS0xLTA_caa69b59-6aaa-4d6e-9ef3-6a4192be8796">3.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI0LTEtMS0xLTA_fa97d360-4ec3-4a23-9ab8-7347bf9b45ca">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI0LTMtMS0xLTA_fb79b8c6-a294-45ac-a5aa-f45267b4911b">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI0LTUtMS0xLTA_90f1da9b-cfa4-4a22-bb5b-881701648c32">2.70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI1LTEtMS0xLTA_dae41f19-f822-4c2e-9101-c3aad588a365">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI1LTMtMS0xLTA_f3211d91-0d72-4221-b0c6-d4b0552226af">5.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI1LTUtMS0xLTA_9694e0fa-9d90-4209-931f-4d2ba3b7c76b">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI3LTEtMS0xLTA_95bccb92-f5e5-4d95-af55-fc6c87e0ccef">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI3LTMtMS0xLTA_9cbbe7dc-7b6b-4915-ab54-e68775233a43">5,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI3LTUtMS0xLTA_98370be2-9fc5-4d5e-8b40-6e70c0491e77">5,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">previously held in escrow for the DaVita HealthCare Partners merger.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_205"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzI4MDM3NTQ2NTA5NDY4_49ee0f76-7920-44a0-900c-9b9abde736cb" continuedAt="i0854ff2abdaa471b9188bcc3fa72604f" escape="true">Restricted cash and equivalents</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0854ff2abdaa471b9188bcc3fa72604f">The Company had restricted cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzk3_9049bc08-5920-4200-829e-830f2261cd36">176,832</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzEwNA_a539cf2d-d397-4787-838d-86f52294d3fb">106,346</ix:nonFraction> at December&#160;31, 2020 and 2019, respectively. Approximately $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzE0OQ_e162562d-fc65-46af-8fe6-d3b2902d2e17">92,286</ix:nonFraction> of the balance at December&#160;31, 2020 represents restricted cash equivalents held in trust to satisfy insurer and state regulatory requirements related to the wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company and $<ix:nonFraction unitRef="usd" contextRef="i0d4d7d40de954bc4a8f5ba7ec06c8900_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzI4MDM3NTQ2NTA5NTYw_98af19fc-554d-4de3-924d-7c67f41cd668">70,000</ix:nonFraction> represents cash held in escrow to fund a previously announced legal settlement pending finalization. The remaining restricted cash and cash equivalents held at December&#160;31, 2020 primarily represents cash pledged to third parties in connection with <ix:nonFraction unitRef="number" contextRef="if18749a859234cf7b23652f60c460caf_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="dva:NumberOfPartnerships" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzU2MA_a1f1e5b5-b787-4999-8494-449ad3f89eb7">one</ix:nonFraction> of the Company's ancillary services.</ix:continuation></span></div><div id="i878840fee65247deaca27d2dd6a8246f_208"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2OTQ_ec87f9b3-d18d-470f-a761-21922f9a5556" continuedAt="i4cd1eefa54094179a782cf2d61f3c03d" escape="true">Short-term and long-term investments</ix:nonNumeric></span></div><ix:continuation id="i4cd1eefa54094179a782cf2d61f3c03d" continuedAt="ibde8696ece04420e80771d764758a1e0"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2OTk_2843e7cb-5438-4a7b-8f72-4e801f8199ea" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab2d52784864cf6ac6e10794af391d6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItMS0xLTEtMA_95b31230-7485-4252-a7c0-b7212d889ada">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab2d52784864cf6ac6e10794af391d6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItMy0xLTEtMA_b1cb8eb0-f263-4d22-99e1-bd00b1f7b90d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab2d52784864cf6ac6e10794af391d6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItNS0xLTEtMA_0189332e-f6fe-4e7a-b676-e17e819524d2">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf901af366f34dbaa56ecfe998516c0a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItNy0xLTEtMA_e607bd30-09dd-4c24-a038-c076c9d2149a">8,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf901af366f34dbaa56ecfe998516c0a_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItOS0xLTEtMA_a96d2366-f9f0-42a4-af83-f2a50f9a3416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf901af366f34dbaa56ecfe998516c0a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItMTEtMS0xLTA_58e62d94-d834-428b-b675-f38c5c7a0019">8,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtMS0xLTEtMA_c8532b47-8ddf-4ecc-8e37-c2cdba5ff295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtMy0xLTEtMA_c15269c2-f25a-42c6-8d21-fd9b97be451c">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtNS0xLTEtMA_c2bd9eea-bb98-4fd7-812a-a36dab758335">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb978d08cfeb4642bd53e53555d6f21e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtNy0xLTEtMA_694669cc-fe53-4534-b7d7-2610cfbfd115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb978d08cfeb4642bd53e53555d6f21e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtOS0xLTEtMA_4b6f209e-6493-4512-9754-47211efe720f">39,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb978d08cfeb4642bd53e53555d6f21e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtMTEtMS0xLTA_db0d5713-09a9-4508-bda5-87e26baa58b4">39,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtMS0xLTEtMA_8fa89708-abf2-4aa5-91cb-4bb6f1422bff">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtMy0xLTEtMA_a9317472-17db-4e51-a750-265536eac2b6">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtNS0xLTEtMA_347ac0c3-13b1-4d10-a886-95a9bd3f70bd">52,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtNy0xLTEtMA_172ad15a-121b-4595-a8f5-54ae1a8863bf">8,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtOS0xLTEtMA_c891d556-8f53-45ed-8e2a-4e6fc1a1a7a1">39,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtMTEtMS0xLTA_c87a1e7a-2407-4c46-9edc-4aaa5f86c3a8">48,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtMS0xLTEtMA_0e9eac24-f9a1-437a-a521-a5139d983d35">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccf23c460b304d34975ca6b21fa9b648_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtMy0xLTEtMA_7d22d1ef-dd7b-4ba1-b6f1-fabace384c86">11,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtNS0xLTEtMA_49089bad-dee3-405d-ae26-c594b43c6c34">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtNy0xLTEtMA_89b7cc56-241a-41f3-b67d-73bcae37eb31">8,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8314d71719804d359b9983c38b6897ef_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtOS0xLTEtMA_a35fd538-fc84-4707-a176-4e31db37b576">3,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtMTEtMS0xLTA_283ecad9-87a7-422d-89af-a726f29ed6ce">11,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtMS0xLTEtMA_3b9d2fba-6519-4db6-8c59-bd4152c9327d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6369add7b9a341bbb8a486c2b65be42f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtMy0xLTEtMA_2bb401ab-e61b-44da-af4b-e111ee9b9c9b">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtNS0xLTEtMA_49f9f3e9-9f9e-4933-bd2c-8c286c14ffa9">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtNy0xLTEtMA_8696932c-b03f-4a1c-92e0-3a0444da60c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2929163ca34ad6b905be96f45d01d4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtOS0xLTEtMA_3ffa53ef-fee4-4ddd-b200-77e0a574a5d4">36,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtMTEtMS0xLTA_78c56a62-331b-4bb2-948f-9dc5b8d581d8">36,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctMS0xLTEtMA_d5320cb8-7f77-4b2d-9c42-850d1cf53c4e">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctMy0xLTEtMA_77e73fba-8bf0-4ccb-a472-6c710d47ce7c">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctNS0xLTEtMA_140bdf22-f652-459f-97f0-f321b2e78186">52,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctNy0xLTEtMA_09bd4be9-fc8b-45be-8a5c-175e3e425949">8,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctOS0xLTEtMA_1adf01d2-e9ee-480e-95db-65a92e6a70a3">39,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctMTEtMS0xLTA_34c054c8-ba04-49b0-b5a8-a367a0186433">48,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI3MDI_882cc221-cc3e-4f17-9191-aaf5d636d483" continuedAt="ia0bd3844622f4e9eaf4d99dd4a451ebb" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2020 and 2019.</span></ix:nonNumeric></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ibde8696ece04420e80771d764758a1e0" continuedAt="i28e07dbef10d47a4b60731a59b787ecc"><ix:continuation id="ia0bd3844622f4e9eaf4d99dd4a451ebb" continuedAt="i74aee04a0e51412f9b5964094143cb8d">Equity securities:</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i28e07dbef10d47a4b60731a59b787ecc"><ix:continuation id="i74aee04a0e51412f9b5964094143cb8d"> The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#8217;s non-qualified deferred compensation plans.</ix:continuation> During 2020, the Company recognized pre-tax net gains of $<ix:nonFraction unitRef="usd" contextRef="i4e82366908fc411981946281d867f868_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzIyODU_7843d0cf-3a17-4872-ab86-eb4b223dd5df">3,818</ix:nonFraction> in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $<ix:nonFraction unitRef="usd" contextRef="i4e82366908fc411981946281d867f868_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI0MTM_935f91aa-e966-4d7a-bcec-45db1d85204a">1,941</ix:nonFraction> and a net increase in unrealized gains of $<ix:nonFraction unitRef="usd" contextRef="i4e82366908fc411981946281d867f868_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI0NTg_ef122b82-42fc-4467-a073-f91027744a43">1,877</ix:nonFraction>. During 2019, the Company recognized pre-tax net gains of $<ix:nonFraction unitRef="usd" contextRef="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI1MTg_fe8e2609-5521-4aa0-b39e-aaa5681fe321">4,383</ix:nonFraction> in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $<ix:nonFraction unitRef="usd" contextRef="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2NDY_28f12be3-57c9-45d1-b832-871b7e77b807">1,459</ix:nonFraction> and a net increase in unrealized gains of $<ix:nonFraction unitRef="usd" contextRef="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2OTE_0f392a95-d126-4d6b-bdbd-a4b0c5870850">2,924</ix:nonFraction>.</ix:continuation> </span></div><div id="i878840fee65247deaca27d2dd6a8246f_211"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90ZXh0cmVnaW9uOjYyMGJlYWNlM2FjNDQwZDU5NGFjMWM5NmVhMzJkYTE3Xzg3_248c93bf-7993-4b47-8cb5-a251490f0af5" continuedAt="i9c6f55dd68ca41c0b7ea80015221a9e9" escape="true">Other receivables</ix:nonNumeric></span></div><ix:continuation id="i9c6f55dd68ca41c0b7ea80015221a9e9"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ScheduleOfOtherReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90ZXh0cmVnaW9uOjYyMGJlYWNlM2FjNDQwZDU5NGFjMWM5NmVhMzJkYTE3Xzgz_a1d464f9-bf74-4580-ba57-d112b5fabfa2" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables were comprised of the following:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"><tr><td style="width:1.0%"></td><td style="width:56.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier rebates and non-trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51c7cd9eeaa64c0a91528e12f2172af6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzItMS0xLTEtMA_7d1ef077-fe69-422d-a333-9dc4aa41db94">390,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a2be35772674635818cdd631d499246_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzItMy0xLTEtMA_c84b8fdf-1f73-44fa-93e2-a95ff0a20f3b">351,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare bad debt claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f29353214f44b529f3e84fdb2acc7f8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzMtMS0xLTEtMA_43df2e55-70ba-43a4-b08e-008a1758641c">153,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39149e895b2b4e0593f509dcaf83e78f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzMtMy0xLTEtMA_c118c7fd-e183-4853-aa82-ee4d20384c94">138,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzQtMS0xLTEtMA_5111a884-e756-40ac-8c65-eae6e84da65e">544,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzQtMy0xLTEtMA_cda742bd-dae5-4bbb-9bb9-3662f0c9cb9c">489,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_214"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzI4NTg3MzAyMzIzMDc1_ce86f42b-f989-4b77-bff9-4f26763e1aab" continuedAt="if0f78bd156da40c5a7015879bee2fb7b" escape="true">Property and equipment</ix:nonNumeric></span></div><ix:continuation id="if0f78bd156da40c5a7015879bee2fb7b"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzU4NQ_913a7d65-9f9a-490d-8791-8b7fd74bbb5c" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:66.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.467%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Land" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzItMS0xLTEtMA_e6f40390-fce3-4981-be20-9083937c2c19">37,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Land" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzItMy0xLTEtMA_2e787105-b15e-4f02-af63-a54f8dddd6de">36,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzMtMS0xLTEtMA_6c83ab4c-f71c-428c-8bd5-c3fd8e27a31c">400,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzMtMy0xLTEtMA_3f5dfb98-b81d-421d-b327-9dfe2eab5c5d">392,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseholdImprovementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzQtMS0xLTEtMA_edb0e8a1-e3fb-4c84-a0aa-00b7de01345a">3,865,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseholdImprovementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzQtMy0xLTEtMA_87a412e1-dcd9-4b79-a1c1-bff6c2cd3963">3,545,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and information systems, including internally developed software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MachineryAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzUtMS0xLTEtMA_4a79223d-fc27-478a-a245-4f403fc4f0f3">3,081,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MachineryAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzUtMy0xLTEtMA_aec06793-127f-4ab6-9ffb-683d08363979">2,880,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New center and capital asset projects in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConstructionInProgressGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzYtMS0xLTEtMA_ae498330-aec3-454d-af76-968170c098ed">616,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConstructionInProgressGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzYtMy0xLTEtMA_d4956414-3218-4756-9229-2c403974e1b2">588,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzctMS0xLTEtMA_59bfa489-c397-41d3-9ab2-02681ed2c79f">8,002,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzctMy0xLTEtMA_c0615540-94ef-4778-a1a5-39d8db86ac37">7,442,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzgtMS0xLTEtMA_6597e358-fe95-400e-8937-692d4a8f739d">4,480,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzgtMy0xLTEtMA_0e37d150-cffc-45ef-8223-af3d07c82a80">3,969,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzktMS0xLTEtMA_3125e236-87d8-4b09-89e1-704857aea3da">3,521,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzktMy0xLTEtMA_c7a1e495-366e-4e15-9235-2bc52622bd29">3,473,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses are computed using the straight-line method over the useful lives of the assets estimated as follows: buildings, <ix:nonNumeric contextRef="i50b4634b59f749b0b5c6631027941142_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY0OTMx_7c6d3bc9-4011-4370-ab88-8d31cc912b4a">25</ix:nonNumeric> years to <ix:nonNumeric contextRef="i33a1bfddc39c4a169c47e840741f335c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY0OTM4_1c0bcc53-7bf7-4767-9bf7-77162491dd33">40</ix:nonNumeric> years; leasehold improvements, the shorter of <ix:nonNumeric contextRef="ied88af0a7c524bc3999fdbfa994108b6_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY0OTgy_999ba535-6e57-494f-8f7b-948d470407ed">ten years</ix:nonNumeric> or the expected lease term; and equipment and information systems, principally <ix:nonNumeric contextRef="i3063267a01f94e3fb4a375c1970717cb_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY1MDY1_967092fd-ba24-4184-9268-41a8cb64f5a8">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="i3b89299a9bfd462b8e5b3a7023ed6334_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY1MDcy_4c374457-77b4-4795-bb47-bcbc5ad0d70c">15</ix:nonNumeric> years. Depreciation expense on property and equipment was $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzE0MQ_0198a5e3-19b0-4b1a-93ff-d31c05fc1740">616,626</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzE0NQ_92f38628-c616-4aba-b138-5f5a4f22fc9c">600,905</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzI3NDg3NzkwNzAzMjk_4aaa490e-4a4b-45c1-b6ed-40813d624c4e">574,799</ix:nonFraction> for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on debt incurred during the development of new centers and other capital asset projects is capitalized as a component of the asset cost based on the respective in-process capital asset balances. Interest capitalized was $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzM4NDgyOTA2OTc4MTc_d2001605-15ce-46a6-8ca5-0021fbf51048">17,944</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzQyMg_6118b0b8-03d9-4305-93ec-1b2823fed01f">27,322</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzQyOQ_6ea69470-de26-44bf-be51-c5b8dae724f3">25,978</ix:nonFraction> for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, the Company recognized asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i51925e49d034403085e491018c02d26d_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzI3NDg3NzkwNzAzMDU_7e59537f-ca81-4cb6-9f29-0220f2c9634d">17,338</ix:nonFraction> related to the restructuring of its pharmacy business.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_217"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwOTI_98582c8d-a7ee-46bd-b6f2-498ed93a4f06" continuedAt="i68f060a234db43faaa338843d49df4f0" escape="true">Intangible assets</ix:nonNumeric></span></div><ix:continuation id="i68f060a234db43faaa338843d49df4f0" continuedAt="idffe82f5884041f796664fc9a63fdef1"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwODg_8f7e2027-9bc8-47d8-95d3-24c93b335aa4" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"><tr><td style="width:1.0%"></td><td style="width:54.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzMtMS0xLTEtMA_6e148db6-ceb7-4698-b3f6-5f0a7e1f13bd">100,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzMtMy0xLTEtMA_f162f79d-87bb-42ee-b5c9-5449872dba5b">90,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedNoncompeteAgreementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMS0xLTEtMTUyMjk_ce9f2a0b-e478-43ee-8055-0a6f0cca9e52">84,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedNoncompeteAgreementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMy0xLTEtMTUyMjk_c9dfd9b7-be21-40c3-a498-49d85e66c6f2">103,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMS0xLTEtMA_ee74f95d-c3d4-4eb0-90c0-b2b1ae4b2a2a">52,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMy0xLTEtMA_02745071-e2c6-4493-861a-1a53cbd5aad1">23,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzUtMS0xLTEtMA_d5a460eb-72c2-4a80-b143-4a5ff762994a">236,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzUtMy0xLTEtMA_dc044600-244d-4b5f-a7f0-8b0dceeebf01">217,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzYtMS0xLTEtMA_9d7c3206-3cb0-4b9e-b9f3-6b8288ae3979">70,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzYtMy0xLTEtMA_ec29e96a-16bc-4d0f-a2ad-c197593eb3be">81,922</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzctMS0xLTEtMA_8998b340-ef51-4728-9916-cb94249c12bb">166,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzctMy0xLTEtMA_6c4aec50-b83c-436a-b9ef-654d80e86335">135,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncompetition agreements are generally amortized over <ix:nonNumeric contextRef="ie087c1d3f9974f219511b176db8eda1f_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2NTQ_ed781d83-3a3f-4814-b8a0-ff4a8bd79500">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="ie16ddbc3f61d4fdd876789fdb7485e3f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2NjY_15a377bd-97b4-41e5-a919-301990f3f990">10</ix:nonNumeric> years and customer relationships are principally amortized over <ix:nonNumeric contextRef="iaaaf284806a9483fb5c0391481bc7d0d_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2NzU_c20a223c-1570-4445-9e1c-cbd9a443fc2b">10</ix:nonNumeric> years to <ix:nonNumeric contextRef="i84b74ed9100c4ce592923a9de27931be_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2ODA_b36b19bd-68cb-4570-8d5b-ced1d0e30102">20</ix:nonNumeric> years. Amortization expense from amortizable intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzE4Mg_e92af3a5-68df-4d8a-947e-ac43a010863d">13,809</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzE4Ng_36859541-4834-4c66-b9af-fc6256b579f0">14,247</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzI3NDg3NzkwNzA2ODI_743f2f4b-c2f5-4e1b-9373-2b0496bee6f8">16,236</ix:nonFraction> for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized <ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzUzNA_2c500cd7-4d33-4499-85c2-18dabb104cb6">no</ix:nonFraction> impairment charges on any intangible assets other than the goodwill impairment charges discussed in Note 10.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idffe82f5884041f796664fc9a63fdef1" continuedAt="i044221ce3fa94046a808157935620309"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwODk_e1216892-231f-4af2-81c5-cd049977a41b" continuedAt="iae7baf4b4b2c44daa3289efc499642c6" escape="true">Scheduled amortization expenses from amortizable intangible assets as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwNTk_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwNTk_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric> were as follows:&#160;</ix:nonNumeric></ix:continuation></span></div><div style="padding-left:27pt"><ix:continuation id="i044221ce3fa94046a808157935620309"><ix:continuation id="iae7baf4b4b2c44daa3289efc499642c6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"><tr><td style="width:1.0%"></td><td style="width:37.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.032%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncompetition<br/>agreements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Customer relationships and other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzEtMS0xLTEtMA_c3a44973-419d-47b0-b74a-dfb6f6a82ead">10,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzEtMy0xLTEtMA_a0d850d7-6b64-41d4-9fe0-b4fc08756e88">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzItMS0xLTEtMA_6822643f-5ea4-48a9-853f-7190b018be1e">6,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzItMy0xLTEtMA_cdf6245b-d9d4-4fd3-8be1-0c61646d66f2">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzMtMS0xLTEtMA_d05b15db-9849-4e45-a3d4-57ba454607f8">3,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzMtMy0xLTEtMA_2b9c00c9-8308-494f-bf91-78ff8f8c8686">3,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzQtMS0xLTEtMA_e87e15da-9658-4a08-8f24-ec26dad7f94c">1,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzQtMy0xLTEtMA_a0c32055-ec57-4dfb-b32e-bb141b53e752">2,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzUtMS0xLTEtMA_d36a056f-37fc-436b-856b-d3316adca777">585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzUtMy0xLTEtMA_26f5d2f8-d4ee-4015-9ae0-8d2a05258926">2,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzYtMS0xLTEtMA_f35989e0-15f7-45b4-9950-9c17fe0e9ee3">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzYtMy0xLTEtMA_b70a8362-f0ea-4e0b-afa8-870204bec88b">28,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzctMS0xLTEtMA_ebfc291e-780a-4e11-8cc0-70ed8112f360">23,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzctMy0xLTEtMA_fdaeb9d0-029e-4b2c-8cf9-3f732315a7ca">43,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i878840fee65247deaca27d2dd6a8246f_223"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM3Mjk_4b5c37c5-3233-4451-86b1-a08357f46980" continuedAt="i67c62384254748baba4ba572af1cb7d1" escape="true">Equity method and other investments</ix:nonNumeric></span></div><ix:continuation id="i67c62384254748baba4ba572af1cb7d1" continuedAt="i5e47d5951abd4697a6f86ec819615b5a"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM3MzE_7aab3de8-a991-4411-bec7-bce021a751e8" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"><tr><td style="width:1.0%"></td><td style="width:56.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.611%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC joint venture</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if835180905f04b80823ceda1bcf614db_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzItMS0xLTEtMA_2967fb38-f23c-4cf2-b18d-a93faab5c9d9">120,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa907c146d64b698d6ea801e89b4f89_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzItMy0xLTEtMA_b1c3eac3-0c33-4dba-9459-49eb4d125f84">116,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other equity method partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6bf19e541046eb93c237e38a4905bc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzMtMS0xLTEtMA_bea6c6d8-ed0d-4fd7-aea5-12ab84965e6a">107,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1023bb732b9148d293570ccb2f49efc1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzMtMy0xLTEtMA_b05add6a-e802-49fc-957c-8d41935fd04b">114,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted cost method and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6f1bc577e6248d9aea0e2a4190a616a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzQtMS0xLTEtMA_0211e906-519c-4146-9c3e-e316c9a768de">29,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8edd1564071a44ce9689f85e2562bf1d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzQtMy0xLTEtMA_2b514395-2143-4803-874c-d89658966cdc">10,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzUtMS0xLTEtMA_d029879d-b959-4700-a364-32bcf9079eec">257,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzUtMy0xLTEtMA_bbb17cd4-6043-45e7-88fc-9a6c4069384b">241,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, the Company recognized equity investment income (loss) of $<ix:nonFraction unitRef="usd" contextRef="ieee6b2ebaa1a4e44884eb99babde1e22_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE0Njk_6f34aa70-f308-472f-a7bc-aa88c858a115">26,916</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iee2cd9df79914869b9cacc76ab090369_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE0NzM_c9786614-c03d-4f15-9669-9e8ddb94a119">12,679</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i176abd0dfd064576a6fca693618a4d85_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE0ODA_c71cc1f8-de49-4a66-a52b-c12cf0192a31">4,484</ix:nonFraction>), respectively, from its equity method investments in nonconsolidated businesses.&#160;</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's largest equity method investment is its ownership interest in DaVita Care Pte. Ltd. (the APAC joint venture, or APAC JV). The Company holds a <ix:nonFraction unitRef="number" contextRef="i743f6eba826d4df9965c6fe5e996c814_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE5ODk_fa22833c-de79-4223-8906-1b974a6e738a">75</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voting and economic interest in the APAC JV and an unrelated noncontrolling investor holds the other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="if835180905f04b80823ceda1bcf614db_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzIwODI_0b0ba8a1-3c9c-4ed5-bf15-b7bd3121635a">25</ix:nonFraction>% voting and economic interest in the joint venture. During 2019 the continuing third party noncontrolling investor made its final subscribed capital contribution to the joint venture and the other previous third party noncontrolling investor elected to exit the joint venture. The governance structure and voting rights established for the APAC JV, which remain unchanged since its formation on August&#160;1, 2016, provide that certain key decisions affecting the joint venture&#8217;s operations are not subject to the unilateral discretion of the Company but rather are under the joint control of the Company and the APAC JV's unrelated noncontrolling investor. As a result, the Company does not consolidate the APAC JV.</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the transactions described above, the Company held a <ix:nonFraction unitRef="number" contextRef="iff2c6d1977b942e7a9758284e817d55c_I20181231" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI2MDY_593dbf93-4455-4d47-91cd-83615f50794d">60</ix:nonFraction>% voting interest and a <ix:nonFraction unitRef="number" contextRef="ib7a1644379314e62bdaab27a9dfd42f2_I20181231" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI2MzE_097c4c22-65a8-409a-b915-5f2fd1de40d5">73.3</ix:nonFraction>% economic interest in the APAC JV, while the other two noncontrolling investors collectively held a <ix:nonFraction unitRef="number" contextRef="ib7a1644379314e62bdaab27a9dfd42f2_I20181231" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI3MzM_56c7fdb3-030f-44a0-bd17-cc4137b3502a">40</ix:nonFraction>% voting interest and a <ix:nonFraction unitRef="number" contextRef="ib7a1644379314e62bdaab27a9dfd42f2_I20181231" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI3NTg_e67dab7c-4095-456a-9abd-f1d7b22f8f96">26.7</ix:nonFraction>% economic interest in the APAC JV. </span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other equity method investments include <ix:nonFraction unitRef="number" contextRef="iadefb36dac0a43168cf91c594bc2b46d_I20201231" decimals="INF" name="dva:NumberOfPartnerships" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzMyNzY_1177beb1-617d-41fd-8278-516f23ca8ce7">22</ix:nonFraction> legal entities over which the Company has significant influence but in which it does not maintain a controlling financial interest. Almost all of these are U.S. dialysis partnerships in the form of limited liability companies. The Company's ownership interests in these partnerships vary, but typically range from <ix:nonFraction unitRef="number" contextRef="ic8d3af328249451ea7b48056f3f531e0_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM1ODQ_539e64da-1c87-4882-9dae-1c4dfd3fa9bf">30</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id5952bbd67214b9a90b15f0edf9153a2_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM1OTA_4b27e178-165d-4b27-918c-31da5dc2625e">50</ix:nonFraction>%.</span></div></ix:continuation><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5e47d5951abd4697a6f86ec819615b5a">There were <ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM2MDU_7f69a817-98a7-4f89-a3c2-892b97ca290b">no</ix:nonFraction> significant impairments or other valuation adjustments on the Company's adjusted cost method and other investments during 2020, 2019 or 2018.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_229"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU5MDE_d1e5ff2f-e3f7-4333-8465-3481d214283a" continuedAt="i43f64610233340a69913ba9286dcf0fa" escape="true">Goodwill</ix:nonNumeric></span></div><ix:continuation id="i43f64610233340a69913ba9286dcf0fa" continuedAt="iad34147595914c60bb662143cef70668"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU5MDI_a204c155-fc0f-40aa-89e7-f60f65c31ef3" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:40.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other - Ancillary<br/>services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5831886c34dd408a8ed406190748f295_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEtMS0xLTEtMA_d620e37e-7aee-47c1-b0b4-c600dcbe4543">6,275,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54da9f2132a4f749e030ac9e3e0c618_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEtMy0xLTEtMA_4cdb3ee5-8e94-445b-b3af-5a4a766eed6c">566,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEtNS0xLTEtMA_daefd641-cf43-49d0-ad5a-1f495b0ad6dc">6,841,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzItMS0xLTEtMA_b179964a-1735-488c-af2c-79a4206ce6e9">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzItMy0xLTEtMA_e11ef2ae-14d5-4187-a3e0-19ad0cbe8f5c">72,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzItNS0xLTEtMA_a4feedea-8cb4-419c-b45a-6757dd32ff4e">90,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzQtMS0xLTEtMA_6f55d9df-68c2-41a7-b4d5-a6f00bce2796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzQtMy0xLTEtMA_27fb1c10-7b61-4ba3-a72b-2f11ffb5d164">124,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzQtNS0xLTEtMA_5c114a79-56b1-40d4-8962-92245f0a1a1b">124,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzUtMS0xLTEtMA_cd136df0-27e2-463b-b265-6369b30eb62d">5,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzUtMy0xLTEtMA_d90fe305-8d4b-440f-b176-b24c70d32f8c">13,666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzUtNS0xLTEtMA_4a5488ed-c85a-413c-82f5-91160fccfec4">19,659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if638379c314e4e40a080f1df9bc6d4eb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzYtMS0xLTEtMA_2edb226d-94c6-45ab-9d00-2072214df2c8">6,287,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzYtMy0xLTEtMA_70d2fde5-12cd-4ec0-a3cf-bb2396e9cc05">500,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzYtNS0xLTEtMA_fedc5ee3-309a-4474-810b-ed5aba4080a3">6,787,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMS0xLTEtMA_a29ac83e-51dd-4210-8f41-abc94830e292">24,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMy0xLTEtMA_2b973645-34ca-4d55-a105-448e5b4f60ea">105,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctNS0xLTEtMA_c4825629-0349-4daf-922b-60bc7134c2b5">130,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMS0xLTEtMTUxMjM_54851f96-d3ec-467e-9c46-0d10a82c130d">1,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMy0xLTEtMTUxMjM_f8455fe9-993b-4045-90ed-0fff0098dd87">6,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctNS0xLTEtMTUxMjM_6d4c0ddf-3a4d-4755-9b84-64e93e282b7c">8,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzktMS0xLTEtMA_927ea38a-92bc-4786-965e-803cd984fc98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzktMy0xLTEtMA_52eb0aa4-7b59-4389-a600-b6b6c5d0ff1c">9,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzktNS0xLTEtMA_4f66b79c-583d-4595-8301-f5e2399847b9">9,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEwLTEtMS0xLTA_8b98b836-e487-4897-abc3-7aef9992b907">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18749a859234cf7b23652f60c460caf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEwLTMtMS0xLTA_f3e16c34-eb4c-4971-a6a6-f38baedbca25">609,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEwLTUtMS0xLTA_4ef13933-cca2-4b32-acd1-511902beac3f">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEyLTEtMS0xLTA_8cf980ea-dd78-4ed1-9722-20cd49cfc212">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18749a859234cf7b23652f60c460caf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEyLTMtMS0xLTA_6ffdf38f-2764-43e2-ace1-2d7cbc5dd1cc">745,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEyLTUtMS0xLTA_354a7d9c-8de7-4678-a1ec-22f5aebc9366">7,055,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEzLTEtMS0xLTA_bbab387e-30e5-44a8-b812-6e4eb8a9404e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18749a859234cf7b23652f60c460caf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEzLTMtMS0xLTA_d5fbb82b-5097-47fb-b272-c83d24c7f7d4">136,551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEzLTUtMS0xLTA_e71923c9-1a75-46aa-ba37-62ae28520907">136,551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzE0LTEtMS0xLTA_dd311407-71d6-47e1-b19b-9482d6a3738e">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18749a859234cf7b23652f60c460caf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzE0LTMtMS0xLTA_8d003d7e-f4d9-4039-843d-98411e3006b6">609,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzE0LTUtMS0xLTA_682507b6-9d69-4cb0-b409-22ebbca62653">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic, further spread or resurgence of the virus, including as a result of the emergence of the new strains of the virus, its impact on the chronic kidney disease (CKD) patient population and the Company's patient population, the availability, acceptance, impact and efficacy of COVID-19 treatments, therapies and vaccines, the pandemic's continuing impact on the U.S. and global economies and unemployment, the responses of the Company's competitors to the pandemic and related changes in the marketplaces, and the timing, scope and effectiveness of governmental responses. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company&#8217;s operating segments described in Note 25 to these consolidated financial statements represents an individual reporting unit for goodwill impairment assessment purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the U.S. dialysis operating segment, the Company considers each of its dialysis centers to constitute an individual business for which discrete financial information is available. However, since these dialysis centers have similar operating and economic characteristics, and the allocation of resources and significant investment decisions concerning these businesses are highly centralized and the benefits broadly distributed, the Company has aggregated these centers and deemed them to constitute a single reporting unit.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has applied a similar aggregation to the physician practices in its physician services reporting units, to the dialysis centers and other health operations within each international reporting unit, and to the vascular access service centers in its former vascular access services reporting unit. For the Company&#8217;s other operating segments, discrete business components below the operating segment level constitute individual reporting units.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing quantitative goodwill impairment assessments, the Company estimates fair value using either appraisals developed with an independent third party valuation firm which consider both discounted cash flow estimates for the subject business and observed market multiples for similar businesses, or offer prices received for the subject business that would be acceptable to the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2019, the Company recognized goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="ib5c4935b96bc45d599d29d673dc708b8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzEwOTk1MTE2MjkwMzgx_dd646613-ac45-4e70-b97e-3c1b5824bbfd">119,476</ix:nonFraction> in its Germany kidney care business. These charges resulted primarily from a decline in then current and expected future patient census and an increase in then current and expected future costs, including due to wage increases expected to result from legislation announced at that time. The changes in the Company's expectations were informed by developments in the business in response to evolving market conditions, including changes in the Company's expected timing and ability to mitigate them, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iad34147595914c60bb662143cef70668"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and based on in-depth operating and strategic reviews completed by the Company's new Germany management team. During the year ended December&#160;31, 2019 the Company also recognized a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ic3604fec36844df58062ea76e02219c2_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzMzMDE_1ef47728-ec18-4080-ba74-de528040d91f">5,416</ix:nonFraction> in its German other health operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its most recent assessments, the Company determined that further changes in expected patient census, increases in operating costs, reductions in reimbursement rates, changes in actual or expected growth rates, or other significant adverse changes in expected future cash flows or valuation assumptions could result in goodwill impairment charges in the future for the following reporting unit, which remains at risk of goodwill impairment as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzQyNjc_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzQyNjc_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>:</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU5MDg_66bee413-8086-4be7-85a2-e02096a26c41" escape="true"><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.660%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reporting unit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Goodwill<br/>balance</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">coverage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sensitivities</span></td></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany kidney care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2f082dee6464c25915568ecfd2d5672_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItMi0xLTEtMA_7dfcd12f-1311-4eda-99db-b6e7fd455788">322,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2f082dee6464c25915568ecfd2d5672_I20201231" decimals="3" name="dva:ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItNC0xLTEtMA_0ed0b1aa-d92d-4da0-a5d7-c2124ab6490c">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic2f082dee6464c25915568ecfd2d5672_I20201231" decimals="3" name="dva:PotentialImpactOnFairValueForReductionInOperatingIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItNi0xLTEtMA_6206cfbe-dabb-4789-96c1-f936716d442e">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2bf9f1c0751e45cb82db545fe4859306_D20200101-20201231" decimals="3" name="dva:PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItOC0xLTEtMA_43d6ce4e-6c80-4eae-a118-03c62ff04bed">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of a sustained, long-term reduction of <ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzQ0Njk_6d9325df-53e2-4274-a977-80eb448b4dfd">3</ix:nonFraction>% in operating income as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described above, <ix:nonFraction unitRef="segment" contextRef="i910ed57bdfbe40edaf7a7ec74018eace_D20200101-20201231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzUzNDc_8073fa2a-9f18-4c82-aa99-6288ac1fe04d">no</ix:nonFraction>ne of the Company&#8217;s other reporting units were considered at risk of significant goodwill impairment as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU0NTQ_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU0NTQ_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>.&#160;Since the dates of the Company&#8217;s last annual goodwill impairment assessments, there have been certain developments, events, changes in operating performance and other changes in key circumstances that have affected the Company&#8217;s businesses. However, these have not caused management to believe it is more likely than not that the fair values of any of the Company&#8217;s reporting units would be less than their respective carrying amounts as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU4OTc_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU4OTc_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_235"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90ZXh0cmVnaW9uOjcwMGMwZGQ5M2E4MTRkYjE4NGI4MDUzNDkzOWRjNmEzXzg2_e354d92a-c8c7-4d3a-8ae1-4c894d90b3e3" continuedAt="ia80da1f48bf44c94a4f9b7b3a617010e" escape="true">Other liabilities</ix:nonNumeric></span></div><ix:continuation id="ia80da1f48bf44c94a4f9b7b3a617010e"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:OtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90ZXh0cmVnaW9uOjcwMGMwZGQ5M2E4MTRkYjE4NGI4MDUzNDkzOWRjNmEzXzgy_273ed8a0-2d32-44e4-9592-511359704bfc" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"><tr><td style="width:1.0%"></td><td style="width:51.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor refunds and retractions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:PayorRefundsAndRetractions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzItMS0xLTEtMA_92d94785-c071-4fb8-ad25-3906b72b03be">371,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:PayorRefundsAndRetractions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzItMy0xLTEtMA_4d1aa72e-5b2c-4dec-942e-5335fbd52126">377,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance and self-insurance accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedInsuranceCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzMtMS0xLTEtMA_ce3e94fc-b5fa-400e-ba05-eaf87367699b">54,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedInsuranceCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzMtMy0xLTEtMA_d8244e88-9ee3-4d2c-ad2f-6738fc72ef53">58,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzQtMS0xLTEtMA_eb102d03-b669-4ec1-a6ec-07a1cfbb18f1">30,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzQtMy0xLTEtMA_9b4cb75c-ce5d-41fe-8da4-2b63eff4bcbb">54,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued non-income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzUtMS0xLTEtMA_d9bfd2c4-38d8-443e-bc2c-4b5d74497ee9">39,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzUtMy0xLTEtMA_a5d7f964-195a-4260-b38e-7d26b86fd961">36,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzYtMS0xLTEtMA_753c4516-abd9-47ac-a50c-352ca0bccf91">315,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzYtMy0xLTEtMA_994b2936-25c4-49f2-a202-3f18b4cdc1c3">229,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzctMS0xLTEtMA_9daa627c-0fbc-4ff8-aa1d-793581f26cf8">810,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzctMy0xLTEtMA_c4fba4f5-99dc-4458-965d-e02d54ffeca8">756,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_238"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzQwMDc_42fea31c-f530-43ea-b547-512e28d60f14" continuedAt="i7582a822af5a49b0a89e2923ff3b6b2d" escape="true">Income taxes</ix:nonNumeric></span></div><ix:continuation id="i7582a822af5a49b0a89e2923ff3b6b2d" continuedAt="ifafb8d702ba94ce59dfe22bbe75dd270"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i42b820e0c9454b70856426af70a2e5ab">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</ix:continuation></span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5OTI_41afc483-7a44-4650-938d-1746c1ff5207" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes from continuing operations consisted of the following:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:37.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzItMS0xLTEtMA_a2fe4604-eb18-4927-9b13-e36555012095">1,287,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzItMy0xLTEtMA_930dbf93-15fd-4efd-8bbb-4c55524a2390">1,307,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzItNS0xLTEtMA_e37b5595-3e96-45b7-a6cc-015c7f400c3d">1,083,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzMtMS0xLTEtMA_466f683c-35cf-4e09-a95f-00daaec6ef0a">30,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzMtMy0xLTEtMA_c9675f81-eee1-4155-96ef-3b463c383e88">111,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzMtNS0xLTEtMA_094a6c89-e72c-4489-ad69-775adeec6a66">35,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzQtMS0xLTEtMA_085d9b92-f959-4a97-bd1f-9781aca3c4d6">1,318,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzQtMy0xLTEtMA_7606672d-c679-4d5d-84b4-407b938cf447">1,195,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzQtNS0xLTEtMA_75e15528-1e95-424e-8d24-e1592b8118c2">1,048,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ifafb8d702ba94ce59dfe22bbe75dd270" continuedAt="i81b1e0f2c92e466783e0f0a60c9e4175"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzQwMTU_3c705540-67cb-44b4-99fd-3e01b33224e8" continuedAt="i123f851aedb2490a95e8238cb7e8c877" escape="true">Income tax expense for continuing operations consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:27pt"><ix:continuation id="i123f851aedb2490a95e8238cb7e8c877"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:37.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzMtMS0xLTEtMA_2ef3dd7b-50a2-43b7-8da2-87b45cda732e">47,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzMtMy0xLTEtMA_ca48bdce-56e7-41e0-8d92-7c3e65d5e18e">208,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzMtNS0xLTEtMA_f852d681-bf83-4b42-bd2c-175045fd308d">140,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzQtMS0xLTEtMA_c3ac8ade-ca05-4424-bc46-f27ac6048309">21,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzQtMy0xLTEtMA_4b0e11d6-c513-4589-a9e5-6c9cc1e38183">58,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzQtNS0xLTEtMA_8a532e22-bc8f-4e8a-9f2d-2bd2d24ee6f5">32,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzUtMS0xLTEtMA_7bc5dca0-91e1-448e-ab3f-799e4d7d49ae">17,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzUtMy0xLTEtMA_b2c328bc-7e83-4a3a-bdbd-be38cb3a69f3">15,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzUtNS0xLTEtMA_ada5eb96-dee5-4143-9d9f-b26d1f362b9d">7,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzYtMS0xLTEtMA_09a9b35e-7b45-4914-bdcd-fd3359151b4a">86,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzYtMy0xLTEtMA_7687fbcf-d2af-4627-afae-495d20513a43">281,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzYtNS0xLTEtMA_281dd21e-fb4c-47a1-bdbb-368a56db4633">180,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzgtMS0xLTEtMA_27a31843-9501-40ba-9769-be77b00459d3">198,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzgtMy0xLTEtMA_3cc4b1db-fc0b-4a76-9c7b-8cebca6aa24a">44,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzgtNS0xLTEtMA_8423b599-8533-4ca1-b51b-8d75fc9099ae">52,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzktMS0xLTEtMA_f9f32633-ebb3-478f-b68e-bb10026f6120">27,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzktMy0xLTEtMA_aa7c86de-c912-4399-a348-9125df4e57bb">25,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzktNS0xLTEtMA_5034a801-9838-4d22-9c6d-da34f2ca5f93">21,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEwLTEtMS0xLTA_ee5c9ec5-10f1-4628-a899-d8912de08116">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEwLTMtMS0xLTA_992688d8-77e7-4776-af2d-41da0f8528d3">20,709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEwLTUtMS0xLTA_4add9135-99f2-47d0-b382-2a9876cbf062">4,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzExLTEtMS0xLTA_13073fff-d3c6-4028-9bcb-8c08370ea694">227,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzExLTMtMS0xLTA_9a427160-4bee-466f-ac27-bc34b05b5c9e">2,282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzExLTUtMS0xLTA_31bc6be6-9254-4ca7-8ce3-483be127933b">77,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEyLTEtMS0xLTA_74485c24-e96d-4e2c-a53c-72ff19f7dc9f">313,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEyLTMtMS0xLTA_9775e6e8-7254-4d6f-8a57-a6cf41fcb770">279,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEyLTUtMS0xLTA_5389540e-bf18-4054-8907-649633d1b936">258,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzQwMTA_9663e62a-3f40-4939-b9c6-995891b5ab9f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are allocated between continuing and discontinued operations as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:37.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzItMS0xLTEtMA_aebd8a95-7582-41f8-8c42-81ffb0099c92">313,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzItMy0xLTEtMA_4f195c3a-9d94-431f-b5ce-26e2fe88d7c5">279,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzItNS0xLTEtMA_25ae73c4-56c1-447d-a512-99adde3f45ab">258,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzMtMS0xLTEtMA_ec0ac095-9130-4e9c-ad70-43633781197a">1,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzMtMy0xLTEtMA_71b7a687-d05d-4378-a2a9-1c7beb659b5d">40,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzMtNS0xLTEtMA_a01980b8-8da6-4eb0-bed6-e208ded62463">99,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzQtMS0xLTEtMA_a6f31475-727e-4c7c-bf7f-59c62fc61791">315,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzQtMy0xLTEtMA_035f99ca-c8d3-4115-924a-d6566086cb5d">320,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzQtNS0xLTEtMA_c2baed55-7443-413f-af4a-5ccffea16ec8">358,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5OTE_ebadacc4-b877-4ae0-9d34-7e530dd3aad4" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the Company&#8217;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"></td><td style="width:49.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzItMS0xLTEtMA_da1c93ef-db7a-4124-97c7-5698f98c4e1d">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzItMy0xLTEtMA_5e1264f0-0862-4e2d-80ef-257e94bc31c0">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzItNS0xLTEtMA_1876dcb9-65c3-4387-8374-525b4d6c9cac">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzMtMS0xLTEtMA_2acda22a-e6a3-406b-bb05-069e9c6990fb">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzMtMy0xLTEtMA_d1322fe3-3c4a-4c84-8747-4f017e62e041">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzMtNS0xLTEtMA_549a8eee-d934-41a5-bc78-8518cdb2832d">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in International valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzQtMS0xLTEtMA_2fd8dbde-5efe-4a2d-9631-5b7d51e75dfa">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzQtMy0xLTEtMA_68be324f-645e-4bff-aa34-4f5922916440">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzQtNS0xLTEtMA_b6edfc6e-0904-4435-97a0-bd806481ef97">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Political advocacy costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzYtMS0xLTEtMA_1944df51-aed9-461b-9460-4c8c70491a80">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzYtMy0xLTEtMA_6dab0b7c-37d2-46e9-9b7d-9613d112590d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzYtNS0xLTEtMA_44f22ddd-74e9-4d12-bdab-e9d2962a8121">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" name="dva:EffectiveIncomeTaxReconciliationInvestmentImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzctMS0xLTEtMA_b89f689c-a578-4e72-8b08-087f98b7f423">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" name="dva:EffectiveIncomeTaxReconciliationInvestmentImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzctMy0xLTEtMA_047f8b4b-7902-4a89-87c9-94883d7126a9">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" name="dva:EffectiveIncomeTaxReconciliationInvestmentImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzctNS0xLTEtMA_d6c6a5d6-cdfa-4645-b9d1-88d26c2cbddf">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzktMS0xLTEtMA_86a63d1b-c804-4d16-9484-d173759f7955">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzktMy0xLTEtMA_f5fabf08-6024-4118-bb98-6c17e5206fff">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzktNS0xLTEtMA_663442ad-056b-4c99-a63a-e47310a4100b">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEwLTEtMS0xLTA_9c78363c-82e9-4c2b-b6c7-c7d547899109">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEwLTMtMS0xLTA_7fb0ca69-0308-4e10-8a91-d57a8a9533df">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEwLTUtMS0xLTA_a0973c3d-12fa-4705-a945-a6fffbb15323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests primarily<br/> attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzExLTEtMS0xLTA_bc530b72-f640-4abd-8b7b-726bf3c3099e">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzExLTMtMS0xLTA_55448c37-ea80-41a3-9582-d40491291203">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzExLTUtMS0xLTA_6cbab914-464c-4d7d-80bb-837ff25bafde">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEyLTEtMS0xLTA_f866870c-b5f2-4281-ab96-7253089dff1d">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEyLTMtMS0xLTA_5e2df137-cce8-48a2-88e1-e3a0fe516eeb">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEyLTUtMS0xLTA_ab289d3e-9a41-43a1-97ea-ed46f0761ae9">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i81b1e0f2c92e466783e0f0a60c9e4175" continuedAt="i48d577aaf7d2477aa990a618be5c0bf0"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5ODg_2ab10d05-88ed-4a48-bb24-5617cea49546" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:54.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.389%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DeferredTaxAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzItMS0xLTEtMA_5369d9f4-659f-447e-80ab-5f317e8be2d4">9,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DeferredTaxAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzItMy0xLTEtMA_470255ce-f3bc-4868-a01d-408623566a8c">19,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzMtMS0xLTEtMA_8013fabe-f2cb-45de-a309-30aff875fe5e">64,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzMtMy0xLTEtMA_ae6e60ce-2ce0-4402-aba2-57dc6b2a4cf3">64,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DeferredTaxAssetsOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzQtMS0xLTEtMA_11903ec4-77ff-46dd-9850-44f4ec8ff8ef">584,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DeferredTaxAssetsOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzQtMy0xLTEtMA_6e41fb6b-e014-4525-ba02-8e6b31b26407">580,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzUtMS0xLTEtMA_677c6b3f-efc0-4a5c-863b-ef454b45d83c">167,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzUtMy0xLTEtMA_c3628edc-9af6-4dee-ac5e-b2d0948b0b54">139,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzYtMS0xLTEtMA_3b9a810c-2e7a-42dd-b6e3-10acb3c89d76">62,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzYtMy0xLTEtMA_f0509cb6-6dc5-4761-935a-134a9980c990">55,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzctMS0xLTEtMA_05896772-dae4-48aa-9b7e-8f43556902a5">888,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzctMy0xLTEtMA_e1d61fc2-c9c4-4df9-bc79-1c8fdb0fff94">858,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzgtMS0xLTEtMA_70dcff37-610b-46fa-9cc0-f2c447500306">114,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzgtMy0xLTEtMA_295dba6e-60e6-4ebe-8f21-1e2f481658ca">91,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzktMS0xLTEtMA_5e77bbd2-0825-4fce-8bce-975dff0c7a7c">773,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzktMy0xLTEtMA_bee451b8-dc28-49a7-9ea4-fdd2c694c6bf">766,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEwLTEtMS0xLTA_9d0bfaf5-9470-45f5-aa97-25278c2e2dba">634,736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEwLTMtMS0xLTA_53e98f76-6039-4339-8b19-d1b3d3ba08d6">563,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzExLTEtMS0xLTA_2dfa0927-be88-4c3d-8442-5a65eccaebce">274,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzExLTMtMS0xLTA_052bd3d9-bc9f-469c-9a40-9d1565732d9c">162,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DeferredTaxLiabilitiesOperatingLeaseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEyLTEtMS0xLTA_97deeaf0-9e2e-498e-be16-476fd92f8b17">532,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DeferredTaxLiabilitiesOperatingLeaseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEyLTMtMS0xLTA_dbdc6556-b5d1-4e75-9b30-523ae33cdfda">527,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEzLTEtMS0xLTA_7717608b-d95b-4bf5-b3ce-e75169596d06">101,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEzLTMtMS0xLTA_d60e01b2-6e3c-4f5a-93dc-e54f4f09d017">64,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE0LTEtMS0xLTA_53db90a7-bb33-40ab-ac0a-b9ac51fa0466">39,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE0LTMtMS0xLTA_b7d73382-f76f-4a7e-b2b1-014c6e2ce67c">25,521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE1LTEtMS0xLTA_968d6e79-e0f9-485a-9231-56dfa63e37fd">1,583,246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE1LTMtMS0xLTA_ca50d0ae-1a6f-41ab-a210-c47689924cf6">1,344,079</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE2LTEtMS0xLTA_a7c058ce-a604-415c-b109-f14a480e71c6">809,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE2LTMtMS0xLTA_52f513f0-07cf-49ca-a08f-3cf8abd5107f">577,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;At December&#160;31, 2020, the Company had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="id62f30525c6a45a4b19b99409e8b6a62_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzE2NzQ_e88ad6c9-5bb0-4b18-986f-3a533e8bb847">99,657</ix:nonFraction> that expire through 2036, although a substantial amount expire by 2029. The Company also had state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ia93e30cc7514476e83496bdfc4e18ffb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzE4MDg_5ec2fe29-442f-4114-9ae4-c31a594fc74b">488,070</ix:nonFraction>, some of which have an indefinite life, although a substantial amount expire by 2040 and international net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="if485fd70c4f140e5a792e18f8695f7b3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzE5NDg_f2622899-1b7c-48d3-8f3b-35a2751163bc">296,451</ix:nonFraction>, some of which will begin to expire in 2021 though the majority have an indefinite life. The Company has a state capital loss carryover of $<ix:nonFraction unitRef="usd" contextRef="idec8d246ff474a11befdb8bf8dc561ab_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzIwODA_018fad44-648b-43ce-bf1d-9df6f88b72c4">297,748</ix:nonFraction>, the majority of which expires in 2024. The utilization of a portion of these losses may be limited in future years based on the profitability of certain entities. A valuation allowance is recorded to account for the unrealizable balances in the table above. The net increase of $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzIzMzY_be680913-6608-42fa-ad3c-6df04345e831">22,899</ix:nonFraction> in the valuation allowance is primarily due to newly created net operating loss carryforwards in state and foreign jurisdictions that the Company does not anticipate being able to utilize.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's foreign earnings continue to be indefinitely reinvested as of December&#160;31, 2020. As a result of the passage of the Tax Cuts and Jobs Act (2017 Tax Act), the Company does not expect such earnings to be taxable if remitted.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unrecognized tax benefits</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5OTU_15423dfa-f9fc-46ce-b4ea-1dfd6ad78c39" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"></td><td style="width:61.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.250%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzItMS0xLTEtMA_26b43db1-980f-4477-a211-4863c05ec624">68,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzItMy0xLTEtMA_c8f76c9f-ee3a-45d6-9ab7-aab305f0b4b7">40,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzMtMS0xLTEtMA_f3a4bb0c-06f0-42ab-86af-5a9af2e0c4f5">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzMtMy0xLTEtMA_f991c5b4-c4b4-464a-b776-fd989f6acc18">3,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzQtMS0xLTEtMA_84fcb656-625c-4c03-b438-234fbb78e730">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzQtMy0xLTEtMA_87d33b2e-40ca-41c0-b25f-f956a491c9d3">24,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions related to lapse of applicable statute</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzUtMS0xLTEtMA_992290c2-1dd7-4794-b8ae-2ae3c8373ee2">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzUtMy0xLTEtMA_374bb265-b7b2-4d66-a212-8af069e7079d">268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzYtMS0xLTEtMA_0efee740-10c1-42b5-b7ca-95147f6cce43">430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzYtMy0xLTEtMA_a14f40b3-d77d-4e1b-ad0b-8bb9c934a1bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzctMS0xLTEtMA_e980add4-e593-40ad-b25a-a9e3217ff4d3">70,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzctMy0xLTEtMA_26b43db1-980f-4477-a211-4863c05ec624">68,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company&#8217;s total liability for unrecognized tax benefits relating to tax positions that do not meet the more-likely-than-not threshold is $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMwNTY_233dc498-5929-4397-970e-4458dfa1bc82">70,202</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMwNjk_9dc6ff2f-3036-463c-b38e-8919fc162b94">66,607</ix:nonFraction> would impact the Company&#8217;s effective tax rate if recognized. This balance represents an increase of $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMxNjM_c9c47b71-4ee2-4f3b-b893-9a72a095cfe4">1,988</ix:nonFraction> from the December&#160;31, 2019 balance of $<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMxODk_83aaf8d4-8e5d-4d76-8873-aca11c908e03">68,214</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. At December&#160;31, 2020 and 2019, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM0MjA_80b621bd-34d6-475c-8c94-5375f4596af7">17,864</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM0Mjc_6a600f76-4912-4276-bade-8dc500ca4cc1">14,428</ix:nonFraction>, respectively, accrued for interest and penalties related to unrecognized tax benefits, net of federal tax benefit.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i48d577aaf7d2477aa990a618be5c0bf0">The Company and its subsidiaries file U.S. federal and state income tax returns and various foreign income tax returns. The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2014 and 2009, respectively. In addition to being under audit in various state and local tax jurisdictions, the Company&#8217;s federal tax returns are under audit by the Internal Revenue Service for the years 2014-2017.</ix:continuation></span></div><div id="i878840fee65247deaca27d2dd6a8246f_244"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTYz_5645d9ca-f9e1-48e8-9aba-1556220a8186" continuedAt="i59f69eacd09c49589f351da98efd8dc5" escape="true"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTY4_4e021d35-803a-44de-9617-c7f4449e8d5b" continuedAt="i1713e65f38f0463fb930b1f91473be9b" escape="true">Long-term debt</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i59f69eacd09c49589f351da98efd8dc5"><ix:continuation id="i1713e65f38f0463fb930b1f91473be9b" continuedAt="i842c6b149e1446b0a64fab6b19436077"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:34.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286706e9b0964d8cbb75adb2d5340592_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtMS0xLTEtMA_a1673b07-90de-44c4-a10b-b949a459adb4">1,684,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i250b8e686fbb4a0eb1114ccbc4b5e9c3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtMy0xLTEtMA_e78f9993-76b4-4d43-8fa5-39f1d54b738b">1,739,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtNS0xLTEtMA_9b3be8f5-0f7a-4cb4-aa9f-a4049e7b182d">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtNy0xLTEtMA_f3b80018-c44c-49cb-8645-fbc6b17e7f3c">LIBOR + 1.50%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286706e9b0964d8cbb75adb2d5340592_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtOS0xLTEtMA_7f3e976e-4824-4213-b5a3-e6b800f6cf1c">1,675,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52324c1dc24d4d8b859c1369fb83eb5d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtMS0xLTEtMA_8f36e883-338c-4518-b4a2-7ab4395d2e63">2,715,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dcd17ac6da84bfca13be11407dd097e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtMy0xLTEtMA_f4380b40-a411-43f6-8c16-ea9466f1de12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtNS0xLTEtMA_62d160fe-077d-4cfa-915e-39a63dda7068">8/12/2026</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtNy0xLTEtMA_569c1b61-c33f-4f4b-ab1e-37987f3fc334">LIBOR + 1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52324c1dc24d4d8b859c1369fb83eb5d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtOS0xLTEtMA_60648622-c84d-4bc0-9ac7-1ef933d0cd92">2,702,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if381450d87824e869bf60a18db4c6586_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzUtMS0xLTEtMA_a7f31105-5ce8-439e-90b0-bb5051fa2d82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a345c6e30c94176b6d3453a7fbf6e28_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzUtMy0xLTEtMA_dfca8004-26de-4214-943f-6f30ed9550db">2,743,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70dcb1ea14854f37b5aeb6d646b2e0f9_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzUtNS0xLTEtMA_8f8484c6-fd69-48a5-a806-b729c159cf24">8/12/2026</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtMS0xLTEtMA_5b7e9f21-e94c-446d-8955-02bd28f5c8af">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10592b24a7d94ae2bbaa1ef42f4ed1a8_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtMy0xLTEtMA_56b05705-2945-472d-a491-236fef686b2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f85fe5578d64f21b789dbb1d9ab19ba_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtNS0xLTEtMA_9adc06c2-8d26-4186-bc91-33acddb21e57">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f85fe5578d64f21b789dbb1d9ab19ba_D20200101-20201231" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtNy0xLTEtMA_27eec104-fd12-4965-8284-f4ca8f8d02d0">ABR + 0.50%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtOS0xLTEtMA_8e7ef7fb-524f-41e2-bbee-cba789a63749">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5b049dd4b914f4ea5123c565a84fdeb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtMS0xLTEtMTAyNg_72faf7ef-fe1d-4e63-af99-0357bc0246ee">1,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a809ec49865440ca9f74653e3e59525_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtMy0xLTEtMTAyNg_17ae5053-2b54-41a0-819f-514d05cf5413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7394d13923fd428d9c2578d297562554_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtNS0xLTEtMTAyNg_96a0af88-7211-429f-b153-bacd14612e03">6/1/2030</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7394d13923fd428d9c2578d297562554_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtNy0xLTEtMTAyNg_3cdb9c0c-340e-431e-91c1-003dadd1d136">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5b049dd4b914f4ea5123c565a84fdeb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtOS0xLTEtMTAyNg_50234277-7187-4f77-b20c-2962974289b2">1,859,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4adb73272a42f5b8ce1b57a5c7617c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTEtMS0xLTA_7bf06eed-d80b-4329-a655-95263de3dd32">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefe49a72ad734e399a94074a044ba38e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTMtMS0xLTA_c3477acb-2864-416a-95f1-b8e566456d67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37d9e5736a9a43eea92eece9c7a70156_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTUtMS0xLTA_8db28f68-7ae0-42ec-9abc-21d3a7f4ce51">2/15/2031</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37d9e5736a9a43eea92eece9c7a70156_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTctMS0xLTA_d0a4584f-9b14-4766-8d14-a4b1e8ec6f9f">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4adb73272a42f5b8ce1b57a5c7617c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTktMS0xLTA_145d9381-aa3f-40e3-bcaa-65e4cfe2177b">1,522,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.125% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f563c4e28454aeb9d6c1ab26ac542f3_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzExLTEtMS0xLTA_9fb05dbd-2f08-4afd-8be6-4cc4d4fb58be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c63e5480b1f427bae9d35c3d385319a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzExLTMtMS0xLTA_12f4877f-f5ca-41ce-8686-0e6178317742">1,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i513c7b56b1594745a1ebb8321dbbfc57_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzExLTUtMS0xLTA_f98c6670-2c56-45cf-b223-12500920d5c8">7/15/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7040636942049efaf5dd11457035dfc_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEyLTEtMS0xLTA_8b1a6054-cc91-4a0a-806b-6aa6c4b8e65d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bef0b2f7a346219d36e58e1f35f48d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEyLTMtMS0xLTA_393d4d90-2461-46db-903f-3bb1ff56172c">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iacef66fccbd84dedacbd5a8f1b5e7b10_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEyLTUtMS0xLTA_7200f20a-590b-4283-8b53-54b65b96cc18">5/1/2025</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aa636c18275409199f124f364f5e504_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:AcquisitionObligationsAndOtherNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTEtMS0xLTA_c6e0cb0e-c1bc-49b4-9345-18d6bcdcf452">164,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18932cd78584f0cb719262f3f8eab08_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:AcquisitionObligationsAndOtherNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTMtMS0xLTA_d193678b-6766-4497-a919-827153eb1fc0">180,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6706bd8a691e4f01b5d9b858653eb878_D20200101-20201231" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTUtMS0xLTA_7646e398-080b-4318-a09a-8c256a54800e">2021-2036</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9aa636c18275409199f124f364f5e504_I20201231" decimals="INF" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTctMS0xLTA_67195e7b-bee7-4542-8107-4c01b75a8939">4.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aa636c18275409199f124f364f5e504_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:AcquisitionObligationsAndOtherNotesPayableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTktMS0xLTA_b0144ff9-88e8-422c-926f-646be3ae5b3b">164,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69633efe6f54a5fa84fd43f264fe79d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTEtMS0xLTA_3fa63900-0296-475b-90f9-1010fabbf835">274,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i856ad81a7b084214953762fad3fc3894_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTMtMS0xLTA_2b99c1ba-62a6-4af9-9d9c-115abeb9bad4">268,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a4f6b88319747d09864ee3399753c01_D20200101-20201231" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTUtMS0xLTA_a72b9c98-e00c-4ad0-bdce-40849ced1fc1">2021-2038</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic69633efe6f54a5fa84fd43f264fe79d_I20201231" decimals="INF" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTctMS0xLTA_53a7bb43-0c79-4269-9f56-1de9fd3f291f">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE1LTEtMS0xLTA_9e56e7f1-099e-4019-bd2e-86e2f2c3f4d5">8,163,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE1LTMtMS0xLTA_cf558d62-ac4d-4932-ac9c-61f9960f2c6e">8,181,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DiscountAndDeferredFinanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE2LTEtMS0xLTA_ec0971da-c151-4dec-a042-1135d0266d48">77,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DiscountAndDeferredFinanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE2LTMtMS0xLTA_2a0a90e0-2e11-4a66-a6db-0e70b6875728">72,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE3LTEtMS0xLTA_c7cbef77-b118-4205-b856-780e0cbf6d4d">8,085,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE3LTMtMS0xLTA_43d28473-39d3-44fc-8599-e9a22ab79053">8,108,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE4LTEtMS0xLTA_17380e09-7874-448e-9853-d0eb16b80fe0">168,541</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE4LTMtMS0xLTA_b9e28bce-ff9d-40f6-92df-2a316f4d73a0">130,708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE5LTEtMS0xLTA_c9ae2f06-7e3a-4c91-a50f-8bccbacb0f8b">7,917,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE5LTMtMS0xLTA_ca561f97-cea9-4617-acc4-5be98c3b0a95">7,977,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The Company's interest rate for its revolving line of credit as of December&#160;31, 2020 was based on an Alternate Base Rate (ABR or Prime Rate) plus <ix:nonFraction unitRef="number" contextRef="ie06b84976de74f0aa4c9de71c05d9548_D20201231-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwOTQ4_a46cbc98-b7d8-4dab-a669-c747a4f984c4">0.50</ix:nonFraction>%, or <ix:nonFraction unitRef="number" contextRef="ie06b84976de74f0aa4c9de71c05d9548_D20201231-20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTE3ODE_db19414c-93ea-47ef-9b65-920b5907c83a">3.75</ix:nonFraction>%. Effective January 6, 2021 this was converted to a LIBOR-based rate of LIBOR plus <ix:nonFraction unitRef="number" contextRef="i94c16909492241318308c8c001933088_D20210106-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwOTY3_c97ca54b-6419-4ab5-ace2-d3030d2fb4d6">1.50</ix:nonFraction>%. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2020.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities includes a discount of $<ix:nonFraction unitRef="usd" contextRef="ida75c1b36c22493e8c7e9267cf54a7aa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NDA_f8ade44d-7c75-4054-8736-3a09a178c9fe">5,461</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="ida75c1b36c22493e8c7e9267cf54a7aa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NDc_38e1a650-9893-4dd6-9ee9-81eb491824ca">35,825</ix:nonFraction> and the carrying amount of the Company's senior notes includes deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i8033f3e1736c4c5b95b3f8eefbe1406a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NTI_28c978db-8d4c-4571-a4c0-e074bdfc24e2">36,431</ix:nonFraction>. As of December&#160;31, 2019, the carrying amount of the Company's senior secured credit facilities included a discount of $<ix:nonFraction unitRef="usd" contextRef="icbb4bf191ef14070a5362746d88603e0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NTc_5bc5f051-1b42-4a4b-9a1b-bdaa2ad78cb7">6,457</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="icbb4bf191ef14070a5362746d88603e0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NjI_b6a32f74-f779-40df-8029-60bcdb342f92">45,444</ix:nonFraction>, and the carrying amount of the Company's senior notes included deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i34f522b31ed94ee9a22ac5be8888a7a7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5Njc_b77230b5-b3ae-4680-9f4b-47f9b71a5d68">20,939</ix:nonFraction>.</span></div></ix:continuation></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i842c6b149e1446b0a64fab6b19436077" continuedAt="ie2f0ffacab7f4169b72b385ee095dc0a"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTcx_f906c6ec-800a-4960-a948-d6dcf24d5935" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled maturities of long-term debt at <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzIzMTQ_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzIzMTQ_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric> were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"><tr><td style="width:1.0%"></td><td style="width:58.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzAtMS0xLTEtMA_c5a8300d-e1e3-4e98-84e0-ffaea0e490ba">168,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzEtMS0xLTEtMA_27916a1a-fac6-4e10-b261-1864ea109c8f">169,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzItMS0xLTEtMA_1d4e4d49-64c8-42d5-ac08-4f35657e6dc1">227,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzMtMS0xLTEtMA_7a543156-65d1-489c-81a8-9b0b0c125595">1,496,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzQtMS0xLTEtMA_d5152535-2d85-449a-8225-5d726896f3f9">69,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzUtMS0xLTEtMA_681cd4f5-9514-45e7-9488-6f28122ff61a">6,031,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i045e4836b7c044119912cf78d7ff47a9_D20200213-20200213" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentIssuanceDate1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3MDM_b19b6732-8a04-40a6-ab1c-dfcfb155dc89">February&#160;13, 2020</ix:nonNumeric>, the Company entered into an amendment (the Repricing Amendment) to refinance and reprice its senior secured Term Loan B with a senior secured Term Loan B-1 that bears interest at a rate equal to LIBOR plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i7314edaaf4ba4f878c3576d48795f7e4_D20200213-20200213" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3MTI_9809a4a3-8cf8-4d24-b33a-36e5243ea526">1.75</ix:nonFraction>% and matures on <ix:nonNumeric contextRef="i045e4836b7c044119912cf78d7ff47a9_D20200213-20200213" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3MzE_9e75f5dd-4ea0-424e-b74c-1b72fdc0967e">August&#160;12, 2026</ix:nonNumeric>. The Repricing Amendment did not change the interest rate on the Term Loan A or the revolving line of credit. <ix:nonFraction unitRef="usd" contextRef="i7e335188f31c48569623a8cbca6e9598_I20200213" decimals="-3" format="ixt-sec:numwordsen" name="dva:AdditionalDebtPrincipalAmountDueToRepricingAgreement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3Mzc_dcdcccbf-8553-4258-9259-c646a7280780">No</ix:nonFraction> additional debt was incurred, nor any additional proceeds received, by the Company in connection with the Repricing Amendment. The majority of the Company's Term Loan B debt was considered modified in this transaction. As a result, the Company recognized debt refinancing charges of $<ix:nonFraction unitRef="usd" contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtRefinancingCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3NTA_730ad8f8-9802-4c15-9371-2ce8fbf2ce21">2,948</ix:nonFraction> in the year ended December 31, 2020 comprised partially of fees incurred on this transaction and partially of deferred financing costs written off for the portion of debt considered extinguished and reborrowed. For the portion of the Term Loan B debt that was considered extinguished and reborrowed in this refinancing, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ic72d397e0f3e4b2891c3e57dbe084568_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3ODI_502a842f-7c00-4297-83ba-4200d19aae43">68,842</ix:nonFraction> in constructive financing cash outflows and financing cash inflows on the statement of cash flows, even though no funds were actually paid or received. Another $<ix:nonFraction unitRef="usd" contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3OTM_c8ed7060-7e81-4168-a732-71c06e2b9cd1">55,895</ix:nonFraction> of the debt considered extinguished in this refinancing represented a non-cash financing activity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $<ix:nonFraction unitRef="usd" contextRef="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4MDQ_08b77aa4-d121-4b12-a8a2-fe090ef00f1a">54,688</ix:nonFraction> on Term Loan A and $<ix:nonFraction unitRef="usd" contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4MTU_49090c21-f83d-406e-a6cc-2d9504f53728">27,431</ix:nonFraction> on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i36e1759fea1d4fe6be3ee89fad61189a_I20200609" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4ODQ_a6c36e13-ca60-4c0d-9163-f1d5ac8d03e1">1,750,000</ix:nonFraction> aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4OTQ_4cd0fd42-02af-4222-a560-948a645a8f69">4.625</ix:nonFraction>% senior notes due 2030 (the 4.625% Senior Notes) in a private offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 4.625% Senior Notes pay interest on June&#160;1 and December&#160;1 of each year beginning <ix:nonNumeric contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentDateOfFirstRequiredPayment1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5Mjc_6fd13ad1-cba1-47d0-8752-a112741dea34">December&#160;1, 2020</ix:nonNumeric>. The 4.625% Senior Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. The 4.625% Senior Notes are guaranteed by each of the Company&#8217;s domestic subsidiaries that guarantee its senior secured credit facilities. The Company may redeem up to <ix:nonFraction unitRef="number" contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5MzQ_c0334989-28e1-4665-805a-aab73d45f7ad">40</ix:nonFraction>% of the aggregate principal amount of the 4.625% Senior Notes at any time prior to June 1, 2023 at <ix:nonFraction unitRef="number" contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5NDU_c0381760-02bf-4bb7-bae8-a00597d8efd6">104.625</ix:nonFraction>% of the aggregate principal amount from the proceeds of one or more equity offerings, plus accrued and unpaid interest. In addition, the Company may redeem the 4.625% Senior Notes at any time prior to June 1, 2025 at a make-whole redemption price plus accrued and unpaid interest or, on and after such date, at certain redemption prices specified in the indenture governing these notes plus accrued and unpaid interest. The 4.625% Senior Notes contain restrictive covenants that limit the ability of the Company and its guarantors to, among other things, create certain liens, enter into certain sale/leaseback transactions, or merge, consolidate or sell all or substantially all of their assets. The 4.625% Senior Notes and related subsidiary guarantees do not have any registration or similar rights and are not expected to be registered for exchange on public markets. During the year ended December 31, 2020, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i36e1759fea1d4fe6be3ee89fad61189a_I20200609" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5NTY_077beb9e-b28b-47e2-ac5a-9608db128e8c">20,386</ix:nonFraction> in fees, discounts and other professional expenses associated with this transaction that were capitalized and will amortize over the term of the 4.625% Senior Notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2020, the Company used the net proceeds from these 4.625% Senior Notes, together with cash on hand, to redeem in full all $<ix:nonFraction unitRef="usd" contextRef="i60afbcc7ed1f4c10bc730c4a41fd1553_I20200715" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtInstrumentRedeemedOutstandingPrincipalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5OTM_d6ff5d21-78ad-47eb-884a-c50e7015801d">1,750,000</ix:nonFraction> aggregate principal amount outstanding of its <ix:nonFraction unitRef="number" contextRef="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwNTk3_4b112678-92ac-480e-820c-1ca96dafefd3">5.125</ix:nonFraction>% Senior Notes plus accrued interest and redemption premium. The Company incurred debt redemption premium charges of $<ix:nonFraction unitRef="usd" contextRef="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMDQ_a183b101-131d-454d-b8a5-63d7c9781a45">29,890</ix:nonFraction> and deferred financing cost write-offs of $<ix:nonFraction unitRef="usd" contextRef="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMTQ_3a0b6d67-355e-4a55-bf78-2596669b10bb">9,764</ix:nonFraction> in connection with this redemption.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i4577c6d1bfd84e039d738058c80d0d6f_I20200811" decimals="3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMjg_067a98fa-92e9-4925-ad15-119e50b0c7a0">1,500,000</ix:nonFraction> aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMzc_c9d24620-cbe7-469e-baae-a685381377d1">3.75</ix:nonFraction>% senior notes due 2031 (the 3.75% Senior Notes) in a private offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 3.75% Senior Notes pay interest on February&#160;15 and August&#160;15 of each year beginning <ix:nonNumeric contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentDateOfFirstRequiredPayment1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwNTg_6b8e4a57-29eb-4f64-8ce8-927bbdf63d45">February&#160;15, 2021</ix:nonNumeric>. The 3.75% Senior Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. The 3.75% Senior Notes are guaranteed by each of the Company&#8217;s domestic subsidiaries that guarantee its senior secured credit facilities. The Company may redeem up to <ix:nonFraction unitRef="number" contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwNjY_300e4676-5551-4bab-b650-7187aec94d36">40</ix:nonFraction>% of the aggregate principal amount of the 3.75% Senior Notes at any time prior to August 15, 2023 at <ix:nonFraction unitRef="number" contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwNzc_91f0271b-8819-4494-b688-0f2c13b636ae">103.75</ix:nonFraction>% of the aggregate principal amount from the proceeds of one or more equity offerings, plus accrued and unpaid interest. In addition, the Company may redeem the 3.75% Senior Notes at any time prior to February 15, 2026 at a make-whole redemption price plus accrued and unpaid interest or, on and after such date, at certain redemption prices specified in the indenture governing these notes plus accrued and unpaid interest. The 3.75% Senior Notes contain restrictive covenants that limit the ability of the Company and its guarantors to, among other things, create </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie2f0ffacab7f4169b72b385ee095dc0a" continuedAt="ia6620073f9dd4084993761a5d2a5ae96"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain liens, enter into certain sale/leaseback transactions, or merge, consolidate or sell all or substantially all of their assets. The 3.75% Senior Notes and related subsidiary guarantees do not have any registration or similar rights and are not expected to be registered for exchange on public markets. During the year ended December 31, 2020, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i4577c6d1bfd84e039d738058c80d0d6f_I20200811" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwODc_65c0e788-73e7-47a1-a224-2edbcf380b9c">17,936</ix:nonFraction> in fees, discounts and other professional expenses associated with this transaction that were capitalized and will amortize over the term of the 3.75% Senior Notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company used the net proceeds from these 3.75% Senior Notes, together with cash on hand, to redeem in full all $<ix:nonFraction unitRef="usd" contextRef="i8c9ee24fbe9340239ddc070e034d80e0_I20200821" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtInstrumentRedeemedOutstandingPrincipalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcxMDE_b180d599-290f-4065-8e48-fb5a1d131799">1,500,000</ix:nonFraction> aggregate principal amount outstanding of its <ix:nonFraction unitRef="number" contextRef="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwNjA0_65dc1082-398f-40c0-85ed-4a1ae8b59d44">5.0</ix:nonFraction>% Senior Notes plus accrued interest and redemption premium. The Company incurred debt redemption premium charges of $<ix:nonFraction unitRef="usd" contextRef="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcxMTI_57defa5c-3a12-4181-bf38-134aac763088">37,500</ix:nonFraction> and deferred financing cost write-offs of $<ix:nonFraction unitRef="usd" contextRef="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcxMjI_ae275f75-6b04-48b8-b201-0c99025843eb">8,866</ix:nonFraction> in connection with this redemption.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's 2015 interest rate cap agreements expired on <ix:nonNumeric contextRef="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231" format="ixt:datemonthdayyearen" name="us-gaap:DerivativeMaturityDates" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDg1NTc_29731eef-6320-4c26-9513-6d9397d363ee">June&#160;30, 2020</ix:nonNumeric>, at which time the Company's 2019 cap agreements became effective. As of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzkwNjI_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzkwNjI_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>, the Company maintains several interest rate cap agreements that have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on specific portions of the Company's floating rate debt, including all of the Term Loan B-1 and a portion of the Term Loan A. The remaining $<ix:nonFraction unitRef="usd" contextRef="i286706e9b0964d8cbb75adb2d5340592_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzkzODQ_ac335348-2a25-4815-8fb8-24179ac5c6b8">900,069</ix:nonFraction> outstanding principal balance of the Term Loan A and the $<ix:nonFraction unitRef="usd" contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjExODk_5b7e9f21-e94c-446d-8955-02bd28f5c8af">75,000</ix:nonFraction> outstanding balance of the revolving line of credit are subject to LIBOR-based interest rate volatility. <ix:continuation id="i7675ee0a47ab4b8da390e29a3c58a8a0">The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The amortization of the original cap premium is recognized as a component of debt expense on the interest method over the terms of the cap agreements.</ix:continuation> These cap agreements do not contain credit-risk contingent features.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTYw_fb2e3b26-ce3f-4af9-8cc9-e4369eb43a45" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNTA5_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNTA5_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric> and December&#160;31, 2019, which are classified in "Other long-term assets" on its consolidated balance sheet:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzEtOS0xLTEtMA_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzEtOS0xLTEtMA_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Recorded OCI loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8da420e4fe43e3abe44f58b0f0c849_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMS0xLTEtMA_d4d09dd1-0172-4650-a315-be72fada2617">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ad2e96f61d94f8eaade51037ef306a9_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMy0xLTEtMA_e868ba81-4660-451b-90ae-417115120cd2">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ed9f709bc0e4ef09c4f9e055ef04e86_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DerivativeInceptionDates" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtNS0xLTEtMA_802fd7aa-c1bd-4043-9096-8365d22ee33d">6/30/2020</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ed9f709bc0e4ef09c4f9e055ef04e86_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DerivativeMaturityDates" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtNy0xLTEtMA_fdfd9607-2e9a-4824-abaa-d26300b282f5">6/30/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f29329fa0a24761880b3da66bfea3f0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzMtOS0xLTEtMTg2OA_f3efb10c-0d0e-4728-8139-ccbc10a49c86">2,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f29329fa0a24761880b3da66bfea3f0_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMTEtMS0xLTA_b294cf4c-fdab-4831-9b6d-373ea8830786">21,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff59c8376d84505bcb4b4231e5bd78f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMTMtMS0xLTA_4a2c5692-87d0-4f0d-8b30-83c9d9c6433b">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff41e1baf8154d9d8e160378c8afe9a5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMTUtMS0xLTEzMDg_ef885a42-3413-480c-966f-a5dbb25700e5">24,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 cap agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19164efdfc254d9a849e3b6592273062_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMS0xLTEtMTg2MQ_e700c8bb-318a-4faf-a289-12ce40842452">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife085c5fc53a464ba6234e3b54b5902b_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMy0xLTEtMTg2MQ_18c95e65-7335-427d-91d4-8863e242a525">3.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DerivativeInceptionDates" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtNS0xLTEtMTg2MQ_0211a54e-d866-49f5-a120-88d29c8dfcd9">6/29/2018</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231" format="ixt:datemonthdayyear" name="us-gaap:DerivativeMaturityDates" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtNy0xLTEtMTg2MQ_29731eef-6320-4c26-9513-6d9397d363ee">6/30/2020</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a62382e0e04fc6a6d5db83d4b94e8d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtOS0xLTEtMTg2MQ_198d4df5-59fe-42c7-a3f5-a4296e1c12d8">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a62382e0e04fc6a6d5db83d4b94e8d_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMTEtMS0xLTE4NjE_16463bd3-e9b3-4445-a176-c6f122ae4bbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19cd8d5f7704699a59ba60718cf6759_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMTMtMS0xLTE4NjE_3bec08d7-d5a5-41d2-84f1-59d4f87af612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88f0f66836c4e39b167ed6b9e1eab25_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMTUtMS0xLTE4NjE_2c0dc0df-0459-43b5-904b-f598a5524d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTYx_010c466f-9861-463a-9734-93bac466b5c6" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of the Company&#8217;s interest rate cap agreements for the years ended <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNzI0_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNzI0_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>, 2019 and 2018:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:28.328%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.102%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (losses) gains in OCI on interest rate cap agreements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of losses </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassification from accumulated other comprehensive income into net income</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b4253a297c545feae0bc83b8afdfbac_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMi0xLTEtMA_27820d6a-14fe-4617-8209-52f590d9e7ba">21,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a73b09375643e2b9ad54bdb2776bab_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtNC0xLTEtMA_da29f474-fcbc-4c46-8f11-e5130f6a1d77">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4f6eb4a12be4460b4491ec67bbeb914_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtNi0xLTEtMA_545defee-9cb0-4cb5-8424-f5a688d377ca">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4253a297c545feae0bc83b8afdfbac_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMTAtMS0xLTA_c1884031-86d7-4c30-929c-592b990a68a3">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a73b09375643e2b9ad54bdb2776bab_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMTItMS0xLTA_7229850a-a67d-482a-bc45-fa5d9ddf8904">8,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f6eb4a12be4460b4491ec67bbeb914_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMTQtMS0xLTA_606e0ded-ee16-4a03-b0eb-fecc466717d7">8,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadc39011cd34e719eb41ca937a418b7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMi0xLTEtMA_5556faa1-4c1d-40e6-af50-eb5f98cba1ad">5,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddf49515840e487e8f2fffe6cb4b0d22_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtNC0xLTEtMA_398cc2a6-35cc-4bf8-8311-1728d747d3c5">415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb973ffc2bf49c1b23aebcc238a4c6c_D20180101-20181231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtNi0xLTEtMA_902d3a5d-769a-42e5-a25c-524703b9f6c8">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaadc39011cd34e719eb41ca937a418b7_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMTAtMS0xLTA_17c3fbb8-db34-4f73-b033-f61541ee9033">1,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddf49515840e487e8f2fffe6cb4b0d22_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMTItMS0xLTA_a9d5da77-be15-46f0-8074-cc3e3f325d38">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacb973ffc2bf49c1b23aebcc238a4c6c_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMTQtMS0xLTA_90b54ad7-0021-4360-b7f9-3687dada904f">2,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMi0xLTEtMA_23efff61-13ce-4468-84e1-971ff42eae65">16,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e3ddb19c4b4f45ab14958866d7c43d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtNC0xLTEtMA_4c8a2f1e-8506-4114-8d44-25db4e8c0c81">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e7008e4c2d54ce6862f4b7e5e90c295_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtNi0xLTEtMA_fb80c3c1-ea6c-475c-a200-8df6404df17f">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMTAtMS0xLTA_bdf15175-53ab-4ff6-8883-9aafe3679ce6">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e3ddb19c4b4f45ab14958866d7c43d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMTItMS0xLTA_ef316097-9eb4-45aa-862d-f18ecc9ef932">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7008e4c2d54ce6862f4b7e5e90c295_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMTQtMS0xLTA_dce68c7c-5beb-42c3-8063-35695b3b2b25">6,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 20 for further details on amounts recorded and reclassified from accumulated other comprehensive (loss) income.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of 2020 was <ix:nonFraction unitRef="number" contextRef="i96fe2a0d86c443a28c19325250d8c04e_I20201231" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwOTc5_34b3033c-287a-41a9-b483-26009307eb4c">2.03</ix:nonFraction>%, based upon the current margins in effect for the Term Loan A, Term Loan B-1 and revolving line of credit as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMDc4_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMDc4_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was <ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDk5MjQ_bfd57388-0ef2-418e-9a08-94f093f05761">3.59</ix:nonFraction>% for the year ended <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTY3_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTY3_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric> and <ix:nonFraction unitRef="number" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDk5ODA_b59ed8f6-4c70-4474-bd4e-fd76fe176b14">3.06</ix:nonFraction>% as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTg3_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTg3_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjA0_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjA0_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>, the Company&#8217;s interest rates were fixed on approximately <ix:nonFraction unitRef="number" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="4" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjY1_ae21784f-3bac-4a65-92e7-be913803e133">44.4</ix:nonFraction>% of its total debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjkz_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjkz_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>, the Company had $<ix:nonFraction unitRef="usd" contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTA5NTU_273276b3-3e82-4288-b97c-e00ecf14aa07">925,000</ix:nonFraction> available and $<ix:nonFraction unitRef="usd" contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTA1OTM_5b7e9f21-e94c-446d-8955-02bd28f5c8af">75,000</ix:nonFraction> drawn on its $<ix:nonFraction unitRef="usd" contextRef="ia424f1cb12ad4530b4ccca1a7530e070_I20190812" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTA2MTE_5dc8fccc-77de-4e1f-af4d-4ceb3bb6f642">1,000,000</ix:nonFraction> revolving line of credit under its senior secured credit facilities. Credit available under this revolver is reduced by the amount of any letters of credit outstanding under this facility, but there were no such letters of credit outstanding as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyNzI_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyNzI_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia6620073f9dd4084993761a5d2a5ae96"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company also had approximately $<ix:nonFraction unitRef="usd" contextRef="i42f14d1dd6ac4677890feb6e64809282_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNTEz_b58a301c-8735-4c72-a39c-c05f7ca97768">64,636</ix:nonFraction> of outstanding letters of credit under a separate bilateral secured letter of credit facility as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyOTM_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyOTM_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric>.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense consisted of interest expense of $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNjcw_707c9166-0946-4a3a-9179-ccac46f0e041">282,932</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNjc0_2892d189-2a6d-4f05-ae23-8bb90e16b504">419,639</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNjgx_296fcc4b-b945-459d-8eb2-3b46b856f87f">461,897</ix:nonFraction> and the amortization and accretion of debt discounts and premiums, amortization of deferred financing costs and the amortization of interest rate cap agreements of $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExODQ4_6fa889e5-4c70-4d73-9cba-9e88a03e7982">21,179</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExODUy_c03488e3-a7ef-4e07-9751-c50597faa2b6">24,185</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExODU5_2caa2b95-4fa3-4935-8d2c-942d37ef5694">25,538</ix:nonFraction> for 2020, 2019 and 2018, respectively. These interest expense amounts are net of capitalized interest.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_250"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:LeasesOfLesseeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMDc_e838f8ce-1da3-4fb7-9f67-a6602aaacd8a" continuedAt="ia128d38833e44ad489eb3f2a95a04840" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="ia128d38833e44ad489eb3f2a95a04840" continuedAt="icacb619d92eb4dccbbeab80d831835ff"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which range in terms from <ix:nonNumeric contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE5OQ_f9ac4a43-faf9-4bb9-99d1-9b0c3ed821ee">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzIwNQ_070cfa70-8b4a-493b-b513-3053a1549e1f">20</ix:nonNumeric> years and which contain renewal options of <ix:nonNumeric contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI0NQ_d57bdf75-4e26-43f8-8254-6b5f90bd9308">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI1MQ_efe801f5-1e8a-46fe-bc3e-63ec744a3e4a">ten years</ix:nonNumeric> at the fair rental value at the time of renewal. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses. See Note 1 for further information on how the Company accounts for leases.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, assets recorded under finance leases were $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzEzMTg_4c7672d8-17a0-4758-8f88-b235c20f1b46">275,389</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzEzMjU_e3c11016-d570-43c5-9a96-a2c79ae330eb">247,246</ix:nonFraction>, respectively, and accumulated amortization associated with finance leases was $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:FinanceLeaseAccumulatedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE0MDc_5540c9ad-b60a-4d80-8379-06eaf0bc3a33">49,345</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:FinanceLeaseAccumulatedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE0MTQ_f22627b9-6c35-4f2e-ad7e-13b0237cd7e1">27,193</ix:nonFraction>, respectively, included in property and equipment, net, on the Company's consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain markets, the Company acquires and develops dialysis centers. Upon completion, the Company sells the center to a third party and leases the space back with the intent of operating the center on a long term basis. Both the sale and leaseback terms are generally market terms. The lease terms are consistent with the Company's other operating leases with the majority of the leases under non-cancellable operating leases ranging in terms from <ix:nonNumeric contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE5NzA_f9ac4a43-faf9-4bb9-99d1-9b0c3ed821ee">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE5NzY_070cfa70-8b4a-493b-b513-3053a1549e1f">20</ix:nonNumeric> years and which contain renewal options of <ix:nonNumeric contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzIwMTY_d57bdf75-4e26-43f8-8254-6b5f90bd9308">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzIwMjI_efe801f5-1e8a-46fe-bc3e-63ec744a3e4a">ten years</ix:nonNumeric> at the fair rental value at the time of renewal.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beginning on January 1, 2019 through a modified retrospective approach for leases existing at the adoption date with a cumulative effect adjustment. Consequently, financial information was not updated for dates and periods before January 1, 2019.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMTU_7514e10b-7ff8-4d60-a492-141cddeb8dc0" continuedAt="i7d209a1f75024b5ba684ca7d21cdc447" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"></td><td style="width:52.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzItMi0xLTEtMA_73b525cb-3c55-4168-b6ab-ac2873045e42">541,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzItNC0xLTEtMjM4MQ_a90a9fe6-4772-4b77-938f-ba193b5dfda4">526,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzMtMi0xLTEtMA_405c937b-9422-4777-be66-33e99df47016">122,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzMtNC0xLTEtMjM4MQ_57be1a3a-bc34-4a3e-a2a2-7d4b6c3ca7c9">119,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzUtMi0xLTEtMA_49532b1f-dc9b-432b-8307-f766d864b3ec">24,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzUtNC0xLTEtMjM4MQ_d0a514b9-71b3-4a16-8ce0-36ae7aacdc6f">23,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzYtMi0xLTEtMA_93064761-ffe8-42fc-bac4-d468a23ec64b">14,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzYtNC0xLTEtMjM4MQ_5688e00f-4ec2-401f-b0a2-517b3d4ca5fc">14,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzctMi0xLTEtMA_a9ed5906-604c-4827-b762-f05f0ea24232">702,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzctNC0xLTEtMjM4MQ_5514fac3-0a6e-4660-b1cc-8b4736b16512">684,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i7d209a1f75024b5ba684ca7d21cdc447">(1) Includes short-term lease expense and sublease income, which are immaterial.</ix:continuation> </span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMTY_71605c9a-aa4f-4ce8-8f55-a76cab48df6a" continuedAt="i9e0c6244cbc841229552944e6f3134b0" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"></td><td style="width:52.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease term and discount rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzItMi0xLTEtMA_ca15c187-22ed-4a91-89a3-a53630c709aa">8.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i808f8139875c457e969c8ed421c88028_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzItNC0xLTEtMjMzOQ_c0e59369-9d18-418b-84dd-d2c0b8f57540">9.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzMtMi0xLTEtMA_6a457d55-e9cb-4b0f-927b-ce96f4458974">10.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i808f8139875c457e969c8ed421c88028_I20191231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzMtNC0xLTEtMjMzOQ_7cc8d876-e3f3-4cf5-96ae-a76aa6637de3">10.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzUtMi0xLTEtMA_8fd481bd-72c5-4a20-9d36-866c1e37c8c8">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzUtNC0xLTEtMjM0NA_fd08520e-d432-4ba4-aac4-28dfb4ada760">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic69633efe6f54a5fa84fd43f264fe79d_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzYtMi0xLTEtMA_22c13431-c39d-4c67-af52-1e1db76aaaaa">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i856ad81a7b084214953762fad3fc3894_I20191231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzYtNC0xLTEtMjM0NA_b0662c81-1f32-48dc-b199-c0c2b4e9a377">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="icacb619d92eb4dccbbeab80d831835ff"><div style="margin-top:9pt;padding-left:27pt"><ix:continuation id="i9e0c6244cbc841229552944e6f3134b0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"></td><td style="width:52.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on sale leasebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzEtMi0xLTEtMA_4d1a5e7d-f106-470a-8fbe-9516bcdbb1e6">34,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzEtNC0xLTEtMjM2NQ_6f2d87b7-5d10-4225-8b9f-afd1128fdf92">20,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the <br/> measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzMtMi0xLTEtMA_3b534c4c-53cc-4460-9297-a661b3af53a6">661,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzMtNC0xLTEtMjM2OQ_7b5dea9f-dd45-4869-a960-a60d5a8a3c30">637,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzQtMi0xLTEtMA_0146f04c-6f33-42e8-ba63-cc45d1501ad1">20,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzQtNC0xLTEtMjM2OQ_c3529170-01e1-40b9-a9cd-5f32f3cc513e">22,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzUtMi0xLTEtMA_74d14f76-e028-4260-93a5-59427dbf4bff">24,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzUtNC0xLTEtMjM2OQ_25e2e680-b1c8-42cc-b772-b712c5932b87">25,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating lease assets obtained in exchange<br/> for new or modified operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzYtMi0xLTEtMA_df56bf95-ff3d-447e-b0d0-f2e44b6c420c">401,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzYtNC0xLTEtMjM2OQ_e13b7e02-c353-4288-94d1-74fd4b94b2ae">432,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ScheduleOfMinimumLeasePaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMTA_67b81296-afed-4cac-b15a-166aa185627e" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI2MTU_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI2MTU_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric> are as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"><tr><td style="width:1.0%"></td><td style="width:52.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzEtMS0xLTEtMA_3137b82e-e02f-4338-bdb8-74029e228158">480,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzEtMy0xLTEtMA_550ca2a7-7bff-4ddc-a59e-d45446d10c83">35,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzItMS0xLTEtMA_47be5050-5dca-44f0-be98-9fe7246a694f">504,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzItMy0xLTEtMA_e598c03c-e20e-44da-803e-5493059e712b">35,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzMtMS0xLTEtMA_7a86afd5-d5e4-4b18-84bd-f51e58cd8c4e">464,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzMtMy0xLTEtMA_e8b2179c-135e-4820-bffc-9c60139f36d5">35,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzQtMS0xLTEtMA_dba19ccc-0dd0-46c9-a1ef-e235370d5cc2">412,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzQtMy0xLTEtMA_d84eb77c-86f0-4f9c-9a95-256d410a0450">35,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzUtMS0xLTEtMA_5ba91fd9-005c-4f6a-8eea-85307142e068">361,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzUtMy0xLTEtMA_8b73cdbb-d718-4b27-be07-c1fdb59d0691">35,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzYtMS0xLTEtMA_eac53a48-7e8f-47cb-ab52-b2a2978c6775">1,437,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzYtMy0xLTEtMA_919f6b90-e4a9-4b8a-b26b-99b9460e340d">174,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzctMS0xLTEtMA_b4f240d9-15ae-4177-ac03-355c389d4203">3,661,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzctMy0xLTEtMA_84bec3bd-fbd7-48e8-91d2-f036faa9e22c">351,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less portion representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzgtMS0xLTEtMA_f7c9d397-65a1-46c4-9a18-306452953f0b">552,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzgtMy0xLTEtMA_c11a933d-be61-4c46-8d1a-372b8b69a7e5">77,631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzktMS0xLTEtMA_186c2aa3-22ff-41a4-962b-c390f91f3168">3,108,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzktMy0xLTEtMA_6a1af13c-202a-4e78-acf2-dae8129b59ee">274,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under all operating leases for 2020, 2019, and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI3MDA_82f4a3b6-736c-4805-b60f-3529bd92ca79">663,819</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI3MDQ_1d639818-abbf-48b0-8d55-571cc2a7c782">646,092</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI3MTE_0d16bc77-ac98-4d2f-a945-6ee407d4ead8">596,117</ix:nonFraction>, respectively. Rent expense is recorded on a straight-line basis over the term of the lease, including leases that contain fixed escalation clauses or include abatement provisions. Leasehold improvement incentives are deferred and amortized to rent expense over the term of the lease. Finance lease obligations are included in long-term debt. See Note 13 for further details on long-term debt.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_253"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzI0NzM_4fa28bf0-9009-419b-bc9d-28cd0b00ee41" continuedAt="i7a5e33882afd4490ae71ef608ec537fd" escape="true">Employee benefit plans</ix:nonNumeric></span></div><ix:continuation id="i7a5e33882afd4490ae71ef608ec537fd"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) retirement savings plan for substantially all of its U.S. employees which has been established pursuant to applicable provisions of the Internal Revenue Code (IRC). The plan allows for employees to contribute a percentage of their base annual salaries on a tax-deferred basis not to exceed IRC limitations. The Company maintains a 401(k) matching program under which the Company matches <ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzQ2OQ_00e63d0a-de24-4f80-80ac-b2d8aa5b5395">50</ix:nonFraction>% of the employee's contribution up to <ix:nonFraction unitRef="number" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzUwOQ_cb51bc90-ddf9-4aae-b19e-f51d9053a44e">6</ix:nonFraction>% of the employee's salary, subject to certain limitations. The matching contributions are subject to certain eligibility and vesting conditions. For the years ended December&#160;31, 2020, 2019 and 2018, the Company accrued matching contributions totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzc1Mw_d118b1a4-3932-49e3-a73f-37830d520250">70,180</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzc2MA_02148085-a071-43aa-84fd-0682c0b5c5f6">64,988</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzI3NDg3NzkwNzIzNTk_835ef3cd-a000-4067-96bf-e03c8740fb0a">67,807</ix:nonFraction>, respectively. Prior to 2018, the Company did not provide matching contributions for its 401(k) savings plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a voluntary compensation deferral plan, the Deferred Compensation Plan, as well as other legacy deferral plans. The Deferred Compensation Plan is non-qualified and permits certain employees whose annualized base salary equals or exceeds a minimum annual threshold amount as set by the Company to elect to defer all or a portion of their annual bonus payment and up to <ix:nonFraction unitRef="number" contextRef="ic824c560585f40d3a9cd728889fd74f9_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzEyODM_2e6823f0-b4f5-4c09-ad07-ed0d32655ae8">50</ix:nonFraction>% of their base salary into a deferral account maintained by the Company. Total contributions to this plan in 2020, 2019 and 2018 were $<ix:nonFraction unitRef="usd" contextRef="i6ef674119c2b4d74aa417195d2c6c430_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE0MTM_d1594d07-e5d4-4793-a32f-b9fe2a668054">3,637</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i41cd8e78e8344b3ebb08e9406b65619d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE0MTc_a7412dbb-c807-4341-ad04-74055cf9c771">1,751</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3f16999941ed40e69576042281e8c119_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE0MjQ_80132447-1a49-47e5-84b1-1d1853f28df6">3,090</ix:nonFraction>, respectively. Deferred amounts are generally paid out in cash at the participant&#8217;s election either in the first or second year following retirement or in a specified future period at least three to four years after the deferral election was effective. During 2020, 2019 and 2018 the Company distributed $<ix:nonFraction unitRef="usd" contextRef="i6ef674119c2b4d74aa417195d2c6c430_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE3MjU_53c8c043-cd41-42e1-94e5-6eacd18c8029">3,139</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i41cd8e78e8344b3ebb08e9406b65619d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE3Mjk_56032726-cb6d-4d48-813b-bb1150b6a36d">2,730</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3f16999941ed40e69576042281e8c119_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE3MzY_d7f07487-8288-4222-ab4f-1436ff008a60">4,652</ix:nonFraction>, respectively, to participants from its deferred compensation plans. Participants are credited with their proportional amount of annual earnings from the plans. The assets of these plans are held in rabbi trusts subject to the claims of the Company&#8217;s general creditors in the event of its bankruptcy. As of December&#160;31, 2020 and 2019, the total fair value of assets held in these plans' trusts was $<ix:nonFraction unitRef="usd" contextRef="ia31bf166ca5d4a4da3dc6b7a74d31624_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzIxMjA_ed38f04a-5a46-4973-8c2b-1e8766a31202">43,844</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i21a3c92cde084cf8b5352300822f8a32_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzIxMjc_f36835e9-a2cf-49f8-abeb-572a44e550bf">39,527</ix:nonFraction>, respectively. The assets of these plans are recorded at fair value with changes in fair value recorded in "Other income, net". Any fair value changes to the corresponding liability balance are recorded as compensation expense. See Note 5 for further details.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_259"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzEzMTQ5_6b337489-f41c-4539-9cb2-4227a2f45d18" continuedAt="ic2bda4783b3d4f119bc7726dffcd5f81" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="ic2bda4783b3d4f119bc7726dffcd5f81" continuedAt="i3b106ce1325b40c3b01107b5a024c600"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of December&#160;31, 2020 and December&#160;31, 2019, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government's investigation covers the period from January&#160;1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government's investigation and that included total monetary consideration of $<ix:nonFraction unitRef="usd" contextRef="i2b6750de267f4090baf50a854a1011e0_D20171201-20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzQwMDY_cd46b1b4-3006-4f31-a1b3-7d19fbe642ed">63,700</ix:nonFraction>, as previously disclosed, of which $<ix:nonFraction unitRef="usd" contextRef="i65d88e830460478cba6dc77e5492cad1_D20171201-20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzQwNDQ_a581c1d0-2a93-41a5-a6d4-1a06ae94a325">41,500</ix:nonFraction> was an incremental cash payment and $<ix:nonFraction unitRef="usd" contextRef="i9df1ffed4d1a4507989270b5f5b4cad0_D20171201-20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzQwODM_f75ef948-9a98-4cf9-93bb-0cf26ed14611">22,200</ix:nonFraction> was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx's historic relationships with certain pharmaceutical manufacturers, and in July 2018 the OIG served the Company with a subpoena seeking additional documents and information relating to those relationships. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018 and May 2019, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 U.S. Attorney Florida Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#8217;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#8217;s Office is conducting an investigation as to whether the Company&#8217;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i3b106ce1325b40c3b01107b5a024c600" continuedAt="i7e332301f3ea4c9390ad9324dbc619c1"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney's Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc. et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. On February 24, 2020, the Company and DaVita Labs filed a motion to dismiss the amended complaint. On June 25, 2020, the court denied the motion to dismiss. The Company and DaVita Labs answered the complaint on July 23, 2020. The Company and DaVita Labs dispute these allegations and intend to defend this action accordingly. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020. The subpoena, as revised, requests information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7e332301f3ea4c9390ad9324dbc619c1"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder and Derivative Claims</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Peace Officers&#8217; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On February 1, 2017, the Peace Officers&#8217; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities laws concerning the Company&#8217;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#8217;s business and operational status and future growth prospects."&#160;In November 2017, the court appointed the lead plaintiff and an amended complaint was filed on January 12, 2018. On March 27, 2018, the Company and various individual defendants filed a motion to dismiss. On March 28, 2019, the court denied the motion to dismiss. The Company answered the complaint on May 28, 2019. On January 31, 2020, the plaintiffs filed a motion for class certification and the Company filed its opposition on June 29, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to dispute the allegations, in July 2020, it reached an agreement in principle to resolve this matter without admitting to any liability. Settlement of this matter on the agreed terms is expected to be covered primarily with insurance proceeds, with the Company contributing an amount that would not have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. A motion for preliminary approval of the settlement was granted by the court on October 27, 2020. The settlement is subject to, among other things, final approval by the court.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re DaVita Inc. Stockholder Derivative Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#8217;s profits. An amended complaint was filed in September 2017, and on December 18, 2017, the Company filed a motion to dismiss and a motion to stay proceedings in the alternative. On April 25, 2019, the court denied the Company's motion to dismiss. The Company answered the complaint on May 28, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the defendants continue to dispute the allegations, in July 2020, an agreement in principle was reached to resolve this matter without admitting to any liability. The Company&#8217;s Board of Directors (Board) approved the settlement on October 20, 2020. The court granted a motion for final approval of the settlement on January 27, 2021 and approved the settlement on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but will not make any financial contribution towards the settlement.</span></div><div style="margin-top:9pt;padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 16 to these consolidated financial statements, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_262"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzQ4ODk_7fe344e8-aaa3-4f91-ab7c-582851e7786d" continuedAt="iadaff12dd4c34bfcbc513b00d5dda28b" escape="true">Noncontrolling interests subject to put provisions and other commitments</ix:nonNumeric></span></div><ix:continuation id="iadaff12dd4c34bfcbc513b00d5dda28b"><ix:continuation id="i9ca2a0cbdb70489da182a802c1426d67"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests subject to put provisions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#8217; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#8217;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#8217; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#8217; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $<ix:nonFraction unitRef="usd" contextRef="i48eb570e320e4ce9a013b7d5c8f0f816_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherCommitment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI4NjM_491f6c22-1a89-4b42-8ef1-0d518e69b9d0">8,663</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain consolidated dialysis partnerships are originally contractually scheduled to dissolve after terms ranging from <ix:nonNumeric contextRef="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231" format="ixt-sec:durwordsen" name="dva:DissolutionTermOfJointVentures" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI5ODY_cd3614a8-536d-4ddb-9abe-e61cf9d4edf1">ten years</ix:nonNumeric> to <ix:nonNumeric contextRef="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231" format="ixt-sec:duryear" name="dva:DissolutionTermOfJointVentures" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI5OTI_7a5a086e-12f6-47d2-aedc-747c2e4b8e5e">50</ix:nonNumeric> years. While noncontrolling interests in these limited life entities qualify as mandatorily redeemable financial instruments, they are subject to a classification and measurement scope exception from the accounting guidance generally applicable to other mandatorily redeemable financial instruments. Future distributions upon dissolution of these entities would be valued below the related noncontrolling interest carrying balances in the consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Company entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on <ix:nonNumeric contextRef="if29e4c04bf37468ebe8740252e6f04c3_D20200101-20201231" format="ixt:datemonthdayyearen" name="dva:LongTermPurchaseCommitmentExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM1ODQ_6d057209-77c7-4203-b7ab-ed23584b2421">December&#160;31, 2022</ix:nonNumeric>. Under the terms of the agreement, the Company will purchase EPO from Amgen in amounts necessary to meet no less than <ix:nonFraction unitRef="number" contextRef="i4528caebac5945689bef0ffaf6291d30_D20200101-20201231" decimals="INF" name="dva:LongTermPurchaseCommitmentPercentageOfQuantityRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM3MDU_d501669b-a844-43f8-a94d-f6e8969e364b">90</ix:nonFraction>% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that the Company will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that the Company serves.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with various suppliers to purchase established amounts of dialysis equipment, parts, and supplies. As of December&#160;31, 2020, the remaining minimum purchase commitments under these arrangements were approximately $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5MTI_6fe3247f-1503-447f-b111-7e96c5a75f0a">542,061</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PurchaseObligationDueInSecondYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5MTY_1925c6c5-80b1-4b39-ae60-61c57d559baf">540,715</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PurchaseObligationDueInThirdYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5MjE_61bdfd19-3be4-4b4a-8c9f-f8cc32ebfb21">179,869</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PurchaseObligationDueInFourthYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5NTc_5118b65b-84b9-4ea4-a5e2-4ffd9bcff073">92,075</ix:nonFraction> for the years 2021, 2022, 2023, and 2024, respectively. If the Company fails to meet the minimum purchase commitments under these contracts during any year, it is required to pay the difference to the supplier.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the letters of credit disclosed in Note 13 to these consolidated financial statements, and the arrangements as described above, the Company has <ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt-sec:numwordsen" name="dva:OffBalanceSheetFinancingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI4MDM3NTQ2NTE1NTg4_dd29c03b-f6b6-4b06-ada9-f227121f2f99">no</ix:nonFraction> off balance sheet financing arrangements as of December&#160;31, 2020.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_268"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDQz_b94435fe-0855-47e2-81b9-bf4190021e4e" continuedAt="i62cf9ff7077b46219a8985a53e658a36" escape="true">Long-term incentive compensation</ix:nonNumeric></span></div><ix:continuation id="i62cf9ff7077b46219a8985a53e658a36" continuedAt="i6f12f59c9ce44d27979ca6eb6274d9cf"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term incentive program (LTIP) compensation includes both stock-based awards (principally stock-settled stock appreciation rights, restricted stock units and performance stock units) as well as long-term performance-based cash awards. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6f12f59c9ce44d27979ca6eb6274d9cf" continuedAt="i5a7900bc9c7e445ab70e7eed8a73aa99"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term incentive compensation expense, which is primarily general and administrative in nature, is attributed to the Company&#8217;s U.S. dialysis business, its corporate administrative support, and its ancillary services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDE1_ce1899df-99ad-45aa-989f-41d08ef1ad4e" escape="true">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all LTIP awards is recognized net of expected forfeitures.</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation to be settled in shares is recorded to the Company&#8217;s shareholders&#8217; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation plans</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2020, the Company&#8217;s stockholders approved the DaVita Inc. 2020 Incentive Award Plan (the 2020 Plan). Prior to June 11, 2020 stock-based awards were granted under the DaVita Healthcare Partners Inc. 2011 Incentive Award Plan (the 2011 Plan). The 2011 Plan was terminated with respect to any new awards upon stockholder approval of the 2020 Plan. At the time the 2020 Plan was approved there were <ix:nonFraction unitRef="shares" contextRef="i09a03f944078404d9b7042cd462b1e45_I20200611" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzI2_a3cb3c82-a181-4bdb-ba93-b618d50886e6">8,730</ix:nonFraction> shares of common stock available for issuance under the 2020 Plan, consisting of <ix:nonFraction unitRef="shares" contextRef="i09a03f944078404d9b7042cd462b1e45_I20200611" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzA2_42785203-b098-4c40-a830-ddb5fdb7a951">5,000</ix:nonFraction> newly authorized shares and <ix:nonFraction unitRef="shares" contextRef="ic29f0bcf68804559a9cb68580986a3d1_I20200611" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzE1_58e88d54-c7e0-46ad-ad28-513c1ab8f749">3,730</ix:nonFraction> shares that were available for issuance under the 2011 Plan as of the effective date of the 2020 Plan and which became available for grant under the 2020 Plan, pursuant to the terms of the 2020 Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan is the Company&#8217;s current omnibus equity compensation plan and provides for grants of stock-based awards to employees, directors and other individuals providing services to the Company, except that incentive stock options may only be awarded to employees. The 2020 Plan provides for the grant of stock appreciation rights, nonqualified stock options, incentive stock options, restricted stock units, restricted stock, performance stock awards, dividend equivalents, stock payments, deferred stock unit awards, deferred stock awards and performance cash awards. The 2020 Plan mandates a maximum award term of <ix:nonNumeric contextRef="i56347587ed084168beda32c60aeec406_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNjg0_cf38615d-710c-43ee-a615-cc487ac52732">10</ix:nonNumeric> years for stock appreciation rights and stock options and stipulates that awards of these types be granted with a base or exercise price per share of not less than the fair market value of the Company's common stock on the date of grant. Shares available under the 2020 Plan are also stated on a full value share basis rather than on an option-equivalent basis. The 2020 Plan therefore provides that shares available for issuance under the plan are reduced by <ix:nonFraction unitRef="shares" contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwMzc5_d9651d16-7462-49a9-b44e-9ee5b8f54dbd">one</ix:nonFraction> share available for every <ix:nonFraction unitRef="shares" contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="dva:StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwMzg3_a0da3e0c-0f63-44b6-a3e3-333f13e06f84">four</ix:nonFraction> shares underlying stock appreciation rights and stock options, and are reduced by <ix:nonFraction unitRef="shares" contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwMzk1_e227e1dc-ff6c-4673-a2c1-39e5c1bc7d35">one</ix:nonFraction> share available for every <ix:nonFraction unitRef="shares" contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="dva:StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwNDAz_e99404ec-05f1-4d5d-88e7-206fd8db0f0a">one</ix:nonFraction> share underlying stock-based awards other than stock appreciation rights and stock options. At December&#160;31, 2020, there were <ix:nonFraction unitRef="shares" contextRef="iefce2246983a490cbf7573fdfb4284f8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI0NzM5MDExNjQ2OTc1_81c790b1-b447-42ac-811b-23394152bc16">8,074</ix:nonFraction> shares available for future grants under the 2020 Plan. The Company&#8217;s stock units awarded under the 2020 Plan generally vest over <ix:nonNumeric contextRef="iec9363113cab4f59bd24f4201b13c82a_D20200101-20201231" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDMx_23dd4c98-d22a-48de-a902-ae9863c2a068">36</ix:nonNumeric> months to <ix:nonNumeric contextRef="i56347587ed084168beda32c60aeec406_D20200101-20201231" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDM4_1fff42d6-3aa5-4d37-a309-74b3d4bcf41e">48</ix:nonNumeric> months from the date of grant. As of December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="i50aab727700a46ef9be399f0944d2e80_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDg3_8c90eea2-3c1e-4d6c-8ff4-30cda5176e3d">no</ix:nonFraction> stock appreciation rights have been awarded under the 2020 Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2011 Plan was the Company&#8217;s prior omnibus equity compensation plan and authorized the Company to award stock options, stock appreciation rights, restricted stock units, restricted stock, and other stock-based or performance-based awards. The 2011 Plan mandated a maximum award term of <ix:nonNumeric contextRef="i8ecc951facbe48a0a302ba1044295757_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzIwMzk_3ef1ab1a-32e9-4964-b49e-815b01347b02">five years</ix:nonNumeric> and stipulated that stock appreciation rights and stock options be granted with prices not less than fair market value on the date of grant. The 2011 Plan also required that full value share awards such as restricted stock units reduce shares available under the 2011 Plan at a ratio of <ix:nonFraction unitRef="number" contextRef="i8ecc951facbe48a0a302ba1044295757_D20200101-20201231" decimals="INF" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzIzMjk_364e8a3d-4986-420e-8911-0c871e31059a">3.5</ix:nonFraction>:1. The Company&#8217;s stock appreciation rights and stock units awarded under the 2011 Plan generally vest over <ix:nonNumeric contextRef="ia83bbff9dda64502a7fbedbbc8a8a4d0_D20200101-20201231" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI0NTI_3c025ec6-d236-4a37-b365-b63a02f9d56d">36</ix:nonNumeric> months to <ix:nonNumeric contextRef="ia6b7c8b669444401a9a4b4002e230983_D20200101-20201231" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI0NTg_ae7bcb47-bb02-4ba7-91ad-aa484bc7b777">48</ix:nonNumeric> months from the date of grant.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5a7900bc9c7e445ab70e7eed8a73aa99" continuedAt="i27e7040f597142c2ac1d4e64bc610ee8"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDI2_068eda82-ebe0-48b8-8814-3ea2aeb16a02" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A combined summary of the status of the Company&#8217;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:37.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.827%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzAtMS0xLTEtMA_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzAtMS0xLTEtMA_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock appreciation rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26848a1a0f5d41bb9f8750c93c848335_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzMtMS0xLTEtMA_a6cd1ae1-5a24-4a4d-bd11-2070566f7885">6,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i26848a1a0f5d41bb9f8750c93c848335_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzMtMy0xLTEtMA_af75a0d9-1502-4f6e-82e4-4fc58711a0d6">64.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ccc591606cc4e39942d003b9bd1727c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzMtNy0xLTEtMA_e77e2b66-625a-464a-9054-578c72e2eb09">3,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzQtMS0xLTEtMA_4063878f-78eb-44d7-9519-9222e50d3c77">2,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzQtMy0xLTEtMA_b37e2c27-f647-49c0-bfdb-9be7ce9321d4">68.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzQtNy0xLTEtMA_ad2d4b2c-0e26-4cf1-becb-ed68ba9c20cc">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Added by performance factor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" decimals="-3" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtNy0xLTEtNjk0Ng_bb3e8c65-18f2-46cd-aafa-b3e4caa989b1">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtMS0xLTEtMA_3c884800-1c18-4965-9bb9-96e7c046de45">894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtMy0xLTEtMA_fed171d0-645e-4c2f-af65-3fae5ffb0000">72.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtNy0xLTEtMA_361ad169-f02f-42e5-bbb0-c95c3e6de1ee">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzYtMS0xLTEtMA_297217ab-7099-49ea-b93a-7a1f370bcdbf">494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzYtMy0xLTEtMA_ae663459-4297-43af-94a3-4664128b95f8">83.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="dva:SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzYtNy0xLTEtMA_a23abd9f-e020-4d4e-a47f-0128cd25289e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzctMS0xLTEtMA_83359aee-f713-4d2e-88d7-a3276859db55">246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzctMy0xLTEtMA_a6a4e9b2-8a67-4920-9e41-e31c44080b87">61.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzctNy0xLTEtMA_855cdc08-9952-4690-a744-7feb20b15f86">318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60a53b9f954142e297133141bab808dd_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtMS0xLTEtMA_33c68171-563f-4ddc-9733-5da9bf203123">8,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60a53b9f954142e297133141bab808dd_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtMy0xLTEtMA_8f94a03f-efb7-4708-8310-18e0097283ff">63.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtNS0xLTEtMA_c46c70e9-9ce6-4d63-b355-86be56c5728c">3.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2584bc113b24dca93703a2c83984853_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtNy0xLTEtMA_790d1ccb-0397-4567-9f9f-96be98a3c881">3,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtOS0xLTEtMA_6e463227-65a1-40cb-877c-db1f9e1615b5">1.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60a53b9f954142e297133141bab808dd_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktMS0xLTEtMA_de453c24-5f72-411d-93a1-4820ec708753">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60a53b9f954142e297133141bab808dd_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktMy0xLTEtMA_42f629e3-a5de-424c-840c-5a960cc6b782">69.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktNS0xLTEtMA_d3d062ac-555c-42d2-ab37-199585b2ef3a">1.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2584bc113b24dca93703a2c83984853_I20201231" decimals="INF" format="ixt:zerodash" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktNy0xLTEtMA_8ce1e8fe-841a-4d9b-9ff2-645c62e2387e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of grants:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzExLTEtMS0xLTA_3f4ec230-c33c-4e72-b1b4-f3a4486e0da4">26.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzExLTctMS0xLTA_2f455abe-b089-4a0f-b7e1-4334df2fa073">77.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c8fd716e0254f41a042164ecba35111_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEyLTEtMS0xLTA_dcfbf480-890c-487b-a106-ae557e1e6228">14.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a79748b304b4708bba0c7e5287e2026_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEyLTctMS0xLTA_c3623f74-b016-4ae6-a656-c9cd76f1a501">50.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4e22cdd25e2e4d95989b353987e285c8_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEzLTEtMS0xLTA_d5e3ff48-8647-429c-8113-ea0a5976bc12">16.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24385aeb87a94f68874b67e43b0ac293_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEzLTctMS0xLTA_d092b95d-dba3-4724-81a4-67176339a1c2">66.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:14pt;padding-left:27pt"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDIy_23d450ce-02c6-4e11-9122-e9b1db967f39" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"><tr><td style="width:1.0%"></td><td style="width:28.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.438%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards Outstanding</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards exercisable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of SSARs base prices</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.01&#8211;$60.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItMi0xLTEtMA_9a3a3bef-a2a3-4b9f-995b-5725e5dd28e0">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItNC0xLTEtMA_eb236f42-79af-4822-88e4-d866c88a8443">52.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItNi0xLTEtMA_0f61b15e-d61c-4dd8-ba88-77de1fe3bad2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItOC0xLTEtMA_1f997c35-8920-4fd5-9c9a-fa655e10bd58">57.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.01&#8211;$70.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtMi0xLTEtMA_7e3dc31f-7e80-43de-b58a-143e3b90261e">5,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtNC0xLTEtMA_0269510f-9b28-409b-be7e-c8b4e824e50b">66.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtNi0xLTEtMA_a48b5c16-184d-4295-8766-8c302c3594e8">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtOC0xLTEtMA_c1c1b314-e123-4edc-98d1-da92eedbdea1">65.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.01&#8211;$80.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtMi0xLTEtMA_eb9deed0-2145-4d87-9253-d853db9bde26">656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtNC0xLTEtMA_9ea116a2-a262-4cbf-b49c-8799cbffd3d8">75.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtNi0xLTEtMA_f67259cb-b490-43e1-9d7f-bfa25124f115">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtOC0xLTEtMA_42e3c326-ac79-4ec3-ac4d-95b846185923">75.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtMi0xLTEtMA_17893532-e601-4e94-a289-94e32921c2aa">8,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtNC0xLTEtMA_70c8cb4b-0500-4b0e-b848-e4f068b1e9d3">63.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtNi0xLTEtMA_f2fff5b3-0ca4-4220-a267-e3196de3d4a2">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtOC0xLTEtMA_51e3339e-b55d-434d-b3ba-57fc99ff4e60">69.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019, and 2018, the aggregate intrinsic value of stock-based awards exercised was $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM1MTY_19685d38-37ae-4b31-a3b9-a34312677105">49,258</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM1MjA_06b30579-0158-4765-857f-dea1c802700c">11,475</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM1Mjc_3ab5610b-364d-4861-aa4d-19aa63cfc311">31,045</ix:nonFraction>, respectively. At December&#160;31, 2020, the aggregate intrinsic value of stock-based awards outstanding was $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM2MjA_f14c7999-8698-47d5-aa4f-b259a74c9152">853,803</ix:nonFraction> and the aggregate intrinsic value of stock awards exercisable was $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM2ODk_6addf332-b59e-4388-af9f-30e7800f59a8">47,208</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimated fair value of stock-based compensation awards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has estimated the grant-date fair value of stock-settled stock appreciation rights awards using the Black-Scholes-Merton valuation model and stock-settled stock unit awards at intrinsic value on the date of grant, except for portions of the Company&#8217;s performance stock unit awards for which a Monte Carlo simulation was used to estimate the grant-date fair value. The following assumptions were used in estimating these values and determining the related stock-based compensation expense attributable to the current period:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term of the awards:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The expected term of awards granted represents the period of time that they are expected to remain outstanding from the date of grant. The Company determines the expected term of its stock awards based on its historical experience with similar awards, considering the Company&#8217;s historical exercise and post-vesting termination patterns.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Expected volatility represents the volatility anticipated over the expected term of the award. The Company determines the expected volatility for its awards based on the volatility of the price of its common stock over the most recent retrospective period commensurate with the expected term of the award, considering the volatilities expected by peer companies in near industries.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected dividend yield:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company has not paid dividends on its common stock and does not currently expect to pay dividends during the term of stock awards granted.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i27e7040f597142c2ac1d4e64bc610ee8" continuedAt="i1e6670fffef54abfb61ef8903df53064"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company bases the expected risk-free interest rate on the implied yield currently available on stripped interest coupons of U.S. Treasury issues with a remaining term equivalent to the expected term of the award.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDMw_dfa9b147-9318-42f5-8f3a-6ae9a0ca6bd7" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"></td><td style="width:40.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzItMS0xLTEtMA_8f150d79-46ad-472e-8785-251040a659ff">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzItMy0xLTEtMA_e12dc6e8-f71d-456a-8d52-b161606b7fab">4.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzItNS0xLTEtMA_9c33a0a6-dbea-4e92-9932-814979d8f99a">4.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzMtMS0xLTEtMA_5f1c6027-6769-425d-b5fd-de27cb77ae11">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzMtMy0xLTEtMA_36eda6d9-4d26-4464-98d0-62fd0724f107">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzMtNS0xLTEtMA_020b73f3-c503-4dda-9422-778590b771d5">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzQtMS0xLTEtMA_1f86ea89-fd00-436f-b3cd-d5942b01270c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzQtMy0xLTEtMA_bf62b3ec-e512-4fdc-9206-d22c6899c21a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzQtNS0xLTEtMA_793d8e83-f121-46e3-b58d-c781d42567a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzUtMS0xLTEtMA_5d419f2b-e3bd-4f7f-ae7c-c21a60a39c23">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzUtMy0xLTEtMA_9b40acb5-a10a-44c2-a17f-d8c77491f56d">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzUtNS0xLTEtMA_27f085c5-b2b6-4e57-a384-743dc133903d">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company estimates expected forfeitures based upon historical experience with separate groups of employees that have exhibited similar forfeiture behavior in the past. Stock-based compensation expense is recorded only for awards that are expected to vest.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 4, 2019, the independent members of the Company&#8217;s Board of Directors (Board) approved an award of <ix:nonFraction unitRef="shares" contextRef="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzYxNjU_2f378e80-e87b-49eb-9bbd-a46fa574d6ee">2,500</ix:nonFraction> premium-priced stock-settled stock appreciation rights (Premium-Priced Award) to the Company&#8217;s Chief Executive Officer (CEO), which award was subject to stockholder approval of a related amendment to the 2011 Plan. Stockholders approved such amendment to the 2011 Plan on January 23, 2020, authorizing the grant to the Company's CEO. Since stockholder approval occurred in 2020, this award was treated as granted in 2020 for accounting purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The base price of the Premium-Priced Award was $<ix:nonFraction unitRef="usdPerShare" contextRef="icebe77b40956462b9ff854742673e44a_I20191104" decimals="2" name="dva:PremiumPricedAwardBasePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY2NTE_ce5aa7c6-4a5a-4fac-afaa-c6a0dadc7652">67.80</ix:nonFraction> per share, which was a <ix:nonFraction unitRef="number" contextRef="icebe77b40956462b9ff854742673e44a_I20191104" decimals="INF" name="dva:PremiumToTheTenderOfferSharePurchasePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY2Nzc_3acf82ac-06e8-4ae4-8cff-eb3bee4d2e7f">20</ix:nonFraction>% premium to the clearing price of the Company's modified Dutch auction tender offer for its shares in 2019 (2019 Tender Offer). The award vests <ix:nonFraction unitRef="number" contextRef="i3eb4d386a219415092cadf2a89fb4b27_D20191104-20191104" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4MDI_f9da7600-7493-4dba-bf29-f73e314db826">50</ix:nonFraction>% on each of <ix:nonNumeric contextRef="i3eb4d386a219415092cadf2a89fb4b27_D20191104-20191104" format="ixt:datemonthdayyearen" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4MTY_77a89389-ef7b-4099-9629-56e5858bd2f3">November&#160;4, 2022</ix:nonNumeric> and <ix:nonNumeric contextRef="ib5d81d4cfd9b4d3a90277b4e0ba77a2f_D20191104-20191104" format="ixt:datemonthdayyearen" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4MjM_59116337-1dd1-4541-b82a-df882ba77d6a">November&#160;4, 2023</ix:nonNumeric> and expires on <ix:nonNumeric contextRef="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4NDE_ae97d49f-4c9d-4888-bb2d-702dbe367f6b">November&#160;4, 2024</ix:nonNumeric>. The award includes a requirement that the CEO hold any shares acquired upon exercise of this award, net of shares used to cover related taxes, until <ix:nonNumeric contextRef="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104" format="ixt:datemonthdayyearen" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY5OTQ_5c45db97-1ed1-494e-809a-48204b1189c8">November&#160;4, 2024</ix:nonNumeric> (that is, for the full term of the award), subject to lapse of the holding period upon a change in control of the Company or due to the CEO's death or termination due to disability.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee stock purchase plan</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Stock Purchase Plan entitles qualifying employees to purchase up to $<ix:nonFraction unitRef="usd" contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231" decimals="INF" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzcyODk_927474ef-799e-4d71-9c68-4a2a5d6f5e9e">25</ix:nonFraction> of the Company&#8217;s common stock during each calendar year. The amounts used to purchase stock are accumulated through payroll withholdings or through optional lump sum payments made in advance of the first day of the purchase right period. This compensatory plan allows employees to purchase stock for the lesser of <ix:nonFraction unitRef="number" contextRef="ide5fa201da08419d8480005b0941c2ef_D20200101-20200101" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc2MDY_d2c75ede-ebd0-48c3-861a-8c0b9da32072">100</ix:nonFraction>% of its fair market value on the first day of the purchase right period or <ix:nonFraction unitRef="number" contextRef="i13cf2d394c7d46048c99aed94e7a3468_D20201231-20201231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc2ODM_472714b6-7b3b-4c88-bea4-72f61b586451">85</ix:nonFraction>% of its fair market value on the last day of the purchase right period. Purchase right periods begin on January&#160;1 and July&#160;1, and end on December&#160;31. Contributions used to purchase the Company&#8217;s common stock under this plan for the 2020, 2019 and 2018 purchase periods were $<ix:nonFraction unitRef="usd" contextRef="i428a7bb3ffa14fe5895e9f5a7c269bed_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzg0_0b50a8ca-8689-4c74-8bdb-28164c4c8911">17,148</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9f3ec9369a584177b5460514179d0117_I20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc5NjI_db9455b1-9798-4c21-88d1-317f1c35d4ca">16,569</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5b178e933b3b47e2ac8bbe854a99a0bb_I20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc5Njk_50699b17-439a-4601-bfa7-085e2e4ddab2">17,398</ix:nonFraction>, respectively. Shares purchased pursuant to the plan&#8217;s 2020, 2019 and 2018 purchase periods were <ix:nonFraction unitRef="shares" contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgwNjg_15eb6c9f-65a2-4b4c-809a-9a296925b491">222</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgwNzI_99b4eb7b-d4ea-4478-b474-19ba5fe3eb8e">315</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgwNzk_417ffd48-609c-4652-ba32-b40597fbe1d0">398</ix:nonFraction>, respectively. At December&#160;31, 2020, there were <ix:nonFraction unitRef="shares" contextRef="i428a7bb3ffa14fe5895e9f5a7c269bed_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgxMTU_e82165df-1f0b-4fb6-9df8-569a8b0dc90f">6,189</ix:nonFraction> shares remaining available for future grants under this plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of participants&#8217; purchase rights was estimated as of the beginning dates of the purchase right periods using the Black-Scholes-Merton valuation model with the following weighted average assumptions for purchase right periods in 2020, 2019 and 2018, respectively: expected volatility of <ix:nonFraction unitRef="number" contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg0NzU_cf45ae57-cce2-47b1-9b05-32774fdae575">40.4</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg0Nzk_fafe3e69-0e0c-429d-810c-812e630d6d8c">28.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg0ODY_de59cf3a-9261-4de0-86c8-73a4a3448da8">24.2</ix:nonFraction>%; risk-free interest rates of <ix:nonFraction unitRef="number" contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1MTg_2a0c0fa2-a1bf-4b58-b661-30b259279591">1.0</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1MjI_859df688-8e28-4af6-ba30-64bc4e50ebd4">2.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1Mjk_ff2373e5-134c-4f0e-a393-74642ada0c77">1.9</ix:nonFraction>%, and <ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1Mzc_8c20787e-a337-4324-a1f7-d410f948201e">no</ix:nonFraction> dividends. Using these assumptions, the weighted average estimated per share fair value of each purchase right was $<ix:nonFraction unitRef="usdPerShare" contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg2NTU_110bb436-eaf4-43bf-948b-5a3a37450e36">22.06</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg2NTk_119e36eb-1e4b-428d-ba60-2a0ae55d4c0e">13.80</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg2NjY_1dd537d2-c705-461b-9a1a-74eaadc81347">17.45</ix:nonFraction> for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation expense and proceeds</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:LongtermIncentiveProgramCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4MTQ_a6f53525-a7fb-4666-9f45-b6e807ffd50a">99,643</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:LongtermIncentiveProgramCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4MTg_a652fe11-730f-4b1c-a834-0abd13188997">118,513</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:LongtermIncentiveProgramCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4MjU_42fbd854-13fc-43df-a393-e51b8a35aa05">85,759</ix:nonFraction>, respectively, in total LTIP expense, of which $<ix:nonFraction unitRef="usd" contextRef="ia4ea773d13594e1e9feb21e2fab910b3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4NzU_239d0064-44fa-4d37-b339-19b34834a870">91,458</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i08f4222a3b2941c78d4c11684f04bb29_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4Nzk_2753f878-5ee5-497f-af7b-8cbfbcb7f0a7">63,705</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i127cf2093ba342448f4db553c0454a5d_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4ODY_a2186d5c-45ad-4c77-8642-f898d75f95dd">73,582</ix:nonFraction>, respectively, was stock-based compensation expense for stock appreciation rights, stock units and discounted employee stock purchase plan purchases, which are primarily included in general and administrative expenses. The estimated tax benefits recorded for stock-based compensation in 2020, 2019 and 2018 were $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzkxODY_681978b3-d6c1-4436-817b-39ed08c52e72">11,775</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzkxOTA_8b55d64b-e611-4f9a-8e04-5315384b8372">9,186</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzkxOTc_bd349e37-ce1f-447f-bd71-cf5db3b9f2af">13,591</ix:nonFraction>, respectively. As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwOTk1MTE2Mjk5MTAx_746086d3-5519-463f-8ca4-443c5afe6fc4">189,713</ix:nonFraction> of total estimated but unrecognized stock-based compensation expense under the Company&#8217;s equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzk2ODE_1aeb68fd-ddfb-431c-b9c7-0bddf0dc913a">1.4</ix:nonNumeric> years. The Company <ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="dva:LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwNDE4_a0696b51-262b-4554-a383-912c14334d36">no</ix:nonFraction> longer has outstanding long-term performance-based cash awards in its principal U.S. dialysis business as the performance and accrual period for these awards ended December 31, 2019 with a final payout of $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwOTk1MTE2Mjk5NjI3_79a589a0-75b0-40e6-833a-b2b2f5da0e2b">66,302</ix:nonFraction> in 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1e6670fffef54abfb61ef8903df53064"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2018, the Company adopted a retirement policy (Rule of 65 policy). The Rule of 65 policy generally provides that Section 16 officers that are a minimum age of 55 with five years of continuous service with the Company receive certain benefits with respect to their outstanding equity awards upon a qualifying retirement if the sum of their age plus years of service is greater than or equal to 65. These benefits generally include accelerated vesting of restricted stock unit awards, continued vesting of stock-settled stock appreciation rights and performance stock unit awards and an exercise window for stock-settled stock appreciation rights from the original vest date through the original expiration date regardless of continued employment, with pro rata vesting for a Rule of 65 retirement within one year of the award grant date. The adoption of the Rule of 65 policy resulted in a $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNTY1_57459833-8311-4bf6-8ccb-f187c6933508">14,704</ix:nonFraction> modification charge and a net acceleration of expense of $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNjI1_bf6494e7-88aa-4488-8b9e-02fbd4970b2d">9,727</ix:nonFraction> during the year ended December&#160;31, 2018 that is included in the expense amounts reported above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019 and 2018, the Company received $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNzgw_710cab16-ee03-4021-85d1-8ab24927ce73">8,957</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNzg0_2cf9d40c-bd06-4199-9682-38493c9e85c3">2,251</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNzkx_fa898939-d5f7-40b3-8b27-0fe2f79cacb8">7,988</ix:nonFraction>, respectively, in actual tax benefits upon the exercise or vesting of stock awards. Since the Company issues stock-settled stock appreciation rights rather than stock options, there were <ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwOTcw_862f3729-c6f3-48c1-babe-30b56b5c3cae">no</ix:nonFraction> cash proceeds from stock option exercises.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_274"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI4MDM3NTQ2NTE0MzYw_ab238e03-e790-488b-bdd4-7ef86eefdd5f" continuedAt="id167c85669264ac7b346c101f75107fd" escape="true">Shareholders&#8217; equity</ix:nonNumeric></span></div><ix:continuation id="id167c85669264ac7b346c101f75107fd" continuedAt="i5d49b8b2b865480db97616b8c0ed7338"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM2MDM_143c843d-84c7-4d05-b699-196ba29da24b" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"></td><td style="width:38.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzItMS0xLTEtMjA4MA_9df1dcf9-a19b-418a-87f6-14406506cb5f">8,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzItMy0xLTEtMjA3NA_921e3ae9-e07f-46af-ae19-0776514f568d">19,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzItNS0xLTEtMjA4Ng_1577d712-70f3-4e72-af49-50307beaf2e8">16,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzMtMS0xLTEtMjA4Mg_2999db83-90df-4631-8d27-965ccfaacbd8">741,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzMtMy0xLTEtMjA3Ng_b23d175f-101f-4d44-b620-5b7d56364932">1,168,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzMtNS0xLTEtMjA4OA_9ab98c26-780d-4c61-a9fa-e90a1bc460e0">1,153,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzQtMS0xLTEtMjA4NA_44f6b93e-4ae7-4469-a641-a3dc37a53b68">87.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzQtMy0xLTEtMjA3OA_f5ee0c3d-c26f-4209-9aee-e5480371a3f4">60.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzQtNS0xLTEtMjA5MA_0bcee15e-cdbd-4f80-a790-ca603bed5227">68.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tender offers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzctMS0xLTEtMjA5Mw_1bc6f87b-615c-4d84-8c96-d008b89199ef">7,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzctMy0xLTEtMjA5OQ_b1078795-0c09-4f1f-afd7-79881b4f8e1c">21,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="shares" contextRef="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231" xsi:nil="true" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzctNS0xLTEtMjEwNQ_eb6a1ebd-2207-4832-9a1a-a4a03e0d23dc"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzgtMS0xLTEtMjA5NQ_3b790b00-0f1d-41f4-b8d5-9f44ecf2092a">704,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzgtMy0xLTEtMjEwMQ_718da310-ab3a-4253-b481-8bf3aebedffd">1,234,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231" xsi:nil="true" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzgtNS0xLTEtMjEwNw_1c2a07d4-3e95-4692-b194-40bff84aa67e"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzktMS0xLTEtMjA5Nw_05c8f44d-dfe8-419d-86be-d148d7307478">88.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzktMy0xLTEtMjEwMw_e9c98f57-50a3-4def-88bf-9e9c8fab9ac9">56.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231" xsi:nil="true" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzktNS0xLTEtMjEwOQ_8a992467-57a5-4ddf-8d6f-20aa2021be08"></ix:nonFraction></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEyLTEtMS0xLTIxMTE_81428583-a392-47b9-9456-2802cb138bd5">16,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEyLTMtMS0xLTIxMTc_a1ff57be-3474-4bd8-b9ec-16d40e2649ad">41,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEyLTUtMS0xLTIxMjM_2358f2de-0421-433b-a16a-5763f660c98f">16,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEzLTEtMS0xLTIxMTM_31081e25-7b8d-415d-bfd1-67a2ee5f6948">1,446,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEzLTMtMS0xLTIxMTk_87bed18f-1532-478a-97b1-18535eb97e1f">2,402,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEzLTUtMS0xLTIxMjU_9f39dd53-cc7c-4c9c-853d-2db054b4ec51">1,153,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzE0LTEtMS0xLTIxMTU_6b414973-ecaa-44d5-a83f-5c315ded4a9d">87.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzE0LTMtMS0xLTIxMjE_884f08fa-0772-4941-84c0-44049142d8b7">58.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzE0LTUtMS0xLTIxMjg_604fbf1f-4483-422d-8198-2609a2ac3755">68.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended December&#160;31, 2020 and 2019, include their clearing prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231" decimals="2" name="dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI5NQ_bb8a71ed-d4d2-4d15-abf4-31159969638b">88.00</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231" decimals="2" name="dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzcxNDY4MjU1ODQ2MDc_a589a0b1-4d74-4a6c-aae0-310c04979d19">56.50</ix:nonFraction> per share, respectively, plus related fees and expenses of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:ShareRepurchaseFeesAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM0Mg_a2b33a02-2104-451f-b3c7-e1e1c4c59fa7">2,529</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:ShareRepurchaseFeesAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzcxNDY4MjU1ODQ1OTc_01ff4192-30d9-44f8-b877-f5dc82bb4c5f">2,343</ix:nonFraction>, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2020 through February 10, 2021, the Company has repurchased <ix:nonFraction unitRef="shares" contextRef="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM5Mg_e3a368ac-75a6-43b7-84a8-b5f30ec158ce">1,063</ix:nonFraction> shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzQyNg_cce66932-bc0a-4ade-b4ff-73b5795fbc58">123,282</ix:nonFraction> at an average cost of $<ix:nonFraction unitRef="usdPerShare" contextRef="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzQ1MQ_050a305f-ff4d-4c7f-9286-0412bca8b15b">115.98</ix:nonFraction> per share. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of the close of business on November 4, 2019, the Board terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $<ix:nonFraction unitRef="usd" contextRef="i76ba37986e6d4a12be3157c80c387fc9_I20191104" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzEyNzM_cf91c5a2-e8cb-4dd6-aca0-93312fce8f0d">2,000,000</ix:nonFraction>. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to the Company under the aforementioned November 4, 2019 authorization and approved a new share repurchase authorization of $<ix:nonFraction unitRef="usd" contextRef="i105b8a0db46c4b329658833071e7f412_I20201210" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI3NDg3NzkwNzQwMDg_8a3ae155-eba1-4935-a43e-128e674a210a">2,000,000</ix:nonFraction>. The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;10, 2021, the Company has a total of $<ix:nonFraction unitRef="usd" contextRef="i7083b873e21941ca8755a4ceb7aeeac8_I20210210" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzE2ODY_c9b3b85d-53c8-466d-bea7-7c2f4f6ec004">1,806,674</ix:nonFraction> available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5d49b8b2b865480db97616b8c0ed7338"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remains subject to share repurchase limitations, including under the terms of the current senior secured credit facilities and the indentures governing the Company's senior notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company retired all shares held in its treasury effective as of December&#160;31, 2020 and December&#160;31, 2019.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charter documents&#160;&amp; Delaware law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice for director nominations and stockholder proposals and granting the Company's Board of Directors the authority to issue up to <ix:nonFraction unitRef="shares" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI2NTI_b8254410-4efb-47aa-8853-b4f1fb154882">5,000</ix:nonFraction> shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, prohibits the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt-sec:durwordsen" name="dva:PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzMwNTk_42a82e54-b06f-40ed-a1b1-9e5726256ec9">three years</ix:nonNumeric> following the date on which that stockholder became an interested stockholder. The provisions described above may discourage, delay or prevent an acquisition of the Company at a price that stockholders may find attractive.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM2MDQ_8ac6d190-5f88-47db-a58e-44a256bcaaba" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries on the Company&#8217;s consolidated equity were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:52.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzItMS0xLTEtMA_49b3f939-8a4e-49e0-8c33-015cd43da6dd">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzItMy0xLTEtMA_da85b60e-970d-4c64-b2c8-90f1de7a8e3e">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzItNS0xLTEtMA_c031532e-8ec8-445a-9e55-ade6a86c5321">159,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in paid-in capital for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMS0xLTEtMjI1MDA_a331dcb1-5b43-4698-9d14-16d95cc553de">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMy0xLTEtMjI1MDA_d9351166-037a-475a-8fc3-1ccd5ee3339c">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtNS0xLTEtMjI1MDA_a34228ba-5650-4e9e-ab4c-fea4dfab7ff7">17,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMS0xLTEtMA_77508a89-c107-46eb-aebb-b0d692d0ee0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMy0xLTEtMA_68ee067e-49a6-455f-b95a-747a52d46eb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" name="dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtNS0xLTEtMA_8fbdbc86-b341-40f3-a0ab-ca6eaec32896">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzYtMS0xLTEtMA_623be55d-3096-46ca-b09f-51c95ba9faf4">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzYtMy0xLTEtMA_ae492ad2-9aa2-41d9-8174-5eceb781dce6">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzYtNS0xLTEtMA_7f2aadfc-d8c3-4bd7-8e5a-d5cfa949661f">17,818</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc. net of transfers in <br/> noncontrolling interests</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzctMS0xLTEtMA_e42d922e-600d-4526-862f-810c58bce52f">778,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzctMy0xLTEtMA_bf1449e4-dca2-4e03-a6f0-dbbd5fe3563d">773,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzctNS0xLTEtMA_4c10d7b7-7b2f-45c8-89d9-1a92a11147fe">141,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired additional ownership interests in several existing majority-owned partnerships for $<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM1NTY_d6e4067d-5dfc-41a7-9ee5-f09be0bb066d">7,831</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM1NjA_adc7d974-8e55-489b-9df8-89964ba55e3c">68,019</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM1Njg_ee948ebc-a36d-424a-96c4-3d45f7ba5b3a">28,082</ix:nonFraction> in 2020, 2019, and 2018, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_280"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90ZXh0cmVnaW9uOmQ1N2ZlOTFmM2NlMzQ3OTRiYzIyNWY1ZmY3YjE0ZDcyXzEwMjk_c6084ccc-5b05-45a7-9742-1df5b93e6731" continuedAt="id223c7ce98d245eba647768e339da7e3" escape="true">Accumulated other comprehensive (loss) income</ix:nonNumeric></span></div><ix:continuation id="id223c7ce98d245eba647768e339da7e3"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90ZXh0cmVnaW9uOmQ1N2ZlOTFmM2NlMzQ3OTRiYzIyNWY1ZmY3YjE0ZDcyXzEwMzI_3acbc361-3ddd-49ae-9bac-98efae40fe8a" continuedAt="i9a4554c00ef640568e7a8f43aa325100" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and credits to other comprehensive (loss) income have been as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate<br/>cap agreements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other<br/>comprehensive<br/>(loss) income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib85e3af4c76943dfb45faef356b1edb8_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtMS0xLTEtMA_2a21b084-7a99-4ef5-b7cb-66814a664af1">12,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia09cc0ebe548468cb11bfb4a15f51203_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtMy0xLTEtMA_067564f0-5bf5-441b-a381-987b4ce28100">5,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4cffaa726b44c38a7415a3a0c9e4a9_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtNS0xLTEtMA_d4087b75-720a-4e31-b42e-98aa8b27dee7">19,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aee781d32fe49c2bb5de5584a9e35d2_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtNy0xLTEtMA_a7709c2f-f0e9-442f-8590-bd6cf9bfc818">13,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting principle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id982bc2b303943b3a1f13e6fa0132c37_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:CumulativeEffectOfChangeInAccountingPrinciple" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMS0xLTEtMTY5_cb07b350-7aa2-4dfa-a84a-9e11f4823d97">2,706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id91bd7812fa548a7aeaa626e95f390fa_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:CumulativeEffectOfChangeInAccountingPrinciple" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMy0xLTEtMTY5_fbb9dc52-decb-4734-aa68-b1679c9105c3">5,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc3a6ff6bb04c1e93904bc9ac788525_I20171231" decimals="-3" format="ixt:zerodash" name="dva:CumulativeEffectOfChangeInAccountingPrinciple" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNS0xLTEtMTY5_d5ec23e8-d13e-4378-a55e-45de335b40b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2676db50d104876ba6149c180d0549c_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:CumulativeEffectOfChangeInAccountingPrinciple" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNy0xLTEtMTY5_addaf7ad-4e35-4571-b40a-66064ada8331">8,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMS0xLTEtMA_17e8e6ce-e321-4763-8b85-bbcf2479555a">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMy0xLTEtMA_be1ee216-0ae9-44a1-808b-f08050205341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNS0xLTEtMA_c5be59ee-1776-44d3-acc3-60fa31ae023e">45,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNy0xLTEtMA_de5350cb-77be-419c-b1ad-75f2a042613b">46,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtMS0xLTEtMA_f3644889-a071-41d6-9341-c3cad2d8767b">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtMy0xLTEtMA_9e211d0d-cf4d-4cee-9011-d6252f4c52a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtNS0xLTEtMA_2af9a6ef-4fc2-448e-bb0c-060233dcd19d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtNy0xLTEtMA_6f2c8299-b7ce-4bcc-b4c1-ee2f6fe69644">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtMS0xLTEtMA_8b80aa20-4b4c-4998-8584-effced2392ed">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtMy0xLTEtMA_6a4db024-862c-40a9-8600-4de116252352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtNS0xLTEtMA_8ebae5d5-9f2e-4864-917b-d87e0f521ce2">45,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtNy0xLTEtMA_99d2da2e-4cdb-4d4f-9d30-b82a0f4fedbc">46,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income (loss) into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtMS0xLTEtMA_8947f0bd-92d7-4284-a1e9-3424be499e53">8,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtMy0xLTEtMA_1ea8e127-a369-417b-b9ad-ff0e7471d335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtNS0xLTEtMA_649f77e7-f5a4-41ea-a640-669c96482586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtNy0xLTEtMA_40e9df8c-5559-4d7e-9b0b-8d24b4d07c50">8,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtMS0xLTEtMA_9000a253-018b-4a42-9c89-85d947b29708">2,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtMy0xLTEtMA_16540359-05f6-45a9-a34e-daa294972fea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtNS0xLTEtMA_ad3019d6-b098-4e8e-89d6-be89cc33f949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtNy0xLTEtMA_785e56de-23a5-4094-a565-dd8d7157f930">2,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctMS0xLTEtMA_88987a12-3879-49a8-9846-1c77ba59d113">6,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctMy0xLTEtMA_2dd09655-49bb-4b4e-99d6-3a052d4668d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctNS0xLTEtMA_6691f60c-1277-4ca8-bb6f-fe989b360b37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctNy0xLTEtMA_bb838981-b962-4cac-a41c-d5d14df5da39">6,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d0662ace310459d8294892cb68ab800_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtMS0xLTEtMA_7fb82938-fad7-438f-a8b4-87e8cbf99ab3">8,961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3eda312133844699a6a4a94669d3aa9_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtMy0xLTEtMA_c6dc6f71-be0e-4544-87c2-064dbc2ca3ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7b5073da4b446ea0318c702a7868ed_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtNS0xLTEtMA_3febc597-02ef-4874-8d92-85b9228016b5">25,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16e862399f5a48ab8399e8f0cdb32c64_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtNy0xLTEtMA_bdf08d62-1402-45d1-bdeb-94d538798d3c">34,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTEtMS0xLTA_c3a80f60-b9e1-459a-8062-4f7ec7dbcd5f">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTMtMS0xLTA_d1128f48-a57e-4ccb-9d73-88e3f5cbb617">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTUtMS0xLTA_e786bda9-9302-492e-90a8-6371b12d3fda">20,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTctMS0xLTA_3ae4bdce-dd72-4a2b-a95c-3ba756cc2e7f">18,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTEtMS0xLTA_31f1757a-f58e-4e3f-9f31-a4f0d55ce9a6">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTMtMS0xLTA_a2644254-a15a-47ba-a35b-a0396c05d2e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTUtMS0xLTA_d1e8fbdb-4380-4735-9d05-5a3e46c4d4ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTctMS0xLTA_ae792af7-78e6-40eb-ad12-54f4ea90a387">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTEtMS0xLTA_8b96e580-2819-482a-8ca8-7d91dbe80024">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTMtMS0xLTA_f3dddf77-c785-4247-b506-c2bc00d718ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTUtMS0xLTA_cc3fe3bc-fa8f-4702-a428-437f257cbd56">20,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTctMS0xLTA_a030b759-718f-41a8-9815-a793dd43f1df">18,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTEtMS0xLTA_9ab7dc13-441e-4d7b-8c80-ce4466d8e55f">8,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTMtMS0xLTA_5a52679f-a8af-4db6-8440-9bd28aa475dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTUtMS0xLTA_54c642b3-595e-4c8d-8b3f-e13f5e9c532e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTctMS0xLTA_b80fd2d3-fdc1-4e2e-833c-1f999468d687">8,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTEtMS0xLTA_0dd7ecf5-a7fe-490b-8569-f5c65fdb7a80">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTMtMS0xLTA_99c61e44-a83c-4c5b-9084-0ce7882c9531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTUtMS0xLTA_bc346c90-115b-4de9-9943-79997958bb83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTctMS0xLTA_caed6add-3f8b-4476-b180-3c293ae9a0b8">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTEtMS0xLTA_49153cd2-cb8e-4c89-bbac-77799ce8a1a0">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTMtMS0xLTA_71a331d3-341b-4b05-87cb-2511a28d5900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTUtMS0xLTA_e973d6fe-1e0f-4d83-acb3-ceaf7fe08f5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTctMS0xLTA_f7ee7043-a613-4884-9093-00f437cbc856">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i400ae66383684fca86f44ab51c352938_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTEtMS0xLTA_4c3090c6-be1b-4596-bb8f-9de39c588a78">1,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie318599ad486430586f67152fedcd6e4_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTMtMS0xLTA_85385573-87d7-4910-a423-7e33c36aa8be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c60b527bad44f338d70eaf4c922c693_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTUtMS0xLTA_04628b03-f897-4d6a-9ae7-ec603ebd49c7">46,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4353b1da6dea495987a98903f6f24d81_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTctMS0xLTA_ca9810e2-aa95-4297-a6dc-90b0170568ee">47,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTEtMS0xLTA_26f3f871-303b-4231-8d94-60cc993e0cb1">21,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTMtMS0xLTA_3fb4da0d-bd62-4355-9440-e90320a5a482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTUtMS0xLTA_b5bdea44-38dd-4ffb-9f04-149790707cd6">7,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTctMS0xLTA_76587db3-3c3a-4f2b-bdea-240214628420">28,861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTEtMS0xLTA_3d416f78-685d-4cfe-8c5e-72653b0325b8">5,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTMtMS0xLTA_44ad8905-a56b-4e02-bc2d-895a0bc5c9bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTUtMS0xLTA_3bab1749-997e-41d2-bcef-092e7f3427b9">543</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTctMS0xLTA_07b45f2b-64e9-4b3e-879a-3afb82cb40ff">4,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTEtMS0xLTA_79eb3e7f-4610-42d1-98c6-b333cafd907f">16,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTMtMS0xLTA_29e2142f-7027-4a1d-b2d1-c97f1725f354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTUtMS0xLTA_150cab59-c830-4a5d-865f-c0272c7c39d5">7,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTctMS0xLTA_3f787f29-b5a2-470d-a53c-c97f8ba0ca7e">23,969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTEtMS0xLTA_ec619f42-3802-4626-9381-58dd44a7dd52">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTMtMS0xLTA_04451989-d4af-4fa3-8398-19b3d2344d44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTUtMS0xLTA_cfe06f1f-cb35-42fb-a5c2-fb4b7385f99d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTctMS0xLTA_5a718975-70e4-4b21-9559-db75e12dab62">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTEtMS0xLTA_ba66ab1a-fa55-4aae-8d46-0534a56d72b8">1,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTMtMS0xLTA_e63c9c68-a4a7-4fe1-8c68-233e4a7b48fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTUtMS0xLTA_aa56e290-afc9-48ee-a37e-70d83aa809ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTctMS0xLTA_71079ea4-7242-442a-8d67-7e866f823f46">1,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTEtMS0xLTA_ee7a5736-987e-4acd-b566-c441a16f1592">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTMtMS0xLTA_fdd4ca66-5fb9-4226-82f3-7d67bbd3991b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTUtMS0xLTA_11107b52-4af4-425d-aad6-b8d727354f40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTctMS0xLTA_e7a3ee39-e239-48d2-acd5-1ba0cc43fe4c">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at <ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTAtMS0xLTA_e532e401-901f-487f-9de3-636e5887c95c"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTAtMS0xLTA_b287dfea-b6e4-4a51-8e4d-99124aea44a9">December 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa528156b4734e65b6f4086215f035cf_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTEtMS0xLTA_8c670239-047d-419d-808d-ed45ec55a12c">12,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c844e403784223aaf6cd1848e6ab04_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTMtMS0xLTA_fa0b9734-aecb-4693-915e-005be8e11869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i121893f4c40449a89e600dbe09cccfb8_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTUtMS0xLTA_f698541e-d707-46f2-bc2c-c6918c05c186">53,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f863d3dd90b4b01b6b02423feddcd8e_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTctMS0xLTA_08682bce-96a4-4d4c-83c9-f5d13b0cde24">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i9a4554c00ef640568e7a8f43aa325100" continuedAt="i0bd1c8ae93a6419384382886d2349d53">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i0bd1c8ae93a6419384382886d2349d53">Reflects the cumulative effect of a change in accounting principle for ASUs 2016-01 and 2018-03 on classification and measurement of financial instruments and ASU 2018-02 on remeasurement and reclassification of deferred tax effects in accumulated other comprehensive income associated with the 2017 Tax Act.</ix:continuation> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90ZXh0cmVnaW9uOmQ1N2ZlOTFmM2NlMzQ3OTRiYzIyNWY1ZmY3YjE0ZDcyXzEwMjc_f1ee24a2-9ca3-4b6f-b84f-7c14d7cb3e73" escape="true">The reclassification of net cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income.</ix:nonNumeric> See Note 13 for further details.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_283"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3NjM_67e304fe-239a-4c98-8cb3-8a08c6840cd4" continuedAt="id729d1f65bb54ebb8362237086808e75" escape="true">Acquisitions and divestitures</ix:nonNumeric></span></div><ix:continuation id="id729d1f65bb54ebb8362237086808e75" continuedAt="i57dcdecca44249a0bfffa7788babea94"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company acquired <ix:nonFraction unitRef="clinic" contextRef="ifa2af9b4b56d4ea9bd2ee38a1c474653_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzky_d98b2999-b1d9-4a67-8d0f-4311eda52c3a">eight</ix:nonFraction> dialysis centers in the U.S. and <ix:nonFraction unitRef="clinic" contextRef="i211344fc537744f5a1e5ca5d7a509101_D20200101-20201231" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEyOA_07e08197-b754-4b2c-9761-8430395c5965">66</ix:nonFraction> dialysis centers outside the U.S. for a total of $<ix:nonFraction unitRef="usd" contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzE4MA_c7d41637-4000-4378-aa73-47705d3fee50">182,013</ix:nonFraction> in net cash, earn-outs of $<ix:nonFraction unitRef="usd" contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3Mzcx_5789110f-f1d2-4961-bc1c-bc30d7765975">14,042</ix:nonFraction> and deferred purchase price and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3NDA3_4f40dee8-fe8f-4479-bec5-00d4617ba4bf">20,415</ix:nonFraction>. The Company also recognized a non-cash gain of $<ix:nonFraction unitRef="usd" contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3MzUy_501a9791-da1d-4f8b-96f5-f108c5fdf102">1,821</ix:nonFraction>. During 2019, the Company acquired <ix:nonFraction unitRef="clinic" contextRef="i34eb33d6da174197975f748888e130fa_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzMwOQ_b372c5e8-a979-462f-b303-a563d52342c9">seven</ix:nonFraction> dialysis centers in the U.S. and <ix:nonFraction unitRef="clinic" contextRef="ib5bdaf5b8e324f16af4b2af8e8b5cea5_D20190101-20191231" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzM0NQ_650ba5a8-2942-4f81-8ad5-e93316df8315">16</ix:nonFraction> dialysis centers outside the U.S. for a total of $<ix:nonFraction unitRef="usd" contextRef="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzM5Nw_c1daba30-d7de-419b-a303-b042966a06b5">98,836</ix:nonFraction> in net cash, earn-outs of $<ix:nonFraction unitRef="usd" contextRef="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQyNg_eca1c315-78be-4d7b-a484-da00da84293b">23,536</ix:nonFraction>, and deferred purchase price and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ4NQ_33ebd42d-bd33-40a8-b763-3598a80190ba">4,326</ix:nonFraction>. During 2018, the Company acquired <ix:nonFraction unitRef="clinic" contextRef="ife8b48f4488041a98b5163ddacda7b3d_D20180101-20181231" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzM4NDgyOTA3MDIwMDM_cfab6c47-b1ff-46bb-98fd-9fe77e820379">18</ix:nonFraction> dialysis centers in the U.S. and <ix:nonFraction unitRef="clinic" contextRef="i42771298d95c4449aba8f0b634283f8a_D20180101-20181231" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzc4NQ_a89ac141-b70c-44cb-8d10-53d57f75781a">28</ix:nonFraction> dialysis centers outside the U.S. for a total of $<ix:nonFraction unitRef="usd" contextRef="ibbedb04193324daca88f65acd841b435_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzgzNw_3b363021-9b66-4725-bfa7-3d3cd4a1bf44">176,161</ix:nonFraction> in net cash, earn-outs of $<ix:nonFraction unitRef="usd" contextRef="ibbedb04193324daca88f65acd841b435_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzg2Ng_f9efc9f3-87f1-4f20-9e84-cea217dc7803">1,246</ix:nonFraction> and deferred purchase price of $<ix:nonFraction unitRef="usd" contextRef="ibbedb04193324daca88f65acd841b435_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzkwMA_56b1cc59-ba9e-4518-b06d-f8557875cf56">34,394</ix:nonFraction>. In one of these 2018 transactions the Company acquired a controlling interest in a previously nonconsolidated U.S. dialysis partnership for which the Company recognized a non-cash gain of $<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3Mjg1_8e176ddf-7351-4b24-b3f5-fb9c2a33249f">28,152</ix:nonFraction> on its prior interest upon consolidation. The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s financial statements, as are their operating results, from the designated effective dates of the acquisitions. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i57dcdecca44249a0bfffa7788babea94" continuedAt="i7656497e27d74aa192217adbd484e892"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. For several of the 2020 acquisitions, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, leases and certain other working capital items relating to several of these acquisitions are pending final quantification.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3NzY_d9756524-ac9b-4caa-8bd4-4d5adf0edfb0" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"></td><td style="width:52.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzItMS0xLTEtMA_6b436cc5-6344-402d-8c86-395ceb9eaed4">23,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzItMy0xLTEtMA_635a8168-a5a5-4ec5-9a0a-ba34bb118d16">6,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzItNS0xLTEtMA_87b55bd8-c418-4456-a1ce-b1ee86da39ad">23,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzMtMS0xLTEtMA_da6ec03b-8c1f-4ca9-9923-dbc85856540e">37,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzMtMy0xLTEtMA_695afd81-4980-4950-a9d4-d140f001f32b">4,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzMtNS0xLTEtMA_0c461315-7824-4737-8b60-b796bab40b0e">11,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMS0xLTEtMTc4MTE_17aaa1c3-da4b-44d6-b09a-667c048542d3">34,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMy0xLTEtMTc4MTE_1d6d1096-9076-4ee6-80b9-6f2eacac57ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtNS0xLTEtMTc4MTE_2e56a9e6-33f6-4256-8e0b-9285398ce821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMS0xLTEtMA_3c37d7e4-4da4-46f7-9f74-c43df0026413">10,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMy0xLTEtMA_41b7f70a-5de8-440f-a008-898b6e79ae9b">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtNS0xLTEtMA_e5a33223-5cdc-4c86-98ae-64b9ab1af187">3,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzUtMS0xLTEtMA_af6925e3-f39b-441f-b501-8a9768306052">22,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzUtMy0xLTEtMA_8668727a-957b-414c-859e-10e74c8b0734">31,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzUtNS0xLTEtMA_19c365ca-8f48-4e33-8635-6fff9fa94542">23,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzYtMS0xLTEtMA_4dc0b9c2-c5b7-4678-8f6f-47170f63dba4">130,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzYtMy0xLTEtMA_47466e56-9fb6-4f65-aa09-e751ceddc763">90,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzYtNS0xLTEtMA_b453d2c9-8b6e-4b4c-b02a-603ef1f32ac6">278,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzctMS0xLTEtMA_d267f1bb-1b8e-4869-a309-f7293aad7ed0">3,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzctMy0xLTEtMA_609d31cd-1fe3-4626-ac36-250a11f35a5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzctNS0xLTEtMA_31b5ca54-2638-46dc-840f-c13c9537ddba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMS0xLTEtNDM3Nw_29f67ff9-085f-48d8-8330-17e2a8549bcf">34,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMy0xLTEtNDM3Nw_4eeff56d-a37c-455d-89c1-d6c033a18b3b">7,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtNS0xLTEtNDM3Nw_532f6996-dfac-4a03-95cf-bb834264e440">19,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMS0xLTEtMA_a14dd876-ddb6-4395-967f-0990ec0240ff">1,729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMy0xLTEtMA_ef193fb0-b058-4e2e-bff3-8d6dbf524e60">1,762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtNS0xLTEtMA_c9a8da97-6d0d-46cb-99a6-7da7134eff01">80,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzEwLTEtMS0xLTA_169ece30-a9fd-484d-acca-154b1d260865">218,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzEwLTMtMS0xLTA_5c8d63ae-aacb-4197-bebf-84fb27e859f8">126,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzEwLTUtMS0xLTA_0ecffd3b-b457-4e50-a04c-9f5fa5669921">239,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzI4MDM3NTQ2NTE3MTk1_aed1a98a-ab14-415d-84be-d002eb010820" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2020, 2019 and 2018, as well as goodwill deductible for tax purposes associated with these acquisitions:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"><tr><td style="width:1.0%"></td><td style="width:56.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average estimated useful lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i19715ea7c0d44a94b2cc8fb506d311dc_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzMtMS0xLTEtMTM3MDg_6348c9c7-e716-4d97-aa6d-6475dddae203">18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonNumeric contextRef="i8a352df164304776a46c85b682e9ab80_D20190101-20191231" xsi:nil="true" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzMtMy0xLTEtMTM3MDg_1e07f1b1-9793-48fd-9e4a-b153275450eb"></ix:nonNumeric></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonNumeric contextRef="i13fc6ded13df4a0880a140b68e18899f_D20180101-20181231" xsi:nil="true" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzMtNS0xLTEtMTM3MDg_2a5587ab-a85b-4c47-b3d8-e1e2e55e9238"></ix:nonNumeric></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8030b65740034eaa9eae02d95f2133a1_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzQtMS0xLTEtMTM3MDg_272a82d1-6c46-4885-974f-eef7d88d864f">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if04951c8b4f5456da29bb184a415e56e_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzQtMy0xLTEtMTM3MDg_d4ca578c-e2fa-499b-8c64-7b016fd89e0b">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id643d82f1c0c49a58e67abb271a5f89b_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzQtNS0xLTEtMTM3MDg_247ce493-65df-4d1b-9106-79246cc93f3d">6</ix:nonNumeric></span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill deductible for tax purposes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzYtMS0xLTEtMTM3MDg_c3c7b6ed-dea0-4184-856d-99ebb45dfd6b">94,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzYtMy0xLTEtMTM3MDg_51d5f2b3-cc93-48cd-8b21-679245ee8afe">88,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzYtNS0xLTEtMTM3MDg_cb3f7987-5a6d-4f06-8929-95879fb2587c">165,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro forma financial information (unaudited)</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3NjI_8284394d-2ca8-4f6d-9713-5f38419b8163" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2020 and 2019 had been consummated as of the beginning of 2019, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"></td><td style="width:62.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.741%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzMtMS0xLTEtMA_21ed7f2a-fee2-4da8-9651-7a29384d7ead">11,636,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzMtMy0xLTEtMA_c353dfbd-f125-43d3-a8c1-bc49cc25a36d">11,570,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net income from continuing operations attributable to<br/> DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzQtMS0xLTEtMA_3a8a4dec-92bf-4b8d-9aa7-54f2eefa0d2f">789,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzQtMy0xLTEtMA_59f732ad-fbb0-4f40-8cf1-1d2cc9dda6d9">718,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic net income per share from continuing operations<br/> attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzUtMS0xLTEtMA_c26b905e-587c-4708-b020-942be5df6f72">6.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzUtMy0xLTEtMA_ef842354-712c-46fc-87a1-2f184d5363ba">4.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma diluted net income per share from continuing operations<br/> attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzYtMS0xLTEtMA_90ab8ef8-cdb0-4d2c-97ff-ac94d00fe042">6.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzYtMy0xLTEtMA_35f40ce2-4654-42f1-90b3-6285cc30842a">4.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7656497e27d74aa192217adbd484e892" continuedAt="i8dddd73cfa0c4e25b63e58988b2a9625"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of RMS Lifeline</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company divested its vascular access business, RMS Lifeline, Inc., effective May 1, 2020 and recognized a loss on sale of approximately $<ix:nonFraction unitRef="usd" contextRef="i61c7d20749714b578bd03a14636c3b75_D20200501-20200501" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzI3NDg3NzkwNzc2MTY_306b05a2-481d-45ac-af1d-8beea9661036">16,252</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired companies a total of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQwNDg_af543002-8065-404b-8abf-0f4af6d37c29">42,378</ix:nonFraction> if certain performance targets or quality margins are met over the next <ix:nonNumeric contextRef="ifd580bc9f0ce4f48a42dcff947bb8c76_D20200101-20201231" format="ixt-sec:durwordsen" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQxMjM_8b82a977-60e6-4528-9d4d-0daddc771fe7">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="if69af729580f4423a3ac3716ba3c2db6_D20200101-20201231" format="ixt-sec:durwordsen" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQxMjk_c69e7d22-d15c-4cab-bfcb-6dbab7cb222c">five years</ix:nonNumeric>. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. See Note 24 for further details. As of December&#160;31, 2020, the Company estimated the fair value of these contingent earn-out obligations to be $<ix:nonFraction unitRef="usd" contextRef="i786a553c52f743c5b1b4a38214be1b9b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ0NjE_3dd28922-f11b-47b0-8112-af23e01fd36c">30,248</ix:nonFraction>, of which a total of $<ix:nonFraction unitRef="usd" contextRef="i6e92165fc1424a7ba5419b7bb4e85b10_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ0ODU_48a38dd0-b22d-4512-82c9-d03b8d191a39">13,025</ix:nonFraction> is included in other current liabilities, and the remaining $<ix:nonFraction unitRef="usd" contextRef="i707d83d1d9eb45bbaa369393203a03a6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ1NDg_fa484d79-257c-45dd-8ed0-4d99a13e906e">17,223</ix:nonFraction> is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3Nzk_80817a14-e758-449e-81e3-24efe09c922a" continuedAt="ib661852413c247ada55eb663d3c2f5ce" escape="true">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2020 and 2019:&#160;</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:9pt;padding-left:27pt"><ix:continuation id="i8dddd73cfa0c4e25b63e58988b2a9625"><ix:continuation id="ib661852413c247ada55eb663d3c2f5ce"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"></td><td style="width:55.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.086%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzAtMS0xLTEtMA_89befc74-3429-44e9-a811-56b8e20b64a2">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzMtMy0xLTEtMTIxNDY_66e51477-f31d-40d4-aa00-b4a71af199ee">2,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzEtMS0xLTEtMA_f20cb794-9fa1-4afc-a33f-da797edfee63">14,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzQtMy0xLTEtMTIxNDY_e8059e82-0bde-4ec8-b4e9-0c6826ee1448">23,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzItMS0xLTEtMA_18c66717-5da9-40c6-bd4b-d46b001cd364">3,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" name="dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzUtMy0xLTEtMTIyMjI_de149e5d-de04-4e1a-9811-69dccf385f4d">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzMtMS0xLTEtMA_858afa11-cbd4-48a0-9bb4-6d6c10b201c5">2,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" name="dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzYtMy0xLTEtMTIxNDY_5426ef53-8fce-431b-b349-b3fcab1aa142">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments or other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzQtMS0xLTEtMA_8d7a470a-acb3-471e-a4a7-fbc2414482ff">2,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzctMy0xLTEtMTIxNDY_9e1b1d7d-8a2f-4ef4-9dc4-95f16579b5b1">774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzUtMS0xLTEtMA_63a67fda-0d35-45d1-b288-9bb16fe55fbf">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzgtMy0xLTEtMTIxNDY_3ffd3efa-dd3e-49b4-b0f5-8924e05fc9ca">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i878840fee65247deaca27d2dd6a8246f_286"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzODQ_3c8df3e7-c1d1-4314-aff9-84701de0ad61" continuedAt="i158cdfd61f49487c882691863068d0a8" escape="true">Discontinued operations previously held for sale</ix:nonNumeric></span></div><ix:continuation id="i158cdfd61f49487c882691863068d0a8" continuedAt="i6372f054abd5490eb85d9e9e8c6e1e4e"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DaVita Medical Group (DMG)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="iab59816d75634fd58eaaa890c090532b_D20190619-20190619" format="ixt:datemonthdayyearen" name="us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2Xzg4_57674c38-c054-45ed-8876-73d602fb4a34">June&#160;19, 2019</ix:nonNumeric>, the Company completed the sale of its DMG business to Optum, a subsidiary of UnitedHealth Group Inc., for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="iab59816d75634fd58eaaa890c090532b_D20190619-20190619" decimals="-3" format="ixt:numdotdecimal" name="dva:PurchaseAndSaleAgreementAggregatePurchasePrice" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIyOQ_4a0f5414-55d6-4c7a-b382-e3ad5ec20835">4,340,000</ix:nonFraction>, prior to certain closing and post-closing adjustments specified in the related equity purchase agreement dated as of <ix:nonNumeric contextRef="ia2343e73177c4a59a625d97fd537e0a2_D20171205-20171205" format="ixt:datemonthdayyearen" name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzM1MA_969bbd09-4493-4ace-8439-fa7c426b7b09">December&#160;5, 2017</ix:nonNumeric>, as amended as of September 20, 2018 and as of December 11, 2018 (as amended, the equity purchase agreement).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a preliminary estimated pre-tax net loss of approximately $<ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzU0Mg_a1063a42-d7e7-42cf-8af3-cdcfb49057a9">23,022</ix:nonFraction> on the sale of its DMG business in 2019. This preliminary net loss was based on initial estimates of the Company's expected aggregate proceeds from the sale, net of transaction costs and obligations, as well as the estimated values of DMG net assets sold as of the closing date. Those estimated net proceeds included $<ix:nonFraction unitRef="usd" contextRef="i9577f3ef1df845c38e9359052401de77_D20190619-20190619" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2Xzg2MA_b354eddb-593a-4879-9d97-5583cf259976">4,465,476</ix:nonFraction> in cash received from Optum at closing, or $<ix:nonFraction unitRef="usd" contextRef="i9577f3ef1df845c38e9359052401de77_D20190619-20190619" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzkwNg_d544ccb0-8801-4b46-b767-d19c78977d68">3,824,509</ix:nonFraction> net of cash and restricted cash included in the DMG net assets sold.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement. In the fourth quarter of 2020, the Company and Optum reached agreement on the final purchase price for the DMG sale, which resulted in an additional payment by the Company to Optum of $<ix:nonFraction unitRef="usd" contextRef="if4ad841931d5470f881644ba3f00c2c2_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzI3NDg3NzkwNzUxNDY_6e1be959-bb8a-4dca-840d-fe0d19b40538">47,000</ix:nonFraction> and an additional loss on sale of $<ix:nonFraction unitRef="usd" contextRef="if4ad841931d5470f881644ba3f00c2c2_D20201001-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzI3NDg3NzkwNzUxNDA_6cb83cba-922f-40da-a5b9-ab2643ebc7ff">17,976</ix:nonFraction>. In the first quarter of 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="id64a66f74d0f4ecba8a1a1be356f290d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzI4MDM3NTQ2NTE0MDUx_194d9471-2433-4405-ad2e-b7c515f7e3b9">9,980</ix:nonFraction> in additional tax benefits under the Coronavirus Aid, Relief and Economic Security Act related to its period of DMG ownership, which were also recognized as an adjustment to the Company's loss on sale of the DMG business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the equity purchase agreement, the Company also has certain continuing indemnification obligations that could require payments to the buyer relating to the Company's previous ownership and operation of the DMG business. Potential payments under these provisions, if any, remain subject to continuing uncertainties and the amounts of such payments could be significant to the Company.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6372f054abd5490eb85d9e9e8c6e1e4e" continuedAt="ibf7a0e77c51642b88a7572284fd32012"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzNzk_9f04a8a0-57e2-48cf-91c5-5e7cca6e2a6c" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the financial results of discontinued operations related to DMG:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:61.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzItMS0xLTEtMA_d8c40e2b-54ea-49e5-903f-63b4f105a1c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzItMy0xLTEtMA_b43ab8ed-e0de-4b03-85ca-ce093a199822">2,713,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzItNS0xLTEtMA_c3f0a035-9f95-4577-8f92-b2e2d0946dd2">4,963,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzMtMS0xLTEtMA_ee78f5a6-9f66-4a5a-b3ce-4c5f70b70096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzMtMy0xLTEtMA_7a397b04-7f27-430a-82c8-02be6102f66c">2,543,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzMtNS0xLTEtMA_8530922f-416b-4a87-b0de-a1480562d498">4,962,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzQtMS0xLTEtMA_17f2797e-a747-4df4-aea9-de0ccc7a4e50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzQtMy0xLTEtMA_42c6e1d3-3841-401c-9d4c-fd1ff66c39be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzQtNS0xLTEtMA_7d12f955-58ae-4d28-b3cd-bb5419812132">41,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment on disposal group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzUtMS0xLTEtMA_d3b99697-982d-4fa5-9d49-986db06eacad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzUtMy0xLTEtMA_9d33daa8-5a9f-4ed0-9f85-a58fe782af59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzUtNS0xLTEtMA_36ea18b7-ec89-4048-bffd-dc920cf4b5fa">316,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzYtMS0xLTEtMA_14e677f3-f9d9-48a4-a055-0d7d68bdb837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzYtMy0xLTEtMA_007fbd0d-6b94-4c62-8b30-3b50a92f5d43">169,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzYtNS0xLTEtMA_80623691-d4ad-4390-9b45-d29c25bd8b7b">357,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of discontinued operations before taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzctMS0xLTEtMA_bd57b960-f559-4fa1-8445-06f1aed48f1b">7,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzctMy0xLTEtMA_b9d5561a-1ad0-4adf-a378-5e53f316794b">23,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzctNS0xLTEtMA_57d2e0e0-9e39-4075-8cc1-acc505b53e1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzgtMS0xLTEtMA_c5d260ba-f81b-411a-b8ba-10fe3ab23494">1,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzgtMy0xLTEtMA_3a83b72e-31bf-4b08-be4e-21a8c500fb77">40,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzgtNS0xLTEtMA_55aab10d-00a4-466e-87f8-a664e58a4f59">99,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzktMS0xLTEtMA_2af5ef3e-c710-4686-a400-79ac2b305c1c">9,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzktMy0xLTEtMA_464bfa7a-d2df-401c-989e-6cd83600385b">105,483</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzktNS0xLTEtMA_6d7e52f3-31d9-48f0-a7ed-d171794fcca2">457,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ReconciliationOfCashFlowsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzODc_003afca8-fe89-45fe-a87b-dfa470576f4d" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flows of discontinued operations related to DMG:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.75pt"><tr><td style="width:1.0pt"></td><td style="width:294.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:55.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:55.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:55.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzItMS0xLTEtMA_540a6e4d-5870-49cb-aa61-a7f817e1a18f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzItMy0xLTEtMA_b0c84259-61e8-4199-832b-6c7c5c218356">99,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzItNS0xLTEtMA_6afe45e4-8300-486e-85b3-a7699c91cb6a">290,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzMtMS0xLTEtMA_ab69b03d-3d7a-4641-aded-4a5792e93a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzMtMy0xLTEtMA_dd7a0ee2-8bae-4784-bfa2-f1e1349a11cc">43,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzMtNS0xLTEtMA_dadf0d6e-e646-44b6-b014-810625bbbfd0">57,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DMG acquisitions</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibf7a0e77c51642b88a7572284fd32012">During the period from January 1, 2019 to June 18, 2019 immediately prior to the sale, the DMG business acquired <ix:nonFraction unitRef="clinic" contextRef="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIwMDc_12b37b5d-5fc4-4d89-ad3c-2ad5e4a3a22b">two</ix:nonFraction> medical businesses for a total of $<ix:nonFraction unitRef="usd" contextRef="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIwNDQ_17df0702-8ea8-4e66-887c-0c0fdafa6097">2,025</ix:nonFraction> in net cash and deferred purchase price of $<ix:nonFraction unitRef="usd" contextRef="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIwOTA_0a4d1c04-b6d9-48fc-990b-181cb171fe06">212</ix:nonFraction>. During 2018, the DMG business acquired other medical businesses for a total of $<ix:nonFraction unitRef="usd" contextRef="id4eac1171b5341d8b967522bcb813373_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIyOTU_c9cb5abd-e1a0-4f5f-986b-e070cc54fc3b">6,995</ix:nonFraction> in net cash and deferred purchase price of $<ix:nonFraction unitRef="usd" contextRef="id4eac1171b5341d8b967522bcb813373_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzMzg_23e1a474-130f-43bf-b441-3765ea1b9d13">1,142</ix:nonFraction></ix:continuation>.</span></div><div id="i878840fee65247deaca27d2dd6a8246f_289"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzMxMjQ_400430f8-3d46-4399-8b2b-232ffb1152a6" continuedAt="ic5a2fbfc4f84434a9aa574e9110bf870" escape="true">Variable interest entities</ix:nonNumeric></span></div><ix:continuation id="ic5a2fbfc4f84434a9aa574e9110bf870" continuedAt="i757a6147e7d249ed84e07bb2daa92320"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzMxMjM_4d6c631a-7fd5-4cbd-b887-2d9960b3f22c" continuedAt="if2a11ff8351b442a84ab8a055081a74d" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#8217;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#8217;s economic performance, the obligation to absorb the entity&#8217;s expected losses, or the right to receive the entity&#8217;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#8217;s losses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if2a11ff8351b442a84ab8a055081a74d">The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#8217;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#8217; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated.</ix:continuation> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, these consolidated financial statements include total assets of VIEs above of $<ix:nonFraction unitRef="usd" contextRef="i65a17e126ac34461a4fca6925ed519bd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzI1NjA_b0d0e408-17be-4a35-8888-32f805945654">310,190</ix:nonFraction> and total liabilities and noncontrolling interests of these VIEs to third parties of $<ix:nonFraction unitRef="usd" contextRef="i65a17e126ac34461a4fca6925ed519bd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzI2NDI_ff86691a-a77a-4964-9833-e7b6c1f00efe">216,632</ix:nonFraction>.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i757a6147e7d249ed84e07bb2daa92320">The Company also sponsors certain non-qualified deferred compensation plans whose trusts qualify as VIEs and the Company consolidates these plans as their primary beneficiary.&#160;The assets of these plans are recorded in short-term or long-term investments with related liabilities recorded in accrued compensation and benefits and other long-term liabilities.&#160;See Note 15 for disclosures concerning the assets of these consolidated non-qualified deferred compensation plans.</ix:continuation></span></div><div id="i878840fee65247deaca27d2dd6a8246f_292"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90ZXh0cmVnaW9uOmUzMTkzNDdlMWJkZDQxY2E5OTVmNWMzNDZjN2QwM2JlXzM2OTU_47e4ab0b-0f49-4623-b398-4fbb8cff0612" continuedAt="if29efa9985a84d339a6e7567395a00cd" escape="true">Fair values of financial instruments</ix:nonNumeric></span></div><ix:continuation id="if29efa9985a84d339a6e7567395a00cd" continuedAt="ic10296ed7fc8442485898c117de0bf8f"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equity that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the FASB.</span></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90ZXh0cmVnaW9uOmUzMTkzNDdlMWJkZDQxY2E5OTVmNWMzNDZjN2QwM2JlXzM2OTE_ce5477b4-06bf-475d-a07f-9f4f4283e66b" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in<br/>active&#160;markets&#160;for<br/>identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant&#160;other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36352b7df66948dba0eacf04441040eb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItMS0xLTEtMA_0ee5e30c-aeaa-40b8-aa05-ac9aa5afe05a">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692b9792fba94d658bf1614514353578_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItMy0xLTEtMA_216b0151-0ec7-4b79-8769-eb8c2009fad1">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8204d20559346598ff50ef21663702d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItNS0xLTEtMA_3c257083-496b-4686-87b9-4b626537f7e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic360e4e817a54ccbb56e6288ed0b1685_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItNy0xLTEtMA_5a3c94f1-e04e-486a-a25f-092e9f9e89a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie862d7ef0c1343e2a506a5ff72228d56_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtMS0xLTEtMA_b6d01bfd-3e21-40ad-9071-129137f5818e">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd4732a8e3d41d984f5f16deb38d1b3_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtMy0xLTEtMA_3001e216-9f92-47d8-a1a1-261081aca60d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757c9663b761453cad7e8ec5f01cb559_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtNS0xLTEtMA_a9671df3-bfa6-4865-bc88-21a55b4634b6">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045ff3fd899a407682817e4edb66922f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtNy0xLTEtMA_7cfd09c2-8687-4c22-813d-29c909551c75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36352b7df66948dba0eacf04441040eb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtMS0xLTEtMA_65defc9d-18f3-4a22-8a24-cee3fc13cada">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692b9792fba94d658bf1614514353578_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtMy0xLTEtMA_1bd2d718-cae6-437a-a4fb-a532743fd007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8204d20559346598ff50ef21663702d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtNS0xLTEtMA_18816548-bbc3-4625-9a2b-8aa7c2030c11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic360e4e817a54ccbb56e6288ed0b1685_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtNy0xLTEtMA_9aaefbb8-9339-4cc8-b19f-8f0937176612">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36352b7df66948dba0eacf04441040eb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctMS0xLTEtMA_7d76456c-2da9-4f88-af9b-8c7446f6ea9a">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692b9792fba94d658bf1614514353578_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctMy0xLTEtMA_97d757cb-9020-416e-9f26-ee8a34ea0673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8204d20559346598ff50ef21663702d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctNS0xLTEtMA_6a985a90-9819-4f7b-9083-893c34256f5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic360e4e817a54ccbb56e6288ed0b1685_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctNy0xLTEtMA_fd015a87-a162-4b37-9168-113e4cb5e28d">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68711243663d45cd9878789705596fad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTEtMS0xLTA_a98bc739-76bb-4876-82d9-28468a022288">39,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTMtMS0xLTA_07a4d7b0-fe49-47f6-bc41-9401cdef5fd4">39,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5178b3f27148099f8931545f27730d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTUtMS0xLTA_630c8704-3068-4e15-b839-f65f569d379f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d92344999cf4f04aef6369cc712a589_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTctMS0xLTA_51697cc7-58d0-433c-bcbe-e5eca77644fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8733faebf4f497296ada527a7cd8acd_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTEtMS0xLTA_66de0d7c-fc56-499a-bd8d-c94737718b2e">24,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3feefe9b7e3f4d1e8e1438498a7ed0e0_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTMtMS0xLTA_5635d82e-20ea-4e7a-9843-4432ac645323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff41e1baf8154d9d8e160378c8afe9a5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTUtMS0xLTA_49e6f692-7654-48c0-93cc-dd32500026d9">24,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i250b1181003d40a3ab8cd67db23630ae_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTctMS0xLTA_9e404f23-0fb2-4244-8c08-57e1d303d716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68711243663d45cd9878789705596fad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTEtMS0xLTA_0a5d9607-3b3d-4c6e-8ace-79edccad3146">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTMtMS0xLTA_8969c73f-a2fd-44f9-a861-9e9b70082d41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5178b3f27148099f8931545f27730d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTUtMS0xLTA_c39eed4f-43cd-43ba-8511-a97d42db211a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d92344999cf4f04aef6369cc712a589_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTctMS0xLTA_d8fa58e4-b217-43bb-a295-c1de4d4fd65e">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68711243663d45cd9878789705596fad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTEtMS0xLTA_99a6756e-fa95-41d9-a40b-6fc06505e114">1,180,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTMtMS0xLTA_82d640c2-ff66-42f0-b1a1-896992299434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5178b3f27148099f8931545f27730d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTUtMS0xLTA_14372acf-8a7b-42c8-9f16-b0c2076c151f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d92344999cf4f04aef6369cc712a589_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTctMS0xLTA_786a5bc0-40af-48c7-bc2c-e184ae629804">1,180,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the year ended at December&#160;31, 2020 and 2019, see Note 21 and the consolidated statement of equity, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 5 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 13 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair value of these contingent earn-out obligations is remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company credit risk adjusted rate that is used to discount obligations to present value. See Note 21 for further discussion.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic10296ed7fc8442485898c117de0bf8f"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of December&#160;31, 2020, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $<ix:nonFraction unitRef="usd" contextRef="ied7ace566871432e8e4240927f2bf074_D20201231-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90ZXh0cmVnaW9uOmUzMTkzNDdlMWJkZDQxY2E5OTVmNWMzNDZjN2QwM2JlXzM5NTgyNDE4NjA1NzMw_090aac6e-bde2-4dd3-9fca-d2bf71a35388">160,000</ix:nonFraction>. See Note 17 for a discussion of the Company&#8217;s methodology for estimating the fair values of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 13 for further discussion of the Company's debt. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in the consolidated financial statements at December&#160;31, 2020 and 2019 at their approximate fair values due to the short-term nature of their settlements.</span></div></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_295"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MDk_271c60e9-df81-4c6f-854e-38c7df428e84" continuedAt="ie0576fa6d5a244308817ffed04de07b6" escape="true">Segment reporting</ix:nonNumeric></span></div><ix:continuation id="ie0576fa6d5a244308817ffed04de07b6" continuedAt="i893d1f2beaf4494abba99fefebbd511c"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its various ancillary services and strategic initiatives, including its international operations (collectively, its ancillary services), and its corporate administrative support. See Note 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Organization" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a summary description of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="iab59816d75634fd58eaaa890c090532b_D20190619-20190619" format="ixt:datemonthdayyearen" name="us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM0Nw_2bc9466f-64a1-4aec-90cf-69c34568c1a4">June 19, 2019</ix:nonNumeric>, the Company completed the sale of its DMG business to Optum. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company&#8217;s chief operating decision maker in making decisions about allocating resources to and assessing the financial performance of the Company&#8217;s various operating lines of business. The chief operating decision maker for the Company is its Chief Executive Officer.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, each of its ancillary services and strategic initiatives, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the APAC joint venture. The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other ancillary services and strategic initiatives operating segments, including the international operating segments, have been combined and disclosed in the other segments category.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segment financial information included in this report is prepared on the internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the financial performance of the Company's operating segments. For internal management reporting, segment operations include direct segment operating expenses but generally exclude corporate administrative support costs, which consist primarily of indirect labor, benefits and long-term incentive compensation expenses of certain departments which provide support to all of the Company&#8217;s various operating lines of business, except to the extent that such costs are charged to and borne by certain ancillary services and strategic initiatives via internal management fees. These corporate administrative support costs are reduced by internal management fees received from the Company&#8217;s ancillary lines of business.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i893d1f2beaf4494abba99fefebbd511c" continuedAt="ia3fb0d64847b4fd282131b85346c3d09"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MDM_5916975b-c6cd-4058-a024-ae4663a4e349" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c3be00a520d4ae2958de6ed78743b3f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzUtMS0xLTEtMA_533b6593-00c9-443b-b609-aee8c4495e4d">10,488,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de5994570ca4c2d88f909bc24fd0c06_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzUtMy0xLTEtMA_9b6e6540-26c2-4475-8231-649aba9a25d2">10,421,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0baec8c73f084f299738f9079b65dd67_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzUtNS0xLTEtMA_388da11d-135b-4eb4-9ada-156a22136248">10,274,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0420ed82e7024d998b6589e8747f9f7d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzYtMS0xLTEtMA_999b3775-51af-4f8c-9856-54312a018714">144,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd8fa94d190c4eed9526f7bfc49e982b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzYtMy0xLTEtMA_d449cc0b-02d1-4868-9bb3-d186f0dc25e3">131,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6be2ddd91d4f4088ed90946f8137ab_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzYtNS0xLTEtMA_5ab0bc86-3898-4914-a405-aebe3405c5af">92,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis revenues before provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzctMS0xLTEtMA_b244f6e8-6ebc-4d8b-adb5-a96edafd3b7e">10,632,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzctMy0xLTEtMA_e3607715-5fec-4017-ad56-b9c7993b88e3">10,552,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzctNS0xLTEtMA_8769f07f-b1ea-4b87-b239-4f216ca11618">10,366,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for uncollectible accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:ProvisionForExpectedCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzgtMS0xLTEtMA_71e17bfc-14ba-4960-982d-152d3d268e1d">13,458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:ProvisionForExpectedCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzgtMy0xLTEtMA_c9ed3aad-af4c-478a-8085-f6b88ee51e3d">21,715</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:ProvisionForExpectedCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzgtNS0xLTEtMA_75525527-5e26-4d53-8446-8eb198a9960c">50,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzktMS0xLTEtMA_e9208d1b-df36-4068-9023-70454ff9e42d">10,619,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzktMy0xLTEtMA_7f1f9a8f-7262-4dd4-a326-9da68bf7df53">10,530,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzktNS0xLTEtMA_1f4be21a-15b6-4668-b2cb-e5bbce377f26">10,316,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c3be00a520d4ae2958de6ed78743b3f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzExLTEtMS0xLTA_c8ba4f00-6e6a-4ca7-81ce-b522d74ba281">39,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de5994570ca4c2d88f909bc24fd0c06_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzExLTMtMS0xLTA_5ed964f1-0c9c-4ab7-bd0b-a6c9ecd6db48">30,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0baec8c73f084f299738f9079b65dd67_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzExLTUtMS0xLTA_eec8e33b-201a-4495-89ef-fc5f11296f14">19,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0420ed82e7024d998b6589e8747f9f7d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEyLTEtMS0xLTA_d9daff83-cb16-4e85-b18a-55ce9435f9e9">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd8fa94d190c4eed9526f7bfc49e982b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEyLTMtMS0xLTA_0faeb2b9-8bdf-42b5-bd2b-42c5359578e2">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6be2ddd91d4f4088ed90946f8137ab_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEyLTUtMS0xLTA_759b94f4-7d5a-47f4-8340-8857fd5f7588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEzLTEtMS0xLTA_3178bcd8-a481-4ebb-b67e-3297f47e2d2c">10,659,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEzLTMtMS0xLTA_c0baf57a-b90a-4984-b6da-f45a45132d6a">10,562,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEzLTUtMS0xLTA_c430e600-b779-473b-9d52-2a72e51f7657">10,335,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE1LTEtMS0xLTA_fe469eb2-46ac-4494-a62c-9df5d4bb1850">550,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE1LTMtMS0xLTA_e823f06b-a9cb-4e70-9188-10026366a645">497,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE1LTUtMS0xLTA_0b53ec36-f2f6-424c-89a9-3b4558391bf9">437,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE2LTEtMS0xLTA_e0d6c519-f4cc-4e28-a3ab-5b84035cf22b">484,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE2LTMtMS0xLTA_6888827f-e7da-48bc-bc77-2e142f90b401">460,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE2LTUtMS0xLTA_3712ecd7-86b7-4436-b032-43d39d710aaf">724,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d0245cc46dc4065a8942a8b290f03b4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE3LTEtMS0xLTA_8ed30af5-5709-445f-81d1-b4e304b927b4">16,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i250b62935f564b88b9b115cc2724bca5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE3LTMtMS0xLTA_35ddcc37-26c0-4134-8b74-4c6c97f5e0d3">14,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15645add5fe64f3da803a62328e47752_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE3LTUtMS0xLTA_69fbfb25-3027-4797-892b-aaa189a5cff9">34,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE4LTEtMS0xLTA_cb0085cf-c1b6-4970-9a83-4bd9a89bf82c">1,052,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE4LTMtMS0xLTA_d6a83cb4-8937-4633-a032-b4cfe4b849fd">971,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE4LTUtMS0xLTA_ac970825-428e-4419-8b7c-b91f0b6a903d">1,196,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d063b2501144da199dc74e77efdc1c8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE5LTEtMS0xLTA_1da83766-e3b5-4947-9303-6db47249eb7b">11,712,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50bc107b4f0a4837842f4727bce2675b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE5LTMtMS0xLTA_9125df7e-e5c5-410a-b6f7-92f25fa195e6">11,534,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326bc266ccc04e9085736f4e63bfcd54_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE5LTUtMS0xLTA_d8323905-6cfc-47f7-9c66-aae808d858e6">11,532,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635c2eebb9e64938a68735ae6c593657_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIwLTEtMS0xLTA_23b89039-7fa3-42ce-8617-0bb01a2f2a13">162,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9b9ab0e8584df69e653fc61911e0cc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIwLTMtMS0xLTA_e5fae141-98d3-4b23-9983-25a2a1ce708d">146,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a04f4ad256b450eb154971edb661d29_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIwLTUtMS0xLTA_9503450a-0215-4279-b875-10b7d26046fa">127,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIxLTEtMS0xLTA_85e4ff00-68d1-454f-a62d-399a537124aa">11,550,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIxLTMtMS0xLTA_22c7eba3-dd81-4e20-a3a1-9db36d5d5493">11,388,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIxLTUtMS0xLTA_96e58ddb-5714-43f4-b552-2755d0ce8ae3">11,404,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIzLTEtMS0xLTA_4e2bbc82-49e7-40f6-8b0d-0f0e3c4575db">1,917,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIzLTMtMS0xLTA_5993147c-14c6-4770-afdd-a20dbcdffb50">1,924,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIzLTUtMS0xLTA_033c636f-29fb-49bc-9ccd-de150e48d875">1,709,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI0LTEtMS0xLTA_f72ef024-bda9-4eea-98e1-cdfeaf4fd4e9">76,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI0LTMtMS0xLTA_76c2e283-b031-43c8-9eb7-daa1a472ced8">189,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI0LTUtMS0xLTA_1f829b73-aa50-4b5a-973e-8a9898527f4d">93,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d063b2501144da199dc74e77efdc1c8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI1LTEtMS0xLTA_7e699d62-5f41-4c3d-a78a-e4b2fdbf344b">1,841,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50bc107b4f0a4837842f4727bce2675b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI1LTMtMS0xLTA_1e5512ab-4b7f-4d77-8785-4c9febd720ef">1,735,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326bc266ccc04e9085736f4e63bfcd54_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI1LTUtMS0xLTA_2b00819b-0f9a-409a-8e3e-352f19141ced">1,615,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating margin to consolidated income from<br/> continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:SegmentReportingInformationCorporateExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI3LTEtMS0xLTA_584d0321-e0b3-467c-99cb-70705ae675ed">146,707</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:SegmentReportingInformationCorporateExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI3LTMtMS0xLTA_10dc816b-2e89-4bf8-b77d-319f40a86d6b">92,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="dva:SegmentReportingInformationCorporateExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI3LTUtMS0xLTA_50406915-8778-4a25-be54-f1bd734a23ef">90,108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI4LTEtMS0xLTA_5ed90504-f1f3-4341-82de-1af88e27d426">1,694,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI4LTMtMS0xLTA_44e64bb2-4fd8-4f8e-a1ce-26ccd4802e02">1,643,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI4LTUtMS0xLTA_7c82b06e-d885-42b0-96d9-8cbf9cd81138">1,525,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI5LTEtMS0xLTA_a47e7cd2-0a4c-4527-bcdc-11d9131d093b">304,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI5LTMtMS0xLTA_9194548f-eab6-4c4f-9aca-09bf577ca656">443,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI5LTUtMS0xLTA_87c3cab9-e9f1-4799-a473-e0f41b8554c8">487,435</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMwLTEtMS0xLTA_3292df5e-4ff5-4532-8074-18bde157cc89">89,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMwLTMtMS0xLTA_8985fb03-73a3-425b-881d-8aeee9931c8f">33,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMwLTUtMS0xLTA_250da049-6ff3-43d5-a260-6afc82e23ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMxLTEtMS0xLTA_6402c34a-0213-42d0-a972-c6b4cfa134f0">16,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMxLTMtMS0xLTA_a827941b-62c9-4046-9add-1d4b709bce20">29,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMxLTUtMS0xLTA_121cca0c-61fb-43a9-81b4-00542ed6a142">10,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMyLTEtMS0xLTA_2c6ef2b5-5042-4fbe-a5aa-7cabba0cb12d">1,318,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMyLTMtMS0xLTA_ad66ddbc-64e9-451c-bfe3-d97befa85086">1,195,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMyLTUtMS0xLTA_b154cac0-7120-45ef-953c-9246a2b6fec6">1,048,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes management fee revenues from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling interest or which are wholly-owned by third parties.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity investment income of $<ix:nonFraction unitRef="usd" contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzExNTQ0ODcyMDk2Mzgy_81ca4088-a8e7-4001-bd7b-d2e697762010">5,866</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzExNTQ0ODcyMDk2Mzk1_05daf0c5-2538-4f3d-ada0-aadb36a34648">9,366</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzExNTQ0ODcyMDk2NDA5_d3eb7d4e-9164-452a-afb0-c751057fdf8d">24,866</ix:nonFraction> in 2020, 2019 and 2018, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div><ix:continuation id="ia3fb0d64847b4fd282131b85346c3d09"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MTg_5ed4d712-6709-4780-b691-51677745dfbc" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:48.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzItMS0xLTEtMA_c503f0e8-3453-452b-9074-6f3fe83f20cf">594,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzItMy0xLTEtMA_06252182-5042-4965-a2d6-c31a524105dd">583,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzItNS0xLTEtMA_a0449fa4-f786-48bd-a106-b384bf445431">558,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzMtMS0xLTEtMA_ccdae1fa-048e-427b-b9b6-47636849d29a">35,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzMtMy0xLTEtMA_4f37ba08-92f6-4472-9882-8905fc92e9fe">31,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d8743c3594411698541aa578ec2aff_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzMtNS0xLTEtMA_c29b24ef-acc2-4bb2-a3a4-3b12677d7f94">32,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzQtMS0xLTEtMA_6f890550-45f0-454f-8de0-4460a6e752f8">630,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzQtMy0xLTEtMA_039c3fd1-ca40-4ded-9af5-a88f4b2f34b9">615,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzQtNS0xLTEtMA_2d03e681-5f7b-446d-bdf9-5e74be1363da">591,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MTU_a106a95b-fd68-4596-b9e1-5bed429b23ee" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summary of assets by reportable segment was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"></td><td style="width:58.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzMtMS0xLTEtMA_8c661a34-f1a8-493a-a7b9-510285b82e6a">15,344,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if638379c314e4e40a080f1df9bc6d4eb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzMtMy0xLTEtMA_77328b71-9ecf-4204-bc2e-c738e4db96e2">15,778,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18749a859234cf7b23652f60c460caf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzQtMS0xLTEtMA_4e62f4f4-a916-4e39-a637-ca2911241378">1,643,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzQtMy0xLTEtMA_1746b0df-facf-4912-9bec-185705e83cda">1,532,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzYtMS0xLTEtMA_ad59549c-eae5-4533-8320-a210d0e558ec">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f8139875c457e969c8ed421c88028_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzYtMy0xLTEtMA_350e7a31-a11a-4e13-ab84-6c33557aed75">17,311,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $<ix:nonFraction unitRef="usd" contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMxODI_1549e6fa-048c-4b4c-b084-403123fd0fa9">122,974</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if638379c314e4e40a080f1df9bc6d4eb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMxNzc_e878544e-8667-40b5-ae8a-8196deb01989">124,188</ix:nonFraction> in 2020 and 2019, respectively. </span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $<ix:nonFraction unitRef="usd" contextRef="if18749a859234cf7b23652f60c460caf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMzMTM_58b18f38-5a73-499c-a9a1-8146484f02d0">134,517</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMzMDg_3cfb53e8-e521-480b-b1fa-9051639a79a2">117,795</ix:nonFraction> in 2020 and 2019, respectively and includes approximately $<ix:nonFraction unitRef="usd" contextRef="i60ede493ecc1446dacb46d6cfbf3cac9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzMzOTg_17540873-47c6-4161-acba-8d03c3cd20ff">181,137</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if5953439c8d14af49838fde6e6488453_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM0MDU_559e4067-3310-4ed9-a8c8-0891541d5011">154,572</ix:nonFraction> in 2020 and 2019, respectively, of net property and equipment related to the Company&#8217;s international operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MDc_01f1b3d4-5d75-4da1-a0be-808f5d252b94" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:48.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzItMS0xLTEtMA_658f86bc-36b6-4df3-9d64-110b178dd498">646,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzItMy0xLTEtMA_410cd2f7-79fc-4e6a-a8d9-fcb71f120c40">681,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzItNS0xLTEtMA_9dec2d4d-edf1-4b65-9097-07a1536ea6e6">856,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzMtMS0xLTEtMA_c6bf8ca3-b5b8-44fd-82b0-af857092bffd">27,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzMtMy0xLTEtMA_3df9cc50-1592-4a4c-8ad3-428e9cfbd28a">46,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d8743c3594411698541aa578ec2aff_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzMtNS0xLTEtMA_8731246e-667b-4a01-9111-f508844d8f0d">45,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG - Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6163ef4be0a465f90685726ac832a2b_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzQtMS0xLTEtMA_5c4d448c-aec3-45dc-a080-d17f2b0f1e14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d2a102026c4112b723366408486f2d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzQtMy0xLTEtMA_fe9697ff-67e9-4a61-b069-c00126607fbb">38,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa612087266445208d57b0d501856183_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzQtNS0xLTEtMA_17e56f3c-18d4-417c-bc6b-2b9892d9ef47">85,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzUtMS0xLTEtMA_9caf0457-afd9-41c1-b985-4ee918c82e1b">674,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzUtMy0xLTEtMA_9a5255fa-4ff9-4f16-b60b-b3ce61c0a1d7">766,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzUtNS0xLTEtMA_b975d8f4-b823-4d80-b823-124ef6f26381">987,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i878840fee65247deaca27d2dd6a8246f_301"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">26.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90ZXh0cmVnaW9uOjlkYmI5MWJlNzA2YTQ0M2M5Y2Q5ODUxYjY3ODA2YzdkXzExMw_b50f3add-8bd1-4619-8ef5-a1d4b474a087" continuedAt="ie0f3986b1512461f83448c9b9ae7a9d1" escape="true">Supplemental cash flow information</ix:nonNumeric></span></div><ix:continuation id="ie0f3986b1512461f83448c9b9ae7a9d1"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90ZXh0cmVnaW9uOjlkYmI5MWJlNzA2YTQ0M2M5Y2Q5ODUxYjY3ODA2YzdkXzEwOQ_4a4dfa91-c566-4b27-83ee-479d61db0d22" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides supplemental cash flow information:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"></td><td style="width:49.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzMtMS0xLTEtMA_dc7b0c4c-050e-4704-ae96-0c5189c6d7fa">154,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzMtMy0xLTEtMA_0fd5eb3e-07f0-445a-8a79-0bbb4ea137ad">157,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzMtNS0xLTEtMA_3e3202bf-0c04-4e26-965d-89a284422ec4">92,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzQtMS0xLTEtMA_9431f2e3-cf92-4d37-bca4-e25774e0a534">326,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzQtMy0xLTEtMA_c5667491-9fed-4259-a07e-3e4d10b50a18">473,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzQtNS0xLTEtMA_a6abe737-442d-49e5-9253-8b4c797d0908">488,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets under financing lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzYtMS0xLTEtMA_1e16cb96-582a-4356-8fc3-e926e76f1c6b">22,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzYtMy0xLTEtMA_ef36a533-fced-40b9-9ed9-5c02d57166e4">18,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzYtNS0xLTEtMA_867214b3-9948-4af5-af41-11be543b82b0">8,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_304"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90ZXh0cmVnaW9uOjUzMDQ2MjBjMmUzZDQ0MDg5NTdjMThiNmMxNjYwZWY1XzMzOQ_e4fae9b7-6ab1-4889-b1ef-d1a5571d9104" continuedAt="i2fdc8a3615064709a6ce3bc2cb44efde" escape="true">Selected quarterly financial data (unaudited)</ix:nonNumeric></span></div><ix:continuation id="i2fdc8a3615064709a6ce3bc2cb44efde"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90ZXh0cmVnaW9uOjUzMDQ2MjBjMmUzZDQ0MDg5NTdjMThiNmMxNjYwZWY1XzMzNQ_866393cb-0dd6-4857-ac7b-4eafdbf59a41" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItMS0xLTEtMA_68fafaa2-de52-4e70-9329-9937b04d5240">2,905,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItMy0xLTEtMA_3c24706f-2dae-4a9c-89c1-1d7dc86f7b5c">2,924,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItNS0xLTEtMA_d915eb25-a0c1-4848-af64-6ec7fc7aca1f">2,879,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItNy0xLTEtMA_9f61e6e0-8b23-4613-912c-248eb413d1d3">2,841,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtMS0xLTEtMA_115d5ff6-b079-419e-876e-c985692d98bc">381,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtMy0xLTEtMA_de3338d0-d819-45e5-b923-4ba291c6b337">437,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtNS0xLTEtMA_94493c98-881c-425c-9c8d-6002388892c7">409,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtNy0xLTEtMA_2d335ada-cff8-4498-87d8-fe10c9325bd1">465,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtMS0xLTEtMA_5a4d3b6d-9821-4102-940c-064b0466e653">193,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtMy0xLTEtMA_bf5b761a-8b43-4159-863e-bcdc6c7d3632">158,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtNS0xLTEtMA_e20d8b0d-5510-43c6-9a14-d63b910cdb23">201,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtNy0xLTEtMA_9ecda216-6374-4145-ba6d-3149b85691a1">229,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtMS0xLTEtMA_8f1c0437-c871-4b25-aa15-d0eef099aac1">19,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtMy0xLTEtMA_43025286-f001-4240-8795-68345380b591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtNS0xLTEtMA_40a1ca7b-dacd-4a06-bd2e-cb1f69ece022">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtNy0xLTEtMA_1615837a-49a6-4a70-b037-dd959d6e70a0">9,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctMS0xLTEtMA_9625777e-27b7-4380-9e26-762f383b7d71">173,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctMy0xLTEtMA_d1921fbc-484d-41d9-a86e-06d185b983f2">158,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctNS0xLTEtMA_779c7bf5-a697-4726-a7dc-eeec2fb13077">201,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctNy0xLTEtMA_e0cb0ae1-1804-4ed3-b096-261833ca2e67">239,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktMS0xLTEtMA_75856f62-7145-4685-9ca6-858fa9a82a5a">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktMy0xLTEtMA_00f15c03-b5ad-4371-baeb-86e6376091dd">1.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktNS0xLTEtMA_c1151458-eca8-4bea-beac-70e9f3ed15a5">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktNy0xLTEtMA_fa0aff3a-e3a0-4b44-849f-df68541246da">1.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTEtMS0xLTA_3089d925-ab07-4231-b9ea-6c5e9317e224">0.17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTMtMS0xLTA_1313f05a-ddc6-4f92-8b73-8ed9ac76ffc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTUtMS0xLTA_475299d5-76c3-4bd9-87de-46e9ea0e12d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTctMS0xLTA_237015a7-ab7c-4176-a946-7443511874c0">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTEtMS0xLTA_1744bcc6-440a-4b7a-8c91-33e7989f693d">1.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTMtMS0xLTA_9751054e-2ce5-4497-a38a-abbe0faf33da">1.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTUtMS0xLTA_0c2ed491-9c16-4cb9-942a-034989867d2f">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTctMS0xLTA_8ba65f3a-f8b8-4e31-9544-0e87ee52b427">1.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTEtMS0xLTA_0385e9c4-1da3-4652-aa2f-d7c1b35e6208">1.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTMtMS0xLTA_2bd1e808-1294-414f-bb9f-3ae00498613e">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTUtMS0xLTA_57285a59-ba25-4710-8bc9-7be2613e39eb">1.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTctMS0xLTA_f25c715c-df88-41a3-abec-010a0f581fd7">1.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTEtMS0xLTA_f59cc37f-0350-425f-b7bb-8b13b10e2b02">0.17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTMtMS0xLTA_cd18f409-51d5-40e0-a888-8995939a3310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTUtMS0xLTA_71e5ebd3-9417-45d7-9a03-8885b3bb78a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTctMS0xLTA_9f8a8ddb-6fc7-44d4-9730-7875a5261005">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTEtMS0xLTA_c4b2ce21-37a4-43ff-91f1-26a6d241e054">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTMtMS0xLTA_65951574-77e7-42a3-8a8f-210ee8b4e184">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTUtMS0xLTA_80b8c896-9a18-4580-a6e3-895d0a4e7799">1.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTctMS0xLTA_57d6e7e1-34fe-4da1-b2da-7f1f348adc89">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTEtMS0xLTA_8a2264cf-66c9-4584-bd58-e82f539927b8">2,898,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTMtMS0xLTA_b0a1dea3-9c40-4abb-a28d-e8a3b68ba1ef">2,904,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTUtMS0xLTA_3fdaebca-8cb7-4993-85f2-0a29b68422b2">2,842,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTctMS0xLTA_5ff8301a-5517-400d-aa5d-87e0974d2ee2">2,743,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTEtMS0xLTA_b61f5a20-7bb3-440c-a026-909da8949cba">462,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTMtMS0xLTA_0bd31919-815a-4451-a7f4-ea5c8b97be0f">378,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTUtMS0xLTA_ae5b7963-2445-4581-938a-612fd3ce1d08">461,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTctMS0xLTA_66336458-6a10-4ef0-8705-48857e077704">340,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTEtMS0xLTA_d60dd19d-26d1-4349-8448-bffc05be1883">242,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTMtMS0xLTA_561cae5f-0eaf-40be-ad0c-3b00fba390a6">150,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTUtMS0xLTA_1678ee36-a0fe-4542-9ee8-b7ee8385b2fb">194,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTctMS0xLTA_7c861728-3b02-476b-b5b3-ba83bfda46bd">120,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTEtMS0xLTA_61976ed3-2a53-483c-86d1-d27fbe26155e">2,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTMtMS0xLTA_56c9ce2d-2acf-4249-9e10-a22082d381a5">6,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTUtMS0xLTA_7f75fa2e-9d17-4ee6-857d-63c72da8b54e">79,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTctMS0xLTA_38255493-8752-4ee1-82fe-151b28a0971b">29,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTEtMS0xLTA_8df342f2-7287-445f-9ac6-c15c299853a0">244,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTMtMS0xLTA_65995f7d-19ec-45c1-8ae0-52f04f29cac8">143,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTUtMS0xLTA_22e970c8-c97a-46ed-8b2d-33283f4dfc2c">273,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTctMS0xLTA_e361ee83-057d-4fbf-85d6-098c5cbcf4a1">149,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTEtMS0xLTA_038275ce-d3ed-4308-85dc-4156ab869b84">1.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTMtMS0xLTA_a00e1f4c-371f-4fed-854a-c085fe00023d">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTUtMS0xLTA_cf73bb7b-116e-49d9-ab53-f76727f3fb8c">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTctMS0xLTA_bbd70137-e62c-48f1-be2a-bb6dc6403512">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTEtMS0xLTA_d5995e34-2883-4684-aff8-22124d7309d8">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTMtMS0xLTA_819125ed-4490-449b-b676-48c7376c1ea5">0.05</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTUtMS0xLTA_57160bb5-c5bb-4831-80f2-bc05876d6540">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTctMS0xLTA_f0d5b71c-9b5d-4987-94cc-3a9265459717">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTEtMS0xLTA_43c78b95-0291-432c-8e86-98174174aab8">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTMtMS0xLTA_d86fe083-f0f2-4743-a7ea-7c076b9dd3f1">0.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTUtMS0xLTA_ef504e43-c537-4af1-991d-5a824c8fef3c">1.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTctMS0xLTA_2f4197f4-5c27-4e96-bcf5-a65e299cfe35">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTEtMS0xLTA_8a0c1df3-e3b8-4067-a62f-0bbff8c52b75">1.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTMtMS0xLTA_504f9df6-44cc-4431-b08a-d6be80b643f8">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTUtMS0xLTA_76996ff7-c0ba-4f62-aec0-ff27a0adf28d">1.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTctMS0xLTA_49dd73d0-ca56-41ce-ab6a-5035fb0eca71">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTEtMS0xLTA_40d737cf-6b7e-4371-b132-e5d26052b84a">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTMtMS0xLTA_8c4dc5d0-358b-495b-89cd-408f4c18a308">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTUtMS0xLTA_640c4cd9-736c-4bf4-bbba-0e1cc76d7209">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTctMS0xLTA_b8ac4918-62fe-4613-9f4a-db18497a71b1">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTEtMS0xLTA_22053bbc-4fda-4adf-b0f4-9297b5dd43a3">1.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTMtMS0xLTA_3fce21ce-d7ad-4c75-98b7-6f156f86dc52">0.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTUtMS0xLTA_f6b60edc-f614-403a-bae4-54c1f45ad1e7">1.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTctMS0xLTA_292ee9ca-50e3-45aa-9a4b-89af44e88b29">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The following table summarizes impairment charges, loss on changes in ownership interest, and a legal settlement included in operating expenses and charges in 2020 and 2019 by quarter:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:489.00pt"><tr><td style="width:1.0pt"></td><td style="width:108.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">&#160;Quarter ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">&#160;Quarter ended</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">December&#160;31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">December&#160;31,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">September 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">June 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">March 31,<br/>2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Certain operating expenses<br/> and charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32f22662e54432da57bda5635cea91f_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzMtMTEtMS0xLTA_e50ac15a-4956-40eb-8ffc-af885939f2f1">83,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b594af4c5946d799a66354ffb0bb8e_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzMtMTUtMS0xLTI0NDg_4e7bdbc7-e57c-45eb-b50e-c9005e7566ea">41,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on changes in<br/> ownership interest, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4aa6d5d9f647368ce987a4ceb5e733_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzQtNS0xLTEtMjQ0Mw_637c2c95-ecdd-4e52-b68b-7ade42e5c57d">16,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accruals for legal matters</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640e3c80e07c4131ab855012b2ae413d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzUtNS0xLTEtODUzOA_6c5709df-745d-4bb4-9c1f-f68e26d07fa8">35,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_313"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:8.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312517362136/d496893dex101.htm">2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Purchase Agreement, dated as of December 5, 2017, by and among DaVita Inc., Collaborative Care Holdings, LLC, and solely with respect to Section 9.3 and Section 9.18 thereto, UnitedHealth Group Incorporated.(2)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312518280459/d621366dex101.htm">2.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 dated as of September 20, 2018, to that certain Equity Purchase Agreement, dated as of December 5, 2017, by and among DaVita, Inc., a Delaware corporation, Collaborative Care Holdings, LLC, a Delaware limited liability company and a wholly owned subsidiary of Optum, Inc., and solely with respect to Section 9.3 and Section 9.18 thereto, UnitedHealth Group Incorporated, a Delaware corporation.(22)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312518350364/d658923dex101.htm">2.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Equity Purchase Agreement by and between DaVita, Inc., a Delaware corporation, and Collaborative Care Holdings, LLC, a Delaware limited liability company, dated as of December 11, 2018, amending that certain Equity Purchase Agreement, dated as of December 5, 2017, by and among DaVita, Inc., Collaborative Care Holdings, LLC, and, solely with respect to Section&#160;9.3 and Section 9.18 thereto, UnitedHealth Group Incorporated (as previously amended).(11)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000156459016027049/dva-ex31_1170.htm">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Certificate of Incorporation of DaVita Inc., as filed with the Secretary of State of Delaware on November 1, 2016.(1)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000266/ex31-davitaamendedandr.htm">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws for DaVita Inc. dated as of December 10, 2020.(33)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000125/exhibit41-indenture692.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture for the 4.625% Senior Notes due 2030, dated as of June 9, 2020, by and among DaVita Inc., the subsidiary guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as Trustee.(20)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000125/exhibit41-indenture692.htm">4.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 4.625% Senior Notes due 2030 and related Guarantee (included in Exhibit 4.1).(20)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000177/ex41-indentureaugust20.htm">4.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture for the 3.750% Senior Notes due 2031, dated August 11, 2020, by and among DaVita Inc., the subsidiary guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as Trustee.(17)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000177/ex41-indentureaugust20.htm">4.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.750% Senior Notes due 2031 and related Guarantee (included in Exhibit 4.3).(17)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000014/dva-123119ex45.htm">4.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Securities.(28)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000162828017004680/dva-33117ex101.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sourcing and Supply Agreement between DaVita Inc. and Amgen USA Inc. effective as of January 6, 2017.(5)**</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000137/ex1012019creditagreement.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit Agreement, dated August 12, 2019, by and among DaVita Inc., certain subsidiary guarantors party thereto, the lenders party thereto, Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A. and MUFG Bank Ltd., as co-syndication agents, Bank of America, N.A., Barclays Bank PLC, Credit Suisse Loan Funding LLC, Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc. and Suntrust Bank, as co-documentation agents, and Wells Fargo Bank, National Association, as administrative agent, collateral agent and swingline lender.(24)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000014/dva-123119ex103.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment, dated as of February 13, 2020, to that certain Credit Agreement, dated as of August 12, 2019, by and among DaVita Inc., certain subsidiary guarantors party thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent, collateral agent and swingline lender.(28)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312508162468/dex101.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective July&#160;25, 2008, between DaVita Inc. and Kent J. Thiry.(12)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000025/dva-123118xex1010.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Employment Agreement, effective December 31, 2014, by and between DaVita Inc. and Kent. J. Thiry.(3)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706618000167/exhibit101.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment Number Two to Employment Agreement, effective August 20, 2018, by and between DaVita Inc. and Kent J. Thiry.(23)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 1 of 5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:8.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519123788/d726706dex102.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Chairman Agreement between Kent J. Thiry and DaVita, Inc., dated as of April 29, 2019.(13)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d28.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units Agreement, effective as of May 15, 2019, by and between DaVita Inc. and Kent Thiry.(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d29.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance Stock Units Agreement, effective as of May 15, 2019, by and between DaVita Inc. and Kent Thiry.(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519123788/d726706dex101.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated as of April 29, 2019, by and between Javier J. Rodriguez and DaVita Inc.(13)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000202/dva-def14a.htm#sE0D95A9952875B7195329C9BDDFC0BDC">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Appreciation Rights Agreement, effective November 4, 2019, by and between Javier J. Rodriguez and DaVita Inc.(27)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000156459017002409/dva-ex1013_1293.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective February 21, 2017, by and between DaVita Inc. and Joel Ackerman.(8)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000162828017004680/dva-33117ex102.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective April 27, 2016, by and between DaVita HealthCare Partners Inc. and Kathleen A. Waters.(5)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312506162730/dex101.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective September&#160;22, 2005, by and between DaVita Inc. and James Hilger.(7)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312509040883/dex1012.htm">10.15</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Mr. Hilger&#8217;s Employment Agreement, effective December 12, 2008.(15)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312513085450/d465470dex1010.htm">10.16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Mr. Hilger&#8217;s Employment Agreement, effective December 27, 2012.(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000025/dva-123118xex1019.htm">10.17</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amendment to Employment Agreement, effective December 31, 2014, by and between DaVita Inc. and James Hilger.(3)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706618000165/dva-63018xex105.htm">10.18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition Agreement, dated as of July 31, 2018, by and between DaVita Inc. and James Hilger.(21)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000014/dva-123119ex1021.htm">10.19</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective April 29, 2015, by and between DaVita HealthCare Partners Inc. and Michael Staffieri.(28)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000164/dva-63020ex101.htm">10.20</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amendment to Stock Appreciation Rights Agreements, effective June 11, 2020, by and between DaVita Inc. and William L. Roper, M.D.(30)*</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000215/dva-93020ex104.htm">10.21</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition Agreement, dated October 1, 2020, by and between DaVita Inc. and LeAnne Zumwalt.(32)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312506257237/dex101.htm">10.22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnity Agreement.(10)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312505041002/dex1028.htm">10.23</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnity Agreement.(6)*</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000156459017002409/dva-ex1016_1294.htm">10.24</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Deferred Compensation Plan.(8)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312505218458/dex101.htm">10.25</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Voluntary Deferral Plan.(4)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312508042304/dex1030.htm">10.26</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Bonus Plan (Prosperity Plan).(14)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312509040883/dex1035.htm">10.27</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to Deferred Bonus Plan (Prosperity Plan).(15)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000104746916013062/a2228594zdef14a.htm#du73201_stockholder_proposals_for_2017_annual_meeting">10.28</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Employee Stock Purchase Plan.(26)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000025/dva-123118xex1032.htm">10.29</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. Severance Plan for Directors and Above.(3)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 2 of 5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:8.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000073/dva-33120ex101.htm">10.30</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. Non-Employee Director Compensation Policy.(16)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312514163315/d701196ddef14a.htm#toc701196_76">10.31</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated DaVita Inc. 2011 Incentive Award Plan.(9)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000202/dva-def14a.htm#s443F0CA95E025906867096037A067CF7">10.32</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to the Amended and Restated DaVita Inc. 2011 Incentive Award Plan.(27)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000064/dva-123119xdef14a.htm">10.33</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. 2020 Incentive Award Plan.(29)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706618000167/exhibit102.htm">10.34</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. Rule of 65 Policy, adopted on August 19, 2018.(23)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706618000165/dva-63018xex101.htm">10.35</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Board members (DaVita Inc. 2011 Incentive Award Plan).(21)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312513085450/d465470dex1061.htm">10.36</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312511210603/dex103.htm">10.37</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(19)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312513085450/d465470dex1062.htm">10.38</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Long-Term Incentive Program Award Agreement (For 162(m) designated teammates) (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312513085450/d465470dex1063.htm">10.39</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Long-Term Incentive Program Award Agreement (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d22.htm">10.40</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d23.htm">10.41</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d24.htm">10.42</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d25.htm">10.43</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d26.htm">10.44</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d27.htm">10.45</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312520221812/d905943dex99d31.htm">10.46</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement (DaVita Inc. 2020 Incentive Award Plan).(31)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312520221812/d905943dex99d32.htm">10.47</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Agreement (DaVita Inc. 2020 Incentive Award Plan).(31)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312520221812/d905943dex99d33.htm">10.48</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Agreement (DaVita Inc. 2020 Incentive Award Plan).(31)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123120ex211.htm">21.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">List of our subsidiaries.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123120ex231.htm">23.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of KPMG LLP, independent registered public accounting firm.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878840fee65247deaca27d2dd6a8246f_316">24.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Powers of Attorney with respect to DaVita. (Included on Page S-1).</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123120ex31110xk.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated February 12, 2021, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123120ex31210xk.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated February 12, 2021, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 3 of 5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:8.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123120ex32110xk.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated February 12, 2021, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123120ex32210xk.htm">32.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated February 12, 2021, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.735%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.413%"><tr><td style="width:1.0%"></td><td style="width:5.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.968%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in this filing.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or executive compensation plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the SEC.</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on November 2, 2016 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on December 6, 2017 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on February 22, 2019 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on November 8, 2005 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on May 2, 2017 as an exhibit to the Company&#8217;s Quarterly Report on 10-Q for the quarter ended March 31, 2017.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on March 3, 2005 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on August 7, 2006 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ending June 30, 2006.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on February 24, 2017 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on April 28, 2014 as Appendix A to the Company's Definitive Proxy Statement on Schedule 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on December 20, 2006 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on December 17, 2018 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on July 31, 2008 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on April 29, 2019 as an exhibit to the Company's Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on February 29, 2008 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2007.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on February 27, 2009 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on May 5, 2020 as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 11, 2020 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on March 1, 2013 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 4 of 5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 4, 2011 as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on June 9, 2020 as an exhibit to the Company's Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 1, 2018 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on September 24, 2018 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 23, 2018 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 14, 2019 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on July 22, 2019 as an exhibit to the Company&#8217;s Tender Offer Statement on Schedule TO-I. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on May 10, 2016 as an appendix to the Company's Proxy Statement on DEF 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on December 6, 2019 as an appendix to the Company's Proxy Statement on DEF 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on February 21, 2020 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on April 27, 2020 as an appendix to the Company's Proxy Statement on DEF 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on July 30, 2020 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 17, 2020 as an exhibit to the Company&#8217;s Tender Offer Statement on Schedule TO-I.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on October 29, 2020 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on December 10, 2020 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 5 of 5</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_316"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, we have duly caused this Annual Report on Form 10-K to be signed on our behalf by the undersigned, thereunto duly authorized, in the City of Denver, State of Colorado, on February&#160;12, 2021.</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.807%"><tr><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.552%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DAVITA INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Javier J. Rodriguez<br/>Chief Executive Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Javier J. Rodriguez, Joel Ackerman, and Kathleen Waters, and each of them his or her true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form&#160;10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Javier J. Rodriguez</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OEL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CKERMAN</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joel Ackerman</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> D. W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INSTEL</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John D. Winstel</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AMELA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> M. A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RWAY</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pamela M. Arway</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HARLES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> G. B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ERG</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles G. Berg</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ARBARA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESOER</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara J. Desoer</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AUL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IAZ</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul J. Diaz</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HAWN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> M. G</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UERTIN</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn M. Guertin</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> M. N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EHRA</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John M. Nehra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AULA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A. P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RICE</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paula A. Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HYLLIS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R. Y</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALE</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phyllis R. Yale</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-2</span></div></div></div><div id="i878840fee65247deaca27d2dd6a8246f_319"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90ZXh0cmVnaW9uOjZkY2FjNDk5Mzc4ZjRkYjA4MDhiMWYxNTBlY2NiOGMwXzY2_60253f1f-bbe8-4333-9e13-b0b5654ef50a" escape="true"><ix:nonNumeric contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90ZXh0cmVnaW9uOjZkY2FjNDk5Mzc4ZjRkYjA4MDhiMWYxNTBlY2NiOGMwXzY2_6540536d-9831-48e5-a635-87895e40e591" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:45.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.772%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>beginning of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts<br/>charged to income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts written off</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at end of year</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for uncollectible accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5a13855d6745d88e71a8dbda06352e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtMi0xLTEtMA_512a17bf-7ab3-4346-aefe-6ab548ed2af4">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtNC0xLTEtMA_792416e4-33b7-4dae-a3a6-fec43f4f5bd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtNi0xLTEtMA_3c4b27dd-a44e-4c75-a95a-cd45466e1117">13,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtOC0xLTEtMA_546f5ebe-01d3-4ad8-958f-8707cde6fc3d">21,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib323764e090d434bbb21570c9e96b6b0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtMTAtMS0xLTA_6648e765-bfa4-473a-9d43-dac18d2af013">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffbc38c3d5d4d4fad2bd3d8db1d28bd_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtMi0xLTEtMA_e9ee58de-bbb7-47c1-a1c9-6b7ec299d012">52,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtNC0xLTEtMA_49d1fe75-2877-42e9-9c27-0740afab1a5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtNi0xLTEtMA_ed9860ff-1555-40e7-b423-fbe6131f7237">21,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtOC0xLTEtMA_b39bccc7-0361-480d-805e-6f90602d68c5">66,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5a13855d6745d88e71a8dbda06352e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtMTAtMS0xLTA_438e440e-b2f6-4b05-8bf6-a22bdac967ea">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea338e77f4034e17a9b6e514cff7d6d3_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtMi0xLTEtMA_137c141b-d490-4d02-85e4-fb8e43451acb">218,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40704e0cd419424eaece0c344ca47892_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtNC0xLTEtMA_8bd36474-f8af-421b-a9f3-ad9800fa0dc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40704e0cd419424eaece0c344ca47892_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtNi0xLTEtMA_d052abb3-61ce-42af-a81a-3bc831249580">42,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40704e0cd419424eaece0c344ca47892_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtOC0xLTEtMA_3b874e5e-c097-4249-bcd4-935f99cbff2c">207,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffbc38c3d5d4d4fad2bd3d8db1d28bd_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtMTAtMS0xLTA_f4d36c2e-12b9-4321-abf4-01ab1ed5e080">52,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>dva-123120ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i566a3e2796ff4534bf36d0abf74f18ff_1"></div><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">Exhibit 21.1 </font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">SUBSIDIARIES OF THE COMPANY </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">as of December&#160;31, 2020&#160;</font></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aberdeen Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adair Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alenes Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Fork Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Medical Insurance, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Animas Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcadia Gardens Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arrowhead Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attell Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austin Dialysis Centers, L.P.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bainbridge Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bannon Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barnell Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barrons Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barton Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basin Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bastrop Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beck Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bellevue Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bemity Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beverly Hills Dialysis Partnership</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Birch Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bladon Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blanco Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bliss Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bluegrass Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bohama Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bothwell Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bottle Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bowan Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Braddock Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bretton Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridges Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brimfield Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brook Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brownsville Kidney Center, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brownwood Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruno Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buckhorn Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buford Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bullards Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bullock Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canyon Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canyon Springs Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capes Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Dialysis Partnership</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capron Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carlton Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Virgin Islands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Dialysis Facility Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Dialysis Facility, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cascades Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caverns Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centennial LV, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Carolina Dialysis Centers, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Georgia Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Iowa Dialysis Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Kentucky Dialysis Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cerito Dialysis Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Channel Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chantry Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheraw Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chipeta Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Churchill Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cimarron Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cinco Rios Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clark Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clayton Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinica Central do Bonfim S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica M&#233;dica DaVita Bandeirantes Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinton Township Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clyfee Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coast Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cobbles Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Columbus-RNA-DaVita, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commerce Township Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conconully Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continental Dialysis Center of Springfield-Fairfax, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continental Dialysis Centers, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coral Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Couer Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Court Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cowell Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cowesett Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crossings Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crystals Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cuivre Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Culbert Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curecanti Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas-Fort Worth Nephrology, L.P.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Damon Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita - Riverside II, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita - Riverside, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita - West, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita &#193;guas Claras Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita APAC Holding B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Bauru Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Brasil Participa&#231;&#245;es e Servi&#231;os de Nefrologia Ltda. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Care (Saudi Arabia)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Ceil&#226;ndia Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Dakota Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Deutschland AG</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Deutschland Beteiligungs GmbH &#38; Co. KG</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita EL Paso East, L.P.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Germany GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita HealthCare Brasil Servi&#231;os M&#233;dicos Ltda. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita International Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Kidney Care Contracting, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Nefromed Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Nephron Care Servi&#231;os de Nefrologia Ltda. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita of New York, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Rien Servi&#231;os de Nefrologia Ltda. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Asa Sul Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Boa Vista Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Campo Grande Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Cuiab&#225; Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia de Araraquara Ltda. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Guarulhos Ltda. </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Pacini Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Santos Dumont Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Sumar&#233; Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Taubat&#233; Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Sp. z o.o.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Sud-Niedersachsen GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Transrim Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita UK Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita UTR Servi&#231;os de Nefrologia Ltda. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita VillageHealth, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DC Healthcare International, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DeSoto Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis of Des Moines, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis of Northern Illinois, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dierks Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dighton Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dolores Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dome Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doves Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Downriver Centers, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DV Care Netherlands B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DV Care Netherlands C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare - Southwest Ohio, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Maryland, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Massachusetts, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of New London, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Norwich, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Tuscaloosa, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare Renal Care, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Holdings Pte. Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Laboratory Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA of New York, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Renal Healthcare, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dworsher Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East End Dialysis Center, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East Ft. Lauderdale, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ebrea Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Edisto Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elandon Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eldrist Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elk Grove Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Empire State DC, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Etowah Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ettleton Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eufaula Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EURODIAL - Centro de Nefrologia e Dialise de Leiria S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Falcon, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fanthorp Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal Way Assurance, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ferne Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fields Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five Star Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fjords Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flagler Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flamingo Park Kidney Center, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forester Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freehold Artificial Kidney Center, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fremont Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frontier Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fullerton Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ganois Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garner Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garrett Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gaviota Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GDC International, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gebhard Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genesis KC Development, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geyser Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gilwards Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GiveLife Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glassland Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glosser Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goliad Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gordina Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Great Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Las Vegas Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Los Angeles Dialysis Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Green Country Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Green Desert Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Griffin Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hanford Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harmony Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hart Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawn Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hazelton Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helmer Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hewett Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heyburn Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hilgards Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hochatown Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holten Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Kidney Care, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Honey Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Honeyman Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Houston Kidney Center&#47;Total Renal Care Integrated Service Network Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hummer Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hunter Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Huntington Artificial Kidney Center, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Huntington Park Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hyattsville Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hyde Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDC -International Dialysis Centers, Lda</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iroquois Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Corpus Christi, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD I Holding Company, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD II Holding Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Kendallville, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Las Vegas, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Lees Summit, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Renal, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Spring Valley, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Summit Renal Care, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacinto Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jenness Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kamiah Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kanika Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kavett Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kearn Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenai Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kershaw Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kidney HOME Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kimball Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kingston Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kinnick Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kinter Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kiowa Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Knickerbocker Dialysis, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Knotts Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kobuk Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lakeshore Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landing Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landor Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lassen Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasburg Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leawood Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legare Development LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liberty RC, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Park Dialysis Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincolnton Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Livingston Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Llano Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lofield Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Logoley Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lone Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long Beach Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Baltimore Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lory Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loup Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lourdes Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyndale Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madigan Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magney Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Makonee Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammoth Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manzano Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maple Grove Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlton Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marseille Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mashero Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mason-Dixon Dialysis Facilities, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mazonia Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mellen Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melnea Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial Dialysis Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mendocino Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meridian Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mermet Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middlesex Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milltown Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minam Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneopa Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monad Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monett Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Morro Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mountain West Dialysis Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mulgee Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Alzey GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Aurich GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Bad Aibling GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Bad Duben GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Dillenburg GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Dinkelsbuhl GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Dormagen GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Duisburg GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Elsterland GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Emden GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Falkensee GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Geilenkirchen GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Gera GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Iserlohn GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Neuss GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Nierenzentrum Aachen Alsdorf GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Nierenzentrum Berlin-Britz GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Nierenzentrum Hamm-Ahlen GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Prenzlau-Pasewalk GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Rhein-Ahr GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Rhein-Ruhr GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Viersen GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Myrtle Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nansen Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natomas Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nauvue Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Navarro Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neoporte Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nephrology Practice Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neptune Artificial Kidney Center, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Bay Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Springs Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norte Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Austin Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oasis Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Odiorne Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio River Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Okanogan Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olive Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordust Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Osage Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owens Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owyhee Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palo Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palomar Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Panther Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient Pathways, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patuk Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peaks Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pearl Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pendster Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percha Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pershing Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfeiffer Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philadelphia-Camden Integrated Kidney Care, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Choice Dialysis Of Alabama, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Choice Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Dialysis Acquisitions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Dialysis of Lancaster, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Dialysis Ventures, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pible Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pinewoods Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pittsburgh Dialysis Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Piute Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plaine Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platte Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise - Benfica, S.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise - Cascais, S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise - Sacavem, S.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise, S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poinsett Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pokagon Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portola Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prineville Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pronomed Cl&#237;nica M&#233;dica Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pyramid Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramsey Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Randolph Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rayburn Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Red Willow Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redcliff Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refuge Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Beaumont, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Fort Dodge, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Lewisville, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Morristown, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Newton, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of North Denton, L.L.L.P.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Port Arthur, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Sewell, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of the Hills, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Tyler, L.P.L.L.L.P.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of West Beaumont, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Westwood, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Life Link, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Services (UK) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - California, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Illinois, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Mid-Atlantic, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Northeast, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Southeast, LP</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - West, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Ventures Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RenalServ LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riddle Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ringwood Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rio Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">River Valley Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RNA - DaVita Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rochester Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rocky Mountain Dialysis Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rollins Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roose Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roushe Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routt Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royale Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rusk Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russell Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rutland Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RV Academy, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saddleback Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sahara Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAKDC-DaVita Dialysis Partners, L.P.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Marcos Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sands Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santiam Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sapelo Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saunders Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seabay Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secour Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sensiba Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shadow Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shayano Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelling Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sherman Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shetek Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shining Star Dialysis, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Siena Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silverwood Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simeon Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skagit Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soledad Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somerville Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Central Florida Dialysis Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Florida Integrated Kidney Care, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Fork Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern Hills Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Atlanta Dialysis Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sprague Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Springpond Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Star Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stevenson Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stewart Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stines Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Storrie Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sugarloaf Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun City Dialysis Center, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun City West Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunapee Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunset Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Talimena Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Targhee Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tarley Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenack Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee Valley Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terre Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Woodlands Dialysis Center, LP</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tortugas Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Care Of North Carolina, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Care Texas Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Care, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Laboratories, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Research, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Toulouse Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Townsend Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transmountain Dialysis, L.P.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC - Indiana, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC - Petersburg, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC EL Paso Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC of New York, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC West, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC-Georgetown Regional Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District Of Columbia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tross Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tugman Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tumalo Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tunnel Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turlock Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tustin Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twain Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyler Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukiah Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unicoi Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">University Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upper Valley Dialysis, L.P.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USC-DaVita Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Springs Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vancleer Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Victory Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VillageHealth DM, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Villanueva Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vively Health, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vogel Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volo Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waddell Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Walker Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Walton Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watkins Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weldon Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Elk Grove Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Sacramento Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weston Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whitney Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Willowbrook Dialysis Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Winds Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wood Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Woodford Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wyandotte Central Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ybor City Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yucaipa Dialysis, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zara Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zephyrhills Dialysis Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>dva-123120ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i994f370ac9cc465c9d8c54496bcb9df9_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:63pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-bottom:20pt;text-align:center"><font><br></font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors <br>DaVita Inc.&#58;</font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the registration statements on Form S-8 (No. 333-240022, No. 333-239191, No. 333&#8209;213119, No. 333&#8209;190434, No. 333&#8209;169467, No. 333&#8209;158220, No. 333&#8209;144097, No. 333&#8209;86550, and No. 333&#8209;30736), and on Form S-4 (No. 333&#8209;182572) of DaVita Inc. of our reports dated February 12, 2021 with respect to the consolidated balance sheets of DaVita Inc. as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income, equity, and cash flow for each of the years in the three-year period ended December 31, 2020, and the related notes and financial statement Schedule II &#8211; Valuation and Qualifying Accounts, and the effectiveness of internal control over financial reporting as of December 31, 2020, which reports appear in the December 31, 2020 annual report on Form 10&#8209;K of DaVita Inc. Our report refers to changes in the method of accounting for leases.</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; KPMG LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;12, 2021</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:63pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>dva-123120ex31110xk.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2dea55c78a4c49378f4b8a91233f3b5a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Javier J. Rodriguez, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.00pt"><tr><td style="width:1.0pt"></td><td style="width:277.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;12, 2021</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>dva-123120ex31210xk.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5a58bb17162f4a8896e47c58b937e966_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joel Ackerman, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;12, 2021</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>dva-123120ex32110xk.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i60bb072397ce4f42ac4a48ef336e04d6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Javier J. Rodriguez, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</font></div></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>dva-123120ex32210xk.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i986649939a1441f7a9abe5125ad4cc23_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Joel Ackerman, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;12, 2021</font></div></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>dva-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cb65dee0-3538-408a-90c8-cfac27791e84,g:bb413262-db44-4a11-afdc-c2a9f72b9180-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dva="http://www.davita.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.davita.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.davita.com/role/DocumentandEntityInformation">
        <link:definition>000010001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>100010002 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME_1" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1">
        <link:definition>100010002 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100030004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100040005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100050006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITY" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY">
        <link:definition>100060007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPolicies" roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Organization and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>240034001 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.davita.com/role/RevenueRecognition">
        <link:definition>210041002 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables">
        <link:definition>230053001 - Disclosure - Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails">
        <link:definition>240064002 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails">
        <link:definition>240074003 - Disclosure - Revenue Recognition and Accounts Receivable - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.davita.com/role/EarningsPerShare">
        <link:definition>210081003 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.davita.com/role/EarningsPerShareTables">
        <link:definition>230093002 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" roleURI="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails">
        <link:definition>240104004 - Disclosure - Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedCashRestrictedCash" roleURI="http://www.davita.com/role/RestrictedCashRestrictedCash">
        <link:definition>210111004 - Disclosure - Restricted Cash Restricted Cash</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedCashTables" roleURI="http://www.davita.com/role/RestrictedCashTables">
        <link:definition>230123003 - Disclosure - Restricted Cash (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedCashandEquivalentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails">
        <link:definition>240134005 - Disclosure - Restricted Cash and Equivalents - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Shorttermandlongterminvestments" roleURI="http://www.davita.com/role/Shorttermandlongterminvestments">
        <link:definition>210141005 - Disclosure - Short-term and long-term investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandlongterminvesmtentsTables" roleURI="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables">
        <link:definition>230153004 - Disclosure - Short-term and long-term invesmtents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandlongterminvestmentsDetails" roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails">
        <link:definition>240164006 - Disclosure - Short-term and long-term investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandlongterminvestmentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails">
        <link:definition>240174007 - Disclosure - Short-term and long-term investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherReceivablesOtherReceivables" roleURI="http://www.davita.com/role/OtherReceivablesOtherReceivables">
        <link:definition>210181006 - Disclosure - Other Receivables Other Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherReceivablesTables" roleURI="http://www.davita.com/role/OtherReceivablesTables">
        <link:definition>230193005 - Disclosure - Other Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherReceivablesDetails" roleURI="http://www.davita.com/role/OtherReceivablesDetails">
        <link:definition>240204008 - Disclosure - Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.davita.com/role/PropertyandEquipment">
        <link:definition>210211007 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.davita.com/role/PropertyandEquipmentTables">
        <link:definition>230223006 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.davita.com/role/PropertyandEquipmentDetails">
        <link:definition>240234009 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentAdditionalInformationDetails" roleURI="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails">
        <link:definition>240244010 - Disclosure - Property and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibles" roleURI="http://www.davita.com/role/Intangibles">
        <link:definition>210251008 - Disclosure - Intangibles</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesTables" roleURI="http://www.davita.com/role/IntangiblesTables">
        <link:definition>230263007 - Disclosure - Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" roleURI="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails">
        <link:definition>240274011 - Disclosure - Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails">
        <link:definition>240284012 - Disclosure - Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesAdditionalInformationDetails" roleURI="http://www.davita.com/role/IntangiblesAdditionalInformationDetails">
        <link:definition>240294013 - Disclosure - Intangibles - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestments" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestments">
        <link:definition>210301009 - Disclosure - Equity Method and Other Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables">
        <link:definition>230313008 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails">
        <link:definition>240324014 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestmentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails">
        <link:definition>240334015 - Disclosure - Equity Method and Other Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.davita.com/role/Goodwill">
        <link:definition>210341010 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.davita.com/role/GoodwillTables">
        <link:definition>230353009 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" roleURI="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails">
        <link:definition>240364016 - Disclosure - Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" roleURI="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails">
        <link:definition>240374017 - Disclosure - Goodwill - Schedule of Reporting Units Goodwill Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAdditionalInformationDetails" roleURI="http://www.davita.com/role/GoodwillAdditionalInformationDetails">
        <link:definition>240384018 - Disclosure - Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilities" roleURI="http://www.davita.com/role/OtherLiabilities">
        <link:definition>210391011 - Disclosure - Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesTables" roleURI="http://www.davita.com/role/OtherLiabilitiesTables">
        <link:definition>230403010 - Disclosure - Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesDetails" roleURI="http://www.davita.com/role/OtherLiabilitiesDetails">
        <link:definition>240414019 - Disclosure - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.davita.com/role/IncomeTaxes">
        <link:definition>210421012 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.davita.com/role/IncomeTaxesTables">
        <link:definition>230433011 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" roleURI="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails">
        <link:definition>240444020 - Disclosure - Income Taxes - Schedule of Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseDetails" roleURI="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails">
        <link:definition>240454021 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" roleURI="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails">
        <link:definition>240464022 - Disclosure - Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" roleURI="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails">
        <link:definition>240474023 - Disclosure - Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails">
        <link:definition>240484024 - Disclosure - Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" roleURI="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails">
        <link:definition>240494025 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>240504026 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.davita.com/role/LongTermDebt">
        <link:definition>210511013 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.davita.com/role/LongTermDebtTables">
        <link:definition>230523012 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtDetails" roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails">
        <link:definition>240534027 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduledMaturitiesofLongtermDebtDetails" roleURI="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails">
        <link:definition>240544028 - Disclosure - Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDerivativeInstrumentsDetails" roleURI="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails">
        <link:definition>240554029 - Disclosure - Long-Term Debt - Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" roleURI="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails">
        <link:definition>240564030 - Disclosure - Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAdditionalinformationDetail" roleURI="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail">
        <link:definition>240574031 - Disclosure - Long-Term Debt - Additional information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.davita.com/role/Leases">
        <link:definition>210581014 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.davita.com/role/LeasesTables">
        <link:definition>230593013 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseExpenseComponentsDetails" roleURI="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails">
        <link:definition>240604032 - Disclosure - Leases Lease Expense Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeasesOtherInformationDetails" roleURI="http://www.davita.com/role/LeasesLeasesOtherInformationDetails">
        <link:definition>240614033 - Disclosure - Leases Leases Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails">
        <link:definition>240624034 - Disclosure - Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1" roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1">
        <link:definition>240624034 - Disclosure - Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.davita.com/role/LeasesAdditionalInformationDetails">
        <link:definition>240634035 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlans" roleURI="http://www.davita.com/role/EmployeeBenefitPlans">
        <link:definition>210641015 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAdditionalInformationDetails" roleURI="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails">
        <link:definition>240654036 - Disclosure - Employee Benefit Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.davita.com/role/Contingencies">
        <link:definition>210661016 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesAdditionalInformationDetails" roleURI="http://www.davita.com/role/ContingenciesAdditionalInformationDetails">
        <link:definition>240674037 - Disclosure - Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments">
        <link:definition>210681017 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails">
        <link:definition>240694038 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquity" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity">
        <link:definition>210701018 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquityTables" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables">
        <link:definition>230713014 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails">
        <link:definition>240724039 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails">
        <link:definition>240734040 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Range of Exercise Prices (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails">
        <link:definition>240744041 - Disclosure - Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails">
        <link:definition>240754042 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Stockholdersequity" roleURI="http://www.davita.com/role/Stockholdersequity">
        <link:definition>210761019 - Disclosure - Stockholder's equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersequityTables" roleURI="http://www.davita.com/role/StockholdersequityTables">
        <link:definition>230773015 - Disclosure - Stockholder's equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockRepurchasesTenderOfferDetails" roleURI="http://www.davita.com/role/StockRepurchasesTenderOfferDetails">
        <link:definition>240784043 - Disclosure - Stock Repurchases Tender Offer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" roleURI="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails">
        <link:definition>240794044 - Disclosure - Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityDetails" roleURI="http://www.davita.com/role/ShareholdersequityDetails">
        <link:definition>240804045 - Disclosure - Shareholder's equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncome" roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome">
        <link:definition>210811020 - Disclosure - Accumulated Other Comprehensive (Loss) Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeTables" roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables">
        <link:definition>230823016 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeDetails" roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails">
        <link:definition>240834046 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestitures" roleURI="http://www.davita.com/role/AcquisitionsandDivestitures">
        <link:definition>210841021 - Disclosure - Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresTables" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresTables">
        <link:definition>230853017 - Disclosure - Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAssetsacquiredandliabilitiesassumedDetails" roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails">
        <link:definition>240864047 - Disclosure - Acquisitions - Assets acquired and liabilities assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" roleURI="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails">
        <link:definition>240874048 - Disclosure - Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails">
        <link:definition>240884049 - Disclosure - Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails">
        <link:definition>240894050 - Disclosure - Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresAdditionalInformationDetails" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails">
        <link:definition>240904051 - Disclosure - Acquisitions and Divestitures - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperations" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations">
        <link:definition>210911022 - Disclosure - Held for Sale and Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsTables" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables">
        <link:definition>230923018 - Disclosure - Held for Sale and Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails">
        <link:definition>240934052 - Disclosure - Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails">
        <link:definition>240944053 - Disclosure - Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails">
        <link:definition>240954054 - Disclosure - Held for Sale and Discontinued Operations - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://www.davita.com/role/VariableInterestEntities">
        <link:definition>210961023 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesAdditionalInformationDetails" roleURI="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails">
        <link:definition>240974055 - Disclosure - Variable Interest Entities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstruments" roleURI="http://www.davita.com/role/FairValuesofFinancialInstruments">
        <link:definition>210981024 - Disclosure - Fair Values of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstrumentsTables" roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables">
        <link:definition>230993019 - Disclosure - Fair Values of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>241004056 - Disclosure - Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstrumentsDetails" roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails">
        <link:definition>241014057 - Disclosure - Fair Values of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.davita.com/role/SegmentReporting">
        <link:definition>211021025 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.davita.com/role/SegmentReportingTables">
        <link:definition>231033020 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails">
        <link:definition>241044058 - Disclosure - Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails">
        <link:definition>241054059 - Disclosure - Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofAssetsbySegmentDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails">
        <link:definition>241064060 - Disclosure - Segment Reporting - Summary of Assets by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails">
        <link:definition>241074061 - Disclosure - Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingAdditionalInformationDetails" roleURI="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails">
        <link:definition>241084062 - Disclosure - Segment Reporting - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformation" roleURI="http://www.davita.com/role/SupplementalCashFlowInformation">
        <link:definition>211091026 - Disclosure - Supplemental Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationTables" roleURI="http://www.davita.com/role/SupplementalCashFlowInformationTables">
        <link:definition>231103021 - Disclosure - Supplemental Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationDetails" roleURI="http://www.davita.com/role/SupplementalCashFlowInformationDetails">
        <link:definition>241114063 - Disclosure - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataunaudited" roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited">
        <link:definition>211121027 - Disclosure - Selected Quarterly Financial Data (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataunauditedTables" roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables">
        <link:definition>231133022 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataunauditedDetails" roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails">
        <link:definition>241144064 - Disclosure - Selected Quarterly Financial Data (unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>211151028 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SECScheduleArticle1209ValuationandQualifyingAccountsTables" roleURI="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables">
        <link:definition>231163023 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>241174065 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dva_TemporaryEquityDecreasePurchaseOfInterests" abstract="false" name="TemporaryEquityDecreasePurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_InternationalOperationsMember" abstract="true" name="InternationalOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OtherGovernmentPayorsMember" abstract="true" name="OtherGovernmentPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CharterdocumentsandDelawarelawAbstract" abstract="true" name="CharterdocumentsandDelawarelawAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" abstract="false" name="NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" abstract="false" name="EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RangeThreeMember" abstract="true" name="RangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayable" abstract="false" name="AcquisitionObligationsAndOtherNotesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CommitmentsToProvideOperatingCapitalMember" abstract="true" name="CommitmentsToProvideOperatingCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_PatientCareCosts" abstract="false" name="PatientCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OtherSourcesofRevenueMember" abstract="true" name="OtherSourcesofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_PremiumPricedAwardBasePricePerShare" abstract="false" name="PremiumPricedAwardBasePricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="dva_DissolutionTermOfJointVentures" abstract="false" name="DissolutionTermOfJointVentures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" abstract="false" name="MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" abstract="true" name="SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_LeasesDisclosureTable" abstract="true" name="LeasesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" abstract="false" name="NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dva_RangeTwoMember" abstract="true" name="RangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" abstract="false" name="ScheduleOfReportingUnitsGoodwillBalancesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_AdjustmentIncomeLossFromEquityMethodInvestments" abstract="false" name="AdjustmentIncomeLossFromEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" abstract="false" name="SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_PotentialImpactOnFairValueForReductionInOperatingIncome" abstract="false" name="PotentialImpactOnFairValueForReductionInOperatingIncome" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_KidneyCareMember" abstract="true" name="KidneyCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_IncrementalCashPortionMember" abstract="true" name="IncrementalCashPortionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" abstract="false" name="DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ShareRepurchaseFeesAndExpenses" abstract="false" name="ShareRepurchaseFeesAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PatientServicesCustomerConcentrationRiskMember" abstract="true" name="PatientServicesCustomerConcentrationRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_DaVitaMedicalGroupMember" abstract="true" name="DaVitaMedicalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" abstract="false" name="RevenueRecognitionAndAccountsReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_ExpectedAmortizationExpenseLineItems" abstract="true" name="ExpectedAmortizationExpenseLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" abstract="false" name="AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" abstract="false" name="RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PremiumToTheTenderOfferSharePurchasePrice" abstract="false" name="PremiumToTheTenderOfferSharePurchasePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_InsuranceAndSelfInsurancePolicyTextBlock" abstract="false" name="InsuranceAndSelfInsurancePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayableFairValue" abstract="false" name="AcquisitionObligationsAndOtherNotesPayableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_USAttorneyPrescriptionDrugInvestigationMember" abstract="true" name="USAttorneyPrescriptionDrugInvestigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_LongtermIncentiveProgramCompensationCost" abstract="false" name="LongtermIncentiveProgramCompensationCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NetLossGainOnDispositionOfBusinessInterests" abstract="false" name="NetLossGainOnDispositionOfBusinessInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PremiumPricedStockSettledStockAppreciationRightsMember" abstract="true" name="PremiumPricedStockSettledStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" abstract="false" name="VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_CommitmentsAndContingenciesDisclosureLineItems" abstract="true" name="CommitmentsAndContingenciesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ExternalSourcesMember" abstract="true" name="ExternalSourcesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" abstract="false" name="StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" abstract="false" name="TreasuryStockAcquiredAverageCostPerShareClearingPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="dva_LeasesDisclosureLineItems" abstract="true" name="LeasesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_ExpectedAmortizationExpenseTable" abstract="true" name="ExpectedAmortizationExpenseTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" abstract="false" name="StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_CashPaidForPortionPreviouslyRefundedMember" abstract="true" name="CashPaidForPortionPreviouslyRefundedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OtherNonoperatingIncomeExpensePolicyTextBlock" abstract="false" name="OtherNonoperatingIncomeExpensePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_SegmentReportingInformationCorporateExpenses" abstract="false" name="SegmentReportingInformationCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" abstract="false" name="PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_ScheduleOfMinimumLeasePaymentsTextBlock" abstract="false" name="ScheduleOfMinimumLeasePaymentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseFromContributions" abstract="false" name="NoncontrollingInterestIncreaseFromContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" abstract="false" name="EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" abstract="true" name="CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_CumulativeEffectOfChangeInAccountingPrinciple" abstract="false" name="CumulativeEffectOfChangeInAccountingPrinciple" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DebtExpenseMember" abstract="true" name="DebtExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_DebtFinancingAndDebtRedemptionCosts" abstract="false" name="DebtFinancingAndDebtRedemptionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" abstract="true" name="SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OtherCompaniesMember" abstract="true" name="OtherCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SegmentRevenuebyMajorPayorAbstract" abstract="true" name="SegmentRevenuebyMajorPayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_LesseeLeaseDescriptionLineItemsAbstract" abstract="true" name="LesseeLeaseDescriptionLineItemsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" abstract="true" name="ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_StockOptionProgramAndStockAppreciationRightProgramMember" abstract="true" name="StockOptionProgramAndStockAppreciationRightProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" abstract="true" name="A2019InterestRateCapAgreementsEffectiveJune302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" abstract="true" name="SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_USDialysisAndRelatedLabServicesMember" abstract="true" name="USDialysisAndRelatedLabServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_FinanceLeaseAccumulatedDepreciation" abstract="false" name="FinanceLeaseAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CommercialPayorsMember" abstract="true" name="CommercialPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" abstract="false" name="BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" abstract="false" name="ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_DeconsolidatedNoncontrollingEntityMember" abstract="true" name="DeconsolidatedNoncontrollingEntityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_PaymentsRelatedToStockPurchasesAndAwards" abstract="false" name="PaymentsRelatedToStockPurchasesAndAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" abstract="false" name="PercentageOfAccountsReceivableSixMonthsOrMorePastDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_AccountsReceivablePeriodOutstanding" abstract="false" name="AccountsReceivablePeriodOutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_StockUnitMember" abstract="true" name="StockUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" abstract="false" name="PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_DeferredTaxLiabilitiesOperatingLeaseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_MutualFundsAndCommonStockMember" abstract="true" name="MutualFundsAndCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" abstract="true" name="SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OtherReportingUnitsMember" abstract="true" name="OtherReportingUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_DeferredTaxAssetsReceivables" abstract="false" name="DeferredTaxAssetsReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" abstract="false" name="LossGainOnDispositionOfBusinessInterestsBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" abstract="false" name="LongTermPurchaseCommitmentPercentageOfQuantityRequired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_LeasesOtherInformationAbstract" abstract="true" name="LeasesOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_CommitmentsAndContingenciesDisclosureTable" abstract="true" name="CommitmentsAndContingenciesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_ProvisionForExpectedCreditLosses" abstract="false" name="ProvisionForExpectedCreditLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_MedicareandMedicareAdvantageMember" abstract="true" name="MedicareandMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" abstract="true" name="CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OpenMarketPurchasesMember" abstract="true" name="OpenMarketPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" abstract="false" name="StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_NumberOfConcentrationRiskCustomers" abstract="false" name="NumberOfConcentrationRiskCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="dva_EpogenMember" abstract="true" name="EpogenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" abstract="false" name="ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_DebtInstrumentRedeemedOutstandingPrincipalAmount" abstract="false" name="DebtInstrumentRedeemedOutstandingPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TaxYear2029Member" abstract="true" name="TaxYear2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" abstract="false" name="ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitions" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NumberOfPartnerships" abstract="false" name="NumberOfPartnerships" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" abstract="false" name="VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" abstract="false" name="IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_IncomeTaxExpenseBenefitMember" abstract="true" name="IncomeTaxExpenseBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" abstract="false" name="LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OffBalanceSheetFinancingArrangements" abstract="false" name="OffBalanceSheetFinancingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SupplierRebatesAndOtherNonTradeReceivablesMember" abstract="true" name="SupplierRebatesAndOtherNonTradeReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SeniorSecuredCreditFacilitiesMember" abstract="true" name="SeniorSecuredCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" abstract="false" name="LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" abstract="false" name="ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" abstract="false" name="StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_LongTermPurchaseCommitmentExpirationDate" abstract="false" name="LongTermPurchaseCommitmentExpirationDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_NumberOfCustomers" abstract="false" name="NumberOfCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" abstract="false" name="NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" abstract="true" name="TemporaryEquityRedeemableNoncontrollingInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_DiscountAndDeferredFinanceCosts" abstract="false" name="DiscountAndDeferredFinanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" abstract="false" name="NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RMSLifelineMember" abstract="true" name="RMSLifelineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_PayorRefundsAndRetractions" abstract="false" name="PayorRefundsAndRetractions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" abstract="false" name="PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_A2015InterestRateCapAgreementsEffectiveJune292018Member" abstract="true" name="A2015InterestRateCapAgreementsEffectiveJune292018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ParentCompanyAndRestrictedSubsidiariesMember" abstract="true" name="ParentCompanyAndRestrictedSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_MedicaidandManagedMedicaidMember" abstract="true" name="MedicaidandManagedMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_FinanceLeaseMember" abstract="true" name="FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" abstract="true" name="EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_NumberOfSites" abstract="false" name="NumberOfSites" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DMGAcquisitionsMember" abstract="true" name="DMGAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" abstract="false" name="SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_DebtPrepaymentRefinancingRedemptionCharges" abstract="false" name="DebtPrepaymentRefinancingRedemptionCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" abstract="false" name="PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" abstract="false" name="NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement" abstract="false" name="AdditionalDebtPrincipalAmountDueToRepricingAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ForeignDialysisCentersMember" abstract="true" name="ForeignDialysisCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TermLoanB1Member" abstract="true" name="TermLoanB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" abstract="false" name="NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_CashPaidDuringPeriodForAbstract" abstract="true" name="CashPaidDuringPeriodForAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_StockIncentivePlanTwentyElevenMember" abstract="true" name="StockIncentivePlanTwentyElevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" abstract="false" name="TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" abstract="false" name="PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AllTrustsMember" abstract="true" name="AllTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TenderOfferMember" abstract="true" name="TenderOfferMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ReconciliationOfCashFlowsTableTextBlock" abstract="false" name="ReconciliationOfCashFlowsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" abstract="false" name="NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" abstract="false" name="ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_ProceedsFromRepricingAgreementOnSecuredDebt" abstract="false" name="ProceedsFromRepricingAgreementOnSecuredDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PurchaseAndSaleAgreementAggregatePurchasePrice" abstract="false" name="PurchaseAndSaleAgreementAggregatePurchasePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AllowanceForUncollectibleAccountsPolicyTextBlock" abstract="false" name="AllowanceForUncollectibleAccountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_RangeOneMember" abstract="true" name="RangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="dva_StockIncentivePlanTwentyTwentyMember" abstract="true" name="StockIncentivePlanTwentyTwentyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ScheduleOfOtherReceivablesTableTextBlock" abstract="false" name="ScheduleOfOtherReceivablesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_DebtRefinancingCharges" abstract="false" name="DebtRefinancingCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" abstract="false" name="EffectiveIncomeTaxReconciliationInvestmentImpairment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>dva-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cb65dee0-3538-408a-90c8-cfac27791e84,g:bb413262-db44-4a11-afdc-c2a9f72b9180-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20201231.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_204e08dc-2879-41e0-9da3-f33e2ed0bfad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_41acc1b4-410c-43b8-a807-af437006c03b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_204e08dc-2879-41e0-9da3-f33e2ed0bfad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_41acc1b4-410c-43b8-a807-af437006c03b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6a6a4f5-2254-420f-9ed0-72512c6ff8e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_204e08dc-2879-41e0-9da3-f33e2ed0bfad" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c6a6a4f5-2254-420f-9ed0-72512c6ff8e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ebaa145e-a6ee-4d0f-bc84-4ee0c43f6530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_0789544a-0c6e-4e98-92b9-8d8ee752aacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ebaa145e-a6ee-4d0f-bc84-4ee0c43f6530" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_0789544a-0c6e-4e98-92b9-8d8ee752aacc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8b6ae78f-9cc7-4bf7-bc82-60d6976a2edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ebaa145e-a6ee-4d0f-bc84-4ee0c43f6530" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8b6ae78f-9cc7-4bf7-bc82-60d6976a2edd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_25e23682-7975-46f0-92e3-84959f6c97fd" xlink:href="dva-20201231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1ce99ccb-d071-4e88-bdab-e2bf28fa54b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_25e23682-7975-46f0-92e3-84959f6c97fd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1ce99ccb-d071-4e88-bdab-e2bf28fa54b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProvisionForExpectedCreditLosses_d5a2188f-0c4b-485b-9f90-73f320355dae" xlink:href="dva-20201231.xsd#dva_ProvisionForExpectedCreditLosses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_25e23682-7975-46f0-92e3-84959f6c97fd" xlink:to="loc_dva_ProvisionForExpectedCreditLosses_d5a2188f-0c4b-485b-9f90-73f320355dae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_df67011c-588c-4f57-abb1-102c355a4c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_6754db1f-be17-44cb-9f20-09aa799c9953" xlink:href="dva-20201231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_df67011c-588c-4f57-abb1-102c355a4c29" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_6754db1f-be17-44cb-9f20-09aa799c9953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_298ff8ff-4bf9-4af2-9394-7a82b77e12bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_df67011c-588c-4f57-abb1-102c355a4c29" xlink:to="loc_us-gaap_OtherIncome_298ff8ff-4bf9-4af2-9394-7a82b77e12bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cfa76661-8f0d-4676-b2e0-56cc12fcab2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7f5a62e6-f0e6-4791-ab46-50da9b24b287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cfa76661-8f0d-4676-b2e0-56cc12fcab2d" xlink:to="loc_us-gaap_OperatingIncomeLoss_7f5a62e6-f0e6-4791-ab46-50da9b24b287" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_65c3e295-ae80-473e-9672-374ea9c76a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cfa76661-8f0d-4676-b2e0-56cc12fcab2d" xlink:to="loc_us-gaap_InterestAndDebtExpense_65c3e295-ae80-473e-9672-374ea9c76a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_58c96fd7-59f2-4624-8006-cd62e33ff7cb" xlink:href="dva-20201231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cfa76661-8f0d-4676-b2e0-56cc12fcab2d" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_58c96fd7-59f2-4624-8006-cd62e33ff7cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_156f2a9d-783b-43fe-b217-1033134ff361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cfa76661-8f0d-4676-b2e0-56cc12fcab2d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_156f2a9d-783b-43fe-b217-1033134ff361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ec4efa2e-38f2-4143-8481-ae9d285ba1b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_19e3d857-1fba-430e-9475-2a72039e6ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ec4efa2e-38f2-4143-8481-ae9d285ba1b2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_19e3d857-1fba-430e-9475-2a72039e6ba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_80230895-3069-4184-86b8-6f52f8a97ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ec4efa2e-38f2-4143-8481-ae9d285ba1b2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_80230895-3069-4184-86b8-6f52f8a97ba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6265bf3e-473b-49a0-9432-58c02294b55f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2da45c52-1688-4a2c-8a7d-910cb5add5c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6265bf3e-473b-49a0-9432-58c02294b55f" xlink:to="loc_us-gaap_Revenues_2da45c52-1688-4a2c-8a7d-910cb5add5c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7e9085a6-c99f-478c-90fc-061d7801e719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6265bf3e-473b-49a0-9432-58c02294b55f" xlink:to="loc_us-gaap_CostsAndExpenses_7e9085a6-c99f-478c-90fc-061d7801e719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_2fccce6a-39f4-4e92-abe9-49c8af85b9fb" xlink:href="dva-20201231.xsd#dva_PatientCareCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_dva_PatientCareCosts_2fccce6a-39f4-4e92-abe9-49c8af85b9fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8cc9bf00-6096-496a-90c9-3380159c0d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8cc9bf00-6096-496a-90c9-3380159c0d8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_412f141d-1923-4ba3-a915-d2b15447e63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_us-gaap_DepreciationAndAmortization_412f141d-1923-4ba3-a915-d2b15447e63c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_99b43824-570a-497e-bdee-ec3ef3235f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_99b43824-570a-497e-bdee-ec3ef3235f21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5b40316e-f085-424e-90fc-e0171f05f5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5b40316e-f085-424e-90fc-e0171f05f5a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_da5d7060-af99-45ba-8a78-4f225a1f6637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_da5d7060-af99-45ba-8a78-4f225a1f6637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9f919f80-5caf-4656-b290-e4d05431bbf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9f919f80-5caf-4656-b290-e4d05431bbf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ba7fd968-b4a3-4e6c-9dbc-5f30af1762c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_0483dfa9-18c2-47e5-b391-73a299f2f002" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ba7fd968-b4a3-4e6c-9dbc-5f30af1762c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME_1"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3237818b-ba8e-4872-b32e-18b337da5971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_47b00e3d-254a-42bc-9ef1-566e91d8a1fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3237818b-ba8e-4872-b32e-18b337da5971" xlink:to="loc_us-gaap_ProfitLoss_47b00e3d-254a-42bc-9ef1-566e91d8a1fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cec1f984-0eef-4a77-b4ad-99bfa3092208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3237818b-ba8e-4872-b32e-18b337da5971" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cec1f984-0eef-4a77-b4ad-99bfa3092208" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f574d3f3-4ae9-45ac-a9dc-744b8eb622a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bbdaef4d-a404-4066-9e07-0214c8f1cef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f574d3f3-4ae9-45ac-a9dc-744b8eb622a8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bbdaef4d-a404-4066-9e07-0214c8f1cef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_610f6dcd-2d66-4a1f-bdb2-351a6112bdb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f574d3f3-4ae9-45ac-a9dc-744b8eb622a8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_610f6dcd-2d66-4a1f-bdb2-351a6112bdb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cf2c6375-51e1-406e-ae9f-90da5440272f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8a1e607a-f11c-4e96-90f0-cd207547fdf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cf2c6375-51e1-406e-ae9f-90da5440272f" xlink:to="loc_us-gaap_ProfitLoss_8a1e607a-f11c-4e96-90f0-cd207547fdf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b8aea564-26f9-4601-9150-21908f245569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cf2c6375-51e1-406e-ae9f-90da5440272f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b8aea564-26f9-4601-9150-21908f245569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c84245da-8468-42ea-bcfe-e60a9fac2e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_76d29a3a-ec8f-4d39-83d4-f81eefe5aad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c84245da-8468-42ea-bcfe-e60a9fac2e10" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_76d29a3a-ec8f-4d39-83d4-f81eefe5aad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_f2b97ee1-d260-40e0-91fd-809814f9dcb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c84245da-8468-42ea-bcfe-e60a9fac2e10" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_f2b97ee1-d260-40e0-91fd-809814f9dcb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_6c4b021d-0cb7-4dd5-aa2f-75beccf3cf31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c84245da-8468-42ea-bcfe-e60a9fac2e10" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_6c4b021d-0cb7-4dd5-aa2f-75beccf3cf31" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2ba0eb9d-bc9f-49e6-b0ba-390ac9e226d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6d08b9be-a68c-4f04-a809-5a4109ac681e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2ba0eb9d-bc9f-49e6-b0ba-390ac9e226d8" xlink:to="loc_us-gaap_AccountsPayableCurrent_6d08b9be-a68c-4f04-a809-5a4109ac681e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_427b809c-89ae-43bb-8b6a-8b5160e43008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2ba0eb9d-bc9f-49e6-b0ba-390ac9e226d8" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_427b809c-89ae-43bb-8b6a-8b5160e43008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_787c9c75-5a89-4754-9fd9-9329cd3ab59d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2ba0eb9d-bc9f-49e6-b0ba-390ac9e226d8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_787c9c75-5a89-4754-9fd9-9329cd3ab59d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_41863dec-4030-4855-b04b-2007f3452ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2ba0eb9d-bc9f-49e6-b0ba-390ac9e226d8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_41863dec-4030-4855-b04b-2007f3452ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a730a36b-cf55-4fb2-9f6b-9133661c853c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2ba0eb9d-bc9f-49e6-b0ba-390ac9e226d8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a730a36b-cf55-4fb2-9f6b-9133661c853c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4dedbac1-04d6-41d3-8f3a-921f708f0582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2ba0eb9d-bc9f-49e6-b0ba-390ac9e226d8" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4dedbac1-04d6-41d3-8f3a-921f708f0582" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cec835c0-80b1-4237-97c2-5089b09c3107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ec885af9-df70-401d-8149-67436224d997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cec835c0-80b1-4237-97c2-5089b09c3107" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ec885af9-df70-401d-8149-67436224d997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_51c708ce-498c-43d5-be77-d997c121a397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cec835c0-80b1-4237-97c2-5089b09c3107" xlink:to="loc_us-gaap_CommonStockValue_51c708ce-498c-43d5-be77-d997c121a397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_92fbd741-1287-4e84-ad16-b09f3adc7f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cec835c0-80b1-4237-97c2-5089b09c3107" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_92fbd741-1287-4e84-ad16-b09f3adc7f05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_68e1c197-a7fd-455c-8fa5-9855ff810489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cec835c0-80b1-4237-97c2-5089b09c3107" xlink:to="loc_us-gaap_PreferredStockValue_68e1c197-a7fd-455c-8fa5-9855ff810489" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a63deceb-d76d-4acc-87be-c8796ffee871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cec835c0-80b1-4237-97c2-5089b09c3107" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a63deceb-d76d-4acc-87be-c8796ffee871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_10cae2eb-3b17-4f67-83cc-cdbe3fd9d55a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_AssetsCurrent_10cae2eb-3b17-4f67-83cc-cdbe3fd9d55a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a4162879-b2f7-44ad-b99d-00aeda9a9d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a4162879-b2f7-44ad-b99d-00aeda9a9d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_66c4333c-7165-4bf5-b79e-407334862894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_66c4333c-7165-4bf5-b79e-407334862894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b2aae893-e5e4-4bd7-98a4-ed2f68611b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b2aae893-e5e4-4bd7-98a4-ed2f68611b9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f018b9c5-8702-4995-90db-9414a7caca0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f018b9c5-8702-4995-90db-9414a7caca0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_7d1bc6a1-adba-4dd2-bcb1-72caf94de35f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_7d1bc6a1-adba-4dd2-bcb1-72caf94de35f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_12acd7f1-a8c8-4c6a-a775-36e7e5b6d137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_12acd7f1-a8c8-4c6a-a775-36e7e5b6d137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b513dec5-d64e-4b20-8086-908fbbbb7591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_edbcef24-569c-432d-9858-801d70a5951f" xlink:to="loc_us-gaap_Goodwill_b513dec5-d64e-4b20-8086-908fbbbb7591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_aecdfad0-de13-4128-9100-d0553c7ff106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_aecdfad0-de13-4128-9100-d0553c7ff106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_ea3263d8-94ec-4e99-8179-dd1d16d8680e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_ea3263d8-94ec-4e99-8179-dd1d16d8680e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e20313f1-c7fa-4a26-b5fd-1c2258658f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e20313f1-c7fa-4a26-b5fd-1c2258658f7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b06e2044-45c4-4dd9-a04a-cb98280d2e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b06e2044-45c4-4dd9-a04a-cb98280d2e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_046bcff0-ab55-4bdb-91db-d141a6c587aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_InventoryNet_046bcff0-ab55-4bdb-91db-d141a6c587aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_a0e230ea-4ad1-433f-a556-5325b5ea1bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_a0e230ea-4ad1-433f-a556-5325b5ea1bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3b8501f7-d073-4285-972e-89f9c8dbabad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3b8501f7-d073-4285-972e-89f9c8dbabad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_0dbaeaa6-e322-4b36-aa9a-2f37c2897277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c9438a4-b24e-4fcd-bea5-48543d10d9d3" xlink:to="loc_us-gaap_IncomeTaxesReceivable_0dbaeaa6-e322-4b36-aa9a-2f37c2897277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffff2006-c364-46e1-a727-40bab1a43e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1fb79280-8ad0-4fff-87d5-c0d2505caa21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffff2006-c364-46e1-a727-40bab1a43e73" xlink:to="loc_us-gaap_StockholdersEquity_1fb79280-8ad0-4fff-87d5-c0d2505caa21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_9c05840f-bc22-40ae-8687-80307252498a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffff2006-c364-46e1-a727-40bab1a43e73" xlink:to="loc_us-gaap_MinorityInterest_9c05840f-bc22-40ae-8687-80307252498a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cfdbddcb-d263-4710-8bd1-58391fb30798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d07753cc-3347-4b76-b0a8-426fffc56bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cfdbddcb-d263-4710-8bd1-58391fb30798" xlink:to="loc_us-gaap_LiabilitiesCurrent_d07753cc-3347-4b76-b0a8-426fffc56bf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c21db9ea-f558-42ee-afd5-46b248172467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cfdbddcb-d263-4710-8bd1-58391fb30798" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c21db9ea-f558-42ee-afd5-46b248172467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_da522bef-9ecf-409d-8a66-f0876d1340f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cfdbddcb-d263-4710-8bd1-58391fb30798" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_da522bef-9ecf-409d-8a66-f0876d1340f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_11787a51-7cc4-4db3-8ffc-7de501bfa417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cfdbddcb-d263-4710-8bd1-58391fb30798" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_11787a51-7cc4-4db3-8ffc-7de501bfa417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3be00d56-77fa-4893-a57f-4788de3c9abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cfdbddcb-d263-4710-8bd1-58391fb30798" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3be00d56-77fa-4893-a57f-4788de3c9abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cd26a8f6-880c-4a0e-a4ae-50a2f713e4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_875d1028-2f1e-4dbd-8974-74a88ac8ceb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cd26a8f6-880c-4a0e-a4ae-50a2f713e4db" xlink:to="loc_us-gaap_Liabilities_875d1028-2f1e-4dbd-8974-74a88ac8ceb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_69b84ee1-22b2-4861-ba81-7a4c413d8b54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cd26a8f6-880c-4a0e-a4ae-50a2f713e4db" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_69b84ee1-22b2-4861-ba81-7a4c413d8b54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bc94eee1-6d4b-4737-8fcb-e3a3b427d52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cd26a8f6-880c-4a0e-a4ae-50a2f713e4db" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bc94eee1-6d4b-4737-8fcb-e3a3b427d52d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_56e028a1-7c54-43f9-9165-408cb0f1f7a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_56e028a1-7c54-43f9-9165-408cb0f1f7a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_c8839ab3-554c-4b62-9af7-0d3a8cda2c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_c8839ab3-554c-4b62-9af7-0d3a8cda2c0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_272e8360-a4f6-44ed-8a53-3b5804a920d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_272e8360-a4f6-44ed-8a53-3b5804a920d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_2a546d8c-87f5-474d-a50d-db0d93827181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_2a546d8c-87f5-474d-a50d-db0d93827181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_be667144-b432-42f7-abc8-ab9dd9061de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_be667144-b432-42f7-abc8-ab9dd9061de1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_180eefe4-a20b-4b89-ab51-14384ea20d27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_180eefe4-a20b-4b89-ab51-14384ea20d27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_21494a76-6793-4c62-bf6e-df3ac50d70e7" xlink:href="dva-20201231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_21494a76-6793-4c62-bf6e-df3ac50d70e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_61dcd7ac-50c9-4fc8-bb05-d2a26b024706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_61dcd7ac-50c9-4fc8-bb05-d2a26b024706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts_e9d299b8-cdd8-40bf-8dab-b227f8a730a9" xlink:href="dva-20201231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_dva_DebtFinancingAndDebtRedemptionCosts_e9d299b8-cdd8-40bf-8dab-b227f8a730a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_295d2575-6c32-4919-9210-6a72be62600c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285063b6-c056-4998-8b3d-152beb61c0b8" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_295d2575-6c32-4919-9210-6a72be62600c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fc107ba2-73c1-4c6a-805d-f88cb7a63356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_ProfitLoss_fc107ba2-73c1-4c6a-805d-f88cb7a63356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_f60718b3-47da-480f-9cbc-09b230b580de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_f60718b3-47da-480f-9cbc-09b230b580de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_52a95b0e-84b3-43ce-96e6-447d96557c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_52a95b0e-84b3-43ce-96e6-447d96557c0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_8d8c8cb8-e498-4730-acd7-681900776d7f" xlink:href="dva-20201231.xsd#dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_8d8c8cb8-e498-4730-acd7-681900776d7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_3e0e5fe9-9c3f-41e8-a411-1ab7420bc895" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_dva_DebtRefinancingCharges_3e0e5fe9-9c3f-41e8-a411-1ab7420bc895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8d535548-85ae-46bc-b50e-c8a9ce574b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_ShareBasedCompensation_8d535548-85ae-46bc-b50e-c8a9ce574b55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_98cc8fb3-1a79-4cf5-bf95-3c1c9b3fb1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_98cc8fb3-1a79-4cf5-bf95-3c1c9b3fb1d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_5ac8f500-713e-4133-b2de-2e7b12e1c1eb" xlink:href="dva-20201231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_5ac8f500-713e-4133-b2de-2e7b12e1c1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_7a642400-18c0-427f-a781-745c80c5e8d0" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_7a642400-18c0-427f-a781-745c80c5e8d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetLossGainOnDispositionOfBusinessInterests_3367244a-5716-41ff-a734-ff37684b2072" xlink:href="dva-20201231.xsd#dva_NetLossGainOnDispositionOfBusinessInterests"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_dva_NetLossGainOnDispositionOfBusinessInterests_3367244a-5716-41ff-a734-ff37684b2072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f0ccdae0-386c-4111-b697-614a3bd1b9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f0ccdae0-386c-4111-b697-614a3bd1b9d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c02b0cb5-04d4-473b-8cc6-9caef2d97446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c02b0cb5-04d4-473b-8cc6-9caef2d97446" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7a4ca9c9-3adb-487e-b115-d680dea1db21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7a4ca9c9-3adb-487e-b115-d680dea1db21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_b715a9c9-5c2e-44c4-9a75-0c1481bfc732" xlink:href="dva-20201231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_b715a9c9-5c2e-44c4-9a75-0c1481bfc732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_29393920-1252-4f5a-ae1a-ae51d69bd1ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_29393920-1252-4f5a-ae1a-ae51d69bd1ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_694351ca-c69f-4261-bd5f-62df29f64c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_694351ca-c69f-4261-bd5f-62df29f64c55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1bc8f231-8324-4f16-85ad-6c9d9a951102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1bc8f231-8324-4f16-85ad-6c9d9a951102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_f14fac1e-a83b-4ccd-8655-481b2fbe955b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_f14fac1e-a83b-4ccd-8655-481b2fbe955b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_293387c7-3276-48e7-959c-b16037fd4dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_293387c7-3276-48e7-959c-b16037fd4dc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_26d879b5-3252-4397-8a0f-a05f68e3e495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_db787d34-a3e6-4cb9-9793-f4a88c73a472" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_26d879b5-3252-4397-8a0f-a05f68e3e495" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9066b06d-df29-47fd-bf6c-4ddc0bd0a353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9066b06d-df29-47fd-bf6c-4ddc0bd0a353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6a0f031a-a677-4347-9a9a-b3a4f06d7430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6a0f031a-a677-4347-9a9a-b3a4f06d7430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_5d629817-e39e-470f-afb3-2f5205a23d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_5d629817-e39e-470f-afb3-2f5205a23d76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_4c1dd8d5-d13b-42d6-9ae4-524f060c2e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_4c1dd8d5-d13b-42d6-9ae4-524f060c2e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_9be4d6cf-f27f-4f7b-8d5e-057b363ff1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_9be4d6cf-f27f-4f7b-8d5e-057b363ff1d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_1cc0a46b-9aef-4d73-9959-b95a1ae2a0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_1cc0a46b-9aef-4d73-9959-b95a1ae2a0cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_190a87d5-14a8-40b0-a45f-37cc27052d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_190a87d5-14a8-40b0-a45f-37cc27052d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cd96fcda-e87b-4726-a54a-22b7ba829671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cd96fcda-e87b-4726-a54a-22b7ba829671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_3c64788d-0784-4898-a3a5-aed13205f9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_077c8dfc-41a0-4d2a-9266-cc6544211dc0" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_3c64788d-0784-4898-a3a5-aed13205f9b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_94a66319-f9c7-4984-85fa-125091508763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_44aad8ea-7fa5-4591-b66e-ceceb454aad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_94a66319-f9c7-4984-85fa-125091508763" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_44aad8ea-7fa5-4591-b66e-ceceb454aad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_053b9a62-750a-43a2-bdc5-f7d5bcf71aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_94a66319-f9c7-4984-85fa-125091508763" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_053b9a62-750a-43a2-bdc5-f7d5bcf71aa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27675a0c-152c-4c99-bedd-8f5536b47c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_94a66319-f9c7-4984-85fa-125091508763" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27675a0c-152c-4c99-bedd-8f5536b47c95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a024d863-3b0c-4636-ae94-8acb17bb8647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_94a66319-f9c7-4984-85fa-125091508763" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a024d863-3b0c-4636-ae94-8acb17bb8647" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITY"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognition" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognition"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RevenueRecognition" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShare" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02404f46-41c0-4a1f-80a0-e0b1581de04a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_e908a2a0-e4db-49d7-b170-d1d26e04b314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02404f46-41c0-4a1f-80a0-e0b1581de04a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_e908a2a0-e4db-49d7-b170-d1d26e04b314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_8e1ffdc1-3bb4-416a-a266-7afb0cb95801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02404f46-41c0-4a1f-80a0-e0b1581de04a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_8e1ffdc1-3bb4-416a-a266-7afb0cb95801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2a5891ea-b473-4fda-9e97-d8385cd62c75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3ee2dbdb-d39e-4ac2-80a6-b3ef13cae699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_2a5891ea-b473-4fda-9e97-d8385cd62c75" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3ee2dbdb-d39e-4ac2-80a6-b3ef13cae699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_c0b0303c-6705-4b53-8bba-536b1734a721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_2a5891ea-b473-4fda-9e97-d8385cd62c75" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_c0b0303c-6705-4b53-8bba-536b1734a721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2cbdfa51-2c9e-456d-8b4c-b0bbb42d4547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_773595ea-bae6-4044-a176-6beb6177bb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_2cbdfa51-2c9e-456d-8b4c-b0bbb42d4547" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_773595ea-bae6-4044-a176-6beb6177bb2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a2e81173-3f3f-44cb-9885-73ef215a3f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_2cbdfa51-2c9e-456d-8b4c-b0bbb42d4547" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a2e81173-3f3f-44cb-9885-73ef215a3f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e768b15-2c52-43f7-a002-c97c58a6e8ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_e1883001-4dc0-4570-bc58-b2b179a550d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e768b15-2c52-43f7-a002-c97c58a6e8ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_e1883001-4dc0-4570-bc58-b2b179a550d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3c762b11-e7bb-48f6-b1d0-158c3a7273d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e768b15-2c52-43f7-a002-c97c58a6e8ce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3c762b11-e7bb-48f6-b1d0-158c3a7273d8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashRestrictedCash"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashTables" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RestrictedCashTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashandEquivalentsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="simple" xlink:href="dva-20201231.xsd#Shorttermandlongterminvestments"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvesmtentsTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_0ad1b5fe-b8a8-40b0-9b99-5b13481172d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_a5a8dd24-742e-41ea-9e83-1b1c9639c4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_0ad1b5fe-b8a8-40b0-9b99-5b13481172d5" xlink:to="loc_us-gaap_HeldToMaturitySecurities_a5a8dd24-742e-41ea-9e83-1b1c9639c4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_40158f8c-6d07-4ba4-aede-fbc5ddbe82c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_0ad1b5fe-b8a8-40b0-9b99-5b13481172d5" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_40158f8c-6d07-4ba4-aede-fbc5ddbe82c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvestmentsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesOtherReceivables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OtherReceivablesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipment"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/PropertyandEquipment" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4e7ea496-6403-4df4-86ab-65f72bcd48ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_6cdda6c4-7fff-41f7-8e0c-0a4853b0fc53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4e7ea496-6403-4df4-86ab-65f72bcd48ff" xlink:to="loc_us-gaap_Land_6cdda6c4-7fff-41f7-8e0c-0a4853b0fc53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_97f64e4e-4b63-46ab-8c6c-6e857635c0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4e7ea496-6403-4df4-86ab-65f72bcd48ff" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_97f64e4e-4b63-46ab-8c6c-6e857635c0e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_be382c01-8b26-4b39-b043-9ec0e6ff31c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4e7ea496-6403-4df4-86ab-65f72bcd48ff" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_be382c01-8b26-4b39-b043-9ec0e6ff31c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_1cb33d7c-095a-4154-bca3-80a2e57e1e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4e7ea496-6403-4df4-86ab-65f72bcd48ff" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_1cb33d7c-095a-4154-bca3-80a2e57e1e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_f92595e2-92c4-4397-9d6a-ef2b11481129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4e7ea496-6403-4df4-86ab-65f72bcd48ff" xlink:to="loc_us-gaap_ConstructionInProgressGross_f92595e2-92c4-4397-9d6a-ef2b11481129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a311b4b8-af5d-4877-9c49-868e93b6c6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0f75ecbf-24a9-4b8b-9209-7b30344e8307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a311b4b8-af5d-4877-9c49-868e93b6c6d8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0f75ecbf-24a9-4b8b-9209-7b30344e8307" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2781e8da-f9f3-49cb-b446-ef42dabe861e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a311b4b8-af5d-4877-9c49-868e93b6c6d8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2781e8da-f9f3-49cb-b446-ef42dabe861e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Intangibles" xlink:type="simple" xlink:href="dva-20201231.xsd#Intangibles"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Intangibles" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IntangiblesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_25281be4-aae7-48b4-b84a-d13d08f417b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_263d3547-49ae-4b33-a7f3-c609d0fdc770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_25281be4-aae7-48b4-b84a-d13d08f417b9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_263d3547-49ae-4b33-a7f3-c609d0fdc770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_72b4fff5-0b47-44dc-a18d-4631c26c99ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_25281be4-aae7-48b4-b84a-d13d08f417b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_72b4fff5-0b47-44dc-a18d-4631c26c99ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1683f2de-9515-4bcd-9e9f-9fdf325eeb11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2e2f3056-2f6d-4480-b299-e8655499c3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1683f2de-9515-4bcd-9e9f-9fdf325eeb11" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2e2f3056-2f6d-4480-b299-e8655499c3ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_67c6d89a-a40a-4b4f-a46d-e3d74f2e95a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1683f2de-9515-4bcd-9e9f-9fdf325eeb11" xlink:to="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_67c6d89a-a40a-4b4f-a46d-e3d74f2e95a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ab0e55cb-1493-49ce-a6d6-752b9ade5c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1683f2de-9515-4bcd-9e9f-9fdf325eeb11" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ab0e55cb-1493-49ce-a6d6-752b9ade5c41" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91affb9c-9480-4c7a-abcd-c65b2d99e1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7bb0a224-c1d7-498e-915a-baae1c694689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91affb9c-9480-4c7a-abcd-c65b2d99e1e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7bb0a224-c1d7-498e-915a-baae1c694689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2ac3ff9e-7cd2-4289-9967-8cade5459f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91affb9c-9480-4c7a-abcd-c65b2d99e1e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2ac3ff9e-7cd2-4289-9967-8cade5459f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3877652b-65ce-4b59-aaf3-a46961c5d869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91affb9c-9480-4c7a-abcd-c65b2d99e1e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3877652b-65ce-4b59-aaf3-a46961c5d869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8f3922ce-2147-438d-94e0-253ef829038d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91affb9c-9480-4c7a-abcd-c65b2d99e1e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8f3922ce-2147-438d-94e0-253ef829038d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0edc8f0d-da13-442e-bdd3-a640874080a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91affb9c-9480-4c7a-abcd-c65b2d99e1e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0edc8f0d-da13-442e-bdd3-a640874080a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4f548361-829e-4d21-82b7-59af69bb2831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91affb9c-9480-4c7a-abcd-c65b2d99e1e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4f548361-829e-4d21-82b7-59af69bb2831" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestments"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmentsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20201231.xsd#Goodwill"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilities" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilities"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OtherLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4b149ff7-f505-45bb-a7c5-182269a6cd5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PayorRefundsAndRetractions_51fe2ba1-83e1-4cff-bc28-454312bcabcb" xlink:href="dva-20201231.xsd#dva_PayorRefundsAndRetractions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4b149ff7-f505-45bb-a7c5-182269a6cd5b" xlink:to="loc_dva_PayorRefundsAndRetractions_51fe2ba1-83e1-4cff-bc28-454312bcabcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_b5119b8a-f5db-430f-aff2-6104354fb35f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4b149ff7-f505-45bb-a7c5-182269a6cd5b" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_b5119b8a-f5db-430f-aff2-6104354fb35f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_89b1276d-755e-4ae8-8e0f-de6b5e7b45bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4b149ff7-f505-45bb-a7c5-182269a6cd5b" xlink:to="loc_us-gaap_InterestPayableCurrent_89b1276d-755e-4ae8-8e0f-de6b5e7b45bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_13018a84-fb59-4fbd-ab3b-fdeea39d96e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4b149ff7-f505-45bb-a7c5-182269a6cd5b" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_13018a84-fb59-4fbd-ab3b-fdeea39d96e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_1d037428-5618-47f9-885d-4070d1323d63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4b149ff7-f505-45bb-a7c5-182269a6cd5b" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_1d037428-5618-47f9-885d-4070d1323d63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_196583af-5547-44cc-a832-f0430c711ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f98106f5-929e-4839-8d99-583417822f73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_196583af-5547-44cc-a832-f0430c711ca9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f98106f5-929e-4839-8d99-583417822f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_101479b8-07de-4ff0-aad1-8c3bddc17e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_196583af-5547-44cc-a832-f0430c711ca9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_101479b8-07de-4ff0-aad1-8c3bddc17e01" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_558a0cac-9f77-440f-a259-e5f805239a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_0c897980-5929-4462-921b-8a9b6b0bfa80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_558a0cac-9f77-440f-a259-e5f805239a8a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_0c897980-5929-4462-921b-8a9b6b0bfa80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_1c3417fc-50b7-439c-b768-14d48e9f792a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_558a0cac-9f77-440f-a259-e5f805239a8a" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_1c3417fc-50b7-439c-b768-14d48e9f792a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_999b9b8f-833a-41f9-b9b8-600eb859e21c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7afd7446-8c11-4550-8ef2-343bbe07c501" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_999b9b8f-833a-41f9-b9b8-600eb859e21c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7afd7446-8c11-4550-8ef2-343bbe07c501" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_41caef7e-f389-4d64-a2fb-a763b1952d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_999b9b8f-833a-41f9-b9b8-600eb859e21c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_41caef7e-f389-4d64-a2fb-a763b1952d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_cf12aedc-caa7-4326-8dfb-8247b2b619e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_999b9b8f-833a-41f9-b9b8-600eb859e21c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_cf12aedc-caa7-4326-8dfb-8247b2b619e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b5b94923-e818-433a-ada1-64bc2b710da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c235859b-413d-42b5-a6f8-056c590dcfd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b5b94923-e818-433a-ada1-64bc2b710da1" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c235859b-413d-42b5-a6f8-056c590dcfd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_abda25ec-f797-4519-8897-ec77e9885ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b5b94923-e818-433a-ada1-64bc2b710da1" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_abda25ec-f797-4519-8897-ec77e9885ea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1b3087e0-3fe6-4b8e-a285-a65ff73974f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b5b94923-e818-433a-ada1-64bc2b710da1" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1b3087e0-3fe6-4b8e-a285-a65ff73974f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_cf72a3dc-26ee-4ab7-9e04-d3e64eb64a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f6335a34-33d2-42ba-8246-7e5574f078a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_cf72a3dc-26ee-4ab7-9e04-d3e64eb64a7f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f6335a34-33d2-42ba-8246-7e5574f078a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_a9f8f999-1664-4dbb-a1c1-538552092eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_cf72a3dc-26ee-4ab7-9e04-d3e64eb64a7f" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_a9f8f999-1664-4dbb-a1c1-538552092eda" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_41c42e23-57b2-4ab9-a1fc-6542956aed14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_41c42e23-57b2-4ab9-a1fc-6542956aed14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e8382527-b950-4098-b4d7-bdffbcfa84c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e8382527-b950-4098-b4d7-bdffbcfa84c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e791e7aa-92c1-48c6-a5d7-70304fee40e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e791e7aa-92c1-48c6-a5d7-70304fee40e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_b2e8ec19-f519-42b5-81db-238deafb59b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_b2e8ec19-f519-42b5-81db-238deafb59b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_9963494c-32c7-4772-acf1-b4bebdcc2d0d" xlink:href="dva-20201231.xsd#dva_EffectiveIncomeTaxReconciliationInvestmentImpairment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_9963494c-32c7-4772-acf1-b4bebdcc2d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_80570bfe-6d03-4efa-bc28-b65b11f6bd62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_80570bfe-6d03-4efa-bc28-b65b11f6bd62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2234a552-f0a8-46e3-80b3-f21692cd01d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2234a552-f0a8-46e3-80b3-f21692cd01d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_e8e4a3fc-3a39-4294-a60a-8326edbbdb16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec1c8552-5eb4-4c02-a192-f5efde23164d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_e8e4a3fc-3a39-4294-a60a-8326edbbdb16" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_cff169bb-05fa-452f-b2d0-90df80347b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_717324b3-f5fe-4ec4-a570-274eec2881cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cff169bb-05fa-452f-b2d0-90df80347b03" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_717324b3-f5fe-4ec4-a570-274eec2881cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_80551c36-fd80-4641-aca1-ef8e21e75d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cff169bb-05fa-452f-b2d0-90df80347b03" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_80551c36-fd80-4641-aca1-ef8e21e75d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_43657b55-1b06-4bc4-b61a-fa6dacf13b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_77df7562-da8d-43a4-b8e4-cbc32404ed0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_43657b55-1b06-4bc4-b61a-fa6dacf13b03" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_77df7562-da8d-43a4-b8e4-cbc32404ed0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d31c4d1e-b829-441d-835d-543309f1e964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_43657b55-1b06-4bc4-b61a-fa6dacf13b03" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d31c4d1e-b829-441d-835d-543309f1e964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_11a8b279-6901-404b-b938-f5767bb87379" xlink:href="dva-20201231.xsd#dva_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_43657b55-1b06-4bc4-b61a-fa6dacf13b03" xlink:to="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_11a8b279-6901-404b-b938-f5767bb87379" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_acd5a800-cae1-4bfb-b811-dfc65254d2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_43657b55-1b06-4bc4-b61a-fa6dacf13b03" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_acd5a800-cae1-4bfb-b811-dfc65254d2c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_5d58b422-345c-463a-ac88-6746032a81cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_43657b55-1b06-4bc4-b61a-fa6dacf13b03" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_5d58b422-345c-463a-ac88-6746032a81cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_86c3131c-06cd-41fa-ab1f-401dc5a0aab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsReceivables_efc4fc47-f9fc-4104-9bb4-f07476aa14ca" xlink:href="dva-20201231.xsd#dva_DeferredTaxAssetsReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_86c3131c-06cd-41fa-ab1f-401dc5a0aab0" xlink:to="loc_dva_DeferredTaxAssetsReceivables_efc4fc47-f9fc-4104-9bb4-f07476aa14ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ded22350-2513-457c-bfff-aa82af1992b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_86c3131c-06cd-41fa-ab1f-401dc5a0aab0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ded22350-2513-457c-bfff-aa82af1992b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_4c28d49d-b75f-4753-9ddc-75c2ce96f8cb" xlink:href="dva-20201231.xsd#dva_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_86c3131c-06cd-41fa-ab1f-401dc5a0aab0" xlink:to="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_4c28d49d-b75f-4753-9ddc-75c2ce96f8cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_55efbb01-769a-4c9d-b688-47c792c1efcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_86c3131c-06cd-41fa-ab1f-401dc5a0aab0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_55efbb01-769a-4c9d-b688-47c792c1efcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_f575ffa6-6bdd-4c26-90bb-2368a6d50b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_86c3131c-06cd-41fa-ab1f-401dc5a0aab0" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_f575ffa6-6bdd-4c26-90bb-2368a6d50b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_dc7884db-1690-4d66-bbbf-dc44bb9f90ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ec16af55-1a17-4ab6-84b6-c99447115417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_dc7884db-1690-4d66-bbbf-dc44bb9f90ee" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_ec16af55-1a17-4ab6-84b6-c99447115417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_709223f1-d794-4f2b-a79e-365dd14999ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_dc7884db-1690-4d66-bbbf-dc44bb9f90ee" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_709223f1-d794-4f2b-a79e-365dd14999ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebt" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebt"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_ae09059b-7258-42cd-b638-6e97f1724876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1bca7616-003e-4f01-b8c3-574d40802e76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_ae09059b-7258-42cd-b638-6e97f1724876" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1bca7616-003e-4f01-b8c3-574d40802e76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_e62a1c27-a170-4fa3-be73-887326cf6d5c" xlink:href="dva-20201231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_ae09059b-7258-42cd-b638-6e97f1724876" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_e62a1c27-a170-4fa3-be73-887326cf6d5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtScheduledMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtAdditionalinformationDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Leases" xlink:type="simple" xlink:href="dva-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesLeaseExpenseComponentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesLeasesOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aec6ee9-4e72-4a3e-a642-e2a146804295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f686a137-6f5d-419b-a05d-1a084d13f580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aec6ee9-4e72-4a3e-a642-e2a146804295" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f686a137-6f5d-419b-a05d-1a084d13f580" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7ecc035a-1477-4aab-8e66-322b40551b30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aec6ee9-4e72-4a3e-a642-e2a146804295" xlink:to="loc_us-gaap_FinanceLeaseLiability_7ecc035a-1477-4aab-8e66-322b40551b30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9011158-a3de-4bf1-a09e-eb3c292d1609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_69ba9d49-f41b-407c-b398-fda9d47bed0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9011158-a3de-4bf1-a09e-eb3c292d1609" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_69ba9d49-f41b-407c-b398-fda9d47bed0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3181a593-af84-4374-a988-fe825969ebea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9011158-a3de-4bf1-a09e-eb3c292d1609" xlink:to="loc_us-gaap_OperatingLeaseLiability_3181a593-af84-4374-a988-fe825969ebea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d120760-e952-48d2-b4de-61ceb51af337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e45e4773-178c-4c65-bf09-af7937aa28e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d120760-e952-48d2-b4de-61ceb51af337" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e45e4773-178c-4c65-bf09-af7937aa28e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_20766c37-67e8-4925-a1cb-f115d2265aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d120760-e952-48d2-b4de-61ceb51af337" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_20766c37-67e8-4925-a1cb-f115d2265aaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fffdf2bf-dcfc-43fd-b9cb-7de48e454863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d120760-e952-48d2-b4de-61ceb51af337" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fffdf2bf-dcfc-43fd-b9cb-7de48e454863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_07fa1350-d97b-43f4-bd75-b209f2d897be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d120760-e952-48d2-b4de-61ceb51af337" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_07fa1350-d97b-43f4-bd75-b209f2d897be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fe06cdce-c45e-4da7-9de1-63e3874f4755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d120760-e952-48d2-b4de-61ceb51af337" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fe06cdce-c45e-4da7-9de1-63e3874f4755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_c9e739c3-2979-408e-bd4c-44cd423d85cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d120760-e952-48d2-b4de-61ceb51af337" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_c9e739c3-2979-408e-bd4c-44cd423d85cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3971d023-2ac7-46b4-8730-ebfe11bf087d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d298cd08-d4fd-4447-b18c-afb2f6d937be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3971d023-2ac7-46b4-8730-ebfe11bf087d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d298cd08-d4fd-4447-b18c-afb2f6d937be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bc08197b-ae8c-465a-a36d-65dfdefb5550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3971d023-2ac7-46b4-8730-ebfe11bf087d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bc08197b-ae8c-465a-a36d-65dfdefb5550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c13b1fbe-d9a8-4551-951a-d96ebd29164d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3971d023-2ac7-46b4-8730-ebfe11bf087d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c13b1fbe-d9a8-4551-951a-d96ebd29164d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_145108c5-e709-4e83-a122-39d338c8ac26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3971d023-2ac7-46b4-8730-ebfe11bf087d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_145108c5-e709-4e83-a122-39d338c8ac26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5038be4b-fe24-4e12-8ecb-c79b01d76303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3971d023-2ac7-46b4-8730-ebfe11bf087d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5038be4b-fe24-4e12-8ecb-c79b01d76303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9b5f928e-6024-41f6-8edc-fb52c440f118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3971d023-2ac7-46b4-8730-ebfe11bf087d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9b5f928e-6024-41f6-8edc-fb52c440f118" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="dva-20201231.xsd#EmployeeBenefitPlans"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EmployeeBenefitPlansAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Contingencies" xlink:type="simple" xlink:href="dva-20201231.xsd#Contingencies"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Contingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ContingenciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="simple" xlink:href="dva-20201231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Stockholdersequity" xlink:type="simple" xlink:href="dva-20201231.xsd#Stockholdersequity"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Stockholdersequity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/StockholdersequityTables" xlink:type="simple" xlink:href="dva-20201231.xsd#StockholdersequityTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/StockholdersequityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#StockRepurchasesTenderOfferDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShareholdersequityDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncome"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncomeTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_9a20f959-f247-4b12-84c7-7c93cfc6a214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_20966436-e002-414f-8da9-989ddaa23cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_9a20f959-f247-4b12-84c7-7c93cfc6a214" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_20966436-e002-414f-8da9-989ddaa23cb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_beeb6d6e-04ed-46b0-a8a8-b878468c7f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_9a20f959-f247-4b12-84c7-7c93cfc6a214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_beeb6d6e-04ed-46b0-a8a8-b878468c7f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8777a429-038c-4edd-9518-836472e2c77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_d28a98dd-f5df-4686-8e93-7a1870b7d223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8777a429-038c-4edd-9518-836472e2c77c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_d28a98dd-f5df-4686-8e93-7a1870b7d223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b1867278-5280-478d-b073-12e2258eb906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8777a429-038c-4edd-9518-836472e2c77c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b1867278-5280-478d-b073-12e2258eb906" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestitures"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsAssetsacquiredandliabilitiesassumedDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d35e6fe3-7a88-46ea-b16d-bb0ae0ef8af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d35e6fe3-7a88-46ea-b16d-bb0ae0ef8af8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ba1f8f77-6c67-4284-be5a-af4073e08c70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ba1f8f77-6c67-4284-be5a-af4073e08c70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b237c019-88a0-4a12-9d57-77f2e0688b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b237c019-88a0-4a12-9d57-77f2e0688b87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e2df2f0c-8329-45a9-85e5-33be4edf3078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e2df2f0c-8329-45a9-85e5-33be4edf3078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_ed90528f-cd50-4dc3-bebf-7eeb0e7415d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_ed90528f-cd50-4dc3-bebf-7eeb0e7415d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b126735a-dac0-468d-96d5-67f68b626836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_Goodwill_b126735a-dac0-468d-96d5-67f68b626836" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_16a311ba-f8ec-473b-a2d5-1df5c7c88417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_16a311ba-f8ec-473b-a2d5-1df5c7c88417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ffa2c758-e45d-405a-8b56-3a09e754c5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ffa2c758-e45d-405a-8b56-3a09e754c5d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d384285e-0777-401a-8f20-29c878d6f6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3beac2bb-aa92-4e99-a2cb-08a0d501ed05" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d384285e-0777-401a-8f20-29c878d6f6cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperations"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="dva-20201231.xsd#VariableInterestEntities"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/VariableInterestEntities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#VariableInterestEntitiesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReporting" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReporting"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentReporting" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentReportingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofAssetsbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformation"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformationTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunauditedTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunauditedDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dva-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>dva-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cb65dee0-3538-408a-90c8-cfac27791e84,g:bb413262-db44-4a11-afdc-c2a9f72b9180-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20201231.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended" id="if04b264464f340de9197a5266784b005_DocumentandEntityInformation"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended" id="i4cf9284561a44207a61967993527111c_CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended" id="i582a7df14ee847eab23808e77a895773_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i83f674098b7b44e0a68f8eff452bdf53_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i1f208d8f77204a22a2e6db5afc983dde_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i177af0823c4c4e29974c9cd34d095cde_CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_21af277e-2290-4e90-9337-c6a27a365cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:to="loc_us-gaap_ProfitLoss_21af277e-2290-4e90-9337-c6a27a365cf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_0bce6a66-0c7e-4a7d-9564-16441be5f0f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_0bce6a66-0c7e-4a7d-9564-16441be5f0f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_19d596e6-4ea2-4427-a28a-acc9fc36ea89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_19d596e6-4ea2-4427-a28a-acc9fc36ea89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_3fccba30-a562-412b-85a8-6f05e0e5516c" xlink:href="dva-20201231.xsd#dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_3fccba30-a562-412b-85a8-6f05e0e5516c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_69d2262f-d5b4-4176-b709-b459fc05b0be" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_DebtRefinancingCharges_69d2262f-d5b4-4176-b709-b459fc05b0be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_62134d98-03af-460e-8523-b016c8f379b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_ShareBasedCompensation_62134d98-03af-460e-8523-b016c8f379b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54beff32-6ddf-4594-a4b0-808aeefde232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54beff32-6ddf-4594-a4b0-808aeefde232" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_05ab7ea1-9ac7-47d5-b27d-d73e6df0c308" xlink:href="dva-20201231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_05ab7ea1-9ac7-47d5-b27d-d73e6df0c308" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_056a35b3-5efc-42c8-b904-d2cbd6593c8f" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_056a35b3-5efc-42c8-b904-d2cbd6593c8f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetLossGainOnDispositionOfBusinessInterests_e01f2c53-e1fe-4894-92ba-9e36d68bf448" xlink:href="dva-20201231.xsd#dva_NetLossGainOnDispositionOfBusinessInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_NetLossGainOnDispositionOfBusinessInterests_e01f2c53-e1fe-4894-92ba-9e36d68bf448" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_0ddc62d6-bc33-4213-8e6d-8343d4dd96f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_0ddc62d6-bc33-4213-8e6d-8343d4dd96f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_70ca183e-1b68-45e6-8486-b8709bf3d7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_70ca183e-1b68-45e6-8486-b8709bf3d7ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_81b7dbeb-937f-4e0e-b790-ee7a0a37f854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_81b7dbeb-937f-4e0e-b790-ee7a0a37f854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_cb9620b6-3186-4569-97e0-f6c1c10bb491" xlink:href="dva-20201231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_cb9620b6-3186-4569-97e0-f6c1c10bb491" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_af8a1cf4-5607-45f9-843c-95b4f09a88be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_af8a1cf4-5607-45f9-843c-95b4f09a88be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_246f29e8-3011-4079-a579-50fe3870f81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_246f29e8-3011-4079-a579-50fe3870f81b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1133515-b7c4-4ac7-a7cd-426df6bd15d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1133515-b7c4-4ac7-a7cd-426df6bd15d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_7e688a09-14d3-4f0c-b89d-21dadf0cdcf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_7e688a09-14d3-4f0c-b89d-21dadf0cdcf1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_84b1e95e-7c4a-47d8-ba1a-2efc1eab30aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_84b1e95e-7c4a-47d8-ba1a-2efc1eab30aa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a783a287-b8d2-4bea-a911-1fa7914a3e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a783a287-b8d2-4bea-a911-1fa7914a3e7a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcad4164-5b24-4abe-b556-c4e372564e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcad4164-5b24-4abe-b556-c4e372564e7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_abad09ee-88b0-4afb-86ec-1b060158c69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_abad09ee-88b0-4afb-86ec-1b060158c69e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_bb388e2a-8a08-45c1-b0af-0ba6b0b9c85c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_bb388e2a-8a08-45c1-b0af-0ba6b0b9c85c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_74490e65-25f2-4ab5-81a5-0f11d5c52aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_74490e65-25f2-4ab5-81a5-0f11d5c52aa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_e9786682-072a-4248-a5ef-9adcf5b722b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_e9786682-072a-4248-a5ef-9adcf5b722b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_27427799-fa82-4864-a91e-aca64114c962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_27427799-fa82-4864-a91e-aca64114c962" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_424d94b1-c379-4e08-a299-c80d1e1d440d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_424d94b1-c379-4e08-a299-c80d1e1d440d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_1806073f-9d5e-4658-aad0-8bdd1215a455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_1806073f-9d5e-4658-aad0-8bdd1215a455" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9e33419e-e6b9-43b9-b522-899fafe6fb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9e33419e-e6b9-43b9-b522-899fafe6fb5d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7bfc593a-d5af-4026-8d76-bf59f477cb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7bfc593a-d5af-4026-8d76-bf59f477cb87" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41008978-1b53-4bb9-9cd8-5ad66aa5409f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41008978-1b53-4bb9-9cd8-5ad66aa5409f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_94bff283-62e7-4457-a1ec-b158875a92b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_94bff283-62e7-4457-a1ec-b158875a92b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0f2a78b1-5144-4cca-aea6-df5c5e93ef22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0f2a78b1-5144-4cca-aea6-df5c5e93ef22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts_83a94149-f174-4c1b-b93a-8ee20f40ceb4" xlink:href="dva-20201231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_dva_DebtFinancingAndDebtRedemptionCosts_83a94149-f174-4c1b-b93a-8ee20f40ceb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b64dbac0-a653-4408-82cf-518c4847a284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b64dbac0-a653-4408-82cf-518c4847a284" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_5ef9bad8-7702-4d3d-bd4c-00d6c4383cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_5ef9bad8-7702-4d3d-bd4c-00d6c4383cef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_6ba7c3ec-f02d-46ee-9453-d97fa3bc7246" xlink:href="dva-20201231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_6ba7c3ec-f02d-46ee-9453-d97fa3bc7246" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2268ca24-c4c2-4dc7-a92c-67ed0450671a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2268ca24-c4c2-4dc7-a92c-67ed0450671a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_84dac2c1-1b3b-4377-a48b-38d36d6daca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_84dac2c1-1b3b-4377-a48b-38d36d6daca0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_b312e430-c9fd-48a0-83e6-d5a705d43502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_b312e430-c9fd-48a0-83e6-d5a705d43502" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_05fb0446-96d0-4465-925b-71cc77f1a846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_05fb0446-96d0-4465-925b-71cc77f1a846" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_705961cc-5f3b-41c9-9442-b28662b4520a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_705961cc-5f3b-41c9-9442-b28662b4520a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a4f714aa-5acc-43e2-a1b9-7f9ab98ecb42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a4f714aa-5acc-43e2-a1b9-7f9ab98ecb42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0909bdc1-6780-48d5-bb4a-67a041f85b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0909bdc1-6780-48d5-bb4a-67a041f85b18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95712ec8-94c2-45dd-9bc4-dfbed3ac0964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95712ec8-94c2-45dd-9bc4-dfbed3ac0964" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_225af042-e10b-4cf5-8c16-4e58b53e1917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7340ac30-e8c4-454e-b796-adbdef6baae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_StatementTable_7340ac30-e8c4-454e-b796-adbdef6baae8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_94da5536-443f-4a55-b9b5-e40f32931088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7340ac30-e8c4-454e-b796-adbdef6baae8" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_94da5536-443f-4a55-b9b5-e40f32931088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_94da5536-443f-4a55-b9b5-e40f32931088_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_94da5536-443f-4a55-b9b5-e40f32931088" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_94da5536-443f-4a55-b9b5-e40f32931088_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_94da5536-443f-4a55-b9b5-e40f32931088" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_0d7829a9-ace2-47bd-9427-7bf1b468c63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_0d7829a9-ace2-47bd-9427-7bf1b468c63a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_334190e8-c9a5-4091-b5db-557e807ccc51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_334190e8-c9a5-4091-b5db-557e807ccc51" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="extended" id="i0f215d3b30524f5ead9104e4eef9f39a_CONSOLIDATEDSTATEMENTSOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_df827e78-5e92-4f59-ba86-66d5992f7535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_df827e78-5e92-4f59-ba86-66d5992f7535" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ae22d172-1f2d-4eb1-b4ae-23ab6e6b044d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ae22d172-1f2d-4eb1-b4ae-23ab6e6b044d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5becb282-736d-4cfb-96bd-0d471e234407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5becb282-736d-4cfb-96bd-0d471e234407" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8db613d6-c9e4-4fff-89f2-226f863fb612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8db613d6-c9e4-4fff-89f2-226f863fb612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_b71410c9-9856-4ad7-8bfc-34c43cab8df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_b71410c9-9856-4ad7-8bfc-34c43cab8df4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_aa733828-55f3-47de-ae46-a2b20c7f5c75" xlink:href="dva-20201231.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_aa733828-55f3-47de-ae46-a2b20c7f5c75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_06b31ac0-e1ce-4570-80c7-0990f37960bc" xlink:href="dva-20201231.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_06b31ac0-e1ce-4570-80c7-0990f37960bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_8ae0ceda-942e-4cf8-ad21-4db49cdd0714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_8ae0ceda-942e-4cf8-ad21-4db49cdd0714" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_5f886693-1600-41b4-b163-a9821d446e81" xlink:href="dva-20201231.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_5f886693-1600-41b4-b163-a9821d446e81" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_50347a4f-752c-47a1-8d48-a539c14a902e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_50347a4f-752c-47a1-8d48-a539c14a902e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8dead559-a97a-4163-b6c4-1c1219366dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_40a09b08-55c3-4cd1-a4a3-bbfda30ed831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_40a09b08-55c3-4cd1-a4a3-bbfda30ed831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3046b0d-0bdb-4f59-843c-4fc8ad8ba168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3046b0d-0bdb-4f59-843c-4fc8ad8ba168" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7aeecb7e-b24c-4cf8-b4f8-54a6b45aa214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7aeecb7e-b24c-4cf8-b4f8-54a6b45aa214" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_49d40e51-04cf-4f93-ba81-afbcae811298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_49d40e51-04cf-4f93-ba81-afbcae811298" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_99f07ba1-d6a6-4640-a540-30d279bd9309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_99f07ba1-d6a6-4640-a540-30d279bd9309" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5aa78896-e5b9-41ee-82d1-8def800e0386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5aa78896-e5b9-41ee-82d1-8def800e0386" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e5f095c-454a-483c-a038-97884bc3b992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e5f095c-454a-483c-a038-97884bc3b992" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0919a7db-dcb6-4f04-b3ab-950149f4dbc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0919a7db-dcb6-4f04-b3ab-950149f4dbc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_3c032ede-f8de-40b8-bd4a-0112ee17fd1b" xlink:href="dva-20201231.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_3c032ede-f8de-40b8-bd4a-0112ee17fd1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_24688623-a116-4fca-8c41-c93085a2b690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_24688623-a116-4fca-8c41-c93085a2b690" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc8ba5b4-db4f-41cb-849c-dfec01d1987c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc8ba5b4-db4f-41cb-849c-dfec01d1987c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_40f89712-cb01-4f26-9974-6c14352b0ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_40f89712-cb01-4f26-9974-6c14352b0ba2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e5c467d5-e635-4ac8-9655-459ee10487c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e5c467d5-e635-4ac8-9655-459ee10487c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f3a51674-02e6-486f-88c9-9926e7c07b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f3a51674-02e6-486f-88c9-9926e7c07b9e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4eeb163d-242e-424e-bf54-27f9c511ecd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4eeb163d-242e-424e-bf54-27f9c511ecd6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_52396582-c2ac-4fcb-aece-34e38d54bc90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_52396582-c2ac-4fcb-aece-34e38d54bc90" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bd4f5de1-efa0-4769-a393-7df2fe727cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bd4f5de1-efa0-4769-a393-7df2fe727cfa" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aa688b2f-cea9-4865-8aff-fcdbb03474f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_96be215c-1de3-4c59-ae65-24e2169b93f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_df827e78-5e92-4f59-ba86-66d5992f7535" xlink:to="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0465f417-4d4f-41aa-86f7-ba235c7bdfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0465f417-4d4f-41aa-86f7-ba235c7bdfa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0465f417-4d4f-41aa-86f7-ba235c7bdfa3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0465f417-4d4f-41aa-86f7-ba235c7bdfa3" xlink:to="loc_us-gaap_EquityComponentDomain_0465f417-4d4f-41aa-86f7-ba235c7bdfa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fe6dcf73-7e71-45f7-bcf3-c5ffa714b6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0465f417-4d4f-41aa-86f7-ba235c7bdfa3" xlink:to="loc_us-gaap_EquityComponentDomain_fe6dcf73-7e71-45f7-bcf3-c5ffa714b6d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fe6dcf73-7e71-45f7-bcf3-c5ffa714b6d2" xlink:to="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_a5a3ec62-99c9-47a0-840a-e82fb6ddb074" xlink:href="dva-20201231.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_a5a3ec62-99c9-47a0-840a-e82fb6ddb074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_76900596-7a81-45b0-aacc-858ad72ff722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_CommonStockMember_76900596-7a81-45b0-aacc-858ad72ff722" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1dfc09e7-87ff-400a-aa7a-029a21bbd14f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1dfc09e7-87ff-400a-aa7a-029a21bbd14f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8e890c41-4b4f-4fd9-892a-22c128677a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_RetainedEarningsMember_8e890c41-4b4f-4fd9-892a-22c128677a89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0ecee9e1-8dfd-45ee-a0fd-2321468bbfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_TreasuryStockMember_0ecee9e1-8dfd-45ee-a0fd-2321468bbfb3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_853b62b7-3559-42af-9fb4-69ecf9f089c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_853b62b7-3559-42af-9fb4-69ecf9f089c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f67a3ae9-d53e-4c76-8390-7aa4a60ca570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f67a3ae9-d53e-4c76-8390-7aa4a60ca570" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_133b3470-a5fb-4dff-a47c-008fdfeebb70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_133b3470-a5fb-4dff-a47c-008fdfeebb70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_133b3470-a5fb-4dff-a47c-008fdfeebb70_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_133b3470-a5fb-4dff-a47c-008fdfeebb70" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_133b3470-a5fb-4dff-a47c-008fdfeebb70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17dc4b84-1e1e-4c22-9c4e-d924acf5841d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_133b3470-a5fb-4dff-a47c-008fdfeebb70" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17dc4b84-1e1e-4c22-9c4e-d924acf5841d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c12e6500-59e0-4366-b3f3-2246592535b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17dc4b84-1e1e-4c22-9c4e-d924acf5841d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c12e6500-59e0-4366-b3f3-2246592535b7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended" id="i5d6eec7025494d288420d3de51e68eab_OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i4498615844b143d3817a8ce934fa842a_OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" id="ic871d91082c145cd8aae60bfa091232c_OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:href="dva-20201231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfSites_51a30a15-b058-4186-b7f7-90378197ff9b" xlink:href="dva-20201231.xsd#dva_NumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_NumberOfSites_51a30a15-b058-4186-b7f7-90378197ff9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1b5e1bf3-ec70-4671-8933-2dd92a408868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1b5e1bf3-ec70-4671-8933-2dd92a408868" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfCustomers_a15747e8-c923-44cb-83fd-62f5b41ef16c" xlink:href="dva-20201231.xsd#dva_NumberOfCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_NumberOfCustomers_a15747e8-c923-44cb-83fd-62f5b41ef16c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c890dfb0-701d-4a2b-bd90-dfbf73326c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c890dfb0-701d-4a2b-bd90-dfbf73326c06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_16f6c873-9843-4ef2-913b-8ebfac56dbb7" xlink:href="dva-20201231.xsd#dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_16f6c873-9843-4ef2-913b-8ebfac56dbb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_0e6ff7e8-4125-450b-96ad-b1ab1d876c18" xlink:href="dva-20201231.xsd#dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_0e6ff7e8-4125-450b-96ad-b1ab1d876c18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_212f2a0a-365a-4aed-9a74-c04088a42e56" xlink:href="dva-20201231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_212f2a0a-365a-4aed-9a74-c04088a42e56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d8085050-fb1f-4706-93c9-7f2db24f663e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_212f2a0a-365a-4aed-9a74-c04088a42e56" xlink:to="loc_srt_StatementGeographicalAxis_d8085050-fb1f-4706-93c9-7f2db24f663e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d8085050-fb1f-4706-93c9-7f2db24f663e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d8085050-fb1f-4706-93c9-7f2db24f663e" xlink:to="loc_srt_SegmentGeographicalDomain_d8085050-fb1f-4706-93c9-7f2db24f663e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d8085050-fb1f-4706-93c9-7f2db24f663e" xlink:to="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e82b6b00-3d22-42c8-89e2-2e74d29c6c83" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:to="loc_country_US_e82b6b00-3d22-42c8-89e2-2e74d29c6c83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InternationalOperationsMember_f7087772-9c81-4943-8992-7e9e60b6bf15" xlink:href="dva-20201231.xsd#dva_InternationalOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:to="loc_dva_InternationalOperationsMember_f7087772-9c81-4943-8992-7e9e60b6bf15" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognition" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognition"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognition" xlink:type="extended" id="i166948240c2546c793ff45c8ed6e6c87_RevenueRecognition"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="extended" id="if2b5dfe3959d4a73b9ed142cbe37f8f0_RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended" id="icf3b1ec2454244c4bf47e9b8f7ba6739_RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9284cfaf-8c1f-4f8b-b85f-08d23fd04724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9284cfaf-8c1f-4f8b-b85f-08d23fd04724" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_f57cd895-9022-4d50-a970-02720045ca95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_OtherIncome_f57cd895-9022-4d50-a970-02720045ca95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_02b0c1b5-b7fd-4b23-b88b-bc9ce87596f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_Revenues_02b0c1b5-b7fd-4b23-b88b-bc9ce87596f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_a792bc56-8374-49df-aab0-323006c9433d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_a792bc56-8374-49df-aab0-323006c9433d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProvisionForExpectedCreditLosses_eb96eadd-8a3e-4357-b737-af1ab6cdffc2" xlink:href="dva-20201231.xsd#dva_ProvisionForExpectedCreditLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_a792bc56-8374-49df-aab0-323006c9433d" xlink:to="loc_dva_ProvisionForExpectedCreditLosses_eb96eadd-8a3e-4357-b737-af1ab6cdffc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb7e3b9e-1306-4ee6-ae7d-cde43c083286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb7e3b9e-1306-4ee6-ae7d-cde43c083286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fb7e3b9e-1306-4ee6-ae7d-cde43c083286_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb7e3b9e-1306-4ee6-ae7d-cde43c083286" xlink:to="loc_us-gaap_SegmentDomain_fb7e3b9e-1306-4ee6-ae7d-cde43c083286_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb7e3b9e-1306-4ee6-ae7d-cde43c083286" xlink:to="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_cd8b20a2-6b0e-43a2-9f1f-e9f180583ff8" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_cd8b20a2-6b0e-43a2-9f1f-e9f180583ff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_fc9121f3-88b9-4e97-8b20-c3a2fb9d0e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:to="loc_us-gaap_AllOtherSegmentsMember_fc9121f3-88b9-4e97-8b20-c3a2fb9d0e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_24f6e8ae-3bd9-44c6-8347-a235b94cee6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_24f6e8ae-3bd9-44c6-8347-a235b94cee6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_24f6e8ae-3bd9-44c6-8347-a235b94cee6d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_24f6e8ae-3bd9-44c6-8347-a235b94cee6d" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_24f6e8ae-3bd9-44c6-8347-a235b94cee6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_24f6e8ae-3bd9-44c6-8347-a235b94cee6d" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_50146938-9f78-43b7-aaf4-d086218e0dfe" xlink:href="dva-20201231.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_50146938-9f78-43b7-aaf4-d086218e0dfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_edef59b7-8036-46d3-9a01-bf5e9c65a4da" xlink:href="dva-20201231.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_edef59b7-8036-46d3-9a01-bf5e9c65a4da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_3ddac046-47cd-4598-8435-45aa9ef74e22" xlink:href="dva-20201231.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_OtherGovernmentPayorsMember_3ddac046-47cd-4598-8435-45aa9ef74e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_51617d1b-aa9f-4fca-9d5b-f9b880f99000" xlink:href="dva-20201231.xsd#dva_CommercialPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_CommercialPayorsMember_51617d1b-aa9f-4fca-9d5b-f9b880f99000" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_32de7866-14d1-4522-bb12-5f33e4b924f3" xlink:href="dva-20201231.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_OtherSourcesofRevenueMember_32de7866-14d1-4522-bb12-5f33e4b924f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e6f2c634-484a-4128-a4fb-36d450fb1818" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:to="loc_srt_ConsolidationItemsAxis_e6f2c634-484a-4128-a4fb-36d450fb1818" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e6f2c634-484a-4128-a4fb-36d450fb1818_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e6f2c634-484a-4128-a4fb-36d450fb1818" xlink:to="loc_srt_ConsolidationItemsDomain_e6f2c634-484a-4128-a4fb-36d450fb1818_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4e7ff49f-8aaa-438a-b9be-0a99ca34ba9c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e6f2c634-484a-4128-a4fb-36d450fb1818" xlink:to="loc_srt_ConsolidationItemsDomain_4e7ff49f-8aaa-438a-b9be-0a99ca34ba9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_1fc06619-3381-42f1-b8a9-65ea54a3544f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4e7ff49f-8aaa-438a-b9be-0a99ca34ba9c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_1fc06619-3381-42f1-b8a9-65ea54a3544f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="extended" id="i6b6600c45198429e98d316e124837bf0_RevenueRecognitionandAccountsReceivableAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b7d0f7d0-45e8-4bae-912f-62cf9966447d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b7d0f7d0-45e8-4bae-912f-62cf9966447d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_a3f777a9-0586-4667-8d6d-833af5ff20fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_a3f777a9-0586-4667-8d6d-833af5ff20fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfConcentrationRiskCustomers_55963177-bb8b-4b81-9f4d-8dea98884b42" xlink:href="dva-20201231.xsd#dva_NumberOfConcentrationRiskCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_dva_NumberOfConcentrationRiskCustomers_55963177-bb8b-4b81-9f4d-8dea98884b42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_12bd5dae-f8ef-4161-819f-1e6f92923980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_12bd5dae-f8ef-4161-819f-1e6f92923980" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_55dc40c3-5542-4882-9f93-f4a29b4f2684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_55dc40c3-5542-4882-9f93-f4a29b4f2684" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_473a6141-e241-4d5c-991d-24f35d3c9016" xlink:href="dva-20201231.xsd#dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_473a6141-e241-4d5c-991d-24f35d3c9016" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AccountsReceivablePeriodOutstanding_cb28809f-492a-4dcb-a575-bb0007e5f70e" xlink:href="dva-20201231.xsd#dva_AccountsReceivablePeriodOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_dva_AccountsReceivablePeriodOutstanding_cb28809f-492a-4dcb-a575-bb0007e5f70e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed3586dd-1fa0-4da0-9504-836274b6a81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed3586dd-1fa0-4da0-9504-836274b6a81f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ed3586dd-1fa0-4da0-9504-836274b6a81f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed3586dd-1fa0-4da0-9504-836274b6a81f" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ed3586dd-1fa0-4da0-9504-836274b6a81f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed3586dd-1fa0-4da0-9504-836274b6a81f" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_714a456d-cf08-4870-84c8-e9dd02f34fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_714a456d-cf08-4870-84c8-e9dd02f34fc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_76afca77-6c42-48eb-b0c9-0b655de890c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:to="loc_us-gaap_AccountsReceivableMember_76afca77-6c42-48eb-b0c9-0b655de890c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_43a01757-4a1e-4f82-8037-2de99496a3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_43a01757-4a1e-4f82-8037-2de99496a3ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_43a01757-4a1e-4f82-8037-2de99496a3ec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_43a01757-4a1e-4f82-8037-2de99496a3ec" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_43a01757-4a1e-4f82-8037-2de99496a3ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6355ebfa-600c-4256-bbc2-1829f4c299a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_43a01757-4a1e-4f82-8037-2de99496a3ec" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6355ebfa-600c-4256-bbc2-1829f4c299a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientServicesCustomerConcentrationRiskMember_852285e8-81f1-41bf-94af-c307e52c5290" xlink:href="dva-20201231.xsd#dva_PatientServicesCustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6355ebfa-600c-4256-bbc2-1829f4c299a7" xlink:to="loc_dva_PatientServicesCustomerConcentrationRiskMember_852285e8-81f1-41bf-94af-c307e52c5290" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d002e660-20c4-4f47-8116-fffa033361b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d002e660-20c4-4f47-8116-fffa033361b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_82245992-fa78-418f-90b7-c010fb4c6537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d002e660-20c4-4f47-8116-fffa033361b6" xlink:to="loc_us-gaap_AccountsReceivableMember_82245992-fa78-418f-90b7-c010fb4c6537" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_05281acc-0185-4fb6-9cbe-4b04481a3e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_05281acc-0185-4fb6-9cbe-4b04481a3e25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_05281acc-0185-4fb6-9cbe-4b04481a3e25_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_05281acc-0185-4fb6-9cbe-4b04481a3e25" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_05281acc-0185-4fb6-9cbe-4b04481a3e25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_454e2e1c-f3f5-4ee3-afa0-bb6c89fe92b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_05281acc-0185-4fb6-9cbe-4b04481a3e25" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_454e2e1c-f3f5-4ee3-afa0-bb6c89fe92b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_4831bbcc-b0a1-4d0d-b8d7-2a8e0a91c9bc" xlink:href="dva-20201231.xsd#dva_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_454e2e1c-f3f5-4ee3-afa0-bb6c89fe92b2" xlink:to="loc_dva_MedicareMember_4831bbcc-b0a1-4d0d-b8d7-2a8e0a91c9bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShare" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EarningsPerShare" xlink:type="extended" id="i271c8dc1a8364afdad79822d838ca08a_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EarningsPerShareTables" xlink:type="extended" id="i45b72dd90c1a441cbc5f8aecce21ec48_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="extended" id="i11b92666513d4acc889eaf09843c4da5_EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashRestrictedCash"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="extended" id="ie085b7a14eff44f797abf9fbf5de9bf4_RestrictedCashRestrictedCash"/>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashTables" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RestrictedCashTables" xlink:type="extended" id="ia426dd3f777d4646ba0fbb9aec17431f_RestrictedCashTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashandEquivalentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="extended" id="i9c7c3cc07f5544d4961249342d32ce70_RestrictedCashandEquivalentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_ac4da28e-b89e-4820-b7a0-2c96bdb6863b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_ac4da28e-b89e-4820-b7a0-2c96bdb6863b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_99482c12-c899-4253-8424-932fa2ff12cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_99482c12-c899-4253-8424-932fa2ff12cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_c1bd72c2-51cb-46eb-b305-d070b4db6cdb" xlink:href="dva-20201231.xsd#dva_NumberOfPartnerships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:to="loc_dva_NumberOfPartnerships_c1bd72c2-51cb-46eb-b305-d070b4db6cdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_0a8a4523-eec4-4b33-ada6-81082a381ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_0a8a4523-eec4-4b33-ada6-81082a381ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0a8a4523-eec4-4b33-ada6-81082a381ef5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_0a8a4523-eec4-4b33-ada6-81082a381ef5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0a8a4523-eec4-4b33-ada6-81082a381ef5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_112fc5a5-2efc-40ca-b771-0230dbb724a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_0a8a4523-eec4-4b33-ada6-81082a381ef5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_112fc5a5-2efc-40ca-b771-0230dbb724a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f53fd057-70da-44b4-b858-13c92ff2ba6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f53fd057-70da-44b4-b858-13c92ff2ba6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f53fd057-70da-44b4-b858-13c92ff2ba6b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f53fd057-70da-44b4-b858-13c92ff2ba6b" xlink:to="loc_us-gaap_SegmentDomain_f53fd057-70da-44b4-b858-13c92ff2ba6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_28236115-602a-465a-a432-31b399a25a23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f53fd057-70da-44b4-b858-13c92ff2ba6b" xlink:to="loc_us-gaap_SegmentDomain_28236115-602a-465a-a432-31b399a25a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_617f97bc-4131-449f-8c65-d51331e30592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_28236115-602a-465a-a432-31b399a25a23" xlink:to="loc_us-gaap_AllOtherSegmentsMember_617f97bc-4131-449f-8c65-d51331e30592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_333edab5-843b-4371-89ad-b652b0f709f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:to="loc_us-gaap_LitigationStatusAxis_333edab5-843b-4371-89ad-b652b0f709f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_333edab5-843b-4371-89ad-b652b0f709f0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_333edab5-843b-4371-89ad-b652b0f709f0" xlink:to="loc_us-gaap_LitigationStatusDomain_333edab5-843b-4371-89ad-b652b0f709f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_e6736d35-024e-42c4-b4f8-d32e29b51e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_333edab5-843b-4371-89ad-b652b0f709f0" xlink:to="loc_us-gaap_LitigationStatusDomain_e6736d35-024e-42c4-b4f8-d32e29b51e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_389147d8-7b6e-425b-81b2-e591c54e4dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_e6736d35-024e-42c4-b4f8-d32e29b51e5a" xlink:to="loc_us-gaap_PendingLitigationMember_389147d8-7b6e-425b-81b2-e591c54e4dec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="simple" xlink:href="dva-20201231.xsd#Shorttermandlongterminvestments"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="extended" id="i88a8ed7f43a645c3be8bebcc5606bd4c_Shorttermandlongterminvestments"/>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvesmtentsTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="extended" id="ib49b7bc8456c4999b833b1e6899f99d0_ShorttermandlongterminvesmtentsTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="extended" id="ic0024433b755434aa1a3ee6aa9458aba_ShorttermandlongterminvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_406690d4-fcab-45e0-bd6e-f360e2656fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_HeldToMaturitySecurities_406690d4-fcab-45e0-bd6e-f360e2656fc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_12593294-46bc-4ba9-b989-e8b7f2cdeb32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_12593294-46bc-4ba9-b989-e8b7f2cdeb32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_8e2d0346-22ca-475b-816c-14c0878af2e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_MarketableSecurities_8e2d0346-22ca-475b-816c-14c0878af2e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_4d03ec18-cd1b-49af-92cb-c5c0e65232d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_4d03ec18-cd1b-49af-92cb-c5c0e65232d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4f600455-f52b-4f68-ab07-dd21d87054df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4f600455-f52b-4f68-ab07-dd21d87054df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_695c5864-736a-4f77-9c64-8df28bb28d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_695c5864-736a-4f77-9c64-8df28bb28d75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_12db30bb-1d82-4bb2-b35a-d15bbb227ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_12db30bb-1d82-4bb2-b35a-d15bbb227ea2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_885704c8-f578-4294-8908-7b0f259122d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_InvestmentHoldingsTable_885704c8-f578-4294-8908-7b0f259122d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_1284ec10-9bc0-4984-a9ef-901c2c111156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_885704c8-f578-4294-8908-7b0f259122d2" xlink:to="loc_us-gaap_InvestmentTypeAxis_1284ec10-9bc0-4984-a9ef-901c2c111156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1284ec10-9bc0-4984-a9ef-901c2c111156_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_1284ec10-9bc0-4984-a9ef-901c2c111156" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1284ec10-9bc0-4984-a9ef-901c2c111156_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_1284ec10-9bc0-4984-a9ef-901c2c111156" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_30b84327-8d5d-482b-b9ea-83c5daa62df6" xlink:href="dva-20201231.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_30b84327-8d5d-482b-b9ea-83c5daa62df6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_872db18c-3541-4cf9-ace5-5de7a530b4e1" xlink:href="dva-20201231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_dva_MutualFundsAndCommonStockMember_872db18c-3541-4cf9-ace5-5de7a530b4e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e6c1871c-aa8b-427c-bb54-08fc0bf1576f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e6c1871c-aa8b-427c-bb54-08fc0bf1576f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_16010a9f-74f0-4054-981e-4fa09c2c0b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_16010a9f-74f0-4054-981e-4fa09c2c0b2e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="extended" id="i8ba114206573468685bbd2cd0741081e_ShorttermandlongterminvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8980d150-31fb-4222-b0e0-91a4fa38674d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8980d150-31fb-4222-b0e0-91a4fa38674d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_e417b745-32f7-4de3-82e3-0c2a17e7226d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_e417b745-32f7-4de3-82e3-0c2a17e7226d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_9d4020ed-a596-4ece-b2c9-ec5196315ea2" xlink:href="dva-20201231.xsd#dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:to="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_9d4020ed-a596-4ece-b2c9-ec5196315ea2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d" xlink:to="loc_us-gaap_EquityComponentDomain_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_77314e73-83c7-4fce-abed-0e4e679909fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d" xlink:to="loc_us-gaap_EquityComponentDomain_77314e73-83c7-4fce-abed-0e4e679909fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c32b9ad5-6d4c-46fa-9390-07529fa7bdc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_77314e73-83c7-4fce-abed-0e4e679909fa" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c32b9ad5-6d4c-46fa-9390-07529fa7bdc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_bdf99b10-9948-4126-9a0d-af5d18af9d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:to="loc_us-gaap_InvestmentTypeAxis_bdf99b10-9948-4126-9a0d-af5d18af9d4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_bdf99b10-9948-4126-9a0d-af5d18af9d4b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_bdf99b10-9948-4126-9a0d-af5d18af9d4b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_bdf99b10-9948-4126-9a0d-af5d18af9d4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_da2697c2-0262-4a20-91c5-b1ca0f7e8a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_bdf99b10-9948-4126-9a0d-af5d18af9d4b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_da2697c2-0262-4a20-91c5-b1ca0f7e8a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_c785ca92-f484-48fd-805d-d3e76d14e25c" xlink:href="dva-20201231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_da2697c2-0262-4a20-91c5-b1ca0f7e8a74" xlink:to="loc_dva_MutualFundsAndCommonStockMember_c785ca92-f484-48fd-805d-d3e76d14e25c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesOtherReceivables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="extended" id="i56d07fcbb94a481ebdc7ce48c0db2c84_OtherReceivablesOtherReceivables"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OtherReceivablesTables" xlink:type="extended" id="icba3ee7173a84d0cb340e9b1f6e398c8_OtherReceivablesTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="extended" id="i0a0e34c31e854a17bf468a41e3be5d26_OtherReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2759600b-056e-47aa-be2f-14eca218c275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_4d445b82-c9b2-4a52-965a-4609ffae36de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2759600b-056e-47aa-be2f-14eca218c275" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_4d445b82-c9b2-4a52-965a-4609ffae36de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ace8e5cf-d522-435c-a931-497d635c4c72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2759600b-056e-47aa-be2f-14eca218c275" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ace8e5cf-d522-435c-a931-497d635c4c72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_85798c0d-181f-44c1-aac8-9740509e9f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ace8e5cf-d522-435c-a931-497d635c4c72" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_85798c0d-181f-44c1-aac8-9740509e9f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_85798c0d-181f-44c1-aac8-9740509e9f44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_85798c0d-181f-44c1-aac8-9740509e9f44" xlink:to="loc_us-gaap_ReceivableTypeDomain_85798c0d-181f-44c1-aac8-9740509e9f44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_85798c0d-181f-44c1-aac8-9740509e9f44" xlink:to="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_e177b268-fdf5-4157-8a82-9e7c8cf28df8" xlink:href="dva-20201231.xsd#dva_SupplierRebatesAndOtherNonTradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:to="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_e177b268-fdf5-4157-8a82-9e7c8cf28df8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_e40d5ce2-5a4f-4ea5-bd52-2434dec53224" xlink:href="dva-20201231.xsd#dva_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:to="loc_dva_MedicareMember_e40d5ce2-5a4f-4ea5-bd52-2434dec53224" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipment"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/PropertyandEquipment" xlink:type="extended" id="i8ecc97499e27457191939377af123d15_PropertyandEquipment"/>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="extended" id="ibcffed71377b4613aae3f342421bcd0b_PropertyandEquipmentTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="extended" id="i009af5df29734e89b0e3bf5d5a094c01_PropertyandEquipmentDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="extended" id="i5febcb3c4569489ea8afa61d8beae013_PropertyandEquipmentAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_00c463f0-251e-49eb-a6d1-7764880f7be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_00c463f0-251e-49eb-a6d1-7764880f7be1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6fa8efbc-4043-43a9-97b1-99652653cdce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6fa8efbc-4043-43a9-97b1-99652653cdce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_84b72803-668c-4c47-9548-2d7839408bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_InterestCostsCapitalized_84b72803-668c-4c47-9548-2d7839408bd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_3c16f80b-1d5c-4399-8396-5ca88b3d0c3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_3c16f80b-1d5c-4399-8396-5ca88b3d0c3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8b535a1a-3cbe-44c4-b980-48be71cb250e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:to="loc_us-gaap_BuildingMember_8b535a1a-3cbe-44c4-b980-48be71cb250e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f568275c-677f-408d-99c4-933a34a48edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f568275c-677f-408d-99c4-933a34a48edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_490fca0e-46f7-467b-bfab-bef89a55bf64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_490fca0e-46f7-467b-bfab-bef89a55bf64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e260e28f-06bd-463f-b044-9af090f4ed8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:to="loc_srt_RangeAxis_e260e28f-06bd-463f-b044-9af090f4ed8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e260e28f-06bd-463f-b044-9af090f4ed8e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e260e28f-06bd-463f-b044-9af090f4ed8e" xlink:to="loc_srt_RangeMember_e260e28f-06bd-463f-b044-9af090f4ed8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e260e28f-06bd-463f-b044-9af090f4ed8e" xlink:to="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d1329bcb-f7d8-4876-ae2e-9bb9faeff41b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:to="loc_srt_MinimumMember_d1329bcb-f7d8-4876-ae2e-9bb9faeff41b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_34afdf62-73ca-464c-a74e-6a8d3d986304" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:to="loc_srt_MaximumMember_34afdf62-73ca-464c-a74e-6a8d3d986304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_99ff467d-732b-4bd5-aaa7-c67a25ab42f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:to="loc_us-gaap_SubsegmentsAxis_99ff467d-732b-4bd5-aaa7-c67a25ab42f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_99ff467d-732b-4bd5-aaa7-c67a25ab42f9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_99ff467d-732b-4bd5-aaa7-c67a25ab42f9" xlink:to="loc_us-gaap_SubsegmentsDomain_99ff467d-732b-4bd5-aaa7-c67a25ab42f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_521498c6-f52e-463a-89dc-8817ff6cda0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_99ff467d-732b-4bd5-aaa7-c67a25ab42f9" xlink:to="loc_us-gaap_SubsegmentsDomain_521498c6-f52e-463a-89dc-8817ff6cda0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naics_ZZ446110_779df6d4-3686-49aa-bd8a-bddb6f863236" xlink:href="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd#naics_ZZ446110"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_521498c6-f52e-463a-89dc-8817ff6cda0a" xlink:to="loc_naics_ZZ446110_779df6d4-3686-49aa-bd8a-bddb6f863236" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Intangibles" xlink:type="simple" xlink:href="dva-20201231.xsd#Intangibles"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Intangibles" xlink:type="extended" id="i81cc49c0f750467fbc5ecfaa8f27acbd_Intangibles"/>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IntangiblesTables" xlink:type="extended" id="ie043210a2082497ca22eb047568cd4c1_IntangiblesTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended" id="id2541140d7004999b649c084d3f3e7d6_IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="extended" id="ie6d2ffdd2e3a4c40947f4bf473eb17a2_IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:href="dva-20201231.xsd#dva_ExpectedAmortizationExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_80be2a03-307d-4f81-94b9-99faebec20ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_80be2a03-307d-4f81-94b9-99faebec20ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9554db2a-074b-4f79-80e1-3b9d6156aba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9554db2a-074b-4f79-80e1-3b9d6156aba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d2ab52dd-fc89-4b1f-a5ca-76c040da0a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d2ab52dd-fc89-4b1f-a5ca-76c040da0a4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_839bff73-92a5-42a8-8385-b36c6e1935dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_839bff73-92a5-42a8-8385-b36c6e1935dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_28dd35bc-9f9e-4790-8251-0f09c719ed86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_28dd35bc-9f9e-4790-8251-0f09c719ed86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8f4977b0-4978-47a1-afb8-b52656b3f808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8f4977b0-4978-47a1-afb8-b52656b3f808" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6aa2282a-7765-41eb-b793-cb39996b5276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6aa2282a-7765-41eb-b793-cb39996b5276" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseTable_53b14c5d-db31-4181-87a1-9e9af2f15d66" xlink:href="dva-20201231.xsd#dva_ExpectedAmortizationExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_dva_ExpectedAmortizationExpenseTable_53b14c5d-db31-4181-87a1-9e9af2f15d66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a8de3119-fd35-46da-a46b-9311caaaf983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_ExpectedAmortizationExpenseTable_53b14c5d-db31-4181-87a1-9e9af2f15d66" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a8de3119-fd35-46da-a46b-9311caaaf983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a8de3119-fd35-46da-a46b-9311caaaf983_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a8de3119-fd35-46da-a46b-9311caaaf983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a8de3119-fd35-46da-a46b-9311caaaf983_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a8de3119-fd35-46da-a46b-9311caaaf983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_1bbe3803-0aa6-4f50-972d-1cdd3f1ba749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_1bbe3803-0aa6-4f50-972d-1cdd3f1ba749" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_e9a35d3c-8b42-4fe2-ad1b-eb8ce1a4346e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:to="loc_us-gaap_ServiceAgreementsMember_e9a35d3c-8b42-4fe2-ad1b-eb8ce1a4346e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="extended" id="i6d266c73f21645e58e8dca1c07beeda4_IntangiblesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_2093ef2f-7ba9-4ad5-a5c2-e7f82ae1194e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_2093ef2f-7ba9-4ad5-a5c2-e7f82ae1194e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_62eee34b-3bfa-43cb-bdc9-0cc59c4cae1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_62eee34b-3bfa-43cb-bdc9-0cc59c4cae1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_75c5653c-8cc2-457c-8ad1-66cbb00962b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_75c5653c-8cc2-457c-8ad1-66cbb00962b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239df1cf-06a9-4ff0-96aa-e65fafaf9907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239df1cf-06a9-4ff0-96aa-e65fafaf9907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_239df1cf-06a9-4ff0-96aa-e65fafaf9907_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239df1cf-06a9-4ff0-96aa-e65fafaf9907" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_239df1cf-06a9-4ff0-96aa-e65fafaf9907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239df1cf-06a9-4ff0-96aa-e65fafaf9907" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_2454496a-2994-4dd9-a143-593c0fa28746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_2454496a-2994-4dd9-a143-593c0fa28746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bc336011-cd98-4377-85e9-ad728c3ce066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bc336011-cd98-4377-85e9-ad728c3ce066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_264aca27-c469-4ebd-958b-310da3dc7e6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:to="loc_srt_RangeAxis_264aca27-c469-4ebd-958b-310da3dc7e6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_264aca27-c469-4ebd-958b-310da3dc7e6b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_264aca27-c469-4ebd-958b-310da3dc7e6b" xlink:to="loc_srt_RangeMember_264aca27-c469-4ebd-958b-310da3dc7e6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_264aca27-c469-4ebd-958b-310da3dc7e6b" xlink:to="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7554d70b-50be-447d-a1ca-81bc9e40dd45" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:to="loc_srt_MinimumMember_7554d70b-50be-447d-a1ca-81bc9e40dd45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_33420849-b734-45de-8e67-902c43bbc894" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:to="loc_srt_MaximumMember_33420849-b734-45de-8e67-902c43bbc894" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestments"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="extended" id="ief45069293b745de84e6e6e945da33ce_EquityMethodandOtherInvestments"/>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="extended" id="i7721390d66694316afd49742a627e46a_EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="extended" id="i05e3db9be340446ca4b6565f725fa447_EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bce0a502-19bd-466a-8002-7b9890c0f6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7305de4a-0662-427d-80c7-1be213db0145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bce0a502-19bd-466a-8002-7b9890c0f6c9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7305de4a-0662-427d-80c7-1be213db0145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bce0a502-19bd-466a-8002-7b9890c0f6c9" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_49ea2c48-e0d8-4ab1-a802-3c25355c0eba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_49ea2c48-e0d8-4ab1-a802-3c25355c0eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOwnershipInterestMember_bec3bb99-7d66-4848-94cd-3de5c0bb2d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOwnershipInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_49ea2c48-e0d8-4ab1-a802-3c25355c0eba" xlink:to="loc_us-gaap_OtherOwnershipInterestMember_bec3bb99-7d66-4848-94cd-3de5c0bb2d52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_02e65af2-bb0a-46e6-b50d-208965910e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:to="loc_us-gaap_InvestmentTypeAxis_02e65af2-bb0a-46e6-b50d-208965910e9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_02e65af2-bb0a-46e6-b50d-208965910e9b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_02e65af2-bb0a-46e6-b50d-208965910e9b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_02e65af2-bb0a-46e6-b50d-208965910e9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_04acdd8d-251e-4c4b-adeb-47fab088e873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_02e65af2-bb0a-46e6-b50d-208965910e9b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_04acdd8d-251e-4c4b-adeb-47fab088e873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_97713c78-4e1f-47b7-83b7-6feb132ff3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_04acdd8d-251e-4c4b-adeb-47fab088e873" xlink:to="loc_us-gaap_EquitySecuritiesMember_97713c78-4e1f-47b7-83b7-6feb132ff3a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ccbd06a3-40e0-42c7-b75d-d9537770864d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:to="loc_srt_OwnershipAxis_ccbd06a3-40e0-42c7-b75d-d9537770864d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ccbd06a3-40e0-42c7-b75d-d9537770864d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_ccbd06a3-40e0-42c7-b75d-d9537770864d" xlink:to="loc_srt_OwnershipDomain_ccbd06a3-40e0-42c7-b75d-d9537770864d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_71aea758-b944-4833-84b7-e5d412223831" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_ccbd06a3-40e0-42c7-b75d-d9537770864d" xlink:to="loc_srt_OwnershipDomain_71aea758-b944-4833-84b7-e5d412223831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_fbdee79a-5fdf-4be1-8264-5108a599b3df" xlink:href="dva-20201231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_71aea758-b944-4833-84b7-e5d412223831" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_fbdee79a-5fdf-4be1-8264-5108a599b3df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="extended" id="ibf9aa721b63f40e9bfc863a6fb45fe09_EquityMethodandOtherInvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b2207439-abae-4c02-ae9d-5ca4165b54f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b2207439-abae-4c02-ae9d-5ca4165b54f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_020835bf-4628-49f4-a85b-078eb55f441a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_020835bf-4628-49f4-a85b-078eb55f441a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_97c79dab-2aa2-465e-bfe5-d9fcae8db947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_97c79dab-2aa2-465e-bfe5-d9fcae8db947" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8a3d1e95-20fa-409b-a57d-67109019e525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8a3d1e95-20fa-409b-a57d-67109019e525" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_df363bb9-f35d-4ac5-b092-32940cc1bbc9" xlink:href="dva-20201231.xsd#dva_NumberOfPartnerships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_dva_NumberOfPartnerships_df363bb9-f35d-4ac5-b092-32940cc1bbc9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_73479b90-673f-4549-b046-97acf0c3fdc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_73479b90-673f-4549-b046-97acf0c3fdc3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_fa966df3-5815-4cf0-afc7-be92f9a9eb02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_fa966df3-5815-4cf0-afc7-be92f9a9eb02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_fa966df3-5815-4cf0-afc7-be92f9a9eb02_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_fa966df3-5815-4cf0-afc7-be92f9a9eb02" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_fa966df3-5815-4cf0-afc7-be92f9a9eb02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_df950e0f-4bee-4c79-ab6e-9039ff2bd0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_fa966df3-5815-4cf0-afc7-be92f9a9eb02" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_df950e0f-4bee-4c79-ab6e-9039ff2bd0a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_83b295d3-7292-480d-b358-70c44d537049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_df950e0f-4bee-4c79-ab6e-9039ff2bd0a3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_83b295d3-7292-480d-b358-70c44d537049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e58c42b8-02ec-491d-9f32-75525eee3157" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:to="loc_srt_RangeAxis_e58c42b8-02ec-491d-9f32-75525eee3157" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e58c42b8-02ec-491d-9f32-75525eee3157_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e58c42b8-02ec-491d-9f32-75525eee3157" xlink:to="loc_srt_RangeMember_e58c42b8-02ec-491d-9f32-75525eee3157_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e58c42b8-02ec-491d-9f32-75525eee3157" xlink:to="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d2e16b76-5893-410f-b2ba-a58d2f75f205" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:to="loc_srt_MinimumMember_d2e16b76-5893-410f-b2ba-a58d2f75f205" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6bd11db9-ff89-4e8a-9679-0521198662f9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:to="loc_srt_MaximumMember_6bd11db9-ff89-4e8a-9679-0521198662f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ebd6ae30-6904-4db6-8855-1e599c8eff38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:to="loc_srt_OwnershipAxis_ebd6ae30-6904-4db6-8855-1e599c8eff38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ebd6ae30-6904-4db6-8855-1e599c8eff38_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_ebd6ae30-6904-4db6-8855-1e599c8eff38" xlink:to="loc_srt_OwnershipDomain_ebd6ae30-6904-4db6-8855-1e599c8eff38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_ebd6ae30-6904-4db6-8855-1e599c8eff38" xlink:to="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_a7937599-d12b-4126-a379-7b0934b08fa9" xlink:href="dva-20201231.xsd#dva_ParentCompanyAndRestrictedSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:to="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_a7937599-d12b-4126-a379-7b0934b08fa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_7b7bd9e3-e874-4d4a-8481-0ad15364d630" xlink:href="dva-20201231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_7b7bd9e3-e874-4d4a-8481-0ad15364d630" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20201231.xsd#Goodwill"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended" id="if0818f0a5fdc4bbb940053e1b02ea2e0_Goodwill"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended" id="ia6ada464c4144485a6549d2d71ce459c_GoodwillTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="extended" id="i758f9b7d72364122aaf3d760b11f1ee0_GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:to="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b5ff0e6f-ac04-484d-b535-8291869093d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_Goodwill_b5ff0e6f-ac04-484d-b535-8291869093d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a44c9433-66c4-473c-93cb-e117d91ec45b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a44c9433-66c4-473c-93cb-e117d91ec45b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_fc0b24b6-40e7-43d8-b267-b3f5588cca61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_fc0b24b6-40e7-43d8-b267-b3f5588cca61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0668703f-aa49-49f0-89fc-24b5198a0623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0668703f-aa49-49f0-89fc-24b5198a0623" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0a6b71dd-0d9e-49d8-9642-f9e54e8ffdcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0a6b71dd-0d9e-49d8-9642-f9e54e8ffdcd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b271608a-679b-495b-9d89-79bfbb939e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_20747679-0544-4b60-a33c-7868f2409e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:to="loc_us-gaap_GoodwillGross_20747679-0544-4b60-a33c-7868f2409e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ddff609b-e9d7-4062-8f79-7c06d8d4b732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ddff609b-e9d7-4062-8f79-7c06d8d4b732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7ae328e7-0e4c-4791-a3e2-ac8df9b51efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7ae328e7-0e4c-4791-a3e2-ac8df9b51efe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3aaa20e5-ff57-4b00-a567-4ed07823303e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7ae328e7-0e4c-4791-a3e2-ac8df9b51efe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3aaa20e5-ff57-4b00-a567-4ed07823303e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3aaa20e5-ff57-4b00-a567-4ed07823303e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3aaa20e5-ff57-4b00-a567-4ed07823303e" xlink:to="loc_us-gaap_SegmentDomain_3aaa20e5-ff57-4b00-a567-4ed07823303e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3aaa20e5-ff57-4b00-a567-4ed07823303e" xlink:to="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_72a7591b-755b-4f07-acbb-923e038425d3" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_72a7591b-755b-4f07-acbb-923e038425d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_c057dcdf-0ae4-4635-8855-4fbb8ea6c607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:to="loc_us-gaap_AllOtherSegmentsMember_c057dcdf-0ae4-4635-8855-4fbb8ea6c607" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="extended" id="i7d73709a81bd47dba363dfa239323afc_GoodwillScheduleofReportingUnitsGoodwillBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1d7817a-b72b-486e-a995-20dfd831f93d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_us-gaap_Goodwill_d1d7817a-b72b-486e-a995-20dfd831f93d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_b315b706-06b9-43a8-b65b-9b3e5c93c5bb" xlink:href="dva-20201231.xsd#dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_b315b706-06b9-43a8-b65b-9b3e5c93c5bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_9438c22a-dfa7-460d-aae5-d1c0ab83b6bd" xlink:href="dva-20201231.xsd#dva_PotentialImpactOnFairValueForReductionInOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_9438c22a-dfa7-460d-aae5-d1c0ab83b6bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0f78391c-87e2-42b5-a1d9-25ebf100c7fe" xlink:href="dva-20201231.xsd#dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0f78391c-87e2-42b5-a1d9-25ebf100c7fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_e289e9eb-1f10-4b22-85ff-f8ee13e10bb3" xlink:href="dva-20201231.xsd#dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_e289e9eb-1f10-4b22-85ff-f8ee13e10bb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b7e24b19-c3c1-4170-8790-ca4c947b8419" xlink:href="dva-20201231.xsd#dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b7e24b19-c3c1-4170-8790-ca4c947b8419" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c30a8432-71e5-4918-9f0e-b70efe8c249d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c30a8432-71e5-4918-9f0e-b70efe8c249d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c30a8432-71e5-4918-9f0e-b70efe8c249d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c30a8432-71e5-4918-9f0e-b70efe8c249d" xlink:to="loc_us-gaap_SegmentDomain_c30a8432-71e5-4918-9f0e-b70efe8c249d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_237f4937-7107-4b73-bf09-836cbce8b98c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c30a8432-71e5-4918-9f0e-b70efe8c249d" xlink:to="loc_us-gaap_SegmentDomain_237f4937-7107-4b73-bf09-836cbce8b98c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_86e9dcf6-44db-49d7-bfee-6d3b1811412e" xlink:href="dva-20201231.xsd#dva_KidneyCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_237f4937-7107-4b73-bf09-836cbce8b98c" xlink:to="loc_dva_KidneyCareMember_86e9dcf6-44db-49d7-bfee-6d3b1811412e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0be577f9-7976-4c4b-9ad2-d0d04b247ea1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:to="loc_srt_StatementGeographicalAxis_0be577f9-7976-4c4b-9ad2-d0d04b247ea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0be577f9-7976-4c4b-9ad2-d0d04b247ea1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0be577f9-7976-4c4b-9ad2-d0d04b247ea1" xlink:to="loc_srt_SegmentGeographicalDomain_0be577f9-7976-4c4b-9ad2-d0d04b247ea1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_83108455-72c8-4118-85e8-2463a6b81047" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0be577f9-7976-4c4b-9ad2-d0d04b247ea1" xlink:to="loc_srt_SegmentGeographicalDomain_83108455-72c8-4118-85e8-2463a6b81047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_5b9c9cd0-fa73-44b3-a15d-003ff6d20311" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_83108455-72c8-4118-85e8-2463a6b81047" xlink:to="loc_country_DE_5b9c9cd0-fa73-44b3-a15d-003ff6d20311" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="extended" id="i32392da87a1b4a66a80707e3947b03e2_GoodwillAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c708e0b4-6205-4281-a81c-c5b9bffe39f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c708e0b4-6205-4281-a81c-c5b9bffe39f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_07289e30-f162-467e-9032-2ca29897bead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_07289e30-f162-467e-9032-2ca29897bead" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3a4878bb-8ff5-43ba-a873-831cbd2aa395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:to="loc_srt_StatementGeographicalAxis_3a4878bb-8ff5-43ba-a873-831cbd2aa395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a4878bb-8ff5-43ba-a873-831cbd2aa395_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3a4878bb-8ff5-43ba-a873-831cbd2aa395" xlink:to="loc_srt_SegmentGeographicalDomain_3a4878bb-8ff5-43ba-a873-831cbd2aa395_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_058b013f-c933-42fd-ab7b-a6b877b0bc69" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3a4878bb-8ff5-43ba-a873-831cbd2aa395" xlink:to="loc_srt_SegmentGeographicalDomain_058b013f-c933-42fd-ab7b-a6b877b0bc69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_ec6499fc-ab15-4508-a75a-76d6345d57e4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_058b013f-c933-42fd-ab7b-a6b877b0bc69" xlink:to="loc_country_DE_ec6499fc-ab15-4508-a75a-76d6345d57e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a5ac52ff-5a0d-4900-bada-13d17bbaeb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a5ac52ff-5a0d-4900-bada-13d17bbaeb87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a5ac52ff-5a0d-4900-bada-13d17bbaeb87_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a5ac52ff-5a0d-4900-bada-13d17bbaeb87" xlink:to="loc_us-gaap_SegmentDomain_a5ac52ff-5a0d-4900-bada-13d17bbaeb87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a5ac52ff-5a0d-4900-bada-13d17bbaeb87" xlink:to="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_fe46aa4f-1962-4efe-960c-b63d215b72e1" xlink:href="dva-20201231.xsd#dva_KidneyCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:to="loc_dva_KidneyCareMember_fe46aa4f-1962-4efe-960c-b63d215b72e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_aff7cd8a-6074-4c60-946d-383f4533f2ae" xlink:href="dva-20201231.xsd#dva_OtherReportingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:to="loc_dva_OtherReportingUnitsMember_aff7cd8a-6074-4c60-946d-383f4533f2ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilities" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilities"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OtherLiabilities" xlink:type="extended" id="ibe5b0e870c2d43bc8b3b4d1119697c5e_OtherLiabilities"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="extended" id="i5e9018bd4a9d4bd490816bf8f5d9c130_OtherLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="extended" id="i1a62ebcac01a4ef287b34cb4e6502b9f_OtherLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxes" xlink:type="extended" id="i6cc6cf4c45574fd9b9452e462a4a8361_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesTables" xlink:type="extended" id="i0fe7df5df3ef4c189b1b9ca51d0bf724_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended" id="i25df6bd577684562986e72801b40cbb4_IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended" id="i5267a1d0c8774187b5dd697d7ff7af2d_IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="extended" id="iba93db2a03b7446ab36bb27d6a395385_IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="extended" id="ifa41f049533a4f8781eef1c2024b9600_IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="extended" id="i9285585cc2264e0da2c9d5a6d3e8dac8_IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="extended" id="id50e8debf28740028d149826fdb2cfff_IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended" id="i034db311ea7b4e5dbf6926f350c94463_IncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:href="dva-20201231.xsd#dva_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_0bd3c4ae-cd93-478f-89a7-d3f14ac730ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_OperatingLossCarryforwards_0bd3c4ae-cd93-478f-89a7-d3f14ac730ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_d72f1831-ca56-4991-b3b2-64d64c028d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_d72f1831-ca56-4991-b3b2-64d64c028d29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_83426b18-fc66-41a4-8a1e-a40374d430fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_83426b18-fc66-41a4-8a1e-a40374d430fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_3785829f-04ab-4ad1-9dca-cf5499330c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_3785829f-04ab-4ad1-9dca-cf5499330c23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_7440a1ab-1be4-4a7b-ad60-199e3ce1a98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_7440a1ab-1be4-4a7b-ad60-199e3ce1a98b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7f2c08fe-b525-4f0f-b3fc-a0e74b74983a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7f2c08fe-b525-4f0f-b3fc-a0e74b74983a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6022df62-5f23-4036-816b-c035b813f02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6022df62-5f23-4036-816b-c035b813f02d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7a162949-ad71-48c6-9951-f54ad6cdf9a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7a162949-ad71-48c6-9951-f54ad6cdf9a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_44f0933e-0e1a-4641-92fa-4565bbaa4b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_44f0933e-0e1a-4641-92fa-4565bbaa4b94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:href="dva-20201231.xsd#dva_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_23e6e8b1-fafc-4e05-99bd-d9004081a187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_23e6e8b1-fafc-4e05-99bd-d9004081a187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_23e6e8b1-fafc-4e05-99bd-d9004081a187_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_23e6e8b1-fafc-4e05-99bd-d9004081a187" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_23e6e8b1-fafc-4e05-99bd-d9004081a187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_23e6e8b1-fafc-4e05-99bd-d9004081a187" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e9027109-3368-46dd-b9d7-c85263b43cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:to="loc_us-gaap_DomesticCountryMember_e9027109-3368-46dd-b9d7-c85263b43cd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_44e92226-fee8-4272-9dd6-62d63dd0aac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_44e92226-fee8-4272-9dd6-62d63dd0aac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f9d9a241-383f-409a-ba19-f9d7be3e335f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:to="loc_us-gaap_ForeignCountryMember_f9d9a241-383f-409a-ba19-f9d7be3e335f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a43be68b-0542-456e-946a-9d66fd66ef5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:to="loc_us-gaap_TaxPeriodAxis_a43be68b-0542-456e-946a-9d66fd66ef5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_a43be68b-0542-456e-946a-9d66fd66ef5f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_a43be68b-0542-456e-946a-9d66fd66ef5f" xlink:to="loc_us-gaap_TaxPeriodDomain_a43be68b-0542-456e-946a-9d66fd66ef5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_e75a9f49-c81a-4f5c-a5b9-c66d1101793e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_a43be68b-0542-456e-946a-9d66fd66ef5f" xlink:to="loc_us-gaap_TaxPeriodDomain_e75a9f49-c81a-4f5c-a5b9-c66d1101793e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TaxYear2029Member_8bed0982-35fc-46f1-8d82-18f175e92202" xlink:href="dva-20201231.xsd#dva_TaxYear2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_e75a9f49-c81a-4f5c-a5b9-c66d1101793e" xlink:to="loc_dva_TaxYear2029Member_8bed0982-35fc-46f1-8d82-18f175e92202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_9fabafc5-27c0-4c5a-bd0b-c07ec7ff2961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_9fabafc5-27c0-4c5a-bd0b-c07ec7ff2961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_8453208a-9d66-42a6-bbaa-652a16eb711d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9fabafc5-27c0-4c5a-bd0b-c07ec7ff2961" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_8453208a-9d66-42a6-bbaa-652a16eb711d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebt" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebt"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebt" xlink:type="extended" id="i23d33ab724374d0a9f92032503db0ecf_LongTermDebt"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtTables" xlink:type="extended" id="i1da801fdc09846a096a123d389cd4ddb_LongTermDebtTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended" id="i5656c40465ab430aba2a50a315b04bc6_LongTermDebtScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_2871ac0a-0f98-44d7-ad4c-1545d912da87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:to="loc_us-gaap_SecuredDebt_2871ac0a-0f98-44d7-ad4c-1545d912da87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_ced14be6-f787-4e89-b265-b3abe54d0154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_ced14be6-f787-4e89-b265-b3abe54d0154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableAbstract_f1b7f30b-3ab1-4da5-b5a5-c49b221701f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_NotesPayableAbstract_f1b7f30b-3ab1-4da5-b5a5-c49b221701f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_6b06b5f4-047a-44c5-a09d-383e156166e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesPayableAbstract_f1b7f30b-3ab1-4da5-b5a5-c49b221701f7" xlink:to="loc_us-gaap_SeniorNotes_6b06b5f4-047a-44c5-a09d-383e156166e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_67024341-6e88-4a2d-96d4-dca5befe7be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_67024341-6e88-4a2d-96d4-dca5befe7be7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8d7078d7-a4c5-4a9e-855c-5a1edbff5d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8d7078d7-a4c5-4a9e-855c-5a1edbff5d7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_ce318b0d-f200-48ea-8cd8-0c8af1fe466d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentFairValue_ce318b0d-f200-48ea-8cd8-0c8af1fe466d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_329f8b11-2337-43b6-b01c-c6d852a981f8" xlink:href="dva-20201231.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_329f8b11-2337-43b6-b01c-c6d852a981f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_bfe87ceb-e606-4c76-b4e4-e9bb1d6acd49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_FinanceLeaseLiability_bfe87ceb-e606-4c76-b4e4-e9bb1d6acd49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_3dcbc02b-9847-472f-8b8a-067eb521504f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_3dcbc02b-9847-472f-8b8a-067eb521504f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_fbab4e23-cd65-4fc7-b3eb-d52745d19124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_fbab4e23-cd65-4fc7-b3eb-d52745d19124" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a6af95c9-5ddc-4b1a-a08f-474a1e1165be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a6af95c9-5ddc-4b1a-a08f-474a1e1165be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_bf7967fb-bb4e-4364-88eb-3c4462586cc9" xlink:href="dva-20201231.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_bf7967fb-bb4e-4364-88eb-3c4462586cc9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ed77d55f-b600-45d7-89e1-ad50bcaab9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ed77d55f-b600-45d7-89e1-ad50bcaab9b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_e0e174d6-a383-4d8b-857d-1adf5d4170c9" xlink:href="dva-20201231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_e0e174d6-a383-4d8b-857d-1adf5d4170c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f8753423-e492-46cb-aed5-c03b23a480a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f8753423-e492-46cb-aed5-c03b23a480a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_66a90497-6b0b-4bab-9650-ffeaf3762794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_66a90497-6b0b-4bab-9650-ffeaf3762794" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cc4c7fd1-d2a3-4b3f-bdd8-64b1b071339b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cc4c7fd1-d2a3-4b3f-bdd8-64b1b071339b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_86afd891-1f7d-473e-88c8-9290dee6bf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_86afd891-1f7d-473e-88c8-9290dee6bf91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6c0347f3-fed1-4e82-87af-630102e3f96b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6c0347f3-fed1-4e82-87af-630102e3f96b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_b75b4523-5e7d-4bb5-834b-d0d6e156fed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:to="loc_us-gaap_DeferredOfferingCosts_b75b4523-5e7d-4bb5-834b-d0d6e156fed1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2eb91770-c519-463e-bc87-37d243b21233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2eb91770-c519-463e-bc87-37d243b21233" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2eb91770-c519-463e-bc87-37d243b21233_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2eb91770-c519-463e-bc87-37d243b21233" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2eb91770-c519-463e-bc87-37d243b21233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2eb91770-c519-463e-bc87-37d243b21233" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_c0f1ab41-d9c6-4f2b-bb32-0feaa0f4ba8a" xlink:href="dva-20201231.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_TermLoanAMember_c0f1ab41-d9c6-4f2b-bb32-0feaa0f4ba8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_0cca5ddc-9205-4a98-bec9-49d1b5d74ac5" xlink:href="dva-20201231.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_TermLoanB1Member_0cca5ddc-9205-4a98-bec9-49d1b5d74ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanBMember_e10a1d6d-b05d-4355-a451-5d16d25d2b82" xlink:href="dva-20201231.xsd#dva_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_TermLoanBMember_e10a1d6d-b05d-4355-a451-5d16d25d2b82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_fe22ab09-0371-4792-8e65-bbe3f405a8da" xlink:href="dva-20201231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_fe22ab09-0371-4792-8e65-bbe3f405a8da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6317cd2f-0e56-4713-8d78-17ce9f07d10d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_us-gaap_SeniorNotesMember_6317cd2f-0e56-4713-8d78-17ce9f07d10d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2650b960-5c4f-442c-8596-bdd108ef31be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_CreditFacilityAxis_2650b960-5c4f-442c-8596-bdd108ef31be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2650b960-5c4f-442c-8596-bdd108ef31be_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2650b960-5c4f-442c-8596-bdd108ef31be" xlink:to="loc_us-gaap_CreditFacilityDomain_2650b960-5c4f-442c-8596-bdd108ef31be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ca421583-8ab2-4e8b-b745-1b6c86836a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2650b960-5c4f-442c-8596-bdd108ef31be" xlink:to="loc_us-gaap_CreditFacilityDomain_ca421583-8ab2-4e8b-b745-1b6c86836a27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7650892c-2ea1-4b59-8ef2-2cc2c5f5826f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ca421583-8ab2-4e8b-b745-1b6c86836a27" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7650892c-2ea1-4b59-8ef2-2cc2c5f5826f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d66630e5-b1c0-47b1-a5d0-11964f39125d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_DebtInstrumentAxis_d66630e5-b1c0-47b1-a5d0-11964f39125d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d66630e5-b1c0-47b1-a5d0-11964f39125d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d66630e5-b1c0-47b1-a5d0-11964f39125d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d66630e5-b1c0-47b1-a5d0-11964f39125d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d66630e5-b1c0-47b1-a5d0-11964f39125d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_62c6d9d4-c591-4b80-9ed2-76b58323067a" xlink:href="dva-20201231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_62c6d9d4-c591-4b80-9ed2-76b58323067a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d746894b-7006-4165-8944-b81393fba6fb" xlink:href="dva-20201231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d746894b-7006-4165-8944-b81393fba6fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_9fbe317a-1c5d-4469-a3c8-bfd5287f1708" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_9fbe317a-1c5d-4469-a3c8-bfd5287f1708" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_60a14de7-8439-4bb3-8286-6841147b33bc" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_60a14de7-8439-4bb3-8286-6841147b33bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_84ac5f79-7fb8-4a47-8532-3b6e93d16051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_84ac5f79-7fb8-4a47-8532-3b6e93d16051" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_31ee664e-28ec-4513-b79d-e0799a751fbd" xlink:href="dva-20201231.xsd#dva_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_FinanceLeaseMember_31ee664e-28ec-4513-b79d-e0799a751fbd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f6ca952f-baad-4ed9-b316-9dcd68dde49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_VariableRateAxis_f6ca952f-baad-4ed9-b316-9dcd68dde49f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f6ca952f-baad-4ed9-b316-9dcd68dde49f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f6ca952f-baad-4ed9-b316-9dcd68dde49f" xlink:to="loc_us-gaap_VariableRateDomain_f6ca952f-baad-4ed9-b316-9dcd68dde49f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f6ca952f-baad-4ed9-b316-9dcd68dde49f" xlink:to="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4ab2e1a4-48ef-43ba-bdc7-9cecff173926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:to="loc_us-gaap_BaseRateMember_4ab2e1a4-48ef-43ba-bdc7-9cecff173926" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f8bd80c2-c685-4634-abed-60cfbc112ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f8bd80c2-c685-4634-abed-60cfbc112ea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_442916bf-4112-40f2-aa90-14eb47c6c48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_442916bf-4112-40f2-aa90-14eb47c6c48d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_442916bf-4112-40f2-aa90-14eb47c6c48d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_442916bf-4112-40f2-aa90-14eb47c6c48d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_442916bf-4112-40f2-aa90-14eb47c6c48d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b5451311-e629-48bb-b7fe-f9cfc2657b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_442916bf-4112-40f2-aa90-14eb47c6c48d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b5451311-e629-48bb-b7fe-f9cfc2657b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a17dacb4-f2b8-4d29-9420-724f92e271cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b5451311-e629-48bb-b7fe-f9cfc2657b59" xlink:to="loc_us-gaap_SubsequentEventMember_a17dacb4-f2b8-4d29-9420-724f92e271cd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtScheduledMaturitiesofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="extended" id="ib6d89a1dab714913960c4235fe843523_LongTermDebtScheduledMaturitiesofLongtermDebtDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="extended" id="if146a0cd07ed438c8982dec5edac2aca_LongTermDebtDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_34b83612-4d53-42a4-9609-d4091447bba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_34b83612-4d53-42a4-9609-d4091447bba2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e2e65ee-9b66-4bb6-9fbe-c12a7ca81d62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e2e65ee-9b66-4bb6-9fbe-c12a7ca81d62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_31d4a91e-7f17-4735-9fd7-2cba5fa06f17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeInceptionDates_31d4a91e-7f17-4735-9fd7-2cba5fa06f17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_939f336e-1084-41ed-ba89-ab0c6c1e51b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeMaturityDates_939f336e-1084-41ed-ba89-ab0c6c1e51b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_35d686f0-1a8c-441b-a62f-c39a4eb2801d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_35d686f0-1a8c-441b-a62f-c39a4eb2801d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_951f9f43-6d0e-4e6d-bcb8-42d6b8776867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_951f9f43-6d0e-4e6d-bcb8-42d6b8776867" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a0ff43b-cd9e-4725-996e-caa72af9b4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a0ff43b-cd9e-4725-996e-caa72af9b4bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6e24aede-0f07-432c-ab1b-181da1ce52b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6e24aede-0f07-432c-ab1b-181da1ce52b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6e24aede-0f07-432c-ab1b-181da1ce52b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e24aede-0f07-432c-ab1b-181da1ce52b3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6e24aede-0f07-432c-ab1b-181da1ce52b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e24aede-0f07-432c-ab1b-181da1ce52b3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a9b25ebd-5798-44d8-af51-d45d268ada39" xlink:href="dva-20201231.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a9b25ebd-5798-44d8-af51-d45d268ada39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_98946072-75be-4ebe-9c3e-50956ffd50a4" xlink:href="dva-20201231.xsd#dva_A2015InterestRateCapAgreementsEffectiveJune292018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:to="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_98946072-75be-4ebe-9c3e-50956ffd50a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_DebtInstrumentAxis_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_49b6ed6f-7adc-46ce-9f04-22e10b60db24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_49b6ed6f-7adc-46ce-9f04-22e10b60db24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_32b9ab62-c014-41d5-973a-96801b3db2c6" xlink:href="dva-20201231.xsd#dva_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49b6ed6f-7adc-46ce-9f04-22e10b60db24" xlink:to="loc_dva_TermLoanFacilityMember_32b9ab62-c014-41d5-973a-96801b3db2c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_069bdfae-f96a-4709-89ab-aed043ec7c83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_srt_RangeAxis_069bdfae-f96a-4709-89ab-aed043ec7c83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_069bdfae-f96a-4709-89ab-aed043ec7c83_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_069bdfae-f96a-4709-89ab-aed043ec7c83" xlink:to="loc_srt_RangeMember_069bdfae-f96a-4709-89ab-aed043ec7c83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e91adcb2-fe22-4eeb-8d38-26459bd209fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_069bdfae-f96a-4709-89ab-aed043ec7c83" xlink:to="loc_srt_RangeMember_e91adcb2-fe22-4eeb-8d38-26459bd209fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f64b92cb-58b0-43af-94d5-5d3ca84367f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e91adcb2-fe22-4eeb-8d38-26459bd209fa" xlink:to="loc_srt_MaximumMember_f64b92cb-58b0-43af-94d5-5d3ca84367f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56aff222-2260-4553-b66f-74f4389d0309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56aff222-2260-4553-b66f-74f4389d0309" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_56aff222-2260-4553-b66f-74f4389d0309_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56aff222-2260-4553-b66f-74f4389d0309" xlink:to="loc_us-gaap_HedgingRelationshipDomain_56aff222-2260-4553-b66f-74f4389d0309_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_52719939-0b2e-4681-afe9-d500956a1fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56aff222-2260-4553-b66f-74f4389d0309" xlink:to="loc_us-gaap_HedgingRelationshipDomain_52719939-0b2e-4681-afe9-d500956a1fe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_bb4035e6-12a4-43c1-995a-d290ddb2f5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_52719939-0b2e-4681-afe9-d500956a1fe6" xlink:to="loc_us-gaap_CashFlowHedgingMember_bb4035e6-12a4-43c1-995a-d290ddb2f5d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fc451214-be39-47e2-a0fe-db21517e671e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fc451214-be39-47e2-a0fe-db21517e671e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fc451214-be39-47e2-a0fe-db21517e671e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fc451214-be39-47e2-a0fe-db21517e671e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fc451214-be39-47e2-a0fe-db21517e671e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_235a6fee-7d1d-47cc-8e35-108392cd3a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fc451214-be39-47e2-a0fe-db21517e671e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_235a6fee-7d1d-47cc-8e35-108392cd3a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_7ee3e679-6eaf-44d1-8566-2b6c9d7d5511" xlink:href="dva-20201231.xsd#dva_DebtExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_235a6fee-7d1d-47cc-8e35-108392cd3a37" xlink:to="loc_dva_DebtExpenseMember_7ee3e679-6eaf-44d1-8566-2b6c9d7d5511" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f4665665-af12-4f1a-ab81-dc9ac2069ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f4665665-af12-4f1a-ab81-dc9ac2069ad4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f4665665-af12-4f1a-ab81-dc9ac2069ad4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f4665665-af12-4f1a-ab81-dc9ac2069ad4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f4665665-af12-4f1a-ab81-dc9ac2069ad4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_831af593-afc1-4542-bc90-015b37894541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f4665665-af12-4f1a-ab81-dc9ac2069ad4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_831af593-afc1-4542-bc90-015b37894541" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_ee3f61ea-fca0-4be8-8e59-193b98850e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_831af593-afc1-4542-bc90-015b37894541" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_ee3f61ea-fca0-4be8-8e59-193b98850e3d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="extended" id="i5e4dc27660774f71b5d4aaa757abc12f_LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_230d1c27-94de-4b4e-8a05-adc3121e1433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_230d1c27-94de-4b4e-8a05-adc3121e1433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_397e40f1-8f82-4639-b4c2-83fa0ef134cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_397e40f1-8f82-4639-b4c2-83fa0ef134cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d24ca785-0225-4724-a856-6dae68e442c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d24ca785-0225-4724-a856-6dae68e442c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d24ca785-0225-4724-a856-6dae68e442c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d24ca785-0225-4724-a856-6dae68e442c2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d24ca785-0225-4724-a856-6dae68e442c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4a9db1d0-28de-4e71-979e-b4c22255ae7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d24ca785-0225-4724-a856-6dae68e442c2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4a9db1d0-28de-4e71-979e-b4c22255ae7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7124fb7b-229d-402c-83aa-cbe61c1abe41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4a9db1d0-28de-4e71-979e-b4c22255ae7c" xlink:to="loc_us-gaap_CashFlowHedgingMember_7124fb7b-229d-402c-83aa-cbe61c1abe41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dba180d2-b926-402e-a4c4-26c28582c53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dba180d2-b926-402e-a4c4-26c28582c53c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dba180d2-b926-402e-a4c4-26c28582c53c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dba180d2-b926-402e-a4c4-26c28582c53c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dba180d2-b926-402e-a4c4-26c28582c53c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4d94780a-9e73-4fbe-aae3-8e06b47bd1b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dba180d2-b926-402e-a4c4-26c28582c53c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4d94780a-9e73-4fbe-aae3-8e06b47bd1b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_400b93e5-b41e-42d1-a021-7cfcd8534508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4d94780a-9e73-4fbe-aae3-8e06b47bd1b7" xlink:to="loc_us-gaap_InterestRateCapMember_400b93e5-b41e-42d1-a021-7cfcd8534508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_4afda64b-d0d4-465d-936b-5e6694ad3cff" xlink:href="dva-20201231.xsd#dva_DebtExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:to="loc_dva_DebtExpenseMember_4afda64b-d0d4-465d-936b-5e6694ad3cff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxExpenseBenefitMember_2403553b-e8cf-456f-b633-fe135fadca5e" xlink:href="dva-20201231.xsd#dva_IncomeTaxExpenseBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:to="loc_dva_IncomeTaxExpenseBenefitMember_2403553b-e8cf-456f-b633-fe135fadca5e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtAdditionalinformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="extended" id="i58599b92c0b14c779448be0e3d09a882_LongTermDebtAdditionalinformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_f64ebe2b-168a-4ff0-97d4-7f0e1bf2a83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_f64ebe2b-168a-4ff0-97d4-7f0e1bf2a83d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25bd4fdb-5342-4a7c-b1b3-832120686981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25bd4fdb-5342-4a7c-b1b3-832120686981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_913be877-c673-42fc-b082-c51431c37f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_913be877-c673-42fc-b082-c51431c37f77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement_b4920b9a-2768-4870-b0bd-9a8b8d398110" xlink:href="dva-20201231.xsd#dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement_b4920b9a-2768-4870-b0bd-9a8b8d398110" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProceedsFromRepricingAgreementOnSecuredDebt_9532acdc-d632-4a6e-9755-776a2e058b72" xlink:href="dva-20201231.xsd#dva_ProceedsFromRepricingAgreementOnSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_ProceedsFromRepricingAgreementOnSecuredDebt_9532acdc-d632-4a6e-9755-776a2e058b72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_44d36eba-695d-4978-a3e0-4058821e7595" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_DebtRefinancingCharges_44d36eba-695d-4978-a3e0-4058821e7595" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_82054e8e-01df-4679-9360-6bed62607af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_82054e8e-01df-4679-9360-6bed62607af6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt_369cddcb-0d1a-4959-ada2-e15cc67e9d9c" xlink:href="dva-20201231.xsd#dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt_369cddcb-0d1a-4959-ada2-e15cc67e9d9c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2d2d6593-0df2-4a86-b193-230012588247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2d2d6593-0df2-4a86-b193-230012588247" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_7c4d1666-275a-4196-be74-be8074e39e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_SeniorNotes_7c4d1666-275a-4196-be74-be8074e39e4e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_3071c5db-38d5-400a-86d9-e9f8310b5807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_3071c5db-38d5-400a-86d9-e9f8310b5807" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_8c82f1eb-f6a3-4b7f-97d8-59f4013ec2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_8c82f1eb-f6a3-4b7f-97d8-59f4013ec2f4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_ecf94932-dce3-4a7d-a331-d4b13302cf19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_ecf94932-dce3-4a7d-a331-d4b13302cf19" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d6ec3dd4-4cde-40b9-95ee-591124a99f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d6ec3dd4-4cde-40b9-95ee-591124a99f14" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_be1c4285-cfb7-46dd-847f-2e2b85a33dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_be1c4285-cfb7-46dd-847f-2e2b85a33dd5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_2eebfaa0-6426-4127-b2d8-bcc57d797e69" xlink:href="dva-20201231.xsd#dva_DebtInstrumentRedeemedOutstandingPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_2eebfaa0-6426-4127-b2d8-bcc57d797e69" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes_a6ac3085-c7fb-4a07-8bff-84f97b613db1" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes_a6ac3085-c7fb-4a07-8bff-84f97b613db1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_35b15f64-c7ac-429c-9185-db5574557577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_35b15f64-c7ac-429c-9185-db5574557577" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_c8b0d492-f3e0-45ad-aa18-ce41ab51a023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DerivativeMaturityDates_c8b0d492-f3e0-45ad-aa18-ce41ab51a023" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_01f98ee8-ef34-4015-ac87-c05a38903534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LineOfCredit_01f98ee8-ef34-4015-ac87-c05a38903534" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_72a2cfcb-e8c0-4b07-9a55-7f562706e9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_SecuredDebt_72a2cfcb-e8c0-4b07-9a55-7f562706e9ce" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7c8f5d7c-e840-4cd7-81a4-494fb7f6dde9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7c8f5d7c-e840-4cd7-81a4-494fb7f6dde9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_98a8deee-2ef1-40e8-a456-154a0c74cf14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_98a8deee-2ef1-40e8-a456-154a0c74cf14" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d0f98bdb-633f-4f9b-9f59-5da34baa52fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d0f98bdb-633f-4f9b-9f59-5da34baa52fc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8e0dab3a-6ac5-4395-8ffb-dd6233112603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8e0dab3a-6ac5-4395-8ffb-dd6233112603" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ad71318b-2e80-4ceb-bb2a-cb77b9901d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ad71318b-2e80-4ceb-bb2a-cb77b9901d14" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_43f72f4c-76ef-4c62-a198-ffd0ed51f910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_InterestExpenseDebt_43f72f4c-76ef-4c62-a198-ffd0ed51f910" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_19bd5474-dda8-4391-9e5f-bcb3fd5d649b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_19bd5474-dda8-4391-9e5f-bcb3fd5d649b" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4513c33f-ed64-4211-98df-75aaff2f704c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4513c33f-ed64-4211-98df-75aaff2f704c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4513c33f-ed64-4211-98df-75aaff2f704c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4513c33f-ed64-4211-98df-75aaff2f704c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4513c33f-ed64-4211-98df-75aaff2f704c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4513c33f-ed64-4211-98df-75aaff2f704c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_f8eb9b35-ef5d-4bfe-ae55-989b8689a67d" xlink:href="dva-20201231.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_TermLoanB1Member_f8eb9b35-ef5d-4bfe-ae55-989b8689a67d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanBMember_666d5dee-d141-4397-be57-5a0c9500ded8" xlink:href="dva-20201231.xsd#dva_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_TermLoanBMember_666d5dee-d141-4397-be57-5a0c9500ded8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_c55d6c76-e4c0-4c53-bf26-8f87c684fe05" xlink:href="dva-20201231.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_TermLoanAMember_c55d6c76-e4c0-4c53-bf26-8f87c684fe05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_646cb474-844a-4f70-b4ca-74570dcd7612" xlink:href="dva-20201231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_646cb474-844a-4f70-b4ca-74570dcd7612" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34374582-51c7-4fc1-96c3-30c43ef27fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_CreditFacilityAxis_34374582-51c7-4fc1-96c3-30c43ef27fcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_34374582-51c7-4fc1-96c3-30c43ef27fcb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_34374582-51c7-4fc1-96c3-30c43ef27fcb" xlink:to="loc_us-gaap_CreditFacilityDomain_34374582-51c7-4fc1-96c3-30c43ef27fcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_34374582-51c7-4fc1-96c3-30c43ef27fcb" xlink:to="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0837115d-59cf-466f-a6de-32d9db09a833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0837115d-59cf-466f-a6de-32d9db09a833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_56976355-3422-4ea2-8e2a-6a13f72b50bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:to="loc_us-gaap_LetterOfCreditMember_56976355-3422-4ea2-8e2a-6a13f72b50bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_23944fcf-6c9e-4804-9662-b1086d1f4c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_VariableRateAxis_23944fcf-6c9e-4804-9662-b1086d1f4c74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_23944fcf-6c9e-4804-9662-b1086d1f4c74_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_23944fcf-6c9e-4804-9662-b1086d1f4c74" xlink:to="loc_us-gaap_VariableRateDomain_23944fcf-6c9e-4804-9662-b1086d1f4c74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_391f47c0-f204-46ba-b573-cfa71fb68bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_23944fcf-6c9e-4804-9662-b1086d1f4c74" xlink:to="loc_us-gaap_VariableRateDomain_391f47c0-f204-46ba-b573-cfa71fb68bb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0cb91d3-c4b0-498f-8fe8-f2cef0af529c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_391f47c0-f204-46ba-b573-cfa71fb68bb8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0cb91d3-c4b0-498f-8fe8-f2cef0af529c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_18bb70a1-64d7-4a34-9de5-b82c65e59e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_18bb70a1-64d7-4a34-9de5-b82c65e59e34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18bb70a1-64d7-4a34-9de5-b82c65e59e34_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_18bb70a1-64d7-4a34-9de5-b82c65e59e34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18bb70a1-64d7-4a34-9de5-b82c65e59e34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_18bb70a1-64d7-4a34-9de5-b82c65e59e34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_eb308176-b865-4e4f-81d7-7a8452e0d448" xlink:href="dva-20201231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_eb308176-b865-4e4f-81d7-7a8452e0d448" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_e2220388-cccb-4fb8-8a07-1dfe6ff0d0d2" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_e2220388-cccb-4fb8-8a07-1dfe6ff0d0d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_c58a0460-818f-483d-bddb-1e00400f2bfa" xlink:href="dva-20201231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_c58a0460-818f-483d-bddb-1e00400f2bfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_f03fd533-2696-4360-b859-274d86ea6d7e" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_f03fd533-2696-4360-b859-274d86ea6d7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_1a30a6ad-6006-47cb-8234-191ddbaf895d" xlink:href="dva-20201231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_1a30a6ad-6006-47cb-8234-191ddbaf895d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a7b903b6-4d27-412a-a7b9-6c54ae2d744f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a7b903b6-4d27-412a-a7b9-6c54ae2d744f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a7b903b6-4d27-412a-a7b9-6c54ae2d744f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7b903b6-4d27-412a-a7b9-6c54ae2d744f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a7b903b6-4d27-412a-a7b9-6c54ae2d744f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92f8494c-7e48-4676-a7d1-674a82cb95fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7b903b6-4d27-412a-a7b9-6c54ae2d744f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92f8494c-7e48-4676-a7d1-674a82cb95fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_80c56189-a8b9-4e87-8668-bbe38fc532f2" xlink:href="dva-20201231.xsd#dva_A2015InterestRateCapAgreementsEffectiveJune292018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f8494c-7e48-4676-a7d1-674a82cb95fe" xlink:to="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_80c56189-a8b9-4e87-8668-bbe38fc532f2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Leases" xlink:type="simple" xlink:href="dva-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Leases" xlink:type="extended" id="ie67b9468bdfa4d9fa654786d44f7ca52_Leases"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesTables" xlink:type="extended" id="ie38058427ac44995aca2ff4c8ced061f_LeasesTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesLeaseExpenseComponentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="extended" id="i3883f251bf1947ecacf4e5e1f87fa9d9_LeasesLeaseExpenseComponentsDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesLeasesOtherInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="extended" id="i52cb372f8d0e45f19d1da22a03797d32_LeasesLeasesOtherInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:to="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7d9a86ea-6cef-432a-b768-877fb127ea54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7d9a86ea-6cef-432a-b768-877fb127ea54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_161f9c78-d6da-4aad-934b-8a01f9da6bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_161f9c78-d6da-4aad-934b-8a01f9da6bde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2e96b72f-4b0f-4c37-949b-22cfa1383fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2e96b72f-4b0f-4c37-949b-22cfa1383fa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb58c064-9c26-4309-95d2-b2071546afc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb58c064-9c26-4309-95d2-b2071546afc5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:href="dva-20201231.xsd#dva_LeasesOtherInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:to="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_9d40ee55-3de7-4b1d-90da-8756f8d7dde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_9d40ee55-3de7-4b1d-90da-8756f8d7dde2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_0e64ec94-a482-4cd8-ad60-b522156ad2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:to="loc_us-gaap_OperatingLeasePayments_0e64ec94-a482-4cd8-ad60-b522156ad2bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_7c842e32-458b-450b-ae96-c575ea420ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_7c842e32-458b-450b-ae96-c575ea420ef3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_11674922-f000-49e5-ae4d-0a07a6b99a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_11674922-f000-49e5-ae4d-0a07a6b99a42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_e1646fbb-1874-4dc9-abd3-d872688bb49b" xlink:href="dva-20201231.xsd#dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:to="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_e1646fbb-1874-4dc9-abd3-d872688bb49b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_59cf897d-5fde-4ae2-8b1f-5cb3e53652c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_59cf897d-5fde-4ae2-8b1f-5cb3e53652c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f74e356f-e1d9-4443-84de-3e1f24c103af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_59cf897d-5fde-4ae2-8b1f-5cb3e53652c5" xlink:to="loc_us-gaap_DebtInstrumentAxis_f74e356f-e1d9-4443-84de-3e1f24c103af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f74e356f-e1d9-4443-84de-3e1f24c103af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f74e356f-e1d9-4443-84de-3e1f24c103af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f74e356f-e1d9-4443-84de-3e1f24c103af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5782b325-87de-4616-a770-fe278841d6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f74e356f-e1d9-4443-84de-3e1f24c103af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5782b325-87de-4616-a770-fe278841d6ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_417830fb-c3dc-4fe6-9434-502059eec533" xlink:href="dva-20201231.xsd#dva_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5782b325-87de-4616-a770-fe278841d6ac" xlink:to="loc_dva_FinanceLeaseMember_417830fb-c3dc-4fe6-9434-502059eec533" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="extended" id="i96bde2644b9e4843b672b71a4bbffa7d_LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="extended" id="idb70eda4864d4c5ba234285895ea458f_LeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:href="dva-20201231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f6f19bc8-bf98-4a66-8901-2d8281696833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f6f19bc8-bf98-4a66-8901-2d8281696833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_12f616c3-5df0-4ab1-899f-e4e8a1a6ef5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_12f616c3-5df0-4ab1-899f-e4e8a1a6ef5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_6560e300-00bd-4562-aa22-8ebcb68ef576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_6560e300-00bd-4562-aa22-8ebcb68ef576" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseAccumulatedDepreciation_49f939eb-bdda-4365-8ba6-0d8db97645ca" xlink:href="dva-20201231.xsd#dva_FinanceLeaseAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_dva_FinanceLeaseAccumulatedDepreciation_49f939eb-bdda-4365-8ba6-0d8db97645ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_50e25d79-c300-4aab-869c-c6fa5a51cc22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_50e25d79-c300-4aab-869c-c6fa5a51cc22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable_b235557d-3861-4518-a526-8cdf49c24ff1" xlink:href="dva-20201231.xsd#dva_LeasesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_dva_LeasesDisclosureTable_b235557d-3861-4518-a526-8cdf49c24ff1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_755821e7-d620-449d-b2b2-a930e0b474cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_LeasesDisclosureTable_b235557d-3861-4518-a526-8cdf49c24ff1" xlink:to="loc_srt_RangeAxis_755821e7-d620-449d-b2b2-a930e0b474cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_755821e7-d620-449d-b2b2-a930e0b474cf_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_755821e7-d620-449d-b2b2-a930e0b474cf" xlink:to="loc_srt_RangeMember_755821e7-d620-449d-b2b2-a930e0b474cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_755821e7-d620-449d-b2b2-a930e0b474cf" xlink:to="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c17ee24f-5f14-4c8f-b2be-da4b10086109" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:to="loc_srt_MinimumMember_c17ee24f-5f14-4c8f-b2be-da4b10086109" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_efe91e1d-bb81-4cbd-8e9a-c5cd347967bf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:to="loc_srt_MaximumMember_efe91e1d-bb81-4cbd-8e9a-c5cd347967bf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="dva-20201231.xsd#EmployeeBenefitPlans"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="extended" id="i629e186d539e421fa0a6edbc06e9ca72_EmployeeBenefitPlans"/>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EmployeeBenefitPlansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="extended" id="ie8b79a1a86be45bca95229f85fea3d95_EmployeeBenefitPlansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_b9fa9946-4b3c-4cb4-9b04-bba57a25b48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_b9fa9946-4b3c-4cb4-9b04-bba57a25b48f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_a3445da4-71f1-4fc3-84de-aa9cb13b6bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_a3445da4-71f1-4fc3-84de-aa9cb13b6bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_dcc58aa4-e137-41c3-9f94-02fa1ccb2c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_dcc58aa4-e137-41c3-9f94-02fa1ccb2c51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_332b0c13-7546-4f69-b7e1-709dfba2aaa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_332b0c13-7546-4f69-b7e1-709dfba2aaa7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_238f8f0f-1b98-4835-844b-be1408f9c512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_238f8f0f-1b98-4835-844b-be1408f9c512" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_2975a03f-9284-4f15-ae83-92c2ac93ce5d" xlink:href="dva-20201231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_2975a03f-9284-4f15-ae83-92c2ac93ce5d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_f7126be8-e3a1-4e07-b360-4eb8e53a1d51" xlink:href="dva-20201231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_f7126be8-e3a1-4e07-b360-4eb8e53a1d51" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_54e132eb-a148-4416-bfbe-3056c39d6ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_54e132eb-a148-4416-bfbe-3056c39d6ca9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_129e5607-727c-4e0b-897f-ac956e22709b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_129e5607-727c-4e0b-897f-ac956e22709b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_89726d6c-1c91-412f-92d9-c1176d17a275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_89726d6c-1c91-412f-92d9-c1176d17a275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_89726d6c-1c91-412f-92d9-c1176d17a275_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_89726d6c-1c91-412f-92d9-c1176d17a275" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_89726d6c-1c91-412f-92d9-c1176d17a275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_37bfd615-7135-4986-8222-3411a11fa8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_89726d6c-1c91-412f-92d9-c1176d17a275" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_37bfd615-7135-4986-8222-3411a11fa8d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_07329e87-4e13-4145-8f60-6d8ddc612c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37bfd615-7135-4986-8222-3411a11fa8d7" xlink:to="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_07329e87-4e13-4145-8f60-6d8ddc612c61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_77a2d533-d1a6-40c3-b827-3a5579debfd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_77a2d533-d1a6-40c3-b827-3a5579debfd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_77a2d533-d1a6-40c3-b827-3a5579debfd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_77a2d533-d1a6-40c3-b827-3a5579debfd5" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_77a2d533-d1a6-40c3-b827-3a5579debfd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3a04cbbf-cf59-440f-ada6-68fd2b9ac9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_77a2d533-d1a6-40c3-b827-3a5579debfd5" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3a04cbbf-cf59-440f-ada6-68fd2b9ac9d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllTrustsMember_4c2cfc70-2112-42d6-b2f1-ac78bb55716f" xlink:href="dva-20201231.xsd#dva_AllTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3a04cbbf-cf59-440f-ada6-68fd2b9ac9d0" xlink:to="loc_dva_AllTrustsMember_4c2cfc70-2112-42d6-b2f1-ac78bb55716f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:to="loc_srt_RangeAxis_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2" xlink:to="loc_srt_RangeMember_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2" xlink:to="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_255181a1-3ee9-4a96-b2b0-9bdf64d37cdc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:to="loc_srt_MinimumMember_255181a1-3ee9-4a96-b2b0-9bdf64d37cdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_022c5906-dee9-4b22-9dbb-9eff6fd1d897" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:to="loc_srt_MaximumMember_022c5906-dee9-4b22-9dbb-9eff6fd1d897" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Contingencies" xlink:type="simple" xlink:href="dva-20201231.xsd#Contingencies"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Contingencies" xlink:type="extended" id="i8ec2200c0030406d852ade9061140d94_Contingencies"/>
  <link:roleRef roleURI="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="extended" id="if0fde2feccd74bd596bcde589cdd4cd9_ContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_5e47e242-9a3f-45f8-b1c0-87ddf65329da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bf73d94b-615b-49dc-adef-7dfa0f996e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_5e47e242-9a3f-45f8-b1c0-87ddf65329da" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bf73d94b-615b-49dc-adef-7dfa0f996e7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_5e47e242-9a3f-45f8-b1c0-87ddf65329da" xlink:to="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:to="loc_us-gaap_TransactionTypeAxis_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d" xlink:to="loc_us-gaap_TransactionDomain_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d" xlink:to="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_15f990bc-891b-4ae4-b2dd-0fc0702d555c" xlink:href="dva-20201231.xsd#dva_IncrementalCashPortionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:to="loc_dva_IncrementalCashPortionMember_15f990bc-891b-4ae4-b2dd-0fc0702d555c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_577a924f-05b8-480c-bf2c-2503649445ab" xlink:href="dva-20201231.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_577a924f-05b8-480c-bf2c-2503649445ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4077bfe7-2baf-432c-906e-1187d0c3de0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:to="loc_srt_LitigationCaseAxis_4077bfe7-2baf-432c-906e-1187d0c3de0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4077bfe7-2baf-432c-906e-1187d0c3de0c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_4077bfe7-2baf-432c-906e-1187d0c3de0c" xlink:to="loc_srt_LitigationCaseTypeDomain_4077bfe7-2baf-432c-906e-1187d0c3de0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cc034610-0f32-4665-9ce0-71114a413c32" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_4077bfe7-2baf-432c-906e-1187d0c3de0c" xlink:to="loc_srt_LitigationCaseTypeDomain_cc034610-0f32-4665-9ce0-71114a413c32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_5168558e-ddb4-4d7c-ba6f-366d7a0855b2" xlink:href="dva-20201231.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_cc034610-0f32-4665-9ce0-71114a413c32" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_5168558e-ddb4-4d7c-ba6f-366d7a0855b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="simple" xlink:href="dva-20201231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="extended" id="i94d068c998594f73be64560aaa735ba8_NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments"/>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="extended" id="if7c10f9b7dce4b0daead1e55b7a00b93_NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:href="dva-20201231.xsd#dva_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_a4e3c4f4-8073-49d9-b49c-2a47b21855b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_OtherCommitment_a4e3c4f4-8073-49d9-b49c-2a47b21855b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DissolutionTermOfJointVentures_0b1a9e0f-9af2-4efb-8288-1b46b862b2b3" xlink:href="dva-20201231.xsd#dva_DissolutionTermOfJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_DissolutionTermOfJointVentures_0b1a9e0f-9af2-4efb-8288-1b46b862b2b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentExpirationDate_f5716f55-efa8-45fb-9f5b-4acaab6ebc20" xlink:href="dva-20201231.xsd#dva_LongTermPurchaseCommitmentExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_LongTermPurchaseCommitmentExpirationDate_f5716f55-efa8-45fb-9f5b-4acaab6ebc20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_69fa8a42-876c-42d3-8757-727e77e2b0c4" xlink:href="dva-20201231.xsd#dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_69fa8a42-876c-42d3-8757-727e77e2b0c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_3faf693d-9511-47dc-bf0c-9475a7ff6563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_3faf693d-9511-47dc-bf0c-9475a7ff6563" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_52474409-81fb-4ade-a8cc-14784183290b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_52474409-81fb-4ade-a8cc-14784183290b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_b32d1196-dd67-4019-a695-d9e718046976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_b32d1196-dd67-4019-a695-d9e718046976" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_46a42dea-54f4-41be-a1df-89913808ea2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_46a42dea-54f4-41be-a1df-89913808ea2d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OffBalanceSheetFinancingArrangements_30fae7c4-57ec-41d9-a24c-1e98f2df6c99" xlink:href="dva-20201231.xsd#dva_OffBalanceSheetFinancingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_OffBalanceSheetFinancingArrangements_30fae7c4-57ec-41d9-a24c-1e98f2df6c99" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:href="dva-20201231.xsd#dva_CommitmentsAndContingenciesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_bf266b2c-d090-4712-8270-f29d1f61e862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:to="loc_us-gaap_OtherCommitmentsAxis_bf266b2c-d090-4712-8270-f29d1f61e862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_bf266b2c-d090-4712-8270-f29d1f61e862_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_bf266b2c-d090-4712-8270-f29d1f61e862" xlink:to="loc_us-gaap_OtherCommitmentsDomain_bf266b2c-d090-4712-8270-f29d1f61e862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_4d484beb-7ee4-434e-a798-dcc633ae2a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_bf266b2c-d090-4712-8270-f29d1f61e862" xlink:to="loc_us-gaap_OtherCommitmentsDomain_4d484beb-7ee4-434e-a798-dcc633ae2a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_4f562de3-31a3-4750-bfd7-98afa904ebef" xlink:href="dva-20201231.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_4d484beb-7ee4-434e-a798-dcc633ae2a58" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_4f562de3-31a3-4750-bfd7-98afa904ebef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_05cc9d82-1d0b-4ebf-8df0-33f7a979f486" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:to="loc_srt_RangeAxis_05cc9d82-1d0b-4ebf-8df0-33f7a979f486" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05cc9d82-1d0b-4ebf-8df0-33f7a979f486_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_05cc9d82-1d0b-4ebf-8df0-33f7a979f486" xlink:to="loc_srt_RangeMember_05cc9d82-1d0b-4ebf-8df0-33f7a979f486_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_05cc9d82-1d0b-4ebf-8df0-33f7a979f486" xlink:to="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2ff06363-8afb-409b-9109-7bb6093ec5e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:to="loc_srt_MinimumMember_2ff06363-8afb-409b-9109-7bb6093ec5e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c571bc0a-f761-4481-be09-376b28427c97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:to="loc_srt_MaximumMember_c571bc0a-f761-4481-be09-376b28427c97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_a72ca87d-b776-4410-9b88-a8b265d4de44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_a72ca87d-b776-4410-9b88-a8b265d4de44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_a72ca87d-b776-4410-9b88-a8b265d4de44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_a72ca87d-b776-4410-9b88-a8b265d4de44" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_a72ca87d-b776-4410-9b88-a8b265d4de44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_421b9599-a6b7-498c-91ce-fa0e9e25652d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_a72ca87d-b776-4410-9b88-a8b265d4de44" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_421b9599-a6b7-498c-91ce-fa0e9e25652d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EpogenMember_e521ed10-5f71-41c6-ab1d-23c47f58e447" xlink:href="dva-20201231.xsd#dva_EpogenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_421b9599-a6b7-498c-91ce-fa0e9e25652d" xlink:to="loc_dva_EpogenMember_e521ed10-5f71-41c6-ab1d-23c47f58e447" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity" xlink:type="extended" id="i0cf11041514648c6b327ff5271e2d9a7_LongtermIncentiveCompensationandShareholdersEquity"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="extended" id="icaa86c8e2fe149ec985c305fe4c7c37f_LongtermIncentiveCompensationandShareholdersEquityTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="extended" id="id7a73fb8fc74477e873b131b93a9d80f_LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ff5f60b6-8f23-4de3-ae07-56c574ff1cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ff5f60b6-8f23-4de3-ae07-56c574ff1cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_964d4208-6dea-4d81-8044-52af66971795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_964d4208-6dea-4d81-8044-52af66971795" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d56220c6-dcdb-44e4-ac0b-064d611168e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d56220c6-dcdb-44e4-ac0b-064d611168e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_99b4fddd-4eb0-4869-a06e-b48c14fbb56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_99b4fddd-4eb0-4869-a06e-b48c14fbb56f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f7ac30cc-8cc6-4304-a00e-801e0ba8006f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f7ac30cc-8cc6-4304-a00e-801e0ba8006f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a944b28c-8f0f-49a4-a689-4806292502fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e214fbcc-0f02-42f2-a638-5a1e162bfe1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e214fbcc-0f02-42f2-a638-5a1e162bfe1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0484d58a-a3ab-4ca4-95ed-96cffd22ddcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0484d58a-a3ab-4ca4-95ed-96cffd22ddcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aa66fa8e-2017-4bbe-86d0-bedb3f2d6118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aa66fa8e-2017-4bbe-86d0-bedb3f2d6118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_526a2e88-9992-4f9a-92cd-f3979830ec7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_526a2e88-9992-4f9a-92cd-f3979830ec7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d141169f-221c-4b04-96a1-7e13490f7f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d141169f-221c-4b04-96a1-7e13490f7f05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_9f843bca-8aa4-4edf-982c-6c490622b4f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_9f843bca-8aa4-4edf-982c-6c490622b4f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_afc28f6b-89d1-4536-88d6-066cd86898cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_afc28f6b-89d1-4536-88d6-066cd86898cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ff63537f-327a-41be-89ff-d20c560c9706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad256fff-04b4-4d36-b9c0-6af404120660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad256fff-04b4-4d36-b9c0-6af404120660" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_edd3fde9-23ad-424e-b67e-e8de480cd8c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_edd3fde9-23ad-424e-b67e-e8de480cd8c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3cce4638-1a6c-4b40-b631-c4f3177a501c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3cce4638-1a6c-4b40-b631-c4f3177a501c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_25a9da6f-59f8-464d-92bd-ed15ddf80a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_25a9da6f-59f8-464d-92bd-ed15ddf80a56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9af6ce5c-c1d7-4e12-9601-5f69e1668165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9af6ce5c-c1d7-4e12-9601-5f69e1668165" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_fc1ea391-dd89-4ae3-8534-09ec1a24ea2b" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_fc1ea391-dd89-4ae3-8534-09ec1a24ea2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_616262ff-e714-4722-8807-164a09b47dba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_616262ff-e714-4722-8807-164a09b47dba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_cc8e11b3-0135-41fb-9ff5-e88f18fd2886" xlink:href="dva-20201231.xsd#dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_cc8e11b3-0135-41fb-9ff5-e88f18fd2886" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fd6bf201-0110-4cfe-a1c3-99b8d88322f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fd6bf201-0110-4cfe-a1c3-99b8d88322f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e2bf4c16-30b1-442e-89d2-bf7154a2c995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281de62f-f24b-4294-980e-edb1188e4cb6" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281de62f-f24b-4294-980e-edb1188e4cb6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c43edfd4-8eb2-4d37-a6df-fb6deaf9c623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c43edfd4-8eb2-4d37-a6df-fb6deaf9c623" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_62fc50cd-494f-4375-914c-f584515a9006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_62fc50cd-494f-4375-914c-f584515a9006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_56d3e5a1-56cd-4d78-aa03-59f1d85740db" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_56d3e5a1-56cd-4d78-aa03-59f1d85740db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_faea21c3-d98a-4aa4-a222-bac037cef79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:to="loc_us-gaap_AwardTypeAxis_faea21c3-d98a-4aa4-a222-bac037cef79c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faea21c3-d98a-4aa4-a222-bac037cef79c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_faea21c3-d98a-4aa4-a222-bac037cef79c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faea21c3-d98a-4aa4-a222-bac037cef79c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_faea21c3-d98a-4aa4-a222-bac037cef79c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_0e4a4297-74b6-495a-86f8-284ce713da04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_0e4a4297-74b6-495a-86f8-284ce713da04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockUnitMember_1fa06f0a-a646-43a5-b8f5-58aeae7b1004" xlink:href="dva-20201231.xsd#dva_StockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:to="loc_dva_StockUnitMember_1fa06f0a-a646-43a5-b8f5-58aeae7b1004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_a5dea479-f94b-476e-868a-c557d6017fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:to="loc_us-gaap_VestingAxis_a5dea479-f94b-476e-868a-c557d6017fe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a5dea479-f94b-476e-868a-c557d6017fe2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_a5dea479-f94b-476e-868a-c557d6017fe2" xlink:to="loc_us-gaap_VestingDomain_a5dea479-f94b-476e-868a-c557d6017fe2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_f28c9955-0584-4a1a-bd36-455850a41e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_a5dea479-f94b-476e-868a-c557d6017fe2" xlink:to="loc_us-gaap_VestingDomain_f28c9955-0584-4a1a-bd36-455850a41e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c0760e74-5310-41c5-8e1f-0339bef8aa75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_f28c9955-0584-4a1a-bd36-455850a41e3b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c0760e74-5310-41c5-8e1f-0339bef8aa75" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="extended" id="ifa80ff5a9b63427eb231f75fdaac6cef_LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_a9f410df-33f6-4206-99b6-adf9962f1910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_a9f410df-33f6-4206-99b6-adf9962f1910" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_439a7f00-1357-43d0-bbe8-57d7c8591b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_439a7f00-1357-43d0-bbe8-57d7c8591b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d61a1d24-2ab4-4958-b190-c5edf12977f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d61a1d24-2ab4-4958-b190-c5edf12977f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_66cecaa2-9bbe-404b-89cf-8b520b633c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_66cecaa2-9bbe-404b-89cf-8b520b633c87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_88fbc0bd-6ec4-4320-b734-02381baabc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_88fbc0bd-6ec4-4320-b734-02381baabc9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_fbbabe00-eeb3-493e-a581-d94416967c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_fbbabe00-eeb3-493e-a581-d94416967c63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_b0be074d-f69a-4994-ae5e-b9c28949cc68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_b0be074d-f69a-4994-ae5e-b9c28949cc68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_b0be074d-f69a-4994-ae5e-b9c28949cc68" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeOneMember_11259262-4c9f-447c-a551-58588dda981b" xlink:href="dva-20201231.xsd#dva_RangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:to="loc_dva_RangeOneMember_11259262-4c9f-447c-a551-58588dda981b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeTwoMember_59d48af1-43e3-4ab2-800a-c28cc06cbcff" xlink:href="dva-20201231.xsd#dva_RangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:to="loc_dva_RangeTwoMember_59d48af1-43e3-4ab2-800a-c28cc06cbcff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeThreeMember_a80988a1-243d-4f6c-8bb4-6ec8a43afaa6" xlink:href="dva-20201231.xsd#dva_RangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:to="loc_dva_RangeThreeMember_a80988a1-243d-4f6c-8bb4-6ec8a43afaa6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="extended" id="i58a2c17e6cb5434fa758a2a5ec333722_LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bb6260d0-ca34-4f4e-9164-937aebd5891c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bb6260d0-ca34-4f4e-9164-937aebd5891c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2179697a-c81e-4b34-88c7-5abcc080fea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2179697a-c81e-4b34-88c7-5abcc080fea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_baabb111-a00d-4749-b2d4-888d9fd62fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_baabb111-a00d-4749-b2d4-888d9fd62fe4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_262b0ab9-620b-44e6-a926-267e42a7ee97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_262b0ab9-620b-44e6-a926-267e42a7ee97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7021f316-de06-48d2-a4ed-fae75f9c7f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7021f316-de06-48d2-a4ed-fae75f9c7f63" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_242ac5aa-5b4c-411a-8360-3b3be62c8774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7021f316-de06-48d2-a4ed-fae75f9c7f63" xlink:to="loc_us-gaap_AwardTypeAxis_242ac5aa-5b4c-411a-8360-3b3be62c8774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_242ac5aa-5b4c-411a-8360-3b3be62c8774_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_242ac5aa-5b4c-411a-8360-3b3be62c8774" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_242ac5aa-5b4c-411a-8360-3b3be62c8774_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b72413-8a87-42bf-91bb-6d3ee98974ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_242ac5aa-5b4c-411a-8360-3b3be62c8774" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b72413-8a87-42bf-91bb-6d3ee98974ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockOptionProgramAndStockAppreciationRightProgramMember_dccdffc9-30c0-4730-922c-2d0e15da8a81" xlink:href="dva-20201231.xsd#dva_StockOptionProgramAndStockAppreciationRightProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b72413-8a87-42bf-91bb-6d3ee98974ae" xlink:to="loc_dva_StockOptionProgramAndStockAppreciationRightProgramMember_dccdffc9-30c0-4730-922c-2d0e15da8a81" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="extended" id="i002f9e0db8874655b67b527ce6d66c2f_LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d820c017-9808-451f-af53-8d51da96de23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d820c017-9808-451f-af53-8d51da96de23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4dbe93cb-c708-4509-a37a-6d2c531a62a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4dbe93cb-c708-4509-a37a-6d2c531a62a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_987e8b89-e6a3-4559-83a7-f26d8029e2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_987e8b89-e6a3-4559-83a7-f26d8029e2c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_a7099e35-d746-4c05-995f-197f4819ada4" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_a7099e35-d746-4c05-995f-197f4819ada4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_54131f9c-16dc-49a2-8f00-6c1b780b7ca5" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_54131f9c-16dc-49a2-8f00-6c1b780b7ca5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0d46102f-5efc-4423-a808-c48ae0871a0d" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0d46102f-5efc-4423-a808-c48ae0871a0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_b7368bd8-b16a-41fc-8fe7-750007a4b3eb" xlink:href="dva-20201231.xsd#dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_b7368bd8-b16a-41fc-8fe7-750007a4b3eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a5febdfc-fabd-4472-9d5f-36c404fc9c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a5febdfc-fabd-4472-9d5f-36c404fc9c86" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d219f8ca-eb59-4916-9f3a-c1cfd30c615a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d219f8ca-eb59-4916-9f3a-c1cfd30c615a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_c6c1bc37-1ed4-4bd9-8a49-367d2e3629f9" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_c6c1bc37-1ed4-4bd9-8a49-367d2e3629f9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0e549647-2395-44e3-91cc-5bba0209d2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0e549647-2395-44e3-91cc-5bba0209d2f5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0f00c431-3ff9-4afd-8f87-72a7523d40bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0f00c431-3ff9-4afd-8f87-72a7523d40bc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_352c8a1a-9344-4526-8884-70d7935c0103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_352c8a1a-9344-4526-8884-70d7935c0103" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_0e27d8dc-18e5-44f8-9946-d948e755b4bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_0e27d8dc-18e5-44f8-9946-d948e755b4bf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3811f95e-3b6c-42c4-ac40-6441af2de1df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3811f95e-3b6c-42c4-ac40-6441af2de1df" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedAwardBasePricePerShare_50b8282f-463e-4808-a97a-a39e90d21f5f" xlink:href="dva-20201231.xsd#dva_PremiumPricedAwardBasePricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_PremiumPricedAwardBasePricePerShare_50b8282f-463e-4808-a97a-a39e90d21f5f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_6d9f2659-419c-4db5-a70d-81783a3d9c5b" xlink:href="dva-20201231.xsd#dva_PremiumToTheTenderOfferSharePurchasePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_6d9f2659-419c-4db5-a70d-81783a3d9c5b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_431e48fd-d125-46ce-99ed-bb6924b0a30c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_431e48fd-d125-46ce-99ed-bb6924b0a30c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_f5521d99-6742-4275-8aaf-fbf2630330bb" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_f5521d99-6742-4275-8aaf-fbf2630330bb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_77e4a958-7d73-45be-b601-d0b2ad5357df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_77e4a958-7d73-45be-b601-d0b2ad5357df" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_503c2528-3844-4db1-baa6-beace1895b63" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_503c2528-3844-4db1-baa6-beace1895b63" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_4d792602-2961-4f01-859c-458a8269beba" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_4d792602-2961-4f01-859c-458a8269beba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4e813b59-472a-4049-9ca8-6fc118181fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4e813b59-472a-4049-9ca8-6fc118181fd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_f23eafb9-4bdd-44d4-bded-ab2e33d5cb26" xlink:href="dva-20201231.xsd#dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_f23eafb9-4bdd-44d4-bded-ab2e33d5cb26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_636a66fb-ef9a-49ab-bd9b-bd283028067a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_636a66fb-ef9a-49ab-bd9b-bd283028067a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c507bdbd-5ab4-41ea-b35d-d20cb8a9bf4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c507bdbd-5ab4-41ea-b35d-d20cb8a9bf4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ce229cc3-461c-4f7f-b032-096c455ba6db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ce229cc3-461c-4f7f-b032-096c455ba6db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_7a4aaeaa-0927-48e3-9f7a-0dcb672b3c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_7a4aaeaa-0927-48e3-9f7a-0dcb672b3c73" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c778a9a7-7202-42d9-8718-f60ce3c13436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c778a9a7-7202-42d9-8718-f60ce3c13436" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveProgramCompensationCost_37bef635-b27b-4728-b5f5-6431362e5077" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveProgramCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_LongtermIncentiveProgramCompensationCost_37bef635-b27b-4728-b5f5-6431362e5077" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_185c3483-5304-46d8-b055-c6ec9b362044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensation_185c3483-5304-46d8-b055-c6ec9b362044" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_42b95091-4086-4d91-8ac2-a3781388d4ae" xlink:href="dva-20201231.xsd#dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_42b95091-4086-4d91-8ac2-a3781388d4ae" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b461ca24-34fe-41d6-ac8d-59ae5a633e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b461ca24-34fe-41d6-ac8d-59ae5a633e3a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bddb4e49-2b72-414f-9a93-ae0f11aa98fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bddb4e49-2b72-414f-9a93-ae0f11aa98fe" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding_76d2dfdd-848f-4235-abb4-2ba2e494346a" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding_76d2dfdd-848f-4235-abb4-2ba2e494346a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards_52060faf-c586-46a4-b0a5-5d06d7de3901" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards_52060faf-c586-46a4-b0a5-5d06d7de3901" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_175b940e-e356-4a2f-9015-9a76ea52d481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_175b940e-e356-4a2f-9015-9a76ea52d481" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_97f3f443-270d-4771-bb6d-9064bc71591f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_97f3f443-270d-4771-bb6d-9064bc71591f" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a9f0d552-777a-4652-8da3-35f8629d5cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a9f0d552-777a-4652-8da3-35f8629d5cb0" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9c0b4d3a-a140-4b85-b0cd-a855a64bf098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9c0b4d3a-a140-4b85-b0cd-a855a64bf098" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d21ffcda-2a1a-4e79-9309-a07f6ec242b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_PlanNameAxis_d21ffcda-2a1a-4e79-9309-a07f6ec242b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d21ffcda-2a1a-4e79-9309-a07f6ec242b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d21ffcda-2a1a-4e79-9309-a07f6ec242b1" xlink:to="loc_us-gaap_PlanNameDomain_d21ffcda-2a1a-4e79-9309-a07f6ec242b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d21ffcda-2a1a-4e79-9309-a07f6ec242b1" xlink:to="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyTwentyMember_671d7eda-4ee6-43a5-80c1-0f9d313bd985" xlink:href="dva-20201231.xsd#dva_StockIncentivePlanTwentyTwentyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:to="loc_dva_StockIncentivePlanTwentyTwentyMember_671d7eda-4ee6-43a5-80c1-0f9d313bd985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyElevenMember_0a54d3f2-ccaf-4d54-96ed-9519a6066025" xlink:href="dva-20201231.xsd#dva_StockIncentivePlanTwentyElevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:to="loc_dva_StockIncentivePlanTwentyElevenMember_0a54d3f2-ccaf-4d54-96ed-9519a6066025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_34b158c4-21ac-44e3-a999-05fe854c4cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_VestingAxis_34b158c4-21ac-44e3-a999-05fe854c4cb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_34b158c4-21ac-44e3-a999-05fe854c4cb7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_34b158c4-21ac-44e3-a999-05fe854c4cb7" xlink:to="loc_us-gaap_VestingDomain_34b158c4-21ac-44e3-a999-05fe854c4cb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_34b158c4-21ac-44e3-a999-05fe854c4cb7" xlink:to="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_9d6f5d36-c8a4-434d-a86a-384807ef8c22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_9d6f5d36-c8a4-434d-a86a-384807ef8c22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_e0080a26-5373-489a-86f0-32c646bafa4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_e0080a26-5373-489a-86f0-32c646bafa4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bfc336ac-5f60-4563-98bc-d10c74b9e68d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_srt_RangeAxis_bfc336ac-5f60-4563-98bc-d10c74b9e68d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bfc336ac-5f60-4563-98bc-d10c74b9e68d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bfc336ac-5f60-4563-98bc-d10c74b9e68d" xlink:to="loc_srt_RangeMember_bfc336ac-5f60-4563-98bc-d10c74b9e68d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bfc336ac-5f60-4563-98bc-d10c74b9e68d" xlink:to="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6eb09afa-9394-48fb-a68b-f1ea32aa3cef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:to="loc_srt_MinimumMember_6eb09afa-9394-48fb-a68b-f1ea32aa3cef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_45994c2a-bbe2-4a95-a457-e4b3e7946a43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:to="loc_srt_MaximumMember_45994c2a-bbe2-4a95-a457-e4b3e7946a43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8f33b30b-0f67-4729-b30e-320e038de62f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_AwardTypeAxis_8f33b30b-0f67-4729-b30e-320e038de62f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f33b30b-0f67-4729-b30e-320e038de62f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8f33b30b-0f67-4729-b30e-320e038de62f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f33b30b-0f67-4729-b30e-320e038de62f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8f33b30b-0f67-4729-b30e-320e038de62f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_b04d0bee-2ea0-4d58-a90f-2389e8d79224" xlink:href="dva-20201231.xsd#dva_PremiumPricedStockSettledStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:to="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_b04d0bee-2ea0-4d58-a90f-2389e8d79224" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeStockPurchasePlanMember_0516c8ec-775c-46a3-a415-b761fe79b7e8" xlink:href="dva-20201231.xsd#dva_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:to="loc_dva_EmployeeStockPurchasePlanMember_0516c8ec-775c-46a3-a415-b761fe79b7e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_c4cc84f6-9692-4c27-9048-5f5283bd7b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_c4cc84f6-9692-4c27-9048-5f5283bd7b5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1746b7b0-251a-453f-9b4a-5688f4df2a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1746b7b0-251a-453f-9b4a-5688f4df2a21" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1746b7b0-251a-453f-9b4a-5688f4df2a21_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1746b7b0-251a-453f-9b4a-5688f4df2a21" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1746b7b0-251a-453f-9b4a-5688f4df2a21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9de8a2cb-444e-475f-9137-0dd65d52947b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1746b7b0-251a-453f-9b4a-5688f4df2a21" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9de8a2cb-444e-475f-9137-0dd65d52947b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_09a52acc-33b3-46bd-9865-dedac952ae59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9de8a2cb-444e-475f-9137-0dd65d52947b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_09a52acc-33b3-46bd-9865-dedac952ae59" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Stockholdersequity" xlink:type="simple" xlink:href="dva-20201231.xsd#Stockholdersequity"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Stockholdersequity" xlink:type="extended" id="i3386e99ad97b45fbb54255e079084c7e_Stockholdersequity"/>
  <link:roleRef roleURI="http://www.davita.com/role/StockholdersequityTables" xlink:type="simple" xlink:href="dva-20201231.xsd#StockholdersequityTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/StockholdersequityTables" xlink:type="extended" id="i5f8247da3d464d57b4f46f42889233cb_StockholdersequityTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#StockRepurchasesTenderOfferDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="extended" id="i1e216d49bb4542e6a703d755d854eecb_StockRepurchasesTenderOfferDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_77210b4c-4ae7-48d2-ae01-6ea4b904cd5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_77210b4c-4ae7-48d2-ae01-6ea4b904cd5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d5b12d8a-cbad-4048-9356-4f15e4e6dfbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d5b12d8a-cbad-4048-9356-4f15e4e6dfbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_05b65e5e-1cd2-475c-a011-5aef366fe1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_05b65e5e-1cd2-475c-a011-5aef366fe1ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_a639bef4-0f53-459c-963e-d422eaff1e4a" xlink:href="dva-20201231.xsd#dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:to="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_a639bef4-0f53-459c-963e-d422eaff1e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareRepurchaseFeesAndExpenses_25e46068-2b2c-44a9-a76d-9f8ab9213a13" xlink:href="dva-20201231.xsd#dva_ShareRepurchaseFeesAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:to="loc_dva_ShareRepurchaseFeesAndExpenses_25e46068-2b2c-44a9-a76d-9f8ab9213a13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_235e88fd-f53c-4804-9492-4a5cac83d449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_235e88fd-f53c-4804-9492-4a5cac83d449" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_fab04dff-d27a-4987-8b47-79457df58bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_235e88fd-f53c-4804-9492-4a5cac83d449" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_fab04dff-d27a-4987-8b47-79457df58bd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_fab04dff-d27a-4987-8b47-79457df58bd3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_fab04dff-d27a-4987-8b47-79457df58bd3" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_fab04dff-d27a-4987-8b47-79457df58bd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_fab04dff-d27a-4987-8b47-79457df58bd3" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_b07d78ec-f5e0-41ed-8a6b-783e6c507623" xlink:href="dva-20201231.xsd#dva_OpenMarketPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:to="loc_dva_OpenMarketPurchasesMember_b07d78ec-f5e0-41ed-8a6b-783e6c507623" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TenderOfferMember_517a9bf8-afed-4b2d-aa51-408fad27e9e4" xlink:href="dva-20201231.xsd#dva_TenderOfferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:to="loc_dva_TenderOfferMember_517a9bf8-afed-4b2d-aa51-408fad27e9e4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="extended" id="iaf9b26c3e7724cb49828d389e702ba09_ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c877f81a-fe4f-480a-9081-85ab010a7815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:to="loc_us-gaap_NetIncomeLoss_c877f81a-fe4f-480a-9081-85ab010a7815" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_931ad767-4e2f-4290-a425-0c2ef6fb2365" xlink:href="dva-20201231.xsd#dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_931ad767-4e2f-4290-a425-0c2ef6fb2365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_3a9d6930-7eeb-431b-89d8-bbd9bacf0916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_3a9d6930-7eeb-431b-89d8-bbd9bacf0916" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_1ad45891-f8f6-4803-9000-19f076420362" xlink:href="dva-20201231.xsd#dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_1ad45891-f8f6-4803-9000-19f076420362" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_c5a1d8ed-55d7-40a3-b3da-a52bd997621d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_c5a1d8ed-55d7-40a3-b3da-a52bd997621d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_fd0cd693-9e89-4ab2-baa7-0630fb2562d5" xlink:href="dva-20201231.xsd#dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_fd0cd693-9e89-4ab2-baa7-0630fb2562d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_925caf77-8abb-431f-8534-1cf42c34d49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_925caf77-8abb-431f-8534-1cf42c34d49f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d4638741-d79e-443f-a776-1cc11fbc261a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_925caf77-8abb-431f-8534-1cf42c34d49f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d4638741-d79e-443f-a776-1cc11fbc261a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d4638741-d79e-443f-a776-1cc11fbc261a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d4638741-d79e-443f-a776-1cc11fbc261a" xlink:to="loc_us-gaap_EquityComponentDomain_d4638741-d79e-443f-a776-1cc11fbc261a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9b448c77-1e0e-47da-af9e-8c3122a3238b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d4638741-d79e-443f-a776-1cc11fbc261a" xlink:to="loc_us-gaap_EquityComponentDomain_9b448c77-1e0e-47da-af9e-8c3122a3238b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1ce48657-cff4-4e04-b54f-6f6b9417262e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9b448c77-1e0e-47da-af9e-8c3122a3238b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1ce48657-cff4-4e04-b54f-6f6b9417262e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShareholdersequityDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="extended" id="id6f8a613a1e94592b4aa41037bad897f_ShareholdersequityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_47c9c1fa-57be-438c-8168-40017e8d1e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_47c9c1fa-57be-438c-8168-40017e8d1e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f44c42b3-a92a-4e38-9dbb-ec2cf0f5bcc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f44c42b3-a92a-4e38-9dbb-ec2cf0f5bcc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_966df3df-de45-4caf-8b8b-752ea8234f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_966df3df-de45-4caf-8b8b-752ea8234f62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3287ac09-8000-49a5-9b90-5b32f7aca080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3287ac09-8000-49a5-9b90-5b32f7aca080" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_55044bb9-5c4f-443c-8512-4ac4888e08c8" xlink:href="dva-20201231.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_55044bb9-5c4f-443c-8512-4ac4888e08c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f7e00422-60f5-46e7-9a24-6f5aec7fdee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f7e00422-60f5-46e7-9a24-6f5aec7fdee3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_05ba88da-ffc6-480f-bf85-7ce590119842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_05ba88da-ffc6-480f-bf85-7ce590119842" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:href="dva-20201231.xsd#dva_CharterdocumentsandDelawarelawAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:to="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9aab53db-e0d9-404a-a46a-4b205160a0d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9aab53db-e0d9-404a-a46a-4b205160a0d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_3ec671e8-fc61-4961-a1a8-6e2bbd1550ca" xlink:href="dva-20201231.xsd#dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:to="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_3ec671e8-fc61-4961-a1a8-6e2bbd1550ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_dfd5fe62-d6b6-4777-83de-afc1a1517ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_dfd5fe62-d6b6-4777-83de-afc1a1517ec6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0656ac5f-43df-4319-8e0f-3342dedd4906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0656ac5f-43df-4319-8e0f-3342dedd4906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0656ac5f-43df-4319-8e0f-3342dedd4906_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0656ac5f-43df-4319-8e0f-3342dedd4906" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0656ac5f-43df-4319-8e0f-3342dedd4906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d33cc60b-3db8-4e71-a2fa-e098340d72bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0656ac5f-43df-4319-8e0f-3342dedd4906" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d33cc60b-3db8-4e71-a2fa-e098340d72bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d8cd7452-5b27-447c-b61b-4f4069233d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d33cc60b-3db8-4e71-a2fa-e098340d72bf" xlink:to="loc_us-gaap_SubsequentEventMember_d8cd7452-5b27-447c-b61b-4f4069233d0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e53d2430-66ef-49f9-a37d-ba5f081f6aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e53d2430-66ef-49f9-a37d-ba5f081f6aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e53d2430-66ef-49f9-a37d-ba5f081f6aa2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e53d2430-66ef-49f9-a37d-ba5f081f6aa2" xlink:to="loc_us-gaap_EquityComponentDomain_e53d2430-66ef-49f9-a37d-ba5f081f6aa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_86f95937-4ce3-44d2-a480-cf5090ee44e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e53d2430-66ef-49f9-a37d-ba5f081f6aa2" xlink:to="loc_us-gaap_EquityComponentDomain_86f95937-4ce3-44d2-a480-cf5090ee44e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ce71895b-468f-4a31-809f-3392b6e7519f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_86f95937-4ce3-44d2-a480-cf5090ee44e9" xlink:to="loc_us-gaap_TreasuryStockMember_ce71895b-468f-4a31-809f-3392b6e7519f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncome"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="extended" id="ibe6baed2977f4c8987c3837c6dd28571_AccumulatedOtherComprehensiveLossIncome"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncomeTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="extended" id="i6ebb791f3ae24d96a5b5e9bd29705467_AccumulatedOtherComprehensiveLossIncomeTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended" id="i7c5d35c78af648aa8534ff0c96a41b31_AccumulatedOtherComprehensiveLossIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b4b8c05c-4681-48ab-bf33-3d30b1a008af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_StockholdersEquity_b4b8c05c-4681-48ab-bf33-3d30b1a008af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CumulativeEffectOfChangeInAccountingPrinciple_78890af6-8996-409a-937e-29ba70569de7" xlink:href="dva-20201231.xsd#dva_CumulativeEffectOfChangeInAccountingPrinciple"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_dva_CumulativeEffectOfChangeInAccountingPrinciple_78890af6-8996-409a-937e-29ba70569de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_4ba01cde-2751-47a3-af84-36f142c5d848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_4ba01cde-2751-47a3-af84-36f142c5d848" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d4a5bad4-e3c5-4c3f-af0c-9decd1ae65f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d4a5bad4-e3c5-4c3f-af0c-9decd1ae65f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09d6bec4-1d58-47aa-963f-9b1518a0068e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09d6bec4-1d58-47aa-963f-9b1518a0068e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_ea03f07a-435e-4a7d-a8fa-5ef53e75f004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_ea03f07a-435e-4a7d-a8fa-5ef53e75f004" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e53570f0-d5db-4d01-b7c8-3ac7f4ce2b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e53570f0-d5db-4d01-b7c8-3ac7f4ce2b6c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cdcc20cc-96c3-4f61-8c88-9976cc5c74bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cdcc20cc-96c3-4f61-8c88-9976cc5c74bf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_02c727db-fda4-4517-864d-1b3bf6e602c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dffe2610-8fe4-442c-bd3a-6a40d8476a95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dffe2610-8fe4-442c-bd3a-6a40d8476a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dffe2610-8fe4-442c-bd3a-6a40d8476a95_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dffe2610-8fe4-442c-bd3a-6a40d8476a95" xlink:to="loc_us-gaap_EquityComponentDomain_dffe2610-8fe4-442c-bd3a-6a40d8476a95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dffe2610-8fe4-442c-bd3a-6a40d8476a95" xlink:to="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_55fed8e9-4a44-4832-af0a-1e2dd5f11926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_55fed8e9-4a44-4832-af0a-1e2dd5f11926" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_482a1964-9383-43aa-bc35-44e56f30cfe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_482a1964-9383-43aa-bc35-44e56f30cfe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4668f7f5-a83b-47cf-a6fc-f02d53004aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4668f7f5-a83b-47cf-a6fc-f02d53004aa5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fa6737b1-e2fe-4357-a7f3-0b313b036996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fa6737b1-e2fe-4357-a7f3-0b313b036996" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_36d0d9ae-b22f-4417-9dbc-c2ff0110f417" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_36d0d9ae-b22f-4417-9dbc-c2ff0110f417" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_36d0d9ae-b22f-4417-9dbc-c2ff0110f417_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_36d0d9ae-b22f-4417-9dbc-c2ff0110f417" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_36d0d9ae-b22f-4417-9dbc-c2ff0110f417_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1ad4176c-59bc-4d9a-9a11-9f64a74a514e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_36d0d9ae-b22f-4417-9dbc-c2ff0110f417" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1ad4176c-59bc-4d9a-9a11-9f64a74a514e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3ee961db-4e80-4c81-a5fc-efcfed150a0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1ad4176c-59bc-4d9a-9a11-9f64a74a514e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3ee961db-4e80-4c81-a5fc-efcfed150a0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestitures"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="extended" id="i31d100b3719b4fae8ec98573c1b462ba_AcquisitionsandDivestitures"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="extended" id="i4370b323f0ae428ca1d7a243a3c768a2_AcquisitionsandDivestituresTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsAssetsacquiredandliabilitiesassumedDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="extended" id="i6b54e5394b1f4c69a5274db0bf8aee82_AcquisitionsAssetsacquiredandliabilitiesassumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3bb4989-13f9-4b34-8069-c4d625d9a590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3bb4989-13f9-4b34-8069-c4d625d9a590" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2f459859-3344-4727-8e30-096d3c6af490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2f459859-3344-4727-8e30-096d3c6af490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_32ef460d-8bae-4c9c-83e5-5812bc267676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_32ef460d-8bae-4c9c-83e5-5812bc267676" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_12ea7b0c-0f49-4774-92f4-b19ebceeaee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_12ea7b0c-0f49-4774-92f4-b19ebceeaee6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_942863ee-e669-4682-a63b-1c829eea1f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_942863ee-e669-4682-a63b-1c829eea1f31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4cc64dbd-d539-4482-a7e2-4293fb92b53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_Goodwill_4cc64dbd-d539-4482-a7e2-4293fb92b53f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4f144063-ff32-4cdb-a2b6-a8a91415e7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4f144063-ff32-4cdb-a2b6-a8a91415e7e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_665a3f49-aeef-4d28-9bed-4012a6317702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_665a3f49-aeef-4d28-9bed-4012a6317702" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d98c8af9-0bd2-46d9-ba39-deb3f0e3dcd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d98c8af9-0bd2-46d9-ba39-deb3f0e3dcd6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5fd02fb1-7aff-4075-a809-eab7c98d8802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5fd02fb1-7aff-4075-a809-eab7c98d8802" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24d750d4-3bb4-4540-b5d4-b2ee92c01310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24d750d4-3bb4-4540-b5d4-b2ee92c01310" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a5a67594-0d82-4dac-8fca-607099918032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24d750d4-3bb4-4540-b5d4-b2ee92c01310" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a5a67594-0d82-4dac-8fca-607099918032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a5a67594-0d82-4dac-8fca-607099918032_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5a67594-0d82-4dac-8fca-607099918032" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a5a67594-0d82-4dac-8fca-607099918032_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10f10539-c3dd-45a0-97a6-ed27b3ee5af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5a67594-0d82-4dac-8fca-607099918032" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10f10539-c3dd-45a0-97a6-ed27b3ee5af3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_be4c2ee0-06f4-454e-b689-7073afcfdedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10f10539-c3dd-45a0-97a6-ed27b3ee5af3" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_be4c2ee0-06f4-454e-b689-7073afcfdedf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="extended" id="ia4f3646acd2b4535bb467f6a8832a4fc_ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a0304b3d-5cd8-4099-a78b-95778c2da0a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a0304b3d-5cd8-4099-a78b-95778c2da0a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_997f888c-36cf-4b97-b7b4-dfdacba4077e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_997f888c-36cf-4b97-b7b4-dfdacba4077e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ca1a231-0421-4462-a16e-bfc0cb23e852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ca1a231-0421-4462-a16e-bfc0cb23e852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ca1a231-0421-4462-a16e-bfc0cb23e852_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ca1a231-0421-4462-a16e-bfc0cb23e852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ca1a231-0421-4462-a16e-bfc0cb23e852_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ca1a231-0421-4462-a16e-bfc0cb23e852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1b5051a3-65dd-45cb-b86b-2d96f929fcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1b5051a3-65dd-45cb-b86b-2d96f929fcf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_99e2bd04-4382-4909-8420-72288c6311aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_99e2bd04-4382-4909-8420-72288c6311aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b6a78292-ac59-473a-847b-f9d91f0c3a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b6a78292-ac59-473a-847b-f9d91f0c3a18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b6a78292-ac59-473a-847b-f9d91f0c3a18_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b6a78292-ac59-473a-847b-f9d91f0c3a18" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b6a78292-ac59-473a-847b-f9d91f0c3a18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad77008a-8d4c-4070-b54a-690ee7aa47e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b6a78292-ac59-473a-847b-f9d91f0c3a18" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad77008a-8d4c-4070-b54a-690ee7aa47e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b58196dd-ee3c-4ae0-9818-64219bfc3879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad77008a-8d4c-4070-b54a-690ee7aa47e6" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b58196dd-ee3c-4ae0-9818-64219bfc3879" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="extended" id="i52a0a91d3f084e7e9ad9480ca3c36a2a_AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="extended" id="i91a5876f64c04774b88b1758f6c0b923_AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="extended" id="ic9a5d20d133b413b885dd30139896bd6_AcquisitionsandDivestituresAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_8bb7a988-77a0-44ab-9b3d-6f3f6377da34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_8bb7a988-77a0-44ab-9b3d-6f3f6377da34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_7629b04c-7f09-4456-b548-3683f562c08b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_7629b04c-7f09-4456-b548-3683f562c08b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_2e4f5d3c-e701-44e7-ad54-d3d6704a5d76" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_2e4f5d3c-e701-44e7-ad54-d3d6704a5d76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2ac011e5-c1af-4c41-bcbf-906fc1293822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2ac011e5-c1af-4c41-bcbf-906fc1293822" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_14a092c7-21fe-48bd-b69f-3bb6ee9a6fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_14a092c7-21fe-48bd-b69f-3bb6ee9a6fb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_362a4b62-9569-4d05-9174-fbe678a4a21a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_362a4b62-9569-4d05-9174-fbe678a4a21a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09f6a5cc-aeb6-4511-9ed6-f20e0cf7c13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09f6a5cc-aeb6-4511-9ed6-f20e0cf7c13c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_da7b202f-d817-43de-b274-d2924f696ce9" xlink:href="dva-20201231.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_da7b202f-d817-43de-b274-d2924f696ce9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_88328987-6d85-4708-ab80-4c77aa4c67ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_88328987-6d85-4708-ab80-4c77aa4c67ee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0e0ba81-62f1-404c-b996-4819be5d511f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0e0ba81-62f1-404c-b996-4819be5d511f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f0e0ba81-62f1-404c-b996-4819be5d511f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0e0ba81-62f1-404c-b996-4819be5d511f" xlink:to="loc_us-gaap_SegmentDomain_f0e0ba81-62f1-404c-b996-4819be5d511f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0e0ba81-62f1-404c-b996-4819be5d511f" xlink:to="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_816244a5-e7da-414a-8732-46af8b05c8d3" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_816244a5-e7da-414a-8732-46af8b05c8d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_9c2b4109-1d8f-438d-9b24-9290bc8861cc" xlink:href="dva-20201231.xsd#dva_ForeignDialysisCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:to="loc_dva_ForeignDialysisCentersMember_9c2b4109-1d8f-438d-9b24-9290bc8861cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f02fabe4-f012-4f73-a2ee-f7d43b18f79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f02fabe4-f012-4f73-a2ee-f7d43b18f79c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f02fabe4-f012-4f73-a2ee-f7d43b18f79c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f02fabe4-f012-4f73-a2ee-f7d43b18f79c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f02fabe4-f012-4f73-a2ee-f7d43b18f79c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7caf66a7-b9e1-47e1-a0af-b822613b206e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f02fabe4-f012-4f73-a2ee-f7d43b18f79c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7caf66a7-b9e1-47e1-a0af-b822613b206e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ed599645-20bf-4f1b-87dd-bc2a696a17b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7caf66a7-b9e1-47e1-a0af-b822613b206e" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ed599645-20bf-4f1b-87dd-bc2a696a17b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfdc9c3b-6211-4b83-b922-5e2a159f1289" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_srt_RangeAxis_cfdc9c3b-6211-4b83-b922-5e2a159f1289" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cfdc9c3b-6211-4b83-b922-5e2a159f1289_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cfdc9c3b-6211-4b83-b922-5e2a159f1289" xlink:to="loc_srt_RangeMember_cfdc9c3b-6211-4b83-b922-5e2a159f1289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cfdc9c3b-6211-4b83-b922-5e2a159f1289" xlink:to="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c2a8bfde-3499-4282-8343-244acef3e1a4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:to="loc_srt_MinimumMember_c2a8bfde-3499-4282-8343-244acef3e1a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f371192-b6f8-411e-8b0b-f94a5702b46d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:to="loc_srt_MaximumMember_1f371192-b6f8-411e-8b0b-f94a5702b46d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a58d2c3c-2587-47da-98fd-ac4d22417713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a58d2c3c-2587-47da-98fd-ac4d22417713" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a58d2c3c-2587-47da-98fd-ac4d22417713_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a58d2c3c-2587-47da-98fd-ac4d22417713" xlink:to="loc_us-gaap_RelatedPartyDomain_a58d2c3c-2587-47da-98fd-ac4d22417713_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2a0ff5f8-2ce3-40d8-8c2b-d3316adc69f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a58d2c3c-2587-47da-98fd-ac4d22417713" xlink:to="loc_us-gaap_RelatedPartyDomain_2a0ff5f8-2ce3-40d8-8c2b-d3316adc69f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_97792110-dac6-4a64-a0f7-c6afdea8f989" xlink:href="dva-20201231.xsd#dva_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2a0ff5f8-2ce3-40d8-8c2b-d3316adc69f5" xlink:to="loc_dva_OtherCompaniesMember_97792110-dac6-4a64-a0f7-c6afdea8f989" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_dc3cf603-3c89-4815-83c7-a8763f674167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_dc3cf603-3c89-4815-83c7-a8763f674167" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_dc3cf603-3c89-4815-83c7-a8763f674167_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_dc3cf603-3c89-4815-83c7-a8763f674167" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_dc3cf603-3c89-4815-83c7-a8763f674167_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f3b11afd-efe0-469c-92d0-262850e2ec44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_dc3cf603-3c89-4815-83c7-a8763f674167" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f3b11afd-efe0-469c-92d0-262850e2ec44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_078dcbaf-a925-4658-bd36-6c32892b0c2b" xlink:href="dva-20201231.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f3b11afd-efe0-469c-92d0-262850e2ec44" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_078dcbaf-a925-4658-bd36-6c32892b0c2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18ec1c5a-c943-4142-ab73-c36a1cea1adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18ec1c5a-c943-4142-ab73-c36a1cea1adb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18ec1c5a-c943-4142-ab73-c36a1cea1adb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18ec1c5a-c943-4142-ab73-c36a1cea1adb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18ec1c5a-c943-4142-ab73-c36a1cea1adb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18ec1c5a-c943-4142-ab73-c36a1cea1adb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_597f9618-28c5-4fde-a8e4-4072d51869a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_597f9618-28c5-4fde-a8e4-4072d51869a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_695d67a2-62d8-465e-8b62-b262745a1f47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_695d67a2-62d8-465e-8b62-b262745a1f47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e0788e2-d9b4-44bd-955a-f6107f247ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e0788e2-d9b4-44bd-955a-f6107f247ce8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6e0788e2-d9b4-44bd-955a-f6107f247ce8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e0788e2-d9b4-44bd-955a-f6107f247ce8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6e0788e2-d9b4-44bd-955a-f6107f247ce8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98e19366-8858-4d6c-8baf-123b138873b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e0788e2-d9b4-44bd-955a-f6107f247ce8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98e19366-8858-4d6c-8baf-123b138873b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember_16c63b6e-68d5-4e0e-a544-1e64d13811f8" xlink:href="dva-20201231.xsd#dva_RMSLifelineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98e19366-8858-4d6c-8baf-123b138873b5" xlink:to="loc_dva_RMSLifelineMember_16c63b6e-68d5-4e0e-a544-1e64d13811f8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperations"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="extended" id="ia943df277bbe49788805dc74f6ce5e4f_HeldforSaleandDiscontinuedOperations"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="extended" id="i56bce398aeb54d7b9175768cea2a9932_HeldforSaleandDiscontinuedOperationsTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="extended" id="i1fd26158dafb4d62bb65da69bb81937a_HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1ffc6a8b-6080-4d4d-909a-96a1fa6eacba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1ffc6a8b-6080-4d4d-909a-96a1fa6eacba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c001169c-7cec-4f11-aa40-f3d2e91c82f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c001169c-7cec-4f11-aa40-f3d2e91c82f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_aa9d9b33-6702-4ff6-9d92-9918d4add05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_aa9d9b33-6702-4ff6-9d92-9918d4add05c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_11bd42bd-ab4e-41f5-944c-e8a59dd10762" xlink:href="dva-20201231.xsd#dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_11bd42bd-ab4e-41f5-944c-e8a59dd10762" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_3708e6bb-529a-4e47-91c6-21d730dbd624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_3708e6bb-529a-4e47-91c6-21d730dbd624" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_43d43f70-d411-4fa3-ac14-1ec068ba24db" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_43d43f70-d411-4fa3-ac14-1ec068ba24db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_904f2262-89a4-482d-87cb-3488c18ef90b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_904f2262-89a4-482d-87cb-3488c18ef90b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_002254c3-a623-4c6b-b2a1-dc7ed0c8cd5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_002254c3-a623-4c6b-b2a1-dc7ed0c8cd5a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1db1671b-da08-427f-91c8-bf9f640ac757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1db1671b-da08-427f-91c8-bf9f640ac757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1db1671b-da08-427f-91c8-bf9f640ac757_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1db1671b-da08-427f-91c8-bf9f640ac757" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1db1671b-da08-427f-91c8-bf9f640ac757_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f04dba8a-dec6-420c-a4d3-6a10a308f400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1db1671b-da08-427f-91c8-bf9f640ac757" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f04dba8a-dec6-420c-a4d3-6a10a308f400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_2f8148eb-a0b1-4846-9f9a-5d660a6bed07" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f04dba8a-dec6-420c-a4d3-6a10a308f400" xlink:to="loc_dva_DaVitaMedicalGroupMember_2f8148eb-a0b1-4846-9f9a-5d660a6bed07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_821ee524-ad68-4815-aea8-e1477319aef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_821ee524-ad68-4815-aea8-e1477319aef1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_821ee524-ad68-4815-aea8-e1477319aef1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_821ee524-ad68-4815-aea8-e1477319aef1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_821ee524-ad68-4815-aea8-e1477319aef1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_43dd31f0-68e4-4a11-81b3-42dd8eab3b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_821ee524-ad68-4815-aea8-e1477319aef1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_43dd31f0-68e4-4a11-81b3-42dd8eab3b5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_4ff20c90-cc16-4cb8-b224-5ffe6a90f86b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_43dd31f0-68e4-4a11-81b3-42dd8eab3b5e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_4ff20c90-cc16-4cb8-b224-5ffe6a90f86b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="extended" id="iba346471e08a4e54a26949fc3cad82a6_HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="extended" id="id8c749ab5b56497dbad7438af9f6d5d8_HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_b8f790fd-a75b-4303-8522-1950ef22e56a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_b8f790fd-a75b-4303-8522-1950ef22e56a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_c039e71a-ee64-4ee6-b7bc-c3073fd91f3d" xlink:href="dva-20201231.xsd#dva_PurchaseAndSaleAgreementAggregatePurchasePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_c039e71a-ee64-4ee6-b7bc-c3073fd91f3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_c6f69144-2a7a-474a-9215-f28edcd089ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_c6f69144-2a7a-474a-9215-f28edcd089ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_67a8a1f8-9355-4f91-83a9-d9360669040c" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_67a8a1f8-9355-4f91-83a9-d9360669040c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_412f8eb2-af40-455b-a932-d8c74e13cae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_412f8eb2-af40-455b-a932-d8c74e13cae4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_ef37c94f-7dda-4492-9c74-8fcb123cbf0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_ef37c94f-7dda-4492-9c74-8fcb123cbf0f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_12de37ff-d4ac-47f4-aae5-8ce06a4f03d4" xlink:href="dva-20201231.xsd#dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_12de37ff-d4ac-47f4-aae5-8ce06a4f03d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_83c816a2-cb59-4994-97c3-95fe31e98f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_83c816a2-cb59-4994-97c3-95fe31e98f90" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_8b7242bb-8e05-4f56-997e-2dedff5b8fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_8b7242bb-8e05-4f56-997e-2dedff5b8fed" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_401b730c-d736-4e18-8169-fee495c5e3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_401b730c-d736-4e18-8169-fee495c5e3ca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f52ca819-9fe4-4d09-97ce-d0b4d183528a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f52ca819-9fe4-4d09-97ce-d0b4d183528a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1122b57e-d200-441f-ae59-c539d0a0546d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1122b57e-d200-441f-ae59-c539d0a0546d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_f3ba533f-b93c-4dbd-a100-681cedaf993a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1122b57e-d200-441f-ae59-c539d0a0546d" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_f3ba533f-b93c-4dbd-a100-681cedaf993a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0567fda-602e-4dfe-a4c7-72495e092e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0567fda-602e-4dfe-a4c7-72495e092e25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e0567fda-602e-4dfe-a4c7-72495e092e25_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0567fda-602e-4dfe-a4c7-72495e092e25" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e0567fda-602e-4dfe-a4c7-72495e092e25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0567fda-602e-4dfe-a4c7-72495e092e25" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DMGAcquisitionsMember_3dc5a659-fd26-4c9b-8fac-d28a1fcaee6e" xlink:href="dva-20201231.xsd#dva_DMGAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:to="loc_dva_DMGAcquisitionsMember_3dc5a659-fd26-4c9b-8fac-d28a1fcaee6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_fac51812-6966-4d24-a58b-5a39f438559f" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:to="loc_dva_DaVitaMedicalGroupMember_fac51812-6966-4d24-a58b-5a39f438559f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_079aa13b-c2c9-412f-8efb-75009634299f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_079aa13b-c2c9-412f-8efb-75009634299f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_079aa13b-c2c9-412f-8efb-75009634299f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_079aa13b-c2c9-412f-8efb-75009634299f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_079aa13b-c2c9-412f-8efb-75009634299f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f80da66-7de0-43c0-94c5-e5558ea472b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_079aa13b-c2c9-412f-8efb-75009634299f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f80da66-7de0-43c0-94c5-e5558ea472b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dc7ad0ba-e719-4de3-b7a3-9c176fee965b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f80da66-7de0-43c0-94c5-e5558ea472b3" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dc7ad0ba-e719-4de3-b7a3-9c176fee965b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_248ec444-0536-4f7b-8d4a-edb7c30f578e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_248ec444-0536-4f7b-8d4a-edb7c30f578e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_248ec444-0536-4f7b-8d4a-edb7c30f578e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_248ec444-0536-4f7b-8d4a-edb7c30f578e" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_248ec444-0536-4f7b-8d4a-edb7c30f578e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_dc76fb69-6903-4288-bbe5-ad596260c857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_248ec444-0536-4f7b-8d4a-edb7c30f578e" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_dc76fb69-6903-4288-bbe5-ad596260c857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_6b861c2f-5806-4a7f-8fb4-a45b48a353fa" xlink:href="dva-20201231.xsd#dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dc76fb69-6903-4288-bbe5-ad596260c857" xlink:to="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_6b861c2f-5806-4a7f-8fb4-a45b48a353fa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="dva-20201231.xsd#VariableInterestEntities"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/VariableInterestEntities" xlink:type="extended" id="i8aa1f24eb2e6450b902907dd248dbae2_VariableInterestEntities"/>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#VariableInterestEntitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="extended" id="i71770be76ad740e99ac12ac3385606b7_VariableInterestEntitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_624a67e3-efdf-4afb-b718-61c4d650d9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:to="loc_us-gaap_Assets_624a67e3-efdf-4afb-b718-61c4d650d9e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_21cacfb9-62ee-42f7-9b1e-2a38b6490ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:to="loc_us-gaap_Liabilities_21cacfb9-62ee-42f7-9b1e-2a38b6490ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6f23726d-598b-4d94-9e3e-b4970fd670f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6f23726d-598b-4d94-9e3e-b4970fd670f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_41fb5178-a6bc-4149-ae94-e00302132aad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6f23726d-598b-4d94-9e3e-b4970fd670f7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_41fb5178-a6bc-4149-ae94-e00302132aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_41fb5178-a6bc-4149-ae94-e00302132aad_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_41fb5178-a6bc-4149-ae94-e00302132aad" xlink:to="loc_srt_ConsolidatedEntitiesDomain_41fb5178-a6bc-4149-ae94-e00302132aad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_949d389e-fa45-4069-9e77-092fc2f1dafb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_41fb5178-a6bc-4149-ae94-e00302132aad" xlink:to="loc_srt_ConsolidatedEntitiesDomain_949d389e-fa45-4069-9e77-092fc2f1dafb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99491ae0-72c7-475b-af5e-6b698300c8a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_949d389e-fa45-4069-9e77-092fc2f1dafb" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99491ae0-72c7-475b-af5e-6b698300c8a8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="extended" id="i0d6e1ebed94d45f5bb0df5d3736a49d8_FairValuesofFinancialInstruments"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="extended" id="i792c9410d08344d8b2695ab7651e53f2_FairValuesofFinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ia4474f4b754c4341b141607335f88153_FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cdadf20b-54c8-4186-95f3-b13f5897c2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cdadf20b-54c8-4186-95f3-b13f5897c2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_cf088d4f-df81-4a5a-a8d8-748bb9bcf410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:to="loc_us-gaap_DerivativeAssets_cf088d4f-df81-4a5a-a8d8-748bb9bcf410" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57782c3e-f996-47de-8dae-571a7b186d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57782c3e-f996-47de-8dae-571a7b186d26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fc848ba4-a519-4921-bad1-e4186c08f0b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57782c3e-f996-47de-8dae-571a7b186d26" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fc848ba4-a519-4921-bad1-e4186c08f0b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_409c8ee0-511b-4cc2-a267-072e54d986f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:to="loc_us-gaap_TemporaryEquityAbstract_409c8ee0-511b-4cc2-a267-072e54d986f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_a22c78ec-6b92-441b-a50c-15b5cac38571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_409c8ee0-511b-4cc2-a267-072e54d986f5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_a22c78ec-6b92-441b-a50c-15b5cac38571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bac85d1-f12f-4866-9345-153006170e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bac85d1-f12f-4866-9345-153006170e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9bac85d1-f12f-4866-9345-153006170e21_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bac85d1-f12f-4866-9345-153006170e21" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9bac85d1-f12f-4866-9345-153006170e21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_70884c1a-f617-41c8-8fb5-b57d9edfad80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bac85d1-f12f-4866-9345-153006170e21" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_70884c1a-f617-41c8-8fb5-b57d9edfad80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9c3fa99e-4e92-455f-b9e3-2e028e5933e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_70884c1a-f617-41c8-8fb5-b57d9edfad80" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9c3fa99e-4e92-455f-b9e3-2e028e5933e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_500c4e05-841e-44ab-87cc-180124a21e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_500c4e05-841e-44ab-87cc-180124a21e05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_500c4e05-841e-44ab-87cc-180124a21e05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_500c4e05-841e-44ab-87cc-180124a21e05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_500c4e05-841e-44ab-87cc-180124a21e05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_500c4e05-841e-44ab-87cc-180124a21e05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_81b97a39-7603-46f5-a8dc-3ac41b31d77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_81b97a39-7603-46f5-a8dc-3ac41b31d77e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c4c68e54-1fc6-4659-813a-e5b5a1afeb64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c4c68e54-1fc6-4659-813a-e5b5a1afeb64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cdf824f1-4201-46f2-8c1b-131eb5646aec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cdf824f1-4201-46f2-8c1b-131eb5646aec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1e7d07ea-562e-4327-9e63-ddb8b09cc41a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1e7d07ea-562e-4327-9e63-ddb8b09cc41a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1e7d07ea-562e-4327-9e63-ddb8b09cc41a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1e7d07ea-562e-4327-9e63-ddb8b09cc41a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1e7d07ea-562e-4327-9e63-ddb8b09cc41a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_438929f5-798d-4174-9b0a-3f5ab86cc09a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1e7d07ea-562e-4327-9e63-ddb8b09cc41a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_438929f5-798d-4174-9b0a-3f5ab86cc09a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_6b5a6ff0-a96f-423b-b7cc-1ff310a12a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_438929f5-798d-4174-9b0a-3f5ab86cc09a" xlink:to="loc_us-gaap_InterestRateCapMember_6b5a6ff0-a96f-423b-b7cc-1ff310a12a1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7f0a0991-3bf7-4ec3-932f-642746dde505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7f0a0991-3bf7-4ec3-932f-642746dde505" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7f0a0991-3bf7-4ec3-932f-642746dde505_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7f0a0991-3bf7-4ec3-932f-642746dde505" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7f0a0991-3bf7-4ec3-932f-642746dde505_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f3292b39-c4c8-41ac-855a-44ad31723cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7f0a0991-3bf7-4ec3-932f-642746dde505" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f3292b39-c4c8-41ac-855a-44ad31723cca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_87ab3a34-5aaa-421e-8c56-a54cd6d024f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f3292b39-c4c8-41ac-855a-44ad31723cca" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_87ab3a34-5aaa-421e-8c56-a54cd6d024f8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="extended" id="i57d0251a20534817817eb588fee51462_FairValuesofFinancialInstrumentsDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReporting" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReporting"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReporting" xlink:type="extended" id="i9174e9021b81429d822eefb2ba3c3609_SegmentReporting"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingTables" xlink:type="extended" id="i233eb0a009a647b598726583bb7c4376_SegmentReportingTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended" id="i2b8cd802b38e4961bf650464037179b7_SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_ad9b3bc6-49cf-4cc6-9b53-79e94213cdb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_ad9b3bc6-49cf-4cc6-9b53-79e94213cdb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProvisionForExpectedCreditLosses_f13b20d0-dc6d-4384-abc6-dccebe588989" xlink:href="dva-20201231.xsd#dva_ProvisionForExpectedCreditLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_ProvisionForExpectedCreditLosses_f13b20d0-dc6d-4384-abc6-dccebe588989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_00a0680d-df0f-4e5b-808f-77656a0dd9ee" xlink:href="dva-20201231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_00a0680d-df0f-4e5b-808f-77656a0dd9ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_6cf44b54-641f-43fa-84a7-12d3aa850419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_OtherIncome_6cf44b54-641f-43fa-84a7-12d3aa850419" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_30f75337-e0f0-4526-b422-81a47d3dd679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_Revenues_30f75337-e0f0-4526-b422-81a47d3dd679" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d56ea0a2-8dfd-4a23-9df5-649c3f855a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_OperatingIncomeLoss_d56ea0a2-8dfd-4a23-9df5-649c3f855a6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_8dd55ed4-0b90-44f0-8b53-8ea5f1936bac" xlink:href="dva-20201231.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_8dd55ed4-0b90-44f0-8b53-8ea5f1936bac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_ea1726ac-1469-430e-bae2-15d19d1275da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_InterestAndDebtExpense_ea1726ac-1469-430e-bae2-15d19d1275da" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_93d1c365-346d-4547-b38a-3eee024e496c" xlink:href="dva-20201231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_93d1c365-346d-4547-b38a-3eee024e496c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5e93df23-e2de-4b2c-b74f-07418027b9a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5e93df23-e2de-4b2c-b74f-07418027b9a8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6a40876f-0b5c-48b6-8c5c-2d9249746e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6a40876f-0b5c-48b6-8c5c-2d9249746e55" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_c6091894-9529-4a92-bba9-6a3e76b98d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_c6091894-9529-4a92-bba9-6a3e76b98d4b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_76fb60b8-33cd-4fd6-84a1-7ea65cda7990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_c6091894-9529-4a92-bba9-6a3e76b98d4b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_76fb60b8-33cd-4fd6-84a1-7ea65cda7990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a53844c4-598e-4892-8902-404aa5db6b85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:to="loc_srt_ConsolidationItemsAxis_a53844c4-598e-4892-8902-404aa5db6b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a53844c4-598e-4892-8902-404aa5db6b85_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a53844c4-598e-4892-8902-404aa5db6b85" xlink:to="loc_srt_ConsolidationItemsDomain_a53844c4-598e-4892-8902-404aa5db6b85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a53844c4-598e-4892-8902-404aa5db6b85" xlink:to="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_10da3635-2d7c-4860-8aae-a7adb7ae0698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:to="loc_us-gaap_OperatingSegmentsMember_10da3635-2d7c-4860-8aae-a7adb7ae0698" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_23893b3f-7338-498c-bfd6-e42c7fd60fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:to="loc_us-gaap_IntersegmentEliminationMember_23893b3f-7338-498c-bfd6-e42c7fd60fb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_77e9a3bd-634f-447b-89ac-46c191d07af1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_77e9a3bd-634f-447b-89ac-46c191d07af1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_77e9a3bd-634f-447b-89ac-46c191d07af1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77e9a3bd-634f-447b-89ac-46c191d07af1" xlink:to="loc_us-gaap_SegmentDomain_77e9a3bd-634f-447b-89ac-46c191d07af1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77e9a3bd-634f-447b-89ac-46c191d07af1" xlink:to="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_2236e075-1671-45ac-8e24-0bc5c8279b3c" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_2236e075-1671-45ac-8e24-0bc5c8279b3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_cf796295-f0f4-41e1-95dd-6c63009e134f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_cf796295-f0f4-41e1-95dd-6c63009e134f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_b30b9a86-c937-4f92-ae7e-1390fd23a1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_b30b9a86-c937-4f92-ae7e-1390fd23a1ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_b30b9a86-c937-4f92-ae7e-1390fd23a1ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_b30b9a86-c937-4f92-ae7e-1390fd23a1ac" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_b30b9a86-c937-4f92-ae7e-1390fd23a1ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_b30b9a86-c937-4f92-ae7e-1390fd23a1ac" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_fcff182b-f1d0-4423-bb43-66af04613c17" xlink:href="dva-20201231.xsd#dva_ExternalSourcesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:to="loc_dva_ExternalSourcesMember_fcff182b-f1d0-4423-bb43-66af04613c17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_8061d209-8f49-4804-9ac9-f72b0e8f20f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_8061d209-8f49-4804-9ac9-f72b0e8f20f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="extended" id="ifb394accb084472eb399df90439c868c_SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d9f3c31d-f760-4a92-addc-f0a596422d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_37978dec-0fbd-4394-8962-f6da709d988e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9f3c31d-f760-4a92-addc-f0a596422d1a" xlink:to="loc_us-gaap_DepreciationAndAmortization_37978dec-0fbd-4394-8962-f6da709d988e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c591f78d-e99a-43f5-9769-9dbbfe125f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9f3c31d-f760-4a92-addc-f0a596422d1a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c591f78d-e99a-43f5-9769-9dbbfe125f14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1dd825b-c16b-484c-9265-fbe4303bec1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c591f78d-e99a-43f5-9769-9dbbfe125f14" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1dd825b-c16b-484c-9265-fbe4303bec1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1dd825b-c16b-484c-9265-fbe4303bec1a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1dd825b-c16b-484c-9265-fbe4303bec1a" xlink:to="loc_us-gaap_SegmentDomain_e1dd825b-c16b-484c-9265-fbe4303bec1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1dd825b-c16b-484c-9265-fbe4303bec1a" xlink:to="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_30383dc5-77de-40fd-9a1d-6bb50f22c93b" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_30383dc5-77de-40fd-9a1d-6bb50f22c93b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_55cabd91-2b2d-42f4-a3da-0ef508d754a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:to="loc_us-gaap_AllOtherSegmentsMember_55cabd91-2b2d-42f4-a3da-0ef508d754a9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofAssetsbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="extended" id="ia925ed2a0d764430b53c04f6e8320454_SegmentReportingSummaryofAssetsbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7d08c3e6-fb01-4048-ac96-8109286652d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7d08c3e6-fb01-4048-ac96-8109286652d6" xlink:to="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1f56b8ec-455f-4791-8441-ff5a687e7afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:to="loc_us-gaap_Assets_1f56b8ec-455f-4791-8441-ff5a687e7afd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_91fe3157-35a0-4044-bf18-db991b0e6cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_91fe3157-35a0-4044-bf18-db991b0e6cf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_531d6f31-9f7a-447b-bb7a-4103340ef2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_531d6f31-9f7a-447b-bb7a-4103340ef2fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7d08c3e6-fb01-4048-ac96-8109286652d6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:to="loc_srt_StatementGeographicalAxis_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98" xlink:to="loc_srt_SegmentGeographicalDomain_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_163e1af5-9e53-4cbb-b3c2-082503a38b38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98" xlink:to="loc_srt_SegmentGeographicalDomain_163e1af5-9e53-4cbb-b3c2-082503a38b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_8f9fffb8-4f90-40ec-b6b9-0a195f87e2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_163e1af5-9e53-4cbb-b3c2-082503a38b38" xlink:to="loc_us-gaap_NonUsMember_8f9fffb8-4f90-40ec-b6b9-0a195f87e2fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3809b4f0-f100-4630-a85a-f1b5f889b271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3809b4f0-f100-4630-a85a-f1b5f889b271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3809b4f0-f100-4630-a85a-f1b5f889b271_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3809b4f0-f100-4630-a85a-f1b5f889b271" xlink:to="loc_us-gaap_SegmentDomain_3809b4f0-f100-4630-a85a-f1b5f889b271_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3809b4f0-f100-4630-a85a-f1b5f889b271" xlink:to="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_42a9e4be-54f0-41c4-a050-2b68cb8d9668" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_42a9e4be-54f0-41c4-a050-2b68cb8d9668" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_f4618760-0aa4-4059-b7b0-c67aa3c86aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:to="loc_us-gaap_AllOtherSegmentsMember_f4618760-0aa4-4059-b7b0-c67aa3c86aeb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="extended" id="i8e6f18e612ba46b7980eaa781ea702f7_SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f31ec0a8-c96f-4172-bd25-eb6fc387d807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cfcb2332-db72-40ad-90ac-f634e4c95c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f31ec0a8-c96f-4172-bd25-eb6fc387d807" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cfcb2332-db72-40ad-90ac-f634e4c95c89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7e502958-2cee-4b8d-9e7a-1a25b33197c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f31ec0a8-c96f-4172-bd25-eb6fc387d807" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7e502958-2cee-4b8d-9e7a-1a25b33197c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d235321f-5c52-4928-8be6-b9750db20975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7e502958-2cee-4b8d-9e7a-1a25b33197c0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d235321f-5c52-4928-8be6-b9750db20975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d235321f-5c52-4928-8be6-b9750db20975_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d235321f-5c52-4928-8be6-b9750db20975" xlink:to="loc_us-gaap_SegmentDomain_d235321f-5c52-4928-8be6-b9750db20975_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d235321f-5c52-4928-8be6-b9750db20975" xlink:to="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_bb1712ca-b398-4d59-9f6c-8c338b4046a5" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_bb1712ca-b398-4d59-9f6c-8c338b4046a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_a141dae3-cfec-4133-a55b-b90be73a5de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:to="loc_us-gaap_AllOtherSegmentsMember_a141dae3-cfec-4133-a55b-b90be73a5de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_a5f4a668-d03d-49e8-bd48-2fc1a372ad55" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:to="loc_dva_DaVitaMedicalGroupMember_a5f4a668-d03d-49e8-bd48-2fc1a372ad55" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="extended" id="i8ce0d513f44f43e2b72c1ca97580e6d9_SegmentReportingAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0da88070-fc93-4050-9e56-c63faa13b25f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_ee7977d8-0578-407e-a805-2ab3771723d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0da88070-fc93-4050-9e56-c63faa13b25f" xlink:to="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_ee7977d8-0578-407e-a805-2ab3771723d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0da88070-fc93-4050-9e56-c63faa13b25f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b8990253-d104-45c6-a6c0-1c41e2e7ab28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b8990253-d104-45c6-a6c0-1c41e2e7ab28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_b2f27b73-1e02-49ba-bb41-294d2f2b4afa" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b8990253-d104-45c6-a6c0-1c41e2e7ab28" xlink:to="loc_dva_DaVitaMedicalGroupMember_b2f27b73-1e02-49ba-bb41-294d2f2b4afa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6e374fb3-8954-4d4b-9812-ae16f69f99ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6e374fb3-8954-4d4b-9812-ae16f69f99ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6e374fb3-8954-4d4b-9812-ae16f69f99ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6e374fb3-8954-4d4b-9812-ae16f69f99ad" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6e374fb3-8954-4d4b-9812-ae16f69f99ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_244dab24-e235-42bf-a117-8c3fca92bddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6e374fb3-8954-4d4b-9812-ae16f69f99ad" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_244dab24-e235-42bf-a117-8c3fca92bddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_0a01bca9-05c2-4626-ac0c-7d324176f92b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_244dab24-e235-42bf-a117-8c3fca92bddd" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_0a01bca9-05c2-4626-ac0c-7d324176f92b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformation"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="extended" id="i717e61fe929848068988c53e1e3c787b_SupplementalCashFlowInformation"/>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformationTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="extended" id="icc422d4a21434987a878591dcdd7fccf_SupplementalCashFlowInformationTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended" id="i4b4e6db9abdb4b5b878627173cc45376_SupplementalCashFlowInformationDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited" xlink:type="extended" id="i5ae04c5ca7b24ebbb73cc98f3aa14994_SelectedQuarterlyFinancialDataunaudited"/>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunauditedTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables" xlink:type="extended" id="i80e0fb47c7e14147b3daf56aa132d879_SelectedQuarterlyFinancialDataunauditedTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunauditedDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails" xlink:type="extended" id="iecfac066673440838494a167be69bf35_SelectedQuarterlyFinancialDataunauditedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3d234d52-069b-4e31-b8e9-e4407de2142c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_Revenues_3d234d52-069b-4e31-b8e9-e4407de2142c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fa7ae612-1e48-468f-9f4b-ad9833833405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_fa7ae612-1e48-468f-9f4b-ad9833833405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_0488133b-0cf3-45e8-8371-6566d4fe5cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_0488133b-0cf3-45e8-8371-6566d4fe5cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_c87c5c27-cb3a-4a70-a7f0-9aec5fc5ae40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_c87c5c27-cb3a-4a70-a7f0-9aec5fc5ae40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b8d4900d-6c7d-4a43-84b2-4ca06bc2f031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:to="loc_us-gaap_NetIncomeLoss_b8d4900d-6c7d-4a43-84b2-4ca06bc2f031" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3b97db9b-79a9-4eab-8a3d-ea4291527fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3b97db9b-79a9-4eab-8a3d-ea4291527fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_e2af8565-8da9-4a54-ba83-9d5b6dfa5a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_e2af8565-8da9-4a54-ba83-9d5b6dfa5a9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bd392f5c-78cb-477b-900f-46ed9ad65f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_EarningsPerShareBasic_bd392f5c-78cb-477b-900f-46ed9ad65f4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1b30583c-fc40-4842-b524-a4f3a3a081d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1b30583c-fc40-4842-b524-a4f3a3a081d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_4ec8cdc1-1e01-4543-b5df-23356210b013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_4ec8cdc1-1e01-4543-b5df-23356210b013" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3c5412a1-2ba7-4357-9c99-19308c54b767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3c5412a1-2ba7-4357-9c99-19308c54b767" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelectedQuarterlyFinancialInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_26a59dcc-635c-4bdc-9719-e09acb00a5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_26a59dcc-635c-4bdc-9719-e09acb00a5fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_81c268f6-954d-481b-9ed0-43112482893d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_81c268f6-954d-481b-9ed0-43112482893d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_59760b4e-9caa-4d27-a073-0fad89d5593c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_59760b4e-9caa-4d27-a073-0fad89d5593c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_890168a0-b7fc-41e4-8073-204c170332d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_890168a0-b7fc-41e4-8073-204c170332d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_890168a0-b7fc-41e4-8073-204c170332d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_890168a0-b7fc-41e4-8073-204c170332d4" xlink:to="loc_us-gaap_SegmentDomain_890168a0-b7fc-41e4-8073-204c170332d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_890168a0-b7fc-41e4-8073-204c170332d4" xlink:to="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_94cc887b-858c-4574-8522-7cd76c4f3b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:to="loc_us-gaap_AllOtherSegmentsMember_94cc887b-858c-4574-8522-7cd76c4f3b91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_37cc5985-cc0c-49ff-8666-b0d7ee3ad0c8" xlink:href="dva-20201231.xsd#dva_KidneyCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:to="loc_dva_KidneyCareMember_37cc5985-cc0c-49ff-8666-b0d7ee3ad0c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_50d19bc5-f513-459b-a8a8-5a23e0823eb4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_srt_StatementGeographicalAxis_50d19bc5-f513-459b-a8a8-5a23e0823eb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_50d19bc5-f513-459b-a8a8-5a23e0823eb4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_50d19bc5-f513-459b-a8a8-5a23e0823eb4" xlink:to="loc_srt_SegmentGeographicalDomain_50d19bc5-f513-459b-a8a8-5a23e0823eb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e08162d-63b8-4c98-9019-a81ed71c92d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_50d19bc5-f513-459b-a8a8-5a23e0823eb4" xlink:to="loc_srt_SegmentGeographicalDomain_0e08162d-63b8-4c98-9019-a81ed71c92d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_f53cf52a-782c-458d-a210-887889b4b297" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e08162d-63b8-4c98-9019-a81ed71c92d4" xlink:to="loc_country_DE_f53cf52a-782c-458d-a210-887889b4b297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_b090a9aa-3ed3-4f47-a631-5624824726fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_us-gaap_LitigationStatusAxis_b090a9aa-3ed3-4f47-a631-5624824726fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b090a9aa-3ed3-4f47-a631-5624824726fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_b090a9aa-3ed3-4f47-a631-5624824726fc" xlink:to="loc_us-gaap_LitigationStatusDomain_b090a9aa-3ed3-4f47-a631-5624824726fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fba79f71-c35c-46c3-b85a-5449c3ae7520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_b090a9aa-3ed3-4f47-a631-5624824726fc" xlink:to="loc_us-gaap_LitigationStatusDomain_fba79f71-c35c-46c3-b85a-5449c3ae7520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c00c3ad8-3fb2-47b4-b0d9-94249af5661a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_fba79f71-c35c-46c3-b85a-5449c3ae7520" xlink:to="loc_us-gaap_PendingLitigationMember_c00c3ad8-3fb2-47b4-b0d9-94249af5661a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f97185dd-d3c9-449e-a6f0-00492bf74403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f97185dd-d3c9-449e-a6f0-00492bf74403" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f97185dd-d3c9-449e-a6f0-00492bf74403_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f97185dd-d3c9-449e-a6f0-00492bf74403" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f97185dd-d3c9-449e-a6f0-00492bf74403_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_01217859-5e9f-4fe3-af03-bd1ccd5b013a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f97185dd-d3c9-449e-a6f0-00492bf74403" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_01217859-5e9f-4fe3-af03-bd1ccd5b013a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember_b8c6f666-18cd-474f-aac4-5dda80886f26" xlink:href="dva-20201231.xsd#dva_RMSLifelineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_01217859-5e9f-4fe3-af03-bd1ccd5b013a" xlink:to="loc_dva_RMSLifelineMember_b8c6f666-18cd-474f-aac4-5dda80886f26" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dva-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended" id="i3da461382757407181d7ea9d837782bb_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:roleRef roleURI="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="extended" id="iaec176c20d174de0b5ff39dc9c01d38d_SECScheduleArticle1209ValuationandQualifyingAccountsTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="i8b0b6eca70fc464a8dab64d6962579cc_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b08d7a6d-e1cf-47bd-91b8-2a9500a50b51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b08d7a6d-e1cf-47bd-91b8-2a9500a50b51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_f7b33dc1-71d2-457f-8cb9-2daed052f921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_f7b33dc1-71d2-457f-8cb9-2daed052f921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_74936e6c-aba1-47c8-aa56-4da44b705996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_74936e6c-aba1-47c8-aa56-4da44b705996" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d6291e1-34f4-4276-94c7-dd99e539f138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d6291e1-34f4-4276-94c7-dd99e539f138" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_ad04d991-4cb5-4283-9589-31f62404a6f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_3b750f96-212c-4f75-9dc4-ece3cba30b59" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_3b750f96-212c-4f75-9dc4-ece3cba30b59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6af1489a-6222-4b2f-9543-a13b084b7580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_3b750f96-212c-4f75-9dc4-ece3cba30b59" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6af1489a-6222-4b2f-9543-a13b084b7580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_6af1489a-6222-4b2f-9543-a13b084b7580_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6af1489a-6222-4b2f-9543-a13b084b7580" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_6af1489a-6222-4b2f-9543-a13b084b7580_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_78583ea0-80cf-413c-afed-ded010846df1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6af1489a-6222-4b2f-9543-a13b084b7580" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_78583ea0-80cf-413c-afed-ded010846df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_ab5734a2-291c-40dd-92ed-379b99f4ea40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_78583ea0-80cf-413c-afed-ded010846df1" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_ab5734a2-291c-40dd-92ed-379b99f4ea40" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>dva-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cb65dee0-3538-408a-90c8-cfac27791e84,g:bb413262-db44-4a11-afdc-c2a9f72b9180-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0f6aa458-060c-4552-aa57-ea567353e101_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_53665062-c592-4741-aa30-b3990c0dd8d7_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e54fbf80-95f2-470d-9a50-596bee06ed9e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f840d0ef-ce2d-46c7-93ba-11748e1a2f82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock awards outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fd26787-4ae6-4aee-831f-2a0d6ead6871_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_434bd9e3-0f93-418c-89e6-73075eef185e_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_2d318442-d9f8-4ee0-b248-dc8b234d5d99_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_facb2e3a-9bf0-4f40-82bd-17bd4a6376ab_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_fd364b19-0c31-4d1b-8c80-7ea05f4fb9d5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Equity Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RangeThreeMember_a942cdb9-232e-4cda-83c1-0f78fb5ff5e5_terseLabel_en-US" xlink:label="lab_dva_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$70.01&#8211;$80.00</link:label>
    <link:label id="lab_dva_RangeThreeMember_label_en-US" xlink:label="lab_dva_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Three [Member]</link:label>
    <link:label id="lab_dva_RangeThreeMember_documentation_en-US" xlink:label="lab_dva_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeThreeMember" xlink:href="dva-20201231.xsd#dva_RangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RangeThreeMember" xlink:to="lab_dva_RangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_44088676-6c36-476d-a3e3-6a3a9d3a3799_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AccountsReceivablePeriodOutstanding_99135c90-fc08-4b74-b9a0-551408b03685_terseLabel_en-US" xlink:label="lab_dva_AccountsReceivablePeriodOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Period Outstanding</link:label>
    <link:label id="lab_dva_AccountsReceivablePeriodOutstanding_label_en-US" xlink:label="lab_dva_AccountsReceivablePeriodOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Period Outstanding</link:label>
    <link:label id="lab_dva_AccountsReceivablePeriodOutstanding_documentation_en-US" xlink:label="lab_dva_AccountsReceivablePeriodOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient accounts receivable months outstanding to be reserved per company policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AccountsReceivablePeriodOutstanding" xlink:href="dva-20201231.xsd#dva_AccountsReceivablePeriodOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AccountsReceivablePeriodOutstanding" xlink:to="lab_dva_AccountsReceivablePeriodOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldInTrustCurrent_499f0626-f741-4216-878c-972eaf8c6b3d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-in-trust, Current</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrustCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-in-trust, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrustCurrent" xlink:to="lab_us-gaap_AssetsHeldInTrustCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EpogenMember_fb544a3a-6c5a-4817-bc4b-daf4a6204c89_terseLabel_en-US" xlink:label="lab_dva_EpogenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPO</link:label>
    <link:label id="lab_dva_EpogenMember_label_en-US" xlink:label="lab_dva_EpogenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Epogen [Member]</link:label>
    <link:label id="lab_dva_EpogenMember_documentation_en-US" xlink:label="lab_dva_EpogenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Epogen.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EpogenMember" xlink:href="dva-20201231.xsd#dva_EpogenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EpogenMember" xlink:to="lab_dva_EpogenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d4b4f213-76cd-4455-a3db-0553bf4bb4fb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab01b07-2270-4a3e-a7da-84cda83e1949_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_3e2a5aef-f001-4547-b7a5-ca091a6006ca_negatedTerseLabel_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment, refinancing and redemption charges</link:label>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_label_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Prepayment Refinancing Redemption Charges</link:label>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_documentation_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment, refinancing and redemption charges related to long-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:href="dva-20201231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:to="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8937ceb3-560d-4de6-8022-c91979a0ccc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_525e7682-a00f-4f4c-8dc8-b885ee93e0f5_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7c348f3a-f3a7-4755-a0f8-787b0aee97f6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of leased assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_3614c12a-cadd-4925-9f73-2465aa74bfe2_terseLabel_en-US" xlink:label="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service net revenues and accounts receivable</link:label>
    <link:label id="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_label_en-US" xlink:label="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition And Accounts Receivable Policy [Text Block]</link:label>
    <link:label id="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_documentation_en-US" xlink:label="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition and accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:href="dva-20201231.xsd#dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:to="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_a7d1c9ac-c51e-44c9-8092-5a254ab53a2b_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ac18495c-ae76-4b2c-9a59-ca343b000763_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7b8d5bfb-a00c-43dd-ad54-6e1f493f22c7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of assets held in trust</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8554144a-3b77-41e5-8fac-20ecd24a94a9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_d9a27f81-5434-4c5c-a7d9-9fb60760f5e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_KidneyCareMember_dc28c7da-ede1-427e-bcbd-74a3df6c5681_terseLabel_en-US" xlink:label="lab_dva_KidneyCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kidney Care</link:label>
    <link:label id="lab_dva_KidneyCareMember_label_en-US" xlink:label="lab_dva_KidneyCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kidney Care [Member]</link:label>
    <link:label id="lab_dva_KidneyCareMember_documentation_en-US" xlink:label="lab_dva_KidneyCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kidney Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember" xlink:href="dva-20201231.xsd#dva_KidneyCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_KidneyCareMember" xlink:to="lab_dva_KidneyCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4ccf0f57-11b5-40fe-8f0b-1eb50fb1976f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_66f0e22c-7b2b-4354-8b56-a6d8a1b71a95_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma diluted net income per share from continuing operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bc29319c-ac16-42e8-9098-fc8eb0f1ce7d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9bd66c1c-a324-4304-9580-48f7e0f1cc0c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_8d0ccd39-f862-4e9b-abce-89fd96c97173_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_9a8e2d73-9cdf-4eab-a210-67c68ed7e28d_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum payments due under finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c05235b4-ca7d-4bf3-bd05-d1d8013931e0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in International valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_fac12c54-abba-40f0-bd57-95d2cd54724a_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other information related to acquired intangibles and goodwill</link:label>
    <link:label id="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other information related to acquisitions [Table Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other information related to acquisitions, including weighted-average estimated useful lives of intangible assets acquired, and goodwill deductible for tax purposes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:href="dva-20201231.xsd#dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:to="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_c1ff73ea-2578-45a5-8151-67bd0b73be9d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e3096a1b-3a0e-4916-943d-2ce52636d533_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicareMember_38b54114-94df-439d-b29a-e8c87f363e02_terseLabel_en-US" xlink:label="lab_dva_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare bad debt claims</link:label>
    <link:label id="lab_dva_MedicareMember_label_en-US" xlink:label="lab_dva_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_dva_MedicareMember_documentation_en-US" xlink:label="lab_dva_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare governmental agency.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember" xlink:href="dva-20201231.xsd#dva_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicareMember" xlink:to="lab_dva_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_2d363d18-2c53-4e32-90cd-54199f692619_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_9a4ba722-ff53-421f-8c72-3d86261fb7df_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f1e1eb25-a51c-4f17-8ac6-9bc12961b607_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d0b97915-cf32-4bed-ba82-679acb06cea3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_1861d058-09d2-4bda-868b-86f91e8f1103_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_22b3bd30-139a-4983-bf4c-95c7bda531f0_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_737b6d03-d4e0-4371-b7b1-9b90a2ec9eb2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_aeb557eb-73d2-40f0-b07c-3a8527cad72e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_ff398515-bc6f-4857-a5d8-7a2275726639_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_376af812-229a-4111-abba-6f602fb6179e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_629dd63c-5426-43c6-a0c9-716aea4b2025_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets acquired, weighted-average estimated useful lives</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockOptionProgramAndStockAppreciationRightProgramMember_f40f4c57-70fd-4c61-a389-da09c4890c8d_terseLabel_en-US" xlink:label="lab_dva_StockOptionProgramAndStockAppreciationRightProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_dva_StockOptionProgramAndStockAppreciationRightProgramMember_label_en-US" xlink:label="lab_dva_StockOptionProgramAndStockAppreciationRightProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Program And Stock Appreciation Right Program [Member]</link:label>
    <link:label id="lab_dva_StockOptionProgramAndStockAppreciationRightProgramMember_documentation_en-US" xlink:label="lab_dva_StockOptionProgramAndStockAppreciationRightProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Program and Stock Appreciation Right Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockOptionProgramAndStockAppreciationRightProgramMember" xlink:href="dva-20201231.xsd#dva_StockOptionProgramAndStockAppreciationRightProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockOptionProgramAndStockAppreciationRightProgramMember" xlink:to="lab_dva_StockOptionProgramAndStockAppreciationRightProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4bfe0278-01dd-4969-b6c9-2c48ecc06805_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_dcfd8308-6b09-4dbc-b0ce-4b59c63dccff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_4b943886-5f8d-42f8-bca3-143af6565b11_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_2cbe6699-695c-46de-bba2-b511d4346c2a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_05176e5f-3771-462c-9dd9-51a831b1bdf2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1d6e8d26-a3ff-4336-baed-1728fb4434a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_dbfdac0d-91cc-4624-9eb8-2272133a486e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_9b430c72-8dfd-4047-b002-591947d4eb6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_801a03e3-5b52-42b4-9b99-7f93affa9f43_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_304caccf-0d58-4f51-a054-fe6353202913_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_b457a48e-990e-4d62-95f7-0477402ced13_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_324dfc63-43c8-450a-8b0b-57755eebd9ef_terseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_75396c3b-e2f2-491c-83b5-e4ff75edcda8_verboseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination contingent consideration acquisitions, earn-outs</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_dc87d69d-d141-46d1-856f-c63de9010f4b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_051ff837-3983-41f4-945f-fe7065408dca_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State capital loss carryforward, amount</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_6983df5c-d7e0-40ab-bd75-1ff4934921d6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock ($0.001 par value, 5,000 shares authorized; none issued)</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_a878cf77-b210-4209-b73e-ffb1b7853955_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, lower range (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_b5f2c747-aa54-494d-bca7-02f889ef022b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income from continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_63555c42-4298-44f8-9d95-901aac428b00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income from continuing operations per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_b1dbf16e-0a4c-4518-aabe-e2a0201581f1_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_eb8ce2e4-0bf9-4106-8f16-a3b4dc744aaf_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8258f607-14ed-4d08-87dd-2bd8af6b10f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d4cfd897-a2c4-4002-b445-575e3e141715_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_abed381f-c369-431a-8e19-ac3ae0486db8_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_883ff866-831b-49a1-8aaf-6e6f9ea4d318_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_459eced9-9c20-4669-af54-f16eddc2e51d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_89ed4d50-7336-4ca9-9b01-f2d7df50fd50_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_6c28f94b-c59f-4e71-beb2-b07d2661ff12_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_2385ce67-bc8d-4192-b6d8-2796c472a9b9_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_ca79faf4-814e-4e50-9cb9-969c0360171a_terseLabel_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_label_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage [Member]</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_documentation_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember" xlink:href="dva-20201231.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicareandMedicareAdvantageMember" xlink:to="lab_dva_MedicareandMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAbstract_8ab50959-6c71-4fbe-bd38-b36ca5a69b62_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares Repurchases, Table Footnotes:</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAbstract_dbf21a66-2fdd-45e9-b8a3-744a05f81225_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAbstract_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract" xlink:to="lab_us-gaap_TreasuryStockSharesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_471e3839-e75a-4b11-b951-ba78aab3e912_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_5c094649-42cf-4e5f-8c0d-9416fc3166e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_e00a46c6-5d29-4927-a051-2e0d246983ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_aaca5470-5548-45ca-81aa-55dca76d915d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_9ed66325-60ab-4dbe-996c-7b9ad1f46e7d_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Increase From Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest increase from contributions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:href="dva-20201231.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:to="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_c23b39bd-359f-4b7d-864f-8e94e45ad9a6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40e07c9e-37d5-402b-8aad-e9d1e54bae1a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terms of award (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a1aac574-0aad-412a-9303-e7c30090b472_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2f6021ba-89f7-439b-80b3-6d7285ed6212_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_def81bd9-443c-44aa-a90f-a1051e143e98_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, weighted average interest rate, at point in time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_69cc0434-7ac2-4a4a-beeb-6b4c106dd9c0_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_c66fcb31-dc95-4691-973f-96064b93613d_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7a55ca52-e502-48ee-b552-4dc7261ec192_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_2d704852-c138-4a64-bb52-5dd197ca45e3_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full share awards to shares available, conversion ratio</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:to="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a93c6e1c-1f61-4910-8ad7-c0d080a3881b_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_d78157da-a85d-4e34-a5a3-6d7387405a25_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_6bbd49b6-7286-4533-aac8-96f817b4af36_terseLabel_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities_05fda7f4-c077-4e50-92bf-18efb2b99747_terseLabel_en-US" xlink:label="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Lease Liabilities</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="dva-20201231.xsd#dva_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RangeOneMember_fcb93221-5b2d-46b6-9d3e-87523c34a58a_terseLabel_en-US" xlink:label="lab_dva_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$50.01&#8211;$60.00</link:label>
    <link:label id="lab_dva_RangeOneMember_label_en-US" xlink:label="lab_dva_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:label id="lab_dva_RangeOneMember_documentation_en-US" xlink:label="lab_dva_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeOneMember" xlink:href="dva-20201231.xsd#dva_RangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RangeOneMember" xlink:to="lab_dva_RangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_e9383477-83fa-444b-89c2-c5b592202edd_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherCompaniesMember_edfdf47b-2487-4d82-8495-543948752b52_terseLabel_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_label_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Companies [Member]</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_documentation_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember" xlink:href="dva-20201231.xsd#dva_OtherCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherCompaniesMember" xlink:to="lab_dva_OtherCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_b2e014b6-e8dc-48b9-8ea2-4370ff44d56f_terseLabel_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_label_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_documentation_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:to="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8387835c-d117-4457-bd40-a594113b2975_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_19fcf120-1888-4aad-a694-3514ee3261eb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_720c43e8-126c-4776-90eb-d6efa34783d7_terseLabel_en-US" xlink:label="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_label_en-US" xlink:label="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_documentation_en-US" xlink:label="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:href="dva-20201231.xsd#dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:to="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_9f5d6d4a-cbcc-4a15-b4ce-3b9a67fe3032_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_0b69e259-df57-4aed-a273-446123cf6a1a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_b5ef4efa-1df1-451c-869b-58ba600c5940_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_40c768f5-d128-4b0d-a0dc-b4c7b8730f6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_36fde3dc-9e2d-40cd-977d-5220e264036d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeconsolidatedNoncontrollingEntityMember_ddd2282d-9a28-4a30-83b6-6d2634671a9a_terseLabel_en-US" xlink:label="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC JV - Deconsolidated Noncontrolling Entity</link:label>
    <link:label id="lab_dva_DeconsolidatedNoncontrollingEntityMember_label_en-US" xlink:label="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidated Noncontrolling Entity [Member]</link:label>
    <link:label id="lab_dva_DeconsolidatedNoncontrollingEntityMember_documentation_en-US" xlink:label="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidated Noncontrolling Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember" xlink:href="dva-20201231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeconsolidatedNoncontrollingEntityMember" xlink:to="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_cba3522f-d734-4e86-adf3-ce3aa8599a86_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reporting Units Goodwill Balances</link:label>
    <link:label id="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reporting Units Goodwill Balances [Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reporting units goodwill balances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:href="dva-20201231.xsd#dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:to="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f1c9a321-e939-44f3-babc-c3186bb2a3ed_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c815e46f-4852-471c-8938-5ab08768cb58_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_5147c717-3bc7-4aec-aec0-c0ea170640d0_terseLabel_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_label_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_documentation_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:href="dva-20201231.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:to="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0eab9064-72b0-4431-a242-4ca89be360ed_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties related to unrecognized tax benefits, net of federal tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_fd7a9cf9-c9df-4d77-8e83-38c6779d2a87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized under the plan</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5a9b6bdd-5620-4613-b017-59d916045edd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember_94ed9e42-3943-4e5a-8e69-760dc5d62e7d_terseLabel_en-US" xlink:label="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company and Restricted Subsidiaries(1)</link:label>
    <link:label id="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember_label_en-US" xlink:label="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company And Restricted Subsidiaries [Member]</link:label>
    <link:label id="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember_documentation_en-US" xlink:label="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent company and restricted subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:href="dva-20201231.xsd#dva_ParentCompanyAndRestrictedSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:to="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPensionPlansDefinedBenefitMember_be873264-6a53-42f1-af25-f2b5e36ade3b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DaVita Voluntary Deferral Plan</link:label>
    <link:label id="lab_us-gaap_OtherPensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_6d3af4fa-7d0b-4139-9fe0-ed2d186220ee_totalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive income into net income net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_24ee57fa-aecc-43c7-86eb-65c77c379bdc_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_08e7756b-c177-493e-8040-39efcd9b89c7_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_52969dbd-4f8b-4eaf-a223-bd2b642dd551_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_e4c0faa9-3a3f-4f24-a5b9-f370f459de76_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_InternationalOperationsMember_05c28680-6472-444e-90eb-1d2e7d62cea9_terseLabel_en-US" xlink:label="lab_dva_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Operations</link:label>
    <link:label id="lab_dva_InternationalOperationsMember_label_en-US" xlink:label="lab_dva_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Operations [Member]</link:label>
    <link:label id="lab_dva_InternationalOperationsMember_documentation_en-US" xlink:label="lab_dva_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InternationalOperationsMember" xlink:href="dva-20201231.xsd#dva_InternationalOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_InternationalOperationsMember" xlink:to="lab_dva_InternationalOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_9fb7e878-d63c-4c63-9533-c4cf6380994c_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_bd981d03-2a95-455e-8061-4ca192cd402d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments and other investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_a4395bf8-e118-4606-b925-de312a8df749_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, deferred purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_df351eb9-24a9-40bc-9816-34ee3513a815_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_9831a064-e93f-42b6-8859-ae5e5f546b71_terseLabel_en-US" xlink:label="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible executive compensation</link:label>
    <link:label id="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_label_en-US" xlink:label="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Investment Impairment</link:label>
    <link:label id="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_documentation_en-US" xlink:label="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Investment Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:href="dva-20201231.xsd#dva_EffectiveIncomeTaxReconciliationInvestmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:to="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_f65acb02-be08-4b9e-8905-b0becb7c9f1b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap and cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_518097ee-40ef-42e7-a89b-b2f8688105e9_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual&#160;life</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_c96df6e6-fd7b-43a3-b27d-89fc16dc3adf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, effective date</link:label>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_label_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Inception Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInceptionDates" xlink:to="lab_us-gaap_DerivativeInceptionDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_84a2c6ce-e5a7-48c5-b655-04f10a088782_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ac1ff38d-c110-4100-bb1d-0e85f87cc38e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_369bb4e1-dba2-4aad-af2f-2ff954df0418_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_72c8a332-47bd-4ec3-afb3-b952b2e2a799_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_735b52ac-61f3-42c8-9337-6cc06a3546be_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_67c75aa8-0a60-4a22-9b5d-8a51219c34ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e45d2895-a689-4da3-82ec-520fbe015ce5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_32415309-7f4c-4dfe-8751-a82e63614c50_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_4cb14779-7963-4fd6-9e55-79dfe6689f41_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_49587ffc-d3c8-4ddf-b11b-ceb119c52b35_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Expense Components</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock_b43c76d1-a8ef-4d86-86dd-8ecbd391fa51_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Minimum Lease Payments</link:label>
    <link:label id="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Minimum Lease Payments [Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of minimum lease payments under non-cancelable operating leases and capital leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:href="dva-20201231.xsd#dva_ScheduleOfMinimumLeasePaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:to="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_7cf7d1a3-e6bd-477e-8bf8-289f99763464_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of long-term debt, net of unamortized discounts</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4bd1dc03-37cd-4861-9614-f41ae731e8bf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f6ed14f5-1fc0-4119-9a60-fbf1d6f76758_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_23bcc720-2ed2-4337-8f7a-6dcebc2d07c2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_a9f19496-a338-4ea0-83fd-756e878a8dbe_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAbstract" xlink:to="lab_us-gaap_RestrictedCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_34c7d501-ab94-403d-9602-0e3357adde2d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0b0a8136-e8f3-45f2-a695-2ac4e0e001c6_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Total</link:label>
    <link:label id="lab_us-gaap_Assets_dcd90324-1625-4c85-b665-585b64e0f23a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignDialysisCentersMember_e5263a24-4fc0-4cb2-8406-8cc8b16a5b6d_terseLabel_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_label_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers [Member]</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_documentation_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign dialysis and other medical businesses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember" xlink:href="dva-20201231.xsd#dva_ForeignDialysisCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignDialysisCentersMember" xlink:to="lab_dva_ForeignDialysisCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_17d525be-d86f-4b51-9e56-ed5c195f1ecf_terseLabel_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_label_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_documentation_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:href="dva-20201231.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:to="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7af83cf1-4f2d-4fd7-8d52-35c720036225_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_5716c02b-0b20-4c26-95e6-c3d311f5ab66_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d6125c7a-7ad4-471c-8cf4-9624974ca31f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived licenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4de2b1f8-10de-487e-9659-273a639b7b89_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51fabd28-ebb5-4724-a8dd-356e731b7b2b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_60705ea5-94d7-4beb-bf7b-dbacd15b68e9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Date of Acquisition Agreement</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Date of Acquisition Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_92540f2b-2de8-46bf-b356-2b32b2800228_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan, distributions</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Distribution Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_740b1439-794f-4c21-92da-21294fdc7403_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed295ee8-9aff-4331-8951-2a8d8951235c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_926e86b0-e351-4562-b63c-3b2a779b145c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangibles</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_5325de9d-0e46-4d5f-98ae-60d55236d613_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_0d9e2fda-00d1-4c4d-ab58-6cd5c633d31e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, effective date of acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Effective Date of Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="lab_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_27872772-5fe6-42a0-917f-ef0c5b246351_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_06b73777-de8c-43de-9525-ce8dbf761b0f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_66768f0f-341e-45f1-aa6c-7e7dfbcb7fd2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_f28d5716-3210-4c72-926b-7f4de29fa4d1_terseLabel_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_label_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_documentation_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election Effective date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:href="dva-20201231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:to="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_012940e8-cf7e-4394-8af9-c4df1cabe7cc_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_fe967f94-5fb5-48e4-8d17-6f63db1c7d39_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIssuanceDate1_a294dd8c-11f8-43a1-a036-bbab5fbea74d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Issuance Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIssuanceDate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Issuance Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIssuanceDate1" xlink:to="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e67c88e7-d0c3-42be-a945-8b5f9441e52f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_985d8168-9873-4776-bcee-2ee2f2aa246f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_0c7937ed-e424-46b4-bf61-33fe8b1ee62c_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_91833459-feb4-4083-839f-6a23d91758fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less portion representing interest, operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_bd60eac7-ad86-487d-ab13-afc041fb4d6b_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other - Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8aab0e98-5e31-4aab-aefc-de38de15ed23_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_17833f88-47f3-4a82-892c-8f0dc6229d94_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;prices&#160;in active&#160;markets&#160;for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2dbfd797-9334-41c5-9537-f4b511de1699_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_cee9bbda-c227-4479-90ea-64cc0b4c53c7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_6d27906b-6696-4f38-aae0-aa4f1e7d2659_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states where dialysis centers are located</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareRepurchaseFeesAndExpenses_84498d6b-a53d-40f3-b269-25caa579540f_terseLabel_en-US" xlink:label="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Fees And Expenses</link:label>
    <link:label id="lab_dva_ShareRepurchaseFeesAndExpenses_label_en-US" xlink:label="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Fees And Expenses</link:label>
    <link:label id="lab_dva_ShareRepurchaseFeesAndExpenses_documentation_en-US" xlink:label="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Fees And Expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareRepurchaseFeesAndExpenses" xlink:href="dva-20201231.xsd#dva_ShareRepurchaseFeesAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareRepurchaseFeesAndExpenses" xlink:to="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_15cd171f-3da1-4f96-93fa-7cc9b58de346_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_bb856450-d317-4af4-8a07-80ededd0ad2a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance related to changes in the estimated tax benefit of foreign and state operating losses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_1dea013c-4635-4b83-bb93-a073314dbbf6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_87c8993a-82c3-4ee8-b2a5-2dbd1f241440_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_86eddfcf-d915-417f-b5ab-32c29ee342b8_terseLabel_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expenditures for Property and Equipment by Segment</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_label_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_documentation_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of capital expenditures for property and equipment from segment to consolidated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:href="dva-20201231.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:to="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_fe2b0352-9c31-4398-85fe-7aaa4b709129_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Added by performance factor (in shares)</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_952a410f-e593-4c32-8672-9879c14a0dd0_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Second Year</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_40df30fa-443e-4a50-8113-da1c5ca15828_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income from continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_76041b87-99a9-4db5-8d6e-4dbda2450bd7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_f0a48a7c-9976-4e51-8f3b-5da68df9aa3b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_5d159968-037c-43a7-b861-f84aaeb41ef4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from asset and business sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_9aac46fb-265f-4dc0-8c1f-8b1e4575d917_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and Information Systems</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_6eb59569-47ea-44fd-b5fb-a1aa2bf3e30d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value estimates</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_b5f0c38a-3b57-4194-a854-30445419c1e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_12a701c5-eaf2-41d9-b4b5-0a6e527f513a_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_52263dce-1abe-4d79-8961-664269637cd3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_18e8cc76-1c2f-471c-b4a9-f972450f2792_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_53849e63-f91a-4b9b-afdd-d0ee796ad623_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_6ec1ef7f-8579-4a0e-a627-52c0461649ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_b981c44c-ba9d-43e0-847d-898405852301_terseLabel_en-US" xlink:label="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</link:label>
    <link:label id="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_label_en-US" xlink:label="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Table Text Block]</link:label>
    <link:label id="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_documentation_en-US" xlink:label="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure Table Text Block.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:href="dva-20201231.xsd#dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:to="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RMSLifelineMember_a9748da6-a7bf-4718-9466-174f71644160_terseLabel_en-US" xlink:label="lab_dva_RMSLifelineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RMS Lifeline</link:label>
    <link:label id="lab_dva_RMSLifelineMember_label_en-US" xlink:label="lab_dva_RMSLifelineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RMS Lifeline [Member]</link:label>
    <link:label id="lab_dva_RMSLifelineMember_documentation_en-US" xlink:label="lab_dva_RMSLifelineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RMS Lifeline.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember" xlink:href="dva-20201231.xsd#dva_RMSLifelineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RMSLifelineMember" xlink:to="lab_dva_RMSLifelineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_f5acda13-e95a-4950-babd-c07b835fe365_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_ab0a9387-732b-4c14-9b46-cd5e17c07f93_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_45489b38-2b52-4c45-869f-e8bf1b8b1fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_2ba89ff5-b798-4208-90ba-207292187083_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a2e92517-7767-4c2c-bdb5-db03f9efd068_terseLabel_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_label_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_documentation_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization consolidation and presentation of financial statements disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:href="dva-20201231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e3753fd3-32de-43c2-a8dd-d55bb6ca201d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f510bba9-8f87-4160-8b71-35ea78365e96_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ad4e5eaa-c536-402b-b653-e755e3314d4c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e4faed76-e0cb-43cf-8069-b6b08ed78745_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_103acde4-b404-495c-8f5d-f98d49c35de2_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_4cc0445d-648f-4c9c-a81d-92d9137b16ca_terseLabel_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out consideration payment period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_label_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Revenue Earnout Period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_documentation_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition contingent consideration revenue earn-out period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:href="dva-20201231.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:to="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_315a3e81-21bb-4701-9aca-a01f1b25839e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9d5bfd9f-1619-41b2-946b-570b5d68d996_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting Interest, in percents</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_ee7a7be7-2ef2-4840-919f-df8a70e5ffc0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award exercises and other share issuances, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_637bcaf1-77cd-4d46-9dec-4558f5053662_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross, total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c1d2f222-ff6b-4c38-8737-12a70c3a2f75_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed incremental shares from stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2a193fc5-c852-43bb-b4d7-056e1a6033f5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_d3da2cd2-245f-4ec8-ab94-9c13a1bc89f1_terseLabel_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_label_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sources of Revenue [Member]</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_documentation_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember" xlink:href="dva-20201231.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherSourcesofRevenueMember" xlink:to="lab_dva_OtherSourcesofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_bc7f38b5-26e7-45a0-ae20-3ad3cfda33c9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances and Reserves Type</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_79bc9820-4d88-4c52-b204-7b5f97bf7c4e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_08618ee1-e0a2-446d-808c-0e720363af7e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6141f63c-8734-4f73-8886-79eea4a02a29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_ac5b3328-7314-4274-8346-fb7469e4cd88_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="dva-20201231.xsd#dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac5c4785-68ec-4f2c-8f2c-0cebe09b658e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_235663e6-2047-4ecd-9d7c-47f9f8d0da00_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and self-insurance accruals</link:label>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Insurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInsuranceCurrent" xlink:to="lab_us-gaap_AccruedInsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d2739552-5766-4dbe-9739-afbfaddaffa8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_86de6871-75bc-43e7-a0ae-3b316c83b9fb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_d74a946e-eac8-46c2-baa5-f1d0b75f4b7d_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities from discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_74b1d44d-1e80-4b50-98fd-e5ac7925b0f8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2e583fa-866a-4bd9-9ec1-6b439725404a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_5a890102-cbf2-42bc-9e4c-f2f5f1aeae95_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_76881f01-ad6a-4a84-9dd1-19c28562e0f4_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_6704b0fb-0ac4-41c1-9287-b70029468d7a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_3e87ecb0-9c6a-4075-a2fd-9a0c56208668_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_2b30a6dc-59e4-4d02-aa38-7c6a262df39f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_7a23cbe3-42b4-428e-848c-88fcca3cc879_negatedLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments or other settlements</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Earnouts Payments</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Earnouts Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_876a1fa4-612b-4273-a7ed-a87240c2d4f0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_879e3d43-6ad4-49cc-88f0-cf0c0a4df0f6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenditures for property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_74b4ae1f-9e4c-4942-81ff-7fb2a99a63d5_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_19980904-c44e-4a27-8cf9-eb13cfdbf80d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_2d26bed1-443a-4396-ad30-1fbe067aa693_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_c97379b9-3bec-49c3-a7ab-f422594b2e84_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_96412f80-6834-4c6e-942b-0186ecc8af7d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment (income) loss</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_17c8900f-d5b4-4a42-910b-77a351b7b2fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment (loss) income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_269bf3ee-fbe6-43c0-8b2e-ac97bee29198_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_334ba55d-1381-43db-8da2-ee62ae5d09f9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_7cf84147-130f-41b5-90da-0429e6791b41_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_c12fd15a-0510-4f0f-af1d-ced6bd42745b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_4abdbff2-2aed-48e2-a6ae-1539b502e7d6_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_db83929d-e9c2-443d-a5d3-b95aed46b2b9_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_63d85b1b-ce9b-4587-b782-b604d81bce79_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_6ad3e86f-1019-4f71-9b1a-ba7e77f020fc_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_c91a6539-66f2-4a29-8784-1ae18d9bfb63_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_5dcaad13-e55b-4c7a-b61d-32dc23f871d2_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Quarterly Financial Data (unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_196a14e7-0ddc-4a5a-b9ac-92363ac6ed5d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_62e4a064-f70e-4a43-b3ce-c29e6e828416_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_ef9d5409-1fd4-4708-82a9-949b22eafa0e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, and equipment useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureLineItems_02ba97a7-be3f-4d3a-9142-42b6e267ee5a_terseLabel_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureLineItems_label_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureLineItems_documentation_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:href="dva-20201231.xsd#dva_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_36b4682e-1663-4589-9a2c-5542b53f2e77_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_fb86a218-6a0e-49c0-b371-a7a2c7ce4bfc_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected quarterly financial information:</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_e8f1c9d0-11ef-44f9-93d4-491db1bc33b7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d89c3634-89df-4ce3-b9e9-b8b614eb62e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_4cd2eabc-1099-47f3-815a-71a656d12f32_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_f9d14e8a-aa2f-4981-9542-f1b8ee113fd3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_5157a403-ebac-4f0a-9d76-0f26a35fcd1e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_d7a071a6-6303-42c1-b67e-7a73ba9c3d77_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa39c439-295b-42c6-984e-0530bd598253_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_3d63cce0-06b2-4c2a-96fa-9abcda5aa88e_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of individually immaterial business acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_33c7eda6-9d40-4551-97be-6d23479d5c4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncomeTaxesLineItems_0e28f10e-0d74-47fc-913f-64c57a7c3ac4_terseLabel_en-US" xlink:label="lab_dva_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_dva_IncomeTaxesLineItems_label_en-US" xlink:label="lab_dva_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_dva_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_dva_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems" xlink:href="dva-20201231.xsd#dva_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncomeTaxesLineItems" xlink:to="lab_dva_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtRefinancingCharges_cb8ac13d-ffcc-423a-a2af-47a0556584ce_terseLabel_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment, refinancing and redemption charges</link:label>
    <link:label id="lab_dva_DebtRefinancingCharges_label_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Charges</link:label>
    <link:label id="lab_dva_DebtRefinancingCharges_documentation_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment refinancing redemption charges related to debt modification of long-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtRefinancingCharges" xlink:to="lab_dva_DebtRefinancingCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_875d5b54-0fd4-45c2-aa1b-fea99176f4f6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_3a5ba6a0-348a-44c9-9278-1ee429e564ac_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9c6d6790-bb4a-4d8b-8b05-9d7ba6e0f83c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommercialPayorsMember_29a5ad10-612e-4a3d-a19b-0be548fc54eb_terseLabel_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_label_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors [Member]</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_documentation_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember" xlink:href="dva-20201231.xsd#dva_CommercialPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommercialPayorsMember" xlink:to="lab_dva_CommercialPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_a80fa371-da05-4046-8e6b-0eac3217d8ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Changes in Contingent Earn-Out Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_60977088-9c25-4b72-90a3-c055bb76fd7d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Interest Rate Swap and Cap Agreements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c00ba67d-4ff2-4c08-80e3-6e6b2d1c3af0_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6beab855-1c91-4236-885c-2beac8bf914d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted Average Valuation Inputs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_4163c1e3-7364-4918-b133-714225a6e130_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent of match</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_b831dc49-d298-4374-bce9-2c6f1ccbd58a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_702336b2-d400-4bf1-a168-b584614ba602_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maturity date, description</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_3ee42920-fdd2-4aff-a1d9-cee3bf85d65b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_12fa1ae6-b4cc-48af-9dd9-9ab93278800c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfPartnerships_c9721c21-3c9d-46b8-a284-54989c4b066d_verboseLabel_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_dva_NumberOfPartnerships_2df4f26a-4a2c-4569-b50e-a81652ad7944_terseLabel_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of partnerships</link:label>
    <link:label id="lab_dva_NumberOfPartnerships_label_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Partnerships</link:label>
    <link:label id="lab_dva_NumberOfPartnerships_documentation_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Partnerships that are included in the Equity Investments category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships" xlink:href="dva-20201231.xsd#dva_NumberOfPartnerships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfPartnerships" xlink:to="lab_dva_NumberOfPartnerships" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_c0b9e9cf-ca3a-4ac6-a00a-61709ea5d575_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a926e7bb-ec9f-4a81-aae0-01f15841e0b7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_69a2eef5-a860-438f-8e76-196d89caff30_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3507dfd5-72d0-4ec4-a1d3-69d1d54c65c9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_064dc264-bdae-45f0-85ef-6ea092ff5336_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_a8edb581-535d-4cc5-8450-55d7eab63e93_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2fe1a726-7308-41e5-b787-77bd976bf059_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a7c2a3f9-627e-44c0-a954-b7a3ebc24073_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_56544bd8-53d4-495f-aec1-f1a040b4ed18_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_7e7000c7-8593-4841-9c86-ef2f5effc042_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_00917cfe-0d53-457a-bd37-2891388c1ae9_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5d660667-5207-49b4-a2fb-ca519bae4d6d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_e070cf99-92b5-4f8b-98f8-973f1c831ec2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_f23d73a3-ec6e-46d5-9613-16be1c72ec7f_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b54bad6a-8ac3-4437-b506-6a94227f3dd5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9e59a62d-2cb8-4e24-be5f-2684160a31fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_def8aa45-fd57-4cda-9dff-9a9f2d8903a3_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less portion representing interest, financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_038ab72d-cfe4-4e3e-8ed4-e3d75a027d9b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of ordinary dividends, common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_b5714e5f-6a82-40c3-a48f-f576280e3ab4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_0fa23555-aa7c-4e31-ae62-230abae64857_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted cost method investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_70c11ce0-4a9c-4653-999c-22e3994772c7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_460c287e-b75c-4280-b085-0f3f5faaaa19_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder's equity</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_bcb3cb0c-fc8c-480a-af93-2c58b6363dcb_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_FinanceLeaseAccumulatedDepreciation_7dd02457-b486-40e1-8da1-b600ad73ad49_terseLabel_en-US" xlink:label="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Accumulated Depreciation</link:label>
    <link:label id="lab_dva_FinanceLeaseAccumulatedDepreciation_label_en-US" xlink:label="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Accumulated Depreciation</link:label>
    <link:label id="lab_dva_FinanceLeaseAccumulatedDepreciation_documentation_en-US" xlink:label="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Accumulated Depreciation, contra asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseAccumulatedDepreciation" xlink:href="dva-20201231.xsd#dva_FinanceLeaseAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_FinanceLeaseAccumulatedDepreciation" xlink:to="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_58e68d56-9fc5-4852-8598-821dcd3303e3_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_00e0e320-b122-4a5d-9a3c-9b544fe7cbee_terseLabel_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. dialysis</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_f0e03f88-246f-4c02-84d1-20a3698ee08c_verboseLabel_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Dialysis And Related Lab Services</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_label_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Dialysis And Related Lab Services [Member]</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_documentation_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US dialysis &#8203;and &#8203;related &#8203;lab&#8203; services&#8203;.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:to="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_09e954f7-deee-45c6-9d49-d9e121d5015e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_7af5f4d3-939c-4940-849d-624801ee5e1f_terseLabel_en-US" xlink:label="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount coverage</link:label>
    <link:label id="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_label_en-US" xlink:label="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit Percentage Of Fair Value In Excess Of Short Of Carrying Amount</link:label>
    <link:label id="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_documentation_en-US" xlink:label="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting unit percentage of fair value in excess of short of carrying amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:href="dva-20201231.xsd#dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:to="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOwnershipInterestMember_b0e36535-3d66-401a-b6f6-9276f1f81f82_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOwnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other equity method partnerships</link:label>
    <link:label id="lab_us-gaap_OtherOwnershipInterestMember_label_en-US" xlink:label="lab_us-gaap_OtherOwnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Ownership Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOwnershipInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOwnershipInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOwnershipInterestMember" xlink:to="lab_us-gaap_OtherOwnershipInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_0acd570d-324e-457d-8f1c-eaadd3ede32f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_2d2a2fa8-464d-4479-ab42-a6a655d35f52_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5f113799-0e22-4135-9d0b-dc048ec66f72_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchase price as percentage of fair market value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_a010fb4c-8483-46d1-9449-99264d0186c4_totalLabel_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_label_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_documentation_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:href="dva-20201231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:to="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_ac0d172b-6ac7-4cdc-8604-75aea98d2238_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6ff72b52-5bed-4660-baf2-4049ab2b3221_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_9fbaa6be-d4b2-4d11-9283-777a7ec3916d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_652f2ff7-c08e-4cbb-a1b5-056a8298b899_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6d5371ae-44fb-476f-a41a-74099eaee927_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_71406223-db7b-4b21-959b-d98b18ecce1f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PaymentsRelatedToStockPurchasesAndAwards_2eef779a-1ee9-41e0-9722-942c6579ff75_negatedTerseLabel_en-US" xlink:label="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (payments) receipts related to stock purchases and awards</link:label>
    <link:label id="lab_dva_PaymentsRelatedToStockPurchasesAndAwards_label_en-US" xlink:label="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to stock purchases and awards</link:label>
    <link:label id="lab_dva_PaymentsRelatedToStockPurchasesAndAwards_documentation_en-US" xlink:label="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to stock purchases and awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:href="dva-20201231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:to="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_fb516408-4926-43f9-9530-3c5297833f37_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_905a968d-f6c6-46a6-b9b5-4ff66191cc6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Value of Goodwill by Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4aa8160a-c560-4fc8-b528-76343a98c2d6_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_b972ec67-6921-46d9-9b72-1263f23cf37d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_42658a14-60eb-435b-b253-edfadc0c37ac_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_1a655942-993d-470b-89ed-ad1ee1a27a9b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale and Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_816ccaef-f1f6-4936-b428-210a79daa190_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8f817f97-b757-43fd-ac37-fffc12a3bf30_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_727dcc0c-e6cd-478a-a84c-0362d4b4ba70_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_17bc152f-df5b-46de-83a9-c1fa5f2812f0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_ddedda41-2067-4d60-8763-2318f5f6e738_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled Amortization Charges from Intangible Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7cd15f7a-e55f-4c8d-b514-4e5f3410ba02_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6a0c4630-7f11-4b5d-bd5d-9ee340f82436_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_f8bda17c-111b-41d7-bad3-7839df8a45b4_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReconciliationOfCashFlowsTableTextBlock_d3b1a236-23c9-423a-ac97-50de712a0f9f_terseLabel_en-US" xlink:label="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Cash Flows</link:label>
    <link:label id="lab_dva_ReconciliationOfCashFlowsTableTextBlock_label_en-US" xlink:label="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Cash Flows [Table Text Block]</link:label>
    <link:label id="lab_dva_ReconciliationOfCashFlowsTableTextBlock_documentation_en-US" xlink:label="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Cash Flows [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:href="dva-20201231.xsd#dva_ReconciliationOfCashFlowsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:to="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_02bcc26a-2004-47e8-b863-3e601a51ffd4_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_049e320c-3b8c-41ed-9707-99727fd2f82f_negatedLabel_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivities, Discount rate</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_label_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Basis Point Increase In Discount Rate</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_documentation_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Basis Point Increase In Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:href="dva-20201231.xsd#dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:to="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_157169fd-8fbe-41e4-84e8-45bfced4d6f4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_d526ab39-bda1-4970-bb09-652345507c69_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c8fdd44a-fb53-4b3e-9889-7e9710807aea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ef0e6b7a-7941-41ca-8fc2-3e4d680c87e5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_ee5827ec-bf1a-4393-b6b1-68b988b74b24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Range of Exercise Prices</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_098b371d-fd16-428f-9297-87032b50adfc_terseLabel_en-US" xlink:label="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation</link:label>
    <link:label id="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_label_en-US" xlink:label="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation</link:label>
    <link:label id="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_documentation_en-US" xlink:label="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law limitation. The Company is subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period three years following the date on which that stockholder became an interested stockholder.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:href="dva-20201231.xsd#dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:to="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_26198379-f98e-435f-ac96-e73b6a593684_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7276fd54-9b88-4851-ae13-abb1faed586c_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_b5989701-82c5-41ef-9f3c-8ebd1c65eb02_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9cca5cba-1cd5-4ec1-946d-3a4704ff3bb0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_8599d0fe-8620-421b-9a47-4bf98aee7083_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock ($0.001 par value, 450,000 shares authorized; 109,933 and 125,843 shares issued and outstanding at December 31, 2020 and 2019, respectively)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8f1118a9-e422-4c21-9629-032421c0482d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a174a112-8d8e-4682-a36c-452941ee89d0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_1202e20c-0106-464c-b6cd-a42a899f3024_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:to="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_38328352-f3df-43b9-9fe5-27809475866a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_91ed0660-350d-493c-bfe0-30a3c8d68d4e_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redeemed Outstanding Principal Amount</link:label>
    <link:label id="lab_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_label_en-US" xlink:label="lab_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redeemed Outstanding Principal Amount</link:label>
    <link:label id="lab_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_documentation_en-US" xlink:label="lab_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redeemed Outstanding Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount" xlink:href="dva-20201231.xsd#dva_DebtInstrumentRedeemedOutstandingPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount" xlink:to="lab_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_d2141cd7-5c8e-4af8-afa9-812f4cb6eb67_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_1bf83759-1f03-4485-9821-74ff256f621a_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions related to settlements with taxing authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_1fb7ebe8-72c7-47d2-ab4f-45b5ec14903c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_5f129b2e-8bb8-4f60-a2fe-4a24d8253e2d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_749d7e2d-47af-486b-9d23-68bfbc0d35cd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_ad024bcc-3dc0-4e7d-99cd-9cd02802ddc6_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable, fair value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:href="dva-20201231.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f80771c7-c5cd-46e8-80b0-00fa3964b813_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_8fefaba4-ad33-4e69-a357-fa3a7303a396_negatedLabel_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables and other current assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_label_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Current Receivables And Other Current Assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in other current receivables and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:href="dva-20201231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:to="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_5058ab80-fe0c-4a4c-a417-c2eae6f3c666_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_14276cbc-e265-405d-b32e-2f5fe4b422e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_89311e92-15b6-4342-80a6-c41e12e3279a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ee93bd35-6d33-4b21-9787-cce0116fc969_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e3210a3f-4edf-4118-8e87-edb81c91f453_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_6328072c-6def-4a00-961b-1628a03084e6_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:href="dva-20201231.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:to="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_e5cc4583-aa19-46c2-a83e-00b317e1f4a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DMGAcquisitionsMember_ab27cef5-baa6-4afb-95bd-ed14c9f49dea_terseLabel_en-US" xlink:label="lab_dva_DMGAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG Acquisitions</link:label>
    <link:label id="lab_dva_DMGAcquisitionsMember_label_en-US" xlink:label="lab_dva_DMGAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG Acquisitions [Member]</link:label>
    <link:label id="lab_dva_DMGAcquisitionsMember_documentation_en-US" xlink:label="lab_dva_DMGAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DMGAcquisitionsMember" xlink:href="dva-20201231.xsd#dva_DMGAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DMGAcquisitionsMember" xlink:to="lab_dva_DMGAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2812fb97-783c-48fb-83af-f186d9bf3a8a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_e922e4ce-8bbf-42be-88c6-641c7d03f43c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ProvisionForExpectedCreditLosses_c0e2aa37-5710-4daa-a2d3-09b0d5dcd313_negatedTerseLabel_en-US" xlink:label="lab_dva_ProvisionForExpectedCreditLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for uncollectible accounts</link:label>
    <link:label id="lab_dva_ProvisionForExpectedCreditLosses_2b88a372-344e-4ec4-a04e-f42ec0a7943b_terseLabel_en-US" xlink:label="lab_dva_ProvisionForExpectedCreditLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for uncollectible accounts</link:label>
    <link:label id="lab_dva_ProvisionForExpectedCreditLosses_label_en-US" xlink:label="lab_dva_ProvisionForExpectedCreditLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Expected Credit Losses</link:label>
    <link:label id="lab_dva_ProvisionForExpectedCreditLosses_documentation_en-US" xlink:label="lab_dva_ProvisionForExpectedCreditLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Expected Credit Losses, contra revenue account.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProvisionForExpectedCreditLosses" xlink:href="dva-20201231.xsd#dva_ProvisionForExpectedCreditLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ProvisionForExpectedCreditLosses" xlink:to="lab_dva_ProvisionForExpectedCreditLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5feeba8a-57e4-460d-8b40-9bdd36049ba6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_d6ebbf9b-b35f-4979-9705-96c7822f7134_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_44ed2994-55c4-4141-a185-d1ae8840ccce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7ad217e2-e710-4b46-a4a6-0bdbca5ec1a6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c3d134fb-cce2-4d16-99d4-8b6619164138_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total DaVita Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_271f8d05-ba02-4b9f-ae82-188381da4382_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_24eaca1e-5502-4e80-a0cf-714a495b9e4f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3f1c98fc-e80a-4dfa-abff-e3e0ec323e82_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_268edbbd-c273-4593-92bd-95014852acfc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_74ba3a46-76e9-40c2-a1f1-5ee4267ab487_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_35f2b0b6-cd6f-44d4-8ed6-3ba5a515b30f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_5a39a8d1-d788-445b-9f61-94da7b8c1566_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d871bd35-e7b3-4cc6-968f-a39452fe2c64_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum percentage of employees' base salary to be maintained into deferral account</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_863604ce-33b6-4e3f-9cc8-b8816364280f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_608dc2ad-4d15-4e28-9a2a-8db81a2a893c_terseLabel_en-US" xlink:label="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions used to purchase shares, employee-related current liabilities</link:label>
    <link:label id="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_label_en-US" xlink:label="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares</link:label>
    <link:label id="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_documentation_en-US" xlink:label="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:href="dva-20201231.xsd#dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:to="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_36f6911d-dfb1-4376-8782-8e6a81c09414_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests subject to put provisions</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_label_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_documentation_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests Temporary Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:href="dva-20201231.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:to="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9d482d2c-d20d-4c5b-8855-f5ddc598006c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_09a5c7d2-d5a6-47a3-a5dc-28d1a4641a85_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and other</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_6ce08a16-d342-479d-b1b1-85eaf52d52c3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt_d91a37f9-1288-4355-bcec-9ac858ff0487_terseLabel_en-US" xlink:label="lab_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Financing Outflows Related To Extinguishment Of Long Term Debt</link:label>
    <link:label id="lab_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt_label_en-US" xlink:label="lab_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Financing Outflows Related To Extinguishment Of Long Term Debt</link:label>
    <link:label id="lab_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt_documentation_en-US" xlink:label="lab_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Financing Outflows Related To Extinguishment Of Long Term Debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" xlink:href="dva-20201231.xsd#dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" xlink:to="lab_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7e46fc9d-0560-4f55-bed3-24b609d1e28f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_c2fc856b-0c0e-4694-ba0d-08c4ea6c2cba_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_7d8e8547-5378-42f8-9ed8-8cbc9672618e_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_ab9fad5a-6d68-4370-a35f-d7382dc7aedb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_b1efa91f-101d-4ebf-8c81-f0f6446b7050_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e6e28d3e-b64b-4d7a-a94f-8e08a1c690d3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77039f2f-9128-4844-84e4-84ac48c3825a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_d3846998-b4b0-4443-89cc-3a4e5b5cb05e_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_db48273f-4326-485b-9607-1d10ad161ea5_verboseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases term and discount rate</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_703e5131-96cf-456f-b275-bb9d64d2cecb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_51d5dcc9-c08a-4874-a047-34253e8af3cb_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_abea1635-0736-4390-9355-68b013704020_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_751ecfae-8fa9-4f92-a594-d12a7cb51148_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2bbfb0e5-f9ac-484e-9a03-6cc252f3c7ec_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_cebb18ab-e2e2-4c20-8f8b-5b8323916e38_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_04dfca94-541b-48a0-967b-ce2f4677dea4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_5303a339-eeea-44a0-bc65-af5c29e4986d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense from continuing and discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_29f425a8-e392-4411-a529-1f306f2b7445_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets and Liabilities Arising from Temporary Differences</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanFacilityMember_3601c3f6-3c1e-40c4-b5c7-bb9120baace7_terseLabel_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_label_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember" xlink:href="dva-20201231.xsd#dva_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanFacilityMember" xlink:to="lab_dva_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b670fe24-23e4-4c0e-8614-8e67cfdcd1c3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_c106bff4-53fb-4b56-9a20-0a62c9193449_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on changes in ownership interest, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_38042c0e-944d-4be6-9086-055138d65a37_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a73aefc3-4c3d-46ff-8b80-0f4a622ccf55_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_2a254dc4-e00c-4fa7-8b35-a57b470f4c0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_a2e71155-3899-407a-b364-9a018a4bf733_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures, noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e7b020ae-0a73-4920-a593-9091b75d7c84_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_eb214e71-0402-42dd-a287-b4b3fe076f1d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_4317ce4b-a0ec-46dc-b4b9-1f6eb9b0851d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_333bfb76-6225-40b3-a0f8-d0f1b5a0d6eb_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_8b8fec92-655f-4491-8ec0-16ce39472e8a_terseLabel_en-US" xlink:label="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_label_en-US" xlink:label="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Discount Rate Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_documentation_en-US" xlink:label="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:href="dva-20201231.xsd#dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:to="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_5876b03e-1b0f-4627-9f2b-e1ddd94d3490_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_6deb238e-6827-43ba-a496-01459662f060_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_2d135b94-b349-4eda-9245-a9f5e6bdec02_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_63e14d9c-6d4a-43fc-b95b-e0cda73c1210_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term Investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6ed1822b-5e2a-46f4-88c5-74c222b274b0_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d4d72e91-d91a-4817-9474-e326cee2208d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_3f22d753-8801-43b4-b78d-b59d911310d8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_1e5fd871-c67b-4240-b2a4-e2ca7153dccb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_ceb17998-3f20-44e0-8e72-7276c652b6c0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from equity method investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_28258deb-f2f8-467c-8d82-3d211eb29b2d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2dc23cda-57a4-4eaa-b201-e8fd0440d3e2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_2ba43f82-3c44-4620-a090-6eaa00c24311_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_424f519a-5f55-4bde-90a7-0fd8629050d1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_bd213b9e-3cf9-49e5-a435-a269778b81c3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PatientServicesCustomerConcentrationRiskMember_f22b0daf-379d-42e6-a350-ecaf921ac61f_terseLabel_en-US" xlink:label="lab_dva_PatientServicesCustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services Customer Concentration Risk</link:label>
    <link:label id="lab_dva_PatientServicesCustomerConcentrationRiskMember_label_en-US" xlink:label="lab_dva_PatientServicesCustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services Customer Concentration Risk [Member]</link:label>
    <link:label id="lab_dva_PatientServicesCustomerConcentrationRiskMember_documentation_en-US" xlink:label="lab_dva_PatientServicesCustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient services customer concentration risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientServicesCustomerConcentrationRiskMember" xlink:href="dva-20201231.xsd#dva_PatientServicesCustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PatientServicesCustomerConcentrationRiskMember" xlink:to="lab_dva_PatientServicesCustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PatientCareCosts_be908ca2-da63-49cb-bf3a-c5d47d2dbd6a_terseLabel_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_label_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Care Costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_documentation_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts" xlink:href="dva-20201231.xsd#dva_PatientCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PatientCareCosts" xlink:to="lab_dva_PatientCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_c48d384f-4a05-413f-b4fa-0ff45c795d65_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6633971f-a4f2-4ba4-a5c0-1de60e385830_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_23b23ebd-8c96-45ac-bf03-6f8c1c409edb_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_b2d6f446-6d5d-43a1-8cc6-e64df4637a7a_negatedLabel_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate administrative support</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_label_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Corporate Expenses</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_documentation_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:href="dva-20201231.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:to="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_706ca456-80f6-4337-8101-dd1f5c9b8881_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a6aba421-aeef-46d2-bb66-44b6adb9f783_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfOtherReceivablesTableTextBlock_90acd1ae-57d6-47b6-bf8d-682ee876e5e6_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Receivables</link:label>
    <link:label id="lab_dva_ScheduleOfOtherReceivablesTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Receivables [Table Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfOtherReceivablesTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of claims held for amounts due to an entity. Examples include non-trade receivables and Medicare bad debt claims.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:href="dva-20201231.xsd#dva_ScheduleOfOtherReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:to="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e854a219-179c-4491-a61f-bddc643ec162_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_20d444f3-3545-47e6-b969-42fa742c73de_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contingently returnable shares attributable to dilutive effect (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f3bd00be-1dde-431f-ac54-c9b2eed32ccc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_322aaaa9-d30b-4680-9935-500992697b68_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in noncontrolling interest from:</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross_999fc70e-4253-4541-8efa-3591ce04d0b3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetition agreements</link:label>
    <link:label id="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Noncompete Agreements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:to="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_6e52c130-6ee0-4d85-9bdd-6117b808d4de_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses and charges:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_e470e3e1-5ade-4411-9c10-08e9fa6d48df_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_77768b71-96f5-485c-8481-ad09e2d4da41_negatedLabel_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income, net</link:label>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment Income Loss From Equity Method Investments</link:label>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_documentation_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:href="dva-20201231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:to="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_33edb12a-e49c-4129-ae5b-070cb0c40641_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_88968763-e5d0-4089-b81d-b7958867f723_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_87432c53-fdf4-4e32-a197-185f5df5f174_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_777ab25b-9b66-4f9e-9e95-6c8efcec507c_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_89f893d1-cd5e-47ec-9a96-8f6407365dea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DaVitaMedicalGroupMember_0cb4bc53-fcbd-40aa-a7ad-8402cda11f46_verboseLabel_en-US" xlink:label="lab_dva_DaVitaMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG - discontinued operations</link:label>
    <link:label id="lab_dva_DaVitaMedicalGroupMember_label_en-US" xlink:label="lab_dva_DaVitaMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Da Vita Medical Group [Member]</link:label>
    <link:label id="lab_dva_DaVitaMedicalGroupMember_documentation_en-US" xlink:label="lab_dva_DaVitaMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DaVita medical group.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DaVitaMedicalGroupMember" xlink:to="lab_dva_DaVitaMedicalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_869a0306-c57c-4460-8cc4-696697d64134_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2a9ed07b-b05b-46d4-aa85-7ffdcc98db99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Divestiture</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d2ddf326-ecba-48c2-89a2-5ee375d6d66e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd8045c9-a610-44ae-aa8f-cfdd5a72602b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e9dd1974-cb6a-4398-91e4-e887bf84f8c3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7445ce8d-a688-4b6a-9271-5bd3c5f67d9b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_48e29b48-83a4-4cd7-adeb-c88fef2170c6_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_bdfdc2ee-23d4-4559-87a2-01e17bf79daf_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_ecb6b75f-19d0-4090-88dd-f8800fe26800_negatedLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contingently returnable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Contingently Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_257a1265-2d73-49f8-a3e3-2c6736a6378a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of DMG division</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_75f7cade-c07f-4f37-9930-f69f5fe22977_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3ec41aa2-5d12-45e0-ac8b-6318b91def9d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_9d16d2df-c882-4cea-93bc-bd4a9638f60e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e29d8d2e-a26f-431b-b22b-13362ed6cc4a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b76a52b6-cf74-4992-9cae-3915487a7422_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_2544845e-d39b-419b-8810-08dc9c67c8ca_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_1948a286-f65c-4277-8290-e9eecfad6400_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember_a8efb907-36ad-41d1-b3f2-9d4886ef2d06_terseLabel_en-US" xlink:label="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium priced stock-settled stock appreciation rights</link:label>
    <link:label id="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember_label_en-US" xlink:label="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Stock-Settled Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Stock-Settled Stock Appreciation Rights Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:href="dva-20201231.xsd#dva_PremiumPricedStockSettledStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:to="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_07ae0a4e-d4c8-4ef2-960b-ffe68f63b8da_terseLabel_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_label_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities [Member]</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_documentation_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:href="dva-20201231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:to="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_10fed921-adb5-49eb-9310-ef273055402d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_481843ba-810b-4947-9aeb-6f431f78baa3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_dbe6de9d-4d80-4039-9d6b-3bbfdf122e23_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_314a6bfc-196d-4ef1-8d47-8df9481c8275_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_838ab9cb-19fa-4a88-b838-a61162617277_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7152b273-adaf-45eb-af19-cbce37fb1e2d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived licenses</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_fa0db65a-e218-488d-b55d-4b39f72d42a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma total revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_058fa721-656d-4d38-bb1a-e3228d9c432d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_8911b179-49df-4b8b-8126-86cf4794955f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_FinanceLeaseMember_c8a138d8-05dd-4fc8-be27-f0c52cf38aab_terseLabel_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Lease</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_d78fa499-7ffa-42e5-9c0c-d822714c2640_verboseLabel_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_label_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_documentation_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember" xlink:href="dva-20201231.xsd#dva_FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_FinanceLeaseMember" xlink:to="lab_dva_FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2e96c22b-9f1b-46a0-8af0-6f2d7e7a860b_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_293d272f-69cf-4b5a-98a9-a6b5acc7f7a8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7f28b4fc-e4ee-4c2e-a2db-498a57091fbf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_d7ca17f6-09c3-4c01-80eb-50f4eccf57fd_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities from discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_eef90dbf-d333-476b-abef-ccfb34e52f1a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_a83afd13-9781-47c4-a6cb-6ee1a85ca3e2_terseLabel_en-US" xlink:label="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_label_en-US" xlink:label="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income Expense Policy [Text Block]</link:label>
    <link:label id="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_documentation_en-US" xlink:label="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other nonoperating income (expense), policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:href="dva-20201231.xsd#dva_OtherNonoperatingIncomeExpensePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:to="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_ef5c0716-b4ce-4276-b19d-f158701b9e27_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Distributions to Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:to="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0a4a697c-b406-4430-9f3e-14da1d983ed5_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6690e834-3fa7-4f93-afe6-43e24561211e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ProceedsFromRepricingAgreementOnSecuredDebt_4c68da05-8797-4d7d-be2e-28b39fe3fcd5_terseLabel_en-US" xlink:label="lab_dva_ProceedsFromRepricingAgreementOnSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Repricing Agreement On Secured Debt</link:label>
    <link:label id="lab_dva_ProceedsFromRepricingAgreementOnSecuredDebt_label_en-US" xlink:label="lab_dva_ProceedsFromRepricingAgreementOnSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Repricing Agreement On Secured Debt</link:label>
    <link:label id="lab_dva_ProceedsFromRepricingAgreementOnSecuredDebt_documentation_en-US" xlink:label="lab_dva_ProceedsFromRepricingAgreementOnSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Repricing Agreement On Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProceedsFromRepricingAgreementOnSecuredDebt" xlink:href="dva-20201231.xsd#dva_ProceedsFromRepricingAgreementOnSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ProceedsFromRepricingAgreementOnSecuredDebt" xlink:to="lab_dva_ProceedsFromRepricingAgreementOnSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_68203d74-ad7c-4e6b-a057-3eeb2a9ce327_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_64bb0e8a-48b3-4736-a7a6-4cf7ef1d866b_terseLabel_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_label_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_documentation_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:href="dva-20201231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:to="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtFinancingAndDebtRedemptionCosts_57efea77-a3c9-42af-a058-c408c7e8c8bb_negatedTerseLabel_en-US" xlink:label="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Financing And Debt Redemption Costs</link:label>
    <link:label id="lab_dva_DebtFinancingAndDebtRedemptionCosts_label_en-US" xlink:label="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Financing And Debt Redemption Costs</link:label>
    <link:label id="lab_dva_DebtFinancingAndDebtRedemptionCosts_documentation_en-US" xlink:label="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Financing And Debt Redemption Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts" xlink:href="dva-20201231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtFinancingAndDebtRedemptionCosts" xlink:to="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_373fe1d1-d391-4904-8a08-899892f593e0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a6485a1b-6425-4402-b245-543744a2b97b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa276482-4833-44e3-b1b6-228ccb7870cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_6390da83-d92d-4c15-ac8f-4bcd08940b12_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_a91362d6-a764-43cb-925c-b173283d9dac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_29463cd4-3796-4def-9782-17d367a66d14_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 4.625% due 2030</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_label_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:href="dva-20201231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:to="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_2a1d0118-cc60-48c5-99fa-53de84970195_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments in nonconsolidated businesses</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_c6b7cb70-5ce3-49dc-8cb9-78aaeca3b15a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition (Detail)</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_c647df01-3dc4-433d-b837-0100d2ff7d93_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c7c62ff-8373-47b6-98bc-19783c74e60e_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8d9ebef3-7439-48a4-b6c1-8bff68e3d8e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7893cb71-70da-48e3-8564-a88b7ff0888f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a645b069-7b8e-40ce-8c25-56233e823b1c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d0de0c9d-6ceb-4b14-ae8f-a4e7bbbdbb17_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_0536aefe-a96b-4631-b443-6abeab900b4f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_33431137-bf87-421b-997e-46ce185d1a7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_8678d471-45f6-4f8b-a13a-40473c909958_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_71f7ed96-66ec-4c3d-8592-11dad03990f7_terseLabel_en-US" xlink:label="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</link:label>
    <link:label id="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_label_en-US" xlink:label="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</link:label>
    <link:label id="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_documentation_en-US" xlink:label="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:href="dva-20201231.xsd#dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:to="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8e871d5e-d88e-4e49-854b-cc244a6282ce_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_826af544-03be-4c0d-a646-fc5968fecae4_terseLabel_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_label_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded [Member]</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_documentation_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Previously Refunded [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:href="dva-20201231.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:to="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_19668c3c-fb90-47f4-9deb-ff16425b78c8_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_33db652e-9167-4b1b-a63c-33f240eb801d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_bcc4df96-0ea2-449c-bb49-95284ec71b64_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_41fca663-a819-45ff-bc06-cbf71e231f97_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1c898907-d63a-4981-bba2-5785769e6891_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock appreciation awards granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_d58442eb-8ef2-429b-b280-1a8a10206f8a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_9b4cb96f-6965-4c62-9e9a-ab8bffdbc526_terseLabel_en-US" xlink:label="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</link:label>
    <link:label id="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_label_en-US" xlink:label="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</link:label>
    <link:label id="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_documentation_en-US" xlink:label="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:href="dva-20201231.xsd#dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:to="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_ff5038f5-72a1-44e6-b22b-ade5205798af_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7d77766a-4935-43ed-821c-401849aab52d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_e6241052-84d0-441e-b56c-a3ddd1d368cf_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances and Reserves</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_644a6215-f734-443a-8929-12ef8cf580d1_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_4ab24939-9b9c-473d-8b5d-7029171e6710_terseLabel_en-US" xlink:label="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier rebates and non-trade receivables</link:label>
    <link:label id="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_label_en-US" xlink:label="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Rebates And Other Non Trade Receivables [Member]</link:label>
    <link:label id="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_documentation_en-US" xlink:label="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Rebates And Other Non Trade Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:href="dva-20201231.xsd#dva_SupplierRebatesAndOtherNonTradeReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:to="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_15e3a29f-cfeb-4ef9-a07b-6a917b5b2b81_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_57fa5e34-9ea7-4b6a-bb83-1bb9e2f9a67e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a4e0a2fd-7a1a-43cc-87fe-cc5b0cfc8ad9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_5dc1da4d-b09a-4a81-8301-31a2c83c9686_terseLabel_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_label_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_documentation_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:href="dva-20201231.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:to="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_26732a6a-f859-486f-aa1a-ee0794294d2a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_243395a2-861a-4508-904f-40a8c28d2801_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_e8b9f0ff-54d5-4e29-872c-cdfa781e627e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0a7f590c-f07d-4772-9b2e-a3f458a015ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_bc2c975e-2a17-4a12-9250-aaf98007254c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_e0527dbd-1d94-4883-850d-62bc57f756bb_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8c131df6-f80c-4043-88dd-f30ef1d57240_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_77eb78a1-7fe5-4239-b39e-8088be261deb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fd6fb5bb-4408-4619-ab8a-f7632b3ba9e8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_f2f1999d-bb80-4891-a5d6-80810b259b7f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_e532c817-0fa1-41d0-a565-01e3a95ee21b_terseLabel_en-US" xlink:label="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_label_en-US" xlink:label="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Operating Income Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_documentation_en-US" xlink:label="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:href="dva-20201231.xsd#dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:to="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_d39d4c23-df05-48f3-9f40-faa7732be6ce_terseLabel_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in mutual funds and common stock</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_label_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_documentation_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember" xlink:href="dva-20201231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MutualFundsAndCommonStockMember" xlink:to="lab_dva_MutualFundsAndCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_eba60b7c-7ad1-495a-9e1e-99319c079bb2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_46d5e205-784e-403a-ac57-449a219de94c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash gain on acquiring additional ownership in business acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7eb3cfb7-eb08-4051-bf4d-8f52fdc9004d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OpenMarketPurchasesMember_db467f0f-7b20-441d-af2a-8ec936aab410_terseLabel_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_label_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases [Member]</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_documentation_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember" xlink:href="dva-20201231.xsd#dva_OpenMarketPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OpenMarketPurchasesMember" xlink:to="lab_dva_OpenMarketPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_8ac44f8c-ea78-450e-8425-4710e64dddf5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncrementalCashPortionMember_8da86a99-b5d7-45f4-af37-c55aeaa7dc99_terseLabel_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_label_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_documentation_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember" xlink:href="dva-20201231.xsd#dva_IncrementalCashPortionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncrementalCashPortionMember" xlink:to="lab_dva_IncrementalCashPortionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1969c800-fa10-4816-9657-77237c9b0d1b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_db163061-a296-4816-848d-d60663863304_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease cost:</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1be2b131-9ed5-4432-9644-53293d724305_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3c82842b-c4cd-4874-8fa1-87b5d94212dc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetLossGainOnDispositionOfBusinessInterests_b4de52d0-6b17-422c-8801-f0f38809b502_negatedLabel_en-US" xlink:label="lab_dva_NetLossGainOnDispositionOfBusinessInterests" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sales of business interests, net</link:label>
    <link:label id="lab_dva_NetLossGainOnDispositionOfBusinessInterests_label_en-US" xlink:label="lab_dva_NetLossGainOnDispositionOfBusinessInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss (Gain) On Disposition Of Business Interests</link:label>
    <link:label id="lab_dva_NetLossGainOnDispositionOfBusinessInterests_documentation_en-US" xlink:label="lab_dva_NetLossGainOnDispositionOfBusinessInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) on disposition of business interests from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetLossGainOnDispositionOfBusinessInterests" xlink:href="dva-20201231.xsd#dva_NetLossGainOnDispositionOfBusinessInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetLossGainOnDispositionOfBusinessInterests" xlink:to="lab_dva_NetLossGainOnDispositionOfBusinessInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_09bb72d2-e558-409e-b1f9-154b678f24aa_negatedLabel_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_label_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_documentation_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:href="dva-20201231.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:to="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c4370bf2-81e7-4186-b177-4d6eb3a9caa6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a343b8f9-5a29-4f2a-9290-c1985346e7e4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ff96c2a9-3b4b-4856-acb8-a3f0fd44c080_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_35812a4e-ad98-4d73-8521-ff4d80996c51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_ea2feaa2-1245-467e-b3b5-dc548ddb7439_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations, other notes payable, and financing lease obligations</link:label>
    <link:label id="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Net, Alternative [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:to="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_d90a9312-1115-474c-8910-878536f83647_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerators:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_2e1aa51e-9cc0-41dd-8a21-d3c93ede5323_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_aef772bc-430e-42e7-b865-0372f91c0930_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_56412c62-02c6-4d3f-956b-fe8c2b3f2b1f_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bdef97d5-4dbe-4add-83cf-064c14c37e3e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ff33ff0a-1961-44b6-9dea-3ebbd969f689_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_e0769d0e-8532-4751-af78-6c996d480f6b_terseLabel_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sales of business interests, net</link:label>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_5d06622e-a24f-418d-8bcc-40bf09cd59e1_negatedTerseLabel_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of discontinued operations before taxes</link:label>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_label_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (Gain) On Disposition Of Business Interests Before Tax</link:label>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_documentation_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (Gain) On Disposition Of Business Interests Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:to="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_c83658ab-65e6-4d62-9257-537861e5f8da_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_30c9eef1-342d-4229-9fa5-6dd60f8a4acc_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CumulativeEffectOfChangeInAccountingPrinciple_0919ecaa-5f76-4a2c-941e-7e8ade409d4b_terseLabel_en-US" xlink:label="lab_dva_CumulativeEffectOfChangeInAccountingPrinciple" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect of change in accounting principle</link:label>
    <link:label id="lab_dva_CumulativeEffectOfChangeInAccountingPrinciple_label_en-US" xlink:label="lab_dva_CumulativeEffectOfChangeInAccountingPrinciple" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect Of Change In Accounting Principle</link:label>
    <link:label id="lab_dva_CumulativeEffectOfChangeInAccountingPrinciple_documentation_en-US" xlink:label="lab_dva_CumulativeEffectOfChangeInAccountingPrinciple" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect Of Change In Accounting Principle.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CumulativeEffectOfChangeInAccountingPrinciple" xlink:href="dva-20201231.xsd#dva_CumulativeEffectOfChangeInAccountingPrinciple"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CumulativeEffectOfChangeInAccountingPrinciple" xlink:to="lab_dva_CumulativeEffectOfChangeInAccountingPrinciple" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncomeTaxExpenseBenefitMember_97b1f478-0416-4c7f-9b6f-fff55f9a3d1c_terseLabel_en-US" xlink:label="lab_dva_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax benefit (expense)</link:label>
    <link:label id="lab_dva_IncomeTaxExpenseBenefitMember_label_en-US" xlink:label="lab_dva_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense Benefit [Member]</link:label>
    <link:label id="lab_dva_IncomeTaxExpenseBenefitMember_documentation_en-US" xlink:label="lab_dva_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxExpenseBenefitMember" xlink:href="dva-20201231.xsd#dva_IncomeTaxExpenseBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncomeTaxExpenseBenefitMember" xlink:to="lab_dva_IncomeTaxExpenseBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_707ad0fc-f544-468b-a91e-b715a1da84e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_04c48a11-db46-417a-9160-775737b90c15_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c8f59914-95d6-47ba-aae6-fafb407bec12_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f2a8db07-e83e-493d-9e74-8049b35b9bdc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_3f8a4a50-7ca9-4204-b9f7-49c78f3699de_terseLabel_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_label_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_documentation_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization consolidation and presentation of financial statements disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:href="dva-20201231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_9433739b-9d71-4306-8722-ad7eb96fceae_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average remaining contractual terms.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_0f3b9703-49ea-4b29-b961-ad6546b9c463_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_d9efb29f-0d61-457a-b1fa-8b8e238b36bf_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_cc6c0d77-b7ec-4e3f-95c3-946c171f09c3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_114f0d2c-1724-4421-aa4b-6534c8be00cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_ca7257b4-332a-4e16-9f53-df265191cbdb_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and information systems, including internally developed software</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_65697c0c-7e60-4fb7-9ad5-5332afb9e562_negatedLabel_en-US" xlink:label="lab_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_label_en-US" xlink:label="lab_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-base Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Expired In Period</link:label>
    <link:label id="lab_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_documentation_en-US" xlink:label="lab_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-base Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Expired In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:href="dva-20201231.xsd#dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:to="lab_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_f55f5083-5d67-454d-a36d-dbffd903cd0d_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_label_en-US" xlink:label="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Gain Related To Redemptions Or Purchase Of Interests</link:label>
    <link:label id="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Gain Related To Redemptions or Purchase of Interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:href="dva-20201231.xsd#dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:to="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f7db047e-5c25-4014-9be5-40eb4e8f86d7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_506f7118-bccc-4a78-b514-34dee0521486_terseLabel_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between Revenue Guidance in Effect before and after Topic 606</link:label>
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_label_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between Revenue Guidance in Effect before and after Topic 606 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:to="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_53a38ba0-5a26-4049-bb00-86c36330ffc5_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New center and capital asset projects in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_17538e35-950c-4377-8318-d30f8155e012_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_3ac6b577-2da8-421b-be77-c1451d51e6cc_terseLabel_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount</link:label>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_label_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount</link:label>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_documentation_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:href="dva-20201231.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:to="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_a2da5ea4-3120-420a-a76e-a8be736e4b56_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AllowanceForUncollectibleAccountsPolicyTextBlock_a8d17b0b-de09-4a58-b578-d6284a22b495_terseLabel_en-US" xlink:label="lab_dva_AllowanceForUncollectibleAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for uncollectible accounts</link:label>
    <link:label id="lab_dva_AllowanceForUncollectibleAccountsPolicyTextBlock_label_en-US" xlink:label="lab_dva_AllowanceForUncollectibleAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Uncollectible Accounts Policy [Text Block]</link:label>
    <link:label id="lab_dva_AllowanceForUncollectibleAccountsPolicyTextBlock_documentation_en-US" xlink:label="lab_dva_AllowanceForUncollectibleAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for uncollectible accounts policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllowanceForUncollectibleAccountsPolicyTextBlock" xlink:href="dva-20201231.xsd#dva_AllowanceForUncollectibleAccountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AllowanceForUncollectibleAccountsPolicyTextBlock" xlink:to="lab_dva_AllowanceForUncollectibleAccountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_ab7a2a0b-8251-40ad-9f1f-7a54e861bb12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_a0594d8b-8231-4314-a28b-a79c697b4924_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_6bd2b218-195a-46e9-9dd2-f70ed22bd7f3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ef99ac65-483a-4369-b7da-51dff352236a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_a5c40aa8-8bcd-4125-a368-b89422ea5551_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State capital loss carryforward, expiration date</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:to="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_a916baa0-3840-4243-8569-ab3578ad7d0a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_cbcb1e04-e52a-4e07-a1de-5be99e2133fd_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filer</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_3ba73e7f-b58d-400e-b0e9-30d034c03a8b_terseLabel_en-US" xlink:label="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated tax benefits recorded for stock-based compensation</link:label>
    <link:label id="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share Based Compensation Estimated Tax Benefit From Compensation Expense</link:label>
    <link:label id="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_documentation_en-US" xlink:label="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee service share-based compensation estimated tax benefit from compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:href="dva-20201231.xsd#dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:to="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_e4640557-55cc-40a1-bd4d-3f856d7023c7_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8593015f-a836-4373-8117-99d524fd605c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_9d22abad-9f92-4e70-b9ed-c86cd2cc52ec_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_04792af0-0ee6-41d3-a780-64f48596683a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_8e3802ff-a921-4066-a744-177f1aaba1f3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_9d3e9aeb-e607-4481-8bc3-9616d9a5073f_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_84fc158e-c79f-466c-b775-67337c722849_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanB1Member_6b593574-a77c-4863-9d5a-04553b3ba104_terseLabel_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1</link:label>
    <link:label id="lab_dva_TermLoanB1Member_label_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1 [Member]</link:label>
    <link:label id="lab_dva_TermLoanB1Member_documentation_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1 member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member" xlink:href="dva-20201231.xsd#dva_TermLoanB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanB1Member" xlink:to="lab_dva_TermLoanB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_8b45ed7b-015b-4a05-8349-33b57cf32ff8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_775689c7-fe54-47d8-9915-bf5d7d69cb1d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward</link:label>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_label_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLossCarryforwardMember" xlink:to="lab_us-gaap_CapitalLossCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_8385b8de-8b74-4f7f-ac7b-60b520bf5ac5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dffa262-64be-420b-9e1a-3600bcb61207_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ce2dbee7-cdc9-4884-a608-8cd8d012ba7e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_3f26b926-e58a-4462-b844-a05719624c67_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee entitlement for purchase of the Company's common stock during each calendar year</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Maximum Share Value Authorized For Purchase</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award maximum share value authorized for purchase.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_3216319b-1489-4670-9796-aa3b821f8a76_terseLabel_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_label_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:to="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_720133cd-c58a-4693-8de0-b72427af71df_terseLabel_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_label_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_documentation_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:to="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_40597ffd-2df9-4cc3-9b12-f50814825bf9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_853b57d9-e5e0-4f70-a8cd-a845623be8ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_6e2dc6f3-6a68-478d-8212-aa151c398a10_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests Subject to Put Provisions and Other Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_a0c9c433-61eb-42af-8afa-f633ceefa0a2_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b6fb4da2-2259-4496-a866-45b62ce3aba3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Purchase Cost Allocations for Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_d4ba91e8-f3b2-432f-bee6-e275481ebd3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchases summary table</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_8833f160-8371-4d99-915b-f1f3e0d08342_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 5.125 % due 2024</link:label>
    <link:label id="lab_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_label_en-US" xlink:label="lab_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Five Point One Two Five Percent Due Twenty Thirty [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes five point one two five percent due twenty thirty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" xlink:to="lab_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_74648f45-4c88-48c1-b47e-bafd7a26714f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockIncentivePlanTwentyTwentyMember_a56c2281-c8d8-48eb-be8d-3fa41453d1bb_terseLabel_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive 2020 Plan</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyTwentyMember_label_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan Twenty Twenty [Member]</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyTwentyMember_documentation_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan Twenty Twenty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyTwentyMember" xlink:href="dva-20201231.xsd#dva_StockIncentivePlanTwentyTwentyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockIncentivePlanTwentyTwentyMember" xlink:to="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OffBalanceSheetFinancingArrangements_c4fe86fc-50e4-4274-98ef-72dea83fe567_terseLabel_en-US" xlink:label="lab_dva_OffBalanceSheetFinancingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off -Balance Sheet Financing Arrangements</link:label>
    <link:label id="lab_dva_OffBalanceSheetFinancingArrangements_label_en-US" xlink:label="lab_dva_OffBalanceSheetFinancingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off -Balance Sheet Financing Arrangements</link:label>
    <link:label id="lab_dva_OffBalanceSheetFinancingArrangements_documentation_en-US" xlink:label="lab_dva_OffBalanceSheetFinancingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off -Balance Sheet Financing Arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OffBalanceSheetFinancingArrangements" xlink:href="dva-20201231.xsd#dva_OffBalanceSheetFinancingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OffBalanceSheetFinancingArrangements" xlink:to="lab_dva_OffBalanceSheetFinancingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_81574caf-a2a3-4bc9-a74b-11f833a8a843_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_845905ac-497f-4213-9f9f-b09843e69500_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and other</link:label>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Indefinite-lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AllTrustsMember_bca28cff-96f2-4929-9b27-40d6f8aa8859_terseLabel_en-US" xlink:label="lab_dva_AllTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rabbi trusts</link:label>
    <link:label id="lab_dva_AllTrustsMember_label_en-US" xlink:label="lab_dva_AllTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trusts [Member]</link:label>
    <link:label id="lab_dva_AllTrustsMember_documentation_en-US" xlink:label="lab_dva_AllTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All trusts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllTrustsMember" xlink:href="dva-20201231.xsd#dva_AllTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AllTrustsMember" xlink:to="lab_dva_AllTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3c0e5f37-dd54-4e90-91f7-65c7844d1c08_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Asset Categories</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_abd7cc6d-35ea-4ac1-9206-9f078ef72c8c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Total</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4ed7eef8-90a1-45ee-96cd-c9153f1a464c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_4847cc36-83da-423e-9d52-7cff234eb6ea_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_3b803546-907a-4988-b3fa-2424ce0112a5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtExpenseMember_20cbfcba-f053-4b20-9cee-1fc6f9d7c1da_terseLabel_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense</link:label>
    <link:label id="lab_dva_DebtExpenseMember_label_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense [Member]</link:label>
    <link:label id="lab_dva_DebtExpenseMember_documentation_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember" xlink:href="dva-20201231.xsd#dva_DebtExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtExpenseMember" xlink:to="lab_dva_DebtExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_108ba19f-fda1-4c86-be9d-0baa90036919_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_ffa0caad-1175-4b81-b71a-f8ef064bf35c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_e37d7cf9-ab23-4d2a-9b8c-530de6236271_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_11165183-0990-43fe-ade8-d172f71d470f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_f0f7a990-b543-4b72-a65d-20c1dd831fbf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_457f4d17-0173-401c-a8fd-6d2af78c5bea_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_8585759b-28da-433f-b858-c89459b7598f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_1ea6a9f4-c793-48c1-a7e1-247a2e3e0507_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains on interest rate cap agreements:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ab039df2-b4ed-4ca7-b88e-a6898ea914ac_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockUnitMember_501f47d7-7cb9-4f63-a037-ecda6aa3c210_terseLabel_en-US" xlink:label="lab_dva_StockUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units</link:label>
    <link:label id="lab_dva_StockUnitMember_label_en-US" xlink:label="lab_dva_StockUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Unit [Member]</link:label>
    <link:label id="lab_dva_StockUnitMember_documentation_en-US" xlink:label="lab_dva_StockUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Unit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockUnitMember" xlink:href="dva-20201231.xsd#dva_StockUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockUnitMember" xlink:to="lab_dva_StockUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement_3f75c465-66be-4394-b9c8-d88b77f58352_terseLabel_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To Repricing Agreement</link:label>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement_label_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To Repricing Agreement</link:label>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement_documentation_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To Repricing Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement" xlink:href="dva-20201231.xsd#dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement" xlink:to="lab_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f5b23e9d-f9a5-4af0-b91a-ba9e888ba7a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_be11ed8c-231c-459d-aeca-a3a636935a9f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma net income from continuing operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_69334d66-7bda-4110-a360-0706a30aed25_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_9d261503-d762-4b3b-9db1-640527593c13_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_94d3b6ea-7882-4d46-b1bc-bdd700949a0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_c7beebc7-5a35-45c6-a698-4c56986ba715_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_46067340-aafe-42e8-9927-d9289814cd5c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock acquired, average cost per share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_bc441954-e796-47bb-8c22-8a3dd5772e35_terseLabel_en-US" xlink:label="lab_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Interest Rate Cap Agreements Effective June 29, 2018</link:label>
    <link:label id="lab_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_label_en-US" xlink:label="lab_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Interest Rate Cap Agreements Effective June 29, 2018 [Member]</link:label>
    <link:label id="lab_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_documentation_en-US" xlink:label="lab_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Interest rate cap agreements effective June 29, 2018.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member" xlink:href="dva-20201231.xsd#dva_A2015InterestRateCapAgreementsEffectiveJune292018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member" xlink:to="lab_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_fa982bcc-192f-4b1c-92fe-dfdadd6eee20_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TenderOfferMember_451aa42b-b446-47e1-93ff-d05c7863239b_terseLabel_en-US" xlink:label="lab_dva_TenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer</link:label>
    <link:label id="lab_dva_TenderOfferMember_label_en-US" xlink:label="lab_dva_TenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer [Member]</link:label>
    <link:label id="lab_dva_TenderOfferMember_documentation_en-US" xlink:label="lab_dva_TenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TenderOfferMember" xlink:href="dva-20201231.xsd#dva_TenderOfferMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TenderOfferMember" xlink:to="lab_dva_TenderOfferMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_45fbe429-2f0c-4d99-8867-01987cc7e022_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense from amortizable intangible assets, other than lease agreements</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_212ac5ff-ba99-4a30-8271-b3631046082a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Political advocacy costs</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_3cd1f79c-7c59-49d0-a1e8-45c7bbfd1b09_terseLabel_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase (Decrease) In Unrealized Gains On Equity Securities</link:label>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_label_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase Decrease In Unrealized Gains On Equity Securities</link:label>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_documentation_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase Decrease In Unrealized Gains On Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:href="dva-20201231.xsd#dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:to="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_6f95130b-f4ed-41cf-b61b-42aacb3264c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_31c07e3d-5720-47de-80b2-d541d4875ca8_terseLabel_en-US" xlink:label="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_label_en-US" xlink:label="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_documentation_en-US" xlink:label="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:href="dva-20201231.xsd#dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:to="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_6f5bfc21-f1fa-44d0-8bc0-3310d948db62_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_b3df2607-0c4a-4745-80e8-d95d1725790d_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_27b9055a-1cbd-4689-9609-61e0c8aca7a6_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_30d5979c-0855-4150-8c73-58acdb556c6d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeferredTaxAssetsReceivables_cfe5a744-e0f2-491e-adb0-ecfb0072b9db_terseLabel_en-US" xlink:label="lab_dva_DeferredTaxAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsReceivables_label_en-US" xlink:label="lab_dva_DeferredTaxAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Receivables</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsReceivables_documentation_en-US" xlink:label="lab_dva_DeferredTaxAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsReceivables" xlink:href="dva-20201231.xsd#dva_DeferredTaxAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeferredTaxAssetsReceivables" xlink:to="lab_dva_DeferredTaxAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3466daf5-fec7-4c0f-aaa2-dab01a1ffc68_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_e97cb3fd-ddfd-4f62-8be4-7a3004ac325c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_e4e72d3f-3230-4667-95aa-c7e8ab5b42e6_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:to="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_dce1872b-2f8c-491e-91f6-963d5fd59b51_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations before taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_c9c2632e-adaf-42be-9fea-1436476df80d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in partnerships</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_cf0426ee-5094-498a-996b-2e49c87a4f1a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_55a2149d-4a9a-4621-8468-bb44b464e102_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_82c1b87b-7f03-4b38-b4d7-b5630cad0c4c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value of grants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cca61bdd-5a63-425e-b515-04744d9d4d6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_394634ed-2caf-42ee-ab5a-591d32c9cbd0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExternalSourcesMember_35b51e38-17aa-4991-8014-9289fa8ebd8d_terseLabel_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_label_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources [Member]</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_documentation_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External sources.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember" xlink:href="dva-20201231.xsd#dva_ExternalSourcesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExternalSourcesMember" xlink:to="lab_dva_ExternalSourcesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_9519f24a-f4ce-4a7c-9784-884d5ca1c78a_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_5d03c387-d134-493b-8881-d672329d0484_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Depreciation and Amortization Expense by Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e073bb44-bb73-4d64-a07d-5eb2ab29ad49_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_eff70bbf-2087-4ecb-a36a-a9d471f6ebfa_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense on property and equipment</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_0b767eda-14a4-4c8d-a6da-267af825b3fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_02a7b80e-ab0e-4c78-8ad5-5f6d3598d3e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_94aad34f-a7fa-485f-bb21-0e6aaace5de2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current economic interest in the APAC JV, Owned by Noncontrolling Investors</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_b493a544-fe45-416c-829e-3c278f6535e6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1deebb1a-db52-438e-ac84-b41212f1c784_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in liability for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfCustomers_46b5c87c-2c49-4f20-bd7a-89731fde6e1d_verboseLabel_en-US" xlink:label="lab_dva_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served</link:label>
    <link:label id="lab_dva_NumberOfCustomers_label_en-US" xlink:label="lab_dva_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers</link:label>
    <link:label id="lab_dva_NumberOfCustomers_documentation_en-US" xlink:label="lab_dva_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfCustomers" xlink:href="dva-20201231.xsd#dva_NumberOfCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfCustomers" xlink:to="lab_dva_NumberOfCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeDisclosureAbstract_2eeeed63-34fc-4ff6-bd0a-182e4dab98e0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LesseeDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeDisclosureAbstract" xlink:to="lab_us-gaap_LesseeDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_ee03a31b-1dfc-4c1c-8b30-0f0103c289a7_verboseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:href="dva-20201231.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_9fe458cb-c163-452e-b276-998e534cd4ce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Date of First Required Payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Date of First Required Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:to="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_8ccbd2a5-6b23-4a79-b6d8-d746088d84b3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_9726cc0d-07a1-4522-8f96-07ba4d39269c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8b1d6269-f4e7-4bb2-88e3-92f0c263c699_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_aacc6978-07fe-45e8-9942-d5fd99b16910_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_c331f56f-05f5-43f6-bf0f-df07d1885932_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_6c9f78e1-a1bb-464f-b299-88a082658b87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, fair value assumptions, expected dividend</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_0f39f5ba-b80d-4845-910d-35264be3a305_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e5d39034-2287-4c0f-9d56-b4fc826e8616_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_419fb72a-f859-46d7-8ca0-5914ffa024d2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (payments) receipts related to stock purchases and awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_ea1ed22a-9d60-4365-96be-89258a120cad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_67bb9077-8cf1-4041-9586-206f5a9a2250_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_fc917a99-eae7-4ef5-8c7f-223fccdfeabf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_56967dae-1fdd-4e47-a5dc-2223dcf59140_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DissolutionTermOfJointVentures_e6e7dd76-fd91-464f-be66-5910c2ee751a_terseLabel_en-US" xlink:label="lab_dva_DissolutionTermOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled dissolution term of joint ventures</link:label>
    <link:label id="lab_dva_DissolutionTermOfJointVentures_label_en-US" xlink:label="lab_dva_DissolutionTermOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dissolution Term Of Joint Ventures</link:label>
    <link:label id="lab_dva_DissolutionTermOfJointVentures_documentation_en-US" xlink:label="lab_dva_DissolutionTermOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dissolution term of joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DissolutionTermOfJointVentures" xlink:href="dva-20201231.xsd#dva_DissolutionTermOfJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DissolutionTermOfJointVentures" xlink:to="lab_dva_DissolutionTermOfJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_493d338c-ef65-4a4b-8b9f-263a219d3669_terseLabel_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_label_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_21b64004-3938-454b-83a6-a0a8e7f983db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Quarterly Financial Data (unaudited)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_ffac296c-1669-4486-8052-9a1c56fefe30_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_f08ecfa0-edf7-4019-a828-30c0d81fc61a_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_75f0523c-36d1-4b3c-a4dd-a0813c93d310_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_ff282c4c-027c-4d79-854f-94bd633de953_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_a1cc143a-5355-489b-a961-bc40f8f5a7bc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of treasury stock acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_c6696e3d-69cf-4ab1-a6dd-31ff3ca90edf_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification into net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20dae41f-49af-4ef6-97ae-47be3b957878_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_85cecb5e-0420-49be-b933-7de641f7fb46_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_b38f4149-4fdc-4612-b8f7-8d176dfe73cd_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_427f65f4-3a6e-441e-bb84-aae3cdb1d08a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_a0d2ddc9-9eeb-46c3-a65b-cf49b44af01a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongtermIncentiveProgramCompensationCost_3ff4aaac-59ea-439b-902a-f8ed38fe52ac_terseLabel_en-US" xlink:label="lab_dva_LongtermIncentiveProgramCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term incentive program (LTIP) expense</link:label>
    <link:label id="lab_dva_LongtermIncentiveProgramCompensationCost_label_en-US" xlink:label="lab_dva_LongtermIncentiveProgramCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Incentive Program Compensation Cost</link:label>
    <link:label id="lab_dva_LongtermIncentiveProgramCompensationCost_documentation_en-US" xlink:label="lab_dva_LongtermIncentiveProgramCompensationCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Long-term Incentive Program compensation cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveProgramCompensationCost" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveProgramCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongtermIncentiveProgramCompensationCost" xlink:to="lab_dva_LongtermIncentiveProgramCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_00b8ee63-3140-40de-8d70-44572511b5c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for uncollectible accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_b247d654-fd27-4c10-a0bf-f212cbd0440f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_003f24fe-6281-47e5-913c-d56e43e39b5c_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual&#160;life</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based Compensation Arrangement by Share based Payment Award, Other than Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_f00842bf-8acb-40f9-8fa0-41285f0564ef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset impairments</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_21a2beaf-92e5-4962-a8ea-0325924cf8d2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_4a033158-e532-415f-a9d3-151bb4162820_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_4375c8f8-0aaf-40dd-8dda-52d03ff50bfb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_62c8bc6a-72d4-49ce-b84e-f9fa86bd6b23_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_5d22420f-d21c-4652-ac27-a007a8d7a465_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on foreign currency translation.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_6109d823-40f2-4691-9211-5ac472ed7239_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_0439de67-2e61-46c1-9847-6c93d1c8b628_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_04403ba7-9829-4e5e-ac44-949bcfe1c9cc_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2413c654-1b96-4609-851c-14d940e3369f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_57d85cbe-75b4-4927-858c-bea4377998aa_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_78c97efe-c530-48b8-8dc7-a548f1075a95_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_7e630d37-bf4b-44cb-b97d-85d86a0f67c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase price and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_75bab3ff-b6c2-4122-a0be-5eb4f251f831_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ef777653-a06e-4573-9ad6-c322ed94b559_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_cf7eb1c9-657f-456e-a1c2-0fbeae3c3f2c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetition agreements and other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_8800dbea-7fc9-435e-bdfb-72b16df8eb8f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gains (losses) in OCI on interest rate cap and swap agreements</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_082ae113-7cd5-45c5-9931-1617547882f9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized (losses) gains in OCI on interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_aa1d22d6-0a47-4c6e-b215-b3064dddf442_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_d518d95f-5c02-4a36-9234-c2af8bfe9ff8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes associated with acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_234ae417-9dc9-4553-9567-b57378f48ef4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0f2ba38e-c930-471e-a5e4-b0674a158763_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_bea16250-041d-4c0e-b2d3-8c127b48548a_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_723001ca-1968-4593-a98e-772e31056d5c_terseLabel_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_label_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_documentation_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:href="dva-20201231.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:to="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_72df04c4-6f43-4de2-8378-8328afd6197a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fbc3fe7d-abce-4f3a-9d93-1a9cd3423a58_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2f749fa6-8ebf-42ca-9b5e-e7ad6b50ee1d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7ce057bd-d80a-48e1-b0b9-59e71b566712_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_2b79fd7a-b3ba-4e49-bcaf-63a5bd2bbbb4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f526c20c-8e8b-4b3d-b735-71cd903bb890_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ebd7bc92-d7f5-4c23-b523-169d0f819e52_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation between U.S. Federal Income Tax Rate and Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_9e9c039d-65ac-4e06-aa07-822630e97300_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts written off</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_55afcdf2-c851-49d0-ba53-917896b12028_totalLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains net</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_3b76d6b2-ef9f-4e64-9795-68310350bcac_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which dialysis centers located</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_45b4916b-d6d5-4522-acd4-9f805304b7d9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_af52d130-fe3a-4f37-b9bc-0f4f85549cdf_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_c50b48b5-dfc8-49cf-ab57-e0daec9fb510_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6b072498-1dea-48e6-8812-7f3f7cdc3ef3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_naics_ZZ446110_52900d64-b310-422a-b9b4-bd0a7c687f84_terseLabel_en-US" xlink:label="lab_naics_ZZ446110" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Business</link:label>
    <link:label id="lab_naics_ZZ446110_label_en-US" xlink:label="lab_naics_ZZ446110" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">446110 Pharmacies and Drug Stores [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naics_ZZ446110" xlink:href="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd#naics_ZZ446110"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naics_ZZ446110" xlink:to="lab_naics_ZZ446110" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PremiumPricedAwardBasePricePerShare_70a117ed-f02b-446a-b43b-2b61c4faaf28_terseLabel_en-US" xlink:label="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Award Base Price Per Share</link:label>
    <link:label id="lab_dva_PremiumPricedAwardBasePricePerShare_label_en-US" xlink:label="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Award Base Price Per Share</link:label>
    <link:label id="lab_dva_PremiumPricedAwardBasePricePerShare_documentation_en-US" xlink:label="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Award Base Price Per Share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedAwardBasePricePerShare" xlink:href="dva-20201231.xsd#dva_PremiumPricedAwardBasePricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PremiumPricedAwardBasePricePerShare" xlink:to="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_dd689a64-533d-400e-b978-5f3ff6029ba7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_ec058e73-1f1e-4789-83fa-0e371622eed8_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3b0312a2-29a5-4eaa-b9aa-df5ce0bcbfde_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_a20b56b4-6bdf-495b-a804-4e5fa0b297ea_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1faa0c84-20ed-45cd-acd9-8f6ad19f8ae2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_5092299a-e510-4998-b836-0401a4f69624_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 5.0 % due 2025</link:label>
    <link:label id="lab_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_label_en-US" xlink:label="lab_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Five Point Zero Percent Due Twenty Twenty Five [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes five point zero percent due twenty twenty five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" xlink:to="lab_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_5f525b7b-c9f7-426b-9414-dfd2269706c6_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_abfb0053-0324-4dd9-a476-390c49cc8edc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cd5baf06-21d3-4cc0-8533-2eb2db7c8c1a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_7f01801a-b4d2-4949-93e6-fdf30166f755_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PremiumToTheTenderOfferSharePurchasePrice_b406523d-9cbb-4366-9982-baf2735018ea_terseLabel_en-US" xlink:label="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium To The Tender Offer Share Purchase Price</link:label>
    <link:label id="lab_dva_PremiumToTheTenderOfferSharePurchasePrice_label_en-US" xlink:label="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium To The Tender Offer Share Purchase Price</link:label>
    <link:label id="lab_dva_PremiumToTheTenderOfferSharePurchasePrice_documentation_en-US" xlink:label="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium To The Tender Offer Share Purchase Price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:href="dva-20201231.xsd#dva_PremiumToTheTenderOfferSharePurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:to="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongTermPurchaseCommitmentExpirationDate_5440afc4-2a60-47fa-be90-c7ab64e8612f_terseLabel_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term purchase commitment, expiration date</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentExpirationDate_label_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Purchase Commitment Expiration Date</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentExpirationDate_documentation_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term purchase commitment expiration date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentExpirationDate" xlink:href="dva-20201231.xsd#dva_LongTermPurchaseCommitmentExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongTermPurchaseCommitmentExpirationDate" xlink:to="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_cabcc899-b9db-4e5a-87fa-f37b7d110812_negatedLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dva-20201231.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f9d28d36-15e3-48d6-bc50-5dfdafddb8d4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_447145ec-9256-4580-b333-88373ad9c2d5_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_385238cc-4d18-47f5-8f64-8cd4c7997391_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent of employees' gross wages</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3cd8a33-eed6-4433-9548-8c2e8fc8c7f6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_d2fc9c44-a8ff-4b72-bd8a-84dab1e25eb9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_76f47c00-6d00-4e5c-8d22-1c851444d134_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureTable_291965f9-71d3-49bb-8fba-f0f4185b22d9_terseLabel_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureTable_label_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureTable_documentation_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureTable" xlink:href="dva-20201231.xsd#dva_CommitmentsAndContingenciesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable" xlink:to="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_5d273836-52f2-46a6-84b8-0520434fa304_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_15363d9e-f6b9-4513-8377-f3acf3e04230_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_6fffe804-26f0-472d-820f-b45c53aca5ce_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8c9285a6-02f1-4711-93da-5c884b59bca5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_5b16c342-9470-4a85-95d6-61ba7493f5ec_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_5c5d3e02-41d7-4b5c-8bc4-2d691f593b54_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses and charges</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e02f314d-4a75-4b8b-be23-22a7bf1095f3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfConcentrationRiskCustomers_eaebc3fb-9780-4f39-8e19-88bf86b3465f_terseLabel_en-US" xlink:label="lab_dva_NumberOfConcentrationRiskCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of concentration risk customers</link:label>
    <link:label id="lab_dva_NumberOfConcentrationRiskCustomers_label_en-US" xlink:label="lab_dva_NumberOfConcentrationRiskCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Concentration Risk Customers</link:label>
    <link:label id="lab_dva_NumberOfConcentrationRiskCustomers_documentation_en-US" xlink:label="lab_dva_NumberOfConcentrationRiskCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Concentration Risk Customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfConcentrationRiskCustomers" xlink:href="dva-20201231.xsd#dva_NumberOfConcentrationRiskCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfConcentrationRiskCustomers" xlink:to="lab_dva_NumberOfConcentrationRiskCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding_8f1fd405-5b09-40cd-b040-6ad2c3258208_terseLabel_en-US" xlink:label="lab_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding</link:label>
    <link:label id="lab_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding_label_en-US" xlink:label="lab_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding</link:label>
    <link:label id="lab_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding_documentation_en-US" xlink:label="lab_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" xlink:to="lab_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_8272fc16-b8b5-4a77-9af9-bda8ddd46626_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_88ddfc75-faef-4345-bc55-e82b9db90797_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_15757527-d9f6-415e-b985-0501f21c46c9_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_e67925a2-0c7e-4f74-be47-28fa71203513_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_55aec0fd-f584-409d-bb74-7007939c278e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_ef5a8943-57e9-450b-a8e4-441641896053_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_e3c9569f-75ce-4023-86c0-4e96576ab4d1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, significant impairments and other valuation adjustments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_9be95f0c-fc17-44e8-be75-63b63cc6801b_negatedLabel_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivities, Operating Income</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_label_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Reduction In Operating Income</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_documentation_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Reduction In Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:href="dva-20201231.xsd#dva_PotentialImpactOnFairValueForReductionInOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:to="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_8f7e2222-b233-4596-8420-5ae12f35e06c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_15adce63-de5f-40e9-8bd8-a0e11b87f9ed_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Asset Categories</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ee1798a6-12d9-4bf0-98af-e4631455e95e_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d7c68849-02d3-4b64-831c-5a2ea2016b32_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_52b73ac4-4106-49c2-a234-b7c8d778ef5a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_00bbef75-79b3-4d10-929c-73f07ac6d70a_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9a87126d-4ffa-4d43-a286-db87715f0261_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_76fbba22-5a81-4413-811c-1a1b3681cce4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Compensation and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_6ab0878a-e7bc-4da0-b3a0-a081df41f048_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments, Net Minimum Payments, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ce690658-576c-4b4f-b3a0-be77fcd4bc99_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term incentive compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_56acc09b-270d-4ea8-beaa-4dd2a236e1e3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_2d14cd82-2572-4c59-b2b5-dabdd157abbe_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement amount awarded to other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_e3987798-2b98-4c2d-98e0-0c0976e9c316_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Third Year</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_c92e1bce-54fb-473a-be7a-adc8a296b570_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c876560f-691c-4787-bc19-1714df88ab7e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_2e5257cc-e05c-458b-b5a4-5389a4ef909f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExpectedAmortizationExpenseLineItems_4d39393c-4629-4a6a-a519-5dc5f890857d_terseLabel_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Line Items]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseLineItems_label_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Line Items]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseLineItems_documentation_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseLineItems" xlink:href="dva-20201231.xsd#dva_ExpectedAmortizationExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems" xlink:to="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f2678396-e358-4d2f-b8a8-200f661bdd77_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross (excluding goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_95423172-4156-4456-9511-62d4361e5d36_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_62ea4b8a-85a5-419c-8f68-50d6f641ff18_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0cfb6c6a-2c88-4772-be01-faccb2351981_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncomeTaxesTable_7bb9b2af-3c2e-4e23-a9c4-4a02f49987b0_terseLabel_en-US" xlink:label="lab_dva_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_dva_IncomeTaxesTable_label_en-US" xlink:label="lab_dva_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_dva_IncomeTaxesTable_documentation_en-US" xlink:label="lab_dva_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable" xlink:href="dva-20201231.xsd#dva_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncomeTaxesTable" xlink:to="lab_dva_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_49e04980-c352-43a7-9b16-fc05131f109b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-qualified deferred compensation plan, contributions</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_3d56a9d5-f674-4a4c-8748-7689546f82b5_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts charged to income</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_91ab822d-3ba6-4670-94de-d58a942c7721_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_f6949c4d-660c-4c0f-b8be-b479026c4574_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_452813ec-ff2c-4850-aea9-5ceb531b85a0_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_de58eb78-e394-41ca-832e-10f9757c367c_terseLabel_en-US" xlink:label="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Accounts Receivable Six Months Or More Past Due</link:label>
    <link:label id="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_label_en-US" xlink:label="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Accounts Receivable Six Months Or More Past Due</link:label>
    <link:label id="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_documentation_en-US" xlink:label="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Accounts Receivable , 6 months or More Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:href="dva-20201231.xsd#dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:to="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8f0656d3-d632-47be-999f-d3427fa7025a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_2690eb15-458f-4c60-9044-764c2332bde0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_1b504b1c-39ac-4aac-afbd-723ef305d22b_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_ccce95bd-27ed-4209-a2e4-50169374d2cc_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other asset impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8a7736ec-3043-494c-a960-e44230298ab0_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due under operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_b8ca12e4-dc82-40ca-923b-599ba13b16f3_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_35fc32fa-f794-43ee-b3dd-b50f11cdac67_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_fc28790a-2d10-4cf5-a2f0-e3265f3f3714_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_9654a53a-3743-40f4-b589-774c06e55954_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma basic net income per share from continuing operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_7bd25bb9-b1da-4131-9403-9bc03bfb2115_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_02b4ef25-ada9-407a-86b6-4ea874dc52e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of debt expense reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_deb39ca0-a91d-4ecb-a49b-241706cf3846_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive income into net income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_dc937232-72cd-452e-bd90-0becd9a57e3c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_0c090101-ae4c-4547-8d25-3dfdc4f7f878_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_2b7af45f-3bf6-4333-b5ab-3afac98adaac_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_b2ab8ccb-2724-4724-a631-6c3ba7614710_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, gross asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a5a1ea82-ee85-4096-a6c6-264880453f1f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant&#160;other observable&#160;inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_ae234e5b-8242-48f3-aa6d-a37ea3018b54_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Other Information</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_a62af971-5231-45f9-9108-e1f40516dedd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_77a4ce52-60b0-4818-a904-a7d4e0619b09_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_49b918f5-8d04-4134-950c-adbbbfee1cdd_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0563f67a-3ded-4464-8632-be259a05984f_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_c158d8b6-a6c5-44b8-a4b8-cfcfcf963f1f_terseLabel_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_label_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid [Member]</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_documentation_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember" xlink:href="dva-20201231.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicaidandManagedMedicaidMember" xlink:to="lab_dva_MedicaidandManagedMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_e24b24f4-13e7-440f-b162-4dc06d32f782_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of interest rate agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_5e51c302-e360-413d-8a42-ff0c9d6b97cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_8824a54d-af5e-49f6-9eb5-42176a6a472b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_009535bd-0799-4f87-ba19-c666b4437943_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_e0dcde08-ba50-4f8c-8d02-d37b12442a5a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_dd451e88-17f5-4019-b8a6-78cb618501f1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2569ba51-07cf-4dd9-bf59-7c38c57e57eb_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_84eb41d9-8092-48ce-92e1-f422915e143a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_d1feb019-f7a9-47b9-8344-156f49921beb_terseLabel_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_label_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors [Member]</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_documentation_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other government payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember" xlink:href="dva-20201231.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherGovernmentPayorsMember" xlink:to="lab_dva_OtherGovernmentPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_53b3df99-e6af-4e3a-877a-ef8cd1ef5a26_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_866a67df-e630-4ace-9171-f771e5c781c0_terseLabel_en-US" xlink:label="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect of transfers from to noncontrolling interests on stock holders equity disclosure</link:label>
    <link:label id="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_label_en-US" xlink:label="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Effect Of Transfers From To Noncontrolling Interests On Stock Holders Equity Disclosure [Text Block]</link:label>
    <link:label id="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_documentation_en-US" xlink:label="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Effect Of Transfers From (To) Noncontrolling Interests on Stock Holders Equity Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:href="dva-20201231.xsd#dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:to="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3e524001-8957-4ee8-a72a-b46a979b33fc_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock_6e342077-92d4-4b82-bd62-f34cdd90a482_terseLabel_en-US" xlink:label="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self insurance</link:label>
    <link:label id="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock_label_en-US" xlink:label="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Self Insurance Policy [Text Block]</link:label>
    <link:label id="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock_documentation_en-US" xlink:label="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and self insurance policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:href="dva-20201231.xsd#dva_InsuranceAndSelfInsurancePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:to="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fbc6727a-4e33-4dc8-a371-c4b713bf9e78_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_be5440b7-658a-4ea4-8d63-ffa10e5148f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5064afa9-ecf8-4450-ac18-3d56c8ea3720_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_79aebe8d-4618-45a0-9603-0874d561aef7_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued non-income tax liabilities</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_52041f2a-db2a-4cf2-9266-e50a3b9f4263_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_6ee0e4c1-3f5d-44b4-8e71-3455f842ef5c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_3df2dfda-02dd-4c69-b05f-422c9cdd7b8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_8938b3c7-08c3-4069-a5b5-1ef5e4da3430_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, short-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_450c0032-4e65-4e13-868b-3b544f734346_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_5ed9ab79-f32d-4aab-8e94-a4733ff52098_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Information Related to Assets Held For Sale and Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_941186c3-4f9e-4454-a54e-6173bfc4d387_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable" xlink:to="lab_us-gaap_InvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_8f16d72d-40ae-4d57-8ec0-a9159c69cf9b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of additional noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfSites_50254e11-114b-461b-bffa-188bfb99e952_terseLabel_en-US" xlink:label="lab_dva_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of dialysis centers that the company operated or provided administrative services</link:label>
    <link:label id="lab_dva_NumberOfSites_label_en-US" xlink:label="lab_dva_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Sites</link:label>
    <link:label id="lab_dva_NumberOfSites_documentation_en-US" xlink:label="lab_dva_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfSites" xlink:href="dva-20201231.xsd#dva_NumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfSites" xlink:to="lab_dva_NumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_ab5f942c-8f9c-4b70-ae3f-74a7f4782bfd_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_6c936ceb-8050-41e6-b725-bb889c2c440e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f7622e87-bad7-4775-b352-b23dd600f61b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues before provision</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d8aa153a-03f9-4730-acff-d54d1e92c877_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_9d98522b-8818-425f-94e3-8ee8a4b8af51_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_251d99ff-24de-4f03-880e-d3817f76328b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_967a7c4b-d87a-4f22-8d0a-b6cc1d084438_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_c30ed52a-de8c-4062-b170-b1e70f188f3d_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b1c4452a-f034-46eb-ae05-872a6c9afebe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock awards exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_6bb7b6db-2841-4e3c-8b1d-d3cf81b22280_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_f7b34328-6d64-4a52-af40-d85f896f4241_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EmployeeStockPurchasePlanMember_2e7095b9-dbcf-4e1b-a592-62cab5d49e33_terseLabel_en-US" xlink:label="lab_dva_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_dva_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_dva_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_dva_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_dva_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeStockPurchasePlanMember" xlink:href="dva-20201231.xsd#dva_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EmployeeStockPurchasePlanMember" xlink:to="lab_dva_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8a526bd2-f4b2-4fec-916a-1fe1707125bc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_525146a8-68cb-428c-bd08-b15cc3227701_terseLabel_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA or Operating Income Performance Targets or Quality Margins</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_label_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E B I T D A Operating Income Performance Targets Or Quality Margins [Member]</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_documentation_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA operating income performance targets or quality margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:href="dva-20201231.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:to="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_2cf0f231-465c-4fbd-9363-847704cd9447_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_4c9196a6-8da3-45a9-b6e7-fb8d01e3bf29_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, weighted average effective interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_4fafd9be-3826-4af9-8229-9d5b7c08e2b5_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_057b5fa6-b82b-4e5c-9286-532967794c45_negatedLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_c89cdcd1-3bed-460a-b75f-b6e908f3dfd3_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_7351435c-97e8-4567-8078-499c97f94a39_terseLabel_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit and other time deposits</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates Of Deposit Commercial Paper And Money Market Funds [Member]</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit, commercial paper, and money market funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:href="dva-20201231.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:to="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract_d2aa33c7-8712-4a93-9016-8d6d51761e8e_terseLabel_en-US" xlink:label="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Footnotes to Selected Quarterly Financial Information:</link:label>
    <link:label id="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Quarterly Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelectedQuarterlyFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:to="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_24df7e21-9f93-4f5c-894c-7bd03841ea94_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award payment plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ff71da3d-7231-4485-9b4c-ef259044ed9f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_d3e94bbb-dcc3-46f7-938b-f9c8c362e7d1_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet the More-Likely-Than-Not Threshold</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_796ac441-7bf2-40a3-8490-d57bdf02a7f7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_d8311504-594c-4871-9f53-180dd8c6c4c0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_05e519a4-5f08-4534-ad00-ce50d7b63a67_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value of grants (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_124253fd-c782-46dc-bad7-dabab1feb620_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_00d5ab41-3eec-4559-8fd1-c494b60e0f21_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableAbstract_db251ffd-13fe-4377-bc5d-23a37cf59f2a_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes:</link:label>
    <link:label id="lab_us-gaap_NotesPayableAbstract_label_en-US" xlink:label="lab_us-gaap_NotesPayableAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableAbstract" xlink:to="lab_us-gaap_NotesPayableAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_d80e76fc-9518-4c39-809c-a3291a46a72b_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_94118e84-0b36-4b01-90cd-bd632cdb0da0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f9eabbf4-f466-4461-afad-0b6b0a67084d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_897e5d45-5a13-493d-bede-07f155d2f5a9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_9b67b334-2f5d-4bcf-aa7a-3aa42e54ce18_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of noncontrolling interests primarily attributable to non-tax paying entities</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_4f2c4497-ff95-406f-a013-7a622b00674e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b8957144-e04b-41e8-9227-26d66a05be5f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_951dea94-f6d8-4468-ba04-871ec74c23b2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_62f4d0d8-4426-4831-b022-53f8e03c0d9a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense under all operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8be34c7f-3356-412c-a4ca-4408b7834830_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_91016242-98af-42f6-9bdd-21439830f648_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_2210f725-45db-43b0-8ae9-624e8a51182c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8574a324-596a-4e73-94a9-f2a6fa7ae1d1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c27ef9d0-935f-478a-991a-566ee5e34bec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_54969ae3-5615-465a-8a70-174e176056c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, footnotes to the table</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:to="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeasesDisclosureTable_b269393f-f347-415b-be13-5bb9bbc2f82f_terseLabel_en-US" xlink:label="lab_dva_LeasesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Table]</link:label>
    <link:label id="lab_dva_LeasesDisclosureTable_label_en-US" xlink:label="lab_dva_LeasesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Table]</link:label>
    <link:label id="lab_dva_LeasesDisclosureTable_documentation_en-US" xlink:label="lab_dva_LeasesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable" xlink:href="dva-20201231.xsd#dva_LeasesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeasesDisclosureTable" xlink:to="lab_dva_LeasesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ccb28784-7db1-410f-aada-019cc34da8a1_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions related to lapse of applicable statute</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9452da62-ffe9-46a9-b8e1-d7e4494f1a29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_683c02dc-8f16-4044-a011-d317f2a6e565_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_48c6c12a-3649-49dc-a2f9-327c585c11a1_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c98e1d9a-62a9-44c4-a444-1ee1403af24a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock-settled awards excluded from calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_a952a9ee-e721-4609-96ba-719d0b2e7b81_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income tax</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_e4b030b5-8af0-48b9-bcd5-c65844095955_terseLabel_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_label_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_documentation_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:to="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_55fd8ae9-4e84-462a-b285-9c2ff6c9bb2b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_c6f201a3-6423-48ee-899b-4dc32d5e292a_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_5436b086-9016-4d2a-b6fe-6d5190878895_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash charges, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5f0ee228-237b-4896-b997-83c8edb2c93e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_cb4d703e-0e46-4b85-bd4e-feb712c375a6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f331527c-c2d2-43c8-88c8-0a64c820d415_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_adaa4819-29f3-4a84-9ae2-a7f482ef9d30_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsExpirationDate_b7e194df-227d-40e8-9da1-1a20c3b6a404_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, expiration date</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsExpirationDate_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_dffa144e-611f-4ddd-a38b-9dcda57d8be1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0014790b-e126-4252-9978-f7cb862d9f3f_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_81f3d8f4-5b59-44c7-9d80-aa485120fd3a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_b8b22e36-cd20-49ab-8ca8-1c0e61578d23_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5e353e63-1a1a-4f4f-8b77-8407787940b8_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_d9ba1a6f-0139-42a9-bfe0-5c41904b33cc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b6733e6d-7d9e-453a-8c23-e65b29abf7fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_90c84b6e-ef81-4c57-bbfe-dc19fad107dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_aad61063-d8cf-4cbb-ae7a-7d095a25dab1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_41797ff4-46f0-4a16-b7cd-72f72b98f67d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_c6b0cd31-8aa6-4449-9db8-07f9d2865611_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_7569933f-fd7d-421d-bbe3-0d6ca8956706_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt totals:</link:label>
    <link:label id="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_f86ba677-90fa-44f6-b7bd-8a09236fae2d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_be2d17ff-319e-4e2b-945e-c65aec5b714f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1f4a3afb-0365-4af1-a945-d25eb20fa78a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_5b18c210-85e7-49cf-b043-7327f60de965_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_fb7116a0-30b7-4a38-9dd5-822cfcb13e93_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:to="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_49795387-b731-430b-9c51-fe60e267a574_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_2faf7bb6-950a-47ab-8172-29308e97f9e0_terseLabel_en-US" xlink:label="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase And Sale Agreement Aggregate Purchase Price</link:label>
    <link:label id="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_label_en-US" xlink:label="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase And Sale Agreement Aggregate Purchase Price</link:label>
    <link:label id="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_documentation_en-US" xlink:label="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase And Sale Agreement Aggregate Purchase Price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:href="dva-20201231.xsd#dva_PurchaseAndSaleAgreementAggregatePurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:to="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_c3a437ec-c53c-4fef-bad7-798500eb16d6_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_4cbf1dc7-2718-4f77-a7a0-70261bd454c3_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive losses (income) into net income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f8a461cc-88de-48a4-b729-f1e7312e6ab1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bfec2284-f763-4fbb-883a-55228675f8ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c0a5f48f-379b-4faa-b41f-47b3fdce2a23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_cc0fe301-7304-4413-a5b9-59105bc3ee92_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TaxYear2029Member_01068190-0c83-4353-a3e7-36784c18253f_terseLabel_en-US" xlink:label="lab_dva_TaxYear2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029</link:label>
    <link:label id="lab_dva_TaxYear2029Member_label_en-US" xlink:label="lab_dva_TaxYear2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029 [Member]</link:label>
    <link:label id="lab_dva_TaxYear2029Member_documentation_en-US" xlink:label="lab_dva_TaxYear2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TaxYear2029Member" xlink:href="dva-20201231.xsd#dva_TaxYear2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TaxYear2029Member" xlink:to="lab_dva_TaxYear2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_54a6bd26-6696-4731-b24c-dec0ae3b6433_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue disaggregation table footnote</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_8a53f55e-a5a3-4a9f-8e15-ecb81394fc85_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_d458ab86-e6ec-42c9-997b-2d3e2c98ab02_terseLabel_en-US" xlink:label="lab_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation adjustment on disposal group</link:label>
    <link:label id="lab_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_label_en-US" xlink:label="lab_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Valuation Adjustment</link:label>
    <link:label id="lab_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_documentation_en-US" xlink:label="lab_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Valuation Adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" xlink:href="dva-20201231.xsd#dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" xlink:to="lab_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_95618202-010e-4acf-ac45-8d2f643aabee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_409264d4-e553-48c4-b513-46da64b2985f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_625880c1-df19-4cd2-a027-127500ac5330_terseLabel_en-US" xlink:label="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</link:label>
    <link:label id="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_label_en-US" xlink:label="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</link:label>
    <link:label id="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_documentation_en-US" xlink:label="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:href="dva-20201231.xsd#dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:to="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_53ad6ae2-6748-46e3-989e-d7293568c798_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted or Issued, Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a2464b38-581e-40ea-adfb-0480e6295696_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_2d0308c8-1c9f-4a35-bb7d-cf030a8aa99e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_30e7a4f4-4b85-46b2-9f97-a20902ab89c5_terseLabel_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term purchase commitment, percentage of quantity required to be purchased</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_label_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Purchase Commitment Percentage Of Quantity Required</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_documentation_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term purchase commitment percentage of quantity required.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:href="dva-20201231.xsd#dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:to="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a1b1f88a-ca63-47b9-a4ef-a3a2987310fd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchase shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_46b4c7cf-7b6d-4fc9-a8d8-03c27f068b3b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued for employee stock purchase plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_5924a3cb-9874-4d31-b8a9-e666b8a2c73c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3d8d79aa-0d14-49e5-9c8d-6e4190709b06_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_85a08ad3-db9b-47e9-bb91-5f583c642b21_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for uncollectible Accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_774bcd7a-1dc3-413b-a4c2-7813acdac736_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_9483c39b-4df3-4a8a-a078-f422874a3cf6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_577c2835-6319-45a0-bdaf-33d88da18685_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 3.75% due 2031</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_label_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:href="dva-20201231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:to="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2d22ccf2-ba21-417f-ae79-edcf1bea62cb_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments exercisable number.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_804ffbb7-a7ee-4575-9f2d-92919812c245_negatedLabel_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount and deferred financing costs</link:label>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_label_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount And Deferred Finance Costs</link:label>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_documentation_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount and deferred finance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts" xlink:href="dva-20201231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DiscountAndDeferredFinanceCosts" xlink:to="lab_dva_DiscountAndDeferredFinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanBMember_ce3dadbc-5fce-4292-9f63-c301a819ece9_terseLabel_en-US" xlink:label="lab_dva_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:label id="lab_dva_TermLoanBMember_label_en-US" xlink:label="lab_dva_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:label id="lab_dva_TermLoanBMember_documentation_en-US" xlink:label="lab_dva_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanBMember" xlink:href="dva-20201231.xsd#dva_TermLoanBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanBMember" xlink:to="lab_dva_TermLoanBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_7daeb0ba-d338-44c8-b559-561bc2753a40_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_244fb09f-c907-4687-be86-a2564aebfcfa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_6a0d0d3a-e0ef-4562-aaa8-acd21b40001d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ea82038a-75ef-4b45-9b82-8b83f2ffe896_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_5b0dc99d-d967-4a37-b36c-bf2135b1afc5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_57dee384-71be-4828-b07f-5240fd58a712_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_8d62564a-290e-4d10-9200-18aa7d960cf5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities:</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentsAbstract" xlink:to="lab_us-gaap_DebtInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanAMember_e43590b3-b434-46d5-88ca-b4b76b5367b8_terseLabel_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_dva_TermLoanAMember_label_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_dva_TermLoanAMember_documentation_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember" xlink:href="dva-20201231.xsd#dva_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanAMember" xlink:to="lab_dva_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_bdd54aaa-0316-472f-b14e-ff061ecb4d4c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_abb7c0c7-33b7-417b-b9c9-670f44e96725_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAbstract" xlink:to="lab_us-gaap_TreasuryStockValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherReportingUnitsMember_1844c0f0-c127-4ef9-9968-cefe8f85950a_terseLabel_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other reporting units</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_label_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_documentation_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember" xlink:href="dva-20201231.xsd#dva_OtherReportingUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherReportingUnitsMember" xlink:to="lab_dva_OtherReportingUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_c5e9ed14-6655-4ece-9afa-746f703d786e_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets other than Goodwill</link:label>
    <link:label id="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Intangible Assets Table [Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Intangible Assets Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:href="dva-20201231.xsd#dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:to="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_7fe9b536-ffb5-4b34-bc6c-489328c7733c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_4a70c97e-9717-4788-afa9-131d1a304b3b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_622f77a3-55c4-45a3-b0b4-12a5e07a3ac3_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:href="dva-20201231.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f7b115ba-61f8-4969-a27e-cb6698e420c7_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_b38d50e0-f7b4-4f22-8de6-48e05ce85819_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df565d12-7cce-4940-8f18-c18d6f3dcec4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_144791eb-0e0e-4961-9ecb-9a9d70a88de5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f721a851-3edd-47a0-9e95-f9f1ab779d29_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR plus interest margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4e903f56-115d-4aa8-b856-c59776797dd7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d70dae5c-b541-47bb-9830-d91b7dfdb27e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6ea157d0-a3aa-4b7b-8a7b-c5d8e93fee71_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information footnote:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_149237bb-7e7e-49ee-8e59-2289bdaa0667_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_99ad51e0-42f4-4530-bd59-518fdde76a65_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_e056890f-abb9-4c42-827d-92639f02cb4d_terseLabel_en-US" xlink:label="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_label_en-US" xlink:label="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_documentation_en-US" xlink:label="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:href="dva-20201231.xsd#dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:to="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PayorRefundsAndRetractions_3eed7deb-c8a8-4dce-abde-4bd044c92733_terseLabel_en-US" xlink:label="lab_dva_PayorRefundsAndRetractions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor refunds and retractions</link:label>
    <link:label id="lab_dva_PayorRefundsAndRetractions_label_en-US" xlink:label="lab_dva_PayorRefundsAndRetractions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor Refunds And Retractions</link:label>
    <link:label id="lab_dva_PayorRefundsAndRetractions_documentation_en-US" xlink:label="lab_dva_PayorRefundsAndRetractions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor Refunds And Retractions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PayorRefundsAndRetractions" xlink:href="dva-20201231.xsd#dva_PayorRefundsAndRetractions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PayorRefundsAndRetractions" xlink:to="lab_dva_PayorRefundsAndRetractions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b8902060-a583-4bc1-908a-2660ba949cd3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeasesOtherInformationAbstract_e6cf2781-f020-4d5f-9d45-df9c43aeb6ae_terseLabel_en-US" xlink:label="lab_dva_LeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Other Information [Abstract]</link:label>
    <link:label id="lab_dva_LeasesOtherInformationAbstract_label_en-US" xlink:label="lab_dva_LeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Other Information [Abstract]</link:label>
    <link:label id="lab_dva_LeasesOtherInformationAbstract_documentation_en-US" xlink:label="lab_dva_LeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Other Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesOtherInformationAbstract" xlink:href="dva-20201231.xsd#dva_LeasesOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeasesOtherInformationAbstract" xlink:to="lab_dva_LeasesOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_f4da0d36-182b-4eb1-a7c9-92fcaf812f74_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_03d87792-eefc-4e3c-85f1-3d993d5f35fc_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_a8e0667d-f90c-4f74-a5ea-c4adcd549b45_terseLabel_en-US" xlink:label="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]</link:label>
    <link:label id="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_label_en-US" xlink:label="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]</link:label>
    <link:label id="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_documentation_en-US" xlink:label="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:href="dva-20201231.xsd#dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:to="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b9990e07-9579-434b-89d9-04225cf421cf_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_f9465808-e062-483a-9c12-b0530b1e8036_terseLabel_en-US" xlink:label="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of legal entities that third parties held noncontrolling equity interests</link:label>
    <link:label id="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_label_en-US" xlink:label="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Entities That Third Parties Held Non Controlling Equity Interests</link:label>
    <link:label id="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_documentation_en-US" xlink:label="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of entities that third parties held non controlling equity interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:href="dva-20201231.xsd#dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:to="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_8d1ae5e2-7b1d-414c-9110-cb6c835f0fcb_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_14a93bdc-fb3d-4d09-89fb-23e0198f2707_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_a847519a-db7a-4261-ae1e-4cf1a346e981_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeasesDisclosureLineItems_59432a3f-2c95-442a-945d-e2c0f3b3c2f5_terseLabel_en-US" xlink:label="lab_dva_LeasesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_LeasesDisclosureLineItems_label_en-US" xlink:label="lab_dva_LeasesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_LeasesDisclosureLineItems_documentation_en-US" xlink:label="lab_dva_LeasesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems" xlink:href="dva-20201231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeasesDisclosureLineItems" xlink:to="lab_dva_LeasesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_0d3d45fb-1d4f-4253-b446-891da7574a69_terseLabel_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_label_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_491d5b84-6ab3-4518-aae2-5b9d11a87c52_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_eb7f32a7-7871-4f2e-85ef-8fa1bbfe809d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8732e66f-9d4c-4eb0-9abf-e34d1a6f2262_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_850a7066-a701-468c-9edd-a4912509a697_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a198d8e-41ee-4489-ade0-3259a706cd5e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4ed3e6e-7db0-4794-aa05-0bd26c9feb26_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash of continuing operations at end of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_b8f14a08-3b9a-4101-8cc6-03ddcd929cad_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, expiration date</link:label>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_2ef823da-28c2-4c9e-869b-2e4928352632_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_label_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMaturityDates" xlink:to="lab_us-gaap_DerivativeMaturityDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_cf5efcc4-6329-4261-98d8-9078b849c12c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_12c867d5-f971-43e0-ab6e-a17139e355d5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_0f16f7bc-fedd-4eeb-98bd-b845d3a2cbdc_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_23d52973-4973-4d48-af83-e6efe06dbc7a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4f4669dc-de1e-4cb9-832a-b8a835403c22_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_321893c5-a4f1-443c-b4a0-7f4cfde7bb27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Summary of Results of Operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExpectedAmortizationExpenseTable_90e7904c-1e0e-4db7-9b4f-61c9adcf2e49_terseLabel_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Table]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseTable_label_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Table]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseTable_documentation_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseTable" xlink:href="dva-20201231.xsd#dva_ExpectedAmortizationExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExpectedAmortizationExpenseTable" xlink:to="lab_dva_ExpectedAmortizationExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_1edf2c6a-d554-4848-8079-3f21f5b4a505_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_de5bbf43-2bb7-4260-9e6f-3ca299b1a346_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_2b355778-88ed-4527-8ffc-56097409a958_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_28982055-aebe-4e76-8846-96d1298ed285_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_893abc97-e114-4669-8441-e2cba3ea472d_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_ca726c41-b212-4ddd-8fd1-1a711f61edb3_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets by Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_e46cbd2a-b3ef-49d9-bad8-349faa108a86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards_5a58ef1f-f170-4fcf-b16b-480fb41a8e6b_terseLabel_en-US" xlink:label="lab_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards</link:label>
    <link:label id="lab_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards_label_en-US" xlink:label="lab_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards</link:label>
    <link:label id="lab_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards_documentation_en-US" xlink:label="lab_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" xlink:to="lab_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c02659ed-b530-4996-927b-5d0748010bc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock awards exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_d0e3d1ed-a425-4ae9-a499-e306abf35ac3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Accelerated Cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Accelerated Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e7ad5f1a-8b41-45a0-bd3b-4a37347587ee_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_85b9c698-82bd-49fa-8239-f37014f02d21_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bb337840-50e0-4755-970a-bb9514112278_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, upper range (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_1fbfeac9-dc44-4b7e-8d74-0b1a4b0c04d0_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_db23261b-5e26-42de-aafb-5ce4fc5b1554_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a7128a89-bf2f-4358-b049-048de10871af_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_c44caf86-001d-4813-9bc2-b0e80e2d08cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d061c6b1-c5a9-49fd-a06f-a65094d313ae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_67b80a44-ba99-419b-a6bc-e58dc288464d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_b7d1cdd2-d004-4194-8e53-0c1a1177a134_negatedTerseLabel_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_label_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Operating Lease Assets</link:label>
    <link:label id="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_documentation_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from operating lease assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:href="dva-20201231.xsd#dva_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:to="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CharterdocumentsandDelawarelawAbstract_935338ff-95e9-462d-95c1-95a1acf7fd2b_terseLabel_en-US" xlink:label="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charter documents and Delaware law:</link:label>
    <link:label id="lab_dva_CharterdocumentsandDelawarelawAbstract_label_en-US" xlink:label="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charter documents and Delaware law [Abstract]</link:label>
    <link:label id="lab_dva_CharterdocumentsandDelawarelawAbstract_documentation_en-US" xlink:label="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charter documents and Delaware law [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CharterdocumentsandDelawarelawAbstract" xlink:href="dva-20201231.xsd#dva_CharterdocumentsandDelawarelawAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract" xlink:to="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_58b05838-d50e-4c99-ab55-cdfef7f7c2ee_terseLabel_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to Provide Operating Capital</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_label_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments To Provide Operating Capital [Member]</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_documentation_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:href="dva-20201231.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:to="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9c2b5dc8-8e50-4dd4-acb1-32d0f672b2f2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity on revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_6cf257c0-59d7-4fec-bec5-1931e96eca0c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_06f78c2e-aa49-4335-93c6-4bb92450d82d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_03ebb58e-e2b4-46cf-8cd0-8c16fa633570_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_a9bcd5b8-e491-4f2e-8aa2-a8279d56d605_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ee7570c7-5352-49fe-ae2b-c951def2962e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_3a02660d-2f61-46b8-8ed3-23d6bf18d13c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a33742ee-67cc-4b5f-8799-d5ed98e5cbde_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Total</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8f9f056a-f81d-42e8-b42b-6c56644c44ce_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_7fc00e4e-bcfb-480e-bfd5-162f0c6427b7_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending legal settlements</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RangeTwoMember_48171a5b-c675-49aa-8b77-756633b3e06e_terseLabel_en-US" xlink:label="lab_dva_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$60.01&#8211;$70.00</link:label>
    <link:label id="lab_dva_RangeTwoMember_label_en-US" xlink:label="lab_dva_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:label id="lab_dva_RangeTwoMember_documentation_en-US" xlink:label="lab_dva_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeTwoMember" xlink:href="dva-20201231.xsd#dva_RangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RangeTwoMember" xlink:to="lab_dva_RangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1495b167-4d1e-4f23-98a0-f83fd68d6a72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8607f827-2541-4e76-9ef6-7c1b94f7e37a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ba0192e0-351e-43bf-8e25-1d3a183b4481_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_baf20bff-b91d-48d3-9bfc-05d0b27ec5fd_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, long-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_586c7c4a-f006-4668-a1c6-029a45f9ef96_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_20c48c30-4a61-4a80-98e8-80d925621ea2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other potential commitments to provide operating capital to several dialysis centers</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ceda6fde-e1c7-4daa-8234-85a04c772d79_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_c7382a9a-bbc2-40df-a587-518f2b5e0fa8_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes_2fbc54f6-d690-4251-9dc8-8d252bf999a0_terseLabel_en-US" xlink:label="lab_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes</link:label>
    <link:label id="lab_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes_label_en-US" xlink:label="lab_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes</link:label>
    <link:label id="lab_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes_documentation_en-US" xlink:label="lab_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" xlink:to="lab_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_7f7a5bb6-3c0e-4593-a4a8-b79156d717d5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentContinuingOperationsMember" xlink:to="lab_us-gaap_SegmentContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b6abe51f-3408-4f5c-aef3-a9a5cabadb66_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_f3ac1e71-a2d7-427d-b825-8b7ee4568ef0_terseLabel_en-US" xlink:label="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</link:label>
    <link:label id="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_label_en-US" xlink:label="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</link:label>
    <link:label id="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_documentation_en-US" xlink:label="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:href="dva-20201231.xsd#dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:to="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_3e6d3ac0-8d7a-4628-b784-74f61b2c4518_terseLabel_en-US" xlink:label="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Lease Assets Obtained In Exchange For Lease Liabilities</link:label>
    <link:label id="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_label_en-US" xlink:label="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Lease Assets Obtained In Exchange For Lease Liabilities</link:label>
    <link:label id="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_documentation_en-US" xlink:label="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Lease Assets Obtained In Exchange For New or Modified Lease Liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:href="dva-20201231.xsd#dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:to="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_89ad671d-5911-4196-9b44-527b6d5f5f78_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7e5fff3f-711d-40f5-b414-161396854636_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_23ff9d54-3571-4d44-85b8-9a56dce7f9d8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CashPaidDuringPeriodForAbstract_5412c737-212b-4843-9fbc-2a8bf9613973_terseLabel_en-US" xlink:label="lab_dva_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid:</link:label>
    <link:label id="lab_dva_CashPaidDuringPeriodForAbstract_label_en-US" xlink:label="lab_dva_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During Period For [Abstract]</link:label>
    <link:label id="lab_dva_CashPaidDuringPeriodForAbstract_documentation_en-US" xlink:label="lab_dva_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during period for.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidDuringPeriodForAbstract" xlink:href="dva-20201231.xsd#dva_CashPaidDuringPeriodForAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CashPaidDuringPeriodForAbstract" xlink:to="lab_dva_CashPaidDuringPeriodForAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockIncentivePlanTwentyElevenMember_35a83cab-2bae-4d6c-8141-20de3b2d83c5_terseLabel_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive 2011 Plan</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyElevenMember_label_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan Twenty Eleven [Member]</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyElevenMember_documentation_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan 2011 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyElevenMember" xlink:href="dva-20201231.xsd#dva_StockIncentivePlanTwentyElevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockIncentivePlanTwentyElevenMember" xlink:to="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LesseeLeaseDescriptionLineItemsAbstract_06a4fc97-1539-49bd-b795-b914372883a9_terseLabel_en-US" xlink:label="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_LesseeLeaseDescriptionLineItemsAbstract_label_en-US" xlink:label="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_LesseeLeaseDescriptionLineItemsAbstract_documentation_en-US" xlink:label="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items] [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:href="dva-20201231.xsd#dva_LesseeLeaseDescriptionLineItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:to="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6352ace2-595b-405e-9db4-708e1cd83a30_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New accounting standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ce0cec8f-90c3-4be6-84bf-6fda1daf4e2a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_1b87ec18-a391-40d8-8cb3-c83986e517fb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_f70a5b98-af7b-4b19-8888-1f44b19fd03f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>dva-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cb65dee0-3538-408a-90c8-cfac27791e84,g:bb413262-db44-4a11-afdc-c2a9f72b9180-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20201231.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_111c97b9-dfe2-4686-9019-60a592688e49" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_DocumentType_111c97b9-dfe2-4686-9019-60a592688e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_3e3aa00d-6c6d-4da0-9b09-f577d1383a73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_DocumentAnnualReport_3e3aa00d-6c6d-4da0-9b09-f577d1383a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_cdf8f31c-2e35-44c2-af4e-5be5c97ec0d0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_DocumentPeriodEndDate_cdf8f31c-2e35-44c2-af4e-5be5c97ec0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_1e1a99eb-1e48-40d0-9a73-858735bf8e73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_CurrentFiscalYearEndDate_1e1a99eb-1e48-40d0-9a73-858735bf8e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_455b6159-184e-4d09-8556-35586386152c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_DocumentTransitionReport_455b6159-184e-4d09-8556-35586386152c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4974816e-f5d6-4e71-8469-f276e97d76bf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityFileNumber_4974816e-f5d6-4e71-8469-f276e97d76bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2de255db-07e6-4956-81b2-398b74d17e79" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityRegistrantName_2de255db-07e6-4956-81b2-398b74d17e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_af649d53-337c-41e9-b83c-fe099b2a9073" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_af649d53-337c-41e9-b83c-fe099b2a9073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8f68e1db-0f34-40ef-bce0-77bd77a4f351" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityTaxIdentificationNumber_8f68e1db-0f34-40ef-bce0-77bd77a4f351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3d4f1661-d9d5-4010-96fb-b8814e75ac22" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityAddressAddressLine1_3d4f1661-d9d5-4010-96fb-b8814e75ac22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_eca01737-13f5-44e1-bc1f-ac05b8824a3e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityAddressCityOrTown_eca01737-13f5-44e1-bc1f-ac05b8824a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d2a41a50-82e0-49a0-9740-46f3e065ab02" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityAddressStateOrProvince_d2a41a50-82e0-49a0-9740-46f3e065ab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f45f8b79-3064-42ca-b879-e60488eb5e83" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityAddressPostalZipCode_f45f8b79-3064-42ca-b879-e60488eb5e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c4d6f3c5-5c55-4333-be41-16150d91eae3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_CityAreaCode_c4d6f3c5-5c55-4333-be41-16150d91eae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_90197546-8a4a-4bf9-b141-54a69396ade6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_LocalPhoneNumber_90197546-8a4a-4bf9-b141-54a69396ade6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1974b090-5a17-4b5c-af4c-1cb0801e0139" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_Security12bTitle_1974b090-5a17-4b5c-af4c-1cb0801e0139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_75bd7c00-943f-453c-8371-ed0e175a114b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_TradingSymbol_75bd7c00-943f-453c-8371-ed0e175a114b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4fdaa50f-f8fe-4ef5-9aa6-d1c01aa79a4b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_SecurityExchangeName_4fdaa50f-f8fe-4ef5-9aa6-d1c01aa79a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_e8e167ff-97f9-421a-ad21-50ef2b23c1bb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_e8e167ff-97f9-421a-ad21-50ef2b23c1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_9844f166-1f8e-496a-a971-764f19cbacf1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityVoluntaryFilers_9844f166-1f8e-496a-a971-764f19cbacf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c4759a59-76e0-4233-8f67-ce82d2c3ae86" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityCurrentReportingStatus_c4759a59-76e0-4233-8f67-ce82d2c3ae86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b7cda706-b879-4999-931f-389538f19f30" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityInteractiveDataCurrent_b7cda706-b879-4999-931f-389538f19f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_21659cd0-7677-47b2-b6a9-a3ed7c49b935" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityFilerCategory_21659cd0-7677-47b2-b6a9-a3ed7c49b935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_fac366a5-eb5f-4256-8371-8f1e89329b07" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntitySmallBusiness_fac366a5-eb5f-4256-8371-8f1e89329b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d1241234-cd81-454d-b785-64cd03808441" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityEmergingGrowthCompany_d1241234-cd81-454d-b785-64cd03808441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_ca4b425c-2ccd-4ee7-8ffe-0dc0db27c054" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_IcfrAuditorAttestationFlag_ca4b425c-2ccd-4ee7-8ffe-0dc0db27c054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d69e543c-ebcc-4367-b520-add1b206ed52" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityShellCompany_d69e543c-ebcc-4367-b520-add1b206ed52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_18523637-ac50-4bab-b699-1e37e3b308de" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityPublicFloat_18523637-ac50-4bab-b699-1e37e3b308de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_43e821b9-a944-4546-a852-82a04ea31ca6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_43e821b9-a944-4546-a852-82a04ea31ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8c8fae8b-4c1a-4a61-a06f-179ba4f5dccf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_AmendmentFlag_8c8fae8b-4c1a-4a61-a06f-179ba4f5dccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_38953357-77d5-4c34-a758-9e2686633ff7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_DocumentFiscalYearFocus_38953357-77d5-4c34-a758-9e2686633ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6cb448f4-05cf-4c4e-9a9f-fc6e44f34b20" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6cb448f4-05cf-4c4e-9a9f-fc6e44f34b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_09e45312-4f2e-4498-82d9-084431488806" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d080d88-b027-468d-a9db-248fd3e8423f" xlink:to="loc_dei_EntityCentralIndexKey_09e45312-4f2e-4498-82d9-084431488806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0cdc0af4-ab2d-4cf9-9c51-cbaa96679c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0cdc0af4-ab2d-4cf9-9c51-cbaa96679c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProvisionForExpectedCreditLosses_6c18dc9f-af1c-4497-9e1a-cac363d93ed0" xlink:href="dva-20201231.xsd#dva_ProvisionForExpectedCreditLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_dva_ProvisionForExpectedCreditLosses_6c18dc9f-af1c-4497-9e1a-cac363d93ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_81c41b42-8672-486d-9a3a-e414a287ff46" xlink:href="dva-20201231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_81c41b42-8672-486d-9a3a-e414a287ff46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_5382cc58-8346-42a8-9680-72d1ef849fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_OtherIncome_5382cc58-8346-42a8-9680-72d1ef849fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_027395f3-8073-4101-aa74-b3ca6e864939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_Revenues_027395f3-8073-4101-aa74-b3ca6e864939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_6ed11f54-ef0c-4a17-b7df-4ac34cce9fce" xlink:href="dva-20201231.xsd#dva_PatientCareCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_dva_PatientCareCosts_6ed11f54-ef0c-4a17-b7df-4ac34cce9fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_624041ae-0ea0-48e3-b0d2-2b608d4181e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_624041ae-0ea0-48e3-b0d2-2b608d4181e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_50ac38b3-84f5-4feb-a222-a37042dc4575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_DepreciationAndAmortization_50ac38b3-84f5-4feb-a222-a37042dc4575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_47a3dc26-ddba-452d-b698-f2fa0c70ecfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_47a3dc26-ddba-452d-b698-f2fa0c70ecfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d272bc9-478b-4fb6-8821-9bafa9b9b3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d272bc9-478b-4fb6-8821-9bafa9b9b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_56a2bbac-3575-4859-8cf3-6fd37f564022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_56a2bbac-3575-4859-8cf3-6fd37f564022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_76e18c03-32b9-4d0c-97ab-7d878acbe2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_76e18c03-32b9-4d0c-97ab-7d878acbe2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_761f6781-7791-4bb1-bb31-1c46ccbcd075" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_761f6781-7791-4bb1-bb31-1c46ccbcd075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_86fb3365-ffb7-4908-b9a1-fc636e4e1f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ebd39a83-b5a2-4545-af68-be1dad21d117" xlink:to="loc_us-gaap_CostsAndExpenses_86fb3365-ffb7-4908-b9a1-fc636e4e1f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c1589c5b-f237-466d-b3da-6b7aee5f2acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_OperatingIncomeLoss_c1589c5b-f237-466d-b3da-6b7aee5f2acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_765b68f1-d6bd-40d0-839c-045245b37e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_InterestAndDebtExpense_765b68f1-d6bd-40d0-839c-045245b37e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_b007acd8-048f-4227-8860-49d376dbc87c" xlink:href="dva-20201231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_b007acd8-048f-4227-8860-49d376dbc87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4cc95eaf-09b3-486f-9f8b-256cd80e59ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4cc95eaf-09b3-486f-9f8b-256cd80e59ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73d4d780-341c-4738-9df3-64619f5a4b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73d4d780-341c-4738-9df3-64619f5a4b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1959a76f-d887-4c94-8ae1-d8ae97883dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1959a76f-d887-4c94-8ae1-d8ae97883dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_ab9814ca-44c9-4616-a995-e4f79171beab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_ab9814ca-44c9-4616-a995-e4f79171beab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_99146bf9-6392-47de-b0a6-ce14081c3f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_99146bf9-6392-47de-b0a6-ce14081c3f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bb7196de-7234-425f-92bd-150e76bdc341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_ProfitLoss_bb7196de-7234-425f-92bd-150e76bdc341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_687669d4-f1c4-4cce-82b5-c0a67aa3ec9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_687669d4-f1c4-4cce-82b5-c0a67aa3ec9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5b283aef-9298-4e1c-983d-052bbfe74f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_NetIncomeLoss_5b283aef-9298-4e1c-983d-052bbfe74f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e44a39c8-8cf2-4fd7-9559-2f4411e4be6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e44a39c8-8cf2-4fd7-9559-2f4411e4be6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_7186c9fa-bb81-4c92-a2c3-e757103b7474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e44a39c8-8cf2-4fd7-9559-2f4411e4be6d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_7186c9fa-bb81-4c92-a2c3-e757103b7474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_533b4629-ee5a-4d80-8ea5-5460fba37958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e44a39c8-8cf2-4fd7-9559-2f4411e4be6d" xlink:to="loc_us-gaap_EarningsPerShareBasic_533b4629-ee5a-4d80-8ea5-5460fba37958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_7c6b6dbe-f937-440b-b147-752ad2a16981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e44a39c8-8cf2-4fd7-9559-2f4411e4be6d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_7c6b6dbe-f937-440b-b147-752ad2a16981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_79e9db79-5c1f-4101-857b-6a50682a2be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e44a39c8-8cf2-4fd7-9559-2f4411e4be6d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_79e9db79-5c1f-4101-857b-6a50682a2be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_991029ab-d693-4300-b3f7-f39466b220c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_991029ab-d693-4300-b3f7-f39466b220c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_744171e7-7ed3-4d0b-8b8e-6218cd96661e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_991029ab-d693-4300-b3f7-f39466b220c7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_744171e7-7ed3-4d0b-8b8e-6218cd96661e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3cb27e2a-1c33-4dcb-938d-0f46fb94a292" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_991029ab-d693-4300-b3f7-f39466b220c7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3cb27e2a-1c33-4dcb-938d-0f46fb94a292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_92923340-83f2-4fa4-ba40-bf040ca6fb62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c3f0756-afd8-4cd6-9d35-3735a0e8e15a" xlink:to="loc_us-gaap_NetIncomeLossAbstract_92923340-83f2-4fa4-ba40-bf040ca6fb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_a1fcbc34-11ea-440c-8b35-f40df6b850f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_92923340-83f2-4fa4-ba40-bf040ca6fb62" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_a1fcbc34-11ea-440c-8b35-f40df6b850f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_aa9601ce-2bc1-4cd6-9f32-1258deb12c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_92923340-83f2-4fa4-ba40-bf040ca6fb62" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_aa9601ce-2bc1-4cd6-9f32-1258deb12c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_08f4685e-d3ae-40f9-90a7-4473b19d27bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_92923340-83f2-4fa4-ba40-bf040ca6fb62" xlink:to="loc_us-gaap_NetIncomeLoss_08f4685e-d3ae-40f9-90a7-4473b19d27bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME_1"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0c811a6-f17a-49a1-9c75-4a81678c45b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f3005b54-03d6-4798-aa55-0c612a54a1a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0c811a6-f17a-49a1-9c75-4a81678c45b9" xlink:to="loc_us-gaap_ProfitLoss_f3005b54-03d6-4798-aa55-0c612a54a1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6179d2b1-b35a-44aa-8bc6-817fb9f1c719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0c811a6-f17a-49a1-9c75-4a81678c45b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6179d2b1-b35a-44aa-8bc6-817fb9f1c719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c455ef5c-a898-45eb-a430-4835774b4320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6179d2b1-b35a-44aa-8bc6-817fb9f1c719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c455ef5c-a898-45eb-a430-4835774b4320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_cdf59135-4417-4cb2-9b36-9409530d2bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c455ef5c-a898-45eb-a430-4835774b4320" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_cdf59135-4417-4cb2-9b36-9409530d2bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_0d30110a-83e6-46ef-9877-09edd765055b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c455ef5c-a898-45eb-a430-4835774b4320" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_0d30110a-83e6-46ef-9877-09edd765055b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_f371a242-f2db-4fe6-b7df-a615ba1907e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6179d2b1-b35a-44aa-8bc6-817fb9f1c719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_f371a242-f2db-4fe6-b7df-a615ba1907e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_aef3465a-9756-4816-837c-f7374b322e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_f371a242-f2db-4fe6-b7df-a615ba1907e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_aef3465a-9756-4816-837c-f7374b322e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5830b116-1443-43df-8714-68cb69c08897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0c811a6-f17a-49a1-9c75-4a81678c45b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5830b116-1443-43df-8714-68cb69c08897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_38846285-4cbd-4d21-bbcf-6c83600bedbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0c811a6-f17a-49a1-9c75-4a81678c45b9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_38846285-4cbd-4d21-bbcf-6c83600bedbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_439319da-ca41-419b-a6eb-496636b6c76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0c811a6-f17a-49a1-9c75-4a81678c45b9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_439319da-ca41-419b-a6eb-496636b6c76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ef2ba502-bbf1-4fa9-b983-d646b5fcc195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0c811a6-f17a-49a1-9c75-4a81678c45b9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ef2ba502-bbf1-4fa9-b983-d646b5fcc195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_746a291e-904b-4ef1-b766-b6d3cc3c4c05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_746a291e-904b-4ef1-b766-b6d3cc3c4c05" xlink:to="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6a0803fe-e7dc-4ffb-95a6-39092ce10bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6a0803fe-e7dc-4ffb-95a6-39092ce10bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_28e8e81e-edf5-491c-b6d4-ea6964030521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_28e8e81e-edf5-491c-b6d4-ea6964030521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_577bae7a-8c03-4bd2-888b-7144958129c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_577bae7a-8c03-4bd2-888b-7144958129c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9fa49610-d5a9-4cdd-91ef-74716768d8d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9fa49610-d5a9-4cdd-91ef-74716768d8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5e099567-d3fc-4b5c-ae58-edea94fca517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_InventoryNet_5e099567-d3fc-4b5c-ae58-edea94fca517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_c2cfe824-07e4-4d24-ae12-2a6ae06dd6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_c2cfe824-07e4-4d24-ae12-2a6ae06dd6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4d8b21f-9cce-480d-b188-8e3ee71f13c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4d8b21f-9cce-480d-b188-8e3ee71f13c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_1548ee08-9f23-4bbb-89ab-238671886e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_IncomeTaxesReceivable_1548ee08-9f23-4bbb-89ab-238671886e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_098fcfa5-2541-4253-a8f3-ed9ef7aa9b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_AssetsCurrent_098fcfa5-2541-4253-a8f3-ed9ef7aa9b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7b467210-016c-490f-a191-83fa397f2469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7b467210-016c-490f-a191-83fa397f2469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f176fa8-86ec-42b9-ab42-d0177014b906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f176fa8-86ec-42b9-ab42-d0177014b906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ee5ec4af-9930-4228-800b-d00387957eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ee5ec4af-9930-4228-800b-d00387957eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c1c17252-2a9a-40ad-bc36-4ee8a093a6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c1c17252-2a9a-40ad-bc36-4ee8a093a6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_60421e47-8b9a-4bb6-8688-1a417e725349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_60421e47-8b9a-4bb6-8688-1a417e725349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6ed732a3-53bb-41ed-838d-eac6d285e123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6ed732a3-53bb-41ed-838d-eac6d285e123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_573d991b-0ed8-4ca0-bc6d-fd086765ba3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_Goodwill_573d991b-0ed8-4ca0-bc6d-fd086765ba3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7f5bb700-dd05-479a-b0b3-7e8ca63ee5fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4abae52d-e662-414b-be71-a2fb0593e15b" xlink:to="loc_us-gaap_Assets_7f5bb700-dd05-479a-b0b3-7e8ca63ee5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_746a291e-904b-4ef1-b766-b6d3cc3c4c05" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_9de8b7bb-9395-4c1e-a7ff-7801ffc5632d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_AccountsPayableCurrent_9de8b7bb-9395-4c1e-a7ff-7801ffc5632d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_89926c51-c10c-4a31-81d8-6260c8eef73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_89926c51-c10c-4a31-81d8-6260c8eef73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_88a29fe7-7356-47da-9e10-795bef798c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_88a29fe7-7356-47da-9e10-795bef798c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e175155-a383-47a9-a67f-de4b992699c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e175155-a383-47a9-a67f-de4b992699c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_83f83c7b-e379-425b-89ee-20139d7143da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_83f83c7b-e379-425b-89ee-20139d7143da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_e8d623c7-4631-4649-aba0-aeb3091293f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_e8d623c7-4631-4649-aba0-aeb3091293f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1bc0d6b4-b629-469f-9b52-4e7e0036d535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_LiabilitiesCurrent_1bc0d6b4-b629-469f-9b52-4e7e0036d535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1c75bbc6-2b78-44c9-b579-653b311eebe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1c75bbc6-2b78-44c9-b579-653b311eebe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6da27c6f-c536-4209-b643-367c982bf854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6da27c6f-c536-4209-b643-367c982bf854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fb85fe83-20d8-4c59-a6d1-ca93d7f20074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fb85fe83-20d8-4c59-a6d1-ca93d7f20074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_40129b84-68be-4dc8-ba4c-bbd5b4d7e6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_40129b84-68be-4dc8-ba4c-bbd5b4d7e6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cf396b51-1a6d-4546-ab02-4d60d83c5e97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_Liabilities_cf396b51-1a6d-4546-ab02-4d60d83c5e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_02f97b22-2b5c-4941-957a-4aee76909734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_02f97b22-2b5c-4941-957a-4aee76909734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ab196e50-57de-4a45-8f69-b225e9ea4abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_02f97b22-2b5c-4941-957a-4aee76909734" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ab196e50-57de-4a45-8f69-b225e9ea4abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7d5ef62c-f63d-42f7-af4b-eb26e0c2ca0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_PreferredStockValue_7d5ef62c-f63d-42f7-af4b-eb26e0c2ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_36f97f38-aa6e-4663-a9df-8c0870252184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_CommonStockValue_36f97f38-aa6e-4663-a9df-8c0870252184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c6291257-c338-4a83-9dc9-f10b33cd4faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c6291257-c338-4a83-9dc9-f10b33cd4faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27f20695-beb0-4d86-85e1-51d1a9e48189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27f20695-beb0-4d86-85e1-51d1a9e48189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_17e25aa2-a82c-4852-9cfa-2172131485e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_17e25aa2-a82c-4852-9cfa-2172131485e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_77b92949-7b41-479c-a155-44c54c8fd6a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_StockholdersEquity_77b92949-7b41-479c-a155-44c54c8fd6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_306107c9-192a-46d0-aeef-2a5810f9da1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_MinorityInterest_306107c9-192a-46d0-aeef-2a5810f9da1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88907f8c-e53d-4f9c-ac44-af8ceb73750a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_20f363c0-0921-419f-bfdd-10a11febeb6c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88907f8c-e53d-4f9c-ac44-af8ceb73750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c50d1fb4-b020-40b1-9fbe-75a8f77eef21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_51c6a347-8d2e-4d3d-b95e-e436816cfaf5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c50d1fb4-b020-40b1-9fbe-75a8f77eef21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bded8687-94bf-49a8-9c3d-a5bf0e0b743b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bded8687-94bf-49a8-9c3d-a5bf0e0b743b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_490ddd9a-97f6-41cb-b163-0b165ed1dc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_490ddd9a-97f6-41cb-b163-0b165ed1dc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_da2316fd-00e5-40cd-bbc3-5fe160d8c71e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_da2316fd-00e5-40cd-bbc3-5fe160d8c71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c93fa6d-eb14-47b5-a832-fe2ee5af596d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c93fa6d-eb14-47b5-a832-fe2ee5af596d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_652deb7f-9a80-4ea7-9c3d-3cefda733991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_652deb7f-9a80-4ea7-9c3d-3cefda733991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7a973e36-46c1-48df-a916-585dbc754662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:to="loc_us-gaap_CommonStockSharesIssued_7a973e36-46c1-48df-a916-585dbc754662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_922344d2-861e-4893-be23-b21bff094bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_70a1a042-9f70-40c8-9ffa-56d9f990e58a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_922344d2-861e-4893-be23-b21bff094bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5371449e-7b33-4f2a-baaf-78bea0e66706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7340ac30-e8c4-454e-b796-adbdef6baae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5371449e-7b33-4f2a-baaf-78bea0e66706" xlink:to="loc_us-gaap_StatementTable_7340ac30-e8c4-454e-b796-adbdef6baae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_94da5536-443f-4a55-b9b5-e40f32931088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7340ac30-e8c4-454e-b796-adbdef6baae8" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_94da5536-443f-4a55-b9b5-e40f32931088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_94da5536-443f-4a55-b9b5-e40f32931088" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_0d7829a9-ace2-47bd-9427-7bf1b468c63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_0d7829a9-ace2-47bd-9427-7bf1b468c63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_334190e8-c9a5-4091-b5db-557e807ccc51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4ad7ab83-2033-4af6-aabf-c6b796f66f3c" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_334190e8-c9a5-4091-b5db-557e807ccc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7340ac30-e8c4-454e-b796-adbdef6baae8" xlink:to="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_21af277e-2290-4e90-9337-c6a27a365cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:to="loc_us-gaap_ProfitLoss_21af277e-2290-4e90-9337-c6a27a365cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_0bce6a66-0c7e-4a7d-9564-16441be5f0f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_0bce6a66-0c7e-4a7d-9564-16441be5f0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_19d596e6-4ea2-4427-a28a-acc9fc36ea89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_19d596e6-4ea2-4427-a28a-acc9fc36ea89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_3fccba30-a562-412b-85a8-6f05e0e5516c" xlink:href="dva-20201231.xsd#dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_3fccba30-a562-412b-85a8-6f05e0e5516c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_69d2262f-d5b4-4176-b709-b459fc05b0be" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_DebtRefinancingCharges_69d2262f-d5b4-4176-b709-b459fc05b0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_62134d98-03af-460e-8523-b016c8f379b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_ShareBasedCompensation_62134d98-03af-460e-8523-b016c8f379b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54beff32-6ddf-4594-a4b0-808aeefde232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54beff32-6ddf-4594-a4b0-808aeefde232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_05ab7ea1-9ac7-47d5-b27d-d73e6df0c308" xlink:href="dva-20201231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_05ab7ea1-9ac7-47d5-b27d-d73e6df0c308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_056a35b3-5efc-42c8-b904-d2cbd6593c8f" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_056a35b3-5efc-42c8-b904-d2cbd6593c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetLossGainOnDispositionOfBusinessInterests_e01f2c53-e1fe-4894-92ba-9e36d68bf448" xlink:href="dva-20201231.xsd#dva_NetLossGainOnDispositionOfBusinessInterests"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_dva_NetLossGainOnDispositionOfBusinessInterests_e01f2c53-e1fe-4894-92ba-9e36d68bf448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_0ddc62d6-bc33-4213-8e6d-8343d4dd96f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_0ddc62d6-bc33-4213-8e6d-8343d4dd96f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169fc181-668d-40f6-85ad-d1fd9a344f86" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_70ca183e-1b68-45e6-8486-b8709bf3d7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_70ca183e-1b68-45e6-8486-b8709bf3d7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_81b7dbeb-937f-4e0e-b790-ee7a0a37f854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_81b7dbeb-937f-4e0e-b790-ee7a0a37f854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_cb9620b6-3186-4569-97e0-f6c1c10bb491" xlink:href="dva-20201231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_cb9620b6-3186-4569-97e0-f6c1c10bb491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_af8a1cf4-5607-45f9-843c-95b4f09a88be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_af8a1cf4-5607-45f9-843c-95b4f09a88be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_246f29e8-3011-4079-a579-50fe3870f81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_246f29e8-3011-4079-a579-50fe3870f81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1133515-b7c4-4ac7-a7cd-426df6bd15d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1133515-b7c4-4ac7-a7cd-426df6bd15d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_7e688a09-14d3-4f0c-b89d-21dadf0cdcf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_7e688a09-14d3-4f0c-b89d-21dadf0cdcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_84b1e95e-7c4a-47d8-ba1a-2efc1eab30aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_84b1e95e-7c4a-47d8-ba1a-2efc1eab30aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a783a287-b8d2-4bea-a911-1fa7914a3e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aaa3e0c2-6745-4dac-986c-5e0e00ed8b26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a783a287-b8d2-4bea-a911-1fa7914a3e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcad4164-5b24-4abe-b556-c4e372564e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b022bb2d-60ff-4505-9035-7dbdf3b984cb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcad4164-5b24-4abe-b556-c4e372564e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_abad09ee-88b0-4afb-86ec-1b060158c69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_abad09ee-88b0-4afb-86ec-1b060158c69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_bb388e2a-8a08-45c1-b0af-0ba6b0b9c85c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_bb388e2a-8a08-45c1-b0af-0ba6b0b9c85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_74490e65-25f2-4ab5-81a5-0f11d5c52aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_74490e65-25f2-4ab5-81a5-0f11d5c52aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_e9786682-072a-4248-a5ef-9adcf5b722b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_e9786682-072a-4248-a5ef-9adcf5b722b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_27427799-fa82-4864-a91e-aca64114c962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_27427799-fa82-4864-a91e-aca64114c962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_424d94b1-c379-4e08-a299-c80d1e1d440d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_424d94b1-c379-4e08-a299-c80d1e1d440d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_1806073f-9d5e-4658-aad0-8bdd1215a455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_1806073f-9d5e-4658-aad0-8bdd1215a455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9e33419e-e6b9-43b9-b522-899fafe6fb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9e33419e-e6b9-43b9-b522-899fafe6fb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7bfc593a-d5af-4026-8d76-bf59f477cb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7bfc593a-d5af-4026-8d76-bf59f477cb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41008978-1b53-4bb9-9cd8-5ad66aa5409f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f0e907d7-13c3-45d8-a9dc-b9886771ccc1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41008978-1b53-4bb9-9cd8-5ad66aa5409f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_94bff283-62e7-4457-a1ec-b158875a92b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_94bff283-62e7-4457-a1ec-b158875a92b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0f2a78b1-5144-4cca-aea6-df5c5e93ef22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0f2a78b1-5144-4cca-aea6-df5c5e93ef22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts_83a94149-f174-4c1b-b93a-8ee20f40ceb4" xlink:href="dva-20201231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_dva_DebtFinancingAndDebtRedemptionCosts_83a94149-f174-4c1b-b93a-8ee20f40ceb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b64dbac0-a653-4408-82cf-518c4847a284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b64dbac0-a653-4408-82cf-518c4847a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_5ef9bad8-7702-4d3d-bd4c-00d6c4383cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_5ef9bad8-7702-4d3d-bd4c-00d6c4383cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_6ba7c3ec-f02d-46ee-9453-d97fa3bc7246" xlink:href="dva-20201231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_6ba7c3ec-f02d-46ee-9453-d97fa3bc7246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2268ca24-c4c2-4dc7-a92c-67ed0450671a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2268ca24-c4c2-4dc7-a92c-67ed0450671a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_84dac2c1-1b3b-4377-a48b-38d36d6daca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_84dac2c1-1b3b-4377-a48b-38d36d6daca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_b312e430-c9fd-48a0-83e6-d5a705d43502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_b312e430-c9fd-48a0-83e6-d5a705d43502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_05fb0446-96d0-4465-925b-71cc77f1a846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_05fb0446-96d0-4465-925b-71cc77f1a846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_705961cc-5f3b-41c9-9442-b28662b4520a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d0a872e-a918-42cc-b2e1-a4d11ef6efb6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_705961cc-5f3b-41c9-9442-b28662b4520a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a4f714aa-5acc-43e2-a1b9-7f9ab98ecb42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a4f714aa-5acc-43e2-a1b9-7f9ab98ecb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0909bdc1-6780-48d5-bb4a-67a041f85b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0909bdc1-6780-48d5-bb4a-67a041f85b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95712ec8-94c2-45dd-9bc4-dfbed3ac0964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95712ec8-94c2-45dd-9bc4-dfbed3ac0964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_225af042-e10b-4cf5-8c16-4e58b53e1917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b7b8ccc-7694-49d5-87cb-e05aa79f2828" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_225af042-e10b-4cf5-8c16-4e58b53e1917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="simple" xlink:href="dva-20201231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b35e9bdb-eb50-49be-9672-ce2c3f75cbc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b35e9bdb-eb50-49be-9672-ce2c3f75cbc0" xlink:to="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0465f417-4d4f-41aa-86f7-ba235c7bdfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0465f417-4d4f-41aa-86f7-ba235c7bdfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fe6dcf73-7e71-45f7-bcf3-c5ffa714b6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0465f417-4d4f-41aa-86f7-ba235c7bdfa3" xlink:to="loc_us-gaap_EquityComponentDomain_fe6dcf73-7e71-45f7-bcf3-c5ffa714b6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fe6dcf73-7e71-45f7-bcf3-c5ffa714b6d2" xlink:to="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_a5a3ec62-99c9-47a0-840a-e82fb6ddb074" xlink:href="dva-20201231.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_a5a3ec62-99c9-47a0-840a-e82fb6ddb074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_76900596-7a81-45b0-aacc-858ad72ff722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_CommonStockMember_76900596-7a81-45b0-aacc-858ad72ff722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1dfc09e7-87ff-400a-aa7a-029a21bbd14f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1dfc09e7-87ff-400a-aa7a-029a21bbd14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8e890c41-4b4f-4fd9-892a-22c128677a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_RetainedEarningsMember_8e890c41-4b4f-4fd9-892a-22c128677a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0ecee9e1-8dfd-45ee-a0fd-2321468bbfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_TreasuryStockMember_0ecee9e1-8dfd-45ee-a0fd-2321468bbfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_853b62b7-3559-42af-9fb4-69ecf9f089c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_853b62b7-3559-42af-9fb4-69ecf9f089c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f67a3ae9-d53e-4c76-8390-7aa4a60ca570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_88489e7d-893b-465a-b3e7-ea2a787811ef" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f67a3ae9-d53e-4c76-8390-7aa4a60ca570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_133b3470-a5fb-4dff-a47c-008fdfeebb70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_133b3470-a5fb-4dff-a47c-008fdfeebb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17dc4b84-1e1e-4c22-9c4e-d924acf5841d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_133b3470-a5fb-4dff-a47c-008fdfeebb70" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17dc4b84-1e1e-4c22-9c4e-d924acf5841d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c12e6500-59e0-4366-b3f3-2246592535b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17dc4b84-1e1e-4c22-9c4e-d924acf5841d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c12e6500-59e0-4366-b3f3-2246592535b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_df827e78-5e92-4f59-ba86-66d5992f7535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dceb0d90-db02-49a9-9840-eef15ccaa746" xlink:to="loc_us-gaap_StatementLineItems_df827e78-5e92-4f59-ba86-66d5992f7535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_df827e78-5e92-4f59-ba86-66d5992f7535" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ae22d172-1f2d-4eb1-b4ae-23ab6e6b044d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ae22d172-1f2d-4eb1-b4ae-23ab6e6b044d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5becb282-736d-4cfb-96bd-0d471e234407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5becb282-736d-4cfb-96bd-0d471e234407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8db613d6-c9e4-4fff-89f2-226f863fb612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8db613d6-c9e4-4fff-89f2-226f863fb612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_b71410c9-9856-4ad7-8bfc-34c43cab8df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_b71410c9-9856-4ad7-8bfc-34c43cab8df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_aa733828-55f3-47de-ae46-a2b20c7f5c75" xlink:href="dva-20201231.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_aa733828-55f3-47de-ae46-a2b20c7f5c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_06b31ac0-e1ce-4570-80c7-0990f37960bc" xlink:href="dva-20201231.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_06b31ac0-e1ce-4570-80c7-0990f37960bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_8ae0ceda-942e-4cf8-ad21-4db49cdd0714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_8ae0ceda-942e-4cf8-ad21-4db49cdd0714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_5f886693-1600-41b4-b163-a9821d446e81" xlink:href="dva-20201231.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_5f886693-1600-41b4-b163-a9821d446e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_50347a4f-752c-47a1-8d48-a539c14a902e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_50347a4f-752c-47a1-8d48-a539c14a902e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8dead559-a97a-4163-b6c4-1c1219366dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0a0cb7c4-8a50-43ab-8db7-da8dead9b9a7" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8dead559-a97a-4163-b6c4-1c1219366dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_40a09b08-55c3-4cd1-a4a3-bbfda30ed831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_40a09b08-55c3-4cd1-a4a3-bbfda30ed831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3046b0d-0bdb-4f59-843c-4fc8ad8ba168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_e277db41-5093-405e-8d78-03336976f85b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3046b0d-0bdb-4f59-843c-4fc8ad8ba168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7aeecb7e-b24c-4cf8-b4f8-54a6b45aa214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7aeecb7e-b24c-4cf8-b4f8-54a6b45aa214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_49d40e51-04cf-4f93-ba81-afbcae811298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_49d40e51-04cf-4f93-ba81-afbcae811298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_99f07ba1-d6a6-4640-a540-30d279bd9309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_99f07ba1-d6a6-4640-a540-30d279bd9309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5aa78896-e5b9-41ee-82d1-8def800e0386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5aa78896-e5b9-41ee-82d1-8def800e0386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e5f095c-454a-483c-a038-97884bc3b992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e5f095c-454a-483c-a038-97884bc3b992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0919a7db-dcb6-4f04-b3ab-950149f4dbc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0919a7db-dcb6-4f04-b3ab-950149f4dbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_3c032ede-f8de-40b8-bd4a-0112ee17fd1b" xlink:href="dva-20201231.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_3c032ede-f8de-40b8-bd4a-0112ee17fd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_24688623-a116-4fca-8c41-c93085a2b690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_24688623-a116-4fca-8c41-c93085a2b690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc8ba5b4-db4f-41cb-849c-dfec01d1987c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc8ba5b4-db4f-41cb-849c-dfec01d1987c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_40f89712-cb01-4f26-9974-6c14352b0ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_40f89712-cb01-4f26-9974-6c14352b0ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e5c467d5-e635-4ac8-9655-459ee10487c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_61f4ff57-f78d-4e00-ada1-dbc2b11112c9" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e5c467d5-e635-4ac8-9655-459ee10487c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f3a51674-02e6-486f-88c9-9926e7c07b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f3a51674-02e6-486f-88c9-9926e7c07b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4eeb163d-242e-424e-bf54-27f9c511ecd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4eeb163d-242e-424e-bf54-27f9c511ecd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_52396582-c2ac-4fcb-aece-34e38d54bc90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_52396582-c2ac-4fcb-aece-34e38d54bc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bd4f5de1-efa0-4769-a393-7df2fe727cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bd4f5de1-efa0-4769-a393-7df2fe727cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aa688b2f-cea9-4865-8aff-fcdbb03474f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aa688b2f-cea9-4865-8aff-fcdbb03474f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_96be215c-1de3-4c59-ae65-24e2169b93f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6766448a-264e-4dc0-bd66-036056c41cb0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_96be215c-1de3-4c59-ae65-24e2169b93f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1430d445-1b97-48cc-abaa-3340f8fc19c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_2991bf52-400e-45ff-88f4-e6cabdec5c18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1430d445-1b97-48cc-abaa-3340f8fc19c1" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_2991bf52-400e-45ff-88f4-e6cabdec5c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_37fbf627-eb40-4c55-86eb-1c78a95019b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_37fbf627-eb40-4c55-86eb-1c78a95019b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5eadae76-6bfa-4019-9cad-41392bc11d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_UseOfEstimates_5eadae76-6bfa-4019-9cad-41392bc11d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_32cea1fa-2617-4e59-a166-afd2650f6226" xlink:href="dva-20201231.xsd#dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_32cea1fa-2617-4e59-a166-afd2650f6226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllowanceForUncollectibleAccountsPolicyTextBlock_cb3fd569-8726-4375-a2ce-cbb09ec2080e" xlink:href="dva-20201231.xsd#dva_AllowanceForUncollectibleAccountsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_dva_AllowanceForUncollectibleAccountsPolicyTextBlock_cb3fd569-8726-4375-a2ce-cbb09ec2080e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_636faa5a-b820-4e58-86d3-0ad38111aa7c" xlink:href="dva-20201231.xsd#dva_OtherNonoperatingIncomeExpensePolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_636faa5a-b820-4e58-86d3-0ad38111aa7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f8e66ba8-89fc-4efd-8979-3b491a786477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f8e66ba8-89fc-4efd-8979-3b491a786477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_48d830a2-d905-4814-abce-d81884e843dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_48d830a2-d905-4814-abce-d81884e843dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_52cdb32c-5051-4199-9318-9eec3acd9671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_52cdb32c-5051-4199-9318-9eec3acd9671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5b30ee08-a870-4bbc-9e2e-395d797f4d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5b30ee08-a870-4bbc-9e2e-395d797f4d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2fc2daf2-39f0-40d3-81c3-082102dcfffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2fc2daf2-39f0-40d3-81c3-082102dcfffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_92ee1a12-7b80-4af6-b370-0aba79d96588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_92ee1a12-7b80-4af6-b370-0aba79d96588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_da639aab-573e-4f77-b6c3-87c0f1dc62c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_da639aab-573e-4f77-b6c3-87c0f1dc62c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_2421bd42-84af-42b5-9963-9abc72fe92a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_2421bd42-84af-42b5-9963-9abc72fe92a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_9039ae93-add6-4dbf-af3e-e67e53173fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_9039ae93-add6-4dbf-af3e-e67e53173fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_252dba20-409e-44e3-81fa-ef70081e4b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_252dba20-409e-44e3-81fa-ef70081e4b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock_ba584a36-71cd-4003-a6d3-6a350b59691f" xlink:href="dva-20201231.xsd#dva_InsuranceAndSelfInsurancePolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock_ba584a36-71cd-4003-a6d3-6a350b59691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ca34278d-7ba2-4f1a-bfa7-65ea7f0fda9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ca34278d-7ba2-4f1a-bfa7-65ea7f0fda9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_7e29ef58-80a0-46ad-8124-0e1503c8b908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_7e29ef58-80a0-46ad-8124-0e1503c8b908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_154106b4-7ce6-49c5-ae80-8703650f5ab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_154106b4-7ce6-49c5-ae80-8703650f5ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_5a0523c5-565a-4147-b3d9-b19a64a6776f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_5a0523c5-565a-4147-b3d9-b19a64a6776f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b4e9026c-3acb-4d58-9c9a-e53886ae65ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b4e9026c-3acb-4d58-9c9a-e53886ae65ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9bff2559-d8d4-4d5a-8a8f-6e122ff13215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9bff2559-d8d4-4d5a-8a8f-6e122ff13215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_60f20a07-01a8-4321-b35a-62790c61ca97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_60f20a07-01a8-4321-b35a-62790c61ca97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_70a555c7-d387-44ea-b362-f44cd8aa0fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_70a555c7-d387-44ea-b362-f44cd8aa0fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_051a12cc-2c53-4990-bc0f-f73f47565df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_051a12cc-2c53-4990-bc0f-f73f47565df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_9b9acd9b-bec9-426c-bcb9-a6da40fcd274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_9b9acd9b-bec9-426c-bcb9-a6da40fcd274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_3621ae81-26af-4af5-8525-b30c877acc85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3624b886-92bc-45c7-bc6c-e51e1653a738" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_3621ae81-26af-4af5-8525-b30c877acc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_eae8b53e-7b1a-480d-8318-5ee750391c5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_212f2a0a-365a-4aed-9a74-c04088a42e56" xlink:href="dva-20201231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eae8b53e-7b1a-480d-8318-5ee750391c5b" xlink:to="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_212f2a0a-365a-4aed-9a74-c04088a42e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d8085050-fb1f-4706-93c9-7f2db24f663e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_212f2a0a-365a-4aed-9a74-c04088a42e56" xlink:to="loc_srt_StatementGeographicalAxis_d8085050-fb1f-4706-93c9-7f2db24f663e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d8085050-fb1f-4706-93c9-7f2db24f663e" xlink:to="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e82b6b00-3d22-42c8-89e2-2e74d29c6c83" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:to="loc_country_US_e82b6b00-3d22-42c8-89e2-2e74d29c6c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InternationalOperationsMember_f7087772-9c81-4943-8992-7e9e60b6bf15" xlink:href="dva-20201231.xsd#dva_InternationalOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_32e5de95-a777-4ccc-aa30-3b29e413c8f3" xlink:to="loc_dva_InternationalOperationsMember_f7087772-9c81-4943-8992-7e9e60b6bf15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:href="dva-20201231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_212f2a0a-365a-4aed-9a74-c04088a42e56" xlink:to="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfSites_51a30a15-b058-4186-b7f7-90378197ff9b" xlink:href="dva-20201231.xsd#dva_NumberOfSites"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_NumberOfSites_51a30a15-b058-4186-b7f7-90378197ff9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1b5e1bf3-ec70-4671-8933-2dd92a408868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1b5e1bf3-ec70-4671-8933-2dd92a408868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfCustomers_a15747e8-c923-44cb-83fd-62f5b41ef16c" xlink:href="dva-20201231.xsd#dva_NumberOfCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_NumberOfCustomers_a15747e8-c923-44cb-83fd-62f5b41ef16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c890dfb0-701d-4a2b-bd90-dfbf73326c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c890dfb0-701d-4a2b-bd90-dfbf73326c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_16f6c873-9843-4ef2-913b-8ebfac56dbb7" xlink:href="dva-20201231.xsd#dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_16f6c873-9843-4ef2-913b-8ebfac56dbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_0e6ff7e8-4125-450b-96ad-b1ab1d876c18" xlink:href="dva-20201231.xsd#dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_0c2b5e1f-58a2-4ec2-a61d-a18e21b506cf" xlink:to="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_0e6ff7e8-4125-450b-96ad-b1ab1d876c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognition" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_06f5057a-7380-4fa4-9b05-af06af5cddb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7132683e-8c3b-4981-add0-f2fce5a733ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_06f5057a-7380-4fa4-9b05-af06af5cddb8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7132683e-8c3b-4981-add0-f2fce5a733ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_8cb22b70-1d0f-45e8-87e5-e1935ce37333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bafbd065-2397-410e-a69e-17b690dd6485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_8cb22b70-1d0f-45e8-87e5-e1935ce37333" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bafbd065-2397-410e-a69e-17b690dd6485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract_54b1a9de-3ef5-4672-80ca-f894e9436683" xlink:href="dva-20201231.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract_54b1a9de-3ef5-4672-80ca-f894e9436683" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb7e3b9e-1306-4ee6-ae7d-cde43c083286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb7e3b9e-1306-4ee6-ae7d-cde43c083286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb7e3b9e-1306-4ee6-ae7d-cde43c083286" xlink:to="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_cd8b20a2-6b0e-43a2-9f1f-e9f180583ff8" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_cd8b20a2-6b0e-43a2-9f1f-e9f180583ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_fc9121f3-88b9-4e97-8b20-c3a2fb9d0e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2254ea7c-48ba-4f24-a014-61ecb81daa62" xlink:to="loc_us-gaap_AllOtherSegmentsMember_fc9121f3-88b9-4e97-8b20-c3a2fb9d0e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_24f6e8ae-3bd9-44c6-8347-a235b94cee6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_24f6e8ae-3bd9-44c6-8347-a235b94cee6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_24f6e8ae-3bd9-44c6-8347-a235b94cee6d" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_50146938-9f78-43b7-aaf4-d086218e0dfe" xlink:href="dva-20201231.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_50146938-9f78-43b7-aaf4-d086218e0dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_edef59b7-8036-46d3-9a01-bf5e9c65a4da" xlink:href="dva-20201231.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_edef59b7-8036-46d3-9a01-bf5e9c65a4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_3ddac046-47cd-4598-8435-45aa9ef74e22" xlink:href="dva-20201231.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_OtherGovernmentPayorsMember_3ddac046-47cd-4598-8435-45aa9ef74e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_51617d1b-aa9f-4fca-9d5b-f9b880f99000" xlink:href="dva-20201231.xsd#dva_CommercialPayorsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_CommercialPayorsMember_51617d1b-aa9f-4fca-9d5b-f9b880f99000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_32de7866-14d1-4522-bb12-5f33e4b924f3" xlink:href="dva-20201231.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_4ac4c84b-bf3b-4416-acb1-0f116414f6e6" xlink:to="loc_dva_OtherSourcesofRevenueMember_32de7866-14d1-4522-bb12-5f33e4b924f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e6f2c634-484a-4128-a4fb-36d450fb1818" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:to="loc_srt_ConsolidationItemsAxis_e6f2c634-484a-4128-a4fb-36d450fb1818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4e7ff49f-8aaa-438a-b9be-0a99ca34ba9c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e6f2c634-484a-4128-a4fb-36d450fb1818" xlink:to="loc_srt_ConsolidationItemsDomain_4e7ff49f-8aaa-438a-b9be-0a99ca34ba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_1fc06619-3381-42f1-b8a9-65ea54a3544f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4e7ff49f-8aaa-438a-b9be-0a99ca34ba9c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_1fc06619-3381-42f1-b8a9-65ea54a3544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_106e5151-618d-476d-b58b-e46a3906b62e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9284cfaf-8c1f-4f8b-b85f-08d23fd04724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9284cfaf-8c1f-4f8b-b85f-08d23fd04724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_f57cd895-9022-4d50-a970-02720045ca95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_OtherIncome_f57cd895-9022-4d50-a970-02720045ca95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_02b0c1b5-b7fd-4b23-b88b-bc9ce87596f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_Revenues_02b0c1b5-b7fd-4b23-b88b-bc9ce87596f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_a792bc56-8374-49df-aab0-323006c9433d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_51534bcd-1005-44f2-84f7-af532bdf0a34" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_a792bc56-8374-49df-aab0-323006c9433d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProvisionForExpectedCreditLosses_eb96eadd-8a3e-4357-b737-af1ab6cdffc2" xlink:href="dva-20201231.xsd#dva_ProvisionForExpectedCreditLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract_a792bc56-8374-49df-aab0-323006c9433d" xlink:to="loc_dva_ProvisionForExpectedCreditLosses_eb96eadd-8a3e-4357-b737-af1ab6cdffc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_2198c195-5ff6-4fd3-9909-2f1197404db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_2198c195-5ff6-4fd3-9909-2f1197404db4" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed3586dd-1fa0-4da0-9504-836274b6a81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed3586dd-1fa0-4da0-9504-836274b6a81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed3586dd-1fa0-4da0-9504-836274b6a81f" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_714a456d-cf08-4870-84c8-e9dd02f34fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_714a456d-cf08-4870-84c8-e9dd02f34fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_76afca77-6c42-48eb-b0c9-0b655de890c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_f37a824d-7145-4e49-a56f-bc759779cafd" xlink:to="loc_us-gaap_AccountsReceivableMember_76afca77-6c42-48eb-b0c9-0b655de890c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_43a01757-4a1e-4f82-8037-2de99496a3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_43a01757-4a1e-4f82-8037-2de99496a3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6355ebfa-600c-4256-bbc2-1829f4c299a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_43a01757-4a1e-4f82-8037-2de99496a3ec" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6355ebfa-600c-4256-bbc2-1829f4c299a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientServicesCustomerConcentrationRiskMember_852285e8-81f1-41bf-94af-c307e52c5290" xlink:href="dva-20201231.xsd#dva_PatientServicesCustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6355ebfa-600c-4256-bbc2-1829f4c299a7" xlink:to="loc_dva_PatientServicesCustomerConcentrationRiskMember_852285e8-81f1-41bf-94af-c307e52c5290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d002e660-20c4-4f47-8116-fffa033361b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ba1865ee-26ec-4ae9-85e2-22bf57e2aa64" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d002e660-20c4-4f47-8116-fffa033361b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_82245992-fa78-418f-90b7-c010fb4c6537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d002e660-20c4-4f47-8116-fffa033361b6" xlink:to="loc_us-gaap_AccountsReceivableMember_82245992-fa78-418f-90b7-c010fb4c6537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_05281acc-0185-4fb6-9cbe-4b04481a3e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_05281acc-0185-4fb6-9cbe-4b04481a3e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_454e2e1c-f3f5-4ee3-afa0-bb6c89fe92b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_05281acc-0185-4fb6-9cbe-4b04481a3e25" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_454e2e1c-f3f5-4ee3-afa0-bb6c89fe92b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_4831bbcc-b0a1-4d0d-b8d7-2a8e0a91c9bc" xlink:href="dva-20201231.xsd#dva_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_454e2e1c-f3f5-4ee3-afa0-bb6c89fe92b2" xlink:to="loc_dva_MedicareMember_4831bbcc-b0a1-4d0d-b8d7-2a8e0a91c9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_2990ad67-fba6-4b2a-a0cc-aa76cf768808" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b7d0f7d0-45e8-4bae-912f-62cf9966447d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b7d0f7d0-45e8-4bae-912f-62cf9966447d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_a3f777a9-0586-4667-8d6d-833af5ff20fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_a3f777a9-0586-4667-8d6d-833af5ff20fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfConcentrationRiskCustomers_55963177-bb8b-4b81-9f4d-8dea98884b42" xlink:href="dva-20201231.xsd#dva_NumberOfConcentrationRiskCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_dva_NumberOfConcentrationRiskCustomers_55963177-bb8b-4b81-9f4d-8dea98884b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_12bd5dae-f8ef-4161-819f-1e6f92923980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_12bd5dae-f8ef-4161-819f-1e6f92923980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_55dc40c3-5542-4882-9f93-f4a29b4f2684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_55dc40c3-5542-4882-9f93-f4a29b4f2684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_473a6141-e241-4d5c-991d-24f35d3c9016" xlink:href="dva-20201231.xsd#dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_473a6141-e241-4d5c-991d-24f35d3c9016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AccountsReceivablePeriodOutstanding_cb28809f-492a-4dcb-a575-bb0007e5f70e" xlink:href="dva-20201231.xsd#dva_AccountsReceivablePeriodOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_65e5eb01-05be-49d8-bb9d-09b342275eaf" xlink:to="loc_dva_AccountsReceivablePeriodOutstanding_cb28809f-492a-4dcb-a575-bb0007e5f70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShare" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dda273f9-6b19-423b-9a96-92fc493646ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_2801f9d3-7159-492d-9d31-110ac374d38e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dda273f9-6b19-423b-9a96-92fc493646ff" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_2801f9d3-7159-492d-9d31-110ac374d38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_028a2bbf-19a2-4266-8363-8d071b0755d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1b5f2e96-96a7-444c-bfd2-38e5cdfd4fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_028a2bbf-19a2-4266-8363-8d071b0755d2" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1b5f2e96-96a7-444c-bfd2-38e5cdfd4fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df282a18-c2cf-4f12-a1dd-5bd6697f707c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_7195c1c0-6c6b-4135-9845-e4ac75271a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df282a18-c2cf-4f12-a1dd-5bd6697f707c" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_7195c1c0-6c6b-4135-9845-e4ac75271a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_9aacefbf-1ad7-4c04-bb47-63b61c8adec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7195c1c0-6c6b-4135-9845-e4ac75271a52" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_9aacefbf-1ad7-4c04-bb47-63b61c8adec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_13c7ec96-4d93-44f2-b282-1f44d5f1dbd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7195c1c0-6c6b-4135-9845-e4ac75271a52" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_13c7ec96-4d93-44f2-b282-1f44d5f1dbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fdc4412b-ea1e-4f3a-af73-652f64304b95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7195c1c0-6c6b-4135-9845-e4ac75271a52" xlink:to="loc_us-gaap_NetIncomeLoss_fdc4412b-ea1e-4f3a-af73-652f64304b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df282a18-c2cf-4f12-a1dd-5bd6697f707c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_c6ca6324-d689-4098-a781-9ae8009a659a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_c6ca6324-d689-4098-a781-9ae8009a659a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_6d1fbee1-19ce-4564-bb4f-a4b454f64459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_6d1fbee1-19ce-4564-bb4f-a4b454f64459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a30fd92e-f57d-485b-8447-cf0c2376d38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a30fd92e-f57d-485b-8447-cf0c2376d38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_8bba8baa-9567-4b8b-a56f-0798cd3e713f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_8bba8baa-9567-4b8b-a56f-0798cd3e713f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b8f07b76-40ff-4957-8a19-59a796e89566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b8f07b76-40ff-4957-8a19-59a796e89566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_534b93c7-54d7-4a35-9708-650bd0f9746c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5baa85fd-5779-4663-9b89-84347b5bf5ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_534b93c7-54d7-4a35-9708-650bd0f9746c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_ae93cf88-db92-4e14-a9af-1cd03774ba4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df282a18-c2cf-4f12-a1dd-5bd6697f707c" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_ae93cf88-db92-4e14-a9af-1cd03774ba4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_57938b32-673d-420b-9bed-f0dc9887de9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ae93cf88-db92-4e14-a9af-1cd03774ba4b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_57938b32-673d-420b-9bed-f0dc9887de9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6ece5edb-3ec2-4db8-8be1-e10c494bfbc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ae93cf88-db92-4e14-a9af-1cd03774ba4b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6ece5edb-3ec2-4db8-8be1-e10c494bfbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_11ca5600-8b4d-4d8b-bc13-b674b465a900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ae93cf88-db92-4e14-a9af-1cd03774ba4b" xlink:to="loc_us-gaap_EarningsPerShareBasic_11ca5600-8b4d-4d8b-bc13-b674b465a900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_949ba103-dbfc-4d38-a792-35c1c4b429b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df282a18-c2cf-4f12-a1dd-5bd6697f707c" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_949ba103-dbfc-4d38-a792-35c1c4b429b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_86ed6719-cae6-4434-9157-168174d302fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_949ba103-dbfc-4d38-a792-35c1c4b429b0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_86ed6719-cae6-4434-9157-168174d302fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_2c62edf0-ba3e-480c-9ee4-de32ac6c4c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_949ba103-dbfc-4d38-a792-35c1c4b429b0" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_2c62edf0-ba3e-480c-9ee4-de32ac6c4c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_27e7d745-c5dc-4035-b9c7-52e7dba31308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_949ba103-dbfc-4d38-a792-35c1c4b429b0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_27e7d745-c5dc-4035-b9c7-52e7dba31308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_72edaa1d-c883-4843-a749-34cf98a16d73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df282a18-c2cf-4f12-a1dd-5bd6697f707c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_72edaa1d-c883-4843-a749-34cf98a16d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashRestrictedCash"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_4a804a29-286d-4fbe-8ed0-d590fdb42492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_f7081ac3-ed4a-492b-abab-a88e0f136bc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_4a804a29-286d-4fbe-8ed0-d590fdb42492" xlink:to="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_f7081ac3-ed4a-492b-abab-a88e0f136bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashTables" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RestrictedCashTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#RestrictedCashandEquivalentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_ce76d115-96b6-4b75-a96e-af0d32614ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_ce76d115-96b6-4b75-a96e-af0d32614ccf" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_0a8a4523-eec4-4b33-ada6-81082a381ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_0a8a4523-eec4-4b33-ada6-81082a381ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_112fc5a5-2efc-40ca-b771-0230dbb724a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_0a8a4523-eec4-4b33-ada6-81082a381ef5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_112fc5a5-2efc-40ca-b771-0230dbb724a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f53fd057-70da-44b4-b858-13c92ff2ba6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f53fd057-70da-44b4-b858-13c92ff2ba6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_28236115-602a-465a-a432-31b399a25a23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f53fd057-70da-44b4-b858-13c92ff2ba6b" xlink:to="loc_us-gaap_SegmentDomain_28236115-602a-465a-a432-31b399a25a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_617f97bc-4131-449f-8c65-d51331e30592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_28236115-602a-465a-a432-31b399a25a23" xlink:to="loc_us-gaap_AllOtherSegmentsMember_617f97bc-4131-449f-8c65-d51331e30592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_333edab5-843b-4371-89ad-b652b0f709f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:to="loc_us-gaap_LitigationStatusAxis_333edab5-843b-4371-89ad-b652b0f709f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_e6736d35-024e-42c4-b4f8-d32e29b51e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_333edab5-843b-4371-89ad-b652b0f709f0" xlink:to="loc_us-gaap_LitigationStatusDomain_e6736d35-024e-42c4-b4f8-d32e29b51e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_389147d8-7b6e-425b-81b2-e591c54e4dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_e6736d35-024e-42c4-b4f8-d32e29b51e5a" xlink:to="loc_us-gaap_PendingLitigationMember_389147d8-7b6e-425b-81b2-e591c54e4dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_4d3affff-a76e-47d8-a03f-42d5b1db39a6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_ac4da28e-b89e-4820-b7a0-2c96bdb6863b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_ac4da28e-b89e-4820-b7a0-2c96bdb6863b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_99482c12-c899-4253-8424-932fa2ff12cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_99482c12-c899-4253-8424-932fa2ff12cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_c1bd72c2-51cb-46eb-b305-d070b4db6cdb" xlink:href="dva-20201231.xsd#dva_NumberOfPartnerships"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_2ef53451-f646-441a-8b55-6aaf39fd27ab" xlink:to="loc_dva_NumberOfPartnerships_c1bd72c2-51cb-46eb-b305-d070b4db6cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="simple" xlink:href="dva-20201231.xsd#Shorttermandlongterminvestments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8582b566-52fd-4ee1-9ac3-6d3065590b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_d0f5fefa-0627-4272-a7c9-5d027af5d816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8582b566-52fd-4ee1-9ac3-6d3065590b87" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_d0f5fefa-0627-4272-a7c9-5d027af5d816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvesmtentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b7736f69-00bf-405e-940b-514c66f907f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_9c816ee4-226f-421c-a829-69c1ea5f1a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b7736f69-00bf-405e-940b-514c66f907f3" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_9c816ee4-226f-421c-a829-69c1ea5f1a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5e5f920e-2024-4142-ad18-1673b7470012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_885704c8-f578-4294-8908-7b0f259122d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5e5f920e-2024-4142-ad18-1673b7470012" xlink:to="loc_us-gaap_InvestmentHoldingsTable_885704c8-f578-4294-8908-7b0f259122d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_1284ec10-9bc0-4984-a9ef-901c2c111156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_885704c8-f578-4294-8908-7b0f259122d2" xlink:to="loc_us-gaap_InvestmentTypeAxis_1284ec10-9bc0-4984-a9ef-901c2c111156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_1284ec10-9bc0-4984-a9ef-901c2c111156" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_30b84327-8d5d-482b-b9ea-83c5daa62df6" xlink:href="dva-20201231.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_30b84327-8d5d-482b-b9ea-83c5daa62df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_872db18c-3541-4cf9-ace5-5de7a530b4e1" xlink:href="dva-20201231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_dva_MutualFundsAndCommonStockMember_872db18c-3541-4cf9-ace5-5de7a530b4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e6c1871c-aa8b-427c-bb54-08fc0bf1576f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e6c1871c-aa8b-427c-bb54-08fc0bf1576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_16010a9f-74f0-4054-981e-4fa09c2c0b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e984f0-4212-4aed-bdb7-2f6ee47e1913" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_16010a9f-74f0-4054-981e-4fa09c2c0b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_885704c8-f578-4294-8908-7b0f259122d2" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_406690d4-fcab-45e0-bd6e-f360e2656fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_HeldToMaturitySecurities_406690d4-fcab-45e0-bd6e-f360e2656fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_12593294-46bc-4ba9-b989-e8b7f2cdeb32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_12593294-46bc-4ba9-b989-e8b7f2cdeb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_8e2d0346-22ca-475b-816c-14c0878af2e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_MarketableSecurities_8e2d0346-22ca-475b-816c-14c0878af2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_4d03ec18-cd1b-49af-92cb-c5c0e65232d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_4d03ec18-cd1b-49af-92cb-c5c0e65232d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4f600455-f52b-4f68-ab07-dd21d87054df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4f600455-f52b-4f68-ab07-dd21d87054df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_695c5864-736a-4f77-9c64-8df28bb28d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_695c5864-736a-4f77-9c64-8df28bb28d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_12db30bb-1d82-4bb2-b35a-d15bbb227ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_e959ed80-c2eb-4763-a921-ddf342496152" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_12db30bb-1d82-4bb2-b35a-d15bbb227ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShorttermandlongterminvestmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4ef6896d-6817-42b5-9269-94078c8da804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4ef6896d-6817-42b5-9269-94078c8da804" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_77314e73-83c7-4fce-abed-0e4e679909fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6dc1b8c3-a3bc-44bc-bfd3-f49923444b5d" xlink:to="loc_us-gaap_EquityComponentDomain_77314e73-83c7-4fce-abed-0e4e679909fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c32b9ad5-6d4c-46fa-9390-07529fa7bdc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_77314e73-83c7-4fce-abed-0e4e679909fa" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c32b9ad5-6d4c-46fa-9390-07529fa7bdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_bdf99b10-9948-4126-9a0d-af5d18af9d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:to="loc_us-gaap_InvestmentTypeAxis_bdf99b10-9948-4126-9a0d-af5d18af9d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_da2697c2-0262-4a20-91c5-b1ca0f7e8a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_bdf99b10-9948-4126-9a0d-af5d18af9d4b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_da2697c2-0262-4a20-91c5-b1ca0f7e8a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_c785ca92-f484-48fd-805d-d3e76d14e25c" xlink:href="dva-20201231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_da2697c2-0262-4a20-91c5-b1ca0f7e8a74" xlink:to="loc_dva_MutualFundsAndCommonStockMember_c785ca92-f484-48fd-805d-d3e76d14e25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8575da4a-32db-452d-a463-ddc430c1f1cd" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8980d150-31fb-4222-b0e0-91a4fa38674d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8980d150-31fb-4222-b0e0-91a4fa38674d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_e417b745-32f7-4de3-82e3-0c2a17e7226d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_e417b745-32f7-4de3-82e3-0c2a17e7226d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_9d4020ed-a596-4ece-b2c9-ec5196315ea2" xlink:href="dva-20201231.xsd#dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_56ecbf26-f84c-4ec1-8644-3cc7bee6da66" xlink:to="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_9d4020ed-a596-4ece-b2c9-ec5196315ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesOtherReceivables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_880a9cc0-209e-4496-9d0d-8af47bee178d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_17c78f23-cfea-4552-89f7-0cc08bea368a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_880a9cc0-209e-4496-9d0d-8af47bee178d" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_17c78f23-cfea-4552-89f7-0cc08bea368a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherReceivablesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_85dab691-5b2e-48ac-96f0-ca0278f5cc58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherReceivablesTableTextBlock_8057f09d-9dd9-48b7-983d-349cb06186af" xlink:href="dva-20201231.xsd#dva_ScheduleOfOtherReceivablesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_85dab691-5b2e-48ac-96f0-ca0278f5cc58" xlink:to="loc_dva_ScheduleOfOtherReceivablesTableTextBlock_8057f09d-9dd9-48b7-983d-349cb06186af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_97da8040-3057-4005-9055-717e077ac884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ace8e5cf-d522-435c-a931-497d635c4c72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_97da8040-3057-4005-9055-717e077ac884" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ace8e5cf-d522-435c-a931-497d635c4c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_85798c0d-181f-44c1-aac8-9740509e9f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ace8e5cf-d522-435c-a931-497d635c4c72" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_85798c0d-181f-44c1-aac8-9740509e9f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_85798c0d-181f-44c1-aac8-9740509e9f44" xlink:to="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_e177b268-fdf5-4157-8a82-9e7c8cf28df8" xlink:href="dva-20201231.xsd#dva_SupplierRebatesAndOtherNonTradeReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:to="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_e177b268-fdf5-4157-8a82-9e7c8cf28df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_e40d5ce2-5a4f-4ea5-bd52-2434dec53224" xlink:href="dva-20201231.xsd#dva_MedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_fbb34cbe-c7d2-441c-ad5e-adeb02a3a349" xlink:to="loc_dva_MedicareMember_e40d5ce2-5a4f-4ea5-bd52-2434dec53224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2759600b-056e-47aa-be2f-14eca218c275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ace8e5cf-d522-435c-a931-497d635c4c72" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2759600b-056e-47aa-be2f-14eca218c275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_4d445b82-c9b2-4a52-965a-4609ffae36de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2759600b-056e-47aa-be2f-14eca218c275" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_4d445b82-c9b2-4a52-965a-4609ffae36de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_55260d82-d194-4d1f-8bf4-a5c20744f1b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_86a33b61-b110-4a41-b5af-975b7c938c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_55260d82-d194-4d1f-8bf4-a5c20744f1b8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_86a33b61-b110-4a41-b5af-975b7c938c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e59c27bf-6e20-45ce-b1b9-e50f1f0400b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c9eebfeb-cb99-4c54-a8ef-623c6f787077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e59c27bf-6e20-45ce-b1b9-e50f1f0400b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c9eebfeb-cb99-4c54-a8ef-623c6f787077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_a9d9bf03-5683-4509-b891-0a562bf5ddf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_Land_a9d9bf03-5683-4509-b891-0a562bf5ddf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_3e50dc00-b8cb-424b-942d-e47fbec603f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_3e50dc00-b8cb-424b-942d-e47fbec603f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_56c3339e-78ba-4073-a62d-300c51221adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_56c3339e-78ba-4073-a62d-300c51221adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_166797cf-c12c-4c72-a41f-5c8169816e97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_166797cf-c12c-4c72-a41f-5c8169816e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_3aee9330-72fd-475b-8d4f-13ffeb422680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_ConstructionInProgressGross_3aee9330-72fd-475b-8d4f-13ffeb422680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ba649543-34a8-4feb-abea-027d37bb332f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ba649543-34a8-4feb-abea-027d37bb332f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6da51511-0905-44b6-812b-8f7afa056379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6da51511-0905-44b6-812b-8f7afa056379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ec78126f-8300-4352-8792-4c1a55c115e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2cd9f5a9-1845-4d4a-80b0-6674ea05011e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ec78126f-8300-4352-8792-4c1a55c115e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#PropertyandEquipmentAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ab8f64f0-c1b0-42c9-a9d2-fac82c7ea6b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ab8f64f0-c1b0-42c9-a9d2-fac82c7ea6b6" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bfe8711a-1f0a-4e33-96ab-49aa52fb36b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8b535a1a-3cbe-44c4-b980-48be71cb250e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:to="loc_us-gaap_BuildingMember_8b535a1a-3cbe-44c4-b980-48be71cb250e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f568275c-677f-408d-99c4-933a34a48edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f568275c-677f-408d-99c4-933a34a48edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_490fca0e-46f7-467b-bfab-bef89a55bf64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edf0865c-eb4f-49bd-9a45-1aababdde0e3" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_490fca0e-46f7-467b-bfab-bef89a55bf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e260e28f-06bd-463f-b044-9af090f4ed8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:to="loc_srt_RangeAxis_e260e28f-06bd-463f-b044-9af090f4ed8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e260e28f-06bd-463f-b044-9af090f4ed8e" xlink:to="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d1329bcb-f7d8-4876-ae2e-9bb9faeff41b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:to="loc_srt_MinimumMember_d1329bcb-f7d8-4876-ae2e-9bb9faeff41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_34afdf62-73ca-464c-a74e-6a8d3d986304" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0c66d0c-0bbf-4ea9-84e4-0b391898655e" xlink:to="loc_srt_MaximumMember_34afdf62-73ca-464c-a74e-6a8d3d986304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_99ff467d-732b-4bd5-aaa7-c67a25ab42f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:to="loc_us-gaap_SubsegmentsAxis_99ff467d-732b-4bd5-aaa7-c67a25ab42f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_521498c6-f52e-463a-89dc-8817ff6cda0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_99ff467d-732b-4bd5-aaa7-c67a25ab42f9" xlink:to="loc_us-gaap_SubsegmentsDomain_521498c6-f52e-463a-89dc-8817ff6cda0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naics_ZZ446110_779df6d4-3686-49aa-bd8a-bddb6f863236" xlink:href="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd#naics_ZZ446110"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_521498c6-f52e-463a-89dc-8817ff6cda0a" xlink:to="loc_naics_ZZ446110_779df6d4-3686-49aa-bd8a-bddb6f863236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_055dafaf-2c18-42c5-a9de-28886091f029" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_00c463f0-251e-49eb-a6d1-7764880f7be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_00c463f0-251e-49eb-a6d1-7764880f7be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6fa8efbc-4043-43a9-97b1-99652653cdce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6fa8efbc-4043-43a9-97b1-99652653cdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_84b72803-668c-4c47-9548-2d7839408bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_InterestCostsCapitalized_84b72803-668c-4c47-9548-2d7839408bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_3c16f80b-1d5c-4399-8396-5ca88b3d0c3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c50a0bfc-16c5-4891-ae2d-366f442063bc" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_3c16f80b-1d5c-4399-8396-5ca88b3d0c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Intangibles" xlink:type="simple" xlink:href="dva-20201231.xsd#Intangibles"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Intangibles" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_acdfd558-352d-4f28-af33-d249efbd185b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_78bb4482-5642-4c16-b79a-8ac5c614e649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_acdfd558-352d-4f28-af33-d249efbd185b" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_78bb4482-5642-4c16-b79a-8ac5c614e649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35f49704-e429-4f27-9564-4436d08b9727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_65693303-96e3-468e-a5f6-c08300f95b98" xlink:href="dva-20201231.xsd#dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35f49704-e429-4f27-9564-4436d08b9727" xlink:to="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_65693303-96e3-468e-a5f6-c08300f95b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7efaf9c3-852e-4f4f-8247-c6ad205cbdd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35f49704-e429-4f27-9564-4436d08b9727" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7efaf9c3-852e-4f4f-8247-c6ad205cbdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0bb3e26-782b-4aae-9004-cc1172a5571d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_bc563a08-6eec-407e-bbdd-8c5dc4b184c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0bb3e26-782b-4aae-9004-cc1172a5571d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_bc563a08-6eec-407e-bbdd-8c5dc4b184c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_e9c81dbd-39ed-4e3f-a54e-d740ce950001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0bb3e26-782b-4aae-9004-cc1172a5571d" xlink:to="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_e9c81dbd-39ed-4e3f-a54e-d740ce950001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_19ad5e82-dfea-45ea-8fa8-49e009c3ad89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0bb3e26-782b-4aae-9004-cc1172a5571d" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_19ad5e82-dfea-45ea-8fa8-49e009c3ad89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fc300bfc-fec7-46bc-8271-4e0749fa9413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0bb3e26-782b-4aae-9004-cc1172a5571d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fc300bfc-fec7-46bc-8271-4e0749fa9413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7cc0472b-80f3-4cfe-ba9f-8f536a0f1d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0bb3e26-782b-4aae-9004-cc1172a5571d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7cc0472b-80f3-4cfe-ba9f-8f536a0f1d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_069cc28b-a91d-44b2-9d51-cec812115de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0bb3e26-782b-4aae-9004-cc1172a5571d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_069cc28b-a91d-44b2-9d51-cec812115de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d8ab782b-c64d-4814-9abc-36221f2c3877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseTable_53b14c5d-db31-4181-87a1-9e9af2f15d66" xlink:href="dva-20201231.xsd#dva_ExpectedAmortizationExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d8ab782b-c64d-4814-9abc-36221f2c3877" xlink:to="loc_dva_ExpectedAmortizationExpenseTable_53b14c5d-db31-4181-87a1-9e9af2f15d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a8de3119-fd35-46da-a46b-9311caaaf983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseTable_53b14c5d-db31-4181-87a1-9e9af2f15d66" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a8de3119-fd35-46da-a46b-9311caaaf983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a8de3119-fd35-46da-a46b-9311caaaf983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_1bbe3803-0aa6-4f50-972d-1cdd3f1ba749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_1bbe3803-0aa6-4f50-972d-1cdd3f1ba749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_e9a35d3c-8b42-4fe2-ad1b-eb8ce1a4346e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad13b2c1-3e1d-412c-9f08-e37a719f41fb" xlink:to="loc_us-gaap_ServiceAgreementsMember_e9a35d3c-8b42-4fe2-ad1b-eb8ce1a4346e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:href="dva-20201231.xsd#dva_ExpectedAmortizationExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseTable_53b14c5d-db31-4181-87a1-9e9af2f15d66" xlink:to="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_80be2a03-307d-4f81-94b9-99faebec20ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_80be2a03-307d-4f81-94b9-99faebec20ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9554db2a-074b-4f79-80e1-3b9d6156aba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9554db2a-074b-4f79-80e1-3b9d6156aba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d2ab52dd-fc89-4b1f-a5ca-76c040da0a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d2ab52dd-fc89-4b1f-a5ca-76c040da0a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_839bff73-92a5-42a8-8385-b36c6e1935dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_839bff73-92a5-42a8-8385-b36c6e1935dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_28dd35bc-9f9e-4790-8251-0f09c719ed86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_28dd35bc-9f9e-4790-8251-0f09c719ed86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8f4977b0-4978-47a1-afb8-b52656b3f808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8f4977b0-4978-47a1-afb8-b52656b3f808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6aa2282a-7765-41eb-b793-cb39996b5276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_8485dfa9-298c-4d22-817d-9eb78f959c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6aa2282a-7765-41eb-b793-cb39996b5276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IntangiblesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b8b1a4d2-62fa-43cd-b05c-94519282f157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b8b1a4d2-62fa-43cd-b05c-94519282f157" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239df1cf-06a9-4ff0-96aa-e65fafaf9907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239df1cf-06a9-4ff0-96aa-e65fafaf9907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239df1cf-06a9-4ff0-96aa-e65fafaf9907" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_2454496a-2994-4dd9-a143-593c0fa28746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_2454496a-2994-4dd9-a143-593c0fa28746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bc336011-cd98-4377-85e9-ad728c3ce066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_526fc352-502e-4711-8780-c93acf6678e2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bc336011-cd98-4377-85e9-ad728c3ce066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_264aca27-c469-4ebd-958b-310da3dc7e6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:to="loc_srt_RangeAxis_264aca27-c469-4ebd-958b-310da3dc7e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_264aca27-c469-4ebd-958b-310da3dc7e6b" xlink:to="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7554d70b-50be-447d-a1ca-81bc9e40dd45" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:to="loc_srt_MinimumMember_7554d70b-50be-447d-a1ca-81bc9e40dd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_33420849-b734-45de-8e67-902c43bbc894" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7770046e-909b-404d-bdc9-f15d2cbd3a24" xlink:to="loc_srt_MaximumMember_33420849-b734-45de-8e67-902c43bbc894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a62b9e36-7095-4f91-855b-e71186262248" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_2093ef2f-7ba9-4ad5-a5c2-e7f82ae1194e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_2093ef2f-7ba9-4ad5-a5c2-e7f82ae1194e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_62eee34b-3bfa-43cb-bdc9-0cc59c4cae1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_62eee34b-3bfa-43cb-bdc9-0cc59c4cae1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_75c5653c-8cc2-457c-8ad1-66cbb00962b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc4bbc42-a12b-452b-991e-6e1a9a03a825" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_75c5653c-8cc2-457c-8ad1-66cbb00962b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_75bc7c61-6678-4fd5-9640-6a1a31b58f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_f83a261d-e2ef-4fff-95a4-3588e8cff7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_75bc7c61-6678-4fd5-9640-6a1a31b58f2d" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_f83a261d-e2ef-4fff-95a4-3588e8cff7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8004fb71-7d83-47cc-9dbd-57530bf109c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_9dfd8829-a854-4631-8682-4c22dcec66a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8004fb71-7d83-47cc-9dbd-57530bf109c7" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_9dfd8829-a854-4631-8682-4c22dcec66a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c8734f22-5f27-443a-903b-fba980c4aff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c8734f22-5f27-443a-903b-fba980c4aff8" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_49ea2c48-e0d8-4ab1-a802-3c25355c0eba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_c046bd8e-4df0-4c6c-b21c-2b55ac039d5e" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_49ea2c48-e0d8-4ab1-a802-3c25355c0eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOwnershipInterestMember_bec3bb99-7d66-4848-94cd-3de5c0bb2d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOwnershipInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_49ea2c48-e0d8-4ab1-a802-3c25355c0eba" xlink:to="loc_us-gaap_OtherOwnershipInterestMember_bec3bb99-7d66-4848-94cd-3de5c0bb2d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_02e65af2-bb0a-46e6-b50d-208965910e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:to="loc_us-gaap_InvestmentTypeAxis_02e65af2-bb0a-46e6-b50d-208965910e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_04acdd8d-251e-4c4b-adeb-47fab088e873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_02e65af2-bb0a-46e6-b50d-208965910e9b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_04acdd8d-251e-4c4b-adeb-47fab088e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_97713c78-4e1f-47b7-83b7-6feb132ff3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_04acdd8d-251e-4c4b-adeb-47fab088e873" xlink:to="loc_us-gaap_EquitySecuritiesMember_97713c78-4e1f-47b7-83b7-6feb132ff3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ccbd06a3-40e0-42c7-b75d-d9537770864d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:to="loc_srt_OwnershipAxis_ccbd06a3-40e0-42c7-b75d-d9537770864d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_71aea758-b944-4833-84b7-e5d412223831" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_ccbd06a3-40e0-42c7-b75d-d9537770864d" xlink:to="loc_srt_OwnershipDomain_71aea758-b944-4833-84b7-e5d412223831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_fbdee79a-5fdf-4be1-8264-5108a599b3df" xlink:href="dva-20201231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_71aea758-b944-4833-84b7-e5d412223831" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_fbdee79a-5fdf-4be1-8264-5108a599b3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bce0a502-19bd-466a-8002-7b9890c0f6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fefe52f0-5518-4a15-9585-4358c9a9ca2a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bce0a502-19bd-466a-8002-7b9890c0f6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7305de4a-0662-427d-80c7-1be213db0145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bce0a502-19bd-466a-8002-7b9890c0f6c9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7305de4a-0662-427d-80c7-1be213db0145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EquityMethodandOtherInvestmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_486a174e-4692-43c1-b090-7481f053d83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_486a174e-4692-43c1-b090-7481f053d83d" xlink:to="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_fa966df3-5815-4cf0-afc7-be92f9a9eb02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_fa966df3-5815-4cf0-afc7-be92f9a9eb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_df950e0f-4bee-4c79-ab6e-9039ff2bd0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_fa966df3-5815-4cf0-afc7-be92f9a9eb02" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_df950e0f-4bee-4c79-ab6e-9039ff2bd0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_83b295d3-7292-480d-b358-70c44d537049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_df950e0f-4bee-4c79-ab6e-9039ff2bd0a3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_83b295d3-7292-480d-b358-70c44d537049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e58c42b8-02ec-491d-9f32-75525eee3157" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:to="loc_srt_RangeAxis_e58c42b8-02ec-491d-9f32-75525eee3157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e58c42b8-02ec-491d-9f32-75525eee3157" xlink:to="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d2e16b76-5893-410f-b2ba-a58d2f75f205" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:to="loc_srt_MinimumMember_d2e16b76-5893-410f-b2ba-a58d2f75f205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6bd11db9-ff89-4e8a-9679-0521198662f9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8ddc5779-ce1a-4841-97e7-af542b3e06e3" xlink:to="loc_srt_MaximumMember_6bd11db9-ff89-4e8a-9679-0521198662f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ebd6ae30-6904-4db6-8855-1e599c8eff38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:to="loc_srt_OwnershipAxis_ebd6ae30-6904-4db6-8855-1e599c8eff38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_ebd6ae30-6904-4db6-8855-1e599c8eff38" xlink:to="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_a7937599-d12b-4126-a379-7b0934b08fa9" xlink:href="dva-20201231.xsd#dva_ParentCompanyAndRestrictedSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:to="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_a7937599-d12b-4126-a379-7b0934b08fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_7b7bd9e3-e874-4d4a-8481-0ad15364d630" xlink:href="dva-20201231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_aff7d898-453a-4d55-aba0-6a4966944cfc" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_7b7bd9e3-e874-4d4a-8481-0ad15364d630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_09a5b977-1708-4227-bde7-6b6231a2530c" xlink:to="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b2207439-abae-4c02-ae9d-5ca4165b54f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b2207439-abae-4c02-ae9d-5ca4165b54f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_020835bf-4628-49f4-a85b-078eb55f441a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_020835bf-4628-49f4-a85b-078eb55f441a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_97c79dab-2aa2-465e-bfe5-d9fcae8db947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_97c79dab-2aa2-465e-bfe5-d9fcae8db947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8a3d1e95-20fa-409b-a57d-67109019e525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8a3d1e95-20fa-409b-a57d-67109019e525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_df363bb9-f35d-4ac5-b092-32940cc1bbc9" xlink:href="dva-20201231.xsd#dva_NumberOfPartnerships"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_dva_NumberOfPartnerships_df363bb9-f35d-4ac5-b092-32940cc1bbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_73479b90-673f-4549-b046-97acf0c3fdc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_887acef5-9643-4bc7-9337-cd5e9a647ee0" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_73479b90-673f-4549-b046-97acf0c3fdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20201231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b45c6d6e-f4e0-4a59-a8e5-beac9f3cdb74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_ef5ace62-1e99-4b0c-96ca-06c7e8bb4bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b45c6d6e-f4e0-4a59-a8e5-beac9f3cdb74" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_ef5ace62-1e99-4b0c-96ca-06c7e8bb4bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a9407cf-617d-4513-bad3-0e8b34b0a4d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_74aa16e4-2626-4273-811b-03bba373f68b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a9407cf-617d-4513-bad3-0e8b34b0a4d4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_74aa16e4-2626-4273-811b-03bba373f68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_b807ddfe-5bb9-4088-908c-7abf9df7c258" xlink:href="dva-20201231.xsd#dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a9407cf-617d-4513-bad3-0e8b34b0a4d4" xlink:to="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_b807ddfe-5bb9-4088-908c-7abf9df7c258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1a4128cb-d3f0-4fde-ba03-029692f5577a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7ae328e7-0e4c-4791-a3e2-ac8df9b51efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1a4128cb-d3f0-4fde-ba03-029692f5577a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7ae328e7-0e4c-4791-a3e2-ac8df9b51efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3aaa20e5-ff57-4b00-a567-4ed07823303e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7ae328e7-0e4c-4791-a3e2-ac8df9b51efe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3aaa20e5-ff57-4b00-a567-4ed07823303e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3aaa20e5-ff57-4b00-a567-4ed07823303e" xlink:to="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_72a7591b-755b-4f07-acbb-923e038425d3" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_72a7591b-755b-4f07-acbb-923e038425d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_c057dcdf-0ae4-4635-8855-4fbb8ea6c607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dfaae10d-94b2-4a24-a20d-0f9aaf49e73e" xlink:to="loc_us-gaap_AllOtherSegmentsMember_c057dcdf-0ae4-4635-8855-4fbb8ea6c607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7ae328e7-0e4c-4791-a3e2-ac8df9b51efe" xlink:to="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:to="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b5ff0e6f-ac04-484d-b535-8291869093d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_Goodwill_b5ff0e6f-ac04-484d-b535-8291869093d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a44c9433-66c4-473c-93cb-e117d91ec45b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a44c9433-66c4-473c-93cb-e117d91ec45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_fc0b24b6-40e7-43d8-b267-b3f5588cca61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_fc0b24b6-40e7-43d8-b267-b3f5588cca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0668703f-aa49-49f0-89fc-24b5198a0623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0668703f-aa49-49f0-89fc-24b5198a0623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0a6b71dd-0d9e-49d8-9642-f9e54e8ffdcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0a6b71dd-0d9e-49d8-9642-f9e54e8ffdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b271608a-679b-495b-9d89-79bfbb939e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c17dfb65-3fe4-4069-a8c3-1b69bc88c847" xlink:to="loc_us-gaap_Goodwill_b271608a-679b-495b-9d89-79bfbb939e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_20747679-0544-4b60-a33c-7868f2409e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:to="loc_us-gaap_GoodwillGross_20747679-0544-4b60-a33c-7868f2409e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ddff609b-e9d7-4062-8f79-7c06d8d4b732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9c7066c-8c87-49b1-b66d-a4d22b228ecf" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ddff609b-e9d7-4062-8f79-7c06d8d4b732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_347e61a4-bec0-4518-a592-d0c2f56865d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_347e61a4-bec0-4518-a592-d0c2f56865d6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c30a8432-71e5-4918-9f0e-b70efe8c249d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c30a8432-71e5-4918-9f0e-b70efe8c249d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_237f4937-7107-4b73-bf09-836cbce8b98c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c30a8432-71e5-4918-9f0e-b70efe8c249d" xlink:to="loc_us-gaap_SegmentDomain_237f4937-7107-4b73-bf09-836cbce8b98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_86e9dcf6-44db-49d7-bfee-6d3b1811412e" xlink:href="dva-20201231.xsd#dva_KidneyCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_237f4937-7107-4b73-bf09-836cbce8b98c" xlink:to="loc_dva_KidneyCareMember_86e9dcf6-44db-49d7-bfee-6d3b1811412e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0be577f9-7976-4c4b-9ad2-d0d04b247ea1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:to="loc_srt_StatementGeographicalAxis_0be577f9-7976-4c4b-9ad2-d0d04b247ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_83108455-72c8-4118-85e8-2463a6b81047" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0be577f9-7976-4c4b-9ad2-d0d04b247ea1" xlink:to="loc_srt_SegmentGeographicalDomain_83108455-72c8-4118-85e8-2463a6b81047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_5b9c9cd0-fa73-44b3-a15d-003ff6d20311" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_83108455-72c8-4118-85e8-2463a6b81047" xlink:to="loc_country_DE_5b9c9cd0-fa73-44b3-a15d-003ff6d20311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_512a4792-62b3-475e-9f71-e24f3d9d8ac5" xlink:to="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1d7817a-b72b-486e-a995-20dfd831f93d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_us-gaap_Goodwill_d1d7817a-b72b-486e-a995-20dfd831f93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_b315b706-06b9-43a8-b65b-9b3e5c93c5bb" xlink:href="dva-20201231.xsd#dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_b315b706-06b9-43a8-b65b-9b3e5c93c5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_9438c22a-dfa7-460d-aae5-d1c0ab83b6bd" xlink:href="dva-20201231.xsd#dva_PotentialImpactOnFairValueForReductionInOperatingIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_9438c22a-dfa7-460d-aae5-d1c0ab83b6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0f78391c-87e2-42b5-a1d9-25ebf100c7fe" xlink:href="dva-20201231.xsd#dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0f78391c-87e2-42b5-a1d9-25ebf100c7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_e289e9eb-1f10-4b22-85ff-f8ee13e10bb3" xlink:href="dva-20201231.xsd#dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_e289e9eb-1f10-4b22-85ff-f8ee13e10bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b7e24b19-c3c1-4170-8790-ca4c947b8419" xlink:href="dva-20201231.xsd#dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8d27606-b862-4d5d-b2f1-5c659d46fed8" xlink:to="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b7e24b19-c3c1-4170-8790-ca4c947b8419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#GoodwillAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_11a61dde-406c-446e-8a91-5312112deffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_11a61dde-406c-446e-8a91-5312112deffe" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3a4878bb-8ff5-43ba-a873-831cbd2aa395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:to="loc_srt_StatementGeographicalAxis_3a4878bb-8ff5-43ba-a873-831cbd2aa395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_058b013f-c933-42fd-ab7b-a6b877b0bc69" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3a4878bb-8ff5-43ba-a873-831cbd2aa395" xlink:to="loc_srt_SegmentGeographicalDomain_058b013f-c933-42fd-ab7b-a6b877b0bc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_ec6499fc-ab15-4508-a75a-76d6345d57e4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_058b013f-c933-42fd-ab7b-a6b877b0bc69" xlink:to="loc_country_DE_ec6499fc-ab15-4508-a75a-76d6345d57e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a5ac52ff-5a0d-4900-bada-13d17bbaeb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a5ac52ff-5a0d-4900-bada-13d17bbaeb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a5ac52ff-5a0d-4900-bada-13d17bbaeb87" xlink:to="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_fe46aa4f-1962-4efe-960c-b63d215b72e1" xlink:href="dva-20201231.xsd#dva_KidneyCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:to="loc_dva_KidneyCareMember_fe46aa4f-1962-4efe-960c-b63d215b72e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_aff7cd8a-6074-4c60-946d-383f4533f2ae" xlink:href="dva-20201231.xsd#dva_OtherReportingUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_32920179-2fdd-4e55-9290-a1fe7194eee2" xlink:to="loc_dva_OtherReportingUnitsMember_aff7cd8a-6074-4c60-946d-383f4533f2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b62bc9e2-b888-4086-bf4a-f868c04bf267" xlink:to="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c708e0b4-6205-4281-a81c-c5b9bffe39f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c708e0b4-6205-4281-a81c-c5b9bffe39f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_07289e30-f162-467e-9032-2ca29897bead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bb789cbd-9d4d-4bbd-9593-35a11f1bcc0f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_07289e30-f162-467e-9032-2ca29897bead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilities" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3ccea813-6ea5-4a64-8e54-a79ff52d1648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_0749af3c-25f9-4f4a-b191-7e5a58a7130b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3ccea813-6ea5-4a64-8e54-a79ff52d1648" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_0749af3c-25f9-4f4a-b191-7e5a58a7130b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_02078f9c-a29d-48f6-b05f-5402e81646e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_d33f9f51-655f-4040-bc4c-a276e35da5b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_02078f9c-a29d-48f6-b05f-5402e81646e5" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_d33f9f51-655f-4040-bc4c-a276e35da5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#OtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_6a29a05a-9dcc-48b1-8008-cd33dd6ef739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PayorRefundsAndRetractions_2339b496-7b4d-402a-ad3a-d0c4438486a3" xlink:href="dva-20201231.xsd#dva_PayorRefundsAndRetractions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_6a29a05a-9dcc-48b1-8008-cd33dd6ef739" xlink:to="loc_dva_PayorRefundsAndRetractions_2339b496-7b4d-402a-ad3a-d0c4438486a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_8895cb3f-7a50-422f-86de-4cf55065a695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_6a29a05a-9dcc-48b1-8008-cd33dd6ef739" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_8895cb3f-7a50-422f-86de-4cf55065a695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_79227384-3f3b-4f80-9f17-1c883973fe10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_6a29a05a-9dcc-48b1-8008-cd33dd6ef739" xlink:to="loc_us-gaap_InterestPayableCurrent_79227384-3f3b-4f80-9f17-1c883973fe10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_7786bc69-ed9d-4edb-aea3-aee6eb8a05a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_6a29a05a-9dcc-48b1-8008-cd33dd6ef739" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_7786bc69-ed9d-4edb-aea3-aee6eb8a05a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_24ef160a-8fbd-44a6-9577-6871bb9d40a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_6a29a05a-9dcc-48b1-8008-cd33dd6ef739" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_24ef160a-8fbd-44a6-9577-6871bb9d40a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c998e008-919d-45e2-8104-5ba18d8d5747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_6a29a05a-9dcc-48b1-8008-cd33dd6ef739" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c998e008-919d-45e2-8104-5ba18d8d5747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7f8caaac-da9c-4f2e-ab8c-b22bb580c45e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1db99328-7ebe-4a5f-9954-25176dc3fe56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7f8caaac-da9c-4f2e-ab8c-b22bb580c45e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1db99328-7ebe-4a5f-9954-25176dc3fe56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1bac4d8d-d5c4-47ec-a49f-488ba08000bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_58e36662-b0e0-44c0-88fe-a1f1a0aa3c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bac4d8d-d5c4-47ec-a49f-488ba08000bc" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_58e36662-b0e0-44c0-88fe-a1f1a0aa3c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_5c83e864-d89a-4896-af46-dc60759ab789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bac4d8d-d5c4-47ec-a49f-488ba08000bc" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_5c83e864-d89a-4896-af46-dc60759ab789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_78a87e8c-7c4e-4cf6-a153-8f86b67de8f8" xlink:href="dva-20201231.xsd#dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bac4d8d-d5c4-47ec-a49f-488ba08000bc" xlink:to="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_78a87e8c-7c4e-4cf6-a153-8f86b67de8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4e352e8e-4267-4137-b508-e1981e8ddbdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bac4d8d-d5c4-47ec-a49f-488ba08000bc" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4e352e8e-4267-4137-b508-e1981e8ddbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_897cf3c8-b3f8-4cd2-86a1-41ac6d51c391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bac4d8d-d5c4-47ec-a49f-488ba08000bc" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_897cf3c8-b3f8-4cd2-86a1-41ac6d51c391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_869e068d-6617-408b-9c75-072283b470e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bac4d8d-d5c4-47ec-a49f-488ba08000bc" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_869e068d-6617-408b-9c75-072283b470e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_764ad09e-a2cf-4d6f-9a26-eeb4ba81ce5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0d5f6a5f-e76c-459b-934f-4d58577bcc10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_764ad09e-a2cf-4d6f-9a26-eeb4ba81ce5e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0d5f6a5f-e76c-459b-934f-4d58577bcc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_bcd2bc89-59cd-46ac-af9d-e02a7de63d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_764ad09e-a2cf-4d6f-9a26-eeb4ba81ce5e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_bcd2bc89-59cd-46ac-af9d-e02a7de63d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_982ec687-9738-461f-b987-75a75897f17d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_764ad09e-a2cf-4d6f-9a26-eeb4ba81ce5e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_982ec687-9738-461f-b987-75a75897f17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_63c9d9b8-6d95-425e-b443-3271b8020618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_89036dd5-156b-48ce-b5c7-080cf2f04b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63c9d9b8-6d95-425e-b443-3271b8020618" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_89036dd5-156b-48ce-b5c7-080cf2f04b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_329abb8a-fc1c-4999-80da-fe3265a05216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_89036dd5-156b-48ce-b5c7-080cf2f04b79" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_329abb8a-fc1c-4999-80da-fe3265a05216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_53db990c-fe47-470d-a0be-33970b2bf503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_89036dd5-156b-48ce-b5c7-080cf2f04b79" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_53db990c-fe47-470d-a0be-33970b2bf503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4a2ea7d9-70c5-4b81-bebf-e6d4bb8b99a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_89036dd5-156b-48ce-b5c7-080cf2f04b79" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4a2ea7d9-70c5-4b81-bebf-e6d4bb8b99a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f03154f8-f009-40e6-b0d1-dcd2175d07ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_89036dd5-156b-48ce-b5c7-080cf2f04b79" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f03154f8-f009-40e6-b0d1-dcd2175d07ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_af92d007-dac4-48cf-90db-52de9b49c800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63c9d9b8-6d95-425e-b443-3271b8020618" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_af92d007-dac4-48cf-90db-52de9b49c800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_762325c3-d429-43e8-82a5-9fd23af4c532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_af92d007-dac4-48cf-90db-52de9b49c800" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_762325c3-d429-43e8-82a5-9fd23af4c532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_51d279f6-37c3-4250-a793-9710c5709f7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_af92d007-dac4-48cf-90db-52de9b49c800" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_51d279f6-37c3-4250-a793-9710c5709f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_5534d2d0-b1b3-4d18-89dc-289f2a2730a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_af92d007-dac4-48cf-90db-52de9b49c800" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_5534d2d0-b1b3-4d18-89dc-289f2a2730a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_92c80aaf-1f88-48fa-9b7a-2e77861c996d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_af92d007-dac4-48cf-90db-52de9b49c800" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_92c80aaf-1f88-48fa-9b7a-2e77861c996d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_76640d3c-3926-4568-9d1d-ac359e362f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63c9d9b8-6d95-425e-b443-3271b8020618" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_76640d3c-3926-4568-9d1d-ac359e362f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2b3b680c-7431-4086-9147-8d3333737203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_41e4c487-2f70-4be4-92ae-d8e6d16693ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2b3b680c-7431-4086-9147-8d3333737203" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_41e4c487-2f70-4be4-92ae-d8e6d16693ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_6753b8da-285d-48ae-9e69-4bc4e426a09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2b3b680c-7431-4086-9147-8d3333737203" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_6753b8da-285d-48ae-9e69-4bc4e426a09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_432b2972-256b-49f5-bb58-29fc84539688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2b3b680c-7431-4086-9147-8d3333737203" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_432b2972-256b-49f5-bb58-29fc84539688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d5506d97-ca8a-4c15-975f-f6cd82c391ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d5506d97-ca8a-4c15-975f-f6cd82c391ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b472ac67-4782-4248-8b76-be859c03541b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b472ac67-4782-4248-8b76-be859c03541b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4e389a62-9ffe-47da-9cbb-ee8546a92a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4e389a62-9ffe-47da-9cbb-ee8546a92a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_092f6c91-f571-436f-be16-43c3c2f45b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_092f6c91-f571-436f-be16-43c3c2f45b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_05d3b1af-7fce-451e-a227-3ed99dbecdba" xlink:href="dva-20201231.xsd#dva_EffectiveIncomeTaxReconciliationInvestmentImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_05d3b1af-7fce-451e-a227-3ed99dbecdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_373c88aa-e670-47f5-be62-a6a8aa8d615c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_373c88aa-e670-47f5-be62-a6a8aa8d615c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f1c4e9c2-73d7-4277-847f-eb1d75d7ebb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f1c4e9c2-73d7-4277-847f-eb1d75d7ebb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_1adbb5d6-f171-482f-b3c2-075c8834b69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_1adbb5d6-f171-482f-b3c2-075c8834b69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3ca9fac6-2814-4a53-8f04-a44fb897e59b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef45e83b-54da-4e93-9c00-eb27a13de191" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3ca9fac6-2814-4a53-8f04-a44fb897e59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsReceivables_22a540b2-14ed-4f3e-865e-602a36afa2b6" xlink:href="dva-20201231.xsd#dva_DeferredTaxAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_dva_DeferredTaxAssetsReceivables_22a540b2-14ed-4f3e-865e-602a36afa2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_1c0d3df2-e49f-4446-865a-ca0d7a10526d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_1c0d3df2-e49f-4446-865a-ca0d7a10526d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_5ae9e689-2391-43a1-8113-9fd23b54d9f7" xlink:href="dva-20201231.xsd#dva_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_5ae9e689-2391-43a1-8113-9fd23b54d9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f8de2334-7009-4fe8-b025-2c51f163da5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f8de2334-7009-4fe8-b025-2c51f163da5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_c2b076ab-a279-4bc0-913f-86abe5e76e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_c2b076ab-a279-4bc0-913f-86abe5e76e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_655ad0a7-edd3-4a59-be60-db6b5503acc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_655ad0a7-edd3-4a59-be60-db6b5503acc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c9dc3079-a60a-4553-bcbe-c54c71255957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c9dc3079-a60a-4553-bcbe-c54c71255957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_acc6d7bf-e5a5-4077-bae3-1300755d57c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_acc6d7bf-e5a5-4077-bae3-1300755d57c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_a347fee3-8b9d-4856-8d06-0484ddfe501e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_a347fee3-8b9d-4856-8d06-0484ddfe501e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1c981e37-a2f5-422d-b300-c600da351c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1c981e37-a2f5-422d-b300-c600da351c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_994be5bd-0b42-4801-be2a-9811819cbc46" xlink:href="dva-20201231.xsd#dva_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_994be5bd-0b42-4801-be2a-9811819cbc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_216447e3-6687-4b9c-97bb-a6a6ebe9126f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_216447e3-6687-4b9c-97bb-a6a6ebe9126f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_40ee4085-79fa-4da5-848d-c18afc1dce2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_40ee4085-79fa-4da5-848d-c18afc1dce2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_8cd3dca3-b966-4994-bc9c-5641cb24ce18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_8cd3dca3-b966-4994-bc9c-5641cb24ce18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_9a8038c6-f640-4829-82d7-8ab46df78cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e88a055f-4647-49d1-b27c-cddd7021f186" xlink:to="loc_us-gaap_DeferredTaxLiabilities_9a8038c6-f640-4829-82d7-8ab46df78cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f39649cb-93f6-4feb-9db8-a5ae52bd3f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f39649cb-93f6-4feb-9db8-a5ae52bd3f8a" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_02a2dd4e-1c29-4a41-89ea-09084112b5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_02a2dd4e-1c29-4a41-89ea-09084112b5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_8f6608c4-e889-4c56-ade0-f44c8d2dc3af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_8f6608c4-e889-4c56-ade0-f44c8d2dc3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5f0ec5e6-cb8b-48f4-8db1-edf68c25d7af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5f0ec5e6-cb8b-48f4-8db1-edf68c25d7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_9123bbbf-b0af-4b76-88d8-372856cf4adc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_9123bbbf-b0af-4b76-88d8-372856cf4adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4c535115-b19d-4834-8e60-c7742823af4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4c535115-b19d-4834-8e60-c7742823af4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1c20534f-f442-4394-9229-78605774ffa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3de2311b-0532-4729-95b4-4eddf566390e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1c20534f-f442-4394-9229-78605774ffa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ba226f8c-6b36-4c67-b941-3ec069bfb2ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:href="dva-20201231.xsd#dva_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba226f8c-6b36-4c67-b941-3ec069bfb2ee" xlink:to="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_23e6e8b1-fafc-4e05-99bd-d9004081a187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_23e6e8b1-fafc-4e05-99bd-d9004081a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_23e6e8b1-fafc-4e05-99bd-d9004081a187" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e9027109-3368-46dd-b9d7-c85263b43cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:to="loc_us-gaap_DomesticCountryMember_e9027109-3368-46dd-b9d7-c85263b43cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_44e92226-fee8-4272-9dd6-62d63dd0aac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_44e92226-fee8-4272-9dd6-62d63dd0aac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f9d9a241-383f-409a-ba19-f9d7be3e335f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cb0f773e-aa5f-4c47-8eb5-2cc04f6113db" xlink:to="loc_us-gaap_ForeignCountryMember_f9d9a241-383f-409a-ba19-f9d7be3e335f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a43be68b-0542-456e-946a-9d66fd66ef5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:to="loc_us-gaap_TaxPeriodAxis_a43be68b-0542-456e-946a-9d66fd66ef5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_e75a9f49-c81a-4f5c-a5b9-c66d1101793e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_a43be68b-0542-456e-946a-9d66fd66ef5f" xlink:to="loc_us-gaap_TaxPeriodDomain_e75a9f49-c81a-4f5c-a5b9-c66d1101793e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TaxYear2029Member_8bed0982-35fc-46f1-8d82-18f175e92202" xlink:href="dva-20201231.xsd#dva_TaxYear2029Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_e75a9f49-c81a-4f5c-a5b9-c66d1101793e" xlink:to="loc_dva_TaxYear2029Member_8bed0982-35fc-46f1-8d82-18f175e92202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_9fabafc5-27c0-4c5a-bd0b-c07ec7ff2961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0c77e968-2f2e-43e2-94ca-9e01cd1a4b0b" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_9fabafc5-27c0-4c5a-bd0b-c07ec7ff2961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_8453208a-9d66-42a6-bbaa-652a16eb711d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9fabafc5-27c0-4c5a-bd0b-c07ec7ff2961" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_8453208a-9d66-42a6-bbaa-652a16eb711d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:href="dva-20201231.xsd#dva_IncomeTaxesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_28e06577-de68-4a06-a12e-064b4b1854c0" xlink:to="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_0bd3c4ae-cd93-478f-89a7-d3f14ac730ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_OperatingLossCarryforwards_0bd3c4ae-cd93-478f-89a7-d3f14ac730ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_d72f1831-ca56-4991-b3b2-64d64c028d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_d72f1831-ca56-4991-b3b2-64d64c028d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_83426b18-fc66-41a4-8a1e-a40374d430fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_83426b18-fc66-41a4-8a1e-a40374d430fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_3785829f-04ab-4ad1-9dca-cf5499330c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_3785829f-04ab-4ad1-9dca-cf5499330c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_7440a1ab-1be4-4a7b-ad60-199e3ce1a98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_7440a1ab-1be4-4a7b-ad60-199e3ce1a98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7f2c08fe-b525-4f0f-b3fc-a0e74b74983a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7f2c08fe-b525-4f0f-b3fc-a0e74b74983a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6022df62-5f23-4036-816b-c035b813f02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6022df62-5f23-4036-816b-c035b813f02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7a162949-ad71-48c6-9951-f54ad6cdf9a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7a162949-ad71-48c6-9951-f54ad6cdf9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_44f0933e-0e1a-4641-92fa-4565bbaa4b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_2b8a7289-7a5e-485d-9845-9e85a3551a20" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_44f0933e-0e1a-4641-92fa-4565bbaa4b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebt" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_068299ea-79e2-47e2-b624-14b50810b716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_37879bc6-958a-4da0-ae56-02fe402ce115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_068299ea-79e2-47e2-b624-14b50810b716" xlink:to="loc_us-gaap_LongTermDebtTextBlock_37879bc6-958a-4da0-ae56-02fe402ce115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_15536a0d-b636-43db-a08f-1ee95d1c002d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d11320aa-e12c-405c-97a2-95232dc9518a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15536a0d-b636-43db-a08f-1ee95d1c002d" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d11320aa-e12c-405c-97a2-95232dc9518a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8d163de6-85d2-46e4-a3b7-b1ae3f340cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15536a0d-b636-43db-a08f-1ee95d1c002d" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8d163de6-85d2-46e4-a3b7-b1ae3f340cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_203e73a0-dd36-4468-bca5-72546628c66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15536a0d-b636-43db-a08f-1ee95d1c002d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_203e73a0-dd36-4468-bca5-72546628c66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_db0b8bc1-0384-43c6-8958-0b92c9b65858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15536a0d-b636-43db-a08f-1ee95d1c002d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_db0b8bc1-0384-43c6-8958-0b92c9b65858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8624b94f-b867-4cfe-a670-1c8b4ffadd17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8624b94f-b867-4cfe-a670-1c8b4ffadd17" xlink:to="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2eb91770-c519-463e-bc87-37d243b21233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2eb91770-c519-463e-bc87-37d243b21233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2eb91770-c519-463e-bc87-37d243b21233" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_c0f1ab41-d9c6-4f2b-bb32-0feaa0f4ba8a" xlink:href="dva-20201231.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_TermLoanAMember_c0f1ab41-d9c6-4f2b-bb32-0feaa0f4ba8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_0cca5ddc-9205-4a98-bec9-49d1b5d74ac5" xlink:href="dva-20201231.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_TermLoanB1Member_0cca5ddc-9205-4a98-bec9-49d1b5d74ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanBMember_e10a1d6d-b05d-4355-a451-5d16d25d2b82" xlink:href="dva-20201231.xsd#dva_TermLoanBMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_TermLoanBMember_e10a1d6d-b05d-4355-a451-5d16d25d2b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_fe22ab09-0371-4792-8e65-bbe3f405a8da" xlink:href="dva-20201231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_fe22ab09-0371-4792-8e65-bbe3f405a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6317cd2f-0e56-4713-8d78-17ce9f07d10d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de54813f-292d-4d8a-b32a-d7dfbe3d389b" xlink:to="loc_us-gaap_SeniorNotesMember_6317cd2f-0e56-4713-8d78-17ce9f07d10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2650b960-5c4f-442c-8596-bdd108ef31be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_CreditFacilityAxis_2650b960-5c4f-442c-8596-bdd108ef31be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ca421583-8ab2-4e8b-b745-1b6c86836a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2650b960-5c4f-442c-8596-bdd108ef31be" xlink:to="loc_us-gaap_CreditFacilityDomain_ca421583-8ab2-4e8b-b745-1b6c86836a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7650892c-2ea1-4b59-8ef2-2cc2c5f5826f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ca421583-8ab2-4e8b-b745-1b6c86836a27" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7650892c-2ea1-4b59-8ef2-2cc2c5f5826f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d66630e5-b1c0-47b1-a5d0-11964f39125d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_DebtInstrumentAxis_d66630e5-b1c0-47b1-a5d0-11964f39125d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d66630e5-b1c0-47b1-a5d0-11964f39125d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_62c6d9d4-c591-4b80-9ed2-76b58323067a" xlink:href="dva-20201231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_62c6d9d4-c591-4b80-9ed2-76b58323067a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d746894b-7006-4165-8944-b81393fba6fb" xlink:href="dva-20201231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d746894b-7006-4165-8944-b81393fba6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_9fbe317a-1c5d-4469-a3c8-bfd5287f1708" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_9fbe317a-1c5d-4469-a3c8-bfd5287f1708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_60a14de7-8439-4bb3-8286-6841147b33bc" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_60a14de7-8439-4bb3-8286-6841147b33bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_84ac5f79-7fb8-4a47-8532-3b6e93d16051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_84ac5f79-7fb8-4a47-8532-3b6e93d16051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_31ee664e-28ec-4513-b79d-e0799a751fbd" xlink:href="dva-20201231.xsd#dva_FinanceLeaseMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69faa365-1730-4c39-8a39-841c9c7e6681" xlink:to="loc_dva_FinanceLeaseMember_31ee664e-28ec-4513-b79d-e0799a751fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f6ca952f-baad-4ed9-b316-9dcd68dde49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_VariableRateAxis_f6ca952f-baad-4ed9-b316-9dcd68dde49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f6ca952f-baad-4ed9-b316-9dcd68dde49f" xlink:to="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4ab2e1a4-48ef-43ba-bdc7-9cecff173926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:to="loc_us-gaap_BaseRateMember_4ab2e1a4-48ef-43ba-bdc7-9cecff173926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f8bd80c2-c685-4634-abed-60cfbc112ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8a81ed17-a179-4f4e-b27f-4a4979256ef7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f8bd80c2-c685-4634-abed-60cfbc112ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_442916bf-4112-40f2-aa90-14eb47c6c48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_442916bf-4112-40f2-aa90-14eb47c6c48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b5451311-e629-48bb-b7fe-f9cfc2657b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_442916bf-4112-40f2-aa90-14eb47c6c48d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b5451311-e629-48bb-b7fe-f9cfc2657b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a17dacb4-f2b8-4d29-9420-724f92e271cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b5451311-e629-48bb-b7fe-f9cfc2657b59" xlink:to="loc_us-gaap_SubsequentEventMember_a17dacb4-f2b8-4d29-9420-724f92e271cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_af2fb4af-55e7-47a6-92c5-c13ddc588d10" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_2871ac0a-0f98-44d7-ad4c-1545d912da87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:to="loc_us-gaap_SecuredDebt_2871ac0a-0f98-44d7-ad4c-1545d912da87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_ced14be6-f787-4e89-b265-b3abe54d0154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_e8808728-ea90-43c9-af5a-ccc787e66d21" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_ced14be6-f787-4e89-b265-b3abe54d0154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableAbstract_f1b7f30b-3ab1-4da5-b5a5-c49b221701f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_NotesPayableAbstract_f1b7f30b-3ab1-4da5-b5a5-c49b221701f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_6b06b5f4-047a-44c5-a09d-383e156166e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesPayableAbstract_f1b7f30b-3ab1-4da5-b5a5-c49b221701f7" xlink:to="loc_us-gaap_SeniorNotes_6b06b5f4-047a-44c5-a09d-383e156166e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_67024341-6e88-4a2d-96d4-dca5befe7be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_67024341-6e88-4a2d-96d4-dca5befe7be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8d7078d7-a4c5-4a9e-855c-5a1edbff5d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8d7078d7-a4c5-4a9e-855c-5a1edbff5d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_ce318b0d-f200-48ea-8cd8-0c8af1fe466d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentFairValue_ce318b0d-f200-48ea-8cd8-0c8af1fe466d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_329f8b11-2337-43b6-b01c-c6d852a981f8" xlink:href="dva-20201231.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_329f8b11-2337-43b6-b01c-c6d852a981f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_bfe87ceb-e606-4c76-b4e4-e9bb1d6acd49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_FinanceLeaseLiability_bfe87ceb-e606-4c76-b4e4-e9bb1d6acd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_3dcbc02b-9847-472f-8b8a-067eb521504f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_3dcbc02b-9847-472f-8b8a-067eb521504f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_fbab4e23-cd65-4fc7-b3eb-d52745d19124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_fbab4e23-cd65-4fc7-b3eb-d52745d19124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a6af95c9-5ddc-4b1a-a08f-474a1e1165be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a6af95c9-5ddc-4b1a-a08f-474a1e1165be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_bf7967fb-bb4e-4364-88eb-3c4462586cc9" xlink:href="dva-20201231.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_de6f9e5b-728d-4496-8d03-5282f6ac1a3f" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_bf7967fb-bb4e-4364-88eb-3c4462586cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ed77d55f-b600-45d7-89e1-ad50bcaab9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ed77d55f-b600-45d7-89e1-ad50bcaab9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_e0e174d6-a383-4d8b-857d-1adf5d4170c9" xlink:href="dva-20201231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_e0e174d6-a383-4d8b-857d-1adf5d4170c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f8753423-e492-46cb-aed5-c03b23a480a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f8753423-e492-46cb-aed5-c03b23a480a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_66a90497-6b0b-4bab-9650-ffeaf3762794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_66a90497-6b0b-4bab-9650-ffeaf3762794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cc4c7fd1-d2a3-4b3f-bdd8-64b1b071339b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_5c597c84-8ba9-4515-8239-7c0d7edc3434" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cc4c7fd1-d2a3-4b3f-bdd8-64b1b071339b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0c22198-2157-462a-9870-32fda1feb349" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_86afd891-1f7d-473e-88c8-9290dee6bf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_86afd891-1f7d-473e-88c8-9290dee6bf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6c0347f3-fed1-4e82-87af-630102e3f96b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6c0347f3-fed1-4e82-87af-630102e3f96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_b75b4523-5e7d-4bb5-834b-d0d6e156fed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cf100126-3bbe-4f19-bf44-218da1e1aeb4" xlink:to="loc_us-gaap_DeferredOfferingCosts_b75b4523-5e7d-4bb5-834b-d0d6e156fed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_9062272e-9bbb-4c1c-b6ee-ceea95090994" xlink:href="dva-20201231.xsd#dva_DebtInstrumentRedeemedOutstandingPrincipalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8624b94f-b867-4cfe-a670-1c8b4ffadd17" xlink:to="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_9062272e-9bbb-4c1c-b6ee-ceea95090994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtScheduledMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fd5f4163-bcc7-410f-97a5-3bb616c134a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_69cd20f0-db90-4ae4-a4df-275902a532c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd5f4163-bcc7-410f-97a5-3bb616c134a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_69cd20f0-db90-4ae4-a4df-275902a532c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5407cbdf-5f37-4668-8436-9549561c5e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd5f4163-bcc7-410f-97a5-3bb616c134a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5407cbdf-5f37-4668-8436-9549561c5e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_90ca846d-acec-4e26-8674-0fe0acc74142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd5f4163-bcc7-410f-97a5-3bb616c134a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_90ca846d-acec-4e26-8674-0fe0acc74142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6dc6d902-d8e7-4f0c-b711-df21cf7e0b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd5f4163-bcc7-410f-97a5-3bb616c134a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6dc6d902-d8e7-4f0c-b711-df21cf7e0b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ecff3901-057b-46f7-8803-4f05ad6fbadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd5f4163-bcc7-410f-97a5-3bb616c134a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ecff3901-057b-46f7-8803-4f05ad6fbadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_2f2af8d2-1a72-4341-b3b3-bbf72b3ead03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd5f4163-bcc7-410f-97a5-3bb616c134a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_2f2af8d2-1a72-4341-b3b3-bbf72b3ead03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7755a21-60f2-41a1-b800-abda9e8bfc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7755a21-60f2-41a1-b800-abda9e8bfc27" xlink:to="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6e24aede-0f07-432c-ab1b-181da1ce52b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6e24aede-0f07-432c-ab1b-181da1ce52b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e24aede-0f07-432c-ab1b-181da1ce52b3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a9b25ebd-5798-44d8-af51-d45d268ada39" xlink:href="dva-20201231.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a9b25ebd-5798-44d8-af51-d45d268ada39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_98946072-75be-4ebe-9c3e-50956ffd50a4" xlink:href="dva-20201231.xsd#dva_A2015InterestRateCapAgreementsEffectiveJune292018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4aef5d75-424f-4ae3-a1de-39c30cd81bce" xlink:to="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_98946072-75be-4ebe-9c3e-50956ffd50a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_DebtInstrumentAxis_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_49b6ed6f-7adc-46ce-9f04-22e10b60db24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_64c4174f-39f7-4bc6-b8a3-5dc468fdcfd7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_49b6ed6f-7adc-46ce-9f04-22e10b60db24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_32b9ab62-c014-41d5-973a-96801b3db2c6" xlink:href="dva-20201231.xsd#dva_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49b6ed6f-7adc-46ce-9f04-22e10b60db24" xlink:to="loc_dva_TermLoanFacilityMember_32b9ab62-c014-41d5-973a-96801b3db2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_069bdfae-f96a-4709-89ab-aed043ec7c83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_srt_RangeAxis_069bdfae-f96a-4709-89ab-aed043ec7c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e91adcb2-fe22-4eeb-8d38-26459bd209fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_069bdfae-f96a-4709-89ab-aed043ec7c83" xlink:to="loc_srt_RangeMember_e91adcb2-fe22-4eeb-8d38-26459bd209fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f64b92cb-58b0-43af-94d5-5d3ca84367f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e91adcb2-fe22-4eeb-8d38-26459bd209fa" xlink:to="loc_srt_MaximumMember_f64b92cb-58b0-43af-94d5-5d3ca84367f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56aff222-2260-4553-b66f-74f4389d0309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56aff222-2260-4553-b66f-74f4389d0309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_52719939-0b2e-4681-afe9-d500956a1fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56aff222-2260-4553-b66f-74f4389d0309" xlink:to="loc_us-gaap_HedgingRelationshipDomain_52719939-0b2e-4681-afe9-d500956a1fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_bb4035e6-12a4-43c1-995a-d290ddb2f5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_52719939-0b2e-4681-afe9-d500956a1fe6" xlink:to="loc_us-gaap_CashFlowHedgingMember_bb4035e6-12a4-43c1-995a-d290ddb2f5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fc451214-be39-47e2-a0fe-db21517e671e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fc451214-be39-47e2-a0fe-db21517e671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_235a6fee-7d1d-47cc-8e35-108392cd3a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fc451214-be39-47e2-a0fe-db21517e671e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_235a6fee-7d1d-47cc-8e35-108392cd3a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_7ee3e679-6eaf-44d1-8566-2b6c9d7d5511" xlink:href="dva-20201231.xsd#dva_DebtExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_235a6fee-7d1d-47cc-8e35-108392cd3a37" xlink:to="loc_dva_DebtExpenseMember_7ee3e679-6eaf-44d1-8566-2b6c9d7d5511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f4665665-af12-4f1a-ab81-dc9ac2069ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f4665665-af12-4f1a-ab81-dc9ac2069ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_831af593-afc1-4542-bc90-015b37894541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f4665665-af12-4f1a-ab81-dc9ac2069ad4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_831af593-afc1-4542-bc90-015b37894541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_ee3f61ea-fca0-4be8-8e59-193b98850e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_831af593-afc1-4542-bc90-015b37894541" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_ee3f61ea-fca0-4be8-8e59-193b98850e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_040c54e9-a235-485d-817f-c756bcc9fbe0" xlink:to="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_34b83612-4d53-42a4-9609-d4091447bba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_34b83612-4d53-42a4-9609-d4091447bba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e2e65ee-9b66-4bb6-9fbe-c12a7ca81d62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e2e65ee-9b66-4bb6-9fbe-c12a7ca81d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_31d4a91e-7f17-4735-9fd7-2cba5fa06f17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeInceptionDates_31d4a91e-7f17-4735-9fd7-2cba5fa06f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_939f336e-1084-41ed-ba89-ab0c6c1e51b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeMaturityDates_939f336e-1084-41ed-ba89-ab0c6c1e51b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_35d686f0-1a8c-441b-a62f-c39a4eb2801d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_35d686f0-1a8c-441b-a62f-c39a4eb2801d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_951f9f43-6d0e-4e6d-bcb8-42d6b8776867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_951f9f43-6d0e-4e6d-bcb8-42d6b8776867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a0ff43b-cd9e-4725-996e-caa72af9b4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d86edc82-3878-4cfc-84d1-4e0c77728c95" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a0ff43b-cd9e-4725-996e-caa72af9b4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4da17f3a-773e-4852-b611-95e4b6429101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4da17f3a-773e-4852-b611-95e4b6429101" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d24ca785-0225-4724-a856-6dae68e442c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d24ca785-0225-4724-a856-6dae68e442c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4a9db1d0-28de-4e71-979e-b4c22255ae7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d24ca785-0225-4724-a856-6dae68e442c2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4a9db1d0-28de-4e71-979e-b4c22255ae7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7124fb7b-229d-402c-83aa-cbe61c1abe41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4a9db1d0-28de-4e71-979e-b4c22255ae7c" xlink:to="loc_us-gaap_CashFlowHedgingMember_7124fb7b-229d-402c-83aa-cbe61c1abe41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dba180d2-b926-402e-a4c4-26c28582c53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dba180d2-b926-402e-a4c4-26c28582c53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4d94780a-9e73-4fbe-aae3-8e06b47bd1b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dba180d2-b926-402e-a4c4-26c28582c53c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4d94780a-9e73-4fbe-aae3-8e06b47bd1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_400b93e5-b41e-42d1-a021-7cfcd8534508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4d94780a-9e73-4fbe-aae3-8e06b47bd1b7" xlink:to="loc_us-gaap_InterestRateCapMember_400b93e5-b41e-42d1-a021-7cfcd8534508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fce1dcf-8ac7-4dc6-8f69-19a883bd0ca7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_4afda64b-d0d4-465d-936b-5e6694ad3cff" xlink:href="dva-20201231.xsd#dva_DebtExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:to="loc_dva_DebtExpenseMember_4afda64b-d0d4-465d-936b-5e6694ad3cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxExpenseBenefitMember_2403553b-e8cf-456f-b633-fe135fadca5e" xlink:href="dva-20201231.xsd#dva_IncomeTaxExpenseBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_07ac5148-354d-44c7-8576-bd2bb3162203" xlink:to="loc_dva_IncomeTaxExpenseBenefitMember_2403553b-e8cf-456f-b633-fe135fadca5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45c39bee-e03b-43c5-b7be-dec26e30f421" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_230d1c27-94de-4b4e-8a05-adc3121e1433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_230d1c27-94de-4b4e-8a05-adc3121e1433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_397e40f1-8f82-4639-b4c2-83fa0ef134cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e4cde1d-1153-4723-af8f-07bea044bf7b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_397e40f1-8f82-4639-b4c2-83fa0ef134cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="simple" xlink:href="dva-20201231.xsd#LongTermDebtAdditionalinformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_be379234-6b20-44ed-9342-2e07ef25162f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_be379234-6b20-44ed-9342-2e07ef25162f" xlink:to="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4513c33f-ed64-4211-98df-75aaff2f704c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4513c33f-ed64-4211-98df-75aaff2f704c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4513c33f-ed64-4211-98df-75aaff2f704c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_f8eb9b35-ef5d-4bfe-ae55-989b8689a67d" xlink:href="dva-20201231.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_TermLoanB1Member_f8eb9b35-ef5d-4bfe-ae55-989b8689a67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanBMember_666d5dee-d141-4397-be57-5a0c9500ded8" xlink:href="dva-20201231.xsd#dva_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_TermLoanBMember_666d5dee-d141-4397-be57-5a0c9500ded8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_c55d6c76-e4c0-4c53-bf26-8f87c684fe05" xlink:href="dva-20201231.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_TermLoanAMember_c55d6c76-e4c0-4c53-bf26-8f87c684fe05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_646cb474-844a-4f70-b4ca-74570dcd7612" xlink:href="dva-20201231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_af9b7b09-3a1d-4f70-a3f6-86a7e105f874" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_646cb474-844a-4f70-b4ca-74570dcd7612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34374582-51c7-4fc1-96c3-30c43ef27fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_CreditFacilityAxis_34374582-51c7-4fc1-96c3-30c43ef27fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_34374582-51c7-4fc1-96c3-30c43ef27fcb" xlink:to="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0837115d-59cf-466f-a6de-32d9db09a833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0837115d-59cf-466f-a6de-32d9db09a833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_56976355-3422-4ea2-8e2a-6a13f72b50bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b810fbef-8e88-412c-a90d-6b3fe7ab2be8" xlink:to="loc_us-gaap_LetterOfCreditMember_56976355-3422-4ea2-8e2a-6a13f72b50bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_23944fcf-6c9e-4804-9662-b1086d1f4c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_VariableRateAxis_23944fcf-6c9e-4804-9662-b1086d1f4c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_391f47c0-f204-46ba-b573-cfa71fb68bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_23944fcf-6c9e-4804-9662-b1086d1f4c74" xlink:to="loc_us-gaap_VariableRateDomain_391f47c0-f204-46ba-b573-cfa71fb68bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0cb91d3-c4b0-498f-8fe8-f2cef0af529c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_391f47c0-f204-46ba-b573-cfa71fb68bb8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c0cb91d3-c4b0-498f-8fe8-f2cef0af529c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_18bb70a1-64d7-4a34-9de5-b82c65e59e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_18bb70a1-64d7-4a34-9de5-b82c65e59e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_18bb70a1-64d7-4a34-9de5-b82c65e59e34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_eb308176-b865-4e4f-81d7-7a8452e0d448" xlink:href="dva-20201231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_eb308176-b865-4e4f-81d7-7a8452e0d448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_e2220388-cccb-4fb8-8a07-1dfe6ff0d0d2" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember_e2220388-cccb-4fb8-8a07-1dfe6ff0d0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_c58a0460-818f-483d-bddb-1e00400f2bfa" xlink:href="dva-20201231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_c58a0460-818f-483d-bddb-1e00400f2bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_f03fd533-2696-4360-b859-274d86ea6d7e" xlink:href="dva-20201231.xsd#dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember_f03fd533-2696-4360-b859-274d86ea6d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_1a30a6ad-6006-47cb-8234-191ddbaf895d" xlink:href="dva-20201231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94be9202-f46c-4bf9-b8c4-21ac15e4ad03" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_1a30a6ad-6006-47cb-8234-191ddbaf895d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a7b903b6-4d27-412a-a7b9-6c54ae2d744f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a7b903b6-4d27-412a-a7b9-6c54ae2d744f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92f8494c-7e48-4676-a7d1-674a82cb95fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7b903b6-4d27-412a-a7b9-6c54ae2d744f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92f8494c-7e48-4676-a7d1-674a82cb95fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_80c56189-a8b9-4e87-8668-bbe38fc532f2" xlink:href="dva-20201231.xsd#dva_A2015InterestRateCapAgreementsEffectiveJune292018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f8494c-7e48-4676-a7d1-674a82cb95fe" xlink:to="loc_dva_A2015InterestRateCapAgreementsEffectiveJune292018Member_80c56189-a8b9-4e87-8668-bbe38fc532f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_567717a6-595c-4a11-a0f4-adfaa2bd78a2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_f64ebe2b-168a-4ff0-97d4-7f0e1bf2a83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_f64ebe2b-168a-4ff0-97d4-7f0e1bf2a83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25bd4fdb-5342-4a7c-b1b3-832120686981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25bd4fdb-5342-4a7c-b1b3-832120686981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_913be877-c673-42fc-b082-c51431c37f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_913be877-c673-42fc-b082-c51431c37f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement_b4920b9a-2768-4870-b0bd-9a8b8d398110" xlink:href="dva-20201231.xsd#dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement_b4920b9a-2768-4870-b0bd-9a8b8d398110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProceedsFromRepricingAgreementOnSecuredDebt_9532acdc-d632-4a6e-9755-776a2e058b72" xlink:href="dva-20201231.xsd#dva_ProceedsFromRepricingAgreementOnSecuredDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_ProceedsFromRepricingAgreementOnSecuredDebt_9532acdc-d632-4a6e-9755-776a2e058b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_44d36eba-695d-4978-a3e0-4058821e7595" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_DebtRefinancingCharges_44d36eba-695d-4978-a3e0-4058821e7595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_82054e8e-01df-4679-9360-6bed62607af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_82054e8e-01df-4679-9360-6bed62607af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt_369cddcb-0d1a-4959-ada2-e15cc67e9d9c" xlink:href="dva-20201231.xsd#dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt_369cddcb-0d1a-4959-ada2-e15cc67e9d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2d2d6593-0df2-4a86-b193-230012588247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2d2d6593-0df2-4a86-b193-230012588247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_7c4d1666-275a-4196-be74-be8074e39e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_SeniorNotes_7c4d1666-275a-4196-be74-be8074e39e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_3071c5db-38d5-400a-86d9-e9f8310b5807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_3071c5db-38d5-400a-86d9-e9f8310b5807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_8c82f1eb-f6a3-4b7f-97d8-59f4013ec2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_8c82f1eb-f6a3-4b7f-97d8-59f4013ec2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_ecf94932-dce3-4a7d-a331-d4b13302cf19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_ecf94932-dce3-4a7d-a331-d4b13302cf19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d6ec3dd4-4cde-40b9-95ee-591124a99f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d6ec3dd4-4cde-40b9-95ee-591124a99f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_be1c4285-cfb7-46dd-847f-2e2b85a33dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_be1c4285-cfb7-46dd-847f-2e2b85a33dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_2eebfaa0-6426-4127-b2d8-bcc57d797e69" xlink:href="dva-20201231.xsd#dva_DebtInstrumentRedeemedOutstandingPrincipalAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount_2eebfaa0-6426-4127-b2d8-bcc57d797e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes_a6ac3085-c7fb-4a07-8bff-84f97b613db1" xlink:href="dva-20201231.xsd#dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes_a6ac3085-c7fb-4a07-8bff-84f97b613db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_35b15f64-c7ac-429c-9185-db5574557577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_35b15f64-c7ac-429c-9185-db5574557577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_c8b0d492-f3e0-45ad-aa18-ce41ab51a023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_DerivativeMaturityDates_c8b0d492-f3e0-45ad-aa18-ce41ab51a023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_01f98ee8-ef34-4015-ac87-c05a38903534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LineOfCredit_01f98ee8-ef34-4015-ac87-c05a38903534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_72a2cfcb-e8c0-4b07-9a55-7f562706e9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_SecuredDebt_72a2cfcb-e8c0-4b07-9a55-7f562706e9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7c8f5d7c-e840-4cd7-81a4-494fb7f6dde9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7c8f5d7c-e840-4cd7-81a4-494fb7f6dde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_98a8deee-2ef1-40e8-a456-154a0c74cf14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_98a8deee-2ef1-40e8-a456-154a0c74cf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d0f98bdb-633f-4f9b-9f59-5da34baa52fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d0f98bdb-633f-4f9b-9f59-5da34baa52fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8e0dab3a-6ac5-4395-8ffb-dd6233112603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8e0dab3a-6ac5-4395-8ffb-dd6233112603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ad71318b-2e80-4ceb-bb2a-cb77b9901d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ad71318b-2e80-4ceb-bb2a-cb77b9901d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_43f72f4c-76ef-4c62-a198-ffd0ed51f910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_InterestExpenseDebt_43f72f4c-76ef-4c62-a198-ffd0ed51f910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_19bd5474-dda8-4391-9e5f-bcb3fd5d649b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_753b9bcf-0935-4fba-bfc1-d23df3f4e659" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_19bd5474-dda8-4391-9e5f-bcb3fd5d649b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Leases" xlink:type="simple" xlink:href="dva-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2dec0786-b115-4343-b8cd-d2ba1f17b832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_5b714e7a-8505-4a19-853d-b7d6fb49a51f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2dec0786-b115-4343-b8cd-d2ba1f17b832" xlink:to="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_5b714e7a-8505-4a19-853d-b7d6fb49a51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6b8cec5e-a65e-4126-9c19-7d32ac09c3c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_381e9611-1842-4526-8bcb-26ff1295a7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6b8cec5e-a65e-4126-9c19-7d32ac09c3c2" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_381e9611-1842-4526-8bcb-26ff1295a7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_efc0712b-ee28-456b-bb3d-8b2957f7212d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6b8cec5e-a65e-4126-9c19-7d32ac09c3c2" xlink:to="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_efc0712b-ee28-456b-bb3d-8b2957f7212d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock_a22c7207-0e80-4de2-993f-f8eff97514f3" xlink:href="dva-20201231.xsd#dva_ScheduleOfMinimumLeasePaymentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6b8cec5e-a65e-4126-9c19-7d32ac09c3c2" xlink:to="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock_a22c7207-0e80-4de2-993f-f8eff97514f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesLeaseExpenseComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_54da90e9-843a-42ca-b77c-0cc7f503d2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_f4d9e347-4ab1-4bd2-b39e-d72ffac19aea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_54da90e9-843a-42ca-b77c-0cc7f503d2c9" xlink:to="loc_us-gaap_LeaseCostAbstract_f4d9e347-4ab1-4bd2-b39e-d72ffac19aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_958047a8-e50a-4567-88b7-6c6cfc689515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_f4d9e347-4ab1-4bd2-b39e-d72ffac19aea" xlink:to="loc_us-gaap_OperatingLeaseExpense_958047a8-e50a-4567-88b7-6c6cfc689515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_60856065-84eb-4a52-a58c-6fb40349775b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_f4d9e347-4ab1-4bd2-b39e-d72ffac19aea" xlink:to="loc_us-gaap_VariableLeaseCost_60856065-84eb-4a52-a58c-6fb40349775b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_4832b7c1-5e05-48a9-b715-05b65914a75b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_54da90e9-843a-42ca-b77c-0cc7f503d2c9" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_4832b7c1-5e05-48a9-b715-05b65914a75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_eda8b813-142f-4886-8beb-0656c4698e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_4832b7c1-5e05-48a9-b715-05b65914a75b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_eda8b813-142f-4886-8beb-0656c4698e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b00d9903-ba92-4e3c-b8da-68234ff622e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_4832b7c1-5e05-48a9-b715-05b65914a75b" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_b00d9903-ba92-4e3c-b8da-68234ff622e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_c9690f93-3584-44bd-8af1-869ea3b86f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_54da90e9-843a-42ca-b77c-0cc7f503d2c9" xlink:to="loc_us-gaap_LeaseCost_c9690f93-3584-44bd-8af1-869ea3b86f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesLeasesOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_LesseeLeaseDescriptionLineItemsAbstract_899fecdf-5800-4742-bb73-1a837dc64208" xlink:href="dva-20201231.xsd#dva_LesseeLeaseDescriptionLineItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_59cf897d-5fde-4ae2-8b1f-5cb3e53652c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LesseeLeaseDescriptionLineItemsAbstract_899fecdf-5800-4742-bb73-1a837dc64208" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_59cf897d-5fde-4ae2-8b1f-5cb3e53652c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f74e356f-e1d9-4443-84de-3e1f24c103af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_59cf897d-5fde-4ae2-8b1f-5cb3e53652c5" xlink:to="loc_us-gaap_DebtInstrumentAxis_f74e356f-e1d9-4443-84de-3e1f24c103af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5782b325-87de-4616-a770-fe278841d6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f74e356f-e1d9-4443-84de-3e1f24c103af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5782b325-87de-4616-a770-fe278841d6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_417830fb-c3dc-4fe6-9434-502059eec533" xlink:href="dva-20201231.xsd#dva_FinanceLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5782b325-87de-4616-a770-fe278841d6ac" xlink:to="loc_dva_FinanceLeaseMember_417830fb-c3dc-4fe6-9434-502059eec533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_59cf897d-5fde-4ae2-8b1f-5cb3e53652c5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:to="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7d9a86ea-6cef-432a-b768-877fb127ea54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7d9a86ea-6cef-432a-b768-877fb127ea54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_161f9c78-d6da-4aad-934b-8a01f9da6bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_161f9c78-d6da-4aad-934b-8a01f9da6bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2e96b72f-4b0f-4c37-949b-22cfa1383fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2e96b72f-4b0f-4c37-949b-22cfa1383fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb58c064-9c26-4309-95d2-b2071546afc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a720a27-2764-4ed9-bfa7-ac53eeb7b36f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb58c064-9c26-4309-95d2-b2071546afc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:href="dva-20201231.xsd#dva_LeasesOtherInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3b89a441-db64-4e92-a617-5202ef0fab83" xlink:to="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_9d40ee55-3de7-4b1d-90da-8756f8d7dde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_9d40ee55-3de7-4b1d-90da-8756f8d7dde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_0e64ec94-a482-4cd8-ad60-b522156ad2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:to="loc_us-gaap_OperatingLeasePayments_0e64ec94-a482-4cd8-ad60-b522156ad2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_7c842e32-458b-450b-ae96-c575ea420ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_7c842e32-458b-450b-ae96-c575ea420ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_11674922-f000-49e5-ae4d-0a07a6b99a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_340e3b25-3093-45f5-8ab2-356aa00b27b2" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_11674922-f000-49e5-ae4d-0a07a6b99a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_e1646fbb-1874-4dc9-abd3-d872688bb49b" xlink:href="dva-20201231.xsd#dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesOtherInformationAbstract_2e92b660-fe1d-432f-8c8f-945f50164a12" xlink:to="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_e1646fbb-1874-4dc9-abd3-d872688bb49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6edace36-2954-4c85-b9fe-dcbc071e54c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6edace36-2954-4c85-b9fe-dcbc071e54c4" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_303b48ea-9fd5-4e36-a543-3e2080fdeea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_303b48ea-9fd5-4e36-a543-3e2080fdeea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dc47e74a-243b-4938-bb37-fc69f1b3f36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dc47e74a-243b-4938-bb37-fc69f1b3f36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f4a1c70e-e94f-4426-8246-67c34b7587e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f4a1c70e-e94f-4426-8246-67c34b7587e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6172a7ed-ceff-4812-8f88-d9e743e4c79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6172a7ed-ceff-4812-8f88-d9e743e4c79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9b1e2e75-51a4-4fcd-9366-6a1ad5729dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9b1e2e75-51a4-4fcd-9366-6a1ad5729dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e9ce95a7-1fdf-4bf5-b8f5-03f845a9141c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e9ce95a7-1fdf-4bf5-b8f5-03f845a9141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_847ad53e-1fa4-4fb2-a571-66f5b1026b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_847ad53e-1fa4-4fb2-a571-66f5b1026b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e91ea899-961c-44da-b8e9-9fbcdab72ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e91ea899-961c-44da-b8e9-9fbcdab72ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2dea8e20-5548-42f4-9c14-4500a7367eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_28309191-eb94-4205-9763-14925ed27c2c" xlink:to="loc_us-gaap_OperatingLeaseLiability_2dea8e20-5548-42f4-9c14-4500a7367eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6edace36-2954-4c85-b9fe-dcbc071e54c4" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e23842ff-023a-4876-89aa-75ca596c589b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e23842ff-023a-4876-89aa-75ca596c589b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_e7c4a4d7-7593-4d4b-966e-4b8e8a1486cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_e7c4a4d7-7593-4d4b-966e-4b8e8a1486cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1b06db21-33bf-4732-8a4f-4f263c747a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1b06db21-33bf-4732-8a4f-4f263c747a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4b40afe8-dd63-4781-adbb-bfb55ed85d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4b40afe8-dd63-4781-adbb-bfb55ed85d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_b34df0c7-56ad-4d52-8dd3-6d681036611b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_b34df0c7-56ad-4d52-8dd3-6d681036611b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_7795609b-89b5-4eec-97e1-d0a31827258c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_7795609b-89b5-4eec-97e1-d0a31827258c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a25cc414-1237-4e5a-bdb2-22235a79d14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a25cc414-1237-4e5a-bdb2-22235a79d14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6a4fd75e-5ee1-4c8c-832a-769392f3b222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6a4fd75e-5ee1-4c8c-832a-769392f3b222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_1d07b8ef-211c-4cdf-9cc3-77a8be7aeeef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_97a65372-d0c5-46b4-9541-3942d019b85d" xlink:to="loc_us-gaap_FinanceLeaseLiability_1d07b8ef-211c-4cdf-9cc3-77a8be7aeeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b027a2f5-763a-48bd-8ed3-a7c60150be41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable_b235557d-3861-4518-a526-8cdf49c24ff1" xlink:href="dva-20201231.xsd#dva_LeasesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b027a2f5-763a-48bd-8ed3-a7c60150be41" xlink:to="loc_dva_LeasesDisclosureTable_b235557d-3861-4518-a526-8cdf49c24ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_755821e7-d620-449d-b2b2-a930e0b474cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_b235557d-3861-4518-a526-8cdf49c24ff1" xlink:to="loc_srt_RangeAxis_755821e7-d620-449d-b2b2-a930e0b474cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_755821e7-d620-449d-b2b2-a930e0b474cf" xlink:to="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c17ee24f-5f14-4c8f-b2be-da4b10086109" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:to="loc_srt_MinimumMember_c17ee24f-5f14-4c8f-b2be-da4b10086109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_efe91e1d-bb81-4cbd-8e9a-c5cd347967bf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3550bee6-9b7c-454f-a03e-6d6066392b35" xlink:to="loc_srt_MaximumMember_efe91e1d-bb81-4cbd-8e9a-c5cd347967bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:href="dva-20201231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_b235557d-3861-4518-a526-8cdf49c24ff1" xlink:to="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f6f19bc8-bf98-4a66-8901-2d8281696833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f6f19bc8-bf98-4a66-8901-2d8281696833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_12f616c3-5df0-4ab1-899f-e4e8a1a6ef5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_12f616c3-5df0-4ab1-899f-e4e8a1a6ef5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_6560e300-00bd-4562-aa22-8ebcb68ef576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_6560e300-00bd-4562-aa22-8ebcb68ef576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseAccumulatedDepreciation_49f939eb-bdda-4365-8ba6-0d8db97645ca" xlink:href="dva-20201231.xsd#dva_FinanceLeaseAccumulatedDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_dva_FinanceLeaseAccumulatedDepreciation_49f939eb-bdda-4365-8ba6-0d8db97645ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_50e25d79-c300-4aab-869c-c6fa5a51cc22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_75b6cd14-e410-4519-ad70-ba0f4cc80786" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_50e25d79-c300-4aab-869c-c6fa5a51cc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="dva-20201231.xsd#EmployeeBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15da1792-ac1e-4f19-b0a8-5987689dab8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_47751d91-46bf-4146-b615-a2729a2366fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15da1792-ac1e-4f19-b0a8-5987689dab8b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_47751d91-46bf-4146-b615-a2729a2366fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#EmployeeBenefitPlansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66d31e65-ddf0-4489-8495-4aa256cf2273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66d31e65-ddf0-4489-8495-4aa256cf2273" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_89726d6c-1c91-412f-92d9-c1176d17a275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_89726d6c-1c91-412f-92d9-c1176d17a275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_37bfd615-7135-4986-8222-3411a11fa8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_89726d6c-1c91-412f-92d9-c1176d17a275" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_37bfd615-7135-4986-8222-3411a11fa8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_07329e87-4e13-4145-8f60-6d8ddc612c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37bfd615-7135-4986-8222-3411a11fa8d7" xlink:to="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_07329e87-4e13-4145-8f60-6d8ddc612c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_77a2d533-d1a6-40c3-b827-3a5579debfd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_77a2d533-d1a6-40c3-b827-3a5579debfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3a04cbbf-cf59-440f-ada6-68fd2b9ac9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_77a2d533-d1a6-40c3-b827-3a5579debfd5" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3a04cbbf-cf59-440f-ada6-68fd2b9ac9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllTrustsMember_4c2cfc70-2112-42d6-b2f1-ac78bb55716f" xlink:href="dva-20201231.xsd#dva_AllTrustsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3a04cbbf-cf59-440f-ada6-68fd2b9ac9d0" xlink:to="loc_dva_AllTrustsMember_4c2cfc70-2112-42d6-b2f1-ac78bb55716f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:to="loc_srt_RangeAxis_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ede0db26-a0c0-49e9-8e34-12e7b63cc0a2" xlink:to="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_255181a1-3ee9-4a96-b2b0-9bdf64d37cdc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:to="loc_srt_MinimumMember_255181a1-3ee9-4a96-b2b0-9bdf64d37cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_022c5906-dee9-4b22-9dbb-9eff6fd1d897" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc01a4cf-1bba-484f-9092-8fe92efcb155" xlink:to="loc_srt_MaximumMember_022c5906-dee9-4b22-9dbb-9eff6fd1d897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_375d2aae-b867-4ecd-b948-1b13b2792a73" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_b9fa9946-4b3c-4cb4-9b04-bba57a25b48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_b9fa9946-4b3c-4cb4-9b04-bba57a25b48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_a3445da4-71f1-4fc3-84de-aa9cb13b6bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_a3445da4-71f1-4fc3-84de-aa9cb13b6bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_dcc58aa4-e137-41c3-9f94-02fa1ccb2c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_dcc58aa4-e137-41c3-9f94-02fa1ccb2c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_332b0c13-7546-4f69-b7e1-709dfba2aaa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_332b0c13-7546-4f69-b7e1-709dfba2aaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_238f8f0f-1b98-4835-844b-be1408f9c512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_238f8f0f-1b98-4835-844b-be1408f9c512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_2975a03f-9284-4f15-ae83-92c2ac93ce5d" xlink:href="dva-20201231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_2975a03f-9284-4f15-ae83-92c2ac93ce5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_f7126be8-e3a1-4e07-b360-4eb8e53a1d51" xlink:href="dva-20201231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_f7126be8-e3a1-4e07-b360-4eb8e53a1d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_54e132eb-a148-4416-bfbe-3056c39d6ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_54e132eb-a148-4416-bfbe-3056c39d6ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_129e5607-727c-4e0b-897f-ac956e22709b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_299ed25f-0176-43c9-93f9-b7ae713f5b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_129e5607-727c-4e0b-897f-ac956e22709b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Contingencies" xlink:type="simple" xlink:href="dva-20201231.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f50562a-5b84-4cfe-a309-110ae6864c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_bda7dd83-ff9d-43ba-ae36-a30bcae9dbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f50562a-5b84-4cfe-a309-110ae6864c3c" xlink:to="loc_us-gaap_LossContingencyDisclosures_bda7dd83-ff9d-43ba-ae36-a30bcae9dbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fc3ee916-8ca8-407e-9615-d2cbe2f3b0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fc3ee916-8ca8-407e-9615-d2cbe2f3b0b2" xlink:to="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:to="loc_us-gaap_TransactionTypeAxis_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_4ff00ac9-1f98-40f4-b2ea-edcc6447cb4d" xlink:to="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_15f990bc-891b-4ae4-b2dd-0fc0702d555c" xlink:href="dva-20201231.xsd#dva_IncrementalCashPortionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:to="loc_dva_IncrementalCashPortionMember_15f990bc-891b-4ae4-b2dd-0fc0702d555c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_577a924f-05b8-480c-bf2c-2503649445ab" xlink:href="dva-20201231.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_c3ea7598-af14-434f-b77d-c10e469c5023" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_577a924f-05b8-480c-bf2c-2503649445ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4077bfe7-2baf-432c-906e-1187d0c3de0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:to="loc_srt_LitigationCaseAxis_4077bfe7-2baf-432c-906e-1187d0c3de0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cc034610-0f32-4665-9ce0-71114a413c32" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_4077bfe7-2baf-432c-906e-1187d0c3de0c" xlink:to="loc_srt_LitigationCaseTypeDomain_cc034610-0f32-4665-9ce0-71114a413c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_5168558e-ddb4-4d7c-ba6f-366d7a0855b2" xlink:href="dva-20201231.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_cc034610-0f32-4665-9ce0-71114a413c32" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_5168558e-ddb4-4d7c-ba6f-366d7a0855b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_5e47e242-9a3f-45f8-b1c0-87ddf65329da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_aba26067-dc40-4a07-b8d1-4cff88970897" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_5e47e242-9a3f-45f8-b1c0-87ddf65329da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bf73d94b-615b-49dc-adef-7dfa0f996e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_5e47e242-9a3f-45f8-b1c0-87ddf65329da" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bf73d94b-615b-49dc-adef-7dfa0f996e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="simple" xlink:href="dva-20201231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_44e1b284-a5ea-4cc5-b578-2663555f1a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_d6a8d7a2-3817-4b9b-8270-7dc9f61c4e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44e1b284-a5ea-4cc5-b578-2663555f1a7f" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_d6a8d7a2-3817-4b9b-8270-7dc9f61c4e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5a4c7367-cec2-48e1-995a-2f6b464afbb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:href="dva-20201231.xsd#dva_CommitmentsAndContingenciesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5a4c7367-cec2-48e1-995a-2f6b464afbb4" xlink:to="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_bf266b2c-d090-4712-8270-f29d1f61e862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:to="loc_us-gaap_OtherCommitmentsAxis_bf266b2c-d090-4712-8270-f29d1f61e862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_4d484beb-7ee4-434e-a798-dcc633ae2a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_bf266b2c-d090-4712-8270-f29d1f61e862" xlink:to="loc_us-gaap_OtherCommitmentsDomain_4d484beb-7ee4-434e-a798-dcc633ae2a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_4f562de3-31a3-4750-bfd7-98afa904ebef" xlink:href="dva-20201231.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_4d484beb-7ee4-434e-a798-dcc633ae2a58" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_4f562de3-31a3-4750-bfd7-98afa904ebef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_05cc9d82-1d0b-4ebf-8df0-33f7a979f486" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:to="loc_srt_RangeAxis_05cc9d82-1d0b-4ebf-8df0-33f7a979f486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_05cc9d82-1d0b-4ebf-8df0-33f7a979f486" xlink:to="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2ff06363-8afb-409b-9109-7bb6093ec5e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:to="loc_srt_MinimumMember_2ff06363-8afb-409b-9109-7bb6093ec5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c571bc0a-f761-4481-be09-376b28427c97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_feff11e2-3cf9-4528-a8b5-5e6d7448ff35" xlink:to="loc_srt_MaximumMember_c571bc0a-f761-4481-be09-376b28427c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_a72ca87d-b776-4410-9b88-a8b265d4de44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_a72ca87d-b776-4410-9b88-a8b265d4de44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_421b9599-a6b7-498c-91ce-fa0e9e25652d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_a72ca87d-b776-4410-9b88-a8b265d4de44" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_421b9599-a6b7-498c-91ce-fa0e9e25652d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EpogenMember_e521ed10-5f71-41c6-ab1d-23c47f58e447" xlink:href="dva-20201231.xsd#dva_EpogenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_421b9599-a6b7-498c-91ce-fa0e9e25652d" xlink:to="loc_dva_EpogenMember_e521ed10-5f71-41c6-ab1d-23c47f58e447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:href="dva-20201231.xsd#dva_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_d955b5ad-a260-4e99-94b7-4bcb2f366366" xlink:to="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_a4e3c4f4-8073-49d9-b49c-2a47b21855b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_OtherCommitment_a4e3c4f4-8073-49d9-b49c-2a47b21855b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DissolutionTermOfJointVentures_0b1a9e0f-9af2-4efb-8288-1b46b862b2b3" xlink:href="dva-20201231.xsd#dva_DissolutionTermOfJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_DissolutionTermOfJointVentures_0b1a9e0f-9af2-4efb-8288-1b46b862b2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentExpirationDate_f5716f55-efa8-45fb-9f5b-4acaab6ebc20" xlink:href="dva-20201231.xsd#dva_LongTermPurchaseCommitmentExpirationDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_LongTermPurchaseCommitmentExpirationDate_f5716f55-efa8-45fb-9f5b-4acaab6ebc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_69fa8a42-876c-42d3-8757-727e77e2b0c4" xlink:href="dva-20201231.xsd#dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_69fa8a42-876c-42d3-8757-727e77e2b0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_3faf693d-9511-47dc-bf0c-9475a7ff6563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_3faf693d-9511-47dc-bf0c-9475a7ff6563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_52474409-81fb-4ade-a8cc-14784183290b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_52474409-81fb-4ade-a8cc-14784183290b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_b32d1196-dd67-4019-a695-d9e718046976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_b32d1196-dd67-4019-a695-d9e718046976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_46a42dea-54f4-41be-a1df-89913808ea2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_46a42dea-54f4-41be-a1df-89913808ea2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OffBalanceSheetFinancingArrangements_30fae7c4-57ec-41d9-a24c-1e98f2df6c99" xlink:href="dva-20201231.xsd#dva_OffBalanceSheetFinancingArrangements"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_61ef4ed5-661b-4240-8fb9-ca455e586062" xlink:to="loc_dva_OffBalanceSheetFinancingArrangements_30fae7c4-57ec-41d9-a24c-1e98f2df6c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_655adcd1-4263-4edd-ab6a-c2a892a1bd92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_917b89ed-bc41-41b7-9d32-6469c9178fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_655adcd1-4263-4edd-ab6a-c2a892a1bd92" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_917b89ed-bc41-41b7-9d32-6469c9178fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55662fa7-f498-47d5-872b-ce6a542c3b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_690da726-3536-4ed2-9b10-d33fce64aa33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55662fa7-f498-47d5-872b-ce6a542c3b09" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_690da726-3536-4ed2-9b10-d33fce64aa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_89fdf509-87b4-4597-886b-ae7f4b339084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55662fa7-f498-47d5-872b-ce6a542c3b09" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_89fdf509-87b4-4597-886b-ae7f4b339084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7930c312-5882-4bc3-8b68-e1042b9480e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55662fa7-f498-47d5-872b-ce6a542c3b09" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7930c312-5882-4bc3-8b68-e1042b9480e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1dda7f81-adac-4597-b5f2-489f3e73fe1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1dda7f81-adac-4597-b5f2-489f3e73fe1b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_faea21c3-d98a-4aa4-a222-bac037cef79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:to="loc_us-gaap_AwardTypeAxis_faea21c3-d98a-4aa4-a222-bac037cef79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_faea21c3-d98a-4aa4-a222-bac037cef79c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_0e4a4297-74b6-495a-86f8-284ce713da04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_0e4a4297-74b6-495a-86f8-284ce713da04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockUnitMember_1fa06f0a-a646-43a5-b8f5-58aeae7b1004" xlink:href="dva-20201231.xsd#dva_StockUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7261726b-08fe-45d3-96a3-e9aede65a6d6" xlink:to="loc_dva_StockUnitMember_1fa06f0a-a646-43a5-b8f5-58aeae7b1004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_a5dea479-f94b-476e-868a-c557d6017fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:to="loc_us-gaap_VestingAxis_a5dea479-f94b-476e-868a-c557d6017fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_f28c9955-0584-4a1a-bd36-455850a41e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_a5dea479-f94b-476e-868a-c557d6017fe2" xlink:to="loc_us-gaap_VestingDomain_f28c9955-0584-4a1a-bd36-455850a41e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c0760e74-5310-41c5-8e1f-0339bef8aa75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_f28c9955-0584-4a1a-bd36-455850a41e3b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c0760e74-5310-41c5-8e1f-0339bef8aa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28015e6d-f310-490a-894c-e6a7a0d20183" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ff5f60b6-8f23-4de3-ae07-56c574ff1cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ff5f60b6-8f23-4de3-ae07-56c574ff1cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_964d4208-6dea-4d81-8044-52af66971795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_964d4208-6dea-4d81-8044-52af66971795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d56220c6-dcdb-44e4-ac0b-064d611168e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d56220c6-dcdb-44e4-ac0b-064d611168e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_99b4fddd-4eb0-4869-a06e-b48c14fbb56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_99b4fddd-4eb0-4869-a06e-b48c14fbb56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f7ac30cc-8cc6-4304-a00e-801e0ba8006f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f7ac30cc-8cc6-4304-a00e-801e0ba8006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a944b28c-8f0f-49a4-a689-4806292502fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_539d48d7-49ed-4dae-a89c-116559d3ff60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a944b28c-8f0f-49a4-a689-4806292502fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e214fbcc-0f02-42f2-a638-5a1e162bfe1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e214fbcc-0f02-42f2-a638-5a1e162bfe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0484d58a-a3ab-4ca4-95ed-96cffd22ddcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0484d58a-a3ab-4ca4-95ed-96cffd22ddcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aa66fa8e-2017-4bbe-86d0-bedb3f2d6118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aa66fa8e-2017-4bbe-86d0-bedb3f2d6118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_526a2e88-9992-4f9a-92cd-f3979830ec7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_526a2e88-9992-4f9a-92cd-f3979830ec7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d141169f-221c-4b04-96a1-7e13490f7f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d141169f-221c-4b04-96a1-7e13490f7f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_9f843bca-8aa4-4edf-982c-6c490622b4f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_9f843bca-8aa4-4edf-982c-6c490622b4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_afc28f6b-89d1-4536-88d6-066cd86898cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_afc28f6b-89d1-4536-88d6-066cd86898cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ff63537f-327a-41be-89ff-d20c560c9706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3100b19a-b99a-4dac-9803-e6d9db014f80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ff63537f-327a-41be-89ff-d20c560c9706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad256fff-04b4-4d36-b9c0-6af404120660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad256fff-04b4-4d36-b9c0-6af404120660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_edd3fde9-23ad-424e-b67e-e8de480cd8c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_edd3fde9-23ad-424e-b67e-e8de480cd8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3cce4638-1a6c-4b40-b631-c4f3177a501c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_8cdfde7f-2bac-4f6e-b984-e060d55e66c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3cce4638-1a6c-4b40-b631-c4f3177a501c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_25a9da6f-59f8-464d-92bd-ed15ddf80a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_25a9da6f-59f8-464d-92bd-ed15ddf80a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9af6ce5c-c1d7-4e12-9601-5f69e1668165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9af6ce5c-c1d7-4e12-9601-5f69e1668165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_fc1ea391-dd89-4ae3-8534-09ec1a24ea2b" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_fc1ea391-dd89-4ae3-8534-09ec1a24ea2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_616262ff-e714-4722-8807-164a09b47dba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_616262ff-e714-4722-8807-164a09b47dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_cc8e11b3-0135-41fb-9ff5-e88f18fd2886" xlink:href="dva-20201231.xsd#dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_cc8e11b3-0135-41fb-9ff5-e88f18fd2886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fd6bf201-0110-4cfe-a1c3-99b8d88322f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fd6bf201-0110-4cfe-a1c3-99b8d88322f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e2bf4c16-30b1-442e-89d2-bf7154a2c995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26d45e7d-8a8a-4968-a256-cc1d15d910e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e2bf4c16-30b1-442e-89d2-bf7154a2c995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281de62f-f24b-4294-980e-edb1188e4cb6" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281de62f-f24b-4294-980e-edb1188e4cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c43edfd4-8eb2-4d37-a6df-fb6deaf9c623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c43edfd4-8eb2-4d37-a6df-fb6deaf9c623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2d5861e-3c28-4b67-be5e-a114ba08226d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_62fc50cd-494f-4375-914c-f584515a9006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_62fc50cd-494f-4375-914c-f584515a9006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_56d3e5a1-56cd-4d78-aa03-59f1d85740db" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_3876a91c-af5c-4feb-98b8-4724cec3bd67" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_56d3e5a1-56cd-4d78-aa03-59f1d85740db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33aca7fe-44c8-4289-b59c-206aa9eaa0de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_b0be074d-f69a-4994-ae5e-b9c28949cc68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33aca7fe-44c8-4289-b59c-206aa9eaa0de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_b0be074d-f69a-4994-ae5e-b9c28949cc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_b0be074d-f69a-4994-ae5e-b9c28949cc68" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0b9c853c-b211-446b-ba2b-ed8de9a1e4f8" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeOneMember_11259262-4c9f-447c-a551-58588dda981b" xlink:href="dva-20201231.xsd#dva_RangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:to="loc_dva_RangeOneMember_11259262-4c9f-447c-a551-58588dda981b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeTwoMember_59d48af1-43e3-4ab2-800a-c28cc06cbcff" xlink:href="dva-20201231.xsd#dva_RangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:to="loc_dva_RangeTwoMember_59d48af1-43e3-4ab2-800a-c28cc06cbcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeThreeMember_a80988a1-243d-4f6c-8bb4-6ec8a43afaa6" xlink:href="dva-20201231.xsd#dva_RangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e36ef0ba-1b60-4ba8-998a-0f32b6593997" xlink:to="loc_dva_RangeThreeMember_a80988a1-243d-4f6c-8bb4-6ec8a43afaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_b0be074d-f69a-4994-ae5e-b9c28949cc68" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_a9f410df-33f6-4206-99b6-adf9962f1910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_a9f410df-33f6-4206-99b6-adf9962f1910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_439a7f00-1357-43d0-bbe8-57d7c8591b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_439a7f00-1357-43d0-bbe8-57d7c8591b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d61a1d24-2ab4-4958-b190-c5edf12977f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d61a1d24-2ab4-4958-b190-c5edf12977f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_66cecaa2-9bbe-404b-89cf-8b520b633c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_66cecaa2-9bbe-404b-89cf-8b520b633c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_88fbc0bd-6ec4-4320-b734-02381baabc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_88fbc0bd-6ec4-4320-b734-02381baabc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_fbbabe00-eeb3-493e-a581-d94416967c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2a6ed073-a80b-4834-8567-5c4534c0e6af" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_fbbabe00-eeb3-493e-a581-d94416967c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b9935cf-db70-4d7e-b756-0ba5911f664d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7021f316-de06-48d2-a4ed-fae75f9c7f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b9935cf-db70-4d7e-b756-0ba5911f664d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7021f316-de06-48d2-a4ed-fae75f9c7f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_242ac5aa-5b4c-411a-8360-3b3be62c8774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7021f316-de06-48d2-a4ed-fae75f9c7f63" xlink:to="loc_us-gaap_AwardTypeAxis_242ac5aa-5b4c-411a-8360-3b3be62c8774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b72413-8a87-42bf-91bb-6d3ee98974ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_242ac5aa-5b4c-411a-8360-3b3be62c8774" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b72413-8a87-42bf-91bb-6d3ee98974ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockOptionProgramAndStockAppreciationRightProgramMember_dccdffc9-30c0-4730-922c-2d0e15da8a81" xlink:href="dva-20201231.xsd#dva_StockOptionProgramAndStockAppreciationRightProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b72413-8a87-42bf-91bb-6d3ee98974ae" xlink:to="loc_dva_StockOptionProgramAndStockAppreciationRightProgramMember_dccdffc9-30c0-4730-922c-2d0e15da8a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7021f316-de06-48d2-a4ed-fae75f9c7f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bb6260d0-ca34-4f4e-9164-937aebd5891c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bb6260d0-ca34-4f4e-9164-937aebd5891c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2179697a-c81e-4b34-88c7-5abcc080fea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2179697a-c81e-4b34-88c7-5abcc080fea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_baabb111-a00d-4749-b2d4-888d9fd62fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_baabb111-a00d-4749-b2d4-888d9fd62fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_262b0ab9-620b-44e6-a926-267e42a7ee97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70e0fd98-856e-4d36-a6b7-9cd611923e23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_262b0ab9-620b-44e6-a926-267e42a7ee97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_247e7896-2e76-4b9f-9c21-7c8870489140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_247e7896-2e76-4b9f-9c21-7c8870489140" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d21ffcda-2a1a-4e79-9309-a07f6ec242b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_PlanNameAxis_d21ffcda-2a1a-4e79-9309-a07f6ec242b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d21ffcda-2a1a-4e79-9309-a07f6ec242b1" xlink:to="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyTwentyMember_671d7eda-4ee6-43a5-80c1-0f9d313bd985" xlink:href="dva-20201231.xsd#dva_StockIncentivePlanTwentyTwentyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:to="loc_dva_StockIncentivePlanTwentyTwentyMember_671d7eda-4ee6-43a5-80c1-0f9d313bd985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyElevenMember_0a54d3f2-ccaf-4d54-96ed-9519a6066025" xlink:href="dva-20201231.xsd#dva_StockIncentivePlanTwentyElevenMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_050f4216-a0d6-4d3f-9d8d-7f1e26899243" xlink:to="loc_dva_StockIncentivePlanTwentyElevenMember_0a54d3f2-ccaf-4d54-96ed-9519a6066025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_34b158c4-21ac-44e3-a999-05fe854c4cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_VestingAxis_34b158c4-21ac-44e3-a999-05fe854c4cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_34b158c4-21ac-44e3-a999-05fe854c4cb7" xlink:to="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_9d6f5d36-c8a4-434d-a86a-384807ef8c22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_9d6f5d36-c8a4-434d-a86a-384807ef8c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_e0080a26-5373-489a-86f0-32c646bafa4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_dfa720cc-75c0-403f-a91e-22a4d3d60e38" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_e0080a26-5373-489a-86f0-32c646bafa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bfc336ac-5f60-4563-98bc-d10c74b9e68d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_srt_RangeAxis_bfc336ac-5f60-4563-98bc-d10c74b9e68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bfc336ac-5f60-4563-98bc-d10c74b9e68d" xlink:to="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6eb09afa-9394-48fb-a68b-f1ea32aa3cef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:to="loc_srt_MinimumMember_6eb09afa-9394-48fb-a68b-f1ea32aa3cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_45994c2a-bbe2-4a95-a457-e4b3e7946a43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_382911e6-4b1b-4c17-8f41-5195ecbb88be" xlink:to="loc_srt_MaximumMember_45994c2a-bbe2-4a95-a457-e4b3e7946a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8f33b30b-0f67-4729-b30e-320e038de62f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_AwardTypeAxis_8f33b30b-0f67-4729-b30e-320e038de62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8f33b30b-0f67-4729-b30e-320e038de62f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_b04d0bee-2ea0-4d58-a90f-2389e8d79224" xlink:href="dva-20201231.xsd#dva_PremiumPricedStockSettledStockAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:to="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_b04d0bee-2ea0-4d58-a90f-2389e8d79224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeStockPurchasePlanMember_0516c8ec-775c-46a3-a415-b761fe79b7e8" xlink:href="dva-20201231.xsd#dva_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:to="loc_dva_EmployeeStockPurchasePlanMember_0516c8ec-775c-46a3-a415-b761fe79b7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_c4cc84f6-9692-4c27-9048-5f5283bd7b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e8d5009-4654-4f53-9de1-3dc61d37d9bf" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_c4cc84f6-9692-4c27-9048-5f5283bd7b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1746b7b0-251a-453f-9b4a-5688f4df2a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1746b7b0-251a-453f-9b4a-5688f4df2a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9de8a2cb-444e-475f-9137-0dd65d52947b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1746b7b0-251a-453f-9b4a-5688f4df2a21" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9de8a2cb-444e-475f-9137-0dd65d52947b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_09a52acc-33b3-46bd-9865-dedac952ae59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9de8a2cb-444e-475f-9137-0dd65d52947b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_09a52acc-33b3-46bd-9865-dedac952ae59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc8600ba-db07-4f6a-90ad-36829b428252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d820c017-9808-451f-af53-8d51da96de23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d820c017-9808-451f-af53-8d51da96de23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4dbe93cb-c708-4509-a37a-6d2c531a62a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4dbe93cb-c708-4509-a37a-6d2c531a62a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_987e8b89-e6a3-4559-83a7-f26d8029e2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_987e8b89-e6a3-4559-83a7-f26d8029e2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_a7099e35-d746-4c05-995f-197f4819ada4" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_a7099e35-d746-4c05-995f-197f4819ada4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_54131f9c-16dc-49a2-8f00-6c1b780b7ca5" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_54131f9c-16dc-49a2-8f00-6c1b780b7ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0d46102f-5efc-4423-a808-c48ae0871a0d" xlink:href="dva-20201231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0d46102f-5efc-4423-a808-c48ae0871a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_b7368bd8-b16a-41fc-8fe7-750007a4b3eb" xlink:href="dva-20201231.xsd#dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_b7368bd8-b16a-41fc-8fe7-750007a4b3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a5febdfc-fabd-4472-9d5f-36c404fc9c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a5febdfc-fabd-4472-9d5f-36c404fc9c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d219f8ca-eb59-4916-9f3a-c1cfd30c615a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d219f8ca-eb59-4916-9f3a-c1cfd30c615a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_c6c1bc37-1ed4-4bd9-8a49-367d2e3629f9" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_c6c1bc37-1ed4-4bd9-8a49-367d2e3629f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0e549647-2395-44e3-91cc-5bba0209d2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0e549647-2395-44e3-91cc-5bba0209d2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0f00c431-3ff9-4afd-8f87-72a7523d40bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0f00c431-3ff9-4afd-8f87-72a7523d40bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_352c8a1a-9344-4526-8884-70d7935c0103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_352c8a1a-9344-4526-8884-70d7935c0103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_0e27d8dc-18e5-44f8-9946-d948e755b4bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_0e27d8dc-18e5-44f8-9946-d948e755b4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3811f95e-3b6c-42c4-ac40-6441af2de1df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3811f95e-3b6c-42c4-ac40-6441af2de1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedAwardBasePricePerShare_50b8282f-463e-4808-a97a-a39e90d21f5f" xlink:href="dva-20201231.xsd#dva_PremiumPricedAwardBasePricePerShare"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_PremiumPricedAwardBasePricePerShare_50b8282f-463e-4808-a97a-a39e90d21f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_6d9f2659-419c-4db5-a70d-81783a3d9c5b" xlink:href="dva-20201231.xsd#dva_PremiumToTheTenderOfferSharePurchasePrice"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_6d9f2659-419c-4db5-a70d-81783a3d9c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_431e48fd-d125-46ce-99ed-bb6924b0a30c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_431e48fd-d125-46ce-99ed-bb6924b0a30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_f5521d99-6742-4275-8aaf-fbf2630330bb" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_f5521d99-6742-4275-8aaf-fbf2630330bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_77e4a958-7d73-45be-b601-d0b2ad5357df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_77e4a958-7d73-45be-b601-d0b2ad5357df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_503c2528-3844-4db1-baa6-beace1895b63" xlink:href="dva-20201231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_503c2528-3844-4db1-baa6-beace1895b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_4d792602-2961-4f01-859c-458a8269beba" xlink:href="dva-20201231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_4d792602-2961-4f01-859c-458a8269beba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4e813b59-472a-4049-9ca8-6fc118181fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4e813b59-472a-4049-9ca8-6fc118181fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_f23eafb9-4bdd-44d4-bded-ab2e33d5cb26" xlink:href="dva-20201231.xsd#dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_f23eafb9-4bdd-44d4-bded-ab2e33d5cb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_636a66fb-ef9a-49ab-bd9b-bd283028067a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_636a66fb-ef9a-49ab-bd9b-bd283028067a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c507bdbd-5ab4-41ea-b35d-d20cb8a9bf4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c507bdbd-5ab4-41ea-b35d-d20cb8a9bf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ce229cc3-461c-4f7f-b032-096c455ba6db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ce229cc3-461c-4f7f-b032-096c455ba6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_7a4aaeaa-0927-48e3-9f7a-0dcb672b3c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_7a4aaeaa-0927-48e3-9f7a-0dcb672b3c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c778a9a7-7202-42d9-8718-f60ce3c13436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_5b98c840-0c29-429b-a1d5-ab8f7a55263b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c778a9a7-7202-42d9-8718-f60ce3c13436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveProgramCompensationCost_37bef635-b27b-4728-b5f5-6431362e5077" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveProgramCompensationCost"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_LongtermIncentiveProgramCompensationCost_37bef635-b27b-4728-b5f5-6431362e5077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_185c3483-5304-46d8-b055-c6ec9b362044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensation_185c3483-5304-46d8-b055-c6ec9b362044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_42b95091-4086-4d91-8ac2-a3781388d4ae" xlink:href="dva-20201231.xsd#dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_42b95091-4086-4d91-8ac2-a3781388d4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b461ca24-34fe-41d6-ac8d-59ae5a633e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b461ca24-34fe-41d6-ac8d-59ae5a633e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bddb4e49-2b72-414f-9a93-ae0f11aa98fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bddb4e49-2b72-414f-9a93-ae0f11aa98fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding_76d2dfdd-848f-4235-abb4-2ba2e494346a" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding_76d2dfdd-848f-4235-abb4-2ba2e494346a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards_52060faf-c586-46a4-b0a5-5d06d7de3901" xlink:href="dva-20201231.xsd#dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards_52060faf-c586-46a4-b0a5-5d06d7de3901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_175b940e-e356-4a2f-9015-9a76ea52d481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_175b940e-e356-4a2f-9015-9a76ea52d481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_97f3f443-270d-4771-bb6d-9064bc71591f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_97f3f443-270d-4771-bb6d-9064bc71591f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a9f0d552-777a-4652-8da3-35f8629d5cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a9f0d552-777a-4652-8da3-35f8629d5cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9c0b4d3a-a140-4b85-b0cd-a855a64bf098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14845df2-7f38-4584-8dbc-afdc37f35654" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9c0b4d3a-a140-4b85-b0cd-a855a64bf098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Stockholdersequity" xlink:type="simple" xlink:href="dva-20201231.xsd#Stockholdersequity"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Stockholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4adc2751-663b-48a0-b75c-48a2cac47f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_87344e54-c33a-420c-b01e-699c832b4e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4adc2751-663b-48a0-b75c-48a2cac47f90" xlink:to="loc_us-gaap_TreasuryStockTextBlock_87344e54-c33a-420c-b01e-699c832b4e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/StockholdersequityTables" xlink:type="simple" xlink:href="dva-20201231.xsd#StockholdersequityTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/StockholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c7a3b846-cdfb-4fc6-bde8-85f954efa672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_df306b77-f4bd-4142-9207-830126dbf0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7a3b846-cdfb-4fc6-bde8-85f954efa672" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_df306b77-f4bd-4142-9207-830126dbf0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_e7611036-da20-402a-8b49-ed927b84f7cd" xlink:href="dva-20201231.xsd#dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7a3b846-cdfb-4fc6-bde8-85f954efa672" xlink:to="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_e7611036-da20-402a-8b49-ed927b84f7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#StockRepurchasesTenderOfferDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract_ca3dbaec-0278-400f-a274-653635eb8b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_235e88fd-f53c-4804-9492-4a5cac83d449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockValueAbstract_ca3dbaec-0278-400f-a274-653635eb8b97" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_235e88fd-f53c-4804-9492-4a5cac83d449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_fab04dff-d27a-4987-8b47-79457df58bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_235e88fd-f53c-4804-9492-4a5cac83d449" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_fab04dff-d27a-4987-8b47-79457df58bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_fab04dff-d27a-4987-8b47-79457df58bd3" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_b07d78ec-f5e0-41ed-8a6b-783e6c507623" xlink:href="dva-20201231.xsd#dva_OpenMarketPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:to="loc_dva_OpenMarketPurchasesMember_b07d78ec-f5e0-41ed-8a6b-783e6c507623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TenderOfferMember_517a9bf8-afed-4b2d-aa51-408fad27e9e4" xlink:href="dva-20201231.xsd#dva_TenderOfferMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_98948551-0ffd-4f61-81f1-bca3f5f3c7d8" xlink:to="loc_dva_TenderOfferMember_517a9bf8-afed-4b2d-aa51-408fad27e9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_235e88fd-f53c-4804-9492-4a5cac83d449" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_77210b4c-4ae7-48d2-ae01-6ea4b904cd5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_77210b4c-4ae7-48d2-ae01-6ea4b904cd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d5b12d8a-cbad-4048-9356-4f15e4e6dfbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_d5b12d8a-cbad-4048-9356-4f15e4e6dfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_05b65e5e-1cd2-475c-a011-5aef366fe1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_05b65e5e-1cd2-475c-a011-5aef366fe1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_33c62338-d06b-472f-9567-3ccc9cec41fa" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_a639bef4-0f53-459c-963e-d422eaff1e4a" xlink:href="dva-20201231.xsd#dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:to="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_a639bef4-0f53-459c-963e-d422eaff1e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareRepurchaseFeesAndExpenses_25e46068-2b2c-44a9-a76d-9f8ab9213a13" xlink:href="dva-20201231.xsd#dva_ShareRepurchaseFeesAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_7cb4ee9f-11e9-41fd-8b91-da2f0487bb2e" xlink:to="loc_dva_ShareRepurchaseFeesAndExpenses_25e46068-2b2c-44a9-a76d-9f8ab9213a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_21207535-aecc-459b-a1d5-8ee7827db0b2" xlink:href="dva-20201231.xsd#dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_925caf77-8abb-431f-8534-1cf42c34d49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_21207535-aecc-459b-a1d5-8ee7827db0b2" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_925caf77-8abb-431f-8534-1cf42c34d49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d4638741-d79e-443f-a776-1cc11fbc261a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_925caf77-8abb-431f-8534-1cf42c34d49f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d4638741-d79e-443f-a776-1cc11fbc261a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9b448c77-1e0e-47da-af9e-8c3122a3238b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d4638741-d79e-443f-a776-1cc11fbc261a" xlink:to="loc_us-gaap_EquityComponentDomain_9b448c77-1e0e-47da-af9e-8c3122a3238b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1ce48657-cff4-4e04-b54f-6f6b9417262e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9b448c77-1e0e-47da-af9e-8c3122a3238b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1ce48657-cff4-4e04-b54f-6f6b9417262e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_925caf77-8abb-431f-8534-1cf42c34d49f" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c877f81a-fe4f-480a-9081-85ab010a7815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:to="loc_us-gaap_NetIncomeLoss_c877f81a-fe4f-480a-9081-85ab010a7815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_acf3ae02-66f5-4837-928d-01cb91c30f36" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_931ad767-4e2f-4290-a425-0c2ef6fb2365" xlink:href="dva-20201231.xsd#dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_931ad767-4e2f-4290-a425-0c2ef6fb2365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_3a9d6930-7eeb-431b-89d8-bbd9bacf0916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_3a9d6930-7eeb-431b-89d8-bbd9bacf0916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_1ad45891-f8f6-4803-9000-19f076420362" xlink:href="dva-20201231.xsd#dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_1ad45891-f8f6-4803-9000-19f076420362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_c5a1d8ed-55d7-40a3-b3da-a52bd997621d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_c5a1d8ed-55d7-40a3-b3da-a52bd997621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_fd0cd693-9e89-4ab2-baa7-0630fb2562d5" xlink:href="dva-20201231.xsd#dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_296c2f0e-179d-4a3a-91ae-235460d19d4c" xlink:to="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_fd0cd693-9e89-4ab2-baa7-0630fb2562d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ShareholdersequityDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9230e730-1783-42c8-b352-ab26d1d48ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9230e730-1783-42c8-b352-ab26d1d48ce7" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0656ac5f-43df-4319-8e0f-3342dedd4906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0656ac5f-43df-4319-8e0f-3342dedd4906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d33cc60b-3db8-4e71-a2fa-e098340d72bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0656ac5f-43df-4319-8e0f-3342dedd4906" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d33cc60b-3db8-4e71-a2fa-e098340d72bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d8cd7452-5b27-447c-b61b-4f4069233d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d33cc60b-3db8-4e71-a2fa-e098340d72bf" xlink:to="loc_us-gaap_SubsequentEventMember_d8cd7452-5b27-447c-b61b-4f4069233d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e53d2430-66ef-49f9-a37d-ba5f081f6aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e53d2430-66ef-49f9-a37d-ba5f081f6aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_86f95937-4ce3-44d2-a480-cf5090ee44e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e53d2430-66ef-49f9-a37d-ba5f081f6aa2" xlink:to="loc_us-gaap_EquityComponentDomain_86f95937-4ce3-44d2-a480-cf5090ee44e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ce71895b-468f-4a31-809f-3392b6e7519f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_86f95937-4ce3-44d2-a480-cf5090ee44e9" xlink:to="loc_us-gaap_TreasuryStockMember_ce71895b-468f-4a31-809f-3392b6e7519f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9b668c73-b308-4a4c-97a5-1bc5b15f055b" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_47c9c1fa-57be-438c-8168-40017e8d1e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_47c9c1fa-57be-438c-8168-40017e8d1e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f44c42b3-a92a-4e38-9dbb-ec2cf0f5bcc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f44c42b3-a92a-4e38-9dbb-ec2cf0f5bcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_966df3df-de45-4caf-8b8b-752ea8234f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_966df3df-de45-4caf-8b8b-752ea8234f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3287ac09-8000-49a5-9b90-5b32f7aca080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3287ac09-8000-49a5-9b90-5b32f7aca080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_55044bb9-5c4f-443c-8512-4ac4888e08c8" xlink:href="dva-20201231.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_55044bb9-5c4f-443c-8512-4ac4888e08c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f7e00422-60f5-46e7-9a24-6f5aec7fdee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f7e00422-60f5-46e7-9a24-6f5aec7fdee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_05ba88da-ffc6-480f-bf85-7ce590119842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_620acc0e-2e09-4d07-89cf-03ea49c2e661" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_05ba88da-ffc6-480f-bf85-7ce590119842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:href="dva-20201231.xsd#dva_CharterdocumentsandDelawarelawAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f067096b-5051-4e12-abb9-7b1d27cd109a" xlink:to="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9aab53db-e0d9-404a-a46a-4b205160a0d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9aab53db-e0d9-404a-a46a-4b205160a0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_3ec671e8-fc61-4961-a1a8-6e2bbd1550ca" xlink:href="dva-20201231.xsd#dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:to="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_3ec671e8-fc61-4961-a1a8-6e2bbd1550ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_dfd5fe62-d6b6-4777-83de-afc1a1517ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_f0509be2-7b31-4d8b-8682-f438ca90fc4e" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_dfd5fe62-d6b6-4777-83de-afc1a1517ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncome"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2e77e0e6-23d8-4863-a625-20c8c034fd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3dd237ed-e811-4869-a0e3-cc2d736e897e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2e77e0e6-23d8-4863-a625-20c8c034fd30" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3dd237ed-e811-4869-a0e3-cc2d736e897e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncomeTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_81ada189-5bda-4209-b53d-deff2cdb7d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d084108f-aeec-451c-97aa-df371c23f776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_81ada189-5bda-4209-b53d-deff2cdb7d66" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d084108f-aeec-451c-97aa-df371c23f776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_46220bce-55e6-432c-8305-29926107bf42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_46220bce-55e6-432c-8305-29926107bf42" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dffe2610-8fe4-442c-bd3a-6a40d8476a95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dffe2610-8fe4-442c-bd3a-6a40d8476a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dffe2610-8fe4-442c-bd3a-6a40d8476a95" xlink:to="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_55fed8e9-4a44-4832-af0a-1e2dd5f11926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_55fed8e9-4a44-4832-af0a-1e2dd5f11926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_482a1964-9383-43aa-bc35-44e56f30cfe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_482a1964-9383-43aa-bc35-44e56f30cfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4668f7f5-a83b-47cf-a6fc-f02d53004aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4668f7f5-a83b-47cf-a6fc-f02d53004aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fa6737b1-e2fe-4357-a7f3-0b313b036996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3d4b05a-db2f-4b0a-b6e1-440aa24d10a1" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fa6737b1-e2fe-4357-a7f3-0b313b036996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_36d0d9ae-b22f-4417-9dbc-c2ff0110f417" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_36d0d9ae-b22f-4417-9dbc-c2ff0110f417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1ad4176c-59bc-4d9a-9a11-9f64a74a514e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_36d0d9ae-b22f-4417-9dbc-c2ff0110f417" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1ad4176c-59bc-4d9a-9a11-9f64a74a514e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3ee961db-4e80-4c81-a5fc-efcfed150a0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1ad4176c-59bc-4d9a-9a11-9f64a74a514e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3ee961db-4e80-4c81-a5fc-efcfed150a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf09724f-5fc0-40d5-a072-bc59d9b55171" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b4b8c05c-4681-48ab-bf33-3d30b1a008af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_StockholdersEquity_b4b8c05c-4681-48ab-bf33-3d30b1a008af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CumulativeEffectOfChangeInAccountingPrinciple_78890af6-8996-409a-937e-29ba70569de7" xlink:href="dva-20201231.xsd#dva_CumulativeEffectOfChangeInAccountingPrinciple"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_dva_CumulativeEffectOfChangeInAccountingPrinciple_78890af6-8996-409a-937e-29ba70569de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_4ba01cde-2751-47a3-af84-36f142c5d848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_4ba01cde-2751-47a3-af84-36f142c5d848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d4a5bad4-e3c5-4c3f-af0c-9decd1ae65f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d4a5bad4-e3c5-4c3f-af0c-9decd1ae65f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09d6bec4-1d58-47aa-963f-9b1518a0068e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09d6bec4-1d58-47aa-963f-9b1518a0068e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_ea03f07a-435e-4a7d-a8fa-5ef53e75f004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_ea03f07a-435e-4a7d-a8fa-5ef53e75f004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e53570f0-d5db-4d01-b7c8-3ac7f4ce2b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e53570f0-d5db-4d01-b7c8-3ac7f4ce2b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cdcc20cc-96c3-4f61-8c88-9976cc5c74bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_cdcc20cc-96c3-4f61-8c88-9976cc5c74bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_02c727db-fda4-4517-864d-1b3bf6e602c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8d024181-4114-4ead-b918-8dd03683991c" xlink:to="loc_us-gaap_StockholdersEquity_02c727db-fda4-4517-864d-1b3bf6e602c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7066fe0d-9015-43cd-ba47-12ccbedee690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_2670263b-2266-4a89-b2b5-061756a790c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7066fe0d-9015-43cd-ba47-12ccbedee690" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_2670263b-2266-4a89-b2b5-061756a790c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_af1ebe01-c44a-46b6-82e6-96434c3558ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_58182599-d6e2-45a2-bf3c-e98823e8654b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_af1ebe01-c44a-46b6-82e6-96434c3558ab" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_58182599-d6e2-45a2-bf3c-e98823e8654b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_f0dc30fe-93d4-40b7-9292-cf10d1a1e5c0" xlink:href="dva-20201231.xsd#dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_af1ebe01-c44a-46b6-82e6-96434c3558ab" xlink:to="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_f0dc30fe-93d4-40b7-9292-cf10d1a1e5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_800c3641-11f9-4295-96f2-6968d44a0967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_af1ebe01-c44a-46b6-82e6-96434c3558ab" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_800c3641-11f9-4295-96f2-6968d44a0967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_e5a5a427-677d-48e8-9039-2fb54d3b6892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_af1ebe01-c44a-46b6-82e6-96434c3558ab" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_e5a5a427-677d-48e8-9039-2fb54d3b6892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsAssetsacquiredandliabilitiesassumedDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_f693f18c-c843-4cc8-8ef6-00569e185f11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24d750d4-3bb4-4540-b5d4-b2ee92c01310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f693f18c-c843-4cc8-8ef6-00569e185f11" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24d750d4-3bb4-4540-b5d4-b2ee92c01310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a5a67594-0d82-4dac-8fca-607099918032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24d750d4-3bb4-4540-b5d4-b2ee92c01310" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a5a67594-0d82-4dac-8fca-607099918032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10f10539-c3dd-45a0-97a6-ed27b3ee5af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5a67594-0d82-4dac-8fca-607099918032" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10f10539-c3dd-45a0-97a6-ed27b3ee5af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_be4c2ee0-06f4-454e-b689-7073afcfdedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10f10539-c3dd-45a0-97a6-ed27b3ee5af3" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_be4c2ee0-06f4-454e-b689-7073afcfdedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24d750d4-3bb4-4540-b5d4-b2ee92c01310" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3bb4989-13f9-4b34-8069-c4d625d9a590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3bb4989-13f9-4b34-8069-c4d625d9a590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2f459859-3344-4727-8e30-096d3c6af490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2f459859-3344-4727-8e30-096d3c6af490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_32ef460d-8bae-4c9c-83e5-5812bc267676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_32ef460d-8bae-4c9c-83e5-5812bc267676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_12ea7b0c-0f49-4774-92f4-b19ebceeaee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_12ea7b0c-0f49-4774-92f4-b19ebceeaee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_942863ee-e669-4682-a63b-1c829eea1f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_942863ee-e669-4682-a63b-1c829eea1f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4cc64dbd-d539-4482-a7e2-4293fb92b53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_Goodwill_4cc64dbd-d539-4482-a7e2-4293fb92b53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4f144063-ff32-4cdb-a2b6-a8a91415e7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4f144063-ff32-4cdb-a2b6-a8a91415e7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_665a3f49-aeef-4d28-9bed-4012a6317702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_665a3f49-aeef-4d28-9bed-4012a6317702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d98c8af9-0bd2-46d9-ba39-deb3f0e3dcd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d98c8af9-0bd2-46d9-ba39-deb3f0e3dcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5fd02fb1-7aff-4075-a809-eab7c98d8802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2658409e-d60e-4c0a-be17-e4cda0ddd3b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5fd02fb1-7aff-4075-a809-eab7c98d8802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b8341c6a-26a6-497b-90d4-8b0dac861693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b8341c6a-26a6-497b-90d4-8b0dac861693" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ca1a231-0421-4462-a16e-bfc0cb23e852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ca1a231-0421-4462-a16e-bfc0cb23e852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ca1a231-0421-4462-a16e-bfc0cb23e852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1b5051a3-65dd-45cb-b86b-2d96f929fcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1b5051a3-65dd-45cb-b86b-2d96f929fcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_99e2bd04-4382-4909-8420-72288c6311aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7959d69d-1f5c-4d9b-a576-416845e97879" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_99e2bd04-4382-4909-8420-72288c6311aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b6a78292-ac59-473a-847b-f9d91f0c3a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b6a78292-ac59-473a-847b-f9d91f0c3a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad77008a-8d4c-4070-b54a-690ee7aa47e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b6a78292-ac59-473a-847b-f9d91f0c3a18" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad77008a-8d4c-4070-b54a-690ee7aa47e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b58196dd-ee3c-4ae0-9818-64219bfc3879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad77008a-8d4c-4070-b54a-690ee7aa47e6" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b58196dd-ee3c-4ae0-9818-64219bfc3879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7497ee5b-bba5-47f1-88d4-9f52a4030c7d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a0304b3d-5cd8-4099-a78b-95778c2da0a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a0304b3d-5cd8-4099-a78b-95778c2da0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_997f888c-36cf-4b97-b7b4-dfdacba4077e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8048ff9e-3973-4b34-b71b-4968e4d3ddaf" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_997f888c-36cf-4b97-b7b4-dfdacba4077e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e19bc4d2-c6c4-4996-bddc-3cd69d8acf2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_aebb7957-f1d6-4767-b233-c989273ba186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e19bc4d2-c6c4-4996-bddc-3cd69d8acf2f" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_aebb7957-f1d6-4767-b233-c989273ba186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_42f455d5-4cb2-43ea-82e5-35b17ba719b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e19bc4d2-c6c4-4996-bddc-3cd69d8acf2f" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_42f455d5-4cb2-43ea-82e5-35b17ba719b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_d9b4855d-771f-4ae8-a0fc-768e83b6473b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e19bc4d2-c6c4-4996-bddc-3cd69d8acf2f" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_d9b4855d-771f-4ae8-a0fc-768e83b6473b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_3da0c320-477d-4935-9af5-7aa3dd313171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e19bc4d2-c6c4-4996-bddc-3cd69d8acf2f" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_3da0c320-477d-4935-9af5-7aa3dd313171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_095fb943-a97b-461c-8c75-ab4b18d27d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_53a18a56-1da0-42a6-b319-0e0d38f2cf44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_095fb943-a97b-461c-8c75-ab4b18d27d12" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_53a18a56-1da0-42a6-b319-0e0d38f2cf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_c690ccc1-dd6d-4bb9-a3c3-dff41cedad58" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_095fb943-a97b-461c-8c75-ab4b18d27d12" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_c690ccc1-dd6d-4bb9-a3c3-dff41cedad58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_7acb67a7-5374-471b-a736-2e5ea292f62f" xlink:href="dva-20201231.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_095fb943-a97b-461c-8c75-ab4b18d27d12" xlink:to="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_7acb67a7-5374-471b-a736-2e5ea292f62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_13c2d33b-664a-4751-a462-532d84efad93" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_095fb943-a97b-461c-8c75-ab4b18d27d12" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_13c2d33b-664a-4751-a462-532d84efad93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_74d54aa5-029c-4032-805f-f94b5f444667" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_095fb943-a97b-461c-8c75-ab4b18d27d12" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_74d54aa5-029c-4032-805f-f94b5f444667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_17731ae7-5bdf-4fd5-a112-5304462324a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_095fb943-a97b-461c-8c75-ab4b18d27d12" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_17731ae7-5bdf-4fd5-a112-5304462324a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#AcquisitionsandDivestituresAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_28960cc5-6e27-4533-807e-4eb29cb091b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_28960cc5-6e27-4533-807e-4eb29cb091b4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0e0ba81-62f1-404c-b996-4819be5d511f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0e0ba81-62f1-404c-b996-4819be5d511f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0e0ba81-62f1-404c-b996-4819be5d511f" xlink:to="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_816244a5-e7da-414a-8732-46af8b05c8d3" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_816244a5-e7da-414a-8732-46af8b05c8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_9c2b4109-1d8f-438d-9b24-9290bc8861cc" xlink:href="dva-20201231.xsd#dva_ForeignDialysisCentersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b6dc41c2-199b-45ed-a932-5b2f266b1119" xlink:to="loc_dva_ForeignDialysisCentersMember_9c2b4109-1d8f-438d-9b24-9290bc8861cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f02fabe4-f012-4f73-a2ee-f7d43b18f79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f02fabe4-f012-4f73-a2ee-f7d43b18f79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7caf66a7-b9e1-47e1-a0af-b822613b206e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f02fabe4-f012-4f73-a2ee-f7d43b18f79c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7caf66a7-b9e1-47e1-a0af-b822613b206e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ed599645-20bf-4f1b-87dd-bc2a696a17b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7caf66a7-b9e1-47e1-a0af-b822613b206e" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ed599645-20bf-4f1b-87dd-bc2a696a17b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfdc9c3b-6211-4b83-b922-5e2a159f1289" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_srt_RangeAxis_cfdc9c3b-6211-4b83-b922-5e2a159f1289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cfdc9c3b-6211-4b83-b922-5e2a159f1289" xlink:to="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c2a8bfde-3499-4282-8343-244acef3e1a4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:to="loc_srt_MinimumMember_c2a8bfde-3499-4282-8343-244acef3e1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f371192-b6f8-411e-8b0b-f94a5702b46d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d071f4b5-a507-44ac-ba29-13641cee7c70" xlink:to="loc_srt_MaximumMember_1f371192-b6f8-411e-8b0b-f94a5702b46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a58d2c3c-2587-47da-98fd-ac4d22417713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a58d2c3c-2587-47da-98fd-ac4d22417713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2a0ff5f8-2ce3-40d8-8c2b-d3316adc69f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a58d2c3c-2587-47da-98fd-ac4d22417713" xlink:to="loc_us-gaap_RelatedPartyDomain_2a0ff5f8-2ce3-40d8-8c2b-d3316adc69f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_97792110-dac6-4a64-a0f7-c6afdea8f989" xlink:href="dva-20201231.xsd#dva_OtherCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2a0ff5f8-2ce3-40d8-8c2b-d3316adc69f5" xlink:to="loc_dva_OtherCompaniesMember_97792110-dac6-4a64-a0f7-c6afdea8f989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_dc3cf603-3c89-4815-83c7-a8763f674167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_dc3cf603-3c89-4815-83c7-a8763f674167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f3b11afd-efe0-469c-92d0-262850e2ec44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_dc3cf603-3c89-4815-83c7-a8763f674167" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f3b11afd-efe0-469c-92d0-262850e2ec44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_078dcbaf-a925-4658-bd36-6c32892b0c2b" xlink:href="dva-20201231.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f3b11afd-efe0-469c-92d0-262850e2ec44" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_078dcbaf-a925-4658-bd36-6c32892b0c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18ec1c5a-c943-4142-ab73-c36a1cea1adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18ec1c5a-c943-4142-ab73-c36a1cea1adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18ec1c5a-c943-4142-ab73-c36a1cea1adb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_597f9618-28c5-4fde-a8e4-4072d51869a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_597f9618-28c5-4fde-a8e4-4072d51869a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_695d67a2-62d8-465e-8b62-b262745a1f47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a81414b4-e208-4509-bc59-027bf78ec7c1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_695d67a2-62d8-465e-8b62-b262745a1f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e0788e2-d9b4-44bd-955a-f6107f247ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e0788e2-d9b4-44bd-955a-f6107f247ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98e19366-8858-4d6c-8baf-123b138873b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e0788e2-d9b4-44bd-955a-f6107f247ce8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98e19366-8858-4d6c-8baf-123b138873b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember_16c63b6e-68d5-4e0e-a544-1e64d13811f8" xlink:href="dva-20201231.xsd#dva_RMSLifelineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98e19366-8858-4d6c-8baf-123b138873b5" xlink:to="loc_dva_RMSLifelineMember_16c63b6e-68d5-4e0e-a544-1e64d13811f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20321252-a4e8-4e7e-9823-333c95542057" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_8bb7a988-77a0-44ab-9b3d-6f3f6377da34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_8bb7a988-77a0-44ab-9b3d-6f3f6377da34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_7629b04c-7f09-4456-b548-3683f562c08b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_7629b04c-7f09-4456-b548-3683f562c08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_2e4f5d3c-e701-44e7-ad54-d3d6704a5d76" xlink:href="dva-20201231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_2e4f5d3c-e701-44e7-ad54-d3d6704a5d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2ac011e5-c1af-4c41-bcbf-906fc1293822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2ac011e5-c1af-4c41-bcbf-906fc1293822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_14a092c7-21fe-48bd-b69f-3bb6ee9a6fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_14a092c7-21fe-48bd-b69f-3bb6ee9a6fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_362a4b62-9569-4d05-9174-fbe678a4a21a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_362a4b62-9569-4d05-9174-fbe678a4a21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09f6a5cc-aeb6-4511-9ed6-f20e0cf7c13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09f6a5cc-aeb6-4511-9ed6-f20e0cf7c13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_da7b202f-d817-43de-b274-d2924f696ce9" xlink:href="dva-20201231.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_da7b202f-d817-43de-b274-d2924f696ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_88328987-6d85-4708-ab80-4c77aa4c67ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_626fd3c5-63aa-4325-865d-5e639c42c04a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_88328987-6d85-4708-ab80-4c77aa4c67ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_1b77fc07-db87-434a-af12-dfcd8e51d0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_703f0337-5c0c-4eef-b504-3f08d7713293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_1b77fc07-db87-434a-af12-dfcd8e51d0fe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_703f0337-5c0c-4eef-b504-3f08d7713293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f41babea-22fc-4eb9-a82e-e63355bf2a14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_1f32753b-2acb-45ab-85cd-c453d32629fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f41babea-22fc-4eb9-a82e-e63355bf2a14" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_1f32753b-2acb-45ab-85cd-c453d32629fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCashFlowsTableTextBlock_3f2737ed-c17e-4445-a389-c6bfecd1a97a" xlink:href="dva-20201231.xsd#dva_ReconciliationOfCashFlowsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f41babea-22fc-4eb9-a82e-e63355bf2a14" xlink:to="loc_dva_ReconciliationOfCashFlowsTableTextBlock_3f2737ed-c17e-4445-a389-c6bfecd1a97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_46d2118e-2bde-4897-9297-9c72ae41ed8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_46d2118e-2bde-4897-9297-9c72ae41ed8e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1db1671b-da08-427f-91c8-bf9f640ac757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1db1671b-da08-427f-91c8-bf9f640ac757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f04dba8a-dec6-420c-a4d3-6a10a308f400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1db1671b-da08-427f-91c8-bf9f640ac757" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f04dba8a-dec6-420c-a4d3-6a10a308f400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_2f8148eb-a0b1-4846-9f9a-5d660a6bed07" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f04dba8a-dec6-420c-a4d3-6a10a308f400" xlink:to="loc_dva_DaVitaMedicalGroupMember_2f8148eb-a0b1-4846-9f9a-5d660a6bed07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_821ee524-ad68-4815-aea8-e1477319aef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_821ee524-ad68-4815-aea8-e1477319aef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_43dd31f0-68e4-4a11-81b3-42dd8eab3b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_821ee524-ad68-4815-aea8-e1477319aef1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_43dd31f0-68e4-4a11-81b3-42dd8eab3b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_4ff20c90-cc16-4cb8-b224-5ffe6a90f86b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_43dd31f0-68e4-4a11-81b3-42dd8eab3b5e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_4ff20c90-cc16-4cb8-b224-5ffe6a90f86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb4d209e-7629-4e94-977a-ca0f1ac84719" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1ffc6a8b-6080-4d4d-909a-96a1fa6eacba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1ffc6a8b-6080-4d4d-909a-96a1fa6eacba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c001169c-7cec-4f11-aa40-f3d2e91c82f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c001169c-7cec-4f11-aa40-f3d2e91c82f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_aa9d9b33-6702-4ff6-9d92-9918d4add05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_aa9d9b33-6702-4ff6-9d92-9918d4add05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_11bd42bd-ab4e-41f5-944c-e8a59dd10762" xlink:href="dva-20201231.xsd#dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment_11bd42bd-ab4e-41f5-944c-e8a59dd10762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_3708e6bb-529a-4e47-91c6-21d730dbd624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_3708e6bb-529a-4e47-91c6-21d730dbd624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_43d43f70-d411-4fa3-ac14-1ec068ba24db" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_43d43f70-d411-4fa3-ac14-1ec068ba24db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_904f2262-89a4-482d-87cb-3488c18ef90b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_904f2262-89a4-482d-87cb-3488c18ef90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_002254c3-a623-4c6b-b2a1-dc7ed0c8cd5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0f1bc324-abfe-4e5b-ac68-3d2b0c8eec82" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_002254c3-a623-4c6b-b2a1-dc7ed0c8cd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c288130d-f175-4e2a-b322-2613591d0473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_e8f13d67-0153-4056-87b8-63bb6655da8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c288130d-f175-4e2a-b322-2613591d0473" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_e8f13d67-0153-4056-87b8-63bb6655da8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_b6dfbbe0-946a-4dc8-a88e-f48ed5800d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c288130d-f175-4e2a-b322-2613591d0473" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_b6dfbbe0-946a-4dc8-a88e-f48ed5800d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_78bef598-ef6f-4512-b651-b95da685ae0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_78bef598-ef6f-4512-b651-b95da685ae0f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1122b57e-d200-441f-ae59-c539d0a0546d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e7530087-ddb4-42f6-abac-c2f7bf0d9a6e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1122b57e-d200-441f-ae59-c539d0a0546d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_f3ba533f-b93c-4dbd-a100-681cedaf993a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1122b57e-d200-441f-ae59-c539d0a0546d" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_f3ba533f-b93c-4dbd-a100-681cedaf993a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0567fda-602e-4dfe-a4c7-72495e092e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0567fda-602e-4dfe-a4c7-72495e092e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0567fda-602e-4dfe-a4c7-72495e092e25" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DMGAcquisitionsMember_3dc5a659-fd26-4c9b-8fac-d28a1fcaee6e" xlink:href="dva-20201231.xsd#dva_DMGAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:to="loc_dva_DMGAcquisitionsMember_3dc5a659-fd26-4c9b-8fac-d28a1fcaee6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_fac51812-6966-4d24-a58b-5a39f438559f" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e8fa0645-85ac-4c30-a0e7-3ef7dc6b5e47" xlink:to="loc_dva_DaVitaMedicalGroupMember_fac51812-6966-4d24-a58b-5a39f438559f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_079aa13b-c2c9-412f-8efb-75009634299f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_079aa13b-c2c9-412f-8efb-75009634299f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f80da66-7de0-43c0-94c5-e5558ea472b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_079aa13b-c2c9-412f-8efb-75009634299f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f80da66-7de0-43c0-94c5-e5558ea472b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dc7ad0ba-e719-4de3-b7a3-9c176fee965b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f80da66-7de0-43c0-94c5-e5558ea472b3" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dc7ad0ba-e719-4de3-b7a3-9c176fee965b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_248ec444-0536-4f7b-8d4a-edb7c30f578e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_248ec444-0536-4f7b-8d4a-edb7c30f578e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_dc76fb69-6903-4288-bbe5-ad596260c857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_248ec444-0536-4f7b-8d4a-edb7c30f578e" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_dc76fb69-6903-4288-bbe5-ad596260c857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_6b861c2f-5806-4a7f-8fb4-a45b48a353fa" xlink:href="dva-20201231.xsd#dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dc76fb69-6903-4288-bbe5-ad596260c857" xlink:to="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_6b861c2f-5806-4a7f-8fb4-a45b48a353fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d4a64dc3-51ef-4ffb-8b94-a5c6c37cdb38" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_b8f790fd-a75b-4303-8522-1950ef22e56a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_b8f790fd-a75b-4303-8522-1950ef22e56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_c039e71a-ee64-4ee6-b7bc-c3073fd91f3d" xlink:href="dva-20201231.xsd#dva_PurchaseAndSaleAgreementAggregatePurchasePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_c039e71a-ee64-4ee6-b7bc-c3073fd91f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_c6f69144-2a7a-474a-9215-f28edcd089ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_c6f69144-2a7a-474a-9215-f28edcd089ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_67a8a1f8-9355-4f91-83a9-d9360669040c" xlink:href="dva-20201231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_67a8a1f8-9355-4f91-83a9-d9360669040c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_412f8eb2-af40-455b-a932-d8c74e13cae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_412f8eb2-af40-455b-a932-d8c74e13cae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_ef37c94f-7dda-4492-9c74-8fcb123cbf0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_ef37c94f-7dda-4492-9c74-8fcb123cbf0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_12de37ff-d4ac-47f4-aae5-8ce06a4f03d4" xlink:href="dva-20201231.xsd#dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_12de37ff-d4ac-47f4-aae5-8ce06a4f03d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_83c816a2-cb59-4994-97c3-95fe31e98f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_83c816a2-cb59-4994-97c3-95fe31e98f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_8b7242bb-8e05-4f56-997e-2dedff5b8fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_8b7242bb-8e05-4f56-997e-2dedff5b8fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_401b730c-d736-4e18-8169-fee495c5e3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_401b730c-d736-4e18-8169-fee495c5e3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f52ca819-9fe4-4d09-97ce-d0b4d183528a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c028869a-c54c-4e81-b475-2cc70ac9ab4f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f52ca819-9fe4-4d09-97ce-d0b4d183528a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="dva-20201231.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19af6a9f-3d01-4f9f-9bde-29659b5017d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_d625defe-e005-46cd-a238-27d445c4fd4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19af6a9f-3d01-4f9f-9bde-29659b5017d2" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_d625defe-e005-46cd-a238-27d445c4fd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#VariableInterestEntitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_40dc4b3d-44f8-4ae1-988f-a93b045e1f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6f23726d-598b-4d94-9e3e-b4970fd670f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_40dc4b3d-44f8-4ae1-988f-a93b045e1f36" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6f23726d-598b-4d94-9e3e-b4970fd670f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_41fb5178-a6bc-4149-ae94-e00302132aad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6f23726d-598b-4d94-9e3e-b4970fd670f7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_41fb5178-a6bc-4149-ae94-e00302132aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_949d389e-fa45-4069-9e77-092fc2f1dafb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_41fb5178-a6bc-4149-ae94-e00302132aad" xlink:to="loc_srt_ConsolidatedEntitiesDomain_949d389e-fa45-4069-9e77-092fc2f1dafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99491ae0-72c7-475b-af5e-6b698300c8a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_949d389e-fa45-4069-9e77-092fc2f1dafb" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99491ae0-72c7-475b-af5e-6b698300c8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6f23726d-598b-4d94-9e3e-b4970fd670f7" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_624a67e3-efdf-4afb-b718-61c4d650d9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:to="loc_us-gaap_Assets_624a67e3-efdf-4afb-b718-61c4d650d9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_21cacfb9-62ee-42f7-9b1e-2a38b6490ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_0ed72d6c-99e8-4585-ab59-e7fa2947ca99" xlink:to="loc_us-gaap_Liabilities_21cacfb9-62ee-42f7-9b1e-2a38b6490ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6b097216-9e8d-4d15-b838-40e4ec84f769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4d61a7c3-386c-42fa-8abc-dd759074b200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6b097216-9e8d-4d15-b838-40e4ec84f769" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4d61a7c3-386c-42fa-8abc-dd759074b200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_07e24975-3392-4a0a-a210-31106851126d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7f8f0b84-e975-4d13-9874-562229ced1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07e24975-3392-4a0a-a210-31106851126d" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7f8f0b84-e975-4d13-9874-562229ced1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dcf7d5ed-813d-44b0-a9b0-78aa140047b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcf7d5ed-813d-44b0-a9b0-78aa140047b8" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bac85d1-f12f-4866-9345-153006170e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bac85d1-f12f-4866-9345-153006170e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_70884c1a-f617-41c8-8fb5-b57d9edfad80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9bac85d1-f12f-4866-9345-153006170e21" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_70884c1a-f617-41c8-8fb5-b57d9edfad80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9c3fa99e-4e92-455f-b9e3-2e028e5933e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_70884c1a-f617-41c8-8fb5-b57d9edfad80" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9c3fa99e-4e92-455f-b9e3-2e028e5933e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_500c4e05-841e-44ab-87cc-180124a21e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_500c4e05-841e-44ab-87cc-180124a21e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_500c4e05-841e-44ab-87cc-180124a21e05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_81b97a39-7603-46f5-a8dc-3ac41b31d77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_81b97a39-7603-46f5-a8dc-3ac41b31d77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c4c68e54-1fc6-4659-813a-e5b5a1afeb64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c4c68e54-1fc6-4659-813a-e5b5a1afeb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cdf824f1-4201-46f2-8c1b-131eb5646aec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f48ea69b-c16a-4d54-9ffe-cfc1b676cfda" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cdf824f1-4201-46f2-8c1b-131eb5646aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1e7d07ea-562e-4327-9e63-ddb8b09cc41a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1e7d07ea-562e-4327-9e63-ddb8b09cc41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_438929f5-798d-4174-9b0a-3f5ab86cc09a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1e7d07ea-562e-4327-9e63-ddb8b09cc41a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_438929f5-798d-4174-9b0a-3f5ab86cc09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_6b5a6ff0-a96f-423b-b7cc-1ff310a12a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_438929f5-798d-4174-9b0a-3f5ab86cc09a" xlink:to="loc_us-gaap_InterestRateCapMember_6b5a6ff0-a96f-423b-b7cc-1ff310a12a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7f0a0991-3bf7-4ec3-932f-642746dde505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7f0a0991-3bf7-4ec3-932f-642746dde505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f3292b39-c4c8-41ac-855a-44ad31723cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7f0a0991-3bf7-4ec3-932f-642746dde505" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f3292b39-c4c8-41ac-855a-44ad31723cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_87ab3a34-5aaa-421e-8c56-a54cd6d024f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f3292b39-c4c8-41ac-855a-44ad31723cca" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_87ab3a34-5aaa-421e-8c56-a54cd6d024f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e129600d-4486-4ff4-bb3d-53f405dd5aac" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cdadf20b-54c8-4186-95f3-b13f5897c2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cdadf20b-54c8-4186-95f3-b13f5897c2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_cf088d4f-df81-4a5a-a8d8-748bb9bcf410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_747d9d8e-a31c-48a4-b9da-fecb8560383b" xlink:to="loc_us-gaap_DerivativeAssets_cf088d4f-df81-4a5a-a8d8-748bb9bcf410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57782c3e-f996-47de-8dae-571a7b186d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57782c3e-f996-47de-8dae-571a7b186d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fc848ba4-a519-4921-bad1-e4186c08f0b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57782c3e-f996-47de-8dae-571a7b186d26" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fc848ba4-a519-4921-bad1-e4186c08f0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_409c8ee0-511b-4cc2-a267-072e54d986f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_70c981b9-3197-4327-8cff-f2812e80b709" xlink:to="loc_us-gaap_TemporaryEquityAbstract_409c8ee0-511b-4cc2-a267-072e54d986f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_a22c78ec-6b92-441b-a50c-15b5cac38571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_409c8ee0-511b-4cc2-a267-072e54d986f5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_a22c78ec-6b92-441b-a50c-15b5cac38571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#FairValuesofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6459752e-8d4d-4361-9dd7-9835dfc58e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_7cb819cd-0fb3-4467-8b04-b79d6d6a3581" xlink:href="dva-20201231.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6459752e-8d4d-4361-9dd7-9835dfc58e13" xlink:to="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_7cb819cd-0fb3-4467-8b04-b79d6d6a3581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReporting" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3c4ce94f-8f57-45a3-9be9-0c50cc612d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d0680439-ee08-470c-a75f-e690bfb51186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3c4ce94f-8f57-45a3-9be9-0c50cc612d74" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d0680439-ee08-470c-a75f-e690bfb51186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_79d00c62-8d1b-49ca-8a92-2fde5c73cfcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_fd56ded9-264c-4310-ba5c-2c7409b4a016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_79d00c62-8d1b-49ca-8a92-2fde5c73cfcb" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_fd56ded9-264c-4310-ba5c-2c7409b4a016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_dfe18956-45fa-4f03-aaff-a62e9e887fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_79d00c62-8d1b-49ca-8a92-2fde5c73cfcb" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_dfe18956-45fa-4f03-aaff-a62e9e887fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_37dde884-f09e-48eb-8c06-3febbfa697b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_79d00c62-8d1b-49ca-8a92-2fde5c73cfcb" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_37dde884-f09e-48eb-8c06-3febbfa697b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_c85935d2-66b9-4eaf-a255-498eb9984acc" xlink:href="dva-20201231.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_79d00c62-8d1b-49ca-8a92-2fde5c73cfcb" xlink:to="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_c85935d2-66b9-4eaf-a255-498eb9984acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_630571dc-14a9-47e4-bf57-a7a4b519f72f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_630571dc-14a9-47e4-bf57-a7a4b519f72f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a53844c4-598e-4892-8902-404aa5db6b85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:to="loc_srt_ConsolidationItemsAxis_a53844c4-598e-4892-8902-404aa5db6b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a53844c4-598e-4892-8902-404aa5db6b85" xlink:to="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_10da3635-2d7c-4860-8aae-a7adb7ae0698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:to="loc_us-gaap_OperatingSegmentsMember_10da3635-2d7c-4860-8aae-a7adb7ae0698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_23893b3f-7338-498c-bfd6-e42c7fd60fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8f349df2-2a2a-488b-886e-e152d7b4c89d" xlink:to="loc_us-gaap_IntersegmentEliminationMember_23893b3f-7338-498c-bfd6-e42c7fd60fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_77e9a3bd-634f-447b-89ac-46c191d07af1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_77e9a3bd-634f-447b-89ac-46c191d07af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77e9a3bd-634f-447b-89ac-46c191d07af1" xlink:to="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_2236e075-1671-45ac-8e24-0bc5c8279b3c" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_2236e075-1671-45ac-8e24-0bc5c8279b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_cf796295-f0f4-41e1-95dd-6c63009e134f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_560568cb-b5d5-4c66-8fd3-1b1b21bd9c4b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_cf796295-f0f4-41e1-95dd-6c63009e134f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_b30b9a86-c937-4f92-ae7e-1390fd23a1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_b30b9a86-c937-4f92-ae7e-1390fd23a1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_b30b9a86-c937-4f92-ae7e-1390fd23a1ac" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_fcff182b-f1d0-4423-bb43-66af04613c17" xlink:href="dva-20201231.xsd#dva_ExternalSourcesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:to="loc_dva_ExternalSourcesMember_fcff182b-f1d0-4423-bb43-66af04613c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_8061d209-8f49-4804-9ac9-f72b0e8f20f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_100059cf-f922-43a6-bf36-d8d0290b6b4a" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_8061d209-8f49-4804-9ac9-f72b0e8f20f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bc095c1c-ab96-4481-b813-e25279cb3740" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_ad9b3bc6-49cf-4cc6-9b53-79e94213cdb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_ad9b3bc6-49cf-4cc6-9b53-79e94213cdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ProvisionForExpectedCreditLosses_f13b20d0-dc6d-4384-abc6-dccebe588989" xlink:href="dva-20201231.xsd#dva_ProvisionForExpectedCreditLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_ProvisionForExpectedCreditLosses_f13b20d0-dc6d-4384-abc6-dccebe588989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_00a0680d-df0f-4e5b-808f-77656a0dd9ee" xlink:href="dva-20201231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_00a0680d-df0f-4e5b-808f-77656a0dd9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_6cf44b54-641f-43fa-84a7-12d3aa850419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_OtherIncome_6cf44b54-641f-43fa-84a7-12d3aa850419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_30f75337-e0f0-4526-b422-81a47d3dd679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_Revenues_30f75337-e0f0-4526-b422-81a47d3dd679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d56ea0a2-8dfd-4a23-9df5-649c3f855a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_OperatingIncomeLoss_d56ea0a2-8dfd-4a23-9df5-649c3f855a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_8dd55ed4-0b90-44f0-8b53-8ea5f1936bac" xlink:href="dva-20201231.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_8dd55ed4-0b90-44f0-8b53-8ea5f1936bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_ea1726ac-1469-430e-bae2-15d19d1275da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_InterestAndDebtExpense_ea1726ac-1469-430e-bae2-15d19d1275da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_93d1c365-346d-4547-b38a-3eee024e496c" xlink:href="dva-20201231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_93d1c365-346d-4547-b38a-3eee024e496c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5e93df23-e2de-4b2c-b74f-07418027b9a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5e93df23-e2de-4b2c-b74f-07418027b9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6a40876f-0b5c-48b6-8c5c-2d9249746e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6a40876f-0b5c-48b6-8c5c-2d9249746e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_c6091894-9529-4a92-bba9-6a3e76b98d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b5133df2-2d62-4770-ac25-f4697e732684" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_c6091894-9529-4a92-bba9-6a3e76b98d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_76fb60b8-33cd-4fd6-84a1-7ea65cda7990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_c6091894-9529-4a92-bba9-6a3e76b98d4b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_76fb60b8-33cd-4fd6-84a1-7ea65cda7990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fa6112b2-9778-4f94-bb74-62ef187841b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c591f78d-e99a-43f5-9769-9dbbfe125f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fa6112b2-9778-4f94-bb74-62ef187841b6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c591f78d-e99a-43f5-9769-9dbbfe125f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1dd825b-c16b-484c-9265-fbe4303bec1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c591f78d-e99a-43f5-9769-9dbbfe125f14" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1dd825b-c16b-484c-9265-fbe4303bec1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1dd825b-c16b-484c-9265-fbe4303bec1a" xlink:to="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_30383dc5-77de-40fd-9a1d-6bb50f22c93b" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_30383dc5-77de-40fd-9a1d-6bb50f22c93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_55cabd91-2b2d-42f4-a3da-0ef508d754a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c0ab9c72-7590-4916-b907-c9a6f9520d9d" xlink:to="loc_us-gaap_AllOtherSegmentsMember_55cabd91-2b2d-42f4-a3da-0ef508d754a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d9f3c31d-f760-4a92-addc-f0a596422d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c591f78d-e99a-43f5-9769-9dbbfe125f14" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d9f3c31d-f760-4a92-addc-f0a596422d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_37978dec-0fbd-4394-8962-f6da709d988e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9f3c31d-f760-4a92-addc-f0a596422d1a" xlink:to="loc_us-gaap_DepreciationAndAmortization_37978dec-0fbd-4394-8962-f6da709d988e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofAssetsbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c3f76132-0579-42d8-8ab2-4bc892b521f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c3f76132-0579-42d8-8ab2-4bc892b521f3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:to="loc_srt_StatementGeographicalAxis_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_163e1af5-9e53-4cbb-b3c2-082503a38b38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e8dc6ecb-0ccb-4c8c-ab61-c950407d0e98" xlink:to="loc_srt_SegmentGeographicalDomain_163e1af5-9e53-4cbb-b3c2-082503a38b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_8f9fffb8-4f90-40ec-b6b9-0a195f87e2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_163e1af5-9e53-4cbb-b3c2-082503a38b38" xlink:to="loc_us-gaap_NonUsMember_8f9fffb8-4f90-40ec-b6b9-0a195f87e2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3809b4f0-f100-4630-a85a-f1b5f889b271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3809b4f0-f100-4630-a85a-f1b5f889b271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3809b4f0-f100-4630-a85a-f1b5f889b271" xlink:to="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_42a9e4be-54f0-41c4-a050-2b68cb8d9668" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_42a9e4be-54f0-41c4-a050-2b68cb8d9668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_f4618760-0aa4-4059-b7b0-c67aa3c86aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0ad1c7b-30c7-4e44-aa44-03b2e70a8351" xlink:to="loc_us-gaap_AllOtherSegmentsMember_f4618760-0aa4-4059-b7b0-c67aa3c86aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7d08c3e6-fb01-4048-ac96-8109286652d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ee1ab43-5b50-4403-ae21-fe0b8da46c8f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7d08c3e6-fb01-4048-ac96-8109286652d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7d08c3e6-fb01-4048-ac96-8109286652d6" xlink:to="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1f56b8ec-455f-4791-8441-ff5a687e7afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:to="loc_us-gaap_Assets_1f56b8ec-455f-4791-8441-ff5a687e7afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_91fe3157-35a0-4044-bf18-db991b0e6cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_91fe3157-35a0-4044-bf18-db991b0e6cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_531d6f31-9f7a-447b-bb7a-4103340ef2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e2a520b1-3fbe-4aec-be5f-48282ce7741b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_531d6f31-9f7a-447b-bb7a-4103340ef2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c72124a0-4bd6-469c-b973-15870ac57fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7e502958-2cee-4b8d-9e7a-1a25b33197c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c72124a0-4bd6-469c-b973-15870ac57fa2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7e502958-2cee-4b8d-9e7a-1a25b33197c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d235321f-5c52-4928-8be6-b9750db20975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7e502958-2cee-4b8d-9e7a-1a25b33197c0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d235321f-5c52-4928-8be6-b9750db20975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d235321f-5c52-4928-8be6-b9750db20975" xlink:to="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_bb1712ca-b398-4d59-9f6c-8c338b4046a5" xlink:href="dva-20201231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_bb1712ca-b398-4d59-9f6c-8c338b4046a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_a141dae3-cfec-4133-a55b-b90be73a5de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:to="loc_us-gaap_AllOtherSegmentsMember_a141dae3-cfec-4133-a55b-b90be73a5de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_a5f4a668-d03d-49e8-bd48-2fc1a372ad55" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3af05403-c927-4ce7-b16b-0258fcf3d4fe" xlink:to="loc_dva_DaVitaMedicalGroupMember_a5f4a668-d03d-49e8-bd48-2fc1a372ad55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f31ec0a8-c96f-4172-bd25-eb6fc387d807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7e502958-2cee-4b8d-9e7a-1a25b33197c0" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f31ec0a8-c96f-4172-bd25-eb6fc387d807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cfcb2332-db72-40ad-90ac-f634e4c95c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f31ec0a8-c96f-4172-bd25-eb6fc387d807" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cfcb2332-db72-40ad-90ac-f634e4c95c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SegmentReportingAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_947bb282-bdbf-49b2-a1be-c15b8459a499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_947bb282-bdbf-49b2-a1be-c15b8459a499" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b8990253-d104-45c6-a6c0-1c41e2e7ab28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4aaf4f4f-d67d-464e-bd45-09a8acf44cfe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b8990253-d104-45c6-a6c0-1c41e2e7ab28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_b2f27b73-1e02-49ba-bb41-294d2f2b4afa" xlink:href="dva-20201231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b8990253-d104-45c6-a6c0-1c41e2e7ab28" xlink:to="loc_dva_DaVitaMedicalGroupMember_b2f27b73-1e02-49ba-bb41-294d2f2b4afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6e374fb3-8954-4d4b-9812-ae16f69f99ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6e374fb3-8954-4d4b-9812-ae16f69f99ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_244dab24-e235-42bf-a117-8c3fca92bddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6e374fb3-8954-4d4b-9812-ae16f69f99ad" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_244dab24-e235-42bf-a117-8c3fca92bddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_0a01bca9-05c2-4626-ac0c-7d324176f92b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_244dab24-e235-42bf-a117-8c3fca92bddd" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_0a01bca9-05c2-4626-ac0c-7d324176f92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0da88070-fc93-4050-9e56-c63faa13b25f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6042f6a2-ad6f-454f-88c8-f29b044d82bb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0da88070-fc93-4050-9e56-c63faa13b25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_ee7977d8-0578-407e-a805-2ab3771723d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0da88070-fc93-4050-9e56-c63faa13b25f" xlink:to="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_ee7977d8-0578-407e-a805-2ab3771723d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_17fbcf32-0918-40f5-8c26-6009bac06218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_4ff47acf-fa40-4b9b-a91c-868b629ee907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_17fbcf32-0918-40f5-8c26-6009bac06218" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_4ff47acf-fa40-4b9b-a91c-868b629ee907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_97e1cad6-7b91-4733-8c1a-e2a6f062a6fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_9929e7e0-c2ab-4c99-afa8-d40d9c8096fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_97e1cad6-7b91-4733-8c1a-e2a6f062a6fb" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_9929e7e0-c2ab-4c99-afa8-d40d9c8096fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_6c4acb8d-4bf7-4381-93e5-35af7b3e8f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidDuringPeriodForAbstract_b09d23a8-44c4-4391-a5e9-6da2125e36d4" xlink:href="dva-20201231.xsd#dva_CashPaidDuringPeriodForAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_6c4acb8d-4bf7-4381-93e5-35af7b3e8f3a" xlink:to="loc_dva_CashPaidDuringPeriodForAbstract_b09d23a8-44c4-4391-a5e9-6da2125e36d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_a323503a-6f29-408d-b87d-5d5f1fbde1ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CashPaidDuringPeriodForAbstract_b09d23a8-44c4-4391-a5e9-6da2125e36d4" xlink:to="loc_us-gaap_IncomeTaxesPaid_a323503a-6f29-408d-b87d-5d5f1fbde1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_b508490c-21d4-4a56-bb1d-553eef9b260f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CashPaidDuringPeriodForAbstract_b09d23a8-44c4-4391-a5e9-6da2125e36d4" xlink:to="loc_us-gaap_InterestPaid_b508490c-21d4-4a56-bb1d-553eef9b260f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_95d415f0-791d-442f-9017-39406eb32bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_6c4acb8d-4bf7-4381-93e5-35af7b3e8f3a" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_95d415f0-791d-442f-9017-39406eb32bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_cdca367b-3b1b-4663-8767-9934fdc3b064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_95d415f0-791d-442f-9017-39406eb32bc1" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_cdca367b-3b1b-4663-8767-9934fdc3b064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_b6c27762-9064-4cc4-a42d-7789ec39c690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_95efcb59-71b5-4516-8336-278b7a1d4868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_b6c27762-9064-4cc4-a42d-7789ec39c690" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_95efcb59-71b5-4516-8336-278b7a1d4868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunauditedTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_17d63681-e608-4db4-a014-b22425a282f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_04935b1f-6926-4887-a5e6-db8ee04428fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_17d63681-e608-4db4-a014-b22425a282f6" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_04935b1f-6926-4887-a5e6-db8ee04428fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SelectedQuarterlyFinancialDataunauditedDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_605b69a1-4478-4619-83da-c8d5c3fd934e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_605b69a1-4478-4619-83da-c8d5c3fd934e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_890168a0-b7fc-41e4-8073-204c170332d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_890168a0-b7fc-41e4-8073-204c170332d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_890168a0-b7fc-41e4-8073-204c170332d4" xlink:to="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_94cc887b-858c-4574-8522-7cd76c4f3b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:to="loc_us-gaap_AllOtherSegmentsMember_94cc887b-858c-4574-8522-7cd76c4f3b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_37cc5985-cc0c-49ff-8666-b0d7ee3ad0c8" xlink:href="dva-20201231.xsd#dva_KidneyCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c1c48d82-9776-46ad-8729-809f5a041108" xlink:to="loc_dva_KidneyCareMember_37cc5985-cc0c-49ff-8666-b0d7ee3ad0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_50d19bc5-f513-459b-a8a8-5a23e0823eb4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_srt_StatementGeographicalAxis_50d19bc5-f513-459b-a8a8-5a23e0823eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e08162d-63b8-4c98-9019-a81ed71c92d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_50d19bc5-f513-459b-a8a8-5a23e0823eb4" xlink:to="loc_srt_SegmentGeographicalDomain_0e08162d-63b8-4c98-9019-a81ed71c92d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_f53cf52a-782c-458d-a210-887889b4b297" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e08162d-63b8-4c98-9019-a81ed71c92d4" xlink:to="loc_country_DE_f53cf52a-782c-458d-a210-887889b4b297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_b090a9aa-3ed3-4f47-a631-5624824726fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_us-gaap_LitigationStatusAxis_b090a9aa-3ed3-4f47-a631-5624824726fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fba79f71-c35c-46c3-b85a-5449c3ae7520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_b090a9aa-3ed3-4f47-a631-5624824726fc" xlink:to="loc_us-gaap_LitigationStatusDomain_fba79f71-c35c-46c3-b85a-5449c3ae7520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c00c3ad8-3fb2-47b4-b0d9-94249af5661a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_fba79f71-c35c-46c3-b85a-5449c3ae7520" xlink:to="loc_us-gaap_PendingLitigationMember_c00c3ad8-3fb2-47b4-b0d9-94249af5661a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f97185dd-d3c9-449e-a6f0-00492bf74403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f97185dd-d3c9-449e-a6f0-00492bf74403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_01217859-5e9f-4fe3-af03-bd1ccd5b013a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f97185dd-d3c9-449e-a6f0-00492bf74403" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_01217859-5e9f-4fe3-af03-bd1ccd5b013a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember_b8c6f666-18cd-474f-aac4-5dda80886f26" xlink:href="dva-20201231.xsd#dva_RMSLifelineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_01217859-5e9f-4fe3-af03-bd1ccd5b013a" xlink:to="loc_dva_RMSLifelineMember_b8c6f666-18cd-474f-aac4-5dda80886f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ba1befbb-209b-4d26-aafe-1e10d4c342c1" xlink:to="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3d234d52-069b-4e31-b8e9-e4407de2142c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_Revenues_3d234d52-069b-4e31-b8e9-e4407de2142c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fa7ae612-1e48-468f-9f4b-ad9833833405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_fa7ae612-1e48-468f-9f4b-ad9833833405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_0488133b-0cf3-45e8-8371-6566d4fe5cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_0488133b-0cf3-45e8-8371-6566d4fe5cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_c87c5c27-cb3a-4a70-a7f0-9aec5fc5ae40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_c87c5c27-cb3a-4a70-a7f0-9aec5fc5ae40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b8d4900d-6c7d-4a43-84b2-4ca06bc2f031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e905469a-f007-4fbd-b66a-f833d4543fcb" xlink:to="loc_us-gaap_NetIncomeLoss_b8d4900d-6c7d-4a43-84b2-4ca06bc2f031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3b97db9b-79a9-4eab-8a3d-ea4291527fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3b97db9b-79a9-4eab-8a3d-ea4291527fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_e2af8565-8da9-4a54-ba83-9d5b6dfa5a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_e2af8565-8da9-4a54-ba83-9d5b6dfa5a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bd392f5c-78cb-477b-900f-46ed9ad65f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_EarningsPerShareBasic_bd392f5c-78cb-477b-900f-46ed9ad65f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1b30583c-fc40-4842-b524-a4f3a3a081d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1b30583c-fc40-4842-b524-a4f3a3a081d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_4ec8cdc1-1e01-4543-b5df-23356210b013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_4ec8cdc1-1e01-4543-b5df-23356210b013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3c5412a1-2ba7-4357-9c99-19308c54b767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a4cbe79-6a87-4aa4-a749-f91022f54562" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3c5412a1-2ba7-4357-9c99-19308c54b767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelectedQuarterlyFinancialInformationAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_92ae7ad2-43d9-4f0d-955c-00e48a13a0ab" xlink:to="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_26a59dcc-635c-4bdc-9719-e09acb00a5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_26a59dcc-635c-4bdc-9719-e09acb00a5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_81c268f6-954d-481b-9ed0-43112482893d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_81c268f6-954d-481b-9ed0-43112482893d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_59760b4e-9caa-4d27-a073-0fad89d5593c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1b94b29f-e114-4284-85f1-1575a45816f0" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_59760b4e-9caa-4d27-a073-0fad89d5593c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dva-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_54ccb673-dd04-49e3-99aa-81648d6770e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_dc8f029e-e30a-4aab-aefa-fdf228d3de26" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_54ccb673-dd04-49e3-99aa-81648d6770e9" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_dc8f029e-e30a-4aab-aefa-fdf228d3de26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="simple" xlink:href="dva-20201231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_1e903a9c-ef60-4715-9583-6ff206bb8c0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_7867056d-af5d-426e-9801-a53868072c00" xlink:href="dva-20201231.xsd#dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_1e903a9c-ef60-4715-9583-6ff206bb8c0c" xlink:to="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_7867056d-af5d-426e-9801-a53868072c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dva-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_6d512d5e-8f12-4338-bb18-7b8a3d7ad571" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_3b750f96-212c-4f75-9dc4-ece3cba30b59" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_6d512d5e-8f12-4338-bb18-7b8a3d7ad571" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_3b750f96-212c-4f75-9dc4-ece3cba30b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6af1489a-6222-4b2f-9543-a13b084b7580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_3b750f96-212c-4f75-9dc4-ece3cba30b59" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6af1489a-6222-4b2f-9543-a13b084b7580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_78583ea0-80cf-413c-afed-ded010846df1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6af1489a-6222-4b2f-9543-a13b084b7580" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_78583ea0-80cf-413c-afed-ded010846df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_ab5734a2-291c-40dd-92ed-379b99f4ea40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_78583ea0-80cf-413c-afed-ded010846df1" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_ab5734a2-291c-40dd-92ed-379b99f4ea40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_3b750f96-212c-4f75-9dc4-ece3cba30b59" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b08d7a6d-e1cf-47bd-91b8-2a9500a50b51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b08d7a6d-e1cf-47bd-91b8-2a9500a50b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_f7b33dc1-71d2-457f-8cb9-2daed052f921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_f7b33dc1-71d2-457f-8cb9-2daed052f921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_74936e6c-aba1-47c8-aa56-4da44b705996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_74936e6c-aba1-47c8-aa56-4da44b705996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d6291e1-34f4-4276-94c7-dd99e539f138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d6291e1-34f4-4276-94c7-dd99e539f138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_ad04d991-4cb5-4283-9589-31f62404a6f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a43493af-c3d6-4d71-adf4-d5400b6f72ee" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_ad04d991-4cb5-4283-9589-31f62404a6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>dva-20201231_g1.gif
<TEXT>
begin 644 dva-20201231_g1.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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MVCG$_QL"?PX6(?:)C28HJQRX@8\'AK]9=96'G Z; V^@"0O,9BF!>-'0;S\
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MD1Y'VIR95NU:MFW=OH4;5^Y<NG7MWL6;5V];L_MPDHRV# [&B1<A_"AH8:%
M@3C@A-K7%^W'O94MPYP\,EJT'Q,K2*08D: %AP]TC$Z<&O7J@:(=BK80NS7B
M-\M0]KV<6W=E:#E7ZILGKV?3IDJI+CV.U>A4K5>A*F?_'BQKU'7DMBJ5NBZ8
M,'TU3^K#O5O\>/+ES9]'GU[]>I+T*$?>%RK-1HP0"JL6C?%'FO#L_:?MCZ7
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MBM,I6!97G=3#5'$MY<9RTE$S(JG@;Z4[725Q)@>>44V!<# &4.POL;>A;EI
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MA'01GQ@&@OV/92"<#)J.[<@'M7S:K.7;OBW8$"R0L+68GBRJK@.LAW+4=TN
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M)G 1FLB&EH*6X_^6YG_V;-U9K9?$;)C>'L#I!BCBI(WI36EQR \<0 2:BC+
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M[,"$,%.KP?\VK_,R^L++1IW.*3TQ!5.\DT5T1,OT%4CD'<*6%61JV/=FU;@
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M:[--(]V3[+)9'1,2R(IRR"35P9*D<+:;HH'#("!Z*C'26V5UDTT"320//<>
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M8.F".!'63Z+2JHMPZ@%3C :-S(C!J[S,8$"B7<$BHQ[%^"0CF%J*1)@%2:4
M9Y(.08YEM)80,65P2_FKR:)P<Y#*E(A2%_')<3YB@8)LSHM!8A,EAR*E1Q:E
M OK!@1I25L<S[O(E.W((?/X6P]L5\E7L>D F HE!"%7');)129?@@JS.*7*:
MPJQF>112$ 2 (E_+NYX^RKB2# 5-(?^K6;.4_V,K-)U'A$5T&]86Z,#A0#)2
MP7E@M#KD,&^N)B86;,D=M;@P%QYLH 49W@_R!4Y>*DD?^ )>&R$BP'@F9U:Q
MNQ(%]-E-FK1&$\-1F !5Z:(-:08_.%PH9^($0NX-=&8?7%?@:MC%64HRDFPK
MW\(<,,:%-G0?RF#4UP14GN,,9X'*4A 1(S.X5D*F<VX33O32<)V33G6#.:A4
M0#WXRF "!7GZG&I]N((A@U!SF,LR:L>0TTZ&X,9NKBG3O]J:-S-I ER+25>0
M F<9-*WRK!][2SL+NL"")<@Q<"(*;NJ5&HB)K"Z<V<F0(&M(VUUSB[4:Z_R4
MH=&O>H<E&G* <2I%//^[7HYJ8$KF/YM"GLS1$W'F"Y<F9*,RLST(.V32"0X&
MFM7_V,JLJ_U;L\;JF(K6L[#(0EB:T*.#',QM23S%BESO$YMHC,$C43K>4\\5
M.XT($*_G7!=!V76K3,$J/8IA2Z?$F,N-<JM"FTV5+^,F3*Q>#2KOB1MSW;N5
M"MUQAI&J@$$E ^"!*C6@SI(3?F0S6^\ !KK@\60TEL'"5+94JT8<,.TXI]4D
MTI"([C%2U$"%G[',=B8EQHE@P *'_CW%;U-SWJ6LR<7_$"D'IYTJ="?4))5
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M+@B%#G1<;(OD8@D+H[.V[]QJ1VLBI2!8%3S/)A163'M@;BX!DS6?4BZU%&3
M\O^B8=(: L#4(RM]9"4S+3]=\V"HT*+_0";U.%0CP^.W&I!%SW5VAJRTD(E
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M6PFIC\B$N6,QUK SI9LV?B$VH7&3_H*RZ+L4=+,(H&.,'X@LK$ T!CR>4%-
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M/YD<.-&L0..9)&0!"1E;SJV:.NYZ5.+<JI+$4]>#@RP\EE1+.J)CS+1*F)E
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M5%NO)8\+]K02WE0PJAWAX+2_^\"T'CUFO7FCT#%_[5QK."T$ 5O[;>@D#FJ
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MZ#W,HJT&C+3@_^U=E9C0 !*3\^3?#K965&27;KB.\(T-YWF:5W$=U3AAMSS
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M] 23[%')M6PA!/'E\UUH('Y5"RU529BH*_I<]*D@5V@+^B2:9.Y9B119=N"
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M6*UZL$VYJ@*]!?5(Q@]@*E6^B(E6ZQGRW$0]0+L*)_CMPR;D(P._V10;,6H
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M.?GF&TSTC%5Z=Y*N2F7XH):<8[-]2,.BM"AK+"<M'66*5EC(4L0\"ZG-MF8
M[W-E+?+P2(FA*[<FLAQ2<I>']PI3.9>Q]O1JA[XN;F]5\.Q2D]\.8=NPF=G_
M#=.S# Y/SI-HBU-*F(JFZ^UI7Q:E^,FMASDJAM-LW$$"SPRJAS-:!@?^8JOZ
M#$YE]^NV*NV9-3"%L*WW.;=7-YO/G)@AL5/#@RA):T=NK'=Y%"1\SHC[=-M1
M+CB+SE9<192X;RI<T/=O "<':Y4WAV*4EO0R\O#Z9B+ F3C0O-40HT]_/VM8
M&E \IK9.W;*+E77" &ZN[\W2?N^_%?8(-3FC3WP;87IDWF*XAQ6%Q%KHLO=
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M5X>VJ60>  $HTMMG512/JC0MQ<3\#3G_)P3KF$>E]J%[6+L[F7;J,.KV'B"
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M&&!"N<[N>"%!ED7Q!QB P2Y8-BVHFLS]F%0(@5E4"DDAL<3#83O_L6:PD*5
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*!]G,9Q9R0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>dva-20201231_g2.jpg
<TEXT>
begin 644 dva-20201231_g2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@!
M6 3B P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#&50#[GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BOF+]N?Q5_P51U#XB>'/AK
M_P $U?"7PIM(8=*FU'QOXP^-$6HG3EWR>7:65DM@?,EN/W=Q)+D;8T\G)!E7
M/D'[(W[0_P#P6(C_ ."DMK^QU^VQKG[/.J:#:_"ZX\9>(;GX3Z+K*W%G&]W]
MBL(7EOI@L;S3+<.!Y;YCM)>5)!H ^_**^ =5\1?\''OQ*US6/B%\);']E/P-
MX(O]3N9_"'A_XEV?B&37[72?,;[,VH_93Y,5RT(1WC4_NRQ5L%2!QGP]_P""
MK/[:;?\ !./X(?&GXJV'P_/Q-_:-^/MA\/\ P+JGAW0[Q-&TW3;R_G@BUAK>
M>X,MP#;6D]S&IDCW_:+?<H <$ _3&BOEK]B#]KKXG?$']KO]H?\ 84^-.IVF
MM:W\$-6T"YTGQ;::>MHVL:1K6G?;+=;B%#Y:W,#I+$[H$1U\M@BG=GT/X5_&
MKQS\=OVB?$R^ +BVB^%_@,3Z#>ZF;</)XB\2K(OVJ.W<_=MK *8'=<^;=2S1
MY7[&XD /8J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"6N>%]5\:Z;IH4Z;!;22LUT?,B:Z:2:6-;6V^T@>1N>5!-#O /O6BOSXN/\
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M\>?\(]K%_P".X-.N[S^R[6[\RV:RO)3'LN8I%'SQ1G( ;Y<9P2#^8'_#[O\
MX*@?]'.?^67HO_R%7WY_P<D?\F8>#_\ LI]K_P"F[4*_%:OZ#\.LER?'<,QJ
MXG#4YRYI:RA&3W[M-G\Y>)6>9U@.*9TL-B:E.'+'2,Y16W9-(^K?^'W?_!4#
M_HYS_P LO1?_ )"H_P"'W?\ P5 _Z.<_\LO1?_D*OE*BONO]6N'/^@*E_P""
MX?Y'P/\ K1Q-_P!!U;_P;/\ ^2/JW_A]W_P5 _Z.<_\ ++T7_P"0J/\ A]W_
M ,%0/^CG/_++T7_Y"KY2HH_U:X<_Z J7_@N'^0?ZT<3?]!U;_P &S_\ DCZM
M_P"'W?\ P5 _Z.<_\LO1?_D*C_A]W_P5 _Z.<_\ ++T7_P"0J^4J*/\ 5KAS
M_H"I?^"X?Y!_K1Q-_P!!U;_P;/\ ^2/JW_A]W_P5 _Z.<_\ ++T7_P"0J_4K
M_@BK^U%\=/VMOV3]8^)?[0?CG_A(-;M?'=WIT%[_ &9:VFVV2TLY%CV6T4:'
M#2R')&[YL9P!C\"*_;C_ (-Q_P#DQ7Q!_P!E/O\ _P!(-/KX/Q'R7)\#PU*K
MAL-3A+GBKQA&+Z]4DS]!\,\[SK'\3JEB<34J1Y).TIRDKZ=&VC[\HHHK^?C^
MB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BH=0ED@L)YHFPR0LRG'0@&OY_O^'W?_  5 _P"CG/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#](-/K\[\4?^25E_CC^I^E>%'_ "5L?\$_T/ORBBBOYK/Z>"BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ K\_O^"K/_)P^C?\ 8EV__I7=U^@-?G]_P59_Y.'T;_L2[?\
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MT/4-/>UU#[!IKWIBM(UF9Y&9_)A9[G[+#&)O.,IB1F !]945\-_#_P#X*_\
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M^'/%\UWIZV&@7\XVF1=[/<^>D3N1MA164D"8$D5UWC']LGQ?JW[3WBG]DO\
M9N^%6@^+?%7@/PIIFO>,E\3>-VT2*"'4'N5M(+7R[*[>YF(M9&?<L448DA!E
M+2$* >^45P'[+WQKU;]HGX%:%\8=?^&M_P"#;_5A<K?^%M5N4FNM+G@N9;>2
M"5D 4R*T1#!<@'(!.,GOZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _/3_@Y(_P"3,/!__93[7_TW:A7XK5^U/_!R1_R9
MAX/_ .RGVO\ Z;M0K\5J_I;PP_Y)2'^.?YG\O>*O_)7S_P $/R"BBBOT(_.
MHHHH **** "OVX_X-Q_^3%?$'_93[_\ ](-/K\1Z_;C_ (-Q_P#DQ7Q!_P!E
M/O\ _P!(-/K\[\4?^25E_CC^I^E>%'_)6Q_P3_0^_****_FL_IX**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"#5?^07<_\ 7N__ *":_E2K^JW5?^07<_\ 7N__ *":_E2K]N\'?AQO
M_</_ -O/PKQIWP/_ '%_]QA1117[4?A@4444 %%%% !7UI_P0X_Y2<?#O_KW
MUG_TT7E?)=?6G_!#C_E)Q\._^O?6?_31>5X?$_\ R3>-_P"O53_TAGO<+?\
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MN\233[0#MC5YX4+-@;I% R3BMN@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *_/[_@JS_R</HW_ &)=O_Z5W=?H#7G_ ,5OV6O@1\;_ !%#XK^*
M'@7^T]0M[);2&X_M.ZAVPJ[N%VPRJI^:1SDC//7@5[.0YC0RO,%7JIM6:TM?
M7U:/$X@RVOFV7/#T6E*Z>M[:>B9^4=%?IK_P[W_9!_Z)%_Y7]0_^2*/^'>_[
M(/\ T2+_ ,K^H?\ R17V_P#KME7\D_NC_P#)'P7^HF;_ ,]/[Y?_ ")\R_\
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MQQ747G@7P1J.M6OB34/!VE3ZC8LS65_-I\33VY)+$HY7<A)))P1R30!^6/\
MP55_:'34=>_X)L>,OVE[_1/!'CC4?C1X6\1>./"]]J"6[:'--8Q_:PZ2-NCA
MBN96B+OP",$YKK_^"@G[/G["_P"VC^VGXD;PM^V)??LY?M/_  O\*Z=<^'/B
M9H'BZ.Q;6-$N8#/"T\,CQI?6L<IE25$8.J^7O<I(L=?II67XB\#^"_%T<<7B
MSPAI>J+%-YT2ZCI\<X23 &\;U.&P ,]< 4 ?.?\ P1N^/?[3O[2W_!/+P+\6
MOVO;2U?QK=F^MKC6K*S^SPZ_:V]Y-!;:JD6U0BW,,:3 JJJX<2(JHZJ/J"@
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ME)$)#QNJ^ET %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2TW1?LM_-IR*/]++W$EO:(\.X7,P$:%V45^AU?.&@_\ &;7[28\:R_OOA/\
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M# HHHH **** "OK3_@AQ_P I./AW_P!>^L_^FB\KY+KZT_X(<?\ *3CX=_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;+P)_P *N_MS[9HT=_\ :O[;^S;-TLL>S;Y#YQY6<Y_BQCCGZ KX _X*M?\
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MSB&4+*J(F]5)P/LFBB@ HHHH **** "BBB@ HHHH **** (-5_Y!=S_U[O\
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M6'[8'A274+V^*K%!;+#>-*SLW"H%7+9XPO/2@#]"?&?[1_P#^'/PQ3XU>/\
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M\6^ ?$'B>/[#;ZKI<7F32I?1QC[3:[#N4K&CR%2NU,AZX'_@G?\ MY_M*O\
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M1H/B[Q/\//#.EZUXU7Q)XX;1$@343<?9+>U"65TUS,4MG=RZPPH)(1YI+L$
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MJO\ B+7#G_/JK_X##_Y8?)_\0>XF_P"?U'_P*?\ \K/Y^**_H'_X<B?\$O\
M_HV/_P O36O_ )-H_P"'(G_!+_\ Z-C_ /+TUK_Y-H_XBUPY_P ^JO\ X##_
M .6!_P 0>XF_Y_4?_ I__*S^?BBOZ!_^'(G_  2__P"C8_\ R]-:_P#DVC_A
MR)_P2_\ ^C8__+TUK_Y-H_XBUPY_SZJ_^ P_^6!_Q![B;_G]1_\  I__ "L_
MGXK]N/\ @W'_ .3%?$'_ &4^_P#_ $@T^O3_ /AR)_P2_P#^C8__ "]-:_\
MDVO;OV<?V7?@7^R3X$N/AI^SYX&_X1_1+K5)-1GLO[3NKO=<O''&TF^YED<9
M6*,8!V_+G&2<_*<9<?9/Q%DKP>&IU%)RB[R44M/23?X'UW!/A[G7#>>+&XFI
M3E'EDK1<F[NW>"7XG?U\ ?\ !5K_ ).!T3_L38/_ $KNZ^_Z\_\ BO\ LM_
MGXW^((/%/Q0\"_VG?VUFMI#/_:=U!MA5W<+MAE53\SL<D9YZ\"OSS(LQHY7F
M"KU4VK-:6OKZM'Z1Q!EM?-LN>'HM*5T];VT]$S\HZ*_37_AWO^R#_P!$B_\
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MW_0O_P#DW+_\71_PJ7X??]"__P"3<O\ \71[3+OY'_7S#V69_P Z_KY'.?\
M"_\ _J4O_)__ .UT?\+_ /\ J4O_ "?_ /M=='_PJ7X??]"__P"3<O\ \71_
MPJ7X??\ 0O\ _DW+_P#%T>TR[^1_U\P]EF?\Z_KY&'I?QR_M+4[;3O\ A%]G
MVB=(]_VW.W<P&<;.>M=_6!:_"_P+974=Y;:'MDBD#QM]IE.&!R#RWK6_7-7E
MAY->R37]>K.K#QQ,4_;23]/^&04445SG0%%%% !1110 4444 0:K_P @NY_Z
M]W_]!-?RI5_5E+%'/$T,JY5U*L,]0:^5/^'(G_!+_P#Z-C_\O36O_DVOT3@+
MB[+>%EB%BX3E[3DMRI/X>:][RCW5MS\V\0N#LSXL>&^J3A'V?/?G<E\7+:UH
MR_E=]C^?BBOZ!_\ AR)_P2__ .C8_P#R]-:_^3:/^'(G_!+_ /Z-C_\ +TUK
M_P"3:_0_^(M<.?\ /JK_ . P_P#EA^;_ /$'N)O^?U'_ ,"G_P#*S^?BBOZ!
M_P#AR)_P2_\ ^C8__+TUK_Y-H_X<B?\ !+__ *-C_P#+TUK_ .3:/^(M<.?\
M^JO_ (##_P"6!_Q![B;_ )_4?_ I_P#RL_GXHK^@?_AR)_P2_P#^C8__ "]-
M:_\ DVC_ (<B?\$O_P#HV/\ \O36O_DVC_B+7#G_ #ZJ_P#@,/\ Y8'_ !![
MB;_G]1_\"G_\K/Y^*^M/^"''_*3CX=_]>^L_^FB\K]4_^'(G_!+_ /Z-C_\
M+TUK_P"3:ZWX&_\ !+?]A/\ 9M^)VG?&3X+? S^Q?$FDK,NGZE_PDVJ7/E"6
M%X9/W<]R\;9CD=>5.,Y&" :\W.?$_(,PRC$86G2JJ52$HJ\86O*+2O:;TU[,
M]/)?"KB'+LXP^+JU:3C3J0D[2G>T9)NUX)7TTU1] 5XU_P % _\ DT/Q?_NV
M/_I?;U[+6-\0?A]X0^*?A"\\!^/-(^WZ3?B/[7:?:)(O,V2+(OS1LK##(IX(
MZ8Z5^*8*O##8VE6EM&46[;V33/W/'T)XK U:,-Y1DE?:[36I^/E%?IK_ ,.]
M_P!D'_HD7_E?U#_Y(H_X=[_L@_\ 1(O_ "OZA_\ )%?HW^NV5?R3^Z/_ ,D?
MF7^HF;_ST_OE_P#(GYE45^FO_#O?]D'_ *)%_P"5_4/_ )(H_P"'>_[(/_1(
MO_*_J'_R11_KME7\D_NC_P#)!_J)F_\ /3^^7_R)^95%?IK_ ,.]_P!D'_HD
M7_E?U#_Y(H_X=[_L@_\ 1(O_ "OZA_\ )%'^NV5?R3^Z/_R0?ZB9O_/3^^7_
M ,B?F517Z:_\.]_V0?\ HD7_ )7]0_\ DBC_ (=[_L@_]$B_\K^H?_)%'^NV
M5?R3^Z/_ ,D'^HF;_P ]/[Y?_(GBW_!(O_7_ ! _W-+_ )W=?:%<7\(OV>?@
M_P# AM0;X4^$/[*.J"(7_P#Q,+B?S?+W[/\ 72/MQYC],9SSG KM*^#SK'4L
MQS*>(I)J,K;[Z)+HWV/T+(\!6RS*Z>&JM.4;[;:R;ZI=^QQOQ>\5Z_X7AL'T
M*_\ (,S2"7]TC;L;<?>!QU-<1_PMKX@_]#!_Y*1?_$5ZQK_A30/%"Q)KMAYX
MA),7[UUVYQG[I&>@K-_X5+\/O^A?_P#)N7_XNLZ&(PE.DHSA=^B-,1AL94JN
M4)V7JSSG_A;7Q!_Z&#_R4B_^(H_X6U\0?^A@_P#)2+_XBO1O^%2_#[_H7_\
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MS)IT@\:Z;>S:=<^//$%JT%@=)35(@)K6%8[=IO+MGAGEE,:%\.D<GW%^P/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)Z?/::;?VT.HW$=E=V\-Q)+)&LMHMO(5:1\,S<]AZ?7YP?\ !PIX'U*^U?\
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MX;\8LSF35+5 4627>2XE&TK('PXD5PP5@0/9J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ([Q+Q[.5-/GCBN#&P@EFB,B(^/E+*&4L <9 89Z9'6OCW]CO\
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MY%^#^O+JA\"V,?PWA_M73Q=W#7(M[^\>Y;[3;K,Q=A%'#+(S$^:B?N3^FE%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>dva-20201231_g3.gif
<TEXT>
begin 644 dva-20201231_g3.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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M@>,'QIZOO[]_@?OA)!]<#=6G3ST#PO=17 G2)1^"'E4W233U1+/,,FDH4\]
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M(9G($DZRD8J\9"0S*2-*2K*3F+3D!\^H##0(D(1=1",<^TA"0K%P4<LY7V]
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MY93$215,*1&Q43[.L@_.$BYND8X(MI%UTG:#V$OWQ7>:EEXG1WNMAX+@-BB
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M%)M-B87"V-C-6""BE#3 0.M 5 =9",H2/'K0%V$30S($V66H722"(5"0ED9
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MP8YP ;>G]!&5$ YI4ENYDY;024']U$\) :B)_;J8(@N64(9J9*L  ( ]WN,
M\../92A:"X"]!(W3\-(ZIE*;,[L7W1,Z.ZF?(!X\&;XM)M/BL?_2HD-#>D4\
MG-(D-$&V2BN2E_M.?[F9/115AG@MS8,#A,)'YEJ]2CH2+,P@8$N\2"XQZ)I#
MITJ92&%'5$,^O$F;D J@5[,J_L*CE5J9I\LU_3/)37HS^Z7@CH$86R6111'(
MF$57N0*3($VJ0-FD5%PO="E8'2U3U9&6I346 ^&[&**<5E2&4.@/8B.&/<WB
M>AZRI[R.@9B6@Y@$,6C8?#:I=\+G(-LQ8G".%2T9OH2KQ_L<@*(A&JJCB'E;
M'DF*0B4&Y)W&&Z3BEJ#& %B!-!@NA!C!?JF0(1XB3F2TB(#5I?V*Q(0L5DP(
MQHPWJN%6N5(1;X;FHN6*LS@^$3.?2R/_(?*DPS<T"&J, 0"( 3@0VRBMXPQ+
MLB>YF;(#&40NYA/;2=X#X:!["HH;N@IUO7/KD50:UWNIN5K.5LB0"GT0 T64
M/PT)D<UA0(0^$MW[X0:5":B]/E25.6?+$J@)8=0X&E [0J@*OV>]M!&RY 49
M",4A#4T A8N^Z#EJ$7JVY\H.MX1XW8&H7KF[1<HAJ.?XN\%+AL,[/:&5('-J
MO.W8%\))"=;Q7TDZ$CXABX$8ADCH+<$8ABV @1NP*(\99LF R%-I)9%+J>-\
M7SDQ%/F9J^K18&GY"+&D%YPATJP6)C.)T2<-(55Y6R+NIE>!L8_!OF&X 1@X
M:AQ8Y<Z-.44[_U,J35&XI3::5K?B;A3W^=LZ<1#2,(T#JBONZ[\E5>@U\V\D
M+4J@((QZ"(,#D#K525/ A5R/.C%4F]%W@;>XJNX2VAA6O;DY?/"A7C@U$Q]S
MK-(A1#H@4IS^H 10*(;AHN(KMNP6![QSQHPHCA9>B<ZB=@Y#%3=I$> K 6&^
M\0JF% ,TZ%#+DLX+\I\N&8FZNPA,D('BA A,4 $ $ ,@#(R8V*M,8RK9F5>2
MS-\_:[CGZMH'%XL5'0F* Q:I116J E,6,\<*:B!#4KUZC*9/\TDC^HRQO+?W
M^T'8;@JI+<6P2RE=Q=5YS=:6]F6Z"[O0*+KD[ R@^(C3[!&4"V+^9/]5[%PE
M6U8W0\0R'V$B1?0W%#(0D_/+JFE@; 6T#U$26S6H)O5EXA-BRZCNFBJN8*;:
M<U-C3^00.*\8@\X$W@V/@<8/OF,1@5'Q''M/%T=VT/JGX7N.=XH&>'.G6"$M
M)P:R(GMD2PI->U%&@((W_72BD_PDSTCOJ_"3>K#!'%A0*KHE #B  #@ =H=0
MBGK&)W1"U&H8OXQQJ98[IO&Z9]15L*%W6*>,Z)RM(*::LT&>%$L\#BWXOPB5
MV^LX)/N)3[-?FTB# P@#,(J!&S"].'T(-XRL@QH?4E_N!3Q73;;?7 Y<"'=N
M%-/O* %7OK8RX4#LV=,^?= $+HIR/6YW'(#_(0YQTJ)<M@)L=<0F#?X;H:KS
MX'NY$O"ZO_<6KR+Y/TZITCU"C69Z"3Q5I_2@[//XNX4 EDD)A>&:E/:;RF1'
M>W+[<29,#C]ERM>-B8GN5DWX8G$CC5NI-+M!PWP)\B_J#X.JS#KVN$Z"#-59
MADVX*=5I#4B][]XYB;9K)#%L8?.M9BQ$B"@#YA"+7&]J$X< A>P]X4D[W[.J
M?'>%:MWIJ6>.1DDKN?L*L<OX<0>AAQC8\\<@B_8ZN%=BUIQ"UYIR&RRDDKGV
M\.1*0HY@B#1X P'QZ@)3.#+B.4A^(GK)1T'+/@)R%4T3+XFT3P:<87TDTGCM
MCA8);)R<ZRGBVC(R_V$V9'4(!J^)/CL3Q12+*2A\'FA\9@M<=(_%Y@\/58:0
M!@A0RS)IVF?P(,*$"A<R;.CP(<2($B=2K&CQ(L:,&C=RE%CO8#UHFC(I6Z9L
M7\E])C414P;-9+1ZT93%/&F2X$F#.3OR[$D/9[1E*H/J6[;LY<N@^XAE0I-F
M4J:HQ#31##ISF=5E](+2I(E5F<R22>LM*QI-956L9=5F)6HTVM9Z7FEN]1H4
MFDRA)8OJ72OTJ-ZE;R:5A'LUZ5JN*,FZ#7N4V&"!,ZUN_8N79EZS<N%B#1M2
M[^2P*D%7]MRVKEJ46>M:_:QV+;VW< &(@>-Z<F>U8P%[_0HXYLNAA8V^])A=
M/&A?M$,W?[4J]C72MUZ/EU26:=+,O'.Y7JT9\S#QMS"'<_==/KKYWS9EAD7>
M>?)TWN6[IG\9'W%YP%$G 0;L^>5GR,VD&EG1X69@5\@E-9QJA?66W5CV957<
M:&:A!@U.T$2D#T;T+#12)L6 $LHRH&RB21J9"-43BRVZ^"*,,<HX(XUX[0,4
M6S#)5=)?72EWU%*9$*,AC?]%&G160M$PU1)O7XVF$E*@I)&&&&@,1)5Q1EFH
MEDU0MM?E>$;9%)=]>LEEIEMLI:2F7^ YAQM\YA$SR1M#-J=694>UI^=]?X$"
M%8^Q%2<AE]W!))VAAIJ7(*+W,:?4<"<]R-Q+14'CW4S*T+/"#6H(B)F$F $6
M'%9U+4>=GD%59FIGE?[VJEVQQ91J7YJE"E::1:4H''"@978HA;1:FI=JE:%D
MF6BY&>9746+)U.!6#?Z5&+&EOF?3LEX&]5^/*NFC"9TEA907?LU)^FE6[(GJ
M75ZK0GI5JZ2I^2F!\C67UYS#@/301\J =5!,&QZDCS(CA0**B,M0==U)'"*$
MI)'_$4L\,<456ZS1,F@0 RE@!)X5S5CH&H62D#M='*.'Q*1(%7N(7::8O]9A
MYV]B[XEY%[DF.=E;65:=]6I-:+7UU8(UVZ<2E-3R.2N[I;KU)T%"CSLHETEO
MBY=E-Z5AY[N_XO5N9;8:ABM8KF9+E[*RX@F>:F^QMJYX ,H%#33TP, %''AA
M[16!=F6I(+!YW05T> ^FM*9-U,'IMYO ZJ8U2D(OFB-?Z"EJ^:&X38[>@G==
MQ:,^2MF,&'T& KU=;P@./OA(:3#J55V?Y>4TV0T>""N<AV:MN&Z;C5LHJ'WY
M-DR= >_+T%G$H&&R1<M 154HRD0?RDC,GWP]]MEKOWU&_Q_=B.5QLX_&XV'C
M*I:ID-R_J(P8UQ%$U:Q\>2Z=,J#(-=K8.+LUN--N"\759>P"%I>D)C #G-77
M^F>6YP"O+8Q"$%;F5+S$Q<TTXO).>+"FI$RX3F^/,UQ_;F>Z<EVN47 25 'G
MTC92 :8HS?H.G^81@QC X4V+&EQ1C&42CY%M:8SYC&8&A)G;A<:#%=+2#H?H
M*[?89"#8(8Y,9&4LM.EO&9\IUK:$6"LD)O"*U\J+8Z(QN*W$QD=)1. /,4-%
M68&15$WD"QQ'0ICO*!$_=$E4I(:BE2R6[2_+LI2.TG0L^3FH.WL*#JA&0HR&
M<"@D"#G)=09&$64P)2K06\8F!/\"HH-83WV>_"0H0RDC?Q$&6_#Y3 *#*!W?
MR$4,DQ E1TR"!A#1:6/380YK$+6T\/ O.[U*$U=HE47!R6<XG7-0?Z@V%%9Y
MAXUZRLW7_)6BX30G3W;$C=CH,Q(L/7- W?Q5<CHS1$E1:XU9M"*ACA6R6#60
MER%TB:96@ ,X[-!:O9H=$>.6HZ2-BI?4)-05J<F=^+P&/-N)6TE2M"S$9*F:
M=\(C1.>50> ];IV"\]N='LJHQ7T0-_&QX64R,0;X];"9:E*.&A44(!_UAG&C
M\]NZ*G.V[@@P*$OJI,-00@QB#&,F3!F&OP!VI'U\1!]%?19:MOD&38Q(( *Q
MSDZ-*B3_HP95)P8QZL,$=M6M&L1[0N7067:RDYS"LJQF/:M5$2(5YS F1[C;
MR\@^B(9,+ 1B:&T(/:!22:@HQG^MH95,G5:@P?93<M'18W1"-:M3(1&&FEF7
M8XYC+_B\*3[?JF5BV_I&P [4E]IY2NK"V$^"QBD_FG-915]EM<T4YC9]1)I7
M D0L3<5 !K8YSZO,MED/?@8UO=+6'M>2P!4BBC46Q"*UO&E$K;5G,\Q,UJNF
MR!DZ\E!VWB0-$X_8.;6Q%%EZ8N%CJ5O/Z;JK=ER:*]D&AUI"#FVAXD&@;,Z4
MV."6!F=\BQ1E(/05IE"%K Z35"6=XJ],M&^1$+%KP9ZGB6(H_V,3RZ!>B2HY
M$TV@81+5:XFF%D+6BGAOP_OPT%U#+.(1(P0:D\!.;!;(F9<Y5W3J#2[[Z$KB
MAX X&M>9Y9I&XT'P=&X\KD'M:9^90 G%AE?:B1,+"95;>WE)B7Q!Z;2.9=/!
MM-9<5EOEX)8YT)-L<UFM<7)C2V,V5B5FBMWBHH[6J1:S=-2?\O77IFZ0M[_4
M:[I5QMSI>HG,7H;G*^#LJTL]FA]4V><Z[[(B39=LV,PQL+/FXO-#0QC<G>F1
ML@5E(.F(:,SWOE,H* (?.J?%7C;>L3<6&JA,7N9'9:5NE]&]VD3]16&3(>DC
MRV@)@4NF#/Y8!R(K.HA))I&&IX)">O_UFQY5TD"5*DUBKE!)0X53L@\/'UBH
M/?'JC+.M;2,!JJ:/6UWAO E#^XQ!QMMVR##T6LRV@:I:R?VV%+N6T6-56D?R
M<8R.:=6W;(D3C^K)G8'&]0E F:M'8'.+!H>C0R4-YG&YI$]66NT<Z&045:MK
M+>!N2;4GM] RCJ4M#7,&N- T#HC62F#8&BL[5T635QTOSXI]9\^ 3O<S='(-
M(*L8N[X.=[R]%9U?GE3J(R:..8!DTY/A.MR4UC?4P$4NS=E'E8\^Y[H7?\T"
M'R><MZ!2/FQDX7?<U4\Z?H<I&>[J(RWY!H)03Q.MPXXD#P)B:.R4(.\C2$LV
M(3VF%H-$Q5[_1AHD 2Z[V]WM:V])6CN")&KOPZ[G?CSD9207DFPQG-AZ;I;F
MTCZ$,#[;,TD?KL03W$2CMBNSG8]Z<[;=CB5H3[:CJ.9XG!HJ#A;68@:6R@C"
M[TSK#G"G/KE1.$AYNY@/N\8W\Y;&EBP-DIKDH!$/>]?4I+HTBQZUG3-*,<@W
M-(_<G?]FM( .)2H-"JOW8T]FCHJCC,&D"4"\>S3Z!7BZ?T.\S^6R8[PDA5@V
M =R$K;;7^6%&)N! ;"$2#&F<TYW1R(0>;DB++V'+G9@*IO5/UY4%)9$$VND$
M)8'"IQ%$B8 "!\F1N=55W4V)L$6%WAU,B9C$P43/)D3/E+Q!B?1=_\&8!"@P
MA>O\FK6Q2$V8!,TH1.=%GA .H4*(%5"<"_V95H*L20+YRUP184+L&EW1Q^]A
M2^CMW.Z$!V/A4^CY!6IEC6@!A^^(&^9Y4&HY&KBI"L,1QBJY7SB-C1ZIT*8I
M"8Z5A&_5WZO@SK<9SL4M3L:%QB[1&_R!C%:42MW45B:0W;=%T=@-%H!XT[GX
MCAMIU_*%D*Q4';E8EZ\\8A]]!@<961$YHA_=GI>0BO+MSP^9#<W=WI"M&F"0
M(M/%RW(HT+74F1>!@A@LTD'=&^]8VB^A#<ZA$V-L1_/U!_X$B/=-6/I$X3!0
MR301@PT6@]OA(@8V7D(X##VL'57\G;&I(/_"W""):$+T%-M3N%WT,-6#B6.$
MN<Y%-%*UZ02X3((8I %00:$]WF-$L,]EM(UI)"!OO<MP-,M3*(3CG1L.-MO&
M:.$MI6&C%0BB-5JI5=&RR-2FV43]#1K%/8@/(5P;T=>R2!/E)5 ?3M8=/5_0
M[%#KI,C.!,9W^>/*(5IPV8H&,0:K]%P WLYLX1LQW$ , (!/ D  '$ ,A*3O
M,(Y#2I;J9-2+Q9XQI:*? 8ZK%!S5) IO\%4/366K25SO-5JG80X(S5N?4=:F
M2=8[_>'_*0J20=$ %D;*?0>^(<YR0)S:-&!A+$@4'8:4W<^HN 9RU47!H('&
M4%+!<-#*U(^('(S_@X%@R20$B!%5XUT'2PA$*!##P8A(@S55B4Q/@RG,L66F
MWZV@4^&$W"V$4.1444U;Y$C*W R0=3S%W8E!028>/LZF$$9%I$0:[[49QZC?
MYM$FW>&$%Z44%&WDN5AA:YC-<!(*.YWBG7Q&)")2<IW+7'+E1A'.916/<1#6
MV;2)[KS0JMT@!SU;+6T=;O'A9(U'93%EECSBNU4.^J'25&"8O]P@5M2;[)'?
ML*AAJ(F&],%1^<&?RS#BR"W<&)+3L7SBO8A.L,PD&:HAMOP<LT#3*M;GX<"'
MMN#*KZ 1J;3<. '7J1FHA"H) 6)E/VG4X-31F=&#%7K+6B!-XSW+O,QE7UE&
M4'C:W6!(!0=V8S<6FX45C"08V,,D&$Z,"/0X52AXHXBD(&4:Z9(J3&:F((1!
M#4,TY@X:Q)Q,@B0(&YUH:8J\CS@.IB28#./%)FV6Z5F%!%/HS.\URX]X$/(=
M2M+T_Z8]&J$F)%/.("/^ 0[K25I)DIP5*F5)MDT<=A^AG,</M231;9VE* ]1
MVI"A,!2+B5L2K07!@$N%09L8^(MRM8N"<BJR*-'M@1-P589R&DK2685].!(,
M'4E-. NIX.FDP=Q'?9^>]0X?9>)\U-ES )EZ )Z*1-.]N0G$55U&3HB)FN?G
M<(=FR:JA,(H>I@?J*&4_(<:W9*H]-9$!]F-@41$U-0N/]$=UT$S,\(C+[=QF
M10.*/(_[P,$TLB Q:)(+2H]MZM6&72!.3*9D?B-G3J8W:J8WSF ++BF_2L\R
ML)]%#)A3H$&5*"RT3<F43%V);(*A8=M"4*F97BQ:64<F7/]4H6A4CF 4$]7$
M$\XF5.A5:UQ%8!U-F#5H(+VAO5%'LL"A>/2)=&EGBV4AI!+.GRI#BB0DGQS1
M/2$G_[P$14+'8!+$+&%-+T[@B[59Z2VEMSV=XZ2)4+ G?3 :Q2EM6T7'[X6J
M&]8LT3I:V&9.8*G'DP@989G8QO954>2;O/6<=+I8RIW9\2F%N-''J"('F_8;
MA%:7N'F1<-%DOU%8G2;%)=)1QV9:GAB&X-##,(A! .# 9"A/#!R "AQ  !A
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M^='->E&O^*?,7J3891:L2:U% JT.&1%<,4UK<DUK-2'J96?_5"TQ2$(,J$
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MA@T25*?\?7)J:<WC5@:MI7RD3\<'E#+0<+J_ZZ^4RCC1G7;N*(#%#3+?:MR
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MCL33H6&.AV93!0WU(]6'CAME<-$%B=Z,%&E$:(I.JZ?HTD_^K.-\2W($E(9
M)@DPVOWR:%Z...9]:*-._AA5V]&-&!ZX/,8MIM03S9=TPBV!G5"[2@+,=C2[
M&<95K76]^NE;>+&:UUJ)H55J7YQNRCE@>-E5EZ>'A;[L&)_-.E8:Q-S_RQH]
ML"F#GV76P=&0)K.&4DQHQ S:^V3Y+L]\\\X_?],^F.(WY-TK':R0,O0,(P8
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MI5^X);=>\IB=UD&Q5H<UR6Q+2E7U(8U%^E'*-15PP!6F:!<HQF*S"DG+LF2
MH1;&VCJ(@16%9*#_]BJRHE9G1!6400]PZ1FN(61<9I4E,@P3X1Y<I3EJ14A"
M*90&\Z_H:KNK<:[X8C\VZY8VJ'D<B*D ,Q^7-6M]^)GFUA$$,2C8@0:@4&24
MD;L:!UCTF8,%,F&;9YV'$[5L H%D>&ITRCB>JK0N,U$$TD[E.9F2,0;?-TV:
M97,&VT1[*UMM@TL8$:R !;<EA4Z4EFM-V"(SA)DR82G_$B%;TD:',N=<=R,T
M>>::H,8VDP.SFT:,>ML07P@UY[-"F*DX$D2&6&.W/^N^>1>IX")"QZ01$IMG
M1>)UNV:!7GI%)TE2_@@V;_L0[3$,[L*1A/NI7D2E'[BF'EEI&=P_A)$)M*-O
MI8@71^E5G;L)9L$7-?9B2$PZ*_9P10E\H^(J4'P\@MD3-7$_&;L:TA(-^@ 9
MPU(8<D@/[K%BJ!0ZQX<J;S&@[>8KMB.BMPM+=2P;GB0MM8LM_VH=WP<1--._
M2:=LE%EI$TBV*$B-2D,@*6(?M@.A")@9"D.<0+%31Z>UE/QZU4FV\QMY37I0
M,F7(0&QK5X=>=8:%^\40/89$_Q^XA4(ED@7%; L+8/_K'V?40:TFJ!*6@YW:
M6A+!.Z,AS&,9S,.\%?D1S,=<%55!S,',S!A*S*N$'],L&=1,/<5,/=F,S<%,
M/<^<S1B*S,<\S-7,.\K,.^W1('J(DC=H0WR#4(J%1:NYSN2F,"^D-*PE:;6H
MRJ\*>-^6=+]E,-H)LJFYC7PXN')CD*XJ:8K12":&%O!V2 @J2*"BJX*A%9A;
M2 $:E%W!N20&E&[Q.A7!T=[G&)F1B=&;&FU"#%29*:L+#;)3BHGHE6E!.WU$
M.ZCX$'8\96VFBI6QN]?<$ ,A&4(M&45MU-ILS=S,S9\@?_?!._C!U+RS&Y&F
M$)D!"O^/4SE&ES<*>\A[^C-WE!!\@U_V\RLDNE*@-T!=DS9@F(YE C 3P[34
M.3>C=4)#)7HP2XRXYH[5]K5_!E!N352(<H8E3"0\9<A-Z!(D0<33.)IATHPQ
MPH)GXH,SX1Z\4=FED0DKQQOP 3.9XA[7<1V8;2+U(MHGFADKY]F9HMFK#1^L
M[=KQ81JGS=F6?1V5G2FQO=DP\P9H$)=CHS _ <OVS#*!9D(?V6&GBDP(!#&5
M2GDDF#9RC<],XG3'/4<0%0TV[#]1RJ7K*%UUXEQ)"-SORS&$P4<>^G#B2BMT
M(2MC9147FL3K38C_ML:B@Z%K ;NL$DBEHQ^U\AF9, R;^!G_0&H;$-'?O-&6
MF5"(]@88X=>MAZ@5@"4].OUFH.0A6_)@0.K?FI ,Q],MNJA*F4 )H@T9F>$&
MO,';DU#B- $9FE'B)H[BFL';:""+,U*AX,&HP%%& &.RC*%U%36W3].]EZ(A
M/)X9)(HIOW*J)%%+LN?7 %.>+J) Q(8SG';7= =;<K=:U@9YJ4>&>(:02#)]
M^U"$TK&!(DAN!AE&8C=H:L01TQ<SATUU37N0@7=-H*L9;MD>SNJ6F>&6;BD)
M>X[G[2'H?:X9\''GF4%]=W[GS@J7C"[HF5'H*Q[ILBCICZ[H> XS@W[I<)GH
M>%X:A-Y\FU$HLWF]LOPBHY4S+2J&_]W5$P^D*'490.,RC^.H:DPW7;,'F=UY
M2RJRHI*MMPWIW1-%GPHUGW1SGD=BH631;D59E/<=;V&!*QS*5Z2$?!QME+W7
M50J>%9ZA*V6]#Z71+"!*&[[B?63Y'9*@<DX,H#&FH9,H&GDQ*),!QA(^95M2
M$Y]!%2Y9+YA!(?&Q1Q=^1D\V#!R^C,N('<3 U B_C+R#'>!QG]\7'58MQ)>V
M*#*(M"@SM  L7&O870%$3F$;R>OWQVPT4\@=,K95;)SF1+RI-JU^X^<F[.@F
MRG%4<OL3UO2!$%/!'XK2P!GV+N'=4.$V):-'4W%&%6"":9=,E_I%)#.D5!Z2
M";*C\,F@X?_ZH8NZN.%,#0H#W_#6D8M;O_5>G^%4?_6CD0Q=/PQ;KPFZB/ :
MKHO^#0J90/5B?_#@T?5RO_9%W"WW 1Z?L+I]3PQ4GPQ7K^%Y_QUI?_698FQ#
MPX94*K7$^4*>EX[SY1'#S:4HF2&3=S@AN%F,+<-@VS_8?31AJ+3]1#3CJ4\C
MF(2AIQY_!7RITGOO;4KANDB=<Q=?L=_XMNU7<3M(3'[G[= 7/=,/#AZ:H#M0
M;R\W@]*K<3Q/AJ&\+0:8%)?DVE6L ]_(AV(?&A[T3EC_NCZ2 2UYM17-$HKE
M7_[-<CPX%C-&S?[M[_[M#W)% R)S6\\VQ))AETS]-#$"QFRZ#!#_T)8)K*<L
MVL!ERA)&RS0ITSZ($:-%I%C1XD6,&35NC$A,TT.$R_0MBU;OX#Z#]$@6+!E-
M&<IH]$XJ'+D,IDR;RVP:Y$D2(<YZ G$>='E0X$N%^W2.%'AP9$R72F,B+-G4
MX$*?(DE>1:I)4M2$*'U""^HS)5&%:+=F=;F3ZC*<2)7F5.8PH3*>1'4*]&ET
M;]^^+_\>5*8)#3%E!96-Q*LOI3*RRNA!>RP9KT)Z>#,G9.S8Y6;+"R%/ADOS
ML6+%*'DR5BGY\]3)D!6+O-R:K%"!GC,+;)@II]JB:YOJ/+B6\$&3H@.OM,J\
M8+VMQ2-KTJ1PJ\SD=.>63>N3Z=CDC.<>YN^.4^GPD9DR:1H8?NE*IR3-&V1Y
M%2'?HVWU$\>:'.?"2=+0)!10EF&OP $/-# 48D)1AL!E"@3%00(??+# PC1)
M XZ/*'E#DTTN7&:]-R8I\2,X/(J000<WD9#"%D5D4 Q-)E)M/4U F>0ECB)*
M2#WJE DQC30D26.2'(N9D#T%#U0RPA4O5)+"P@S\2*1Z>M1R2RZ[]/)++J&A
M*$ME/'(H2(4*# 7*%RVD$DH&E4G#-YY(D^W.Q/!"[3*DZM'$H3P/ O(IA01J
MRJ3N2LH+NK=Z.@Y1O8HJJZ;SY,MIGYB(S(28??0!__-34"6*:%-BR HNOT0+
M-6ZP[A"R#U7D)"7H./Z.$DLL6@TE3B6_LAINJJ9XQ4FFJUPR"2=BU ,OOIKD
MTTLPJ!(#ZS:M@BLKV.*B=0G(PHA9B2>IB'5/*Z2@VJI2RC01 R]R\RP-,YX*
M4BFRJ1S[*3+)$IJW(-;R;8VTS3)[34_-\D3J8,7854E@T,2"YE^%\I6XH(8T
M(?8WZ*(--ZJSG+T6/G);*J_7:(B"#B64Z,EDA0/@B"8WG=H;SB"^,$TLOV7*
M,DLOF,EREJOBOMLGP&%H[17GD(8[5*"YSG//7*;\*PIHE.9D#T)00J10PBA#
M=/') 85\D,!B"D,C@  . /_@@+1S !$OPP)@F>6TQX!C3:TG?)!)!\,.Y4"/
M,N'QHSE!";Q'?;)$*1,!E0&E,%"*%,,AKD6<\$4$8W012B;9](@83D,5?732
M2\?()<-R;'#O%B=<,108)VQ]1<,%S*PU>>\J*#+>=R]HGU*3W=&LH=,@QMA8
M!RN+6+2"@\D]GVNFB;A$]]6O)V4FSP0-B!0W_?N*Z*%(O;3RRCEY\]KCN"3U
MRTWN^9DD!?JJJ)D>RSOFSJ\6J?R?NC@^MEP%4<EIBS(8EZ>Y\"5H(4%)<H9#
M%?MDZWQ74<I3]H(H_3'.2&_PC?VN%QT0[@<A+#$)Q="@"<:X1C)'"0J\(B8Q
M@^7_J341@XM0V"4QU93F+CJ4V,(H4Q^#Z>LN];HAO&8(L8%AAC+"RT3S[A-
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M #K%@0&I1,?YM#K__:(8>(/982W3[)O>M+77BY #PA0N^0A&8\4+220E62W
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ME19VP/RQ61/U4OT1*Q3V._:&+WK9Z)J !H:@T""IK&/TR^C:A&68DA4!:#$
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M ZG(L<RT93+  DW[C'(0YPE/>O-#2!K$D#K5+<F;-AO#??MEI.AM=%1*XM.
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M.V "  !!,H11#N&H<_#A:QSB8?T-M?V6X8;(+@6'O.1J-EI=V>A2ILKE*JY
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MQ 2#2-;/#-VH,'([HDA3DPE&)/1X&WR;:/*B"8J^%\7_Y5Q*.FM30Z!!Z4M
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M41EG$MZ 5X^)8(N3=V;'&*O)O'I5*L*',C#J(3"B)B1P5AAJ"QH@^&0"#7
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M5J:M3KURU22U:R9-]/:I7<NVK5NU^O:ER825Z=2J89-F$G,@QQM-H#3AB'$
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M'Q)>2.(CCC-1/^(10D(_J[,LOG8A$Q(2"L8J.F)$5B=N%98A_S)"-(V"'<M
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M"$*\00R%-1S_GCH< 1!XKY$<GSH<J<=58M&6U.$:DZ 1*6*+F8 ):' #PX$
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MAG3SY]ZS%#D19/E 0DAJL9#(-"/PS6XRN$SIAEI*0YQPH FS/_NT?_MI #
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MQ&G8"\U8B8U(D)W!'Z$2&YFN=ZR3V1$P_#*<+X$X,9@$-!@#29#9-(#9B#
M -#9 -A9,7B#2< $[%&4G(T!/8+8_W$T9&,FD4@BD("5D%#7(I7:E% &!/N!
M,9#9K+79K0U&KMW:K,7:L/7:8/2!,4@#'T@#'#C;,4!;M2U;K77;L 7;N>7:
M>J.W8*0WF[7;O44#>LO:O 7<DQ,#O.U;O?W;PKW;O]5;PLU:-.!;K'5<K$U<
MR5W<RJ4WR?]U7,'56\A-W,[MV\%=W+X5W;LE7<\=7#3 @='5!+R;L+<KNX0)
M*[<CN7OQ4Z/\C,<L#7?9C4#I2ZO2H<D4#=AXJGB95.)XL^"5C7\<U<,3J*>9
M.TF4(TCR*T03HZ_ H:PX"YSQ& 4!"?](C<1 O3%BQJ"@$$#1N?]X@^RA*%'M
ME%^;,C"*"YW+A($  !G(! QKO(L0B-0*A5-01IZZF*+YNHZSS<Z+E8I:/E1*
M3VW4ODY2)=P*I6_-+=ZJ&^N#@TCID9#0AVFRP6S*A O$+CT)20MMKS/A+_V4
MIS/IG8QM5S338._IG'W\FZ-) _=;I>@K)00+QGI#@QS VARP62#__N$:GENL
M5=M@Q-K-K=D=/N(TR &9]0&\O=JL?>(AQMNM5=LF/A;+J1-[-4@*##]=FM^.
MH$D<4 &=/8"\58XEP01)" .=!8  B(&3LS_2U5M),36>((8,GK](&9ZI!>1*
M68:^S>(T^ $QN%JT_0$T..0?.%LG3EM#?N1%IF1##L9#7MN3FV))OF1&9MN7
M=>2R561/[N%@_-D,0>5)2&6(4V6(0^57OK]6CEF(,U!7;N4,N;](4659?N5;
MWN4TD 167N5?WN681:\,*>8,"695IK=6/N5??F57MC_[XV5;IF:(>^93GF9?
M%H.^D:$>NHS6N$RW,Z)%1!A,K8PP<Q?1_W34P$M%M8I,@'(AHN@A/J0->S$B
MN2NSCEB.IRC?64&RGFJDQJO5 VJBSS0L:#U"^"$+2B.I4N.? ]E$<%FI\M4.
M4OV\ZU$.- N/BG(+N]**9"F:F<P$&"C:1I#(OJJ*9$4DCCDT4R0?X_LJ/5TB
MT&P+# $NN-G6NK'&\LQI2R+74P(1'MG6Y_L:: A8]X1:BA =('&1%*:G<,NO
M]#M(^BJ=ILY8*TF.^<L4H!0)]U@2LYV2:F/@*)%FB*LW.E9KM7;DLW;EM(:X
MMDYKLWUKMX9KN%[KND9K5YZ2=/JO%6:G$=Z=^AL&Y1,#')4>&1A<V9/!^16#
M+< !I;F!P>7G>O^;F$CIYHI@#^UPV(\0B<!ANJ@-Y-%NN;@& D?^@=0VY!SX
M@=-.;==N[=3^ 1U([1PX;=:.;=F&;=G6;=[.;=<V9->&;4D>&-G0JG]!;A8M
M;MYE4>9.[N)^[NA^;N>6;N66[M8 G>JV;CG]E]880BRM4SQ%BL<H;#X,LQ/2
MC-#8,T8T#;:"9T(4#76>#*FB,WEA%ZX"J+.;3!TJF#0U(DKUC7=QQ.3@S)O"
MWA]C+<N",I2QU7#)F./CH/-&TBD*PVJ*SP4)FBG4NGQ"Z+K"HI%B))F@$M=J
M:/E@K.#$E>F(F>U)$1L(@#<@'\I(5M5B,,! 39QA\&5<(O6I3;%#L&S_Y!#>
M.J6W,<\*QIMR!9&UZ>EGNSYK].,1"PF?((9)L,AWM4@AD6H /,@]D:^&$R<<
M\2^3;(CQBB7L;N68 FJRN;YG0Z4/&6NC_J3GNV W!Q'ENN!/BG. E',ZEW,]
MC_,_[_/M;#X#S00DB4>"(SC8608I&8:ERU%DB89A,&E2.QX6G..UV @<31N9
MR(3.$0M)F/"9NXB)V6 /HVS21G5X\S @!H)6;W4C>'4@@'57=_59K_58E_5;
MI_5=Y_5>]_5<;VN)$],7TXNL,!"@*Z!.C'&!)O;M:/9GWQA1OZ"+D!)?L0DM
MXIJ)BA#5^PC':T.YX-&T6)[VEHP5,DPV>\S:_^V-1WTC%IWOVAT.L*+4/:/=
M.I2J+UOOUO XM6+GKMH7X- F( L7DO*43D6,9'^R%10^Q6#6)J(*:,B$ RA6
M1YJHRYA1 *"UXLDT1-/"F3O?H0DJ5NP)4)"]:2$@KZ@0K= :\$"J9!"& +@E
M"\($YQRCAS9%9ZFLSLO?C+$I'JN'Y#@6X@I/3/+6;B77(]]SZIO&YUL;[HL_
M[]N>Y  W_30_J)8O'<&31+^=$=XW@ALR$/L;O$B.>E.NY4LE4+*D:8MS2S(E
M;G1[9BM/9K-@;4S[3.)&WK)&:B-J:N-[MO?&GN80M(&X:?M(AE-0JI^3&[$1
M1D>#&! #B4N&.XH!!_\PBF08A@-0 YZ@!WT8A@# @3B !D90(E8)YM%'2J20
M<LX<B11!@WQ,]=='$4<^;2 H @O@]=8^;5B/[=R??=SW_=D'=ENW=>"7]=8V
M N.G_58O N*'N#.TO!-+2HF2"Y\?BP3)\+$PRC.,($YL2EQ]WM20EB<ZS3-2
M".6H&?<(,BADE:C4C[F:K9CKH*4;'LBD#<& 71EZ*CI4L^%XS*T""'K*Z$4;
MN,R@06@(EPEDJ.R@,F7U(D*;&'%?Q(D""]([J-"BQ6@-!T9TR'#9QXB9,DV*
MM@_E,IC08LZ$6;#@LI<8H]5;QG.FLF@T)PHM2M!GSJ /]<5\B;(>M&&38@#_
MD 'G9=&@!_<-$V-@S$.M3$4BQ6D6ID^)-85"C5EP9T^A0>O=5*8I#3&;RK#&
M9%IQ)L9E?N/"#$HO;T%H/)4) X #3M*#^J8&".53H5#%!+6^?7@3Z<RL/CO.
M?>N6:*8T<#3!";5:DR8[FD"MW@3'-BA-<6;#H<TZE";7N6UOT@UJ]^PTFO;N
M:^Y<GW-EDU8N Z4LU$/LVD$MTU2]&'?OW(EAK[Z,/'EEF]1S!Z7]>OOJZ\%/
M9^[2^7WG^O<[K[<O_W[$K/3&)&^\!AL:J]FQ"6VN,7A;:PH6=P>$F\@6!VT/
M:G*')KB]MF!OM_D&XG&L^<9AB!O^MAJ*KAEWVX+&_\&FR1MIO"%>==MUE^-U
M\)F'8QJ9*).)&)D@A9$D:%2VC#"+(!!<6LK,LP(.<>P3Y%@':2))&GL=5%1;
M&'797'XK37(1?VFJN2:;;;KY)IQQJED/=/L0DT8:0.@)Q ] %&%!GT 8$6B@
M@NH9J!%\)NKGGGT2RB>D12@*Z:-\6@!IHWS^T-)#H7WIUJ=:?>G99FG9%!-2
MH!;V65&J>IH9:*JVRA.8?_7T$ET=[40,@::]FI90@GUJJE!^N2719Z8R!:Q=
M:&3"E#+0;"0000))%*U%PB(T$FG*0&O23-9RI!!*'74D;;GA[J76M=>"1.Y(
M3'6+$4F"J>401QEA.^1T-/]%AM513AT%JU9 @:F444^9:G!D9H6521@W !#
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M1*J5$77%D2,'>:,:-3&=CQ&%64PKVI=&^*\@<J8M6?D,_U;Z2*NMZ(,>F0!
M#,(0 !E8"31 T9@88I"&GUT,,*="BE8X<[&ST.53@TG5RQP6))L<I31>:MJZ
MA!6LF2AD8SC0Q,>$,@Q)!&"30J0'-"0A2>]\!H>?,B:P0'D6%LZ%B3Q)2VI^
M$QP1\28W%6+1[\2F. P9+T:[<5"(WK:F:$PB#3A PQAP@(,TB $'8Q!#.\?@
M WCB@)[OC"<^X0G/ZO5(?A$IAC*L8SV[6 \VJ=$'3^JT#WH(D#^\&H/RN(8B
M!)F(F[EQW339-DVSE4UULKF-B7Y'F]PL*$,PXDUL4LJAD5HT;5P[3HF^YIO7
MX&EQ[KD.>AZG'?%@AT&AH,]RBO]6RH$L0@P'\%B3K!*3HB5C"S@ PCXD822L
M*&,8:8CB4HBH#.S5+T@#B08QN!2S_C6TK&8]:YPRUYP[$<J"@[I4GRZEIPH(
MZ@<66!1=]00H2T&*@AJ<8*4<J,"W9@H(>'+*RE[U2E$9DB%%_(P-7XB6N@BE
M<TDY8JL0!A.2E25@R3SD"X/"JZD6K"PNZ\N1-$M+4*TE+3O1"S'$H E]1 1:
MWIHCN];8*6LU)"46JZU'&'))VP8&773$+;LF8A%YX5:XV5I7O6@+DFAY$8TK
M,1)2"!*7IY5RA*5DF PKVZE.CI*\FOUL3@2D G=B@DIP$(G*!),)&,0@!S[A
M(V1_(JS_BA2+:K0DV4V^>RQ8'I(T>%$9K.+GPZR$Z21=.4"7("(&&,@@."Z1
MC'1@T#V;K2PGPT+F6$JI,V*E:K5;Q1-LX'#2:P)G;2Z*Z>J*4Z&4^B8VQ=%C
M)AC*O]1,9T9OF]'G? QD(1NTR#.J$1KPI.0D,SD-8VCR597,SK=51'.8VT\T
MHCDCV0"G-]P4 S>!1SL0K8AL:^-=:WXW(1M+:,8?)2EQ5$0<+Z>806B^:(E>
M:CP8W1C% 8V<CT#!O/8,FD=!@LK3E#*,&%!,*,(XPPK> $IZ#,.]RPA28#S'
MDE7:1$!IX!)8/S>)Z>A/JF@]-:I3W:8LYRFN$)Q4I!2H0 1*_ZJ!A8TKI. *
M!$#A=4]_PE2M=?V#-.RD6N)];8"C03-D ]BUR=3A3[8;,G_)!2X**^)DQXMH
MDZ42E/5AFM2J)A-_%1)J1JS9P+RD%?=)<;J.1<A7$2(M,1:&--8JH[[L+6^+
MZ+N+5(3(1!0R$C1*YF<DF2*Z+J(OX6*87W K[6IA)4-/+N:9L/1P,?5B\<9B
M,6.2\$XR5D#)CYW+7F$ P!@T\=K.9M9FGY(X*)VRV@9G6^90S$M-5 :P$/:7
MB+%2MD#:&8,;#%T,HSN6=(@. Q4$( 8<RX1.'/NE),9JW 1+6,OX$DW?N"A"
M(\4=2+T6TH_:>*1BQ]!N[+";-XQ!?__+$?5*9A30'LUF[M:QB]WS;IV]!W0Y
M+'E?D%13($ID(F^$^QSA!/>V^I"I.3J>FYN@LM;"O\TWW-QS<6+FM:^#E,NO
M&UOGYVSV#''-133>?)Q3-.84NZ;+99.1A&(Z-M;))DBPT4YZ&/2CZ.F4/<M8
M3]L[3I.C 6 %D)'6,&1P TE#)1,WZ&4HH+''M QT&.]+QD'TEQIB3$(2>X$B
M&L20/[BINOSF/RMTZG$76V/P@74]E 8+.^L%PE6P"'0_I18H:PX.F]C*7&JP
M;)'\G,6J2$0/>9B7$)(?U9S4@99IU PA\<6"+0Q=C%:N7)V_. 5<!." I5:J
M,(T@T0L4/8O_1P2<O97+0731%%D+'!E7P!5<M#!<&ED$O01&%J$$NP#3=(G$
MNFQ&=6$$&*4$O$'7"3X,=8@7 AX1P%06#^7<!RJ%B"V1AZU6M<C$4/D$)JS7
M54Q6,O1"#,C &^!$<(E*B!G3S! %42R6!FH<$8W0ND"16/S?U61;"(5+JTP$
M)D@2  #  =S2QY2$,IS<Q.SA 4R,+VG%:WE*:0A+9)3AJ7B&4DB'\G#(-Z6.
M;;28C8G-UQ@'Z@"/<*2.C+"3[8'.^B@%[_G()EA&*EK&3WE/,;@B++9B>]P%
MGA1.BJ'-[\Q8V*T&'*1!2W!.X\E)G0S)+8&=2>'9:HQ!;] .<8R48N]P"-EP
MGC5QE$4QHS>I"-?(!C2J'C;R(HQ]U"7F(DIU'FS8R&SLR$WU5#J&AWFT!R@<
MVH6)T:(!0 [@DLG5%W<, R8PVFKL@VRUA5T(B3*(GT"2VB1 PYT<Q##\G?B=
MR?D]_R1$P@DP.D<PN9]=+0H0Y%6AY%6MS95@)= %19 &<1#^E20:;.# / VH
MP,K.5(V F<:IM,PAE=(%#@Q,;$9W,0U29$E:()J"*9-T'.2Q8)PLC1=.R&0H
M%1=HT-QJH<3-D<1TA441CH1P+<5N2646Z59U=4L1D@2].,04U<L0@B6]< L)
MS1&&F9'%T-;]P&-B)1/#C)L&SH4=OA*QS&$*F58KP4K(/89IB,0DG-P-X(#3
MU5=P>$E@.$RK*-8S,8QF+4L,K618R%9)P$5HM(4C[L3*")$H)5*U?99+T K.
M&!%JE<S4D1).\ 5"F1'VJ$'I<(V*>%U*I<Y%C9U&<<@GPO_&ZI6(C=@%D.6(
M>QRF[HD'?-@%=N1&0.W=<;IC\VQ:1HE=FD6(1O$B\*28C4B1)@R#1#0'=*3?
M0O&@M]!)=XS.[8"C[-P.'&@>.:*GA9@9F\691:64;I).-4G(@FC(\-!&BZ19
M?&(([9R>@Y04A- B;#R$>Y!'*C).>CQ.Y'C'7<B,1]!#,DP"#AS C3PA.VW!
MT%%8&GA,- 2)R?"+@(P!E]1/D:S+="QD7JS)1/)/1+[HB]9#)LA:!.F) UG
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MDHL&I]2$U[GNM;#=<JXTQ  &8-T40<*8!LB(8;$R00,.$)"S,&(M!S,Q&D:
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MTG2GM2;.@.%( H  3N?5F379V61',^T 1C3O[KW;>)HT+PU3!A, 2"8T*@
M"* &\&3$RC"E_AN*&&O$B#,AUU1^M)W-YDM_TJ0B!H3.ON'(UQ0'=Z9),63
M^?1&!?S2ZGL+C0-TF*^\SH9+;S37RM,DC4RB$6.SS$+)S#?>!/3--0LM='"S
M3=+#[;7,,@O1N!!#M)"SXC[+;1,%0=%,Q@1!],VXW#+C;)A,<#@@@.D B&&,
MPH;!1(4#QB@O$TG$ $ -3?399\IH]JEG2BRSU')++K<<1I@8< !EGVCTT6>8
M+7!8;9]Y&-D"@1M@+8AASC _VD>?2<(X8,X]5X@A#4VJI =,.H64\X; -.(E
M!C]OF!.'-(JAJDM**_^U]%),NZP2R_+2 *((('X (M1/+1C55%!)%=4(44=5
M==160S5"5E=;W6#467^P8%92@6!U5%!_8!4YI*"J::J;6FJ(H8_H\2@MM)B5
M]J&B3BKHHYJ**@JIE)8=:"&+='+)):QF(HB8-S)!Z*2;N+*(V8G"6NHHK9*M
MR"F-H")WHZVN#>NB>M_-UZ*AELE$R:W0FJFFL*1=:""&^2T7K7 OJJHBK4#2
M-RN.OJ*)WH*4DHA?E+CB>"UR4P(80DV*/8M;DD*FJ*PJMS*(767-,JJILY@B
M*>:OW(6WX(1(@@HMGY1)R:."V7IWHYW>@BRO[_C29+&KK_YKLL6^J_HQ[_3_
MH@OLJAFK3.O "/ONZC=8CF^X%=_F3;?9:K-O1@'/TP0U 5RCL3<8*]0$!@ @
M@.PUT!!O.R^M\\J$BB CGPX!R/@B[&K:$F!ML;RH#L6[\0#%4, 0/_/-/QD>
MD-'#X4P+#11)#I#AN3=@T$$-^T!Q#1,T C!01>,L//%&"LG;1XP3/4P1[Q'I
M+BW "TLG3C/67-NP/AEO'(W%^ (G+D#31C,-1-$"-.[PS-# H0%(TQ #ASES
MJ"N3, #(89-0/I$D$WIB$$.-*5TI4P.T4I;.) G_M>Q.](,!#C91I7:<(08(
M0(,FB)$,-&S! 5?3ASO"$*9,*$,9T E3&LHTC$64_U"$PT##"G 0*'U@(@PR
MJ* RB)&)+>0@#03D80]]J"4I34D9;W 5K(HHJU8)JU:P,D(%<-6K(I@J5J+2
MU:]>!:M=B<J)5HP5&JBE,*^X2VD<"9A#RJ@O,A:-8QZAF43(DC&,6(PB:FS(
M6*Z%E!M.0A\ LTA1'&86<I'%)MA"22#;6!"($(V/Y%K7S!*&LZPT9&_#,(I+
MQ#(P,(+L(-82I+6>Y2U 8J4A\UI&4096,#]^2XV1E-99:.:LCUG2*BH!"C%
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MBD4 M3+)$@$2N78;AD69$T>! 1G0K#MA$TG  0<2.&6(!( KDXBSJ"*\DTB
MGXZ+.,JI$C-!DQ@(#&7X('NS-SE)K!N8."2,PP$ZPBDQ,D\9_ZY6@;E8214C
M2B(K2I6:LP ETCGHJCE A!4UV"$QBI?O*KRBJ FG68N78(L&:Y;V:AIL@9C^
M.@N*>42BP H^(J^0>(J<4 8(D2.CD9GK>B1H\:]$ D7UPB15>AA(G$0X D68
MP!B7D2L18HA&4HN<P#N@:0JU6".@X;M,U)F?T1EL:4:T4XIDK EK:0JV:R2
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M"J4SEA&SEV'D1*L EU(2FJ[PI/[:F[B8&)J0NK(H1G,I%DZJKW;IF+SCKZT
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MIF7+]D4CEFGD2$TC*94<.4F3I#22,IDTF7+23),TTTQ*@X8FS9)O8L+1% 8
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M!U='BN(2WJ38@V")4WZ=YQ*F#HIJ>0S#3R) &IR"=E@%&LC 94@"&H3! >
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MKT;8Y_6AA4Z,A]':!;_"!()NBD #S ;[GUS A;T1X-%(_PT&(_1V)44O@0W
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MCF.<Y"R4.-[=3 QC(1;SWG!0&+T.GPD=$YA*1SL<I:B>FGA#7.*R2)[41PP
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MVC# 2,8LA*:_J@F[\ (P$"T-?HDT,@Z60";HV&9L;@D&Q:)4^@T _\]/_M3
M!_]G$G00#=Y $M @!@( !Q"#BUB,/"3&M_:F:88#3[ +E+R)@!ZJ^BKG2:ZO
MG28DQ\I/[\H/QS9'22;E>T"D\#XD=68OR?AC=79$SF#D=, DR6YD=MBDU"8G
MJ2:*=\KO26QL[[ /5&SQ?M @$RR,8GRHR$JD\9#LS9A,1>",19ALI9KJ>^;G
M2L+@ ,* W@*-C\9'$FX@++9"$@ @!Z3FDSRN3HKJ?CC$2Z9*G:JO0 )D0 ;D
M^S:%T^ D0;!D)SHE2^"$2:K$U(0CNKZ' @VK'F3M@Y3O!H(O!FX@$QHEY@[
M? H%$QAA)&-@!>Y/MUQ($IH%#7 @^%: I_^D1A_HX?](4HQ0!C&$K2.+DH6X
MAR+*S0,YPB64Z-HRZXF^Y8G(;0/5Q2GGI:4HIFI,HVQ4*3PXXY($HVK<+9(
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M&QR )K3TAH:R)X5!^"@!&MH!MW*@U?0A&0 K O_Y&)1EZ V"Z+-(4$Y1PB5
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M?VU$B]_D(R)1&,-P31)'AB$9&EY$D7/_"6A@RNB(,MHB S5XQ2CZH$<F A"
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M/#>2-IP?XA9$17WU,&8IN1@F?[4P(VZ%+\4J[R5%R%H^"FP9"N$;LIAX6H_
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M[#49!\4B^*$WDX 3!8%KD;0N=Z%%N19)710P05%^"8$&X.(PYE4ME(<&*G
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M& ?1D98S7!L(@C^XA-P68PDA!CJX5Q636\IP U<( *!S  !P &-P'F)@=S$
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M&<Q)@;K8-Z$'*<&!%@,?BIK@D^5@0"%/-0!*3*&/'\O1^_E!2ID?+F3"2N$
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MY^K82-U+/AVY#S2@)U!8GS08AI$0K?(;"? V03>_[@ZFAWYVD.\6[UW'$V7
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M#* $XI\">DRSZ(O\K1\!]I_]B6 $YD;%Z(O^L9_Z5<SUO2#^M<;XP-RK<,;
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M>WZ+D1>W!WL8)TJ;1]2@T#%9.:1L80H#>=..H53@WUN0%AQK\)B$-=\,<O7
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M<W*U]C@(0PYV68]\Y8U\Q5?1;4FO5G"71!W$GW_3<L64E?6&%W)MO3[J_ZI
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M5O]AU_'22-TB[S>.PY(TCSF:9CJ&8UA-,3<[[;$T33R89A11KU8M;Y'\""1
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M*@W";'6EI\<,KFL,(]!PAO1'2X7B)V2"[D"!$2*A:O7<-.!<!G) $_)A'K9
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MXI#&C"]F28\DC,00 XU?:;1EFVZ^"6><<LY)9YUVWHEGGG?JXZ:6FDSR Q!
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M>5H1=4+&B-HQ8F*0"8QP  ]0.8M'##=P &_ 9)BQ>$:" %)V P@ 9>6D%<,
M $!@<I>(',:4&L7T3I,83H,S8YBQ=MPA$F^ !I^'!KZ#5.Z#(TVE"<*S!5R
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M@AA#%*NCWD5;Y,H:D1ZO0E\I:::",1&O(C6"^91\L30+^%[1G$J-.3$$%R7
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M@?8!M$/-021QUB#UB$D$DER*V >]$P6+(0![2%:<DI%Y:4R"&/O*2.2EK(U
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M&KYTO-[!04[&8U.9@&=.<9(S>'!B82;PQ+P>.<A"J9QFZ&PCOMEDHA$' -!
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M.HS#0/\<1(J-E= ++LG(EF_Q6)#%%D\<69(=6:=<,3C8+Z9:6?!A*O !G\F
M@TQXV4JL64V 65]3GBBQ.L:CU86:G;Z92X% -,EXJ3-$"8#9%IKJ")OZ-)*
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M#>SI#M_0,Q[M &&9SVP/>:;9'O94QWYB> ,Q&N<:(^D2=$,STM=F9A_-A&U
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M!@$X:-=HN>W__P,@1_\L7S2H#K H0S% @P;9A$VT5L!P3,) 11T1DE?8FU0
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MIDC)9[B)3N%4FMA)YKE)3L&9YUU*^L"),^X)G$1'V:R&TL%,U0R4/DP"# 3
M 3P4Z_#0%Q65LN' 5+9FH?_LW7-8E"9<R74RD/60&9A4&MB,$?'](PYD4?^U
ME9YY!*?A0/D9A#"DFAHPA%X%QO7YU6C-PS#T$+* 7PRTWS[L0A?% 444'Y$)
MQ#!T49,TQ/K]0!852QAHC1;YCJZ%P0VTY$P*Z9"6%DQBVTF<R#3^P%* (" E
MC 6$S&T-Q2!M8%(>S%#*UL>$C,;HT5+.T<:0S&.5HA_"9GT\U\!Q8=:QQ0=A
M5R<%F%TD@R8]0"BD8'/]Y0YZ39X")VON1>[\(=2@EU2%(EARIE/11B:,Y6T(
MQV90F>YL772QF-.X1GIYX8&!H79(6-[TG!F^S6-VQ]M01WC8C1%(&-\<F'L8
M 67_,H2F$4W'D41:"$1?2$XJ15EH#N;(617_6-W&M2)&O9Z +6J 6DA;10-C
MJ*)LDF) WL>B]D<B.H?4#-YE6E(XQ4B'F=Z.K!/,88@^').G3.<Z<AET.AI,
ME0H#64GYI$IW I7YW%2>; *[3MZ[SHG\0&,RIL]VI@DH2$>L]-+A^-=J!$I(
MP  ERL!Q(-$!I 'R,1\C' !NU*:?4275  MH;(_T8.?%/H^4G!2KR H9F9^M
M0)%#I"0'G1\CP"@'"<,BW$#"JFCUK5H-B4'][<,P--^!?00C8 1#[D.J;<&.
MTL,\A- &15;!FM#ZJ4$6J6P,X) .20(.K-!<W0 "G-JU_QDID5KMU;+$"?&*
M0(YL1"B#>RSI5-P6!3*I54"%!@+7Q?@6E@IEV?;15] 1461%J@9,?-0'?]GI
MHD"7X000<FA2?<UJR$$##@H F6A7X[A2*(+-Y" -AB&B*>VA9;2<O_Z()SU7
M"PK&,XQE=B4N_T!=S-#8"Y+8@SP770S#S(VA&1[FWGQ'8W*JZC;8S?7<&JK!
M&VRJ[=H/T0E+YM"&\(@&_F#KDZ5@1V&.(P5HP;$@+1F' 2TBI)22GS+.X2R4
M6U"&C,S'B>AE]1H'@ !L@4U"WHD<L!8GR/%%1]$3HU+46Q38 C&)ISSGEH59
MQG)5HVV9E41>36D>O;(K>+XK>/_>U#/.3Y^@#_K(CTQ-35X\'0*C##%@ F)Q
M(EG%Z+B ;Q,AK(\]"D15SLMX(:8X#Y: ":=P"8':4["1ECY4VP8]A+VH7R0@
M0!H$I/HEQ-%&@X>Z7X\5!&#=@+EYQ(G&P:[L R]4%AR8WXMN$$&%@0Q@B$>T
M@ZW\@(842PS< :\(@].NT!: +#]B;19K\;Y<VT$L0R:$+5@0#%+ $51$Z0;N
M6[M9*7#U$4Z\44Y@8%8\A1I'!<F@@1CD4XCM#VOXEV7LS@J*(B]0XGWF4PL*
M<GT5*^]&$EWV9C7.Q1 IU^-(\M% '=.9S=>L& 9_E(#A8 )P9G%&;M;-AA5&
MZM]%2!?_&MB#Z=RG1IC==,<:[-R"M>[;2!@SL6%U0)@:!DX#%F#A7,@LO4R4
M74XC]U<>JHP0UL6B=,[F',BU) U^;6]4$0X_69QF@!QJ+"LVHZ# M28]V(CX
M;:%^R=*T*O-I5N[!*8<75A!7*=[\=M662&>7X-Z7V6$H *?;H E0X4D^XU3F
MV>L PXE/O9F<\?/X *>@O,;H>DWKQ)5BX8 ,^%@I>LM[MH,P!,#1+N[CS-/^
M8(X]G<E)D9FD&:"2G$EHF)8.%1&_8IO0Y.,B&%NZ\ HOV I>E:3+[D,RM%J*
M)@.)YA@3,0(7G*1)Y.B.0L,2IY\^Q)H,.$D.90*Q"3'6_!.=_ZY?S#H+0R&
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MA(NMO<<D@-"(P &M?606"42.8J0R&#5'"IMDB8&E3=:(:(@^U-H6_T0Q$JW
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M96(GXG18TR%Z&.(%@ #B@&F^BB**AD #HX$)O_GJ<X@BAOZ#*;\$:\IDC$P
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MXQ(*\M0*76)\ID<;JM!3'W=<)(V>7,)$A<UIDHG"^O(#%$+@&S)4),I).C[
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MQ-@Q^=8@8_&9R4Q+(FE*5^R]DH/I2UP"*<MM_%$TO93$</B!&MH$AS?$B3G
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MWSD%R79\/$K>8]4ZOS/',%#VJ=PZTP"+\,=Y78+$W8MQ<E."#>JUR+HD/,V
M?F^M+$(AG%BB"R43Q"  A (__Q)CC1RYT_=4&=*BT$0:#MUW&="XAH@"\GQ%
M4%QH_H?BSV@EYTDO7? ((.!HV@0GE*8[FD#!V:0ICB9-=A(*5+@IHD)- C&"
M.HBQ(D&#=P0BS AGC*9HR_8IB[9R631Z*9758[EO6<QH]98I4[E,7\QET%RF
MA,82FB8T8C+M6\JTJ=.G4*-*G4JUJM6KR;0  " @FM1A6KEZO4JVK-FS:-.J
M7<NV+=M,8B;M+$O/:C1B;WX V?M#+Q C? -7^.O7+Q"_1?8>5ER8[X\T:33M
M1*D2)TN@-W-"J[=2L\Z:+%%BKIR39;V@-%V>QHS2)\Z@+NF)]MD2)>S+M%'B
M7+DST_^83"F7R;89M'9ME\J$UAQ-/#;FVRU9MVP9%'7RXJ)1K\XN%#/UT<E-
M4\XT*<T;-7#0&T&?'HX1.$#<HU?//CZ<(/+AM(>OGSW](_NQE]Y[]K%'8'[Q
MK=??@?R])^!Z!T*XGX/M29B@?!+J%R"%_>7'7WSVV8>#,CNY9%E**/&V&F]
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M*!P12J?T$*1B3P0D3S(">\A!(OL0%&Y$:U"(3,%5/5-A7*H6D1B9D;R"=),
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MK_@J?O[Q _)#4-"*'2"$'3:!;B#$BU:U0<)S;#>Y&VW8*0XS7U<90=?J:=%
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M>L >D3EE5X)1/$!V9$>(E132Y17?!-EG_Z'-JZ:=,G[C..X64 H<N7':DOS
M%G:L3]L9S.A@&:6MH?NT%XUE>QC%===/6R,)<=<B&71MJL$P']HOK\=1" 7?
MZ++9'WI7'5J-DBRP>LB,*,0Q'E-B.!94TIVC[Z%CY"?288G=Y??2)NI#"5+'
MQAV+I+LSK]OG=:Z7)8'3U &BF8G:(723 JHU0;X;Y"$&DJ$U\$*)J=>T6CQ6
M;L@32CN"DG4X=N8WF: %#Y #%MA7PH"R:_"Q 3!U@ 5T*M#"8B*"1A>G&X$&
ML%1*&!$&,2!<0+!9J85:C 0 ,B"CCY8&-[#A&J(A]A@H@G)*<<#7.RC8X+TT
M-N)0#]%0#!D5TO^5XT^A#X0 XK7R &,![N+N*N3N[>J^[E1A:Y+P&R2BJR$T
M,1NZWC[1X[3'4:&-V;LDE24$V^)!+[?SQ2^B5PL&0 BD0,*GU-!!Y;<AF4:L
M0 JO*:VM*0A[YK.Q#!K-;S(:NSD:,D$4BZ3(?3US?CE%NS^DB3CT'V]NY]7=
MKW<LN[#HB4QD,E0D+Q$E\%H*3']HK%[5>UW%-715@ 7KSR5TV5TN)0-V%QW3
MO0SX9X?U$.:+:9H@"0A0['72IC' F8)S  B0)%?--X ERWM3O[W9.6_ 2)8$
M  Z@!OJ+.@S!-0"@ HX3'PV1"9\@!HX4!PQQ$:9E)A=.2VNM.039)9P8XH?*
M '/ZPNYIH0^M<NX \ #1\_CG+OF,_W_YC%\L)!)J<;NPP H:AEPNC$A1_W?;
MT2&]:^1>J1W)4XG1N_1MH+VY>$7ZES+(&*,92.HP?PMM#_JAA+@_%PV(L%>Y
M4W(_.,$QA57&'(_G^ '=3@3G_9:N<*QQYKIC#E=]T)]BX!=P,&I#/S5C)+W\
MZZ$T["V-_XDNWM+OH)W4.+^P>24&5828]"0N%:J4.LFP]0!T>"..D6.. *$,
ME"8Q.' <B'$#AQI-RT )U(1#1HP#!M-H:@AJ62A0H91Y!/E1))J+FN!@Q$$1
M!QH ,H#8T10'U$E-=C(5/'"CXH]-,#]INB$CS::9)C?!F=FSYM&:&._ "75R
M8)HTRNHM@_]&C"K69<HF9:*W3^Q8LF7-GD6;5NU:MFW=OH4;5^Y<NG7MWL6;
M5^]>OGW][E-&+).FP<- $5,6C2NT98KW+6L,&5J]:,H:6V:LF''C>HDI+]/'
M5?/GQY45<TT,V;3ERH\G,P8<[?/GQ,HTH=%D]33CU)FY1D:M6'AJT\$OC^[]
MV7?QRK\WGRXN6O)EKI^;*TZ<:5*:-VJ,P%$#![P1[^#% SDO/KQY..C)?T??
M7KQ\\NG9QW=??GUX(VO@U&=//_7F*R^_ 0$L<,#[_O./OO7D^R\\_O:#CT (
MS?MAF&CH<:PQ>K"B3)G'EHD-Q.&P8PZXR4CDRK40T<@D,0Y1 VS_Q.=J0W'&
M$4.C[K'0HM$.#F4V^4@C33S:Q*%B0'G(-C0*&B.-P3;2Z*%,T, !2B$Y2A*4
M)4,A)I2,B!03%*H&BTJ3- QZ(Q, '!!O*3N4P@2A R:I:+TX" OJC:-Z O0D
M.#:)21-0]C0)HSWOP.BVW"8#Y<I,B(E&$TPT^2M333?EM%-//P4U5%%'S:N>
MLS+)) W<E+%,Q&5F],U5WV#ST,/K%H-LQ^EJ4VZ9SSAT%;3C5&.M-EQENS*W
MUE)S$400&?NQ'L: ?4S6JV3;D$3=;"66,\]DY(S6;%?<4+'0)E-,1V-A<[6>
M5--0T+O]X#ABO?CTJY"] .T++XY[Q0N"_U\%#40PPN_4B /"]_8U[^#O#CYP
M0H@AI'#"A@F<6+Y_X_L!,<U^^QA785=C,5C A'65Y,JLXBU59;LJ+;)RM<5V
MY.DR8_8W$H,4"4R0?JYR28U"@:RACXY<)C>/5.O*T"]#XL@AJ+6"%R.D$GUC
M$A404(-1I>! %0< 8OA!DX34F-.F3&Z(X2)!F9*)**GV1 I0F 35Y(<80Q1,
M2E0G)35PP0<GO'###T?<<,OHT>XK5H^C;$;H),=,9IJOE?98R4,<&4=B3ZOV
MY- C>RSS:+;+A.ER69-NMV&A<XZZS6*U,?-JTX4N6,;034[GDT<C/;7>EGEW
MO L++MAX>R.,\/\(Y3,VT#Q_#69X0N<I7/#B!/?U+]_NL5]^8?8@5J->]3(V
M?D Q'B+M65\[C(['$E4>UC?1%1-L$C$TF4S6KIJ;7;=&PYC/1(LUG=G'9%R6
MM"IQY$O+V$34C*2TCB0-,D0C&I,,9:@,(JDC81J2D7SV$#4-!E%QBI0*'("V
MF%Q-$VY8P0%RT*8#< %AB4I## )P !XZ  ?P2LJ@-,&HNM%D3D7!R*HVQ"K"
M$(9287E,XJ0X12I6T8I7Q")?LC*IP<3H?Y;1EF@L$ZUI70='K NC8RIWFF@M
MBT6[DQEQ6/8_86G'BZ%)S65"E+D9R6^,SD+7JQ1CNZYP;C.C^Y&V2M/_KN;4
MZ'^1,XVTKB4BUH5F1/O0Q"1^,*\X "AZ$CN0>CH)OH@!Z'P7>M#"/NFP\2&,
M8M"CWL0L)K#D-4Q"_QF?+1<FH8>EP6.9\PVN#IE'G-DL-A_*EFP\PQMEH$I5
MVV(.YEH#R,S=3("W(E'6. A",H70(4F#VD>(T1%R@JDCEEE:1K[4,R-]<VB$
M :))TK2)*VVM:X:Z6AK"$( <A"<3,< !$&(R$#BL"0<Y,(@,;A >4"CE;H2"
MR9P$)2:8Y" 3G:F,8%!%C"QVU*,?!6E(1?J7:)"EI&)IYB2^DIO$-#)FT3A1
M9%QE,O<-1S3 %&!D=G>M#_'NI=113*IB%#-*_\8T1<\!V?#,E:MB80NCQ=H5
M=<#(&^Q,IRO F>I5062L;V7B#?"BF'UT&:#K*8^6_-$7>N*3/2#$X4'S0A K
MEV=6\DP/#@WB95CC.E9Y0>P]%@N/^<"3, &%YR+V@\RY>,JMF97(5L01H^L
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MD@3(K_S(OZS+D@3-S_R;G01,<-!4P7SM 'VM[!10"#QQ3'G)/,+%!&5>KQC
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M*&;+!%_-V"W'YJVC^.2:H EJA*P/EBS,D)]"QH7,QFKU!(K7R6TD.N/1F:[
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M1^*YIH,<]VF8:*3=)@$4!C%J.O'Y7*HGG:\?&].C4 (!#N   B  EK+_ ]$
M!PX  "A3!GY@1)3C9?9A%P  !U0@ .! +55SCJ!!-.K&(@.M\ZZMS\32?T",
MML!R<!9L-7E3+&"M643Q(+*.'3N'I@AI=4@')&"Q, H)6@@"90[I.9>#@GHS
M?EA$$G"@-#^S+1P@ '(@#K0C#33S $ 1)1H 3>(#)7# )I*!"@0@$ZB@(:MS
M/EE*)Q:.([5M?VZ+\V)3/S/2*Z.JVPZ-/H,J,6U#&7@#KX"/K0##NO+2<\;G
M%0\E.N3B,[_J/2Q49=!@#'  HMB.0-U&$B8S!T;B#<3@!@)@(8H #0Y !DC4
MR'  #3[S!SZ3[_1A$0 @!S A/N\ 1'VT;>J!RX?2A0FO2<,J3Q&/T"(7,3]?
MXXT8\T?E)WL,%#2P<,;^11[5#&,>*0S!L ^]4*X(8C[N"'+X(EH69"=;#TI]
MA7'$X !BH,TR,P!2Y@8.  <8)3^(\@V H"UP0!D4$@'00!).\RK5M%"U9?O^
MIZC:R/+*B ACJYK"C3_YTS0&U%"1,4'$!Y,V\ R-S0B,ZWPJ(F1HS/8HI3EB
M34[JHFI*TE+51A\F82F!X#OBX U^( P"  CV- ;(4R!$[0UNH %\8#DR00LL
M4T%.<Q-8_S59?87+\"8)]9,VL4WSPNW_T,C##&8WE16,TK0V'(<[5O&*E).#
MTN/WU /4+")/3(2G,"4FE$\K>L3ELA5;YDTL.,L@CL!$430Q?$ %$" ^-B(Q
M;@ '@@4EPD %'D 3]&Y0XW5AKS#"Q,*\7#,2;Y.,RO)1-<]1I7%[=I)AO6A;
M/8-V"D\OR[$OO?6YMFY1;JHZ/I N?,1@MD(U&C-[/)9C<0-F,B$^),@T$0 (
MC" - $ &=$!K3$0,8C0-]C0-8"  ,"4:AB$^4U,L#"=M=I!FJ?8R,L>AEF@L
MK\DKH]4:ES#H<F[0Z*9J84ZL; T-C&PA1.U/YI+JS#'@SE"\^O^I<QX%#@AO
M[.*F0_:#;-4FRW@L#&(@1Q5"# #  ?K-1(A21]+@!G*T*>@A&126;R57YM#+
M83WJ[=  ;_;,SY@T_QX5C9ZJPS067B>7P48L9]XJTS@B'L_100<.)S7HN2JF
MW1+C#2BA+3#!4V:V=(7$5&9L+ACW5A40#0) !DP6<G! ##[3"-! !01 H89B
M'N)S$Z:4=R?7<+:O76R.>\2 2BB,C* D?"W6J:HQ(SUL;[#5>LU-&<3Q6S<B
MGTH(4-X,W]*1A,#P45!U+UZF>M572!"DK-* ,G?5;@G7</'H#1(7/A@7%-<5
M<@.@1Q>G?R68M42#-"2M*)9D2:Q-;VK_,THX+R-%UTAO<^@F6 K-SLT:B,CH
MB=-.I\< XS<NIB71*24P58-WMX1!P_1R91+2+ ?HM$Z!("*(%P&"5CT0& >"
MM7G[E;26H3T#( Y8*'N>%(?5U"7BIC6V#W"\!8N[*0"!#A)A*S<;4=MRB-RH
M.-I$XX+XT"5#QZ8Z1SV,"Y)V;QS;K63P[HR[1+-$Q$30 $41( <,@R(6-P9(
M5!;;0E=!D7&K<I$9N2H3P-GPF&8Q>#1(D!@^(6\WN!F;L(MQR_(D438#T$DC
MV<ZHAOU4<2\++E1K$OUBI&%X R66Y T:86-'>4O,CRY0U %R(#A/ D5)-.N(
MB4YW69$;N9$?_SDLOK&66;4KT."A""=3;LC^\N?_&-&#.5?G/)<V=5.9$XU%
M*.T"'R)0>"F%)<(\,J)1X.U,Y(012)>;@R3*QF S_WA:!$,\8^ R228- H \
M9ZQ&/[-Y \ !TH!_W9D^,\<HKG%N9#.JK+FA)U%K+_*:I20M"]K!_I<\G"OJ
M.N;?G@LOWQ@B2D82\N/M4H2@*YHS:&@94,('8B  8L!"?Q&!)S,]Q?, ' "Y
MC)96X>,H 1H.Y.VDE54O],Q9G62-^F_0JOF3&W4V.=(1I2I]@=JJSF89D&R5
M;;"0M"L=3^[&+.(^8JA[!3&JB<0TQ$ 2%#D $""M9: !9."/2\2>$17@!B03
M ?!Y()0RIWCZ-./ G,;B#L7_FD"WCXTXF)/_3W3!]N;XK*'7B*+_.K4XY8*^
M=$O=L;N@"T;^N5.4T25NN+$G@YR684%:FB$9LC))6Y<MI:8KLTYSC*;2( <<
MP %^@&?38"%#H0<YNU GV66::HV@2@F?=3_-4IJ<<).O*::T][:%*GO^=Y+F
M*E2I@\W0T:.?,\FX!ZJ1VS:R!];0X VX9S[(-!2OKBT2(T^B8U(^HBT.\[I]
ME*1+8PF9\$F6FGR56H3!6)._F 35.ZB6*TY$5KH+952_;A;Q5U(F 1/:.;\W
M0X]Q1TR/HR0@,&6-$YVT)DR[0JPV&\$?SUZ^!933!8?VDU$3NRNU^38]=R6F
M&,/G_P=FNJ*L].C'ZH.#9"2%4*)&D:,HQ( M49PVRJS1-B6TE 7?<% >*\5.
MVH(T'A/\<APK2XMODGI>.,P:AYN#.4\:;5.3[^>-M#')E6GN(!L[C OX1 8#
M__(PPD6 RL*DM3PO.&55-@7%J.Y&QGR?_A(_T#S-XP_"OF5XC&* PB7S//A(
M+;8(P792%1LD[7R9;"UK3%D,T:-\3"@]6 Y%=&(KNNBRDOG0T^*=8LPNF#8!
MH^,O#XIR"*XZ4$++S.+",1W12N6-HOE=!"BEJES0^U/0J#6B/9BQ4]V65-IH
MPX2NS!68#V5&2@1W!F@2ZCS7R<*TMHP8ZD%$TFR?<#;@F/]3J\%FP6;CQ)$=
M*,G"Y7:-ARIXSY>1SZB<RGE[:YW:V\9V;:Z'<>00Q[.]KUVL73AIKBYBR.@2
M3_R)E\(T#<2@PM_=,UCD3;H5QWB/A8.=.@"CW> R5XKB@-;DTO\=M6#JP!V#
M;@!H6AM:A(^JR>\O= <'%^<'V[7<-#+A1;CF9.FI Z.SS:!E02 ^XB]CCS.0
MQM+P?K7Z)-+@G9I"$E 0YNDLRS,CL'.NDX,N +U8N*NU4>_"Y^G(;\2N(][W
M@0*#7*'^3TA=TIE>,S*KY#,!S@&NO ]W2__0C[K(*U ]ZY4)?Z8M<)3:"(VT
MOL>W8LLW-;!\?LX>P7WW;:UH06<>WD]@V;K1?C+L92\J;>53F$;6##P&92ZX
MCT7.QHD"_S_1,.ZU:@@U<&@C;6NV= +;IC4LXWY?CCOR+8NU7,10L%2@\!*Z
MVX(@$TX,SN;8__V8FB(_3DW4Q?!S%M1U^NCE19_!K 01'2-+<N;W<>OB=<MN
M+HS<95T)B111>Q^!?->2O#Z@^'):M,I4T>#Y;RGUPA7(OM#3 LXA3#1++DOD
MM1^,#":#\Q;PHZJ% .=NS!>;AYY),6_G:C/=^U:S^'$? S]\  (.$#AJC, A
M>% -0B,%$<(Q""0.PS=ITJ"I>%',)&7[.NKK"#*DR)$D2YH\B3*ERI4L6[I\
M"3.F3),?1VI*\Z:APH4[=1KLF3"H08<$T6B"-C.ITJ5,FSI]"O\UJM2I))75
MXYAITB0TRI"2)*9U4J9,5KN655;V*C2T9=?66VOV;5JT5Z^RM4L7KEQE8SE2
MG8J6V-_!A L;/CQ2V;(T.Q$.9&C0R)J@ @G^3)CFQYB+6M&0!5D/L>C1I$M+
MC7;3H<Z$/R];KER9H<.! ]-HLFHZM^[=O'OOSB2F;TF^:-"($<.V;5V]:=W2
M/=L6+32US:U.O^N<6";!OE&&CD8OL-_NY,N;3[F,(E'*.Q_O-+AF:!HX&,5F
ME:3IO/[]_%\N4Y9&:SRQ]U!\J@VE$$0'#41?)OGU!V&$$D[(E%LF*2,6,<]9
M%YUR<6VX3U[/V5676="]16)7VF7B57__T>RCG29C98(&,=-1B&..3MTTD$(]
M*BC;@ PB-%^1%J417$@UZ<ADDU1]5,]\/3[4$Y! P6'@@%?29UM-XSD)9IAB
M(A8:2642PU5R'&VXW%DD,K=FFQR.V!5>;"JC'7<1YJD8GGP].&:@8.I3STU7
M!OE>@HT5E.""5*9!8R8@O2AHI99V1$]'+Q(*4B9JO$$9@XM2J>!K[\6FQA&?
M0IK),I>^"FNL,F&X'5LAGG4KFVXY)Y>=MCYWZW76H5@G7&.5V9U?XX7G8#3*
M1//68I+(2JU^J%6$:JBF.JJ::A1I(LDDH%5+KI,U&6K9?*_)ANA!L"EZH+OT
M(5=NO?8&&MIT^C1J*"Q>=N7:;W)PAHABBG2>R.:*R8:$%DC+U KM,M L$^.]
M%I-63R;J4OG:D -V3"J1DF@LZ4=+7HRR?O3<E%/+5S((V8%QM,>M0FI\.L:7
M*>_,,WE\:>?FK\[%F1RQ)0;<<-)[!?MF6RLBVQTT0'=*%CTO+J./C)+VS#54
M #*F1ASN[C398Y-MVRV78H7;==N^W51110U%=J6BKC$HZFL'X="PVW[__1>M
MTJE58M >,@=GKVK>Q3CA1:.U78N^9=P(&L@JH\DDMSV[S$8Z PYZ2M!HHIY
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M(>2LL0SC* _3!*#V8;6Y[J:3GOJA3^)UMM41A"(S%:WX+K)2^YGR;AR3S92
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73,,2-6S#-XS#.:S#.\S#/>S#H!L0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>dva-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:dva="http://www.davita.com/20201231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dva-20201231.xsd" xlink:type="simple"/>
    <context id="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i455090d9ae6c4bde8821c7170863d88e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1de112d305e94047b9078f3339c24026_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i808f8139875c457e969c8ed421c88028_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7411005e6a69450f90e334cbe2a78126_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3fac62eb6d9e438d9cffedfad9480206_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i84f9f0f6c1854cc2b831462ed14ee61e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iea92518235484ea8bf5f60c37164f758_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i339c0adb944141beb35f1f190097beba_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7aed65b31414464481f45589046dd452_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iee29f3075d90411e97da80cfb155be40_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i821341ce571140c0813c92a7b329684f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ic7a7ef37ab494bd3867be9a034c8ae17_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i036278cf7d8347788f7fcdf25acbf8b5_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i9adcf1b689594ff49c7827e7c45a99ba_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i11909335cca546ad85c586bcfb13dce1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="id6e22f6f3f724a35bed885f82b31bb8a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i4d06c26940f24e1fbe98edcd4bba0d49_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i0b135446f5334d709fef3456c13e371b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ie32a7f3467e74c40b5ee59a7db8b3af9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6a10dd7b6f72489798f395a4ba7d5774_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i2999225279c547bb86d45264eed0b5a9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if64308cbce6e4abe90bdf552304e7cbe_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5b5d1183ea1e473eaec3e4b8f2b2518b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i66313af05c484394a3714b810b898338_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie5b8c698b4f44d7b880f261b5acd9515_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7ade1676d7ef4cda9e4d3f1b875b9feb_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibc34c3096bcb4003b347988f2fb970ad_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iaa5780e8d82a48b59708a1ff1276a66c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3387e99cd35649b49ab4860ac21de1b2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic9d247586e6c4138a61320064b0c31f7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib825ca1aa06a4e079d3c844ba6177f19_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if4c874d135ae405b86b7b38ebcf9f62c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iecd4fd2059754cc49cb4f8aac8c883f1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i25f880539ba04aa6bf3a2d7cf33b0b29_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ice9f2467e9a64adeaff985f8e4c19438_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6e915932320b4ae6acd3fbb11411779a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib5bb9dfef3744514a0f063432ab36168_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i84b966e5887040ab818abe14226ea392_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5495b245d279498ba671db088b9cd741_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a96a317245446879f226ad58e296daa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id00ebe3d20f44469990e8c005164fa4a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i12d1c51a49e14e6280972be024b74db0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d5e9b53ace74efe9eed270c48169e97_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i42fa656b3e574210b01ef1b7211cc59f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ce9502863624611b7b5cfc59cc39ee9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1759c41f6f1649ea99256fdf926d649e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if90c222c41994c9798b61036606e41ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i15c39adcdfcd42309a9115c0d0fdcc55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie0e12f9281dc4d0f9e7d785149a69a88_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55b232edb6214093a0c5d7e31595d14d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i47223b014646447aac32d557643104a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3fc62187afaa4e38b48175be5f574c2c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a37cb5f5593422481356f9dc98a3f3b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94bfac29df0345ed80042412796b3ada_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib27b1a608e9d425fb9716950917809df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe1d0c26345f4dd988fa30758fc01afe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6922cd861e2a48a59394b6ef51aaff96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3fd3e2a7d3d4e1a85627c011b215e0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i392918f6cd454f4482fe89cf50ebc86f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54db2eb8f1ec40a89ceed1e1d8b4f241_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2dc41b2293ce4a6a80887886af6405df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4902d542b6e047d884a728d3dcf0e573_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1bbb20c229b4a6d8445cfaf1ad7307a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05384b4fdc8c489886da60a656894693_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i317edbea3c674863a4195c7cc9cb635b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaf248d771016450592bc55285a8f1c42_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73a5d338ecdd42329c520f41a32fe9c4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i80c5922bf87c4c29a6121290f1760795_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ae27697d58642a8a39741ac5b46b72d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1f7687b20c34347a978c801bcbfd456_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ide1f2f90b0234c6386c95ee837e0334b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb582b032e9d46908fb473a5d0de200f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie70348b0c0a94bb5b0ed3de0b4debc07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id59d792b2bf74f6e9847d2fd9f3bbca7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50ab540b60374ad4aad5a23a7bf8dddd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i867730cbcf0748fcb37173e698317b23_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44562b75ffb5414b8b4eb109b9499d54_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i254282fb16c34ab2945f3c18a75f8323_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4206fb8a521a438eadb170f4aaec89d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0914af09be91438c9bdd1e22b951a0df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41625250859e40bda54bf40e92bd1151_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i635c2eebb9e64938a68735ae6c593657_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a6ed05dcee04d00b0acebc6f9646492_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibfbe0a9a2b6e487387fc940140536289_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9039b41e698646108961d8438f298065_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i29a5025fe7d546f59cb2d4b2ffb19b92_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic73e85c3fcad4252b56e5ca71804381f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i68577d74812348348e7271f689002b75_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i10176a49705641908ef22710eb3ceb0f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i90161d3cc08b4d05b4c9a4bc96f77638_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iafc956536376499ca4f18116e1a28156_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifd1d128a80ca4c31ab1a4b08899c3bee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i331cb12a3bc84e9dbd3524df3c61c1e5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9225d7ed664b4437a955e3239e2d4672_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1ad6e19bfd204637ac41e31412365fde_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i57e64e40c6c949a4a0c172e586effb9e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icbdb192b5cd84c0aa25e94fee7bff238_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i164e3c5e63494e49a4973e32ed991ff5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia940e3b4e9754716a7d35abf7b1359f0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2f9b9ab0e8584df69e653fc61911e0cc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icaf2fdbccba5422e8e3b2a15008e502e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i14af6fc05fe24609a9ef1d172b06d3ed_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8bfe5b640ee64eca89b909864373b865_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i799a2b20a00e45e0b3f08db269fa3736_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i39bda8f256e44c4884a542b1ea607df5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6c528d2849c2446c8b9fb3e906e29ece_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibc14ea5b25b54be1945bb52726f391c6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i74881d974a934edab7eb395774d2e72a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie830c422acbf447b830d5ba05d456555_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie092dc1a9f334a2d8959b7937c63b6da_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id0e35707e465473fb9d209c48d673e9c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0b2c11e9409a4ebfb1af5af31c5eec06_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib57b9bde3eb844b8825af8894f08bd19_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i47790222420f478db2f7ad17705accb2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i21697e32a0ec4bf1904f2fc73b9dbbad_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if961d3964d254d87be469310f7624b7c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i72f27d9ed3464afea1d79fe17c36cc36_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3a04f4ad256b450eb154971edb661d29_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i10d8743c3594411698541aa578ec2aff_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i33a90a56c3c54abe92e41788859d9e6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59029b4957e44e428f8a80a0cb5a4790_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie0da31cd8a6a4e4a97290ebfc52869b0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib87a97e373bd46c89dac120c212a644a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibabc1893044f4e66a6479c0d43899227_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i884b650f6da14ccebfbdcc5a5e3c9c2a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i444084475ebc4fe2ad288f8829a0542f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0827e76d53914466af9eff1dc6c5d343_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8497a3de1675439ca2a3f1871e38384e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">dva:PatientServicesCustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0d4d7d40de954bc4a8f5ba7ec06c8900_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if18749a859234cf7b23652f60c460caf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ab2d52784864cf6ac6e10794af391d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf901af366f34dbaa56ecfe998516c0a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb978d08cfeb4642bd53e53555d6f21e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iccf23c460b304d34975ca6b21fa9b648_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8314d71719804d359b9983c38b6897ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6369add7b9a341bbb8a486c2b65be42f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica2929163ca34ad6b905be96f45d01d4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e82366908fc411981946281d867f868_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51c7cd9eeaa64c0a91528e12f2172af6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a2be35772674635818cdd631d499246_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3f29353214f44b529f3e84fdb2acc7f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39149e895b2b4e0593f509dcaf83e78f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50b4634b59f749b0b5c6631027941142_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i33a1bfddc39c4a169c47e840741f335c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied88af0a7c524bc3999fdbfa994108b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3063267a01f94e3fb4a375c1970717cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b89299a9bfd462b8e5b3a7023ed6334_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i51925e49d034403085e491018c02d26d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">naics:ZZ446110</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie087c1d3f9974f219511b176db8eda1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie16ddbc3f61d4fdd876789fdb7485e3f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaaaf284806a9483fb5c0391481bc7d0d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84b74ed9100c4ce592923a9de27931be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e26a206867842e28cae11fb48c778d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie28a01afc63f4186886299ee6dea4de7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if835180905f04b80823ceda1bcf614db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaa907c146d64b698d6ea801e89b4f89_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ida6bf19e541046eb93c237e38a4905bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1023bb732b9148d293570ccb2f49efc1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic6f1bc577e6248d9aea0e2a4190a616a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8edd1564071a44ce9689f85e2562bf1d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieee6b2ebaa1a4e44884eb99babde1e22_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee2cd9df79914869b9cacc76ab090369_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i176abd0dfd064576a6fca693618a4d85_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i743f6eba826d4df9965c6fe5e996c814_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff2c6d1977b942e7a9758284e817d55c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib7a1644379314e62bdaab27a9dfd42f2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iadefb36dac0a43168cf91c594bc2b46d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8d3af328249451ea7b48056f3f531e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5952bbd67214b9a90b15f0edf9153a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5831886c34dd408a8ed406190748f295_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic54da9f2132a4f749e030ac9e3e0c618_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if638379c314e4e40a080f1df9bc6d4eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5c4935b96bc45d599d29d673dc708b8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic3604fec36844df58062ea76e02219c2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic2f082dee6464c25915568ecfd2d5672_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2bf9f1c0751e45cb82db545fe4859306_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i910ed57bdfbe40edaf7a7ec74018eace_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id62f30525c6a45a4b19b99409e8b6a62_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia93e30cc7514476e83496bdfc4e18ffb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if485fd70c4f140e5a792e18f8695f7b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idec8d246ff474a11befdb8bf8dc561ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ed3cefb5e264fc19465d2168eeb14b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3faf499aa9a748f1954b1f5b2998f2f7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">dva:TaxYear2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46cc1be6f24843f99366871f9141b719_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7242eb9d60a04733a2c41990205ffce0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48f1c17b32af4699bc7a441a7ef30448_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i286706e9b0964d8cbb75adb2d5340592_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i250b8e686fbb4a0eb1114ccbc4b5e9c3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i52324c1dc24d4d8b859c1369fb83eb5d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dcd17ac6da84bfca13be11407dd097e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if381450d87824e869bf60a18db4c6586_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a345c6e30c94176b6d3453a7fbf6e28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i70dcb1ea14854f37b5aeb6d646b2e0f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14df805acc674d20a7c5aa1dba69bf55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10592b24a7d94ae2bbaa1ef42f4ed1a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f85fe5578d64f21b789dbb1d9ab19ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic5b049dd4b914f4ea5123c565a84fdeb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a809ec49865440ca9f74653e3e59525_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7394d13923fd428d9c2578d297562554_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f4adb73272a42f5b8ce1b57a5c7617c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iefe49a72ad734e399a94074a044ba38e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i37d9e5736a9a43eea92eece9c7a70156_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f563c4e28454aeb9d6c1ab26ac542f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c63e5480b1f427bae9d35c3d385319a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i513c7b56b1594745a1ebb8321dbbfc57_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7040636942049efaf5dd11457035dfc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4bef0b2f7a346219d36e58e1f35f48d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacef66fccbd84dedacbd5a8f1b5e7b10_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9aa636c18275409199f124f364f5e504_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie18932cd78584f0cb719262f3f8eab08_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6706bd8a691e4f01b5d9b858653eb878_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic69633efe6f54a5fa84fd43f264fe79d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i856ad81a7b084214953762fad3fc3894_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a4f6b88319747d09864ee3399753c01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie06b84976de74f0aa4c9de71c05d9548_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94c16909492241318308c8c001933088_D20210106-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ida75c1b36c22493e8c7e9267cf54a7aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8033f3e1736c4c5b95b3f8eefbe1406a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbb4bf191ef14070a5362746d88603e0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34f522b31ed94ee9a22ac5be8888a7a7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i045e4836b7c044119912cf78d7ff47a9_D20200213-20200213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-13</startDate>
            <endDate>2020-02-13</endDate>
        </period>
    </context>
    <context id="i7314edaaf4ba4f878c3576d48795f7e4_D20200213-20200213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-13</startDate>
            <endDate>2020-02-13</endDate>
        </period>
    </context>
    <context id="i7e335188f31c48569623a8cbca6e9598_I20200213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-13</instant>
        </period>
    </context>
    <context id="ic72d397e0f3e4b2891c3e57dbe084568_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i36e1759fea1d4fe6be3ee89fad61189a_I20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-09</instant>
        </period>
    </context>
    <context id="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-09</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="i60afbcc7ed1f4c10bc730c4a41fd1553_I20200715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-15</instant>
        </period>
    </context>
    <context id="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-15</startDate>
            <endDate>2020-07-15</endDate>
        </period>
    </context>
    <context id="i4577c6d1bfd84e039d738058c80d0d6f_I20200811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-11</instant>
        </period>
    </context>
    <context id="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-11</startDate>
            <endDate>2020-08-11</endDate>
        </period>
    </context>
    <context id="i8c9ee24fbe9340239ddc070e034d80e0_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-08-21</endDate>
        </period>
    </context>
    <context id="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e8da420e4fe43e3abe44f58b0f0c849_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ad2e96f61d94f8eaade51037ef306a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ed9f709bc0e4ef09c4f9e055ef04e86_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f29329fa0a24761880b3da66bfea3f0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifff59c8376d84505bcb4b4231e5bd78f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff41e1baf8154d9d8e160378c8afe9a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19164efdfc254d9a849e3b6592273062_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife085c5fc53a464ba6234e3b54b5902b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7a62382e0e04fc6a6d5db83d4b94e8d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie19cd8d5f7704699a59ba60718cf6759_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib88f0f66836c4e39b167ed6b9e1eab25_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2015InterestRateCapAgreementsEffectiveJune292018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2b4253a297c545feae0bc83b8afdfbac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4a73b09375643e2b9ad54bdb2776bab_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic4f6eb4a12be4460b4491ec67bbeb914_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iaadc39011cd34e719eb41ca937a418b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iddf49515840e487e8f2fffe6cb4b0d22_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iacb973ffc2bf49c1b23aebcc238a4c6c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3e3ddb19c4b4f45ab14958866d7c43d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e7008e4c2d54ce6862f4b7e5e90c295_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i96fe2a0d86c443a28c19325250d8c04e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia424f1cb12ad4530b4ccca1a7530e070_I20190812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-12</instant>
        </period>
    </context>
    <context id="i42f14d1dd6ac4677890feb6e64809282_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a37e07755da4c969e25d18ca6f25243_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62132ed6d58b423cba1f3c99ca102a0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic824c560585f40d3a9cd728889fd74f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ef674119c2b4d74aa417195d2c6c430_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41cd8e78e8344b3ebb08e9406b65619d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3f16999941ed40e69576042281e8c119_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia31bf166ca5d4a4da3dc6b7a74d31624_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21a3c92cde084cf8b5352300822f8a32_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2b6750de267f4090baf50a854a1011e0_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i65d88e830460478cba6dc77e5492cad1_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i9df1ffed4d1a4507989270b5f5b4cad0_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i48eb570e320e4ce9a013b7d5c8f0f816_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if29e4c04bf37468ebe8740252e6f04c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4528caebac5945689bef0ffaf6291d30_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i09a03f944078404d9b7042cd462b1e45_I20200611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-11</instant>
        </period>
    </context>
    <context id="ic29f0bcf68804559a9cb68580986a3d1_I20200611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-11</instant>
        </period>
    </context>
    <context id="i56347587ed084168beda32c60aeec406_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i40641a42352446a9899eac8cf4b67998_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iefce2246983a490cbf7573fdfb4284f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec9363113cab4f59bd24f4201b13c82a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50aab727700a46ef9be399f0944d2e80_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ecc951facbe48a0a302ba1044295757_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia83bbff9dda64502a7fbedbbc8a8a4d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6b7c8b669444401a9a4b4002e230983_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i26848a1a0f5d41bb9f8750c93c848335_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ccc591606cc4e39942d003b9bd1727c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60a53b9f954142e297133141bab808dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2584bc113b24dca93703a2c83984853_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c8fd716e0254f41a042164ecba35111_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7a79748b304b4708bba0c7e5287e2026_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4e22cdd25e2e4d95989b353987e285c8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i24385aeb87a94f68874b67e43b0ac293_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i93d09393df004ac29505b1eca4c5d9f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i398441769aa34ea5b548ab2875ab7937_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib34487485c5647c193bb709cf8e7c4cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockOptionProgramAndStockAppreciationRightProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockOptionProgramAndStockAppreciationRightProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockOptionProgramAndStockAppreciationRightProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-04</startDate>
            <endDate>2019-11-04</endDate>
        </period>
    </context>
    <context id="icebe77b40956462b9ff854742673e44a_I20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-04</instant>
        </period>
    </context>
    <context id="i3eb4d386a219415092cadf2a89fb4b27_D20191104-20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-04</startDate>
            <endDate>2019-11-04</endDate>
        </period>
    </context>
    <context id="ib5d81d4cfd9b4d3a90277b4e0ba77a2f_D20191104-20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-04</startDate>
            <endDate>2019-11-04</endDate>
        </period>
    </context>
    <context id="i24e9613618454126afe7f679892ff495_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ide5fa201da08419d8480005b0941c2ef_D20200101-20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="i13cf2d394c7d46048c99aed94e7a3468_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i428a7bb3ffa14fe5895e9f5a7c269bed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f3ec9369a584177b5460514179d0117_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5b178e933b3b47e2ac8bbe854a99a0bb_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7def829c92e542139bac66fe336262de_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia4ea773d13594e1e9feb21e2fab910b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i08f4222a3b2941c78d4c11684f04bb29_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i127cf2093ba342448f4db553c0454a5d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifd91e8a803cd4443a8f9187ba2180bb8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5225de491d414cc396c96583c06b3790_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4869c0e869c345499d845df4d1726074_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibbd08d038cf54271ba04c5bae7ea2247_D20200701-20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib743729442954729b874209aa3b7ad4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-02</startDate>
            <endDate>2021-02-10</endDate>
        </period>
    </context>
    <context id="i76ba37986e6d4a12be3157c80c387fc9_I20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2019-11-04</instant>
        </period>
    </context>
    <context id="i105b8a0db46c4b329658833071e7f412_I20201210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-12-10</instant>
        </period>
    </context>
    <context id="i7083b873e21941ca8755a4ceb7aeeac8_I20210210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-10</instant>
        </period>
    </context>
    <context id="ib85e3af4c76943dfb45faef356b1edb8_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia09cc0ebe548468cb11bfb4a15f51203_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6e4cffaa726b44c38a7415a3a0c9e4a9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i2aee781d32fe49c2bb5de5584a9e35d2_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="id982bc2b303943b3a1f13e6fa0132c37_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="id91bd7812fa548a7aeaa626e95f390fa_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i0dc3a6ff6bb04c1e93904bc9ac788525_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="if2676db50d104876ba6149c180d0549c_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1d0662ace310459d8294892cb68ab800_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id3eda312133844699a6a4a94669d3aa9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3c7b5073da4b446ea0318c702a7868ed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i16e862399f5a48ab8399e8f0cdb32c64_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i400ae66383684fca86f44ab51c352938_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie318599ad486430586f67152fedcd6e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8c60b527bad44f338d70eaf4c922c693_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4353b1da6dea495987a98903f6f24d81_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifa528156b4734e65b6f4086215f035cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41c844e403784223aaf6cd1848e6ab04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i121893f4c40449a89e600dbe09cccfb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f863d3dd90b4b01b6b02423feddcd8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa2af9b4b56d4ea9bd2ee38a1c474653_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i211344fc537744f5a1e5ca5d7a509101_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34eb33d6da174197975f748888e130fa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib5bdaf5b8e324f16af4b2af8e8b5cea5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife8b48f4488041a98b5163ddacda7b3d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i42771298d95c4449aba8f0b634283f8a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibbedb04193324daca88f65acd841b435_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ffcc4ae070e4183aea32935e65560e6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9fe2c2378655447c9ff1bb02277688af_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i19715ea7c0d44a94b2cc8fb506d311dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a352df164304776a46c85b682e9ab80_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i13fc6ded13df4a0880a140b68e18899f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8030b65740034eaa9eae02d95f2133a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if04951c8b4f5456da29bb184a415e56e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id643d82f1c0c49a58e67abb271a5f89b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i61c7d20749714b578bd03a14636c3b75_D20200501-20200501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:RMSLifelineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-01</endDate>
        </period>
    </context>
    <context id="ifd580bc9f0ce4f48a42dcff947bb8c76_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if69af729580f4423a3ac3716ba3c2db6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i786a553c52f743c5b1b4a38214be1b9b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e92165fc1424a7ba5419b7bb4e85b10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i707d83d1d9eb45bbaa369393203a03a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab59816d75634fd58eaaa890c090532b_D20190619-20190619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-19</startDate>
            <endDate>2019-06-19</endDate>
        </period>
    </context>
    <context id="ia2343e73177c4a59a625d97fd537e0a2_D20171205-20171205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-05</startDate>
            <endDate>2017-12-05</endDate>
        </period>
    </context>
    <context id="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9577f3ef1df845c38e9359052401de77_D20190619-20190619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-06-19</startDate>
            <endDate>2019-06-19</endDate>
        </period>
    </context>
    <context id="if4ad841931d5470f881644ba3f00c2c2_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id64a66f74d0f4ecba8a1a1be356f290d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dva:CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45a0c036d197423599d73e88e5341015_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DMGAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-18</endDate>
        </period>
    </context>
    <context id="id4eac1171b5341d8b967522bcb813373_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DMGAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i65a17e126ac34461a4fca6925ed519bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36352b7df66948dba0eacf04441040eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i692b9792fba94d658bf1614514353578_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8204d20559346598ff50ef21663702d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic360e4e817a54ccbb56e6288ed0b1685_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie862d7ef0c1343e2a506a5ff72228d56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iebd4732a8e3d41d984f5f16deb38d1b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i757c9663b761453cad7e8ec5f01cb559_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i045ff3fd899a407682817e4edb66922f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68711243663d45cd9878789705596fad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0b5178b3f27148099f8931545f27730d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d92344999cf4f04aef6369cc712a589_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia8733faebf4f497296ada527a7cd8acd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3feefe9b7e3f4d1e8e1438498a7ed0e0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i250b1181003d40a3ab8cd67db23630ae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ied7ace566871432e8e4240927f2bf074_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c3be00a520d4ae2958de6ed78743b3f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5de5994570ca4c2d88f909bc24fd0c06_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0baec8c73f084f299738f9079b65dd67_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0420ed82e7024d998b6589e8747f9f7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idd8fa94d190c4eed9526f7bfc49e982b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5e6be2ddd91d4f4088ed90946f8137ab_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee1168a88cd84c8194c82fee58056484_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i338ebbb235e94664b8762945904b8e65_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0d0245cc46dc4065a8942a8b290f03b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i250b62935f564b88b9b115cc2724bca5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i15645add5fe64f3da803a62328e47752_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7d063b2501144da199dc74e77efdc1c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50bc107b4f0a4837842f4727bce2675b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i326bc266ccc04e9085736f4e63bfcd54_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i60ede493ecc1446dacb46d6cfbf3cac9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5953439c8d14af49838fde6e6488453_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6163ef4be0a465f90685726ac832a2b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if3d2a102026c4112b723366408486f2d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifa612087266445208d57b0d501856183_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="if32f22662e54432da57bda5635cea91f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic1b594af4c5946d799a66354ffb0bb8e_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iaa4aa6d5d9f647368ce987a4ceb5e733_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:RMSLifelineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i640e3c80e07c4131ab855012b2ae413d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6d5a13855d6745d88e71a8dbda06352e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib323764e090d434bbb21570c9e96b6b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ffbc38c3d5d4d4fad2bd3d8db1d28bd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iea338e77f4034e17a9b6e514cff7d6d3_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i40704e0cd419424eaece0c344ca47892_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="clinic">
        <measure>dva:clinic</measure>
    </unit>
    <unit id="state">
        <measure>dva:state</measure>
    </unit>
    <unit id="patient">
        <measure>dva:patient</measure>
    </unit>
    <unit id="country">
        <measure>dva:country</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="entity">
        <measure>dva:entity</measure>
    </unit>
    <unit id="segment">
        <measure>dva:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl8yLTEtMS0xLTA_72dd95eb-2ac2-4ecc-a7bc-8e09e1be563d">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl8zLTEtMS0xLTA_c52b91be-3f3b-4a54-8274-50cb4f278a13">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl80LTEtMS0xLTA_4ab362bc-2efa-4b9b-902d-cfc442774a19">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl80L2ZyYWc6ZDE3OWE3N2NiMmNmNDcyYTgxYWM5YWU5MjhmMzc1ZGUvdGFibGU6NDFjYjVkMjQ1Njc3NGE3OTkxZDE3OWIwOGZmMGMxYWYvdGFibGVyYW5nZTo0MWNiNWQyNDU2Nzc0YTc5OTFkMTc5YjA4ZmYwYzFhZl81LTEtMS0xLTA_424921f3-c8c0-4151-b771-c3f7622d7403">0000927066</dei:EntityCentralIndexKey>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzItMS0xLTEtMA_e50a0205-c338-4f55-a4ec-d11fc849e665"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzItMi0xLTEtMA_74a0261a-897b-49a0-ac0e-bb5587951820"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzMtMS0xLTEtMA_1ecd2763-dccb-4023-afbe-4604992a49aa"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzMtMi0xLTEtMA_f2ebf2a9-0589-4eb5-9ae3-1c0a3f767f89"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzQtMS0xLTEtMA_f3ff6b6d-2c19-47dd-a0f7-040fae50a277"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzQtMi0xLTEtMA_47618c40-92c2-4a6f-b780-0225a500fc8b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzUtMS0xLTEtMA_5d4374f6-c3da-40cf-9cc7-cd71dada6476"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzUtMi0xLTEtMA_62f0c6ff-ab85-4b08-8ade-f61b13a995d4"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzYtMS0xLTEtMA_83508764-974e-4d2a-9281-056fcf7a0c9c"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzYtMi0xLTEtMA_a8ee7a56-f658-404c-b3df-b2764771e255"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzctMS0xLTEtMA_f9ac3b11-daa3-4aae-9c8f-726e8aee76c6"
      unitRef="shares">109933000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzctMi0xLTEtMA_2fa68549-ae15-4097-bcaa-25f1e1309cb7"
      unitRef="shares">125843000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzgtMS0xLTEtMA_a8f70893-4fca-4182-ba19-db3156751702"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODEvZnJhZzpkMmM1MGYzODFlZDU0YjRiYTg5OGIyMDE2NDk1MmRlMy90YWJsZToxYjQ5MTJhY2VjOWQ0MTEzYWZlMmM1MDQzMTMxMmEzNC90YWJsZXJhbmdlOjFiNDkxMmFjZWM5ZDQxMTNhZmUyYzUwNDMxMzEyYTM0XzgtMi0xLTEtMA_c230f8f6-d776-468c-bf5b-d357643d57ac"
      unitRef="shares">125843000</us-gaap:CommonStockSharesOutstanding>
    <dva:NumberOfConcentrationRiskCustomers
      contextRef="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzI4MDM3NTQ2NTA4NjEx_9fb1f867-3bab-4615-a9e8-112a820166c8"
      unitRef="number">0</dva:NumberOfConcentrationRiskCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzI4MDM3NTQ2NTA4NjMy_d32bd530-8401-4070-9fee-1cb69ce68159"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue
      contextRef="i0827e76d53914466af9eff1dc6c5d343_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzIw_618662da-8833-4cbb-bb7c-c46087f22d38"
      unitRef="number">0.18</dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue>
    <dva:AccountsReceivablePeriodOutstanding
      contextRef="i752032a4ec0a43aca613ce6474506e9e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTkvZnJhZzpmMWZiOWRhMGE0ZmU0MWQzODg5ZGU4NDc5ZjkyZTkxOC90ZXh0cmVnaW9uOmYxZmI5ZGEwYTRmZTQxZDM4ODlkZTg0NzlmOTJlOTE4XzEyNw_89a83a49-0c54-4a32-9bb7-0cfa3a7c8c36">P6M</dva:AccountsReceivablePeriodOutstanding>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjAvZnJhZzo1YjBmY2FkYTJmZDM0NjNhOTljMWVlMjYzMjllMjUwMS90ZXh0cmVnaW9uOjViMGZjYWRhMmZkMzQ2M2E5OWMxZWUyNjMyOWUyNTAxXzY2_b1b5a29e-23cc-4f75-b645-caccc19d8508"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjAvZnJhZzo1YjBmY2FkYTJmZDM0NjNhOTljMWVlMjYzMjllMjUwMS90ZXh0cmVnaW9uOjViMGZjYWRhMmZkMzQ2M2E5OWMxZWUyNjMyOWUyNTAxXzE5Ng_be7fdb06-e4cd-489e-acf3-708360283b60"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjYvZnJhZzo1NWQzM2IwOTUzMGE0ODU3YjhkOWEzZGRkYjkzOGFhOC90ZXh0cmVnaW9uOjU1ZDMzYjA5NTMwYTQ4NTdiOGQ5YTNkZGRiOTM4YWE4XzE2_bb2c8c94-270f-4f30-bc59-1961ab09af0a"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjYvZnJhZzo1NWQzM2IwOTUzMGE0ODU3YjhkOWEzZGRkYjkzOGFhOC90ZXh0cmVnaW9uOjU1ZDMzYjA5NTMwYTQ4NTdiOGQ5YTNkZGRiOTM4YWE4XzI4NTg3MzAyMzIyNDU1_b36e9656-f29f-4e24-98d1-061c31fdd65a"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <dva:PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzIvZnJhZzo2YjcyZTcyNDUyYWE0OWJlOGUyNzlkOWJjN2E5MWYzNS90ZXh0cmVnaW9uOjZiNzJlNzI0NTJhYTQ5YmU4ZTI3OWQ5YmM3YTkxZjM1Xzgz_9baeebc2-79fb-47f4-8a20-40a75a558e9c"
      unitRef="number">0.0100</dva:PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="i8ed3cefb5e264fc19465d2168eeb14b6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNDky_16edd235-5259-4498-82b0-f1d0de7d36e2">2036-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="i3faf499aa9a748f1954b1f5b2998f2f7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4MDM3NTQ2NTA4NTk0_fae82ee4-1e77-4f7e-8680-c3bd76ee6399">2029-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="i46cc1be6f24843f99366871f9141b719_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNDk2_1186c4b4-02cb-42f2-97ab-82019426e967">2040-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="i7242eb9d60a04733a2c41990205ffce0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNTAw_626e597d-7fd6-478f-b67d-3f5d7a25eca3">2021-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="i48f1c17b32af4699bc7a441a7ef30448_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDEvZnJhZzozYjdkODBhYmU4NmI0NDlmYjMwMjMxYWZkMGY4NTJhOC90ZXh0cmVnaW9uOjNiN2Q4MGFiZTg2YjQ0OWZiMzAyMzFhZmQwZjg1MmE4XzI4NTg3MzAyMzIyNTA0_1d01f9ac-b49d-4a9c-8733-287cb9ec4afc">2024-12-31</us-gaap:TaxCreditCarryforwardExpirationDate>
    <dva:ProceedsFromRepricingAgreementOnSecuredDebt
      contextRef="i7e335188f31c48569623a8cbca6e9598_I20200213"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDcvZnJhZzoyNjZhMzQ2YjMzNDM0NTVhYTkxOWExZDJhZjAzNmJlNy90ZXh0cmVnaW9uOjI2NmEzNDZiMzM0MzQ1NWFhOTE5YTFkMmFmMDM2YmU3XzI4MDM3NTQ2NTA5MzI3_6b067d1a-4b79-4ca6-bb38-adb0dc75cfc2"
      unitRef="usd">0</dva:ProceedsFromRepricingAgreementOnSecuredDebt>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate
      contextRef="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzky_dfd5b969-8e00-45e6-8179-c401433cd25b">P1Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate
      contextRef="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzk4_d7248c68-dea9-430e-9c5a-594570a18d4e">P2Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection
      contextRef="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzE2Mw_5554c2e8-966b-4b2e-95f3-9be46728114b">P3Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection
      contextRef="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTYvZnJhZzoyMDQ2NjcyM2IyMTQ0ODA1YTRhNmFiNWJjOGFhOTc5MC90ZXh0cmVnaW9uOjIwNDY2NzIzYjIxNDQ4MDVhNGE2YWI1YmM4YWE5NzkwXzE2OQ_59f1b6ff-0077-4e82-b754-de010bc6576c">P4Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzk4_0db614d5-71f6-46db-8d97-cccc8db7d1c5">P0Y</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ifd91e8a803cd4443a8f9187ba2180bb8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzMtMS0xLTEtMA_9d40663e-7e91-4a14-b2ae-3ce4c1c230eb"
      unitRef="usdPerShare">50.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ifd91e8a803cd4443a8f9187ba2180bb8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzMtMi0xLTEtMA_77bd4666-aa44-4b0e-85b2-66e4e00b4143"
      unitRef="usdPerShare">60.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i5225de491d414cc396c96583c06b3790_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzQtMS0xLTEtMA_439e3a79-2bd2-4944-a5bd-9fda1ff84a2d"
      unitRef="usdPerShare">60.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i5225de491d414cc396c96583c06b3790_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzQtMi0xLTEtMA_c961c681-7502-44ff-9d53-f64b69bcca20"
      unitRef="usdPerShare">70.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i4869c0e869c345499d845df4d1726074_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzUtMS0xLTEtMA_84570900-e65c-4117-814a-1d444edffedc"
      unitRef="usdPerShare">70.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i4869c0e869c345499d845df4d1726074_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90YWJsZTo0YTcxMGNkZGIwNzU0NTE0ODI3MTJjN2Y2YTRlZDc0YS90YWJsZXJhbmdlOjRhNzEwY2RkYjA3NTQ1MTQ4MjcxMmM3ZjZhNGVkNzRhXzUtMi0xLTEtMA_2b64b0b7-fd68-487b-b0f1-ddda565937e0"
      unitRef="usdPerShare">80.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ib5d81d4cfd9b4d3a90277b4e0ba77a2f_D20191104-20191104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzI2Ng_f5ad62a1-3a96-4f0e-80cf-572681e71412"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ibbd08d038cf54271ba04c5bae7ea2247_D20200701-20200701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzM3NQ_a020ed18-fa21-467e-962a-610068a54adf"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzU2MA_b8da859f-e29c-4f01-a147-d2bc298d9298"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzcxNQ_e98e87f0-78e8-4715-84a3-d6a88354c575"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzI4NTg3MzAyMzIzMTQ1_9ce0257b-fcf0-4f65-9712-274e8590df13"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzc2Mw_5c80e3b5-93f9-4f07-b7d7-b8d9e88c71c6"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzEvZnJhZzowNDgwMWM4YTgzMzE0MDllOTU1YjA3N2Y4YmZjNjA0YS90ZXh0cmVnaW9uOjA0ODAxYzhhODMzMTQwOWU5NTViMDc3ZjhiZmM2MDRhXzc3OA_cb12741f-b57c-410d-895a-becc3f079b7b"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount
      contextRef="i76ba37986e6d4a12be3157c80c387fc9_I20191104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4NTg3MzAyMzIyODgz_d78fc656-e24a-47d4-a254-50290adde1c7"
      unitRef="usd">246373000</dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount>
    <dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount
      contextRef="i105b8a0db46c4b329658833071e7f412_I20201210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4NTg3MzAyMzIyOTE2_070de8e5-d436-4fdf-87d1-3e23111239d4"
      unitRef="usd">329302000</dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4MDM3NTQ2NTA5MTU1_19d544e4-9081-421d-84ef-440f44a9dc3e"
      unitRef="shares">-16477000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzcvZnJhZzoyMjA2NDllMmM5MmY0OTU3OGQwY2NjYTYxNGVhOWE0MS90ZXh0cmVnaW9uOjIyMDY0OWUyYzkyZjQ5NTc4ZDBjY2NhNjE0ZWE5YTQxXzI4MDM3NTQ2NTA5MjQ1_75a697ab-4316-41bc-8234-cf7ae2261dcc"
      unitRef="shares">-41020000</us-gaap:TreasuryStockSharesRetired>
    <dei:DocumentType
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjU1_a147bd0d-d13b-4fb3-9014-4163ddd17099">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6OTM4ZmFkMGRlNWFjNDhhNzgzNjZlNTI3OTlkNjdiYTkvdGFibGVyYW5nZTo5MzhmYWQwZGU1YWM0OGE3ODM2NmU1Mjc5OWQ2N2JhOV8wLTAtMS0xLTA_b599f04a-8dff-4be6-99d4-322c0cc80b47">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8xMjI_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8xMjI_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MDYyNGU2ZmYxZmE3NDczM2FmNThiNGJmODQ1NGNlYjcvdGFibGVyYW5nZTowNjI0ZTZmZjFmYTc0NzMzYWY1OGI0YmY4NDU0Y2ViN18wLTAtMS0xLTA_c569c7cb-fc99-46eb-94f1-0e9290518988">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUw_4ed09732-a129-4c8d-ad11-0f8ce5730122">1-14106</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUx_bb79ca2e-aa95-43f2-99ca-67088d997507">DAVITA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MTk3MTcxYzBhZDM5NDcwNmJhODUzYWJlMDNmNjlkMmYvdGFibGVyYW5nZToxOTcxNzFjMGFkMzk0NzA2YmE4NTNhYmUwM2Y2OWQyZl8wLTAtMS0xLTA_40852495-e607-4252-9852-1825ba3be7b5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MTk3MTcxYzBhZDM5NDcwNmJhODUzYWJlMDNmNjlkMmYvdGFibGVyYW5nZToxOTcxNzFjMGFkMzk0NzA2YmE4NTNhYmUwM2Y2OWQyZl8wLTItMS0xLTA_e10ab564-b8ac-480f-b491-7f8edceacbeb">51-0354549</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8wLTAtMS0xLTA_5d7e26d4-184b-46b6-9ce7-458d885c66d0">2000 16th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8xLTAtMS0xLTA_bccf0fa6-bc9a-4e0d-a874-ac1855454e91">Denver,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8xLTEtMS0xLTA_58d07dd4-5695-4bc9-9821-e50f96a4e92f">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6MzA0OWZmYWE4M2QxNDAxZmI1NmIzZTM4ZTk1YTg0ZmIvdGFibGVyYW5nZTozMDQ5ZmZhYTgzZDE0MDFmYjU2YjNlMzhlOTVhODRmYl8xLTItMS0xLTA_3f276071-0d2f-4977-9311-15e8bdc95847">80202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjU2_1650924d-e040-40a4-929b-49b24e1b7690">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjQ3_df44821a-7d0c-45d0-aade-d8e6a588b937">631-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZGVlMTA1ZjQ0NTRhNDAwMmI3YmQxM2NjZTllMzQ2M2IvdGFibGVyYW5nZTpkZWUxMDVmNDQ1NGE0MDAyYjdiZDEzY2NlOWUzNDYzYl8xLTAtMS0xLTA_3c18376e-0c4d-456f-a148-09e6e2e8c871">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZGVlMTA1ZjQ0NTRhNDAwMmI3YmQxM2NjZTllMzQ2M2IvdGFibGVyYW5nZTpkZWUxMDVmNDQ1NGE0MDAyYjdiZDEzY2NlOWUzNDYzYl8xLTItMS0xLTA_63c9401c-dd2a-4444-a320-601719c180cd">DVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZGVlMTA1ZjQ0NTRhNDAwMmI3YmQxM2NjZTllMzQ2M2IvdGFibGVyYW5nZTpkZWUxMDVmNDQ1NGE0MDAyYjdiZDEzY2NlOWUzNDYzYl8xLTQtMS0xLTA_3e773b5f-fc5e-4942-be53-394400698790">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjQ4_2f7bb62d-6e25-411b-855c-6dfc0f078912">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUy_43daf786-89cd-414e-acda-b1e3159de68a">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjUz_d08d3ffb-de7e-4e2b-9352-9f97a7e79543">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjQ5_541532a3-490b-4f72-bca1-c90245ba7e1d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZDVhMjZhZmQ1OGM2NGU2YjgwOWM3Y2IzMDkxNGQyNTcvdGFibGVyYW5nZTpkNWEyNmFmZDU4YzY0ZTZiODA5YzdjYjMwOTE0ZDI1N18wLTAtMS0xLTA_e0162893-43bd-456a-9ac3-92c49a78f4ab">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZDVhMjZhZmQ1OGM2NGU2YjgwOWM3Y2IzMDkxNGQyNTcvdGFibGVyYW5nZTpkNWEyNmFmZDU4YzY0ZTZiODA5YzdjYjMwOTE0ZDI1N18xLTUtMS0xLTA_17979017-83d3-41ee-b26b-9aa47453ecd8">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGFibGU6ZDVhMjZhZmQ1OGM2NGU2YjgwOWM3Y2IzMDkxNGQyNTcvdGFibGVyYW5nZTpkNWEyNmFmZDU4YzY0ZTZiODA5YzdjYjMwOTE0ZDI1N18yLTUtMS0xLTA_15a27251-5759-4032-989b-31ae172912f5">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yODAzNzU0NjUxMTM3NQ_2ef490e6-b50d-4593-a485-0c5f561dce96">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNjU0_7c10106c-5b36-4721-9a9b-6c6414ae6f90">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i455090d9ae6c4bde8821c7170863d88e_I20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yMzU2_ad3b5600-0e0a-45d2-b671-71748a460fc6"
      unitRef="usd">9700000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1de112d305e94047b9078f3339c24026_I20210129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xL2ZyYWc6M2FlYWZlMDU3MWExNDY2ZjkyNGM5ODM1ODBlODJhNjUvdGV4dHJlZ2lvbjozYWVhZmUwNTcxYTE0NjZmOTI0Yzk4MzU4MGU4MmE2NV8yNDU0_4253c2bf-f5d3-40ad-91aa-108a490ab8e7"
      unitRef="shares">109400000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzItMS0xLTEtMA_b97480dd-ab0a-4a50-982e-453aa74a2ebe"
      unitRef="usd">11039709000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzItMy0xLTEtMA_b5fcd6b5-ec37-44b2-8652-04a89da2de5e"
      unitRef="usd">10918421000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzItNS0xLTEtMA_53aa4821-d6e0-4229-9983-fa7cf295d90c"
      unitRef="usd">10709981000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <dva:ProvisionForExpectedCreditLosses
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMtMS0xLTEtMA_d7102ad5-4f1c-42d3-9bc2-ab425b160665"
      unitRef="usd">13458000</dva:ProvisionForExpectedCreditLosses>
    <dva:ProvisionForExpectedCreditLosses
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMtMy0xLTEtMA_a84b1968-db99-4139-a6a5-ba6ec6e65db5"
      unitRef="usd">21715000</dva:ProvisionForExpectedCreditLosses>
    <dva:ProvisionForExpectedCreditLosses
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMtNS0xLTEtMA_65e9f676-3793-42a6-8bc0-4b915f709f30"
      unitRef="usd">49587000</dva:ProvisionForExpectedCreditLosses>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQtMS0xLTEtMA_0db97280-4b65-4ee8-969c-1c9645ef901a"
      unitRef="usd">11026251000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQtMy0xLTEtMA_4f66473a-f297-4df7-9932-e61dfa2dc794"
      unitRef="usd">10896706000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQtNS0xLTEtMA_d46fbffe-338b-49bd-b50c-cc5add77d2e1"
      unitRef="usd">10660394000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <us-gaap:OtherIncome
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzUtMS0xLTEtMA_51db0ae3-6906-4753-8504-a1878a74e4b6"
      unitRef="usd">524353000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzUtMy0xLTEtMA_582e1350-3c49-43ca-8c1b-c1141925ba1b"
      unitRef="usd">491773000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzUtNS0xLTEtMA_5c98630a-32c8-47f3-afeb-631bab755057"
      unitRef="usd">744457000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzYtMS0xLTEtMA_33b8f4cc-6938-4747-a0b0-366bf92cfdb0"
      unitRef="usd">11550604000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzYtMy0xLTEtMA_a3e80159-7bd7-404b-b525-40b6668321ef"
      unitRef="usd">11388479000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzYtNS0xLTEtMA_0a5748b5-236c-4967-b938-92a96ba37446"
      unitRef="usd">11404851000</us-gaap:Revenues>
    <dva:PatientCareCosts
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzgtMS0xLTEtMA_103df5a9-a4f7-4f4f-9517-884e7f064046"
      unitRef="usd">7988613000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzgtMy0xLTEtMA_4f6e8093-7976-4604-b85b-cfd6ff486c06"
      unitRef="usd">7914485000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzgtNS0xLTEtMA_f2fa94a5-6bbd-4dc5-819b-1c82a5dc718d"
      unitRef="usd">8195513000</dva:PatientCareCosts>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzktMS0xLTEtMA_4b652ac0-8a64-4f81-b97e-55b620ef1b6d"
      unitRef="usd">1247584000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzktMy0xLTEtMA_0795ac8e-be89-4204-abce-26dfa3965ff7"
      unitRef="usd">1103312000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzktNS0xLTEtMA_92df231c-cf8f-4962-8f25-87023c25c2af"
      unitRef="usd">1135454000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEwLTEtMS0xLTA_3f21f16c-b756-418d-8ad3-8d44a04922f5"
      unitRef="usd">630435000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEwLTMtMS0xLTA_a3c5297a-666b-47f8-b7f4-479136d78fed"
      unitRef="usd">615152000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEwLTUtMS0xLTA_580996f7-b7f3-497b-aa42-26a7f3ef58f6"
      unitRef="usd">591035000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzExLTEtMS0xLTA_4b4376bf-62a3-44ae-a85b-1554b8f67bd5"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzExLTMtMS0xLTA_1c6987a6-bb65-4792-8d7f-1c8ee4f162cd"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzExLTUtMS0xLTA_fad79436-abbc-4af4-b134-63a651e34315"
      unitRef="usd">7300000</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEyLTEtMS0xLTA_45bff8dc-e8b1-4d3a-83f6-5da6ea93d3fd"
      unitRef="usd">26916000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEyLTMtMS0xLTA_0d51151d-15f4-4c36-83e6-04690be69bf5"
      unitRef="usd">12679000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEyLTUtMS0xLTA_526cff40-963b-4dcd-bfb4-b527b58a248c"
      unitRef="usd">-4484000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEzLTEtMS0xLTA_9f850db0-4477-4b89-8dfa-7e66412536a9"
      unitRef="usd">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEzLTMtMS0xLTA_c69b2aa8-45df-479b-8093-9a17efb9e73e"
      unitRef="usd">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzEzLTUtMS0xLTA_90070bb0-bf15-424e-858c-abd4de85a3ac"
      unitRef="usd">17338000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE0LTEtMS0xLTA_469413c9-ef64-47d3-8c66-5fca7f5340aa"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE0LTMtMS0xLTA_0f63e7c4-d009-4ce6-8d93-7c83ecf4f5c2"
      unitRef="usd">124892000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE0LTUtMS0xLTA_a1260521-e84d-4cd5-9c08-543a6547c27c"
      unitRef="usd">3106000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE1LTEtMS0xLTA_41af6b61-be3e-4b77-beb1-3617d7b4e5b8"
      unitRef="usd">-16252000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE1LTMtMS0xLTA_5e7b0901-08e3-4fa6-812b-11eaf8d0224c"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE1LTUtMS0xLTA_cd5d2937-e7ac-4328-8aa0-44abde42ae6b"
      unitRef="usd">60603000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:CostsAndExpenses
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE3LTEtMS0xLTA_e8adffce-956c-46b7-83db-9b0ae6b9e355"
      unitRef="usd">9855968000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE3LTMtMS0xLTA_3041c3c1-4bf0-4bbf-a12d-887fee9018cb"
      unitRef="usd">9745162000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE3LTUtMS0xLTA_42f9c29f-8bf8-4f2d-8212-9f2e93bc0cfe"
      unitRef="usd">9879027000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE4LTEtMS0xLTA_0ae702be-2bbf-4d10-98bc-f1e2381a4b7f"
      unitRef="usd">1694636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE4LTMtMS0xLTA_4bb55b28-8b48-4f17-91ed-34d01bc739e2"
      unitRef="usd">1643317000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE4LTUtMS0xLTA_5cd12cc6-2bdc-44b1-a0d8-82caad150a01"
      unitRef="usd">1525824000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE5LTEtMS0xLTA_a47e7cd2-0a4c-4527-bcdc-11d9131d093b"
      unitRef="usd">304111000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE5LTMtMS0xLTA_9194548f-eab6-4c4f-9aca-09bf577ca656"
      unitRef="usd">443824000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzE5LTUtMS0xLTA_87c3cab9-e9f1-4799-a473-e0f41b8554c8"
      unitRef="usd">487435000</us-gaap:InterestAndDebtExpense>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIwLTEtMS0xLTA_3292df5e-4ff5-4532-8074-18bde157cc89"
      unitRef="usd">89022000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIwLTMtMS0xLTA_8985fb03-73a3-425b-881d-8aeee9931c8f"
      unitRef="usd">33402000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIwLTUtMS0xLTA_250da049-6ff3-43d5-a260-6afc82e23ab3"
      unitRef="usd">0</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIxLTEtMS0xLTA_6402c34a-0213-42d0-a972-c6b4cfa134f0"
      unitRef="usd">16759000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIxLTMtMS0xLTA_a827941b-62c9-4046-9add-1d4b709bce20"
      unitRef="usd">29348000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIxLTUtMS0xLTA_121cca0c-61fb-43a9-81b4-00542ed6a142"
      unitRef="usd">10089000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIyLTEtMS0xLTA_2593fbd9-f679-4de3-8ca8-3b7f85f4e14d"
      unitRef="usd">1318262000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIyLTMtMS0xLTA_b891f00e-06e0-43bf-8905-939a1d95998f"
      unitRef="usd">1195439000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIyLTUtMS0xLTA_730d54ac-6d91-4e45-b587-1fca427173e7"
      unitRef="usd">1048478000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIzLTEtMS0xLTA_3f04e2a3-2011-4506-8aa8-cc6a74a3f1da"
      unitRef="usd">313932000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIzLTMtMS0xLTA_1b32508f-0a9d-46b4-b803-b471ded6b53b"
      unitRef="usd">279628000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzIzLTUtMS0xLTA_7d355790-c3d1-4b88-9d29-dac0afe7d933"
      unitRef="usd">258400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI0LTEtMS0xLTA_7e471ce0-3f79-49d5-992a-f7c69ede4176"
      unitRef="usd">1004330000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI0LTMtMS0xLTA_3cf9ac8f-d664-4772-afd9-6ef36637e082"
      unitRef="usd">915811000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI0LTUtMS0xLTA_e528f2a8-7dcb-46c5-859a-032366557af3"
      unitRef="usd">790078000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI1LTEtMS0xLTA_6a2be20e-e8fc-4618-9d1c-87c7dacf271d"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI1LTMtMS0xLTA_feea139f-188d-4b7a-bfd8-472db311f745"
      unitRef="usd">105483000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI1LTUtMS0xLTA_075a0a76-ca71-4d39-952b-145fa220b6dd"
      unitRef="usd">-457038000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI2LTEtMS0xLTA_6a01009f-a959-4417-885a-95046efebfeb"
      unitRef="usd">994677000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI2LTMtMS0xLTA_65e53e36-4143-44c2-b8f0-23e2d91132c8"
      unitRef="usd">1021294000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI2LTUtMS0xLTA_b004a6be-2fa0-4dbd-be21-a19e1b3e75e0"
      unitRef="usd">333040000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI3LTEtMS0xLTA_889f2d86-378e-4cc2-a058-9206931c9776"
      unitRef="usd">221035000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI3LTMtMS0xLTA_57589928-4698-485c-be73-97b7bbc1d3a1"
      unitRef="usd">210313000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI3LTUtMS0xLTA_698028dd-c87b-4b1e-8865-47891e996579"
      unitRef="usd">173646000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI4LTEtMS0xLTA_dfb5763e-d267-405c-925b-f0447e6e9700"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI4LTMtMS0xLTA_9e311d3e-1fc4-41ac-9443-6885c493cb30"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzI4LTUtMS0xLTA_b8e265dd-d330-4bdb-9ab6-ff10ca4c1a5b"
      unitRef="usd">159394000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMwLTEtMS0xLTA_2d900bda-22af-435c-ae02-37439754f585"
      unitRef="usdPerShare">6.54</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMwLTMtMS0xLTA_a183d623-941d-47d4-a90e-99c41a21d2ca"
      unitRef="usdPerShare">4.61</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMwLTUtMS0xLTA_4706b716-ec96-420b-8500-b4dfffeff1cf"
      unitRef="usdPerShare">3.66</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMxLTEtMS0xLTA_c899f3b7-ae77-401b-9c5f-770a8d1f49ac"
      unitRef="usdPerShare">6.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMxLTMtMS0xLTA_d6432bdf-6c51-4a38-8611-4febf3b6c6e2"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMxLTUtMS0xLTA_db01ae63-9640-45a3-a194-8ad676165f33"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMyLTEtMS0xLTA_4aa53c23-1947-46ca-8f54-76163ea1f320"
      unitRef="usdPerShare">6.39</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMyLTMtMS0xLTA_313fa9d4-ff9b-4584-ab52-ab9aeaef08f9"
      unitRef="usdPerShare">4.60</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMyLTUtMS0xLTA_caa69b59-6aaa-4d6e-9ef3-6a4192be8796"
      unitRef="usdPerShare">3.62</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMzLTEtMS0xLTA_dae41f19-f822-4c2e-9101-c3aad588a365"
      unitRef="usdPerShare">6.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMzLTMtMS0xLTA_f3211d91-0d72-4221-b0c6-d4b0552226af"
      unitRef="usdPerShare">5.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzMzLTUtMS0xLTA_9694e0fa-9d90-4209-931f-4d2ba3b7c76b"
      unitRef="usdPerShare">0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM1LTEtMS0xLTA_bbc6921f-e374-48c0-aec3-90a9bb6ebf60"
      unitRef="shares">119797000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM1LTMtMS0xLTA_4f61be2c-608c-428b-9007-0241eaf2cace"
      unitRef="shares">153181000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM1LTUtMS0xLTA_cb501814-795d-4c7a-9c2c-e1b9335a9003"
      unitRef="shares">170786000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM2LTEtMS0xLTA_9f2670eb-5b6e-4cae-9754-7146d950ebf5"
      unitRef="shares">122623000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM2LTMtMS0xLTA_373a3ab4-9498-4a3f-850c-ac100f2a671b"
      unitRef="shares">153812000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM2LTUtMS0xLTA_3e668ea5-ad25-41c0-9aba-0220a17338e0"
      unitRef="shares">172365000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM4LTEtMS0xLTA_92471df0-e307-4e68-9920-4d957959b742"
      unitRef="usd">783295000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM4LTMtMS0xLTA_28372998-f966-4989-a285-9b4b54f9ce73"
      unitRef="usd">706832000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM4LTUtMS0xLTA_804ebe7c-7772-43f2-9cb6-721b818546e9"
      unitRef="usd">624321000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM5LTEtMS0xLTA_a1860ae4-c4c4-4d28-9092-20a98f5b5b42"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM5LTMtMS0xLTA_cd4c689c-6874-4ac3-b135-fa220b2ceafa"
      unitRef="usd">104149000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzM5LTUtMS0xLTA_859c8bc6-2cfe-4ddd-b314-a13328cf6973"
      unitRef="usd">-464927000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQwLTEtMS0xLTA_49b3f939-8a4e-49e0-8c33-015cd43da6dd"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQwLTMtMS0xLTA_da85b60e-970d-4c64-b2c8-90f1de7a8e3e"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzIvZnJhZzphMDMxODE4ZjcxZDc0YTM1OTQyOGY5NjlkNGZkZTY1ZS90YWJsZTpiNzI5ZTc4MzBmN2E0NzA3OWQ2NjZlMDVkYjFjZmJiOC90YWJsZXJhbmdlOmI3MjllNzgzMGY3YTQ3MDc5ZDY2NmUwNWRiMWNmYmI4XzQwLTUtMS0xLTA_c031532e-8ec8-445a-9e55-ade6a86c5321"
      unitRef="usd">159394000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzItMS0xLTEtMA_6a01009f-a959-4417-885a-95046efebfeb"
      unitRef="usd">994677000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzItMy0xLTEtMA_65e53e36-4143-44c2-b8f0-23e2d91132c8"
      unitRef="usd">1021294000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzItNS0xLTEtMA_b004a6be-2fa0-4dbd-be21-a19e1b3e75e0"
      unitRef="usd">333040000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzUtMS0xLTEtMA_1fbe6015-7736-43f3-a2ef-32697305e38a"
      unitRef="usd">-16346000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzUtMy0xLTEtMA_a9cd0128-10e0-4f68-bf62-da8e0f601a89"
      unitRef="usd">1151000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzUtNS0xLTEtMA_d3ba7c6c-720d-4255-bd3c-e521527ef680"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzYtMS0xLTEtMA_f07b0575-e5b9-499d-b65f-cee712c290b7"
      unitRef="usd">-5313000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzYtMy0xLTEtMA_bf511a16-4344-4fa6-b432-10d01c04d802"
      unitRef="usd">-6377000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzYtNS0xLTEtMA_1a5a2a7b-24b2-4b9f-80d7-f481a6572828"
      unitRef="usd">-6286000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzExLTEtMS0xLTA_3453fdee-eb94-417a-be0e-77d23fcdd930"
      unitRef="usd">-7623000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzExLTMtMS0xLTA_c5bf6361-c249-4578-8c78-4bbb46399ac7"
      unitRef="usd">-20102000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzExLTUtMS0xLTA_892e06c1-b3b2-4379-a684-1fd8e2df7191"
      unitRef="usd">-45944000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEyLTEtMS0xLTA_40b5f3e5-977b-4a29-943a-db97f5c0e1d6"
      unitRef="usd">-18656000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEyLTMtMS0xLTA_8cac647d-08c9-4ec0-bbd8-423c2bb907f4"
      unitRef="usd">-12574000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEyLTUtMS0xLTA_d2f0eea8-2b94-4897-b2ad-5239c4496d12"
      unitRef="usd">-39791000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEzLTEtMS0xLTA_c0021bed-7274-425b-8f6e-cdeb6528c16e"
      unitRef="usd">976021000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEzLTMtMS0xLTA_ab313328-0669-4661-a62d-81933e5b5940"
      unitRef="usd">1008720000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzEzLTUtMS0xLTA_69c8aeeb-560d-43c6-8dec-33c4b6836398"
      unitRef="usd">293249000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE0LTEtMS0xLTA_9c63403d-0380-4b40-8d89-30b9f1312aa7"
      unitRef="usd">221035000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE0LTMtMS0xLTA_98d99ea4-1cc9-4b67-a854-5c43e0371cf1"
      unitRef="usd">210313000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE0LTUtMS0xLTA_70ca9960-721d-40e6-baeb-b3fac0a75639"
      unitRef="usd">173646000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE1LTEtMS0xLTA_a02e7ff7-2a1b-4b84-b3d9-89e16caa11f6"
      unitRef="usd">754986000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE1LTMtMS0xLTA_294aea12-53c1-429c-9661-e5a5888f150c"
      unitRef="usd">798407000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzUvZnJhZzpkODMxYjU2OTg0Mjk0NWI1YTlkYmM0ODNkOGRhMWY4Yy90YWJsZTphZTVjMzViOTk1ZWE0NmY3ODU2ZTdjMThmMzYwN2IwYi90YWJsZXJhbmdlOmFlNWMzNWI5OTVlYTQ2Zjc4NTZlN2MxOGYzNjA3YjBiXzE1LTUtMS0xLTA_78f16e4f-3ba2-4636-9700-d525e81c37d7"
      unitRef="usd">119603000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzItMS0xLTEtMA_8dacf3be-31e3-4147-90ef-430d7c64ca52"
      unitRef="usd">324958000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzItMy0xLTEtMA_ed558ee5-cf6c-40c8-82bd-bad1d3e66ed2"
      unitRef="usd">1102372000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMtMS0xLTEtMA_9049bc08-5920-4200-829e-830f2261cd36"
      unitRef="usd">176832000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMtMy0xLTEtMA_a539cf2d-d397-4787-838d-86f52294d3fb"
      unitRef="usd">106346000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQtMS0xLTEtMA_23a8af23-650d-4f2c-9b01-bd73b8f9db2a"
      unitRef="usd">20101000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQtMy0xLTEtMA_0a35fc01-bee0-4ea8-b1f4-452690a8cff4"
      unitRef="usd">11572000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzUtMS0xLTEtMA_a5c39b39-902b-4f02-82f3-ab06a75a424f"
      unitRef="usd">1824282000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzUtMy0xLTEtMA_5c38cee6-9f0e-4024-bf4b-840a85c11083"
      unitRef="usd">1795598000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzYtMS0xLTEtMA_e30be2f5-c02e-4d7c-bfe8-314ed39596b8"
      unitRef="usd">111625000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzYtMy0xLTEtMA_aff07628-10fd-4d6e-8c6c-71116bd9c841"
      unitRef="usd">97949000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzctMS0xLTEtMA_cade24f1-a16d-4397-bb3f-7a6884267769"
      unitRef="usd">544376000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzctMy0xLTEtMA_3abf4746-819e-417d-a8d1-0b7068e15f83"
      unitRef="usd">489695000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzgtMS0xLTEtMA_28bbd5d3-cb52-4022-8b38-2db984600019"
      unitRef="usd">76387000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzgtMy0xLTEtMA_a3a38611-ba99-4111-9957-630df6af5b04"
      unitRef="usd">66866000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzktMS0xLTEtMA_aab97d70-5e92-4391-b9ca-c16d2c5b037b"
      unitRef="usd">70163000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzktMy0xLTEtMA_e974f129-ddc7-4031-b6d5-9f3ec8bf0f78"
      unitRef="usd">19772000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzExLTEtMS0xLTA_75fbb017-2f94-4a6b-b2a6-6d9b3041b12f"
      unitRef="usd">3148724000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzExLTMtMS0xLTA_95817cc3-c5fc-4362-817a-3fcaad30e394"
      unitRef="usd">3690170000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEyLTEtMS0xLTA_a1d581eb-1360-4208-9827-a7dd9919a96f"
      unitRef="usd">3521824000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEyLTMtMS0xLTA_1df75261-64e6-4013-a021-50beb62bcd21"
      unitRef="usd">3473384000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEzLTEtMS0xLTA_c7d1bce1-0b00-4133-8967-59e40810fd53"
      unitRef="usd">2863089000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzEzLTMtMS0xLTA_548ef30a-1f8e-4f33-9e9e-afe65bf9811b"
      unitRef="usd">2830047000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE0LTEtMS0xLTA_8998b340-ef51-4728-9916-cb94249c12bb"
      unitRef="usd">166585000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE0LTMtMS0xLTA_6c4aec50-b83c-436a-b9ef-654d80e86335"
      unitRef="usd">135684000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE1LTEtMS0xLTA_021e7148-2740-422d-9a10-7f5cb1d0bc8c"
      unitRef="usd">257491000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE1LTMtMS0xLTA_81f94ce5-2348-41cd-83b5-6c8a2a7ca221"
      unitRef="usd">241983000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE2LTEtMS0xLTA_2407ce5b-a1ed-492b-a1d4-bd6277e9ebe0"
      unitRef="usd">32193000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE2LTMtMS0xLTA_7c66d2da-fae8-48ca-8646-3f28a3610f40"
      unitRef="usd">36519000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE3LTEtMS0xLTA_44f56d7d-82c7-42ab-ac21-9b1e1d083667"
      unitRef="usd">79501000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE3LTMtMS0xLTA_e3332d95-6bdb-4d36-bd3d-634f589090a7"
      unitRef="usd">115972000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE4LTEtMS0xLTA_dc9efe79-96f1-48e0-b8f1-e06983205bc1"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE4LTMtMS0xLTA_cf23b16b-cea4-47bf-b4c9-aeba50c57ab0"
      unitRef="usd">6787635000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE5LTEtMS0xLTA_9a2caf59-8d98-4669-932f-44b175894359"
      unitRef="usd">16988516000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzE5LTMtMS0xLTA_416b910b-cc99-4650-abf1-b12d8161787e"
      unitRef="usd">17311394000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIxLTEtMS0xLTA_3124b846-9dc7-4eb2-874d-eff87614b9b3"
      unitRef="usd">434253000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIxLTMtMS0xLTA_c35be31d-b850-4e76-9ee7-6ffda143e9cb"
      unitRef="usd">403840000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIyLTEtMS0xLTA_3d1654b4-71b4-41fa-bf56-e7c17d1663aa"
      unitRef="usd">810529000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIyLTMtMS0xLTA_457084a3-286c-4c5c-8f31-551519b964ee"
      unitRef="usd">756174000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIzLTEtMS0xLTA_37bb064e-99d4-4030-a5ba-b2f92b20b2b4"
      unitRef="usd">685555000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzIzLTMtMS0xLTA_106d3736-e155-4ec0-82ae-c8299ff97c50"
      unitRef="usd">695052000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI0LTEtMS0xLTA_7801376b-17b8-4b21-921f-7d650f5d9ff0"
      unitRef="usd">369497000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI0LTMtMS0xLTA_e767a0ea-76c6-45ed-9744-23594d1b9cfb"
      unitRef="usd">343912000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI1LTEtMS0xLTA_fda79bb0-8a10-4ada-b88b-ba83048d7ed8"
      unitRef="usd">168541000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI1LTMtMS0xLTA_966ef7d1-577c-423f-938e-0c35f99dc5dc"
      unitRef="usd">130708000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI2LTEtMS0xLTA_63c056e6-0a6d-4c95-aa68-d983aa515a8d"
      unitRef="usd">7768000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI2LTMtMS0xLTA_5691b098-5351-43a6-a808-2726cc24bec7"
      unitRef="usd">42412000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI4LTEtMS0xLTA_b0558c0f-5f47-46c4-9e38-16709a2056d7"
      unitRef="usd">2476143000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI4LTMtMS0xLTA_af42ca63-d3c8-4830-a384-732195098a4b"
      unitRef="usd">2372098000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI5LTEtMS0xLTA_e0736ace-3b2b-4fa0-96ae-dcc8b5342752"
      unitRef="usd">2738670000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzI5LTMtMS0xLTA_e571dc37-6713-47eb-ac0b-514bacfef522"
      unitRef="usd">2723800000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMwLTEtMS0xLTA_206f8289-13c2-4188-862b-8e2c3d9548c8"
      unitRef="usd">7917263000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMwLTMtMS0xLTA_21293b24-0b3f-4021-b74e-e03705463d59"
      unitRef="usd">7977526000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMxLTEtMS0xLTA_069a4b43-9c77-4748-b819-662a1932b9c2"
      unitRef="usd">150060000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMxLTMtMS0xLTA_5ed26443-88b2-4302-a604-ac880c621ce3"
      unitRef="usd">160809000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMyLTEtMS0xLTA_c54e264f-cb92-42f0-ae36-7989028f463d"
      unitRef="usd">809600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMyLTMtMS0xLTA_9fd7744b-4dc8-4679-a070-e52c7dec2f62"
      unitRef="usd">577543000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMzLTEtMS0xLTA_f7309b69-6e1c-497c-b0c9-5f81f3f97a36"
      unitRef="usd">14091736000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzMzLTMtMS0xLTA_067bde58-7ae9-4897-a4c5-f369912a372a"
      unitRef="usd">13811776000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM1LTEtMS0xLTA_ad6dec72-6716-4a1e-affe-9fc98ed90e05"
      unitRef="usd">1330028000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM1LTMtMS0xLTA_2e3829c5-9eea-4361-8c36-1dcb09e0c775"
      unitRef="usd">1180376000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockValue
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM3LTEtMS0xLTA_313aa742-85d1-490e-9d8e-4e4d004e58d7"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM3LTMtMS0xLTA_a326ee6d-1735-4a41-b1b1-a506d6c27330"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM4LTEtMS0xLTA_422e394e-4223-4ec7-981a-e3399902f1fb"
      unitRef="usd">110000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM4LTMtMS0xLTA_495e5c74-4563-4c57-b501-219403faaab7"
      unitRef="usd">126000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM5LTEtMS0xLTA_7dabc8d5-5f1a-4c90-a3f4-c265ef3d6158"
      unitRef="usd">597073000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzM5LTMtMS0xLTA_10822e9e-fff5-4cbd-ac07-402800987558"
      unitRef="usd">749043000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQwLTEtMS0xLTA_5785a804-21fa-46e6-a755-34206c1260a5"
      unitRef="usd">852537000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQwLTMtMS0xLTA_0075d03a-6048-4b73-b131-009867c6b31e"
      unitRef="usd">1431738000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQxLTEtMS0xLTA_3e83edae-ef6c-4e81-a192-6362b30bb9b7"
      unitRef="usd">-66154000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQxLTMtMS0xLTA_524b0f3e-3aa8-4549-a725-d2d55450c4e7"
      unitRef="usd">-47498000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQyLTEtMS0xLTA_967f0175-5463-42e6-bcf0-dac682d79ea4"
      unitRef="usd">1383566000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQyLTMtMS0xLTA_215643ed-3fd3-4aff-965b-49b9fa6e775b"
      unitRef="usd">2133409000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQzLTEtMS0xLTA_32ec4848-9f16-4eac-9d5a-a521588ce80f"
      unitRef="usd">183186000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQzLTMtMS0xLTA_851ef53b-9f83-4722-b568-b278cd75bdd4"
      unitRef="usd">185833000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ0LTEtMS0xLTA_0c3c838a-ae4f-4e1c-9353-39f0b8bcf4cb"
      unitRef="usd">1566752000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ0LTMtMS0xLTA_b64ce50b-9ccc-4164-9af1-84d7e648d230"
      unitRef="usd">2319242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ1LTEtMS0xLTA_51342596-0910-447c-ae27-c29d36ea1465"
      unitRef="usd">16988516000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xNzgvZnJhZzplYTZjYzdhMTRiMGQ0OTM0OWRmZjkyNzkwNzY3MmU3ZS90YWJsZTowNTNjZWNhNzZiZDg0NDA4YTkwMmQzMjk3NGZhZWFkNi90YWJsZXJhbmdlOjA1M2NlY2E3NmJkODQ0MDhhOTAyZDMyOTc0ZmFlYWQ2XzQ1LTMtMS0xLTA_e68b0dfa-876e-4fcc-9bfa-be82576e2986"
      unitRef="usd">17311394000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMtMS0xLTEtMA_80f65fc3-8294-4357-9f37-bb8032c6128e"
      unitRef="usd">994677000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMtMy0xLTEtMA_8b6816dc-a5c7-4884-99f7-362895aac005"
      unitRef="usd">1021294000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMtNS0xLTEtMA_3a20d1cc-7ad5-4719-a1ae-0729c6606fff"
      unitRef="usd">333040000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUtMS0xLTEtMA_edc4c3e1-94ea-402d-b7ed-08133a778aca"
      unitRef="usd">630435000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUtMy0xLTEtMA_63c84d76-462f-41ef-a107-2b3ff22ca0c2"
      unitRef="usd">615152000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUtNS0xLTEtMA_caf7603b-558c-4720-b779-2e9c0e598b8f"
      unitRef="usd">591035000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzYtMS0xLTEtMA_60b9be5e-a801-4cd8-ba39-a954ae66ae81"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzYtMy0xLTEtMA_c82377ba-5af3-4cdc-8145-cf99065cd87a"
      unitRef="usd">124892000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzYtNS0xLTEtMA_3d70c106-581a-4308-9e56-b088c205ea00"
      unitRef="usd">61981000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzctMS0xLTEtMA_05d2bb0f-47f2-4078-bac2-c7653c530af4"
      unitRef="usd">0</dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment>
    <dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzctMy0xLTEtMA_38970846-92d2-4532-827c-f47376b4abea"
      unitRef="usd">0</dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment>
    <dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzctNS0xLTEtMA_2f57c177-cbb9-41ff-81d5-66ec9b0a0b05"
      unitRef="usd">316840000</dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment>
    <dva:DebtRefinancingCharges
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzgtMS0xLTEtMA_e9994244-d9c5-4072-9bb0-325f295bd93a"
      unitRef="usd">86957000</dva:DebtRefinancingCharges>
    <dva:DebtRefinancingCharges
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzgtMy0xLTEtMA_895b7bc3-24dd-45cb-baa5-486c97b3b286"
      unitRef="usd">33402000</dva:DebtRefinancingCharges>
    <dva:DebtRefinancingCharges
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzgtNS0xLTEtMA_8604a393-13c9-4fe9-9c2f-4f399b392d9d"
      unitRef="usd">0</dva:DebtRefinancingCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzktMS0xLTEtMA_125c9075-3d86-4fa0-982e-db85eacd9b62"
      unitRef="usd">91458000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzktMy0xLTEtMA_2eb37ee7-9d1e-4076-95bf-92222fa0e287"
      unitRef="usd">67850000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzktNS0xLTEtMA_0af9115d-7c8d-4b70-9454-41c145beb6b1"
      unitRef="usd">73061000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEwLTEtMS0xLTA_fd5c4fb0-f622-4f10-bfec-e9ced3866bfd"
      unitRef="usd">240848000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEwLTMtMS0xLTA_4f4fd27a-a821-4929-a03a-2c162ec8339c"
      unitRef="usd">41723000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEwLTUtMS0xLTA_7e467b51-b21e-40d4-8a09-4af5f657003f"
      unitRef="usd">273660000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzExLTEtMS0xLTA_e1c52525-b1af-4d94-af30-926829501f7d"
      unitRef="usd">-13830000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzExLTMtMS0xLTA_2dcee004-1384-4419-88f7-1a38931bf359"
      unitRef="usd">-8582000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzExLTUtMS0xLTA_527fe4c7-fa42-4f02-91a2-48eabcea4eb3"
      unitRef="usd">-26449000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEyLTEtMS0xLTA_720d3a9f-67c0-4910-bdd3-687e6835da2f"
      unitRef="usd">24248000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEyLTMtMS0xLTA_c18ea45a-57c1-4ff7-a902-22fb1e8d138e"
      unitRef="usd">23022000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <dva:NetLossGainOnDispositionOfBusinessInterests
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEyLTUtMS0xLTA_ce713d59-65d7-4767-8e28-3ba5bfb82163"
      unitRef="usd">85699000</dva:NetLossGainOnDispositionOfBusinessInterests>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEzLTEtMS0xLTA_03e624e4-a74c-464c-ad3b-ed1d88f91e68"
      unitRef="usd">-747000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEzLTMtMS0xLTA_8eab4c5a-dd2d-4f3f-8472-409fa937e563"
      unitRef="usd">-49579000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzEzLTUtMS0xLTA_23abaa6e-cc21-4dae-a909-b7d97b61a78e"
      unitRef="usd">-82374000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE1LTEtMS0xLTA_f47c4b35-0703-4e5e-8427-c9c01ee5dde4"
      unitRef="usd">21087000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE1LTMtMS0xLTA_5d9accf2-e2df-4ec2-9373-398c6bb196f1"
      unitRef="usd">79957000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE1LTUtMS0xLTA_7cc38df2-84b9-4a5b-a0a3-5f6f0102d756"
      unitRef="usd">81176000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE2LTEtMS0xLTA_e01fed9f-d62e-4d80-804b-73a9e196deff"
      unitRef="usd">12349000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE2LTMtMS0xLTA_87140f2d-03dc-493a-8820-1619718cfb3f"
      unitRef="usd">-10158000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE2LTUtMS0xLTA_3f9afbbe-8090-4743-bd6a-3eab47afbab8"
      unitRef="usd">-73505000</us-gaap:IncreaseDecreaseInInventories>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE3LTEtMS0xLTA_8abc2ead-1464-46f4-ace9-81924e549c80"
      unitRef="usd">79277000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE3LTMtMS0xLTA_f29adb7f-56d6-48e3-abf6-22ce5056c8b9"
      unitRef="usd">-2790000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE3LTUtMS0xLTA_bfcc02f3-55a2-4fe7-ae0c-9c3c7685438b"
      unitRef="usd">-236995000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE4LTEtMS0xLTA_46b4e91b-91c6-4e2d-8216-36a20666b174"
      unitRef="usd">6123000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE4LTMtMS0xLTA_3aee5e6b-4d02-40ea-ae46-86676256a781"
      unitRef="usd">-6965000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE4LTUtMS0xLTA_a09e5671-8fb0-4181-8d77-c682b888b774"
      unitRef="usd">-3497000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE5LTEtMS0xLTA_dd2037e3-935e-4b28-be29-65a22a52a764"
      unitRef="usd">37200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE5LTMtMS0xLTA_577a388f-e2cc-49ae-a0f8-51d6ee0090e0"
      unitRef="usd">-84539000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzE5LTUtMS0xLTA_b312d6c2-aaad-4e14-afc3-1bed37553b55"
      unitRef="usd">-35959000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIwLTEtMS0xLTA_29166071-dbcc-4c7d-a6b3-1323015f4401"
      unitRef="usd">-20931000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIwLTMtMS0xLTA_1ffe2053-f0ce-414a-8083-47e05aa8518e"
      unitRef="usd">-14697000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIwLTUtMS0xLTA_bc543e95-0257-4780-baa9-0c3f99c58d11"
      unitRef="usd">84165000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIxLTEtMS0xLTA_01f2f658-0d67-4b0b-8328-7dd49afb65bb"
      unitRef="usd">105637000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIxLTMtMS0xLTA_e4d22172-7122-40b6-bbe8-eba4b9262b88"
      unitRef="usd">181940000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIxLTUtMS0xLTA_347ee363-8e56-4c95-affa-9189f905e66f"
      unitRef="usd">-157462000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIyLTEtMS0xLTA_2b9a71fd-c981-4cd9-904a-10fd23347aa7"
      unitRef="usd">-87391000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIyLTMtMS0xLTA_da78e4c2-6f61-4873-a7ce-629fc80f51c8"
      unitRef="usd">95645000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIyLTUtMS0xLTA_9b016315-ae2b-452c-a85e-0d963dcd96de"
      unitRef="usd">-23635000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIzLTEtMS0xLTA_8bc5d620-e4b3-4c9c-9fb3-b177eb647ee4"
      unitRef="usd">-19851000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIzLTMtMS0xLTA_86f556f3-d8d8-412f-9cc4-0593111aee5c"
      unitRef="usd">-31446000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzIzLTUtMS0xLTA_5ebc14b5-1169-4ae2-87ff-8dd4a723b8f8"
      unitRef="usd">-1031000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI0LTEtMS0xLTA_e45c6b9b-a699-40e0-9fe4-1574294d0c84"
      unitRef="usd">1979028000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI0LTMtMS0xLTA_773662dd-f4f0-4f04-85d2-ad1af5d0c40b"
      unitRef="usd">2072355000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI0LTUtMS0xLTA_a2d0df79-3457-4b6c-afc1-fabab40343f7"
      unitRef="usd">1771640000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI2LTEtMS0xLTA_9cf5bef1-e389-4b02-89d3-00e04bdd0411"
      unitRef="usd">674541000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI2LTMtMS0xLTA_75e7d8c6-cbb6-4c08-8f99-0c74076762f9"
      unitRef="usd">766546000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI2LTUtMS0xLTA_36a87438-2cae-4c72-91be-cd985c33b16d"
      unitRef="usd">987138000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI3LTEtMS0xLTA_f1227ccd-18cb-4503-a3fa-1b6f157c0075"
      unitRef="usd">182013000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI3LTMtMS0xLTA_82ae734f-d509-4880-ab36-20643209124c"
      unitRef="usd">100861000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI3LTUtMS0xLTA_87460e77-414b-4cd1-a9b7-6f1a781af6da"
      unitRef="usd">183156000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI4LTEtMS0xLTA_4908fb23-1009-408a-b0e0-7a2e6d55e397"
      unitRef="usd">50139000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI4LTMtMS0xLTA_4f2b1359-f717-4f37-8c3e-b62cab8a3f72"
      unitRef="usd">3877392000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI4LTUtMS0xLTA_b2cc74ae-6123-48f1-8364-d1cb0667161f"
      unitRef="usd">150205000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTEtMS0xLTYyNQ_57b3a8a8-8bcc-4621-bde8-cc5b5bdfab75"
      unitRef="usd">150701000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTMtMS0xLTYyNQ_a4d28908-1668-4600-a930-85a663a406f4"
      unitRef="usd">101462000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTUtMS0xLTYyNQ_d282d432-0f7f-42ef-b562-dde1aa2bf99f"
      unitRef="usd">5963000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTEtMS0xLTA_462fbd54-b581-49a6-b600-1e207bc0309f"
      unitRef="usd">3757000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTMtMS0xLTA_334f6e80-1990-4c09-a4c8-a06fe9daa071"
      unitRef="usd">5458000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzI5LTUtMS0xLTA_df46c8e3-42b7-4a07-9308-fecf633edcad"
      unitRef="usd">8448000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTEtMS0xLTYzMQ_64d46774-6bb0-402a-b516-e62949c154e1"
      unitRef="usd">151213000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTMtMS0xLTYzMQ_ee4117b3-a658-49c6-b37b-496059270712"
      unitRef="usd">95376000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTUtMS0xLTYzMQ_3b7de801-8ede-4423-8e55-256f1b89948e"
      unitRef="usd">34862000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTEtMS0xLTA_8047f9c2-6b77-471e-99d5-20c1a28dd54e"
      unitRef="usd">3491000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTMtMS0xLTA_664ee3d8-6f0d-4e48-8550-95f38e60ae01"
      unitRef="usd">3676000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMxLTUtMS0xLTA_6fb916f1-5ca0-461c-b869-dcab87353ecb"
      unitRef="usd">9526000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMzLTEtMS0xLTA_e8f4f883-da20-4c1e-ac10-92303804c3a0"
      unitRef="usd">22341000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMzLTMtMS0xLTA_7e33f004-4539-4bc4-a79d-86d65fbeaf34"
      unitRef="usd">9366000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzMzLTUtMS0xLTA_dac441f0-1187-440b-9eb1-3013f4bb39dd"
      unitRef="usd">19177000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM0LTEtMS0xLTA_94aac866-1bc6-4744-8432-2012f1b7492b"
      unitRef="usd">3139000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM0LTMtMS0xLTA_c08f5c2a-a9b2-4a30-9481-4847c00bc4d5"
      unitRef="usd">2589000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM0LTUtMS0xLTA_2cabb512-e338-49f6-ab36-4dcf2dfbef48"
      unitRef="usd">3646000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM1LTEtMS0xLTA_bf50187a-c90e-4a24-9b50-557b79cdd485"
      unitRef="usd">-825371000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM1LTMtMS0xLTA_ca7b3172-3efe-43cf-b588-af7c03c9854c"
      unitRef="usd">2995340000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM1LTUtMS0xLTA_1cb55d14-55d7-42bc-a7a6-32a691c5f41a"
      unitRef="usd">-1005643000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM3LTEtMS0xLTA_d5b50b5f-9259-4da2-b399-b4c42c88eaf3"
      unitRef="usd">4046775000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM3LTMtMS0xLTA_322a1fcf-e54c-49e9-963d-1aa328627fda"
      unitRef="usd">38525850000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM3LTUtMS0xLTA_4c09bc36-1c82-44ee-9d24-4a39968161f8"
      unitRef="usd">59934750000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM4LTEtMS0xLTA_e246b81f-68c6-4b10-9c30-1de27e67359e"
      unitRef="usd">4110304000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM4LTMtMS0xLTA_f16d7c9d-a403-49e3-8492-717a4496792e"
      unitRef="usd">40520722000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM4LTUtMS0xLTA_204af097-842f-4087-a3df-5066b7bb0667"
      unitRef="usd">59234946000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <dva:DebtFinancingAndDebtRedemptionCosts
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTEtMS0xLTY3Mw_88c05d69-778b-4ce9-a1b0-0215dbcc58ea"
      unitRef="usd">105848000</dva:DebtFinancingAndDebtRedemptionCosts>
    <dva:DebtFinancingAndDebtRedemptionCosts
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTMtMS0xLTY3Mw_3b59cda0-824d-4aee-9e74-17721cd4b9c1"
      unitRef="usd">85319000</dva:DebtFinancingAndDebtRedemptionCosts>
    <dva:DebtFinancingAndDebtRedemptionCosts
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTUtMS0xLTY3Mw_c9c7b0c0-7a9f-483f-bfd8-d9b09e4f8146"
      unitRef="usd">5027000</dva:DebtFinancingAndDebtRedemptionCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTEtMS0xLTA_fc205cde-02d1-476a-adcb-3c73642018b7"
      unitRef="usd">1458442000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTMtMS0xLTA_6f2c1b9f-5fd9-4faf-8f6d-98df3eaf1497"
      unitRef="usd">2383816000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzM5LTUtMS0xLTA_64b528da-c9dd-4364-bea2-e16d6e353523"
      unitRef="usd">1161511000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQwLTEtMS0xLTA_a05906cc-c7ed-4492-8678-b00481b4409d"
      unitRef="usd">253118000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQwLTMtMS0xLTA_d3799ea7-9d1d-4285-8317-a58788e73449"
      unitRef="usd">233123000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQwLTUtMS0xLTA_4827cbee-25a1-4344-992b-94e4ebcda21d"
      unitRef="usd">196441000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <dva:PaymentsRelatedToStockPurchasesAndAwards
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQxLTEtMS0xLTA_6239f210-681e-4351-9552-dd8d9ddc3733"
      unitRef="usd">975000</dva:PaymentsRelatedToStockPurchasesAndAwards>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQxLTMtMS0xLTA_e21a5546-8655-4a06-bf31-2fccb1673fc7"
      unitRef="usd">11382000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQxLTUtMS0xLTA_3e5e62fb-b8be-4eab-a2a7-72839eb4bbb5"
      unitRef="usd">13577000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQyLTEtMS0xLTA_c2ba8ef2-9d61-48b6-a81e-a8358a656bd2"
      unitRef="usd">42966000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQyLTMtMS0xLTA_d2e95edd-5a2b-4c94-936f-6d434ad323f5"
      unitRef="usd">57317000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQyLTUtMS0xLTA_e87624ab-c486-43d6-954a-883d5ccf3594"
      unitRef="usd">52311000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQzLTEtMS0xLTA_6394b55d-7abc-4b88-9b1a-79e103f0eaf9"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQzLTMtMS0xLTA_38194a1f-7b2c-4792-8730-04fa1b7dc2f4"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQzLTUtMS0xLTA_fb5dadf9-8dff-493c-a0b7-5ba0fd8ba6c1"
      unitRef="usd">15000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ0LTEtMS0xLTA_edd0b099-c966-4180-b494-449da3cbd1bc"
      unitRef="usd">7831000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ0LTMtMS0xLTA_bfb04f25-3594-4826-accc-93e1141ee84d"
      unitRef="usd">68019000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ0LTUtMS0xLTA_e1860bbb-d269-4641-8708-6f73e41e4d13"
      unitRef="usd">28082000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ1LTEtMS0xLTA_cfccfa1b-a379-4e89-b449-f37af898f8cd"
      unitRef="usd">-1846777000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ1LTMtMS0xLTA_c90777d0-9f9a-4542-8044-7dd9392de2ca"
      unitRef="usd">-4696450000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ1LTUtMS0xLTA_ea28b7e9-22b7-4b24-b2ee-0e1ea8e686b9"
      unitRef="usd">-625354000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ2LTEtMS0xLTA_e3b7eae2-a0c9-4626-8f12-c5450004b5a6"
      unitRef="usd">-13808000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ2LTMtMS0xLTA_c1553335-dc58-4027-82e9-a891ec209c87"
      unitRef="usd">-1760000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ2LTUtMS0xLTA_b8835e8d-2d7d-4d5d-8dee-95c447c5def4"
      unitRef="usd">-3350000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ3LTEtMS0xLTA_d005edc0-041e-4d9a-ae98-5c98fb750470"
      unitRef="usd">-706928000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ3LTMtMS0xLTA_9560055f-3063-4af4-ab59-a4a5c37c9a11"
      unitRef="usd">369485000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ3LTUtMS0xLTA_ef57651a-f404-4bc2-bb2a-6bafc9831eb2"
      unitRef="usd">137293000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7411005e6a69450f90e334cbe2a78126_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ4LTEtMS0xLTA_c9f1e791-2d91-4bf3-bd04-16045a4bc654"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3fac62eb6d9e438d9cffedfad9480206_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ4LTMtMS0xLTA_5b703ffe-0d61-4dcc-842a-3e2f378df496"
      unitRef="usd">-423813000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i84f9f0f6c1854cc2b831462ed14ee61e_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ4LTUtMS0xLTA_a4b362e3-99d3-413a-8b49-4e7efadb34e2"
      unitRef="usd">240793000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iea92518235484ea8bf5f60c37164f758_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ5LTEtMS0xLTA_035e381e-2b1b-495f-834c-78621106693d"
      unitRef="usd">-706928000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i339c0adb944141beb35f1f190097beba_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ5LTMtMS0xLTA_11c71b01-b6e1-4ab7-92c7-7ede86190957"
      unitRef="usd">793298000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7aed65b31414464481f45589046dd452_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzQ5LTUtMS0xLTA_a9613723-6b31-4772-8b52-c83b722a261b"
      unitRef="usd">-103500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUwLTEtMS0xLTA_65c77ae4-8f81-4e50-96d8-da0c8db6826a"
      unitRef="usd">1208718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUwLTMtMS0xLTA_a5b41010-cd8f-46b1-9acd-ae2a531edb4f"
      unitRef="usd">415420000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iee29f3075d90411e97da80cfb155be40_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUwLTUtMS0xLTA_e1b35b04-692e-4449-9030-a3bd30788ad8"
      unitRef="usd">518920000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUxLTEtMS0xLTA_44b49fad-ead4-4553-ad60-adf064a2c330"
      unitRef="usd">501790000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUxLTMtMS0xLTA_3f614174-a436-407b-92e3-853a39e5a467"
      unitRef="usd">1208718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODQvZnJhZzo5NDFmOGQyMTRiNTQ0NjNjYWViZjg3ZGE1ZTEyMzNmMi90YWJsZToxNTRmNTdmNTUzYjk0YTYxYTMxZTAzODNkZjJjNjZjZi90YWJsZXJhbmdlOjE1NGY1N2Y1NTNiOTRhNjFhMzFlMDM4M2RmMmM2NmNmXzUxLTUtMS0xLTA_bab47018-a180-4acf-acab-c919b4727bb1"
      unitRef="usd">415420000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i821341ce571140c0813c92a7b329684f_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMS0xLTEtMA_4dca24bb-bcbd-4e45-af4b-3332d878b4c3"
      unitRef="usd">1011360000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic7a7ef37ab494bd3867be9a034c8ae17_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMy0xLTEtMA_78922e78-054a-433a-acab-8c10bc5d5654"
      unitRef="shares">182462000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7a7ef37ab494bd3867be9a034c8ae17_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtNS0xLTEtMA_9b1ef53b-4e25-4780-bd03-0ec22157f60f"
      unitRef="usd">182000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i036278cf7d8347788f7fcdf25acbf8b5_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtNy0xLTEtMA_8090e9bc-63c4-4e80-ae6b-7d43513ee558"
      unitRef="usd">1042899000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9adcf1b689594ff49c7827e7c45a99ba_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtOS0xLTEtMA_96c8a8e9-35c2-438f-8a31-6e8c30e6e7ef"
      unitRef="usd">3633713000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i11909335cca546ad85c586bcfb13dce1_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTEtMS0xLTA_f3f94710-ae0a-4eb4-924d-c95545af5ca3"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i11909335cca546ad85c586bcfb13dce1_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTMtMS0xLTA_121805f2-e054-4cd5-862f-55b28903ac37"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6e22f6f3f724a35bed885f82b31bb8a_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTUtMS0xLTA_56c91e74-583b-4b48-a3d2-07d868c9efe8"
      unitRef="usd">13235000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d06c26940f24e1fbe98edcd4bba0d49_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTctMS0xLTA_7b58f27c-1609-4748-9029-d7b50b2b556f"
      unitRef="usd">4690029000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b135446f5334d709fef3456c13e371b_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMtMTktMS0xLTA_a3cb07e7-4370-4fce-9a7d-ce12da773984"
      unitRef="usd">196037000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie32a7f3467e74c40b5ee59a7db8b3af9_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzQtOS0xLTEtNDc1_44ef360f-777c-4c7c-b478-868cc8b950e7"
      unitRef="usd">8368000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a10dd7b6f72489798f395a4ba7d5774_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzQtMTUtMS0xLTQ3NQ_52c487dd-4a90-4c66-9941-32da227a6698"
      unitRef="usd">-8368000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2999225279c547bb86d45264eed0b5a9_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzQtMTctMS0xLTQ3NQ_299a259a-36e3-49ca-8bc6-bbddc3bea0de"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtMS0xLTEtMA_e7a25000-66a9-442a-b129-5ead5eb26425"
      unitRef="usd">105531000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="if64308cbce6e4abe90bdf552304e7cbe_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtOS0xLTEtMA_07015395-8673-4e33-88b0-cdedd53ce334"
      unitRef="usd">159394000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtMTctMS0xLTA_2250109d-ca62-4c53-adac-30d0528c2ae7"
      unitRef="usd">159394000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzUtMTktMS0xLTA_64a3a08e-0d10-43c1-9864-12a66352ecee"
      unitRef="usd">68115000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b5d1183ea1e473eaec3e4b8f2b2518b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzYtMTUtMS0xLTA_2108ccd3-6968-4642-9409-53be55439e67"
      unitRef="usd">-39791000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzYtMTctMS0xLTA_8829e80a-d405-4f88-8b07-883874c25ded"
      unitRef="usd">-39791000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzctMy0xLTEtMA_3fe9f502-9d4a-4675-9069-d759b80ee00d"
      unitRef="shares">398000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktNS0xLTEtMjEzMjU_f85ba4d8-3f65-46b6-adb9-884d0fda57a5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzctNy0xLTEtMA_f7449a49-cef2-47b4-83f5-561496774af5"
      unitRef="usd">17398000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzctMTctMS0xLTA_3b3439c4-731e-4ebf-a474-367e2c1e6ecb"
      unitRef="usd">17398000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktMy0xLTEtMzc0NA_cf46c30d-3ce4-48ae-a904-0f24484ab370"
      unitRef="shares">371000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktNS0xLTEtMzc0OQ_4ed89f1f-fc2e-44a4-822b-3303f30fe1d6"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktNy0xLTEtMzc0OQ_5cddeb62-bb50-465c-b285-49250dee1ffb"
      unitRef="usd">5335000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzktMTctMS0xLTM3NTE_82dbf58d-19b4-4a7d-b005-8d2a46383499"
      unitRef="usd">5334000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEwLTctMS0xLTA_38836730-2670-415f-bf12-65b4b0857fb1"
      unitRef="usd">73081000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEwLTE3LTEtMS0w_5ab06084-fb9a-4e4e-a738-ffb6b174f02c"
      unitRef="usd">73081000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEyLTEtMS0xLTA_6a9ceeea-9c5a-47df-86b1-5f62a8cec2ea"
      unitRef="usd">119173000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEyLTE5LTEtMS0w_46897c3f-3e60-41c1-9996-91fa4ff60ef6"
      unitRef="usd">77268000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEzLTEtMS0xLTA_8fddf151-8951-48da-94e7-c7bb8abb1578"
      unitRef="usd">32918000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzEzLTE5LTEtMS0w_bd400df4-73c5-4d5b-9cc6-f553efaa1905"
      unitRef="usd">19393000</dva:NoncontrollingInterestIncreaseFromContributions>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTEtMS0xLTA_237316e4-2749-4af1-8538-0d35d5546d04"
      unitRef="usd">79078000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTctMS0xLTA_f34a72a2-a78c-4e59-b1a3-02178e3cbe66"
      unitRef="usd">3546000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTE3LTEtMS0w_580e13cc-1790-4016-a75d-2bb14c1ce703"
      unitRef="usd">3546000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE0LTE5LTEtMS0w_7646787a-1d1c-44fb-82d1-3d3425d2f0c8"
      unitRef="usd">318000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTEtMS0xLTA_3e4412ff-8479-4ade-86b4-01f4216a69a8"
      unitRef="usd">8546000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTctMS0xLTA_aea80f45-1cb2-49ca-ba15-1124b2861fce"
      unitRef="usd">17897000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTE3LTEtMS0w_8ede897b-8407-4480-9095-fcdb3b56c4d0"
      unitRef="usd">17897000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ie74df117a019457aab66dcc662ec6d62_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE1LTE5LTEtMS0w_efb1e076-03ec-4809-94e8-1b5bd7f74523"
      unitRef="usd">1639000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i445a58d7a538433cbe5388f491a72f4c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE2LTEtMS0xLTA_cacd8530-af3f-4f39-b328-6becbb78e8b1"
      unitRef="usd">23473000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE2LTctMS0xLTA_7943cd85-8896-4a34-afbb-c4df35e14b55"
      unitRef="usd">-23473000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE2LTE3LTEtMS0w_0bb632d0-4bf1-4f0d-8b9d-014c92c67013"
      unitRef="usd">-23473000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE3LTExLTEtMS0w_b117c01a-c128-40ee-b0a4-0e25ca506dac"
      unitRef="shares">16844000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE3LTEzLTEtMS0w_c42730c6-e3d0-41f6-8dcd-38dca646a876"
      unitRef="usd">1153511000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE3LTE3LTEtMS0w_1541b736-64c1-4bec-93b3-4bbcd3337a50"
      unitRef="usd">1153511000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTMtMS0xLTA_65cdaa69-46d4-4ed5-9918-c06d6cc9b182"
      unitRef="shares">16844000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i66313af05c484394a3714b810b898338_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTUtMS0xLTA_a48db9c1-db0f-4dfd-baf2-77160277ea65"
      unitRef="usd">17000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTctMS0xLTA_2900ff3c-697e-4db8-a6db-b948144a60fa"
      unitRef="usd">95213000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="if64308cbce6e4abe90bdf552304e7cbe_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTktMS0xLTA_453d9239-5a37-48ee-b48c-48b4656ebf8a"
      unitRef="usd">1058281000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTExLTEtMS0w_6d4721a0-7df0-4679-9447-99283f9c912c"
      unitRef="shares">-16844000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ie122f31fa48a4e418749b479aaa5a563_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE4LTEzLTEtMS0w_5905890f-499e-4ad7-89c1-baf37b8259c5"
      unitRef="usd">-1153511000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i377c744b53834d1ab139aecb360ade3f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE3LTEtMS01MDU_c5eb19d8-0d3f-46a8-8cbd-5e503edb8de8"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ie5b8c698b4f44d7b880f261b5acd9515_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTEtMS0xLTA_c95a7165-107c-4deb-9165-adb0004b59b0"
      unitRef="usd">1124641000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7ade1676d7ef4cda9e4d3f1b875b9feb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTMtMS0xLTA_b1543c13-e330-4771-8dac-fa7ab8d565a2"
      unitRef="shares">166387000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ade1676d7ef4cda9e4d3f1b875b9feb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTUtMS0xLTA_d12d337a-e1c6-4a26-a1aa-8f7f6a0920a6"
      unitRef="usd">166000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc34c3096bcb4003b347988f2fb970ad_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTctMS0xLTA_788a97ce-6a93-4a5a-bda6-a9cbade1fd30"
      unitRef="usd">995006000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa5780e8d82a48b59708a1ff1276a66c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTktMS0xLTA_4fd69c5f-5ccb-4534-9406-887ec9529dbf"
      unitRef="usd">2743194000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3387e99cd35649b49ab4860ac21de1b2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTExLTEtMS0w_541dafa6-b90e-48d8-8b58-390730cdce65"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3387e99cd35649b49ab4860ac21de1b2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTEzLTEtMS0w_17607759-d601-44f6-bdc2-3631f1309562"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9d247586e6c4138a61320064b0c31f7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE1LTEtMS0w_74957ece-4d82-4ddd-9109-bc2e64dec59c"
      unitRef="usd">-34924000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib825ca1aa06a4e079d3c844ba6177f19_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE3LTEtMS0w_a8cdfe93-7e82-42ac-bcdc-7a6a43c90809"
      unitRef="usd">3703442000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4c874d135ae405b86b7b38ebcf9f62c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzE5LTE5LTEtMS0w_542b6ed9-a6f0-4504-aab9-57d83ad5ebe6"
      unitRef="usd">204956000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iecd4fd2059754cc49cb4f8aac8c883f1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIxLTEtMS0xLTUxMg_15bf8df9-45e2-4e41-8c13-5453bb22a88c"
      unitRef="usd">-38000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25f880539ba04aa6bf3a2d7cf33b0b29_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIwLTktMS0xLTA_93b0bb5a-e5e3-4a3a-aac5-72c39524a240"
      unitRef="usd">39876000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice9f2467e9a64adeaff985f8e4c19438_I20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIwLTE1LTEtMS0w_09620955-574c-4c3f-902f-e77a78162b24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e915932320b4ae6acd3fbb11411779a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIwLTE3LTEtMS0w_679c35b0-7bd2-40e1-8a2d-4648ae94c4c6"
      unitRef="usd">39876000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5bb9dfef3744514a0f063432ab36168_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIxLTE5LTEtMS01MjQ_321bd97c-605f-425c-bce3-389192b4e677"
      unitRef="usd">-6000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTEtMS0xLTA_48251a48-ebd2-437d-b518-5069cb103dfa"
      unitRef="usd">143413000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5495b245d279498ba671db088b9cd741_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTktMS0xLTA_16ac8d7b-190e-45d1-ac48-61e0d5a262b7"
      unitRef="usd">810981000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTE3LTEtMS0w_1363ecb2-f389-46f2-9a36-f13abf00c1ee"
      unitRef="usd">810981000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIyLTE5LTEtMS0w_42826e86-495d-4db3-a2ac-41d68baaaab8"
      unitRef="usd">66900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id00ebe3d20f44469990e8c005164fa4a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIzLTE1LTEtMS0w_953934d5-f934-4af4-a623-dc6c57e1f698"
      unitRef="usd">-12574000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzIzLTE3LTEtMS0w_d6df895d-1429-4056-857a-ce17ae4075c2"
      unitRef="usd">-12574000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI0LTMtMS0xLTA_8e95b92b-4dc5-499b-8c34-84cb28918e58"
      unitRef="shares">315000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTUtMS0xLTUxOQ_c077fa3f-6066-4a35-9c8b-3c46850c25b4"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI0LTctMS0xLTA_9bf18429-92d8-4ca7-b474-95cec58b0fde"
      unitRef="usd">16569000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI0LTE3LTEtMS0w_61b19670-fc31-431f-ac15-e9e6f369ef2a"
      unitRef="usd">16570000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTMtMS0xLTM3NzE_811163a8-028e-44b8-b5a1-c17694790096"
      unitRef="shares">161000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI2LTUtMS0xLTIxMzMx_7c74baf2-91a3-47b4-b95a-af61feea9b5c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTctMS0xLTM3NzE_71c966f4-aa48-4a4b-9bda-f723fdc59308"
      unitRef="usd">3290000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI1LTE3LTEtMS0zNzcx_241c7e3e-0e92-4f2e-b572-009bac85fa1a"
      unitRef="usd">3290000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI3LTctMS0xLTA_b54bcbe9-d5c8-4a6c-b517-64cbe1e8ff5c"
      unitRef="usd">67549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI3LTE3LTEtMS0w_14ace259-988f-4e5e-abd0-20069ac5337a"
      unitRef="usd">67549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI5LTEtMS0xLTA_dbf47415-0ac8-467d-8793-dc417b40388e"
      unitRef="usd">155011000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzI5LTE5LTEtMS0w_58b0d79d-412d-4bf5-8ac4-6532b45f7f7c"
      unitRef="usd">78112000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMwLTEtMS0xLTA_1a2f0af6-78b5-4592-9e64-5154fc36ff2f"
      unitRef="usd">35572000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMwLTE5LTEtMS0w_83f1d03d-7fe8-473a-a52a-32c4422590a9"
      unitRef="usd">21745000</dva:NoncontrollingInterestIncreaseFromContributions>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMxLTEtMS0xLTA_e0cb866a-73e1-480d-9712-d0dc5663c387"
      unitRef="usd">-6332000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMxLTE5LTEtMS0w_a3dce628-04ce-4dfd-81df-5f12b304be2f"
      unitRef="usd">-10170000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTEtMS0xLTA_f181936d-ee4f-4bda-a8ba-cb0ba59db2ff"
      unitRef="usd">11394000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTctMS0xLTA_166882d3-fde8-4516-8a9c-2e6a51d19f88"
      unitRef="usd">37145000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTE3LTEtMS0w_ab91eba9-2a05-489b-aca3-6c44b7e1d7a0"
      unitRef="usd">37145000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i5a96a317245446879f226ad58e296daa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMyLTE5LTEtMS0w_f7fa6000-eaf3-4132-b9dd-c4c5fe9deae7"
      unitRef="usd">19480000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i84b966e5887040ab818abe14226ea392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMzLTEtMS0xLTA_79fc7662-c27f-4bb5-ba63-d65b244cafa7"
      unitRef="usd">49525000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMzLTctMS0xLTA_8d051844-9e36-483b-b69b-19a0d9831662"
      unitRef="usd">-49525000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzMzLTE3LTEtMS0w_7609f785-a946-4ce5-9485-86d876fdfae4"
      unitRef="usd">-49525000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM0LTExLTEtMS0w_5e5ae116-3854-4f55-98cd-ab6830cb8494"
      unitRef="shares">41020000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM0LTEzLTEtMS0w_fab24964-49ba-4d29-b859-9a794cb3eef9"
      unitRef="usd">2402475000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM0LTE3LTEtMS0w_fd6bc099-5eab-4718-a5b8-1b9c25aa9761"
      unitRef="usd">2402475000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTMtMS0xLTA_d86ff850-16fd-48eb-a2b6-2f3541985ccd"
      unitRef="shares">41020000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i62f93b6e03ab4043b112a35b4616caa4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTUtMS0xLTA_7c5d8e4c-0016-4fcb-a018-8891dfe5f1d2"
      unitRef="usd">41000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTctMS0xLTA_add8c05a-def7-4406-b292-9b361869a110"
      unitRef="usd">240121000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5495b245d279498ba671db088b9cd741_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTktMS0xLTA_bfca850c-ab2f-41b6-b7eb-272f22392796"
      unitRef="usd">2162313000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTExLTEtMS0w_793d41de-bc0d-44ae-9867-a58e196b675b"
      unitRef="shares">-41020000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ice1f36af9bc048baa128c35877b2c65f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTEzLTEtMS0w_be16b6be-4cba-4374-8a7a-0f65e607007a"
      unitRef="usd">-2402475000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i21ae63fd516940c09d9b3f9a37baf346_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM1LTE3LTEtMS0w_8e512243-01b9-4de8-b7e4-11e63dacfb01"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i12d1c51a49e14e6280972be024b74db0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTEtMS0xLTA_fe99618a-ae31-421f-ba30-482d58bd7a85"
      unitRef="usd">1180376000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTMtMS0xLTA_43a12928-5677-4326-9ba4-0866e43f21a1"
      unitRef="shares">125843000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTUtMS0xLTA_2be81d5d-ac8b-4aa2-9fab-d44b4d7e6feb"
      unitRef="usd">126000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42fa656b3e574210b01ef1b7211cc59f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTctMS0xLTA_1bd00f4f-a420-4a07-863c-a49de330ee3f"
      unitRef="usd">749043000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ce9502863624611b7b5cfc59cc39ee9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTktMS0xLTA_191d37d2-7ad3-48f4-995a-bcd4896c2a6f"
      unitRef="usd">1431738000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTExLTEtMS0w_b6f0e8cd-f560-478d-999c-5928957671ca"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTEzLTEtMS0w_b5fe7c26-592a-41f2-a824-f1586201e7e8"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if90c222c41994c9798b61036606e41ed_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTE1LTEtMS0w_6eff05b0-f70a-4d79-8514-cf137769a394"
      unitRef="usd">-47498000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15c39adcdfcd42309a9115c0d0fdcc55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTE3LTEtMS0w_4484e9bc-e30a-4fcf-8a60-a1eb20b9542d"
      unitRef="usd">2133409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0e12f9281dc4d0f9e7d785149a69a88_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZTpmYTcxMDJjOWUyNjI0YTkxYmFjNjY0NTMyM2E0MmVmMi90YWJsZXJhbmdlOmZhNzEwMmM5ZTI2MjRhOTFiYWM2NjQ1MzIzYTQyZWYyXzM2LTE5LTEtMS0w_3e3a1058-a827-4232-9904-b3529a944fbc"
      unitRef="usd">185833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i12d1c51a49e14e6280972be024b74db0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMS0xLTEtMA_fe99618a-ae31-421f-ba30-482d58bd7a85"
      unitRef="usd">1180376000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMy0xLTEtMA_43a12928-5677-4326-9ba4-0866e43f21a1"
      unitRef="shares">125843000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d5e9b53ace74efe9eed270c48169e97_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtNS0xLTEtMA_2be81d5d-ac8b-4aa2-9fab-d44b4d7e6feb"
      unitRef="usd">126000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42fa656b3e574210b01ef1b7211cc59f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtNy0xLTEtMA_1bd00f4f-a420-4a07-863c-a49de330ee3f"
      unitRef="usd">749043000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ce9502863624611b7b5cfc59cc39ee9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtOS0xLTEtMA_191d37d2-7ad3-48f4-995a-bcd4896c2a6f"
      unitRef="usd">1431738000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTEtMS0xLTA_b6f0e8cd-f560-478d-999c-5928957671ca"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1759c41f6f1649ea99256fdf926d649e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTMtMS0xLTA_b5fe7c26-592a-41f2-a824-f1586201e7e8"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if90c222c41994c9798b61036606e41ed_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTUtMS0xLTA_6eff05b0-f70a-4d79-8514-cf137769a394"
      unitRef="usd">-47498000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15c39adcdfcd42309a9115c0d0fdcc55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTctMS0xLTA_4484e9bc-e30a-4fcf-8a60-a1eb20b9542d"
      unitRef="usd">2133409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0e12f9281dc4d0f9e7d785149a69a88_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzQtMTktMS0xLTA_3e3a1058-a827-4232-9904-b3529a944fbc"
      unitRef="usd">185833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtMS0xLTEtMA_0d7c781a-0a91-4e6b-bb04-861d87d333a1"
      unitRef="usd">141879000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i55b232edb6214093a0c5d7e31595d14d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtOS0xLTEtMA_7d93289d-2836-4b0e-80e8-303c09456cbc"
      unitRef="usd">773642000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtMTctMS0xLTA_aba02c1b-e315-41e3-83a3-50e4118339c9"
      unitRef="usd">773642000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzYtMTktMS0xLTA_67a31b01-16f5-448b-b1a6-1555be60eea9"
      unitRef="usd">79156000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3fc62187afaa4e38b48175be5f574c2c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzctMTUtMS0xLTA_a908abbd-a03c-4792-9fc1-47e6af7c1637"
      unitRef="usd">-18656000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzctMTctMS0xLTA_bccb3d8d-19a3-4321-a85c-de12aab02a15"
      unitRef="usd">-18656000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtMy0xLTEtMA_a3c98aa0-7e21-4daa-85c5-c40a04c6eab6"
      unitRef="shares">222000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtNS0xLTEtMA_05a2f63d-a7ed-413a-8de2-a7f79a0ab7f5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtNy0xLTEtMA_8ef94532-5b03-49a7-b13e-a4fb4e4a0f06"
      unitRef="usd">17148000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzgtMTctMS0xLTA_a7cc9c38-a724-45bb-aa3f-7f9577acd009"
      unitRef="usd">17148000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktMy0xLTEtMzc5NA_bb083494-3ca9-4f35-8d1a-2977c75ec785"
      unitRef="shares">345000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktNS0xLTEtMzc5NA_00e17b39-912f-4892-b812-3da20eccb018"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktNy0xLTEtMzc5NA_deb899c1-8fda-4d9d-b0bf-dfb2aa5dfe61"
      unitRef="usd">17801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzktMTctMS0xLTM3OTQ_d056c3c3-afc9-4009-ac91-a6328642df18"
      unitRef="usd">17801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzExLTctMS0xLTA_137283c2-1fd1-45f6-bc60-587ccd032a45"
      unitRef="usd">90007000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzExLTE3LTEtMS0w_0f9148a1-203c-461e-8a84-ea4d5540dcab"
      unitRef="usd">90007000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzEzLTEtMS0xLTA_23ac0053-516e-46f7-a50d-ebd2442b466c"
      unitRef="usd">163175000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzEzLTE5LTEtMS0w_4270c22b-0859-4362-b9d9-ca19b240b0eb"
      unitRef="usd">89943000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE0LTEtMS0xLTA_bcfb0ca1-4124-4c60-97dc-210998aeda06"
      unitRef="usd">30154000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE0LTE5LTEtMS0w_7c77ce16-0d6f-48a8-9717-9f8799d8bea2"
      unitRef="usd">12812000</dva:NoncontrollingInterestIncreaseFromContributions>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE1LTEtMS0xLTA_e6d13e35-b1b8-4073-b899-dc3a209d1daa"
      unitRef="usd">-3215000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE1LTE5LTEtMS0w_d6958961-0f44-4a20-9dc9-9cc0b89d8a9c"
      unitRef="usd">-248000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTEtMS0xLTA_be4f7356-7914-4320-89ca-e83c0a52ef63"
      unitRef="usd">7771000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTctMS0xLTA_626de235-3886-4860-ac3d-a554f2c9a785"
      unitRef="usd">-4364000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTE3LTEtMS0w_8cd9d8a1-0d98-4c84-9d00-997eb64638d9"
      unitRef="usd">-4364000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i47223b014646447aac32d557643104a1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE2LTE5LTEtMS0w_2f1027f2-0cca-43a3-9867-bfbcc744b747"
      unitRef="usd">4424000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i5228c9925d06473b9fc0d9c359ef99c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE3LTEtMS0xLTA_615fb34f-639f-47cd-bfd2-6565dc4ad27d"
      unitRef="usd">151780000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE3LTctMS0xLTA_6ca7ee09-6591-42b6-8f6e-b3f3e4b76d97"
      unitRef="usd">-151780000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE3LTE3LTEtMS0w_8a190b4f-ad43-481f-8dc9-613edf661a49"
      unitRef="usd">-151780000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE4LTExLTEtMS0w_23ecc71c-57e9-45bf-8916-e92b422a736c"
      unitRef="shares">16477000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE4LTEzLTEtMS0w_1e2d8c20-700d-4860-9ae0-d5ae841715c3"
      unitRef="usd">1446767000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE4LTE3LTEtMS0w_02634b76-39d1-4e82-8f47-df6673818f98"
      unitRef="usd">1446767000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTMtMS0xLTA_83d8e8cf-ab25-43e8-8a57-27326e25e990"
      unitRef="shares">16477000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i98b03de37d6646c6beadbd2a414a9536_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTUtMS0xLTA_46209425-dcff-4ca8-b567-9d077f0f80dc"
      unitRef="usd">16000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTctMS0xLTA_d28be41e-3eed-4ee8-8c3e-deb98ef9bff3"
      unitRef="usd">93908000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i55b232edb6214093a0c5d7e31595d14d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTktMS0xLTA_469bf25c-008f-4037-a1f1-420562c6d41f"
      unitRef="usd">1352843000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTExLTEtMS0w_20d8730b-c34a-4bd5-ae52-9776f9400ce4"
      unitRef="shares">-16477000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i99d93323e1a4439b8ca3cefcdd96b08b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTEzLTEtMS0w_7762dbb1-1221-4fe1-a2bf-d98656cfb1a3"
      unitRef="usd">-1446767000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i4b46c41bea684d90801b2840b47476a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzE5LTE3LTEtMS0w_a5bd9fc2-3d26-46a5-9c43-c6bb3832b062"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i6a37cb5f5593422481356f9dc98a3f3b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTEtMS0xLTA_c71b7d2d-0c04-4d10-b74c-6c13d676892a"
      unitRef="usd">1330028000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i94bfac29df0345ed80042412796b3ada_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTMtMS0xLTA_1d55d4a7-b165-4f88-a538-15ae04533421"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94bfac29df0345ed80042412796b3ada_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTUtMS0xLTA_c5431c87-8439-4133-8330-9375e4cbb9ab"
      unitRef="usd">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib27b1a608e9d425fb9716950917809df_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTctMS0xLTA_8f13897f-b441-4b70-a22f-023acf732c65"
      unitRef="usd">597073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe1d0c26345f4dd988fa30758fc01afe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTktMS0xLTA_4876d000-8ffe-402a-82f6-fe6715acae7f"
      unitRef="usd">852537000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6922cd861e2a48a59394b6ef51aaff96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTExLTEtMS0w_9ba634a8-859a-4370-8612-5368a4d2dad9"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6922cd861e2a48a59394b6ef51aaff96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTEzLTEtMS0w_1745fa47-71cf-4597-b6db-e50a6f72d95f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3fd3e2a7d3d4e1a85627c011b215e0c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTE1LTEtMS0w_3ea6b2c4-e338-4608-b7aa-6b08aab97840"
      unitRef="usd">-66154000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i392918f6cd454f4482fe89cf50ebc86f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTE3LTEtMS0w_ec69a3ec-68f7-457d-ace8-7329f27d59e7"
      unitRef="usd">1383566000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i54db2eb8f1ec40a89ceed1e1d8b4f241_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xODcvZnJhZzo5NjhhNzM3YTA5NjM0Zjk5ODQ3OTBlZmJlMzRkZDk5Yi90YWJsZToxODcxNGM0Nzg0Mjc0YmNmYjQ1MzgyMjY5NjM1NThiZi90YWJsZXJhbmdlOjE4NzE0YzQ3ODQyNzRiY2ZiNDUzODIyNjk2MzU1OGJmXzIwLTE5LTEtMS0w_ca184e0d-0322-4789-a81c-cc3a0e33aaa1"
      unitRef="usd">183186000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDI4_ab41fd96-8540-4143-8331-6450c915c161">Organization and summary of significant accounting policies&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operations are comprised of its dialysis and related lab services to patients in the United States (its U.S. dialysis business), its ancillary services and strategic initiatives including its international operations (collectively, its ancillary services), and its corporate administrative support.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s largest line of business is its U.S. dialysis business, which operates kidney dialysis centers in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December&#160;31, 2020, the Company operated or provided administrative services through a network of 2,816 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 204,200 patients. In addition, as of December&#160;31, 2020, the Company operated or provided administrative services to a total of 321 outpatient dialysis centers serving approximately 36,200 patients located in ten countries outside of the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2019, the Company completed the sale of its DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented in these consolidated financial statements. For financial information about the DMG business, see Note 22.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s U.S. dialysis business qualifies as a separately reportable segment and the Company&#x2019;s ancillary services, including its international operations, have been combined and disclosed in the other segments category.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company only has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#x2019;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#x2019;s international subsidiaries from their functional currencies into the Company&#x2019;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#x2019;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2018, the Company adopted Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 606 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 606) using the cumulative effect method for those contracts that were not substantially completed as of January 1, 2018. Results for reporting periods beginning on and after January 1, 2018 are presented under Topic 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The adoption of this new standard primarily changed the Company&#x2019;s presentation of revenues, provision for uncollectible accounts and allowance for doubtful accounts. Topic 606 requires revenue to be recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Accordingly, for performance obligations satisfied after the adoption of Topic 606, the Company no longer separately presents a provision for uncollectible accounts on the consolidated income statement and no longer presents the related allowance for doubtful accounts on the consolidated balance sheet. However, as a result of the Company&#x2019;s election to apply Topic 606 only to contracts not substantially completed as of January 1, 2018, the Company continued to maintain an allowance for doubtful accounts related to performance obligations satisfied prior to the adoption of Topic 606. Net collections or write-offs of accounts receivable generated prior to January 1, 2018, beyond amounts previously reserved thereon, are presented in the provision for uncollectible accounts on the consolidated income statement in accordance with Topic 605.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#x2019;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#x2019;s commercial health plan secondary coverage, or the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under Medicare&#x2019;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#x2019;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#x2019;s base payment rate as well as these other variable factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#x2019;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#x2019;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#x2019;s usual and customary rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services and strategic initiatives. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and ESRD seamless care organizations are estimated in the period services are provided. Revenues associated with pharmacy services until that business was closed in 2018 were estimated as prescriptions were filled and shipped to patients. Revenues associated with direct primary care until that business was sold in 2018 were estimated over the membership period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted cash and equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow for certain legal settlements pending finalization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in debt and equity securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#x2019;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within "Other income, net". These debt and equity investments are classified as "short-term investments" or "long-term investments" on the Company's consolidated balance sheet. See Note 5 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels from the manufacturer and related data submission.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#x2019;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortizable intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: non-competition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method and other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as &#x201c;Equity method and other investments&#x201d; on the Company's consolidated balance sheet.&#160;See Note 9 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Self-insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#x2019; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes. As of December&#160;31, 2020, third parties held noncontrolling equity interests in 688 consolidated legal entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based compensation, as applicable. The Company has also classified its assets, liabilities and temporary equity into the appropriate fair value hierarchy levels as defined by the FASB. See Note 24 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New accounting standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in this ASU amend the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments and off-balance sheet credit exposures. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied using a modified retrospective basis. The adoption of ASU No. 2016-13 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework -Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The applicable amendments in this ASU remove requirements for disclosures concerning transfers between fair value measurement levels 1, 2 and 3 and disclosures concerning &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;valuation processes for level 3 fair value measurements. The applicable amendments in this ASU also add a requirement to separately disclose the changes in unrealized gains and losses included in other comprehensive income for the reporting period for level 3 items measured at fair value on a recurring basis, and require disclosure of the range and weighted average of significant unobservable inputs used to develop level 3 fair value measurements.&#160;The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied on a prospective basis.&#160;The adoption of this ASU did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other-Internal Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU No. 2018-15 aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted this ASU as of January 1, 2020, using the prospective transition approach, which allows the Company to change the accounting method without restating prior periods or booking cumulative adjustments. The adoption of ASU No. 2018-15 did not have a material impact on the Company's consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The Company has evaluated the impact of this standard on its consolidated financial statements, including accounting policies, processes, and systems, and does not expect the impact to be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <dva:NumberOfSites
      contextRef="i2dc41b2293ce4a6a80887886af6405df_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzcwMg_95ede915-1471-406d-8e0d-e7cc12aa0188"
      unitRef="clinic">2816</dva:NumberOfSites>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i2dc41b2293ce4a6a80887886af6405df_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2Xzc0MQ_1f9684e5-159b-44b0-b12b-4b16ba18ce5e"
      unitRef="state">46</us-gaap:NumberOfStatesInWhichEntityOperates>
    <dva:NumberOfCustomers
      contextRef="i4902d542b6e047d884a728d3dcf0e573_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzgxNA_6c7ae56f-39b0-4cab-87aa-4139759259c6"
      unitRef="patient">204200</dva:NumberOfCustomers>
    <dva:NumberOfSites
      contextRef="ie1bbb20c229b4a6d8445cfaf1ad7307a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzkyMQ_2c7ee1e6-ff6c-4567-8d3f-0e921cdd0598"
      unitRef="clinic">321</dva:NumberOfSites>
    <dva:NumberOfCustomers
      contextRef="i05384b4fdc8c489886da60a656894693_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2Xzk3NA_b297dda1-08cd-4727-bb13-1016ade66656"
      unitRef="patient">36200</dva:NumberOfCustomers>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="ie1bbb20c229b4a6d8445cfaf1ad7307a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2Xzk5Nw_1e580cac-a869-43a2-b8f7-ea42862fc104"
      unitRef="country">10</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDQ4_573646fe-276d-4559-a0c1-69c5cc6d900b">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company only has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#x2019;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#x2019;s international subsidiaries from their functional currencies into the Company&#x2019;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTY0_7b15d4b1-933d-41bd-b69b-aeacef56a2e1">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#x2019;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDQ5_203ee8ce-6896-44cf-b8f1-526e62268087">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2018, the Company adopted Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 606 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 606) using the cumulative effect method for those contracts that were not substantially completed as of January 1, 2018. Results for reporting periods beginning on and after January 1, 2018 are presented under Topic 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The adoption of this new standard primarily changed the Company&#x2019;s presentation of revenues, provision for uncollectible accounts and allowance for doubtful accounts. Topic 606 requires revenue to be recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Accordingly, for performance obligations satisfied after the adoption of Topic 606, the Company no longer separately presents a provision for uncollectible accounts on the consolidated income statement and no longer presents the related allowance for doubtful accounts on the consolidated balance sheet. However, as a result of the Company&#x2019;s election to apply Topic 606 only to contracts not substantially completed as of January 1, 2018, the Company continued to maintain an allowance for doubtful accounts related to performance obligations satisfied prior to the adoption of Topic 606. Net collections or write-offs of accounts receivable generated prior to January 1, 2018, beyond amounts previously reserved thereon, are presented in the provision for uncollectible accounts on the consolidated income statement in accordance with Topic 605.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#x2019;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#x2019;s commercial health plan secondary coverage, or the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under Medicare&#x2019;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#x2019;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#x2019;s base payment rate as well as these other variable factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#x2019;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#x2019;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#x2019;s usual and customary rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services and strategic initiatives. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and ESRD seamless care organizations are estimated in the period services are provided. Revenues associated with pharmacy services until that business was closed in 2018 were estimated as prescriptions were filled and shipped to patients. Revenues associated with direct primary care until that business was sold in 2018 were estimated over the membership period.&lt;/span&gt;&lt;/div&gt;</dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock>
    <dva:AllowanceForUncollectibleAccountsPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDM1_9d3c1756-3a0e-4a5a-a1a2-c29e27ab367a">The adoption of this new standard primarily changed the Company&#x2019;s presentation of revenues, provision for uncollectible accounts and allowance for doubtful accounts. Topic 606 requires revenue to be recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Accordingly, for performance obligations satisfied after the adoption of Topic 606, the Company no longer separately presents a provision for uncollectible accounts on the consolidated income statement and no longer presents the related allowance for doubtful accounts on the consolidated balance sheet. However, as a result of the Company&#x2019;s election to apply Topic 606 only to contracts not substantially completed as of January 1, 2018, the Company continued to maintain an allowance for doubtful accounts related to performance obligations satisfied prior to the adoption of Topic 606. Net collections or write-offs of accounts receivable generated prior to January 1, 2018, beyond amounts previously reserved thereon, are presented in the provision for uncollectible accounts on the consolidated income statement in accordance with Topic 605.</dva:AllowanceForUncollectibleAccountsPolicyTextBlock>
    <dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI4MDM3NTQ2NTQ3OTgw_55cea711-49da-4dd0-afd2-f04ed4d1b770"
      unitRef="number">0.80</dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor>
    <dva:OtherNonoperatingIncomeExpensePolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDM5_0eb5389b-ec53-4b65-a872-f008fa3cb700">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.&lt;/span&gt;&lt;/div&gt;</dva:OtherNonoperatingIncomeExpensePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTky_2e87968a-7792-460d-896f-bd2d1a1d811a">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTgz_ebfd13b6-368d-4e81-b5a8-07e510cc3d55">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted cash and equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow for certain legal settlements pending finalization.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDUw_34a0039e-1e6d-4e6a-b443-b6c2c166e42b">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in debt and equity securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#x2019;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within "Other income, net". These debt and equity investments are classified as "short-term investments" or "long-term investments" on the Company's consolidated balance sheet. See Note 5 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTkz_6e4f3091-fefa-4081-b79a-e8a92d01301e">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels from the manufacturer and related data submission.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTg2_3a2e18c7-b4af-4584-ab42-c30752dd0df5">Property and equipmentProperty and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDI0_d39cb0ea-4ebb-436f-b3e2-eb710cc2f703">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#x2019;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.&lt;/span&gt;&lt;/div&gt;Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDE5_c3a1a265-6404-4ebc-a40a-9c5a9159d0ab">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortizable intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: non-competition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDQx_b6d84988-1f54-42b2-b8ff-1273472f1714">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDEy_1d5b54f7-10a6-43e7-8eba-59d02aeb64db">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method and other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as &#x201c;Equity method and other investments&#x201d; on the Company's consolidated balance sheet.&#160;See Note 9 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDEz_ef59bd22-93a0-44dc-9675-e883626c054e">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <dva:InsuranceAndSelfInsurancePolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDA3_5d988889-6458-4c59-b8ba-690ed233dad3">Self-insuranceThe Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#x2019; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims.</dva:InsuranceAndSelfInsurancePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTc0_95a8352a-1dbe-4f4a-b5e6-4e4cb8af39b3">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.&lt;/span&gt;&lt;/div&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTk1_b84746e1-0e6e-43e8-912a-f963689b26f0">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDIw_15954a84-2e39-4509-bec8-4335a590c1fb">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.&lt;/span&gt;&lt;/div&gt;The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The amortization of the original cap premium is recognized as a component of debt expense on the interest method over the terms of the cap agreements.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTk4_bf82b3b4-c268-498c-a841-89c4aebd0046">Noncontrolling interestsNoncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes.&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#x2019; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#x2019; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#x2019;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#x2019; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#x2019; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <dva:NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzIwMTI0_5b24326b-df91-45ac-b736-6da0122b8283"
      unitRef="entity">688</dva:NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI1OTYz_279b529a-0d16-4a5a-8295-d701481e8da3">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity.&lt;/span&gt;&lt;/div&gt;The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based compensation, as applicable. The Company has also classified its assets, liabilities and temporary equity into the appropriate fair value hierarchy levels as defined by the FASB.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTMvZnJhZzo2ZDVhM2VhNzQxYzI0NGNjYmFjMGJmZWE2MmFjNTQ1Ni90ZXh0cmVnaW9uOjZkNWEzZWE3NDFjMjQ0Y2NiYWMwYmZlYTYyYWM1NDU2XzI2MDIx_78a53dc6-43a0-4531-b8ec-44cfc46d7e05">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New accounting standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in this ASU amend the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments and off-balance sheet credit exposures. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied using a modified retrospective basis. The adoption of ASU No. 2016-13 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework -Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The applicable amendments in this ASU remove requirements for disclosures concerning transfers between fair value measurement levels 1, 2 and 3 and disclosures concerning &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;valuation processes for level 3 fair value measurements. The applicable amendments in this ASU also add a requirement to separately disclose the changes in unrealized gains and losses included in other comprehensive income for the reporting period for level 3 items measured at fair value on a recurring basis, and require disclosure of the range and weighted average of significant unobservable inputs used to develop level 3 fair value measurements.&#160;The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied on a prospective basis.&#160;The adoption of this ASU did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other-Internal Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU No. 2018-15 aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted this ASU as of January 1, 2020, using the prospective transition approach, which allows the Company to change the accounting method without restating prior periods or booking cumulative adjustments. The adoption of ASU No. 2018-15 did not have a material impact on the Company's consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The Company has evaluated the impact of this standard on its consolidated financial statements, including accounting policies, processes, and systems, and does not expect the impact to be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI4MDM3NTQ2NTE1MTQ0_5b40c1c2-770f-4da7-92d9-b3fbc2068cbc">Revenue recognition and accounts receivable&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment and primary payor source were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,048,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,048,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,514,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,129,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,129,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,286,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,430,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,430,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,063,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,063,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,176,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,242,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,404,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no allowance for doubtful accounts related to performance obligations satisfied in years prior to January 1, 2018 as of December&#160;31, 2020 and such allowance was $8,328 as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 1, there are significant risks associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues including determining applicable primary and secondary coverage, changes in patient coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period. As a result of these changes in estimates, no additional revenue was recognized during the year ended December&#160;31, 2020 associated with performance obligations satisfied prior to January 1, 2018 and additional revenue of $37,274 was recognized during the year ended December&#160;31, 2019 associated with performance obligations satisfied in years prior to January 1, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is no single commercial payor that accounted for more than 10% of total consolidated accounts receivable or consolidated revenues at or for the years ended December&#160;31, 2020 or 2019.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;Net dialysis services accounts receivable and other receivables from Medicare, including Medicare Advantage plans, and Medicaid, including managed Medicaid plans, were approximately $1,101,837 and $1,038,248 as of December&#160;31, 2020 and 2019, respectively. Approximately 17% and 18% of the Company&#x2019;s net patient services accounts receivable balances as of December&#160;31, 2020 and 2019, respectively, were more than six months old. There were no significant balances over one year old at December&#160;31, 2020. The Company's accounts receivable are principally due from Medicare and Medicaid programs and commercial insurance plans.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI4NTc_8d06c243-d08b-4078-a918-5265b44edc71">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment and primary payor source were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,048,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,048,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,514,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,129,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,129,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,286,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,430,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,430,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,063,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,063,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,176,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,242,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,404,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i317edbea3c674863a4195c7cc9cb635b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzMtMS0xLTEtMA_2728b2e5-9c52-4206-a6ea-54a6b953f7a7"
      unitRef="usd">6048043000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaf248d771016450592bc55285a8f1c42_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzMtNS0xLTEtMA_6cac2cfa-f33b-456c-98f0-bca8cd8dc0c8"
      unitRef="usd">6048043000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i73a5d338ecdd42329c520f41a32fe9c4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzQtMS0xLTEtMA_7e99e4ff-f825-4769-ab1d-02ee039d9160"
      unitRef="usd">744862000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i80c5922bf87c4c29a6121290f1760795_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzQtNS0xLTEtMA_17463540-102e-4cc6-97e3-25df530ac5b2"
      unitRef="usd">744862000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2ae27697d58642a8a39741ac5b46b72d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzUtMS0xLTEtMA_cc35b0f1-d508-48a4-9a76-89fb1fd5d540"
      unitRef="usd">455897000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie1f7687b20c34347a978c801bcbfd456_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzUtMy0xLTEtMA_c9c821ad-6b37-42b0-b1b3-efd4b36dee21"
      unitRef="usd">380584000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ide1f2f90b0234c6386c95ee837e0334b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzUtNS0xLTEtMA_bf84a2f6-e5cf-4adb-91ce-cb737ab43e92"
      unitRef="usd">836481000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icb582b032e9d46908fb473a5d0de200f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzYtMS0xLTEtMA_f272fe8e-7bcf-47b7-9528-61c1abf76372"
      unitRef="usd">3370562000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie70348b0c0a94bb5b0ed3de0b4debc07_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzYtMy0xLTEtMA_18ce8f59-d471-4532-93ed-e3e325f83d7f"
      unitRef="usd">170394000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id59d792b2bf74f6e9847d2fd9f3bbca7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzYtNS0xLTEtMA_281cc82a-23a7-4e9d-9829-4119b7b4d60c"
      unitRef="usd">3540956000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i50ab540b60374ad4aad5a23a7bf8dddd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzgtMy0xLTEtMA_040ac17a-dff7-4e7d-9bd6-358d40cdb26e"
      unitRef="usd">419662000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iaf248d771016450592bc55285a8f1c42_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzgtNS0xLTEtMA_201527b4-cf2b-4cda-b20a-b9148bb849be"
      unitRef="usd">419662000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i867730cbcf0748fcb37173e698317b23_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzktMy0xLTEtMA_0123a1db-acc1-4d23-91e9-4a2afbedc3d8"
      unitRef="usd">1227000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i80c5922bf87c4c29a6121290f1760795_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzktNS0xLTEtMA_401909b1-9d7a-42c3-8ffd-40ff74b205e3"
      unitRef="usd">1227000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ie70348b0c0a94bb5b0ed3de0b4debc07_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEwLTMtMS0xLTA_fe982f60-aa6b-4dc2-b9f6-9e4e676efe44"
      unitRef="usd">33246000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="id59d792b2bf74f6e9847d2fd9f3bbca7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEwLTUtMS0xLTA_ff9371f7-0708-4120-a81f-ccabca6d6fe1"
      unitRef="usd">33246000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i44562b75ffb5414b8b4eb109b9499d54_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzExLTEtMS0xLTA_c1e5d2ac-31bc-400a-ac84-027e4f1d0986"
      unitRef="usd">40571000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i254282fb16c34ab2945f3c18a75f8323_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzExLTMtMS0xLTA_caba969e-fd15-43aa-a808-1eeb322d33fa"
      unitRef="usd">47585000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i4206fb8a521a438eadb170f4aaec89d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzExLTUtMS0xLTA_817aed46-5fb8-44c7-a8f6-b73c74d67a33"
      unitRef="usd">88156000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i0914af09be91438c9bdd1e22b951a0df_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEyLTEtMS0xLTA_a464dc05-84cd-4376-b908-41de0684c820"
      unitRef="usd">-145286000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41625250859e40bda54bf40e92bd1151_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEyLTMtMS0xLTA_dc814c28-fe19-4e25-9ae3-9b50ba88a718"
      unitRef="usd">-16743000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i635c2eebb9e64938a68735ae6c593657_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEyLTUtMS0xLTA_afb806da-9cf0-4ed7-b2dd-c67c73e39467"
      unitRef="usd">-162029000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEzLTEtMS0xLTA_d7380342-8472-499e-a4b7-4214853ab405"
      unitRef="usd">10514649000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEzLTMtMS0xLTA_d8ed19cb-40c5-4197-ab7b-3b95460bc8c7"
      unitRef="usd">1035955000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTpkZTNjY2I1MGFkYjU0YTM2ODc4YjE4NTUyZWEyYmEwOS90YWJsZXJhbmdlOmRlM2NjYjUwYWRiNTRhMzY4NzhiMTg1NTJlYTJiYTA5XzEzLTUtMS0xLTA_6c1e4bc5-64fe-4809-8498-d5490eb90811"
      unitRef="usd">11550604000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2a6ed05dcee04d00b0acebc6f9646492_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzMtMS0xLTEtMA_ea8e89cc-3e26-40e4-a57c-6aa16d8df886"
      unitRef="usd">6129697000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibfbe0a9a2b6e487387fc940140536289_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzMtNS0xLTEtMA_a3e714bf-b876-4965-8d74-f0896a5988a8"
      unitRef="usd">6129697000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9039b41e698646108961d8438f298065_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzQtMS0xLTEtMA_b48ccd72-8f91-4613-b2d5-c772c5beb7de"
      unitRef="usd">669089000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i29a5025fe7d546f59cb2d4b2ffb19b92_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzQtNS0xLTEtMA_ee50b436-54e6-43c1-817b-78c4f3b96f69"
      unitRef="usd">669089000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic73e85c3fcad4252b56e5ca71804381f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzUtMS0xLTEtMA_15bb26ac-a410-4886-bba0-28f0bc6876b8"
      unitRef="usd">446010000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i68577d74812348348e7271f689002b75_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzUtMy0xLTEtMA_7700d91c-8156-47e5-b3d0-dfd97b6b9c1c"
      unitRef="usd">352765000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i10176a49705641908ef22710eb3ceb0f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzUtNS0xLTEtMA_adcbc897-d5e4-4463-835f-93304fbdc5f6"
      unitRef="usd">798775000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i90161d3cc08b4d05b4c9a4bc96f77638_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzYtMS0xLTEtMA_eac06e95-2b96-43ef-a93e-a8d2117af3ae"
      unitRef="usd">3286089000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iafc956536376499ca4f18116e1a28156_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzYtMy0xLTEtMA_6997bf5b-68d6-4899-a376-7e1e46ed38d5"
      unitRef="usd">144256000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifd1d128a80ca4c31ab1a4b08899c3bee_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzYtNS0xLTEtMA_e5e36cf2-0e23-4648-89f7-537775f9645d"
      unitRef="usd">3430345000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i331cb12a3bc84e9dbd3524df3c61c1e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzgtMy0xLTEtMA_623058f4-a5a5-41b9-a600-62605ac661ae"
      unitRef="usd">264538000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ibfbe0a9a2b6e487387fc940140536289_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzgtNS0xLTEtMA_e162b7e1-1495-4608-a63a-a34977f2e95f"
      unitRef="usd">264538000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i9225d7ed664b4437a955e3239e2d4672_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzktMy0xLTEtMA_f9bdde4a-8685-45dc-8ab1-a9a7b2181fba"
      unitRef="usd">606000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i29a5025fe7d546f59cb2d4b2ffb19b92_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzktNS0xLTEtMA_227f7d19-3827-4e9f-99d1-0b604dfebfff"
      unitRef="usd">606000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iafc956536376499ca4f18116e1a28156_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEwLTMtMS0xLTA_e3c92db1-e6ce-4f97-b8a8-612a01ed9d55"
      unitRef="usd">130823000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ifd1d128a80ca4c31ab1a4b08899c3bee_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEwLTUtMS0xLTA_52e81e2f-a6cb-4294-bc34-7a18ab3a0e28"
      unitRef="usd">130823000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i1ad6e19bfd204637ac41e31412365fde_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzExLTEtMS0xLTA_bb96f3cf-1f82-427c-885c-1ec1ef406d2f"
      unitRef="usd">32021000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i57e64e40c6c949a4a0c172e586effb9e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzExLTMtMS0xLTA_2a7b328f-6633-48b3-a9ce-847fc6f5316c"
      unitRef="usd">78940000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="icbdb192b5cd84c0aa25e94fee7bff238_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzExLTUtMS0xLTA_a2fa4db1-9259-44eb-9ef7-bb66aa7f405e"
      unitRef="usd">110961000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i164e3c5e63494e49a4973e32ed991ff5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEyLTEtMS0xLTA_99c611d6-0516-4276-b83d-1e427bc745cc"
      unitRef="usd">-132325000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia940e3b4e9754716a7d35abf7b1359f0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEyLTMtMS0xLTA_3ab2e852-83e5-4599-8c31-5eccb7b0ad50"
      unitRef="usd">-14030000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f9b9ab0e8584df69e653fc61911e0cc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEyLTUtMS0xLTA_d05773fd-d952-4caf-acfb-becc99fcc56f"
      unitRef="usd">-146355000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEzLTEtMS0xLTA_1d2f007b-c5fb-406a-a8a3-faf9058f30a6"
      unitRef="usd">10430581000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEzLTMtMS0xLTA_3e73c845-6afa-4719-86ec-c87e53c89e74"
      unitRef="usd">957898000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTowOTEyYjU0MTAxZWU0ZmUxOGMzNDYyY2Y4ZjY0NzFkZS90YWJsZXJhbmdlOjA5MTJiNTQxMDFlZTRmZTE4YzM0NjJjZjhmNjQ3MWRlXzEzLTUtMS0xLTA_19f5f65d-5a67-4e6f-b32f-31657d3ace49"
      unitRef="usd">11388479000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icaf2fdbccba5422e8e3b2a15008e502e_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzMtMS0xLTEtMA_cbeb49e6-103a-4b30-9514-2f7033d76de6"
      unitRef="usd">6063891000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i14af6fc05fe24609a9ef1d172b06d3ed_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzMtNS0xLTEtMA_c86d787f-9ff7-4c90-97a2-20e1daa2f624"
      unitRef="usd">6063891000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8bfe5b640ee64eca89b909864373b865_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzQtMS0xLTEtMA_2eebf8bf-d247-40ec-bc9b-d07e40516103"
      unitRef="usd">628766000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i799a2b20a00e45e0b3f08db269fa3736_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzQtNS0xLTEtMA_d55202a8-ed97-4905-b1ec-286a2504b1ca"
      unitRef="usd">628766000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i39bda8f256e44c4884a542b1ea607df5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzUtMS0xLTEtMA_1bf0682b-1af6-40fa-a506-a04e7b1f8c42"
      unitRef="usd">446999000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6c528d2849c2446c8b9fb3e906e29ece_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzUtMy0xLTEtMA_e91d351d-e91b-48fd-8c13-d8762ceaac18"
      unitRef="usd">335594000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibc14ea5b25b54be1945bb52726f391c6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzUtNS0xLTEtMA_0c8e3faa-4ef8-4e35-845a-93d5430fbd94"
      unitRef="usd">782593000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i74881d974a934edab7eb395774d2e72a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzYtMS0xLTEtMA_1da0c28f-bae1-42f8-946b-c8381b66e384"
      unitRef="usd">3176413000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie830c422acbf447b830d5ba05d456555_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzYtMy0xLTEtMA_92449004-6e37-49e2-9953-d3449b510b64"
      unitRef="usd">101681000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie092dc1a9f334a2d8959b7937c63b6da_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzYtNS0xLTEtMA_109e7e52-50f2-423d-904c-e7fda82c85ca"
      unitRef="usd">3278094000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="id0e35707e465473fb9d209c48d673e9c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzgtMy0xLTEtMA_77a373fe-7c4d-4715-8b8e-6811302690f0"
      unitRef="usd">492812000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i14af6fc05fe24609a9ef1d172b06d3ed_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzgtNS0xLTEtMA_963ec812-eaeb-4c6a-beea-751c0af02e88"
      unitRef="usd">492812000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0b2c11e9409a4ebfb1af5af31c5eec06_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzktMy0xLTEtMA_b32fa382-1c11-462f-a103-b9611041bdc9"
      unitRef="usd">44246000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i799a2b20a00e45e0b3f08db269fa3736_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzktNS0xLTEtMA_2ed54281-0887-43cf-9073-71e0c1b41c85"
      unitRef="usd">44246000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ie830c422acbf447b830d5ba05d456555_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEwLTMtMS0xLTA_5f27a09e-1994-4034-b687-51e498a49c37"
      unitRef="usd">90890000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ie092dc1a9f334a2d8959b7937c63b6da_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEwLTUtMS0xLTA_ab301777-a762-4d00-9c55-7b1f120be125"
      unitRef="usd">90890000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib57b9bde3eb844b8825af8894f08bd19_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzExLTEtMS0xLTA_3778989d-ef69-45d6-b3ae-c3c47779c93c"
      unitRef="usd">19880000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i47790222420f478db2f7ad17705accb2_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzExLTMtMS0xLTA_4c063570-cafa-4236-bfe6-97c69f4bd079"
      unitRef="usd">130865000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i21697e32a0ec4bf1904f2fc73b9dbbad_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzExLTUtMS0xLTA_12966822-9bcb-4d9f-a7e6-a29add9e2aa5"
      unitRef="usd">150745000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="if961d3964d254d87be469310f7624b7c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEyLTEtMS0xLTA_a9412edd-5bbc-44a3-b795-0a438c881b6a"
      unitRef="usd">-92950000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72f27d9ed3464afea1d79fe17c36cc36_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEyLTMtMS0xLTA_2f1efc52-6c35-4f9c-b3af-0c272cffaca1"
      unitRef="usd">-34236000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a04f4ad256b450eb154971edb661d29_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEyLTUtMS0xLTA_452e40c8-5a2d-43a7-8aa1-c4375a14ff83"
      unitRef="usd">-127186000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEzLTEtMS0xLTA_4b58f97d-bc2d-42fc-a056-f528436c0221"
      unitRef="usd">10242999000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i10d8743c3594411698541aa578ec2aff_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEzLTMtMS0xLTA_b87f55ba-c1cf-4e39-b971-7f233f1a4d51"
      unitRef="usd">1161852000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90YWJsZTo0NmY4MTg4M2RiOTU0ZGQ1YjEyODZlYmQ5ODhjYjUwZS90YWJsZXJhbmdlOjQ2ZjgxODgzZGI5NTRkZDViMTI4NmViZDk4OGNiNTBlXzEzLTUtMS0xLTA_05bc69e4-2524-4815-8012-9290e4b56425"
      unitRef="usd">11404851000</us-gaap:Revenues>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i33a90a56c3c54abe92e41788859d9e6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzEwNTg_f01fbc0e-504b-4835-a3ac-4c086d3d3564"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i59029b4957e44e428f8a80a0cb5a4790_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzEwNjU_1fb33cca-b87d-4a2d-8de0-aae5796af4d6"
      unitRef="usd">8328000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ie0da31cd8a6a4e4a97290ebfc52869b0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI4MDM3NTQ2NTE1MTYx_75616f0c-21c3-4f12-946e-0243b98d114c"
      unitRef="usd">0</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ib87a97e373bd46c89dac120c212a644a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzE4ODk_c4ebcad5-995e-4137-86d1-408620dc790e"
      unitRef="usd">37274000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <dva:NumberOfConcentrationRiskCustomers
      contextRef="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzIxNjc_aacc69c3-3a0c-4270-9d45-726dc29d1249"
      unitRef="number">0</dva:NumberOfConcentrationRiskCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzIyMjM_feb9d9a6-efdd-48b3-820d-e09825b8532d"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibabc1893044f4e66a6479c0d43899227_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI1MTE_84075dfa-69a3-48cf-8de5-e5c0013776af"
      unitRef="usd">1101837000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i884b650f6da14ccebfbdcc5a5e3c9c2a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI1MTg_690a2251-f123-4fe1-9361-6ffa117a51c9"
      unitRef="usd">1038248000</us-gaap:AccountsReceivableNetCurrent>
    <dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue
      contextRef="i444084475ebc4fe2ad288f8829a0542f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI1NjY_25b73a4f-855e-48d3-9031-58556001be0e"
      unitRef="number">0.17</dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue>
    <dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue
      contextRef="i0827e76d53914466af9eff1dc6c5d343_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzM4NDgyOTA3MDQwMjI_618662da-8833-4cbb-bb7c-c46087f22d38"
      unitRef="number">0.18</dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue>
    <dva:AccountsReceivablePeriodOutstanding
      contextRef="i9758849d775b4407b5d3c422fe4c19ac_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI2NzM_2f873a5b-4e65-4f6c-a8ed-0ba61b73311c">P6M</dva:AccountsReceivablePeriodOutstanding>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i444084475ebc4fe2ad288f8829a0542f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI2OTI_03b0df94-1b71-4d36-8aae-aa7db0c065b4"
      unitRef="usd">0</us-gaap:AccountsReceivableNetCurrent>
    <dva:AccountsReceivablePeriodOutstanding
      contextRef="i8497a3de1675439ca2a3f1871e38384e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8xOTYvZnJhZzplMWQ5Y2Y3OTQwOWY0NGY2ODEzMzVlNTM3ZmM3ZDA5ZC90ZXh0cmVnaW9uOmUxZDljZjc5NDA5ZjQ0ZjY4MTMzNWU1MzdmYzdkMDlkXzI3MjE_a314884f-9cf7-4739-a4e9-9d974a8dc3d6">P1Y</dva:AccountsReceivablePeriodOutstanding>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90ZXh0cmVnaW9uOjU3YTM5OTY3N2ZmOTRjNDk5MjAyYjVjMGQxYzllNDYzXzEyNjE_78a86f5e-2d63-4a62-a62e-d462e0d8b169">Earnings&#160;per share&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding, reduced for 2018 by the weighted average shares held in escrow that under certain circumstances may have been returned to the Company. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units (under the treasury stock method) and, for 2018, the weighted average contingently returnable shares held in escrow that were outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;During the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently returnable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently returnable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;previously held in escrow for the DaVita HealthCare Partners merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90ZXh0cmVnaW9uOjU3YTM5OTY3N2ZmOTRjNDk5MjAyYjVjMGQxYzllNDYzXzEyNjU_a1662d9d-b58b-4a8d-86c3-36da2319e3c7">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding, reduced for 2018 by the weighted average shares held in escrow that under certain circumstances may have been returned to the Company. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units (under the treasury stock method) and, for 2018, the weighted average contingently returnable shares held in escrow that were outstanding during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90ZXh0cmVnaW9uOjU3YTM5OTY3N2ZmOTRjNDk5MjAyYjVjMGQxYzllNDYzXzEyNjc_b2f670e0-faeb-4304-b184-b4ffd6331922">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;During the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently returnable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently returnable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;previously held in escrow for the DaVita HealthCare Partners merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzMtMS0xLTEtMA_92471df0-e307-4e68-9920-4d957959b742"
      unitRef="usd">783295000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzMtMy0xLTEtMA_28372998-f966-4989-a285-9b4b54f9ce73"
      unitRef="usd">706832000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzMtNS0xLTEtMA_804ebe7c-7772-43f2-9cb6-721b818546e9"
      unitRef="usd">624321000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzQtMS0xLTEtMA_a1860ae4-c4c4-4d28-9092-20a98f5b5b42"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzQtMy0xLTEtMA_cd4c689c-6874-4ac3-b135-fa220b2ceafa"
      unitRef="usd">104149000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzQtNS0xLTEtMA_859c8bc6-2cfe-4ddd-b314-a13328cf6973"
      unitRef="usd">-464927000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzUtMS0xLTEtMA_49b3f939-8a4e-49e0-8c33-015cd43da6dd"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzUtMy0xLTEtMA_da85b60e-970d-4c64-b2c8-90f1de7a8e3e"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzUtNS0xLTEtMA_c031532e-8ec8-445a-9e55-ade6a86c5321"
      unitRef="usd">159394000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzgtMS0xLTEtMA_6dc3092a-2dc1-4b39-942e-0dfa2de98589"
      unitRef="shares">119797000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzgtMy0xLTEtMA_44d72f5a-e52a-4be3-ae52-e50e90bd47de"
      unitRef="shares">153181000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzgtNS0xLTEtMA_18732573-7a92-41e4-b9ea-a5f1005c173e"
      unitRef="shares">171886000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzktMS0xLTEtMA_813bd04e-4b61-4448-9689-0819630c07bd"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzktMy0xLTEtMA_183c7450-475a-4e10-b063-e894990a45d9"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzktNS0xLTEtMA_e426aa3c-04ca-40cb-b952-1e9669d8f39b"
      unitRef="shares">1100000</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTEtMS0xLTA_3be29fec-261c-4bc9-9a2d-6e83559b2626"
      unitRef="shares">119797000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTMtMS0xLTA_e0618ddf-e433-42d5-8906-4429d882326a"
      unitRef="shares">153181000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTUtMS0xLTA_465ba5c4-38e8-4cdf-a5e0-3402b302df74"
      unitRef="shares">170786000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTEtMS0xLTY4MTg_c1f7d0f6-5d5b-4aa9-9415-c482749fb916"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTMtMS0xLTY4MTg_7b0dc701-6b5b-42d5-a89e-0698613da982"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEwLTUtMS0xLTY4MTg_72c967fc-1cd3-4c66-8a27-c4f0bf05c38d"
      unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzExLTEtMS0xLTY4MTg_6bfc0f25-1079-470a-a4c8-394f40569a4b"
      unitRef="shares">2826000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzExLTMtMS0xLTY4MTg_84ac4a4e-0ee8-482b-a3eb-5c308a806348"
      unitRef="shares">631000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzExLTUtMS0xLTY4MTg_4f067a40-c3db-4137-83c5-b3deed90998e"
      unitRef="shares">479000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEyLTEtMS0xLTY4MTg_3f4c40ae-6616-488b-8ab6-225d7d1d321e"
      unitRef="shares">122623000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEyLTMtMS0xLTY4MTg_a5c2b875-feb3-4a81-8862-8e4252d57246"
      unitRef="shares">153812000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEyLTUtMS0xLTY4MTg_3c70b8e1-eb1e-4907-992c-b79ea58b0446"
      unitRef="shares">172365000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEzLTEtMS0xLTA_2d900bda-22af-435c-ae02-37439754f585"
      unitRef="usdPerShare">6.54</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEzLTMtMS0xLTA_a183d623-941d-47d4-a90e-99c41a21d2ca"
      unitRef="usdPerShare">4.61</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzEzLTUtMS0xLTA_4706b716-ec96-420b-8500-b4dfffeff1cf"
      unitRef="usdPerShare">3.66</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE0LTEtMS0xLTA_b7756e80-94fe-43d0-94d8-1f73e0877b32"
      unitRef="usdPerShare">-0.08</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE0LTMtMS0xLTA_b5ab02a4-255d-45b6-81ec-16c4ba77f7b7"
      unitRef="usdPerShare">0.68</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE0LTUtMS0xLTA_c5bfdfd6-7045-4178-bb7b-bac2538d41f3"
      unitRef="usdPerShare">-2.73</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE1LTEtMS0xLTA_c899f3b7-ae77-401b-9c5f-770a8d1f49ac"
      unitRef="usdPerShare">6.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE1LTMtMS0xLTA_d6432bdf-6c51-4a38-8611-4febf3b6c6e2"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzE1LTUtMS0xLTA_db01ae63-9640-45a3-a194-8ad676165f33"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzIzLTEtMS0xLTA_4aa53c23-1947-46ca-8f54-76163ea1f320"
      unitRef="usdPerShare">6.39</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzIzLTMtMS0xLTA_313fa9d4-ff9b-4584-ab52-ab9aeaef08f9"
      unitRef="usdPerShare">4.60</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzIzLTUtMS0xLTA_caa69b59-6aaa-4d6e-9ef3-6a4192be8796"
      unitRef="usdPerShare">3.62</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI0LTEtMS0xLTA_fa97d360-4ec3-4a23-9ab8-7347bf9b45ca"
      unitRef="usdPerShare">-0.08</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI0LTMtMS0xLTA_fb79b8c6-a294-45ac-a5aa-f45267b4911b"
      unitRef="usdPerShare">0.67</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI0LTUtMS0xLTA_90f1da9b-cfa4-4a22-bb5b-881701648c32"
      unitRef="usdPerShare">-2.70</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI1LTEtMS0xLTA_dae41f19-f822-4c2e-9101-c3aad588a365"
      unitRef="usdPerShare">6.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI1LTMtMS0xLTA_f3211d91-0d72-4221-b0c6-d4b0552226af"
      unitRef="usdPerShare">5.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI1LTUtMS0xLTA_9694e0fa-9d90-4209-931f-4d2ba3b7c76b"
      unitRef="usdPerShare">0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI3LTEtMS0xLTA_95bccb92-f5e5-4d95-af55-fc6c87e0ccef"
      unitRef="shares">2301000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI3LTMtMS0xLTA_9cbbe7dc-7b6b-4915-ab54-e68775233a43"
      unitRef="shares">5936000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDIvZnJhZzo1N2EzOTk2NzdmZjk0YzQ5OTIwMmI1YzBkMWM5ZTQ2My90YWJsZTplOTY2Y2ViYWFlZmM0MDYyOThlYzI3OGU4YmQ5ZmM3NS90YWJsZXJhbmdlOmU5NjZjZWJhYWVmYzQwNjI5OGVjMjc4ZThiZDlmYzc1XzI3LTUtMS0xLTA_98370be2-9fc5-4d5e-8b40-6e70c0491e77"
      unitRef="shares">5295000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CashAndCashEquivalentsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzI4MDM3NTQ2NTA5NDY4_49ee0f76-7920-44a0-900c-9b9abde736cb">Restricted cash and equivalentsThe Company had restricted cash and cash equivalents of $176,832 and $106,346 at December&#160;31, 2020 and 2019, respectively. Approximately $92,286 of the balance at December&#160;31, 2020 represents restricted cash equivalents held in trust to satisfy insurer and state regulatory requirements related to the wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company and $70,000 represents cash held in escrow to fund a previously announced legal settlement pending finalization. The remaining restricted cash and cash equivalents held at December&#160;31, 2020 primarily represents cash pledged to third parties in connection with one of the Company's ancillary services.</us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzk3_9049bc08-5920-4200-829e-830f2261cd36"
      unitRef="usd">176832000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzEwNA_a539cf2d-d397-4787-838d-86f52294d3fb"
      unitRef="usd">106346000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzE0OQ_e162562d-fc65-46af-8fe6-d3b2902d2e17"
      unitRef="usd">92286000</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="i0d4d7d40de954bc4a8f5ba7ec06c8900_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzI4MDM3NTQ2NTA5NTYw_98af19fc-554d-4de3-924d-7c67f41cd668"
      unitRef="usd">70000000</us-gaap:AssetsHeldInTrustCurrent>
    <dva:NumberOfPartnerships
      contextRef="if18749a859234cf7b23652f60c460caf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDUvZnJhZzoxNTU3OWVlZTQ0MGM0MTRmYWQ2ODdmZTAzMzkzNzY4Mi90ZXh0cmVnaW9uOjE1NTc5ZWVlNDQwYzQxNGZhZDY4N2ZlMDMzOTM3NjgyXzU2MA_a1f1e5b5-b787-4999-8494-449ad3f89eb7"
      unitRef="number">1</dva:NumberOfPartnerships>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2OTQ_ec87f9b3-d18d-470f-a761-21922f9a5556">Short-term and long-term investments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;Equity securities: The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#x2019;s non-qualified deferred compensation plans. During 2020, the Company recognized pre-tax net gains of $3,818 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,941 and a net increase in unrealized gains of $1,877. During 2019, the Company recognized pre-tax net gains of $4,383 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,459 and a net increase in unrealized gains of $2,924.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2OTk_2843e7cb-5438-4a7b-8f72-4e801f8199ea">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i9ab2d52784864cf6ac6e10794af391d6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItMS0xLTEtMA_95b31230-7485-4252-a7c0-b7212d889ada"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9ab2d52784864cf6ac6e10794af391d6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItMy0xLTEtMA_b1cb8eb0-f263-4d22-99e1-bd00b1f7b90d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i9ab2d52784864cf6ac6e10794af391d6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItNS0xLTEtMA_0189332e-f6fe-4e7a-b676-e17e819524d2"
      unitRef="usd">8217000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ibf901af366f34dbaa56ecfe998516c0a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItNy0xLTEtMA_e607bd30-09dd-4c24-a038-c076c9d2149a"
      unitRef="usd">8140000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibf901af366f34dbaa56ecfe998516c0a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItOS0xLTEtMA_a96d2366-f9f0-42a4-af83-f2a50f9a3416"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ibf901af366f34dbaa56ecfe998516c0a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzItMTEtMS0xLTA_58e62d94-d834-428b-b675-f38c5c7a0019"
      unitRef="usd">8140000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtMS0xLTEtMA_c8532b47-8ddf-4ecc-8e37-c2cdba5ff295"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtMy0xLTEtMA_c15269c2-f25a-42c6-8d21-fd9b97be451c"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ia0a149716a734ca6bcaca1a46dfdfad3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtNS0xLTEtMA_c2bd9eea-bb98-4fd7-812a-a36dab758335"
      unitRef="usd">44077000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ifb978d08cfeb4642bd53e53555d6f21e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtNy0xLTEtMA_694669cc-fe53-4534-b7d7-2610cfbfd115"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifb978d08cfeb4642bd53e53555d6f21e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtOS0xLTEtMA_4b6f209e-6493-4512-9754-47211efe720f"
      unitRef="usd">39951000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ifb978d08cfeb4642bd53e53555d6f21e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzMtMTEtMS0xLTA_db0d5713-09a9-4508-bda5-87e26baa58b4"
      unitRef="usd">39951000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtMS0xLTEtMA_8fa89708-abf2-4aa5-91cb-4bb6f1422bff"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtMy0xLTEtMA_a9317472-17db-4e51-a750-265536eac2b6"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtNS0xLTEtMA_347ac0c3-13b1-4d10-a886-95a9bd3f70bd"
      unitRef="usd">52294000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtNy0xLTEtMA_172ad15a-121b-4595-a8f5-54ae1a8863bf"
      unitRef="usd">8140000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtOS0xLTEtMA_c891d556-8f53-45ed-8e2a-4e6fc1a1a7a1"
      unitRef="usd">39951000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzQtMTEtMS0xLTA_c87a1e7a-2407-4c46-9edc-4aaa5f86c3a8"
      unitRef="usd">48091000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtMS0xLTEtMA_0e9eac24-f9a1-437a-a521-a5139d983d35"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iccf23c460b304d34975ca6b21fa9b648_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtMy0xLTEtMA_7d22d1ef-dd7b-4ba1-b6f1-fabace384c86"
      unitRef="usd">11884000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtNS0xLTEtMA_49089bad-dee3-405d-ae26-c594b43c6c34"
      unitRef="usd">20101000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtNy0xLTEtMA_89b7cc56-241a-41f3-b67d-73bcae37eb31"
      unitRef="usd">8140000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8314d71719804d359b9983c38b6897ef_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtOS0xLTEtMA_a35fd538-fc84-4707-a176-4e31db37b576"
      unitRef="usd">3432000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzUtMTEtMS0xLTA_283ecad9-87a7-422d-89af-a726f29ed6ce"
      unitRef="usd">11572000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtMS0xLTEtMA_3b9d2fba-6519-4db6-8c59-bd4152c9327d"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6369add7b9a341bbb8a486c2b65be42f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtMy0xLTEtMA_2bb401ab-e61b-44da-af4b-e111ee9b9c9b"
      unitRef="usd">32193000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtNS0xLTEtMA_49f9f3e9-9f9e-4933-bd2c-8c286c14ffa9"
      unitRef="usd">32193000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtNy0xLTEtMA_8696932c-b03f-4a1c-92e0-3a0444da60c7"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ica2929163ca34ad6b905be96f45d01d4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtOS0xLTEtMA_3ffa53ef-fee4-4ddd-b200-77e0a574a5d4"
      unitRef="usd">36519000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzYtMTEtMS0xLTA_78c56a62-331b-4bb2-948f-9dc5b8d581d8"
      unitRef="usd">36519000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctMS0xLTEtMA_d5320cb8-7f77-4b2d-9c42-850d1cf53c4e"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctMy0xLTEtMA_77e73fba-8bf0-4ccb-a472-6c710d47ce7c"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctNS0xLTEtMA_140bdf22-f652-459f-97f0-f321b2e78186"
      unitRef="usd">52294000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctNy0xLTEtMA_09bd4be9-fc8b-45be-8a5c-175e3e425949"
      unitRef="usd">8140000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctOS0xLTEtMA_1adf01d2-e9ee-480e-95db-65a92e6a70a3"
      unitRef="usd">39951000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90YWJsZTo3OTAxNWEzNmYzYzQ0M2QwODQ1Y2QxZDM1OGRiNDMzYy90YWJsZXJhbmdlOjc5MDE1YTM2ZjNjNDQzZDA4NDVjZDFkMzU4ZGI0MzNjXzctMTEtMS0xLTA_34c054c8-ba04-49b0-b5a8-a367a0186433"
      unitRef="usd">48091000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI3MDI_882cc221-cc3e-4f17-9191-aaf5d636d483">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2020 and 2019.&lt;/span&gt;Equity securities: The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#x2019;s non-qualified deferred compensation plans.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i4e82366908fc411981946281d867f868_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzIyODU_7843d0cf-3a17-4872-ab86-eb4b223dd5df"
      unitRef="usd">3818000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i4e82366908fc411981946281d867f868_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI0MTM_935f91aa-e966-4d7a-bcec-45db1d85204a"
      unitRef="usd">1941000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities
      contextRef="i4e82366908fc411981946281d867f868_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI0NTg_ef122b82-42fc-4467-a073-f91027744a43"
      unitRef="usd">1877000</dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI1MTg_fe8e2609-5521-4aa0-b39e-aaa5681fe321"
      unitRef="usd">4383000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2NDY_28f12be3-57c9-45d1-b832-871b7e77b807"
      unitRef="usd">1459000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities
      contextRef="i6531aa2325ac4cfba71ea8642ae4fdc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMDgvZnJhZzo4NmQ0ZjFkZDU1MDc0OTgzOGE3MTJjNjNmOWNmOTMxYi90ZXh0cmVnaW9uOjg2ZDRmMWRkNTUwNzQ5ODM4YTcxMmM2M2Y5Y2Y5MzFiXzI2OTE_0f392a95-d126-4d6b-bdbd-a4b0c5870850"
      unitRef="usd">2924000</dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90ZXh0cmVnaW9uOjYyMGJlYWNlM2FjNDQwZDU5NGFjMWM5NmVhMzJkYTE3Xzg3_248c93bf-7993-4b47-8cb5-a251490f0af5">Other receivables&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables were comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier rebates and non-trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare bad debt claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <dva:ScheduleOfOtherReceivablesTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90ZXh0cmVnaW9uOjYyMGJlYWNlM2FjNDQwZDU5NGFjMWM5NmVhMzJkYTE3Xzgz_a1d464f9-bf74-4580-ba57-d112b5fabfa2">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables were comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier rebates and non-trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare bad debt claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfOtherReceivablesTableTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i51c7cd9eeaa64c0a91528e12f2172af6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzItMS0xLTEtMA_7d1ef077-fe69-422d-a333-9dc4aa41db94"
      unitRef="usd">390508000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i2a2be35772674635818cdd631d499246_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzItMy0xLTEtMA_c84b8fdf-1f73-44fa-93e2-a95ff0a20f3b"
      unitRef="usd">351650000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i3f29353214f44b529f3e84fdb2acc7f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzMtMS0xLTEtMA_43df2e55-70ba-43a4-b08e-008a1758641c"
      unitRef="usd">153868000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i39149e895b2b4e0593f509dcaf83e78f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzMtMy0xLTEtMA_c118c7fd-e183-4853-aa82-ee4d20384c94"
      unitRef="usd">138045000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzQtMS0xLTEtMA_5111a884-e756-40ac-8c65-eae6e84da65e"
      unitRef="usd">544376000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTEvZnJhZzo2MjBiZWFjZTNhYzQ0MGQ1OTRhYzFjOTZlYTMyZGExNy90YWJsZTo4MDk2NGFiY2Q3N2M0ZWU2YmQ2OGQ1MzhjY2U3MWM5ZS90YWJsZXJhbmdlOjgwOTY0YWJjZDc3YzRlZTZiZDY4ZDUzOGNjZTcxYzllXzQtMy0xLTEtMA_cda742bd-dae5-4bbb-9bb9-3662f0c9cb9c"
      unitRef="usd">489695000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzI4NTg3MzAyMzIzMDc1_ce86f42b-f989-4b77-bff9-4f26763e1aab">Property and equipment&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,865,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment and information systems, including internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,880,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New center and capital asset projects in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,442,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,480,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,969,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,521,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,473,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expenses are computed using the straight-line method over the useful lives of the assets estimated as follows: buildings, 25 years to 40 years; leasehold improvements, the shorter of ten years or the expected lease term; and equipment and information systems, principally three years to 15 years. Depreciation expense on property and equipment was $616,626, $600,905, and $574,799 for 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on debt incurred during the development of new centers and other capital asset projects is capitalized as a component of the asset cost based on the respective in-process capital asset balances. Interest capitalized was $17,944, $27,322 and $25,978 for 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2018, the Company recognized asset impairment charges of $17,338 related to the restructuring of its pharmacy business.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzU4NQ_913a7d65-9f9a-490d-8791-8b7fd74bbb5c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,865,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment and information systems, including internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,880,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New center and capital asset projects in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,002,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,442,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,480,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,969,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,521,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,473,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzItMS0xLTEtMA_e6f40390-fce3-4981-be20-9083937c2c19"
      unitRef="usd">37924000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzItMy0xLTEtMA_2e787105-b15e-4f02-af63-a54f8dddd6de"
      unitRef="usd">36480000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzMtMS0xLTEtMA_6c83ab4c-f71c-428c-8bd5-c3fd8e27a31c"
      unitRef="usd">400616000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzMtMy0xLTEtMA_3f5dfb98-b81d-421d-b327-9dfe2eab5c5d"
      unitRef="usd">392256000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzQtMS0xLTEtMA_edb0e8a1-e3fb-4c84-a0aa-00b7de01345a"
      unitRef="usd">3865729000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzQtMy0xLTEtMA_87a412e1-dcd9-4b79-a1c1-bff6c2cd3963"
      unitRef="usd">3545224000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzUtMS0xLTEtMA_4a79223d-fc27-478a-a245-4f403fc4f0f3"
      unitRef="usd">3081298000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzUtMy0xLTEtMA_aec06793-127f-4ab6-9ffb-683d08363979"
      unitRef="usd">2880645000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzYtMS0xLTEtMA_ae498330-aec3-454d-af76-968170c098ed"
      unitRef="usd">616686000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzYtMy0xLTEtMA_d4956414-3218-4756-9229-2c403974e1b2"
      unitRef="usd">588345000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzctMS0xLTEtMA_59bfa489-c397-41d3-9ab2-02681ed2c79f"
      unitRef="usd">8002253000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzctMy0xLTEtMA_c0615540-94ef-4778-a1a5-39d8db86ac37"
      unitRef="usd">7442950000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzgtMS0xLTEtMA_6597e358-fe95-400e-8937-692d4a8f739d"
      unitRef="usd">4480429000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzgtMy0xLTEtMA_0e37d150-cffc-45ef-8223-af3d07c82a80"
      unitRef="usd">3969566000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzktMS0xLTEtMA_3125e236-87d8-4b09-89e1-704857aea3da"
      unitRef="usd">3521824000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90YWJsZTozNDFjZjk4Y2VjMjM0NmYyODg1Mzg5NmIwOGVhMzQ0My90YWJsZXJhbmdlOjM0MWNmOThjZWMyMzQ2ZjI4ODUzODk2YjA4ZWEzNDQzXzktMy0xLTEtMA_c7a1e495-366e-4e15-9235-2bc52622bd29"
      unitRef="usd">3473384000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i50b4634b59f749b0b5c6631027941142_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY0OTMx_7c6d3bc9-4011-4370-ab88-8d31cc912b4a">P25Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i33a1bfddc39c4a169c47e840741f335c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY0OTM4_1c0bcc53-7bf7-4767-9bf7-77162491dd33">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ied88af0a7c524bc3999fdbfa994108b6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY0OTgy_999ba535-6e57-494f-8f7b-948d470407ed">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3063267a01f94e3fb4a375c1970717cb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY1MDY1_967092fd-ba24-4184-9268-41a8cb64f5a8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3b89299a9bfd462b8e5b3a7023ed6334_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzEwNDQ1MzYwNDY1MDcy_4c374457-77b4-4795-bb47-bcbc5ad0d70c">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzE0MQ_0198a5e3-19b0-4b1a-93ff-d31c05fc1740"
      unitRef="usd">616626000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzE0NQ_92f38628-c616-4aba-b138-5f5a4f22fc9c"
      unitRef="usd">600905000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzI3NDg3NzkwNzAzMjk_4aaa490e-4a4b-45c1-b6ed-40813d624c4e"
      unitRef="usd">574799000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestCostsCapitalized
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzM4NDgyOTA2OTc4MTc_d2001605-15ce-46a6-8ca5-0021fbf51048"
      unitRef="usd">17944000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzQyMg_6118b0b8-03d9-4305-93ec-1b2823fed01f"
      unitRef="usd">27322000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzQyOQ_6ea69470-de26-44bf-be51-c5b8dae724f3"
      unitRef="usd">25978000</us-gaap:InterestCostsCapitalized>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i51925e49d034403085e491018c02d26d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTQvZnJhZzo4MTFmMTUxMjRmNDQ0NzVmYTE3ZTUwOGU1MzkxNTQ0YS90ZXh0cmVnaW9uOjgxMWYxNTEyNGY0NDQ3NWZhMTdlNTA4ZTUzOTE1NDRhXzI3NDg3NzkwNzAzMDU_7e59537f-ca81-4cb6-9f29-0220f2c9634d"
      unitRef="usd">17338000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwOTI_98582c8d-a7ee-46bd-b6f2-498ed93a4f06">Intangible assets&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets other than goodwill were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncompetition agreements are generally amortized over three years to 10 years and customer relationships are principally amortized over 10 years to 20 years. Amortization expense from amortizable intangible assets was $13,809, $14,247, and $16,236 for 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized no impairment charges on any intangible assets other than the goodwill impairment charges discussed in Note 10.&lt;/span&gt;&lt;/div&gt;Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2020 were as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncompetition&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwODg_8f7e2027-9bc8-47d8-95d3-24c93b335aa4">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets other than goodwill were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzMtMS0xLTEtMA_6e148db6-ceb7-4698-b3f6-5f0a7e1f13bd"
      unitRef="usd">100138000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzMtMy0xLTEtMA_f162f79d-87bb-42ee-b5c9-5449872dba5b"
      unitRef="usd">90209000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedNoncompeteAgreementsGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMS0xLTEtMTUyMjk_ce9f2a0b-e478-43ee-8055-0a6f0cca9e52"
      unitRef="usd">84022000</us-gaap:FiniteLivedNoncompeteAgreementsGross>
    <us-gaap:FiniteLivedNoncompeteAgreementsGross
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMy0xLTEtMTUyMjk_c9dfd9b7-be21-40c3-a498-49d85e66c6f2"
      unitRef="usd">103510000</us-gaap:FiniteLivedNoncompeteAgreementsGross>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMS0xLTEtMA_ee74f95d-c3d4-4eb0-90c0-b2b1ae4b2a2a"
      unitRef="usd">52566000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzQtMy0xLTEtMA_02745071-e2c6-4493-861a-1a53cbd5aad1"
      unitRef="usd">23887000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzUtMS0xLTEtMA_d5a460eb-72c2-4a80-b143-4a5ff762994a"
      unitRef="usd">236726000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzUtMy0xLTEtMA_dc044600-244d-4b5f-a7f0-8b0dceeebf01"
      unitRef="usd">217606000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzYtMS0xLTEtMA_9d7c3206-3cb0-4b9e-b9f3-6b8288ae3979"
      unitRef="usd">70141000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzYtMy0xLTEtMA_ec29e96a-16bc-4d0f-a2ad-c197593eb3be"
      unitRef="usd">81922000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzctMS0xLTEtMA_8998b340-ef51-4728-9916-cb94249c12bb"
      unitRef="usd">166585000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjOTE3OGU4MzQ4YjI0ZDk4YjQ3ZTUyOTZiZDNkYmY4NC90YWJsZXJhbmdlOmM5MTc4ZTgzNDhiMjRkOThiNDdlNTI5NmJkM2RiZjg0XzctMy0xLTEtMA_6c4aec50-b83c-436a-b9ef-654d80e86335"
      unitRef="usd">135684000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ie087c1d3f9974f219511b176db8eda1f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2NTQ_ed781d83-3a3f-4814-b8a0-ff4a8bd79500">P3Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ie16ddbc3f61d4fdd876789fdb7485e3f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2NjY_15a377bd-97b4-41e5-a919-301990f3f990">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="iaaaf284806a9483fb5c0391481bc7d0d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2NzU_c20a223c-1570-4445-9e1c-cbd9a443fc2b">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i84b74ed9100c4ce592923a9de27931be_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzM4NDgyOTA2OTk2ODA_b36b19bd-68cb-4570-8d5b-ced1d0e30102">P20Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzE4Mg_e92af3a5-68df-4d8a-947e-ac43a010863d"
      unitRef="usd">13809000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzE4Ng_36859541-4834-4c66-b9af-fc6256b579f0"
      unitRef="usd">14247000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzI3NDg3NzkwNzA2ODI_743f2f4b-c2f5-4e1b-9373-2b0496bee6f8"
      unitRef="usd">16236000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzUzNA_2c500cd7-4d33-4499-85c2-18dabb104cb6"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwODk_e1216892-231f-4af2-81c5-cd049977a41b">Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2020 were as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncompetition&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwNTk_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90ZXh0cmVnaW9uOmQyNmJmMjY4NDRlNjRkYjY5NTNmMjc0MTlhYjI3MTc4XzEwNTk_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzEtMS0xLTEtMA_c3a44973-419d-47b0-b74a-dfb6f6a82ead"
      unitRef="usd">10274000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzEtMy0xLTEtMA_a0d850d7-6b64-41d4-9fe0-b4fc08756e88"
      unitRef="usd">3143000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzItMS0xLTEtMA_6822643f-5ea4-48a9-853f-7190b018be1e"
      unitRef="usd">6680000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzItMy0xLTEtMA_cdf6245b-d9d4-4fd3-8be1-0c61646d66f2"
      unitRef="usd">3139000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzMtMS0xLTEtMA_d05b15db-9849-4e45-a3d4-57ba454607f8"
      unitRef="usd">3883000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzMtMy0xLTEtMA_2b9c00c9-8308-494f-bf91-78ff8f8c8686"
      unitRef="usd">3102000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzQtMS0xLTEtMA_e87e15da-9658-4a08-8f24-ec26dad7f94c"
      unitRef="usd">1714000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzQtMy0xLTEtMA_a0c32055-ec57-4dfb-b32e-bb141b53e752"
      unitRef="usd">2851000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzUtMS0xLTEtMA_d36a056f-37fc-436b-856b-d3316adca777"
      unitRef="usd">585000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzUtMy0xLTEtMA_26f5d2f8-d4ee-4015-9ae0-8d2a05258926"
      unitRef="usd">2660000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzYtMS0xLTEtMA_f35989e0-15f7-45b4-9950-9c17fe0e9ee3"
      unitRef="usd">168000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzYtMy0xLTEtMA_b70a8362-f0ea-4e0b-afa8-870204bec88b"
      unitRef="usd">28248000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2e26a206867842e28cae11fb48c778d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzctMS0xLTEtMA_ebfc291e-780a-4e11-8cc0-70ed8112f360"
      unitRef="usd">23304000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie28a01afc63f4186886299ee6dea4de7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMTcvZnJhZzpkMjZiZjI2ODQ0ZTY0ZGI2OTUzZjI3NDE5YWIyNzE3OC90YWJsZTpjY2VlOTU1MTM2Yzg0ZDZiOGQ0NzAxYzU5NTc0NDBmZC90YWJsZXJhbmdlOmNjZWU5NTUxMzZjODRkNmI4ZDQ3MDFjNTk1NzQ0MGZkXzctMy0xLTEtMA_fdaeb9d0-029e-4b2c-8cf9-3f732315a7ca"
      unitRef="usd">43143000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM3Mjk_4b5c37c5-3233-4451-86b1-a08357f46980">Equity method and other investments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC joint venture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other equity method partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted cost method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, 2019 and 2018, the Company recognized equity investment income (loss) of $26,916, $12,679 and $(4,484), respectively, from its equity method investments in nonconsolidated businesses.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's largest equity method investment is its ownership interest in DaVita Care Pte. Ltd. (the APAC joint venture, or APAC JV). The Company holds a 75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;voting and economic interest in the APAC JV and an unrelated noncontrolling investor holds the other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25% voting and economic interest in the joint venture. During 2019 the continuing third party noncontrolling investor made its final subscribed capital contribution to the joint venture and the other previous third party noncontrolling investor elected to exit the joint venture. The governance structure and voting rights established for the APAC JV, which remain unchanged since its formation on August&#160;1, 2016, provide that certain key decisions affecting the joint venture&#x2019;s operations are not subject to the unilateral discretion of the Company but rather are under the joint control of the Company and the APAC JV's unrelated noncontrolling investor. As a result, the Company does not consolidate the APAC JV.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the transactions described above, the Company held a 60% voting interest and a 73.3% economic interest in the APAC JV, while the other two noncontrolling investors collectively held a 40% voting interest and a 26.7% economic interest in the APAC JV. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's other equity method investments include 22 legal entities over which the Company has significant influence but in which it does not maintain a controlling financial interest. Almost all of these are U.S. dialysis partnerships in the form of limited liability companies. The Company's ownership interests in these partnerships vary, but typically range from 30% to 50%.&lt;/span&gt;&lt;/div&gt;There were no significant impairments or other valuation adjustments on the Company's adjusted cost method and other investments during 2020, 2019 or 2018.</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM3MzE_7aab3de8-a991-4411-bec7-bce021a751e8">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC joint venture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other equity method partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted cost method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="if835180905f04b80823ceda1bcf614db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzItMS0xLTEtMA_2967fb38-f23c-4cf2-b18d-a93faab5c9d9"
      unitRef="usd">120787000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="idaa907c146d64b698d6ea801e89b4f89_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzItMy0xLTEtMA_b1c3eac3-0c33-4dba-9459-49eb4d125f84"
      unitRef="usd">116924000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ida6bf19e541046eb93c237e38a4905bc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzMtMS0xLTEtMA_bea6c6d8-ed0d-4fd7-aea5-12ab84965e6a"
      unitRef="usd">107599000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i1023bb732b9148d293570ccb2f49efc1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzMtMy0xLTEtMA_b05add6a-e802-49fc-957c-8d41935fd04b"
      unitRef="usd">114611000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ic6f1bc577e6248d9aea0e2a4190a616a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzQtMS0xLTEtMA_0211e906-519c-4146-9c3e-e316c9a768de"
      unitRef="usd">29105000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i8edd1564071a44ce9689f85e2562bf1d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzQtMy0xLTEtMA_2b514395-2143-4803-874c-d89658966cdc"
      unitRef="usd">10448000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzUtMS0xLTEtMA_d029879d-b959-4700-a364-32bcf9079eec"
      unitRef="usd">257491000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90YWJsZTo1YzA2MjM5NTU3YzY0NzlmYWY3ZWRmMWVmNGY1YmRlMy90YWJsZXJhbmdlOjVjMDYyMzk1NTdjNjQ3OWZhZjdlZGYxZWY0ZjViZGUzXzUtMy0xLTEtMA_bbb17cd4-6043-45e7-88fc-9a6c4069384b"
      unitRef="usd">241983000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ieee6b2ebaa1a4e44884eb99babde1e22_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE0Njk_6f34aa70-f308-472f-a7bc-aa88c858a115"
      unitRef="usd">26916000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iee2cd9df79914869b9cacc76ab090369_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE0NzM_c9786614-c03d-4f15-9669-9e8ddb94a119"
      unitRef="usd">12679000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i176abd0dfd064576a6fca693618a4d85_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE0ODA_c71cc1f8-de49-4a66-a52b-c12cf0192a31"
      unitRef="usd">-4484000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i743f6eba826d4df9965c6fe5e996c814_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzE5ODk_fa22833c-de79-4223-8906-1b974a6e738a"
      unitRef="number">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="if835180905f04b80823ceda1bcf614db_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzIwODI_0b0ba8a1-3c9c-4ed5-bf15-b7bd3121635a"
      unitRef="number">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="iff2c6d1977b942e7a9758284e817d55c_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI2MDY_593dbf93-4455-4d47-91cd-83615f50794d"
      unitRef="number">0.60</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ib7a1644379314e62bdaab27a9dfd42f2_I20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI2MzE_097c4c22-65a8-409a-b915-5f2fd1de40d5"
      unitRef="number">0.733</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ib7a1644379314e62bdaab27a9dfd42f2_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI3MzM_56c7fdb3-030f-44a0-bd17-cc4137b3502a"
      unitRef="number">0.40</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ib7a1644379314e62bdaab27a9dfd42f2_I20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzI3NTg_e67dab7c-4095-456a-9abd-f1d7b22f8f96"
      unitRef="number">0.267</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <dva:NumberOfPartnerships
      contextRef="iadefb36dac0a43168cf91c594bc2b46d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzMyNzY_1177beb1-617d-41fd-8278-516f23ca8ce7"
      unitRef="number">22</dva:NumberOfPartnerships>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ic8d3af328249451ea7b48056f3f531e0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM1ODQ_539e64da-1c87-4882-9dae-1c4dfd3fa9bf"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="id5952bbd67214b9a90b15f0edf9153a2_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM1OTA_4b27e178-165d-4b27-918c-31da5dc2625e"
      unitRef="number">0.50</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjMvZnJhZzoxOTczNTVmZmFmNGQ0NTdhOGY0OTZhNjQ5ZWMzOGQxNS90ZXh0cmVnaW9uOjE5NzM1NWZmYWY0ZDQ1N2E4ZjQ5NmE2NDllYzM4ZDE1XzM2MDU_7f69a817-98a7-4f89-a3c2-892b97ca290b"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU5MDE_d1e5ff2f-e3f7-4333-8465-3481d214283a">Goodwill&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other - Ancillary&lt;br/&gt;services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,275,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,287,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,787,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,055,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic, further spread or resurgence of the virus, including as a result of the emergence of the new strains of the virus, its impact on the chronic kidney disease (CKD) patient population and the Company's patient population, the availability, acceptance, impact and efficacy of COVID-19 treatments, therapies and vaccines, the pandemic's continuing impact on the U.S. and global economies and unemployment, the responses of the Company's competitors to the pandemic and related changes in the marketplaces, and the timing, scope and effectiveness of governmental responses. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the Company&#x2019;s operating segments described in Note 25 to these consolidated financial statements represents an individual reporting unit for goodwill impairment assessment purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the U.S. dialysis operating segment, the Company considers each of its dialysis centers to constitute an individual business for which discrete financial information is available. However, since these dialysis centers have similar operating and economic characteristics, and the allocation of resources and significant investment decisions concerning these businesses are highly centralized and the benefits broadly distributed, the Company has aggregated these centers and deemed them to constitute a single reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has applied a similar aggregation to the physician practices in its physician services reporting units, to the dialysis centers and other health operations within each international reporting unit, and to the vascular access service centers in its former vascular access services reporting unit. For the Company&#x2019;s other operating segments, discrete business components below the operating segment level constitute individual reporting units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When performing quantitative goodwill impairment assessments, the Company estimates fair value using either appraisals developed with an independent third party valuation firm which consider both discounted cash flow estimates for the subject business and observed market multiples for similar businesses, or offer prices received for the subject business that would be acceptable to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2019, the Company recognized goodwill impairment charges of $119,476 in its Germany kidney care business. These charges resulted primarily from a decline in then current and expected future patient census and an increase in then current and expected future costs, including due to wage increases expected to result from legislation announced at that time. The changes in the Company's expectations were informed by developments in the business in response to evolving market conditions, including changes in the Company's expected timing and ability to mitigate them, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and based on in-depth operating and strategic reviews completed by the Company's new Germany management team. During the year ended December&#160;31, 2019 the Company also recognized a goodwill impairment charge of $5,416 in its German other health operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on its most recent assessments, the Company determined that further changes in expected patient census, increases in operating costs, reductions in reimbursement rates, changes in actual or expected growth rates, or other significant adverse changes in expected future cash flows or valuation assumptions could result in goodwill impairment charges in the future for the following reporting unit, which remains at risk of goodwill impairment as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;br/&gt;balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;coverage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Sensitivities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Discount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany kidney care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as described above, none of the Company&#x2019;s other reporting units were considered at risk of significant goodwill impairment as of December&#160;31, 2020.&#160;Since the dates of the Company&#x2019;s last annual goodwill impairment assessments, there have been certain developments, events, changes in operating performance and other changes in key circumstances that have affected the Company&#x2019;s businesses. However, these have not caused management to believe it is more likely than not that the fair values of any of the Company&#x2019;s reporting units would be less than their respective carrying amounts as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU5MDI_a204c155-fc0f-40aa-89e7-f60f65c31ef3">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other - Ancillary&lt;br/&gt;services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,275,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,287,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,787,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,055,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i5831886c34dd408a8ed406190748f295_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEtMS0xLTEtMA_d620e37e-7aee-47c1-b0b4-c600dcbe4543"
      unitRef="usd">6275004000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic54da9f2132a4f749e030ac9e3e0c618_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEtMy0xLTEtMA_4cdb3ee5-8e94-445b-b3af-5a4a766eed6c"
      unitRef="usd">566956000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEtNS0xLTEtMA_daefd641-cf43-49d0-ad5a-1f495b0ad6dc"
      unitRef="usd">6841960000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzItMS0xLTEtMA_b179964a-1735-488c-af2c-79a4206ce6e9"
      unitRef="usd">18089000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzItMy0xLTEtMA_e11ef2ae-14d5-4187-a3e0-19ad0cbe8f5c"
      unitRef="usd">72137000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzItNS0xLTEtMA_a4feedea-8cb4-419c-b45a-6757dd32ff4e"
      unitRef="usd">90226000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzQtMS0xLTEtMA_6f55d9df-68c2-41a7-b4d5-a6f00bce2796"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzQtMy0xLTEtMA_27fb1c10-7b61-4ba3-a72b-2f11ffb5d164"
      unitRef="usd">124892000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzQtNS0xLTEtMA_5c114a79-56b1-40d4-8962-92245f0a1a1b"
      unitRef="usd">124892000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzUtMS0xLTEtMA_cd136df0-27e2-463b-b265-6369b30eb62d"
      unitRef="usd">5993000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzUtMy0xLTEtMA_d90fe305-8d4b-440f-b176-b24c70d32f8c"
      unitRef="usd">13666000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzUtNS0xLTEtMA_4a5488ed-c85a-413c-82f5-91160fccfec4"
      unitRef="usd">19659000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="if638379c314e4e40a080f1df9bc6d4eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzYtMS0xLTEtMA_2edb226d-94c6-45ab-9d00-2072214df2c8"
      unitRef="usd">6287100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzYtMy0xLTEtMA_70d2fde5-12cd-4ec0-a3cf-bb2396e9cc05"
      unitRef="usd">500535000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzYtNS0xLTEtMA_fedc5ee3-309a-4474-810b-ed5aba4080a3"
      unitRef="usd">6787635000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMS0xLTEtMA_a29ac83e-51dd-4210-8f41-abc94830e292"
      unitRef="usd">24377000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMy0xLTEtMA_2b973645-34ca-4d55-a105-448e5b4f60ea"
      unitRef="usd">105680000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctNS0xLTEtMA_c4825629-0349-4daf-922b-60bc7134c2b5"
      unitRef="usd">130057000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMS0xLTEtMTUxMjM_54851f96-d3ec-467e-9c46-0d10a82c130d"
      unitRef="usd">1549000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctMy0xLTEtMTUxMjM_f8455fe9-993b-4045-90ed-0fff0098dd87"
      unitRef="usd">6744000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzctNS0xLTEtMTUxMjM_6d4c0ddf-3a4d-4755-9b84-64e93e282b7c"
      unitRef="usd">8293000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzktMS0xLTEtMA_927ea38a-92bc-4786-965e-803cd984fc98"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzktMy0xLTEtMA_52eb0aa4-7b59-4389-a600-b6b6c5d0ff1c"
      unitRef="usd">-9710000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzktNS0xLTEtMA_4f66b79c-583d-4595-8301-f5e2399847b9"
      unitRef="usd">-9710000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEwLTEtMS0xLTA_8b98b836-e487-4897-abc3-7aef9992b907"
      unitRef="usd">6309928000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if18749a859234cf7b23652f60c460caf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEwLTMtMS0xLTA_f3e16c34-eb4c-4971-a6a6-f38baedbca25"
      unitRef="usd">609181000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEwLTUtMS0xLTA_4ef13933-cca2-4b32-acd1-511902beac3f"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEyLTEtMS0xLTA_8cf980ea-dd78-4ed1-9722-20cd49cfc212"
      unitRef="usd">6309928000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="if18749a859234cf7b23652f60c460caf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEyLTMtMS0xLTA_6ffdf38f-2764-43e2-ace1-2d7cbc5dd1cc"
      unitRef="usd">745732000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEyLTUtMS0xLTA_354a7d9c-8de7-4678-a1ec-22f5aebc9366"
      unitRef="usd">7055660000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEzLTEtMS0xLTA_bbab387e-30e5-44a8-b812-6e4eb8a9404e"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="if18749a859234cf7b23652f60c460caf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEzLTMtMS0xLTA_d5fbb82b-5097-47fb-b272-c83d24c7f7d4"
      unitRef="usd">136551000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzEzLTUtMS0xLTA_e71923c9-1a75-46aa-ba37-62ae28520907"
      unitRef="usd">136551000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzE0LTEtMS0xLTA_dd311407-71d6-47e1-b19b-9482d6a3738e"
      unitRef="usd">6309928000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if18749a859234cf7b23652f60c460caf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzE0LTMtMS0xLTA_8d003d7e-f4d9-4039-843d-98411e3006b6"
      unitRef="usd">609181000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiNmRkNDhjYzJmNTY0ZmQzODAyNzE3ZjNhYjNiMTkxNi90YWJsZXJhbmdlOmI2ZGQ0OGNjMmY1NjRmZDM4MDI3MTdmM2FiM2IxOTE2XzE0LTUtMS0xLTA_682507b6-9d69-4cb0-b409-22ebbca62653"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib5c4935b96bc45d599d29d673dc708b8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzEwOTk1MTE2MjkwMzgx_dd646613-ac45-4e70-b97e-3c1b5824bbfd"
      unitRef="usd">119476000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic3604fec36844df58062ea76e02219c2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzMzMDE_1ef47728-ec18-4080-ba74-de528040d91f"
      unitRef="usd">5416000</us-gaap:GoodwillImpairmentLoss>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzQyNjc_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzQyNjc_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU5MDg_66bee413-8086-4be7-85a2-e02096a26c41">&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;br/&gt;balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;coverage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Sensitivities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Discount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany kidney care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;</dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock>
    <us-gaap:Goodwill
      contextRef="ic2f082dee6464c25915568ecfd2d5672_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItMi0xLTEtMA_7dfcd12f-1311-4eda-99db-b6e7fd455788"
      unitRef="usd">322736000</us-gaap:Goodwill>
    <dva:ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount
      contextRef="ic2f082dee6464c25915568ecfd2d5672_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItNC0xLTEtMA_0ed0b1aa-d92d-4da0-a5d7-c2124ab6490c"
      unitRef="number">0.023</dva:ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount>
    <dva:PotentialImpactOnFairValueForReductionInOperatingIncome
      contextRef="ic2f082dee6464c25915568ecfd2d5672_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItNi0xLTEtMA_6206cfbe-dabb-4789-96c1-f936716d442e"
      unitRef="number">0.015</dva:PotentialImpactOnFairValueForReductionInOperatingIncome>
    <dva:PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate
      contextRef="i2bf9f1c0751e45cb82db545fe4859306_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90YWJsZTpiMzNiOTI4OTIxZjc0OWIyOTM4NmRkNGE0NzczNmQzNS90YWJsZXJhbmdlOmIzM2I5Mjg5MjFmNzQ5YjI5Mzg2ZGQ0YTQ3NzM2ZDM1XzItOC0xLTEtMA_43d6ce4e-6c80-4eae-a118-03c62ff04bed"
      unitRef="number">0.101</dva:PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate>
    <dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzQ0Njk_6d9325df-53e2-4274-a977-80eb448b4dfd"
      unitRef="number">0.03</dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i910ed57bdfbe40edaf7a7ec74018eace_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzUzNDc_8073fa2a-9f18-4c82-aa99-6288ac1fe04d"
      unitRef="segment">0</us-gaap:NumberOfOperatingSegments>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU0NTQ_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU0NTQ_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU4OTc_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMjkvZnJhZzphYWE3OGZjZjViNWE0YTExOWY5NzgyY2ZlNDhiOGY0ZS90ZXh0cmVnaW9uOmFhYTc4ZmNmNWI1YTRhMTE5Zjk3ODJjZmU0OGI4ZjRlXzU4OTc_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90ZXh0cmVnaW9uOjcwMGMwZGQ5M2E4MTRkYjE4NGI4MDUzNDkzOWRjNmEzXzg2_e354d92a-c8c7-4d3a-8ae1-4c894d90b3e3">Other liabilities&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payor refunds and retractions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance and self-insurance accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued non-income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90ZXh0cmVnaW9uOjcwMGMwZGQ5M2E4MTRkYjE4NGI4MDUzNDkzOWRjNmEzXzgy_273ed8a0-2d32-44e4-9592-511359704bfc">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payor refunds and retractions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance and self-insurance accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued non-income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <dva:PayorRefundsAndRetractions
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzItMS0xLTEtMA_92d94785-c071-4fb8-ad25-3906b72b03be"
      unitRef="usd">371183000</dva:PayorRefundsAndRetractions>
    <dva:PayorRefundsAndRetractions
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzItMy0xLTEtMA_4d1aa72e-5b2c-4dec-942e-5335fbd52126"
      unitRef="usd">377044000</dva:PayorRefundsAndRetractions>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzMtMS0xLTEtMA_ce3e94fc-b5fa-400e-ba05-eaf87367699b"
      unitRef="usd">54438000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzMtMy0xLTEtMA_d8244e88-9ee3-4d2c-ad2f-6738fc72ef53"
      unitRef="usd">58941000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzQtMS0xLTEtMA_eb102d03-b669-4ec1-a6ec-07a1cfbb18f1"
      unitRef="usd">30066000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzQtMy0xLTEtMA_9b4cb75c-ce5d-41fe-8da4-2b63eff4bcbb"
      unitRef="usd">54899000</us-gaap:InterestPayableCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzUtMS0xLTEtMA_d9bfd2c4-38d8-443e-bc2c-4b5d74497ee9"
      unitRef="usd">39075000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzUtMy0xLTEtMA_a5d7f964-195a-4260-b38e-7d26b86fd961"
      unitRef="usd">36285000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzYtMS0xLTEtMA_753c4516-abd9-47ac-a50c-352ca0bccf91"
      unitRef="usd">315767000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzYtMy0xLTEtMA_994b2936-25c4-49f2-a202-3f18b4cdc1c3"
      unitRef="usd">229005000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzctMS0xLTEtMA_9daa627c-0fbc-4ff8-aa1d-793581f26cf8"
      unitRef="usd">810529000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzUvZnJhZzo3MDBjMGRkOTNhODE0ZGIxODRiODA1MzQ5MzlkYzZhMy90YWJsZTpmNjc0NTlhNzBiMTc0NDMwYjE4YzFmODBkNjVmMTM0MC90YWJsZXJhbmdlOmY2NzQ1OWE3MGIxNzQ0MzBiMThjMWY4MGQ2NWYxMzQwXzctMy0xLTEtMA_c4fba4f5-99dc-4458-965d-e02d54ffeca8"
      unitRef="usd">756174000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzQwMDc_42fea31c-f530-43ea-b547-512e28d60f14">Income taxes&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes from continuing operations consisted of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Income tax expense for continuing operations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are allocated between continuing and discontinued operations as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between the Company&#x2019;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in International valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Political advocacy costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests primarily&lt;br/&gt; attributable to non-tax paying entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(634,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(527,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,583,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,344,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(577,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;At December&#160;31, 2020, the Company had federal net operating loss carryforwards of approximately $99,657 that expire through 2036, although a substantial amount expire by 2029. The Company also had state net operating loss carryforwards of $488,070, some of which have an indefinite life, although a substantial amount expire by 2040 and international net operating loss carryforwards of $296,451, some of which will begin to expire in 2021 though the majority have an indefinite life. The Company has a state capital loss carryover of $297,748, the majority of which expires in 2024. The utilization of a portion of these losses may be limited in future years based on the profitability of certain entities. A valuation allowance is recorded to account for the unrealizable balances in the table above. The net increase of $22,899 in the valuation allowance is primarily due to newly created net operating loss carryforwards in state and foreign jurisdictions that the Company does not anticipate being able to utilize.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's foreign earnings continue to be indefinitely reinvested as of December&#160;31, 2020. As a result of the passage of the Tax Cuts and Jobs Act (2017 Tax Act), the Company does not expect such earnings to be taxable if remitted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions related to lapse of applicable statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions related to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company&#x2019;s total liability for unrecognized tax benefits relating to tax positions that do not meet the more-likely-than-not threshold is $70,202, of which $66,607 would impact the Company&#x2019;s effective tax rate if recognized. This balance represents an increase of $1,988 from the December&#160;31, 2019 balance of $68,214.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. At December&#160;31, 2020 and 2019, the Company had approximately $17,864 and $14,428, respectively, accrued for interest and penalties related to unrecognized tax benefits, net of federal tax benefit.&lt;/span&gt;&lt;/div&gt;The Company and its subsidiaries file U.S. federal and state income tax returns and various foreign income tax returns. The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2014 and 2009, respectively. In addition to being under audit in various state and local tax jurisdictions, the Company&#x2019;s federal tax returns are under audit by the Internal Revenue Service for the years 2014-2017.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5OTI_41afc483-7a44-4650-938d-1746c1ff5207">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes from continuing operations consisted of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzItMS0xLTEtMA_a2fe4604-eb18-4927-9b13-e36555012095"
      unitRef="usd">1287976000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzItMy0xLTEtMA_930dbf93-15fd-4efd-8bbb-4c55524a2390"
      unitRef="usd">1307299000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzItNS0xLTEtMA_e37b5595-3e96-45b7-a6cc-015c7f400c3d"
      unitRef="usd">1083578000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzMtMS0xLTEtMA_466f683c-35cf-4e09-a95f-00daaec6ef0a"
      unitRef="usd">30286000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzMtMy0xLTEtMA_c9675f81-eee1-4155-96ef-3b463c383e88"
      unitRef="usd">-111860000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzMtNS0xLTEtMA_094a6c89-e72c-4489-ad69-775adeec6a66"
      unitRef="usd">-35100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzQtMS0xLTEtMA_085d9b92-f959-4a97-bd1f-9781aca3c4d6"
      unitRef="usd">1318262000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzQtMy0xLTEtMA_7606672d-c679-4d5d-84b4-407b938cf447"
      unitRef="usd">1195439000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZToxZjJiMzQwMjhmZTk0ZDQwOThhNDE0MGVkNzBkNjlhNC90YWJsZXJhbmdlOjFmMmIzNDAyOGZlOTRkNDA5OGE0MTQwZWQ3MGQ2OWE0XzQtNS0xLTEtMA_75e15528-1e95-424e-8d24-e1592b8118c2"
      unitRef="usd">1048478000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzQwMTU_3c705540-67cb-44b4-99fd-3e01b33224e8">Income tax expense for continuing operations consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzMtMS0xLTEtMA_2ef3dd7b-50a2-43b7-8da2-87b45cda732e"
      unitRef="usd">47171000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzMtMy0xLTEtMA_ca48bdce-56e7-41e0-8d92-7c3e65d5e18e"
      unitRef="usd">208339000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzMtNS0xLTEtMA_f852d681-bf83-4b42-bd2c-175045fd308d"
      unitRef="usd">140064000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzQtMS0xLTEtMA_c3ac8ade-ca05-4424-bc46-f27ac6048309"
      unitRef="usd">21442000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzQtMy0xLTEtMA_4b0e11d6-c513-4589-a9e5-6c9cc1e38183"
      unitRef="usd">58026000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzQtNS0xLTEtMA_8a532e22-bc8f-4e8a-9f2d-2bd2d24ee6f5"
      unitRef="usd">32990000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzUtMS0xLTEtMA_7bc5dca0-91e1-448e-ab3f-799e4d7d49ae"
      unitRef="usd">17481000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzUtMy0xLTEtMA_b2c328bc-7e83-4a3a-bdbd-be38cb3a69f3"
      unitRef="usd">15545000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzUtNS0xLTEtMA_ada5eb96-dee5-4143-9d9f-b26d1f362b9d"
      unitRef="usd">7557000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzYtMS0xLTEtMA_09a9b35e-7b45-4914-bdcd-fd3359151b4a"
      unitRef="usd">86094000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzYtMy0xLTEtMA_7687fbcf-d2af-4627-afae-495d20513a43"
      unitRef="usd">281910000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzYtNS0xLTEtMA_281dd21e-fb4c-47a1-bdbb-368a56db4633"
      unitRef="usd">180611000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzgtMS0xLTEtMA_27a31843-9501-40ba-9769-be77b00459d3"
      unitRef="usd">198623000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzgtMy0xLTEtMA_3cc4b1db-fc0b-4a76-9c7b-8cebca6aa24a"
      unitRef="usd">44263000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzgtNS0xLTEtMA_8423b599-8533-4ca1-b51b-8d75fc9099ae"
      unitRef="usd">52034000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzktMS0xLTEtMA_f9f32633-ebb3-478f-b68e-bb10026f6120"
      unitRef="usd">27206000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzktMy0xLTEtMA_aa7c86de-c912-4399-a348-9125df4e57bb"
      unitRef="usd">-25836000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzktNS0xLTEtMA_5034a801-9838-4d22-9c6d-da34f2ca5f93"
      unitRef="usd">21096000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEwLTEtMS0xLTA_ee5c9ec5-10f1-4628-a899-d8912de08116"
      unitRef="usd">2009000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEwLTMtMS0xLTA_992688d8-77e7-4776-af2d-41da0f8528d3"
      unitRef="usd">-20709000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEwLTUtMS0xLTA_4add9135-99f2-47d0-b382-2a9876cbf062"
      unitRef="usd">4659000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzExLTEtMS0xLTA_13073fff-d3c6-4028-9bcb-8c08370ea694"
      unitRef="usd">227838000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzExLTMtMS0xLTA_9a427160-4bee-466f-ac27-bc34b05b5c9e"
      unitRef="usd">-2282000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzExLTUtMS0xLTA_31bc6be6-9254-4ca7-8ce3-483be127933b"
      unitRef="usd">77789000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEyLTEtMS0xLTA_74485c24-e96d-4e2c-a53c-72ff19f7dc9f"
      unitRef="usd">313932000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEyLTMtMS0xLTA_9775e6e8-7254-4d6f-8a57-a6cf41fcb770"
      unitRef="usd">279628000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpkYWE1YzliOGRmOTA0ZTNmYTNkZWE4NzUxNWQ2Yzc5YS90YWJsZXJhbmdlOmRhYTVjOWI4ZGY5MDRlM2ZhM2RlYTg3NTE1ZDZjNzlhXzEyLTUtMS0xLTA_5389540e-bf18-4054-8907-649633d1b936"
      unitRef="usd">258400000</us-gaap:IncomeTaxExpenseBenefit>
    <dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzQwMTA_9663e62a-3f40-4939-b9c6-995891b5ab9f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are allocated between continuing and discontinued operations as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzItMS0xLTEtMA_aebd8a95-7582-41f8-8c42-81ffb0099c92"
      unitRef="usd">313932000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzItMy0xLTEtMA_4f195c3a-9d94-431f-b5ce-26e2fe88d7c5"
      unitRef="usd">279628000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzItNS0xLTEtMA_25ae73c4-56c1-447d-a512-99adde3f45ab"
      unitRef="usd">258400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzMtMS0xLTEtMA_ec0ac095-9130-4e9c-ad70-43633781197a"
      unitRef="usd">1657000</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzMtMy0xLTEtMA_71b7a687-d05d-4378-a2a9-1c7beb659b5d"
      unitRef="usd">40689000</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzMtNS0xLTEtMA_a01980b8-8da6-4eb0-bed6-e208ded62463"
      unitRef="usd">99768000</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzQtMS0xLTEtMA_a6f31475-727e-4c7c-bf7f-59c62fc61791"
      unitRef="usd">315589000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzQtMy0xLTEtMA_035f99ca-c8d3-4115-924a-d6566086cb5d"
      unitRef="usd">320317000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo5ZGNhZjMxNDhlYjM0ZDVmYTVhMzljMDI1ZjBlMmNmZi90YWJsZXJhbmdlOjlkY2FmMzE0OGViMzRkNWZhNWEzOWMwMjVmMGUyY2ZmXzQtNS0xLTEtMA_c2baed55-7443-413f-af4a-5ccffea16ec8"
      unitRef="usd">358168000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5OTE_ebadacc4-b877-4ae0-9d34-7e530dd3aad4">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between the Company&#x2019;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in International valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Political advocacy costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests primarily&lt;br/&gt; attributable to non-tax paying entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzItMS0xLTEtMA_da1c93ef-db7a-4124-97c7-5698f98c4e1d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzItMy0xLTEtMA_5e1264f0-0862-4e2d-80ef-257e94bc31c0"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzItNS0xLTEtMA_1876dcb9-65c3-4387-8374-525b4d6c9cac"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzMtMS0xLTEtMA_2acda22a-e6a3-406b-bb05-069e9c6990fb"
      unitRef="number">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzMtMy0xLTEtMA_d1322fe3-3c4a-4c84-8747-4f017e62e041"
      unitRef="number">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzMtNS0xLTEtMA_549a8eee-d934-41a5-bc78-8518cdb2832d"
      unitRef="number">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzQtMS0xLTEtMA_2fd8dbde-5efe-4a2d-9631-5b7d51e75dfa"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzQtMy0xLTEtMA_68be324f-645e-4bff-aa34-4f5922916440"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzQtNS0xLTEtMA_b6edfc6e-0904-4435-97a0-bd806481ef97"
      unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzYtMS0xLTEtMA_1944df51-aed9-461b-9460-4c8c70491a80"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzYtMy0xLTEtMA_6dab0b7c-37d2-46e9-9b7d-9613d112590d"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzYtNS0xLTEtMA_44f22ddd-74e9-4d12-bdab-e9d2962a8121"
      unitRef="number">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <dva:EffectiveIncomeTaxReconciliationInvestmentImpairment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzctMS0xLTEtMA_b89f689c-a578-4e72-8b08-087f98b7f423"
      unitRef="number">0.012</dva:EffectiveIncomeTaxReconciliationInvestmentImpairment>
    <dva:EffectiveIncomeTaxReconciliationInvestmentImpairment
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzctMy0xLTEtMA_047f8b4b-7902-4a89-87c9-94883d7126a9"
      unitRef="number">0.008</dva:EffectiveIncomeTaxReconciliationInvestmentImpairment>
    <dva:EffectiveIncomeTaxReconciliationInvestmentImpairment
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzctNS0xLTEtMA_d6c6a5d6-cdfa-4645-b9d1-88d26c2cbddf"
      unitRef="number">0.007</dva:EffectiveIncomeTaxReconciliationInvestmentImpairment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzktMS0xLTEtMA_86a63d1b-c804-4d16-9484-d173759f7955"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzktMy0xLTEtMA_f5fabf08-6024-4118-bb98-6c17e5206fff"
      unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzktNS0xLTEtMA_663442ad-056b-4c99-a63a-e47310a4100b"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEwLTEtMS0xLTA_9c78363c-82e9-4c2b-b6c7-c7d547899109"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEwLTMtMS0xLTA_7fb0ca69-0308-4e10-8a91-d57a8a9533df"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEwLTUtMS0xLTA_a0973c3d-12fa-4705-a945-a6fffbb15323"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzExLTEtMS0xLTA_bc530b72-f640-4abd-8b7b-726bf3c3099e"
      unitRef="number">-0.048</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzExLTMtMS0xLTA_55448c37-ea80-41a3-9582-d40491291203"
      unitRef="number">-0.049</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzExLTUtMS0xLTA_6cbab914-464c-4d7d-80bb-837ff25bafde"
      unitRef="number">-0.046</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEyLTEtMS0xLTA_f866870c-b5f2-4281-ab96-7253089dff1d"
      unitRef="number">0.238</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEyLTMtMS0xLTA_5e2df137-cce8-48a2-88e1-e3a0fe516eeb"
      unitRef="number">0.234</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTpjMGU2ZjMzNjY3N2Y0OGEyODdhZDZiY2YyNDBhZjkyZi90YWJsZXJhbmdlOmMwZTZmMzM2Njc3ZjQ4YTI4N2FkNmJjZjI0MGFmOTJmXzEyLTUtMS0xLTA_ab289d3e-9a41-43a1-97ea-ed46f0761ae9"
      unitRef="number">0.246</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5ODg_2ab10d05-88ed-4a48-bb24-5617cea49546">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(634,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(527,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,583,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,344,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(577,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <dva:DeferredTaxAssetsReceivables
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzItMS0xLTEtMA_5369d9f4-659f-447e-80ab-5f317e8be2d4"
      unitRef="usd">9324000</dva:DeferredTaxAssetsReceivables>
    <dva:DeferredTaxAssetsReceivables
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzItMy0xLTEtMA_470255ce-f3bc-4868-a01d-408623566a8c"
      unitRef="usd">19095000</dva:DeferredTaxAssetsReceivables>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzMtMS0xLTEtMA_8013fabe-f2cb-45de-a309-30aff875fe5e"
      unitRef="usd">64982000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzMtMy0xLTEtMA_ae6e60ce-2ce0-4402-aba2-57dc6b2a4cf3"
      unitRef="usd">64458000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <dva:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzQtMS0xLTEtMA_11903ec4-77ff-46dd-9850-44f4ec8ff8ef"
      unitRef="usd">584656000</dva:DeferredTaxAssetsOperatingLeaseLiabilities>
    <dva:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzQtMy0xLTEtMA_6e41fb6b-e014-4525-ba02-8e6b31b26407"
      unitRef="usd">580110000</dva:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzUtMS0xLTEtMA_677c6b3f-efc0-4a5c-863b-ef454b45d83c"
      unitRef="usd">167398000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzUtMy0xLTEtMA_c3628edc-9af6-4dee-ac5e-b2d0948b0b54"
      unitRef="usd">139690000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzYtMS0xLTEtMA_3b9a810c-2e7a-42dd-b6e3-10acb3c89d76"
      unitRef="usd">62110000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzYtMy0xLTEtMA_f0509cb6-6dc5-4761-935a-134a9980c990"
      unitRef="usd">55108000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzctMS0xLTEtMA_05896772-dae4-48aa-9b7e-8f43556902a5"
      unitRef="usd">888470000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzctMy0xLTEtMA_e1d61fc2-c9c4-4df9-bc79-1c8fdb0fff94"
      unitRef="usd">858461000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzgtMS0xLTEtMA_70dcff37-610b-46fa-9cc0-f2c447500306"
      unitRef="usd">114824000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzgtMy0xLTEtMA_295dba6e-60e6-4ebe-8f21-1e2f481658ca"
      unitRef="usd">91925000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzktMS0xLTEtMA_5e77bbd2-0825-4fce-8bce-975dff0c7a7c"
      unitRef="usd">773646000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzktMy0xLTEtMA_bee451b8-dc28-49a7-9ea4-fdd2c694c6bf"
      unitRef="usd">766536000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEwLTEtMS0xLTA_9d0bfaf5-9470-45f5-aa97-25278c2e2dba"
      unitRef="usd">634736000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEwLTMtMS0xLTA_53e98f76-6039-4339-8b19-d1b3d3ba08d6"
      unitRef="usd">563914000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzExLTEtMS0xLTA_2dfa0927-be88-4c3d-8442-5a65eccaebce"
      unitRef="usd">274742000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzExLTMtMS0xLTA_052bd3d9-bc9f-469c-9a40-9d1565732d9c"
      unitRef="usd">162628000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <dva:DeferredTaxLiabilitiesOperatingLeaseAssets
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEyLTEtMS0xLTA_97deeaf0-9e2e-498e-be16-476fd92f8b17"
      unitRef="usd">532082000</dva:DeferredTaxLiabilitiesOperatingLeaseAssets>
    <dva:DeferredTaxLiabilitiesOperatingLeaseAssets
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEyLTMtMS0xLTA_dbdc6556-b5d1-4e75-9b30-523ae33cdfda"
      unitRef="usd">527056000</dva:DeferredTaxLiabilitiesOperatingLeaseAssets>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEzLTEtMS0xLTA_7717608b-d95b-4bf5-b3ce-e75169596d06"
      unitRef="usd">101996000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzEzLTMtMS0xLTA_d60e01b2-6e3c-4f5a-93dc-e54f4f09d017"
      unitRef="usd">64960000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE0LTEtMS0xLTA_53db90a7-bb33-40ab-ac0a-b9ac51fa0466"
      unitRef="usd">39690000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE0LTMtMS0xLTA_b7d73382-f76f-4a7e-b2b1-014c6e2ce67c"
      unitRef="usd">25521000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE1LTEtMS0xLTA_968d6e79-e0f9-485a-9231-56dfa63e37fd"
      unitRef="usd">1583246000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE1LTMtMS0xLTA_ca50d0ae-1a6f-41ab-a210-c47689924cf6"
      unitRef="usd">1344079000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE2LTEtMS0xLTA_a7c058ce-a604-415c-b109-f14a480e71c6"
      unitRef="usd">809600000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo0MTEzNTFlZjU5MGU0MDE5YjI0OGQzZmEwNTNhZTVjNy90YWJsZXJhbmdlOjQxMTM1MWVmNTkwZTQwMTliMjQ4ZDNmYTA1M2FlNWM3XzE2LTMtMS0xLTA_52f513f0-07cf-49ca-a08f-3cf8abd5107f"
      unitRef="usd">577543000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="id62f30525c6a45a4b19b99409e8b6a62_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzE2NzQ_e88ad6c9-5bb0-4b18-986f-3a533e8bb847"
      unitRef="usd">99657000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia93e30cc7514476e83496bdfc4e18ffb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzE4MDg_5ec2fe29-442f-4114-9ae4-c31a594fc74b"
      unitRef="usd">488070000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if485fd70c4f140e5a792e18f8695f7b3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzE5NDg_f2622899-1b7c-48d3-8f3b-35a2751163bc"
      unitRef="usd">296451000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="idec8d246ff474a11befdb8bf8dc561ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzIwODA_018fad44-648b-43ce-bf1d-9df6f88b72c4"
      unitRef="usd">297748000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzIzMzY_be680913-6608-42fa-ad3c-6df04345e831"
      unitRef="usd">22899000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM5OTU_15423dfa-f9fc-46ce-b4ea-1dfd6ad78c39">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions related to lapse of applicable statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions related to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzItMS0xLTEtMA_26b43db1-980f-4477-a211-4863c05ec624"
      unitRef="usd">68214000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzItMy0xLTEtMA_c8f76c9f-ee3a-45d6-9ab7-aab305f0b4b7"
      unitRef="usd">40382000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzMtMS0xLTEtMA_f3a4bb0c-06f0-42ab-86af-5a9af2e0c4f5"
      unitRef="usd">2293000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzMtMy0xLTEtMA_f991c5b4-c4b4-464a-b776-fd989f6acc18"
      unitRef="usd">3378000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzQtMS0xLTEtMA_84fcb656-625c-4c03-b438-234fbb78e730"
      unitRef="usd">258000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzQtMy0xLTEtMA_87d33b2e-40ca-41c0-b25f-f956a491c9d3"
      unitRef="usd">24722000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzUtMS0xLTEtMA_992290c2-1dd7-4794-b8ae-2ae3c8373ee2"
      unitRef="usd">133000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzUtMy0xLTEtMA_374bb265-b7b2-4d66-a212-8af069e7079d"
      unitRef="usd">268000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzYtMS0xLTEtMA_0efee740-10c1-42b5-b7ca-95147f6cce43"
      unitRef="usd">430000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzYtMy0xLTEtMA_a14f40b3-d77d-4e1b-ad0b-8bb9c934a1bc"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzctMS0xLTEtMA_e980add4-e593-40ad-b25a-a9e3217ff4d3"
      unitRef="usd">70202000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90YWJsZTo4MzFjYTYyZTQ1N2I0NDUwYTE3M2Y4NDM2ZWQ2NmI5Mi90YWJsZXJhbmdlOjgzMWNhNjJlNDU3YjQ0NTBhMTczZjg0MzZlZDY2YjkyXzctMy0xLTEtMA_26b43db1-980f-4477-a211-4863c05ec624"
      unitRef="usd">68214000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMwNTY_233dc498-5929-4397-970e-4458dfa1bc82"
      unitRef="usd">70202000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMwNjk_9dc6ff2f-3036-463c-b38e-8919fc162b94"
      unitRef="usd">66607000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMxNjM_c9c47b71-4ee2-4f3b-b893-9a72a095cfe4"
      unitRef="usd">1988000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzMxODk_83aaf8d4-8e5d-4d76-8873-aca11c908e03"
      unitRef="usd">68214000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM0MjA_80b621bd-34d6-475c-8c94-5375f4596af7"
      unitRef="usd">17864000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yMzgvZnJhZzo2ZjE4MDY4MzBkZDA0NTUxYmQxYTc3Yjc5ZGQxNjQwYi90ZXh0cmVnaW9uOjZmMTgwNjgzMGRkMDQ1NTFiZDFhNzdiNzlkZDE2NDBiXzM0Mjc_6a600f76-4912-4276-bade-8dc500ca4cc1"
      unitRef="usd">14428000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTYz_5645d9ca-f9e1-48e8-9aba-1556220a8186">Long-term debt&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,684,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,675,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,715,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,702,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABR + 0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.125% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7/15/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,163,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,181,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,085,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,108,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,917,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,977,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The Company's interest rate for its revolving line of credit as of December&#160;31, 2020 was based on an Alternate Base Rate (ABR or Prime Rate) plus 0.50%, or 3.75%. Effective January 6, 2021 this was converted to a LIBOR-based rate of LIBOR plus 1.50%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,461 and deferred financing costs of $35,825 and the carrying amount of the Company's senior notes includes deferred financing costs of $36,431. As of December&#160;31, 2019, the carrying amount of the Company's senior secured credit facilities included a discount of $6,457 and deferred financing costs of $45,444, and the carrying amount of the Company's senior notes included deferred financing costs of $20,939.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTY4_4e021d35-803a-44de-9617-c7f4449e8d5b">Long-term debt&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,684,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,675,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,715,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,702,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABR + 0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.125% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7/15/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,163,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,181,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,085,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,108,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,917,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,977,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The Company's interest rate for its revolving line of credit as of December&#160;31, 2020 was based on an Alternate Base Rate (ABR or Prime Rate) plus 0.50%, or 3.75%. Effective January 6, 2021 this was converted to a LIBOR-based rate of LIBOR plus 1.50%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,461 and deferred financing costs of $35,825 and the carrying amount of the Company's senior notes includes deferred financing costs of $36,431. As of December&#160;31, 2019, the carrying amount of the Company's senior secured credit facilities included a discount of $6,457 and deferred financing costs of $45,444, and the carrying amount of the Company's senior notes included deferred financing costs of $20,939.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled maturities of long-term debt at December&#160;31, 2020 were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,496,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,031,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;13, 2020, the Company entered into an amendment (the Repricing Amendment) to refinance and reprice its senior secured Term Loan B with a senior secured Term Loan B-1 that bears interest at a rate equal to LIBOR plus an applicable margin of 1.75% and matures on August&#160;12, 2026. The Repricing Amendment did not change the interest rate on the Term Loan A or the revolving line of credit. No additional debt was incurred, nor any additional proceeds received, by the Company in connection with the Repricing Amendment. The majority of the Company's Term Loan B debt was considered modified in this transaction. As a result, the Company recognized debt refinancing charges of $2,948 in the year ended December 31, 2020 comprised partially of fees incurred on this transaction and partially of deferred financing costs written off for the portion of debt considered extinguished and reborrowed. For the portion of the Term Loan B debt that was considered extinguished and reborrowed in this refinancing, the Company recognized $68,842 in constructive financing cash outflows and financing cash inflows on the statement of cash flows, even though no funds were actually paid or received. Another $55,895 of the debt considered extinguished in this refinancing represented a non-cash financing activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $54,688 on Term Loan A and $27,431 on Term Loan B-1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 9, 2020, the Company issued $1,750,000 aggregate principal amount of 4.625% senior notes due 2030 (the 4.625% Senior Notes) in a private offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 4.625% Senior Notes pay interest on June&#160;1 and December&#160;1 of each year beginning December&#160;1, 2020. The 4.625% Senior Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. The 4.625% Senior Notes are guaranteed by each of the Company&#x2019;s domestic subsidiaries that guarantee its senior secured credit facilities. The Company may redeem up to 40% of the aggregate principal amount of the 4.625% Senior Notes at any time prior to June 1, 2023 at 104.625% of the aggregate principal amount from the proceeds of one or more equity offerings, plus accrued and unpaid interest. In addition, the Company may redeem the 4.625% Senior Notes at any time prior to June 1, 2025 at a make-whole redemption price plus accrued and unpaid interest or, on and after such date, at certain redemption prices specified in the indenture governing these notes plus accrued and unpaid interest. The 4.625% Senior Notes contain restrictive covenants that limit the ability of the Company and its guarantors to, among other things, create certain liens, enter into certain sale/leaseback transactions, or merge, consolidate or sell all or substantially all of their assets. The 4.625% Senior Notes and related subsidiary guarantees do not have any registration or similar rights and are not expected to be registered for exchange on public markets. During the year ended December 31, 2020, the Company incurred $20,386 in fees, discounts and other professional expenses associated with this transaction that were capitalized and will amortize over the term of the 4.625% Senior Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 15, 2020, the Company used the net proceeds from these 4.625% Senior Notes, together with cash on hand, to redeem in full all $1,750,000 aggregate principal amount outstanding of its 5.125% Senior Notes plus accrued interest and redemption premium. The Company incurred debt redemption premium charges of $29,890 and deferred financing cost write-offs of $9,764 in connection with this redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 11, 2020, the Company issued $1,500,000 aggregate principal amount of 3.75% senior notes due 2031 (the 3.75% Senior Notes) in a private offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 3.75% Senior Notes pay interest on February&#160;15 and August&#160;15 of each year beginning February&#160;15, 2021. The 3.75% Senior Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. The 3.75% Senior Notes are guaranteed by each of the Company&#x2019;s domestic subsidiaries that guarantee its senior secured credit facilities. The Company may redeem up to 40% of the aggregate principal amount of the 3.75% Senior Notes at any time prior to August 15, 2023 at 103.75% of the aggregate principal amount from the proceeds of one or more equity offerings, plus accrued and unpaid interest. In addition, the Company may redeem the 3.75% Senior Notes at any time prior to February 15, 2026 at a make-whole redemption price plus accrued and unpaid interest or, on and after such date, at certain redemption prices specified in the indenture governing these notes plus accrued and unpaid interest. The 3.75% Senior Notes contain restrictive covenants that limit the ability of the Company and its guarantors to, among other things, create &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;certain liens, enter into certain sale/leaseback transactions, or merge, consolidate or sell all or substantially all of their assets. The 3.75% Senior Notes and related subsidiary guarantees do not have any registration or similar rights and are not expected to be registered for exchange on public markets. During the year ended December 31, 2020, the Company incurred $17,936 in fees, discounts and other professional expenses associated with this transaction that were capitalized and will amortize over the term of the 3.75% Senior Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 21, 2020, the Company used the net proceeds from these 3.75% Senior Notes, together with cash on hand, to redeem in full all $1,500,000 aggregate principal amount outstanding of its 5.0% Senior Notes plus accrued interest and redemption premium. The Company incurred debt redemption premium charges of $37,500 and deferred financing cost write-offs of $8,866 in connection with this redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's 2015 interest rate cap agreements expired on June&#160;30, 2020, at which time the Company's 2019 cap agreements became effective. As of December&#160;31, 2020, the Company maintains several interest rate cap agreements that have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on specific portions of the Company's floating rate debt, including all of the Term Loan B-1 and a portion of the Term Loan A. The remaining $900,069 outstanding principal balance of the Term Loan A and the $75,000 outstanding balance of the revolving line of credit are subject to LIBOR-based interest rate volatility. The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The amortization of the original cap premium is recognized as a component of debt expense on the interest method over the terms of the cap agreements. These cap agreements do not contain credit-risk contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of December&#160;31, 2020 and December&#160;31, 2019, which are classified in "Other long-term assets" on its consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Recorded OCI loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/29/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of the Company&#x2019;s interest rate cap agreements for the years ended December&#160;31, 2020, 2019 and 2018:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized (losses) gains in OCI on interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassification from accumulated other comprehensive income into net income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 20 for further details on amounts recorded and reclassified from accumulated other comprehensive (loss) income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s weighted average effective interest rate on its senior secured credit facilities at the end of 2020 was 2.03%, based upon the current margins in effect for the Term Loan A, Term Loan B-1 and revolving line of credit as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was 3.59% for the year ended December&#160;31, 2020 and 3.06% as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company&#x2019;s interest rates were fixed on approximately 44.4% of its total debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company had $925,000 available and $75,000 drawn on its $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this revolver is reduced by the amount of any letters of credit outstanding under this facility, but there were no such letters of credit outstanding as of December&#160;31, 2020. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company also had approximately $64,636 of outstanding letters of credit under a separate bilateral secured letter of credit facility as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt expense consisted of interest expense of $282,932, $419,639 and $461,897 and the amortization and accretion of debt discounts and premiums, amortization of deferred financing costs and the amortization of interest rate cap agreements of $21,179, $24,185 and $25,538 for 2020, 2019 and 2018, respectively. These interest expense amounts are net of capitalized interest.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:SecuredDebt
      contextRef="i286706e9b0964d8cbb75adb2d5340592_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtMS0xLTEtMA_a1673b07-90de-44c4-a10b-b949a459adb4"
      unitRef="usd">1684375000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i250b8e686fbb4a0eb1114ccbc4b5e9c3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtMy0xLTEtMA_e78f9993-76b4-4d43-8fa5-39f1d54b738b"
      unitRef="usd">1739063000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtNS0xLTEtMA_9b3be8f5-0f7a-4cb4-aa9f-a4049e7b182d">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtNy0xLTEtMA_f3b80018-c44c-49cb-8645-fbc6b17e7f3c">LIBOR + 1.50%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i286706e9b0964d8cbb75adb2d5340592_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzMtOS0xLTEtMA_7f3e976e-4824-4213-b5a3-e6b800f6cf1c"
      unitRef="usd">1675953000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="i52324c1dc24d4d8b859c1369fb83eb5d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtMS0xLTEtMA_8f36e883-338c-4518-b4a2-7ab4395d2e63"
      unitRef="usd">2715694000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i0dcd17ac6da84bfca13be11407dd097e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtMy0xLTEtMA_f4380b40-a411-43f6-8c16-ea9466f1de12"
      unitRef="usd">0</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtNS0xLTEtMA_62d160fe-077d-4cfa-915e-39a63dda7068">2026-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtNy0xLTEtMA_569c1b61-c33f-4f4b-ab1e-37987f3fc334">LIBOR + 1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i52324c1dc24d4d8b859c1369fb83eb5d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzQtOS0xLTEtMA_60648622-c84d-4bc0-9ac7-1ef933d0cd92"
      unitRef="usd">2702115000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="if381450d87824e869bf60a18db4c6586_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzUtMS0xLTEtMA_a7f31105-5ce8-439e-90b0-bb5051fa2d82"
      unitRef="usd">0</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i3a345c6e30c94176b6d3453a7fbf6e28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzUtMy0xLTEtMA_dfca8004-26de-4214-943f-6f30ed9550db"
      unitRef="usd">2743125000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i70dcb1ea14854f37b5aeb6d646b2e0f9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzUtNS0xLTEtMA_8f8484c6-fd69-48a5-a806-b729c159cf24">2026-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:SecuredDebt
      contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtMS0xLTEtMA_5b7e9f21-e94c-446d-8955-02bd28f5c8af"
      unitRef="usd">75000000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i10592b24a7d94ae2bbaa1ef42f4ed1a8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtMy0xLTEtMA_56b05705-2945-472d-a491-236fef686b2f"
      unitRef="usd">0</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i1f85fe5578d64f21b789dbb1d9ab19ba_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtNS0xLTEtMA_9adc06c2-8d26-4186-bc91-33acddb21e57">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i1f85fe5578d64f21b789dbb1d9ab19ba_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtNy0xLTEtMA_27eec104-fd12-4965-8284-f4ca8f8d02d0">ABR + 0.50%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzYtOS0xLTEtMA_8e7ef7fb-524f-41e2-bbee-cba789a63749"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="ic5b049dd4b914f4ea5123c565a84fdeb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtMS0xLTEtMTAyNg_72faf7ef-fe1d-4e63-af99-0357bc0246ee"
      unitRef="usd">1750000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i5a809ec49865440ca9f74653e3e59525_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtMy0xLTEtMTAyNg_17ae5053-2b54-41a0-819f-514d05cf5413"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i7394d13923fd428d9c2578d297562554_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtNS0xLTEtMTAyNg_96a0af88-7211-429f-b153-bacd14612e03">2030-06-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i7394d13923fd428d9c2578d297562554_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtNy0xLTEtMTAyNg_3cdb9c0c-340e-431e-91c1-003dadd1d136"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic5b049dd4b914f4ea5123c565a84fdeb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzgtOS0xLTEtMTAyNg_50234277-7187-4f77-b20c-2962974289b2"
      unitRef="usd">1859375000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="i4f4adb73272a42f5b8ce1b57a5c7617c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTEtMS0xLTA_7bf06eed-d80b-4329-a655-95263de3dd32"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="iefe49a72ad734e399a94074a044ba38e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTMtMS0xLTA_c3477acb-2864-416a-95f1-b8e566456d67"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i37d9e5736a9a43eea92eece9c7a70156_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTUtMS0xLTA_8db28f68-7ae0-42ec-9abc-21d3a7f4ce51">2031-02-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i37d9e5736a9a43eea92eece9c7a70156_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTctMS0xLTA_d0a4584f-9b14-4766-8d14-a4b1e8ec6f9f"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4f4adb73272a42f5b8ce1b57a5c7617c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEwLTktMS0xLTA_145d9381-aa3f-40e3-bcaa-65e4cfe2177b"
      unitRef="usd">1522500000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="i9f563c4e28454aeb9d6c1ab26ac542f3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzExLTEtMS0xLTA_9fb05dbd-2f08-4afd-8be6-4cc4d4fb58be"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i6c63e5480b1f427bae9d35c3d385319a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzExLTMtMS0xLTA_12f4877f-f5ca-41ce-8686-0e6178317742"
      unitRef="usd">1750000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i513c7b56b1594745a1ebb8321dbbfc57_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzExLTUtMS0xLTA_f98c6670-2c56-45cf-b223-12500920d5c8">2024-07-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:SeniorNotes
      contextRef="ic7040636942049efaf5dd11457035dfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEyLTEtMS0xLTA_8b1a6054-cc91-4a0a-806b-6aa6c4b8e65d"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="id4bef0b2f7a346219d36e58e1f35f48d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEyLTMtMS0xLTA_393d4d90-2461-46db-903f-3bb1ff56172c"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="iacef66fccbd84dedacbd5a8f1b5e7b10_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEyLTUtMS0xLTA_7200f20a-590b-4283-8b53-54b65b96cc18">2025-05-01</us-gaap:DebtInstrumentMaturityDate>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="i9aa636c18275409199f124f364f5e504_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTEtMS0xLTA_c6e0cb0e-c1bc-49b4-9345-18d6bcdcf452"
      unitRef="usd">164160000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="ie18932cd78584f0cb719262f3f8eab08_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTMtMS0xLTA_d193678b-6766-4497-a919-827153eb1fc0"
      unitRef="usd">180352000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i6706bd8a691e4f01b5d9b858653eb878_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTUtMS0xLTA_7646e398-080b-4318-a09a-8c256a54800e">2021-2036</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i9aa636c18275409199f124f364f5e504_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTctMS0xLTA_67195e7b-bee7-4542-8107-4c01b75a8939"
      unitRef="number">0.0488</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <dva:AcquisitionObligationsAndOtherNotesPayableFairValue
      contextRef="i9aa636c18275409199f124f364f5e504_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzEzLTktMS0xLTA_b0144ff9-88e8-422c-926f-646be3ae5b3b"
      unitRef="usd">164160000</dva:AcquisitionObligationsAndOtherNotesPayableFairValue>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic69633efe6f54a5fa84fd43f264fe79d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTEtMS0xLTA_3fa63900-0296-475b-90f9-1010fabbf835"
      unitRef="usd">274292000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i856ad81a7b084214953762fad3fc3894_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTMtMS0xLTA_2b99c1ba-62a6-4af9-9d9c-115abeb9bad4"
      unitRef="usd">268534000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i4a4f6b88319747d09864ee3399753c01_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTUtMS0xLTA_a72b9c98-e00c-4ad0-bdce-40849ced1fc1">2021-2038</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ic69633efe6f54a5fa84fd43f264fe79d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE0LTctMS0xLTA_53a7bb43-0c79-4269-9f56-1de9fd3f291f"
      unitRef="number">0.051</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE1LTEtMS0xLTA_9e56e7f1-099e-4019-bd2e-86e2f2c3f4d5"
      unitRef="usd">8163521000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE1LTMtMS0xLTA_cf558d62-ac4d-4932-ac9c-61f9960f2c6e"
      unitRef="usd">8181074000</us-gaap:DebtInstrumentCarryingAmount>
    <dva:DiscountAndDeferredFinanceCosts
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE2LTEtMS0xLTA_ec0971da-c151-4dec-a042-1135d0266d48"
      unitRef="usd">77717000</dva:DiscountAndDeferredFinanceCosts>
    <dva:DiscountAndDeferredFinanceCosts
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE2LTMtMS0xLTA_2a0a90e0-2e11-4a66-a6db-0e70b6875728"
      unitRef="usd">72840000</dva:DiscountAndDeferredFinanceCosts>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE3LTEtMS0xLTA_c7cbef77-b118-4205-b856-780e0cbf6d4d"
      unitRef="usd">8085804000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE3LTMtMS0xLTA_43d28473-39d3-44fc-8599-e9a22ab79053"
      unitRef="usd">8108234000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE4LTEtMS0xLTA_17380e09-7874-448e-9853-d0eb16b80fe0"
      unitRef="usd">168541000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE4LTMtMS0xLTA_b9e28bce-ff9d-40f6-92df-2a316f4d73a0"
      unitRef="usd">130708000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE5LTEtMS0xLTA_c9ae2f06-7e3a-4c91-a50f-8bccbacb0f8b"
      unitRef="usd">7917263000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo4NDg3ZDE1NWYyNDY0ZTRlOGEyZjllN2NhNjQ0YTk1Yy90YWJsZXJhbmdlOjg0ODdkMTU1ZjI0NjRlNGU4YTJmOWU3Y2E2NDRhOTVjXzE5LTMtMS0xLTA_ca561f97-cea9-4617-acc4-5be98c3b0a95"
      unitRef="usd">7977526000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie06b84976de74f0aa4c9de71c05d9548_D20201231-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwOTQ4_a46cbc98-b7d8-4dab-a669-c747a4f984c4"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ie06b84976de74f0aa4c9de71c05d9548_D20201231-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTE3ODE_db19414c-93ea-47ef-9b65-920b5907c83a"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i94c16909492241318308c8c001933088_D20210106-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwOTY3_c97ca54b-6419-4ab5-ace2-d3030d2fb4d6"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ida75c1b36c22493e8c7e9267cf54a7aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NDA_f8ade44d-7c75-4054-8736-3a09a178c9fe"
      unitRef="usd">5461000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="ida75c1b36c22493e8c7e9267cf54a7aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NDc_38e1a650-9893-4dd6-9ee9-81eb491824ca"
      unitRef="usd">35825000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i8033f3e1736c4c5b95b3f8eefbe1406a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NTI_28c978db-8d4c-4571-a4c0-e074bdfc24e2"
      unitRef="usd">36431000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="icbb4bf191ef14070a5362746d88603e0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NTc_5bc5f051-1b42-4a4b-9a1b-bdaa2ad78cb7"
      unitRef="usd">6457000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="icbb4bf191ef14070a5362746d88603e0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5NjI_b6a32f74-f779-40df-8029-60bcdb342f92"
      unitRef="usd">45444000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i34f522b31ed94ee9a22ac5be8888a7a7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjA5Njc_b77230b5-b3ae-4680-9f4b-47f9b71a5d68"
      unitRef="usd">20939000</us-gaap:DeferredOfferingCosts>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTcx_f906c6ec-800a-4960-a948-d6dcf24d5935">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled maturities of long-term debt at December&#160;31, 2020 were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,496,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,031,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzIzMTQ_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzIzMTQ_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzAtMS0xLTEtMA_c5a8300d-e1e3-4e98-84e0-ffaea0e490ba"
      unitRef="usd">168541000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzEtMS0xLTEtMA_27916a1a-fac6-4e10-b261-1864ea109c8f"
      unitRef="usd">169782000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzItMS0xLTEtMA_1d4e4d49-64c8-42d5-ac08-4f35657e6dc1"
      unitRef="usd">227062000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzMtMS0xLTEtMA_7a543156-65d1-489c-81a8-9b0b0c125595"
      unitRef="usd">1496892000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzQtMS0xLTEtMA_d5152535-2d85-449a-8225-5d726896f3f9"
      unitRef="usd">69440000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTpjNTlkMGYyNjc1ZTU0NDhhYTlmYjlkZDdmZGU3MzAwOS90YWJsZXJhbmdlOmM1OWQwZjI2NzVlNTQ0OGFhOWZiOWRkN2ZkZTczMDA5XzUtMS0xLTEtMA_681cd4f5-9514-45e7-9488-6f28122ff61a"
      unitRef="usd">6031804000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="i045e4836b7c044119912cf78d7ff47a9_D20200213-20200213"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3MDM_b19b6732-8a04-40a6-ab1c-dfcfb155dc89">2020-02-13</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7314edaaf4ba4f878c3576d48795f7e4_D20200213-20200213"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3MTI_9809a4a3-8cf8-4d24-b33a-36e5243ea526"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i045e4836b7c044119912cf78d7ff47a9_D20200213-20200213"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3MzE_9e75f5dd-4ea0-424e-b74c-1b72fdc0967e">2026-08-12</us-gaap:DebtInstrumentMaturityDate>
    <dva:AdditionalDebtPrincipalAmountDueToRepricingAgreement
      contextRef="i7e335188f31c48569623a8cbca6e9598_I20200213"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3Mzc_dcdcccbf-8553-4258-9259-c646a7280780"
      unitRef="usd">0</dva:AdditionalDebtPrincipalAmountDueToRepricingAgreement>
    <dva:DebtRefinancingCharges
      contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3NTA_730ad8f8-9802-4c15-9371-2ce8fbf2ce21"
      unitRef="usd">2948000</dva:DebtRefinancingCharges>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ic72d397e0f3e4b2891c3e57dbe084568_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3ODI_502a842f-7c00-4297-83ba-4200d19aae43"
      unitRef="usd">68842000</us-gaap:RepaymentsOfSecuredDebt>
    <dva:NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt
      contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY3OTM_c8ed7060-7e81-4168-a732-71c06e2b9cd1"
      unitRef="usd">55895000</dva:NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ib092624e003d464a9ca804f9541d61a3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4MDQ_08b77aa4-d121-4b12-a8a2-fe090ef00f1a"
      unitRef="usd">54688000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i29e102103bb846b4875d5bfdfffaba88_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4MTU_49090c21-f83d-406e-a6cc-2d9504f53728"
      unitRef="usd">27431000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:SeniorNotes
      contextRef="i36e1759fea1d4fe6be3ee89fad61189a_I20200609"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4ODQ_a6c36e13-ca60-4c0d-9163-f1d5ac8d03e1"
      unitRef="usd">1750000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY4OTQ_4cd0fd42-02af-4222-a560-948a645a8f69"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1
      contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5Mjc_6fd13ad1-cba1-47d0-8752-a112741dea34">2020-12-01</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5MzQ_c0334989-28e1-4665-805a-aab73d45f7ad"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="iaaeb4cf6367f43359b96cdb819b3c286_D20200609-20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5NDU_c0381760-02bf-4bb7-bae8-a00597d8efd6"
      unitRef="number">1.04625</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i36e1759fea1d4fe6be3ee89fad61189a_I20200609"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5NTY_077beb9e-b28b-47e2-ac5a-9608db128e8c"
      unitRef="usd">20386000</us-gaap:DebtInstrumentFeeAmount>
    <dva:DebtInstrumentRedeemedOutstandingPrincipalAmount
      contextRef="i60afbcc7ed1f4c10bc730c4a41fd1553_I20200715"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDY5OTM_d6ff5d21-78ad-47eb-884a-c50e7015801d"
      unitRef="usd">1750000000</dva:DebtInstrumentRedeemedOutstandingPrincipalAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwNTk3_4b112678-92ac-480e-820c-1ca96dafefd3"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <dva:DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes
      contextRef="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMDQ_a183b101-131d-454d-b8a5-63d7c9781a45"
      unitRef="usd">29890000</dva:DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ifab588319fda47a286a01aa8c6fb7a98_D20200715-20200715"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMTQ_3a0b6d67-355e-4a55-bf78-2596669b10bb"
      unitRef="usd">9764000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:SeniorNotes
      contextRef="i4577c6d1bfd84e039d738058c80d0d6f_I20200811"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMjg_067a98fa-92e9-4925-ad15-119e50b0c7a0"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwMzc_c9d24620-cbe7-469e-baae-a685381377d1"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1
      contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwNTg_6b8e4a57-29eb-4f64-8ce8-927bbdf63d45">2021-02-15</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwNjY_300e4676-5551-4bab-b650-7187aec94d36"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i2220cc5e6e90416dbbc5637cef42981a_D20200811-20200811"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwNzc_91f0271b-8819-4494-b688-0f2c13b636ae"
      unitRef="number">1.0375</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i4577c6d1bfd84e039d738058c80d0d6f_I20200811"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcwODc_65c0e788-73e7-47a1-a224-2edbcf380b9c"
      unitRef="usd">17936000</us-gaap:DebtInstrumentFeeAmount>
    <dva:DebtInstrumentRedeemedOutstandingPrincipalAmount
      contextRef="i8c9ee24fbe9340239ddc070e034d80e0_I20200821"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcxMDE_b180d599-290f-4065-8e48-fb5a1d131799"
      unitRef="usd">1500000000</dva:DebtInstrumentRedeemedOutstandingPrincipalAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI4MDM3NTQ2NTUwNjA0_65dc1082-398f-40c0-85ed-4a1ae8b59d44"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <dva:DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes
      contextRef="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcxMTI_57defa5c-3a12-4181-bf38-134aac763088"
      unitRef="usd">37500000</dva:DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ie0a4166a0d724744925733e42c2959f3_D20200821-20200821"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDcxMjI_ae275f75-6b04-48b8-b201-0c99025843eb"
      unitRef="usd">8866000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:DerivativeMaturityDates
      contextRef="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzQzOTgwNDY1NDg1NTc_29731eef-6320-4c26-9513-6d9397d363ee">2020-06-30</us-gaap:DerivativeMaturityDates>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzkwNjI_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzkwNjI_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LineOfCredit
      contextRef="i286706e9b0964d8cbb75adb2d5340592_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzkzODQ_ac335348-2a25-4815-8fb8-24179ac5c6b8"
      unitRef="usd">900069000</us-gaap:LineOfCredit>
    <us-gaap:SecuredDebt
      contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5Xzg3OTYwOTMwNjExODk_5b7e9f21-e94c-446d-8955-02bd28f5c8af"
      unitRef="usd">75000000</us-gaap:SecuredDebt>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTYw_fb2e3b26-ce3f-4af9-8cc9-e4369eb43a45">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of December&#160;31, 2020 and December&#160;31, 2019, which are classified in "Other long-term assets" on its consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Recorded OCI loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/29/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNTA5_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNTA5_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzEtOS0xLTEtMA_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzEtOS0xLTEtMA_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i4e8da420e4fe43e3abe44f58b0f0c849_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMS0xLTEtMA_d4d09dd1-0172-4650-a315-be72fada2617"
      unitRef="usd">3500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9ad2e96f61d94f8eaade51037ef306a9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMy0xLTEtMA_e868ba81-4660-451b-90ae-417115120cd2"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInceptionDates
      contextRef="i7ed9f709bc0e4ef09c4f9e055ef04e86_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtNS0xLTEtMA_802fd7aa-c1bd-4043-9096-8365d22ee33d">2020-06-30</us-gaap:DerivativeInceptionDates>
    <us-gaap:DerivativeMaturityDates
      contextRef="i7ed9f709bc0e4ef09c4f9e055ef04e86_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtNy0xLTEtMA_fdfd9607-2e9a-4824-abaa-d26300b282f5">2024-06-30</us-gaap:DerivativeMaturityDates>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i2f29329fa0a24761880b3da66bfea3f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzMtOS0xLTEtMTg2OA_f3efb10c-0d0e-4728-8139-ccbc10a49c86"
      unitRef="usd">2755000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i2f29329fa0a24761880b3da66bfea3f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMTEtMS0xLTA_b294cf4c-fdab-4831-9b6d-373ea8830786"
      unitRef="usd">-21781000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifff59c8376d84505bcb4b4231e5bd78f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMTMtMS0xLTA_4a2c5692-87d0-4f0d-8b30-83c9d9c6433b"
      unitRef="usd">2671000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssets
      contextRef="iff41e1baf8154d9d8e160378c8afe9a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzQtMTUtMS0xLTEzMDg_ef885a42-3413-480c-966f-a5dbb25700e5"
      unitRef="usd">24452000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i19164efdfc254d9a849e3b6592273062_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMS0xLTEtMTg2MQ_e700c8bb-318a-4faf-a289-12ce40842452"
      unitRef="usd">3500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ife085c5fc53a464ba6234e3b54b5902b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMy0xLTEtMTg2MQ_18c95e65-7335-427d-91d4-8863e242a525"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInceptionDates
      contextRef="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtNS0xLTEtMTg2MQ_0211a54e-d866-49f5-a120-88d29c8dfcd9">2018-06-29</us-gaap:DerivativeInceptionDates>
    <us-gaap:DerivativeMaturityDates
      contextRef="i381b5bdcb0924c57ae6c5abbfd753d8a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtNy0xLTEtMTg2MQ_29731eef-6320-4c26-9513-6d9397d363ee">2020-06-30</us-gaap:DerivativeMaturityDates>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="if7a62382e0e04fc6a6d5db83d4b94e8d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtOS0xLTEtMTg2MQ_198d4df5-59fe-42c7-a3f5-a4296e1c12d8"
      unitRef="usd">4326000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="if7a62382e0e04fc6a6d5db83d4b94e8d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMTEtMS0xLTE4NjE_16463bd3-e9b3-4445-a176-c6f122ae4bbc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie19cd8d5f7704699a59ba60718cf6759_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMTMtMS0xLTE4NjE_3bec08d7-d5a5-41d2-84f1-59d4f87af612"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib88f0f66836c4e39b167ed6b9e1eab25_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo3MmZiMTBmYWY1ZTI0NTFmOTdmM2UyZWYwY2IwNjNlNi90YWJsZXJhbmdlOjcyZmIxMGZhZjVlMjQ1MWY5N2YzZTJlZjBjYjA2M2U2XzUtMTUtMS0xLTE4NjE_2c0dc0df-0459-43b5-904b-f598a5524d73"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExOTYx_010c466f-9861-463a-9734-93bac466b5c6">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of the Company&#x2019;s interest rate cap agreements for the years ended December&#160;31, 2020, 2019 and 2018:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized (losses) gains in OCI on interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassification from accumulated other comprehensive income into net income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNzI0_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwNzI0_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i2b4253a297c545feae0bc83b8afdfbac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMi0xLTEtMA_27820d6a-14fe-4617-8209-52f590d9e7ba"
      unitRef="usd">-21781000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ie4a73b09375643e2b9ad54bdb2776bab_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtNC0xLTEtMA_da29f474-fcbc-4c46-8f11-e5130f6a1d77"
      unitRef="usd">1566000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ic4f6eb4a12be4460b4491ec67bbeb914_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtNi0xLTEtMA_545defee-9cb0-4cb5-8424-f5a688d377ca"
      unitRef="usd">-181000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i2b4253a297c545feae0bc83b8afdfbac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMTAtMS0xLTA_c1884031-86d7-4c30-929c-592b990a68a3"
      unitRef="usd">7081000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie4a73b09375643e2b9ad54bdb2776bab_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMTItMS0xLTA_7229850a-a67d-482a-bc45-fa5d9ddf8904"
      unitRef="usd">8591000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ic4f6eb4a12be4460b4491ec67bbeb914_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzMtMTQtMS0xLTA_606e0ded-ee16-4a03-b0eb-fecc466717d7"
      unitRef="usd">8466000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="iaadc39011cd34e719eb41ca937a418b7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMi0xLTEtMA_5556faa1-4c1d-40e6-af50-eb5f98cba1ad"
      unitRef="usd">5435000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="iddf49515840e487e8f2fffe6cb4b0d22_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtNC0xLTEtMA_398cc2a6-35cc-4bf8-8311-1728d747d3c5"
      unitRef="usd">-415000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="iacb973ffc2bf49c1b23aebcc238a4c6c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtNi0xLTEtMA_902d3a5d-769a-42e5-a25c-524703b9f6c8"
      unitRef="usd">48000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iaadc39011cd34e719eb41ca937a418b7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMTAtMS0xLTA_17c3fbb8-db34-4f73-b033-f61541ee9033"
      unitRef="usd">-1768000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iddf49515840e487e8f2fffe6cb4b0d22_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMTItMS0xLTA_a9d5da77-be15-46f0-8074-cc3e3f325d38"
      unitRef="usd">-2214000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iacb973ffc2bf49c1b23aebcc238a4c6c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzQtMTQtMS0xLTA_90b54ad7-0021-4360-b7f9-3687dada904f"
      unitRef="usd">-2180000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMi0xLTEtMA_23efff61-13ce-4468-84e1-971ff42eae65"
      unitRef="usd">-16346000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ic3e3ddb19c4b4f45ab14958866d7c43d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtNC0xLTEtMA_4c8a2f1e-8506-4114-8d44-25db4e8c0c81"
      unitRef="usd">1151000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i6e7008e4c2d54ce6862f4b7e5e90c295_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtNi0xLTEtMA_fb80c3c1-ea6c-475c-a200-8df6404df17f"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMTAtMS0xLTA_bdf15175-53ab-4ff6-8883-9aafe3679ce6"
      unitRef="usd">5313000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ic3e3ddb19c4b4f45ab14958866d7c43d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMTItMS0xLTA_ef316097-9eb4-45aa-862d-f18ecc9ef932"
      unitRef="usd">6377000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i6e7008e4c2d54ce6862f4b7e5e90c295_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90YWJsZTo1Yjk0ZDEwZWIzNzI0MjA5YjE5MTIyMWI2OTNhZmM0Ni90YWJsZXJhbmdlOjViOTRkMTBlYjM3MjQyMDliMTkxMjIxYjY5M2FmYzQ2XzUtMTQtMS0xLTA_dce68c7c-5beb-42c3-8063-35695b3b2b25"
      unitRef="usd">6286000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i96fe2a0d86c443a28c19325250d8c04e_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzEwOTc5_34b3033c-287a-41a9-b483-26009307eb4c"
      unitRef="number">0.0203</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMDc4_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMDc4_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDk5MjQ_bfd57388-0ef2-418e-9a08-94f093f05761"
      unitRef="number">0.0359</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTY3_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTY3_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDk5ODA_b59ed8f6-4c70-4474-bd4e-fd76fe176b14"
      unitRef="number">0.0306</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTg3_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMTg3_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjA0_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjA0_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjY1_ae21784f-3bac-4a65-92e7-be913803e133"
      unitRef="number">0.444</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjkz_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExMjkz_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTA5NTU_273276b3-3e82-4288-b97c-e00ecf14aa07"
      unitRef="usd">925000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:SecuredDebt
      contextRef="i14df805acc674d20a7c5aa1dba69bf55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTA1OTM_5b7e9f21-e94c-446d-8955-02bd28f5c8af"
      unitRef="usd">75000000</us-gaap:SecuredDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia424f1cb12ad4530b4ccca1a7530e070_I20190812"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMTA2MTE_5dc8fccc-77de-4e1f-af4d-4ceb3bb6f642"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyNzI_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyNzI_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i42f14d1dd6ac4677890feb6e64809282_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNTEz_b58a301c-8735-4c72-a39c-c05f7ca97768"
      unitRef="usd">64636000</us-gaap:LettersOfCreditOutstandingAmount>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyOTM_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzI3NDg3NzkxMDkyOTM_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:InterestExpenseDebt
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNjcw_707c9166-0946-4a3a-9179-ccac46f0e041"
      unitRef="usd">282932000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNjc0_2892d189-2a6d-4f05-ae23-8bb90e16b504"
      unitRef="usd">419639000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExNjgx_296fcc4b-b945-459d-8eb2-3b46b856f87f"
      unitRef="usd">461897000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExODQ4_6fa889e5-4c70-4d73-9cba-9e88a03e7982"
      unitRef="usd">21179000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExODUy_c03488e3-a7ef-4e07-9751-c50597faa2b6"
      unitRef="usd">24185000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNDQvZnJhZzoyZDRiNjc5MDA2ZDM0MzNlYjc0NTgwM2FiMDI4NzQyOS90ZXh0cmVnaW9uOjJkNGI2NzkwMDZkMzQzM2ViNzQ1ODAzYWIwMjg3NDI5XzExODU5_2caa2b95-4fa3-4935-8d2c-942d37ef5694"
      unitRef="usd">25538000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMDc_e838f8ce-1da3-4fb7-9f67-a6602aaacd8a">Leases&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#x2019;s facilities are leased under non-cancellable operating leases which range in terms from five years to 20 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses. See Note 1 for further information on how the Company accounts for leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 and December&#160;31, 2019, assets recorded under finance leases were $275,389 and $247,246, respectively, and accumulated amortization associated with finance leases was $49,345 and $27,193, respectively, included in property and equipment, net, on the Company's consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain markets, the Company acquires and develops dialysis centers. Upon completion, the Company sells the center to a third party and leases the space back with the intent of operating the center on a long term basis. Both the sale and leaseback terms are generally market terms. The lease terms are consistent with the Company's other operating leases with the majority of the leases under non-cancellable operating leases ranging in terms from five years to 20 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; beginning on January 1, 2019 through a modified retrospective approach for leases existing at the adoption date with a cumulative effect adjustment. Consequently, financial information was not updated for dates and periods before January 1, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 7.75pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Includes short-term lease expense and sublease income, which are immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains on sale leasebacks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the &lt;br/&gt; measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating lease assets obtained in exchange&lt;br/&gt; for new or modified operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2020 are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,661,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less portion representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under all operating leases for 2020, 2019, and 2018 was $663,819, $646,092 and $596,117, respectively. Rent expense is recorded on a straight-line basis over the term of the lease, including leases that contain fixed escalation clauses or include abatement provisions. Leasehold improvement incentives are deferred and amortized to rent expense over the term of the lease. Finance lease obligations are included in long-term debt. See Note 13 for further details on long-term debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE5OQ_f9ac4a43-faf9-4bb9-99d1-9b0c3ed821ee">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzIwNQ_070cfa70-8b4a-493b-b513-3053a1549e1f">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI0NQ_d57bdf75-4e26-43f8-8254-6b5f90bd9308">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI1MQ_efe801f5-1e8a-46fe-bc3e-63ec744a3e4a">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzEzMTg_4c7672d8-17a0-4758-8f88-b235c20f1b46"
      unitRef="usd">275389000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzEzMjU_e3c11016-d570-43c5-9a96-a2c79ae330eb"
      unitRef="usd">247246000</us-gaap:FinanceLeaseRightOfUseAsset>
    <dva:FinanceLeaseAccumulatedDepreciation
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE0MDc_5540c9ad-b60a-4d80-8379-06eaf0bc3a33"
      unitRef="usd">49345000</dva:FinanceLeaseAccumulatedDepreciation>
    <dva:FinanceLeaseAccumulatedDepreciation
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE0MTQ_f22627b9-6c35-4f2e-ad7e-13b0237cd7e1"
      unitRef="usd">27193000</dva:FinanceLeaseAccumulatedDepreciation>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE5NzA_f9ac4a43-faf9-4bb9-99d1-9b0c3ed821ee">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzE5NzY_070cfa70-8b4a-493b-b513-3053a1549e1f">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i6a37e07755da4c969e25d18ca6f25243_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzIwMTY_d57bdf75-4e26-43f8-8254-6b5f90bd9308">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i62132ed6d58b423cba1f3c99ca102a0a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzIwMjI_efe801f5-1e8a-46fe-bc3e-63ec744a3e4a">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMTU_7514e10b-7ff8-4d60-a492-141cddeb8dc0">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 7.75pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Includes short-term lease expense and sublease income, which are immaterial.</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzItMi0xLTEtMA_73b525cb-3c55-4168-b6ab-ac2873045e42"
      unitRef="usd">541090000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzItNC0xLTEtMjM4MQ_a90a9fe6-4772-4b77-938f-ba193b5dfda4"
      unitRef="usd">526352000</us-gaap:OperatingLeaseExpense>
    <us-gaap:VariableLeaseCost
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzMtMi0xLTEtMA_405c937b-9422-4777-be66-33e99df47016"
      unitRef="usd">122729000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzMtNC0xLTEtMjM4MQ_57be1a3a-bc34-4a3e-a2a2-7d4b6c3ca7c9"
      unitRef="usd">119740000</us-gaap:VariableLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzUtMi0xLTEtMA_49532b1f-dc9b-432b-8307-f766d864b3ec"
      unitRef="usd">24720000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzUtNC0xLTEtMjM4MQ_d0a514b9-71b3-4a16-8ce0-36ae7aacdc6f"
      unitRef="usd">23724000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzYtMi0xLTEtMA_93064761-ffe8-42fc-bac4-d468a23ec64b"
      unitRef="usd">14421000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzYtNC0xLTEtMjM4MQ_5688e00f-4ec2-401f-b0a2-517b3d4ca5fc"
      unitRef="usd">14932000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzctMi0xLTEtMA_a9ed5906-604c-4827-b762-f05f0ea24232"
      unitRef="usd">702960000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo3N2M1MGFjYTdjMTU0YjllOTc3MDEwMWJiMmNmYzYzNy90YWJsZXJhbmdlOjc3YzUwYWNhN2MxNTRiOWU5NzcwMTAxYmIyY2ZjNjM3XzctNC0xLTEtMjM4MQ_5514fac3-0a6e-4660-b1cc-8b4736b16512"
      unitRef="usd">684748000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMTY_71605c9a-aa4f-4ce8-8f55-a76cab48df6a">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains on sale leasebacks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the &lt;br/&gt; measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating lease assets obtained in exchange&lt;br/&gt; for new or modified operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzItMi0xLTEtMA_ca15c187-22ed-4a91-89a3-a53630c709aa">P8Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzItNC0xLTEtMjMzOQ_c0e59369-9d18-418b-84dd-d2c0b8f57540">P9Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzMtMi0xLTEtMA_6a457d55-e9cb-4b0f-927b-ce96f4458974">P10Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzMtNC0xLTEtMjMzOQ_7cc8d876-e3f3-4cf5-96ae-a76aa6637de3">P10Y2M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzUtMi0xLTEtMA_8fd481bd-72c5-4a20-9d36-866c1e37c8c8"
      unitRef="number">0.038</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzUtNC0xLTEtMjM0NA_fd08520e-d432-4ba4-aac4-28dfb4ada760"
      unitRef="number">0.041</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ic69633efe6f54a5fa84fd43f264fe79d_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzYtMi0xLTEtMA_22c13431-c39d-4c67-af52-1e1db76aaaaa"
      unitRef="number">0.051</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i856ad81a7b084214953762fad3fc3894_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5NjFjOTliMzY3Yzk0ZmU5YTZiYjU2YjFmYWNmNGQzOS90YWJsZXJhbmdlOjk2MWM5OWIzNjdjOTRmZTlhNmJiNTZiMWZhY2Y0ZDM5XzYtNC0xLTEtMjM0NA_b0662c81-1f32-48dc-b199-c0c2b4e9a377"
      unitRef="number">0.054</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzEtMi0xLTEtMA_4d1a5e7d-f106-470a-8fbe-9516bcdbb1e6"
      unitRef="usd">34301000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzEtNC0xLTEtMjM2NQ_6f2d87b7-5d10-4225-8b9f-afd1128fdf92"
      unitRef="usd">20833000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:OperatingLeasePayments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzMtMi0xLTEtMA_3b534c4c-53cc-4460-9297-a661b3af53a6"
      unitRef="usd">661318000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzMtNC0xLTEtMjM2OQ_7b5dea9f-dd45-4869-a960-a60d5a8a3c30"
      unitRef="usd">637655000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzQtMi0xLTEtMA_0146f04c-6f33-42e8-ba63-cc45d1501ad1"
      unitRef="usd">20981000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzQtNC0xLTEtMjM2OQ_c3529170-01e1-40b9-a9cd-5f32f3cc513e"
      unitRef="usd">22257000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzUtMi0xLTEtMA_74d14f76-e028-4260-93a5-59427dbf4bff"
      unitRef="usd">24780000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzUtNC0xLTEtMjM2OQ_25e2e680-b1c8-42cc-b772-b712c5932b87"
      unitRef="usd">25692000</us-gaap:FinanceLeasePrincipalPayments>
    <dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzYtMi0xLTEtMA_df56bf95-ff3d-447e-b0d0-f2e44b6c420c"
      unitRef="usd">401559000</dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities>
    <dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTo5Yzg0NGI3NmVlNTg0Y2JkODVjZmQwZGEzYzI5ODY2ZS90YWJsZXJhbmdlOjljODQ0Yjc2ZWU1ODRjYmQ4NWNmZDBkYTNjMjk4NjZlXzYtNC0xLTEtMjM2OQ_e13b7e02-c353-4288-94d1-74fd4b94b2ae"
      unitRef="usd">432074000</dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities>
    <dva:ScheduleOfMinimumLeasePaymentsTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzMxMTA_67b81296-afed-4cac-b15a-166aa185627e">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2020 are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,661,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less portion representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfMinimumLeasePaymentsTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI2MTU_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI2MTU_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzEtMS0xLTEtMA_3137b82e-e02f-4338-bdb8-74029e228158"
      unitRef="usd">480439000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzEtMy0xLTEtMA_550ca2a7-7bff-4ddc-a59e-d45446d10c83"
      unitRef="usd">35039000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzItMS0xLTEtMA_47be5050-5dca-44f0-be98-9fe7246a694f"
      unitRef="usd">504789000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzItMy0xLTEtMA_e598c03c-e20e-44da-803e-5493059e712b"
      unitRef="usd">35124000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzMtMS0xLTEtMA_7a86afd5-d5e4-4b18-84bd-f51e58cd8c4e"
      unitRef="usd">464023000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzMtMy0xLTEtMA_e8b2179c-135e-4820-bffc-9c60139f36d5"
      unitRef="usd">35645000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzQtMS0xLTEtMA_dba19ccc-0dd0-46c9-a1ef-e235370d5cc2"
      unitRef="usd">412419000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzQtMy0xLTEtMA_d84eb77c-86f0-4f9c-9a95-256d410a0450"
      unitRef="usd">35669000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzUtMS0xLTEtMA_5ba91fd9-005c-4f6a-8eea-85307142e068"
      unitRef="usd">361447000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzUtMy0xLTEtMA_8b73cdbb-d718-4b27-be07-c1fdb59d0691"
      unitRef="usd">35539000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzYtMS0xLTEtMA_eac53a48-7e8f-47cb-ab52-b2a2978c6775"
      unitRef="usd">1437965000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzYtMy0xLTEtMA_919f6b90-e4a9-4b8a-b26b-99b9460e340d"
      unitRef="usd">174907000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzctMS0xLTEtMA_b4f240d9-15ae-4177-ac03-355c389d4203"
      unitRef="usd">3661082000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzctMy0xLTEtMA_84bec3bd-fbd7-48e8-91d2-f036faa9e22c"
      unitRef="usd">351923000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzgtMS0xLTEtMA_f7c9d397-65a1-46c4-9a18-306452953f0b"
      unitRef="usd">552915000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzgtMy0xLTEtMA_c11a933d-be61-4c46-8d1a-372b8b69a7e5"
      unitRef="usd">77631000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzktMS0xLTEtMA_186c2aa3-22ff-41a4-962b-c390f91f3168"
      unitRef="usd">3108167000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90YWJsZTpiYjlhMmY0YTRlNGI0NmEzYmUxNzgyMGUwNzlmMzdiNy90YWJsZXJhbmdlOmJiOWEyZjRhNGU0YjQ2YTNiZTE3ODIwZTA3OWYzN2I3XzktMy0xLTEtMA_6a1af13c-202a-4e78-acf2-dae8129b59ee"
      unitRef="usd">274292000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI3MDA_82f4a3b6-736c-4805-b60f-3529bd92ca79"
      unitRef="usd">663819000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI3MDQ_1d639818-abbf-48b0-8d55-571cc2a7c782"
      unitRef="usd">646092000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTAvZnJhZzo2NzExNmY4ZmQzMjU0ZWFmYjAwYjY0ZDdmYzk5NWNmMy90ZXh0cmVnaW9uOjY3MTE2ZjhmZDMyNTRlYWZiMDBiNjRkN2ZjOTk1Y2YzXzI3MTE_0d16bc77-ac98-4d2f-a945-6ee407d4ead8"
      unitRef="usd">596117000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzI0NzM_4fa28bf0-9009-419b-bc9d-28cd0b00ee41">Employee benefit plans&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a 401(k) retirement savings plan for substantially all of its U.S. employees which has been established pursuant to applicable provisions of the Internal Revenue Code (IRC). The plan allows for employees to contribute a percentage of their base annual salaries on a tax-deferred basis not to exceed IRC limitations. The Company maintains a 401(k) matching program under which the Company matches 50% of the employee's contribution up to 6% of the employee's salary, subject to certain limitations. The matching contributions are subject to certain eligibility and vesting conditions. For the years ended December&#160;31, 2020, 2019 and 2018, the Company accrued matching contributions totaling approximately $70,180, $64,988 and $67,807, respectively. Prior to 2018, the Company did not provide matching contributions for its 401(k) savings plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains a voluntary compensation deferral plan, the Deferred Compensation Plan, as well as other legacy deferral plans. The Deferred Compensation Plan is non-qualified and permits certain employees whose annualized base salary equals or exceeds a minimum annual threshold amount as set by the Company to elect to defer all or a portion of their annual bonus payment and up to 50% of their base salary into a deferral account maintained by the Company. Total contributions to this plan in 2020, 2019 and 2018 were $3,637, $1,751 and $3,090, respectively. Deferred amounts are generally paid out in cash at the participant&#x2019;s election either in the first or second year following retirement or in a specified future period at least three to four years after the deferral election was effective. During 2020, 2019 and 2018 the Company distributed $3,139, $2,730 and $4,652, respectively, to participants from its deferred compensation plans. Participants are credited with their proportional amount of annual earnings from the plans. The assets of these plans are held in rabbi trusts subject to the claims of the Company&#x2019;s general creditors in the event of its bankruptcy. As of December&#160;31, 2020 and 2019, the total fair value of assets held in these plans' trusts was $43,844 and $39,527, respectively. The assets of these plans are recorded at fair value with changes in fair value recorded in "Other income, net". Any fair value changes to the corresponding liability balance are recorded as compensation expense. See Note 5 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzQ2OQ_00e63d0a-de24-4f80-80ac-b2d8aa5b5395"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzUwOQ_cb51bc90-ddf9-4aae-b19e-f51d9053a44e"
      unitRef="number">0.06</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzc1Mw_d118b1a4-3932-49e3-a73f-37830d520250"
      unitRef="usd">70180000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzc2MA_02148085-a071-43aa-84fd-0682c0b5c5f6"
      unitRef="usd">64988000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzI3NDg3NzkwNzIzNTk_835ef3cd-a000-4067-96bf-e03c8740fb0a"
      unitRef="usd">67807000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="ic824c560585f40d3a9cd728889fd74f9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzEyODM_2e6823f0-b4f5-4c09-ad07-ed0d32655ae8"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i6ef674119c2b4d74aa417195d2c6c430_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE0MTM_d1594d07-e5d4-4793-a32f-b9fe2a668054"
      unitRef="usd">3637000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i41cd8e78e8344b3ebb08e9406b65619d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE0MTc_a7412dbb-c807-4341-ad04-74055cf9c771"
      unitRef="usd">1751000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i3f16999941ed40e69576042281e8c119_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE0MjQ_80132447-1a49-47e5-84b1-1d1853f28df6"
      unitRef="usd">3090000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid
      contextRef="i6ef674119c2b4d74aa417195d2c6c430_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE3MjU_53c8c043-cd41-42e1-94e5-6eacd18c8029"
      unitRef="usd">3139000</us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid>
    <us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid
      contextRef="i41cd8e78e8344b3ebb08e9406b65619d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE3Mjk_56032726-cb6d-4d48-813b-bb1150b6a36d"
      unitRef="usd">2730000</us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid>
    <us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid
      contextRef="i3f16999941ed40e69576042281e8c119_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzE3MzY_d7f07487-8288-4222-ab4f-1436ff008a60"
      unitRef="usd">4652000</us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia31bf166ca5d4a4da3dc6b7a74d31624_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzIxMjA_ed38f04a-5a46-4973-8c2b-1e8766a31202"
      unitRef="usd">43844000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i21a3c92cde084cf8b5352300822f8a32_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTMvZnJhZzoyNWMzN2IwZjc4NzU0NzliYWQzZTk2YzQ1OWM4MDk4Yy90ZXh0cmVnaW9uOjI1YzM3YjBmNzg3NTQ3OWJhZDNlOTZjNDU5YzgwOThjXzIxMjc_f36835e9-a2cf-49f8-abeb-572a44e550bf"
      unitRef="usd">39527000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:LossContingencyDisclosures
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzEzMTQ5_6b337489-f41c-4539-9cb2-4227a2f45d18">Contingencies&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#x2019;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#x2019;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits, governmental investigations (which frequently arise from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of December&#160;31, 2020 and December&#160;31, 2019, the Company&#x2019;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#x2019;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Governmental Inquiries and Related Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 U.S. Attorney Texas Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#x2019;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#x2019;s relationships with pharmaceutical manufacturers. The government's investigation covers the period from January&#160;1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government's investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#x2019;s investigation is ongoing with respect to issues related to DaVita Rx's historic relationships with certain pharmaceutical manufacturers, and in July 2018 the OIG served the Company with a subpoena seeking additional documents and information relating to those relationships. The Company is continuing to cooperate with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2017 U.S. Attorney Colorado Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In November 2017, the U.S. Attorney&#x2019;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#x2019;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018 and May 2019, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2018 U.S. Attorney Florida Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#x2019;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#x2019;s Office is conducting an investigation as to whether the Company&#x2019;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney's Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc. et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. On February 24, 2020, the Company and DaVita Labs filed a motion to dismiss the amended complaint. On June 25, 2020, the court denied the motion to dismiss. The Company and DaVita Labs answered the complaint on July 23, 2020. The Company and DaVita Labs dispute these allegations and intend to defend this action accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 U.S. Attorney New Jersey Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2020, the U.S. Attorney&#x2019;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#x2019;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#x2019;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 California Department of Insurance Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020. The subpoena, as revised, requests information on a number of topics, including but not limited to the Company&#x2019;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#x2019; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 Department of Justice Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#x2019;s reputation, required changes to the Company&#x2019;s business practices, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholder and Derivative Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Peace Officers&#x2019; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On February 1, 2017, the Peace Officers&#x2019; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;federal securities laws concerning the Company&#x2019;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#x2019;s business and operational status and future growth prospects."&#160;In November 2017, the court appointed the lead plaintiff and an amended complaint was filed on January 12, 2018. On March 27, 2018, the Company and various individual defendants filed a motion to dismiss. On March 28, 2019, the court denied the motion to dismiss. The Company answered the complaint on May 28, 2019. On January 31, 2020, the plaintiffs filed a motion for class certification and the Company filed its opposition on June 29, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company continues to dispute the allegations, in July 2020, it reached an agreement in principle to resolve this matter without admitting to any liability. Settlement of this matter on the agreed terms is expected to be covered primarily with insurance proceeds, with the Company contributing an amount that would not have a material impact on the Company&#x2019;s consolidated financial position, results of operations or cash flows. A motion for preliminary approval of the settlement was granted by the court on October 27, 2020. The settlement is subject to, among other things, final approval by the court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;In re DaVita Inc. Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#x2019;s profits. An amended complaint was filed in September 2017, and on December 18, 2017, the Company filed a motion to dismiss and a motion to stay proceedings in the alternative. On April 25, 2019, the court denied the Company's motion to dismiss. The Company answered the complaint on May 28, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the defendants continue to dispute the allegations, in July 2020, an agreement in principle was reached to resolve this matter without admitting to any liability. The Company&#x2019;s Board of Directors (Board) approved the settlement on October 20, 2020. The court granted a motion for final approval of the settlement on January 27, 2021 and approved the settlement on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but will not make any financial contribution towards the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the foregoing, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 16 to these consolidated financial statements, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#x2019;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#x2019;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, or otherwise harm the Company&#x2019;s business, results of operations, financial condition, cash flows or reputation.&lt;/span&gt;&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i2b6750de267f4090baf50a854a1011e0_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzQwMDY_cd46b1b4-3006-4f31-a1b3-7d19fbe642ed"
      unitRef="usd">63700000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i65d88e830460478cba6dc77e5492cad1_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzQwNDQ_a581c1d0-2a93-41a5-a6d4-1a06ae94a325"
      unitRef="usd">41500000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9df1ffed4d1a4507989270b5f5b4cad0_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNTkvZnJhZzozMWMwNjRhZDc4N2Y0ODk4YjBkMGE1NmY3YTM0MzhlZi90ZXh0cmVnaW9uOjMxYzA2NGFkNzg3ZjQ4OThiMGQwYTU2ZjdhMzQzOGVmXzQwODM_f75ef948-9a98-4cf9-93bb-0cf26ed14611"
      unitRef="usd">22200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzQ4ODk_7fe344e8-aaa3-4f91-ab7c-582851e7786d">Noncontrolling interests subject to put provisions and other commitments&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#x2019; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#x2019; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#x2019;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#x2019; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#x2019; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $8,663.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain consolidated dialysis partnerships are originally contractually scheduled to dissolve after terms ranging from ten years to 50 years. While noncontrolling interests in these limited life entities qualify as mandatorily redeemable financial instruments, they are subject to a classification and measurement scope exception from the accounting guidance generally applicable to other mandatorily redeemable financial instruments. Future distributions upon dissolution of these entities would be valued below the related noncontrolling interest carrying balances in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, the Company entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on December&#160;31, 2022. Under the terms of the agreement, the Company will purchase EPO from Amgen in amounts necessary to meet no less than 90% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that the Company will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that the Company serves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreements with various suppliers to purchase established amounts of dialysis equipment, parts, and supplies. As of December&#160;31, 2020, the remaining minimum purchase commitments under these arrangements were approximately $542,061, $540,715, $179,869, and $92,075 for the years 2021, 2022, 2023, and 2024, respectively. If the Company fails to meet the minimum purchase commitments under these contracts during any year, it is required to pay the difference to the supplier.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than the letters of credit disclosed in Note 13 to these consolidated financial statements, and the arrangements as described above, the Company has no off balance sheet financing arrangements as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:OtherCommitment
      contextRef="i48eb570e320e4ce9a013b7d5c8f0f816_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI4NjM_491f6c22-1a89-4b42-8ef1-0d518e69b9d0"
      unitRef="usd">8663000</us-gaap:OtherCommitment>
    <dva:DissolutionTermOfJointVentures
      contextRef="ia17c891217a04175aaa5d089ccfe53cc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI5ODY_cd3614a8-536d-4ddb-9abe-e61cf9d4edf1">P10Y</dva:DissolutionTermOfJointVentures>
    <dva:DissolutionTermOfJointVentures
      contextRef="idc9b6f348e7445618e8a93ac2e704418_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI5OTI_7a5a086e-12f6-47d2-aedc-747c2e4b8e5e">P50Y</dva:DissolutionTermOfJointVentures>
    <dva:LongTermPurchaseCommitmentExpirationDate
      contextRef="if29e4c04bf37468ebe8740252e6f04c3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM1ODQ_6d057209-77c7-4203-b7ab-ed23584b2421">2022-12-31</dva:LongTermPurchaseCommitmentExpirationDate>
    <dva:LongTermPurchaseCommitmentPercentageOfQuantityRequired
      contextRef="i4528caebac5945689bef0ffaf6291d30_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM3MDU_d501669b-a844-43f8-a94d-f6e8969e364b"
      unitRef="number">0.90</dva:LongTermPurchaseCommitmentPercentageOfQuantityRequired>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5MTI_6fe3247f-1503-447f-b111-7e96c5a75f0a"
      unitRef="usd">542061000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5MTY_1925c6c5-80b1-4b39-ae60-61c57d559baf"
      unitRef="usd">540715000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5MjE_61bdfd19-3be4-4b4a-8c9f-f8cc32ebfb21"
      unitRef="usd">179869000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzM4NDgyOTA3MDM5NTc_5118b65b-84b9-4ea4-a5e2-4ffd9bcff073"
      unitRef="usd">92075000</us-gaap:PurchaseObligationDueInFourthYear>
    <dva:OffBalanceSheetFinancingArrangements
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjIvZnJhZzo4MDkwYTQ0NjRkYWQ0NmY3YTY5ZjkxMDE2MDYwMDA4ZC90ZXh0cmVnaW9uOjgwOTBhNDQ2NGRhZDQ2ZjdhNjlmOTEwMTYwNjAwMDhkXzI4MDM3NTQ2NTE1NTg4_dd29c03b-f6b6-4b06-ada9-f227121f2f99"
      unitRef="usd">0</dva:OffBalanceSheetFinancingArrangements>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDQz_b94435fe-0855-47e2-81b9-bf4190021e4e">Long-term incentive compensation&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term incentive compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term incentive program (LTIP) compensation includes both stock-based awards (principally stock-settled stock appreciation rights, restricted stock units and performance stock units) as well as long-term performance-based cash awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term incentive compensation expense, which is primarily general and administrative in nature, is attributed to the Company&#x2019;s U.S. dialysis business, its corporate administrative support, and its ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all LTIP awards is recognized net of expected forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation to be settled in shares is recorded to the Company&#x2019;s shareholders&#x2019; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term incentive compensation plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 11, 2020, the Company&#x2019;s stockholders approved the DaVita Inc. 2020 Incentive Award Plan (the 2020 Plan). Prior to June 11, 2020 stock-based awards were granted under the DaVita Healthcare Partners Inc. 2011 Incentive Award Plan (the 2011 Plan). The 2011 Plan was terminated with respect to any new awards upon stockholder approval of the 2020 Plan. At the time the 2020 Plan was approved there were 8,730 shares of common stock available for issuance under the 2020 Plan, consisting of 5,000 newly authorized shares and 3,730 shares that were available for issuance under the 2011 Plan as of the effective date of the 2020 Plan and which became available for grant under the 2020 Plan, pursuant to the terms of the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Plan is the Company&#x2019;s current omnibus equity compensation plan and provides for grants of stock-based awards to employees, directors and other individuals providing services to the Company, except that incentive stock options may only be awarded to employees. The 2020 Plan provides for the grant of stock appreciation rights, nonqualified stock options, incentive stock options, restricted stock units, restricted stock, performance stock awards, dividend equivalents, stock payments, deferred stock unit awards, deferred stock awards and performance cash awards. The 2020 Plan mandates a maximum award term of 10 years for stock appreciation rights and stock options and stipulates that awards of these types be granted with a base or exercise price per share of not less than the fair market value of the Company's common stock on the date of grant. Shares available under the 2020 Plan are also stated on a full value share basis rather than on an option-equivalent basis. The 2020 Plan therefore provides that shares available for issuance under the plan are reduced by one share available for every four shares underlying stock appreciation rights and stock options, and are reduced by one share available for every one share underlying stock-based awards other than stock appreciation rights and stock options. At December&#160;31, 2020, there were 8,074 shares available for future grants under the 2020 Plan. The Company&#x2019;s stock units awarded under the 2020 Plan generally vest over 36 months to 48 months from the date of grant. As of December&#160;31, 2020, no stock appreciation rights have been awarded under the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2011 Plan was the Company&#x2019;s prior omnibus equity compensation plan and authorized the Company to award stock options, stock appreciation rights, restricted stock units, restricted stock, and other stock-based or performance-based awards. The 2011 Plan mandated a maximum award term of five years and stipulated that stock appreciation rights and stock options be granted with prices not less than fair market value on the date of grant. The 2011 Plan also required that full value share awards such as restricted stock units reduce shares available under the 2011 Plan at a ratio of 3.5:1. The Company&#x2019;s stock appreciation rights and stock units awarded under the 2011 Plan generally vest over 36 months to 48 months from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A combined summary of the status of the Company&#x2019;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Added by performance factor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised/Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value of grants:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:14pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of SSARs base prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$50.01&#x2013;$60.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$60.01&#x2013;$70.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$70.01&#x2013;$80.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2020, 2019, and 2018, the aggregate intrinsic value of stock-based awards exercised was $49,258, $11,475 and $31,045, respectively. At December&#160;31, 2020, the aggregate intrinsic value of stock-based awards outstanding was $853,803 and the aggregate intrinsic value of stock awards exercisable was $47,208.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Estimated fair value of stock-based compensation awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has estimated the grant-date fair value of stock-settled stock appreciation rights awards using the Black-Scholes-Merton valuation model and stock-settled stock unit awards at intrinsic value on the date of grant, except for portions of the Company&#x2019;s performance stock unit awards for which a Monte Carlo simulation was used to estimate the grant-date fair value. The following assumptions were used in estimating these values and determining the related stock-based compensation expense attributable to the current period:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected term of the awards:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The expected term of awards granted represents the period of time that they are expected to remain outstanding from the date of grant. The Company determines the expected term of its stock awards based on its historical experience with similar awards, considering the Company&#x2019;s historical exercise and post-vesting termination patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected volatility:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Expected volatility represents the volatility anticipated over the expected term of the award. The Company determines the expected volatility for its awards based on the volatility of the price of its common stock over the most recent retrospective period commensurate with the expected term of the award, considering the volatilities expected by peer companies in near industries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected dividend yield:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company has not paid dividends on its common stock and does not currently expect to pay dividends during the term of stock awards granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-free interest rate:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company bases the expected risk-free interest rate on the implied yield currently available on stripped interest coupons of U.S. Treasury issues with a remaining term equivalent to the expected term of the award.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company estimates expected forfeitures based upon historical experience with separate groups of employees that have exhibited similar forfeiture behavior in the past. Stock-based compensation expense is recorded only for awards that are expected to vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 4, 2019, the independent members of the Company&#x2019;s Board of Directors (Board) approved an award of 2,500 premium-priced stock-settled stock appreciation rights (Premium-Priced Award) to the Company&#x2019;s Chief Executive Officer (CEO), which award was subject to stockholder approval of a related amendment to the 2011 Plan. Stockholders approved such amendment to the 2011 Plan on January 23, 2020, authorizing the grant to the Company's CEO. Since stockholder approval occurred in 2020, this award was treated as granted in 2020 for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The base price of the Premium-Priced Award was $67.80 per share, which was a 20% premium to the clearing price of the Company's modified Dutch auction tender offer for its shares in 2019 (2019 Tender Offer). The award vests 50% on each of November&#160;4, 2022 and November&#160;4, 2023 and expires on November&#160;4, 2024. The award includes a requirement that the CEO hold any shares acquired upon exercise of this award, net of shares used to cover related taxes, until November&#160;4, 2024 (that is, for the full term of the award), subject to lapse of the holding period upon a change in control of the Company or due to the CEO's death or termination due to disability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Employee Stock Purchase Plan entitles qualifying employees to purchase up to $25 of the Company&#x2019;s common stock during each calendar year. The amounts used to purchase stock are accumulated through payroll withholdings or through optional lump sum payments made in advance of the first day of the purchase right period. This compensatory plan allows employees to purchase stock for the lesser of 100% of its fair market value on the first day of the purchase right period or 85% of its fair market value on the last day of the purchase right period. Purchase right periods begin on January&#160;1 and July&#160;1, and end on December&#160;31. Contributions used to purchase the Company&#x2019;s common stock under this plan for the 2020, 2019 and 2018 purchase periods were $17,148, $16,569 and $17,398, respectively. Shares purchased pursuant to the plan&#x2019;s 2020, 2019 and 2018 purchase periods were 222, 315 and 398, respectively. At December&#160;31, 2020, there were 6,189 shares remaining available for future grants under this plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of participants&#x2019; purchase rights was estimated as of the beginning dates of the purchase right periods using the Black-Scholes-Merton valuation model with the following weighted average assumptions for purchase right periods in 2020, 2019 and 2018, respectively: expected volatility of 40.4%, 28.8% and 24.2%; risk-free interest rates of 1.0%, 2.6% and 1.9%, and no dividends. Using these assumptions, the weighted average estimated per share fair value of each purchase right was $22.06, $13.80 and $17.45 for 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term incentive compensation expense and proceeds&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized $99,643, $118,513 and $85,759, respectively, in total LTIP expense, of which $91,458, $63,705 and $73,582, respectively, was stock-based compensation expense for stock appreciation rights, stock units and discounted employee stock purchase plan purchases, which are primarily included in general and administrative expenses. The estimated tax benefits recorded for stock-based compensation in 2020, 2019 and 2018 were $11,775, $9,186 and $13,591, respectively. As of December&#160;31, 2020, there was $189,713 of total estimated but unrecognized stock-based compensation expense under the Company&#x2019;s equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.4 years. The Company no longer has outstanding long-term performance-based cash awards in its principal U.S. dialysis business as the performance and accrual period for these awards ended December 31, 2019 with a final payout of $66,302 in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2018, the Company adopted a retirement policy (Rule of 65 policy). The Rule of 65 policy generally provides that Section 16 officers that are a minimum age of 55 with five years of continuous service with the Company receive certain benefits with respect to their outstanding equity awards upon a qualifying retirement if the sum of their age plus years of service is greater than or equal to 65. These benefits generally include accelerated vesting of restricted stock unit awards, continued vesting of stock-settled stock appreciation rights and performance stock unit awards and an exercise window for stock-settled stock appreciation rights from the original vest date through the original expiration date regardless of continued employment, with pro rata vesting for a Rule of 65 retirement within one year of the award grant date. The adoption of the Rule of 65 policy resulted in a $14,704 modification charge and a net acceleration of expense of $9,727 during the year ended December&#160;31, 2018 that is included in the expense amounts reported above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2020, 2019 and 2018, the Company received $8,957, $2,251 and $7,988, respectively, in actual tax benefits upon the exercise or vesting of stock awards. Since the Company issues stock-settled stock appreciation rights rather than stock options, there were no cash proceeds from stock option exercises.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDE1_ce1899df-99ad-45aa-989f-41d08ef1ad4e">The Company&#x2019;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all LTIP awards is recognized net of expected forfeitures.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i09a03f944078404d9b7042cd462b1e45_I20200611"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzI2_a3cb3c82-a181-4bdb-ba93-b618d50886e6"
      unitRef="shares">8730000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i09a03f944078404d9b7042cd462b1e45_I20200611"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzA2_42785203-b098-4c40-a830-ddb5fdb7a951"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ic29f0bcf68804559a9cb68580986a3d1_I20200611"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzE1_58e88d54-c7e0-46ad-ad28-513c1ab8f749"
      unitRef="shares">3730000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i56347587ed084168beda32c60aeec406_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNjg0_cf38615d-710c-43ee-a615-cc487ac52732">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions
      contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwMzc5_d9651d16-7462-49a9-b44e-9ee5b8f54dbd"
      unitRef="shares">1</dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions>
    <dva:StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance
      contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwMzg3_a0da3e0c-0f63-44b6-a3e3-333f13e06f84"
      unitRef="shares">4</dva:StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance>
    <dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward
      contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwMzk1_e227e1dc-ff6c-4673-a2c1-39e5c1bc7d35"
      unitRef="shares">1</dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward>
    <dva:StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance
      contextRef="i40641a42352446a9899eac8cf4b67998_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwNDAz_e99404ec-05f1-4d5d-88e7-206fd8db0f0a"
      unitRef="shares">1</dva:StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iefce2246983a490cbf7573fdfb4284f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI0NzM5MDExNjQ2OTc1_81c790b1-b447-42ac-811b-23394152bc16"
      unitRef="shares">8074000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iec9363113cab4f59bd24f4201b13c82a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDMx_23dd4c98-d22a-48de-a902-ae9863c2a068">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i56347587ed084168beda32c60aeec406_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDM4_1fff42d6-3aa5-4d37-a309-74b3d4bcf41e">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i50aab727700a46ef9be399f0944d2e80_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMyMDg3_8c90eea2-3c1e-4d6c-8ff4-30cda5176e3d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8ecc951facbe48a0a302ba1044295757_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzIwMzk_3ef1ab1a-32e9-4964-b49e-815b01347b02">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio
      contextRef="i8ecc951facbe48a0a302ba1044295757_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzIzMjk_364e8a3d-4986-420e-8911-0c871e31059a"
      unitRef="number">3.5</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia83bbff9dda64502a7fbedbbc8a8a4d0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI0NTI_3c025ec6-d236-4a37-b365-b63a02f9d56d">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia6b7c8b669444401a9a4b4002e230983_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI0NTg_ae7bcb47-bb02-4ba7-91ad-aa484bc7b777">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDI2_068eda82-ebe0-48b8-8814-3ea2aeb16a02">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A combined summary of the status of the Company&#x2019;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Added by performance factor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised/Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value of grants:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzAtMS0xLTEtMA_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzAtMS0xLTEtMA_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i26848a1a0f5d41bb9f8750c93c848335_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzMtMS0xLTEtMA_a6cd1ae1-5a24-4a4d-bd11-2070566f7885"
      unitRef="shares">6953000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i26848a1a0f5d41bb9f8750c93c848335_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzMtMy0xLTEtMA_af75a0d9-1502-4f6e-82e4-4fc58711a0d6"
      unitRef="usdPerShare">64.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6ccc591606cc4e39942d003b9bd1727c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzMtNy0xLTEtMA_e77e2b66-625a-464a-9054-578c72e2eb09"
      unitRef="shares">3160000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzQtMS0xLTEtMA_4063878f-78eb-44d7-9519-9222e50d3c77"
      unitRef="shares">2765000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzQtMy0xLTEtMA_b37e2c27-f647-49c0-bfdb-9be7ce9321d4"
      unitRef="usdPerShare">68.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzQtNy0xLTEtMA_ad2d4b2c-0e26-4cf1-becb-ed68ba9c20cc"
      unitRef="shares">1027000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtNy0xLTEtNjk0Ng_bb3e8c65-18f2-46cd-aafa-b3e4caa989b1"
      unitRef="shares">19000</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtMS0xLTEtMA_3c884800-1c18-4965-9bb9-96e7c046de45"
      unitRef="shares">894000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtMy0xLTEtMA_fed171d0-645e-4c2f-af65-3fae5ffb0000"
      unitRef="usdPerShare">72.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzUtNy0xLTEtMA_361ad169-f02f-42e5-bbb0-c95c3e6de1ee"
      unitRef="shares">351000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzYtMS0xLTEtMA_297217ab-7099-49ea-b93a-7a1f370bcdbf"
      unitRef="shares">494000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzYtMy0xLTEtMA_ae663459-4297-43af-94a3-4664128b95f8"
      unitRef="usdPerShare">83.61</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <dva:SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzYtNy0xLTEtMA_a23abd9f-e020-4d4e-a47f-0128cd25289e"
      unitRef="shares">0</dva:SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzctMS0xLTEtMA_83359aee-f713-4d2e-88d7-a3276859db55"
      unitRef="shares">246000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzctMy0xLTEtMA_a6a4e9b2-8a67-4920-9e41-e31c44080b87"
      unitRef="usdPerShare">61.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzctNy0xLTEtMA_855cdc08-9952-4690-a744-7feb20b15f86"
      unitRef="shares">318000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i60a53b9f954142e297133141bab808dd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtMS0xLTEtMA_33c68171-563f-4ddc-9733-5da9bf203123"
      unitRef="shares">8084000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i60a53b9f954142e297133141bab808dd_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtMy0xLTEtMA_8f94a03f-efb7-4708-8310-18e0097283ff"
      unitRef="usdPerShare">63.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtNS0xLTEtMA_c46c70e9-9ce6-4d63-b355-86be56c5728c">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie2584bc113b24dca93703a2c83984853_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtNy0xLTEtMA_790d1ccb-0397-4567-9f9f-96be98a3c881"
      unitRef="shares">3537000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzgtOS0xLTEtMA_6e463227-65a1-40cb-877c-db1f9e1615b5">P1Y9M18D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i60a53b9f954142e297133141bab808dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktMS0xLTEtMA_de453c24-5f72-411d-93a1-4820ec708753"
      unitRef="shares">987000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i60a53b9f954142e297133141bab808dd_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktMy0xLTEtMA_42f629e3-a5de-424c-840c-5a960cc6b782"
      unitRef="usdPerShare">69.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktNS0xLTEtMA_d3d062ac-555c-42d2-ab37-199585b2ef3a">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="ie2584bc113b24dca93703a2c83984853_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzktNy0xLTEtMA_8ce1e8fe-841a-4d9b-9ff2-645c62e2387e"
      unitRef="shares">0</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzExLTEtMS0xLTA_3f4ec230-c33c-4e72-b1b4-f3a4486e0da4"
      unitRef="usdPerShare">26.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2a9de29b1453423890c10dc156527bd2_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzExLTctMS0xLTA_2f455abe-b089-4a0f-b7e1-4334df2fa073"
      unitRef="usdPerShare">77.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7c8fd716e0254f41a042164ecba35111_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEyLTEtMS0xLTA_dcfbf480-890c-487b-a106-ae557e1e6228"
      unitRef="usdPerShare">14.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7a79748b304b4708bba0c7e5287e2026_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEyLTctMS0xLTA_c3623f74-b016-4ae6-a656-c9cd76f1a501"
      unitRef="usdPerShare">50.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4e22cdd25e2e4d95989b353987e285c8_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEzLTEtMS0xLTA_d5e3ff48-8647-429c-8113-ea0a5976bc12"
      unitRef="usdPerShare">16.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i24385aeb87a94f68874b67e43b0ac293_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkYTQ3ZWJiMGY4NmE0NjM0Yjk4NDUyOTZiYTFmYzAwNy90YWJsZXJhbmdlOmRhNDdlYmIwZjg2YTQ2MzRiOTg0NTI5NmJhMWZjMDA3XzEzLTctMS0xLTA_d092b95d-dba3-4724-81a4-67176339a1c2"
      unitRef="usdPerShare">66.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDIy_23d450ce-02c6-4e11-9122-e9b1db967f39">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Awards exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of SSARs base prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$50.01&#x2013;$60.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$60.01&#x2013;$70.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$70.01&#x2013;$80.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItMi0xLTEtMA_9a3a3bef-a2a3-4b9f-995b-5725e5dd28e0"
      unitRef="shares">2263000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItNC0xLTEtMA_eb236f42-79af-4822-88e4-d866c88a8443"
      unitRef="usdPerShare">52.53</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItNi0xLTEtMA_0f61b15e-d61c-4dd8-ba88-77de1fe3bad2"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i93d09393df004ac29505b1eca4c5d9f0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzItOC0xLTEtMA_1f997c35-8920-4fd5-9c9a-fa655e10bd58"
      unitRef="usdPerShare">57.88</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtMi0xLTEtMA_7e3dc31f-7e80-43de-b58a-143e3b90261e"
      unitRef="shares">5165000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtNC0xLTEtMA_0269510f-9b28-409b-be7e-c8b4e824e50b"
      unitRef="usdPerShare">66.99</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtNi0xLTEtMA_a48b5c16-184d-4295-8766-8c302c3594e8"
      unitRef="shares">610000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i398441769aa34ea5b548ab2875ab7937_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzMtOC0xLTEtMA_c1c1b314-e123-4edc-98d1-da92eedbdea1"
      unitRef="usdPerShare">65.95</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtMi0xLTEtMA_eb9deed0-2145-4d87-9253-d853db9bde26"
      unitRef="shares">656000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtNC0xLTEtMA_9ea116a2-a262-4cbf-b49c-8799cbffd3d8"
      unitRef="usdPerShare">75.60</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtNi0xLTEtMA_f67259cb-b490-43e1-9d7f-bfa25124f115"
      unitRef="shares">375000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ib34487485c5647c193bb709cf8e7c4cc_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzQtOC0xLTEtMA_42e3c326-ac79-4ec3-ac4d-95b846185923"
      unitRef="usdPerShare">75.50</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtMi0xLTEtMA_17893532-e601-4e94-a289-94e32921c2aa"
      unitRef="shares">8084000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtNC0xLTEtMA_70c8cb4b-0500-4b0e-b848-e4f068b1e9d3"
      unitRef="usdPerShare">63.64</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtNi0xLTEtMA_f2fff5b3-0ca4-4220-a267-e3196de3d4a2"
      unitRef="shares">987000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTpkNDFkZjRlMmZjNjU0OTljOGZjMzdkNjIxZTBmZmQyZi90YWJsZXJhbmdlOmQ0MWRmNGUyZmM2NTQ5OWM4ZmMzN2Q2MjFlMGZmZDJmXzYtOC0xLTEtMA_51e3339e-b55d-434d-b3ba-57fc99ff4e60"
      unitRef="usdPerShare">69.56</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM1MTY_19685d38-37ae-4b31-a3b9-a34312677105"
      unitRef="usd">49258000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM1MjA_06b30579-0158-4765-857f-dea1c802700c"
      unitRef="usd">11475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM1Mjc_3ab5610b-364d-4861-aa4d-19aa63cfc311"
      unitRef="usd">31045000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM2MjA_f14c7999-8698-47d5-aa4f-b259a74c9152"
      unitRef="usd">853803000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzM2ODk_6addf332-b59e-4388-af9f-30e7800f59a8"
      unitRef="usd">47208000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExMDMw_dfa9b147-9318-42f5-8f3a-6ae9a0ca6bd7">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzItMS0xLTEtMA_8f150d79-46ad-472e-8785-251040a659ff">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzItMy0xLTEtMA_e12dc6e8-f71d-456a-8d52-b161606b7fab">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzItNS0xLTEtMA_9c33a0a6-dbea-4e92-9932-814979d8f99a">P4Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzMtMS0xLTEtMA_5f1c6027-6769-425d-b5fd-de27cb77ae11"
      unitRef="number">0.282</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzMtMy0xLTEtMA_36eda6d9-4d26-4464-98d0-62fd0724f107"
      unitRef="number">0.295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzMtNS0xLTEtMA_020b73f3-c503-4dda-9422-778590b771d5"
      unitRef="number">0.238</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzQtMS0xLTEtMA_1f86ea89-fd00-436f-b3cd-d5942b01270c"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzQtMy0xLTEtMA_bf62b3ec-e512-4fdc-9206-d22c6899c21a"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzQtNS0xLTEtMA_793d8e83-f121-46e3-b58d-c781d42567a3"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzUtMS0xLTEtMA_5d419f2b-e3bd-4f7f-ae7c-c21a60a39c23"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ibf4a7cbd721346d0b6d000064beb7515_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzUtMy0xLTEtMA_9b40acb5-a10a-44c2-a17f-d8c77491f56d"
      unitRef="number">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i35ce896f985949f8b3ab3d3f3da1607f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90YWJsZTplNDg4ZTk4ZjAzNjA0YTU2YTEyM2U4MDkzYTM4ZDk0YS90YWJsZXJhbmdlOmU0ODhlOThmMDM2MDRhNTZhMTIzZTgwOTNhMzhkOTRhXzUtNS0xLTEtMA_27f085c5-b2b6-4e57-a384-743dc133903d"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzYxNjU_2f378e80-e87b-49eb-9bbd-a46fa574d6ee"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <dva:PremiumPricedAwardBasePricePerShare
      contextRef="icebe77b40956462b9ff854742673e44a_I20191104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY2NTE_ce5aa7c6-4a5a-4fac-afaa-c6a0dadc7652"
      unitRef="usdPerShare">67.80</dva:PremiumPricedAwardBasePricePerShare>
    <dva:PremiumToTheTenderOfferSharePurchasePrice
      contextRef="icebe77b40956462b9ff854742673e44a_I20191104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY2Nzc_3acf82ac-06e8-4ae4-8cff-eb3bee4d2e7f"
      unitRef="number">0.20</dva:PremiumToTheTenderOfferSharePurchasePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i3eb4d386a219415092cadf2a89fb4b27_D20191104-20191104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4MDI_f9da7600-7493-4dba-bf29-f73e314db826"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate
      contextRef="i3eb4d386a219415092cadf2a89fb4b27_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4MTY_77a89389-ef7b-4099-9629-56e5858bd2f3">2022-11-04</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate
      contextRef="ib5d81d4cfd9b4d3a90277b4e0ba77a2f_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4MjM_59116337-1dd1-4541-b82a-df882ba77d6a">2023-11-04</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY4NDE_ae97d49f-4c9d-4888-bb2d-702dbe367f6b">2024-11-04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate
      contextRef="i938c7ca6d90f4049a0088ca29fdb92b7_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzY5OTQ_5c45db97-1ed1-494e-809a-48204b1189c8">2024-11-04</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase
      contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzcyODk_927474ef-799e-4d71-9c68-4a2a5d6f5e9e"
      unitRef="usd">25000</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ide5fa201da08419d8480005b0941c2ef_D20200101-20200101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc2MDY_d2c75ede-ebd0-48c3-861a-8c0b9da32072"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i13cf2d394c7d46048c99aed94e7a3468_D20201231-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc2ODM_472714b6-7b3b-4c88-bea4-72f61b586451"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares
      contextRef="i428a7bb3ffa14fe5895e9f5a7c269bed_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzExNTQ0ODcyMTEzNzg0_0b50a8ca-8689-4c74-8bdb-28164c4c8911"
      unitRef="usd">17148000</dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares>
    <dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares
      contextRef="i9f3ec9369a584177b5460514179d0117_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc5NjI_db9455b1-9798-4c21-88d1-317f1c35d4ca"
      unitRef="usd">16569000</dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares>
    <dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares
      contextRef="i5b178e933b3b47e2ac8bbe854a99a0bb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzc5Njk_50699b17-439a-4601-bfa7-085e2e4ddab2"
      unitRef="usd">17398000</dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgwNjg_15eb6c9f-65a2-4b4c-809a-9a296925b491"
      unitRef="shares">222000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgwNzI_99b4eb7b-d4ea-4478-b474-19ba5fe3eb8e"
      unitRef="shares">315000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgwNzk_417ffd48-609c-4652-ba32-b40597fbe1d0"
      unitRef="shares">398000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i428a7bb3ffa14fe5895e9f5a7c269bed_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzgxMTU_e82165df-1f0b-4fb6-9df8-569a8b0dc90f"
      unitRef="shares">6189000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg0NzU_cf45ae57-cce2-47b1-9b05-32774fdae575"
      unitRef="number">0.404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg0Nzk_fafe3e69-0e0c-429d-810c-812e630d6d8c"
      unitRef="number">0.288</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg0ODY_de59cf3a-9261-4de0-86c8-73a4a3448da8"
      unitRef="number">0.242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1MTg_2a0c0fa2-a1bf-4b58-b661-30b259279591"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1MjI_859df688-8e28-4af6-ba30-64bc4e50ebd4"
      unitRef="number">0.026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1Mjk_ff2373e5-134c-4f0e-a393-74642ada0c77"
      unitRef="number">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg1Mzc_8c20787e-a337-4324-a1f7-d410f948201e"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i24e9613618454126afe7f679892ff495_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg2NTU_110bb436-eaf4-43bf-948b-5a3a37450e36"
      unitRef="usdPerShare">22.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i490f24dcebac43ce923ec231d79816a6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg2NTk_119e36eb-1e4b-428d-ba60-2a0ae55d4c0e"
      unitRef="usdPerShare">13.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7def829c92e542139bac66fe336262de_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg2NjY_1dd537d2-c705-461b-9a1a-74eaadc81347"
      unitRef="usdPerShare">17.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <dva:LongtermIncentiveProgramCompensationCost
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4MTQ_a6f53525-a7fb-4666-9f45-b6e807ffd50a"
      unitRef="usd">99643000</dva:LongtermIncentiveProgramCompensationCost>
    <dva:LongtermIncentiveProgramCompensationCost
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4MTg_a652fe11-730f-4b1c-a834-0abd13188997"
      unitRef="usd">118513000</dva:LongtermIncentiveProgramCompensationCost>
    <dva:LongtermIncentiveProgramCompensationCost
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4MjU_42fbd854-13fc-43df-a393-e51b8a35aa05"
      unitRef="usd">85759000</dva:LongtermIncentiveProgramCompensationCost>
    <us-gaap:ShareBasedCompensation
      contextRef="ia4ea773d13594e1e9feb21e2fab910b3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4NzU_239d0064-44fa-4d37-b339-19b34834a870"
      unitRef="usd">91458000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i08f4222a3b2941c78d4c11684f04bb29_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4Nzk_2753f878-5ee5-497f-af7b-8cbfbcb7f0a7"
      unitRef="usd">63705000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i127cf2093ba342448f4db553c0454a5d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzg4ODY_a2186d5c-45ad-4c77-8642-f898d75f95dd"
      unitRef="usd">73582000</us-gaap:ShareBasedCompensation>
    <dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzkxODY_681978b3-d6c1-4436-817b-39ed08c52e72"
      unitRef="usd">11775000</dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense>
    <dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzkxOTA_8b55d64b-e611-4f9a-8e04-5315384b8372"
      unitRef="usd">9186000</dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense>
    <dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzkxOTc_bd349e37-ce1f-447f-bd71-cf5db3b9f2af"
      unitRef="usd">13591000</dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwOTk1MTE2Mjk5MTAx_746086d3-5519-463f-8ca4-443c5afe6fc4"
      unitRef="usd">189713000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5Xzk2ODE_1aeb68fd-ddfb-431c-b9c7-0bddf0dc913a">P1Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <dva:LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzI4MDM3NTQ2NTMwNDE4_a0696b51-262b-4554-a383-912c14334d36"
      unitRef="usd">0</dva:LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding>
    <dva:LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwOTk1MTE2Mjk5NjI3_79a589a0-75b0-40e6-833a-b2b2f5da0e2b"
      unitRef="usd">66302000</dva:LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNTY1_57459833-8311-4bf6-8ccb-f187c6933508"
      unitRef="usd">14704000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNjI1_bf6494e7-88aa-4488-8b9e-02fbd4970b2d"
      unitRef="usd">9727000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNzgw_710cab16-ee03-4021-85d1-8ab24927ce73"
      unitRef="usd">8957000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNzg0_2cf9d40c-bd06-4199-9682-38493c9e85c3"
      unitRef="usd">2251000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwNzkx_fa898939-d5f7-40b3-8b27-0fe2f79cacb8"
      unitRef="usd">7988000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNjgvZnJhZzpjMWFlNDAyYzM2NmI0OWYxYTgwMmUxNDI0OWQ4MTkzOS90ZXh0cmVnaW9uOmMxYWU0MDJjMzY2YjQ5ZjFhODAyZTE0MjQ5ZDgxOTM5XzEwOTcw_862f3729-c6f3-48c1-babe-30b56b5c3cae"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI4MDM3NTQ2NTE0MzYw_ab238e03-e790-488b-bdd4-7ef86eefdd5f">Shareholders&#x2019; equity&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tender offers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,234,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,402,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended December&#160;31, 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$2,529 and $2,343, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2020 through February 10, 2021, the Company has repurchased 1,063 shares of its common stock for $123,282 at an average cost of $115.98 per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective as of the close of business on November 4, 2019, the Board terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $2,000,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to the Company under the aforementioned November 4, 2019 authorization and approved a new share repurchase authorization of $2,000,000. The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of February&#160;10, 2021, the Company has a total of $1,806,674 available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;remains subject to share repurchase limitations, including under the terms of the current senior secured credit facilities and the indentures governing the Company's senior notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company retired all shares held in its treasury effective as of December&#160;31, 2020 and December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Charter documents&#160;&amp;amp; Delaware law&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice for director nominations and stockholder proposals and granting the Company's Board of Directors the authority to issue up to 5,000 shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, prohibits the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder. The provisions described above may discourage, delay or prevent an acquisition of the Company at a price that stockholders may find attractive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in DaVita Inc.&#x2019;s ownership interests in consolidated subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of changes in DaVita Inc.&#x2019;s ownership interests in consolidated subsidiaries on the Company&#x2019;s consolidated equity were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in paid-in capital for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales of noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers in noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc. net of transfers in &lt;br/&gt; noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acquired additional ownership interests in several existing majority-owned partnerships for $7,831, $68,019, and $28,082 in 2020, 2019, and 2018, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM2MDM_143c843d-84c7-4d05-b699-196ba29da24b">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tender offers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,234,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,402,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended December&#160;31, 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$2,529 and $2,343, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzItMS0xLTEtMjA4MA_9df1dcf9-a19b-418a-87f6-14406506cb5f"
      unitRef="shares">8495000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzItMy0xLTEtMjA3NA_921e3ae9-e07f-46af-ae19-0776514f568d"
      unitRef="shares">19218000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzItNS0xLTEtMjA4Ng_1577d712-70f3-4e72-af49-50307beaf2e8"
      unitRef="shares">16844000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzMtMS0xLTEtMjA4Mg_2999db83-90df-4631-8d27-965ccfaacbd8"
      unitRef="usd">741850000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzMtMy0xLTEtMjA3Ng_b23d175f-101f-4d44-b620-5b7d56364932"
      unitRef="usd">1168321000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzMtNS0xLTEtMjA4OA_9ab98c26-780d-4c61-a9fa-e90a1bc460e0"
      unitRef="usd">1153511000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzQtMS0xLTEtMjA4NA_44f6b93e-4ae7-4469-a641-a3dc37a53b68"
      unitRef="usdPerShare">87.32</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ib0b310af9eea450d9b9eaae62e959a99_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzQtMy0xLTEtMjA3OA_f5ee0c3d-c26f-4209-9aee-e5480371a3f4"
      unitRef="usdPerShare">60.79</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="id19e616d98c54c0b9241d6658bb0cc9a_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzQtNS0xLTEtMjA5MA_0bcee15e-cdbd-4f80-a790-ca603bed5227"
      unitRef="usdPerShare">68.48</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzctMS0xLTEtMjA5Mw_1bc6f87b-615c-4d84-8c96-d008b89199ef"
      unitRef="shares">7982000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzctMy0xLTEtMjA5OQ_b1078795-0c09-4f1f-afd7-79881b4f8e1c"
      unitRef="shares">21802000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzctNS0xLTEtMjEwNQ_eb6a1ebd-2207-4832-9a1a-a4a03e0d23dc"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzgtMS0xLTEtMjA5NQ_3b790b00-0f1d-41f4-b8d5-9f44ecf2092a"
      unitRef="usd">704917000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzgtMy0xLTEtMjEwMQ_718da310-ab3a-4253-b481-8bf3aebedffd"
      unitRef="usd">1234154000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzgtNS0xLTEtMjEwNw_1c2a07d4-3e95-4692-b194-40bff84aa67e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzktMS0xLTEtMjA5Nw_05c8f44d-dfe8-419d-86be-d148d7307478"
      unitRef="usdPerShare">88.32</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzktMy0xLTEtMjEwMw_e9c98f57-50a3-4def-88bf-9e9c8fab9ac9"
      unitRef="usdPerShare">56.61</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ieb5395c736b34e679fe5d771ba086f17_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzktNS0xLTEtMjEwOQ_8a992467-57a5-4ddf-8d6f-20aa2021be08"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEyLTEtMS0xLTIxMTE_81428583-a392-47b9-9456-2802cb138bd5"
      unitRef="shares">16477000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEyLTMtMS0xLTIxMTc_a1ff57be-3474-4bd8-b9ec-16d40e2649ad"
      unitRef="shares">41020000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEyLTUtMS0xLTIxMjM_2358f2de-0421-433b-a16a-5763f660c98f"
      unitRef="shares">16844000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEzLTEtMS0xLTIxMTM_31081e25-7b8d-415d-bfd1-67a2ee5f6948"
      unitRef="usd">1446767000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEzLTMtMS0xLTIxMTk_87bed18f-1532-478a-97b1-18535eb97e1f"
      unitRef="usd">2402475000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzEzLTUtMS0xLTIxMjU_9f39dd53-cc7c-4c9c-853d-2db054b4ec51"
      unitRef="usd">1153511000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzE0LTEtMS0xLTIxMTU_6b414973-ecaa-44d5-a83f-5c315ded4a9d"
      unitRef="usdPerShare">87.80</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzE0LTMtMS0xLTIxMjE_884f08fa-0772-4941-84c0-44049142d8b7"
      unitRef="usdPerShare">58.57</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTo3YzI3MmM4MWIyY2M0ODRjYjZiNmJiZGQ0YTcxNGVjYy90YWJsZXJhbmdlOjdjMjcyYzgxYjJjYzQ4NGNiNmI2YmJkZDRhNzE0ZWNjXzE0LTUtMS0xLTIxMjg_604fbf1f-4483-422d-8198-2609a2ac3755"
      unitRef="usdPerShare">68.48</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice
      contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI5NQ_bb8a71ed-d4d2-4d15-abf4-31159969638b"
      unitRef="usdPerShare">88.00</dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice>
    <dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice
      contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzcxNDY4MjU1ODQ2MDc_a589a0b1-4d74-4a6c-aae0-310c04979d19"
      unitRef="usdPerShare">56.50</dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice>
    <dva:ShareRepurchaseFeesAndExpenses
      contextRef="ib743729442954729b874209aa3b7ad4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM0Mg_a2b33a02-2104-451f-b3c7-e1e1c4c59fa7"
      unitRef="usd">2529000</dva:ShareRepurchaseFeesAndExpenses>
    <dva:ShareRepurchaseFeesAndExpenses
      contextRef="if696d808d7744a14a0e6569ce4743dac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzcxNDY4MjU1ODQ1OTc_01ff4192-30d9-44f8-b877-f5dc82bb4c5f"
      unitRef="usd">2343000</dva:ShareRepurchaseFeesAndExpenses>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM5Mg_e3a368ac-75a6-43b7-84a8-b5f30ec158ce"
      unitRef="shares">1063000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzQyNg_cce66932-bc0a-4ade-b4ff-73b5795fbc58"
      unitRef="usd">123282000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i87c3bb4721a94e48b0105584a2c5b648_D20210102-20210210"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzQ1MQ_050a305f-ff4d-4c7f-9286-0412bca8b15b"
      unitRef="usdPerShare">115.98</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i76ba37986e6d4a12be3157c80c387fc9_I20191104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzEyNzM_cf91c5a2-e8cb-4dd6-aca0-93312fce8f0d"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i105b8a0db46c4b329658833071e7f412_I20201210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI3NDg3NzkwNzQwMDg_8a3ae155-eba1-4935-a43e-128e674a210a"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i7083b873e21941ca8755a4ceb7aeeac8_I20210210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzE2ODY_c9b3b85d-53c8-466d-bea7-7c2f4f6ec004"
      unitRef="usd">1806674000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzI2NTI_b8254410-4efb-47aa-8853-b4f1fb154882"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <dva:PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzMwNTk_42a82e54-b06f-40ed-a1b1-9e5726256ec9">P3Y</dva:PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation>
    <dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM2MDQ_8ac6d190-5f88-47db-a58e-44a256bcaaba">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of changes in DaVita Inc.&#x2019;s ownership interests in consolidated subsidiaries on the Company&#x2019;s consolidated equity were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in paid-in capital for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales of noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers in noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc. net of transfers in &lt;br/&gt; noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzItMS0xLTEtMA_49b3f939-8a4e-49e0-8c33-015cd43da6dd"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzItMy0xLTEtMA_da85b60e-970d-4c64-b2c8-90f1de7a8e3e"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzItNS0xLTEtMA_c031532e-8ec8-445a-9e55-ade6a86c5321"
      unitRef="usd">159394000</us-gaap:NetIncomeLoss>
    <dva:NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMS0xLTEtMjI1MDA_a331dcb1-5b43-4698-9d14-16d95cc553de"
      unitRef="usd">4364000</dva:NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMy0xLTEtMjI1MDA_d9351166-037a-475a-8fc3-1ccd5ee3339c"
      unitRef="usd">37145000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtNS0xLTEtMjI1MDA_a34228ba-5650-4e9e-ab4c-fea4dfab7ff7"
      unitRef="usd">17897000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMS0xLTEtMA_77508a89-c107-46eb-aebb-b0d692d0ee0b"
      unitRef="usd">0</dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests>
    <dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtMy0xLTEtMA_68ee067e-49a6-455f-b95a-747a52d46eb4"
      unitRef="usd">0</dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests>
    <dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzQtNS0xLTEtMA_8fbdbc86-b341-40f3-a0ab-ca6eaec32896"
      unitRef="usd">79000</dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzYtMS0xLTEtMA_623be55d-3096-46ca-b09f-51c95ba9faf4"
      unitRef="usd">4364000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzYtMy0xLTEtMA_ae492ad2-9aa2-41d9-8174-5eceb781dce6"
      unitRef="usd">-37145000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzYtNS0xLTEtMA_7f2aadfc-d8c3-4bd7-8e5a-d5cfa949661f"
      unitRef="usd">-17818000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests
      contextRef="ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzctMS0xLTEtMA_e42d922e-600d-4526-862f-810c58bce52f"
      unitRef="usd">778006000</dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests>
    <dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests
      contextRef="i193dba70c11d45c2b503fae471187a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzctMy0xLTEtMA_bf1449e4-dca2-4e03-a6f0-dbbd5fe3563d"
      unitRef="usd">773836000</dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests>
    <dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests
      contextRef="i97bf84e224274228af4b5a7acbd187b5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90YWJsZTplOGJjMmY3OTUwMmE0YzAwOThmYWM5MjcyNjA1MzU4My90YWJsZXJhbmdlOmU4YmMyZjc5NTAyYTRjMDA5OGZhYzkyNzI2MDUzNTgzXzctNS0xLTEtMA_4c10d7b7-7b2f-45c8-89d9-1a92a11147fe"
      unitRef="usd">141576000</dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM1NTY_d6e4067d-5dfc-41a7-9ee5-f09be0bb066d"
      unitRef="usd">7831000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM1NjA_adc7d974-8e55-489b-9df8-89964ba55e3c"
      unitRef="usd">68019000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yNzQvZnJhZzphYzc1MTJmNWRkYTk0ZTI1OWVkY2YwZGIzNjcwNzk0Yi90ZXh0cmVnaW9uOmFjNzUxMmY1ZGRhOTRlMjU5ZWRjZjBkYjM2NzA3OTRiXzM1Njg_ee948ebc-a36d-424a-96c4-3d45f7ba5b3a"
      unitRef="usd">28082000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90ZXh0cmVnaW9uOmQ1N2ZlOTFmM2NlMzQ3OTRiYzIyNWY1ZmY3YjE0ZDcyXzEwMjk_c6084ccc-5b05-45a7-9742-1df5b93e6731">Accumulated other comprehensive (loss) income&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges and credits to other comprehensive (loss) income have been as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;br/&gt;cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investment&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated other&lt;br/&gt;comprehensive&lt;br/&gt;(loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect of change in accounting principle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of income (loss) into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Reflects the cumulative effect of a change in accounting principle for ASUs 2016-01 and 2018-03 on classification and measurement of financial instruments and ASU 2018-02 on remeasurement and reclassification of deferred tax effects in accumulated other comprehensive income associated with the 2017 Tax Act. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reclassification of net cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income. See Note 13 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90ZXh0cmVnaW9uOmQ1N2ZlOTFmM2NlMzQ3OTRiYzIyNWY1ZmY3YjE0ZDcyXzEwMzI_3acbc361-3ddd-49ae-9bac-98efae40fe8a">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges and credits to other comprehensive (loss) income have been as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;br/&gt;cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investment&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated other&lt;br/&gt;comprehensive&lt;br/&gt;(loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect of change in accounting principle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of income (loss) into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)Reflects the cumulative effect of a change in accounting principle for ASUs 2016-01 and 2018-03 on classification and measurement of financial instruments and ASU 2018-02 on remeasurement and reclassification of deferred tax effects in accumulated other comprehensive income associated with the 2017 Tax Act.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="ib85e3af4c76943dfb45faef356b1edb8_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtMS0xLTEtMA_2a21b084-7a99-4ef5-b7cb-66814a664af1"
      unitRef="usd">-12408000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia09cc0ebe548468cb11bfb4a15f51203_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtMy0xLTEtMA_067564f0-5bf5-441b-a381-987b4ce28100"
      unitRef="usd">5662000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e4cffaa726b44c38a7415a3a0c9e4a9_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtNS0xLTEtMA_d4087b75-720a-4e31-b42e-98aa8b27dee7"
      unitRef="usd">19981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2aee781d32fe49c2bb5de5584a9e35d2_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEtNy0xLTEtMA_a7709c2f-f0e9-442f-8590-bd6cf9bfc818"
      unitRef="usd">13235000</us-gaap:StockholdersEquity>
    <dva:CumulativeEffectOfChangeInAccountingPrinciple
      contextRef="id982bc2b303943b3a1f13e6fa0132c37_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMS0xLTEtMTY5_cb07b350-7aa2-4dfa-a84a-9e11f4823d97"
      unitRef="usd">-2706000</dva:CumulativeEffectOfChangeInAccountingPrinciple>
    <dva:CumulativeEffectOfChangeInAccountingPrinciple
      contextRef="id91bd7812fa548a7aeaa626e95f390fa_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMy0xLTEtMTY5_fbb9dc52-decb-4734-aa68-b1679c9105c3"
      unitRef="usd">-5662000</dva:CumulativeEffectOfChangeInAccountingPrinciple>
    <dva:CumulativeEffectOfChangeInAccountingPrinciple
      contextRef="i0dc3a6ff6bb04c1e93904bc9ac788525_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNS0xLTEtMTY5_d5ec23e8-d13e-4378-a55e-45de335b40b7"
      unitRef="usd">0</dva:CumulativeEffectOfChangeInAccountingPrinciple>
    <dva:CumulativeEffectOfChangeInAccountingPrinciple
      contextRef="if2676db50d104876ba6149c180d0549c_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNy0xLTEtMTY5_addaf7ad-4e35-4571-b40a-66064ada8331"
      unitRef="usd">-8368000</dva:CumulativeEffectOfChangeInAccountingPrinciple>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMS0xLTEtMA_17e8e6ce-e321-4763-8b85-bbcf2479555a"
      unitRef="usd">-181000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItMy0xLTEtMA_be1ee216-0ae9-44a1-808b-f08050205341"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNS0xLTEtMA_c5be59ee-1776-44d3-acc3-60fa31ae023e"
      unitRef="usd">-45944000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzItNy0xLTEtMA_de5350cb-77be-419c-b1ad-75f2a042613b"
      unitRef="usd">-46125000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtMS0xLTEtMA_f3644889-a071-41d6-9341-c3cad2d8767b"
      unitRef="usd">-48000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtMy0xLTEtMA_9e211d0d-cf4d-4cee-9011-d6252f4c52a7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtNS0xLTEtMA_2af9a6ef-4fc2-448e-bb0c-060233dcd19d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzMtNy0xLTEtMA_6f2c8299-b7ce-4bcc-b4c1-ee2f6fe69644"
      unitRef="usd">-48000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtMS0xLTEtMA_8b80aa20-4b4c-4998-8584-effced2392ed"
      unitRef="usd">-133000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtMy0xLTEtMA_6a4db024-862c-40a9-8600-4de116252352"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtNS0xLTEtMA_8ebae5d5-9f2e-4864-917b-d87e0f521ce2"
      unitRef="usd">-45944000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzQtNy0xLTEtMA_99d2da2e-4cdb-4d4f-9d30-b82a0f4fedbc"
      unitRef="usd">-46077000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtMS0xLTEtMA_8947f0bd-92d7-4284-a1e9-3424be499e53"
      unitRef="usd">8466000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtMy0xLTEtMA_1ea8e127-a369-417b-b9ad-ff0e7471d335"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtNS0xLTEtMA_649f77e7-f5a4-41ea-a640-669c96482586"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzUtNy0xLTEtMA_40e9df8c-5559-4d7e-9b0b-8d24b4d07c50"
      unitRef="usd">8466000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtMS0xLTEtMA_9000a253-018b-4a42-9c89-85d947b29708"
      unitRef="usd">2180000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtMy0xLTEtMA_16540359-05f6-45a9-a34e-daa294972fea"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtNS0xLTEtMA_ad3019d6-b098-4e8e-89d6-be89cc33f949"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzYtNy0xLTEtMA_785e56de-23a5-4094-a565-dd8d7157f930"
      unitRef="usd">2180000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="if37eb327d75e4782b79c61b8e3fe79a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctMS0xLTEtMA_88987a12-3879-49a8-9846-1c77ba59d113"
      unitRef="usd">6286000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i08df583a464c4af7831803cbb70ef3dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctMy0xLTEtMA_2dd09655-49bb-4b4e-99d6-3a052d4668d4"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ib4c1d03af4744c68840212394d89b48a_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctNS0xLTEtMA_6691f60c-1277-4ca8-bb6f-fe989b360b37"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i55f8cac7642b4008b10b8c8e5fd907bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzctNy0xLTEtMA_bb838981-b962-4cac-a41c-d5d14df5da39"
      unitRef="usd">6286000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i1d0662ace310459d8294892cb68ab800_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtMS0xLTEtMA_7fb82938-fad7-438f-a8b4-87e8cbf99ab3"
      unitRef="usd">-8961000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id3eda312133844699a6a4a94669d3aa9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtMy0xLTEtMA_c6dc6f71-be0e-4544-87c2-064dbc2ca3ff"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c7b5073da4b446ea0318c702a7868ed_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtNS0xLTEtMA_3febc597-02ef-4874-8d92-85b9228016b5"
      unitRef="usd">-25963000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i16e862399f5a48ab8399e8f0cdb32c64_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzgtNy0xLTEtMA_bdf08d62-1402-45d1-bdeb-94d538798d3c"
      unitRef="usd">-34924000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTEtMS0xLTA_c3a80f60-b9e1-459a-8062-4f7ec7dbcd5f"
      unitRef="usd">1566000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTMtMS0xLTA_d1128f48-a57e-4ccb-9d73-88e3f5cbb617"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTUtMS0xLTA_e786bda9-9302-492e-90a8-6371b12d3fda"
      unitRef="usd">-20102000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEwLTctMS0xLTA_3ae4bdce-dd72-4a2b-a95c-3ba756cc2e7f"
      unitRef="usd">-18536000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTEtMS0xLTA_31f1757a-f58e-4e3f-9f31-a4f0d55ce9a6"
      unitRef="usd">415000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTMtMS0xLTA_a2644254-a15a-47ba-a35b-a0396c05d2e9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTUtMS0xLTA_d1e8fbdb-4380-4735-9d05-5a3e46c4d4ad"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzExLTctMS0xLTA_ae792af7-78e6-40eb-ad12-54f4ea90a387"
      unitRef="usd">415000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTEtMS0xLTA_8b96e580-2819-482a-8ca8-7d91dbe80024"
      unitRef="usd">1151000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTMtMS0xLTA_f3dddf77-c785-4247-b506-c2bc00d718ec"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTUtMS0xLTA_cc3fe3bc-fa8f-4702-a428-437f257cbd56"
      unitRef="usd">-20102000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEyLTctMS0xLTA_a030b759-718f-41a8-9815-a793dd43f1df"
      unitRef="usd">-18951000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTEtMS0xLTA_9ab7dc13-441e-4d7b-8c80-ce4466d8e55f"
      unitRef="usd">8591000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTMtMS0xLTA_5a52679f-a8af-4db6-8440-9bd28aa475dc"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTUtMS0xLTA_54c642b3-595e-4c8d-8b3f-e13f5e9c532e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzEzLTctMS0xLTA_b80fd2d3-fdc1-4e2e-833c-1f999468d687"
      unitRef="usd">8591000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTEtMS0xLTA_0dd7ecf5-a7fe-490b-8569-f5c65fdb7a80"
      unitRef="usd">2214000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTMtMS0xLTA_99c61e44-a83c-4c5b-9084-0ce7882c9531"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTUtMS0xLTA_bc346c90-115b-4de9-9943-79997958bb83"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE0LTctMS0xLTA_caed6add-3f8b-4476-b180-3c293ae9a0b8"
      unitRef="usd">2214000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i430e67c53dba4d2f8c7b2488541c7fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTEtMS0xLTA_49153cd2-cb8e-4c89-bbac-77799ce8a1a0"
      unitRef="usd">6377000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i899ef69b0474468086ce98c0b9cec1d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTMtMS0xLTA_71a331d3-341b-4b05-87cb-2511a28d5900"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ieeb340010d304efbbfd9f9f39a540ebc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTUtMS0xLTA_e973d6fe-1e0f-4d83-acb3-ceaf7fe08f5e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ia599ef6c74f644909f22c2f246d13054_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE1LTctMS0xLTA_f7ee7043-a613-4884-9093-00f437cbc856"
      unitRef="usd">6377000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i400ae66383684fca86f44ab51c352938_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTEtMS0xLTA_4c3090c6-be1b-4596-bb8f-9de39c588a78"
      unitRef="usd">-1433000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie318599ad486430586f67152fedcd6e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTMtMS0xLTA_85385573-87d7-4910-a423-7e33c36aa8be"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c60b527bad44f338d70eaf4c922c693_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTUtMS0xLTA_04628b03-f897-4d6a-9ae7-ec603ebd49c7"
      unitRef="usd">-46065000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4353b1da6dea495987a98903f6f24d81_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE2LTctMS0xLTA_ca9810e2-aa95-4297-a6dc-90b0170568ee"
      unitRef="usd">-47498000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTEtMS0xLTA_26f3f871-303b-4231-8d94-60cc993e0cb1"
      unitRef="usd">-21781000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTMtMS0xLTA_3fb4da0d-bd62-4355-9440-e90320a5a482"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTUtMS0xLTA_b5bdea44-38dd-4ffb-9f04-149790707cd6"
      unitRef="usd">-7080000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE3LTctMS0xLTA_76587db3-3c3a-4f2b-bdea-240214628420"
      unitRef="usd">-28861000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTEtMS0xLTA_3d416f78-685d-4cfe-8c5e-72653b0325b8"
      unitRef="usd">-5435000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTMtMS0xLTA_44ad8905-a56b-4e02-bc2d-895a0bc5c9bf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTUtMS0xLTA_3bab1749-997e-41d2-bcef-092e7f3427b9"
      unitRef="usd">543000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE4LTctMS0xLTA_07b45f2b-64e9-4b3e-879a-3afb82cb40ff"
      unitRef="usd">-4892000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTEtMS0xLTA_79eb3e7f-4610-42d1-98c6-b333cafd907f"
      unitRef="usd">-16346000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTMtMS0xLTA_29e2142f-7027-4a1d-b2d1-c97f1725f354"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTUtMS0xLTA_150cab59-c830-4a5d-865f-c0272c7c39d5"
      unitRef="usd">-7623000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzE5LTctMS0xLTA_3f787f29-b5a2-470d-a53c-c97f8ba0ca7e"
      unitRef="usd">-23969000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTEtMS0xLTA_ec619f42-3802-4626-9381-58dd44a7dd52"
      unitRef="usd">7081000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTMtMS0xLTA_04451989-d4af-4fa3-8398-19b3d2344d44"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTUtMS0xLTA_cfe06f1f-cb35-42fb-a5c2-fb4b7385f99d"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIwLTctMS0xLTA_5a718975-70e4-4b21-9559-db75e12dab62"
      unitRef="usd">7081000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTEtMS0xLTA_ba66ab1a-fa55-4aae-8d46-0534a56d72b8"
      unitRef="usd">1768000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTMtMS0xLTA_e63c9c68-a4a7-4fe1-8c68-233e4a7b48fa"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTUtMS0xLTA_aa56e290-afc9-48ee-a37e-70d83aa809ea"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIxLTctMS0xLTA_71079ea4-7242-442a-8d67-7e866f823f46"
      unitRef="usd">1768000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="id8752880e5fc4af6b6b88862889d8e08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTEtMS0xLTA_ee7a5736-987e-4acd-b566-c441a16f1592"
      unitRef="usd">5313000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i4cc1f6a634e8410b9096f76c05b8fc0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTMtMS0xLTA_fdd4ca66-5fb9-4226-82f3-7d67bbd3991b"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i380e6d3651cb4deebc38af65ebf053af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTUtMS0xLTA_11107b52-4af4-425d-aad6-b8d727354f40"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ie84fc7cfde2446fa9151edb58a71b609_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIyLTctMS0xLTA_e7a3ee39-e239-48d2-acd5-1ba0cc43fe4c"
      unitRef="usd">5313000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <dei:DocumentPeriodEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTAtMS0xLTA_e532e401-901f-487f-9de3-636e5887c95c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTAtMS0xLTA_b287dfea-b6e4-4a51-8e4d-99124aea44a9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:StockholdersEquity
      contextRef="ifa528156b4734e65b6f4086215f035cf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTEtMS0xLTA_8c670239-047d-419d-808d-ed45ec55a12c"
      unitRef="usd">-12466000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41c844e403784223aaf6cd1848e6ab04_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTMtMS0xLTA_fa0b9734-aecb-4693-915e-005be8e11869"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i121893f4c40449a89e600dbe09cccfb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTUtMS0xLTA_f698541e-d707-46f2-bc2c-c6918c05c186"
      unitRef="usd">-53688000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f863d3dd90b4b01b6b02423feddcd8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90YWJsZToyOTlmYzc2Mzg1M2U0ZjVlODEzYjg3YjM1Mjg1MzQ0ZC90YWJsZXJhbmdlOjI5OWZjNzYzODUzZTRmNWU4MTNiODdiMzUyODUzNDRkXzIzLTctMS0xLTA_08682bce-96a4-4d4c-83c9-f5d13b0cde24"
      unitRef="usd">-66154000</us-gaap:StockholdersEquity>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODAvZnJhZzpkNTdmZTkxZjNjZTM0Nzk0YmMyMjVmNWZmN2IxNGQ3Mi90ZXh0cmVnaW9uOmQ1N2ZlOTFmM2NlMzQ3OTRiYzIyNWY1ZmY3YjE0ZDcyXzEwMjc_f1ee24a2-9ca3-4b6f-b84f-7c14d7cb3e73">The reclassification of net cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3NjM_67e304fe-239a-4c98-8cb3-8a08c6840cd4">Acquisitions and divestitures&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Routine acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company acquired eight dialysis centers in the U.S. and 66 dialysis centers outside the U.S. for a total of $182,013 in net cash, earn-outs of $14,042 and deferred purchase price and liabilities assumed of $20,415. The Company also recognized a non-cash gain of $1,821. During 2019, the Company acquired seven dialysis centers in the U.S. and 16 dialysis centers outside the U.S. for a total of $98,836 in net cash, earn-outs of $23,536, and deferred purchase price and liabilities assumed of $4,326. During 2018, the Company acquired 18 dialysis centers in the U.S. and 28 dialysis centers outside the U.S. for a total of $176,161 in net cash, earn-outs of $1,246 and deferred purchase price of $34,394. In one of these 2018 transactions the Company acquired a controlling interest in a previously nonconsolidated U.S. dialysis partnership for which the Company recognized a non-cash gain of $28,152 on its prior interest upon consolidation. The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#x2019;s financial statements, as are their operating results, from the designated effective dates of the acquisitions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. For several of the 2020 acquisitions, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, leases and certain other working capital items relating to several of these acquisitions are pending final quantification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2020, 2019 and 2018, as well as goodwill deductible for tax purposes associated with these acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average estimated useful lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill deductible for tax purposes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pro forma financial information (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2020 and 2019 had been consummated as of the beginning of 2019, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,636,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,570,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma net income from continuing operations attributable to&lt;br/&gt; DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma basic net income per share from continuing operations&lt;br/&gt; attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma diluted net income per share from continuing operations&lt;br/&gt; attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale of RMS Lifeline&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company divested its vascular access business, RMS Lifeline, Inc., effective May 1, 2020 and recognized a loss on sale of approximately $16,252.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired companies a total of up to approximately $42,378 if certain performance targets or quality margins are met over the next one year to five years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. See Note 24 for further details. As of December&#160;31, 2020, the Company estimated the fair value of these contingent earn-out obligations to be $30,248, of which a total of $13,025 is included in other current liabilities, and the remaining $17,223 is included in other long-term liabilities in the Company&#x2019;s consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2020 and 2019:&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments or other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ifa2af9b4b56d4ea9bd2ee38a1c474653_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzky_d98b2999-b1d9-4a67-8d0f-4311eda52c3a"
      unitRef="clinic">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i211344fc537744f5a1e5ca5d7a509101_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEyOA_07e08197-b754-4b2c-9761-8430395c5965"
      unitRef="clinic">66</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzE4MA_c7d41637-4000-4378-aa73-47705d3fee50"
      unitRef="usd">182013000</us-gaap:PaymentsToAcquireBusinessesGross>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3Mzcx_5789110f-f1d2-4961-bc1c-bc30d7765975"
      unitRef="usd">14042000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3NDA3_4f40dee8-fe8f-4479-bec5-00d4617ba4bf"
      unitRef="usd">20415000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="ia580decb8e4f448183406ca43a9601f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3MzUy_501a9791-da1d-4f8b-96f5-f108c5fdf102"
      unitRef="usd">1821000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i34eb33d6da174197975f748888e130fa_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzMwOQ_b372c5e8-a979-462f-b303-a563d52342c9"
      unitRef="clinic">7</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ib5bdaf5b8e324f16af4b2af8e8b5cea5_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzM0NQ_650ba5a8-2942-4f81-8ad5-e93316df8315"
      unitRef="clinic">16</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzM5Nw_c1daba30-d7de-419b-a303-b042966a06b5"
      unitRef="usd">98836000</us-gaap:PaymentsToAcquireBusinessesGross>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQyNg_eca1c315-78be-4d7b-a484-da00da84293b"
      unitRef="usd">23536000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i24a609545a8141fcb0326d0579b2a567_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ4NQ_33ebd42d-bd33-40a8-b763-3598a80190ba"
      unitRef="usd">4326000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ife8b48f4488041a98b5163ddacda7b3d_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzM4NDgyOTA3MDIwMDM_cfab6c47-b1ff-46bb-98fd-9fe77e820379"
      unitRef="clinic">18</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i42771298d95c4449aba8f0b634283f8a_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzc4NQ_a89ac141-b70c-44cb-8d10-53d57f75781a"
      unitRef="clinic">28</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibbedb04193324daca88f65acd841b435_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzgzNw_3b363021-9b66-4725-bfa7-3d3cd4a1bf44"
      unitRef="usd">176161000</us-gaap:PaymentsToAcquireBusinessesGross>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="ibbedb04193324daca88f65acd841b435_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzg2Ng_f9efc9f3-87f1-4f20-9e84-cea217dc7803"
      unitRef="usd">1246000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ibbedb04193324daca88f65acd841b435_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzkwMA_56b1cc59-ba9e-4518-b06d-f8557875cf56"
      unitRef="usd">34394000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzEzNzQzODk1MzU3Mjg1_8e176ddf-7351-4b24-b3f5-fb9c2a33249f"
      unitRef="usd">28152000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3NzY_d9756524-ac9b-4caa-8bd4-4d5adf0edfb0">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzItMS0xLTEtMA_6b436cc5-6344-402d-8c86-395ceb9eaed4"
      unitRef="usd">23607000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzItMy0xLTEtMA_635a8168-a5a5-4ec5-9a0a-ba34bb118d16"
      unitRef="usd">6713000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzItNS0xLTEtMA_87b55bd8-c418-4456-a1ce-b1ee86da39ad"
      unitRef="usd">23686000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzMtMS0xLTEtMA_da6ec03b-8c1f-4ca9-9923-dbc85856540e"
      unitRef="usd">37457000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzMtMy0xLTEtMA_695afd81-4980-4950-a9d4-d140f001f32b"
      unitRef="usd">4842000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzMtNS0xLTEtMA_0c461315-7824-4737-8b60-b796bab40b0e"
      unitRef="usd">11421000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMS0xLTEtMTc4MTE_17aaa1c3-da4b-44d6-b09a-667c048542d3"
      unitRef="usd">34625000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMy0xLTEtMTc4MTE_1d6d1096-9076-4ee6-80b9-6f2eacac57ff"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtNS0xLTEtMTc4MTE_2e56a9e6-33f6-4256-8e0b-9285398ce821"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMS0xLTEtMA_3c37d7e4-4da4-46f7-9f74-c43df0026413"
      unitRef="usd">10168000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtMy0xLTEtMA_41b7f70a-5de8-440f-a008-898b6e79ae9b"
      unitRef="usd">1980000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzQtNS0xLTEtMA_e5a33223-5cdc-4c86-98ae-64b9ab1af187"
      unitRef="usd">3079000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzUtMS0xLTEtMA_af6925e3-f39b-441f-b501-8a9768306052"
      unitRef="usd">22136000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzUtMy0xLTEtMA_8668727a-957b-414c-859e-10e74c8b0734"
      unitRef="usd">31858000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzUtNS0xLTEtMA_19c365ca-8f48-4e33-8635-6fff9fa94542"
      unitRef="usd">23656000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzYtMS0xLTEtMA_4dc0b9c2-c5b7-4678-8f6f-47170f63dba4"
      unitRef="usd">130057000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzYtMy0xLTEtMA_47466e56-9fb6-4f65-aa09-e751ceddc763"
      unitRef="usd">90226000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzYtNS0xLTEtMA_b453d2c9-8b6e-4b4c-b02a-603ef1f32ac6"
      unitRef="usd">278348000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzctMS0xLTEtMA_d267f1bb-1b8e-4869-a309-f7293aad7ed0"
      unitRef="usd">3962000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzctMy0xLTEtMA_609d31cd-1fe3-4626-ac36-250a11f35a5d"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzctNS0xLTEtMA_31b5ca54-2638-46dc-840f-c13c9537ddba"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMS0xLTEtNDM3Nw_29f67ff9-085f-48d8-8330-17e2a8549bcf"
      unitRef="usd">34068000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMy0xLTEtNDM3Nw_4eeff56d-a37c-455d-89c1-d6c033a18b3b"
      unitRef="usd">7159000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtNS0xLTEtNDM3Nw_532f6996-dfac-4a03-95cf-bb834264e440"
      unitRef="usd">19946000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMS0xLTEtMA_a14dd876-ddb6-4395-967f-0990ec0240ff"
      unitRef="usd">1729000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtMy0xLTEtMA_ef193fb0-b058-4e2e-bff3-8d6dbf524e60"
      unitRef="usd">1762000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzgtNS0xLTEtMA_c9a8da97-6d0d-46cb-99a6-7da7134eff01"
      unitRef="usd">80291000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzEwLTEtMS0xLTA_169ece30-a9fd-484d-acca-154b1d260865"
      unitRef="usd">218291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzEwLTMtMS0xLTA_5c8d63ae-aacb-4197-bebf-84fb27e859f8"
      unitRef="usd">126698000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTowZWI0NDVjZTc1NWU0ZGQzYWFjYjc4OTAxNTJlZmYyYS90YWJsZXJhbmdlOjBlYjQ0NWNlNzU1ZTRkZDNhYWNiNzg5MDE1MmVmZjJhXzEwLTUtMS0xLTA_0ecffd3b-b457-4e50-a04c-9f5fa5669921"
      unitRef="usd">239953000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzI4MDM3NTQ2NTE3MTk1_aed1a98a-ab14-415d-84be-d002eb010820">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2020, 2019 and 2018, as well as goodwill deductible for tax purposes associated with these acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average estimated useful lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill deductible for tax purposes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i19715ea7c0d44a94b2cc8fb506d311dc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzMtMS0xLTEtMTM3MDg_6348c9c7-e716-4d97-aa6d-6475dddae203">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8a352df164304776a46c85b682e9ab80_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzMtMy0xLTEtMTM3MDg_1e07f1b1-9793-48fd-9e4a-b153275450eb"
      xsi:nil="true"/>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i13fc6ded13df4a0880a140b68e18899f_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzMtNS0xLTEtMTM3MDg_2a5587ab-a85b-4c47-b3d8-e1e2e55e9238"
      xsi:nil="true"/>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8030b65740034eaa9eae02d95f2133a1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzQtMS0xLTEtMTM3MDg_272a82d1-6c46-4885-974f-eef7d88d864f">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if04951c8b4f5456da29bb184a415e56e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzQtMy0xLTEtMTM3MDg_d4ca578c-e2fa-499b-8c64-7b016fd89e0b">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id643d82f1c0c49a58e67abb271a5f89b_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzQtNS0xLTEtMTM3MDg_247ce493-65df-4d1b-9106-79246cc93f3d">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i7dc49d84a9614fb89eb7381fb55a24ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzYtMS0xLTEtMTM3MDg_c3c7b6ed-dea0-4184-856d-99ebb45dfd6b"
      unitRef="usd">94318000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i8ffcc4ae070e4183aea32935e65560e6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzYtMy0xLTEtMTM3MDg_51d5f2b3-cc93-48cd-8b21-679245ee8afe"
      unitRef="usd">88517000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i9fe2c2378655447c9ff1bb02277688af_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZToyM2Q3M2VhNGE5ZTE0ZjY3OGRkNzM3NWNlOWJhMWQ0MS90YWJsZXJhbmdlOjIzZDczZWE0YTllMTRmNjc4ZGQ3Mzc1Y2U5YmExZDQxXzYtNS0xLTEtMTM3MDg_cb3f7987-5a6d-4f06-8929-95879fb2587c"
      unitRef="usd">165013000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3NjI_8284394d-2ca8-4f6d-9713-5f38419b8163">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2020 and 2019 had been consummated as of the beginning of 2019, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,636,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,570,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma net income from continuing operations attributable to&lt;br/&gt; DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma basic net income per share from continuing operations&lt;br/&gt; attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma diluted net income per share from continuing operations&lt;br/&gt; attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzMtMS0xLTEtMA_21ed7f2a-fee2-4da8-9651-7a29384d7ead"
      unitRef="usd">11636416000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzMtMy0xLTEtMA_c353dfbd-f125-43d3-a8c1-bc49cc25a36d"
      unitRef="usd">11570086000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzQtMS0xLTEtMA_3a8a4dec-92bf-4b8d-9aa7-54f2eefa0d2f"
      unitRef="usd">789473000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzQtMy0xLTEtMA_59f732ad-fbb0-4f40-8cf1-1d2cc9dda6d9"
      unitRef="usd">718928000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzUtMS0xLTEtMA_c26b905e-587c-4708-b020-942be5df6f72"
      unitRef="usdPerShare">6.59</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzUtMy0xLTEtMA_ef842354-712c-46fc-87a1-2f184d5363ba"
      unitRef="usdPerShare">4.69</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzYtMS0xLTEtMA_90ab8ef8-cdb0-4d2c-97ff-ac94d00fe042"
      unitRef="usdPerShare">6.44</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTo5ZWYyNDA2MTVlMGE0OWViODMxZjQ0YTRjNjNhMzdhOS90YWJsZXJhbmdlOjllZjI0MDYxNWUwYTQ5ZWI4MzFmNDRhNGM2M2EzN2E5XzYtMy0xLTEtMA_35f40ce2-4654-42f1-90b3-6285cc30842a"
      unitRef="usdPerShare">4.67</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i61c7d20749714b578bd03a14636c3b75_D20200501-20200501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzI3NDg3NzkwNzc2MTY_306b05a2-481d-45ac-af1d-8beea9661036"
      unitRef="usd">-16252000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQwNDg_af543002-8065-404b-8abf-0f4af6d37c29"
      unitRef="usd">42378000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="ifd580bc9f0ce4f48a42dcff947bb8c76_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQxMjM_8b82a977-60e6-4528-9d4d-0daddc771fe7">P1Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="if69af729580f4423a3ac3716ba3c2db6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQxMjk_c69e7d22-d15c-4cab-bfcb-6dbab7cb222c">P5Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i786a553c52f743c5b1b4a38214be1b9b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ0NjE_3dd28922-f11b-47b0-8112-af23e01fd36c"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i6e92165fc1424a7ba5419b7bb4e85b10_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ0ODU_48a38dd0-b22d-4512-82c9-d03b8d191a39"
      unitRef="usd">13025000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i707d83d1d9eb45bbaa369393203a03a6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ1NDg_fa484d79-257c-45dd-8ed0-4d99a13e906e"
      unitRef="usd">17223000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90ZXh0cmVnaW9uOjBjZjQ1YjU2ODNhMTQzODc5OTMyODc4NGY2OWQzY2RiXzQ3Nzk_80817a14-e758-449e-81e3-24efe09c922a">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2020 and 2019:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments or other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzAtMS0xLTEtMA_89befc74-3429-44e9-a811-56b8e20b64a2"
      unitRef="usd">24586000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4ebe7ed535ef4f93a64f12f3e3aa02fb_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzMtMy0xLTEtMTIxNDY_66e51477-f31d-40d4-aa00-b4a71af199ee"
      unitRef="usd">2608000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzEtMS0xLTEtMA_f20cb794-9fa1-4afc-a33f-da797edfee63"
      unitRef="usd">14042000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzQtMy0xLTEtMTIxNDY_e8059e82-0bde-4ec8-b4e9-0c6826ee1448"
      unitRef="usd">23536000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzItMS0xLTEtMA_18c66717-5da9-40c6-bd4b-d46b001cd364"
      unitRef="usd">3688000</dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations>
    <dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzUtMy0xLTEtMTIyMjI_de149e5d-de04-4e1a-9811-69dccf385f4d"
      unitRef="usd">905000</dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzMtMS0xLTEtMA_858afa11-cbd4-48a0-9bb4-6d6c10b201c5"
      unitRef="usd">2630000</dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzYtMy0xLTEtMTIxNDY_5426ef53-8fce-431b-b349-b3fcab1aa142"
      unitRef="usd">-121000</dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzQtMS0xLTEtMA_8d7a470a-acb3-471e-a4a7-fbc2414482ff"
      unitRef="usd">2062000</dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzctMy0xLTEtMTIxNDY_9e1b1d7d-8a2f-4ef4-9dc4-95f16579b5b1"
      unitRef="usd">774000</dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzUtMS0xLTEtMA_63a67fda-0d35-45d1-b288-9bb16fe55fbf"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODMvZnJhZzowY2Y0NWI1NjgzYTE0Mzg3OTkzMjg3ODRmNjlkM2NkYi90YWJsZTplNGI1NTA4M2YwY2Y0Zjk1Yjc2ZTlmOWM3OTc3NGVjMC90YWJsZXJhbmdlOmU0YjU1MDgzZjBjZjRmOTViNzZlOWY5Yzc5Nzc0ZWMwXzgtMy0xLTEtMTIxNDY_3ffd3efa-dd3e-49b4-b0f5-8924e05fc9ca"
      unitRef="usd">24586000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzODQ_3c8df3e7-c1d1-4314-aff9-84701de0ad61">Discontinued operations previously held for sale&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DaVita Medical Group (DMG)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;19, 2019, the Company completed the sale of its DMG business to Optum, a subsidiary of UnitedHealth Group Inc., for an aggregate purchase price of $4,340,000, prior to certain closing and post-closing adjustments specified in the related equity purchase agreement dated as of December&#160;5, 2017, as amended as of September 20, 2018 and as of December 11, 2018 (as amended, the equity purchase agreement).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a preliminary estimated pre-tax net loss of approximately $23,022 on the sale of its DMG business in 2019. This preliminary net loss was based on initial estimates of the Company's expected aggregate proceeds from the sale, net of transaction costs and obligations, as well as the estimated values of DMG net assets sold as of the closing date. Those estimated net proceeds included $4,465,476 in cash received from Optum at closing, or $3,824,509 net of cash and restricted cash included in the DMG net assets sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement. In the fourth quarter of 2020, the Company and Optum reached agreement on the final purchase price for the DMG sale, which resulted in an additional payment by the Company to Optum of $47,000 and an additional loss on sale of $17,976. In the first quarter of 2020, the Company recognized $9,980 in additional tax benefits under the Coronavirus Aid, Relief and Economic Security Act related to its period of DMG ownership, which were also recognized as an adjustment to the Company's loss on sale of the DMG business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the equity purchase agreement, the Company also has certain continuing indemnification obligations that could require payments to the buyer relating to the Company's previous ownership and operation of the DMG business. Potential payments under these provisions, if any, remain subject to continuing uncertainties and the amounts of such payments could be significant to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the financial results of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,963,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,962,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation adjustment on disposal group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on sale of discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(457,038)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cash flows of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:294.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash used in investing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DMG acquisitions&lt;/span&gt;&lt;/div&gt;During the period from January 1, 2019 to June 18, 2019 immediately prior to the sale, the DMG business acquired two medical businesses for a total of $2,025 in net cash and deferred purchase price of $212. During 2018, the DMG business acquired other medical businesses for a total of $6,995 in net cash and deferred purchase price of $1,142</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1
      contextRef="iab59816d75634fd58eaaa890c090532b_D20190619-20190619"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2Xzg4_57674c38-c054-45ed-8876-73d602fb4a34">2019-06-19</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <dva:PurchaseAndSaleAgreementAggregatePurchasePrice
      contextRef="iab59816d75634fd58eaaa890c090532b_D20190619-20190619"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIyOQ_4a0f5414-55d6-4c7a-b382-e3ad5ec20835"
      unitRef="usd">4340000000</dva:PurchaseAndSaleAgreementAggregatePurchasePrice>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="ia2343e73177c4a59a625d97fd537e0a2_D20171205-20171205"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzM1MA_969bbd09-4493-4ace-8439-fa7c426b7b09">2017-12-05</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzU0Mg_a1063a42-d7e7-42cf-8af3-cdcfb49057a9"
      unitRef="usd">23022000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i9577f3ef1df845c38e9359052401de77_D20190619-20190619"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2Xzg2MA_b354eddb-593a-4879-9d97-5583cf259976"
      unitRef="usd">4465476000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i9577f3ef1df845c38e9359052401de77_D20190619-20190619"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzkwNg_d544ccb0-8801-4b46-b767-d19c78977d68"
      unitRef="usd">3824509000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <dva:AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice
      contextRef="if4ad841931d5470f881644ba3f00c2c2_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzI3NDg3NzkwNzUxNDY_6e1be959-bb8a-4dca-840d-fe0d19b40538"
      unitRef="usd">47000000</dva:AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if4ad841931d5470f881644ba3f00c2c2_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzI3NDg3NzkwNzUxNDA_6cb83cba-922f-40da-a5b9-ab2643ebc7ff"
      unitRef="usd">-17976000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="id64a66f74d0f4ecba8a1a1be356f290d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzI4MDM3NTQ2NTE0MDUx_194d9471-2433-4405-ad2e-b7c515f7e3b9"
      unitRef="usd">9980000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzNzk_9f04a8a0-57e2-48cf-91c5-5e7cca6e2a6c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the financial results of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,963,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,962,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation adjustment on disposal group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on sale of discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(457,038)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzItMS0xLTEtMA_d8c40e2b-54ea-49e5-903f-63b4f105a1c1"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzItMy0xLTEtMA_b43ab8ed-e0de-4b03-85ca-ce093a199822"
      unitRef="usd">2713059000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzItNS0xLTEtMA_c3f0a035-9f95-4577-8f92-b2e2d0946dd2"
      unitRef="usd">4963792000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzMtMS0xLTEtMA_ee78f5a6-9f66-4a5a-b3ce-4c5f70b70096"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzMtMy0xLTEtMA_7a397b04-7f27-430a-82c8-02be6102f66c"
      unitRef="usd">2543865000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzMtNS0xLTEtMA_8530922f-416b-4a87-b0de-a1480562d498"
      unitRef="usd">4962686000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzQtMS0xLTEtMA_17f2797e-a747-4df4-aea9-de0ccc7a4e50"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzQtMy0xLTEtMA_42c6e1d3-3841-401c-9d4c-fd1ff66c39be"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzQtNS0xLTEtMA_7d12f955-58ae-4d28-b3cd-bb5419812132"
      unitRef="usd">41537000</us-gaap:GoodwillImpairmentLoss>
    <dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment
      contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzUtMS0xLTEtMA_d3b99697-982d-4fa5-9d49-986db06eacad"
      unitRef="usd">0</dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment>
    <dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzUtMy0xLTEtMA_9d33daa8-5a9f-4ed0-9f85-a58fe782af59"
      unitRef="usd">0</dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment>
    <dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment
      contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzUtNS0xLTEtMA_36ea18b7-ec89-4048-bffd-dc920cf4b5fa"
      unitRef="usd">316840000</dva:DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzYtMS0xLTEtMA_14e677f3-f9d9-48a4-a055-0d7d68bdb837"
      unitRef="usd">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzYtMy0xLTEtMA_007fbd0d-6b94-4c62-8b30-3b50a92f5d43"
      unitRef="usd">169194000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzYtNS0xLTEtMA_80623691-d4ad-4390-9b45-d29c25bd8b7b"
      unitRef="usd">-357271000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzctMS0xLTEtMA_bd57b960-f559-4fa1-8445-06f1aed48f1b"
      unitRef="usd">7996000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzctMy0xLTEtMA_b9d5561a-1ad0-4adf-a378-5e53f316794b"
      unitRef="usd">23022000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzctNS0xLTEtMA_57d2e0e0-9e39-4075-8cc1-acc505b53e1f"
      unitRef="usd">0</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
      contextRef="id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzgtMS0xLTEtMA_c5d260ba-f81b-411a-b8ba-10fe3ab23494"
      unitRef="usd">1657000</us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal>
    <us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
      contextRef="i4a2001e7365f49b196850bc72bd864a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzgtMy0xLTEtMA_3a83b72e-31bf-4b08-be4e-21a8c500fb77"
      unitRef="usd">40689000</us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal>
    <us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
      contextRef="i45a0c036d197423599d73e88e5341015_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzgtNS0xLTEtMA_55aab10d-00a4-466e-87f8-a664e58a4f59"
      unitRef="usd">99768000</us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzktMS0xLTEtMA_2af5ef3e-c710-4686-a400-79ac2b305c1c"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzktMy0xLTEtMA_464bfa7a-d2df-401c-989e-6cd83600385b"
      unitRef="usd">105483000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZTphYzMwNDlhNzE0Yjc0OTczOWEwYmZhZTQwOGNjMmMxZS90YWJsZXJhbmdlOmFjMzA0OWE3MTRiNzQ5NzM5YTBiZmFlNDA4Y2MyYzFlXzktNS0xLTEtMA_6d7e52f3-31d9-48f0-a7ed-d171794fcca2"
      unitRef="usd">-457038000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <dva:ReconciliationOfCashFlowsTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzODc_003afca8-fe89-45fe-a87b-dfa470576f4d">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cash flows of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:294.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash used in investing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ReconciliationOfCashFlowsTableTextBlock>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzItMS0xLTEtMA_540a6e4d-5870-49cb-aa61-a7f817e1a18f"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzItMy0xLTEtMA_b0c84259-61e8-4199-832b-6c7c5c218356"
      unitRef="usd">99634000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzItNS0xLTEtMA_6afe45e4-8300-486e-85b3-a7699c91cb6a"
      unitRef="usd">290684000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzMtMS0xLTEtMA_ab69b03d-3d7a-4641-aded-4a5792e93a77"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzMtMy0xLTEtMA_dd7a0ee2-8bae-4784-bfa2-f1e1349a11cc"
      unitRef="usd">-43442000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90YWJsZToxMWM2OTJhMWYzYTk0ZDk3YmYzZGVhMTZmNzY3ZGMzNi90YWJsZXJhbmdlOjExYzY5MmExZjNhOTRkOTdiZjNkZWExNmY3NjdkYzM2XzMtNS0xLTEtMA_dadf0d6e-e646-44b6-b014-810625bbbfd0"
      unitRef="usd">-57382000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIwMDc_12b37b5d-5fc4-4d89-ad3c-2ad5e4a3a22b"
      unitRef="clinic">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIwNDQ_17df0702-8ea8-4e66-887c-0c0fdafa6097"
      unitRef="usd">2025000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="icd25cebb5ffa428cbd5f91f493025b16_D20190101-20190618"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIwOTA_0a4d1c04-b6d9-48fc-990b-181cb171fe06"
      unitRef="usd">212000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="id4eac1171b5341d8b967522bcb813373_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIyOTU_c9cb5abd-e1a0-4f5f-986b-e070cc54fc3b"
      unitRef="usd">6995000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="id4eac1171b5341d8b967522bcb813373_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODYvZnJhZzozNTQxNjA0MDE5MDM0MzBjODhiYWFjMjZhZTMxYmVmNi90ZXh0cmVnaW9uOjM1NDE2MDQwMTkwMzQzMGM4OGJhYWMyNmFlMzFiZWY2XzIzMzg_23e1a474-130f-43bf-b441-3765ea1b9d13"
      unitRef="usd">1142000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzMxMjQ_400430f8-3d46-4399-8b2b-232ffb1152a6">Variable interest entities&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#x2019;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#x2019;s economic performance, the obligation to absorb the entity&#x2019;s expected losses, or the right to receive the entity&#x2019;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#x2019;s losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#x2019;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#x2019; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, these consolidated financial statements include total assets of VIEs above of $310,190 and total liabilities and noncontrolling interests of these VIEs to third parties of $216,632.&lt;/span&gt;&lt;/div&gt;The Company also sponsors certain non-qualified deferred compensation plans whose trusts qualify as VIEs and the Company consolidates these plans as their primary beneficiary.&#160;The assets of these plans are recorded in short-term or long-term investments with related liabilities recorded in accrued compensation and benefits and other long-term liabilities.&#160;See Note 15 for disclosures concerning the assets of these consolidated non-qualified deferred compensation plans.</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzMxMjM_4d6c631a-7fd5-4cbd-b887-2d9960b3f22c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#x2019;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#x2019;s economic performance, the obligation to absorb the entity&#x2019;s expected losses, or the right to receive the entity&#x2019;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#x2019;s losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.&lt;/span&gt;&lt;/div&gt;The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#x2019;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#x2019; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:Assets
      contextRef="i65a17e126ac34461a4fca6925ed519bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzI1NjA_b0d0e408-17be-4a35-8888-32f805945654"
      unitRef="usd">310190000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i65a17e126ac34461a4fca6925ed519bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yODkvZnJhZzoyYTJlZjI3MTIzZWI0ZjkyOTI2MWRlNmFjZTJjMzk5NS90ZXh0cmVnaW9uOjJhMmVmMjcxMjNlYjRmOTI5MjYxZGU2YWNlMmMzOTk1XzI2NDI_ff86691a-a77a-4964-9833-e7b6c1f00efe"
      unitRef="usd">216632000</us-gaap:Liabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90ZXh0cmVnaW9uOmUzMTkzNDdlMWJkZDQxY2E5OTVmNWMzNDZjN2QwM2JlXzM2OTU_47e4ab0b-0f49-4623-b398-4fbb8cff0612">Fair values of financial instruments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equity that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the FASB.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&#160;in&lt;br/&gt;active&#160;markets&#160;for&lt;br/&gt;identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&#160;other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the year ended at December&#160;31, 2020 and 2019, see Note 21 and the consolidated statement of equity, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 5 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 13 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair value of these contingent earn-out obligations is remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company credit risk adjusted rate that is used to discount obligations to present value. See Note 21 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of December&#160;31, 2020, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $160,000. See Note 17 for a discussion of the Company&#x2019;s methodology for estimating the fair values of noncontrolling interests subject to put obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 13 for further discussion of the Company's debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in the consolidated financial statements at December&#160;31, 2020 and 2019 at their approximate fair values due to the short-term nature of their settlements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90ZXh0cmVnaW9uOmUzMTkzNDdlMWJkZDQxY2E5OTVmNWMzNDZjN2QwM2JlXzM2OTE_ce5477b4-06bf-475d-a07f-9f4f4283e66b">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&#160;in&lt;br/&gt;active&#160;markets&#160;for&lt;br/&gt;identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&#160;other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i36352b7df66948dba0eacf04441040eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItMS0xLTEtMA_0ee5e30c-aeaa-40b8-aa05-ac9aa5afe05a"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i692b9792fba94d658bf1614514353578_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItMy0xLTEtMA_216b0151-0ec7-4b79-8769-eb8c2009fad1"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia8204d20559346598ff50ef21663702d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItNS0xLTEtMA_3c257083-496b-4686-87b9-4b626537f7e4"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic360e4e817a54ccbb56e6288ed0b1685_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzItNy0xLTEtMA_5a3c94f1-e04e-486a-a25f-092e9f9e89a7"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="ie862d7ef0c1343e2a506a5ff72228d56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtMS0xLTEtMA_b6d01bfd-3e21-40ad-9071-129137f5818e"
      unitRef="usd">2671000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iebd4732a8e3d41d984f5f16deb38d1b3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtMy0xLTEtMA_3001e216-9f92-47d8-a1a1-261081aca60d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i757c9663b761453cad7e8ec5f01cb559_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtNS0xLTEtMA_a9671df3-bfa6-4865-bc88-21a55b4634b6"
      unitRef="usd">2671000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i045ff3fd899a407682817e4edb66922f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzMtNy0xLTEtMA_7cfd09c2-8687-4c22-813d-29c909551c75"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i36352b7df66948dba0eacf04441040eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtMS0xLTEtMA_65defc9d-18f3-4a22-8a24-cee3fc13cada"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i692b9792fba94d658bf1614514353578_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtMy0xLTEtMA_1bd2d718-cae6-437a-a4fb-a532743fd007"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia8204d20559346598ff50ef21663702d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtNS0xLTEtMA_18816548-bbc3-4625-9a2b-8aa7c2030c11"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic360e4e817a54ccbb56e6288ed0b1685_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzUtNy0xLTEtMA_9aaefbb8-9339-4cc8-b19f-8f0937176612"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i36352b7df66948dba0eacf04441040eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctMS0xLTEtMA_7d76456c-2da9-4f88-af9b-8c7446f6ea9a"
      unitRef="usd">1330028000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i692b9792fba94d658bf1614514353578_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctMy0xLTEtMA_97d757cb-9020-416e-9f26-ee8a34ea0673"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ia8204d20559346598ff50ef21663702d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctNS0xLTEtMA_6a985a90-9819-4f7b-9083-893c34256f5b"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ic360e4e817a54ccbb56e6288ed0b1685_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzctNy0xLTEtMA_fd015a87-a162-4b37-9168-113e4cb5e28d"
      unitRef="usd">1330028000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i68711243663d45cd9878789705596fad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTEtMS0xLTA_a98bc739-76bb-4876-82d9-28468a022288"
      unitRef="usd">39951000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTMtMS0xLTA_07a4d7b0-fe49-47f6-bc41-9401cdef5fd4"
      unitRef="usd">39951000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0b5178b3f27148099f8931545f27730d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTUtMS0xLTA_630c8704-3068-4e15-b839-f65f569d379f"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9d92344999cf4f04aef6369cc712a589_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEwLTctMS0xLTA_51697cc7-58d0-433c-bcbe-e5eca77644fa"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="ia8733faebf4f497296ada527a7cd8acd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTEtMS0xLTA_66de0d7c-fc56-499a-bd8d-c94737718b2e"
      unitRef="usd">24452000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3feefe9b7e3f4d1e8e1438498a7ed0e0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTMtMS0xLTA_5635d82e-20ea-4e7a-9843-4432ac645323"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iff41e1baf8154d9d8e160378c8afe9a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTUtMS0xLTA_49e6f692-7654-48c0-93cc-dd32500026d9"
      unitRef="usd">24452000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i250b1181003d40a3ab8cd67db23630ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzExLTctMS0xLTA_9e404f23-0fb2-4244-8c08-57e1d303d716"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i68711243663d45cd9878789705596fad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTEtMS0xLTA_0a5d9607-3b3d-4c6e-8ace-79edccad3146"
      unitRef="usd">24586000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTMtMS0xLTA_8969c73f-a2fd-44f9-a861-9e9b70082d41"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0b5178b3f27148099f8931545f27730d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTUtMS0xLTA_c39eed4f-43cd-43ba-8511-a97d42db211a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9d92344999cf4f04aef6369cc712a589_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzEzLTctMS0xLTA_d8fa58e4-b217-43bb-a295-c1de4d4fd65e"
      unitRef="usd">24586000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i68711243663d45cd9878789705596fad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTEtMS0xLTA_99a6756e-fa95-41d9-a40b-6fc06505e114"
      unitRef="usd">1180376000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ibef91d36fd9e4fe59e9f6e396a8c1939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTMtMS0xLTA_82d640c2-ff66-42f0-b1a1-896992299434"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i0b5178b3f27148099f8931545f27730d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTUtMS0xLTA_14372acf-8a7b-42c8-9f16-b0c2076c151f"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i9d92344999cf4f04aef6369cc712a589_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90YWJsZTo1ZmQ1YzkxZjNmOGQ0MmZkYmU4NDQ1MjNkZWM4NTJjNy90YWJsZXJhbmdlOjVmZDVjOTFmM2Y4ZDQyZmRiZTg0NDUyM2RlYzg1MmM3XzE1LTctMS0xLTA_786a5bc0-40af-48c7-bc2c-e184ae629804"
      unitRef="usd">1180376000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple
      contextRef="ied7ace566871432e8e4240927f2bf074_D20201231-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTIvZnJhZzplMzE5MzQ3ZTFiZGQ0MWNhOTk1ZjVjMzQ2YzdkMDNiZS90ZXh0cmVnaW9uOmUzMTkzNDdlMWJkZDQxY2E5OTVmNWMzNDZjN2QwM2JlXzM5NTgyNDE4NjA1NzMw_090aac6e-bde2-4dd3-9fca-d2bf71a35388"
      unitRef="usd">160000</dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MDk_271c60e9-df81-4c6f-854e-38c7df428e84">Segment reporting&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its various ancillary services and strategic initiatives, including its international operations (collectively, its ancillary services), and its corporate administrative support. See Note 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;"Organization" &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a summary description of the Company's businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2019, the Company completed the sale of its DMG business to Optum. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company&#x2019;s chief operating decision maker in making decisions about allocating resources to and assessing the financial performance of the Company&#x2019;s various operating lines of business. The chief operating decision maker for the Company is its Chief Executive Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s separate operating segments include its U.S. dialysis and related lab services business, each of its ancillary services and strategic initiatives, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the APAC joint venture. The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other ancillary services and strategic initiatives operating segments, including the international operating segments, have been combined and disclosed in the other segments category.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating segment financial information included in this report is prepared on the internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the financial performance of the Company's operating segments. For internal management reporting, segment operations include direct segment operating expenses but generally exclude corporate administrative support costs, which consist primarily of indirect labor, benefits and long-term incentive compensation expenses of certain departments which provide support to all of the Company&#x2019;s various operating lines of business, except to the extent that such costs are charged to and borne by certain ancillary services and strategic initiatives via internal management fees. These corporate administrative support costs are reduced by internal management fees received from the Company&#x2019;s ancillary lines of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,488,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,421,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis revenues before provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,632,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,552,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,366,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for uncollectible accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,619,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,530,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,316,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,659,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,562,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,335,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,712,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,534,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,532,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,404,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,924,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,841,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,615,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating margin to consolidated income from&lt;br/&gt; continuing operations before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(487,435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt prepayment, refinancing and redemption charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes management fee revenues from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling interest or which are wholly-owned by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity investment income of $5,866, $9,366, and $24,866 in 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summary of assets by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,344,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,778,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,988,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,311,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $122,974 and $124,188 in 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $134,517 and 117,795 in 2020 and 2019, respectively and includes approximately $181,137 and $154,572 in 2020 and 2019, respectively, of net property and equipment related to the Company&#x2019;s international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for property and equipment by reportable segment were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DMG - Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1
      contextRef="iab59816d75634fd58eaaa890c090532b_D20190619-20190619"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM0Nw_2bc9466f-64a1-4aec-90cf-69c34568c1a4">2019-06-19</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MDM_5916975b-c6cd-4058-a024-ae4663a4e349">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,488,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,421,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis revenues before provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,632,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,552,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,366,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for uncollectible accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,619,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,530,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,316,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,659,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,562,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,335,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,712,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,534,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,532,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,404,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,924,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,841,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,615,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating margin to consolidated income from&lt;br/&gt; continuing operations before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(487,435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt prepayment, refinancing and redemption charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes management fee revenues from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling interest or which are wholly-owned by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity investment income of $5,866, $9,366, and $24,866 in 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3c3be00a520d4ae2958de6ed78743b3f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzUtMS0xLTEtMA_533b6593-00c9-443b-b609-aee8c4495e4d"
      unitRef="usd">10488731000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5de5994570ca4c2d88f909bc24fd0c06_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzUtMy0xLTEtMA_9b6e6540-26c2-4475-8231-649aba9a25d2"
      unitRef="usd">10421401000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0baec8c73f084f299738f9079b65dd67_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzUtNS0xLTEtMA_388da11d-135b-4eb4-9ada-156a22136248"
      unitRef="usd">10274046000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0420ed82e7024d998b6589e8747f9f7d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzYtMS0xLTEtMA_999b3775-51af-4f8c-9856-54312a018714"
      unitRef="usd">144091000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idd8fa94d190c4eed9526f7bfc49e982b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzYtMy0xLTEtMA_d449cc0b-02d1-4868-9bb3-d186f0dc25e3"
      unitRef="usd">131199000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5e6be2ddd91d4f4088ed90946f8137ab_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzYtNS0xLTEtMA_5ab0bc86-3898-4914-a405-aebe3405c5af"
      unitRef="usd">92950000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzctMS0xLTEtMA_b244f6e8-6ebc-4d8b-adb5-a96edafd3b7e"
      unitRef="usd">10632822000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzctMy0xLTEtMA_e3607715-5fec-4017-ad56-b9c7993b88e3"
      unitRef="usd">10552600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzctNS0xLTEtMA_8769f07f-b1ea-4b87-b239-4f216ca11618"
      unitRef="usd">10366996000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <dva:ProvisionForExpectedCreditLosses
      contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzgtMS0xLTEtMA_71e17bfc-14ba-4960-982d-152d3d268e1d"
      unitRef="usd">13458000</dva:ProvisionForExpectedCreditLosses>
    <dva:ProvisionForExpectedCreditLosses
      contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzgtMy0xLTEtMA_c9ed3aad-af4c-478a-8085-f6b88ee51e3d"
      unitRef="usd">21715000</dva:ProvisionForExpectedCreditLosses>
    <dva:ProvisionForExpectedCreditLosses
      contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzgtNS0xLTEtMA_75525527-5e26-4d53-8446-8eb198a9960c"
      unitRef="usd">50927000</dva:ProvisionForExpectedCreditLosses>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzktMS0xLTEtMA_e9208d1b-df36-4068-9023-70454ff9e42d"
      unitRef="usd">10619364000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzktMy0xLTEtMA_7f1f9a8f-7262-4dd4-a326-9da68bf7df53"
      unitRef="usd">10530885000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzktNS0xLTEtMA_1f4be21a-15b6-4668-b2cb-e5bbce377f26"
      unitRef="usd">10316069000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <us-gaap:OtherIncome
      contextRef="i3c3be00a520d4ae2958de6ed78743b3f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzExLTEtMS0xLTA_c8ba4f00-6e6a-4ca7-81ce-b522d74ba281"
      unitRef="usd">39376000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i5de5994570ca4c2d88f909bc24fd0c06_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzExLTMtMS0xLTA_5ed964f1-0c9c-4ab7-bd0b-a6c9ecd6db48"
      unitRef="usd">30895000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0baec8c73f084f299738f9079b65dd67_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzExLTUtMS0xLTA_eec8e33b-201a-4495-89ef-fc5f11296f14"
      unitRef="usd">19880000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0420ed82e7024d998b6589e8747f9f7d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEyLTEtMS0xLTA_d9daff83-cb16-4e85-b18a-55ce9435f9e9"
      unitRef="usd">1195000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idd8fa94d190c4eed9526f7bfc49e982b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEyLTMtMS0xLTA_0faeb2b9-8bdf-42b5-bd2b-42c5359578e2"
      unitRef="usd">1126000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i5e6be2ddd91d4f4088ed90946f8137ab_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEyLTUtMS0xLTA_759b94f4-7d5a-47f4-8340-8857fd5f7588"
      unitRef="usd">0</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEzLTEtMS0xLTA_3178bcd8-a481-4ebb-b67e-3297f47e2d2c"
      unitRef="usd">10659935000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEzLTMtMS0xLTA_c0baf57a-b90a-4984-b6da-f45a45132d6a"
      unitRef="usd">10562906000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzEzLTUtMS0xLTA_c430e600-b779-473b-9d52-2a72e51f7657"
      unitRef="usd">10335949000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE1LTEtMS0xLTA_fe469eb2-46ac-4494-a62c-9df5d4bb1850"
      unitRef="usd">550978000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE1LTMtMS0xLTA_e823f06b-a9cb-4e70-9188-10026366a645"
      unitRef="usd">497021000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE1LTUtMS0xLTA_0b53ec36-f2f6-424c-89a9-3b4558391bf9"
      unitRef="usd">437275000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE2LTEtMS0xLTA_e0d6c519-f4cc-4e28-a3ab-5b84035cf22b"
      unitRef="usd">484977000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE2LTMtMS0xLTA_6888827f-e7da-48bc-bc77-2e142f90b401"
      unitRef="usd">460877000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE2LTUtMS0xLTA_3712ecd7-86b7-4436-b032-43d39d710aaf"
      unitRef="usd">724577000</us-gaap:OtherIncome>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0d0245cc46dc4065a8942a8b290f03b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE3LTEtMS0xLTA_8ed30af5-5709-445f-81d1-b4e304b927b4"
      unitRef="usd">16743000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i250b62935f564b88b9b115cc2724bca5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE3LTMtMS0xLTA_35ddcc37-26c0-4134-8b74-4c6c97f5e0d3"
      unitRef="usd">14030000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i15645add5fe64f3da803a62328e47752_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE3LTUtMS0xLTA_69fbfb25-3027-4797-892b-aaa189a5cff9"
      unitRef="usd">34236000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE4LTEtMS0xLTA_cb0085cf-c1b6-4970-9a83-4bd9a89bf82c"
      unitRef="usd">1052698000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE4LTMtMS0xLTA_d6a83cb4-8937-4633-a032-b4cfe4b849fd"
      unitRef="usd">971928000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE4LTUtMS0xLTA_ac970825-428e-4419-8b7c-b91f0b6a903d"
      unitRef="usd">1196088000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d063b2501144da199dc74e77efdc1c8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE5LTEtMS0xLTA_1da83766-e3b5-4947-9303-6db47249eb7b"
      unitRef="usd">11712633000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i50bc107b4f0a4837842f4727bce2675b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE5LTMtMS0xLTA_9125df7e-e5c5-410a-b6f7-92f25fa195e6"
      unitRef="usd">11534834000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i326bc266ccc04e9085736f4e63bfcd54_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzE5LTUtMS0xLTA_d8323905-6cfc-47f7-9c66-aae808d858e6"
      unitRef="usd">11532037000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i635c2eebb9e64938a68735ae6c593657_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIwLTEtMS0xLTA_23b89039-7fa3-42ce-8617-0bb01a2f2a13"
      unitRef="usd">-162029000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f9b9ab0e8584df69e653fc61911e0cc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIwLTMtMS0xLTA_e5fae141-98d3-4b23-9983-25a2a1ce708d"
      unitRef="usd">-146355000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a04f4ad256b450eb154971edb661d29_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIwLTUtMS0xLTA_9503450a-0215-4279-b875-10b7d26046fa"
      unitRef="usd">-127186000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIxLTEtMS0xLTA_85e4ff00-68d1-454f-a62d-399a537124aa"
      unitRef="usd">11550604000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIxLTMtMS0xLTA_22c7eba3-dd81-4e20-a3a1-9db36d5d5493"
      unitRef="usd">11388479000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIxLTUtMS0xLTA_96e58ddb-5714-43f4-b552-2755d0ce8ae3"
      unitRef="usd">11404851000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="id7bc705ed1f746dbbbad5cf55faebfac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIzLTEtMS0xLTA_4e2bbc82-49e7-40f6-8b0d-0f0e3c4575db"
      unitRef="usd">1917604000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic08add4c00e3413d863668546ea0bfe8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIzLTMtMS0xLTA_5993147c-14c6-4770-afdd-a20dbcdffb50"
      unitRef="usd">1924826000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iee1168a88cd84c8194c82fee58056484_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzIzLTUtMS0xLTA_033c636f-29fb-49bc-9ccd-de150e48d875"
      unitRef="usd">1709721000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI0LTEtMS0xLTA_f72ef024-bda9-4eea-98e1-cdfeaf4fd4e9"
      unitRef="usd">-76261000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI0LTMtMS0xLTA_76c2e283-b031-43c8-9eb7-daa1a472ced8"
      unitRef="usd">-189174000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI0LTUtMS0xLTA_1f829b73-aa50-4b5a-973e-8a9898527f4d"
      unitRef="usd">-93789000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7d063b2501144da199dc74e77efdc1c8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI1LTEtMS0xLTA_7e699d62-5f41-4c3d-a78a-e4b2fdbf344b"
      unitRef="usd">1841343000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i50bc107b4f0a4837842f4727bce2675b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI1LTMtMS0xLTA_1e5512ab-4b7f-4d77-8785-4c9febd720ef"
      unitRef="usd">1735652000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i326bc266ccc04e9085736f4e63bfcd54_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI1LTUtMS0xLTA_2b00819b-0f9a-409a-8e3e-352f19141ced"
      unitRef="usd">1615932000</us-gaap:OperatingIncomeLoss>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI3LTEtMS0xLTA_584d0321-e0b3-467c-99cb-70705ae675ed"
      unitRef="usd">146707000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI3LTMtMS0xLTA_10dc816b-2e89-4bf8-b77d-319f40a86d6b"
      unitRef="usd">92335000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI3LTUtMS0xLTA_50406915-8778-4a25-be54-f1bd734a23ef"
      unitRef="usd">90108000</dva:SegmentReportingInformationCorporateExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI4LTEtMS0xLTA_5ed90504-f1f3-4341-82de-1af88e27d426"
      unitRef="usd">1694636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI4LTMtMS0xLTA_44e64bb2-4fd8-4f8e-a1ce-26ccd4802e02"
      unitRef="usd">1643317000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI4LTUtMS0xLTA_7c82b06e-d885-42b0-96d9-8cbf9cd81138"
      unitRef="usd">1525824000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI5LTEtMS0xLTA_a47e7cd2-0a4c-4527-bcdc-11d9131d093b"
      unitRef="usd">304111000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI5LTMtMS0xLTA_9194548f-eab6-4c4f-9aca-09bf577ca656"
      unitRef="usd">443824000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzI5LTUtMS0xLTA_87c3cab9-e9f1-4799-a473-e0f41b8554c8"
      unitRef="usd">487435000</us-gaap:InterestAndDebtExpense>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMwLTEtMS0xLTA_3292df5e-4ff5-4532-8074-18bde157cc89"
      unitRef="usd">89022000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMwLTMtMS0xLTA_8985fb03-73a3-425b-881d-8aeee9931c8f"
      unitRef="usd">33402000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMwLTUtMS0xLTA_250da049-6ff3-43d5-a260-6afc82e23ab3"
      unitRef="usd">0</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMxLTEtMS0xLTA_6402c34a-0213-42d0-a972-c6b4cfa134f0"
      unitRef="usd">16759000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMxLTMtMS0xLTA_a827941b-62c9-4046-9add-1d4b709bce20"
      unitRef="usd">29348000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMxLTUtMS0xLTA_121cca0c-61fb-43a9-81b4-00542ed6a142"
      unitRef="usd">10089000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMyLTEtMS0xLTA_2c6ef2b5-5042-4fbe-a5aa-7cabba0cb12d"
      unitRef="usd">1318262000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMyLTMtMS0xLTA_ad66ddbc-64e9-451c-bfe3-d97befa85086"
      unitRef="usd">1195439000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZToyNzk1MTllYjRiOTc0Y2IwYWYyZjJlMzY2Y2NmYWMxOC90YWJsZXJhbmdlOjI3OTUxOWViNGI5NzRjYjBhZjJmMmUzNjZjY2ZhYzE4XzMyLTUtMS0xLTA_b154cac0-7120-45ef-953c-9246a2b6fec6"
      unitRef="usd">1048478000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i10b0f8418a84438d986e0b4ed2bed3ec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzExNTQ0ODcyMDk2Mzgy_81ca4088-a8e7-4001-bd7b-d2e697762010"
      unitRef="usd">5866000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibffa135ac38c4058941e382a69be8a34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzExNTQ0ODcyMDk2Mzk1_05daf0c5-2538-4f3d-ada0-aadb36a34648"
      unitRef="usd">9366000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i338ebbb235e94664b8762945904b8e65_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzExNTQ0ODcyMDk2NDA5_d3eb7d4e-9164-452a-afb0-c751057fdf8d"
      unitRef="usd">24866000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MTg_5ed4d712-6709-4780-b691-51677745dfbc">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationAndAmortization
      contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzItMS0xLTEtMA_c503f0e8-3453-452b-9074-6f3fe83f20cf"
      unitRef="usd">594552000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzItMy0xLTEtMA_06252182-5042-4965-a2d6-c31a524105dd"
      unitRef="usd">583454000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzItNS0xLTEtMA_a0449fa4-f786-48bd-a106-b384bf445431"
      unitRef="usd">558810000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzMtMS0xLTEtMA_ccdae1fa-048e-427b-b9b6-47636849d29a"
      unitRef="usd">35883000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzMtMy0xLTEtMA_4f37ba08-92f6-4472-9882-8905fc92e9fe"
      unitRef="usd">31698000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i10d8743c3594411698541aa578ec2aff_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzMtNS0xLTEtMA_c29b24ef-acc2-4bb2-a3a4-3b12677d7f94"
      unitRef="usd">32225000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzQtMS0xLTEtMA_6f890550-45f0-454f-8de0-4460a6e752f8"
      unitRef="usd">630435000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzQtMy0xLTEtMA_039c3fd1-ca40-4ded-9af5-a88f4b2f34b9"
      unitRef="usd">615152000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTowODEyYWU2ZTI2YmI0MzNiOTc5M2QwOGQ4OGNjMjQ4YS90YWJsZXJhbmdlOjA4MTJhZTZlMjZiYjQzM2I5NzkzZDA4ZDg4Y2MyNDhhXzQtNS0xLTEtMA_2d03e681-5f7b-446d-bdf9-5e74be1363da"
      unitRef="usd">591035000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MTU_a106a95b-fd68-4596-b9e1-5bed429b23ee">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summary of assets by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,344,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,778,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,988,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,311,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $122,974 and $124,188 in 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $134,517 and 117,795 in 2020 and 2019, respectively and includes approximately $181,137 and $154,572 in 2020 and 2019, respectively, of net property and equipment related to the Company&#x2019;s international operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzMtMS0xLTEtMA_8c661a34-f1a8-493a-a7b9-510285b82e6a"
      unitRef="usd">15344647000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if638379c314e4e40a080f1df9bc6d4eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzMtMy0xLTEtMA_77328b71-9ecf-4204-bc2e-c738e4db96e2"
      unitRef="usd">15778880000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if18749a859234cf7b23652f60c460caf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzQtMS0xLTEtMA_4e62f4f4-a916-4e39-a637-ca2911241378"
      unitRef="usd">1643869000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzQtMy0xLTEtMA_1746b0df-facf-4912-9bec-185705e83cda"
      unitRef="usd">1532514000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9f8f54d48fef43fa83c36824d46a3cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzYtMS0xLTEtMA_ad59549c-eae5-4533-8320-a210d0e558ec"
      unitRef="usd">16988516000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i808f8139875c457e969c8ed421c88028_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkYmI1ZThiZWQzMzI0MWRlYTkyYmNlOWM4ZmVjOWE1YS90YWJsZXJhbmdlOmRiYjVlOGJlZDMzMjQxZGVhOTJiY2U5YzhmZWM5YTVhXzYtMy0xLTEtMA_350e7a31-a11a-4e13-ab84-6c33557aed75"
      unitRef="usd">17311394000</us-gaap:Assets>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i4fb2cf0a2f7c462eafce7273c7712b87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMxODI_1549e6fa-048c-4b4c-b084-403123fd0fa9"
      unitRef="usd">122974000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="if638379c314e4e40a080f1df9bc6d4eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMxNzc_e878544e-8667-40b5-ae8a-8196deb01989"
      unitRef="usd">124188000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="if18749a859234cf7b23652f60c460caf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMzMTM_58b18f38-5a73-499c-a9a1-8146484f02d0"
      unitRef="usd">134517000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="iae74ab1ddeea451fb1856db5dcc3d2a8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzI3NDg3NzkwNzMzMDg_3cfb53e8-e521-480b-b1fa-9051639a79a2"
      unitRef="usd">117795000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i60ede493ecc1446dacb46d6cfbf3cac9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzMzOTg_17540873-47c6-4161-acba-8d03c3cd20ff"
      unitRef="usd">181137000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if5953439c8d14af49838fde6e6488453_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM0MDU_559e4067-3310-4ed9-a8c8-0891541d5011"
      unitRef="usd">154572000</us-gaap:PropertyPlantAndEquipmentNet>
    <dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90ZXh0cmVnaW9uOjI0M2QzMDY0MjYxNDRkZGJhZjQ2MzgzN2Q5MzcyNjgxXzM2MDc_01f1b3d4-5d75-4da1-a0be-808f5d252b94">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for property and equipment by reportable segment were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DMG - Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzItMS0xLTEtMA_658f86bc-36b6-4df3-9d64-110b178dd498"
      unitRef="usd">646870000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i77b7ef3550634880a30b4b52f9895140_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzItMy0xLTEtMA_410cd2f7-79fc-4e6a-a8d9-fcb71f120c40"
      unitRef="usd">681339000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0330bdd5854c49589e6a2a8db6dbdee6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzItNS0xLTEtMA_9dec2d4d-edf1-4b65-9097-07a1536ea6e6"
      unitRef="usd">856108000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i942a5fb23ec5409fa97ae09b30029fe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzMtMS0xLTEtMA_c6bf8ca3-b5b8-44fd-82b0-af857092bffd"
      unitRef="usd">27671000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic402a1f1800c407bb56be70836d08afd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzMtMy0xLTEtMA_3df9cc50-1592-4a4c-8ad3-428e9cfbd28a"
      unitRef="usd">46741000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i10d8743c3594411698541aa578ec2aff_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzMtNS0xLTEtMA_8731246e-667b-4a01-9111-f508844d8f0d"
      unitRef="usd">45806000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia6163ef4be0a465f90685726ac832a2b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzQtMS0xLTEtMA_5c4d448c-aec3-45dc-a080-d17f2b0f1e14"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if3d2a102026c4112b723366408486f2d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzQtMy0xLTEtMA_fe9697ff-67e9-4a61-b069-c00126607fbb"
      unitRef="usd">38466000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifa612087266445208d57b0d501856183_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzQtNS0xLTEtMA_17e56f3c-18d4-417c-bc6b-2b9892d9ef47"
      unitRef="usd">85224000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzUtMS0xLTEtMA_9caf0457-afd9-41c1-b985-4ee918c82e1b"
      unitRef="usd">674541000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzUtMy0xLTEtMA_9a5255fa-4ff9-4f16-b60b-b3ce61c0a1d7"
      unitRef="usd">766546000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8yOTUvZnJhZzoyNDNkMzA2NDI2MTQ0ZGRiYWY0NjM4MzdkOTM3MjY4MS90YWJsZTpkNDYwMmY1NWIxZDg0ZGQ3OTc3ZWEyNTk4NGIyNDdkNy90YWJsZXJhbmdlOmQ0NjAyZjU1YjFkODRkZDc5NzdlYTI1OTg0YjI0N2Q3XzUtNS0xLTEtMA_b975d8f4-b823-4d80-b823-124ef6f26381"
      unitRef="usd">987138000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90ZXh0cmVnaW9uOjlkYmI5MWJlNzA2YTQ0M2M5Y2Q5ODUxYjY3ODA2YzdkXzExMw_b50f3add-8bd1-4619-8ef5-a1d4b474a087">Supplemental cash flow information&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides supplemental cash flow information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets under financing lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90ZXh0cmVnaW9uOjlkYmI5MWJlNzA2YTQ0M2M5Y2Q5ODUxYjY3ODA2YzdkXzEwOQ_4a4dfa91-c566-4b27-83ee-479d61db0d22">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides supplemental cash flow information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets under financing lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzMtMS0xLTEtMA_dc7b0c4c-050e-4704-ae96-0c5189c6d7fa"
      unitRef="usd">154850000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzMtMy0xLTEtMA_0fd5eb3e-07f0-445a-8a79-0bbb4ea137ad"
      unitRef="usd">157983000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzMtNS0xLTEtMA_3e3202bf-0c04-4e26-965d-89a284422ec4"
      unitRef="usd">92526000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaid
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzQtMS0xLTEtMA_9431f2e3-cf92-4d37-bca4-e25774e0a534"
      unitRef="usd">326165000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzQtMy0xLTEtMA_c5667491-9fed-4259-a07e-3e4d10b50a18"
      unitRef="usd">473176000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzQtNS0xLTEtMA_a6abe737-442d-49e5-9253-8b4c797d0908"
      unitRef="usd">488974000</us-gaap:InterestPaid>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzYtMS0xLTEtMA_1e16cb96-582a-4356-8fc3-e926e76f1c6b"
      unitRef="usd">22042000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="idee8e94b2db346e7aac9801606c4dadb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzYtMy0xLTEtMA_ef36a533-fced-40b9-9ed9-5c02d57166e4"
      unitRef="usd">18953000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i35cf0952b11945e08c9c231a53846a77_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDEvZnJhZzo5ZGJiOTFiZTcwNmE0NDNjOWNkOTg1MWI2NzgwNmM3ZC90YWJsZTpiMzZjODkxNTg2YTA0MjdiYTU5MTI1ZDY1ZWNhYmZjZC90YWJsZXJhbmdlOmIzNmM4OTE1ODZhMDQyN2JhNTkxMjVkNjVlY2FiZmNkXzYtNS0xLTEtMA_867214b3-9948-4af5-af41-11be543b82b0"
      unitRef="usd">8828000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90ZXh0cmVnaW9uOjUzMDQ2MjBjMmUzZDQ0MDg5NTdjMThiNmMxNjYwZWY1XzMzOQ_e4fae9b7-6ab1-4889-b1ef-d1a5571d9104">Selected quarterly financial data (unaudited)&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,905,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,924,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income from continuing operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Per share attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,898,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,904,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income from continuing operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Per share attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The following table summarizes impairment charges, loss on changes in ownership interest, and a legal settlement included in operating expenses and charges in 2020 and 2019 by quarter:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:489.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:108.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:46.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:46.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;&#160;Quarter ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;&#160;Quarter ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Certain operating expenses&lt;br/&gt; and charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;83,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;41,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Loss on changes in&lt;br/&gt; ownership interest, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;16,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Accruals for legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;35,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90ZXh0cmVnaW9uOjUzMDQ2MjBjMmUzZDQ0MDg5NTdjMThiNmMxNjYwZWY1XzMzNQ_866393cb-0dd6-4857-ac7b-4eafdbf59a41">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,905,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,924,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income from continuing operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Per share attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,898,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,904,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income from continuing operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Per share attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The following table summarizes impairment charges, loss on changes in ownership interest, and a legal settlement included in operating expenses and charges in 2020 and 2019 by quarter:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:489.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:108.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:46.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:46.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:39.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;&#160;Quarter ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;&#160;Quarter ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Certain operating expenses&lt;br/&gt; and charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;83,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;41,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Loss on changes in&lt;br/&gt; ownership interest, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;16,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Accruals for legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;35,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItMS0xLTEtMA_68fafaa2-de52-4e70-9329-9937b04d5240"
      unitRef="usd">2905322000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItMy0xLTEtMA_3c24706f-2dae-4a9c-89c1-1d7dc86f7b5c"
      unitRef="usd">2924066000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItNS0xLTEtMA_d915eb25-a0c1-4848-af64-6ec7fc7aca1f"
      unitRef="usd">2879979000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzItNy0xLTEtMA_9f61e6e0-8b23-4613-912c-248eb413d1d3"
      unitRef="usd">2841237000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtMS0xLTEtMA_115d5ff6-b079-419e-876e-c985692d98bc"
      unitRef="usd">381671000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtMy0xLTEtMA_de3338d0-d819-45e5-b923-4ba291c6b337"
      unitRef="usd">437669000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtNS0xLTEtMA_94493c98-881c-425c-9c8d-6002388892c7"
      unitRef="usd">409920000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzMtNy0xLTEtMA_2d335ada-cff8-4498-87d8-fe10c9325bd1"
      unitRef="usd">465376000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtMS0xLTEtMA_5a4d3b6d-9821-4102-940c-064b0466e653"
      unitRef="usd">193406000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtMy0xLTEtMA_bf5b761a-8b43-4159-863e-bcdc6c7d3632"
      unitRef="usd">158674000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtNS0xLTEtMA_e20d8b0d-5510-43c6-9a14-d63b910cdb23"
      unitRef="usd">201602000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzUtNy0xLTEtMA_9ecda216-6374-4145-ba6d-3149b85691a1"
      unitRef="usd">229613000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtMS0xLTEtMA_8f1c0437-c871-4b25-aa15-d0eef099aac1"
      unitRef="usd">-19633000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtMy0xLTEtMA_43025286-f001-4240-8795-68345380b591"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtNS0xLTEtMA_40a1ca7b-dacd-4a06-bd2e-cb1f69ece022"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzYtNy0xLTEtMA_1615837a-49a6-4a70-b037-dd959d6e70a0"
      unitRef="usd">9980000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctMS0xLTEtMA_9625777e-27b7-4380-9e26-762f383b7d71"
      unitRef="usd">173773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctMy0xLTEtMA_d1921fbc-484d-41d9-a86e-06d185b983f2"
      unitRef="usd">158674000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctNS0xLTEtMA_779c7bf5-a697-4726-a7dc-eeec2fb13077"
      unitRef="usd">201602000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzctNy0xLTEtMA_e0cb0ae1-1804-4ed3-b096-261833ca2e67"
      unitRef="usd">239593000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktMS0xLTEtMA_75856f62-7145-4685-9ca6-858fa9a82a5a"
      unitRef="usdPerShare">1.73</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktMy0xLTEtMA_00f15c03-b5ad-4371-baeb-86e6376091dd"
      unitRef="usdPerShare">1.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktNS0xLTEtMA_c1151458-eca8-4bea-beac-70e9f3ed15a5"
      unitRef="usdPerShare">1.65</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzktNy0xLTEtMA_fa0aff3a-e3a0-4b44-849f-df68541246da"
      unitRef="usdPerShare">1.84</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTEtMS0xLTA_3089d925-ab07-4231-b9ea-6c5e9317e224"
      unitRef="usdPerShare">-0.17</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTMtMS0xLTA_1313f05a-ddc6-4f92-8b73-8ed9ac76ffc6"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTUtMS0xLTA_475299d5-76c3-4bd9-87de-46e9ea0e12d9"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEwLTctMS0xLTA_237015a7-ab7c-4176-a946-7443511874c0"
      unitRef="usdPerShare">0.08</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTEtMS0xLTA_1744bcc6-440a-4b7a-8c91-33e7989f693d"
      unitRef="usdPerShare">1.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTMtMS0xLTA_9751054e-2ce5-4497-a38a-abbe0faf33da"
      unitRef="usdPerShare">1.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTUtMS0xLTA_0c2ed491-9c16-4cb9-942a-034989867d2f"
      unitRef="usdPerShare">1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzExLTctMS0xLTA_8ba65f3a-f8b8-4e31-9544-0e87ee52b427"
      unitRef="usdPerShare">1.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTEtMS0xLTA_0385e9c4-1da3-4652-aa2f-d7c1b35e6208"
      unitRef="usdPerShare">1.67</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTMtMS0xLTA_2bd1e808-1294-414f-bb9f-3ae00498613e"
      unitRef="usdPerShare">1.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTUtMS0xLTA_57285a59-ba25-4710-8bc9-7be2613e39eb"
      unitRef="usdPerShare">1.62</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEyLTctMS0xLTA_f25c715c-df88-41a3-abec-010a0f581fd7"
      unitRef="usdPerShare">1.81</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTEtMS0xLTA_f59cc37f-0350-425f-b7bb-8b13b10e2b02"
      unitRef="usdPerShare">-0.17</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTMtMS0xLTA_cd18f409-51d5-40e0-a888-8995939a3310"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTUtMS0xLTA_71e5ebd3-9417-45d7-9a03-8885b3bb78a6"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzEzLTctMS0xLTA_9f8a8ddb-6fc7-44d4-9730-7875a5261005"
      unitRef="usdPerShare">0.08</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTEtMS0xLTA_c4b2ce21-37a4-43ff-91f1-26a6d241e054"
      unitRef="usdPerShare">1.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9bcc0ccbce6e4822a6f88eb91aa000e5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTMtMS0xLTA_65951574-77e7-42a3-8a8f-210ee8b4e184"
      unitRef="usdPerShare">1.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1308e729a34b461ca9b8ffe9354e38f6_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTUtMS0xLTA_80b8c896-9a18-4580-a6e3-895d0a4e7799"
      unitRef="usdPerShare">1.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i21bdb3d1c97a4c71a8cd5456db926d84_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE0LTctMS0xLTA_57d6e7e1-34fe-4da1-b2da-7f1f348adc89"
      unitRef="usdPerShare">1.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:Revenues
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTEtMS0xLTA_8a2264cf-66c9-4584-bd58-e82f539927b8"
      unitRef="usd">2898584000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTMtMS0xLTA_b0a1dea3-9c40-4abb-a28d-e8a3b68ba1ef"
      unitRef="usd">2904078000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTUtMS0xLTA_3fdaebca-8cb7-4993-85f2-0a29b68422b2"
      unitRef="usd">2842705000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE2LTctMS0xLTA_5ff8301a-5517-400d-aa5d-87e0974d2ee2"
      unitRef="usd">2743112000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTEtMS0xLTA_b61f5a20-7bb3-440c-a026-909da8949cba"
      unitRef="usd">462588000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTMtMS0xLTA_0bd31919-815a-4451-a7f4-ea5c8b97be0f"
      unitRef="usd">378336000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTUtMS0xLTA_ae5b7963-2445-4581-938a-612fd3ce1d08"
      unitRef="usd">461886000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE3LTctMS0xLTA_66336458-6a10-4ef0-8705-48857e077704"
      unitRef="usd">340507000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTEtMS0xLTA_d60dd19d-26d1-4349-8448-bffc05be1883"
      unitRef="usd">242242000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTMtMS0xLTA_561cae5f-0eaf-40be-ad0c-3b00fba390a6"
      unitRef="usd">150113000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTUtMS0xLTA_1678ee36-a0fe-4542-9ee8-b7ee8385b2fb"
      unitRef="usd">194223000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzE5LTctMS0xLTA_7c861728-3b02-476b-b5b3-ba83bfda46bd"
      unitRef="usd">120254000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTEtMS0xLTA_61976ed3-2a53-483c-86d1-d27fbe26155e"
      unitRef="usd">2629000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTMtMS0xLTA_56c9ce2d-2acf-4249-9e10-a22082d381a5"
      unitRef="usd">-6843000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTUtMS0xLTA_7f75fa2e-9d17-4ee6-857d-63c72da8b54e"
      unitRef="usd">79328000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIwLTctMS0xLTA_38255493-8752-4ee1-82fe-151b28a0971b"
      unitRef="usd">29035000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTEtMS0xLTA_8df342f2-7287-445f-9ac6-c15c299853a0"
      unitRef="usd">244871000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTMtMS0xLTA_65995f7d-19ec-45c1-8ae0-52f04f29cac8"
      unitRef="usd">143270000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTUtMS0xLTA_22e970c8-c97a-46ed-8b2d-33283f4dfc2c"
      unitRef="usd">273551000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIxLTctMS0xLTA_e361ee83-057d-4fbf-85d6-098c5cbcf4a1"
      unitRef="usd">149289000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTEtMS0xLTA_038275ce-d3ed-4308-85dc-4156ab869b84"
      unitRef="usdPerShare">1.87</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTMtMS0xLTA_a00e1f4c-371f-4fed-854a-c085fe00023d"
      unitRef="usdPerShare">1.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTUtMS0xLTA_cf73bb7b-116e-49d9-ab53-f76727f3fb8c"
      unitRef="usdPerShare">1.17</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzIzLTctMS0xLTA_bbd70137-e62c-48f1-be2a-bb6dc6403512"
      unitRef="usdPerShare">0.72</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTEtMS0xLTA_d5995e34-2883-4684-aff8-22124d7309d8"
      unitRef="usdPerShare">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTMtMS0xLTA_819125ed-4490-449b-b676-48c7376c1ea5"
      unitRef="usdPerShare">-0.05</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTUtMS0xLTA_57160bb5-c5bb-4831-80f2-bc05876d6540"
      unitRef="usdPerShare">0.47</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI0LTctMS0xLTA_f0d5b71c-9b5d-4987-94cc-3a9265459717"
      unitRef="usdPerShare">0.18</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTEtMS0xLTA_43c78b95-0291-432c-8e86-98174174aab8"
      unitRef="usdPerShare">1.89</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTMtMS0xLTA_d86fe083-f0f2-4743-a7ea-7c076b9dd3f1"
      unitRef="usdPerShare">0.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTUtMS0xLTA_ef504e43-c537-4af1-991d-5a824c8fef3c"
      unitRef="usdPerShare">1.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI1LTctMS0xLTA_2f4197f4-5c27-4e96-bcf5-a65e299cfe35"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTEtMS0xLTA_8a0c1df3-e3b8-4067-a62f-0bbff8c52b75"
      unitRef="usdPerShare">1.86</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTMtMS0xLTA_504f9df6-44cc-4431-b08a-d6be80b643f8"
      unitRef="usdPerShare">0.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTUtMS0xLTA_76996ff7-c0ba-4f62-aec0-ff27a0adf28d"
      unitRef="usdPerShare">1.16</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI2LTctMS0xLTA_49dd73d0-ca56-41ce-ab6a-5035fb0eca71"
      unitRef="usdPerShare">0.72</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTEtMS0xLTA_40d737cf-6b7e-4371-b132-e5d26052b84a"
      unitRef="usdPerShare">0.02</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTMtMS0xLTA_8c4dc5d0-358b-495b-89cd-408f4c18a308"
      unitRef="usdPerShare">-0.04</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTUtMS0xLTA_640c4cd9-736c-4bf4-bbba-0e1cc76d7209"
      unitRef="usdPerShare">0.48</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI3LTctMS0xLTA_b8ac4918-62fe-4613-9f4a-db18497a71b1"
      unitRef="usdPerShare">0.18</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie04c44dea88b49e2ae0efd559ba16d64_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTEtMS0xLTA_22053bbc-4fda-4adf-b0f4-9297b5dd43a3"
      unitRef="usdPerShare">1.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8aded22c6e1344878859f45236d2a20d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTMtMS0xLTA_3fce21ce-d7ad-4c75-98b7-6f156f86dc52"
      unitRef="usdPerShare">0.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5079426d72b34ffe9bdd484c9c2290b9_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTUtMS0xLTA_f6b60edc-f614-403a-bae4-54c1f45ad1e7"
      unitRef="usdPerShare">1.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6c3c2a983b6747cdbee70d4950cf495b_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTo3MGE3NTcyZWJmM2Y0ZTQzYTY3MzIyZDk5ZThlODNhNS90YWJsZXJhbmdlOjcwYTc1NzJlYmYzZjRlNDNhNjczMjJkOTllOGU4M2E1XzI4LTctMS0xLTA_292ee9ca-50e3-45aa-9a4b-89af44e88b29"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if32f22662e54432da57bda5635cea91f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzMtMTEtMS0xLTA_e50ac15a-4956-40eb-8ffc-af885939f2f1"
      unitRef="usd">83855000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic1b594af4c5946d799a66354ffb0bb8e_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzMtMTUtMS0xLTI0NDg_4e7bdbc7-e57c-45eb-b50e-c9005e7566ea"
      unitRef="usd">41037000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="iaa4aa6d5d9f647368ce987a4ceb5e733_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzQtNS0xLTEtMjQ0Mw_637c2c95-ecdd-4e52-b68b-7ade42e5c57d"
      unitRef="usd">-16252000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i640e3c80e07c4131ab855012b2ae413d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMDQvZnJhZzo1MzA0NjIwYzJlM2Q0NDA4OTU3YzE4YjZjMTY2MGVmNS90YWJsZTphNjY2ZWZlYjBlNWE0OGE4OWRjNDIyYzA2NjI3NjBhNC90YWJsZXJhbmdlOmE2NjZlZmViMGU1YTQ4YTg5ZGM0MjJjMDY2Mjc2MGE0XzUtNS0xLTEtODUzOA_6c5709df-745d-4bb4-9c1f-f68e26d07fa8"
      unitRef="usd">35000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90ZXh0cmVnaW9uOjZkY2FjNDk5Mzc4ZjRkYjA4MDhiMWYxNTBlY2NiOGMwXzY2_60253f1f-bbe8-4333-9e13-b0b5654ef50a">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;DAVITA INC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II&#x2014;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts&lt;br/&gt;charged to income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at end of year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for uncollectible accounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90ZXh0cmVnaW9uOjZkY2FjNDk5Mzc4ZjRkYjA4MDhiMWYxNTBlY2NiOGMwXzY2_6540536d-9831-48e5-a635-87895e40e591">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;DAVITA INC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II&#x2014;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts&lt;br/&gt;charged to income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at end of year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for uncollectible accounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6d5a13855d6745d88e71a8dbda06352e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtMi0xLTEtMA_512a17bf-7ab3-4346-aefe-6ab548ed2af4"
      unitRef="usd">8328000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtNC0xLTEtMA_792416e4-33b7-4dae-a3a6-fec43f4f5bd6"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtNi0xLTEtMA_3c4b27dd-a44e-4c75-a95a-cd45466e1117"
      unitRef="usd">13458000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id167ef58ba8e47bd911a36fc44c79750_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtOC0xLTEtMA_546f5ebe-01d3-4ad8-958f-8707cde6fc3d"
      unitRef="usd">21786000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib323764e090d434bbb21570c9e96b6b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzQtMTAtMS0xLTA_6648e765-bfa4-473a-9d43-dac18d2af013"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8ffbc38c3d5d4d4fad2bd3d8db1d28bd_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtMi0xLTEtMA_e9ee58de-bbb7-47c1-a1c9-6b7ec299d012"
      unitRef="usd">52924000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtNC0xLTEtMA_49d1fe75-2877-42e9-9c27-0740afab1a5b"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtNi0xLTEtMA_ed9860ff-1555-40e7-b423-fbe6131f7237"
      unitRef="usd">21715000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iad1e2c9805e04b5daa80510c5484b041_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtOC0xLTEtMA_b39bccc7-0361-480d-805e-6f90602d68c5"
      unitRef="usd">66311000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6d5a13855d6745d88e71a8dbda06352e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzUtMTAtMS0xLTA_438e440e-b2f6-4b05-8bf6-a22bdac967ea"
      unitRef="usd">8328000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iea338e77f4034e17a9b6e514cff7d6d3_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtMi0xLTEtMA_137c141b-d490-4d02-85e4-fb8e43451acb"
      unitRef="usd">218399000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="i40704e0cd419424eaece0c344ca47892_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtNC0xLTEtMA_8bd36474-f8af-421b-a9f3-ad9800fa0dc4"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i40704e0cd419424eaece0c344ca47892_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtNi0xLTEtMA_d052abb3-61ce-42af-a81a-3bc831249580"
      unitRef="usd">42287000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i40704e0cd419424eaece0c344ca47892_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtOC0xLTEtMA_3b874e5e-c097-4249-bcd4-935f99cbff2c"
      unitRef="usd">207762000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8ffbc38c3d5d4d4fad2bd3d8db1d28bd_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODg0MGZlZTY1MjQ3ZGVhY2EyN2QyZGQ2YTgyNDZmL3NlYzo4Nzg4NDBmZWU2NTI0N2RlYWNhMjdkMmRkNmE4MjQ2Zl8zMTkvZnJhZzo2ZGNhYzQ5OTM3OGY0ZGIwODA4YjFmMTUwZWNjYjhjMC90YWJsZTozNjZmODcyMTRlNmE0NTg2YmFkNDA4YWUxYmI3Mzg2My90YWJsZXJhbmdlOjM2NmY4NzIxNGU2YTQ1ODZiYWQ0MDhhZTFiYjczODYzXzYtMTAtMS0xLTA_f4d36c2e-12b9-4321-abf4-01ab1ed5e080"
      unitRef="usd">52924000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394849549496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-14106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DAVITA INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0354549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000 16th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845822040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="nump">$ 11,039,709<span></span>
</td>
<td class="nump">$ 10,918,421<span></span>
</td>
<td class="nump">$ 10,709,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ProvisionForExpectedCreditLosses', window );">Provision for uncollectible accounts</a></td>
<td class="num">(13,458)<span></span>
</td>
<td class="num">(21,715)<span></span>
</td>
<td class="num">(49,587)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts', window );">Dialysis patient service revenues</a></td>
<td class="nump">11,026,251<span></span>
</td>
<td class="nump">10,896,706<span></span>
</td>
<td class="nump">10,660,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">524,353<span></span>
</td>
<td class="nump">491,773<span></span>
</td>
<td class="nump">744,457<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,550,604<span></span>
</td>
<td class="nump">11,388,479<span></span>
</td>
<td class="nump">11,404,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses and charges:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PatientCareCosts', window );">Patient care costs</a></td>
<td class="nump">7,988,613<span></span>
</td>
<td class="nump">7,914,485<span></span>
</td>
<td class="nump">8,195,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,247,584<span></span>
</td>
<td class="nump">1,103,312<span></span>
</td>
<td class="nump">1,135,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">630,435<span></span>
</td>
<td class="nump">615,152<span></span>
</td>
<td class="nump">591,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease', window );">Provision for uncollectible accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment (income) loss</a></td>
<td class="num">(26,916)<span></span>
</td>
<td class="num">(12,679)<span></span>
</td>
<td class="nump">4,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Other asset impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,892<span></span>
</td>
<td class="nump">3,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss (gain) on changes in ownership interest, net</a></td>
<td class="nump">16,252<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(60,603)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses and charges</a></td>
<td class="nump">9,855,968<span></span>
</td>
<td class="nump">9,745,162<span></span>
</td>
<td class="nump">9,879,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,694,636<span></span>
</td>
<td class="nump">1,643,317<span></span>
</td>
<td class="nump">1,525,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(304,111)<span></span>
</td>
<td class="num">(443,824)<span></span>
</td>
<td class="num">(487,435)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtPrepaymentRefinancingRedemptionCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="num">(89,022)<span></span>
</td>
<td class="num">(33,402)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">16,759<span></span>
</td>
<td class="nump">29,348<span></span>
</td>
<td class="nump">10,089<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">1,318,262<span></span>
</td>
<td class="nump">1,195,439<span></span>
</td>
<td class="nump">1,048,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">313,932<span></span>
</td>
<td class="nump">279,628<span></span>
</td>
<td class="nump">258,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income from continuing operations</a></td>
<td class="nump">1,004,330<span></span>
</td>
<td class="nump">915,811<span></span>
</td>
<td class="nump">790,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net (loss) income from discontinued operations, net of tax</a></td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">105,483<span></span>
</td>
<td class="num">(457,038)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">994,677<span></span>
</td>
<td class="nump">1,021,294<span></span>
</td>
<td class="nump">333,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="num">(221,035)<span></span>
</td>
<td class="num">(210,313)<span></span>
</td>
<td class="num">(173,646)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
<td class="nump">$ 159,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income from continuing operations (in usd per share)</a></td>
<td class="nump">$ 6.54<span></span>
</td>
<td class="nump">$ 4.61<span></span>
</td>
<td class="nump">$ 3.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (in usd per share)</a></td>
<td class="nump">6.46<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
<td class="nump">0.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income from continuing operations (in usd per share)</a></td>
<td class="nump">6.39<span></span>
</td>
<td class="nump">4.60<span></span>
</td>
<td class="nump">3.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (in usd per share)</a></td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares for earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares (in shares)</a></td>
<td class="nump">119,797,000<span></span>
</td>
<td class="nump">153,181,000<span></span>
</td>
<td class="nump">170,786,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares (in shares)</a></td>
<td class="nump">122,623,000<span></span>
</td>
<td class="nump">153,812,000<span></span>
</td>
<td class="nump">172,365,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Amounts attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="nump">$ 783,295<span></span>
</td>
<td class="nump">$ 706,832<span></span>
</td>
<td class="nump">$ 624,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net (loss) income from discontinued operations</a></td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">104,149<span></span>
</td>
<td class="num">(464,927)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
<td class="nump">$ 159,394<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtPrepaymentRefinancingRedemptionCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment, refinancing and redemption charges related to long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtPrepaymentRefinancingRedemptionCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PatientCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PatientCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ProvisionForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision For Expected Credit Losses, contra revenue account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ProvisionForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846839944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 994,677<span></span>
</td>
<td class="nump">$ 1,021,294<span></span>
</td>
<td class="nump">$ 333,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized (losses) gains on interest rate cap agreements:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized (losses) gains</a></td>
<td class="num">(16,346)<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Reclassification into net income</a></td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized losses on foreign currency translation.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized losses on foreign currency translation</a></td>
<td class="num">(7,623)<span></span>
</td>
<td class="num">(20,102)<span></span>
</td>
<td class="num">(45,944)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(18,656)<span></span>
</td>
<td class="num">(12,574)<span></span>
</td>
<td class="num">(39,791)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">976,021<span></span>
</td>
<td class="nump">1,008,720<span></span>
</td>
<td class="nump">293,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(221,035)<span></span>
</td>
<td class="num">(210,313)<span></span>
</td>
<td class="num">(173,646)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to DaVita Inc.</a></td>
<td class="nump">$ 754,986<span></span>
</td>
<td class="nump">$ 798,407<span></span>
</td>
<td class="nump">$ 119,603<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394849650856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 324,958<span></span>
</td>
<td class="nump">$ 1,102,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and equivalents</a></td>
<td class="nump">176,832<span></span>
</td>
<td class="nump">106,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">20,101<span></span>
</td>
<td class="nump">11,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,824,282<span></span>
</td>
<td class="nump">1,795,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">111,625<span></span>
</td>
<td class="nump">97,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">544,376<span></span>
</td>
<td class="nump">489,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">76,387<span></span>
</td>
<td class="nump">66,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">70,163<span></span>
</td>
<td class="nump">19,772<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,148,724<span></span>
</td>
<td class="nump">3,690,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">3,521,824<span></span>
</td>
<td class="nump">3,473,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,863,089<span></span>
</td>
<td class="nump">2,830,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of accumulated amortization</a></td>
<td class="nump">166,585<span></span>
</td>
<td class="nump">135,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">257,491<span></span>
</td>
<td class="nump">241,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">32,193<span></span>
</td>
<td class="nump">36,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">79,501<span></span>
</td>
<td class="nump">115,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,919,109<span></span>
</td>
<td class="nump">6,787,635<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets, Total</a></td>
<td class="nump">16,988,516<span></span>
</td>
<td class="nump">17,311,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">434,253<span></span>
</td>
<td class="nump">403,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">810,529<span></span>
</td>
<td class="nump">756,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">685,555<span></span>
</td>
<td class="nump">695,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">369,497<span></span>
</td>
<td class="nump">343,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">168,541<span></span>
</td>
<td class="nump">130,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">7,768<span></span>
</td>
<td class="nump">42,412<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,476,143<span></span>
</td>
<td class="nump">2,372,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">2,738,670<span></span>
</td>
<td class="nump">2,723,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">7,917,263<span></span>
</td>
<td class="nump">7,977,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">150,060<span></span>
</td>
<td class="nump">160,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">809,600<span></span>
</td>
<td class="nump">577,543<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,091,736<span></span>
</td>
<td class="nump">13,811,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,330,028<span></span>
</td>
<td class="nump">1,180,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock ($0.001 par value, 5,000 shares authorized; none issued)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock ($0.001 par value, 450,000 shares authorized; 109,933 and 125,843 shares issued and outstanding at December 31, 2020 and 2019, respectively)</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">597,073<span></span>
</td>
<td class="nump">749,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">852,537<span></span>
</td>
<td class="nump">1,431,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(66,154)<span></span>
</td>
<td class="num">(47,498)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total DaVita Inc. shareholders' equity</a></td>
<td class="nump">1,383,566<span></span>
</td>
<td class="nump">2,133,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests not subject to put provisions</a></td>
<td class="nump">183,186<span></span>
</td>
<td class="nump">185,833<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">1,566,752<span></span>
</td>
<td class="nump">2,319,242<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 16,988,516<span></span>
</td>
<td class="nump">$ 17,311,394<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845803688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">450,000,000<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">109,933,000<span></span>
</td>
<td class="nump">125,843,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">109,933,000<span></span>
</td>
<td class="nump">125,843,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394936067880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 994,677<span></span>
</td>
<td class="nump">$ 1,021,294<span></span>
</td>
<td class="nump">$ 333,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">630,435<span></span>
</td>
<td class="nump">615,152<span></span>
</td>
<td class="nump">591,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,892<span></span>
</td>
<td class="nump">61,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment', window );">Valuation adjustment on disposal group</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">316,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtRefinancingCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="nump">86,957<span></span>
</td>
<td class="nump">33,402<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">91,458<span></span>
</td>
<td class="nump">67,850<span></span>
</td>
<td class="nump">73,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">240,848<span></span>
</td>
<td class="nump">41,723<span></span>
</td>
<td class="nump">273,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdjustmentIncomeLossFromEquityMethodInvestments', window );">Equity investment income, net</a></td>
<td class="nump">13,830<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
<td class="nump">26,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss (gain) on sales of business interests, net</a></td>
<td class="nump">24,248<span></span>
</td>
<td class="nump">23,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetLossGainOnDispositionOfBusinessInterests', window );">Loss (gain) on sales of business interests, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash charges, net</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">49,579<span></span>
</td>
<td class="nump">82,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(21,087)<span></span>
</td>
<td class="num">(79,957)<span></span>
</td>
<td class="num">(81,176)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(12,349)<span></span>
</td>
<td class="nump">10,158<span></span>
</td>
<td class="nump">73,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets', window );">Other receivables and other current assets</a></td>
<td class="num">(79,277)<span></span>
</td>
<td class="nump">2,790<span></span>
</td>
<td class="nump">236,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(6,123)<span></span>
</td>
<td class="nump">6,965<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">37,200<span></span>
</td>
<td class="num">(84,539)<span></span>
</td>
<td class="num">(35,959)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(20,931)<span></span>
</td>
<td class="num">(14,697)<span></span>
</td>
<td class="nump">84,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">105,637<span></span>
</td>
<td class="nump">181,940<span></span>
</td>
<td class="num">(157,462)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(87,391)<span></span>
</td>
<td class="nump">95,645<span></span>
</td>
<td class="num">(23,635)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(19,851)<span></span>
</td>
<td class="num">(31,446)<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities, Total</a></td>
<td class="nump">1,979,028<span></span>
</td>
<td class="nump">2,072,355<span></span>
</td>
<td class="nump">1,771,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions of property and equipment</a></td>
<td class="num">(674,541)<span></span>
</td>
<td class="num">(766,546)<span></span>
</td>
<td class="num">(987,138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisitions</a></td>
<td class="num">(182,013)<span></span>
</td>
<td class="num">(100,861)<span></span>
</td>
<td class="num">(183,156)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from asset and business sales</a></td>
<td class="nump">50,139<span></span>
</td>
<td class="nump">3,877,392<span></span>
</td>
<td class="nump">150,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchase of debt investments held-to-maturity</a></td>
<td class="num">(150,701)<span></span>
</td>
<td class="num">(101,462)<span></span>
</td>
<td class="num">(5,963)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Purchase of other debt and equity investments</a></td>
<td class="num">(3,757)<span></span>
</td>
<td class="num">(5,458)<span></span>
</td>
<td class="num">(8,448)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from debt investments held-to-maturity</a></td>
<td class="nump">151,213<span></span>
</td>
<td class="nump">95,376<span></span>
</td>
<td class="nump">34,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sale of other debt and equity investments</a></td>
<td class="nump">3,491<span></span>
</td>
<td class="nump">3,676<span></span>
</td>
<td class="nump">9,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investments</a></td>
<td class="num">(22,341)<span></span>
</td>
<td class="num">(9,366)<span></span>
</td>
<td class="num">(19,177)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distributions from equity method investments</a></td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">3,646<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities, Total</a></td>
<td class="num">(825,371)<span></span>
</td>
<td class="nump">2,995,340<span></span>
</td>
<td class="num">(1,005,643)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings</a></td>
<td class="nump">4,046,775<span></span>
</td>
<td class="nump">38,525,850<span></span>
</td>
<td class="nump">59,934,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payments on long-term debt</a></td>
<td class="num">(4,110,304)<span></span>
</td>
<td class="num">(40,520,722)<span></span>
</td>
<td class="num">(59,234,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtFinancingAndDebtRedemptionCosts', window );">Debt Financing And Debt Redemption Costs</a></td>
<td class="num">(105,848)<span></span>
</td>
<td class="num">(85,319)<span></span>
</td>
<td class="num">(5,027)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(1,458,442)<span></span>
</td>
<td class="num">(2,383,816)<span></span>
</td>
<td class="num">(1,161,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDistributionsToAffiliates', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(253,118)<span></span>
</td>
<td class="num">(233,123)<span></span>
</td>
<td class="num">(196,441)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PaymentsRelatedToStockPurchasesAndAwards', window );">Net (payments) receipts related to stock purchases and awards</a></td>
<td class="num">(975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Net (payments) receipts related to stock purchases and awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,382<span></span>
</td>
<td class="nump">13,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">42,966<span></span>
</td>
<td class="nump">57,317<span></span>
</td>
<td class="nump">52,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Proceeds from sales of additional noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchases of noncontrolling interests</a></td>
<td class="num">(7,831)<span></span>
</td>
<td class="num">(68,019)<span></span>
</td>
<td class="num">(28,082)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,846,777)<span></span>
</td>
<td class="num">(4,696,450)<span></span>
</td>
<td class="num">(625,354)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(13,808)<span></span>
</td>
<td class="num">(1,760)<span></span>
</td>
<td class="num">(3,350)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(706,928)<span></span>
</td>
<td class="nump">369,485<span></span>
</td>
<td class="nump">137,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</a></td>
<td class="nump">1,208,718<span></span>
</td>
<td class="nump">415,420<span></span>
</td>
<td class="nump">518,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash of continuing operations at end of the year</a></td>
<td class="nump">501,790<span></span>
</td>
<td class="nump">1,208,718<span></span>
</td>
<td class="nump">415,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(423,813)<span></span>
</td>
<td class="nump">240,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">$ (706,928)<span></span>
</td>
<td class="nump">$ 793,298<span></span>
</td>
<td class="num">$ (103,500)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdjustmentIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdjustmentIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtFinancingAndDebtRedemptionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Financing And Debt Redemption Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtFinancingAndDebtRedemptionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtRefinancingCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment refinancing redemption charges related to debt modification of long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtRefinancingCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operations Valuation Adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in other current receivables and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss (Gain) On Disposition Of Business Interests Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LossGainOnDispositionOfBusinessInterestsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetLossGainOnDispositionOfBusinessInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net loss (gain) on disposition of business interests from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetLossGainOnDispositionOfBusinessInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PaymentsRelatedToStockPurchasesAndAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments related to stock purchases and awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PaymentsRelatedToStockPurchasesAndAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDistributionsToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDistributionsToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394855072792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total</div></th>
<th class="th">
<div>Total </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Non-controlling interests subject to put provisions</div></th>
<th class="th">
<div>Non-controlling interests subject to put provisions </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th">
<div>Accumulated other comprehensive income (loss) </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Non-controlling interests not subject to put provisions</div></th>
<th class="th">
<div>Non-controlling interests not subject to put provisions </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,690,029<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 1,042,899<span></span>
</td>
<td class="nump">$ 3,633,713<span></span>
</td>
<td class="nump">$ 8,368<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,235<span></span>
</td>
<td class="num">$ (8,368)<span></span>
</td>
<td class="nump">$ 196,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, beginning balance at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,011,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(119,173)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,124,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">$ (39,791)<span></span>
</td>
<td class="num">(39,791)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,791)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock purchase shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">17,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award payment plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(5,335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77,268)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Acquisitions and divestitures, noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="num">(16,844,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,844,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="num">$ (1,153,511)<span></span>
</td>
<td class="num">(1,153,511)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,153,511)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,844,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,844,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="num">(95,213)<span></span>
</td>
<td class="num">(1,058,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,153,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,703,442<span></span>
</td>
<td class="nump">$ 39,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (38)<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">995,006<span></span>
</td>
<td class="nump">2,743,194<span></span>
</td>
<td class="nump">$ 39,876<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(34,924)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">204,956<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155,011)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,180,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">810,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">810,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">$ (12,574)<span></span>
</td>
<td class="num">(12,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock purchase shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">16,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award payment plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(3,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Acquisitions and divestitures, noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,480)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="num">(41,020,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,020,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="num">$ (2,402,475)<span></span>
</td>
<td class="num">(2,402,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,402,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,020,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (41)<span></span>
</td>
<td class="num">(240,121)<span></span>
</td>
<td class="num">(2,162,313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 2,319,242<span></span>
</td>
<td class="nump">2,133,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">749,043<span></span>
</td>
<td class="nump">1,431,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(47,498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">125,843,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,843,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,771)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,330,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">773,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">773,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">$ (18,656)<span></span>
</td>
<td class="num">(18,656)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,656)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock purchase shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">17,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award payment plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(17,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Acquisitions and divestitures, noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="num">(16,477,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,477,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="num">$ (1,446,767)<span></span>
</td>
<td class="num">(1,446,767)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,446,767)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,477,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">(93,908)<span></span>
</td>
<td class="num">(1,352,843)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,566,752<span></span>
</td>
<td class="nump">$ 1,383,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 597,073<span></span>
</td>
<td class="nump">$ 852,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (66,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">109,933,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,933,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseFromContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest increase from contributions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseFromContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasePurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease Purchase Of Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasePurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843715000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization and Summary of Significant Accounting Policies</a></td>
<td class="text">Organization and summary of significant accounting policies<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its dialysis and related lab services to patients in the United States (its U.S. dialysis business), its ancillary services and strategic initiatives including its international operations (collectively, its ancillary services), and its corporate administrative support.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s largest line of business is its U.S. dialysis business, which operates kidney dialysis centers in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December&#160;31, 2020, the Company operated or provided administrative services through a network of 2,816 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 204,200 patients. In addition, as of December&#160;31, 2020, the Company operated or provided administrative services to a total of 321 outpatient dialysis centers serving approximately 36,200 patients located in ten countries outside of the U.S.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented in these consolidated financial statements. For financial information about the DMG business, see Note 22.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. dialysis business qualifies as a separately reportable segment and the Company&#8217;s ancillary services, including its international operations, have been combined and disclosed in the other segments category.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of presentation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company only has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#8217;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#8217;s international subsidiaries from their functional currencies into the Company&#8217;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#8217;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, the Company adopted Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 606) using the cumulative effect method for those contracts that were not substantially completed as of January 1, 2018. Results for reporting periods beginning on and after January 1, 2018 are presented under Topic 606.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of this new standard primarily changed the Company&#8217;s presentation of revenues, provision for uncollectible accounts and allowance for doubtful accounts. Topic 606 requires revenue to be recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Accordingly, for performance obligations satisfied after the adoption of Topic 606, the Company no longer separately presents a provision for uncollectible accounts on the consolidated income statement and no longer presents the related allowance for doubtful accounts on the consolidated balance sheet. However, as a result of the Company&#8217;s election to apply Topic 606 only to contracts not substantially completed as of January 1, 2018, the Company continued to maintain an allowance for doubtful accounts related to performance obligations satisfied prior to the adoption of Topic 606. Net collections or write-offs of accounts receivable generated prior to January 1, 2018, beyond amounts previously reserved thereon, are presented in the provision for uncollectible accounts on the consolidated income statement in accordance with Topic 605.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare&#8217;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#8217;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#8217;s base payment rate as well as these other variable factors.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#8217;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#8217;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#8217;s usual and customary rates.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services and strategic initiatives. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and ESRD seamless care organizations are estimated in the period services are provided. Revenues associated with pharmacy services until that business was closed in 2018 were estimated as prescriptions were filled and shipped to patients. Revenues associated with direct primary care until that business was sold in 2018 were estimated over the membership period.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted cash and equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow for certain legal settlements pending finalization.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in debt and equity securities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#8217;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within "Other income, net". These debt and equity investments are classified as "short-term investments" or "long-term investments" on the Company's consolidated balance sheet. See Note 5 for further details.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels from the manufacturer and related data submission.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and equipment</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortizable intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: non-competition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indefinite-lived intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity method and other investments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as &#8220;Equity method and other investments&#8221; on the Company's consolidated balance sheet.&#160;See Note 9 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Self-insurance</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#8217; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate cap agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes. As of December&#160;31, 2020, third parties held noncontrolling equity interests in 688 consolidated legal entities.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based compensation, as applicable. The Company has also classified its assets, liabilities and temporary equity into the appropriate fair value hierarchy levels as defined by the FASB. See Note 24 for further details.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New accounting standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this ASU amend the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments and off-balance sheet credit exposures. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied using a modified retrospective basis. The adoption of ASU No. 2016-13 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework -Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The applicable amendments in this ASU remove requirements for disclosures concerning transfers between fair value measurement levels 1, 2 and 3 and disclosures concerning </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation processes for level 3 fair value measurements. The applicable amendments in this ASU also add a requirement to separately disclose the changes in unrealized gains and losses included in other comprehensive income for the reporting period for level 3 items measured at fair value on a recurring basis, and require disclosure of the range and weighted average of significant unobservable inputs used to develop level 3 fair value measurements.&#160;The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied on a prospective basis.&#160;The adoption of this ASU did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2018-15 aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted this ASU as of January 1, 2020, using the prospective transition approach, which allows the Company to change the accounting method without restating prior periods or booking cumulative adjustments. The adoption of ASU No. 2018-15 did not have a material impact on the Company's consolidated financial statements. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The Company has evaluated the impact of this standard on its consolidated financial statements, including accounting policies, processes, and systems, and does not expect the impact to be material.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843885016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">Revenue recognition and accounts receivable<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and primary payor source were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,048,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,048,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,514,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,129,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,129,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,286,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,430,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,430,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,063,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,063,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,176,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,242,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,404,851&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no allowance for doubtful accounts related to performance obligations satisfied in years prior to January 1, 2018 as of December&#160;31, 2020 and such allowance was $8,328 as of December&#160;31, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 1, there are significant risks associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues including determining applicable primary and secondary coverage, changes in patient coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period. As a result of these changes in estimates, no additional revenue was recognized during the year ended December&#160;31, 2020 associated with performance obligations satisfied prior to January 1, 2018 and additional revenue of $37,274 was recognized during the year ended December&#160;31, 2019 associated with performance obligations satisfied in years prior to January 1, 2018.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no single commercial payor that accounted for more than 10% of total consolidated accounts receivable or consolidated revenues at or for the years ended December&#160;31, 2020 or 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div>Net dialysis services accounts receivable and other receivables from Medicare, including Medicare Advantage plans, and Medicaid, including managed Medicaid plans, were approximately $1,101,837 and $1,038,248 as of December&#160;31, 2020 and 2019, respectively. Approximately 17% and 18% of the Company&#8217;s net patient services accounts receivable balances as of December&#160;31, 2020 and 2019, respectively, were more than six months old. There were no significant balances over one year old at December&#160;31, 2020. The Company's accounts receivable are principally due from Medicare and Medicaid programs and commercial insurance plans.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843715000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings&#160;per share<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding, reduced for 2018 by the weighted average shares held in escrow that under certain circumstances may have been returned to the Company. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units (under the treasury stock method) and, for 2018, the weighted average contingently returnable shares held in escrow that were outstanding during the period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464,927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently returnable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently returnable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">previously held in escrow for the DaVita HealthCare Partners merger.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394844955720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Cash Restricted Cash<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAbstract', window );"><strong>Restricted Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">Cash and Cash Equivalents Disclosure [Text Block]</a></td>
<td class="text">Restricted cash and equivalentsThe Company had restricted cash and cash equivalents of $176,832 and $106,346 at December&#160;31, 2020 and 2019, respectively. Approximately $92,286 of the balance at December&#160;31, 2020 represents restricted cash equivalents held in trust to satisfy insurer and state regulatory requirements related to the wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company and $70,000 represents cash held in escrow to fund a previously announced legal settlement pending finalization. The remaining restricted cash and cash equivalents held at December&#160;31, 2020 primarily represents cash pledged to third parties in connection with one of the Company's ancillary services.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843927144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and long-term investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments in Debt and Equity Securities</a></td>
<td class="text">Short-term and long-term investments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,884&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,432&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,572&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2020 and 2019.</span></div>Equity securities: The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#8217;s non-qualified deferred compensation plans. During 2020, the Company recognized pre-tax net gains of $3,818 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,941 and a net increase in unrealized gains of $1,877. During 2019, the Company recognized pre-tax net gains of $4,383 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,459 and a net increase in unrealized gains of $2,924.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851389224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables Other Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Other Receivables</a></td>
<td class="text">Other receivables<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables were comprised of the following:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"><tr><td style="width:1.0%"/><td style="width:56.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier rebates and non-trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare bad debt claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851524360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and equipment<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:66.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.467%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,865,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and information systems, including internally developed software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,880,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New center and capital asset projects in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,442,950&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,480,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,969,566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,521,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,473,384&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses are computed using the straight-line method over the useful lives of the assets estimated as follows: buildings, 25 years to 40 years; leasehold improvements, the shorter of ten years or the expected lease term; and equipment and information systems, principally three years to 15 years. Depreciation expense on property and equipment was $616,626, $600,905, and $574,799 for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on debt incurred during the development of new centers and other capital asset projects is capitalized as a component of the asset cost based on the respective in-process capital asset balances. Interest capitalized was $17,944, $27,322 and $25,978 for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, the Company recognized asset impairment charges of $17,338 related to the restructuring of its pharmacy business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845623960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangibles</a></td>
<td class="text">Intangible assets<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"><tr><td style="width:1.0%"/><td style="width:54.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncompetition agreements are generally amortized over three years to 10 years and customer relationships are principally amortized over 10 years to 20 years. Amortization expense from amortizable intangible assets was $13,809, $14,247, and $16,236 for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized no impairment charges on any intangible assets other than the goodwill impairment charges discussed in Note 10.</span></div>Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2020 were as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"><tr><td style="width:1.0%"/><td style="width:37.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.032%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncompetition<br/>agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Customer relationships and other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,304&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845325624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method and Other Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Equity Method Investments and Joint Ventures Disclosure</a></td>
<td class="text">Equity method and other investments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"><tr><td style="width:1.0%"/><td style="width:56.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.611%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.612%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC joint venture</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other equity method partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted cost method and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,983&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, the Company recognized equity investment income (loss) of $26,916, $12,679 and $(4,484), respectively, from its equity method investments in nonconsolidated businesses.&#160;</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's largest equity method investment is its ownership interest in DaVita Care Pte. Ltd. (the APAC joint venture, or APAC JV). The Company holds a 75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voting and economic interest in the APAC JV and an unrelated noncontrolling investor holds the other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25% voting and economic interest in the joint venture. During 2019 the continuing third party noncontrolling investor made its final subscribed capital contribution to the joint venture and the other previous third party noncontrolling investor elected to exit the joint venture. The governance structure and voting rights established for the APAC JV, which remain unchanged since its formation on August&#160;1, 2016, provide that certain key decisions affecting the joint venture&#8217;s operations are not subject to the unilateral discretion of the Company but rather are under the joint control of the Company and the APAC JV's unrelated noncontrolling investor. As a result, the Company does not consolidate the APAC JV.</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the transactions described above, the Company held a 60% voting interest and a 73.3% economic interest in the APAC JV, while the other two noncontrolling investors collectively held a 40% voting interest and a 26.7% economic interest in the APAC JV. </span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other equity method investments include 22 legal entities over which the Company has significant influence but in which it does not maintain a controlling financial interest. Almost all of these are U.S. dialysis partnerships in the form of limited liability companies. The Company's ownership interests in these partnerships vary, but typically range from 30% to 50%.</span></div>There were no significant impairments or other valuation adjustments on the Company's adjusted cost method and other investments during 2020, 2019 or 2018.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843866952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:40.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other - Ancillary<br/>services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,275,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,841,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,659)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,287,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,787,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,055,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,551)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,551)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic, further spread or resurgence of the virus, including as a result of the emergence of the new strains of the virus, its impact on the chronic kidney disease (CKD) patient population and the Company's patient population, the availability, acceptance, impact and efficacy of COVID-19 treatments, therapies and vaccines, the pandemic's continuing impact on the U.S. and global economies and unemployment, the responses of the Company's competitors to the pandemic and related changes in the marketplaces, and the timing, scope and effectiveness of governmental responses. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company&#8217;s operating segments described in Note 25 to these consolidated financial statements represents an individual reporting unit for goodwill impairment assessment purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the U.S. dialysis operating segment, the Company considers each of its dialysis centers to constitute an individual business for which discrete financial information is available. However, since these dialysis centers have similar operating and economic characteristics, and the allocation of resources and significant investment decisions concerning these businesses are highly centralized and the benefits broadly distributed, the Company has aggregated these centers and deemed them to constitute a single reporting unit.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has applied a similar aggregation to the physician practices in its physician services reporting units, to the dialysis centers and other health operations within each international reporting unit, and to the vascular access service centers in its former vascular access services reporting unit. For the Company&#8217;s other operating segments, discrete business components below the operating segment level constitute individual reporting units.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing quantitative goodwill impairment assessments, the Company estimates fair value using either appraisals developed with an independent third party valuation firm which consider both discounted cash flow estimates for the subject business and observed market multiples for similar businesses, or offer prices received for the subject business that would be acceptable to the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2019, the Company recognized goodwill impairment charges of $119,476 in its Germany kidney care business. These charges resulted primarily from a decline in then current and expected future patient census and an increase in then current and expected future costs, including due to wage increases expected to result from legislation announced at that time. The changes in the Company's expectations were informed by developments in the business in response to evolving market conditions, including changes in the Company's expected timing and ability to mitigate them, </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and based on in-depth operating and strategic reviews completed by the Company's new Germany management team. During the year ended December&#160;31, 2019 the Company also recognized a goodwill impairment charge of $5,416 in its German other health operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its most recent assessments, the Company determined that further changes in expected patient census, increases in operating costs, reductions in reimbursement rates, changes in actual or expected growth rates, or other significant adverse changes in expected future cash flows or valuation assumptions could result in goodwill impairment charges in the future for the following reporting unit, which remains at risk of goodwill impairment as of December&#160;31, 2020:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.660%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reporting unit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Goodwill<br/>balance</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">coverage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sensitivities</span></td></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany kidney care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described above, none of the Company&#8217;s other reporting units were considered at risk of significant goodwill impairment as of December&#160;31, 2020.&#160;Since the dates of the Company&#8217;s last annual goodwill impairment assessments, there have been certain developments, events, changes in operating performance and other changes in key circumstances that have affected the Company&#8217;s businesses. However, these have not caused management to believe it is more likely than not that the fair values of any of the Company&#8217;s reporting units would be less than their respective carrying amounts as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843886680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Liabilities</a></td>
<td class="text">Other liabilities<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"><tr><td style="width:1.0%"/><td style="width:51.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.898%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.759%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor refunds and retractions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance and self-insurance accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued non-income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851526952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income taxes<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes from continuing operations consisted of the following:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Income tax expense for continuing operations consisted of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,838&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,789&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are allocated between continuing and discontinued operations as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the Company&#8217;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"/><td style="width:49.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in International valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Political advocacy costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests primarily<br/> attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"/><td style="width:54.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(634,736)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563,914)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(527,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583,246)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,344,079)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(577,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;At December&#160;31, 2020, the Company had federal net operating loss carryforwards of approximately $99,657 that expire through 2036, although a substantial amount expire by 2029. The Company also had state net operating loss carryforwards of $488,070, some of which have an indefinite life, although a substantial amount expire by 2040 and international net operating loss carryforwards of $296,451, some of which will begin to expire in 2021 though the majority have an indefinite life. The Company has a state capital loss carryover of $297,748, the majority of which expires in 2024. The utilization of a portion of these losses may be limited in future years based on the profitability of certain entities. A valuation allowance is recorded to account for the unrealizable balances in the table above. The net increase of $22,899 in the valuation allowance is primarily due to newly created net operating loss carryforwards in state and foreign jurisdictions that the Company does not anticipate being able to utilize.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's foreign earnings continue to be indefinitely reinvested as of December&#160;31, 2020. As a result of the passage of the Tax Cuts and Jobs Act (2017 Tax Act), the Company does not expect such earnings to be taxable if remitted.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unrecognized tax benefits</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:61.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.250%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions related to lapse of applicable statute</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,214&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company&#8217;s total liability for unrecognized tax benefits relating to tax positions that do not meet the more-likely-than-not threshold is $70,202, of which $66,607 would impact the Company&#8217;s effective tax rate if recognized. This balance represents an increase of $1,988 from the December&#160;31, 2019 balance of $68,214.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. At December&#160;31, 2020 and 2019, the Company had approximately $17,864 and $14,428, respectively, accrued for interest and penalties related to unrecognized tax benefits, net of federal tax benefit.</span></div>The Company and its subsidiaries file U.S. federal and state income tax returns and various foreign income tax returns. The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2014 and 2009, respectively. In addition to being under audit in various state and local tax jurisdictions, the Company&#8217;s federal tax returns are under audit by the Internal Revenue Service for the years 2014-2017.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843917512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-term debt<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:34.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,684,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR + 1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,702,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR + 0.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.125% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/15/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021-2036</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021-2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,163,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,181,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,085,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,108,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,541)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,917,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,977,526&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The Company's interest rate for its revolving line of credit as of December&#160;31, 2020 was based on an Alternate Base Rate (ABR or Prime Rate) plus 0.50%, or 3.75%. Effective January 6, 2021 this was converted to a LIBOR-based rate of LIBOR plus 1.50%. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2020.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,461 and deferred financing costs of $35,825 and the carrying amount of the Company's senior notes includes deferred financing costs of $36,431. As of December&#160;31, 2019, the carrying amount of the Company's senior secured credit facilities included a discount of $6,457 and deferred financing costs of $45,444, and the carrying amount of the Company's senior notes included deferred financing costs of $20,939.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled maturities of long-term debt at December&#160;31, 2020 were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"><tr><td style="width:1.0%"/><td style="width:58.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.441%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,031,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;13, 2020, the Company entered into an amendment (the Repricing Amendment) to refinance and reprice its senior secured Term Loan B with a senior secured Term Loan B-1 that bears interest at a rate equal to LIBOR plus an applicable margin of 1.75% and matures on August&#160;12, 2026. The Repricing Amendment did not change the interest rate on the Term Loan A or the revolving line of credit. No additional debt was incurred, nor any additional proceeds received, by the Company in connection with the Repricing Amendment. The majority of the Company's Term Loan B debt was considered modified in this transaction. As a result, the Company recognized debt refinancing charges of $2,948 in the year ended December 31, 2020 comprised partially of fees incurred on this transaction and partially of deferred financing costs written off for the portion of debt considered extinguished and reborrowed. For the portion of the Term Loan B debt that was considered extinguished and reborrowed in this refinancing, the Company recognized $68,842 in constructive financing cash outflows and financing cash inflows on the statement of cash flows, even though no funds were actually paid or received. Another $55,895 of the debt considered extinguished in this refinancing represented a non-cash financing activity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $54,688 on Term Loan A and $27,431 on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2020, the Company issued $1,750,000 aggregate principal amount of 4.625% senior notes due 2030 (the 4.625% Senior Notes) in a private offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 4.625% Senior Notes pay interest on June&#160;1 and December&#160;1 of each year beginning December&#160;1, 2020. The 4.625% Senior Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. The 4.625% Senior Notes are guaranteed by each of the Company&#8217;s domestic subsidiaries that guarantee its senior secured credit facilities. The Company may redeem up to 40% of the aggregate principal amount of the 4.625% Senior Notes at any time prior to June 1, 2023 at 104.625% of the aggregate principal amount from the proceeds of one or more equity offerings, plus accrued and unpaid interest. In addition, the Company may redeem the 4.625% Senior Notes at any time prior to June 1, 2025 at a make-whole redemption price plus accrued and unpaid interest or, on and after such date, at certain redemption prices specified in the indenture governing these notes plus accrued and unpaid interest. The 4.625% Senior Notes contain restrictive covenants that limit the ability of the Company and its guarantors to, among other things, create certain liens, enter into certain sale/leaseback transactions, or merge, consolidate or sell all or substantially all of their assets. The 4.625% Senior Notes and related subsidiary guarantees do not have any registration or similar rights and are not expected to be registered for exchange on public markets. During the year ended December 31, 2020, the Company incurred $20,386 in fees, discounts and other professional expenses associated with this transaction that were capitalized and will amortize over the term of the 4.625% Senior Notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2020, the Company used the net proceeds from these 4.625% Senior Notes, together with cash on hand, to redeem in full all $1,750,000 aggregate principal amount outstanding of its 5.125% Senior Notes plus accrued interest and redemption premium. The Company incurred debt redemption premium charges of $29,890 and deferred financing cost write-offs of $9,764 in connection with this redemption.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2020, the Company issued $1,500,000 aggregate principal amount of 3.75% senior notes due 2031 (the 3.75% Senior Notes) in a private offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 3.75% Senior Notes pay interest on February&#160;15 and August&#160;15 of each year beginning February&#160;15, 2021. The 3.75% Senior Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. The 3.75% Senior Notes are guaranteed by each of the Company&#8217;s domestic subsidiaries that guarantee its senior secured credit facilities. The Company may redeem up to 40% of the aggregate principal amount of the 3.75% Senior Notes at any time prior to August 15, 2023 at 103.75% of the aggregate principal amount from the proceeds of one or more equity offerings, plus accrued and unpaid interest. In addition, the Company may redeem the 3.75% Senior Notes at any time prior to February 15, 2026 at a make-whole redemption price plus accrued and unpaid interest or, on and after such date, at certain redemption prices specified in the indenture governing these notes plus accrued and unpaid interest. The 3.75% Senior Notes contain restrictive covenants that limit the ability of the Company and its guarantors to, among other things, create </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain liens, enter into certain sale/leaseback transactions, or merge, consolidate or sell all or substantially all of their assets. The 3.75% Senior Notes and related subsidiary guarantees do not have any registration or similar rights and are not expected to be registered for exchange on public markets. During the year ended December 31, 2020, the Company incurred $17,936 in fees, discounts and other professional expenses associated with this transaction that were capitalized and will amortize over the term of the 3.75% Senior Notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company used the net proceeds from these 3.75% Senior Notes, together with cash on hand, to redeem in full all $1,500,000 aggregate principal amount outstanding of its 5.0% Senior Notes plus accrued interest and redemption premium. The Company incurred debt redemption premium charges of $37,500 and deferred financing cost write-offs of $8,866 in connection with this redemption.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's 2015 interest rate cap agreements expired on June&#160;30, 2020, at which time the Company's 2019 cap agreements became effective. As of December&#160;31, 2020, the Company maintains several interest rate cap agreements that have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on specific portions of the Company's floating rate debt, including all of the Term Loan B-1 and a portion of the Term Loan A. The remaining $900,069 outstanding principal balance of the Term Loan A and the $75,000 outstanding balance of the revolving line of credit are subject to LIBOR-based interest rate volatility. The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The amortization of the original cap premium is recognized as a component of debt expense on the interest method over the terms of the cap agreements. These cap agreements do not contain credit-risk contingent features.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of December&#160;31, 2020 and December&#160;31, 2019, which are classified in "Other long-term assets" on its consolidated balance sheet:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Recorded OCI loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 cap agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/29/2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of the Company&#8217;s interest rate cap agreements for the years ended December&#160;31, 2020, 2019 and 2018:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (losses) gains in OCI on interest rate cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of losses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassification from accumulated other comprehensive income into net income</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 20 for further details on amounts recorded and reclassified from accumulated other comprehensive (loss) income.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of 2020 was 2.03%, based upon the current margins in effect for the Term Loan A, Term Loan B-1 and revolving line of credit as of December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was 3.59% for the year ended December&#160;31, 2020 and 3.06% as of December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company&#8217;s interest rates were fixed on approximately 44.4% of its total debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had $925,000 available and $75,000 drawn on its $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this revolver is reduced by the amount of any letters of credit outstanding under this facility, but there were no such letters of credit outstanding as of December&#160;31, 2020. The </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company also had approximately $64,636 of outstanding letters of credit under a separate bilateral secured letter of credit facility as of December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense consisted of interest expense of $282,932, $419,639 and $461,897 and the amortization and accretion of debt discounts and premiums, amortization of deferred financing costs and the amortization of interest rate cap agreements of $21,179, $24,185 and $25,538 for 2020, 2019 and 2018, respectively. These interest expense amounts are net of capitalized interest.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843866952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which range in terms from five years to 20 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses. See Note 1 for further information on how the Company accounts for leases.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, assets recorded under finance leases were $275,389 and $247,246, respectively, and accumulated amortization associated with finance leases was $49,345 and $27,193, respectively, included in property and equipment, net, on the Company's consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain markets, the Company acquires and develops dialysis centers. Upon completion, the Company sells the center to a third party and leases the space back with the intent of operating the center on a long term basis. Both the sale and leaseback terms are generally market terms. The lease terms are consistent with the Company's other operating leases with the majority of the leases under non-cancellable operating leases ranging in terms from five years to 20 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beginning on January 1, 2019 through a modified retrospective approach for leases existing at the adoption date with a cumulative effect adjustment. Consequently, financial information was not updated for dates and periods before January 1, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"/><td style="width:52.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 7.75pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684,748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Includes short-term lease expense and sublease income, which are immaterial. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"/><td style="width:52.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease term and discount rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"/><td style="width:52.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on sale leasebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the <br/> measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating lease assets obtained in exchange<br/> for new or modified operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2020 are as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"><tr><td style="width:1.0%"/><td style="width:52.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,661,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less portion representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under all operating leases for 2020, 2019, and 2018 was $663,819, $646,092 and $596,117, respectively. Rent expense is recorded on a straight-line basis over the term of the lease, including leases that contain fixed escalation clauses or include abatement provisions. Leasehold improvement incentives are deferred and amortized to rent expense over the term of the lease. Finance lease obligations are included in long-term debt. See Note 13 for further details on long-term debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851927848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text">Employee benefit plans<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) retirement savings plan for substantially all of its U.S. employees which has been established pursuant to applicable provisions of the Internal Revenue Code (IRC). The plan allows for employees to contribute a percentage of their base annual salaries on a tax-deferred basis not to exceed IRC limitations. The Company maintains a 401(k) matching program under which the Company matches 50% of the employee's contribution up to 6% of the employee's salary, subject to certain limitations. The matching contributions are subject to certain eligibility and vesting conditions. For the years ended December&#160;31, 2020, 2019 and 2018, the Company accrued matching contributions totaling approximately $70,180, $64,988 and $67,807, respectively. Prior to 2018, the Company did not provide matching contributions for its 401(k) savings plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a voluntary compensation deferral plan, the Deferred Compensation Plan, as well as other legacy deferral plans. The Deferred Compensation Plan is non-qualified and permits certain employees whose annualized base salary equals or exceeds a minimum annual threshold amount as set by the Company to elect to defer all or a portion of their annual bonus payment and up to 50% of their base salary into a deferral account maintained by the Company. Total contributions to this plan in 2020, 2019 and 2018 were $3,637, $1,751 and $3,090, respectively. Deferred amounts are generally paid out in cash at the participant&#8217;s election either in the first or second year following retirement or in a specified future period at least three to four years after the deferral election was effective. During 2020, 2019 and 2018 the Company distributed $3,139, $2,730 and $4,652, respectively, to participants from its deferred compensation plans. Participants are credited with their proportional amount of annual earnings from the plans. The assets of these plans are held in rabbi trusts subject to the claims of the Company&#8217;s general creditors in the event of its bankruptcy. As of December&#160;31, 2020 and 2019, the total fair value of assets held in these plans' trusts was $43,844 and $39,527, respectively. The assets of these plans are recorded at fair value with changes in fair value recorded in "Other income, net". Any fair value changes to the corresponding liability balance are recorded as compensation expense. See Note 5 for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845105800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of December&#160;31, 2020 and December&#160;31, 2019, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government's investigation covers the period from January&#160;1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government's investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx's historic relationships with certain pharmaceutical manufacturers, and in July 2018 the OIG served the Company with a subpoena seeking additional documents and information relating to those relationships. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018 and May 2019, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 U.S. Attorney Florida Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#8217;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#8217;s Office is conducting an investigation as to whether the Company&#8217;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney's Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc. et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. On February 24, 2020, the Company and DaVita Labs filed a motion to dismiss the amended complaint. On June 25, 2020, the court denied the motion to dismiss. The Company and DaVita Labs answered the complaint on July 23, 2020. The Company and DaVita Labs dispute these allegations and intend to defend this action accordingly. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020. The subpoena, as revised, requests information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder and Derivative Claims</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Peace Officers&#8217; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On February 1, 2017, the Peace Officers&#8217; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities laws concerning the Company&#8217;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#8217;s business and operational status and future growth prospects."&#160;In November 2017, the court appointed the lead plaintiff and an amended complaint was filed on January 12, 2018. On March 27, 2018, the Company and various individual defendants filed a motion to dismiss. On March 28, 2019, the court denied the motion to dismiss. The Company answered the complaint on May 28, 2019. On January 31, 2020, the plaintiffs filed a motion for class certification and the Company filed its opposition on June 29, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to dispute the allegations, in July 2020, it reached an agreement in principle to resolve this matter without admitting to any liability. Settlement of this matter on the agreed terms is expected to be covered primarily with insurance proceeds, with the Company contributing an amount that would not have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. A motion for preliminary approval of the settlement was granted by the court on October 27, 2020. The settlement is subject to, among other things, final approval by the court.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re DaVita Inc. Stockholder Derivative Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#8217;s profits. An amended complaint was filed in September 2017, and on December 18, 2017, the Company filed a motion to dismiss and a motion to stay proceedings in the alternative. On April 25, 2019, the court denied the Company's motion to dismiss. The Company answered the complaint on May 28, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the defendants continue to dispute the allegations, in July 2020, an agreement in principle was reached to resolve this matter without admitting to any liability. The Company&#8217;s Board of Directors (Board) approved the settlement on October 20, 2020. The court granted a motion for final approval of the settlement on January 27, 2021 and approved the settlement on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but will not make any financial contribution towards the settlement.</span></div><div style="margin-top:9pt;padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 16 to these consolidated financial statements, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127163<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845172488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interests Subject to Put Provisions and Other Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Noncontrolling Interests Subject to Put Provisions and Other Commitments</a></td>
<td class="text">Noncontrolling interests subject to put provisions and other commitments<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests subject to put provisions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#8217; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#8217;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#8217; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#8217; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $8,663.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain consolidated dialysis partnerships are originally contractually scheduled to dissolve after terms ranging from ten years to 50 years. While noncontrolling interests in these limited life entities qualify as mandatorily redeemable financial instruments, they are subject to a classification and measurement scope exception from the accounting guidance generally applicable to other mandatorily redeemable financial instruments. Future distributions upon dissolution of these entities would be valued below the related noncontrolling interest carrying balances in the consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Company entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on December&#160;31, 2022. Under the terms of the agreement, the Company will purchase EPO from Amgen in amounts necessary to meet no less than 90% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that the Company will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that the Company serves.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with various suppliers to purchase established amounts of dialysis equipment, parts, and supplies. As of December&#160;31, 2020, the remaining minimum purchase commitments under these arrangements were approximately $542,061, $540,715, $179,869, and $92,075 for the years 2021, 2022, 2023, and 2024, respectively. If the Company fails to meet the minimum purchase commitments under these contracts during any year, it is required to pay the difference to the supplier.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the letters of credit disclosed in Note 13 to these consolidated financial statements, and the arrangements as described above, the Company has no off balance sheet financing arrangements as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851389224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Long-term Incentive Compensation and Shareholders&#8217; Equity</a></td>
<td class="text">Long-term incentive compensation<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term incentive program (LTIP) compensation includes both stock-based awards (principally stock-settled stock appreciation rights, restricted stock units and performance stock units) as well as long-term performance-based cash awards. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term incentive compensation expense, which is primarily general and administrative in nature, is attributed to the Company&#8217;s U.S. dialysis business, its corporate administrative support, and its ancillary services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all LTIP awards is recognized net of expected forfeitures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation to be settled in shares is recorded to the Company&#8217;s shareholders&#8217; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation plans</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2020, the Company&#8217;s stockholders approved the DaVita Inc. 2020 Incentive Award Plan (the 2020 Plan). Prior to June 11, 2020 stock-based awards were granted under the DaVita Healthcare Partners Inc. 2011 Incentive Award Plan (the 2011 Plan). The 2011 Plan was terminated with respect to any new awards upon stockholder approval of the 2020 Plan. At the time the 2020 Plan was approved there were 8,730 shares of common stock available for issuance under the 2020 Plan, consisting of 5,000 newly authorized shares and 3,730 shares that were available for issuance under the 2011 Plan as of the effective date of the 2020 Plan and which became available for grant under the 2020 Plan, pursuant to the terms of the 2020 Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan is the Company&#8217;s current omnibus equity compensation plan and provides for grants of stock-based awards to employees, directors and other individuals providing services to the Company, except that incentive stock options may only be awarded to employees. The 2020 Plan provides for the grant of stock appreciation rights, nonqualified stock options, incentive stock options, restricted stock units, restricted stock, performance stock awards, dividend equivalents, stock payments, deferred stock unit awards, deferred stock awards and performance cash awards. The 2020 Plan mandates a maximum award term of 10 years for stock appreciation rights and stock options and stipulates that awards of these types be granted with a base or exercise price per share of not less than the fair market value of the Company's common stock on the date of grant. Shares available under the 2020 Plan are also stated on a full value share basis rather than on an option-equivalent basis. The 2020 Plan therefore provides that shares available for issuance under the plan are reduced by one share available for every four shares underlying stock appreciation rights and stock options, and are reduced by one share available for every one share underlying stock-based awards other than stock appreciation rights and stock options. At December&#160;31, 2020, there were 8,074 shares available for future grants under the 2020 Plan. The Company&#8217;s stock units awarded under the 2020 Plan generally vest over 36 months to 48 months from the date of grant. As of December&#160;31, 2020, no stock appreciation rights have been awarded under the 2020 Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2011 Plan was the Company&#8217;s prior omnibus equity compensation plan and authorized the Company to award stock options, stock appreciation rights, restricted stock units, restricted stock, and other stock-based or performance-based awards. The 2011 Plan mandated a maximum award term of five years and stipulated that stock appreciation rights and stock options be granted with prices not less than fair market value on the date of grant. The 2011 Plan also required that full value share awards such as restricted stock units reduce shares available under the 2011 Plan at a ratio of 3.5:1. The Company&#8217;s stock appreciation rights and stock units awarded under the 2011 Plan generally vest over 36 months to 48 months from the date of grant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A combined summary of the status of the Company&#8217;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:37.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.827%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock appreciation rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,953&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Added by performance factor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.56&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of grants:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.04&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:14pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"><tr><td style="width:1.0%"/><td style="width:28.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.438%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards Outstanding</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards exercisable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of SSARs base prices</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.01&#8211;$60.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.01&#8211;$70.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.01&#8211;$80.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,084&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019, and 2018, the aggregate intrinsic value of stock-based awards exercised was $49,258, $11,475 and $31,045, respectively. At December&#160;31, 2020, the aggregate intrinsic value of stock-based awards outstanding was $853,803 and the aggregate intrinsic value of stock awards exercisable was $47,208.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimated fair value of stock-based compensation awards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has estimated the grant-date fair value of stock-settled stock appreciation rights awards using the Black-Scholes-Merton valuation model and stock-settled stock unit awards at intrinsic value on the date of grant, except for portions of the Company&#8217;s performance stock unit awards for which a Monte Carlo simulation was used to estimate the grant-date fair value. The following assumptions were used in estimating these values and determining the related stock-based compensation expense attributable to the current period:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term of the awards:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The expected term of awards granted represents the period of time that they are expected to remain outstanding from the date of grant. The Company determines the expected term of its stock awards based on its historical experience with similar awards, considering the Company&#8217;s historical exercise and post-vesting termination patterns.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Expected volatility represents the volatility anticipated over the expected term of the award. The Company determines the expected volatility for its awards based on the volatility of the price of its common stock over the most recent retrospective period commensurate with the expected term of the award, considering the volatilities expected by peer companies in near industries.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected dividend yield:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company has not paid dividends on its common stock and does not currently expect to pay dividends during the term of stock awards granted.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company bases the expected risk-free interest rate on the implied yield currently available on stripped interest coupons of U.S. Treasury issues with a remaining term equivalent to the expected term of the award.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:40.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company estimates expected forfeitures based upon historical experience with separate groups of employees that have exhibited similar forfeiture behavior in the past. Stock-based compensation expense is recorded only for awards that are expected to vest.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 4, 2019, the independent members of the Company&#8217;s Board of Directors (Board) approved an award of 2,500 premium-priced stock-settled stock appreciation rights (Premium-Priced Award) to the Company&#8217;s Chief Executive Officer (CEO), which award was subject to stockholder approval of a related amendment to the 2011 Plan. Stockholders approved such amendment to the 2011 Plan on January 23, 2020, authorizing the grant to the Company's CEO. Since stockholder approval occurred in 2020, this award was treated as granted in 2020 for accounting purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The base price of the Premium-Priced Award was $67.80 per share, which was a 20% premium to the clearing price of the Company's modified Dutch auction tender offer for its shares in 2019 (2019 Tender Offer). The award vests 50% on each of November&#160;4, 2022 and November&#160;4, 2023 and expires on November&#160;4, 2024. The award includes a requirement that the CEO hold any shares acquired upon exercise of this award, net of shares used to cover related taxes, until November&#160;4, 2024 (that is, for the full term of the award), subject to lapse of the holding period upon a change in control of the Company or due to the CEO's death or termination due to disability.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee stock purchase plan</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Stock Purchase Plan entitles qualifying employees to purchase up to $25 of the Company&#8217;s common stock during each calendar year. The amounts used to purchase stock are accumulated through payroll withholdings or through optional lump sum payments made in advance of the first day of the purchase right period. This compensatory plan allows employees to purchase stock for the lesser of 100% of its fair market value on the first day of the purchase right period or 85% of its fair market value on the last day of the purchase right period. Purchase right periods begin on January&#160;1 and July&#160;1, and end on December&#160;31. Contributions used to purchase the Company&#8217;s common stock under this plan for the 2020, 2019 and 2018 purchase periods were $17,148, $16,569 and $17,398, respectively. Shares purchased pursuant to the plan&#8217;s 2020, 2019 and 2018 purchase periods were 222, 315 and 398, respectively. At December&#160;31, 2020, there were 6,189 shares remaining available for future grants under this plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of participants&#8217; purchase rights was estimated as of the beginning dates of the purchase right periods using the Black-Scholes-Merton valuation model with the following weighted average assumptions for purchase right periods in 2020, 2019 and 2018, respectively: expected volatility of 40.4%, 28.8% and 24.2%; risk-free interest rates of 1.0%, 2.6% and 1.9%, and no dividends. Using these assumptions, the weighted average estimated per share fair value of each purchase right was $22.06, $13.80 and $17.45 for 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation expense and proceeds</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized $99,643, $118,513 and $85,759, respectively, in total LTIP expense, of which $91,458, $63,705 and $73,582, respectively, was stock-based compensation expense for stock appreciation rights, stock units and discounted employee stock purchase plan purchases, which are primarily included in general and administrative expenses. The estimated tax benefits recorded for stock-based compensation in 2020, 2019 and 2018 were $11,775, $9,186 and $13,591, respectively. As of December&#160;31, 2020, there was $189,713 of total estimated but unrecognized stock-based compensation expense under the Company&#8217;s equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.4 years. The Company no longer has outstanding long-term performance-based cash awards in its principal U.S. dialysis business as the performance and accrual period for these awards ended December 31, 2019 with a final payout of $66,302 in 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2018, the Company adopted a retirement policy (Rule of 65 policy). The Rule of 65 policy generally provides that Section 16 officers that are a minimum age of 55 with five years of continuous service with the Company receive certain benefits with respect to their outstanding equity awards upon a qualifying retirement if the sum of their age plus years of service is greater than or equal to 65. These benefits generally include accelerated vesting of restricted stock unit awards, continued vesting of stock-settled stock appreciation rights and performance stock unit awards and an exercise window for stock-settled stock appreciation rights from the original vest date through the original expiration date regardless of continued employment, with pro rata vesting for a Rule of 65 retirement within one year of the award grant date. The adoption of the Rule of 65 policy resulted in a $14,704 modification charge and a net acceleration of expense of $9,727 during the year ended December&#160;31, 2018 that is included in the expense amounts reported above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020, 2019 and 2018, the Company received $8,957, $2,251 and $7,988, respectively, in actual tax benefits upon the exercise or vesting of stock awards. Since the Company issues stock-settled stock appreciation rights rather than stock options, there were no cash proceeds from stock option exercises.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843623080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">Stockholder's equity</a></td>
<td class="text">Shareholders&#8217; equity<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"/><td style="width:38.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tender offers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended December&#160;31, 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$2,529 and $2,343, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2020 through February 10, 2021, the Company has repurchased 1,063 shares of its common stock for $123,282 at an average cost of $115.98 per share. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of the close of business on November 4, 2019, the Board terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $2,000,000. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to the Company under the aforementioned November 4, 2019 authorization and approved a new share repurchase authorization of $2,000,000. The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;10, 2021, the Company has a total of $1,806,674 available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remains subject to share repurchase limitations, including under the terms of the current senior secured credit facilities and the indentures governing the Company's senior notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company retired all shares held in its treasury effective as of December&#160;31, 2020 and December&#160;31, 2019.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charter documents&#160;&amp; Delaware law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice for director nominations and stockholder proposals and granting the Company's Board of Directors the authority to issue up to 5,000 shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, prohibits the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder. The provisions described above may discourage, delay or prevent an acquisition of the Company at a price that stockholders may find attractive.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries on the Company&#8217;s consolidated equity were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"/><td style="width:52.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in paid-in capital for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,818)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc. net of transfers in <br/> noncontrolling interests</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,576&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired additional ownership interests in several existing majority-owned partnerships for $7,831, $68,019, and $28,082 in 2020, 2019, and 2018, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851225480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive (Loss) Income</a></td>
<td class="text">Accumulated other comprehensive (loss) income<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and credits to other comprehensive (loss) income have been as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate<br/>cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other<br/>comprehensive<br/>(loss) income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,408)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting principle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,706)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,368)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,077)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income (loss) into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,963)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,536)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,065)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,498)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,969)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Reflects the cumulative effect of a change in accounting principle for ASUs 2016-01 and 2018-03 on classification and measurement of financial instruments and ASU 2018-02 on remeasurement and reclassification of deferred tax effects in accumulated other comprehensive income associated with the 2017 Tax Act. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification of net cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income. See Note 13 for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843623080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and Divestitures</a></td>
<td class="text">Acquisitions and divestitures<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company acquired eight dialysis centers in the U.S. and 66 dialysis centers outside the U.S. for a total of $182,013 in net cash, earn-outs of $14,042 and deferred purchase price and liabilities assumed of $20,415. The Company also recognized a non-cash gain of $1,821. During 2019, the Company acquired seven dialysis centers in the U.S. and 16 dialysis centers outside the U.S. for a total of $98,836 in net cash, earn-outs of $23,536, and deferred purchase price and liabilities assumed of $4,326. During 2018, the Company acquired 18 dialysis centers in the U.S. and 28 dialysis centers outside the U.S. for a total of $176,161 in net cash, earn-outs of $1,246 and deferred purchase price of $34,394. In one of these 2018 transactions the Company acquired a controlling interest in a previously nonconsolidated U.S. dialysis partnership for which the Company recognized a non-cash gain of $28,152 on its prior interest upon consolidation. The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s financial statements, as are their operating results, from the designated effective dates of the acquisitions. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. For several of the 2020 acquisitions, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, leases and certain other working capital items relating to several of these acquisitions are pending final quantification.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"/><td style="width:52.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,962)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,729)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,698&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,953&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2020, 2019 and 2018, as well as goodwill deductible for tax purposes associated with these acquisitions:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"><tr><td style="width:1.0%"/><td style="width:56.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average estimated useful lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill deductible for tax purposes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro forma financial information (unaudited)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2020 and 2019 had been consummated as of the beginning of 2019, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"/><td style="width:62.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,636,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,570,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net income from continuing operations attributable to<br/> DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic net income per share from continuing operations<br/> attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma diluted net income per share from continuing operations<br/> attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of RMS Lifeline</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company divested its vascular access business, RMS Lifeline, Inc., effective May 1, 2020 and recognized a loss on sale of approximately $16,252.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired companies a total of up to approximately $42,378 if certain performance targets or quality margins are met over the next one year to five years. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. See Note 24 for further details. As of December&#160;31, 2020, the Company estimated the fair value of these contingent earn-out obligations to be $30,248, of which a total of $13,025 is included in other current liabilities, and the remaining $17,223 is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2020 and 2019:&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"/><td style="width:55.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.088%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments or other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851225480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale and Discontinued Operations</a></td>
<td class="text">Discontinued operations previously held for sale<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DaVita Medical Group (DMG)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;19, 2019, the Company completed the sale of its DMG business to Optum, a subsidiary of UnitedHealth Group Inc., for an aggregate purchase price of $4,340,000, prior to certain closing and post-closing adjustments specified in the related equity purchase agreement dated as of December&#160;5, 2017, as amended as of September 20, 2018 and as of December 11, 2018 (as amended, the equity purchase agreement).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a preliminary estimated pre-tax net loss of approximately $23,022 on the sale of its DMG business in 2019. This preliminary net loss was based on initial estimates of the Company's expected aggregate proceeds from the sale, net of transaction costs and obligations, as well as the estimated values of DMG net assets sold as of the closing date. Those estimated net proceeds included $4,465,476 in cash received from Optum at closing, or $3,824,509 net of cash and restricted cash included in the DMG net assets sold.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement. In the fourth quarter of 2020, the Company and Optum reached agreement on the final purchase price for the DMG sale, which resulted in an additional payment by the Company to Optum of $47,000 and an additional loss on sale of $17,976. In the first quarter of 2020, the Company recognized $9,980 in additional tax benefits under the Coronavirus Aid, Relief and Economic Security Act related to its period of DMG ownership, which were also recognized as an adjustment to the Company's loss on sale of the DMG business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the equity purchase agreement, the Company also has certain continuing indemnification obligations that could require payments to the buyer relating to the Company's previous ownership and operation of the DMG business. Potential payments under these provisions, if any, remain subject to continuing uncertainties and the amounts of such payments could be significant to the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the financial results of discontinued operations related to DMG:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"/><td style="width:61.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,963,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,962,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment on disposal group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of discontinued operations before taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,483&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(457,038)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flows of discontinued operations related to DMG:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.75pt"><tr><td style="width:1.0pt"/><td style="width:294.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DMG acquisitions</span></div>During the period from January 1, 2019 to June 18, 2019 immediately prior to the sale, the DMG business acquired two medical businesses for a total of $2,025 in net cash and deferred purchase price of $212. During 2018, the DMG business acquired other medical businesses for a total of $6,995 in net cash and deferred purchase price of $1,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845322824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable interest entities<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#8217;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#8217;s economic performance, the obligation to absorb the entity&#8217;s expected losses, or the right to receive the entity&#8217;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#8217;s losses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#8217;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#8217; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, these consolidated financial statements include total assets of VIEs above of $310,190 and total liabilities and noncontrolling interests of these VIEs to third parties of $216,632.</span></div>The Company also sponsors certain non-qualified deferred compensation plans whose trusts qualify as VIEs and the Company consolidates these plans as their primary beneficiary.&#160;The assets of these plans are recorded in short-term or long-term investments with related liabilities recorded in accrued compensation and benefits and other long-term liabilities.&#160;See Note 15 for disclosures concerning the assets of these consolidated non-qualified deferred compensation plans.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845754776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Values of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Values of Financial Instruments</a></td>
<td class="text">Fair values of financial instruments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equity that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the FASB.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in<br/>active&#160;markets&#160;for<br/>identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant&#160;other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,452&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,452&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the year ended at December&#160;31, 2020 and 2019, see Note 21 and the consolidated statement of equity, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 5 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 13 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair value of these contingent earn-out obligations is remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company credit risk adjusted rate that is used to discount obligations to present value. See Note 21 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of December&#160;31, 2020, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $160,000. See Note 17 for a discussion of the Company&#8217;s methodology for estimating the fair values of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 13 for further discussion of the Company's debt. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in the consolidated financial statements at December&#160;31, 2020 and 2019 at their approximate fair values due to the short-term nature of their settlements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843901336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment reporting<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its various ancillary services and strategic initiatives, including its international operations (collectively, its ancillary services), and its corporate administrative support. See Note 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Organization" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a summary description of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its DMG business to Optum. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company&#8217;s chief operating decision maker in making decisions about allocating resources to and assessing the financial performance of the Company&#8217;s various operating lines of business. The chief operating decision maker for the Company is its Chief Executive Officer.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, each of its ancillary services and strategic initiatives, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the APAC joint venture. The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other ancillary services and strategic initiatives operating segments, including the international operating segments, have been combined and disclosed in the other segments category.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segment financial information included in this report is prepared on the internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the financial performance of the Company's operating segments. For internal management reporting, segment operations include direct segment operating expenses but generally exclude corporate administrative support costs, which consist primarily of indirect labor, benefits and long-term incentive compensation expenses of certain departments which provide support to all of the Company&#8217;s various operating lines of business, except to the extent that such costs are charged to and borne by certain ancillary services and strategic initiatives via internal management fees. These corporate administrative support costs are reduced by internal management fees received from the Company&#8217;s ancillary lines of business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,488,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,421,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis revenues before provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,632,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,552,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,366,996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for uncollectible accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,458)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,619,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,530,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,316,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,659,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,562,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,335,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,712,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,534,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,532,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,404,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,841,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615,932&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating margin to consolidated income from<br/> continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487,435)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,022)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes management fee revenues from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling interest or which are wholly-owned by third parties.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity investment income of $5,866, $9,366, and $24,866 in 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summary of assets by reportable segment was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:58.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,344,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,778,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,988,516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,311,394&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $122,974 and $124,188 in 2020 and 2019, respectively. </span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $134,517 and 117,795 in 2020 and 2019, respectively and includes approximately $181,137 and $154,572 in 2020 and 2019, respectively, of net property and equipment related to the Company&#8217;s international operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG - Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674,541&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987,138&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845223304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">Supplemental cash flow information<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides supplemental cash flow information:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"/><td style="width:49.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets under financing lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843911768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Selected Quarterly Financial Data (unaudited)</a></td>
<td class="text">Selected quarterly financial data (unaudited)<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.509%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,905,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,924,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,898,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,904,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The following table summarizes impairment charges, loss on changes in ownership interest, and a legal settlement included in operating expenses and charges in 2020 and 2019 by quarter:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:489.00pt"><tr><td style="width:1.0pt"/><td style="width:108.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">&#160;Quarter ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">&#160;Quarter ended</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">December&#160;31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">December&#160;31,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">September 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">June 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">March 31,<br/>2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Certain operating expenses<br/> and charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">83,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">41,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on changes in<br/> ownership interest, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accruals for legal matters</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845108216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:45.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.772%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>beginning of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts<br/>charged to income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts written off</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at end of year</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for uncollectible accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850671000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of presentation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company only has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#8217;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#8217;s international subsidiaries from their functional currencies into the Company&#8217;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#8217;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock', window );">Patient service net revenues and accounts receivable</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, the Company adopted Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 606) using the cumulative effect method for those contracts that were not substantially completed as of January 1, 2018. Results for reporting periods beginning on and after January 1, 2018 are presented under Topic 606.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of this new standard primarily changed the Company&#8217;s presentation of revenues, provision for uncollectible accounts and allowance for doubtful accounts. Topic 606 requires revenue to be recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Accordingly, for performance obligations satisfied after the adoption of Topic 606, the Company no longer separately presents a provision for uncollectible accounts on the consolidated income statement and no longer presents the related allowance for doubtful accounts on the consolidated balance sheet. However, as a result of the Company&#8217;s election to apply Topic 606 only to contracts not substantially completed as of January 1, 2018, the Company continued to maintain an allowance for doubtful accounts related to performance obligations satisfied prior to the adoption of Topic 606. Net collections or write-offs of accounts receivable generated prior to January 1, 2018, beyond amounts previously reserved thereon, are presented in the provision for uncollectible accounts on the consolidated income statement in accordance with Topic 605.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare&#8217;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#8217;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#8217;s base payment rate as well as these other variable factors.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#8217;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#8217;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#8217;s usual and customary rates.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services and strategic initiatives. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and ESRD seamless care organizations are estimated in the period services are provided. Revenues associated with pharmacy services until that business was closed in 2018 were estimated as prescriptions were filled and shipped to patients. Revenues associated with direct primary care until that business was sold in 2018 were estimated over the membership period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AllowanceForUncollectibleAccountsPolicyTextBlock', window );">Allowance for uncollectible accounts</a></td>
<td class="text">The adoption of this new standard primarily changed the Company&#8217;s presentation of revenues, provision for uncollectible accounts and allowance for doubtful accounts. Topic 606 requires revenue to be recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Accordingly, for performance obligations satisfied after the adoption of Topic 606, the Company no longer separately presents a provision for uncollectible accounts on the consolidated income statement and no longer presents the related allowance for doubtful accounts on the consolidated balance sheet. However, as a result of the Company&#8217;s election to apply Topic 606 only to contracts not substantially completed as of January 1, 2018, the Company continued to maintain an allowance for doubtful accounts related to performance obligations satisfied prior to the adoption of Topic 606. Net collections or write-offs of accounts receivable generated prior to January 1, 2018, beyond amounts previously reserved thereon, are presented in the provision for uncollectible accounts on the consolidated income statement in accordance with Topic 605.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OtherNonoperatingIncomeExpensePolicyTextBlock', window );">Other income</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash and equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted cash and equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow for certain legal settlements pending finalization.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments in debt and equity securities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in debt and equity securities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#8217;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within "Other income, net". These debt and equity investments are classified as "short-term investments" or "long-term investments" on the Company's consolidated balance sheet. See Note 5 for further details.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels from the manufacturer and related data submission.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text">Property and equipmentProperty and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.</span></div>Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Amortizable intangibles</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortizable intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: non-competition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">Indefinite-lived intangibles</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indefinite-lived intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity investments and other investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity method and other investments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as &#8220;Equity method and other investments&#8221; on the Company's consolidated balance sheet.&#160;See Note 9 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_InsuranceAndSelfInsurancePolicyTextBlock', window );">Self insurance</a></td>
<td class="text">Self-insuranceThe Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#8217; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.</span></div>The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based compensation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Interest rate swap and cap agreements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate cap agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.</span></div>The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The amortization of the original cap premium is recognized as a component of debt expense on the interest method over the terms of the cap agreements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Noncontrolling interests</a></td>
<td class="text">Noncontrolling interestsNoncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes.<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests subject to put provisions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#8217; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#8217;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#8217; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#8217; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value estimates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity.</span></div>The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based compensation, as applicable. The Company has also classified its assets, liabilities and temporary equity into the appropriate fair value hierarchy levels as defined by the FASB.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New accounting standards</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New accounting standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this ASU amend the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments and off-balance sheet credit exposures. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied using a modified retrospective basis. The adoption of ASU No. 2016-13 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework -Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The applicable amendments in this ASU remove requirements for disclosures concerning transfers between fair value measurement levels 1, 2 and 3 and disclosures concerning </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation processes for level 3 fair value measurements. The applicable amendments in this ASU also add a requirement to separately disclose the changes in unrealized gains and losses included in other comprehensive income for the reporting period for level 3 items measured at fair value on a recurring basis, and require disclosure of the range and weighted average of significant unobservable inputs used to develop level 3 fair value measurements.&#160;The amendments in this ASU became effective for the Company beginning on January 1, 2020 and were applied on a prospective basis.&#160;The adoption of this ASU did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2018-15 aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted this ASU as of January 1, 2020, using the prospective transition approach, which allows the Company to change the accounting method without restating prior periods or booking cumulative adjustments. The adoption of ASU No. 2018-15 did not have a material impact on the Company's consolidated financial statements. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The Company has evaluated the impact of this standard on its consolidated financial statements, including accounting policies, processes, and systems, and does not expect the impact to be material.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding, reduced for 2018 by the weighted average shares held in escrow that under certain circumstances may have been returned to the Company. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units (under the treasury stock method) and, for 2018, the weighted average contingently returnable shares held in escrow that were outstanding during the period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term and long-term investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2020 and 2019.</span>Equity securities: The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#8217;s non-qualified deferred compensation plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Long-term incentive compensation</a></td>
<td class="text">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all LTIP awards is recognized net of expected forfeitures.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Other Comprehensive (Loss) Income</a></td>
<td class="text">The reclassification of net cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#8217;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#8217;s economic performance, the obligation to absorb the entity&#8217;s expected losses, or the right to receive the entity&#8217;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#8217;s losses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.</span></div>The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#8217;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#8217; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AllowanceForUncollectibleAccountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for uncollectible accounts policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AllowanceForUncollectibleAccountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_InsuranceAndSelfInsurancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance and self insurance policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_InsuranceAndSelfInsurancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_OtherNonoperatingIncomeExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other nonoperating income (expense), policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_OtherNonoperatingIncomeExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognition and accounts receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845231080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and primary payor source were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,048,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,048,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,514,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,129,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,129,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,286,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,430,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,430,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,063,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,063,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,176,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,242,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,404,851&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845325624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464,927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently returnable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently returnable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">previously held in escrow for the DaVita HealthCare Partners merger.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845010424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and long-term invesmtents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,884&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,432&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,572&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843883848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfOtherReceivablesTableTextBlock', window );">Schedule of Other Receivables</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables were comprised of the following:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"><tr><td style="width:1.0%"/><td style="width:56.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier rebates and non-trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare bad debt claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfOtherReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of claims held for amounts due to an entity. Examples include non-trade receivables and Medicare bad debt claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfOtherReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394844952200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:66.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.467%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,865,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and information systems, including internally developed software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,880,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New center and capital asset projects in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,442,950&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,480,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,969,566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,521,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,473,384&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845015928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets other than Goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"><tr><td style="width:1.0%"/><td style="width:54.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Scheduled Amortization Charges from Intangible Assets and Liabilities</a></td>
<td class="text">Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2020 were as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"><tr><td style="width:1.0%"/><td style="width:37.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.032%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncompetition<br/>agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Customer relationships and other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,304&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Finite And Indefinite Intangible Assets Table</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843802248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method and Other Investmetns Equity Method and Other Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"><tr><td style="width:1.0%"/><td style="width:56.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.611%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.612%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC joint venture</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other equity method partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted cost method and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,983&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845034664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Value of Goodwill by Reportable Segments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:40.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other - Ancillary<br/>services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,275,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,841,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,659)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,287,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,787,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,055,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,551)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,551)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock', window );">Schedule of Reporting Units Goodwill Balances</a></td>
<td class="text"><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.660%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reporting unit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Goodwill<br/>balance</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">coverage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sensitivities</span></td></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany kidney care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of reporting units goodwill balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843942984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"><tr><td style="width:1.0%"/><td style="width:51.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.898%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.759%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor refunds and retractions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance and self-insurance accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued non-income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843646744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes from continuing operations consisted of the following:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of Income Tax Expense (Benefit)</a></td>
<td class="text">Income tax expense for continuing operations consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,838&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,789&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Allocation of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are allocated between continuing and discontinued operations as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation between U.S. Federal Income Tax Rate and Effective Tax Rate</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the Company&#8217;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"/><td style="width:49.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in International valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Political advocacy costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests primarily<br/> attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred Tax Assets and Liabilities Arising from Temporary Differences</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"/><td style="width:54.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(634,736)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563,914)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(527,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583,246)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,344,079)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(577,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Reconciliation of the Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet the More-Likely-Than-Not Threshold</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:61.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.250%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions related to lapse of applicable statute</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,214&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845292968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term Debt</a></td>
<td class="text">Long-term debt<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:34.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,684,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR + 1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,702,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR + 0.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.125% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/15/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021-2036</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021-2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,163,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,181,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,085,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,108,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,541)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,917,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,977,526&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The Company's interest rate for its revolving line of credit as of December&#160;31, 2020 was based on an Alternate Base Rate (ABR or Prime Rate) plus 0.50%, or 3.75%. Effective January 6, 2021 this was converted to a LIBOR-based rate of LIBOR plus 1.50%. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2020.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,461 and deferred financing costs of $35,825 and the carrying amount of the Company's senior notes includes deferred financing costs of $36,431. As of December&#160;31, 2019, the carrying amount of the Company's senior secured credit facilities included a discount of $6,457 and deferred financing costs of $45,444, and the carrying amount of the Company's senior notes included deferred financing costs of $20,939.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Scheduled Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled maturities of long-term debt at December&#160;31, 2020 were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"><tr><td style="width:1.0%"/><td style="width:58.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.441%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,031,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of December&#160;31, 2020 and December&#160;31, 2019, which are classified in "Other long-term assets" on its consolidated balance sheet:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Recorded OCI loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 cap agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/29/2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effects of Interest Rate Swap and Cap Agreements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of the Company&#8217;s interest rate cap agreements for the years ended December&#160;31, 2020, 2019 and 2018:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (losses) gains in OCI on interest rate cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of losses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassification from accumulated other comprehensive income into net income</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394965656696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Expense Components</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"/><td style="width:52.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 7.75pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684,748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Includes short-term lease expense and sublease income, which are immaterial.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Leases Other Information</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"/><td style="width:52.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease term and discount rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"/><td style="width:52.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on sale leasebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the <br/> measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating lease assets obtained in exchange<br/> for new or modified operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfMinimumLeasePaymentsTextBlock', window );">Schedule Of Minimum Lease Payments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2020 are as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"><tr><td style="width:1.0%"/><td style="width:52.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,661,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less portion representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfMinimumLeasePaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of minimum lease payments under non-cancelable operating leases and capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfMinimumLeasePaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 1,3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121549808&amp;loc=d3e36991-112694<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846918504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A combined summary of the status of the Company&#8217;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:37.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.827%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock appreciation rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,953&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Added by performance factor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.56&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of grants:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.04&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Range of Exercise Prices</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"><tr><td style="width:1.0%"/><td style="width:28.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.438%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards Outstanding</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards exercisable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of SSARs base prices</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.01&#8211;$60.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.01&#8211;$70.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.01&#8211;$80.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,084&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Valuation Inputs</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:40.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394844961112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Shares repurchases summary table</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"/><td style="width:38.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tender offers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended December&#160;31, 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$2,529 and $2,343, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock', window );">Net effect of transfers from to noncontrolling interests on stock holders equity disclosure</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries on the Company&#8217;s consolidated equity were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"/><td style="width:52.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in paid-in capital for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,818)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc. net of transfers in <br/> noncontrolling interests</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,576&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Effect Of Transfers From (To) Noncontrolling Interests on Stock Holders Equity Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394844967112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Other Comprehensive (Loss) Income</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and credits to other comprehensive (loss) income have been as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate<br/>cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other<br/>comprehensive<br/>(loss) income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,408)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting principle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,706)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,368)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,077)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income (loss) into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,963)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,536)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,065)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,498)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,969)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)Reflects the cumulative effect of a change in accounting principle for ASUs 2016-01 and 2018-03 on classification and measurement of financial instruments and ASU 2018-02 on remeasurement and reclassification of deferred tax effects in accumulated other comprehensive income associated with the 2017 Tax Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394951449240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Aggregate Purchase Cost Allocations for Acquisitions</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"/><td style="width:52.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,962)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,729)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,698&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,953&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock', window );">Schedule of other information related to acquired intangibles and goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2020, 2019 and 2018, as well as goodwill deductible for tax purposes associated with these acquisitions:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"><tr><td style="width:1.0%"/><td style="width:56.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average estimated useful lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill deductible for tax purposes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro Forma Summary of Results of Operations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2020 and 2019 had been consummated as of the beginning of 2019, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"/><td style="width:62.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,636,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,570,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net income from continuing operations attributable to<br/> DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic net income per share from continuing operations<br/> attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma diluted net income per share from continuing operations<br/> attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Reconciliation of Changes in Contingent Earn-Out Obligations</a></td>
<td class="text">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2020 and 2019:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"/><td style="width:55.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.088%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments or other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of other information related to acquisitions, including weighted-average estimated useful lives of intangible assets acquired, and goodwill deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394844988264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Summary of Information Related to Assets Held For Sale and Discontinued Operations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the financial results of discontinued operations related to DMG:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"/><td style="width:61.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,963,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,962,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment on disposal group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of discontinued operations before taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,483&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(457,038)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ReconciliationOfCashFlowsTableTextBlock', window );">Reconciliation of Cash Flows</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flows of discontinued operations related to DMG:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.75pt"><tr><td style="width:1.0pt"/><td style="width:294.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReconciliationOfCashFlowsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation Of Cash Flows [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReconciliationOfCashFlowsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851221864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Values of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in<br/>active&#160;markets&#160;for<br/>identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant&#160;other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,452&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,452&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394944655128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,488,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,421,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis revenues before provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,632,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,552,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,366,996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for uncollectible accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,458)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,619,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,530,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,316,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,659,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,562,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,335,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,712,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,534,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,532,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,404,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,841,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615,932&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating margin to consolidated income from<br/> continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487,435)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,022)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes management fee revenues from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling interest or which are wholly-owned by third parties.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity investment income of $5,866, $9,366, and $24,866 in 2020, 2019 and 2018, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Summary of Depreciation and Amortization Expense by Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Summary of Assets by Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summary of assets by reportable segment was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:58.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,344,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,778,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,988,516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,311,394&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $122,974 and $124,188 in 2020 and 2019, respectively. </span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $134,517 and 117,795 in 2020 and 2019, respectively and includes approximately $181,137 and $154,572 in 2020 and 2019, respectively, of net property and equipment related to the Company&#8217;s international operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock', window );">Summary of Expenditures for Property and Equipment by Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG - Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674,541&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987,138&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of capital expenditures for property and equipment from segment to consolidated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845198168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides supplemental cash flow information:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"/><td style="width:49.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets under financing lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843619112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Selected Quarterly Financial Data (unaudited)</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.509%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,905,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,924,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,898,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,904,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The following table summarizes impairment charges, loss on changes in ownership interest, and a legal settlement included in operating expenses and charges in 2020 and 2019 by quarter:</span></div><div style="margin-top:5pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:489.00pt"><tr><td style="width:1.0pt"/><td style="width:108.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">&#160;Quarter ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">&#160;Quarter ended</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">December&#160;31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">December&#160;31,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">September 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">June 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">March 31,<br/>2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Certain operating expenses<br/> and charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">83,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">41,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on changes in<br/> ownership interest, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accruals for legal matters</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845762920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:45.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.772%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>beginning of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts<br/>charged to income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts written off</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at end of year</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for uncollectible accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846270616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>clinic </div>
<div>patient </div>
<div>state </div>
<div>entity </div>
<div>country</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor', window );">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests', window );">Number of legal entities that third parties held noncontrolling equity interests | entity</a></td>
<td class="nump">688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfSites', window );">Number of dialysis centers that the company operated or provided administrative services | clinic</a></td>
<td class="nump">2,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states where dialysis centers are located | state</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfCustomers', window );">Number of patients served | patient</a></td>
<td class="nump">204,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=dva_InternationalOperationsMember', window );">International Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfSites', window );">Number of dialysis centers that the company operated or provided administrative services | clinic</a></td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfCustomers', window );">Number of patients served | patient</a></td>
<td class="nump">36,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which dialysis centers located | country</a></td>
<td class="nump">10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of entities that third parties held non controlling equity interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of sites.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization consolidation and presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=dva_InternationalOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=dva_InternationalOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394854978872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,039,709<span></span>
</td>
<td class="nump">$ 10,918,421<span></span>
</td>
<td class="nump">$ 10,709,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,353<span></span>
</td>
<td class="nump">491,773<span></span>
</td>
<td class="nump">744,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 2,905,322<span></span>
</td>
<td class="nump">$ 2,924,066<span></span>
</td>
<td class="nump">$ 2,879,979<span></span>
</td>
<td class="nump">$ 2,841,237<span></span>
</td>
<td class="nump">$ 2,898,584<span></span>
</td>
<td class="nump">$ 2,904,078<span></span>
</td>
<td class="nump">$ 2,842,705<span></span>
</td>
<td class="nump">$ 2,743,112<span></span>
</td>
<td class="nump">11,550,604<span></span>
</td>
<td class="nump">11,388,479<span></span>
</td>
<td class="nump">11,404,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract', window );"><strong>Revenue disaggregation table footnote</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ProvisionForExpectedCreditLosses', window );">Provision for uncollectible accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,458<span></span>
</td>
<td class="nump">21,715<span></span>
</td>
<td class="nump">49,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162,029)<span></span>
</td>
<td class="num">(146,355)<span></span>
</td>
<td class="num">(127,186)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember', window );">Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,048,043<span></span>
</td>
<td class="nump">6,129,697<span></span>
</td>
<td class="nump">6,063,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">419,662<span></span>
</td>
<td class="nump">264,538<span></span>
</td>
<td class="nump">492,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember', window );">Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,862<span></span>
</td>
<td class="nump">669,089<span></span>
</td>
<td class="nump">628,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">44,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember', window );">Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">836,481<span></span>
</td>
<td class="nump">798,775<span></span>
</td>
<td class="nump">782,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember', window );">Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,540,956<span></span>
</td>
<td class="nump">3,430,345<span></span>
</td>
<td class="nump">3,278,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,246<span></span>
</td>
<td class="nump">130,823<span></span>
</td>
<td class="nump">90,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,156<span></span>
</td>
<td class="nump">110,961<span></span>
</td>
<td class="nump">150,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,514,649<span></span>
</td>
<td class="nump">10,430,581<span></span>
</td>
<td class="nump">10,242,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145,286)<span></span>
</td>
<td class="num">(132,325)<span></span>
</td>
<td class="num">(92,950)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,048,043<span></span>
</td>
<td class="nump">6,129,697<span></span>
</td>
<td class="nump">6,063,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,862<span></span>
</td>
<td class="nump">669,089<span></span>
</td>
<td class="nump">628,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">455,897<span></span>
</td>
<td class="nump">446,010<span></span>
</td>
<td class="nump">446,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,370,562<span></span>
</td>
<td class="nump">3,286,089<span></span>
</td>
<td class="nump">3,176,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,571<span></span>
</td>
<td class="nump">32,021<span></span>
</td>
<td class="nump">19,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,035,955<span></span>
</td>
<td class="nump">957,898<span></span>
</td>
<td class="nump">1,161,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,743)<span></span>
</td>
<td class="num">(14,030)<span></span>
</td>
<td class="num">(34,236)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">419,662<span></span>
</td>
<td class="nump">264,538<span></span>
</td>
<td class="nump">492,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">44,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,584<span></span>
</td>
<td class="nump">352,765<span></span>
</td>
<td class="nump">335,594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,394<span></span>
</td>
<td class="nump">144,256<span></span>
</td>
<td class="nump">101,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,246<span></span>
</td>
<td class="nump">130,823<span></span>
</td>
<td class="nump">90,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,585<span></span>
</td>
<td class="nump">$ 78,940<span></span>
</td>
<td class="nump">$ 130,865<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ProvisionForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision For Expected Credit Losses, contra revenue account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ProvisionForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394936079368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 1,824,282<span></span>
</td>
<td class="nump">$ 1,795,598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareMember', window );">Medicare bad debt claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 1,101,837<span></span>
</td>
<td class="nump">$ 1,038,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AccountsReceivablePeriodOutstanding', window );">Accounts Receivable Period Outstanding</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=dva_PatientServicesCustomerConcentrationRiskMember', window );">Patient Services Customer Concentration Risk | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfConcentrationRiskCustomers', window );">Number of concentration risk customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue', window );">Percentage Of Accounts Receivable Six Months Or More Past Due</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AccountsReceivablePeriodOutstanding', window );">Accounts Receivable Period Outstanding</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member', window );">Difference between Revenue Guidance in Effect before and after Topic 606</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 37,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AccountsReceivablePeriodOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patient accounts receivable months outstanding to be reserved per company policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AccountsReceivablePeriodOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfConcentrationRiskCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Concentration Risk Customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfConcentrationRiskCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Accounts Receivable , 6 months or More Past Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=dva_PatientServicesCustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=dva_PatientServicesCustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394847911848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="nump">$ 193,406<span></span>
</td>
<td class="nump">$ 158,674<span></span>
</td>
<td class="nump">$ 201,602<span></span>
</td>
<td class="nump">$ 229,613<span></span>
</td>
<td class="nump">$ 242,242<span></span>
</td>
<td class="nump">$ 150,113<span></span>
</td>
<td class="nump">$ 194,223<span></span>
</td>
<td class="nump">$ 120,254<span></span>
</td>
<td class="nump">$ 783,295<span></span>
</td>
<td class="nump">$ 706,832<span></span>
</td>
<td class="nump">$ 624,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Discontinued operations</a></td>
<td class="num">(19,633)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
<td class="nump">2,629<span></span>
</td>
<td class="num">(6,843)<span></span>
</td>
<td class="nump">79,328<span></span>
</td>
<td class="nump">29,035<span></span>
</td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">104,149<span></span>
</td>
<td class="num">(464,927)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 173,773<span></span>
</td>
<td class="nump">$ 158,674<span></span>
</td>
<td class="nump">$ 201,602<span></span>
</td>
<td class="nump">$ 239,593<span></span>
</td>
<td class="nump">$ 244,871<span></span>
</td>
<td class="nump">$ 143,270<span></span>
</td>
<td class="nump">$ 273,551<span></span>
</td>
<td class="nump">$ 149,289<span></span>
</td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
<td class="nump">$ 159,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average shares outstanding during the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,797,000<span></span>
</td>
<td class="nump">153,181,000<span></span>
</td>
<td class="nump">171,886,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable', window );">Weighted average contingently returnable shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,100,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares - basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,797,000<span></span>
</td>
<td class="nump">153,181,000<span></span>
</td>
<td class="nump">170,786,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Weighted average contingently returnable shares attributable to dilutive effect (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Assumed incremental shares from stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,826,000<span></span>
</td>
<td class="nump">631,000<span></span>
</td>
<td class="nump">479,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares - diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,623,000<span></span>
</td>
<td class="nump">153,812,000<span></span>
</td>
<td class="nump">172,365,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic net income (loss) attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (Loss) from Continuing Operations, Per Basic Share</a></td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.84<span></span>
</td>
<td class="nump">$ 1.87<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="nump">$ 6.54<span></span>
</td>
<td class="nump">$ 4.61<span></span>
</td>
<td class="nump">$ 3.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="num">(0.17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.05)<span></span>
</td>
<td class="nump">0.47<span></span>
</td>
<td class="nump">0.18<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.68<span></span>
</td>
<td class="num">(2.73)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">1.56<span></span>
</td>
<td class="nump">1.31<span></span>
</td>
<td class="nump">1.65<span></span>
</td>
<td class="nump">1.92<span></span>
</td>
<td class="nump">1.89<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="nump">1.64<span></span>
</td>
<td class="nump">0.90<span></span>
</td>
<td class="nump">6.46<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
<td class="nump">0.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted net income (loss) attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income from continuing operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">1.67<span></span>
</td>
<td class="nump">1.28<span></span>
</td>
<td class="nump">1.62<span></span>
</td>
<td class="nump">1.81<span></span>
</td>
<td class="nump">1.86<span></span>
</td>
<td class="nump">0.99<span></span>
</td>
<td class="nump">1.16<span></span>
</td>
<td class="nump">0.72<span></span>
</td>
<td class="nump">6.39<span></span>
</td>
<td class="nump">4.60<span></span>
</td>
<td class="nump">3.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Diluted net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="num">(0.17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0.48<span></span>
</td>
<td class="nump">0.18<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.67<span></span>
</td>
<td class="num">(2.70)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
<td class="nump">$ 1.89<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="nump">$ 1.64<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock-settled awards excluded from calculation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,301,000<span></span>
</td>
<td class="nump">5,936,000<span></span>
</td>
<td class="nump">5,295,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares.  Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 54<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2603-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 44<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2062-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1828-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2600-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2597-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2538-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2538-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2574-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850693816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restricted Cash and Equivalents - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and equivalents</a></td>
<td class="nump">$ 176,832<span></span>
</td>
<td class="nump">$ 106,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Assets Held-in-trust, Current</a></td>
<td class="nump">92,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Assets Held-in-trust, Current</a></td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfPartnerships', window );">Number Of Businesses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfPartnerships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Partnerships that are included in the Equity Investments category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfPartnerships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394849059896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term and long-term investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">$ 8,217<span></span>
</td>
<td class="nump">$ 8,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">44,077<span></span>
</td>
<td class="nump">39,951<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">52,294<span></span>
</td>
<td class="nump">48,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesCurrent', window );">Debt securities, short-term investments</a></td>
<td class="nump">8,217<span></span>
</td>
<td class="nump">8,140<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total, short-term investments</a></td>
<td class="nump">20,101<span></span>
</td>
<td class="nump">11,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesNoncurrent', window );">Debt securities, long-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Total, long-term investments</a></td>
<td class="nump">32,193<span></span>
</td>
<td class="nump">36,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember', window );">Certificates of deposit and other time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">8,217<span></span>
</td>
<td class="nump">8,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">8,217<span></span>
</td>
<td class="nump">8,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember', window );">Investments in mutual funds and common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">44,077<span></span>
</td>
<td class="nump">39,951<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">44,077<span></span>
</td>
<td class="nump">39,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">11,884<span></span>
</td>
<td class="nump">3,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Other long-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">$ 32,193<span></span>
</td>
<td class="nump">$ 36,519<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845742696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and long-term investments - Additional Information (Details) - Investments in mutual funds and common stock - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity Securities, FV-NI, Gain (Loss)</a></td>
<td class="nump">$ 3,818<span></span>
</td>
<td class="nump">$ 4,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Equity Securities, FV-NI, Realized Gain (Loss)</a></td>
<td class="nump">1,941<span></span>
</td>
<td class="nump">1,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities', window );">Net Increase (Decrease) In Unrealized Gains On Equity Securities</a></td>
<td class="nump">$ 1,877<span></span>
</td>
<td class="nump">$ 2,924<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase Decrease In Unrealized Gains On Equity Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845021208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Receivables (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 544,376<span></span>
</td>
<td class="nump">$ 489,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_SupplierRebatesAndOtherNonTradeReceivablesMember', window );">Supplier rebates and non-trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">390,508<span></span>
</td>
<td class="nump">351,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_MedicareMember', window );">Medicare bad debt claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 153,868<span></span>
</td>
<td class="nump">$ 138,045<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_SupplierRebatesAndOtherNonTradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_SupplierRebatesAndOtherNonTradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845448584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 37,924<span></span>
</td>
<td class="nump">$ 36,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">400,616<span></span>
</td>
<td class="nump">392,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">3,865,729<span></span>
</td>
<td class="nump">3,545,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Equipment and information systems, including internally developed software</a></td>
<td class="nump">3,081,298<span></span>
</td>
<td class="nump">2,880,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">New center and capital asset projects in progress</a></td>
<td class="nump">616,686<span></span>
</td>
<td class="nump">588,345<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross, total</a></td>
<td class="nump">8,002,253<span></span>
</td>
<td class="nump">7,442,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(4,480,429)<span></span>
</td>
<td class="num">(3,969,566)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 3,521,824<span></span>
</td>
<td class="nump">$ 3,473,384<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394936073288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense on property and equipment</a></td>
<td class="nump">$ 616,626<span></span>
</td>
<td class="nump">$ 600,905<span></span>
</td>
<td class="nump">$ 574,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">17,944<span></span>
</td>
<td class="nump">27,322<span></span>
</td>
<td class="nump">25,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Other asset impairments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">17,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=naics_ZZ446110', window );">Pharmacy Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Other asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Equipment and Information Systems | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Equipment and Information Systems | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=naics_ZZ446110">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=naics_ZZ446110</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394852008376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived licenses</a></td>
<td class="nump">$ 100,138<span></span>
</td>
<td class="nump">$ 90,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedNoncompeteAgreementsGross', window );">Noncompetition agreements</a></td>
<td class="nump">84,022<span></span>
</td>
<td class="nump">103,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIndefiniteLivedIntangibleAssets', window );">Customer relationships and other</a></td>
<td class="nump">52,566<span></span>
</td>
<td class="nump">23,887<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross (excluding goodwill)</a></td>
<td class="nump">236,726<span></span>
</td>
<td class="nump">217,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(70,141)<span></span>
</td>
<td class="num">(81,922)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets</a></td>
<td class="nump">$ 166,585<span></span>
</td>
<td class="nump">$ 135,684<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedNoncompeteAgreementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of payments made to third parties in exchange for their agreement not to engage in specified competitive practices in specified geographic territories for a specified period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedNoncompeteAgreementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851262216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ExpectedAmortizationExpenseLineItems', window );"><strong>Expected Amortization Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 10,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">6,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">3,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">1,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">23,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Customer relationships and other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ExpectedAmortizationExpenseLineItems', window );"><strong>Expected Amortization Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">3,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">3,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">3,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">2,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">2,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">28,248<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 43,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ExpectedAmortizationExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Amortization Expense [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ExpectedAmortizationExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845858248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense from amortizable intangible assets, other than lease agreements</a></td>
<td class="nump">$ 13,809<span></span>
</td>
<td class="nump">$ 14,247<span></span>
</td>
<td class="nump">$ 16,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394852093784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Method and Other Investmetns Equity Method and Other Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">$ 257,491<span></span>
</td>
<td class="nump">$ 241,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember', window );">APAC JV - Deconsolidated Noncontrolling Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">120,787<span></span>
</td>
<td class="nump">116,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Adjusted cost method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">29,105<span></span>
</td>
<td class="nump">10,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_OtherOwnershipInterestMember', window );">Other equity method partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">$ 107,599<span></span>
</td>
<td class="nump">$ 114,611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_OtherOwnershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_OtherOwnershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850860408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method and Other Investments - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment (loss) income</a></td>
<td class="nump">$ 26,916<span></span>
</td>
<td class="nump">$ 12,679<span></span>
</td>
<td class="num">$ (4,484)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Equity method investment, significant impairments and other valuation adjustments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dva_ParentCompanyAndRestrictedSubsidiariesMember', window );">Company and Restricted Subsidiaries(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Voting Interest, in percents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Parent</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember', window );">APAC JV - Deconsolidated Noncontrolling Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Voting Interest, in percents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Current economic interest in the APAC JV, Owned by Noncontrolling Investors</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Company and Restricted Subsidiaries(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Parent</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Company and Restricted Subsidiaries(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Parent</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember', window );">Equity method investments in nonconsolidated businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment (loss) income</a></td>
<td class="nump">$ 26,916<span></span>
</td>
<td class="nump">$ 12,679<span></span>
</td>
<td class="num">$ (4,484)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfPartnerships', window );">Number of partnerships</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfPartnerships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Partnerships that are included in the Equity Investments category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfPartnerships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dva_ParentCompanyAndRestrictedSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dva_ParentCompanyAndRestrictedSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846700936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,787,635<span></span>
</td>
<td class="nump">$ 6,841,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,057<span></span>
</td>
<td class="nump">90,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(124,892)<span></span>
</td>
<td class="num">$ (3,106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,710<span></span>
</td>
<td class="num">(19,659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,919,109<span></span>
</td>
<td class="nump">6,787,635<span></span>
</td>
<td class="nump">6,841,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,055,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,287,100<span></span>
</td>
<td class="nump">6,275,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,377<span></span>
</td>
<td class="nump">18,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,549)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,309,928<span></span>
</td>
<td class="nump">6,287,100<span></span>
</td>
<td class="nump">6,275,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,309,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,535<span></span>
</td>
<td class="nump">566,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,680<span></span>
</td>
<td class="nump">72,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,744)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="num">$ (83,855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124,892)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,710<span></span>
</td>
<td class="num">(13,666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609,181<span></span>
</td>
<td class="nump">$ 500,535<span></span>
</td>
<td class="nump">$ 566,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">745,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (136,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851767816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Schedule of Reporting Units Goodwill Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 6,919,109<span></span>
</td>
<td class="nump">$ 6,787,635<span></span>
</td>
<td class="nump">$ 6,841,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment', window );">Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment', window );">Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember', window );">Kidney Care | GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 322,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount', window );">Carrying amount coverage</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PotentialImpactOnFairValueForReductionInOperatingIncome', window );">Sensitivities, Operating Income</a></td>
<td class="num">(1.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate', window );">Sensitivities, Discount rate</a></td>
<td class="num">(10.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Impact On Fair Value For Basis Point Increase In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialImpactOnFairValueForReductionInOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Impact On Fair Value For Reduction In Operating Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialImpactOnFairValueForReductionInOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reporting unit percentage of fair value in excess of short of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851262088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 124,892<span></span>
</td>
<td class="nump">$ 3,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember', window );">Other reporting units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY | Kidney Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">$ 41,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY | Other reporting units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394852085896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PayorRefundsAndRetractions', window );">Payor refunds and retractions</a></td>
<td class="nump">$ 371,183<span></span>
</td>
<td class="nump">$ 377,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Insurance and self-insurance accruals</a></td>
<td class="nump">54,438<span></span>
</td>
<td class="nump">58,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">30,066<span></span>
</td>
<td class="nump">54,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Accrued non-income tax liabilities</a></td>
<td class="nump">39,075<span></span>
</td>
<td class="nump">36,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">315,767<span></span>
</td>
<td class="nump">229,005<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">$ 810,529<span></span>
</td>
<td class="nump">$ 756,174<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PayorRefundsAndRetractions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payor Refunds And Retractions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PayorRefundsAndRetractions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845258056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 1,287,976<span></span>
</td>
<td class="nump">$ 1,307,299<span></span>
</td>
<td class="nump">$ 1,083,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="nump">30,286<span></span>
</td>
<td class="num">(111,860)<span></span>
</td>
<td class="num">(35,100)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total</a></td>
<td class="nump">$ 1,318,262<span></span>
</td>
<td class="nump">$ 1,195,439<span></span>
</td>
<td class="nump">$ 1,048,478<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394852334664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 47,171<span></span>
</td>
<td class="nump">$ 208,339<span></span>
</td>
<td class="nump">$ 140,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">21,442<span></span>
</td>
<td class="nump">58,026<span></span>
</td>
<td class="nump">32,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">17,481<span></span>
</td>
<td class="nump">15,545<span></span>
</td>
<td class="nump">7,557<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax</a></td>
<td class="nump">86,094<span></span>
</td>
<td class="nump">281,910<span></span>
</td>
<td class="nump">180,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">198,623<span></span>
</td>
<td class="nump">44,263<span></span>
</td>
<td class="nump">52,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">27,206<span></span>
</td>
<td class="num">(25,836)<span></span>
</td>
<td class="nump">21,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="nump">2,009<span></span>
</td>
<td class="num">(20,709)<span></span>
</td>
<td class="nump">4,659<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Total deferred income tax</a></td>
<td class="nump">227,838<span></span>
</td>
<td class="num">(2,282)<span></span>
</td>
<td class="nump">77,789<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Continuing operations</a></td>
<td class="nump">$ 313,932<span></span>
</td>
<td class="nump">$ 279,628<span></span>
</td>
<td class="nump">$ 258,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851412920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income Taxes - Allocation of Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Continuing operations</a></td>
<td class="nump">$ 313,932<span></span>
</td>
<td class="nump">$ 279,628<span></span>
</td>
<td class="nump">$ 258,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod', window );">Discontinued operations</a></td>
<td class="nump">1,657<span></span>
</td>
<td class="nump">40,689<span></span>
</td>
<td class="nump">99,768<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems', window );">Income tax (benefit) expense from continuing and discontinued operations</a></td>
<td class="nump">$ 315,589<span></span>
</td>
<td class="nump">$ 320,317<span></span>
</td>
<td class="nump">$ 358,168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) attributable to income (loss) from operations classified as a discontinued operation. Excludes tax expense (benefit) for gain (loss) on disposal and for provision for gain (loss) until disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120385818&amp;loc=d3e40084-109325<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851580792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in International valuation allowance</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Political advocacy costs</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment', window );">Nondeductible executive compensation</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Unrecognized tax benefits</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Impact of noncontrolling interests primarily attributable to non-tax paying entities</a></td>
<td class="num">(4.80%)<span></span>
</td>
<td class="num">(4.90%)<span></span>
</td>
<td class="num">(4.60%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">23.80%<span></span>
</td>
<td class="nump">23.40%<span></span>
</td>
<td class="nump">24.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Investment Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_EffectiveIncomeTaxReconciliationInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845925048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DeferredTaxAssetsReceivables', window );">Receivables</a></td>
<td class="nump">$ 9,324<span></span>
</td>
<td class="nump">$ 19,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">64,982<span></span>
</td>
<td class="nump">64,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">584,656<span></span>
</td>
<td class="nump">580,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">167,398<span></span>
</td>
<td class="nump">139,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">62,110<span></span>
</td>
<td class="nump">55,108<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">888,470<span></span>
</td>
<td class="nump">858,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(114,824)<span></span>
</td>
<td class="num">(91,925)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">773,646<span></span>
</td>
<td class="nump">766,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(634,736)<span></span>
</td>
<td class="num">(563,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(274,742)<span></span>
</td>
<td class="num">(162,628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DeferredTaxLiabilitiesOperatingLeaseAssets', window );">Operating lease assets</a></td>
<td class="num">(532,082)<span></span>
</td>
<td class="num">(527,056)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Investments in partnerships</a></td>
<td class="num">(101,996)<span></span>
</td>
<td class="num">(64,960)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(39,690)<span></span>
</td>
<td class="num">(25,521)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(1,583,246)<span></span>
</td>
<td class="num">(1,344,079)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (809,600)<span></span>
</td>
<td class="num">$ (577,543)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DeferredTaxAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DeferredTaxAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DeferredTaxLiabilitiesOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from operating lease assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DeferredTaxLiabilitiesOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850959544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 68,214<span></span>
</td>
<td class="nump">$ 40,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions related to current year</a></td>
<td class="nump">2,293<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions related to prior years</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">24,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions related to lapse of applicable statute</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Reductions related to settlements with taxing authorities</a></td>
<td class="num">(430)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 70,202<span></span>
</td>
<td class="nump">$ 68,214<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850027496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance related to changes in the estimated tax benefit of foreign and state operating losses</a></td>
<td class="nump">$ 22,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liability for unrecognized tax benefits</a></td>
<td class="nump">70,202<span></span>
</td>
<td class="nump">$ 68,214<span></span>
</td>
<td class="nump">$ 40,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">66,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Increase in liability for unrecognized tax benefits</a></td>
<td class="nump">1,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to unrecognized tax benefits, net of federal tax benefits</a></td>
<td class="nump">17,864<span></span>
</td>
<td class="nump">$ 14,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember', window );">Capital Loss Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">State capital loss carryforward, amount</a></td>
<td class="nump">$ 297,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">State capital loss carryforward, expiration date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 99,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority | Tax Year 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 488,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 296,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the tax credit carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=dva_TaxYear2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=dva_TaxYear2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394855376968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-Term Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 21, 2020</div></th>
<th class="th"><div>Aug. 11, 2020</div></th>
<th class="th"><div>Jul. 15, 2020</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Feb. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.59%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract', window );"><strong>Acquisition obligations, other notes payable, and financing lease obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="nump">$ 274,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">3.06%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.06%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract', window );"><strong>Long-term debt totals:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt principal outstanding</a></td>
<td class="nump">$ 8,163,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,163,521,000<span></span>
</td>
<td class="nump">$ 8,181,074,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DiscountAndDeferredFinanceCosts', window );">Discount and deferred financing costs</a></td>
<td class="num">(77,717,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77,717,000)<span></span>
</td>
<td class="num">(72,840,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Carrying amount of long-term debt, net of unamortized discounts</a></td>
<td class="nump">8,085,804,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,085,804,000<span></span>
</td>
<td class="nump">8,108,234,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="num">(168,541,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168,541,000)<span></span>
</td>
<td class="num">(130,708,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">7,917,263,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,917,263,000<span></span>
</td>
<td class="nump">7,977,526,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes 4.625% due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">1,859,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,859,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount', window );">Debt Instrument Redeemed Outstanding Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember', window );">Senior Notes 3.75% due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 15,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">1,522,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,522,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes 5.125 % due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 15,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember', window );">Senior Notes 5.0 % due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount', window );">Debt Instrument Redeemed Outstanding Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Acquisition obligations and other notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract', window );"><strong>Acquisition obligations, other notes payable, and financing lease obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayable', window );">Acquisition obligations and other notes payable</a></td>
<td class="nump">$ 164,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,160,000<span></span>
</td>
<td class="nump">180,352,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021-2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue', window );">Acquisition obligations and other notes payable, fair value</a></td>
<td class="nump">$ 164,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Financing Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract', window );"><strong>Acquisition obligations, other notes payable, and financing lease obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="nump">$ 274,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,292,000<span></span>
</td>
<td class="nump">$ 268,534,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021-2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate, percent</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">ABR + 0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest margin</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit | London Interbank Offered Rate (LIBOR) | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 1,684,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,684,375,000<span></span>
</td>
<td class="nump">1,739,063,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">1,675,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,675,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">2,715,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,715,694,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">2,702,115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,702,115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1 | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,743,125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="nump">5,461,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,461,000<span></span>
</td>
<td class="nump">6,457,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="nump">35,825,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,825,000<span></span>
</td>
<td class="nump">45,444,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="nump">$ 36,431,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,431,000<span></span>
</td>
<td class="nump">$ 20,939,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition Obligations And Other Notes Payable, Fair Value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Redeemed Outstanding Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentRedeemedOutstandingPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DiscountAndDeferredFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount and deferred finance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DiscountAndDeferredFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011391&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845133272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 168,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">169,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">227,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">1,496,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">69,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 6,031,804<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394848545032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Derivative Instruments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of debt expense reclassified from accumulated OCI into income</a></td>
<td class="nump">$ 5,313,000<span></span>
</td>
<td class="nump">$ 6,377,000<span></span>
</td>
<td class="nump">$ 6,286,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of unrealized gains (losses) in OCI on interest rate cap and swap agreements</a></td>
<td class="num">$ (16,346,000)<span></span>
</td>
<td class="nump">1,151,000<span></span>
</td>
<td class="num">$ (133,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInceptionDates', window );">Derivative, effective date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, expiration date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020 | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">$ 2,671,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020 | Cash Flow Hedging | Debt Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of debt expense reclassified from accumulated OCI into income</a></td>
<td class="nump">2,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of unrealized gains (losses) in OCI on interest rate cap and swap agreements</a></td>
<td class="num">(21,781,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020 | Term Loan Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts of interest rate agreements</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest margin</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member', window );">2015 Interest Rate Cap Agreements Effective June 29, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInceptionDates', window );">Derivative, effective date</a></td>
<td class="text">Jun. 29,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, expiration date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member', window );">2015 Interest Rate Cap Agreements Effective June 29, 2018 | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member', window );">2015 Interest Rate Cap Agreements Effective June 29, 2018 | Cash Flow Hedging | Debt Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of debt expense reclassified from accumulated OCI into income</a></td>
<td class="nump">4,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of unrealized gains (losses) in OCI on interest rate cap and swap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member', window );">2015 Interest Rate Cap Agreements Effective June 29, 2018 | Term Loan Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts of interest rate agreements</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest margin</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInceptionDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the entity entered into the derivative contract, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInceptionDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeMaturityDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the derivative contract matures, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeMaturityDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394855032424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details) - Cash Flow Hedging - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of unrealized (losses) gains in OCI on interest rate cap agreements</a></td>
<td class="num">$ (16,346)<span></span>
</td>
<td class="nump">$ 1,151<span></span>
</td>
<td class="num">$ (133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Reclassification from accumulated other comprehensive income into net income</a></td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Related income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of unrealized (losses) gains in OCI on interest rate cap agreements</a></td>
<td class="nump">5,435<span></span>
</td>
<td class="num">(415)<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Reclassification from accumulated other comprehensive income into net income</a></td>
<td class="num">(1,768)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
<td class="num">(2,180)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Interest rate cap agreements | Debt Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of unrealized (losses) gains in OCI on interest rate cap agreements</a></td>
<td class="num">(21,781)<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Reclassification from accumulated other comprehensive income into net income</a></td>
<td class="nump">$ 7,081<span></span>
</td>
<td class="nump">$ 8,591<span></span>
</td>
<td class="nump">$ 8,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_IncomeTaxExpenseBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_IncomeTaxExpenseBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394855636184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Additional information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 21, 2020</div></th>
<th class="th"><div>Aug. 11, 2020</div></th>
<th class="th"><div>Jul. 15, 2020</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Feb. 13, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Aug. 12, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtRefinancingCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,957,000<span></span>
</td>
<td class="nump">$ 33,402,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Long-term debt, weighted average effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.59%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.06%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282,932,000<span></span>
</td>
<td class="nump">419,639,000<span></span>
</td>
<td class="nump">461,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,179,000<span></span>
</td>
<td class="nump">24,185,000<span></span>
</td>
<td class="nump">$ 25,538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member', window );">2015 Interest Rate Cap Agreements Effective June 29, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes 4.625% due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Long-term debt, weighted average effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1', window );">Debt Instrument, Date of First Required Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt Instrument, Fee Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,386,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount', window );">Debt Instrument Redeemed Outstanding Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes 5.125 % due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 15,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Long-term debt, weighted average effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes', window );">Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of Deferred Debt Issuance Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,764,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember', window );">Senior Notes 3.75% due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 15,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Long-term debt, weighted average effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1', window );">Debt Instrument, Date of First Required Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt Instrument, Fee Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,936,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember', window );">Senior Notes 5.0 % due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Long-term debt, weighted average effective interest rate during period</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount', window );">Debt Instrument Redeemed Outstanding Principal Amount</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes', window );">Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes</a></td>
<td class="nump">37,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of Deferred Debt Issuance Cost</a></td>
<td class="nump">$ 8,866,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on revolving credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 13,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement', window );">Additional Debt Principal Amount Due To Repricing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ProceedsFromRepricingAgreementOnSecuredDebt', window );">Proceeds From Repricing Agreement On Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtRefinancingCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,948,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt', window );">Noncash Financing Outflows Related To Extinguishment Of Long Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,431,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,715,694,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1 | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,842,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,743,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,688,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,069,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,684,375,000<span></span>
</td>
<td class="nump">$ 1,739,063,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Debt Principal Amount Due To Repricing Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentRedeemedOutstandingPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Redeemed Outstanding Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentRedeemedOutstandingPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtRefinancingCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment refinancing redemption charges related to debt modification of long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtRefinancingCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Financing Outflows Related To Extinguishment Of Long Term Debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ProceedsFromRepricingAgreementOnSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Repricing Agreement On Secured Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ProceedsFromRepricingAgreementOnSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt agreement requires the first payment to be made, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDateOfFirstRequiredPayment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuanceDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt instrument was issued, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuanceDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeMaturityDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the derivative contract matures, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeMaturityDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2015InterestRateCapAgreementsEffectiveJune292018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843780600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Lease Expense Components (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Fixed lease expense</a></td>
<td class="nump">$ 541,090<span></span>
</td>
<td class="nump">$ 526,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">122,729<span></span>
</td>
<td class="nump">119,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Financing lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of leased assets</a></td>
<td class="nump">24,720<span></span>
</td>
<td class="nump">23,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">14,421<span></span>
</td>
<td class="nump">14,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost</a></td>
<td class="nump">$ 702,960<span></span>
</td>
<td class="nump">$ 684,748<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394852468968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Leases Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases term and discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 years 6 months<span></span>
</td>
<td class="text">10 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesOtherInformationAbstract', window );"><strong>Leases Other Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Sale and Leaseback Transaction, Gain (Loss), Net</a></td>
<td class="nump">$ 34,301<span></span>
</td>
<td class="nump">$ 20,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">661,318<span></span>
</td>
<td class="nump">637,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="nump">20,981<span></span>
</td>
<td class="nump">22,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="nump">24,780<span></span>
</td>
<td class="nump">25,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities', window );">Net Operating Lease Assets Obtained In Exchange For Lease Liabilities</a></td>
<td class="nump">$ 401,559<span></span>
</td>
<td class="nump">$ 432,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Finance Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases term and discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate, percent</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases Other Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Operating Lease Assets Obtained In Exchange For New or Modified Lease Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121606570&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850782568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 480,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">504,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">464,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">412,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">361,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,437,965<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments due under operating leases</a></td>
<td class="nump">3,661,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less portion representing interest, operating lease liabilities</a></td>
<td class="num">(552,915)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities, operating leases</a></td>
<td class="nump">3,108,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">35,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">35,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">35,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">35,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">35,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">174,907<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum payments due under finance leases</a></td>
<td class="nump">351,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less portion representing interest, financing lease liabilities</a></td>
<td class="num">(77,631)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="nump">$ 274,292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394848223560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 275,389<span></span>
</td>
<td class="nump">$ 247,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_FinanceLeaseAccumulatedDepreciation', window );">Finance Lease Accumulated Depreciation</a></td>
<td class="nump">49,345<span></span>
</td>
<td class="nump">27,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense under all operating leases</a></td>
<td class="nump">$ 663,819<span></span>
</td>
<td class="nump">$ 646,092<span></span>
</td>
<td class="nump">$ 596,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_FinanceLeaseAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Accumulated Depreciation, contra asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_FinanceLeaseAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LeasesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LeasesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846632008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent of match</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer matching contribution, percent of employees' gross wages</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">$ 70,180<span></span>
</td>
<td class="nump">$ 64,988<span></span>
</td>
<td class="nump">$ 67,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember', window );">DaVita Voluntary Deferral Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum percentage of employees' base salary to be maintained into deferral account</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer', window );">Non-qualified deferred compensation plan, contributions</a></td>
<td class="nump">$ 3,637<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">3,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid', window );">Deferred compensation plan, distributions</a></td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">2,730<span></span>
</td>
<td class="nump">$ 4,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember', window );">DaVita Voluntary Deferral Plan | Rabbi trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Total fair value of assets held in trust</a></td>
<td class="nump">$ 43,844<span></span>
</td>
<td class="nump">$ 39,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election Effective date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution made to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=dva_AllTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=dva_AllTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850963288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies - Additional Information (Details) - US Attorney Prescription Drug Investigation<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount awarded to other party</a></td>
<td class="nump">$ 63,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember', window );">Incremental Cash Portion</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount awarded to other party</a></td>
<td class="nump">41,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember', window );">Cash Paid For Portion Previously Refunded</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount awarded to other party</a></td>
<td class="nump">$ 22,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846784712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Purchase Obligation, Due in Next Twelve Months</a></td>
<td class="nump">$ 542,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Purchase Obligation, Due in Second Year</a></td>
<td class="nump">540,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Purchase Obligation, Due in Third Year</a></td>
<td class="nump">179,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Purchase Obligation, to be Paid, Year Four</a></td>
<td class="nump">92,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OffBalanceSheetFinancingArrangements', window );">Off -Balance Sheet Financing Arrangements</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=dva_EpogenMember', window );">EPO</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LongTermPurchaseCommitmentExpirationDate', window );">Long term purchase commitment, expiration date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DissolutionTermOfJointVentures', window );">Scheduled dissolution term of joint ventures</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | EPO</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired', window );">Long-term purchase commitment, percentage of quantity required to be purchased</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DissolutionTermOfJointVentures', window );">Scheduled dissolution term of joint ventures</a></td>
<td class="text">50 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember', window );">Commitments to Provide Operating Capital</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other potential commitments to provide operating capital to several dialysis centers</a></td>
<td class="nump">$ 8,663<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CommitmentsAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CommitmentsAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DissolutionTermOfJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dissolution term of joint ventures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DissolutionTermOfJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongTermPurchaseCommitmentExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term purchase commitment expiration date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongTermPurchaseCommitmentExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term purchase commitment percentage of quantity required.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_OffBalanceSheetFinancingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Off -Balance Sheet Financing Arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_OffBalanceSheetFinancingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=dva_EpogenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=dva_EpogenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394840141144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">6,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">2,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(894,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(494,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(246,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">8,084,000<span></span>
</td>
<td class="nump">6,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="nump">987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of grants</a></td>
<td class="nump">$ 26.70<span></span>
</td>
<td class="nump">$ 14.04<span></span>
</td>
<td class="nump">$ 16.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of year (USD per share)</a></td>
<td class="nump">64.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="nump">68.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="nump">72.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (USD per share)</a></td>
<td class="nump">83.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled (USD per share)</a></td>
<td class="nump">61.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (USD per share)</a></td>
<td class="nump">63.64<span></span>
</td>
<td class="nump">$ 64.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 69.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted average remaining contractual&#160;life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at end of period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at end of period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dva_StockUnitMember', window );">Stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">3,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,027,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod', window );">Added by performance factor (in shares)</a></td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Exercised (in shares)</a></td>
<td class="num">(351,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod', window );">Expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(318,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">3,537,000<span></span>
</td>
<td class="nump">3,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of grants (USD per share)</a></td>
<td class="nump">$ 77.83<span></span>
</td>
<td class="nump">$ 50.58<span></span>
</td>
<td class="nump">$ 66.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted average remaining contractual&#160;life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Outstanding at end of period</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms', window );">Exercisable at end of period</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average remaining contractual terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments exercisable number.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based Compensation Arrangement by Share based Payment Award, Other than Options, Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-base Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Expired In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_StockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_StockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394987702056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Range of Exercise Prices (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">8,084,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 63.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">987,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 69.56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeOneMember', window );">$50.01&#8211;$60.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">2,263,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 52.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 57.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower range (USD per share)</a></td>
<td class="nump">50.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, upper range (USD per share)</a></td>
<td class="nump">$ 60.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeTwoMember', window );">$60.01&#8211;$70.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">5,165,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 66.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">610,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 65.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower range (USD per share)</a></td>
<td class="nump">60.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, upper range (USD per share)</a></td>
<td class="nump">$ 70.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeThreeMember', window );">$70.01&#8211;$80.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">656,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 75.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">375,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 75.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower range (USD per share)</a></td>
<td class="nump">70.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, upper range (USD per share)</a></td>
<td class="nump">$ 80.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846234664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details) - Stock Options and Stock Appreciation Rights<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">28.20%<span></span>
</td>
<td class="nump">29.50%<span></span>
</td>
<td class="nump">23.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_StockOptionProgramAndStockAppreciationRightProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_StockOptionProgramAndStockAppreciationRightProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394847223768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 01, 2020</div></th>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th">
<div>Nov. 04, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 11, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock awards exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,258,000<span></span>
</td>
<td class="nump">$ 11,475,000<span></span>
</td>
<td class="nump">$ 31,045,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of stock awards outstanding</a></td>
<td class="nump">$ 853,803,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">853,803,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of stock awards exercisable</a></td>
<td class="nump">47,208,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,208,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends, common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract', window );"><strong>Employee stock purchase plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Share-based awards, fair value assumptions, expected dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LongtermIncentiveProgramCompensationCost', window );">Long-term incentive program (LTIP) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,643,000<span></span>
</td>
<td class="nump">118,513,000<span></span>
</td>
<td class="nump">85,759,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,458,000<span></span>
</td>
<td class="nump">67,850,000<span></span>
</td>
<td class="nump">73,061,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense', window );">Estimated tax benefits recorded for stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,775,000<span></span>
</td>
<td class="nump">9,186,000<span></span>
</td>
<td class="nump">13,591,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</a></td>
<td class="nump">189,713,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,713,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding', window );">Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards', window );">Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,302,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Share-based Payment Arrangement, Plan Modification, Incremental Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,704,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Share-based Payment Arrangement, Accelerated Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,727,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,957,000<span></span>
</td>
<td class="nump">2,251,000<span></span>
</td>
<td class="nump">7,988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Stock award exercises and other share issuances, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract', window );"><strong>Employee stock purchase plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,458,000<span></span>
</td>
<td class="nump">63,705,000<span></span>
</td>
<td class="nump">73,582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dva_PremiumPricedStockSettledStockAppreciationRightsMember', window );">Premium priced stock-settled stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PremiumPricedAwardBasePricePerShare', window );">Premium Priced Award Base Price Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PremiumToTheTenderOfferSharePurchasePrice', window );">Premium To The Tender Offer Share Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dva_EmployeeStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants | shares</a></td>
<td class="nump">6,189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract', window );"><strong>Employee stock purchase plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase', window );">Employee entitlement for purchase of the Company's common stock during each calendar year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Stock purchase price as percentage of fair market value</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares', window );">Contributions used to purchase shares, employee-related current liabilities</a></td>
<td class="nump">$ 17,148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,148,000<span></span>
</td>
<td class="nump">$ 16,569,000<span></span>
</td>
<td class="nump">$ 17,398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock issued for employee stock purchase plans | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="nump">398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.40%<span></span>
</td>
<td class="nump">28.80%<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.06<span></span>
</td>
<td class="nump">$ 13.80<span></span>
</td>
<td class="nump">$ 17.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock appreciation awards granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract', window );"><strong>Employee stock purchase plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.70<span></span>
</td>
<td class="nump">$ 14.04<span></span>
</td>
<td class="nump">$ 16.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-based Payment Arrangement, Tranche One | Premium priced stock-settled stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Share-based Payment Arrangement, Tranche Two | Premium priced stock-settled stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember', window );">Stock Incentive 2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants | shares</a></td>
<td class="nump">8,074,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,074,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,730,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized under the plan | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions', window );">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance', window );">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward', window );">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance', window );">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember', window );">Stock Incentive 2020 Plan | Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock appreciation awards granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember', window );">Stock Incentive 2020 Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember', window );">Stock Incentive 2020 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Terms of award (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember', window );">Stock Incentive 2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,730,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Terms of award (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio', window );">Full share awards to shares available, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember', window );">Stock Incentive 2011 Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember', window );">Stock Incentive 2011 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee service share-based compensation estimated tax benefit from compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongtermIncentiveProgramCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Long-term Incentive Program compensation cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongtermIncentiveProgramCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PremiumPricedAwardBasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premium Priced Award Base Price Per Share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PremiumPricedAwardBasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PremiumToTheTenderOfferSharePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premium To The Tender Offer Share Purchase Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PremiumToTheTenderOfferSharePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award maximum share value authorized for purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_PremiumPricedStockSettledStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_PremiumPricedStockSettledStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394849115480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Repurchases Tender Offer (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">16,477<span></span>
</td>
<td class="nump">41,020<span></span>
</td>
<td class="nump">16,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
<td class="nump">$ 1,153,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 87.80<span></span>
</td>
<td class="nump">$ 58.57<span></span>
</td>
<td class="nump">$ 68.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember', window );">Open Market Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">8,495<span></span>
</td>
<td class="nump">19,218<span></span>
</td>
<td class="nump">16,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 741,850<span></span>
</td>
<td class="nump">$ 1,168,321<span></span>
</td>
<td class="nump">$ 1,153,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 87.32<span></span>
</td>
<td class="nump">$ 60.79<span></span>
</td>
<td class="nump">$ 68.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=dva_TenderOfferMember', window );">Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">7,982<span></span>
</td>
<td class="nump">21,802<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 704,917<span></span>
</td>
<td class="nump">$ 1,234,154<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 88.32<span></span>
</td>
<td class="nump">$ 56.61<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Treasury Stock, Shares Repurchases, Table Footnotes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice', window );">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</a></td>
<td class="nump">$ 88.00<span></span>
</td>
<td class="nump">$ 56.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareRepurchaseFeesAndExpenses', window );">Share Repurchase Fees And Expenses</a></td>
<td class="nump">$ 2,529<span></span>
</td>
<td class="nump">$ 2,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareRepurchaseFeesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Repurchase Fees And Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareRepurchaseFeesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired, Average Cost Per Share, Clearing Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dva_TenderOfferMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dva_TenderOfferMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394850743240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to DaVita Inc.</a></td>
<td class="nump">$ 173,773<span></span>
</td>
<td class="nump">$ 158,674<span></span>
</td>
<td class="nump">$ 201,602<span></span>
</td>
<td class="nump">$ 239,593<span></span>
</td>
<td class="nump">$ 244,871<span></span>
</td>
<td class="nump">$ 143,270<span></span>
</td>
<td class="nump">$ 273,551<span></span>
</td>
<td class="nump">$ 149,289<span></span>
</td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
<td class="nump">$ 159,394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests', window );">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
<td class="num">(17,897)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests', window );">Purchase of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Noncontrolling Interest, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
<td class="num">(17,818)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests', window );">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 778,006<span></span>
</td>
<td class="nump">$ 773,836<span></span>
</td>
<td class="nump">$ 141,576<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Gain Related To Redemptions or Purchase of Interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394854926056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder's equity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 10, 2020</div></th>
<th class="th"><div>Nov. 04, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Stock repurchases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="nump">16,844,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
<td class="nump">$ 1,153,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
<td class="nump">$ 58.57<span></span>
</td>
<td class="nump">$ 68.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount', window );">Terminated Remaining Prior Share Repurchases Authorized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329,302<span></span>
</td>
<td class="nump">$ 246,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CharterdocumentsandDelawarelawAbstract', window );"><strong>Charter documents and Delaware law:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation', window );">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,831<span></span>
</td>
<td class="nump">$ 68,019<span></span>
</td>
<td class="nump">$ 28,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Stock repurchases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="nump">16,844,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
<td class="nump">$ 1,153,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="nump">16,844,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Stock repurchases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">1,063,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 123,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 115.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 1,806,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CharterdocumentsandDelawarelawAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Charter documents and Delaware law [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CharterdocumentsandDelawarelawAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law limitation. The Company is subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period three years following the date on which that stockholder became an interested stockholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Terminated Remaining Prior Share Repurchases Authorized, Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394855513720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 2,133,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">1,383,566<span></span>
</td>
<td class="nump">$ 2,133,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1,433)<span></span>
</td>
<td class="num">(8,961)<span></span>
</td>
<td class="num">$ (12,408)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized (losses) gains</a></td>
<td class="num">(21,781)<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax</a></td>
<td class="nump">5,435<span></span>
</td>
<td class="num">(415)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Unrealized (losses) gains net</a></td>
<td class="num">(16,346)<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive losses (income) into net income</a></td>
<td class="nump">7,081<span></span>
</td>
<td class="nump">8,591<span></span>
</td>
<td class="nump">8,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(1,768)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
<td class="num">(2,180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(12,466)<span></span>
</td>
<td class="num">(1,433)<span></span>
</td>
<td class="num">(8,961)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Interest rate cap agreements | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CumulativeEffectOfChangeInAccountingPrinciple', window );">Cumulative effect of change in accounting principle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,706)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized (losses) gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Unrealized (losses) gains net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive losses (income) into net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Investment securities | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CumulativeEffectOfChangeInAccountingPrinciple', window );">Cumulative effect of change in accounting principle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,662)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(46,065)<span></span>
</td>
<td class="num">(25,963)<span></span>
</td>
<td class="nump">19,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized (losses) gains</a></td>
<td class="num">(7,080)<span></span>
</td>
<td class="num">(20,102)<span></span>
</td>
<td class="num">(45,944)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax</a></td>
<td class="num">(543)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Unrealized (losses) gains net</a></td>
<td class="num">(7,623)<span></span>
</td>
<td class="num">(20,102)<span></span>
</td>
<td class="num">(45,944)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive losses (income) into net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(53,688)<span></span>
</td>
<td class="num">(46,065)<span></span>
</td>
<td class="num">(25,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CumulativeEffectOfChangeInAccountingPrinciple', window );">Cumulative effect of change in accounting principle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(47,498)<span></span>
</td>
<td class="num">(34,924)<span></span>
</td>
<td class="nump">13,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized (losses) gains</a></td>
<td class="num">(28,861)<span></span>
</td>
<td class="num">(18,536)<span></span>
</td>
<td class="num">(46,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax</a></td>
<td class="nump">4,892<span></span>
</td>
<td class="num">(415)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Unrealized (losses) gains net</a></td>
<td class="num">(23,969)<span></span>
</td>
<td class="num">(18,951)<span></span>
</td>
<td class="num">(46,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive losses (income) into net income</a></td>
<td class="nump">7,081<span></span>
</td>
<td class="nump">8,591<span></span>
</td>
<td class="nump">8,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(1,768)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
<td class="num">(2,180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (66,154)<span></span>
</td>
<td class="num">$ (47,498)<span></span>
</td>
<td class="num">$ (34,924)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated other comprehensive (loss) income | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CumulativeEffectOfChangeInAccountingPrinciple', window );">Cumulative effect of change in accounting principle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,368)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CumulativeEffectOfChangeInAccountingPrinciple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Effect Of Change In Accounting Principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CumulativeEffectOfChangeInAccountingPrinciple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846288312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Assets acquired and liabilities assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 6,919,109<span></span>
</td>
<td class="nump">$ 6,787,635<span></span>
</td>
<td class="nump">$ 6,841,960<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="nump">23,607<span></span>
</td>
<td class="nump">6,713<span></span>
</td>
<td class="nump">23,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">37,457<span></span>
</td>
<td class="nump">4,842<span></span>
</td>
<td class="nump">11,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Customer relationships</a></td>
<td class="nump">34,625<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Noncompetition agreements and other long-term assets</a></td>
<td class="nump">10,168<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
<td class="nump">3,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Indefinite-lived licenses</a></td>
<td class="nump">22,136<span></span>
</td>
<td class="nump">31,858<span></span>
</td>
<td class="nump">23,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">130,057<span></span>
</td>
<td class="nump">90,226<span></span>
</td>
<td class="nump">278,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="num">(3,962)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities Assumed</a></td>
<td class="num">(34,068)<span></span>
</td>
<td class="num">(7,159)<span></span>
</td>
<td class="num">(19,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interests assumed</a></td>
<td class="num">(1,729)<span></span>
</td>
<td class="num">(1,762)<span></span>
</td>
<td class="num">(80,291)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Aggregate purchase price</a></td>
<td class="nump">$ 218,291<span></span>
</td>
<td class="nump">$ 126,698<span></span>
</td>
<td class="nump">$ 239,953<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845792744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details) - Series of individually immaterial business acquisitions - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes associated with acquisitions</a></td>
<td class="nump">$ 94,318<span></span>
</td>
<td class="nump">$ 88,517<span></span>
</td>
<td class="nump">$ 165,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortizable intangible assets acquired, weighted-average estimated useful lives</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortizable intangible assets acquired, weighted-average estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851648408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma total revenues</a></td>
<td class="nump">$ 11,636,416<span></span>
</td>
<td class="nump">$ 11,570,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma net income from continuing operations attributable to DaVita Inc.</a></td>
<td class="nump">$ 789,473<span></span>
</td>
<td class="nump">$ 718,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Pro forma basic net income per share from continuing operations attributable to DaVita Inc.</a></td>
<td class="nump">$ 6.59<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Pro forma diluted net income per share from continuing operations attributable to DaVita Inc.</a></td>
<td class="nump">$ 6.44<span></span>
</td>
<td class="nump">$ 4.67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846582168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Beginning balance</a></td>
<td class="nump">$ 24,586<span></span>
</td>
<td class="nump">$ 2,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Acquisitions</a></td>
<td class="nump">14,042<span></span>
</td>
<td class="nump">23,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations', window );">Foreign currency translation</a></td>
<td class="num">(3,688)<span></span>
</td>
<td class="num">(905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss', window );">Fair value remeasurements</a></td>
<td class="num">(2,630)<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments', window );">Payments or other settlements</a></td>
<td class="num">(2,062)<span></span>
</td>
<td class="num">(774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Ending balance</a></td>
<td class="nump">$ 30,248<span></span>
</td>
<td class="nump">$ 24,586<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions Earnouts Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394855594008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,013<span></span>
</td>
<td class="nump">$ 100,861<span></span>
</td>
<td class="nump">$ 183,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Business combination contingent consideration acquisitions, earn-outs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,042<span></span>
</td>
<td class="nump">23,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Non-cash gain on acquiring additional ownership in business acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,248<span></span>
</td>
<td class="nump">24,586<span></span>
</td>
<td class="nump">2,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember', window );">RMS Lifeline</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain (Loss) on Divestiture</a></td>
<td class="nump">$ 16,252<span></span>
</td>
<td class="nump">$ 16,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Long-term Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember', window );">Other companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,013<span></span>
</td>
<td class="nump">98,836<span></span>
</td>
<td class="nump">176,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Business combination contingent consideration acquisitions, earn-outs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,042<span></span>
</td>
<td class="nump">23,536<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Deferred Purchase price and liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,415<span></span>
</td>
<td class="nump">$ 4,326<span></span>
</td>
<td class="nump">$ 34,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Non-cash gain on acquiring additional ownership in business acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U S Dialysis And Related Lab Services | Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember', window );">Foreign Dialysis Centers | Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition contingent consideration revenue earn-out period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845878296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations Financial results for discontinued operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill and other asset impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 124,892<span></span>
</td>
<td class="nump">$ 3,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment', window );">Valuation adjustment on disposal group</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">316,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="num">(24,248)<span></span>
</td>
<td class="num">(23,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net (loss) income from discontinued operations, net of tax</a></td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">105,483<span></span>
</td>
<td class="num">(457,038)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember', window );">DMG - discontinued operations | Discontinued Operations, Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Net revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,713,059<span></span>
</td>
<td class="nump">4,963,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,543,865<span></span>
</td>
<td class="nump">4,962,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill and other asset impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">41,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment', window );">Valuation adjustment on disposal group</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">316,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) from discontinued operations before taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">169,194<span></span>
</td>
<td class="num">(357,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="num">(7,996)<span></span>
</td>
<td class="num">(23,022)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal', window );">Income tax expense</a></td>
<td class="nump">$ 1,657<span></span>
</td>
<td class="nump">$ 40,689<span></span>
</td>
<td class="nump">$ 99,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operations Valuation Adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss (Gain) On Disposition Of Business Interests Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LossGainOnDispositionOfBusinessInterestsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit on (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851610680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by operating activities from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 99,634<span></span>
</td>
<td class="nump">$ 290,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used in investing activities from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (43,442)<span></span>
</td>
<td class="num">$ (57,382)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394848056168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 05, 2017</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 18, 2019 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,248)<span></span>
</td>
<td class="num">$ (23,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of DMG division</a></td>
<td class="nump">$ 4,465,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">$ 3,824,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,252)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 60,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,013<span></span>
</td>
<td class="nump">100,861<span></span>
</td>
<td class="nump">183,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,013<span></span>
</td>
<td class="nump">98,836<span></span>
</td>
<td class="nump">176,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DMGAcquisitionsMember', window );">DMG Acquisitions | Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Business combination, deferred purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Held-for-sale | DMG - discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Business acquisition, effective date of acquisition</a></td>
<td class="text">Jun. 19,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PurchaseAndSaleAgreementAggregatePurchasePrice', window );">Purchase And Sale Agreement Aggregate Purchase Price</a></td>
<td class="nump">$ 4,340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Business Acquisition, Date of Acquisition Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  05,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,996)<span></span>
</td>
<td class="num">$ (23,022)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice', window );">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,976)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Held-for-sale | DMG - discontinued operations | Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss (Gain) On Disposition Of Business Interests Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LossGainOnDispositionOfBusinessInterestsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PurchaseAndSaleAgreementAggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase And Sale Agreement Aggregate Purchase Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PurchaseAndSaleAgreementAggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e848-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e845-128460<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DMGAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DMGAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843821784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 16,988,516<span></span>
</td>
<td class="nump">$ 17,311,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">14,091,736<span></span>
</td>
<td class="nump">$ 13,811,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">310,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">$ 216,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394847427576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 44,077<span></span>
</td>
<td class="nump">$ 39,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">42,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">44,077<span></span>
</td>
<td class="nump">39,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">30,248<span></span>
</td>
<td class="nump">24,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,330,028<span></span>
</td>
<td class="nump">1,180,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">2,671<span></span>
</td>
<td class="nump">24,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted&#160;prices&#160;in active&#160;markets&#160;for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">44,077<span></span>
</td>
<td class="nump">39,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted&#160;prices&#160;in active&#160;markets&#160;for identical assets (Level 1) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant&#160;other observable&#160;inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant&#160;other observable&#160;inputs (Level 2) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">2,671<span></span>
</td>
<td class="nump">24,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">30,248<span></span>
</td>
<td class="nump">24,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,330,028<span></span>
</td>
<td class="nump">1,180,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394961896504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Values of Financial Instruments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple', window );">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</a></td>
<td class="nump">$ 160<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394848805816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,039,709<span></span>
</td>
<td class="nump">$ 10,918,421<span></span>
</td>
<td class="nump">$ 10,709,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ProvisionForExpectedCreditLosses', window );">Provision for uncollectible accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,458)<span></span>
</td>
<td class="num">(21,715)<span></span>
</td>
<td class="num">(49,587)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts', window );">Dialysis patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,026,251<span></span>
</td>
<td class="nump">10,896,706<span></span>
</td>
<td class="nump">10,660,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,353<span></span>
</td>
<td class="nump">491,773<span></span>
</td>
<td class="nump">744,457<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 2,905,322<span></span>
</td>
<td class="nump">$ 2,924,066<span></span>
</td>
<td class="nump">$ 2,879,979<span></span>
</td>
<td class="nump">$ 2,841,237<span></span>
</td>
<td class="nump">$ 2,898,584<span></span>
</td>
<td class="nump">$ 2,904,078<span></span>
</td>
<td class="nump">$ 2,842,705<span></span>
</td>
<td class="nump">$ 2,743,112<span></span>
</td>
<td class="nump">11,550,604<span></span>
</td>
<td class="nump">11,388,479<span></span>
</td>
<td class="nump">11,404,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">$ 381,671<span></span>
</td>
<td class="nump">$ 437,669<span></span>
</td>
<td class="nump">$ 409,920<span></span>
</td>
<td class="nump">$ 465,376<span></span>
</td>
<td class="nump">$ 462,588<span></span>
</td>
<td class="nump">$ 378,336<span></span>
</td>
<td class="nump">$ 461,886<span></span>
</td>
<td class="nump">$ 340,507<span></span>
</td>
<td class="nump">1,694,636<span></span>
</td>
<td class="nump">1,643,317<span></span>
</td>
<td class="nump">1,525,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SegmentReportingInformationCorporateExpenses', window );">Corporate administrative support</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(146,707)<span></span>
</td>
<td class="num">(92,335)<span></span>
</td>
<td class="num">(90,108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(304,111)<span></span>
</td>
<td class="num">(443,824)<span></span>
</td>
<td class="num">(487,435)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtPrepaymentRefinancingRedemptionCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,022)<span></span>
</td>
<td class="num">(33,402)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,759<span></span>
</td>
<td class="nump">29,348<span></span>
</td>
<td class="nump">10,089<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,318,262<span></span>
</td>
<td class="nump">1,195,439<span></span>
</td>
<td class="nump">1,048,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Reporting Information footnote:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,916<span></span>
</td>
<td class="nump">12,679<span></span>
</td>
<td class="num">(4,484)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,514,649<span></span>
</td>
<td class="nump">10,430,581<span></span>
</td>
<td class="nump">10,242,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,035,955<span></span>
</td>
<td class="nump">957,898<span></span>
</td>
<td class="nump">1,161,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,712,633<span></span>
</td>
<td class="nump">11,534,834<span></span>
</td>
<td class="nump">11,532,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,841,343<span></span>
</td>
<td class="nump">1,735,652<span></span>
</td>
<td class="nump">1,615,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,632,822<span></span>
</td>
<td class="nump">10,552,600<span></span>
</td>
<td class="nump">10,366,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ProvisionForExpectedCreditLosses', window );">Provision for uncollectible accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,458)<span></span>
</td>
<td class="num">(21,715)<span></span>
</td>
<td class="num">(50,927)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts', window );">Dialysis patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,619,364<span></span>
</td>
<td class="nump">10,530,885<span></span>
</td>
<td class="nump">10,316,069<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,659,935<span></span>
</td>
<td class="nump">10,562,906<span></span>
</td>
<td class="nump">10,335,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,917,604<span></span>
</td>
<td class="nump">1,924,826<span></span>
</td>
<td class="nump">1,709,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | External Sources</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,488,731<span></span>
</td>
<td class="nump">10,421,401<span></span>
</td>
<td class="nump">10,274,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,376<span></span>
</td>
<td class="nump">30,895<span></span>
</td>
<td class="nump">19,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,091<span></span>
</td>
<td class="nump">131,199<span></span>
</td>
<td class="nump">92,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,978<span></span>
</td>
<td class="nump">497,021<span></span>
</td>
<td class="nump">437,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484,977<span></span>
</td>
<td class="nump">460,877<span></span>
</td>
<td class="nump">724,577<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,052,698<span></span>
</td>
<td class="nump">971,928<span></span>
</td>
<td class="nump">1,196,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,261)<span></span>
</td>
<td class="num">(189,174)<span></span>
</td>
<td class="num">(93,789)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Reporting Information footnote:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,866<span></span>
</td>
<td class="nump">9,366<span></span>
</td>
<td class="nump">24,866<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other - Ancillary services | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,743<span></span>
</td>
<td class="nump">14,030<span></span>
</td>
<td class="nump">34,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162,029)<span></span>
</td>
<td class="num">(146,355)<span></span>
</td>
<td class="num">(127,186)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145,286)<span></span>
</td>
<td class="num">(132,325)<span></span>
</td>
<td class="num">(92,950)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,743)<span></span>
</td>
<td class="num">$ (14,030)<span></span>
</td>
<td class="num">$ (34,236)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtPrepaymentRefinancingRedemptionCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment, refinancing and redemption charges related to long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtPrepaymentRefinancingRedemptionCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ProvisionForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision For Expected Credit Losses, contra revenue account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ProvisionForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SegmentReportingInformationCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SegmentReportingInformationCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846196488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 630,435<span></span>
</td>
<td class="nump">$ 615,152<span></span>
</td>
<td class="nump">$ 591,035<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">594,552<span></span>
</td>
<td class="nump">583,454<span></span>
</td>
<td class="nump">558,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 35,883<span></span>
</td>
<td class="nump">$ 31,698<span></span>
</td>
<td class="nump">$ 32,225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394849138120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Reporting - Summary of Assets by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 16,988,516<span></span>
</td>
<td class="nump">$ 17,311,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">257,491<span></span>
</td>
<td class="nump">241,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">3,521,824<span></span>
</td>
<td class="nump">3,473,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">15,344,647<span></span>
</td>
<td class="nump">15,778,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">122,974<span></span>
</td>
<td class="nump">124,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,643,869<span></span>
</td>
<td class="nump">1,532,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">134,517<span></span>
</td>
<td class="nump">117,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">$ 181,137<span></span>
</td>
<td class="nump">$ 154,572<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394851784056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 674,541<span></span>
</td>
<td class="nump">$ 766,546<span></span>
</td>
<td class="nump">$ 987,138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">646,870<span></span>
</td>
<td class="nump">681,339<span></span>
</td>
<td class="nump">856,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">27,671<span></span>
</td>
<td class="nump">46,741<span></span>
</td>
<td class="nump">45,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_DaVitaMedicalGroupMember', window );">DMG - discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 38,466<span></span>
</td>
<td class="nump">$ 85,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845041896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Reporting - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Jun. 19, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember', window );">DMG - discontinued operations | Discontinued Operations, Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Business acquisition, effective date of acquisition</a></td>
<td class="text">Jun. 19,  2019<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e848-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e845-128460<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394845133272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes, net</a></td>
<td class="nump">$ 154,850<span></span>
</td>
<td class="nump">$ 157,983<span></span>
</td>
<td class="nump">$ 92,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest</a></td>
<td class="nump">326,165<span></span>
</td>
<td class="nump">473,176<span></span>
</td>
<td class="nump">488,974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Fixed assets under financing lease obligations</a></td>
<td class="nump">$ 22,042<span></span>
</td>
<td class="nump">$ 18,953<span></span>
</td>
<td class="nump">$ 8,828<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid during period for.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394846123896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Selected quarterly financial information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,905,322<span></span>
</td>
<td class="nump">$ 2,924,066<span></span>
</td>
<td class="nump">$ 2,879,979<span></span>
</td>
<td class="nump">$ 2,841,237<span></span>
</td>
<td class="nump">$ 2,898,584<span></span>
</td>
<td class="nump">$ 2,904,078<span></span>
</td>
<td class="nump">$ 2,842,705<span></span>
</td>
<td class="nump">$ 2,743,112<span></span>
</td>
<td class="nump">$ 11,550,604<span></span>
</td>
<td class="nump">$ 11,388,479<span></span>
</td>
<td class="nump">$ 11,404,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,671<span></span>
</td>
<td class="nump">437,669<span></span>
</td>
<td class="nump">409,920<span></span>
</td>
<td class="nump">465,376<span></span>
</td>
<td class="nump">462,588<span></span>
</td>
<td class="nump">378,336<span></span>
</td>
<td class="nump">461,886<span></span>
</td>
<td class="nump">340,507<span></span>
</td>
<td class="nump">1,694,636<span></span>
</td>
<td class="nump">1,643,317<span></span>
</td>
<td class="nump">1,525,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Amounts attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,406<span></span>
</td>
<td class="nump">158,674<span></span>
</td>
<td class="nump">201,602<span></span>
</td>
<td class="nump">229,613<span></span>
</td>
<td class="nump">242,242<span></span>
</td>
<td class="nump">150,113<span></span>
</td>
<td class="nump">194,223<span></span>
</td>
<td class="nump">120,254<span></span>
</td>
<td class="nump">783,295<span></span>
</td>
<td class="nump">706,832<span></span>
</td>
<td class="nump">624,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net (loss) income from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,633)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
<td class="nump">2,629<span></span>
</td>
<td class="num">(6,843)<span></span>
</td>
<td class="nump">79,328<span></span>
</td>
<td class="nump">29,035<span></span>
</td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">104,149<span></span>
</td>
<td class="num">(464,927)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173,773<span></span>
</td>
<td class="nump">$ 158,674<span></span>
</td>
<td class="nump">$ 201,602<span></span>
</td>
<td class="nump">$ 239,593<span></span>
</td>
<td class="nump">$ 244,871<span></span>
</td>
<td class="nump">$ 143,270<span></span>
</td>
<td class="nump">$ 273,551<span></span>
</td>
<td class="nump">$ 149,289<span></span>
</td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
<td class="nump">$ 159,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (Loss) from Continuing Operations, Per Basic Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.84<span></span>
</td>
<td class="nump">$ 1.87<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="nump">$ 6.54<span></span>
</td>
<td class="nump">$ 4.61<span></span>
</td>
<td class="nump">$ 3.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.05)<span></span>
</td>
<td class="nump">0.47<span></span>
</td>
<td class="nump">0.18<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.68<span></span>
</td>
<td class="num">(2.73)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.56<span></span>
</td>
<td class="nump">1.31<span></span>
</td>
<td class="nump">1.65<span></span>
</td>
<td class="nump">1.92<span></span>
</td>
<td class="nump">1.89<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="nump">1.64<span></span>
</td>
<td class="nump">0.90<span></span>
</td>
<td class="nump">6.46<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
<td class="nump">0.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income from continuing operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.67<span></span>
</td>
<td class="nump">1.28<span></span>
</td>
<td class="nump">1.62<span></span>
</td>
<td class="nump">1.81<span></span>
</td>
<td class="nump">1.86<span></span>
</td>
<td class="nump">0.99<span></span>
</td>
<td class="nump">1.16<span></span>
</td>
<td class="nump">0.72<span></span>
</td>
<td class="nump">6.39<span></span>
</td>
<td class="nump">4.60<span></span>
</td>
<td class="nump">3.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Diluted net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0.48<span></span>
</td>
<td class="nump">0.18<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.67<span></span>
</td>
<td class="num">(2.70)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
<td class="nump">$ 1.89<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="nump">$ 1.64<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Footnotes to Selected Quarterly Financial Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 124,892<span></span>
</td>
<td class="nump">$ 3,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember', window );">RMS Lifeline</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Footnotes to Selected Quarterly Financial Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain (Loss) on Divestiture</a></td>
<td class="nump">$ 16,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Footnotes to Selected Quarterly Financial Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Selected quarterly financial information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,035,955<span></span>
</td>
<td class="nump">957,898<span></span>
</td>
<td class="nump">$ 1,161,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Footnotes to Selected Quarterly Financial Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember', window );">Kidney Care | GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Footnotes to Selected Quarterly Financial Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelectedQuarterlyFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140394843813736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - Allowance for uncollectible Accounts - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of year</a></td>
<td class="nump">$ 8,328<span></span>
</td>
<td class="nump">$ 52,924<span></span>
</td>
<td class="nump">$ 218,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Amounts charged to income</a></td>
<td class="nump">13,458<span></span>
</td>
<td class="nump">21,715<span></span>
</td>
<td class="nump">42,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Amounts written off</a></td>
<td class="nump">21,786<span></span>
</td>
<td class="nump">66,311<span></span>
</td>
<td class="nump">207,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,328<span></span>
</td>
<td class="nump">$ 52,924<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>140
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M],O$[UF#_(V'2&S3HVMBI[)0ZLD.IN%EP[.,1"P"8R$X_#R+L8ACBP0\_BU
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M>U.P*KHFIWGA<#>/&*M2S_U:>CX&8AI(364H7LA7X=YI.!2<P;P^._=ZSC9
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ME],4+);Z\3"=+1=@_@U,Y@^/3]/OT]GB_F4*[F=Z/ 5?P?,B!9\_?0&?0,[
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M:*N)9(6YJ^9,JIO/#%/U;0)< ]3^@C'Y-M'77_.U$_T#4$L#!!0    ( .N
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M=P)@T#:FJ-Z+$89,XH0!: $MS[O,V51L- X1/PY]3<IT<WIZ[\\I 7H=Q_X
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M2:9!0\0Q,?6[<\"O=YNYQD#N;\K\JAS4_1S5,S:"(2C"IBHWXG8/AQ$A-#0
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MT_==3TK^EI1!Q)_3\+O03>1*+4^'OGU-\*P&E)'LCFOB$Y'GTI[$R$ZCP\+
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M]>T>K%J[(_-263J N]N2_O&@9@/ZOE+*[AXXP/ ?ZOQO4$L#!!0    ( .N
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MP1P+-7:L#XX"=5-G6H^KT<8\VZ#VN*.^AX))WPNZ&]&FNN(R\J!GJ"(VM/[
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MHIHZI'S._EW<_VPWBB4+#1VS14%"3@V4>RV#DKHE]8I\Z14Y^);TOUG*O**
M+%YD!;"XFF=>,0??:"PNRQ2^$#CRG?-E+BM@%96C@B_:<4E>J+OSU+LK1G_/
M73C)Q95.$;3AX;(TR7OEQMM]TDYOX_7X)'P[/CZL'REC0EF0N"/3=+:81V#&
MQVI<.#V$!V*K':4KB!V][VC\ =K?:<KO:>$=3/\8-G\#4$L#!!0    ( .N
M3%+Z+P'S@ 4  #H-   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;(U7
M:V_;-A3]*X27;BV@V9;\[I( 3M)A+58L:+;LP[ /M$1;;"E2)2F[WJ_?N93D
M1Q*G 1*;HGA?YYY[+WV^,?:+RX7P[%NAM+OHY-Z7;WL]E^:BX*YK2J'Q9FEL
MP3T>[:KG2BMX%H0*U4OZ_7&OX%)W+L_#WJV]/#>55U*+6\M<513<;J^$,IN+
M3MQI-S[)5>YIHW=Y7O*5N!/^K_+6XJFWTY+)0F@GC696+"\Z\_CMU9#.AP/W
M4FS<P9I1) MCOM##^^RBTR>'A!*I)PT<7VMQ+90B17#C:Z.SLS-)@H?K5ONO
M(7;$LN!.7!OUM\Q\?M&9=E@FEKQ2_I/9_"::>$:D+S7*A4^VJ<^.QAV65LZ;
MHA&&!X74]3?_UN!P(##MGQ!(&H$D^%T;"E[><,\OSZW9,$NGH8T6(=0@#>>D
MIJ3<>8NW$G+^\MW72OHM^RA\;C+&=<;^\+FP[+U>"^>!OG?G/0]#=+R7-DJO
M:J7)":5QPCX:[7/'WNE,9,<*>O!PYV;2NGF5/*OQ1J1=-H@CEO23_C/Z!KNP
M!T'?X(2^@_ B=B,6/H3>@'$GTLI*+X5C_\P7SEM0Y]]GC YW1H?!Z/!%6!^X
M$(Q_,%)[=H_GRL+RC72I,@[KI_!_D:%BGU03DBH/3/Z9"W9MBI)K'$3Q>OP[
M)DY(@GGF6%YJAC>LM'+-O6!NCYE9LE18TM<(YX(KGZ?<BJ!Q__BS%0K"&5M4
M#B$X)Y"-%$Y9Z;#+'5L:A;;AWB)'J2@64-:2 !_QC,UOY]?L<T!N72/'SEB<
M]*/)=$*K>!S-DF'#Z>/@2FZ]%M;ELG0L[D^BT6P&@6$TCF,VSSZC]N!#:IQ_
M'LAD%L7]$31$P^$4-I/1)!K.8EH-XV@V'; ;(*-7P>NH=ILT83&- H9M&JQ(
MS4K+_V"V<75O!TL (]AK<,*](8S/$L2&^-A9G$3C2:WT[/4P&DZ';R(H<Z4(
M+4]M([:TIF#2/TSP@X1J R/:&26S!VGI'O+E)\<4MRM(GE3'I OFS*:!&.^\
ML"0".S?\7GK.KHD1MUYTV>\^Z[+7A,7CA$8,S O;'^[?'/G!<J,R% ^;C%ZQ
MM?$$,H$ &+4I9'ID<Z?\PWTXQ#6K=,N_.G!OP3924L<!L[4!$JWSGKS0T%$
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MQ_Z?10<2,9AJEQ#%62P]8IW_@.YOK-ZXC]8+;:U>N\N5%,!)"_!^J;4=;\C
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M9<X?MTHBUJ@!OE^7*(+F@0;H?\?VYG\!4$L#!!0    ( .N 3%*5V;QQMP<
M +H2   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;,U8^X_;N!'^5PAW
MVR: 8NOIQW9W@=V]IDUQCR"YW*$H^@,M41832=21U#[ZU_<;4K)E;W8O_:V
M(5.CF>$\/XYT<:_T%U,)8=E#4[?F<E99VYTO%B:O1,/-7'6BQ9-2Z89;W.K=
MPG1:\,()-?4B#L/EHN&RG5U=.-I[?76A>EO+5KS7S/1-P_7CC:C5_>4LFHV$
M#W)762(LKBXZOA,?A?W4O=>X6^RU%+(1K9&J95J4E[/KZ/PF)7['\(L4]V:R
M9N3)5JDO=/.NN)R%9)"H16Y) \??G;@5=4V*8,9O@\[9?DL2G*Y'[6^=[_!E
MRXVX5?6OLK#5Y6P]8X4H>5_;#^K^[V+P)R-]N:J-N[)[SQN!.>^-5<T@# L:
MV?I__C#$82*P#I\1B >!V-GM-W)6?L<MO[K0ZIYIXH8V6CA7G32,DRTEY:/5
M>"HA9Z^^%W#)7"PL=!%ED0]R-UXN?D8NBMD/JK6587]M"U$<*UC B+TE\6C)
M3?RBQN]$/F=)%+ XC,,7]"5[SQ*G+WG1,_:OZZVQ&LG_]PLZT[W.U.E,_^=H
M?8L<^[D2[%8U'6\?6>U)IH=YO+62U_4CPX6IDDEKV*?YQSDK0'XTTK"2Y[*6
M5@HS=UH:_EEI:1^)VQZT_ND/ZSA:_67*S[@6?K."]4B59JUJW^2\S=$)?%L+
MA@;7W,IV-]IT7\F\8IJW.\%DRZS0#31JU; 2'<0>!=>&685$#6O>%H-0CIH
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M>=LL4=PKX$2XPC%#QU/Y8C22@/(>KF-HC((-+/A>&,,Z0B[7Y'CY-N#TI^N
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MD4M$?B=U$_;2&$='>A#,JXX[U_I@N4A6RV64_4ER.'\TDU_.BH54+6\ED-R
M02A&5LAJ0R'*P:O> H]'OT;]H]24B(K\"$%#48/U'4J78F.9'V]L4*96,FY[
M*<9'E=$WI-R^B.B>KR'L6W3%+P9GD,.P8^2-#436A!&CW?BI4^)D</@NR6["
M)P;C0UWM.;Q_VG_%7+2']X?E[2?0)VDWO.EHRF$Z'1\?CH1M/RO:&V_J<)1/
MC<>'0;@L\"5&EA?@?6[ /=ZP@_[;[OQ?4$L#!!0    ( .N 3%(2C"H2P!4
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M4Y@%TKS F3M\S^H8) ; 8^3=#\-+!MA"%+GP:G W$>EYCTDN>,H_UBF&CX^
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M3(G3;PYD\S=4$,J@J4@RI)5HLJA3<EYSQ4IA-'S+.6.'$%O$&_M4"JQ$]]\
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MWVDKT=FVQ*INF/ML]D,@1VT+ ?_N:GIQ<3H3K[NN>M2)_5D06M  UMHR9/L
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M@/>[JFK<%]R@^T7LF_\%4$L#!!0    ( .N 3%+2P/F]@ @  )@5   9
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MND]"%(QUM-ZD$]0<85)TQA!W/!EGRG->!MT@\;[O2*N:W X?NTK:WX--J0$
MI1W4)!)0Q';2]'.(SJDM(2\@M,M_06817A[(/T;[! Q'$RG7CF33VVN%\HDF
M\ *0*/!/.K;CA:QA:L_$M$%"CG(=T> >V6'44#".!:>7!:O('3<G^CMI^ASO
MN;02=4G()D)U:$5LATB*>[3X> &Z]S;>SMA;"(5]<&O14;);]@UOVE=86O,#
M.0H_4XWZ2QJX_,'&H; 1"4CKD>@J$'O#[X!96EN!UR5Q#M*97.%SI<8TC$=7
M=4M^A5RU#R4#Z'4&30%FA[>2\*Y0(^C(B&9\] )AY>3Z.]IICY=32S'OF>DD
M'8-RV'CG-?0)<Y# @]<5Y.K9)1^X!;4Z%RA+4F$6@Q H*QXS&\-*YH !(GVB
MBB<N.A\3^1T[&.G "3Y-O3V&[K[^.K!= ,UW0%%YRU4A"!NX'_AD*H&(PGF\
M-#U+!+1-CB(56FUY'6;VL-L]Q%TH)0277F2X1/<)!U?" =+:#OG>TGA%5#VI
MZ8@9F(SP&4JZA[R>.A#2#+6&08VP7JC^HD.S]T4,%$QS2HAP>]MUQM/9U, 0
M4EX_K!RUU=-\_]2WP,EB.1PZ@OLO0H$<:VPWK>Y)Y&\ _*&2115-I8@OA6A[
MCAC">])RA-@*M>=[<K14GLG'&\F$TJTWTD\/8!(GP8LHB=%<2ZJ['GV<^*8(
M!<GS*5V)I"Z#048,M\])=P3-B [I(N&MZ:5,/)B+@C>>0A]7(WAV NM2V,+(
MG.@HIVSRB2UMH3NZM3V2RW2E*X!H*Z>E;+PM.;*#KKT/=+->-AR HYQO64%M
MGJP&%GC'?P9IL^]5,1LI21\035O)]IBDM)2R2]>R#*4;MUU92MRY^X8R,&?@
MF_^Q>*VF]AZ9<[JA;W8/D$=1#P&T%^R?B.>3S<2Q^_Q1$",!7,([2N:=&VYU
M$Q.HP=LLHW5*75N&JK_-?(NYVD;+;3IU*S5,+\DHWDJJ_P#;!?LP;:255CTO
MUP'G@RO2:+E.V;?+312GJQ=HRC91MMV@^^3ULSN9=TSR:OQ%+TMF>:[V/1?T
M^:].C;,77^L8)7RC<7(6.2L#TZU[MV5+&L7H:5>;]0G;>'#[\GR\WSR!$BMN
M/=.(+])Z)F[X+YYC7](&4".J:;\Q-)GG,(0"?KZ&+M2^A!8.#VB7I)I\FXC&
MCQ.GO=WLL:\\\\G7LD:8O?\F2)A$OQP^G(UOQ\^.U^%KVW%Y^&;Y S=[NEO5
M8H>MB]EF=1;(?GAPNO7?WG+MG&[\L!(<Z4T+,+_3N/#T#W3 ^#'VZC=02P,$
M%     @ ZX!,4DD3:]RO!   WPL  !D   !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&ULG59M;^,V#/XK0C8,":!++-E6G"X-D/9VV &[K6BOVX=A'Q2;CHVS
MK4Q2FMY^_2C92=/&R5Z^6!(M/B0?2A3G.Z6_F + DN>Z:LSUH+!V<S69F+2
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M$-VVD^W"JHUOX5;*8D/HIP5VX*#=!OR?*W2^6S@#AYY^\3=02P,$%     @
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M2*[@.X,%'SD0KYI%_YQ]'#P<QAZG\P/NO1SRAX0+T),HQE3%/G_X[)VUP7W
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M2@?6Q3_72N:JH@7XOBQ1;\T#*3C\9\7=_P!02P,$%     @ ZX!,4FZ9D7S
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M!E\5Y-SU:RIR@=R*#[(@(:M<W"J;Z<JIJJ9<_+@C(SE\]G+DH(Z%1ED#_3Q
M)T] CQ/Q%D!;*UY6.>7' "/8V1F;M,8^3TXBWE)V(2;C2"1Q$I_ FW3.3SS>
MY"F\S[O:AF&GK2S$*Z/KG16_W:RL,RBBWT\H3CO%J5><_A]1/PU]!*0//J%E
M[Y2N;?$@MJUVR]IOY4?EI'A+N<I:=\7P]NVK<_%C);ZK*Q+C)8><_[HMB1>Z
MW,GJ063X+<A!#:]Z++T6RED!8;&J+2RS5C@-?UQ=1D*B]5=6Y0K=SUM_KA2D
M7Y,LW+;1^Z;*+B)OFT3';C:&-M*1V-4FVZ+WX(7*O)JS-)JD<13'<<2+$(">
MC(P##XFLT%"^\8%%$MW7W4+^!UH*G (C[8XRM58P'Q+L@:%"LC?TJ5;NX:!3
MP@IB&9'[[]*R :A%*E=DQ-3'9A[QNL2VO-OR@78N[$EBOVGA+7HD/QXWWX8'
M@!#H)PTYOQ _]1)A*-/&J^4L%PHTP1$FZU3I+<;JUT[>BPHDCTAX_7*W,_K>
M;T!)G"63*$X2H:O3R42HN!!8O[)'VCKL/=Q@GLP93"'%"E75VN)5]XKH*ROH
M'HGP<3VDV^B,*+=B;739&11Y'2QO9&5E8/4,Z0T-JU>%VH1B][G8@^GYUT>R
M"\6=+.I@!?O%@-):XG+019L:EF@KAE/.WFK;1V&YSDA5947-X4=-IK-IE,YG
M'*=,VBVGAC!U\N")[P,A78L>"=3MV21:)&DTC9>M?UZ273+0B()GC7ZMT]14
M[&=<N! W 9Y:3WA3"-]QW#&VO#<>P2>\\\@0CW/H0;_^@>1P;\$67=0^YFQB
MTVE'W?6H2_O-EI/-C%H=3'^RMB_  7['6M<&O/"IEL:A3:"46?^8@CA((:@X
MD."\DO>:M2GE-<JS>&P:$\QQ;/9;E7&Z+,(2K&0"RG/%'C. ?/"HJX<C UIR
M"Y0T9SX*/7XD''JNZMKJ#'2QG,\.KBICW6E/N<<WE?J+RVP9+1>Q-_&@@MM[
M116MN65K<(AIQ T^WRE36W&CP"OOT;&T]C:^Q)S0I<K 4UEM.!LW2'7+@O",
MH3! E,[;?M'[BHS=JET;L#T9Y*ZPNF\@\UC52S]C'=?>XX"TN6AYY@*SH77A
MR4IY5 IL!#8<AD"8@ER8"F!E!;+/9"C@ U4 @_M1UP6W&U3!GR;7MK5[53_
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MW$.WYIOI^!)LQ;?!<QN"+?AQI20PGC;@^\(B-=,+"6C_/7#Q?U!+ P04
M" #K@$Q2\6].NR<*  !X&P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6RM66MSV[@5_2L8U=-U9AB9[T?6]HSCI&TZDXTGWFVGT^D'B(0D;"A"(4 _
M]M?W7("D9%FRG62_V'P ]WGNN1?4Z:UJO^BE$(;=K>I&GTV6QJS?G)SH<BE6
M7$_56C1X,U?MBAO<MHL3O6X%K^RF57T2^GYZLN*RF9R?VF=7[?FIZDPM&W'5
M,MVM5KR]?RMJ=7LV"2;#@\]RL33TX.3\=,T7XEJ8W]97+>Y.1BF57(E&2]6P
M5LS/)A?!F[<QK;<+_B7%K=ZZ9N3)3*DO=/.A.IOX9)"H16E( L>_&W$IZIH$
MP8ROO<S)J)(V;E\/TO]F?8<O,Z[%I:K_+2NS/)OD$U:).>]J\UG=_D/T_B0D
MKU2UMG_9K5L;%A-6=MJH5;\9%JQDX_[SNSX.6QMR_\"&L-\06KN=(FOE.V[X
M^6FK;EE+JR&-+JRK=C>,DPTEY=JT>"NQSYQ?BP5";-AGL5:MD<WB],1 ++T\
M*7L1;YV(\("((&0?56.6FKUO*E$]%' ">T:CPL&HM^&3$M^)<LJBP&.A'_I/
MR(M&)R,K+WJID^R_%S-M6D#B?T^(CT?QL14?_T@,GQ1!I?=&KWDISB:H+2W:
M&S$9Y;:CV;\N!;M4JS5O[G_2#)79<L*V9KP5K,2+5FI1,35GTFCVV_1ZRBK)
MZWLML:2I(*GF!@MJ/F.D1)9"LUFG88W6[/CQIN'=*\]*O.&M5!W)*F5=HX@W
M4D@\A=2(A2R9;*21G I.8V=3UEU%]I,,V1C1-M9N7F_[< PLVV*]$?6]T_=8
M#PPA3?2R5"WB H6,5Z@,:;5C,PAF30&;LFLAV"\*"P(V^=0N>"/_L+HF#&S&
M^,!$J&)=MG)M:0*Q,P^B/(1 Z"G[U+!_=@WD%81-^KNUUB:@%A1?>JIY+89,
MO/OX]TV8C6*?UJ9;3=D%/$1.-!C$Z47$X42CN:4LC_;! K="TY*M<"TY7)T)
MT?3X@%JND3E=HAAETQ$.-JNMPW7-\$2J2C.+,F2BFFZ#ZJ]_R<,@^WF$%E*F
M'0BW]8'TX$EEV1!*&N>N6'.;#+RCM"&WLG%-0]HEW#!)OBPZ)+2^AP6JZDJR
MV@+S!GQ+,N^W0SK:4RZEF&]958E2VKZPXE]$"TUTL?T"D9VA!Y'/JG1[X+'J
M6L(J,D!*.255TRM2N;$;6JSA32EVX##:,Q3"QB*J:)NB(<\NL,\83FG9AA B
M1'BYM+O>WXFRLXC^-)\#_.W^7(V1WY,T5WKB>^C 8X*7RP'!WUCQV/%%5HU
M41 U;0$1J;)RX3DZ9L.TNA'NZO<.[%7)'OHD0B$T+5L*7IOE]\@8F$)\[:2Y
M9RMAE@I/&MAH++-*A]V+JXM+]KL",[$;/.Y:X2+]K03ZM>.UG$N*#57VD!B
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M%X^K_1=A#ON?4+RRG,5%YOEAP.(H0^*37I[8]33.8RS/6)S"5_S/PMA+\/^
MLZF7Q1&@XOF1SZ+8"Z.T]W8/*P6>3S H<E9D 9*8VV A"WG>;VJ$>531+*#,
M8U\4T64"+7D4N\L0>C/VOI:@J;&.Y5Y3CP-$U0\+("B(4R]*"$M!F'E!GKX"
M(VW5]W9JH 4!3/W8W40HIC@KW$WLPY0D&"OV ./L%C#V>D60#4(1"(@);;J]
MS"^\#%EZ(MO'(0S/4B], _(@+[P@BW%51%Z6PST7R<'_WI+ RV-83[D"&23
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M#WY'0\'+Y]+)\U.C=\3XW8CFA4 U:*-SK?*'<N,,/FU1SYW?A/C DOPQ2./
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M$PXL=P#W7ULQ&_O]"!'.?1/W?&O$>.H:\BP 5E6<SI]4:QD BOQ<5?8./UZ
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M,VRR1C$ID5,0<C")2-UHT;]DBJ,-!7!(L&9 DB.--%IO+V$).+<K+:,O.+]
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MZ-;$)XP"D%/C-^(N-_<.K!T945N\8N_&9Y0=/PP#TLD9)?\8)R72. FGPD@
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M;0)G@P)3&.8,^,W%FUE-4XX%RP?Y#?1)&G\'8 @XSBD;Y#.G6> @05F."YX
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M)D;(=M?Y;N+-.EZAY\;#A3P.5_ %I&S8 .L+8_Q^$AP,WU2S?P%02P,$%
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M'+7+Q3LM%<%GEEN#%KXN5I8,7[9O)SQG!\^9]YS]K^??I?DDE&ONB6U$CK.
MN]>BV6(PORT1+G7="/4 KH.)'PO8>:T?ZZU]O?GZ:0/R*'ZI@$^@,7(K",%B
MWAI)DM.@UY"C<7B]<8FBHC(7!CWBH_C28,7&!:Q:RYRM11M"SJ2,M+PK+*QU
MQ;/#3H +B_6*P?;%Y5<RAL7-XA*^^S)LNS+ ,TC2.!Q=C-PJ.0_':=9?VJ?!
M-<*00F-+V5A(XE$X'(_9( O/DP06Q7=N0.:0:TN_IN,X$>DX3.(A(X19=L$^
MT^$HS,:)6V5).+X8P.]N0W34MS6:C9].EMVUBKH6/NP>!N"BZ_M']6YZ7@NS
M<;6K<,VF\=EH&(#I)E(GD&[\%%AIXIGBEUR# HU3X/.UUK07G(/#;V'^$U!+
M P04    " #K@$Q2<7 #^6T$  !4"@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970T-"YX;6R55EMSXC84_BMG:+<39KP@R_B6 C,D>VD>=C:3--N'3A^$+4"-
M+;&2#.'?]T@&0W82LGT ZW:^\YV;=,9;I1_-BG,+3W4ES:2WLG9].1R:8L5K
M9@9JS27N+)2NF<6I7@[-6G-6>J&Z&E)"DF'-A.Q-QW[M5D_'JK&5D/Q6@VGJ
MFNG=%:_4=M(+>X>%.[%<6;<PG([7;,GON7U8WVJ<#3N44M1<&J$D:+Z8]&;A
MY57LSOL#WP3?FI,Q.$OF2CVZR4TYZ1%'B%>\L Z!X6?#KWE5.2"D\7V/V>M4
M.L'3\0']D[<=;9DSPZ]5]9<H[6K2RWI0\@5K*GNGMG_PO3V>8*$JX_]AVYY-
M4&/1&*OJO3#.:R';+WO:^^%$(".O"-"] /6\6T6>Y0=FV72LU1:T.XUH;N!-
M]=)(3D@7E'NK<5>@G)U^5JK<BJJ"BS_9O.*F/QY:A'6;PV(/<=5"T%<@0@I?
ME+0K Q]ER<OG $/DTY&B!U)7]"SB!UX,( H#H(22,WA19V3D\:*WC&2RA!MI
MF5P*-!9FQG!KX(,P1:5,HSG\/9L;JS%5_CFC=M2I'7FUHU?47J]0$3<@)%PS
MK7="+N$;JQH.:@$=I_D.[OA::>O\#_=\B2EOS4MA.*O-5>^E6;."3WI8GH;K
M#>^=4K K#L6!QN9 8WE"0Q]IF)8&;#DZA1E8J K+UUS"P^!^ *5@U<X( U\1
M5,-[F,D",;"HX5I)HRI1,LM+N&(5DP4"6,"0\GJ.A]NPAAG\"DE TS@@9(3C
M.$F"/$[\:C8*@SPA,"N^-\((5[T&PBP@60XI#<(HA9P$E"9P4Z^9T)YIL6+:
M6?K;+QD-Z>]P$=)1D.6T?S+".L8JE5A76G-9['P^*&\#*__%8O.NAXLXR//(
M"49!DB1ND =)G/?/&92W!F5I$!+B#"(DB*/8KZ:XFN#XF4%(*DI3"$D<)!F!
M,"(!B5-,Q@TW5EC,1F02!O$(]5X@QFB$WRR@CME/&G+P11ZD(=G_OVX")9YL
M1/(@ISX^. JST*_FZ(*0Y&?%+X])_1PH'<5!&E$W0AO17A_<HJF;RN>).!?&
M* GB..R?C-YF>:9XXZYXX[/%>X_/7]E4ODC:^G1U\R %^K4S<^^-%ZOU//P1
MLD'((V)W4;!:-<X?:L,UOHYH?A\O!^FR9X,_=-'7->YX""$+5>,13'%WEWE!
MW,(5S)7/'!\ON8-'44J^<U< 1U]%E&)($J"#"-XA^"#N^R\9A.V@#Q^?T#+C
M['<)6?M(+3!.Q\O#72GZN2&.+C@?%3\8PLQ!PL7<N 6#\#[H[K88>/JWRN("
M7B\^)PK$DZ]J9]A)&(M]!R\#J)1<OK=H*A(JF_;%QS/1.W?UJ1\]]1-DHO])
M1CIL;(L,=QK+TS!X9>Y6P/8!+\VU$JXXW^3P4A(/3U[ZFF.EN'X&G>UTM8]^
MM]JU3+.V4S@>;_NM+UAH N^ABB]0E Q23%C=]C#MQ*JU[QOFRF(7XH<K;/NX
M=@=P?Z'0/_N)4] UDM/_ %!+ P04    " #K@$Q2"[;FY*P"  "?!0  &0
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M+ +0W3KH#E;MO 17RI*@O;FE#8K:!=#]6BE[/+@"_4Z>_0502P,$%     @
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MM!CQ\.^!^UF%70M(QQK+$VS$%(=DF,*CLKR!ZF0THL#5:)A11"1!CA9\%<;
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M1:I;%KX7BO]BZ:QPY=94J[LQ<(:N] ,7HN#=68(;'S,V3"B;X]##K YIA4%
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M;@;(9F/5R@UM^%KB".B62YRYN28"O)\K9=L-*>BF^/$_4$L#!!0    ( .N
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M.,%1UKJ_+?4;JUIW0UDKB_<=MZSP@LDU&>#WC5)VOZ$ XY7U[%]02P,$%
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M[> M$+H5/+ZD\1/@_TIKMQ]X!X?GW/P_4$L#!!0    ( .N 3%*STX<C4@8
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M[. 8A1ZR](=%B\#WR@TGJMW7W7GT9CB&[9</A]D?N$'L+&O% EO#<SK^F>&
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MNQ:U,Z#WI5+VH+@ _?9>_ %02P,$%     @ ZX!,4IZ'#7J^!   SPP  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3<N>&ULM5=M3R,W$/XK5EI5(%F)U]Y7
M"DB\]'14O98>]/JAZ@=G,R2KV[5SMI= ?WW']I*&DD1'13_ CKV>9^:9E_7D
M>*7-9[L <.2A:Y4]&2V<6QY-)K9>0"?M6"]!X9L[;3KI<&GF$[LT(&=!J6LG
MG+%\TLE&C4Z/P]ZU.3W6O6L;!=>&V+[KI'D\AU:O3D;)Z&GC8S-?.+\Q.3U>
MRCG<@/MM>6UP-5FCS)H.E&VT(@;N3D9GR=%YZL^' Y\:6-D-F7@F4ZT_^\75
M[&3$O$/00NT\@L3'/5Q VWH@=./+@#E:F_2*F_(3^KO ';E,I84+W?[>S-SB
M9%2.R SN9-^ZCWKU'@8^F<>K=6O#?[**9[-L1.K>.MT-RNA!UZCXE ]#'#84
M2K9#@0\*//@=#04O+Z63I\=&KXCQIQ'-"X%JT$;G&N63<N,,OFU0SYW>A/C
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M4^UP  [B G]Q@/$'\/V=UNYIX0VL?\.<_@U02P,$%     @ ZX!,4MXFMIL
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M:GS5ZP2@:PFL-U;MO>RLE241\^:._C50NP ZWRAE3QM7H/D?&O\"4$L#!!0
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M='6#YG73<383JRK?Y2V5Q9[1#POLTD&[ [B_4LKN)LY U_=/OP-02P,$%
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M]9LB?:Z>XGY,BR)=5"]G.IKHK!28[\NGLC9OR@ZVO^,X_S]02P,$%     @
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MS/+Z;9SZ0F6/U1L1]YE2V;KZN!)A)/(2H+]?9IEZN2@7:-^).OT74$L#!!0
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ME#V ^W,IS69B&WY[P:>_ 5!+ P04    " #K@$Q2$R_QJ=<#  "F$   &0
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MI<I/+N\SQN6U)+P N-R G)6[ID7+)R*DFC IP.M;(C'-Q1MP#;[<WX+7K]Z
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M;PBO#=3W+6/RN5%?5;M_32S_ U!+ P04    " #K@$Q2V';A#,\"   ,!P
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M/<]YK*QT)+(,*9@H>D'XTW1,3CXUR"<#_I:(7"%(]5R-H8PU-RH##(L _H$
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M NT,\/U**?NX<=-V^+I:_ ]02P,$%     @ ZX!,4L AI"'- P  "1   !D
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MZ&QBKH*LFJEJHD7I&IBET*;:W3 S#2A(N\&\WPBAGR>V)VI:VL4?4$L#!!0
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M9P?OZ&A8Y$+HARUU7;,88AS8M06UMF!0V]/*O =?)-.:<M/!*].V&=$T!5J
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M6%_Z0!@#O3[G7*T'QD%YC>S_ U!+ P04    " #K@$Q2SC*/)+D"  "U!P
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M+IA4O=8L"S4^@6L#=9\S)K<;[: ;R)/_4$L#!!0    ( .N 3%+(,B;Y[ ,
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M&L_I]C'%JQ259@)^GPNAMP/CH+J<#?\#4$L#!!0    ( .N 3%*^,FJAD@,
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MC2X']CBHNMO7"R-+WV$?I>V+W$\+>T.B<@'V_5I*LU\X@O;.G?P!4$L#!!0
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M<+=%N<$RBTT%*/ '.;[;T)M)[Y3Y_6#L;1IX]2I>O9_F-4=:?Q'\B5PW$2J
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MAL9A'X]7/#H @]_$$."Q!SLP&"J'=BXW;#H 1-"2#CC&7@<(P^C03NEV1AT
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MK9E<(AUI"X\;V%YWPS9^>+IF.H5?5T0)EQ9S\[LEH'X=4-\'U-\3T,5K0=\
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MVBV@^852]JWC-JC?7Y,_4$L#!!0    ( .N 3%*FC[4,M@L  %@_   :
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M$@ZR28X>\T2*46/B8<OV@N0KF#Q[-YZ8$@)6;LVX#.ZZ",X^$1RVT5>6RZU
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M<J\OG+69XI\!.'9MDER@E*[!)+ /-#,O+MO%0+*=OGX^,0F76?VXI02(0PG
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M#3%JA]B3TB(*?,6HC_;N7 #)B(,=TK4)T#'N,]9CE,82/026J F4,6?=[U1
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MKU.PHX]?'\<7JZJZ'U\J"P6I?MS!%QO7#@#S&Z7LZXMK\=MOP/D_4$L#!!0
M   ( .N 3%+7T%;Q8 ,  & *   :    >&PO=V]R:W-H965T<R]S:&5E=#$P
M-BYX;6S%5EEOVS@0_BL#H0\MT$:'SP2V 1][!.@1Q&WW8;$/M#2VB%*B2E)6
MLK]^AY2LV*VM!KLH]D7B]7US<SBII/JB4T0##YG(]=1+C2EN?%_'*69,7\D"
M<]K92I4Q0U.U\W6AD"4.E D_"H*AGS&>>[.)6[M3LXDLC> YWBG0998Q];A
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MK &NKZ0T[P,;H/WT&/\!4$L#!!0    ( .N 3%+(8;#[L04  /L9   :
M>&PO=V]R:W-H965T<R]S:&5E=#$P.2YX;6S%65]OVS80_RJ$T8<6:&J)E&2E
M2 (D=K-E2-HL:;>'80^T1=M$)=$EJ;@!]N%WE&51EB4ZVVKL)9&H^W_'WQWI
ML[607]62,8V^9VFNS@=+K5?OAT,U6[*,JG=BQ7+X,A<RHQI>Y6*H5I+1I&3*
MTB'VO&B849X/+L[*M7MY<28*G?*<W4NDBBRC\OF*I6)]/O 'VX4'OEAJLS"\
M.%O1!7MD^LOJ7L+;L):2\(SEBHL<238_'USZ[Z_)R#"4%+]QME:-9V1<F0KQ
MU;S<).<#SUC$4C;31@2%?T]LS-+42 ([OE5"![5.P]A\WDJ_+IT'9Z94L;%(
M?^>)7IX/X@%*V)P6J7X0ZY]9Y5!HY,U$JLJ_:%W1>@,T*Y066<4,%F0\W_RG
MWZM -!AP'P.N&'";P>]A(!4#:3.,>AB"BB%X*4-8,80O98@JAJB,_2989:0G
M5-.+,RG62!IJD&8>RG25W!!@GIO*>M02OG+@TQ>7LV\%5]QD62&:)V@"B5::
MZT(RA4[099*4'VF*;O)-(9N">#UAFO)4O4&O$,_1YZ4H%'"KLZ$&HXSHX:PR
MX&IC .XQX(X^(\]_B["'O2^/$_3ZU9L.(6.WD%^*_!TBWB$I$[>4"9N!E%U;
M9D#$9QVR/KQ8EG]Z2-;URV7%#EE#R'U= +@N %P*)SW"KPH%*TJA1B6@/VYA
M#=UHEJD_'3I(K8.4.H(>'6.JEFA%>8*T "P!/9*A::6X*T\;<:-2G,'&IPL_
M!N?)V?"IF8(.,L^+(W^7[+I+&O'#J";;<2JHG0J<3M6!FXELRO/-OIB)7/-\
MP7)M'A5/F*05@MI]]A8Q*O,3P/E.YS=JXZ:Y@1?@EN_[5)B$I,>GL/8I=/KT
M4>0G,Y.L!?0DM#5;@D>(6B 0ZYQ)M>0KL_6W:6QZV%7BX;Z]L1_B;GNCVM[(
M75@VW-N0(C%-^:(,>F=THST[ DQ&<;<=H]J.D=..:\HE>J)IP9"8-XN@MFJG
M&KKL&NW913P<Q*VL[U/A((RC5L%W4$5>CXMQ[6+L=/'A[A'=\CDSZPY(.*W%
MG1X-=GS/-C?/:?1/IHQ?WPH%C0KD-WI;9Z/R]H$BPF%KYXT/DNT:V^C$OM/8
M3WK))+H5^>)$,YE!M.F4IQ 9IES!L$#O'P_I?0OUOAOK?\!6J#3L(. (8](3
M8 O8OANQ-P$>%U(:>UX87@N=?GB\\%K \]V(]R/"NP^!/F!-V!->BX&^&P0W
MX85NN*+Y@:!:T/'CXP758I%_>O2@GNZ!PBY^[PYG%L&P&\'N8,S+B@S]A5KA
MA94/5S>?)Y=(2/1I59H&;?HF!PJ&[IDLA_5\QM!G*A=,*T/W:T&AXI_1'2SQ
M=G_<M=#"%O:/EB+<F%*Q,PX?.C,!0^5S9A(%_G.1="7F@%P?/4.2729:Y,-N
MY+NCW_^?5%D Q,'Q4F6!$+N'R'^?*K?<L$R5,Q(61K$;1A_!"$@,[':>)_R)
M)Q#M]!GQ#,ZW\ F&W*ZYUJG;XB0>'2\+%CFQ>U[[QV>N2M[!0U=%UVP?IW%,
MVC-H!YD_BOS&X6S7,0O6V W61SMW57H/';PZR'9/7I7_'=)PT',^([8?$'<_
MF+ Y@_DE0?>%G"VI8F@E.2"'N;I)[42#J%)%QCJW6:5AQP$O\,/VX7I_S T(
M;KO9044"<AKT^&F["G$/P\<[B4XJS:U"[ZE+8CL4<7>2+^@1#A@T?58<MC:D
MXX&E "8)NJ53!'CS!&DRK>#'0P]IW,.0XUWVV#9#W'/VQR*;0O\##[>>,+6%
MH 0BT'L/-B'[MQKM$W 'R:A=DQTW*#V#&+%=C;B[S[60C"]RF^(Q@ T4WW$R
M:AL9B8Z74=NRB'NT_P\9W;^+B*)V2O=I_#V<Z;C3:.=TV+@&-S^+5*,32MD<
MF+QW(\BPW/S2L'G18E7>C$^%UB(K'Y>,0N\P!/!]+H3>OIC+]OKWGHN_ 5!+
M P04    " #K@$Q2T3C_.54$   1$   &@   'AL+W=O<FMS:&5E=',O<VAE
M970Q,3 N>&ULU9A+;]LX$,>_"F'TD )Q).JMPC&01&T:H-D-FCX.BSTP$FUS
M2XE>DHI38#_\#B5%=O1R#MO#7F*1^L]P?AQQ2&:Q$_*'VE"JT5/."W4^VVB]
M?6=9*MW0G*@SL:4%O%D)F1,-3;FVU%92DE5&.;<<VPZLG+!BMEQ4?7=RN1"E
MYJR@=Q*I,L^)_'E)N=B=S_#LN>,S6V^TZ;"6BRU9TWNJOV[O)+2LUDO&<EHH
M)@HDZ>I\=H'?)3@P!I7B&Z,[=?",#,J#$#],XR8[G]DF(LIIJHT+ C^/](IR
M;CQ!''\W3F?MF,;P\/G9^X<*'F >B*)7@G]GF=Z<SZ(9RNB*E%Q_%KN/M 'R
MC;]4<%7]1;M&:\]06BHM\L88(LA94?^2IV8B#@P =-C :0R<KH$W8N V!NYK
M#;S&P*MFID:IYB$AFBP74NR0-&KP9AZJR:RL 9\5)N_W6L);!G9Z^9'R#,'G
M@^X)IX@4&4J82D6A65'2#/V^I9*8!"GT@16D2!GAD&X%LZHJL^Q0+?;JDX1J
MPKAZB^;HZWV"3MZ\16\0*]"7C2@5C*,6EH;X3116VL1Z6<?JC,2*'70+8VT4
M>E]D-'OIP +PEMYYIK]T)CTF-#U#+CY%CNW8 P%=O=H<QP/FR>O-HPD:M\VE
M6_ES1_S=%*G(*;K71%-8FOH471(..8.NJH28[%YD&3,9@C2:1'.A2D@G>OAI
MFENAH/]:BG*K3A&XXV7&BO7H)_'')X@ W<!HZL^)^+TV?J^*WQN)_UJ(;,<X
MKP(5>D,E(DI!X"S?$B8-$DHW1*[IX,=3.P\KYZ;</2XAI8^'V>PKL.-%L?-2
MEO1E+K:#5O2"S6_9_$FV;X27I*YTV5^PK"L8:&7/L[XVLSZ$5?N-)K".*I*^
MPL5!Y-G#3$'+%$PR?1)*&09E2H=8C=:"!PJ5@B)-GH83%_2BFSL>)*:#.21S
M;<<9A@A;B' 2XC?XODY@&4"E8O7Z64F1C[&<H@+TP HP0RAA/\8X\-T.25^%
M;=^+.K)DP)GGA[8;#1-'+7$T29S<7D-1'DO6/V.K_129O6(.J9R;A$^L][@-
M)/Y?UBML[S=/^^C'(^DCA8&&]S/[Z.(=D#@A=FT_[GP- T(O#MPP'ED ^. (
M@"<IWC_!*5*-$.#C!'V)XWMN%/A=@KX0")P@&JFMV-D3.+]RYVB\3T(>E20#
M$@_[;C@"M]_5L?N+MH[&\23744DR()G:/?!^N\?3^WVS_IOJ.U5VCVXAS4B3
MI'T)#F(<>UW<OF[N^B$LRA'>_1$ 3Y\!_JO]$O>W\WD8QT$7>$#V<L-L@*?.
M#R]1]R<#/'TT:%(+"(C6U640).@?R (_['+T59X=1+WZV)?%<1AT-TOKX*Z4
M4Z@(YLZI4"K*0M<7A[:WO==>5+>Y3O^EN>]6=["]F_JR? N%AD$>.5V!2_LL
MA F6]?VS;FBQK6YD#T+#_:YZW,"=G4HC@/<K(?1SPPS0_A=@^2]02P,$%
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MB1G\]9Q^D:F_&K=$+JGI1(8+(QF<7YC49#V)ZXT6I9M-<Z'-I'/+W'R\4%J
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M.U_?=DBU9K>\/;S8A\-BL.-6@YAE^2[>\:W)V@ [+>3R2^?\3N=NF>1P=$"
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M3-F,YJFYE^M/K"ZH3#"1J2[_@G5M&_= DFLCL]K99I!Q4?VG/VLA-AP@V>&
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M1 K@*].,!4K8ALKR9*UGZX8_-6VN-3_3%P'3G%YIREO$'>8K0@7*8:DHG=Y
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M$8$L [_:)&46B,J&[G^-ZGR2XZC>7%R<&A8=K)O[<A^9SCGV74"&E-/)]65
M=/LUM(95E=_ @[*XS_Y8X \$M M ?Z:4/1INJ?M?4OP'4$L#!!0    ( .N
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M8'Y?&D^^?2A>S#J\>GG]/U!+ P04    " #K@$Q2=X@X\D@#   O"0  &@
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MKCOS(-RNWOYJCN>OVH+]_XGX-U!+ P04    " #K@$Q2EXJ[',     3 @
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M1[_W0R.23@/SD8%\9@.YF'NSQWM@.M</&6C ;*"#TJSO=)[5O>'J>A03&6C
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M4$L! A0#%     @ ZX!,4L]"NLT !   TPP  !@              ("!@!8
M 'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .N 3%+YOG$>
MUP<  "L@   8              " @;8:  !X;"]W;W)K<VAE971S+W-H965T
M-"YX;6Q02P$"% ,4    " #K@$Q2^%1=WL8"  #Y"   &
M@('#(@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ ZX!,
M4C:10O8""P  9S(  !@              ("!OR4  'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;%!+ 0(4 Q0    ( .N 3%)?C',110P  /Y'   8
M      " @?<P  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M" #K@$Q2J^#C'<<A  #O;0  &               @(%R/0  >&PO=V]R:W-H
M965T<R]S:&5E=#@N>&UL4$L! A0#%     @ ZX!,4M076*2S!@  HA(  !@
M             ("!;U\  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4
M Q0    ( .N 3%*1O?^S4P4  $\-   9              " @5AF  !X;"]W
M;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ ZX!,4F%X3]Q= P
M>@<  !D              ("!XFL  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX
M;6Q02P$"% ,4    " #K@$Q2-EP+JK #  #2"   &0              @(%V
M;P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( .N 3%)<
MC35S9 (  #D%   9              " @5US  !X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL4$L! A0#%     @ ZX!,4IN9>)E9!   A D  !D
M     ("!^'4  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .N 3%)D&0SHU0D  -$8   9              "
M@3^2  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ ZX!,
M4G1=WD2.$   TS8  !D              ("!2YP  'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6Q02P$"% ,4    " #K@$Q2E=F\<;<'  "Z$@  &0
M        @($0K0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0
M   ( .N 3%(55DASZP4  .<-   9              " @?ZT  !X;"]W;W)K
M<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ ZX!,4A*,*A+ %0  +T
M !D              ("!(+L  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q0
M2P$"% ,4    " #K@$Q2K2 +E*T(   '%P  &0              @($7T0
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( .N 3%+G*,]G
MT1(  !T[   9              " @?O9  !X;"]W;W)K<VAE971S+W-H965T
M,C4N>&UL4$L! A0#%     @ ZX!,4M+ ^;V "   F!4  !D
M ("! ^T  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #K
M@$Q221-KW*\$  #?"P  &0              @(&Z]0  >&PO=V]R:W-H965T
M<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( .N 3%*[?<CK:PD  +@8   9
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M970S,BYX;6Q02P$"% ,4    " #K@$Q2M!:VNJT"  #C!0  &0
M    @(&D) $ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (
M .N 3%+H]LGWOP0  /0,   9              " @8@G 0!X;"]W;W)K<VAE
M971S+W-H965T,S0N>&UL4$L! A0#%     @ ZX!,4HNNS1SF @  608  !D
M             ("!?BP! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"
M% ,4    " #K@$Q2W;YIS9PF  !-C   &0              @(&;+P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( .N 3%(9?X!&K 0
M %\-   9              " @6Y6 0!X;"]W;W)K<VAE971S+W-H965T,S<N
M>&UL4$L! A0#%     @ ZX!,4B/KON)?!   ; H  !D              ("!
M45L! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #K@$Q2
M\+>*@$ #  !B!P  &0              @('G7P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,Y+GAM;%!+ 0(4 Q0    ( .N 3%+NH^-*;@(  "H%   9
M      " @5YC 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%
M  @ ZX!,4LT\X)(" P  (@8  !D              ("! V8! 'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #K@$Q2@8'B,VX#  "X!P
M&0              @($\:0$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+
M 0(4 Q0    ( .N 3%*R(9ZWSP(  "(&   9              " @>%L 0!X
M;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ ZX!,4G%P _EM
M!   5 H  !D              ("!YV\! 'AL+W=O<FMS:&5E=',O<VAE970T
M-"YX;6Q02P$"% ,4    " #K@$Q2"[;FY*P"  "?!0  &0
M@(&+= $ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( .N
M3%)!.>LW@@<  $03   9              " @6YW 0!X;"]W;W)K<VAE971S
M+W-H965T-#8N>&UL4$L! A0#%     @ ZX!,4F@"3@-T"   BA8  !D
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M=#4Q+GAM;%!+ 0(4 Q0    ( .N 3%*STX<C4@8  +$/   9
M  " @>6: 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @
MZX!,4GA1:B6Z P  "0D  !D              ("!;J$! 'AL+W=O<FMS:&5E
M=',O<VAE970U,RYX;6Q02P$"% ,4    " #K@$Q2L3E906(#  !@"   &0
M            @(%?I0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4
M Q0    ( .N 3%($PC-XC@<  -(3   9              " @?BH 0!X;"]W
M;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ ZX!,4II*Y8JS @
MR04  !D              ("!O; ! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX
M;6Q02P$"% ,4    " #K@$Q2GH<->KX$  #/#   &0              @(&G
MLP$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( .N 3%+>
M)K:;  ,  ),&   9              " @9RX 0!X;"]W;W)K<VAE971S+W-H
M965T-3@N>&UL4$L! A0#%     @ ZX!,4NR/P ?3 P   PP  !D
M     ("!T[L! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .N 3%(3+_&IUP,  *80   9              "
M@=S7 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ ZX!,
M4MAVX0S/ @  # <  !D              ("!ZML! 'AL+W=O<FMS:&5E=',O
M<VAE970V-2YX;6Q02P$"% ,4    " #K@$Q2Z2!:N(\"  ",!P  &0
M        @('PW@$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0
M   ( .N 3%+H_V+N3 ,  &D)   9              " @;;A 0!X;"]W;W)K
M<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ ZX!,4L AI"'- P  "1
M !D              ("!.>4! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q0
M2P$"% ,4    " #K@$Q25%AI3O\"   ;"   &0              @($]Z0$
M>&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( .N 3%)/?'2A
M,0,  -X*   9              " @7/L 0!X;"]W;W)K<VAE971S+W-H965T
M-S N>&UL4$L! A0#%     @ ZX!,4B_GFH)O P  (@T  !D
M ("!V^\! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " #K
M@$Q2R4I0^=D"  !Y"0  &0              @(&!\P$ >&PO=V]R:W-H965T
M<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( .N 3%+B'X#O000  !P1   9
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M970W-RYX;6Q02P$"% ,4    " #K@$Q2_*>DN/ "  "W!P  &0
M    @('K"0( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    (
M .N 3%*C8'/FD0,  !T,   9              " @1(- @!X;"]W;W)K<VAE
M971S+W-H965T-SDN>&UL4$L! A0#%     @ ZX!,4KO1!O_$ @  G <  !D
M             ("!VA " 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"
M% ,4    " #K@$Q2R#(F^>P#  "9#@  &0              @('5$P( >&PO
M=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( .N 3%*-FLR5 00
M -0-   9              " @?@7 @!X;"]W;W)K<VAE971S+W-H965T.#(N
M>&UL4$L! A0#%     @ ZX!,4EYS-Y%T P  <@D  !D              ("!
M,!P" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " #K@$Q2
M>^3G9WT$   7$@  &0              @(';'P( >&PO=V]R:W-H965T<R]S
M:&5E=#@T+GAM;%!+ 0(4 Q0    ( .N 3%)J,A%9*PH  "(^   9
M      " @8\D @!X;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%
M  @ ZX!,4CJ+2\A< @  # 8  !D              ("!\2X" 'AL+W=O<FMS
M:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " #K@$Q2UD'D30 %  #5%P
M&0              @(&$,0( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+
M 0(4 Q0    ( .N 3%(BO&MQN@,  .H,   9              " @;LV @!X
M;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @ ZX!,4CBF*B6K
M"0  .S8  !D              ("!K#H" 'AL+W=O<FMS:&5E=',O<VAE970X
M.2YX;6Q02P$"% ,4    " #K@$Q2)L+-*]L"   &"   &0
M@(&.1 ( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( .N
M3%+BP&9$$00  *@-   9              " @:!' @!X;"]W;W)K<VAE971S
M+W-H965T.3$N>&UL4$L! A0#%     @ ZX!,4KXR:J&2 P  [0P  !D
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M=#DV+GAM;%!+ 0(4 Q0    ( .N 3%+&H1I_8P4  $L8   9
M  " @2A? @!X;"]W;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @
MZX!,4L:*8QI,!   6!0  !D              ("!PF0" 'AL+W=O<FMS:&5E
M=',O<VAE970Y."YX;6Q02P$"% ,4    " #K@$Q2$BB,H!4#  "+"0  &0
M            @(%%:0( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4
M Q0    ( .N 3%*FC[4,M@L  %@_   :              " @9%L @!X;"]W
M;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0    ( .N 3%)']^PN7@0
M /X0   :              " @7]X @!X;"]W;W)K<VAE971S+W-H965T,3 Q
M+GAM;%!+ 0(4 Q0    ( .N 3%*?"Q#,A 0  +D0   :              "
M@15] @!X;"]W;W)K<VAE971S+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( .N
M3%)\],[4'@4   D4   :              " @=&! @!X;"]W;W)K<VAE971S
M+W-H965T,3 S+GAM;%!+ 0(4 Q0    ( .N 3%+@YD.S2@<  *DK   :
M          " @2>' @!X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4
M Q0    ( .N 3%*8C$MU&@0   \.   :              " @:F. @!X;"]W
M;W)K<VAE971S+W-H965T,3 U+GAM;%!+ 0(4 Q0    ( .N 3%+7T%;Q8 ,
M & *   :              " @?N2 @!X;"]W;W)K<VAE971S+W-H965T,3 V
M+GAM;%!+ 0(4 Q0    ( .N 3%+[_MVH^@(  !$(   :              "
M@9.6 @!X;"]W;W)K<VAE971S+W-H965T,3 W+GAM;%!+ 0(4 Q0    ( .N
M3%*;ZE<-& ,  (8(   :              " @<69 @!X;"]W;W)K<VAE971S
M+W-H965T,3 X+GAM;%!+ 0(4 Q0    ( .N 3%+(8;#[L04  /L9   :
M          " @16= @!X;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;%!+ 0(4
M Q0    ( .N 3%+1./\Y500  !$0   :              " @?ZB @!X;"]W
M;W)K<VAE971S+W-H965T,3$P+GAM;%!+ 0(4 Q0    ( .N 3%+9,E\-K (
M !H'   :              " @8NG @!X;"]W;W)K<VAE971S+W-H965T,3$Q
M+GAM;%!+ 0(4 Q0    ( .N 3%+/+= *N04  !08   :              "
M@6^J @!X;"]W;W)K<VAE971S+W-H965T,3$R+GAM;%!+ 0(4 Q0    ( .N
M3%*\]F"S;0(  ,D&   :              " @6"P @!X;"]W;W)K<VAE971S
M+W-H965T,3$S+GAM;%!+ 0(4 Q0    ( .N 3%)]SUF5X 0  -8:   :
M          " @06S @!X;"]W;W)K<VAE971S+W-H965T,3$T+GAM;%!+ 0(4
M Q0    ( .N 3%*DY!55+@(  $,$   :              " @1VX @!X;"]W
M;W)K<VAE971S+W-H965T,3$U+GAM;%!+ 0(4 Q0    ( .N 3%(W5_@UJ0D
M #<S   :              " @8.Z @!X;"]W;W)K<VAE971S+W-H965T,3$V
M+GAM;%!+ 0(4 Q0    ( .N 3%)%L+9]ZP(  "H)   :              "
M@63$ @!X;"]W;W)K<VAE971S+W-H965T,3$W+GAM;%!+ 0(4 Q0    ( .N
M3%)]IB7C4P,  % +   :              " @8?' @!X;"]W;W)K<VAE971S
M+W-H965T,3$X+GAM;%!+ 0(4 Q0    ( .N 3%*0,<Y2-P,  /@*   :
M          " @1++ @!X;"]W;W)K<VAE971S+W-H965T,3$Y+GAM;%!+ 0(4
M Q0    ( .N 3%(E$=>,' (  )X$   :              " @8'. @!X;"]W
M;W)K<VAE971S+W-H965T,3(P+GAM;%!+ 0(4 Q0    ( .N 3%*DK0)NU0(
M *T'   :              " @=70 @!X;"]W;W)K<VAE971S+W-H965T,3(Q
M+GAM;%!+ 0(4 Q0    ( .N 3%*AK+YJ1 @  (8I   :              "
M@>+3 @!X;"]W;W)K<VAE971S+W-H965T,3(R+GAM;%!+ 0(4 Q0    ( .N
M3%)WB#CR2 ,  "\)   :              " @5[< @!X;"]W;W)K<VAE971S
M+W-H965T,3(S+GAM;%!+ 0(4 Q0    ( .N 3%*[CX4[4@(  %P,   -
M          "  =[? @!X;"]S='EL97,N>&UL4$L! A0#%     @ ZX!,4I>*
MNQS     $P(   L              ( !6^(" %]R96QS+RYR96QS4$L! A0#
M%     @ ZX!,4H&&XM?D"   PE    \              ( !1.," 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( .N 3%+SYG6 8 ,  "I(   :
M      "  57L @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( .N 3%)>^TE#H0(  "E%   3              "  >WO @!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@    "# (, )"0  +_R @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>484</ContextCount>
  <ElementCount>714</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>128</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Organization and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210041002 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210081003 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210111004 - Disclosure - Restricted Cash Restricted Cash</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RestrictedCashRestrictedCash</Role>
      <ShortName>Restricted Cash Restricted Cash</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210141005 - Disclosure - Short-term and long-term investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Shorttermandlongterminvestments</Role>
      <ShortName>Short-term and long-term investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210181006 - Disclosure - Other Receivables Other Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherReceivablesOtherReceivables</Role>
      <ShortName>Other Receivables Other Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210211007 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210251008 - Disclosure - Intangibles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Intangibles</Role>
      <ShortName>Intangibles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210301009 - Disclosure - Equity Method and Other Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestments</Role>
      <ShortName>Equity Method and Other Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210341010 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210391011 - Disclosure - Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherLiabilities</Role>
      <ShortName>Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210421012 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210511013 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210581014 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210641015 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210661016 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210681017 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments</Role>
      <ShortName>Noncontrolling Interests Subject to Put Provisions and Other Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210701018 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210761019 - Disclosure - Stockholder's equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Stockholdersequity</Role>
      <ShortName>Stockholder's equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210811020 - Disclosure - Accumulated Other Comprehensive (Loss) Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>210841021 - Disclosure - Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestitures</Role>
      <ShortName>Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>210911022 - Disclosure - Held for Sale and Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperations</Role>
      <ShortName>Held for Sale and Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>210961023 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>210981024 - Disclosure - Fair Values of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstruments</Role>
      <ShortName>Fair Values of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>211021025 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>211091026 - Disclosure - Supplemental Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>Supplemental Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>211121027 - Disclosure - Selected Quarterly Financial Data (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited</Role>
      <ShortName>Selected Quarterly Financial Data (unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>211151028 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230093002 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/EarningsPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230153004 - Disclosure - Short-term and long-term invesmtents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShorttermandlongterminvesmtentsTables</Role>
      <ShortName>Short-term and long-term invesmtents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Shorttermandlongterminvestments</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230193005 - Disclosure - Other Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherReceivablesTables</Role>
      <ShortName>Other Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherReceivablesOtherReceivables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230223006 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/PropertyandEquipment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230263007 - Disclosure - Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesTables</Role>
      <ShortName>Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Intangibles</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230313008 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables</Role>
      <ShortName>Equity Method and Other Investmetns Equity Method and Other Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230353009 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Goodwill</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230403010 - Disclosure - Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherLiabilitiesTables</Role>
      <ShortName>Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherLiabilities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230433011 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/IncomeTaxes</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230523012 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/LongTermDebt</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230593013 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Leases</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>230713014 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>230773015 - Disclosure - Stockholder's equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/StockholdersequityTables</Role>
      <ShortName>Stockholder's equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Stockholdersequity</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>230823016 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>230853017 - Disclosure - Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresTables</Role>
      <ShortName>Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/AcquisitionsandDivestitures</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>230923018 - Disclosure - Held for Sale and Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables</Role>
      <ShortName>Held for Sale and Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/HeldforSaleandDiscontinuedOperations</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>230993019 - Disclosure - Fair Values of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstrumentsTables</Role>
      <ShortName>Fair Values of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/FairValuesofFinancialInstruments</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>231033020 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/SegmentReporting</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>231103021 - Disclosure - Supplemental Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SupplementalCashFlowInformationTables</Role>
      <ShortName>Supplemental Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>231133022 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables</Role>
      <ShortName>Selected Quarterly Financial Data (unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>231163023 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables</Role>
      <ShortName>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240034001 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240074003 - Disclosure - Revenue Recognition and Accounts Receivable - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240104004 - Disclosure - Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240134005 - Disclosure - Restricted Cash and Equivalents - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails</Role>
      <ShortName>Restricted Cash and Equivalents - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240164006 - Disclosure - Short-term and long-term investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShorttermandlongterminvestmentsDetails</Role>
      <ShortName>Short-term and long-term investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/ShorttermandlongterminvesmtentsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240174007 - Disclosure - Short-term and long-term investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails</Role>
      <ShortName>Short-term and long-term investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240204008 - Disclosure - Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherReceivablesDetails</Role>
      <ShortName>Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherReceivablesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240234009 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240244010 - Disclosure - Property and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240274011 - Disclosure - Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails</Role>
      <ShortName>Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240284012 - Disclosure - Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails</Role>
      <ShortName>Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240294013 - Disclosure - Intangibles - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesAdditionalInformationDetails</Role>
      <ShortName>Intangibles - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240324014 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails</Role>
      <ShortName>Equity Method and Other Investmetns Equity Method and Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240334015 - Disclosure - Equity Method and Other Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Equity Method and Other Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240364016 - Disclosure - Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails</Role>
      <ShortName>Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240374017 - Disclosure - Goodwill - Schedule of Reporting Units Goodwill Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails</Role>
      <ShortName>Goodwill - Schedule of Reporting Units Goodwill Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240384018 - Disclosure - Goodwill - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillAdditionalInformationDetails</Role>
      <ShortName>Goodwill - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240414019 - Disclosure - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherLiabilitiesDetails</Role>
      <ShortName>Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherLiabilitiesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240444020 - Disclosure - Income Taxes - Schedule of Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240454021 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240464022 - Disclosure - Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240474023 - Disclosure - Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240484024 - Disclosure - Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240494025 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240504026 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240534027 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240544028 - Disclosure - Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240554029 - Disclosure - Long-Term Debt - Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails</Role>
      <ShortName>Long-Term Debt - Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240564030 - Disclosure - Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails</Role>
      <ShortName>Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240574031 - Disclosure - Long-Term Debt - Additional information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtAdditionalinformationDetail</Role>
      <ShortName>Long-Term Debt - Additional information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240604032 - Disclosure - Leases Lease Expense Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails</Role>
      <ShortName>Leases Lease Expense Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240614033 - Disclosure - Leases Leases Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesLeasesOtherInformationDetails</Role>
      <ShortName>Leases Leases Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240624034 - Disclosure - Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails</Role>
      <ShortName>Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240634035 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240654036 - Disclosure - Employee Benefit Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails</Role>
      <ShortName>Employee Benefit Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240674037 - Disclosure - Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ContingenciesAdditionalInformationDetails</Role>
      <ShortName>Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240694038 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails</Role>
      <ShortName>Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240724039 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240734040 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity - Summary of Range of Exercise Prices (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity - Summary of Range of Exercise Prices (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240744041 - Disclosure - Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240754042 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240784043 - Disclosure - Stock Repurchases Tender Offer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/StockRepurchasesTenderOfferDetails</Role>
      <ShortName>Stock Repurchases Tender Offer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240794044 - Disclosure - Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails</Role>
      <ShortName>Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240804045 - Disclosure - Shareholder's equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShareholdersequityDetails</Role>
      <ShortName>Shareholder's equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240834046 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240864047 - Disclosure - Acquisitions - Assets acquired and liabilities assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails</Role>
      <ShortName>Acquisitions - Assets acquired and liabilities assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240874048 - Disclosure - Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails</Role>
      <ShortName>Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240884049 - Disclosure - Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails</Role>
      <ShortName>Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240894050 - Disclosure - Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails</Role>
      <ShortName>Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240904051 - Disclosure - Acquisitions and Divestitures - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails</Role>
      <ShortName>Acquisitions and Divestitures - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240934052 - Disclosure - Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails</Role>
      <ShortName>Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240944053 - Disclosure - Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails</Role>
      <ShortName>Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240954054 - Disclosure - Held for Sale and Discontinued Operations - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails</Role>
      <ShortName>Held for Sale and Discontinued Operations - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>240974055 - Disclosure - Variable Interest Entities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails</Role>
      <ShortName>Variable Interest Entities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241004056 - Disclosure - Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241014057 - Disclosure - Fair Values of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Values of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/FairValuesofFinancialInstrumentsTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241044058 - Disclosure - Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails</Role>
      <ShortName>Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241054059 - Disclosure - Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails</Role>
      <ShortName>Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241064060 - Disclosure - Segment Reporting - Summary of Assets by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails</Role>
      <ShortName>Segment Reporting - Summary of Assets by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241074061 - Disclosure - Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails</Role>
      <ShortName>Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>241084062 - Disclosure - Segment Reporting - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingAdditionalInformationDetails</Role>
      <ShortName>Segment Reporting - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>241114063 - Disclosure - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SupplementalCashFlowInformationDetails</Role>
      <ShortName>Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SupplementalCashFlowInformationTables</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>241144064 - Disclosure - Selected Quarterly Financial Data (unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails</Role>
      <ShortName>Selected Quarterly Financial Data (unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables</ParentRole>
      <Position>122</Position>
    </Report>
    <Report instance="dva-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>241174065 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="dva-20201231.htm">dva-20201231.htm</File>
    <File>dva-123120ex211.htm</File>
    <File>dva-123120ex231.htm</File>
    <File>dva-123120ex31110xk.htm</File>
    <File>dva-123120ex31210xk.htm</File>
    <File>dva-123120ex32110xk.htm</File>
    <File>dva-123120ex32210xk.htm</File>
    <File>dva-20201231.xsd</File>
    <File>dva-20201231_cal.xml</File>
    <File>dva-20201231_def.xml</File>
    <File>dva-20201231_lab.xml</File>
    <File>dva-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dva-20201231_g1.gif</File>
    <File>dva-20201231_g2.jpg</File>
    <File>dva-20201231_g3.gif</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/naics/2017-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>146
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dva-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 53,
   "contextCount": 484,
   "dts": {
    "calculationLink": {
     "local": [
      "dva-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dva-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dva-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dva-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dva-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dva-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 1044,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 39,
    "http://www.davita.com/20201231": 12,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 55
   },
   "keyCustom": 101,
   "keyStandard": 613,
   "memberCustom": 57,
   "memberStandard": 67,
   "nsprefix": "dva",
   "nsuri": "http://www.davita.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Document and Entity Information",
     "role": "http://www.davita.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210081003 - Disclosure - Earnings Per Share",
     "role": "http://www.davita.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754042 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity - Additional Information (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784043 - Disclosure - Stock Repurchases Tender Offer (Details)",
     "role": "http://www.davita.com/role/StockRepurchasesTenderOfferDetails",
     "shortName": "Stock Repurchases Tender Offer (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ieeea61245c8246f7bf7f8c512b8bacfd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794044 - Disclosure - Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)",
     "role": "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails",
     "shortName": "Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ifd642cd5b1d24a88883cb68c3b87ab37_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804045 - Disclosure - Shareholder's equity (Details)",
     "role": "http://www.davita.com/role/ShareholdersequityDetails",
     "shortName": "Shareholder's equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i105b8a0db46c4b329658833071e7f412_I20201210",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i808f8139875c457e969c8ed421c88028_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834046 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Details)",
     "role": "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ib85e3af4c76943dfb45faef356b1edb8_I20171231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864047 - Disclosure - Acquisitions - Assets acquired and liabilities assumed (Details)",
     "role": "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
     "shortName": "Acquisitions - Assets acquired and liabilities assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i7dc49d84a9614fb89eb7381fb55a24ec_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i7dc49d84a9614fb89eb7381fb55a24ec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874048 - Disclosure - Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)",
     "role": "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails",
     "shortName": "Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i7dc49d84a9614fb89eb7381fb55a24ec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884049 - Disclosure - Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails",
     "shortName": "Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i808f8139875c457e969c8ed421c88028_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894050 - Disclosure - Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails",
     "shortName": "Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904051 - Disclosure - Acquisitions and Divestitures - Additional Information (Details)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
     "shortName": "Acquisitions and Divestitures - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i35cf0952b11945e08c9c231a53846a77_D20180101-20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210111004 - Disclosure - Restricted Cash Restricted Cash",
     "role": "http://www.davita.com/role/RestrictedCashRestrictedCash",
     "shortName": "Restricted Cash Restricted Cash",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934052 - Disclosure - Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
     "shortName": "Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "id4e4d2ee8252479ebe1a61fd919b6a04_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCashFlowsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944053 - Disclosure - Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails",
     "shortName": "Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCashFlowsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:LossGainOnDispositionOfBusinessInterestsBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954054 - Disclosure - Held for Sale and Discontinued Operations - Additional Information (Details)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
     "shortName": "Held for Sale and Discontinued Operations - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9577f3ef1df845c38e9359052401de77_D20190619-20190619",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974055 - Disclosure - Variable Interest Entities - Additional Information (Details)",
     "role": "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails",
     "shortName": "Variable Interest Entities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i65a17e126ac34461a4fca6925ed519bd_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004056 - Disclosure - Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i36352b7df66948dba0eacf04441040eb_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ied7ace566871432e8e4240927f2bf074_D20201231-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014057 - Disclosure - Fair Values of Financial Instruments (Details)",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails",
     "shortName": "Fair Values of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ied7ace566871432e8e4240927f2bf074_D20201231-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044058 - Disclosure - Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
     "shortName": "Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:SegmentReportingInformationCorporateExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054059 - Disclosure - Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
     "shortName": "Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064060 - Disclosure - Segment Reporting - Summary of Assets by Segment (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
     "shortName": "Segment Reporting - Summary of Assets by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i4fb2cf0a2f7c462eafce7273c7712b87_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074061 - Disclosure - Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
     "shortName": "Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i52836cb5bb7945cba8388d20fe53feb5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210141005 - Disclosure - Short-term and long-term investments",
     "role": "http://www.davita.com/role/Shorttermandlongterminvestments",
     "shortName": "Short-term and long-term investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "iab59816d75634fd58eaaa890c090532b_D20190619-20190619",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241084062 - Disclosure - Segment Reporting - Additional Information (Details)",
     "role": "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
     "shortName": "Segment Reporting - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114063 - Disclosure - Supplemental Cash Flow Information (Details)",
     "role": "http://www.davita.com/role/SupplementalCashFlowInformationDetails",
     "shortName": "Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241144064 - Disclosure - Selected Quarterly Financial Data (unaudited) (Details)",
     "role": "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails",
     "shortName": "Selected Quarterly Financial Data (unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i640e3c80e07c4131ab855012b2ae413d_I20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyEstimateOfPossibleLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i6d5a13855d6745d88e71a8dbda06352e_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241174065 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "iea338e77f4034e17a9b6e514cff7d6d3_I20171231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210181006 - Disclosure - Other Receivables Other Receivables",
     "role": "http://www.davita.com/role/OtherReceivablesOtherReceivables",
     "shortName": "Other Receivables Other Receivables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210211007 - Disclosure - Property and Equipment",
     "role": "http://www.davita.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210251008 - Disclosure - Intangibles",
     "role": "http://www.davita.com/role/Intangibles",
     "shortName": "Intangibles",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210301009 - Disclosure - Equity Method and Other Investments",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestments",
     "shortName": "Equity Method and Other Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210341010 - Disclosure - Goodwill",
     "role": "http://www.davita.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210391011 - Disclosure - Other Liabilities",
     "role": "http://www.davita.com/role/OtherLiabilities",
     "shortName": "Other Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210421012 - Disclosure - Income Taxes",
     "role": "http://www.davita.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:PatientCareCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210511013 - Disclosure - Long-Term Debt",
     "role": "http://www.davita.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210581014 - Disclosure - Leases",
     "role": "http://www.davita.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210641015 - Disclosure - Employee Benefit Plans",
     "role": "http://www.davita.com/role/EmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210661016 - Disclosure - Contingencies",
     "role": "http://www.davita.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210681017 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments",
     "role": "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments",
     "shortName": "Noncontrolling Interests Subject to Put Provisions and Other Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210701018 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210761019 - Disclosure - Stockholder's equity",
     "role": "http://www.davita.com/role/Stockholdersequity",
     "shortName": "Stockholder's equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210811020 - Disclosure - Accumulated Other Comprehensive (Loss) Income",
     "role": "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome",
     "shortName": "Accumulated Other Comprehensive (Loss) Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210841021 - Disclosure - Acquisitions and Divestitures",
     "role": "http://www.davita.com/role/AcquisitionsandDivestitures",
     "shortName": "Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210911022 - Disclosure - Held for Sale and Discontinued Operations",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperations",
     "shortName": "Held for Sale and Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961023 - Disclosure - Variable Interest Entities",
     "role": "http://www.davita.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981024 - Disclosure - Fair Values of Financial Instruments",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstruments",
     "shortName": "Fair Values of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211021025 - Disclosure - Segment Reporting",
     "role": "http://www.davita.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211091026 - Disclosure - Supplemental Cash Flow Information",
     "role": "http://www.davita.com/role/SupplementalCashFlowInformation",
     "shortName": "Supplemental Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211121027 - Disclosure - Selected Quarterly Financial Data (unaudited)",
     "role": "http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited",
     "shortName": "Selected Quarterly Financial Data (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211151028 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)",
     "role": "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables",
     "shortName": "Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230093002 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.davita.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230153004 - Disclosure - Short-term and long-term invesmtents (Tables)",
     "role": "http://www.davita.com/role/ShorttermandlongterminvesmtentsTables",
     "shortName": "Short-term and long-term invesmtents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfOtherReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230193005 - Disclosure - Other Receivables (Tables)",
     "role": "http://www.davita.com/role/OtherReceivablesTables",
     "shortName": "Other Receivables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfOtherReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230223006 - Disclosure - Property and Equipment (Tables)",
     "role": "http://www.davita.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230263007 - Disclosure - Intangibles (Tables)",
     "role": "http://www.davita.com/role/IntangiblesTables",
     "shortName": "Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230313008 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Tables)",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables",
     "shortName": "Equity Method and Other Investmetns Equity Method and Other Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230353009 - Disclosure - Goodwill (Tables)",
     "role": "http://www.davita.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230403010 - Disclosure - Other Liabilities (Tables)",
     "role": "http://www.davita.com/role/OtherLiabilitiesTables",
     "shortName": "Other Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230433011 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.davita.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230523012 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.davita.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230593013 - Disclosure - Leases (Tables)",
     "role": "http://www.davita.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230713014 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity (Tables)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230773015 - Disclosure - Stockholder's equity (Tables)",
     "role": "http://www.davita.com/role/StockholdersequityTables",
     "shortName": "Stockholder's equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230823016 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Tables)",
     "role": "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230853017 - Disclosure - Acquisitions and Divestitures (Tables)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresTables",
     "shortName": "Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230923018 - Disclosure - Held for Sale and Discontinued Operations (Tables)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables",
     "shortName": "Held for Sale and Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993019 - Disclosure - Fair Values of Financial Instruments (Tables)",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstrumentsTables",
     "shortName": "Fair Values of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231033020 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.davita.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231103021 - Disclosure - Supplemental Cash Flow Information (Tables)",
     "role": "http://www.davita.com/role/SupplementalCashFlowInformationTables",
     "shortName": "Supplemental Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231133022 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables)",
     "role": "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables",
     "shortName": "Selected Quarterly Financial Data (unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231163023 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)",
     "role": "http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables",
     "shortName": "SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240034001 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)",
     "role": "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "iaf248d771016450592bc55285a8f1c42_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074003 - Disclosure - Revenue Recognition and Accounts Receivable - Additional Information (Details)",
     "role": "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails",
     "shortName": "Revenue Recognition and Accounts Receivable - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ibabc1893044f4e66a6479c0d43899227_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i07cc868a83ae4fc8b205f050eef50517_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104004 - Disclosure - Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)",
     "role": "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
     "shortName": "Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134005 - Disclosure - Restricted Cash and Equivalents - Additional Information (Details)",
     "role": "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
     "shortName": "Restricted Cash and Equivalents - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsHeldInTrustCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164006 - Disclosure - Short-term and long-term investments (Details)",
     "role": "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails",
     "shortName": "Short-term and long-term investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i4e82366908fc411981946281d867f868_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174007 - Disclosure - Short-term and long-term investments - Additional Information (Details)",
     "role": "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
     "shortName": "Short-term and long-term investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i4e82366908fc411981946281d867f868_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204008 - Disclosure - Other Receivables (Details)",
     "role": "http://www.davita.com/role/OtherReceivablesDetails",
     "shortName": "Other Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i51c7cd9eeaa64c0a91528e12f2172af6_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234009 - Disclosure - Property and Equipment (Details)",
     "role": "http://www.davita.com/role/PropertyandEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244010 - Disclosure - Property and Equipment - Additional Information (Details)",
     "role": "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails",
     "shortName": "Property and Equipment - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274011 - Disclosure - Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)",
     "role": "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails",
     "shortName": "Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ic7a7ef37ab494bd3867be9a034c8ae17_I20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ic7a7ef37ab494bd3867be9a034c8ae17_I20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i2e26a206867842e28cae11fb48c778d0_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284012 - Disclosure - Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)",
     "role": "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
     "shortName": "Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i2e26a206867842e28cae11fb48c778d0_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294013 - Disclosure - Intangibles - Additional Information (Details)",
     "role": "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
     "shortName": "Intangibles - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324014 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Details)",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
     "shortName": "Equity Method and Other Investmetns Equity Method and Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "if835180905f04b80823ceda1bcf614db_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334015 - Disclosure - Equity Method and Other Investments - Additional Information (Details)",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
     "shortName": "Equity Method and Other Investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i808f8139875c457e969c8ed421c88028_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364016 - Disclosure - Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)",
     "role": "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
     "shortName": "Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374017 - Disclosure - Goodwill - Schedule of Reporting Units Goodwill Balances (Details)",
     "role": "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
     "shortName": "Goodwill - Schedule of Reporting Units Goodwill Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384018 - Disclosure - Goodwill - Additional Information (Details)",
     "role": "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
     "shortName": "Goodwill - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i910ed57bdfbe40edaf7a7ec74018eace_D20200101-20201231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PayorRefundsAndRetractions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414019 - Disclosure - Other Liabilities (Details)",
     "role": "http://www.davita.com/role/OtherLiabilitiesDetails",
     "shortName": "Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PayorRefundsAndRetractions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444020 - Disclosure - Income Taxes - Schedule of Income Before Income Taxes (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Income Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454021 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes - Components of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Organization and Summary of Significant Accounting Policies",
     "role": "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464022 - Disclosure - Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474023 - Disclosure - Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails",
     "shortName": "Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:DeferredTaxAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484024 - Disclosure - Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails",
     "shortName": "Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:DeferredTaxAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i808f8139875c457e969c8ed421c88028_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494025 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504026 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534027 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "role": "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i808f8139875c457e969c8ed421c88028_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544028 - Disclosure - Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)",
     "role": "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails",
     "shortName": "Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554029 - Disclosure - Long-Term Debt - Derivative Instruments (Details)",
     "role": "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
     "shortName": "Long-Term Debt - Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i7ed9f709bc0e4ef09c4f9e055ef04e86_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i8c2826afbc8a4432a3c64c9fa13c36f2_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564030 - Disclosure - Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)",
     "role": "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails",
     "shortName": "Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "iaadc39011cd34e719eb41ca937a418b7_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:DebtRefinancingCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574031 - Disclosure - Long-Term Debt - Additional information (Detail)",
     "role": "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
     "shortName": "Long-Term Debt - Additional information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtPercentageBearingFixedInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210041002 - Disclosure - Revenue Recognition",
     "role": "http://www.davita.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604032 - Disclosure - Leases Lease Expense Components (Details)",
     "role": "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails",
     "shortName": "Leases Lease Expense Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614033 - Disclosure - Leases Leases Other Information (Details)",
     "role": "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
     "shortName": "Leases Leases Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfMinimumLeasePaymentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624034 - Disclosure - Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)",
     "role": "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails",
     "shortName": "Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfMinimumLeasePaymentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634035 - Disclosure - Leases - Additional Information (Details)",
     "role": "http://www.davita.com/role/LeasesAdditionalInformationDetails",
     "shortName": "Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654036 - Disclosure - Employee Benefit Plans - Additional Information (Details)",
     "role": "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
     "shortName": "Employee Benefit Plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i41c2761ae3dd47eea3c751d65416ee8e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i2b6750de267f4090baf50a854a1011e0_D20171201-20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674037 - Disclosure - Contingencies - Additional Information (Details)",
     "role": "http://www.davita.com/role/ContingenciesAdditionalInformationDetails",
     "shortName": "Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i2b6750de267f4090baf50a854a1011e0_D20171201-20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694038 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)",
     "role": "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
     "shortName": "Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i26848a1a0f5d41bb9f8750c93c848335_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724039 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i800d2d39bddf429e92e5f08a4ae03142_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734040 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Range of Exercise Prices (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Range of Exercise Prices (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "i9f8f54d48fef43fa83c36824d46a3cd1_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744041 - Disclosure - Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20201231.htm",
      "contextRef": "ib55e9f9088e140fb958fa804e90552d6_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 128,
   "tag": {
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "GERMANY"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r879",
      "r880",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r879",
      "r880",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dva_A2015InterestRateCapAgreementsEffectiveJune292018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Interest rate cap agreements effective June 29, 2018.",
        "label": "2015 Interest Rate Cap Agreements Effective June 29, 2018 [Member]",
        "terseLabel": "2015 Interest Rate Cap Agreements Effective June 29, 2018"
       }
      }
     },
     "localname": "A2015InterestRateCapAgreementsEffectiveJune292018Member",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_A2019InterestRateCapAgreementsEffectiveJune302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Interest Rate Cap Agreements Effective June 30, 2020.",
        "label": "2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]",
        "terseLabel": "2019 Interest Rate Cap Agreements Effective June 30, 2020"
       }
      }
     },
     "localname": "A2019InterestRateCapAgreementsEffectiveJune302020Member",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_AccountsReceivablePeriodOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient accounts receivable months outstanding to be reserved per company policy.",
        "label": "Accounts Receivable Period Outstanding",
        "terseLabel": "Accounts Receivable Period Outstanding"
       }
      }
     },
     "localname": "AccountsReceivablePeriodOutstanding",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.",
        "label": "Acquisition Obligations And Other Notes Payable",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayable",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Obligations And Other Notes Payable, Fair Value.",
        "label": "Acquisition Obligations And Other Notes Payable, Fair Value",
        "terseLabel": "Acquisition obligations and other notes payable, fair value"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayableFairValue",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdditionalDebtPrincipalAmountDueToRepricingAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Debt Principal Amount Due To Repricing Agreement",
        "label": "Additional Debt Principal Amount Due To Repricing Agreement",
        "terseLabel": "Additional Debt Principal Amount Due To Repricing Agreement"
       }
      }
     },
     "localname": "AdditionalDebtPrincipalAmountDueToRepricingAgreement",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price",
        "label": "Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price",
        "terseLabel": "Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price"
       }
      }
     },
     "localname": "AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdjustmentIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.",
        "label": "Adjustment Income Loss From Equity Method Investments",
        "negatedLabel": "Equity investment income, net"
       }
      }
     },
     "localname": "AdjustmentIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AllTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All trusts.",
        "label": "All Trusts [Member]",
        "terseLabel": "Rabbi trusts"
       }
      }
     },
     "localname": "AllTrustsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_AllowanceForUncollectibleAccountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for uncollectible accounts policy.",
        "label": "Allowance For Uncollectible Accounts Policy [Text Block]",
        "terseLabel": "Allowance for uncollectible accounts"
       }
      }
     },
     "localname": "AllowanceForUncollectibleAccountsPolicyTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition contingent consideration revenue earn-out period.",
        "label": "Business Acquisition Contingent Consideration Revenue Earnout Period",
        "terseLabel": "Earn-out consideration payment period"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.",
        "label": "Business Combination Contingent Consideration Acquisitions",
        "terseLabel": "Acquisitions",
        "verboseLabel": "Business combination contingent consideration acquisitions, earn-outs"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitions",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions Earnouts Payments",
        "label": "Business Combination Contingent Consideration Acquisitions Earnouts Payments",
        "negatedLabel": "Payments or other settlements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "label": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "negatedLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid during period for.",
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CashPaidForPortionPreviouslyRefundedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Amounts Previously Refunded [Member]",
        "label": "Cash Paid For Portion Previously Refunded [Member]",
        "terseLabel": "Cash Paid For Portion Previously Refunded"
       }
      }
     },
     "localname": "CashPaidForPortionPreviouslyRefundedMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit, commercial paper, and money market funds.",
        "label": "Certificates Of Deposit Commercial Paper And Money Market Funds [Member]",
        "terseLabel": "Certificates of deposit and other time deposits"
       }
      }
     },
     "localname": "CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CharterdocumentsandDelawarelawAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charter documents and Delaware law [Abstract]",
        "label": "Charter documents and Delaware law [Abstract]",
        "terseLabel": "Charter documents and Delaware law:"
       }
      }
     },
     "localname": "CharterdocumentsandDelawarelawAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CommercialPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Payors in healthcare industry.",
        "label": "Commercial Payors [Member]",
        "terseLabel": "Commercial Payors"
       }
      }
     },
     "localname": "CommercialPayorsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CommitmentsAndContingenciesDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies disclosure.",
        "label": "Commitments And Contingencies Disclosure [Line Items]",
        "terseLabel": "Commitments And Contingencies Disclosure [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureLineItems",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CommitmentsAndContingenciesDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies disclosure.",
        "label": "Commitments And Contingencies Disclosure [Table]",
        "terseLabel": "Commitments And Contingencies Disclosure [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTable",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CommitmentsToProvideOperatingCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments to provide operating capital.",
        "label": "Commitments To Provide Operating Capital [Member]",
        "terseLabel": "Commitments to Provide Operating Capital"
       }
      }
     },
     "localname": "CommitmentsToProvideOperatingCapitalMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]"
       }
      }
     },
     "localname": "ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "xbrltype": "stringItemType"
    },
    "dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member.",
        "label": "Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]",
        "terseLabel": "Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CumulativeEffectOfChangeInAccountingPrinciple": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect Of Change In Accounting Principle.",
        "label": "Cumulative Effect Of Change In Accounting Principle",
        "terseLabel": "Cumulative effect of change in accounting principle"
       }
      }
     },
     "localname": "CumulativeEffectOfChangeInAccountingPrinciple",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DMGAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DMG Acquisitions [Member]",
        "label": "DMG Acquisitions [Member]",
        "terseLabel": "DMG Acquisitions"
       }
      }
     },
     "localname": "DMGAcquisitionsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DaVitaMedicalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DaVita medical group.",
        "label": "Da Vita Medical Group [Member]",
        "verboseLabel": "DMG - discontinued operations"
       }
      }
     },
     "localname": "DaVitaMedicalGroupMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DebtExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt expense.",
        "label": "Debt Expense [Member]",
        "terseLabel": "Debt Expense"
       }
      }
     },
     "localname": "DebtExpenseMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DebtFinancingAndDebtRedemptionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Financing And Debt Redemption Costs",
        "label": "Debt Financing And Debt Redemption Costs",
        "negatedTerseLabel": "Debt Financing And Debt Redemption Costs"
       }
      }
     },
     "localname": "DebtFinancingAndDebtRedemptionCosts",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DebtInstrumentRedeemedOutstandingPrincipalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Redeemed Outstanding Principal Amount",
        "label": "Debt Instrument Redeemed Outstanding Principal Amount",
        "terseLabel": "Debt Instrument Redeemed Outstanding Principal Amount"
       }
      }
     },
     "localname": "DebtInstrumentRedeemedOutstandingPrincipalAmount",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DebtPrepaymentRefinancingRedemptionCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment, refinancing and redemption charges related to long-term debt.",
        "label": "Debt Prepayment Refinancing Redemption Charges",
        "negatedTerseLabel": "Debt prepayment, refinancing and redemption charges"
       }
      }
     },
     "localname": "DebtPrepaymentRefinancingRedemptionCharges",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes",
        "label": "Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes",
        "terseLabel": "Debt Refinancing Call Premium Redemption Charge Incurred Upon Redemption Of Senior Notes"
       }
      }
     },
     "localname": "DebtRefinancingCallPremiumRedemptionChargeIncurredUponRedemptionOfSeniorNotes",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DebtRefinancingCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment refinancing redemption charges related to debt modification of long-term debt.",
        "label": "Debt Refinancing Charges",
        "terseLabel": "Debt prepayment, refinancing and redemption charges"
       }
      }
     },
     "localname": "DebtRefinancingCharges",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DeconsolidatedNoncontrollingEntityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deconsolidated Noncontrolling Entity [Member]",
        "label": "Deconsolidated Noncontrolling Entity [Member]",
        "terseLabel": "APAC JV - Deconsolidated Noncontrolling Entity"
       }
      }
     },
     "localname": "DeconsolidatedNoncontrollingEntityMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liabilities.",
        "label": "Deferred Tax Assets Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DeferredTaxAssetsReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, receivables.",
        "label": "Deferred Tax Assets Receivables",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "DeferredTaxAssetsReceivables",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DeferredTaxLiabilitiesOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from operating lease assets.",
        "label": "Deferred Tax Liabilities Operating Lease Assets",
        "negatedTerseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseAssets",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DiscountAndDeferredFinanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount and deferred finance costs.",
        "label": "Discount And Deferred Finance Costs",
        "negatedLabel": "Discount and deferred financing costs"
       }
      }
     },
     "localname": "DiscountAndDeferredFinanceCosts",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operations Valuation Adjustment.",
        "label": "Disposal Group Including Discontinued Operations Valuation Adjustment",
        "terseLabel": "Valuation adjustment on disposal group"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsValuationAdjustment",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DissolutionTermOfJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dissolution term of joint ventures.",
        "label": "Dissolution Term Of Joint Ventures",
        "terseLabel": "Scheduled dissolution term of joint ventures"
       }
      }
     },
     "localname": "DissolutionTermOfJointVentures",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EBITDA operating income performance targets or quality margins.",
        "label": "E B I T D A Operating Income Performance Targets Or Quality Margins [Member]",
        "terseLabel": "EBITDA or Operating Income Performance Targets or Quality Margins"
       }
      }
     },
     "localname": "EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_EffectiveIncomeTaxReconciliationInvestmentImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Investment Impairment",
        "label": "Effective Income Tax Reconciliation, Investment Impairment",
        "terseLabel": "Nondeductible executive compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationInvestmentImpairment",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee service share-based compensation estimated tax benefit from compensation expense.",
        "label": "Employee Service Share Based Compensation Estimated Tax Benefit From Compensation Expense",
        "terseLabel": "Estimated tax benefits recorded for stock-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares.",
        "label": "Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares",
        "terseLabel": "Contributions used to purchase shares, employee-related current liabilities"
       }
      }
     },
     "localname": "EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_EpogenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Epogen.",
        "label": "Epogen [Member]",
        "terseLabel": "EPO"
       }
      }
     },
     "localname": "EpogenMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ExpectedAmortizationExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Amortization Expense [Line Items]",
        "label": "Expected Amortization Expense [Line Items]",
        "terseLabel": "Expected Amortization Expense [Line Items]"
       }
      }
     },
     "localname": "ExpectedAmortizationExpenseLineItems",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ExpectedAmortizationExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Amortization Expense [Table]",
        "label": "Expected Amortization Expense [Table]",
        "terseLabel": "Expected Amortization Expense [Table]"
       }
      }
     },
     "localname": "ExpectedAmortizationExpenseTable",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ExternalSourcesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External sources.",
        "label": "External Sources [Member]",
        "terseLabel": "External Sources"
       }
      }
     },
     "localname": "ExternalSourcesMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_FinanceLeaseAccumulatedDepreciation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Accumulated Depreciation, contra asset.",
        "label": "Finance Lease Accumulated Depreciation",
        "terseLabel": "Finance Lease Accumulated Depreciation"
       }
      }
     },
     "localname": "FinanceLeaseAccumulatedDepreciation",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease [Member]",
        "label": "Finance Lease [Member]",
        "terseLabel": "Financing Lease",
        "verboseLabel": "Finance Lease"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation Adjustment For Contingent Earn Out Obligations",
        "label": "Foreign Currency Translation Adjustment For Contingent Earn Out Obligations",
        "negatedLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ForeignDialysisCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign dialysis and other medical businesses.",
        "label": "Foreign Dialysis Centers [Member]",
        "terseLabel": "Foreign Dialysis Centers"
       }
      }
     },
     "localname": "ForeignDialysisCentersMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IncomeTaxExpenseBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax expense benefit.",
        "label": "Income Tax Expense Benefit [Member]",
        "terseLabel": "Related income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in other current receivables and other current assets.",
        "label": "Increase Decrease In Other Current Receivables And Other Current Assets",
        "negatedLabel": "Other receivables and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests",
        "label": "Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests",
        "terseLabel": "Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_IncrementalCashPortionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Cash Portion [Member]",
        "label": "Incremental Cash Portion [Member]",
        "terseLabel": "Incremental Cash Portion"
       }
      }
     },
     "localname": "IncrementalCashPortionMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_InsuranceAndSelfInsurancePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance and self insurance policy.",
        "label": "Insurance And Self Insurance Policy [Text Block]",
        "terseLabel": "Self insurance"
       }
      }
     },
     "localname": "InsuranceAndSelfInsurancePolicyTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_InternationalOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International operations.",
        "label": "International Operations [Member]",
        "terseLabel": "International Operations"
       }
      }
     },
     "localname": "InternationalOperationsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_KidneyCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kidney Care [Member]",
        "label": "Kidney Care [Member]",
        "terseLabel": "Kidney Care"
       }
      }
     },
     "localname": "KidneyCareMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_LeasesDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Disclosure [Line Items]",
        "label": "Leases Disclosure [Line Items]",
        "terseLabel": "Leases Disclosure [Line Items]"
       }
      }
     },
     "localname": "LeasesDisclosureLineItems",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_LeasesDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Disclosure [Table]",
        "label": "Leases Disclosure [Table]",
        "terseLabel": "Leases Disclosure [Table]"
       }
      }
     },
     "localname": "LeasesDisclosureTable",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_LeasesOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Other Information [Abstract]",
        "label": "Leases Other Information [Abstract]",
        "terseLabel": "Leases Other Information [Abstract]"
       }
      }
     },
     "localname": "LeasesOtherInformationAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_LesseeLeaseDescriptionLineItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Lease, Description [Line Items] [Abstract]",
        "label": "Lessee, Lease, Description [Line Items] [Abstract]",
        "terseLabel": "Lessee, Lease, Description [Line Items] [Abstract]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItemsAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "xbrltype": "stringItemType"
    },
    "dva_LongTermPurchaseCommitmentExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term purchase commitment expiration date.",
        "label": "Long Term Purchase Commitment Expiration Date",
        "terseLabel": "Long term purchase commitment, expiration date"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentExpirationDate",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term purchase commitment percentage of quantity required.",
        "label": "Long Term Purchase Commitment Percentage Of Quantity Required",
        "terseLabel": "Long-term purchase commitment, percentage of quantity required to be purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentPercentageOfQuantityRequired",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding",
        "label": "Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding",
        "terseLabel": "Longterm Incentive Compensation Cash Awards, Number Of Awards Outstanding"
       }
      }
     },
     "localname": "LongtermIncentiveCompensationCashAwardsNumberOfAwardsOutstanding",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards",
        "label": "Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards",
        "terseLabel": "Longterm Incentive Program Awards Compensation Cost Related To Long-Term Performance-Based Cash Awards"
       }
      }
     },
     "localname": "LongtermIncentiveProgramAwardsCompensationCostRelatedToLongTermPerformanceBasedCashAwards",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_LongtermIncentiveProgramCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Long-term Incentive Program compensation cost.",
        "label": "Longterm Incentive Program Compensation Cost",
        "terseLabel": "Long-term incentive program (LTIP) expense"
       }
      }
     },
     "localname": "LongtermIncentiveProgramCompensationCost",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_LossGainOnDispositionOfBusinessInterestsBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss (Gain) On Disposition Of Business Interests Before Tax",
        "label": "Loss (Gain) On Disposition Of Business Interests Before Tax",
        "negatedTerseLabel": "Loss on sale of discontinued operations before taxes",
        "terseLabel": "Loss (gain) on sales of business interests, net"
       }
      }
     },
     "localname": "LossGainOnDispositionOfBusinessInterestsBeforeTax",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_MedicaidandManagedMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Managed Medicaid Member.",
        "label": "Medicaid and Managed Medicaid [Member]",
        "terseLabel": "Medicaid and Managed Medicaid"
       }
      }
     },
     "localname": "MedicaidandManagedMedicaidMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare governmental agency.",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare bad debt claims"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor",
        "label": "Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor",
        "terseLabel": "Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor"
       }
      }
     },
     "localname": "MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_MedicareandMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare and Medicare Advantage",
        "label": "Medicare and Medicare Advantage [Member]",
        "terseLabel": "Medicare and Medicare Advantage"
       }
      }
     },
     "localname": "MedicareandMedicareAdvantageMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MutualFundsAndCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual Funds And Common Stock [Member]",
        "label": "Mutual Funds And Common Stock [Member]",
        "terseLabel": "Investments in mutual funds and common stock"
       }
      }
     },
     "localname": "MutualFundsAndCommonStockMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Effect Of Transfers From (To) Noncontrolling Interests on Stock Holders Equity Disclosure",
        "label": "Net Effect Of Transfers From To Noncontrolling Interests On Stock Holders Equity Disclosure [Text Block]",
        "terseLabel": "Net effect of transfers from to noncontrolling interests on stock holders equity disclosure"
       }
      }
     },
     "localname": "NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/StockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.",
        "label": "Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.",
        "terseLabel": "Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests."
       }
      }
     },
     "localname": "NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase Decrease In Unrealized Gains On Equity Securities",
        "label": "Net Increase Decrease In Unrealized Gains On Equity Securities",
        "terseLabel": "Net Increase (Decrease) In Unrealized Gains On Equity Securities"
       }
      }
     },
     "localname": "NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NetLossGainOnDispositionOfBusinessInterests": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net loss (gain) on disposition of business interests from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation).",
        "label": "Net Loss (Gain) On Disposition Of Business Interests",
        "negatedLabel": "Loss (gain) on sales of business interests, net"
       }
      }
     },
     "localname": "NetLossGainOnDispositionOfBusinessInterests",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Lease Assets Obtained In Exchange For New or Modified Lease Liabilities.",
        "label": "Net Operating Lease Assets Obtained In Exchange For Lease Liabilities",
        "terseLabel": "Net Operating Lease Assets Obtained In Exchange For Lease Liabilities"
       }
      }
     },
     "localname": "NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Financing Outflows Related To Extinguishment Of Long Term Debt.",
        "label": "Noncash Financing Outflows Related To Extinguishment Of Long Term Debt",
        "terseLabel": "Noncash Financing Outflows Related To Extinguishment Of Long Term Debt"
       }
      }
     },
     "localname": "NoncashFinancingOutflowsRelatedToExtinguishmentOfLongTermDebt",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Gain Related To Redemptions or Purchase of Interests.",
        "label": "Noncontrolling Interest, Gain Related To Redemptions Or Purchase Of Interests",
        "terseLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestIncreaseFromContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest increase from contributions.",
        "label": "Noncontrolling Interest Increase From Contributions",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromContributions",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NumberOfConcentrationRiskCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Concentration Risk Customers.",
        "label": "Number Of Concentration Risk Customers",
        "terseLabel": "Number of concentration risk customers"
       }
      }
     },
     "localname": "NumberOfConcentrationRiskCustomers",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "dva_NumberOfCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of customers.",
        "label": "Number Of Customers",
        "verboseLabel": "Number of patients served"
       }
      }
     },
     "localname": "NumberOfCustomers",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of entities that third parties held non controlling equity interests.",
        "label": "Number Of Entities That Third Parties Held Non Controlling Equity Interests",
        "terseLabel": "Number of legal entities that third parties held noncontrolling equity interests"
       }
      }
     },
     "localname": "NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dva_NumberOfPartnerships": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Partnerships that are included in the Equity Investments category.",
        "label": "Number Of Partnerships",
        "terseLabel": "Number of partnerships",
        "verboseLabel": "Number Of Businesses"
       }
      }
     },
     "localname": "NumberOfPartnerships",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "dva_NumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of sites.",
        "label": "Number Of Sites",
        "terseLabel": "Number of dialysis centers that the company operated or provided administrative services"
       }
      }
     },
     "localname": "NumberOfSites",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dva_OffBalanceSheetFinancingArrangements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Off -Balance Sheet Financing Arrangements.",
        "label": "Off -Balance Sheet Financing Arrangements",
        "terseLabel": "Off -Balance Sheet Financing Arrangements"
       }
      }
     },
     "localname": "OffBalanceSheetFinancingArrangements",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_OpenMarketPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Purchases Member.",
        "label": "Open Market Purchases [Member]",
        "terseLabel": "Open Market Purchases"
       }
      }
     },
     "localname": "OpenMarketPurchasesMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_OtherCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other companies.",
        "label": "Other Companies [Member]",
        "terseLabel": "Other companies"
       }
      }
     },
     "localname": "OtherCompaniesMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherGovernmentPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other government payors in healthcare industry.",
        "label": "Other Government Payors [Member]",
        "terseLabel": "Other Government Payors"
       }
      }
     },
     "localname": "OtherGovernmentPayorsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherNonoperatingIncomeExpensePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other nonoperating income (expense), policy.",
        "label": "Other Nonoperating Income Expense Policy [Text Block]",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpensePolicyTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_OtherReportingUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Reporting Units [Member]",
        "label": "Other Reporting Units [Member]",
        "terseLabel": "Other reporting units"
       }
      }
     },
     "localname": "OtherReportingUnitsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherSourcesofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).",
        "label": "Other Sources of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSourcesofRevenueMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ParentCompanyAndRestrictedSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Parent company and restricted subsidiaries.",
        "label": "Parent Company And Restricted Subsidiaries [Member]",
        "terseLabel": "Company and Restricted Subsidiaries(1)"
       }
      }
     },
     "localname": "ParentCompanyAndRestrictedSubsidiariesMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PatientCareCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.",
        "label": "Patient Care Costs",
        "terseLabel": "Patient care costs"
       }
      }
     },
     "localname": "PatientCareCosts",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PatientServicesCustomerConcentrationRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient services customer concentration risk.",
        "label": "Patient Services Customer Concentration Risk [Member]",
        "terseLabel": "Patient Services Customer Concentration Risk"
       }
      }
     },
     "localname": "PatientServicesCustomerConcentrationRiskMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PaymentsRelatedToStockPurchasesAndAwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments related to stock purchases and awards",
        "label": "Payments related to stock purchases and awards",
        "negatedTerseLabel": "Net (payments) receipts related to stock purchases and awards"
       }
      }
     },
     "localname": "PaymentsRelatedToStockPurchasesAndAwards",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PayorRefundsAndRetractions": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor Refunds And Retractions",
        "label": "Payor Refunds And Retractions",
        "terseLabel": "Payor refunds and retractions"
       }
      }
     },
     "localname": "PayorRefundsAndRetractions",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment.",
        "label": "Percentage Change In Discount Rate Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment",
        "terseLabel": "Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment"
       }
      }
     },
     "localname": "PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment.",
        "label": "Percentage Change In Operating Income Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment",
        "terseLabel": "Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment"
       }
      }
     },
     "localname": "PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Accounts Receivable , 6 months or More Past Due",
        "label": "Percentage Of Accounts Receivable Six Months Or More Past Due",
        "terseLabel": "Percentage Of Accounts Receivable Six Months Or More Past Due"
       }
      }
     },
     "localname": "PercentageOfAccountsReceivableSixMonthsOrMorePastDue",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law limitation. The Company is subject to Section\u00a0203 of the Delaware General Corporation Law which, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period three years following the date on which that stockholder became an interested stockholder.",
        "label": "Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation",
        "terseLabel": "Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation"
       }
      }
     },
     "localname": "PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Impact On Fair Value For Basis Point Increase In Discount Rate",
        "label": "Potential Impact On Fair Value For Basis Point Increase In Discount Rate",
        "negatedLabel": "Sensitivities, Discount rate"
       }
      }
     },
     "localname": "PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PotentialImpactOnFairValueForReductionInOperatingIncome": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Impact On Fair Value For Reduction In Operating Income",
        "label": "Potential Impact On Fair Value For Reduction In Operating Income",
        "negatedLabel": "Sensitivities, Operating Income"
       }
      }
     },
     "localname": "PotentialImpactOnFairValueForReductionInOperatingIncome",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple",
        "label": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple",
        "terseLabel": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple"
       }
      }
     },
     "localname": "PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PremiumPricedAwardBasePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium Priced Award Base Price Per Share.",
        "label": "Premium Priced Award Base Price Per Share",
        "terseLabel": "Premium Priced Award Base Price Per Share"
       }
      }
     },
     "localname": "PremiumPricedAwardBasePricePerShare",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "dva_PremiumPricedStockSettledStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium Priced Stock-Settled Stock Appreciation Rights Member.",
        "label": "Premium Priced Stock-Settled Stock Appreciation Rights [Member]",
        "terseLabel": "Premium priced stock-settled stock appreciation rights"
       }
      }
     },
     "localname": "PremiumPricedStockSettledStockAppreciationRightsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PremiumToTheTenderOfferSharePurchasePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium To The Tender Offer Share Purchase Price.",
        "label": "Premium To The Tender Offer Share Purchase Price",
        "terseLabel": "Premium To The Tender Offer Share Purchase Price"
       }
      }
     },
     "localname": "PremiumToTheTenderOfferSharePurchasePrice",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_ProceedsFromRepricingAgreementOnSecuredDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Repricing Agreement On Secured Debt",
        "label": "Proceeds From Repricing Agreement On Secured Debt",
        "terseLabel": "Proceeds From Repricing Agreement On Secured Debt"
       }
      }
     },
     "localname": "ProceedsFromRepricingAgreementOnSecuredDebt",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ProvisionForExpectedCreditLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision For Expected Credit Losses, contra revenue account.",
        "label": "Provision For Expected Credit Losses",
        "negatedTerseLabel": "Provision for uncollectible accounts",
        "terseLabel": "Provision for uncollectible accounts"
       }
      }
     },
     "localname": "ProvisionForExpectedCreditLosses",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PurchaseAndSaleAgreementAggregatePurchasePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase And Sale Agreement Aggregate Purchase Price.",
        "label": "Purchase And Sale Agreement Aggregate Purchase Price",
        "terseLabel": "Purchase And Sale Agreement Aggregate Purchase Price"
       }
      }
     },
     "localname": "PurchaseAndSaleAgreementAggregatePurchasePrice",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_RMSLifelineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RMS Lifeline.",
        "label": "RMS Lifeline [Member]",
        "terseLabel": "RMS Lifeline"
       }
      }
     },
     "localname": "RMSLifelineMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range One [Member]",
        "label": "Range One [Member]",
        "terseLabel": "$50.01\u2013$60.00"
       }
      }
     },
     "localname": "RangeOneMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Three [Member]",
        "label": "Range Three [Member]",
        "terseLabel": "$70.01\u2013$80.00"
       }
      }
     },
     "localname": "RangeThreeMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Two [Member]",
        "label": "Range Two [Member]",
        "terseLabel": "$60.01\u2013$70.00"
       }
      }
     },
     "localname": "RangeTwoMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of capital expenditures for property and equipment from segment to consolidated.",
        "label": "Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]",
        "terseLabel": "Summary of Expenditures for Property and Equipment by Segment"
       }
      }
     },
     "localname": "ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ReconciliationOfCashFlowsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation Of Cash Flows [Table Text Block]",
        "label": "Reconciliation Of Cash Flows [Table Text Block]",
        "terseLabel": "Reconciliation of Cash Flows"
       }
      }
     },
     "localname": "ReconciliationOfCashFlowsTableTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reporting unit percentage of fair value in excess of short of carrying amount.",
        "label": "Reporting Unit Percentage Of Fair Value In Excess Of Short Of Carrying Amount",
        "terseLabel": "Carrying amount coverage"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "label": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "totalLabel": "Dialysis patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognition and accounts receivable",
        "label": "Revenue Recognition And Accounts Receivable Policy [Text Block]",
        "terseLabel": "Patient service net revenues and accounts receivable"
       }
      }
     },
     "localname": "RevenueRecognitionAndAccountsReceivablePolicyTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure Table Text Block.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Table Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure"
       }
      }
     },
     "localname": "SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]",
        "label": "Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Intangible Assets Table",
        "label": "Schedule Of Finite And Indefinite Intangible Assets Table [Text Block]",
        "terseLabel": "Schedule of Intangible Assets other than Goodwill"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfMinimumLeasePaymentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of minimum lease payments under non-cancelable operating leases and capital leases.",
        "label": "Schedule Of Minimum Lease Payments [Text Block]",
        "terseLabel": "Schedule Of Minimum Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfMinimumLeasePaymentsTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other information related to acquisitions, including weighted-average estimated useful lives of intangible assets acquired, and goodwill deductible for tax purposes.",
        "label": "Schedule of other information related to acquisitions [Table Text Block]",
        "terseLabel": "Schedule of other information related to acquired intangibles and goodwill"
       }
      }
     },
     "localname": "ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfOtherReceivablesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of claims held for amounts due to an entity. Examples include non-trade receivables and Medicare bad debt claims.",
        "label": "Schedule Of Other Receivables [Table Text Block]",
        "terseLabel": "Schedule of Other Receivables"
       }
      }
     },
     "localname": "ScheduleOfOtherReceivablesTableTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of reporting units goodwill balances.",
        "label": "Schedule Of Reporting Units Goodwill Balances [Text Block]",
        "terseLabel": "Schedule of Reporting Units Goodwill Balances"
       }
      }
     },
     "localname": "ScheduleOfReportingUnitsGoodwillBalancesTextBlock",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_SegmentReportingInformationCorporateExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.",
        "label": "Segment Reporting Information Corporate Expenses",
        "negatedLabel": "Corporate administrative support"
       }
      }
     },
     "localname": "SegmentReportingInformationCorporateExpenses",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentRevenuebyMajorPayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Revenue by Major Payor [Abstract]",
        "label": "Segment Revenue by Major Payor [Abstract]",
        "terseLabel": "Segment Revenue by Major Payor [Abstract]"
       }
      }
     },
     "localname": "SegmentRevenuebyMajorPayorAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "xbrltype": "stringItemType"
    },
    "dva_SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes five point one two five percent due twenty thirty.",
        "label": "Senior Notes Five Point One Two Five Percent Due Twenty Thirty [Member]",
        "terseLabel": "Senior Notes 5.125 % due 2024"
       }
      }
     },
     "localname": "SeniorNotesFivePointOneTwoFivePercentDueTwentyThirtyMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes five point zero percent due twenty twenty five.",
        "label": "Senior Notes Five Point Zero Percent Due Twenty Twenty Five [Member]",
        "terseLabel": "Senior Notes 5.0 % due 2025"
       }
      }
     },
     "localname": "SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty.",
        "label": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]",
        "terseLabel": "Senior Notes 4.625% due 2030"
       }
      }
     },
     "localname": "SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One",
        "label": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]",
        "terseLabel": "Senior Notes 3.75% due 2031"
       }
      }
     },
     "localname": "SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorSecuredCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior secured credit facilities.",
        "label": "Senior Secured Credit Facilities [Member]",
        "terseLabel": "Senior Secured Credit Facilities"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilitiesMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average remaining contractual terms.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms",
        "terseLabel": "Exercisable at end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award maximum share value authorized for purchase.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Share Value Authorized For Purchase",
        "terseLabel": "Employee entitlement for purchase of the Company's common stock during each calendar year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable number.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted average remaining contractual\u00a0life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based Compensation Arrangement by Share based Payment Award, Other than Options, Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted average remaining contractual\u00a0life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period",
        "terseLabel": "Added by performance factor (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_ShareRepurchaseFeesAndExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Fees And Expenses.",
        "label": "Share Repurchase Fees And Expenses",
        "terseLabel": "Share Repurchase Fees And Expenses"
       }
      }
     },
     "localname": "ShareRepurchaseFeesAndExpenses",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-base Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Expired In Period",
        "label": "Share-base Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Expired In Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "SharebaseCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio",
        "terseLabel": "Full share awards to shares available, conversion ratio"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance",
        "label": "Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance",
        "terseLabel": "Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance"
       }
      }
     },
     "localname": "StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_StockIncentivePlanTwentyElevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive Plan 2011 [Member]",
        "label": "Stock Incentive Plan Twenty Eleven [Member]",
        "terseLabel": "Stock Incentive 2011 Plan"
       }
      }
     },
     "localname": "StockIncentivePlanTwentyElevenMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockIncentivePlanTwentyTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive Plan Twenty Twenty",
        "label": "Stock Incentive Plan Twenty Twenty [Member]",
        "terseLabel": "Stock Incentive 2020 Plan"
       }
      }
     },
     "localname": "StockIncentivePlanTwentyTwentyMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockOptionProgramAndStockAppreciationRightProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option Program and Stock Appreciation Right Program [Member]",
        "label": "Stock Option Program And Stock Appreciation Right Program [Member]",
        "terseLabel": "Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "StockOptionProgramAndStockAppreciationRightProgramMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Unit.",
        "label": "Stock Unit [Member]",
        "terseLabel": "Stock units"
       }
      }
     },
     "localname": "StockUnitMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options",
        "label": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options",
        "terseLabel": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options"
       }
      }
     },
     "localname": "StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award",
        "label": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award",
        "terseLabel": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award"
       }
      }
     },
     "localname": "StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance",
        "label": "Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance",
        "terseLabel": "Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance"
       }
      }
     },
     "localname": "StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_SupplierRebatesAndOtherNonTradeReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Rebates And Other Non Trade Receivables [Member]",
        "label": "Supplier Rebates And Other Non Trade Receivables [Member]",
        "terseLabel": "Supplier rebates and non-trade receivables"
       }
      }
     },
     "localname": "SupplierRebatesAndOtherNonTradeReceivablesMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TaxYear2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2029",
        "label": "Tax Year 2029 [Member]",
        "terseLabel": "Tax Year 2029"
       }
      }
     },
     "localname": "TaxYear2029Member",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TemporaryEquityDecreasePurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease Purchase Of Interests",
        "label": "Temporary Equity, Decrease Purchase Of Interests",
        "negatedTerseLabel": "Partial purchases"
       }
      }
     },
     "localname": "TemporaryEquityDecreasePurchaseOfInterests",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions"
       }
      }
     },
     "localname": "TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "label": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "verboseLabel": "Contributions"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityRedeemableNoncontrollingInterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests Temporary Equity [Member]",
        "label": "Temporary Equity Redeemable Noncontrolling Interests [Member]",
        "terseLabel": "Non-controlling interests subject to put provisions"
       }
      }
     },
     "localname": "TemporaryEquityRedeemableNoncontrollingInterestsMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TenderOfferMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tender Offer Member.",
        "label": "Tender Offer [Member]",
        "terseLabel": "Tender Offer"
       }
      }
     },
     "localname": "TenderOfferMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A.",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B-1 member",
        "label": "Term Loan B-1 [Member]",
        "terseLabel": "Term Loan B-1"
       }
      }
     },
     "localname": "TermLoanB1Member",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B member.",
        "label": "Term Loan B [Member]",
        "terseLabel": "Term Loan B"
       }
      }
     },
     "localname": "TermLoanBMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terminated Remaining Prior Share Repurchases Authorized, Amount.",
        "label": "Terminated Remaining Prior Share Repurchases Authorized, Amount",
        "terseLabel": "Terminated Remaining Prior Share Repurchases Authorized, Amount"
       }
      }
     },
     "localname": "TerminatedRemainingPriorShareRepurchasesAuthorizedAmount",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Acquired, Average Cost Per Share, Clearing Price",
        "label": "Treasury Stock Acquired, Average Cost Per Share, Clearing Price",
        "terseLabel": "Treasury Stock Acquired, Average Cost Per Share, Clearing Price"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShareClearingPrice",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "dva_USAttorneyPrescriptionDrugInvestigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Attorney Prescription Drug Investigation [Member]",
        "label": "US Attorney Prescription Drug Investigation [Member]",
        "terseLabel": "US Attorney Prescription Drug Investigation"
       }
      }
     },
     "localname": "USAttorneyPrescriptionDrugInvestigationMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_USDialysisAndRelatedLabServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US dialysis \u200band \u200brelated \u200blab\u200b services\u200b.",
        "label": "U S Dialysis And Related Lab Services [Member]",
        "terseLabel": "U.S. dialysis",
        "verboseLabel": "U S Dialysis And Related Lab Services"
       }
      }
     },
     "localname": "USDialysisAndRelatedLabServicesMember",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election Effective date.",
        "label": "Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election",
        "terseLabel": "Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election"
       }
      }
     },
     "localname": "VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date.",
        "label": "Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date",
        "terseLabel": "Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date"
       }
      }
     },
     "localname": "VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate",
     "nsuri": "http://www.davita.com/20201231",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "naics_ZZ446110": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "446110 Pharmacies and Drug Stores [Member]",
        "terseLabel": "Pharmacy Business"
       }
      }
     },
     "localname": "ZZ446110",
     "nsuri": "http://xbrl.sec.gov/naics/2017-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r624",
      "r625",
      "r636",
      "r637",
      "r876",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r624",
      "r625",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r251",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r251",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r195",
      "r200",
      "r301",
      "r530",
      "r531",
      "r532",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r195",
      "r200",
      "r301",
      "r530",
      "r531",
      "r532",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r195",
      "r200",
      "r301",
      "r530",
      "r531",
      "r532",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r483",
      "r488",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r749",
      "r830",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r483",
      "r488",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r749",
      "r830",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r426",
      "r483",
      "r488",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r749",
      "r830",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r426",
      "r483",
      "r488",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r749",
      "r830",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r190",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r278",
      "r279",
      "r391",
      "r394",
      "r831",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r278",
      "r279",
      "r391",
      "r394",
      "r831",
      "r862",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r885",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r190",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r31",
      "r54",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r39",
      "r74",
      "r537"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrual for Taxes Other than Income Taxes, Current",
        "terseLabel": "Accrued non-income tax liabilities"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r48",
      "r774",
      "r804"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r38",
      "r39",
      "r74"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "terseLabel": "Insurance and self-insurance accruals"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r68",
      "r337"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r97",
      "r107",
      "r110",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r99",
      "r107",
      "r110",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r107",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r57",
      "r104",
      "r106",
      "r107",
      "r807",
      "r837",
      "r838"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r103",
      "r107",
      "r110",
      "r192",
      "r193",
      "r194",
      "r631",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Amortizable intangible assets acquired, weighted-average estimated useful lives"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r490",
      "r492",
      "r535",
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-settled stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r246",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other - Ancillary services"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for uncollectible Accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r61",
      "r285",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "negatedTerseLabel": "Provision for uncollectible accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r131",
      "r161",
      "r708"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of Debt Issuance Costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r161",
      "r322",
      "r329"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense from amortizable intangible assets, other than lease agreements"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock-settled awards excluded from calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r103",
      "r107",
      "r110",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r174",
      "r259",
      "r266",
      "r273",
      "r298",
      "r624",
      "r636",
      "r691",
      "r772",
      "r803"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Assets, Total"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r33",
      "r34",
      "r92",
      "r174",
      "r298",
      "r624",
      "r636",
      "r691"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustCurrent": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Current",
        "terseLabel": "Assets Held-in-trust, Current"
       }
      }
     },
     "localname": "AssetsHeldInTrustCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r494",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r659",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r36",
      "r336"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r479",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r479",
      "r484",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the business acquisition agreement was executed, in CCYY-MM-DD format.",
        "label": "Business Acquisition, Date of Acquisition Agreement",
        "terseLabel": "Business Acquisition, Date of Acquisition Agreement"
       }
      }
     },
     "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": {
     "auth_ref": [
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.",
        "label": "Business Acquisition, Effective Date of Acquisition",
        "terseLabel": "Business acquisition, effective date of acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "verboseLabel": "Voting Interest, in percents"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Pro forma basic net income per share from continuing operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Pro forma diluted net income per share from continuing operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Pro Forma Summary of Results of Operations"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r614"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for tax purposes associated with acquisitions"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r593",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Pro forma net income from continuing operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r593",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Pro forma total revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "negatedTerseLabel": "Noncontrolling interests assumed"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r604",
      "r606",
      "r607",
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Deferred Purchase price and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Business Combination, Consideration Transferred, Other",
        "terseLabel": "Business combination, deferred purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Fair value of contingent earn-out consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r605",
      "r608",
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent earn-out obligations"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Indefinite-lived licenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r597",
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Noncompetition agreements and other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r597",
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r597",
      "r598"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Non-cash gain on acquiring additional ownership in business acquisition"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Leases, Future Minimum Payments, Net Minimum Payments, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLossCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.",
        "label": "Capital Loss Carryforward [Member]",
        "terseLabel": "Capital Loss Carryforward"
       }
      }
     },
     "localname": "CapitalLossCarryforwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29",
      "r64",
      "r163"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.",
        "label": "Cash and Cash Equivalents Disclosure [Text Block]",
        "terseLabel": "Cash and Cash Equivalents Disclosure [Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashRestrictedCash"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r42",
      "r164",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r42",
      "r164",
      "r172",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r157",
      "r163",
      "r169"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash of continuing operations at end of the year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash of continuing operations at beginning of the year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r157",
      "r694"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Less: Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r20",
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "terseLabel": "Net cash used in investing activities from discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r20",
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by operating activities from discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Noncontrolling Interests Subject to Put Provisions and Other Commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r192",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r53",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock ($0.001 par value, 450,000 shares authorized; 109,933 and 125,843 shares issued and outstanding at December 31, 2020 and 2019, respectively)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r171",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r113",
      "r115",
      "r116",
      "r128",
      "r792",
      "r821"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to DaVita Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r113",
      "r115",
      "r127",
      "r620",
      "r621",
      "r647",
      "r791",
      "r820"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r113",
      "r115",
      "r126",
      "r619",
      "r647",
      "r790",
      "r819"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r125",
      "r140",
      "r789",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r240",
      "r241",
      "r281",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r281",
      "r689",
      "r690",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r281",
      "r689",
      "r690",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r240",
      "r241",
      "r281",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r240",
      "r241",
      "r281",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r632",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r172",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r172",
      "r635",
      "r639",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r336"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "New center and capital asset projects in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Contract with Customer, Performance Obligation Satisfied in Previous Period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses and charges"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses and charges:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r568",
      "r575"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r179",
      "r568"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r568",
      "r575",
      "r577"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income tax"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r568",
      "r575"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r46",
      "r48",
      "r49",
      "r773",
      "r776",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "LIBOR plus interest margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r49",
      "r357",
      "r776",
      "r801"
     ],
     "calculation": {
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "totalLabel": "Total debt principal outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDateOfFirstRequiredPayment1": {
     "auth_ref": [
      "r81",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt agreement requires the first payment to be made, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Date of First Required Payment",
        "terseLabel": "Debt Instrument, Date of First Required Payment"
       }
      }
     },
     "localname": "DebtInstrumentDateOfFirstRequiredPayment1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.",
        "label": "Debt Instrument, Description of Variable Rate Basis",
        "terseLabel": "Debt Instrument, Description of Variable Rate Basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure [Abstract]",
        "terseLabel": "Debt Instrument, footnotes to the table"
       }
      }
     },
     "localname": "DebtInstrumentFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Debt Instrument, Fee Amount"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r77",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Long-term debt, weighted average effective interest rate during period",
        "verboseLabel": "Debt interest rate during period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentIssuanceDate1": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt instrument was issued, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Issuance Date",
        "terseLabel": "Debt Instrument, Issuance Date"
       }
      }
     },
     "localname": "DebtInstrumentIssuanceDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r78",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
        "label": "Debt Instrument, Maturity Date, Description",
        "terseLabel": "Debt instrument, maturity date, description"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r81",
      "r177",
      "r367",
      "r368",
      "r369",
      "r370",
      "r706",
      "r707",
      "r709",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r706",
      "r709"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]",
        "terseLabel": "Senior Secured Credit Facilities:"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Contributions by Employer",
        "terseLabel": "Non-qualified deferred compensation plan, contributions"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution made to individual in accordance with deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Distribution Paid",
        "terseLabel": "Deferred compensation plan, distributions"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualDistributionPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r569",
      "r575"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r569",
      "r575"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r161",
      "r175",
      "r569",
      "r575",
      "r576",
      "r577"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r50",
      "r51",
      "r558",
      "r775",
      "r800"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r541",
      "r542"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "totalLabel": "Total deferred income tax"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r91",
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r569",
      "r575"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r559"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r560"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r542",
      "r561"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "negatedLabel": "Investments in partnerships"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r412",
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r452",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Asset Categories"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r416",
      "r427",
      "r429",
      "r430",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Total fair value of assets held in trust"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employer matching contribution, percent of employees' gross wages"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution, percent of match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r161",
      "r335"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r161",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation expense on property and equipment"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r651",
      "r652",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts of interest rate agreements"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r94",
      "r95",
      "r688"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r93",
      "r96",
      "r661",
      "r748"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "verboseLabel": "Derivative asset, fair value, gross asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInceptionDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the entity entered into the derivative contract, in CCYY-MM-DD format.",
        "label": "Derivative, Inception Date",
        "terseLabel": "Derivative, effective date"
       }
      }
     },
     "localname": "DerivativeInceptionDates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r660",
      "r662",
      "r666",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r656",
      "r660",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r656",
      "r660",
      "r666",
      "r669",
      "r670",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r665",
      "r668"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Reclassification from accumulated other comprehensive income into net income",
        "verboseLabel": "Amount of debt expense reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeMaturityDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the derivative contract matures, in CCYY-MM-DD format.",
        "label": "Derivative, Maturity Date",
        "terseLabel": "Derivative, Maturity Date",
        "verboseLabel": "Derivative, expiration date"
       }
      }
     },
     "localname": "DerivativeMaturityDates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r650",
      "r653",
      "r654",
      "r656",
      "r658",
      "r664",
      "r666",
      "r671",
      "r673",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r172",
      "r180",
      "r650",
      "r653",
      "r656",
      "r658",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Interest rate swap and cap agreements"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.",
        "label": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]",
        "terseLabel": "Difference between Revenue Guidance in Effect before and after Topic 606"
       }
      }
     },
     "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r18",
      "r123",
      "r816"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Income (loss) from discontinued operations before taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Diluted net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod": {
     "auth_ref": [
      "r7",
      "r23",
      "r582"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) attributable to income (loss) from operations classified as a discontinued operation. Excludes tax expense (benefit) for gain (loss) on disposal and for provision for gain (loss) until disposal.",
        "label": "Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period",
        "terseLabel": "Discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal": {
     "auth_ref": [
      "r8",
      "r10",
      "r23",
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit on (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.",
        "label": "Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r2",
      "r5",
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "terseLabel": "Expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r19",
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Net revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r27",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale and Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r479",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r129",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r206",
      "r209",
      "r223",
      "r224",
      "r225",
      "r229",
      "r230",
      "r793",
      "r822"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (in usd per share)",
        "totalLabel": "Basic net income per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic net income (loss) attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r129",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r209",
      "r223",
      "r224",
      "r225",
      "r229",
      "r230",
      "r793",
      "r822"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (in usd per share)",
        "totalLabel": "Diluted net income per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted net income (loss) attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r172",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerators:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r694"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r544",
      "r579"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r544",
      "r579"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in International valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r544",
      "r579"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "terseLabel": "Impact of noncontrolling interests primarily attributable to non-tax paying entities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r544",
      "r579"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Political advocacy costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r544",
      "r579"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r544",
      "r579"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "auth_ref": [
      "r544",
      "r579"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r197",
      "r203",
      "r205",
      "r235",
      "r301",
      "r366",
      "r371",
      "r530",
      "r531",
      "r532",
      "r571",
      "r572",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r702",
      "r833",
      "r834",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r26",
      "r174",
      "r298",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r26",
      "r174",
      "r298",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember": {
     "auth_ref": [
      "r26",
      "r174",
      "r298",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee classified as other. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee, Other [Member]",
        "terseLabel": "Equity method investments in nonconsolidated businesses"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Equity method investment, significant impairments and other valuation adjustments"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Equity Method Investments and Joint Ventures Disclosure"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r65",
      "r156",
      "r172",
      "r296",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity investments and other investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities, FV-NI",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r293",
      "r825"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Realized Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r43",
      "r47",
      "r292",
      "r802",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Adjusted cost method investments"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r472",
      "r678",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r427",
      "r429",
      "r434",
      "r472",
      "r678",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0prices\u00a0in active\u00a0markets\u00a0for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r427",
      "r429",
      "r434",
      "r472",
      "r678",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant\u00a0other observable\u00a0inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r472",
      "r678",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r472",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r682",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r681",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r172",
      "r685",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair value estimates"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r717",
      "r725",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r720",
      "r728"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r716",
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total future minimum payments due under finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less portion representing interest, financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r719",
      "r728"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r717",
      "r725",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of leased assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r730",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance lease, weighted average discount rate, percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r729",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r323",
      "r325",
      "r328",
      "r332",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r323",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r328",
      "r754"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Finite-Lived Intangible Assets, Remaining Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedNoncompeteAgreementsGross": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of payments made to third parties in exchange for their agreement not to engage in specified competitive practices in specified geographic territories for a specified period of time.",
        "label": "Finite-Lived Noncompete Agreements, Gross",
        "terseLabel": "Noncompetition agreements"
       }
      }
     },
     "localname": "FiniteLivedNoncompeteAgreementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r161",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 8.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Loss (gain) on changes in ownership interest, net",
        "terseLabel": "Gain (Loss) on Disposition of Business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r132",
      "r133",
      "r161",
      "r785",
      "r823"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "negatedTerseLabel": "Gain (Loss) on Divestiture"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r308",
      "r310",
      "r771"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r172",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r172",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Indefinite-lived intangibles"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency and other adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r311",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r311",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedLabel": "Accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r161",
      "r309",
      "r314",
      "r318"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairment charges",
        "terseLabel": "Goodwill impairment charges",
        "verboseLabel": "Goodwill and other asset impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]",
        "verboseLabel": "Selected quarterly financial information:"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Goodwill, Written off Related to Sale of Business Unit"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "terseLabel": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Domain]",
        "terseLabel": "Health Care Organization, Revenue Sources [Domain]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r288",
      "r291",
      "r779"
     ],
     "calculation": {
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesCurrent": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as current.",
        "label": "Debt Securities, Held-to-maturity, Current",
        "terseLabel": "Debt securities, short-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesNoncurrent": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.",
        "label": "Debt Securities, Held-to-maturity, Noncurrent",
        "terseLabel": "Debt securities, long-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r161",
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r135",
      "r162",
      "r198",
      "r199",
      "r200",
      "r201",
      "r222",
      "r225",
      "r618"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r178",
      "r578"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r121",
      "r259",
      "r265",
      "r269",
      "r272",
      "r275",
      "r768",
      "r786",
      "r794",
      "r826"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r178",
      "r578"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r178",
      "r259",
      "r265",
      "r269",
      "r272",
      "r275"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r174",
      "r196",
      "r259",
      "r265",
      "r269",
      "r272",
      "r275",
      "r298",
      "r619",
      "r691"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r119",
      "r129",
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r209",
      "r223",
      "r224",
      "r783",
      "r787",
      "r793",
      "r815"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income (Loss) from Continuing Operations, Per Basic Share",
        "verboseLabel": "Basic net income from continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r119",
      "r129",
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r209",
      "r223",
      "r224",
      "r225",
      "r793",
      "r815",
      "r818",
      "r822"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Diluted net income from continuing operations per share attributable to DaVita Inc. (in usd per share)",
        "verboseLabel": "Diluted net income from continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r23",
      "r26",
      "r584",
      "r816"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r18",
      "r23",
      "r619"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net (loss) income from discontinued operations",
        "verboseLabel": "Discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r123",
      "r129",
      "r214",
      "r223",
      "r224",
      "r793",
      "r816",
      "r818",
      "r822"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r122",
      "r161",
      "r256",
      "r295",
      "r784",
      "r814"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity investment (income) loss",
        "terseLabel": "Equity investment (loss) income"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r479",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r21",
      "r24",
      "r25",
      "r26",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r545",
      "r556",
      "r563",
      "r573",
      "r580",
      "r585",
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r204",
      "r205",
      "r257",
      "r543",
      "r574",
      "r581",
      "r827"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems": {
     "auth_ref": [
      "r583"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations.",
        "label": "Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations",
        "totalLabel": "Income tax (benefit) expense from continuing and discontinued operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r172",
      "r539",
      "r540",
      "r556",
      "r557",
      "r562",
      "r570",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r158",
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes, net"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r86",
      "r780",
      "r813"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": {
     "auth_ref": [
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares.  Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares",
        "terseLabel": "Weighted average contingently returnable shares attributable to dilutive effect (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r210",
      "r211",
      "r213",
      "r225"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Assumed incremental shares from stock plans (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived licenses"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Axis]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Domain]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Intangibles"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r172",
      "r327",
      "r750",
      "r751",
      "r752",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Amortizable intangibles"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross (excluding goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r321",
      "r326"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net of accumulated amortization",
        "totalLabel": "Total intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r705"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Debt expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r138",
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r39",
      "r40",
      "r74"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r251",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersubsegmentEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in subsegment consolidation.",
        "label": "Intersubsegment Eliminations [Member]",
        "terseLabel": "Intersubsegment Eliminations"
       }
      }
     },
     "localname": "IntersubsegmentEliminationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r30",
      "r89"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r90",
      "r172",
      "r232",
      "r304",
      "r305",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r842",
      "r852",
      "r855",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r296",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments in debt and equity securities"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r853",
      "r854",
      "r857",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r853",
      "r854",
      "r857",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Equity method and other investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r292",
      "r769",
      "r796",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments in Debt and Equity Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Shorttermandlongterminvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r35",
      "r67"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r731",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Operating lease cost:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Expense Components"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r36",
      "r336"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]",
        "verboseLabel": "Leases term and discount rate"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
        "label": "Leases of Lessee Disclosure [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Disclosure [Abstract]",
        "terseLabel": "Lessee Disclosure [Abstract]"
       }
      }
     },
     "localname": "LesseeDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Financing lease cost:"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments due under operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less portion representing interest, operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lessee, Operating Lease, Renewal Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r72",
      "r174",
      "r267",
      "r298",
      "r625",
      "r636",
      "r637",
      "r691"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r60",
      "r174",
      "r298",
      "r691",
      "r778",
      "r810"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r76",
      "r174",
      "r298",
      "r625",
      "r636",
      "r637",
      "r691"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r49",
      "r776",
      "r801"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity on revolving credit facilities"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement amount awarded to other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Other Receivables"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesOtherReceivables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Carrying amount of long-term debt, net of unamortized discounts"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r181",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r181",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r181",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r181",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r181",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r181",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt and Lease Obligation, Net, Alternative [Abstract]",
        "terseLabel": "Acquisition obligations, other notes payable, and financing lease obligations"
       }
      }
     },
     "localname": "LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r81",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-term debt, weighted average interest rate, at point in time"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r348",
      "r349",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Loss Contingency, Estimate of Possible Loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r36",
      "r336"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Equipment and information systems, including internally developed software"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Equipment and Information Systems"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r782"
     ],
     "calculation": {
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r32",
      "r73"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term investments",
        "totalLabel": "Total, short-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term investments",
        "totalLabel": "Total, long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Short-term and long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvesmtentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r27",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r88",
      "r174",
      "r298",
      "r691",
      "r777",
      "r809"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests not subject to put provisions"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r371",
      "r622",
      "r623"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Purchase of noncontrolling interests",
        "negatedTerseLabel": "Partial purchases"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Current economic interest in the APAC JV, Owned by Noncontrolling Investors"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "verboseLabel": "Ownership percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Noncontrolling Interest, Period Increase (Decrease)"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r88",
      "r136",
      "r617",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Provided by (Used in) Investing Activities, Total"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r157",
      "r159",
      "r162"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by (Used in) Operating Activities, Total"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r26",
      "r111",
      "r114",
      "r124",
      "r162",
      "r174",
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r204",
      "r205",
      "r222",
      "r259",
      "r265",
      "r269",
      "r272",
      "r275",
      "r298",
      "r691",
      "r788",
      "r817"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income attributable to DaVita Inc.",
        "totalLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Amounts attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r111",
      "r114",
      "r204",
      "r205",
      "r628",
      "r646"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r362",
      "r628",
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New accounting standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r166",
      "r167",
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Fixed assets under financing lease obligations"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompetition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r372",
      "r622",
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r372",
      "r622",
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Acquisitions and divestitures, noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest Items [Abstract]",
        "terseLabel": "Changes in noncontrolling interest from:"
       }
      }
     },
     "localname": "NoncontrollingInterestItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r371",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling interests not subject to put provisions"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable [Abstract]",
        "terseLabel": "Senior Notes:"
       }
      }
     },
     "localname": "NotesPayableAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which dialysis centers located"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "verboseLabel": "Number of states where dialysis centers are located"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Unrealized (losses) gains"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r107",
      "r118"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "totalLabel": "Unrealized (losses) gains net"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r259",
      "r265",
      "r269",
      "r272",
      "r275"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r718"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Fixed lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r716"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities, operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r716"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r716"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r721",
      "r728"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r715"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r730",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r729",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r353",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.",
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "terseLabel": "Leases Other Information"
       }
      }
     },
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r712"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent expense under all operating leases"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsExpirationDate": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.",
        "label": "Operating Loss Carryforwards, Expiration Date",
        "terseLabel": "Operating loss carryforwards, expiration date"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r28",
      "r191",
      "r245",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r161",
      "r339"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Other asset impairments"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other potential commitments to provide operating capital to several dialysis centers"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Unrealized (losses) gains on interest rate cap agreements:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]",
        "terseLabel": "Unrealized losses on foreign currency translation."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r98",
      "r104",
      "r692",
      "r693",
      "r695"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Unrealized losses on foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Related income tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r112",
      "r115",
      "r118",
      "r125",
      "r366",
      "r696",
      "r701",
      "r702",
      "r789",
      "r818"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r104",
      "r108",
      "r109",
      "r657"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedLabel": "Reclassification into net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r99",
      "r104",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Amount of unrealized gains (losses) in OCI on interest rate cap and swap agreements",
        "verboseLabel": "Amount of unrealized (losses) gains in OCI on interest rate cap agreements"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r99",
      "r104",
      "r676"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "terseLabel": "Unrealized (losses) gains"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r828"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.",
        "label": "Other Indefinite-lived Intangible Assets",
        "terseLabel": "Customer relationships and other"
       }
      }
     },
     "localname": "OtherIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r38",
      "r74"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities",
        "totalLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-term Investments [Member]",
        "terseLabel": "Other long-term Investments"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash charges, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Long-term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "verboseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOwnershipInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holder of an ownership interest in a partnership who is not classified as a general partner, preferred partner, or limited partner.",
        "label": "Other Ownership Interest [Member]",
        "terseLabel": "Other equity method partnerships"
       }
      }
     },
     "localname": "OtherOwnershipInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPensionPlansDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Other Pension Plan [Member]",
        "terseLabel": "DaVita Voluntary Deferral Plan"
       }
      }
     },
     "localname": "OtherPensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r74",
      "r354"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests.",
        "label": "Partner Type [Axis]",
        "terseLabel": "Partner Type [Axis]"
       }
      }
     },
     "localname": "PartnerTypeOfPartnersCapitalAccountAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": {
     "auth_ref": [
      "r374",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests.",
        "label": "Partner Type of Partners' Capital Account, Name [Domain]",
        "terseLabel": "Partner Type of Partners' Capital Account, Name [Domain]"
       }
      }
     },
     "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDistributionsToAffiliates": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Payments of Distributions to Affiliates",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDistributionsToAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "terseLabel": "Payments of ordinary dividends, common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecurities": {
     "auth_ref": [
      "r146",
      "r289"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.",
        "label": "Payments to Acquire Available-for-sale Securities",
        "negatedLabel": "Purchase of other debt and equity investments"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r147",
      "r609"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Acquisitions",
        "terseLabel": "Cash paid to acquire business",
        "verboseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "auth_ref": [
      "r145",
      "r289"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.",
        "label": "Payments to Acquire Held-to-maturity Securities",
        "negatedLabel": "Purchase of debt investments held-to-maturity"
       }
      }
     },
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions of property and equipment",
        "terseLabel": "Expenditures for property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Purchases of noncontrolling interests",
        "terseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending legal settlements"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r426",
      "r428",
      "r434",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r472",
      "r474",
      "r475",
      "r477",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r452",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Plan Asset Categories"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r494",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock ($0.001 par value, 5,000 shares authorized; none issued)"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r33",
      "r62",
      "r63"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of DMG division"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from Divestiture of Businesses, Net of Cash Divested"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r143",
      "r156"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Distributions from equity method investments"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r149",
      "r529"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Net (payments) receipts related to stock purchases and awards"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Proceeds from sales of additional noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r141",
      "r289"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities",
        "terseLabel": "Proceeds from debt investments held-to-maturity"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r142",
      "r289"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.",
        "label": "Proceeds from Sale of Available-for-sale Securities",
        "terseLabel": "Proceeds from sale of other debt and equity investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from asset and business sales"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r149",
      "r529"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Stock award exercises and other share issuances, net"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r26",
      "r111",
      "r114",
      "r155",
      "r174",
      "r196",
      "r204",
      "r205",
      "r259",
      "r265",
      "r269",
      "r272",
      "r275",
      "r298",
      "r619",
      "r627",
      "r629",
      "r646",
      "r647",
      "r691",
      "r794"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r68",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r344",
      "r864",
      "r865",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r67",
      "r336"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross, total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r44",
      "r45",
      "r338",
      "r811"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net of accumulated depreciation",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/PropertyandEquipmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r66",
      "r172",
      "r338",
      "r864",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r44",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r44",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, and equipment useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "Purchase Obligation, to be Paid, Year Four"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase Obligation, Due in Next Twelve Months"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "Purchase Obligation, Due in Second Year"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "Purchase Obligation, Due in Third Year"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]",
        "terseLabel": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Selected Quarterly Financial Data (unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Reclassification from accumulated other comprehensive losses (income) into net income"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r107",
      "r118"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "totalLabel": "Reclassification from accumulated other comprehensive income into net income net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r105",
      "r109"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "negatedTerseLabel": "Related income tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r266",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Assets by Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r265",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Depreciation and Amortization Expense by Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r360",
      "r361",
      "r363",
      "r364"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r360",
      "r361",
      "r363",
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r452",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r452",
      "r735",
      "r737",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "terseLabel": "Repayments of Secured Debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash [Abstract]",
        "terseLabel": "Restricted Cash [Abstract]"
       }
      }
     },
     "localname": "RestrictedCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r42",
      "r163",
      "r169",
      "r770",
      "r806"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
        "label": "Restricted Cash and Cash Equivalents [Axis]",
        "terseLabel": "Restricted Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r56",
      "r371",
      "r533",
      "r808",
      "r836",
      "r838"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r197",
      "r203",
      "r205",
      "r301",
      "r530",
      "r531",
      "r532",
      "r571",
      "r572",
      "r833",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r455",
      "r459",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r455",
      "r459",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r250",
      "r251",
      "r264",
      "r270",
      "r271",
      "r277",
      "r278",
      "r281",
      "r390",
      "r391",
      "r753"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Dialysis patient service revenues before provision",
        "verboseLabel": "Patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r388",
      "r389",
      "r392",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Abstract]",
        "terseLabel": "Revenue disaggregation table footnote"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition (Detail)"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]",
        "terseLabel": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r120",
      "r174",
      "r250",
      "r251",
      "r264",
      "r270",
      "r271",
      "r277",
      "r278",
      "r281",
      "r298",
      "r691",
      "r794"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving line of credit",
        "verboseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r727",
      "r733",
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Sale and Leaseback Transaction, Gain (Loss), Net"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r107",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Reconciliation of Changes in Contingent Earn-Out Obligations"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r81",
      "r177",
      "r367",
      "r368",
      "r369",
      "r370",
      "r706",
      "r707",
      "r709",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Deferred Tax Assets and Liabilities Arising from Temporary Differences"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r660",
      "r666",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effects of Interest Rate Swap and Cap Agreements"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r0",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r21",
      "r24",
      "r25",
      "r26",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Summary of Information Related to Assets Held For Sale and Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation between U.S. Federal Income Tax Rate and Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r26",
      "r174",
      "r297",
      "r298",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r323",
      "r327",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r317",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r317",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Value of Goodwill by Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Scheduled Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r68",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "verboseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Selected Quarterly Financial Data (unaudited)"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Aggregate Purchase Cost Allocations for Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": {
     "auth_ref": [
      "r42",
      "r169",
      "r770",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r259",
      "r262",
      "r268",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r508",
      "r513",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r494",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of Range of Exercise Prices"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted Average Valuation Inputs"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Shares repurchases summary table"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/StockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r624",
      "r625",
      "r636",
      "r637",
      "r638",
      "r640",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Scheduled Amortization Charges from Intangible Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r49",
      "r776",
      "r805"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured Debt [Abstract]",
        "terseLabel": "Long-term debt totals:"
       }
      }
     },
     "localname": "SecuredLongtermDebtCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentContinuingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity expected to operate in the foreseeable future.",
        "label": "Continuing Operations [Member]",
        "terseLabel": "Continuing Operations"
       }
      }
     },
     "localname": "SegmentContinuingOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r246",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r246",
      "r248",
      "r249",
      "r259",
      "r263",
      "r269",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r280",
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information footnote:"
       }
      }
     },
     "localname": "SegmentReportingInformationOperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelectedQuarterlyFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selected Quarterly Financial Information [Abstract]",
        "terseLabel": "Footnotes to Selected Quarterly Financial Information:"
       }
      }
     },
     "localname": "SelectedQuarterlyFinancialInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r781",
      "r812"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Series of individually immaterial business acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Customer relationships and other"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
        "label": "Share-based Payment Arrangement, Accelerated Cost",
        "terseLabel": "Share-based Payment Arrangement, Accelerated Cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average fair value of grants (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Outstanding at end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the equity-based award expires, in CCYY-MM-DD format.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility",
        "verboseLabel": "Expected volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Share-based awards, fair value assumptions, expected dividend"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum percentage of employees' base salary to be maintained into deferral account"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized under the plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock awards exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Stock granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Stock appreciation awards granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value",
        "verboseLabel": "Weighted-average fair value of grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock awards outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r502",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (USD per share)",
        "periodStartLabel": "Outstanding at beginning of year (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Share-based Payment Arrangement, Plan Modification, Incremental Cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r491",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r172",
      "r494",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Long-term incentive compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Range of exercise prices, lower range (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Awards exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Range of exercise prices, upper range (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Terms of award (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r520",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock awards exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Stock purchase price as percentage of fair market value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r857",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r11",
      "r246",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r317",
      "r341",
      "r345",
      "r346",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://www.davita.com/role/SelectedQuarterlyFinancialDataunauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r85",
      "r192",
      "r193",
      "r194",
      "r197",
      "r203",
      "r205",
      "r235",
      "r301",
      "r366",
      "r371",
      "r530",
      "r531",
      "r532",
      "r571",
      "r572",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r702",
      "r833",
      "r834",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r235",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Granted or Issued, Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharebasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r52",
      "r53",
      "r366",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Stock purchase shares issued (in shares)",
        "verboseLabel": "Stock issued for employee stock purchase plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r52",
      "r53",
      "r366",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock award payment plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r52",
      "r53",
      "r366",
      "r371",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r52",
      "r53",
      "r366",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r52",
      "r53",
      "r371",
      "r493",
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "negatedTerseLabel": "Stock award plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r53",
      "r58",
      "r59",
      "r174",
      "r286",
      "r298",
      "r691"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total DaVita Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r174",
      "r192",
      "r193",
      "r194",
      "r197",
      "r203",
      "r298",
      "r301",
      "r371",
      "r530",
      "r531",
      "r532",
      "r571",
      "r572",
      "r616",
      "r617",
      "r645",
      "r691",
      "r696",
      "r697",
      "r702",
      "r834",
      "r835"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r173",
      "r371",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Long-term Incentive Compensation and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r703",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r703",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r703",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r547",
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Reconciliation of the Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet the More-Likely-Than-Not Threshold"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "State capital loss carryforward, amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardExpirationDate": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the tax credit carryforward, in CCYY-MM-DD format.",
        "label": "Tax Credit Carryforward, Expiration Date",
        "terseLabel": "State capital loss carryforward, expiration date"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary equity"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r83",
      "r174",
      "r298",
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Temporary equity, ending balance",
        "periodStartLabel": "Temporary equity, beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]",
        "terseLabel": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury stock acquired, average cost per share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r84",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r53",
      "r366",
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Shares [Abstract]",
        "terseLabel": "Stock repurchases",
        "verboseLabel": "Treasury Stock, Shares Repurchases, Table Footnotes:"
       }
      }
     },
     "localname": "TreasuryStockSharesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r53",
      "r366",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchase of treasury stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)",
        "verboseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r53",
      "r366",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Retirement of treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "Stockholder's equity"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Stockholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Value [Abstract]",
        "terseLabel": "Treasury Stock, Value [Abstract]"
       }
      }
     },
     "localname": "TreasuryStockValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r366",
      "r371",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchase of treasury stock",
        "terseLabel": "Value of treasury stock acquired"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r538",
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Liability for unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Reductions related to settlements with taxing authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties related to unrecognized tax benefits, net of federal tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions related to current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Increase in liability for unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Reductions related to lapse of applicable statute"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance related to changes in the estimated tax benefit of foreign and state operating losses"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r182",
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Amounts charged to income"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Amounts written off"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "Valuation Allowances and Reserves"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from business combination.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesReservesOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "Valuation Allowances and Reserves Type"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r624",
      "r625",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r726",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r208",
      "r225"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted shares (in shares)",
        "totalLabel": "Weighted average shares - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable": {
     "auth_ref": [
      "r207"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares, Contingently Issuable",
        "negatedLabel": "Weighted average contingently returnable shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesContingentlyIssuable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r206",
      "r207"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Weighted average shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares for earnings per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r206",
      "r225"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares (in shares)",
        "totalLabel": "Weighted average shares - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of Deferred Debt Issuance Cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(b))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2062-109256"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "48",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2538-109256"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "48",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2538-109256"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2574-109256"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2597-109256"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2600-109256"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2603-109256"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=27011391&loc=d3e105025-122735"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127163"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127197"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/subtopic&trid=2208821"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL108322424-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385818&loc=d3e40084-109325"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e845-128460"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e848-128460"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759068-111685"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549808&loc=d3e36991-112694"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 1,3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611322-123010"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r877": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r878": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r879": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r880": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r881": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r882": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r883": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r884": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r885": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r886": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r887": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r888": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>147
<FILENAME>0000927066-21-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927066-21-000008-xbrl.zip
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M,5JG?B^4\N2PHPLH!\II H[QU/@ 6OM'/R;FN%:?"1:"A1K!M,^UF8@NDKQ
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M+7:FB'O?1.0J?!0R"&>^,]KX2F*Y&CSM'RV[\#&61&%W=]E%CSL_N2C_A@]
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MN:=0RX2]K:4\LV9,RV\W?;NUGZO.@E,U:WNN^VO-D!YW8Y$IE"=Q?_E8LGG
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M$%T$#^XIUXW/("MWO85,L?O-U?8MV[)XZZ5G]5M>P9K+X.-_ %!+ P04
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M=M" J>B=SY9= *-55IJKSL%H3>1271IHYE%&-SN8-'%RRD1OO9&44P#*CJH
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ME ))LD.DC+Y0".Q 0B\6W0%D+^+<]DA"*%)#ZGIG\<<#.@O#>-BFF9X.1U^
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M$85_N,<I\V,"PEUY'%3*I0\,/BBV+$L,,%0)\<(@%1XEE$6<!=1+.$A7JF*
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MN)0TIB(1A"0N3^RYT69HTE*>VQWYFYG;<R_G%@I?$);$/@\C&@G)E8I<29/
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M&B& G9]-ALHYU =N/AXZH,5R!:>Z[5Q,<,RW&N#) \R*?"(F%2@3]2HDJ/.
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M5+-K,':'J";#*Z^MIJLU3#\S@>?5=UH#O2S@T$$%@;-!10?IU^HX\S41;=:
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M9B:>X9.T;<"!ZA1JD2B#$:1IKKYD/-.*_)55E!$=AXVC@AFE%I4+T/>&I;I
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M.-00#CJ5N@B!N@A&(U5I*U.L_["ML-?5XB88<I-V.*L3_:/V<!AM[#K/U5J
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MO;&<D^*S&QJA7>20BCAM[%1+OVA9;@+YX4^_8E_.$T^UZ46Z:=V"4TA[8=
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MI"+7!Q&NBWRYY,;//N[>KS7<SFB&=-E:NF@3U]_$%J1P1)KP-WOJ:_E57+"
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M@B]1(^%%CTN5VZ0A<DS\RD(0PV"R2!C*MR5$VF(16Z6HIY)@/Y%B$S)<B5:
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MB[J<<0:Z4/7XT7M1_HRH^:AGFZ0T\1N^SGJSW>@\#1^[77$?:<41\'?% C;
M#-#<H#L&4)+\RZ3#?H]F;A+4- BE^CHLK\N I&)$XEC6>K+2J=^,0A5VB!(F
M%,?NTDL]<03DY$A;S]PYZ?.Y$ ,!T[1L]/;_2TVK]K._[X29J5@KN:>(RGQQ
M%B-7]=K:F;16*^>T@9NI^IR0QH07IZP@B"<I8*0K%;,>X*-K.3K1<"NVSH9Q
MGO0)=:Y+RC&_M<[&4/1B5'%OHV%XHA\4RS5^O+G!665?&&79&W 9$%3:_21?
M+[NX:QOE=97]V(7H4YKE[G,L\.SUCV$UM5V_HS"OJKIC7>ETPXPHR=(>HUR,
MJ<W^]\'!Y,F3QZ"!>O!P\O#A0228XL,+CL4D6X7E<C5U$Q%72)"!,Q%HCN&%
M)'W+<MHY,2QQ.BA>R;6F<^UH@?-(^>9(,569:-RZC;Q877I+1GP-3R^057:M
MP'%H9!@HWA93"$D&&S!#EJ8LF"V+^JG.3&%7\#](\C,D@?^\0""U*M;,%Z&<
M6DDRFT/_:]+?TYJ[%9JF)G2BYZ>SI$W4^5&B-@"46F42D4<E>AYFL-IV(3 I
MGX<U6,1(0?.B%0<,JZ8$Y8Y^W_,F-<4YR5]?T+UFA<]$\:=JSF$B-60<2OAL
MVG>G_7G]ZQ$G@7OL*???L> TV%DB@8WDD<(T& XJBEQ;8Q.KS/$4DOU<*U'T
M!X@O\R"/:BP?'4K2:DH*WP-A;])-H)GFYT#J@'\CX"9*8]V(0B["^+:P?FTY
M"!(4F6'.!OKU.#)$44<Z*3 -L/H.0C?9XBCBJ3H]V*G,HOE .2':=.]Q)H*+
MMPRZY)VWKOLHO*VA4)IWV>K"?AB<\0O+LEVG=_M>K\@%Z=])/FN^^5).1-J_
MU[WE)'OT +IS1_O9__S7P9.OGV8'#Q_<S_>^SB=7)]%X'7/@X_A4(FVA>$#1
M:5*K3G3(X5@*.Z+C D'!)*4&7\_] >+I!6NBY5P[>Q\,:[>&,8L(DNU9M[\D
M3N'KW< IW,:Z[QOK'M^0KG?<L@^I]2/NFOJ!F]D>9=0W6O8R)H#1K4LA)K=]
MG".@HI\S[5C)68;"<7L+/#QG/\3Z5_)6J4SANK9C!]73&Y\]MPOJ/1?4Z_F\
M0'VR*99=)4 /3IZ^V,H;ZVBO-A^R2$H"_[T57%!9S1<@M&%'S%^9T)MPBAL#
M7;J'&9#'LSN7N[X0RR[<YGL_U@(Z;#1,[JF7Y96N 0E)96VD+*D#^0]XT=L9
MBV\G\F--I, RA ;URF#N=A(^UB2\RM_B;,>Q/G+$_^&%L,1%0#)Q*!X563LU
MD[%]@]XNC<^Z-+B#<J%8-"F(29X+7PK_;@KQ%"TSXH"A<T*EEXQS$!@NUR%.
MQ5LTZ#I*8FJ]&7E7D=0YDUI:7C]<WE82<JVB*=+<9#710KQ=41]I1;WP.33*
M>4IA!:2$::4FJR^O E7L6MW@Q)&_QIP&LB6Q,B#E$JZTS6Y>R[&,9QA,@BY.
MLED1KHH<M?3IXUH+%&PL0]GK4\VKGAH$14U("TL74UI:6-?$>)UJ0\1,?S\4
M,VPB6E8$!BB/4H_IT?>J8"\&:O1C,FQ_@H3ABS#@Y5F5'=5-TZW6!OO>18S>
M;T4?/KDEAWW5.V=W7QP=']Y33_U?%1)PVH7G^I:DQ4R2"Q!G%&IA9,>CRH !
MI8T'1NBCJ;Y-=[9M4S9A59[GBSDOPB4.Q%C=CK(>P/3B'5QFO9XCKO14\I$P
MM#ZEVH;T)G.A&*!=@;/O9X=C)<+C0RJ%=-9-AD;!,T6F^6/VP@@Q#+8\+K0X
MS+F"*S:M*T^,8%3Z:@QV[VAG816D*49+_IW7YP3:Y31OV/6C$0U'O%HI^]A$
M7^X\IUI)+?TTVN4Q48VW3]-LPJA,ZS?Y,YB8XZ:\R*>,23HIIET30N8=LRQ4
M=! ]PI=5VS4@^3@.#H6)YY!\^11&0']UR&2U!]]^^\3TT1/*WY4;EU;&I0=>
M;QD<X\AUY5RRAZ&,$"__-\7TO&(!.=K_S\.2"G[Q%)<_4F8S^1[LW \OWSP_
M^H'^?6^2W4VZ0HP=!W2\V0\OCP\/[TT4OB*($JW_&;MS4Z^+R)]@;<_"E1^,
MFZCKE?&IN1Z+ZU\['M1)P*7@A?V><VI43Z1O42_$HFZET>'XAY?B[XEZ,)E*
MITROEEK[;-,3GG7GT91JLR:M&66%]TT;X"91NA$O3+/!9'+Y/#QKWLQTT-;"
MPA)?DB*(;MH;F$AF[T?#M]1I-VY!$]?4X7;TSMJKXT=.&W8P7S8QHD(BGB(U
M?-.2-\I-*-3+*3H^>;NXBV^VU#!@Z7)WK):7#96<AWPINA/T; %:@YNN\C:>
M840T.24$!2\O[6R6U5OP)![U5NN(SYI@? 9 _>"[\RIW2 +W#OG(\\07(@ZN
MQO6?!O,3_!V$MWU!AY'+7%BFC8=;>!5&/@E,@J@X$PBH8O<B]DVY0>#I$H?)
M:2>TTW"FZC>XUV<_^VXXV)&TR=!#2??.$!9QL\6"N(9JP'0JM#)REW#M>+1&
MWAL3D+Z=$ZR![V:*=Z@V16,0'_2TV-3:9T@A6<NW2R^[:YMTN.X[@RQE5,R=
MGC.JIJLP&>&C9.AI0.%\%3.7BV^M=:RK6&J35;@*:FK3(CM'?T7XHL-X0F\=
MW3BRL/C6C SJ+4LD%5MQC/>SGSV2$T_/77*2P9*PY ?1'&/-JNTO5E87]>*"
M)0(T-GY\_SYM0< BF?=!@M1PI=_#^FQGI30"RLT@TTP*= MHV0 T"M",-B/$
MDW/D$?A$#%M^6>A&M><5(KN1S5HW8PN_" ]ZNJ!D:ZR^BDI31G#8<$B=&A4)
M:F[1PR&4'IKN@ NCI!_U*/XJ##:^B2XVWJ6=BJE%!^1V,[YN5)?E0JQ13O*-
MN:Z"."GQ.T31)OJ-6&3^R745L@ L&_U"PJ*MKR\+SU^'NS_]Z^_8[CY.8*D>
MOLQ>7+(4U8F#X$WPTAH6T1!7.+JO]!L.*>F4*[$(74O;W.V<_W[,^J843L=X
M%]K6(H"Z_Y@00_>?+@ED2,S2X9.;(F\<$)F\NM@'VTMKZ9DAZ$* XP9T-4YQ
M]8$\$3N-%>Z%Y1>.G1:=RLHER%!X$F5-!C%&]LX%IA\Q=/3E6^B0APY]LQO0
MH<\T/&QQ5#&Z+1:+"3<$S1FF .AF+U;A15XOET1+P-F0$%"$$9Q$KO.SG 7Q
MEI0T@+VF=(O)W&H/=![655,5&U/I9+<7  [I+9<(LRT*9,>*$G:TK'[OF( $
M-D30YV6%.(8TA>AU+@:-^3<,!^2D0C.!*%/+5RATPY/;>;QK)GD<]BN1O)C@
MB0^.8QH3SLVR*-;;1K 7K3JV+4Z:AH$[JQLQB+96DC#X*-XMWVCG!^L*+#'O
M<1ERY&7K@&FCBE-(V#*SC7;X>T+'-\RLO%&*-=*4%3Z.(CE]/2+_I,9*UW16
M]G-'JD^LO(<28?*]R"*6OG%+Z0Q$WLG'*;W+VT)"[R+2ZUO^D]O#8R,,U"Y<
MF)!<L3=E?9KZZV</<C$RY&YU,.$"Z.\8%AL?E/^DB2_E1=K++T(TBE5 WM=-
MQ0^>?!';Y> Q.*#6>7\(F'Y$7<*S1?#A%EIUPLJ:S?S4.*)@ZL=@?W417,-%
M%L[\MY;T!F$$)[<)<N;6;)CZYQT5!3@+_KW82CS;<7RV7\R$97>_?W;\R[W@
M0$[SI>:I:>&%/[T*3_C@,?47'7S#^3CZK+).2]K <:7C9<V-MV8-?J P(?^J
M<,/G_[J7$)$@>S=KTY#]^;_8K^X/J*MPQ+7K5CN^!#'@@<O^_%_N);BVV0YZ
M4_HW#<:>5$SBCDBB;T?B(<6*^%H^+""^3&FG99<T1UR!CTBJP1H-Z?$F_LJ#
MNNPJ;\7=[3^MIR>&N/-*+;?VNX6A>?0W5"WJ9C%#^Q(5O4$3%+[P/__US<,G
MCYX^N)^)FRNJ;EB-(@WEJ*R]!1,9.*L:GVYD#6+-V,>JL-L&="Q<Y %71M%+
MAMLEP'PH4F]A#]BJ2D7<OD(CBS;"DFN64#E1D\E 0$:\%SMF,*JQF889@:(V
M3!0!>4E->,%>Q@:\(^KAH8'ZD9HCII9]ZNT![=&CIR\KA_\[F09?8MEF+U^"
M%D<:F*J+X!S-C!;Z^?Z_]O>HBR'3"LK)>4D-0YQ4LH8>=<_@)(4-E;Z@+ Q<
MYXT]>K="ZY$]+REY,(9FCRDAN.99S2A</9)T)H$;CQ;<Y'[WY.BHO;?M45K9
MV^./XDNJW.N@BVG<2.J2J[TQ@%EJ18JE3/A+_?$&7W7J7B"VO//,OIZN:P@V
MVN1BJ'K-@3*39UV8GVIJY.W\*)2:"+%[(EVX_8FB-QV?1 [**OLYW':9/H[-
M4=^Z?U?3Y-Q]_NSXNV!IUWG[EE8QJ/]0C;1<09^4GDT/CF0RX)/H;=1<I2*Q
M=?+9Y6TG^"UA\)94C8J*B\L0D'?2EP[0$^>.>;+U-5D),DY7_XF>/S\<.P-Z
M874R$G&U8G*XNJ&O0ZF:)@1MJ7W)C16-'IRL$RU@JY3'29F/+=JRF<4*OY@9
M99'-2.H>"3^*F<(L(#7?B>[E:D%B;&?AS*ED%*-7I96:&2GRU2OQD\E7(-(M
M?AB,5O'.KR,>NW"$4Q-G.(V1/T]]A60&E-9Q?"&HJK"J"0\EC%(WD!>/%ZD>
MK4AP+\25Q7*U\I^W6/X9(Z^MKB06M/F3.JM_@$<)T^8=R1>@$\QIC<G)%HZ@
ML+"J,L^.U.%W-@>%XR, 9 :NI F[<JLZ!P3<$0J'7_)V[@Z'$NV; UO+22N7
MD!.+8"@E0R[Y'*12E&C98'&VKO*F1GE6>WP+V59W8UBC<XR77M-GP#E-JVZ)
M5L;)#&FEF?B< 22!I+D,U-_;U':XQS\+>W$=P]8D4M,GD.JK^=@@25=2[Q"4
M-61;%9B6?LG=B8TA$OS;&QP=T$:>;$S]POA>.,,QF"VA8A!]2'ZDM521,3)3
MEQW2%^?RF&$&1F)^FFNI+P3?F36!D_*-_ZR%JRXP/BEI8A%VA@,9>2C3-5I'
MMD<?S_]<7.2SG.EE<S!RPFH5[\)JFA6*7^!Q& M8O(>L))E-8<WH\"<5-Q9"
MC581D6\<6SD3GM3-65C _U9+/B#1Q7SY=I/^LL$6:#31PBBSD7"-%HL'&9!U
M&3H@;L]<U"#%EZBDMY/50_V%'X;-Q/$OA_=D989_&MR"0L$5^]ST@"2^,52'
M#K=_./%':[ */!N\JON3X)PI%YK8FZ:^XU6VP:^*Q,**,93A=H*3B$.B4X0G
M8TXHK(D5!3)"_J?+OFO["2"V%R^E5GA)4E53Q')A8Y&WXL9Z$ TRO25L&C8Q
MWGJAFD,&?Y%[.Q4C'/)"]4#GQ'@BR'86NWG4;T],([3V\C!.D;9''@2]SASU
M-1P;Q$7 ;R:]<9'@5$U=+/*XP%BY6WHV/ Q??!4A-[SF!50*:5'D,VD;$<^W
M*2']-]S;%M'S8.+Q=43'#^ H"2CAKF82'(91DI@JHEY)D99@.,L/8_O\LA+(
MD@_AJCTW7SHSQ@ +I-Y]:K*'W65C*U=*V)'(7.YGS\'P@@_)ND<1-;@&?#.-
M?BQ<U(0 )QX%O,*7IX-1/8@M&=JQDVJ2%?MG^UN2P=YCS1D:F'Z7\Q'!:5\6
MHH'4MI=U,R,L[E1XI"V'!-R!/"URN%<4KR=61C'.3ZVF6#,T]FHI-@!$R28F
M08FP>1.>"J%!;L\RJXNDM1F?)'*5VDAZ?<0 9H,U^G/*]0AZJ4\]&FQ !]FJ
MS=;'Y_Z:D3?>.2FRHS0ASU)R"A3<XA556$;-+,9P\T&7 J<:=2$Z,,0PZAP(
M=!/:W- IJ(LE'UG[)T1-:*!#]L:UMKXA 007J3/.Q6*-Z+G[+1J1EAZMD[R3
MY1RT2*U9BS1!B+>X+7S[PO>WMX7O*X8G1-O=LHBI$LZYC&!PRI20+^S<B:EH
M;=V$$8/L5GO<3O@&&]"(&]8+",<_+VO76&6)=$>)1X_TK#.0&7FM!.[MNQKI
M$X;AIB3?H$A(F;,NO!9<M8LRC#,#96;#ETQ\Q"4[3=RL&?T?VZ!\#G%Z0M&,
M=%MBO5X:'UUZ Z0Q_@S=$#_$0GI3T*K:L9/K)14,F^"%/+A_$ )$>.X>'< O
MY:-<4**$8UXIRRS'OC['D8]?'!*O&)4"Y <[^GWMC9R2X"&]=<'VX,ZM+EQL
M B31BCYHN7A'Y&( [=MS7A1)-6Y$X29-TU:.Z!^;KZ"0D4_7IG * <MPTW*U
M +:%Q+M::4<M>!N@P4/?VH;$/9:F46)*+VSFQ:*@_3RQHV[)Q'[3@C<[_YUB
M;4D<08-OSC@X&?Z3;@5A!E2$R.F,#R6)#)?89@.B=H4>=;P3:CRIFY7SWOFO
M/90.;4T7!=1O2AY.>(-9PHGEX.UMY/?AI  [&$>O7KTDV<Z"'46ZIC4M:--.
M\4Y,X7[V&GU>$,.02!WV":#.*3'U+6C"V3>B()GPXA8.*%*F:&C(PZ%I"H5)
M=P4'UWNK?"/AB&*D!@^F\L#;%J3-BG7&4<)'V9PY_IZB/.Y:D@1M@5_XQ ;.
M@*[10&3NGRP^$OGL[Y>\1]$FXF:OG(%PS>9M(;YGFNBAB[-J:KIO_:Y(=F-_
M<"SDD,==6$WY#YVTOD+S/%[HM, 2ZBI!$EDF<\Y](>R^QI;SH]>_OGRV=_!M
MAH0C]6W57B\8DTG Y<H2>]3#+E^V18T!J[P^+HP@/T*SQUQTP&GG'Z@J\AE/
M'E+>=7Z,.V$\R(!!AK2R8IVH%6A853AD&*NHD7%6CX.#5YC00C+^EC)B)<J(
M2_#)PSRK$/$#;Q&<Y0FK%5G/J,2^NH=Z51=J[D6Z\JK5/3B*IDJ7W#K27&0,
MC?&",5?##5BSVIR3$(VT:9X76RTT@Q/XU=G$Q.]X PSVE8YI +#0P_4U]:)*
MT:L%A*WDE-MNG<'#$5N L<A#"&6V[8Q)V(Q*-[)JH:A1+$IN"Q9;Y[\[S5=6
M]@52%46@L.6ZL +R=S2(8=5D=P^/WQS=DR(6E8J0$+:VJHP)"/*U<(( BHJ[
M+#Q1&-:'#14OI8]CB=Q5#5VE.UT.V>'W>3H8>R '"3T$Y><KSF /.KCWL^.K
M5.G#QY%<']BSB15#8,&Z2O)-ZXWH'H:5W*"6'>MN[,?-_&[0^Y"SP)D--J-)
MWZPM791+X1 D4#1=^D.WU;(+VO".-X\QC-G9==*.*Y^6%A1Z6K24C>*?$F%P
M2:W0#N.MEQZG?X)XARZL/MD\ZXDX]A0=C7Y/7/E=.Z"0'M5T&-?30Y3T;?9<
MXXWL->C^N/\P?/#HU0E2H5SI42H:&2Z$+_FBTRYG+I+Q,,+00]):U:3(CH"%
M06V;0@$[)H XIR/)%*]IU-^6,ZKF B9"AF"MWP4OQ2)\?89BCGYIGQYW8L:;
MO&V'(N+]@#:7YV^.PF%'0"'@&OU;T?5.BM6::XP'W_@Z/WT-]15"U<AYAUX>
M?T<.@_)@/J26";C:NY(.UV".'M[_&W?OJ;(W&M_#^TZ;VMK4",>S\<5&AAL<
M[)I#E "D:"DQXPV+ ,B,6$;5'(,Y61C*=E4@]9%5P&WOZ0*,G4>LIWA64W0X
M)];R%2V^L8;YL'5GG90@039O^AP7_,O_#:>B9-:FRJ6:'GIDT(.5H7-K>LYM
M[?*0L^ *Y^(-/S_YY1E6)"!@\H1K5I-(7P-6II3>Q54C+7V-=('2,U6%< DE
M^Z.HB*J='F.P4Y+J?>]V$C&UM$"[!?QM@LU-#1N'[7BX:LH%5AWM*"QOZ9"@
M<2 .45P'1ZJ)PO,3]Z8TS&.XDJN;/Z 'PQ55G)VAW#-I$R<&?4I,&#$.>A?)
MLUM)0.)9SYR,I\EUQ-6CA^MED:1=(@ZR+6P:C ;B(E%^[&*^/FRI+OBX&QW9
M_GWB/<@46(HH#&6X#A)#6$":C1U=GQA&N!,0*E95VUAY.#QZ[0_J,FRG"_:Z
M>\=8XH FQUC/&W5)#&T$C9@!@5T]/\I>P4#>34@I!.R0^C^T](,5S9=HO3VB
MV[]VJ)'VGJB$P/]\5BPI":RQ?GPQ?IO][+?"SW?$A]@384S9VL<,@H10[J[T
MQ<.F_'=83Y/L1;" Y2P7XJW9[_F4*1LYXB><23"!/U)HSHF*XZ*JVLTB>..E
MPJ;"_9^?T%SP4\"579#&@ A$R"WHG\]"T.9 *XSDAI?(S_,A3\%I"=O$0%?@
MOIK]#.<%C1T%=]/SNN8.L][.<0@!63S2KL8,@N'#5?B!QY(]35NGS"D+7C6D
M[_:SY\"05O1@N:<9:%#2CJ0&CG&6]51Y&YHWZ])D,5)-8@^%MK:4EA$6F(HV
M!LTG7P1K$$L/TX-JMOY-O+A)A.1/-46EUI_++.W:-A/C10NEXC1'P$N"\#/\
MO=WZ%']O'=VW/,7?28-F,8UD#;M\R.<1:T.Y7(";:YJA:N!E3RPX.2VQ(L)#
M)%EYEX":=P0WRE=BDH*]<3:#V81HH"F/7U(MBDYXS,A1"/<:R8)$MX[1GVRZ
MOGO^YLWS7[)_\@F*J3J<KFF+E^U(ZD.DF<.2.1<>=24BT!MK+1P.AH B]3$F
M@C@^[<H%-!?X9)C6-:$Y\;98;+;X7>[$[)T ?7 AP\T!/^X'12,5HUK3PY2[
MDM;%61/OYU(LT+H.7]I3IL+;&K5;[ _NW]:HKQB>Q#V-WJ@9;AQ(\/B$*W>6
M>&6D5^G@:=BUV"I ,DO#H5^WP218==:J<UR@(=M<P='C!)2F"=$ZPH%HW%TE
ML]@/ ;#.S)M903P C"D:* S'>&5V"4=6=.BQ.\DN42*TVFC'NCT;D$WXI7^8
M4M&MDVO?\[*(H:HDY,/E*#=*MG0C%<9"Z5 -$@7[$6XY34;*-4OD$ 5,"=88
M@E6LN?($L(_=:S!G:ICDSHJL;,,AR#XZ50-R@93YMR=0)N;*FI'8]6Q9L-"A
MPE+0,'V*LNA+Y"F*9JG])I9\]Y,04VGI6;0$+#8<]D7>]!+D3.JHG8D,<89Q
M9M(><%(JOPPE LOE:1=<.A,NTQIC?[[Y-LY%FQ$MYD)'SOHO)%>*.R\(@!RV
MA51DXFV3A'U9R4/'62NJBS+$LLQ7W1;L#0%SRP4A^LY+(K$].,Q^H5^_D#I1
MK(^&Y\!._<@LR^^9W[O#[4-I<8K?O$CVQ+5Q4-*O1>-WUM27U,+'>V:C6=;(
M7II0##+]7DD)[4L1B .#1</U?Q&#$S<9S&R@9*65I)69A2\8YH))_X-ZD^[L
MFN.IJ16N?''_8]2:'!8PD387W\[]&#WXW#E)9/$F6WN'PO_"#K;1;;+:2A);
M2P<A.:>TZC@,ZU4]\G@1JEQDP<T[I/1D?F8F,^SJZ)'*$TI[&\QGY>I>F@R1
M_B$-]K$FYH5PY84[H+2R;_\*)KU3-F 8]=1.48N+2"]6Q5F]%ELFLHL0-XR$
MPH+81U^0O=N+%R=L[> $I!@8ET2.]E>+F7,^H*4H3RX!OY OFDW$2T:AA$QU
MFX!#?#&'0Q3JAUV".+<1?SY$*'0NZC1BSES>;[$ HPO'V<*@$0=/O.Q2 A$;
M<MIC=*MPND[?0O9:CAFMT_"A6D]#I" S[)]5XEQ>]D7%<V>BE$82TXNUW";H
M4X@.E_@8!7*X6'TAJ9T:>&@4ZLNEL9B"2I"2FFC 5JPK6[2J6#,&:A:<"NIU
M  E4MY;!=+EO>/(\>'%!OH$[$AZ <[F<&XAWZG$XQRE0OAU0)2Y+0X$W^D!M
M%KD]*,FFCQ&=TW!2V.4$#,4+G_T.@ Q;UT5@G<-\0R[8KYN2RYQEO/.$O[\5
M\!'+\^FRP]9J4>MW3U9)M9\N%P<"-DZ0\!27,A4;5/_V=$IL2""HZC9('/X7
M2#R3G]&:<X@.3>=+:-Z=;)GB649<AO;F/D,[^;*<ANS.ZP1#T?K&@%P!N.&E
M89\B*('<QIL6515018W-'0?A^0PFS-KB_.<E@[5)H;+#3WUB O#)T$4!3SF3
M?M93]&Q1_5]\=N3SIF4S[99"2'K5%2+-^=,[']NOO')!Y%$%Y4M9H?$490@T
MIEP#4#VDL0"9^S>"*UA<4*9$CA!Q23@>8<GA_A?H/^0%S JJ6O8P<9,$7<:=
MSO9UMEMI^Y2:2DF7T6<0S)U5G%L>\=J-V;HG=":/IZ]I,0V"O6O=^I& ;"(0
M%9QV D-,\"J\F,VNZGD/E_UJ4H$_? />V;F,<>I^L_NNU20GAN'\=T#MP2"!
ML8EX4<<\N@BVAG&X:%5C7X/=8B[#:H[F-<E0&"/.SXKX/](D;,W'X]4,]G=?
M_WQT3\!X=)9?%WZT7N>CYY5M<\+<6>&A1^-O[<!HX='^WMKSO\F.@C\9FQ./
M)?_2;[OB31\&:D^IZV>ZL9"7"^]37.2F6?T5G'I,C&NS;RQ\W23/Z3POP4JH
M1Q?637^ZMEW0B6%I%FG) Q(61G YB/7G\/AE>T_M%_"4+E'5>"9ZR9JP<MM_
ME)D<79V]W*3KV6Y1 ./V8,UM5M>F-[.\!][I/^(-HJC"]D%8(GZQ[IP)28I.
M HF%GY'L?J'65& E)Z3#P%(3N'?0M/DI 1WJK$?UB'*J)+9;;N!7O!(*QJ6_
MCXT8<0KI[KMDE!1-))\0O8R#%(VYO8#CT;/ZBB\\TD8/)B:I(^Z>B1B<(QEB
MRN3-AZCCGEI# A.M>UT*HP?9GP$H^%I<>!N''=LSKY5?)ZG2Z#$5EJACHG.M
MJJG7EC82GN?_#B:<?K[,6R$Q)?[V^'O-:O+?9V78+ZT$20FYR QLYW2VA(4Z
M1Y;&740*\6M0Z=&%5EJ,X4X\?:%(B?=Z.NU6>K2?Y/-":OJJ+^/@ZLRN.# &
MVI205#K(VV.2F!HC4[O;I'(-X62N9Z[8KP89D&1D%?%FXAZJ(]M8Q[(3J^D)
MIM!1.*ZS0O 3ARD*1^+(^=-/OZ0D',E;P_Y18=FK6''^C!T89:$U1$;QCNOE
M'S  .8MLX RF]"4;M=RT3'!IYF=#NZED19.3(#Y][L5!W 362E8;!HHF;AT&
MXKNPJJ=3>;_6<4+K'%!Y)%QJ99P9TG[&RVI67#!WA[Y698\8UA<* 1,RP.L]
M>P4YJ]69G]>43-[K5I/^/N%NV__M?!/M3/'?F>1TN+/5VG#WL^?),'AA@5F?
M04WW,[M!>V^+8M6GP]ANN_^2"("#W4  ?"FG3@H/RN;AJL(_Y?E0@_FW9!LL
MP-1B%D1J ,!:UX2::VV>41#,4H"SKN-G_OX&\<_@JX"[U)?P=X?$6E,$28^R
MTJ.U_?=RZ7XG/AES^PE<40C,UHXF&.A"U_>?YE*Q/B6SQ;B+J[.K[\,8>:.B
M; ]HX-A@'X$/^UN&-YP(5NNYG<<O$[I-9OO=4V9;U^+_FS@TOY%NQ]V3YR__
M=2^BWG)/9X6A!U$SD8?7'DJ3W3W&5_@5'CR4 +QEOARF34'A4^*?;8Z,Z^70
MQ@B_49//NO2*%=;I&>=S^BAW1D_D*IA787IROUM3 PK;C%7,U/?8TI <C42Y
M<(FLNQ&L;:)F@NI/<$H]-7.*V9=7VL]^$_PO\0@.QI) C$WQ>Z&L2D)K%X9-
MP,/ G'90/VR]BC(0*,2CN<)@EVN#_U)N9'BG-H&B\HQ[1[A.D5 ]<K,F)1,,
M?YUW:_)MH \S<9VEJ:81GMUHS88O +_F(VZ[FX$A=BT?\ERQ0#:39.\X*:D%
M*6_8.$4)ND9CC'9=M.DP)KDK<?1[U$J3035+)@.I+E2VJ!B,%JA\]CO1MP"S
MO7')!H:],Q]Q@E;ZU)*V ]A5V4Z[5JF9KZR(1E"6-MWD5<(5&/%99!I<;U.L
MH+K;;:F?#I@2XC<&E=5=+:PJP=T-:JNW5=4/KJK>P07&ELAI/GU[AIK#GJR6
M.?[OZ6=$\GU92_DHKI@ASYV+.OPA6B<)Q$^]JNZ,A#;E[/_<*;_Y^IMO'MV?
M%\63QP\>?3TK\FG^X.O9@]GL2?[-@T=/YO__HX=W/C_F_.LM3(4JFN0X3B54
MW+%3W)O&(=^HJ4MGB;;K*R %30B"2^@0]7!-@W#FIU>,E"]+"30XN,$*_9.,
M$4/'<=8YM2Q5#YRH -J0F6I4]%(2?E;4QZ%5NM*@JCI14PVYO<S*S"E?2G7*
MHZZ+?+GL PL35KBU(">M[HG$F>-8+UD(ESJU@UT-UV(86OCWDBHJJZYAE1[)
M0>NEI'[[CYLNLQ4Y%=79WJ*8AR7PN+?P]@Z^^6PKCUI5'SQY^OD0-NG8'#SB
M;,HAVG2UZB;JI: :80^,&;O".M./4)M9W$%/;R?F(TW,F\9)>E+4FQLHWK8C
M&X(0CR_81PZ[9EZTW,^M195E356C2ZK)2C<,,\CUO.;4%PN6+)Q_HK\:35GL
MPJD*\(Q)$S]LE[4$D^%PQNMZC_)V$7VL1?2,@SS;WKZ]PI]0 QK16 $QGA'C
M(!6E'Q+C[BO*O->T<YV'(MCQV]\NBX]F](FS7Q?%LJ[*8 (TTG7\5G+Z1U+$
MKE+$O867NA+F(KG)&2@Y1OCZ2@4K(7U"B%]6$DRA!%%7"8E^,$/"+QY&H2J:
MIYG#B-XNBC]X43PG(C%>!=S=2(?'BJ!WT.=HU\5*>$M;)E2%',/6Z6,?=886
M3*8K(#*\(G_+QY!GU$J^N&L,/ IJ(^=_5GA_&N.HV@+)N3W)EFB3MRW&.F[A
MAV>Q-6WKN0ZKK$S]T"5#<[^2-G.I6UK8]>$H3JVKS9(*T6Z2SNLU<,9HKDF\
MBM@@44MF_V:[5EN5M+L*H@7Q*3?,N7IT7A9S]%+(UQ@QVCC2)V5JZH=1TENV
M[0+\K&VDPA#9*_Z"8^'2&XI#<W2>EXUA^-)E_/\*8P68[-?KHM@^;=E=_MUU
M5[A'BHXA=$(0A8H#:&^33-T\/.<>=.=C /X2^$6ZU.%94W!,>O?HY>$]/G]?
MO_R>QX?@)/8V+P\IL ,VP=>W'FA]2U8*GH!5-OB34(6]+U)>HG]=T#W"HIJA
M*H/>V[6HVE$@*+,3[GBWO.<@$6)2(KQ<6^@6459.^V73^6Z?ADN%:ZFBCWU3
M=9GB5_8B$Z#S,F:=G6V]4<&5_6,JM-\=B>RTJ(8)K>;*D[+H1R>#Y_/E,(\.
MGB@>EII8N:%,>_G9WT\U(<->GC)<59&-E+D"W6(?>\D=4UA_QHMTW3J<2$S'
MWKSICJ8LHB[_X:X7=X/NH?A":/=.QLF?#+.+LJV;Y(%QM(?IN+@'/Y/TMV8#
MN2+?T)"4)R&M*YU"M(I^#[.XSHCDBT*8O&DHC2C*%[=0&P^U>7 +M7E?_F$I
MPCK]O'#%J15TA80Z_!2L2H%#TF0RET2^#J!%0JJ65!6T78C,+!5.C#/#,].;
M.I\"!QTIQ=NJO@QV9+%1VT4<D+,%UVN&\+0K0[9ZC*74P)#;:IB^Y!S%?9#'
M>!<^@RH:4HR.IHI+<9KE3VG;' ?Q)R\2Q4*.E!ZL,O3AF?XG7W"F7UJ[ZFK'
MW/ W*FE@6!!E$D3.GA+;35F@6Y_V9@V5;1Q5%U+-7>3!>0Z.CJ KB.I&&]V%
M^M\UOA$%LC8H)*=X0EK<%*3)G3,CEWG46/KZ)X+P0+=,J7+.ZY9(N,3/KXK5
M>4/]4$2/G! 8YU-5.$,[L>5Y*#][52LX2A["^";LH,%/80JA)CIB/>(-H(#K
M ;P];K$>^R/P,-1L4[5%'#?=]\&<28<?@=>[)68Z-B2EI-.&=%%&$7/M8;\Z
MSE$#4T0U&!H6@4FMZ38T;'-FTE.YS,@Y<%[WR/OP9O\N[-*,'6X\LPCXZ^ B
M.]"SN9!]CA$'F#_RPU#;$,.7=0EV=FSII[."3-_JO&0@$4?16-D\KDCI,46:
MOC[8DFAP=<RM:],;Y6CX*)CG]4=Y?B<1:J996K$8!*%- *06A%H0D,\Z,;B/
M&^?>XJ7.'2*=[+.P9.GXPLYSI^T*A S<Z%]?.N@:)Z*HC=#PIOO9JW"ZTFZ6
M;1+7HS9^.7%LO5#$L:+/1[':Z:>%+7+"&MG3/V!!T_2/K%2_OR/DCAW08+3.
MRU4;1SV:M*0CEQH<F+\<3\;NR A:$R'*M.EB(C"2ZL0EWKXM%R"P540?(_>K
M8N&?=41:P;JC-7,<>XD''/1*/%PW2D0_L%Y*E9=KU*OL^&HM][/#.)[MY#TL
MXL3UFGE3OF4"^EHE/;*0+:1%J6"$.81]JJ%BYKJR:5]'-J5>IV3L,'*OG:'1
MQE3SD((#IR]?AGNU_:5DE*X?(@O<O9G U]+!X1Z;N)FMS=RM5C]XUI:Z#H%=
MY*04U1+/H!46Q\YA!M_485>?&[UK>!L8BG;MWFJ2O0B;M:C*3JF.%MGW3=VM
MLKLO7AW=@]%1[5"8C83L_.N'?^-5M_W ]W);K\#'PP>__IV663"NG*OKPER'
MV\9 ABT;CL"F)DJ@$5."-BU<@66^J4RTX.M%;R;\B?K6Y"H);?!^]H-\3.1I
MM,FM?TLV^^O-BD:)-DTC,=6LI'0>T;10-F#*:%B0(]E:W.,G_$-:$3[CDJ+)
M$6J:JB,2&"[4,7\K<KF>^YZJ,PL+OJS!RM$28YM=6J$YUGJN6E*7=;.8$5!=
M")6"#S7>87]&&YD>F7G@26J%2-U;]KH[:"3EHDZ TI*'@=O[L;;G924]B93%
M2?D'Z0[DY:.1H:XL/ZN[38:!\^U^ >-JO<%) P)MBT!4 "_8T:P?3+)NI5R!
ME&&UI!G*FF">M1.+C0 VEZ.K?LB]Q(PZQ_ JZR63/)YR&H&US]?,?,URX",7
M]C([4<TW3$S'K.'1[=&WG8C7SS>3Q0+'@:XG+8BX;Y3LT6?_G_\Z>'+_Z4/?
M#.WNI0_B+F<CRW$5LK*6D:6CS+W1@K@8*7G((^SUE>;C$-VX=-..!TDLZTF6
MDD'9BB[4;'!&5(YP^;+YYSMJ-/J]/GXT52N"1^MT \,;/!>'S1X:?&W0M-B,
MD[$,^%J#F4*RNTDG=/!-]](@8C)&;N_X]M?*!X)$FQ M)VH*:%V+D"1?OW89
MHU- N)MNY97[^EH#J>(6%BL1LE&$&+R;^=HJ4NIK1ZBY[[3CA5A<#W+OW[+'
M)XIZ^7_(%#K)4&V^_[&KS>\)[+TE#+U)]O%SLG'M8]T<C&!P;ICD_/:+37*^
M5,6T';/BO_&."49T5A,<&$Y!6';S/6C :8\,E04C*8_A!OA88P)1DUS>&%8W
M+."_\Q:L6F%L %Q'#_W+\^#3;\2)#B8/]B^J]IEP]#Y[!?*L\%3?XX&5[<!V
M7J0"$/X4Y0&+>1 +39T2'O%"(\YF,K$)%S+BXTH\$W:C#,%@8";IX+G?FS&0
M(BL_(\,)['?N\Z.C&\+P#0% 5-LZOJ<1H)GG)N=M)<S:,_*19AY*3:?VTFJT
MDXR#**F"D M--@:44CX,EUQC>!<I]LPAW@B'FS\=3C#_(QN^";&M%DBS>?;M
M6$7RBT)41K/C:&>%3 $!!UO*T12U9U/P^'7)!"[SA;$RN'G73,LPQ[CUFC;>
MD6#6IXJ;\H)&6"]H(N>,8XG[R#",N-Z6AS"EB*(!C5%E)&GAKK-.2:A&GIY'
MZHJ8[)9"(JEK/]Q>U[[Y&?;XP9TOL1C^F8[-'[IP"9&(63A[\R?@<GA]0>GE
MXG+''(+#=?8L_S6\Y42]:6HUYL0;F8M7)8XOG$D/GA)A4*'--0CD)B8_A;-
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M(YT;;()CZWY;G-<+KH]/F[KEA17KTI73B5/6=X;MI&T0-/]%58(;4!_NPQR
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MF0%>EB>.*^_W<$]2\,D5[+R??5>$#5@9WWB?(8PR3PGE8HA?Q.A3^H^SMS1
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M&AYK26E<Q\.-(;6APG=TRE0RS6=8PE!.3^"U"TP1[9G-YPV3IB&"![0I4U]
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M/(+G+I%7.IW]=%F1\2'XRGCHK@MZN9\9W!H.\C@1/#'7M#@!WT%K,TT<E]Z
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MB 2>D[[SU++6M,WY$4I]=._DZFQ&<,[I)@3Z\7:G9?)$?0R>C+\)K&[FV7Q
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M^#=#C5@E:E+#7'7]B6>Z$!!Q^@A\ (,$+KDEZR:CHX3F,6QY(W#DO'\8S_
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MEHSFLEF5]%'QDD&USC<*@U0 "U2*IH8RU^VSZ7QV!.\#7J843]C $PBQP_3
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MHG_EZE\KX"GB21]3+KI'3T!-L*C\E0B\$4BH@G5:94Z?G9V?47>:.!X)4D6
M?$XO.7:?HN-I[GT2YZDS#TMRL;SCLS&5:$0>2]03))-AG8^R "5,G2&8<R?5
M%Y\1#4M_V27EX8CIHFR!%DV@NF5U6]^:IUM*L@\Z2X).=2TS\CRGL^^:MJ2[
MS67RZ5[;8MDVI6H8QIY=2VV  =I#Q]FYS?%GU@5G1"<DXQ)<AN7<C]=];KU,
M4$LW8C=T=) SY6AL]/NY62B'A<P;<[88_M+S;[X/C.D6I(TK0X5K#37>0]AP
M\57]A4.,KDIB').LC<)5M<]Z8O)T4VH7E'L5@:,+>35=+SZ"AH#Y$\!T8OJN
MLRK<Z&U4EX>._&*Y))Z/IP?4^:82CI1]'<*<,H4%1._R[8UWO"CNUOPL"N"+
M4D7 >77<K2YZ:*E.;JP4=6? VF0K,5V-/!>3.]VY =,%VM(HEQ@Z^IWHP@).
MU]0GU.U\32BF\,AQQ%Q?M/ 6A:_%?"BR>XR)2H>36VJSKQ]L7E5)/]>"<P#E
M)S'4&,D5VQS#H;+KK+MM\M/P=_KB7:G@F+1WF/ZB,*"VV0@.M6-,1\2'NGX/
M]@0-;02@I/53RH1*COD.I"VQV&&==YH#7J\U8Z0'JIW*JI2H9$LCFN8##B N
MI/TF":C_D.<C!(J %<EAG+E$ZFM(^X]Z%-.//YD\TRLSWB&ANTYGU<C"_.WW
M(( G<0-Y/FXJ:4#2,>2<UZL3,8]K_-_+CV4L+V;WG4EYSR3AD:KI2-7D(_R'
M\" ^X58^<WL37U(Y$/? K+L\2#>[7:T/Q#0:=1V,;)X ?FKLY#RU7 UG-]H)
MB+(%< ?"B \'/Y@9Q57XCXPX<U7F@'_OP^]Y+"/#VA^Q/&9"MH>#%EUK)KHW
MG'M"^1@;DK@X0U-T<3,B=;ALMDI^H,AJ[U;H$: 8"_.;$\V@:'G0TZ(?7A:[
MR#*-&$)+:6C19:89,2;A_HYGYB%2MYY.]A8"[R=F."A0F9AG1W:6-BS39X.]
M)Y)Q^23BRG#SOJE+SZ+W[,TKB"@2MQM%2JL9*.5_060;!N_%7_YCFA7PMS$"
M\E1I#XNH2H;;';$A'AORUR,VY,#PB.!8(KX(N3Y9K\I+II8SJW--[2<3$R4
M"=I%$1Z+#X[.2<T24K=5;RSKJNC(G($9J0;[W[4P#YOTZ>>?O?C;[.M?RN6
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MUPX[8S'2;[H4>^;@KL,<AT<XG9V-A&YF7_']SH46P\H5+UYP>>"KBC"C51@
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M="65#13*A()*F6E7C1(J8<L&I^9?A647V6ZCCS/_WMAG@Z^&5FM?+O7-!_1
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MM%B>D?%^; 9&7'@PQK_9"",+,+:L3^TT3N*=;R!:40U*\+&9_:-MAAU+<V.
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M-4H7/C:&JQE*O"@R(8A[9,&00AEU_M!=Y32+P$D&33)74623Y*;AA 7;()Q
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M2E!Q$P-;JW-HW^ZT S5TQ449Q1P\;^(=1!K2!=&V!Y%Z[68%EQK($5*3N8[
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MFA*%=;'E0+1NT,JU0KJE2^4E9#YA0AQF,5'Z%S?T;N[L[5::CDM^TO4!;MT
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M4+*/[$"YV#I7&?:B25CTX;JHGUT@9%UY]?00LH7D60=OS,2R(:RWF#X^$H#
M3_1D&IB?=E BUC!"<YZ75%H'MSRFS\@V"QS3L?:'-!M@$WGZ==L8#4%7'T*I
MU51W(J2;2'FL[ 4PQ?R3Z^+VFZR/J8/_RPPFP8L\6TCCQ!*D*!!#"PS( M0S
M *Y2*R4W@ FFZ$?KJ;)*/UX:S?>SULX-U,_.UVQFI@0HDYI#F;T4=N=Z_\QT
M&[B2L  2?%?)YK?8EC'9GAHE)>A3O4_')YD/.>@/U?;KV^SO$E_BK;P]\'N_
MP@V'DL:M-/OX*M.H&:6"A$6N$3Y%<N%?R PC))+.L09^6>@CK[&>E402%1%
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MB7S7^4,D2;Z-P?+"WS[#;YC&QF_\TZ?>K(6,I6B/U167[M9>@2.;)_1%S*U
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MWO &U]P;<J-1?=N_RWLI.?".&^@DR/62:21KP)@V%"M*2Q@U1& AJC8Q@HG
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MT?=B<1'EB%T"U\(&>Q$2RH.N <;AGP(*R*AM=$14GC(1K(%Y<\)WF1,PC\&
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M:4Y8TNT#PD^ 79;3&4@S>;5'"0C22T' FH7/8OU+DEZQ "D3_CF+\B^Y_$N
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MEXRDIMR6>5F9N,LB0QMWJHAB3>U(^:!9[GA#8N5+,@/EF,J@O:4<;L=I;8"
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MN""$]9,\J,@+^A!XW"^<*QC8OQ2UIWQG./G>R5=^)G"J>!JJ>P<T_B(*!PL
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M=&Z*$5*4K,(T1F?_ ?X%(JB4+4,9$"J0MDU\Q'B>$I99[ 4CP"(<4XC!H.#
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M,J1)5;BIKM!FQ.73P$M WWX!@W&61D!?D0$>NY/&L31!$Z&)MU^D]-+&6O
MF!L17V*0 O_EQ42MN_8,O_@U3#B0M]*_H/O(?R8C9>8%: ;!?N,$/L!'JGD?
M#3=./Y5N+_>Y@^6;S<:PU]'F:_EDF1'[ $9/P.=,.)Y2[Z"IM2:"\*6H?L0P
M8]/P'C\#4(+YLMC<1%@9XL+2W+.A#>-VR5VR+IT0M(6R(M]_^N?'#[?6I,AX
MNXQNL8ECK===IG#)5M\TO#>W@6\G8[QH=9=R_ J $;;K7KBIKW/;5R$7[ 78
M*9JZ(0FRQU]!3P+T#J'A@/A[A"R\IQUPR@,^\Y+" 7,C?Q:%2V':"Z/YENQL
M%-;2MH>E$XH.N:FC_'M'!G-#$KSP/B\$DD*KGP<Q?P3/;D: <;I:^1X@6U B
MOFH!7 E++C$TX'O)>I,\=\A1S_WK*V\\&H_[W1GGPX'='[F<.<P>N;;K#MG8
M[@]G_Y[T7STJCEY<^HQVVZYA!*H((][,!>O=BY.(R(?@ X!HF3!][#BD+#U$
M>$Z%X>R%;9::JLXXIPGE _M''<6U@B_\,)C?@A!8(AL!@A&>**6 WT343?)>
M*4  <G?&R2("9@/>B"E(ZW+D3K)*C(>%)^3SO>?F",*0#*P C"XL=&#OM*0(
M4?+BUYDW#_*1!$L'-J6PKU9C?ARJL*Z+N@@L_2C%'<%F?!"5O@%&>X+7.,:C
MM*-$C('*(%L41-$<H!518R=W\]GLF5 JJ**Q)@.2F:5V7!BQ4:[!G8!OO W@
M<U*UF7L&2"?2,XB()M!CE:IP>]/D&O0RSZ"!KMO3Q&%&GKF"_&[0+SI"&RK;
MC>#Q@ R[O9C>95 0EV(8/Z&+$[(LG,=V5S(M'OWUCK.H_>^.]<9@[X%;[O#\
M+!E9>($('.!=@&O\F8+4 M, J$$$ N(X!"<+M_7@P4DHRLL##R#!OW$GI7WY
MG+DR/D+>/QU=G*F\CUR^[I*JQUL=H^9;';<^X,!7ENACW"6CK'A15CC&X PW
MZY.^.9ATC[E9'_3,_F!2Z6:]SK(6/#BVCUKV\'>#T7&KZLV>8[-CTQI5(ZY'
M,N#;E.B^.Q,K.]2DRJ'$%<QICC5^3$;2J?Z/LV@CE<'H69T*4YT>S<EK*43N
M@@!-=W$#4:><HQ'$O'G&HVAY*XEJ.Q'T4(U*\W"*YM133KLW7ZQ^ZMG^W-JV
M@=2:/(>4N"ZHW2W#-$@:0HH'X=HZT'[F$6[J&(F]/ZW<NC1)>..BDQ)1.%_Z
MW_&;.C!K=H?T2:5.!:]^^,"GF2M_J1W1J\+B\CKQ5CUYKUNW/J9EK7@U*5\+
M*??[5T[*UT"M;2+(&ZM_\M%WNC%'#?ST+'/0ZMF$54]Z03TY:IFWJXBOV%J4
MG41<INP%<YE?ZO+EBBZ -F]%VM>=\?GE;8/:,U8]W'C2^K%KFN3:17*]]L_*
MU"37+I(;Z.&233<LK>'D$J9+GLBZ;&/P]!/E1(NT0BK%>I(?>VE2M86^NE67
M7YOGKFN2:Q?)V77=%4URFN2>&I&L,9NE>>1V\0')?K_." ,=D&R3R?AC5NDN
MJU$2]LW U.R]J3 7ZAW9O=K30R_&.=(.=%42.;)MIR:1IJYQH:3:O5Y*;?\X
MVR?K;E%9+YMB%1H283L[EB21-TU%O502;I><GNDP@EP_L']Z"3,^!L[+=)(9
MFM:HPG;V3TSJV=OU81<\,JFR:AR;=2\ +L9/T&YD51(YSV"M"R21IJQQH:3:
MO5Y*;770HV+!Z*\\41;3IC44A &:35'H^Z)]HVQLV.(D+#TB]P>[]CRZYF4G
M:(IK%<59=4?K:8IKU#5:@TBN<K) ^X7<I8?E!F;=T;67%99[;'#0[@X_USM*
MZ <],:AP[NN9&(3][1LS^J5Q$X/VC7[!-FS\.6+BA2BT'@RSNR2_'0T0BUO/
M^D:[V[-;RDVED8["-(D3%B#QP7>PRI3YV"MP5Q-JI(X0>PGZOB&V@VT/\8,Y
M+Q&D""8(<I0-06EMV:=03$FIO5*Q+3A0SN1UJ8?TP.Q:KU6/:-&U7C20[U5N
M($\M'E6K>R^ OY:2YP*YP'(5!O1+R85T*@1485P$_')IQ-A"5FY%CV$I4.IP
MW,8Q+ T45$<65[9(GM4[H6@+_]UXLM75=6/&DNRTKAZ'7\U2T8F9NK4B6W]G
M 3494S4-;SZ/L-L\VK7 UMX*6R!3&Z62](0%!J9E#UZK%JE@)Q=F8<":@^Y1
M:W;+*ZH)6**+OCP\@$K8W#CQ"X%7."%\L_3 7B].YW#YC$=1+@?A7=@@WGB(
MO(3?8D/YG<U?8;-A5-R->!G-]4"QO&*>JR"J]IEO,1M2DF&FU+:Z,( 0?88"
MQM42*( CCS1;H?F]:+L-RZ1T(BFL$2*>(X&(>_\=.\_^$@(Q_TV,&2LNL0<>
M,0$DX;BC639^D8::J!$H7BQ@0!W7P7J'-8"'8('4BQ?4C!NI%2Q[\)^X*[MX
MR[DMV9[=(^B=6C879C;NHG*Y'LWN 1K/:2W3\D5J0R<MVL8S6'HI;A(, ==+
MC!E#VS#Q)"5ML),$-E"[?1P'C0:;Y+Y_  V^230^/@)^V829Z@;"14R8*=1.
MG;-7>76OL4%ZJ0B\W3,6<IM5_@HICL5BR ?]@_^9>O?,)S,2/XP7($YNMR80
MW,,:1'1(S(#;_TA9D@;9GW/F!6IT 4YI*8I8TFR%-?!76U-;"].ZMA8#([UX
MV-RIV-$L?9=SL0,.R*Z+T$=>)_&U'RZ9@MCR01X_PT7XHI]Q7 2).50ZN8O/
MXU;R#<X^WA^Q0"P_=SQC1W?\;8(M]Z</0@Q2X@0>7(ZY]Z'#@,#RP3FH(\2P
M(5*HI(PB#EN48T1*PS+PQS2NJ'P05ICR(W\%;Z/H*.D9^BF:3E[>X%^:5KLF
MG)86R]K[;YIN::"F">%FE-.8L=DEJ+6GY#JTAX>*Y%KSM'L';Q%U28X Z@;!
M@R8LBP(2TV#8*]JAP6DNT. :U![1HYR+&:N1XO!$!PT[Y%)2'F >PR*HP;SE
M-(UB&6<!TW?)7'IC-N9*6'/[WT&"4/U:C:K*)FD='HN%7.;RW+Q3QOM#N.==
M<&J<L7X+C"F".,<.I["ZO5>/4MB+$]3NZ11WCH,F.)D-'%0O$%![6,(:R)F"
M):.=;1^I$-!,L@[S0HGVB@-/=WTEW#0,*U@FX#/W9^#W&".8#-5'2.(X_UJ,
MI.OD_C@Y(*6QJ8.)X;*UT"B#L?@W^;MBPM_-AR^?WFPNA[-[A \7/HC#(#>
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MW=2PN=CI=<9V^UOK7CB2;@!+(QT7:S""K*[N-'+YOOU5=AJQ]!5[@[%CUVA
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M(\KRJ]1,1V D;):5[INQ4LPR;@5P*5Y&]Q0JT/:4,3][DZR+ZUB#"X3CW5;
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M?K@Z.&KS4EWP40VJTQ&2DPN%D8Z0G"9"\CD*X0BN#([$#%R;<&;$W)_=2O$
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M1UX$8"H;,,??U6N(:8AIB&F(G1IBI\YH*02SY!)BO+MEF?;@')$]D2X;PC[
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M:1")D87!IG!^0#R""<D8N3JCMUA0]3V+O##%^F*@>0\;,5&%L5PZ!H)2I ;
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MAB1@V5$R%_[DN))TB)#>T#X%/$I8EM"KB&W*'9:B;EIPY*;[T+]'I;5 6DJ
M^E*$!H$/]D9M3Z6G OMF:*LZ@C>DE(F%U1P"YR!%>@Z\1.)D"=+HVP8G9F<V
MC9\ -A@?P-5@?P6^ZP"U<.,S6.W&QX_&1Z!*PQITC%<O$LC(M0"M^!:+TSRG
M@E[X\=O"FY*!^E,&Y"^*AXPOSH*[*8CC5P8E!EKOI/V1_?GJ4S1G@>0!R=?+
M)?K)0$U%L;9#M[XP) Z>^Y6PE4'X1,J8+J%JW#A,[<!/G$=1Z&\$^P>6L',"
MUGRUUS*2O^O;Y@@#ZMM3?66D7(3""P_*V'4W?X1-P9))D_V/%"X0' I!G<GN
M&@TV9A 7_G>1A?%7;,YOIZ!-OMZR&6SV+?,?V#I^]7W9L@2S<@.&F\<7A_SA
M?Z81/+KCQ4VP4VO2_3_,+V8>$*FAW,[*!6C;HNZ'_]]AW)&:]N*O&%R+0V!J
MLJ_0E"['YG:?7474LE@#V>3&'%@HD/8NB5DR?$R0:VL2YE%F/X5 8T'18BUN
M,5.=%)A0$6GX$= :IS"6M'>D?>50[&^^$6[%@!./2%PMP$A*%@XY$3X&#44
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M7+RXF1F,;Y-R@  GK2P,A).HV8CG%F&L^+:<.D<99NF21Y0IGJA0)IP"8!0
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M8%M/QK??<L/B]T2,&">SR]'^>38-+[^ 78T4B#Y?D&ND_$;V+^55L?73+-0
MSEQ;P^O3+R>Y\T\U@EOGO'@3@,O8:'RWA8%AVZ*W/7N H"WV!\:$/3D:3D[=
MWNQ]GNA39_.H<&WV)'%:RA#.X4KF'<"JNZO'1IX7%6:<5(\KY;T[CZ-*/+7
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MVG>_;@T."JT?XW0XNNJ] D%E5)>1&$[@N?I:[X:5]?Q8=&W6&0-VSSZ!D^:
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MMA:S%E]FP-V'#,R&#-P18M\)YW_7  #D0RM#CTNSJ;.5-F%+E<C0PK?ZHU9
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ME_,CLA\>?=^EQW__08X^?^H?[OWUY>/G7S]_.O]7?ORVNN=__W6FSG7_^/R
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M&/" LIN-H'SQDL["0$=MTI[YGY[Y&]NV%*D&5$\0#DV(6,83I#).D):)"3.
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M1HU(%:!12(.$K:J49$?UI\X!2Q7[ETN5]UVXJW?C/W78W^\-,3SZ/ A]9JI
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M!"\T(&$*-"O#@[2AT3-BO&Y[?RNYC#BKK-%=UG@4B5598P-98R;=G-9<1!V
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M&X,4+HL^BB@1-4THA#8$90@HV(/D85:*Z3C%S E!(RE7C(/,SPB@4BP+0<'
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M,"\5H;S2__7+[CBP;] A.]"9]RJ_I#=,O<FH=6!\ZK5#3FH;WKK&1J^Q<^&
M&V<\1\I8XJ7-D[88,:M.- Z5L=8**R1?J;?MDD#:"M+IT.>V_G<40S4W%C,W
MBJGQ<5;J3JGRA%KPE&E $B,X8A%(9,);062P?F^?RD;CE@XHVSDPWQ#;>RPD
MMWKA"LC/AN/)89R\&U9(WP/2G[] VB-3G'@)D1<909,$'7P GO^T$J75JLQZ
M;JC@C:#?SLW8"E1W98W*+FO-!ZKL\C#L,O-/4('4*2Y!HJ> +GHPW/'\ROG
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M.<#@19E*[$#[;(!I](YI0W44V>SB5'3(NU/1O/(2H35!^5_V]"+>BN0*Y,6
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MW!YR>\B]JSRRH I+" '858I952II!"ZH$(7P#'MW/N9>/R*]1^#[0F#<(+
M2BBX*5 HBUC&JU1(<LR0#9B6I5":ILI\Y9"ILRKSM:OL]-C;8^_3PM[KB+O<
M4J6==<$Z1FBAM,+PM\(5P5G+>6^F?,"(VP;R,R:95\8B3R/B!AN0U*) &GM#
M"J,X(RXE]U(Z9(7JI=X>>7ODO5WD]87')"@BL;,,X%;YTI51#%(:)" I>^1]
MP,C;-GBDGFI<<!EM#"4"%DN04@5#AG("S):Q8.S.<RSY4-)'XYA/>4__3+<*
M_NM&GY[_-_Q3S[LSEO7QDE74^OR_S>R?SYO%/LBO56C (ER<3.>C>(H_S/Q8
M+T:?_(^?1VYQ5$-%YUO5217M5[2!4UDNSO_*>?.[,<C#Q66(1U*#3(2+U=WH
M_GLTJ^=SHC]Z9&9>_X5T@.G^H,>?]>E\YY\KJSH>3>KA.8/WKZ_^_#.X\@'>
MW@:5&S?HY>Y_]@YW!WL'+YY=^[+=]5Q?O#EX]^;GO9>[AZ]>#MX=PG_V7QT<
MOAN\>3UX]>MO>X?O!R@QL=%DZ=W6K^8[!XQ,S^8#/0',3'[+P6@R6!Q-ES"L
MFW]_T\1_K&<?X0)'7%UK:]N,DC"Q)?N$PS9.\V3N?ZA_^-&-YB=C??K#:))6
ME;[T8S5ZA17Q!6L8G-Z7/ZX(1ZEGC*I(.U42:O7BBJR>);):XRK59^H9EOC<
MCXMGYW]VT;#B&2'TJT:]^#->L!N?*W]6J/*!S)4]4UP\D+F*9X(]G+F"@/Y
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M@#G\8UX]D1A]Q[!PI&$6QOL)?!X- Y&;1SO)O+%\=9^.>K >CZ.A?#1U<Y
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MVV3?3@7(JSIQ%<8T!0#/5EOMI.2?Y1;S!"+-]%MPC\;OBTXHX5RT"C;&F^'
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M0;0'T1Y$SS<&?D67]QY$[QI$6RN"L-@S _@I6/"(R4*!4*HD<IRIPD=K/L8
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M0F31:<Z=UE38I+7A8!&Z0$Q!TEH@Z;?%KCY,*6VT"2@F:1 702+';$2>>0X
M:[QAN1NJ:6I=6JV_8MZ%S3:84LHI3EQE!TY2-H",Q<)Z[VCAW;KP[MR"X1[+
MG N ?-5+AC+@W10E,J"ZFL1=P"HW0F"@!LGE9HJ%>5\-\U(BC8J,6AP]=XD8
MS!--7C%G@G.VQ)5KP[P+74RHD5)3BHSS#DP8D\"8 >:UU "MFDBM!1.&"-Q4
MO$[,^\:\L.][W7YW8/.B5WTLNKFT]CCN5YTLSK,TW]B!L+NT:DY&DL",Y($*
M'K1RD4O#"$Y@N'.G;I.N5EHU/Q5 G2Y:!M9P0F,(2#CG$>>6(:>,0-ARIKW.
MA[[LVH:A32-*H_57RKV*)JI & 7&);<I6A*429$HSZ3WMPKN%NY]0NZ=VP8T
MD9B\H$AZ)A!/QF>[/B'LJ:(^)>LM6=M@O E60^'>U\F]S((=P"U(7NFXP-$1
MP8TB,3@)0IG>QA]7N/<)N7=N''!!(\=>(V%I0)Q9A;2U!'G.E+"$IZ09& =4
M-8FN"?NN,N&4F-I8!5<?TNH,)\MI&3?-M'2G?;H%JC>(WR4SEC'L0A!:<,^-
MT"9*2ZT&" \NQ/@8=7\*=-\1NL\6S2;NA$Y&!>1\AFZ:/+)82)0$U1RT9DPI
MR2?HFY33%1;F>_[NM*7'=T'1NJ(HP4$KSL 4,IP3(@W *;%6*!T]M2D5%*T%
MBL[-5Z=5$L)9Y(E/N2::00Y,%Z0292P1RX/(*-HDDC2U>/#!JP*B!40+B-[D
M3A ^82.H([GZ9,3:&P] :0737%JE"HC6 D3G7@0LG)<F<D0%Y8CK?.X<$XH,
M-3B"GBIYSI(DI,DQ!Q1=5=.?YT?1RA?QCZH3^\:\T?O&$S=T)V:=<WZ?ANY&
MKQM\_<=7] <__\*,M]FT?_V/N@K/9G*7EJ=+*WI^R]GBY V%)_]T(=>4Z'/9
MT!V$.)B\0_F=5:.=N0GL:.4\G>=P/OG3+ZZ*6A<TK\*TV@_ [+@[GE0!YGYU
M>+F_V# X11A#M*-!#(WNH &7-$9Q?!1]3EYM_#SLPUQ.&_F!^0;N> ROQN.&
M'3=.8J^7?P\7BPHUTFC8K^XRN_1_X+M+?:[7+V6[ C1D:= ='%?!\.OVWUS:
M;:J>(]&XVNW.?(:- QL:=Q%US!ILA?3,"VY=-#1RHK36P@03I?^\33'(N!]+
M.!BWSU+N!!AN' >71=QFKS<\@76/'X:C+0#(23KN;7H/@#H9_QY]['[-W/;S
M\6@$Z_A=#N(7*@?W_G. ??_/@?W+'._T/WW;V^H=[AUZT<Z?'W[$>X=9/K;.
MVG]](JVST-\]@V=O];[DS/]V9_]SPB0YCR/*35A EC&!++,><8^U#"PPD0L3
M#H9+,JQAS]<Y[TTEBO)*-^QLJ1M5%CAPUF38.(JC:O_REX<.8'V6]S&&W^/4
MG;+?*7#BN'$TZL+=X)I_6^ (X!O2;&2MI^*VU-B"#>R[.)I*4%9]2'%5G6!\
M[ \6!G4"%_S7'4A3&$R-XT:HR'GD5"=M-;;8.V&Y,CB3)C$/4K[N1YDO54-[
M$&4>?OH,=,F8]Q:!S1I0/D&$=(@861N%,M(F'N3:AFXRJJ\@SFNI!;2'BPA<
M>[S=' /!C?VHZZ:,TAY.8F:++'MB(Y<9R]'$;@*E*>=.=<=?LHP:#WVWXK^3
M[N2@$<<3H$B0,OOGTJJ9)>)I7J63@RYPSL1^@1O!9R/;F_$B<"'(PV'O:UQO
M .B/X_EM8&[58X_=(0C+_+WA8'^8;]X=C(]'%?_YW$0()&[#']C!?APW&_MQ
MN#^R1_"T^8>AFQ+, BZ +TS_F-YF$D='HSB9)XCY607+^;69Z:<"^,B> FAT
MQ^/C?)L%^7P$UV>)/_T(;CNK> D+"@_H=P?YM3TZZL':9146T*>?0:?"DPB/
M#/FO\R<VS^>2=^'\UA>&XX<@DV9I;97.$ <Q=2?C]09LXN2*)1S!QUG]R#=I
MP ?P#% @#QK3LS1?IW<=Q'T[_2,<'H\G68>9;<Y4[YC>R ^!",[FJHR?XD@&
MW^XP5".P>3^/>Y,\M.EH%B;T?6#-NTCTB(-EQ =MI078M$9E(\CE% DMC</9
M>*5X9KP^5+1?5<7TM[ELV?DN6OXX%RS;@]]@E;K#X_%OU3*\87F_S5M;+=;N
M?(2QO2>MSNZWSTI((A/VB!+/$$_9AN4R(DPY<T8'0KB_1OB#SIU? 5:<4V$6
MN M4&(XK3LZ4F-&D$0%'P[7R^Q)<W:PP7*\G ,-<,3J@^+MH R!S;$[]5LR%
MW/G'!.L!C3TEU$K.IX=7S;E/YF%JP0JI^@WJ"GQGZ\MGSZ/S-HA<5#LB3IA"
MH+T2Q$&)I3AXT-_BV@933:J6Z^[>GW*)N0?EWJCJOC3]I%/I(=WQ]6(#R!]6
M[A*+&26TYB8H)1SG6#D16*[UD"+WQ%A_@^38;G^XC>@(7^V[=O7XG02,YF/F
MM3RZWT%/.N>V\5L6"]_:A_ZS!;--&A "#"P>Q*G"R 0ND*(R>&H"H=Q<+0G&
MP"N]K.Z=5U69:6.3 SLY-P:!ZK.-V!\"G<#[@Z>E%'H%X%ZD T#1_ 9H<>0[
M)2#Z]DCAM'78^IRB,\%8B6(*8'=IQY &#$41&TV%TX+1D!,MEDCAORNU,F=P
M58ZW[/RL<''!(W!NXS:&HXO?.3_QT0"B@<]214!Q!I0_5!W@FQ>,NI4BX.5S
M[U<#X"5W_LU^O=G5/-]^^=3\S(\]=50O7#7S+./Y)=;!"AY/KK]DP;V?"1PX
MZWE$Q =$]*7U6?AY\-W-?@0LB-PHVB_()ACN.]L[L:?CM7]<%(,@ V>W%[JJ
M+E"?^2_E-5;SW]K\<[NSV=AN_WR]<*_+6-L[G?=_-#H[C9]WVG_L_+J]M=EY
MO]7XL-W>;/^\O?EKXX\.O-%ZW^[\T4"-O\UH/(:_WZ2US.-6/]5EJG\+.38U
M&D_M_0.PH\=3ZQDT:W@++.'XS<>CRH:>?MX N++73_6ZB6W\TXV AJ_@@-IK
M=_^\!&13H>B9$21YKY(#BY$1'<!@3"()Q1UQN<]%.TX: =2!TS%HAN?!CRME
MP=R/,W]S/ VFG!?2;RZX;I:+ZS>.>C#!YD+I_6Y8O*)_J6[M^?=/*O_9T=%H
M^*WR?/1.[V8C6N>)-@QSGGB4$@Q#93P.G&EC*%6W"F;<X#%>\@[#LA8'\39I
M==Y_UJ *BI LDL8R4%1\R@YB@:+PH PRI:1-52X3)DW-U!5.#*"7NVPX**%.
M"IQDL(1[G^OI!N^%%9'EE V[BA!!V?#K-GS_LS384BH(2K#&B*=(D&&2()F2
M)41907)I7-+$3#<IOU-48!9#ROO77 @"]T[7&YL7 .)NE@L'<T5SKD1T'L9+
M;:!:)ZVIL5APFJZ&B,JTG9NO<^MD)RW3QQ_=;RUXY,%X9]0"^^HW.YYL'<<W
M;<:0]N'N9S!5%+,<,$%DEQ (*&0P(TC WQ+PP<7L$B++L/#?%27<;9^QIBHJ
M&00SA',0!<G$E$CPTH.MRMG5R%#V^4'[W(*Q[9_N=#99:^OC2>MP^[,D6DH:
M+-*: 4!XYY!SRB//)=8J41J8ACU?1H;_GD5$SO,:_N__T92HG\:- 6@QYY&>
M'RHQSO:RSV]\'XR9:2)+[I'V<1]T-K\"9\AE/UDX'EWA)ULFNJE[>>=X,I[
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MWW;/>KWVUNY9/F??!BY2VFJ90-^F08("9B5%\"^BP.$G#MH1::;BK?(9;F;
M"DF"2AY($-APRYU+GCFJE<_&MC)^K1%! !UE[]H(%-Z-\S6?;O!WS]QEEKQ(
MYU<ZL6Y\\L83D\]OPU[7G[YM(OKTV9*LQ)N G-"@<0'X(BUS:%(&"XMH(BST
M9:*HOQ_U7W8,%!1G.[[@4>Z.&Z!?^>-IMJP#Z.]^[59^RVQ\=*N*@"!;)J.N
M.YX>M)@,%VV5?$G^<_KT'&^;):1-+=5I[EP?]-)S#_=P+NRS'1*._2P^6^7/
M7'>WV<4'L1>FV6)^-#R91GF/87%'#1]'$PN?^.[('_?S$[*VT[<Y2?PK&$@Q
M#N!ID^,JW?[B%-8;?UU^W+5#GOEUJU1]6!.?+QI/@%LJ';IA3RQH/;/H,ZSN
M8-CH#0?[>;7GV8HPV12[,)0\+&^/QW&6_ _2MUMEUU5#GN=LP)>S?QI^=$>-
M^"WG"\*SON:4N9PI$D<@B8?9?SWICJ9G#&*ON]]UW5YW<@IO_^_Q[/W+Z?^U
M)]NM;@XPABL)=[H156(C$"U\+^<HQI3R*@/5+6Y:M4,PALFD]WV_LN<]YMR9
M#,C5Z:.I.G,\R M[85O'C;]-B2P_:C**%K2<T]GG_3@Y&(:_YTN;W\FX>341
M3V7 /JQI[W1&C-.C2]<3=V6N+4YE(3UHEEJY'/E=E$./*T+^\ ? P;VXDRX+
MDPIP-@=AMH.=/-&W+5K\9T>35#ABX)7<=9)ACAS1\(.G!!H+"!=*7YYHZ4RQ
M:YC/&G7G&=.90@>9[.QD.(MQPDB'5=G-_ ; 7@7$WZ4/V*A91E5?O)[MIU&S
M,;!:/LZPT$G]QW'?'*9?6+YIGX2G/3AHS+K"ZCX'!Z589Y3>ZN#@G<XCKDO,
M[G77'W\FV/WN^IK&*N]RS/.Z,YWW;1#R'"?.KSY4_'U21-QF5M.LA:>9E[Y5
M2;#=Y13<!B/-"_-\";MX>;;WVL2ET\:W.NM=[PW.FLVJ)GR;;GRO:.&(*0MW
MOX73=\&/V]9WK(EXN'K2[;DSX6^]X7C\]R6?PI;]LSNQC>V!7W]W&[JZ;E56
M1G"/V7OS]0SR1937O4*NK;2P*5VG=>]X\//4_YQ]!\.C.#U\L-3AX"Z3?Z4E
MHEYGD:=[N7KNF40X[2+S*X#\A]&P/Z>[G>]D5Y=4PGL[@J;EGXYZ.YU=NDO_
M[.[^]:&WUV_AUM;NZ4[G ,:QS79^^<1S":@<)FY?+O_4_R3:AWN'>W_]^V#W
MKS_[\*R3]N&VV/GES\/6H>=[G8/NWE8/WO?D/V?G]?.J+M^&<D5"PB@RK')"
MB$;&4)Q;S0A5]3CE=&U#:=:DIDX-9IZH!%Y!J#K-[0X(%3(,&>YH<(S+J*SU
M1F.@5NEYL,&M\LAS0:C5(]3I=X2BFBEJC$;)2(FXT099J@4RCCN16U9$Q0"A
ML&QJMJH2GP6A"D*]ID*9!:%6CE#MN0ZE,8\N*H^44A1QEB@RWDFD*'&:: 'R
MQZQM2,J;C*ZJ?&;=FO2]!)MUJSO^GJSU ZNU] 9:I9UW]]Y %\%J<=/F<-6.
MDYW4L=\V%[Q^G>'O\6@XRBD1[^&"R6G!M#MAVL=%N] 2+;&-''GN.5B#%.Q"
M;"ALLS4Z"2=<M@M-4PI6C\Y"I3'8J[&@"LL_(<O/#2T?N)?:>"2U I:WGB%'
MF !"I!0[ZJ---I=*X4W"']R0IG!^C<7^"DR3(O9?#@8LFC+">.V\1-2G"&(_
M!.08X<@2QJCV29KL;.&2-PU=/FS\\EL*O@ KIGU]'OU"S/N>[1C>>BN7M]2I
MY2F#>$"T<WPO 'TG@/ZT:)=QXU@RS"!M.0"TB1AISQC"1(#^QH*5(:QM*,6:
MDJ^XX=5KZ6=5,.[M8-Q3&K$%XQZ$<7-#-%@MG,01&84# J.4(S _LP,JD0![
MJ".+:QN:X*;1*VY'53"N7JQ>,*Y>@<2"<0_!N 5#VV-&!*,1Z0C(QKFPR$0A
MD U16BT]?)9;EPK39&:YR'M-,>[J-G/Z1VWFGBCA^(K^@C5,BWY=HUR18Z8F
M\NGJ<PA+)_V7C_C?[_3!#6I N<=#".VEYS%</K/_QC(8KM6-ILSWC&ZN<SC8
MG*+!>:N.JH+!>#NW[0I5(8.B.=U)<]I?](#)X!DVU"(:/$'<,8,,!T4*AV1I
MB$8+G>OF$M-49CE$4<*4KXFWG]*]4WC[L7A[[OGA/"B:P!:* AB<N\B0A9?P
M)XX&NY!K^66KB#7)PST_A;=KS=M/Z=8HO/U(O+W@\2!:,2H40\H:BCB)'#D3
M+;(B 7D(3Q2K2IB3IM:R1KS]U&;L0LVA"\W@":DLDV<][[M4:^Q1^E3)]1L[
M5<&8KN@UE;T3B*U?43[)V7',-UC;^!NYU/#F3N![VT,W+QU\5VPTG<71,-CQ
MP9UP=Y'D,@9G>BL ?"< _K)H.&G"7, Y:\!),)PXU\A(;1#6Q$B&/58NY-H&
MFA+Z4XV.J:S:S53X>^6&4^'O9^/OTP4%"T":"XRX @N*1X*1PY*AJ TW!ELN
M@BG\_5+Y^_K\[7I;3X7+5\#E"V94Y%1:4,<0YAZX''L'9I2@B$0CI0DZ,>.F
M?>*6>]K>/C^[KJ=,=?VC,]/2Z%.F?$A@YF&9//4#L!<:M5EH)E-<0'?'KO<G
M%6Y5^+7YF;E(38H>44D\V"'>(&-I0#)J)H1Q5%*YZMA-;3+[5NC\?=O84)NH
M3\&&!V-#ZSLV1"R)#B&AR'.[0QH$T@9+Q#D%M493!GK/JF,_!1M>&S;4QNXI
MV/!@;/CT'1NX%,X*SQ'342/N 24L;"YB'%/', U)\1P[PDVULMC14V7+EL!2
M"2S=G*+]^I'[B4).VP,_;5YE>S]77;FF<'VQHL!53JL_9H,N,'Y/\R^W+-W_
M[$E2 2>)1,@=B*W-Z7M$(,\U5=PD9XA<M9?Z=ESU@OS7;Q@FGBAR56#BN2S!
M*4PHAX-7L(G299C(UJ#5)B(LC9:$!6LT+3!18*(.=F#!BN>R#&=80;V1*GE$
M?&#YO'AN:4\5J!0)NX2%9SI<%Q*K(U*\M?-,F\ ._9A[E7[GHVFW^&E+U*KW
M>SGB5)-@V:W [KQE:PR_V=/\Y<W1R +X54V#"][=#>^^73:AI$L>)RH0P<H@
MKK!%EGN-F.&)8R&-Y6YM@S8UK5,>=3DC44MCJ'#WLW/W1<M'<^MY+NZ%8_9U
M:^J09=$A4&.PMAI+QO7:AF3E_-/KYNT56#"%MY^=MR]:*F"02&4Y1IX%ASAA
M"FGF!7(,D#P8;(R.:QM<U:F\\DKKJ[Z _+VM6;/X!V3PK:06UTO'KQID\,VV
M<BD@7W#L;CAV>MD"88E[CFU$4A().HIV2%LG$:4BJ$ "HR2?Y:2T*>ER?XB:
M5J^JDX/V32!$#?+X"D*L#"$N6C%6>.JT$BA%QQ"WFB"M)44Z<BIH$(IR.<WF
M \VU($1!B&>/XA2$>&R$N&@+@3J(G8X$14=R)7.L<N=ACYPRT0KM,*\00M$F
MDZOJ/%PJ8)Y7;7P!A25?[!#?0N'+Z2FWP;P7R=]ZP_'X[S]J25(*83[V/=Y:
MX'C>R':AG6>NB3EUWCS$6_;:RJ-?-<47JBD>C\-O<50I9*MU.=&[MTV&@51(
M.!O-3"7$126\C4IXMG@TE :#L0L646H3XJ#Y(QLQ14QQ9I3@26BQMB'7Q8.K
MH=<O[E6 Z94#TP,]7068GAR8YN=2+=$L2,KR,86 N H<69.;TQC/B:4D4&_7
M-OBZ?(4!^0),KQR8'NA@*\#TY,"T<"A68>D4D2AZ(Q&GV"$M,$:.![ 0@7:)
M3VL;;%W6*0OPK75K7>QC?"LC]2[!@1?H__]A&^I',^N^=Z.^?\OI@EL/P"V\
M:.DYI82,&H-"E7M,LY!?!8U(4@PDD%*.T;4-O(YU/0J8E?J$+](J*NS\F.P\
MMX^<L Y3RQ$5 NPCX232)'I$8!<=J)!).97962ZS<ZDY6F^>OH^P?KA%483U
MLW/WW,CPPJ60@D0*<X$X41HYIQP",J>PI8&3Q-8VZ+I:3O-[^=5&7X!]L12'
M_6Y8_"@4^VBUD%ZI$^@M=!5^HIC:>SL:P&J-SQ]WL3A:@>A;0319M*>\-B8Q
MIY"-2B&.B4/&BX24PE8'DKBQ/D?.^(NIC/9$WNN":F\6U59M>A946PVJS<W*
M(#FC+B0DO2"(6Z:1E@1>I>@ [:27D:YMB'6ZJK-R!=4*JM5IXC6(YA546PVJ
MS<WIX#"HTI(A(SE&7%B&+.P5TC9(T+*E2(QE9YEY\*FY)ZYB^Z",]Q7FQ5Z?
MJ_W@C/(RRIM'N2+W2TTDTM6I[^<'Q)\@^7V%AQA>_3W>6F;!JI+?;QN>J-T"
MW%XSO&J*KT[Y>Y;D]\73D44QO)-BN'TA_9U;T-)!64>@#2K$I;=()\%15@I9
MM"0QBK,3CSW8W*U?%+5 TRN'IF=)?R_0]"!HFGOB&&')FL!12L:!S:HYLDY0
M^&%LM#%AG4R5 +^JZKH%F@HTO52768&FQX>FA>P4:Z5QPB!IK44\R(A,3 S^
MY,10%[4RLDJ!7U6)F9*B4I<4^)=;!K16*?!7YM'=(M5N(=.NH-G]T>Q"8CQH
M62HPB1&//M?,RF<.K=-(,:X<Z%Y<Y).&#TR,K]\APU?.[C6PEPJ3/S>3SZVI
MY)1QVDMDJ>$Y NB1%:"\)"ZH5(X;0ER5+K^J_M>%T^LLV!\M7;[P_'/S_-Q,
M,3B18(U#/EF>!3M%+K<UTYHH@'6N?3[Q1M?5L@?E603[6PNE71'176T:_7)
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MCXXG%4WNI,OB?K,/.S@IK6+N)NW9HFO&".>],Q0E$07(>".034*@Y*77*F+
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MR!O,/Q./G?>"(>52SC67"IG\2BDB*3<D!,;RH?FK-_BG1N_*,Z'-*6H< ,0
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M]]YA1_)&^!YV3-NY@$[Y[D%GM)/FW:\%G[=ZQ<[L#Z$OP[..^XB ((:*R$W
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M@K_'-FANUI479H2/('%A6#EVNGN_:$CN86$'#P=SZ"O(3S^!1V6E;^2GF@7
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M G0;Z0H)OXQX8JX #;\Y//MZ6=_R^QHKEBRUR*2< >@U1=8:@R35VGJ2(N:
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M.9$L@D40D;-8H&B35DPJ:8Q;VQ"\RIE>4''C)2KM7DKO,Z@:I?0N6'HGND8
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ME>#7 1-AI2MX/.4=7V6-H.5O<& ?.QE^#SIPDRHLYF('SF2JF+E\LAGGQ1*
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MLI>_D:GZ<FOVV[=;?SP9?]X+[N_QMFUV 'NK_=RL]O<E\QK>^;JYK[&3E+B
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M2(B$KF)OY$>(Q3X;*Y^:2# EF#FGN71<*Q&$2P&4..NLUK5K[+$9=,HU)FD
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MY8KGV(]B+'+JJ1$FC2O/@7#0/ JJHRUWSY7YNHE!!@1/8',1,SK3B,<(5,&
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MKBWS3<IKLY'0R#9#>U@:GQ/'ZX7.\Z53].IVGYN5$0**.NS/HFW3J)8*RVA
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MMF_;?O\\^W%MKQ3=[6[G )7Q\2H=92T+UQRGF\II"><*3_\PQL&KFW@X10F
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MMXVQ/&FA]UBH9J&+<R?H[B3H#MM()F5AS.$,29Y;23C--0%BYL3P6"H*, ;
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MHR;V#.YX8M0EMC:WPX9>;?'KSDA/<9U_PI-'YLW0[,#77QQU[M+^P<<C*Q@
M,]A(4%TYX3+)26HL(S&+K9 RT:G0-W>>O]?#FC^HU],Q'-WD;8%J#:OQ7_99
M950F)K>*9+'EA"L1$6FY(2F@#:ZLXERE&UMUJP*OCEBTV.NH%_@:]OF_NH',
MK;FU"\KL*4RO36GZG<U(@'P?I+_'][4X^49_CU \1#,2^3#-2$)QN]L^A38:
MM[0I5L/ ^^FP\B3Z/7Q']_WGNA4WM,&]I]R&M68%4#316K6S>.GEW<^WPOO[
M)E#<*83XSI:EM?/.F29#K;9V=Z9V#Q9U<&$'7VP?4>US\<J<%X>G@Y/^V6%X
M"%AU[W=XUMF;J\.SCU]A#9?]WS]>[%T-SOI7IMB[7/#*G/U1[/_]YO+3Z5\G
M>[]_# ]/\3WVBD\';^!]=R\^'6RS_;\/K_;H+G/=+3[,BK@B!N8SM9CY .8)
M8Y)D)I,DX2%-+:4R$G)CB\NPQ]D/>Y._H\W0.N=%=%*PDX+W+P7;B12=]'L(
MZ7?92#\A0JVH2DB2Y2#]C-%$B12';@C.8Q.%6K*-+29ZX=,1?B\AZ0*8C';-
MZY^XH+LMW$._Y,'%J)-S=Y)SNVV4QY/,BE"$1!BM".=Y2#*;2I+F-J%PHG'*
M\XTM$6*"ZS/,&>C8>HWP2\?.W\G.,]AB12IUR#2Q."&,<Z.(#)DE@J<L!/R2
M1#1SL"6B:Q=%?_X>.=8--7SB(NQ.R.1D;&TGS.XDS/IM;)(H&:O<"&($!EVS
M2!+),T-R$5DAM9&:8TY0S'N.M=8FN;UC[*?'V+?")AU#?P]#M]")S&B4I)I$
M3  ZD12,C3S7)-5Q&+$T9[$1#IW$_!DVWUEW=,([O\D3%V)W02=O1]-Q)\ON
M),O>M\&)R524:JU):$Q(>*Q3HB*;@^'%!$M"([2F $XBVN-1YSCI^/JAP4G'
MS]_#SS-L8B2W69)H(N,<^#D'E)*J5! J8L.C4(5<A!Z;Q.O$SB_$<R(ZS\D3
MEV%WPB;%E\[.NILL^]C&)B)3:92;E(2AT"#+8D6DM?"/8&$2<6K#6((LBZ,>
MYS_<=*ISG+QHOKX5-NGX^3OX>89-9)8PG"=%3!))PC.:D,R&"=' Y)E(31BG
MD<,FXMZ243J_R>V8\>#$CJV;P-UY3YZX)+LM0MG&T^[$VG>)M<,V3+%*"Z:X
M)(F5.>&)SHC*!"49531-I(Z31&QL 4AA22^-?]@CW#E17C1[?PNH=&S]0VP]
M0RMIE.9QEH;$<I4"6I$*.#K.2)IF*8]#RWAH@*T3WDO#9]CR=KWARFBB!D%^
M4P>!Q_:T_%CM1"<%[P?D= +P3@)0MW%-QG,*,BXED5"6\"A)B-(A(TP(S61J
M. VQ=J"' [!">5]M&9]*[50G"]9%%GP+$74RX*XRH.6RX9G5#)/5,I,0+JTD
M:60HR4,6YTIA :5&ETW42^\M=ZTK(+H'%D4%&9R/QHX_Q_9\;$L[="T5BFI&
M1N?HN?.FOEHOP7<C"/HX-$6I<3ZR-6^^:OCJMIN6W$G#.TG#XS8BRA.=&I8F
M)!8JPF093E(52<+"F N:"I:'V<:6$+271LM^GE\Z%T_'V-^/:#J&OB^&GL$;
M'44J9<R0S,; T)K'1)I($9;03&9QJA(K-K:2I!>SY?%KC\+/+\&[\Z<'*\$7
M-9A:[/1X/_WB[Z<91M52CL'YF=$4&]35&])UR[BW#5IO;;%>RN(:_->IA3NI
MA<]MG!?)6%.E&*$4NV9$"G!>3#.B61KF:92SR"4>]:)0]J+XOE*/[H]_GD9;
MH4Z2=I)TK23I2MC=R=&[RM$9O(Y5I/*(:6S;K BWB21*YY089;&A>292BT-#
M$]ZC]S;6Z?&EZ'PO?=?W>*%5\OHW9_\+\;?]>FZ' +Q]+W8U&"R.</*S19'O
ML"5TE/8"-33XDPPN5!G\GS4;ZK,:,97XKF_\J^[9IV]._T"/<-;?V3Z2-.>*
M93%)6*P)EZ$@61SF! < 9R:E6B7IQE8<LYY<41'6N].I_\SY?=VI7W_J[X^
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M6JXP$O,O0QZ'/)$Z4['126(%Q[YX)NK(Y#'(9&_G_9$2,M*1"0E5*<.6S8+
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MW3R(&%TFYLS3L\C;6$0R'38U-9Z?/3H&;LY\ ZYZ&ZL:=?2RN!E%F&"HRK+
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MO1;0?"Z$ S=9Y4[JGA*D-9!^1E0BGHG O04ID9M"+F?U%;!S&T&!+U(Z&L8
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MK]/)N2/9GDP[1PR/>R.X;1AL@E/MX]EP)OTUV*&]_%$O>[#M_[@^R/ *#5B
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MMQ@9Q@A-/NJ$0_:801WR?TLZ^(0U#V1T[)J.?4_\(]1K5(1=\RL6Q#F>PH3
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M$]?L52L <W^8X WCB:_F?6;:8=9_G[B3+PY(]K\>-#^W.+6:1L&1PS(A#N0
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M-O\)$WB=WW/"Q,/>$^SNDZ[&Q5)8,+TL%\O7-;_?!2W#B(KY#!JYUTTMWER
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M.ZI"C+D?J2FCAPJ\%7BC%M1!D\!HBMQXZIP(40@-R!:9"+3 VT+ VU0_$*6
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M,4=/*'0IH<^%"Q"4#+3Y8=?%M;R+J*Q03"*C<T6N]0$Y(27RG!-+9"+"T-Q
M@Y'9--4%C7R679)5#3P4E)@K2DPB$BD$[BW @D@.G!=*)=(T,:2 YC@7F#'$
ME=W4@A-+$LLH.#%7G)@J>B'@"CD!3I!-''!"!&1MD,CIH*AB@B<^OSGS!2=>
M(TXL7'2D@,5<P6(2-@'/@\7(#(J4Y8AHH C<#X%(+GSQG*7(_9*Y'JO0061J
M?O1(K9MG)W H?\,O()XJ26QDP!U5C)9Y)4B0@A,9H[[=+YC6W& '\02.>!3L
MQ47,ZC96WQ!;;[:Z'LXZUM'M3MB"CQ<EO(\27H+R3910,!HY+(+!)($2JN$T
M8"29C$)KY8WP5_C]ZQ?Z^B*/</AM*Z/L/LA 6>?'KK.C6H44+7(R9[A909".
M/"#PW"BWN76\-6L;4P/AQY [6O.-/"">XINO/K($<0A@;QC ;.B>@4&]0N&5
M'=8W_P>TV)3P(3MFR0JJB9".*\:C%$Z"'Z$E)2)A)GS*T_SF505=IOG- 7<F
M\67MI<*9WV&N N+$!*2Q#B@&+J(7PA(*]H70.I?SZZ0T!^UYX>WR@J,%1^<?
MJB=><PYLCRG-*676)ND#T5Q':1WF=\-H&6O_3, Y%7*WV!DP=\A&[Q"7AB%#
M1$08"P>LFA MS2_J-57@L\#GJL#G0V@HH40;EKCGF'-CM8D2X^ B-M[[Y'2A
MH0N&II.-B22-%IQ$%!16@*:I&B/@D9>&:(^%!SA=VQ"L+O4<<K0*CA8<+3AZ
M)XZ*I"4++ 2#'7>8..DPY92E&((/.A8<73 <G6KLKJ6FSD=DI.6(!^Z19MZ@
M) )A#ON\:[>V(66="/X:<+3:T/EWM><'_X;6MXV9"&CU8O6)J_L97A7<2]N>
M]N.;\2^_AU;_M&TOWK0ZE0)57_K]Q/8.6YWQ3>8ZVQM75%WQ\.W?SUMA</2&
MF'7.>7;^1GM-HQ./WEVO_,(;#WGXGM'K!M_]-EXG__/&7M;X R-M9Y5]N,.\
M7%NNNQ?DFI6YY0G#C_$A1P\G+S"<>7P$E W#&Z+'UJ+5";$S>(/R*_/&/_,S
M^*-C+SQC7*MS-FP%5R&+L5P([C&.27(LI([*ZL3!\694 &X.<1&^$\-F!C/L
M KCH-AIF)2>&:<XTU5KFSC8F" 8P2_Y5">#TN:Z"\,]^W]?70ZT+6CW_6Y_%
MS^\-C$,[^D&_-CB*-7]V<M:&KW^+-4 ">#DWU[,U?V0[A[F]7LUZ#X@!)SFL
MG?9:'=\Z!04$LU#;_/BI7P/S(1$F-=L)^7>-,*O!E=SHUY??/8FV?]:+>2\Q
MGR*U.A8.9MMPCOZ@5^TQ]JL/PG%'AZ+Y4/DKDV_F#_1N:0<88HJ]7@RY('UT
M(_W1U0]O$-[JYODD( E3 TK&9>QPN"Y<3/[4>6MP5#T9N 95VX/#;?K!^JPP
MU*Y ]@>Z9&YH#E7S5YR?$P<Z%;^:W];B=?M_R]R7OP&4_,7PYQZ<ZX\V4(0E
MY0)?_GN$_<D_'?O9G.V>O"=-.-KNWMN3!FVVP?:SW;T/K?W+G8OFYWWRY60?
M>,$V_K+E+_Y[N7W>./8'B42PV)8BXRU#W,F$G.8)*4]X4#X/00!\C\"83N&A
M@C[$M8T]$,+;9#VWNX3/P7M@MRY!9-O=?C_VA[TPQP+=J[Z;#44 Z0;]<(-:
M_'X*ZU-I=:7Z7="8_FFWDZ$E"T1E12HEZ _R7G&EDE>]-M=O6N3:QQAKS>X@
MU@BK$"&=]2H5"W%@6^W^^G4-F873K#.5-&BE-<<I1BDH5R%:;ZD*- 1I-04G
M\H!JMO933?OEBJ5N52Q*UH=1P-F?OUCG&K%W"'1[TP/?[K>J#L*;G; %Y*<[
M^A-^]R =@)[]Q=' QD@#N^?[=!\W/^^0YO'AY?[>-@:&#9KT];)170.PY>/V
M5]"PK_LW-?#XC^,OQ^_)_O$GNKL%Y]E[#PS;B]V]!AS?\^:[?;K[^?WE/OW0
M^B]H9_.X<2!59)BGB"@S%G%O--*@=TA;G(N^.7!J?I,G!$5-($D*YP2/SFDF
M*64JDW,,'$/<U-CIE:A,%<AJ[ ]:@[P =V[I5U)]JRW_^?FO7Z]0X-=%[RWG
ME!N+74K)*E N9UVT!CR&>]HIPM;%KU2HZHAO6@, ,'\/V_6A>P9W":@V]7R7
MS/QNG?4RRF95KE?HFPVF[5P,[RDSESL=>P]':_F9K7IJDP&W7LC 86U=H#$R
M;8GGBDO!?I*^N=-\>\VYA]ORV<$_!XO1GR0'C9$&9-;%WF[ZXZP/=Y:MS>;H
MLJ^\?+QRN/+UXB 8[:@Q!CD2#.)6*J0#3H@S0F*P@GIFUS8J.9CQT@$<;/NB
MW^K7/,@FX/C8+G]:_[A>H<?#)((2PCA/7C"EX%]A213>BJ"LP ;DX#X245;]
MIZN^?;&;Y^Y%K(E1R"E1]3'SR( Q1^!L86:$%T:*')ZYQZ(#M/5;(4Y6/C,I
M6QMT 1PS^?H?#PCX6:$QK*C3D2?.-=&,8PG6@%DC,4ETGCG=?]N+BB#N=4="
M,9&2=ST@I L4_GMV$>&-S0.O\LATIA#8 PR H#2R5@'W5PJ+P(#L"KRV032M
MXUORKC,6#'E^_ZA>B[;705E0%E$@PC?[9KSV8-0<./;YLOZLF,DAB C\EB6\
M5[T\39%6640NFY?Y_:^D<?F)-2[]]P.AM"$$C$?*XWJY 3AQGGCXP7!02@H#
MA&^#\#KFL\,\AVQS' 0Y/>OY(PN>WBD0S5B]UVY9UVK#<P=* PXE<-"PB,(T
M1I?;!6HB1GL]X&+#N_UK<F<['9\SF4,1K)%@-;<VV4$N!@O@4J(4-5 3KH"N
M1"\0QH%+HISE>;0[\%).Q(Q@K=?VILEJN]^MX@J'G2KR8&OP691!JG9H6YTE
MDZB/@W@ZA4?#;:N=;);!:=OIC.Q:_# =@7P'MUG$ZPJW/ET<"$RL48:@D.?T
M\:0=,C()@#%PK$4*\"_-75DTG>WINEZ[\HN(F8M?Q,!/9BQ(N!C%@:$!:";%
M-?P7"</)9I$B9B12Q!2_:/XRTCC??7_@F*)> .ADV<AS1A)RP(V1%9(%01FG
MWJQM]..WV/GEGI$3+M@D &88Y8E(FX"QVZ2C=L)'*^XC$V7=?[[NN/G^0 KL
MK+ :49-[-"4-3I$- D7#&)$A:48RBWENSXB";XZ-X'!EA)/D'694!BR4 4D0
M4OU$!(IG-"<1$<WS T^"=99A%%2(N53!(9NAP0&Q-5):+!V(B-%US6X1D_DX
M1L\A#\4Q>DRP_J)Y>!"])1Z  BGM0$*" @GAF@/# ,YJ-8@)<]6X/G&+A-2?
MPQ=Z3CPIOM!C98F#06(LNL!I0"XPAC@&T^249(@)HZW.B^3LV@:OP_K]D)[J
M^83M@7-PG9T=C3GP9F @! A1L#Y8Y5BHY$:/Y487*O)(.P/7=GBQN[?)&EL[
MYXVMQH%/UDG/%7(D@1,L'7@I.@5D4E0J:HJ9,CD<]\O)**=*$6IT,,+SG-[N
MK$[826#$FB5MBP3,10)\UGVKC?6 SZ#QV"/.O4,Z$(P$N" J*:$T =VG]UGT
M>9)1YV( LD. $E,.JF^U3E( !&A.'&?B)R)0R.A\1.3P$L@H<TPRG.?0."D1
M5U0@EZQ"+# ?N"4NY4%W1,DZD;/QBSFQT><0B,)&'R,B%-AH,C%YDQC2*A%P
M:2E&)@(;]=%2HH)7&K,<X*+\%G?E1UQT :6D<,ZG)@6<-S8/A'3$>V&0LP;\
M%T& <V(94-(";(X2/@FYML& =)K9[/WUVDZGUNU4X@'6IE]EHNK:(#_QX4?Z
MMS-16XE+K]MN9\K:&L6QJRQ8$+CXK=4]Z[<O<L3^6JY?9<VN[-VI[0TZ8/".
M6J>5B3L_:OFC:^>;7_@_MY0 )XHZ0@P7$6MO/ BM%4QS:97ZQ0)=PO]/#?\?
M'Y(#'<$XAI"08H+D5 B.',OA?P>+:3-4F;R[I.M$W+)MF3/=P%X"'H*L78GL
MV6G.(;\24OCD<!L*G/4XRA*?]N$K*M9N7TL/JYW':RFP@RS#K5XMI^.=5'*?
M+/SYS;;/<A2@>KN6%:(_TKOK1\NGS#FUK8YOGX5J_MFT4E3EX>KW_E1:^R2%
MMIX3</.7AU?0/:TP%%04[O6LG=]/O>[)\ )BKKRJ+F^8Q)YSU.^\JO7:?3)L
MK]>5\%SX,LX/?=.+P]S_<;W+L&1EZENC&A,\^8IUL"IG@[N_,E7X,R3/+Y1Q
M]Q9Q<N/Y3/T\NBJX.;6'$;E>M%^137"Y;VS[W%[TU_Y]/:NPU1D?7NB<'+E
M]W][7O+6YC\[>YNUG>:?ZW?F2B[*M39W][8_UO9V:W_N-C_N_K6SM;FWO55[
MN]/<;/ZYL_E7[>,>O-#8;NY]K*':;U=)K__Z61+HI*+M]T6YU=]"KE+K#2&E
M?P2X,(HH@'6&EP -XG<?3P<U@(GA^QD [-VW>M>-;?QOU_OWQFT:<&NN\4]S
MAV_D&BLI)#<J4A44MY88"@AH@PM<\ZAS,_O%3\K--J4%_"3C]<TX<;O='99<
M#.W+D(E=(V%'%L#9Q=BY9F9N-S .CAPJ:]<94I:J+.J;;;6K@L9!MP8W T!T
M5>1TW@*#YF)E4(95'N='<"8?>X/,M*X=IM?+Q5HA'P6^T77Y$_ GW,W5Y44
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MVWG7[8:<T5U@[4&P]G[B[>QYWMC;/B#*VMP;!@7+'>(\2.2PL4A*Y3'7@M/
MJLI*26=[&3XNO+- <>X"#/-U>>X:L5LP8:$QX>(&)@09"#82&:PDXC%*I+$S
M2"::)XEXH5*:]P3? @H+" KS<7X**"PC*#1O$ 4:A;0&H("Q!*! !8!"Q X9
MJ@4SVD= @T4$A578ZVGFJI^3TS@8UA+9PUZ,D_EOPW*^=K=SB :Q=W)']F@)
M^2R]CU3VN1_M#6T>,,]44#$7,^8!L3(I9)+BR',6$L94<I*;$N$ZD;/MS4K
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MSB*L.RSR6"I/;.^PU:EDRXR-6:N30><-595A?6: IAF@]XXBX&>[W3W/&]J
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MUG+WX9O^<P:1'ZZV-#8I:F#-$^>4668]4T0Z  D:7%GM9UWMKP=>F@A\D:)
MA$?<6X=<\@[)X*Q3WE%*_=I&R@0V+W?_YGJOUY;,+O^$950 UHLGT?;/LJT$
M<4ZVU0/6WSZ+-9N_Y(_@ Z>YP0A86G K(YC%0:M=H=V5=?>5>:V.U>^VOXVM
MN3^R\&Y_;+;;8SM5"V?55MVP^\KH[+FGR;2; %^*HT#F>NUCC+5F%TY.>=6/
M-YWU\KQML*T UVWXP&9E],?-#H8Q-S9R0.K72,-DNF#%&R:W.VS*TH\_)2UP
MY2X^B"XH+:T0S N:%(=_'''<,DW!9XG$&?>L=&&SU\O+4O60^9!_VTV[9X.\
MZ]K_)S^(_P/RL\I, C>/MP]8"%0;0(I$B$-@G3'2A%!P4BB+F*0 #N;:!L-U
MRF>91#W+TOE1*[?GF7#.!_FUT5 B1?*$4VZ5LR*W: *.P*,&Z<%%8!9)8':W
M/AT E6,Z!(S B&2'%F1%4V]0P,SI0 RQ#*@G875,Q2W4LS_J_#0$OFX%;OZL
MU\L@-,;-5N[GE(,I(]P$HII!^4% A%70+)!@HN/".6N9-,PPBIF%_V61JP62
M*Y)=FF1Y+N\VB(J<5RE"0#J&O#UNC"4L&BPCR)6J4SI;J'.[7+6[G4,TB+V3
M:<FZX5O_K_\/K)/ZO5]U+LOM/RJ+Z6R[<HGZ1S$.EHX,_>(VA!_]40QG.2!X
M6V7('Q<_9^HKW:+P\NN!QIHH2SB*2FC$N8E@="-#E,<4L?%@C^W-304G)=&"
M<@(>%5<V ,^*\!H+\'<2/MYL:7B]86 K1X4RZ00*"\HP[J W15QO(X/3:E--
MAS@:^0LW>FY=IZ%7;0'?C+>$[QB0<K53>^?.[ W]NJWUWJT[-O?8@;GU>S]]
MR,_=ZD^:=8S%8UK]";'.I9I[]SR*U[&6OZ#5GQ:/:R#XTXN]7P?!>[:_NK.'
M6&F@=__V:J^@W=;+]*5[%0_N87WG7D4!X1]7_6]'Q/*AJ?;W7O_7EC+YX/M?
MWGS*F\-,L$Z:,*.5\%RH:*3QX!!Q2KS6F.HY#C,I'NQ4VN5IN_D./K^WR1MT
MO_K^E^.OP.X]_;+7/MG]W(#O>]9\]\]QX\\;:9<GGS!X :2Q=7CYI?(*/ISL
M[OW3:EY^:>]^WA?[EUXT+SW^\KEQ_M_+S>F,<&U<3%YQQ#@UX!!$@ZPF! GI
M=*3826XI8">OB[GU$GJ(25GDFL,"C2L'C3RZJ&(03,3$DV%6\D1H8I%9BVER
M<YR/4J#Q!:!QJM7:WL[WYM;^@911$*X42BQG4>' $2PU1HY;16PBQD3PS6E=
MXGG-J_OE\#BGRL?JW&K!06TZ/GBGUT0?=N^WPOERP]HS-!^;SJBX![9-K5O!
ML =AV/8TO4L4>Z<,1R99@KA-'EG&$@I6&3!D*4;)UC8(KV,^FP2Z]"5_1<.?
MLVM7T?!GTO#W,RPE:BQ,U!1A%R+BT6L@*.#*82\U!0@GG&M@*:PNV).]N,5K
MX;443.1MMP=_=D8I!_ZB-@#VWF]7NO H9G+?SC>+AUN_+2 U&2W/GZ/5V9LL
MSN;5/##XS 3,<K(GN%N[DZRU@F(/0K&=:9Y"M)=2$85$L ;<+"^1"]RAP*6#
MU?6!2;ZVP>I2S[I9_UKBOE9%T^=)48HZOYPZ?YHF)1>-XYV# +3#1!%0B)@#
M*2$6F1Q:EB9XGY@6B8>U#8-GD_5>1*-7*2SR=I*3?2T[?-5B)(O(1![G0N45
MK:*^'Z;7<UQ'6[#LH6'@J1TRH6VR@%L>& GBVF)DG.-(!ND)=K#27E018(:?
M &0E>/*J@R=7)?!%SQ=(S_=G BF"4QF38$@G'Q%GQ"%8<P,_DK>.6$MR@S1"
M28FBO$Q'2WLQG,S=[8U2[?MQ,&@_@;RLAG.UV.1E5#C;'Z]N@;&'QH.GZ$I0
MEBMLD?6.(:Y(1)9;A9+SE.<X,$TITQ4L9S=\2B3E52C[7",I1:-?0*/]##$Q
MD3@25$#:TH1X3!R9X.&'2$0*99QP9&U#J=G&K<L<3%EH+K+="8])K![=Z?6!
M[PR><^B>Y0*??.%W)P&]ZL3">3Z:Q8;S96V$5'(.?T7@?,+>)+-2I6 1#DSD
M6F2"'-4Z1YR(3%&(Y-*=31$>YX+.0]L6O+5WP=J"M:7TI6#MY>$,KV8I!1:3
M10'^0=PXCAQ. FE#><0B>>/MO.I?%@!PKS<LGRF GWUEK@HK[M5$XL93O>I\
M,:RO5UISG/-6!>4J1.LM58&&("UP(ID.J)9K/^V7\4)MIBE='][<[,]?W#EC
MJ]4_[?9M^QT(Y&E_IVI8 K($+U_U>MB]FOJ37VUW\]["XK3+V!^CRV5S[_WW
MYO$F;FQMB\96 ]#EC^/=K:/6_N>WQXWC+T=?]AK?]T_^.6G.M,MHD.;6-FUL
MO3]O['T];UR^OVR\:_#==_\YVO_<N&B>O&TW+M^VOGS>I_^]W+G<W7I_P+P.
MB46%/ $FQAGAR*9DD.8*DQ"Q#9+<;)=!A/8AP1N)&ZX5& XJ#=&28:D#MOIF
MNXSI-9@>#7_:B]]:W;-^^Z)V%-NA:H.1VSG_N*G%K<TE?GY)UV]!,D43%MRZ
M(+C!T6D13#11>QE)Y'%9VXB/!E<U8L@ 6:N4H?;;5N/=3WO6+UB?G=W.#YMB
M6B>,)C(H(1G/_5"CM58;[+'!@M%Q % 2@\:_7&<PN1?1"1SQ*-B+W'9ETACS
M!\-1ML>MR;?@V[MIZAVR<O!QR ^$DHI[II''>:")B %IK212+,A<*\@MXVL;
M_SGKQ*$%(*9>&_8HN*[?UWLKYE[+[3CNK3AN[Y[[R(,87_6.SPT4=T\'9R?U
MFJWUK[JFYX]^ O8;P_^)MCTX&FG L+-\QA>09'MXV(N'N0OEZ5G/']D^_ *7
M$1_:7^]1,OB(':>_1U>YV0FY5_PF7'U%F3?']S'^P-_Y+A:(+S^[1;O8?7_
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MT/;[>=Y O]L>8TC5;'MDN+)!R'?;[4\?)7_OZB*O6GX^:*2%4 J\R41"TEP
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MK#4P2;SV4,=SS[U>@)XYN:":P_7D^ ?\[D]?) 5V/O(@O63$(I6"0!ST9N1
MF4<T&".Q8XE2?WE3$[6$I*29( "UU&ING<Y="K$F5JWJH5X0N?#FTQ8\S![
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M]::);?S3#8&&K^& 2S!1&_Z>8&ID#"IYS3GE6FBC/2$J1.R23FNK+#5!./R
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M /"TY6@* "P" .9V"LUULXEQ""=C$<?PAXY@IS!!$V U)SY6U30E$6W#5@8
M7D(V[%\1N-!W>]WSDC2CF_)CQX/,L?-CJMV*>5II.#C^IQO^8Z/BYVY_DF^9
MW@R7MUP$OHRSJ\?V:QS=*\=V6?)3E_H9+RH3]O5@>#( <HLM&XZ[_>YH/*SB
M>ZW1Y 1^&+^PQGEW<1,^QOGA\-G^/$VZ_ROF_:@$;WT;#.]\]]Y\/8G]43F9
M<E=1?*%=7JZK@QDE*&+'$)?*(V.\0PHKG.MD*1&G=5K@FWOX#)<OC:MP]:,>
MF2U<_>!<W;"P<?":2(=HU ;,[*214RH@1DSBV&H9I%O;,+3-V'V*+Q6F7F*F
M?HQ#HH6I'YRIYU:SP!Q+0P322FG$+17(1<%1(BXH!G]GV6UF<)O@JPTHGH2I
M%UFI=06LBH:M.S>&:SNV=,1;^G)%Q<EW;[BZT!P/# ># ;, GQ)8%HP3I&F(
MB-BD=:0J<"HK)Y_A;7G_'IZE4=9S!(#'+.93 & 1 # W0CB/DCM'$4\!])6D
M(\J57W/3;A^XQC1B6@$ 9VU&[EU^O@# <P2 QRQU4P!@$0 P-UB4U]1A&5'0
M.;H/GY&1P2#M73(^:$)83BQN"RK:FM[[_/HJ-LU;>JMF*[IQ*];F>XF++(6A
MLIU[@,31>+,?\NY,?2L%J>Z&5!<:XUG8,^4#1=ARC[B@"CD?/"(D&,)(P(:Y
MM0V&>9N0^QQF*@[3)>;AQ[0U"@\OB(>;7>Y 0>0ZH6B=1-SSA(SU%F'CDE#*
M6RGDV@8'8^,Z7:/P\+/@X<<T%PH/+XB'YQ:#5IYYZPR*)A'$E3$(1#-#$2=.
MG!:">[ 8N%9MOBR!RQ<5XZBL@9-A/+&G.>;7;@UCZO9MW^=(A^WG5A0A'I]4
M7.H/[?"@-*=;@F2JO&M_G&_:7_,M^^M\MU[7FU7 ZT[@U;G0L8Y10T,2$?&4
M!!@1C"*-%4=$NUR%1GFOS=J&-FU,KZ8TEV/4SX*E'RN3JK#T [+TW*;(IZ:3
MPPPI5C6A% YI30+2-L:8Z^!YG=8V&&MS7%AZA5CZZ2R*LS@<!#LZ+,S\2,S<
M.'4D<+"8&R13E9 0!+)48B1M\II&RJQC:QO_[_]H2N@O"PI&E'C##Y6"NT?2
MU.KZ.9;,<CB/BN8=V1GT!Q>CH\7=\4.(=*&YFP2UP3->==G,ZD7 R!I%D9>.
M^UQ9BZ=<2E>VE5A4UZ/BMEQ"=G[4+*?"SHMEY[FU8#55AA.')/4&<<PE,D"W
MB 3N%#:Y- 6P,S5MQJ\F:!=V?C;L_*@Y2X6=%\O.C6IJE'AOL4>2Y)+2S!JD
MB>,(8\%I#-(2GO,7<1M?4TUMY>M)KT9)M>UY38';EQ/XP8RR>J+7-9=ZL2T8
M%[] ST8(/&Y&V"Q?]5=@A-?G?+![S@;_JKB@OFXO\T"GVQ\,N^/31A#[XE/>
M_'<"/W?B^'  OWR&2[)SJGB@[BA13IOV'O4R)NH$$ICGM'@7D176(N6M<R!I
M'*%5W1M&=)O*>]>]63AW/K%3NN!TP>F5MKT+3B\S3C<,^2!E" XT?Q[!D!?$
M(Y<B0\$H4">M%EA71Q>)$6W.[JW\%YPN.%UP>HF<*@6GEQFGYQX:1P3WUF.D
M",6 TS$A(YA'A@))4"=3]!5.8Z[;7-W;Y[HT.%VY>/XQMO#21^=;FOD6S=:L
M&L/YBM7SAD'T[,DH_CS[\$OHCDYZ]O3G;K]Z5'73+W65R-DR7M-3JUJ3^N=?
MOG3#^/!G8M8YYQDWIOZMZ8NGOZY7D')I&^O?C%XW^.:?\3KYOY?\9[,+IO-F
ME82[04!>((B;M_QJQ<4'V4-YJRV\1/M5J[)&:[CI[DR[J<^F,.\45U-LMQ\
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M-85OI 5,($79>AKPWF\J6S8(([CQ*-HH$!>,(<TH1I82'' 40D</X"W;1FM
M[ZO]*'[,2%T0LRRY?ZT 9@',.P"FQCIIPHQ6PG.AHI'&ZYQ#1[S6F!9M]^D
M<Z[M,H&CLHP@2X@%ZY0P9)WF2'K&A% V!B4 ,%6;$=)FYM[J[G( YC4YN8W<
MQJ=/721FG1K]#'N#WJGY8M6S:5F:+RYO:\YI\\7CJDM9U=QC4+F!Y]T81W?M
MP_@( >%&.[7M_F9*57YZ'+V=N%$W=.VP&T> [@-??;O9#[\/NOWQW]->H2N/
M^#^>I+[-=K8.V,[9T9>=L\[7W:WMCP04WBCK^DH><<<]<A@@G&,&.Y0"3M8
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M3QI,%5#.*L ,Q)8)Q+FC:Z^1-U[9D^,U(K$BL9;0D1:)]?S$&CWU@ N,:$J
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M V^J;A;3/GG1:^F>;70+89^X+M"#[9E=7:#?3[5J506:_7S;_>1U0$X4,2F
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MIYF1J1+A5(ZUUT3(&B'3.F@H,BDR:9E<7Y%)TV#2T NF'4N%X@1@SZ.P-XB
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M:F:=Y,58ROT?L5Y1Q$)%L/"[LJ=\A HQG'<2*ER=#3T!$F+QTXB$2B$!88\
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MZ>N;JL<.U[&<OL>.B#I7S^%>5(I/O;'8OPG':^SC'32SU.IO&H2W=C!*9\!
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M16BM)K2>H%=ME+M6!^V-=J?K7]_Z>>Y:G:AG30RMH9Y%#$VQL!9H2AWP(\J
M5DP#8RFCG#N$D%A[C4B-LJAH169%9DW*K$UG>T5S.Q%3$V)J;ZA;>19ES*4.
M0&2].:BM!(K)#$@!A;'.CRRQ:Z\QJ@G)(Z8BIA8$4RG!1'#JH(*6$IJF*49,
M0*.<XBE/8?!4/9<9&)U4CW12':QW=_8#F=:_<4ZE$YR!--,44$$T4'X@@=4&
MR>"C@HA4T>2;TG[[$FPM(/4<VU23]..R ?NN1UP:8,LL2PV17MM@EEJ::8M3
M2ZRT*;)8IK;86I!Q:Z%BU/XRNK7@E'-,6@?\<BL\M T"&AD%>"J<P4I9O^"N
MO6:XIC!]*K-_P\WGTB4CFE833=HBAXV2D#E(4V:U]K\B:!B5-(44!9,7J;[)
M^_#V9]Q;F#NS1O86J+(H<X(!+(5G%G8**(,%@()"G>D4:99.3=&,T(K06DQH
MQ;V%^4-K1-&R2G*890 QQ@"%3H"48@*RU'%$4"8P$:73#K'(K,BLR*RXMS K
M3(WL+:1$I<88KTP1'LIK0 O"V *>*<@AMEP:MO::\QI!*&(J8FI!,!6C8!<4
M3:,;#)1(1[WF!%*<<>"7%P9DZG_3&/N!-(H+IZ<4!CM%-,7,A:OM!1DS%^)^
M\-C,=IIX@1<BHY!0AX16*7<,49-EPG)+"F:+R.R*,?MP='L!$6$012FP5$%
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M<I5O-@?2.,USG5,XTL'?U9+DKDR@RBWWG+"@G:CR5F0?L#VUT<N+4G5.]BW
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M.W0!"NZUBLZT>W.Z2OX[ 9/(CR*AV-QV>P!#$S@Z&J:;;"UY/YEW">)WF*P
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MP=+ZRWB<?Q^>G1&LE_6LZ>,PGN&3Z90$=_X9AI,JT8$@^R-8M+3R@V1:2\=
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MX&UB]="!<\P^RB9AGNX0_V1:*WUNH-[!!^8WH3Y):7Q!HB1!XO +Q#,<.)Y
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M\CM,\G1@([BDR)(K7&:F+2(+FB9!#JZ BLE);3OL9EW?]ZBXTDP1C>-)5S[
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M)[?CZY% GTARDW01D=&G.)K6'EMW$VH/!FPC4X^::)"VM82R >3S^?[5"=^
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M ;'F;M:;WRO$3\//+Y<MLE<Q04PJQA"8(Y^>:4\H@TZ9J8P$+$:939.DD-M
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MR091E2=G9_-[,RLB+U$E;APYW85QJ(Z_K3&!FBVER0_V"#99WB24MAG.]\B
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MPIW?OWK[=G0])C*/O^)OI6"ZGN7=3*I6?D?:#4VVWA;RT<$GIK6(#*PL+*D
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M(0=K<:P_D!AL) NA%LJM=:"48T&'R*1,!80BJPV:]$/9%^B3YE!3K31(+'^
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M)\<,1#+&/"^X;@"=>%79?6S/<R:<$5_.J0/90T-\/?P^S&1MS 98(_91",&
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M7KU8]>^I@W9K+O?[/%WT\#B/^1-./^?Y[-WT/RZPUK/\3E^/+R\GF'4I!BR
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M--?@U/R04\Y?Z\K_H"43^TGH]+N?+\.P"[27TAVA$-&Z',$$+VHCG4!O HO
M== 1HW3TXK4@VHXXCY#$V8=^)\,II\'FU/ =7 V7Y\(;QA(MS=5LZD+F:I )
MM"R*Z90T8I/97ZT7-E0&R<EODB?%H&/GK]P2RB_KM==/?3W-__<BG\<?BYM:
M'S Z379(J868M#9RNJ72].9+Q@RW+(LFVW(';,?*<CDM+MU%])YTVG(WWP9P
M?>'; 6++LK$.&(]3.M:[?N_B3\_*.1*/+'-.18Y0"!<H'ETM+]$0M$T^IX+)
M-?&$C\:?!PK*3H$^N^AD(-K,+G?I=19(E 6]SZ!R-7BUKLTWLP21F7!9>RGS
M8+S9!'=$'[@OK79@S4$J:7 '=.W-N?SK/\:9'+/XY<?;_#V?+5X>S5A4=9R.
M4YR@*@S@;"1/R3$N% I./VML+]T#[]EDNM]DZDNS#>(I6]^1VWA7;V,7L$/;
M3W>B/;HEU9O:N^QKO>ILJ//Q3M!%N8S&!XC<(*BD%?A2,L02>3#6Q)*:W(*?
M ,&ZFUJGP:]=5-625XM-?+:0 %^=[36L8U%ZL*86HINBZPUO!(E1\2!YLK9)
M+YI[,)V&E=63-N_BS8&J:&EF78,F5M"BBH8L/06\1#KD:Z-1QR5"UD$CQY*#
M:3*B_!Y,/QM+]E'%0'N)7$-+Q0E5."A!JB0""W"T6."2YZ"-,IC;QO)O8_K9
M6+*/*EITW+_T-*[RB#^,9_^].'=YMHG9C*!-;8)=;Q-\-K+.?W&!^4B[79M9
M)_> >G;/MA"L-RTVZ!1[A:WF=]1KV4_T+]>C83I@:SJXX1YP1YK<U9LJ[^1(
M3WIHFC^Z!:.2S@M/MI;UCMX2;FD'#@Q!%HW!F1B9;[P;#<61A^9T'84BNXB_
M 376:1<?<)Y?XK?+UE@:32D,T)M"1ZBLS5*J9UB*Y RY0-YD@-M6-$?H<]^;
MPFZ-&SI4V@W\GNM=1]].K@VFLX4A\YZT%(H%E:,$+T4!HX15)J6LVP24[P+T
M;*-LH50OVFO0G74;KO5]30=D35O8WPGM2+WK>U%A!UX<(/\6Z>5W(RQ2>!&D
MA[BLM\$(3FNL,<HDN14RQB8VR=#,>*A/_<#$V$7L#0CQ;OXE3VM6*.V?9'LM
M2W#6L4&+0:)40'LA 1(\DS^O#:!6,9G$R-=OTK7B'DQ'Z#/?D^HF;>1^"CTI
MVM77#U89WZ6F79,W(C1'P;14CEOZ?P[:N9*SYLH\W"MARVIV4</'91KHA_QM
M,JW%)7O(^]9''"S8^T%M2-"3X9X]$SPXKH1/3HB<2Q !992&^=%]^ X1U=ZM
M/.[XH-[%UJ%5AY RD\_#R-4QR@;MG15&.QG(;U'2FEO".ZPUQ^:G?;SX6COH
M3,KJ!V27?\C?\SFQ??6=U0"$6E90)RR\G<QJTX:;MO?E/U_^SGQRO0O0\GMU
M"UZ63UW09UU-5?@EE\DT+W_G$_Z=#]AV'L_:>B?:Z2[U7NX'%Y-C=-BZK+SA
MH1C-E%%,6FY]L+>X?[K+/'2@T,UU7NL!_?:R<B)H+F4J D0R I2U## *#449
M;[.5PK@F%Z==P!U>9[;0XNN5V&N<Z#_'\R\O+V9SDO3T<C)+-:CH_XED/\+D
M@PSUXM+'4DNG#/B@)5B?/5E7,J;0)*:R!];A[=O>&76[^*RMQGJ>+/I^.OD^
MKI[BZ\GTU[^_Y4BO^G*J0MTB\FQ4N R")08IF@1*.@58H:88<\AD#WKG'SA_
MNCSG"3&A=['V/(5D#X;2>?*N7%_3G[33GYW1LL9D=+V(<7)!!O^(D;UF'$N0
M"B,>9QW ,5? 6J,-LI1\[C)UN!G )T:RTU!D@]2&1;1@:4R,3"Q*!:W *$Y0
M9$%P"BUPD22B([N(-VD4=@W#$Z+-H1)ND&6P-E1'DA6KI;2066&@M# 0E!#@
M."J;9$K&-M'T&L 35/->LFUP4[/%^Q@E;3(R) RIT F(0H)/11,+:RU,C2R:
M)@'X+5B>H.8/E?AM$NA#;(Y[UOMR,JT=(.:YVDGGU39R*6F=DX(ZQ@F4(L:Z
M:@Z[C+IP+TW8[%>PU8S8Y9E/B %-Q7V;%J:O]) 7Y^E5#O,5K%%&;H7!")S6
M2J<2RU#G> '7B?O$A=5M2B^VPWE"_.A1[K?98 _9)"J,]]/\#7\L5UZ6EPKG
MGVM#EZ_?%NS]@M//Q%DO$X_2:)"JND]:60C2(<B<,Q.J1LVZ;!'=G_B$"-!0
MU+<)X?JZL9W</-#6=-79U_5+R")E4$%$"%858%9QQX0-OLVH@?MA/2&V--##
M;9;XPP^1M97SNFN$^O?Q^:3.\;RV#][\E'7;[?F7"?WD._W*XEIS9% Q9PVM
M+>C:_3.8>E\=2:A>*&^5R;I)?'7 -3Y!_IXJ0[8$]PY.M[Q'F%O\@LN>:]$P
MSUT=5Z4%'?WH!82 '@S*;$WP+JDF7<7W@_L$.3J WK;0K8<$[RXOQ6(8,PL.
MI(QD1Y1D:IB)@\UH=$QHO6_2=.3Q;7B]Z?K>+; //36=;GF/A'[YL?KA,KDY
M1.9UY!$PU&ZVRG$(CE=;1 OK8Y!6-:'6'EB'ZEG8?J]JK*=CMQ&\.;.+UK(0
MV2(U%K5T2D55!SR2K>OH'72>D0"90M0IF."Z&( [SKN[#N'X(S ;*7WK-+R]
MA=]L!.(:T2HSM@NF=J,P;X(YYB#,_15UK]X/D/)0#'!%*K_825$@87,!G#,9
M,M<BV:"B\PWFX@ZA^4X#,-LJ?A?AMJ@96)MCJVUMG;?.64)II*;3TU8OSS!P
MB!G08@H6,S.^3>AI.YYCC;,\1%EW75H=(.D&U8L+_W]E3OQZ-OZZ&GJP B>D
M\S+( E9*!\J["*$:S5F):.DOK+091W$OJB= AOZDWL)+F>-\86>NAV&L&;NL
MG;+9HPP)C%2%3!Y+R_9(S#61>YZ8Q=*DK?2]J)ZZS=B_:AID-JVPK*LD.X!I
M6:5Z \UQ"E-[U-;V8-H!HFZQ;]P I0W3QL4 02<-*AH#KB0)// @>$@^-@VX
M'K'L="BU[R+AGM-L__SX:HQG/V;CV8M::'%6BRC>8OB8I]_',:]-&R&DR<QJ
MX,9R4+H65691<S&BCHXVNR"[7&1W>MC1@IS[*&/24I(-C,079V>+*](-TS46
MZXWP&@HK"A3/'+Q.Q.QH)&,^<V)XBU=\.YS'R( >!=QB0[\(*QMU=H<['"2K
ME]\&HI<65"%W&+/-P*5G)0F)O,WTG0>1_30&8:\J:I !?2_ U9O3!6)34_%A
MC$<R(/O5[B[<.4 U0^]$ZV9QC#%=:\P(I  ET9#7+ TDEYCP+)B@FB15'HT]
M#YFA1R?/+AKIV4#]]>]YGI[CV<?)Q?3*C"JQ%.Y$@$*&-NVT0D((2H(Q6)@R
M7$9N.QBD6S_\".9'WRJ8]"F_9K'*RU5?"YQ=MEMAAB?!/%E>RH-R3 'Y5AZ*
M%8%E5P394>WBE?<@>SKL:*.,.U__'GO?W-E8X%7^-LUQV2< S].+K_7G_V_Q
MY2H%-*PMM@:-*O9X>KM6$H>*8J/90PG2*XPQ,*>4%9F^]*EXIJ2/CIRENYL]
M[ %D@'8,R1<9)4_$8<.6&4J84B3_#+4W2HC4IO7T$.T8KDO\Q4V)CZ3UUJ4<
M@950*[J] D>>*123T#*?O'--ICS<@^FDLMKV8\CM1K?]:*#!T;N/7QNUYX5
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M0!(VY2  %)VQS3CT.5#]LX/;T_BWN6\;#M9F!B^OZR/@.3\^? %02P,$%
M  @ [(!,4B&G\9GRR   ]<@  !,   !D=F$M,C R,#$R,S%?9S$N9VEF1'=E
M5!3N$^Z22W=W-P@L7=+=2(?DTMT(N'1W+MVQA'2+="X(R)(B)0T* H* [OW]
M[_UPY]N<.6>>F>>9=\Z\:AJJ$I)V[.CY* ^ _V<@   , $ ! #@ @ 3P @"\
M(  O&, +!?#" ;Q(@#$ 8 P"&(,!QE" ,1Q@C 1    ("  ! R!0  0.@" !
M,   !@+ P  8% "# V!(  ( 0(  "#   04@X  $\K_< "0(@ 0#D%  $@Y
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M?MS6FTGY5$JL?E:_@JZVAHFZU6I3RK9 -?F=&CW*C!IN<4(0;V"G#6_3+J2
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M1LXPN0YJTLYT7'UG".GDT8N2A4<6A^Z.E\*@PQ;5*,SF7LQ3+!Q>'U%7%&K
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M_(:$5+%,MF49]*,B$<8M:NH>X_(G<PN!/'(]HDB>>.*6E,<RN4-M6&F^U'-
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MU=]V+ZO;O!^)UBM>/#R&2@\]\LZ_EJ" J5Z93"<MN?2&9:\7"$J2!C :1^Z
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M3$JO9=)3$RTVO A!H ZA"H,"K>@5I\A0^UC*=$K3+%J8<"Q2U#DP+%"X A\
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M/U0P+S25VR<:WL#<KBL'>&2/S=DZ'$[$(FN4\\\;+P*"2= <>U')OS!"#4=
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MQ96\M_4)V32O=@MV4AE>73?G<;8]B 4:4'&)%JZT&T>>5WP)'3*M$5&/$(P
M5A_S[8P[/6:48> XZ9[<!VWN$'7LO0U6$R]J;0 :URXM$()<<\^60SELQQ0/
MJYP$JMNEK(;Z*>$,&G=#>*%C5/X>5DBT9$ZWC/'(_V][II?FNMRFTF#>M7(H
MA]TWX$"6_ENJKL'CQ8TH'Q!-J),68EVF*KH[[VTF=PB"(&6&,,Q62JQFN=LB
M*2@H:7!U#=;2/CU<3-Q59RW1+F@]JB.)Q\O]^COP,X]24IG*MTVO5 B\0"71
MKP^?M&;K^"Z\2MED0K*&X.DZ2ZJ!=WWFM9M=[>R>ZD;(_Q<",;MH,'UFD>]Y
MO7( \S1B;W&@AZSG,$P8%#F R.$@QX\'.2H<S &D @2&%AXTA/#@X<.)%BE"
M9*@Q8H6,'"5BK AJ'\F2)D^B3*ER)<N6+O61=)#QX8^/&S5>S!E2I\>-.3 ^
MR.1R*-&B1HM&*PES7U*%#O^.0+1H<RK.G58?W)SZ(X?)I4E9+MU7+UK8I-'>
MY(#P$ C6@U3?\GQH4VK'AQNMWJSXH*U!@P0'_OCQ!HXF3:% A4JL.%JH:,L8
M%[2KUF+6K'3G7J7[(/#1SBBCP=EKH8)DK&\KGP9YN2/#B6H%+B,9MF2]DM$>
ML,4=-R=JU#I_YB1X$IIGHU^9[H/3^BISG@V;-]_\(';QH8QQ1*0\M6?JY3ES
M-KR8 T[U\N97UDXYFV2T: [84NRX&SKXWI-W3@W94$?'@P81(I2##P2E801A
M<""FS"F/-=;8,HWE5A=OJC7'T6X,U8331#E0=YZ'']J6@UO9V5=B=Z=M1AZ(
M*[+_J%(T.>AVXDWUG;@:! 4]\,9)Z:5T7$O1:"*=10696*2,X7W$DT9L 5@0
M03_  4=BGR'G(G)[66A!:J9IA)&,KE641HLNA0(C$#=&E.&15<W'DUND[?6&
MCRII\H,#][6IY49Y:D910S".-.>8*VD"'&M;,N===AA)&!Y&#B@SJ&U<JI;E
M1!)6:.2>'6DBJ*2?OD326/O@ *-$%>@@5TU\[GG5FA%MEQL$,/HUF":@M%<E
M44G!H68%E>WD'7UR>0=<1:'H"JJRMI'JI:;;#2L5L7]JLJRU*J4W)V,.=/2J
ML$HNFI9]!G7*%#U%\7B28[?11:N?%;EJ6;1V:><:94/N_R538%+FJFYQIK6)
MZ*4RZC!D&IY^&DUD&6GF;7<3.B315DE%NE)H$\GZ+:,",\>10,B=>ZU)RHD&
M%W[R&NFKQ-.!&LI>;,;K<&6:Z0"E>B*?ER["),7VHG] +20:GY(]:V)% ,*X
M%92=YKKSKIM@=:B\0W.7<L4X6_L?!(Y2JC'5\\:9+-8XPU1;KR6/"_:T$MY4
M,*H=X>"TO_O M!X]9KUYH] Q?^U<:S@M! %;^VWH) YJ@/+8H&:"I[:-,Q(=
MGG!8]UJIU%RW2J/7F7'Y4 [5GM1A;#\$#9$%0&R,:=5?VI3#P:'C7"AI,#I^
M,E7U$KV7,G*;=XI;*N-D9-_!CO\W-HOKH<0CKP6AWE-4S17--47 0:0FEA6P
M):*(_)K%HB8(#1_^3A8]@"QMQK>8U$#WY3TAQ#2^#^M&6X&.OO'MX;@;M.&[
MEE5%! F*=RZ*1AKVMJ$N04QZ75/@WQ2()0MH23= * @.!*.XXYG$/0Q95)_Z
MEB3\1,0'8A+;H& "&<V)3W^;0I-#=".GDY2-/3+IWU[")Z,6Z@UTR&M1NFSS
M/<LQ4(&U8QBC=.   5;',3(AUN-D1B'X2>0!(\F@_9+(GI*$;#:,H5U=I+:A
M#FZI1+H1#0ZQ)QT1O4$3IR"AA\P2&B\-T7:9LQ02JUB<GS71-VMSX!YG5@$5
MV1%K+]+_#00WQR45/I&)?B)?0RH@AFCTL"NA8D^0G'>1CQ2D1LYZ(@?U=+3<
MP"@-C2G*#HU"*YBE<).;@L]>7C>W3ZEA,Y;:I-],MD"<V.0'"$A*AT[BLLC\
M))$>J24J,T.3N$D2:S^\7!XM%$3510Z7%7! +\?D.V@F<(YZA-]."E(NN@42
M1%_)%E/R!T$#1E.8JNQDU2!&$+_ H5]7+([<-D&D_4T+D5-3)/FN!LYPFD=]
M!8L@*C&C.4U*)#LY$ I Q[1#T+P,(JJ1YG:\@TK*#)1AK$2C2R().UXZX)YU
MB0BC3'>9)E)-(D#(36[V]94Z!A0K>EH=^>#%,"2Q[8.F4<T/_T:(,]"\J8/!
M.E62&O@MG/($*P_0X6=BV1J0* IR1*14385V2?GX5&1D\:%2,Z4:&YV4GV+M
M2S5;Y+)L?H>?#3QD:8IID>(UM#QS"IEMG"H7)@FM6VE;G33#FD_<A%* 2REE
M *F(G-"PB6N8(RK ^IH[9V4D!^:+ZX=@9%$2*=9KWN$FE_@3G@I\D[(8-$E@
M5"I3L.93CNR<FEH0,D79&)99-V/*Q>@EF2*J;IM2[2/7^D(07,US)3"]H@F#
MFTGMN%634\T+^5PI*FLI3&A\/*A>B\I;14W$<S\XCLYP1#N"SH6=Z]2L;APP
M69(01YE4A2S8B@0<S.7@M8,J4TZ%:O_#<?T-KJ+U4,62$HKW;&TT40GB>AOK
MS.5H["9!$X@KRVI%EYP-FW$<9FJIZN#]&B<:..@?$$TD/F%^#L-C,LLR+G4]
M)V9N8Z;14\'(M]T>_0BVE-P+7OUX2TNEF,(V:FE@0GL^-H(()DLTC;'XBN+P
MZ" \/45?+.FS*$,.$4-MZ5!9SHJQ9QI4O/,!20Z069(+*ZMR70W8LQ)8'X,,
MMS,N*Z-!59MCU4K%9B(^"L+:0[O-$ LHCK,E'*U*D'BB9"GI54DI VUHI@0I
M6LJ-%DY\Y-$YLT1$X-IG2F>FIXGJ"-+GH2M)X "C5+4/;%2SWFT[DM65%+HD
MD=J*ZBK=89EVP4A$/CZ)/UGD(Q$QQ+.N4:Z6*PP4YRHK*2:LTRQ3J---*K(U
M#@"T6$SR/1T P2UN/M*%(@K(0[/HT4&B]'4YV&OD(A=2:3;*,@!4;%K&;)M7
MX=2X(<UI(+WG4!Z,'FHB:!#"R'9%J2Y)'$0*Q%HV<V:Z]ER@-/]-2J8X0"XT
MT>FQPTKF)]+/X-5!WHOTBMH;4YJ#WQI<]@"Y[Q\KI3:%BE%]67-))^]VS(PZ
MR$#D21).)U,?M1FLC#USFPU65YM$W6NP[$634R\K6W>V:;K5F51XS>A4$RD(
MT,NIU(3F^,@7 65\?[Q5K?X08.-U.*,U+CF626J+%_=PT5G;D8+)%\@27P\O
M<60!M\'GW#2UW=&G;I ?S+KF,-3[Q&=,;X>9.2F/ECB5<(W9,A=]@>,C3[LE
MGI20@2+4#]?ZA7 \F2@JN]WZ\%$TV *?O0JQ3=+\R:?/&>TNUR^0[J)NZ%%.
M4JQXUM2-M_D_/6T1EKY/Q7N,2W:DEQ;_T52=)/V]LZ4!OC;GS66,/U"[R HU
MFC:GDO*H"4^MTS?F,@MOW21:ZNS#B;!S =4R#==^CM5$T.8I_P' MM_W\E9\
M14?5VS@!,^%[M.$(CM=2K.+89AA:?RLZ57BPTK3UQM>\5X" 2)TD&9Y SZO4
ME+B 2?5L1@Y<#?U=2]=@G$Y5VB5)1]-="R@\$/9LD+2P7I& "012Q)F0A@.D
M'DELFVD SY<HVD9=FU:IR_>\#/\E'47M!G_<2T%88$"5B>@]S**M!HRTX/_M
M7968T  2D_/DWPZV5E1DEVZXCO"-#>=YFE=Q'=4X8;<\P* I84M(VE"I6_0)
M#F7HUQ@.17<5_]D.NEH>@<>J6,!X+,/'F41Z+$7/%!"-#<SF,%S\!0_FX(;D
M4),=K4<,2I415MY;+1_S@<C,F81"Z,5SR%VT$"&J^%D.=$^G'02<'!@G\9SF
M8 2'=*)2J!=&Q-[A'9E;5<3N) P&>EU5&9,!\2!D?1,>0EI8I$?DR<5]U4C<
MF5A%Z(V<=-^*X" !&E0'22$&GA<;?H:&*5P.KI775)7#L>)W)"$T4LE21,K%
MG&%F?56F3!5^B,@S5L<RW$EN$&.C;)9:X9-4E,Q:3--V':.MR<3VV=3X357=
M880*;H8'#DKW;%YR"$W0!&+=&9^.1<1/V,4ALD?%*5T!ZA]O@8M'!/_&/1X%
MCY1%UKFC,,F?EEG("K6&G6CD2H @[$W:_O#9;F"4%'$CPGC%#V348^D3!VE'
M=)S.7MB))E!'%F%;L+W@\9EA,W5A/G$B-T::T*PBV:&0&8)$D@B&4AJ'2&5@
MYEC&MYA=0CU$2+6;\B0'CK#CI"$26U$>(45%]OS !9T$S 7;22@BF7$'ZU55
M>*P?SI280XX1T9V4-99==NS-%4X*'A$E,867A/!$QS64ITG8F;&7 >'.XY@&
M1$I**/C;1V*F8597-IW*>)RD:%7<7.;3.U85I='A1= $$#B &BQA%57.-H4D
M:4*E15E$I'3(X!&>^M2$[AF9II2E78085:[_!'&8$!Q\H6926\]=A6I2 M^U
M!,65RGUD$I0]7-*M#5L,1-K%5A9*%Z7]'>^]5:;A3#T4U\+<7@G*('5QG'PD
MY3XLP[9]UA-Z5=2U$&S<#&X.RC(9&2GV9I:I#A"VS%4"8SBV1G#FV]H%EP\9
MW83I!YMHB$$T'5U]IE$P9N7]W=18QH0VE&6)5P%R8;?-".,)9TJDRW0ZB@.2
MWY;LYEX$7W6 GS(,8V,R:/^(BUJH% ($B@FYI?TD1$G-*/0$D^Q1R;5L(03Q
MY?-=:"!^50LM54F8J"OZ7/2I(%=H"_HDFF3N68D467;@@':NB&.XW4TYY82-
M)+-!XZ,I3.#(:/0=_]_ 9,]+.>>R"$HRLBER,L0!ED\R*:7ZI$7JB&(KOI['
M&.B(+B%0U2G\+59V+)EGZ -U](SMX<F-V5?7N<E=[D/UB4RVH---)FFQ".28
M1))CD)'216'#O<K"M)9G,H5TS)0A<1O5&,04[:B<9A .+A 1]@U6JF$0FL>:
MH8CK):FL":=7P)9E7EZGOEI(!)5:A!25_9.&@L5G;.&A\HFEM">AEL300>%-
M\D^P9)HNBMC5U%I29-),8<1I/N80O5XIUJ!1).*O/,=5QF/9Z9IT4 Q K<>6
M(N:/@MNE"2G(B4Q@9,3;0!_8O 50W,4#'-$^N(R-LHV\IAQ]+ 0.Q :XAL)9
MD:43LD9L/T%K2?@.9ZK.[60L*_;5'PF*Q>Y74FS"B/AFEL8G1JC!(\;8V.!@
M8XKD&:;.=W@I-VZ>AGD'\%"K?JS-H&+K2309*"T2<HGL\ #'PK#%6AYH9PR2
MOP*JIM1A4'2LA\"$+1:L63YFC@T.0H@GV=C&FI'/*#H.N& L#G1* &[,%U9M
M=C@71R;HB@R>?@9M.^D9P!1$UC)%B6$3EB'K'!(MH4+4.>U>XO:G_^ +;O0'
M+X'FE4:A?5E>_"$7A_\4;;;2SK$^99WNAX;DG>&Z)T(DU *IS*W2G:]Y!$&U
MTE?(G+OZ4B..U?'%)K0<!,7.F41RYD(*D3!MUB/ZK4N\R%C.;H&E&WC:UF0H
M1'1=6KW4+F>-'Q)2U@LV9=<J(^0H$*2 RL?NK9^"GB#NSUZ8*<#.F1Z*3;D>
MC>6YI$5>5VZH >_X",J:Q]GPZ]+2';*,DW"JCV: ;\-8'$XQEE$ETD(1*J8J
M3$WZAX5<'!,MEH-&I6TES3;:''QZ;U].E$$)XD!YSJ<"E,I1'F:MI&S2XI\L
MJAV9)V?QTS5&#G69E "63W>B;EK=4KWT!@#%Z;5T) +AY&A:3C^61N0$%4W_
M@%UE<HO (!4 2U7F)"9,9BY32!N'[9]4*6WP8 4H[4SPPEBM>K!-N:H"O07U
M2,8/8"I5OHB)5NL9\MQ$/4"["B?X[<,FY",#O]D4&S%J .0#>-D_H<M)O %W
MS!2*\A4CG2<3IP=^&H\9VZ3K7601-1<6/Y>+1)Z^SN)\KM8X*LD8M1"<G8QH
MMHGZF82S6NGUL63T8&"%Z4[6VAE"\--G 7*Z7N,:0B*&A6H-V=8')Q9ULA,K
MW0A75.P>7XL=8.Q!V?*K^:_^H>.(HDWHI1RT>(L.=&D3EX1EBD:&#*.DYI]1
M:LG&=)F(GL<@W6FQ\=_DFM]F.++49A#7.B6?'6Q;_\BLM1!K!BU135;GO/;$
M0,D;J3Y'AF34>;9R$T4<MM3MB)V$F.&<36SR$+G3 P3O6?'KJYX&+(_H>_I'
M)G-J[7HH\+$QJHG,L&UQWJ*;192S(!G>AJ0NU8!OMQP?-Q?M,O1Q\^P<8Y7J
M'$-'5';$#Z3=K+)$>D577:1%':/H[TT&;C"%_.),7-(S?12?76)-*=D>G/PE
M=2IG3P!%4$?193Q$[*&GIEQK<!'U1M()Y>*RSJ7<ICS &(,(]TZ5I81DP-G2
M7N3BL+H@JW:GU)'?AAS17 4EU@!S^&AL/V5N4FS8X>TGO^Y$X=H1C^B,GJ)$
MQ4AT1S!)'1)-,,?TD:S%6_^I=$#=R;34\LAN[![ES8W48$BWQ+OE(!V7LC]B
M(T7GP ME8:UV2^5^VT'39?J>$_9PQ"KVIYGI&01.3FO>3\U.-GTF)Y? "*\F
M$>#F;3#&&1-745B@+'=E4!ID2) :H>,X!.GY\@W;;4DPYB@KJ5CO<)P=LW"R
MZB4:IJMI(G".;15YU$-UHTF @GP,\RVCR&TWC(%1"@6Y;G74AG^A(!V+T5J[
MRM(U:5ZC3U@0Q+J>9P.VK$J2<""EQSNIX*LM,U3W8$%EGV$666Y,!'_<]7;:
MS[3F7-T!LD;4Z$T\\Z>$P@2A#5J":!@1,PNIZA6=2U<+KV(CMHT[J0Q_-#_B
M4T/_RL?RP:EH;8)\ .O^8/AM(V:M&?(N\FGS/O4H-Q$#;H8$Q^0RX%HVF_2?
M@K=1F0;ZK7&RS%Z=P.:W!-P4&P10Y, :12U L4MNB6)&W>R1"*9O+TMQ/IV_
MOM?ULI/4X6RU3>.,( 2)!E+615E+:I]28>Z@U,80C@^+4=2%\@:[-I2-LQT.
MV#9%&ZR1,/*,8UCXN5_<"K-&&+<2KIX7+Z),GW%X<%]##3GYYAM,](Q5>G>2
MKDIE^*"6G&.S?4C#HK0H:RPG+1UEBE98R%+$/ NIS;9F .]S92WR\$B)H2NW
M)K(<4G*7A_<*4SF7L?;T:H>^+FYO5?#L4I/?#F';L)G9_PW3LPP.3\Z3:(M3
M2IB*INOM:5\6I?C)K8<Y*H;3;-Q! L\,JH<S6@8'_F*K^@Q.9??KMBKMF34P
MA;"M]SFW5S>;SYR8(;%3PX,H26M';JQW>10D?,Z(^W3;42XXB\Y67$64N&\J
M7-#W;P G!VN5-X=BE);T,O+P^F8BP)DXT+S5$*-/?S]K6!I0/*:V3MVRBY5U
MP@!NKN_-TG[OOQ7V"#4YHT]\&V%Z9-YBN(<5A<1:Z++W0*?YLLNQCMEDL9FU
M4JX>7_:Y;AF=_%A()L"[.=?M<<QD%5>R60HWP!45J78$1);%/N TH<^8UPFB
M##^\ .^-28+XAM;AZSFA8)/L!5'GU&99ZD!"F+:N</.Z%7T;$BV"E>469N[@
MB9*=;#A)KKS"JN,0NS59%M5"K^CG'KA]UE;#^O\-7>EWL07;!T$=1+6D?2#%
M 6&RL,"7N8X!O8[_N[K/;DVP9SA0X%U<:9%P1>-6X)_&\W4E:Z5:7'63'H?F
M.9M2S8@3SJ@#H9F(>45I[Z/S6W)E?WP5T5=_2G9%(UZN?@1D+0J7$3"&D<RO
M T0%" \L$'P@$"&$A 8+-F3X0*'!!T .*ASXXT&T?1LY=O3X$>3'>M$>8"08
MD:+#A"LMLJSPT&%,@P-]+.MH,V1.G3MUZN.Y4Z.#BB\+MC2Z4&92@Q5TN,R1
M \Y/J5.!@H3S$F;6F$>-SG09L>!+C1SK435[%NW'IP[!:GW(]>M7"SE:/M"D
MT6=:O6GS<NP;;6U!MTJ+$AW\5JE$BAC']MT[%@[&@1:.'B8,4>Y!'6%Q_^#<
MYWAO:+(>Z5;(0=DK7-5QC19,^2#'CY"@17?T698C-([1WCPX;'$B9JZ64[-&
M2)SRRH?'!:K,.+9V](Z:3F/.NKKNY9@"ET9\H RZ](Z D9='ZA;(2M.:;(MW
MGQ.OVNK:RU^VF%QACC<;?7I^'SH4V.B3Z:ON*J"/NU#^6]"L:(3*SBWCL)-P
M/0;/HFT\H-*0#*(!Z[O.L+ F\\T"UQQ@+SK<-M)$(><*Z^I%"B&$0+#80+%0
M.L!>6JV\"=N**(<T<#PK&CAR>(FEK-Z2D4D?70(1@A]^;*Z@V#Q2<<B?HM$$
M(>X0=+*R&%O*X0'__HL&AX,\7'-)X,(2SK0',O_I",LLV\L1AX2P^Y# RL@4
MTB\[J=((#N(F=&NX%TLR4U <-8KMI.":E+"X$8UR(*I&?ZISHWKR@@8WW$(A
M<\2YQ$S2/@G98BI$@IZ*)AH5,43+R%.' E.YRP2BR"Z.Z-F(44U#>J I8H]K
MZE"EW$3TI30T"D]3:$G2H:3M)BL-UVQSY1-*HJJ[Z$1A0^)TQ8/@A%"FMM*-
MJZ+NS%7&T2-+%<Z\93U4#H>Q?A56MWV@"_8L!U*RU\##"E04M8)^ %3<D/;U
M* Z,YJ.74C:!6^A&:!MV#\US*ZUT(>ZVE?"''%#<F,[9KMQM'TU*:M=+;E4Z
M%$;?TO/-@1O'U4LCEUO_G=12"CLTZ(>[/II5W&=O-11HEY U;;^4Q2VKK&C2
M>! ARA2BELU5(42U38F\-H^H@6[.02-R&X8VLHBTG1?7Y<C4F.,TZ:NKYJYO
M1>@I@#55.ZV.+6C50X+5%7LA,M'F#_"U_2UT[ZS.T]LU W/P&^7HU@IS;[BX
M%8A&ZRK8CV['5^Z4OXV*K "(K4LB$VS50 YZ7H?$]HU:(<E%>BJ70Y\YYN&.
M6Y=VPZ(L":3&!>UOGV4H$FCB91,]=W@EBQ),MJ.C_0N4X+QJ\^#9/Z:\\Y@?
M>DU$[$O/?#J&PB>8ON6B'-%+''2V$*/).Y=<]B^/^T$-_E+=/I3'H/7IA&Z0
M_]):^&($OMJUJR5S<8!G#J@IQ_R (BWZC8P^]  %C89]HM$'K-(4J59Y#G[C
M*\Y#3!;" 4YE&583D'4J@I_(N8V!0V&65ZCU.NCXI(*#ZI[Q1-:6(K*+<R("
MG:M\$,2I0<=EOHE9GXB(MQV%[(&N"5*CRN(8NBU#*$.A#/ H-I#C&-&,>8-9
M%D$&I["]R0*;\8W]7.B1OW!)BO0"GAK=A<0G78Y!(]P'1HA7/=N-C7C\DUMX
M'C8UM("F8U-*H_[V"+:P* HC-\*<L'#SK".U*Y&K*J,.<0B1-;JJ7W44#PX,
M=Y[O2:^(2V+(0,:4*55ZY&$X@14H<N" AEA$8E=4X_\A=7@JN"5$2D2Q $:$
M-!;_Z$-%!?3(6$8U+TK>#F$./,Y)L (> @KPEOLH5(G())@C$FR*VO288)P5
M0M 4"@B$',A,N 4FZY$(G\$[CQ4)<AQ>+6Z3F>,2C;!U1N4<KI7TTV!$1/8=
M)_+,2"PQ9PIM)1@E$H<[1AO2K$;",M'DCYO3(Z;P((298A5EB[<,#WF2X[4G
M6<PXOOE@.$.CD9( YWGH@DG3W#2Q"LS)A6.AFU"7H0;?$,1VS4&J_'A:'[H<
M-7N?D6IT\K(,<Q&(:9YS:8L@T-4*X"!3J0RHH!YUU5GJ\VTOK8YIHBJL V[B
M01,YD#WO9DG+I+4K*]&/*M7_%E%MLK%IU(--1H9DU*WF<$U;J]Y98Q,?38UU
M*D)-0TC3J<3^_15)$$DF;!XJJ(=MZ2"D"BQ,)QDER-*4)R5,SH><-)BZ0(6F
M><G+LXI40M;E\;+XN29%#T,BK%P..G4:BS3AH]29O3&K+MG1:CMC1U7RTGMZ
MJYE(]>@;AG4DE?_A%&Y2&0T@?+*!EJWL[+!(N BE]6EM*8E&45NN-^&524R-
M"+QP=!68'"Y^QC102Y!50^M&X[3_R01[.@O.CQ3J):W#;#VO2*VR/2!<^V@D
M^\8"*1J]%)\PHEVW#O> C+4W<#H*6G7SB]ECYH? .T-=I_K2XD"]T, @1*#J
MJ".4L;E&ZF9CW._2"CG,>YK--T:P)98*+)(76E68WI(N:[JCP9+\X'Z NTUH
M>,>R9UT-"**\3(^$]H.V+L_ >>GD/H#@  BDQ)A)3J&/4@.EAXBO@<,KV7!5
M"1U"C5=9:+TF2Z(7IP";Y5>@+5P5F]3CA/32B2Y.G9$_4[45#W 9;XA!.Q?]
M0ZG(4+?3@Z6/R6C#I\3XT5.5&HQCW-EH EA@:L)GFI-(G*<Y>"#A(:Y46JRO
M1?];Z"GRC1V3$5DPI5: O8H6-6BB"4)/X=*C*E8='.Q&684DF;S:4N?QTM.0
M(!69*HT\S<0,?6+]X?<A#F@G?3.D[&]Z5*BD[@M]X16-AT'7M3PUI!L=8J51
MLV\99+IJHM+*8#:/%ZDHL6ZR:4H=P^SZ;=\C)D(<X$T+696>0&.6%?-Z'W/E
M #QCH:\^EN$8W)";U-GUJ*,C<Q!QPVHCN5RQK#^B"4+NMTD3/V*[TI,#G<%K
M5D$\8-K\XA_=_"77%T6?_+@LN^/0]]A$*O>]9Z.Q*O/$0:!+%77%2_6EP-8]
MM+'SOAHY9@%&NI?/R_.:OQU?KYGD>K#Y ;8'U9$?I!/_S[J.VT5-]N<%]4LC
MHWH95T04[37&%TD,>WJCH@&-<LY27A?+5IOK:G7[O.DX.9@IB,5Y1E;S>L%D
MG)L!5<=M4%)/IV3WD6#*# 10WT0J#U,1N>F[C+<GN"11F75(> D<Q0O-L@:+
M8'!RX)%E[(M1N!G\3WX?7%AY^345,*]2TBEZK]1[\O_!D&QY,OQI[F,M!CDI
MZ+=U>6"BJTKL@62R[4Q^@N_D4^,)Q61?YINGQEUOS9<_22="$1Q$_SV.*51V
MP#V]<^ZZ.TIF[8"%=]+M]%;LV$)%QO8!Y/8A%-Y 7GB,1"Y+T_2'5\(B!TRO
MO?RJ1#CLE"QJU8K.KOS'32)B_\Y2CO(,[G XJ) 0198:<$'>CONFJ[*XS?-L
MA2BR3.W0!G.>9>GNK?RBP<L<@%H68U$XHMWN!(%$;' H< 3E:SD(@E=*QFCZ
M0FU @_JFZC:R\ !9)@V,"C-"B<0^1Z$,PNX:Y/H.T">JC W]1;6PB934+&QB
MJ2A"IRLPXF06).E P@=51QF,1"B ((,.Q&8D:0ZMZ8%VC'CRYW=@(\("R2-
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M34'(LBIV8TLV1!I[J"&*PJQ^0"1U0OA"8E2:BCLIY2 4K$H>( UB" 6C5#I
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M5E9(D'6R8(YK2LC$<,]6=4#*5' 7$\OQH#D'X?"L<FRR==!.71!F66CSMG0
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M S@_T"*,S.9AG!1.)>AO$9$&$#=<$D-7XN@2.8"0:;B3>2$K[(0HS.9..-!
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ME>-2I28K=@Q)M2+)K'.=/H"#8!)-93UIEBTX,UI:( [2@)JY#W!-@M'@Y*C
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M\A#_V#5D32B/3/S'>?ZKY<N'5/4E^4 ?!0W"*+KJO$QD*6"\(>PP'VBY#-N
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M&219][J3@U_\Q4SAX/5JM9P&\7#NRO)J\![H== [M.0-?<4+7'.P/8"EV]G
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MS>ZV\S>)/Z^6>KC&+FQ]\O-9]P>R;]II9,84]<\):^;T2+M]5*Y\)4L_P?S
M?":%=*<LE(>98^L7.SL?OA42?+!M;-RZ3.UUO9C,->N%@>NRDA.'#J[%K_Z
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MF'E[GZ>&S6FG;2E1;CD<NS^/H& ]8$G_&SS*08VCH0]$YD.,%4T-#&E+HJ-
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MV1=4>4DNO$\_Q^Y%G$:7['0Y-&F3YCBVH/,*7#?&YG!AK>^Y,$_$AC)R'3D
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M=P?0JB+%<6%"#590-2.6,<THEQYE4CF@@QKY#<!'>_V+6ZXE7N2,)X^-&J'
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M:C!_A-Q] H3/WAV\%*EF#,/@F=*<-G(M_A[++0\D<P1D(2C<BDQ"3?T(F9J
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M07+'FUW]"ADMQ$?&:%5HD$J$!7\:9,GTW@7DOQR+N1>EU=R-2,S)8F2UD;>
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M0" !""P @0=@   ,&("! S!(  8+P. !.   !P;@X  <$H## G#X?V\#\&
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MD\=\0)ASLASNN/3UU/KXT]H!A1S45<]/!X3S[7'IC7[41_[R_;3CV ^3*5S
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M:\M]3'/1K16J4RM@)/)-/ZPYTC_W8Q_*L[E[/2H2YM\E[]F6DF+?'YYE8\!
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MA+2N\&@I<5M4_E=#9":<<E!W".JY9"89"IG*$LYA=DY?J NGUF22]Z;;!Q%
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M+A<CVRN\BYO=S@LH'OM.&V'NFU*<=D,/+2H;;K]XH3VD4KI8_K[J7TKDWP4
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MUY&>\=69,W$HNR0Y))Y]);6>'[JU;WF1/F3"#:Q G6""##@ F@?_DW,,0Q@
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M(TQ)-^ %FXA"!ULCT2['-\*B(XQI!AV.+2@-;\P(U1:F,.(.(J"!'C A#!#
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MI1K*::"FVG 2#94HH4RJ$2O*9TQT*1O$1MCP:!(*0NH0BA+*4-Z@1.X/#<3
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MB!LT&J!XBML$GXZ8B;7X/^(.B+VXBZ.8=2$BBXV6"A4"@8WVAR$"3*XX,M,
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MBUD?;CQ)&6),PBM6.9U61',5SU3E8.QKI2M?"4M@,00[1_&00VJYLZ/00Q(
MB $<W,4+ 0@@%%^TVP#1$Q%;1N,[RHOEM80E!OS@4$$JHES8E/$XR?3MA$0Q
MFT7,MJ&1K&A%[^I3HI*&'@0U$%Z40LK#$I(B D7NBKQ#0WC81+^L45&=W]QF
M4G@'(K<]IB9WFR;0<D) O1U42BJ:V$_F$S*)Q:U(-QK./!>EL#91S7\:1>#$
M)E5"&UT,7BZ*%!875TWR929P&IJ8QM(6Q__^)72:2FFG11-$IK8I+D\^S!L7
MMPFWGXR'I @TT&AX$PW@+&2$'XL:2I<ZS3<2E5\R1>F.[$,PT'BE59QCRZA
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M]C+V5RV%5+$<R\ (FU)#19M/6RSU'>F0\WX&U0H:B?+&=CIT(1H2'$R*!;2
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M_92@<$<&;19@T4:#"C.&2RCSL3 >30S L%5I95+_<Q^PB+"R^%9Z<<J@< E
MJ5(%TJ+V>5+!L"*=VI\MI4)RJH^MHT9%^8CM7+WU8!PB<8@CX2#[LP[.0@,Q
M*!H8<A<8.HJ H3)M6AB;U#8R>J%N>XS.P"DATQ-890UCF9@-[1T/O0R?1,DI
MG$ ^S+G\*:\O_PP+@(1#=O*Z@DB&&%B!D72)K 2%4P *D5$Q:U0:<-6?MZ"6
MN02.@7P)HM$+X;BS7]E1$9P+H("9.^K'.[*5M7"]<F4=$?&;71I4!RDMSXS!
M-+B! _B!38 ^]>"0UXJ!&$@#Z"M5RB3&-LU42D E! D<>]N25:14T:(NW2--
M";G4!KE,MJ60<3M6P;4(>[,1&$R(->D<2;--633-U+NDA)B34LD,IGN,G,NF
ME4R6]0 A>K UO).KLK*5"/0_(8V-[3&D%+J,_V(N?J6MP>T2>S.O</ROJG#*
MD7K#/(HP^-HH+[55J (/IR+!J&D>E=C5XD@:/WP+LJM ^Z&FB6C.<O\Y%^2E
MCZQ@#.3A#[D I/8",14;#@V!#'O5USE!@R(J7YV@(9OYDS<8AMU!H,900B1S
M(:+[#$/Y+AEJT3ZA#&(Q6%:='CS9#-:P(6C$DZ>R#'C)6'BA&'PZ3_L<CEU-
MC@B*WE/ITD"J([/0!S&( 1HI&5"(A !P&<"H2/C;CP0485/!BOH4M*B),7 "
M+XAZ'O\3EB =TR<*H6\%H!.FE;Q0W[=I4^I2$K7%),\K#$O""ZM$  [!SBB#
MK,+DD%,8+F:Z3!=!TD:5K(](#"^Q&L U32<9U=/TM<7U/5USU-<BMM<]XXK
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M4\I:2W+<Z@JEJN9+6U+JY_)+YFJQGN]4]44,W[KJ6NPE.)Y4@% 6BE@H4,M
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M:A##/)"=OT12)BQ" , !=#F,+WK7A5 9-7$7_[H(R*$H!.(@#BL1%FU065K
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M)-Q #7$A#!"&Q:#=%L02"IFA<T57Q5!;'2+6_=T2N]1>UCD0*GD%0V"""L1
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M3556MDWP=UK/G?+X(XPWYSX\(H8/ .X]2MTN(Y@R":84_FR%XRY5U>TM*,9
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MVN?W*!!CZJ\E![.Y!J768.4E8"+8_$\F\B(O,"(9?.TIB)$Q;K4JJ #_ (
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MEJLI?0Z%'96/5ZFG=AC*O7+EG_PQF%(B&8,##6+@!Q1T&+)3'-UQ  $@!AP
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M;5/*!)8),?M5G)\R\%&%V6S%^.946%31UMNV3V%K%553016R)"H D$,:P@&
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MZ422B@/0]&[31;N "UUB@5A..\C";/'T-4G)"#2P%I=)G 4Z9*F+;C(1!A@
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M\C_<&!*PU$O2!B,*HF+7)G14*$D61G]6J'XE14#+LE*28V330CKKIB*Q=">
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MCQ(]W,,]]Z("=3<7M@(?8N!#![ ",7 #:; 5REA9)C8,;'@>EUF=H54U%*-
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MF">LBXWL,(OI2<\NR)^DN*IX;0F0,I!&N-T$+#KPZ@UQ:!.OS22,7^G"EVS
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MAKDC=QZ)3!VATC0?6I+FA@2!D] 01F0$3#6U,TOGO%*-R#0[PZV3=(J[$^.
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M#W3[$)-&&D#H"<0/0!1A09] &!%HH(+J&:@1?";JYYY]$LHGI$4H"NFC?%H
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MY8H79]*8_UUG9FHIN*5%BP@GAKIX6' F8C< 1#YP $",  =BC,FD21DQ-#
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MEIW)00"0**Y%(3Z"*A!N &GBN@1FNV@B6X2HL:Q%)L0@:/S/UABN^\!/9!
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M=Q;Q1J"&^O_2JI\@S3X@<\;R$-".9?3VLUFOCWP[I7VYSJ?@AC- DWU%)*(
M%_3>3'(#:Y7IQ/G^B<1V!SM=PW-&DUEP3)\(5Z^Z1$>@JCK-5U5D1[YV]W*3
M97IY)W4Q$WG/M4/\6,4:"A*=2G$I%YG1]SI?;#!P#W4?)$&BK_6&KU#CB3,)
MD5<0B_=0B#+W3!'WH54RX6501KIR8D'?@B:\CP#QJ"&%!C!.YB$="648@K00
M-F(E.(LXPJ U@HE-8D,C0C&XII(BLD&)MB>F8F5YS8.C0H<B,M<LUB@6-&9Z
M2&7]#2(IBP!!$K9F5B1#(1, X !T(*5? @[@  <B(P#2@"!R6$3_-\-H<.
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M9+!GSZ&2JK'7%RIM+2YRXF!FBZAK-$+1F[8TJ63W69.(+;4*<K5$*X$U%%Y
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M0FB(>B",PBT<<,%9=+AT:[A(6!_CXL*M@K(BGB'-S]K_<&)BMBU)/[!E]T@
MX68%1%RFA3*,T "1A*N-?&C:*29_@T+"V^N*GNBT $+9,DV:,J41DV92)DW$
MEBD+M0F4)HD2#6I*<S#3LFC[.GK\"#*DR)$D2YH\B3*ERI4L2^I3INE'F@I
M@-#\4;,F32 X@13A"<0(3B,U<?;D2=1"4:(]<2K]650I4ZDXBRAM*I->M(W*
M]BU;IF\CUVA:E^U3%JU>-&5JN2Z#]O9KVK1QX6Z%.S;NUK5[Q8:U^_6OW'J
MT?H5N]9K6KC*)DV"5L\L6GH;"9L-_+9M5\QX^1)6NWFQPZV5X2K^:I<RX[-Q
M$6M.VQ4F&DT"MVK=#)DT7,MK_^.JKH<V,EW(NV&3C6NX[-BREL-R_5Q9[-?0
ME/F6A<MXJV6[P,6B%:B87II, DT[9 V8[\;;;3/W3F^8KV&WK+5O=;[5\.[.
MU'O?1;V,5M4)5QV :AF4S&CEB76;6%ZU]Z!W9T'WX%9>;>856)+9MA9O @GD
M4(AL9:=@0F]L D<HFL"Q8D1Q@,*B)G<0!(=$<6@22HTK:H)BCCBFJ&.0/-JQ
M(XQ#HF@D1@*!LDDHRH 2"BC%,,GD0S@JLPF6H"RSI29<?NDEE ]MN:63%Z5!
MD(R:$/FBD#3& 4>/1;(8XXYJUGACG6EJTN8F=KAH)YV@Y+GFBK/%":21,&ZR
MXY]_#O\JT9\3W?C&"@'\H"(<-;Z1!IX$@9+)) <@\ .CB[(Y$1HQR #GH#^Z
M"".D-_XIZ(TKBA'F,BIR.>643H9"S!MHI('&0C ]229,!25D+#'*=(421RU-
M2VVUUEZ+[4?+H,'I#T0%5=-/3=5DP5%.&1744T A96Y1[@(U[K@Y>>ON#Y.0
M==QW]RW3'HGZ:3@79WH16)J&E\5V&7&C"7Q89V4UF-]9^?6V#RB3O/&?6(!A
M)]=HUW4LF%Z&S><5Q[H%2)=Z;5F8V7>9F:Q,)KC"I1QISP5,5X9[O18;:?C.
M9Q^_$0/=FF)L[:7OB'V%)MQ7%\ZE;V3P97@A8^-I,IQKB8'_M^!_@%76FW/.
ME>Q>7K<A+3%HI^$+X%[L^:=Q76-)_18Q"VGDE5=A[?SSUGQ!%AIB27OVWG0B
M.O2DL\HX"\KBH! C$8@7[A/L) G5R***,]KIXXHJSMIBG)"RZ.>./2*:(Y,I
M\EFHYWR"@M&7C6>9Y:]C3LFE[2K^&F:4 _$*)3%1$G-FH7$6FF>4FOAP PY
ME+[ZK0T <,"HG;*>HY\1O3'& 3B\ 22*1;[X(J!$9@\']Y@;>7I$J\=()*)I
M9OZ&"CCH &E!/]R @*8H^BF&&.0 4Z3#TZ R@0,!YHA(*S)2B\:W)NT1A$AJ
MF U,?D4F,@DO9@<9UD(F01"'$&02#6X8!K1"HA5]9&N%+&S_H0NQ58^/0&,2
M ZS7NGP2+J0 A2DY@5=-C'"5'SKE)Q: BE!^J$,=HLN'/$'#/G33%N=PK#@
MJ]G@+H,<]70&0/"9&(-\UC*?648OE8D/W32CD,_ 16SG<=IDEG:7,<X%.$$3
M#'<ZU$7*@.8X-.M+P#*C(4V@P5G_^0MTLK,@C@DF.$MCS1?/IB\)329A*,N+
M6IJFH;(4#F)QV1N .LE%"27D67IIT!;O6,DHUJ4M&XL+*RW#2LS$C3_U"<XD
M3[88.J92.QP[32:*E8E@ADJ8Q%1(0>Z6"4H$\YC$#*9"[O;,: I3(>.YF&,,
M@DT36?-BY/G.LL9#NM?!#WJR*M2,_Y!DO"&Q;G0TLE&@5"=!!F)$2O3$H*^P
M])!\UBY78@*6/\GT3UW!Q UHBJ"14L>B7\8@  '( 8ML!3L<(  ' TP@13T%
MI&59CTZE*^>.6$0D\;&(4VAX*(\R&D&0:B].YTL403(1@ .42B(L2L,! H #
MS DR!@BX'AS2D(/K:8)3,6B &N"PN<\="4:?6U2M:(2#3#@)3*%P4I.Z],M)
MH.&::/#@,QER0A:J,(;[H,='U (2?<20(VKM2%JN]=:P[$.%>GNA75NB#[92
M+@WHXJ$1;O(N=Y4K*#C9P+N6B).=' 5>0>Q)!;[E+74)$0@8H6/-!E8P_JRG
M0_99D&+:4O\60W86EL$IVQK)J###[.UL6<1-W=Z@$<1(9V) &Q$EN2*Q^7 L
M.GQ$C&H$IQZD<>BWD,F+S&C3'EPR4C+1J0\EWRBXE8T&--3MRUAJ<S.788<W
MR%G;9O!S'D86*#&;M4RQ-/%$76ZH.0"*C\LX:R#X6J:VA%.MT]PHVX\5,FYN
M.QG'7D.93(Q!# 0^2!K&@ 8$CP$CDD@#(PXBB3%(8JL4=LPDQ*!5RSU8# U&
MR+ >G&",:'4,EK-<0DY<XC0T^,3$F,NP:+0FG;:)(#?RD8YLY:D;S8B!F&,4
MD)3*U(SJU*1VL-R7? =0?/H.1TGVI_#(1-5\^I,VQ4.41 CB)R+_B>$& % !
M G1@!Z86A,LX4 -!0J&J \#A1C"*D21N$  @K!G+\HN@H_ZGHQEQRL$LBI7G
MCE<C\47PHWE*G["JEP,U@*\@;PB@##"2OC!,M,\(Q$&9.24&B>842;4RDI6M
M##WC 7-/;V#2)AP2$=@IY,($%D.HK*D,L]YU']  B;0\8E:MS%HD9-VUKU=B
MD!\T)8@Y>2RYH$*OQ?;DB(0%U[J.2*\<6H#92UP78)M(Z\TB##UD3)MZ9HE%
M1&:,ML&-C\C^D[+Q&@QN@#2:X!0RR;#TK"PEXVX<-]LQW+I1/K[%+.!8MNV%
M?5L]6I%9XT")FY5Y5D$66M!E> FPJ/GG_U^&Q O9]@:>N.AL8;'$^-" Z][7
M?'(\+:Z-;=&-&E46EVWOB:5\ )XV"2ULBF[Q^,%T=K3?YF5O=#0W- 0YF\<U
M;B+$N_*>C+ZG@L!A(4F?"$&>5(S$;<EQ#6G<X[CT9*M#R>H7>18QP/DC)KT.
M>T(* P 2  <BG9-(#C3[ VX$NDRH  !TK[O=!;!F*LTX=AL$5I5JUR6K6NEW
M6Q^(5<6TS]P-Q" %==4=\DX0-!C   <   )RP.:1QL![,0:5& XPAH=2Z0T)
MQ/ND8I5G&!=*=9[&2$FSIZ8&!CISGU911;AL=P P] %S_ND-*D]W!(0^%' 2
MY._I'E,'I$%\,__2,8Q?-.C9'RGV \9] !X=IC(50\62T(<D;IH)CL3FUQ\A
M2TANK=:\>N36V%(A7:455O++7UL8&1>SH<+$=N%P*#]H+! &RT-'<6W*5A,<
ML$3X9Q3WTEY]81[,A1<6]T9'LTKD93#>AD5C UT/ W&%(3$W@S+_PAW%I0SC
M(1JR]1_FQAYVH5O <19D<T>;T3.A=!CN56ZJM"];87"EI1XC$W,FPW![E$AR
M84OH!DM;I'%$$QJ,]!UI\U_YP5\:LAG:]A^Y53)7DTL$!W%>!&X XQ;%M7)R
M0UL=:!P$PS:N5#CUY2!*Z!TLDQMF83>X<B41D3L;9'7",Q$4X701X73_0@=U
M4 8E E55NO(KQ1 *1Z8,A!@*44=XRW WT6 YQH-.[\,Z=I &<P<  K Y(,4Z
MF^ &EB@ ;,=2<I=[N=<_'\5Z2A(E@)<[3S()9H=\F3,FA&=V"=!D /4EC-<Z
MM$(C;[!Y".%E#V Z=E!!FV8K,G,I=#(1;Q &.#4&,)(G\,0B,P)[SP@ZEH,K
M*A6-)]5 F:>-X801".%Z?*4&>EA3!@9IXD-3)L97D#8IJ\=2[L,ZTK=C@9()
M-[ JKH<#S3,1NW(1P80),8 #E!!_OT8/RC ,'$8L8N!!9N$1,=-@#-D1=&4M
M:C4,#@8*3S1_&1D2]8 &!+@NWK)L/6%80V$3__.R%#GD0]^"0RC)+N!R% C(
M0VB +UJA%I2!'^]%1]O1,4C3+T(H7'(#@D+H%N0F-:#Q17FA-X,Q,FNA$#,W
M7ZP1'F0T,459;J3!;7FA;VKC<Q781B2B''#Q2XKC&=Q!-*@D5T*H2@ECE**Q
MEKY%@2T'&&6QE$+I7Y<1%GLD'9V1DX:A&?LP!IE0<O5U,AHB,6]325M#25XC
M')8AAFT325,SE+ $-[OE,/LR'_*V%D'W9%P">(E85858)KHBFO0DFE75F3CB
M)?L(.1&A);:W.X6W=85852,X"<3 +:%C)#.2C43BBL&'.NL$![UI>7.V.6V2
M*9FB"6[W8RQ%$+$S=?]+9B;"^8JWLR688(D)P&2^(CQVN'@8,4&GDR,&86FE
M!@ R\ !Z&#^!LB8R<P .13XR Y!C$ >2@IPMM2/S*"F+<BLEQ7JE8V>,PB9,
MTE(YLCH$NE)M-A%]YF.H!WL\8G3N,V.G0R,=Y7RZJ4XS\H\'( -PX!"9$ ,Q
M4"H/H2*:( G_& -C@'XO))$>H4+#( D?"J/VZ&IHP1'S$$ XT&(L% WZH _#
M\*&TP7X:^6L0J0P_, 8_P '/-E@FN5@VA$/$MA,W!%B*M11.P43(]I&4E09C
ME!XO\W#FII:3I(),R"]]%" %0S5E0Z89 C/& 4J3J4L[.!X9XDD^\U[,Q7/_
MD?0O&L(=92,8+R<7OP%<<X-NL:$6%T8;[B8:^U(<#@>H6K0P[F%RY/5OV*5Q
MO.5P;,0VA=E9$V<<MT$V/TDBT' U5%,>:M,:[%9N6)0Q4+F !G): %.4Z]$:
MYL$?-T@@C-HVU6%&RE!27B)E^<0EL_,D P$3Q&H[H"!TH!EUNB,[SPIE,&&L
MM'.L=OA+YT@DDF(KF:@),'")/X &EVBA;)()WBH X H  R!C[I2-*=*)<49G
MN#E*^R1EF: %P_DKF6!F&$0,PBD 2+:*&,2(WLF<GX*,FE(_[7E.?[940_5Y
MXT@C&9I3KJ)C@/8CG7,C(A4K"8F.MC)CT?=1/C*B_YJ2H VT(^B3(]*8>9GR
M>+D98Q,AH?_I5"7[.C@&(V(  #?P T]GFSS%9$\2*F(  S& 7B#1:RTD+3'4
MH\+PH0< HYL7 VG D.P@"3"0 Z$P5T=K+?30HUL@ YO $>8GI!FI#_57@#S!
M?X'5DE8Q6>N"I229;"Y)6$IADH=%M]/6%&B@2K]16WZ:14/)7&#417F1-%V(
ME<&5DW'#IF4J<&;8H??R,1'X6<'%<)CJ%9K4<R=(&F.3<E\3J_*VN'C)%X)$
M&V:H6Z9;@E(4&6ST<'+DN&O8%F1*<XL:-X +AG3C13]IF)@+&5LE$)R$2]RE
M,)/36@W'@&!3-G8*1S[9NO^HM2&&FZK-"ZDN8T$2D8B!)SQS&"6!*+!00H@"
MI8J]\V3:&26X@R/0^BL"U24OEHW;Z+*9L (Y0"22,)QJ4CKP^P,L0K_]<SRZ
MF#\Q,HM(94XEBQ&"!YI9$@D \ #EVT\/D26@<*\!  ?TFP!V8+[^A"56A8OZ
M^7C.IR/=:IXQXI\.] :3P#\.90=Q@@EP%E,!0'<7E:#LU&=M(F;%.& ]EJTM
MHHNK(XTQDHU*%2,UIHDQXD#;NB?01WLBI28XUK$\DGE!MB*2-HYI\ :T\68(
M,!&G<&K#@ , D -_N:/K]T0\NFO#P L "2T]&@9;$ -5I0_S\*(Y "W2 I%Q
M!1;_':$6/*IK=RQK^^"C,0 ETB*179%7NC:08SLM=,6(/E!M.2%9($FW\8*2
M/6%$ ^@N/ 044,&V]Y=_&-&!K62!?QL>QEL;[ 6#=%I& <-S$*>5;BH?M=2I
M>\2KB7%,*<>J)N=*IP4UK^R88E%=M\7+0Z.\:^A:8W06 M8X1L,AX5:KSZN"
MA5HXWK:$2E@X19-Q8FB8JT5>QB%>#5>!-(A;\W$UVGQRC.NF@,LR4"-)#B@T
MI]JHO'$V=+-;$S*5RS7*"Q(UN0&#RT L$[&*M3-X8C(E%T1/@'>LO///4I9D
M<B@FV1D\RL,K0S4&58S$KM(B+ILIX2H ,X8ZH@,'&CTC_PZDBT(LBD! 8VG2
M?&>BT!LD=W@G.[@#9?"K!E%"O__:P-O[$)!3/+)'CI.8/EZ6 U!,/BO2Q;J7
M S\R$6*P @?@4Z+24',F/CF"/G>B)C!"++/!9M@S/IYF)S-BH6EWL3HE02E-
MP_+3LAV]>N6C(X_B*?%#4]N((\H8 #[ *.-QD!)UO<\2!IOW=&B5M6>%+4$Z
M5W[\HCB M6PU#%MP RFR#^VPUT&]#UH;D8/=$1 9$A)9:W_L)&&,R!DY@D%%
M+X_5R$PZ+]]R%9@<6"\9%3LD+^<26-"6!DR(JH:[R@Y'(F3CO(7JO(;;2EZT
M&AV#RH61,M.5'Q?#I7*#R@/G</\;]S5V%#=*B'-2":KA%3#_TH%A^5X%DAVO
MI+R7Y+B,.7-M1,QU5##71:N3^4F:FY>OFJI'8ULU1W*!*QU_NC!DND@4 UWJ
MX8(F:&Z>]#2IREIE^'*1%+L%XZEO09MOL)W;VW=*!B4&+&79&WC4B634"M ,
M#(A^*#L&4<4IY2/_:V-J$J[\"RLF>R,CCB@'VE$LHM&UIXFP([4YC4'[RX\"
M>R6@Z228<(E+QIDR7HC7.L-K(L3Y(W?F:2L+!&/<DP;YF%-$4H\KD%-@#9_\
M&RN"9K+OF.07MJXKLCK)HR92C8SV^U&,PM'MU&-CQT"1J%0V*S_].WW&>; >
MZ@ X,%3_#0:0:> DRBH)2^T],7 #8G 9N[:B?LRT=#[871L#<K8/< R0FC ,
M6E4L:(''3S0,,N-!Q("1$4D/F3!AC,#I?HXC@VTW745RT:!7G0U7ZS<,/]7(
MT/9L.>3: A@5E/Q_0A')D_S(3*&2XE(4]J+.MWI9+C/*!S.6[0Q:QDN&])9Q
M!E/;L41SA^$U!F,7P:(1+'=)/AA:R(N9;Z-)%]A&@#J\M'I*'=.GSTP8FH K
M&3>FDDI)C3HPLUM:PCW=?$J79;.&DCKLG'L<?ZKL;-.&9J2"VP*8^/TS7P2#
M@PEQN+VY='GLOX%'0ID:=KG>]I5N^Z9="Y/M^%(/H((FAIB*_[$(K P=4 \-
M9;F2FK*#T/5T0=SY=ULB8NW(0!8*?50M2.F:GJ&#3B#=.BBE8^5Z*7WR0+:B
M)!&Q9,I@=D!@XP';=\)#P53RK%="&Y3@G:[B*NT*(_5S>8N"Q'KH=&D@ T^=
M"?7C &-0.EKV>4  =[%"/E1/)SZ2$()$YJ>RH-+W46'M(W?F9^5S9R?E9\?3
M)QX=PVKM/@@E:!5->R_U>=XS!O:X LUX:J 2 SF;:1\:!E++?H/N0O3@H@")
MM1VA^5JPH7#0V&=PYUO6BU(;D0890!^JCZ&0QUR;"6%@CW_."*NR";4&#<2
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M3ZP0T86]SR#FKXZ="/@<H[VYP*,!NJ,),))PQES41!9-HZ?-3Y8-8IMU(X4
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M([W[Z9JA9TXJ2\9CS()))NB(AO((6F4^ZNBB1H@M4&&"1&J8[!DCV2HXP
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M6HJ6)=X;F^D"/OP'#IQ'N\8>%SFZC4]G/-]XS,;_$R%9BL\E*-_^EZ(HFUT
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M6"*SG*8.?+&\66UB<OJ>LL75MY8P\:GRH3FB!$!YMNU&NAE(" "@6.JU/YC
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MLWTK^Y%8]H!.UU>,X/19Q[I:UYK$-5]G"JC1+!F-MAR@00WBOKC!7 /X$1L
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MB]%7+K[J]L\+JZ-CGFM:;2)2Y=.4_ ZK_N8P![68D=S3<M#*-$C$PO&X-^U
M9-CXC9MM=T4.KF$3$$M0$R<OUU&SUWK5C\P)9YI)>,IW@HFO,Y-WT,')O,QV
MT)I!%,C43ZA6.LT5.U:9W>?E[-)M_E&>,C_CDOL]V),)HJ&G<LC"L#CP['13
MYFLT?P8.\%$P?+K*(MCU3\"((,^>N19B@C^L#B5*+&#F86ASBO"=YW0W5&^R
M;*J,5]Z9XU:R=KW9#$Y!<+JP:%4O@;0OQZ(N.9_:[@V^X.&-0G6>QL>WB\7A
MS\5IN%=IG@:5OST5X@)(TE[^1N1X[+%&[W40R29F0Z):&1VQWAU$R%K[$?)K
MY^J8\Z]:">BC?"RWQ8YKOI+],/C+B%IU2]2G*K#7G9M++;@6<9EUK]&I?+FW
M/])IW<B;QO<5QI3B6^^/[AZ*<#ST_G+SK)4Q,S^=^^O36"17TP!S]F>% ).1
M)NU=_G7(0[_;+89^K1FWN_>E?5'B_[1-]C9/58$E7(%Y=-P/PG>%QLBRW>=?
M^M[B?+U_T[$4+%JYK;<P'86K%P@/9W787PP58V]J'F5/Y]" T<O1:I^)X@75
M NL<OSGPD*R[>1M!3M;J=EY&Z">ZU8<A?R7N?'1W+?[NO$5[RGL0Z!XX_;5C
M.F!;Z%)RHG=1.W(U0"GC1$A3GS6)A:T]UCQEF1+5%K%X\K?';S26A3O)\Y]X
M3+YF#,82X#(SO+Q&6W3HU@V@"\(@.#6428<REFRRQ_#M>E20U?KV [IMUKZE
M12-/9U]<CAO]S;=GMS(7CV488T*Z;2*=V7FC$?'XW\Z2K.>A+.X &EUOI83;
M7(PQ2E7# WL5*]HT\9Y[K1*M5@.,;"W-= _7KR<1T3N65/7&[MO%.=>.VZU7
M&/M2D?%$0\4M*:LY2=8BQF:=@N+H6Q]!>1-% _%/]UML_S]1 DW,J;">;IA\
MF<+^8WZ<&.YK[E1^OI./:].S9"H2C=NY@=X]_''\&=?>?3E_M2]B4\Z@*"<D
M:BB(T9<V:M>R2C[;S8JG>>\TR#?"I-/;0/-@4"5R=N_UO+5N8/$4RZ.XJ2WK
MY,@@4K&V 6Q($*#8];LE?^";]]!*C*Q*6KYS6K,H4^;#\1O"/2=L$\.Z(SYR
MUESN,H#6'"),=*'7PFUNDHB5/>D5T2OQUZL4<^5+_[.8'6JY35@EA'K3$<FG
M5>FK7P69CULX_<.0_J2:\[#A+5ZK3+AAHY&UX7R4_Q.UGS]\&J^-.W9LH<&Z
M] T]Z9C7!K?7,5^#G$ORO7K>$/_\#%0O"!0\-\<=!:2-!+JZFV.\+4",Q)DG
MC?S:F20/F/W-KNNB2]O?,E4*H9<YN,?;0[+KZ-GSVYCX05$WP/^-@9XU!=HY
ML$*@\D?C0>X#66J_)8.\;1PUJJ;.YE/;/XV5KZI7.F+S);+GE],_M"EG./[)
MD=@87:$($LGU(W0F7>49M[ &MS>E'VR )+>/G([UJI".;@W]'K'R,EGUUL)-
M=;0['CG!9.Y]U9:8#UG"MRO#GN;<L;J-\C=YIQZ+U@0U]26,C6!=!/I-?'B_
MBG_D4OL:%-#-5,#\]=GD[#.=M$>&5Y-\?&3C7,.29_O;F')>P,37]![^Y^ A
MDNN_AT_I?9OB[CGBO(M%\S)_WFV\R^*$%UMPE(L.A(*/DZ?AV-*]5SEEUIK&
MJS[ #Q676BDI5LR&+)9Q)_OAKH37]MN\7M5QP>YW2*2ROPRGJ)%4@3#-JUE:
MSJM"3'+/R6TC(^:R33&V6C$2$(^*I&^>?;'?/SJ#)Y@+]$$*K^N\::6Y>[8B
M/KO ?D@S.-?7D3G!@RCM^7H$8LJGC7V!<X>4Y']W4X:=@Z4M<D_?RC=J(!!A
MU&S93IO2"R7>TQ":. 5Y-S?_$ ='72%D4]X5/25SNHA !4&6@+<VUP5\LQ[>
MUA:83U*2<+$IT@4%E-HY&QH;7"-6^=4L#CA\I$>1PDUU;*B$#-&D#VUYYA+#
MK&2@%3MY+A+8E&<K?_=1!DNS^-W/SZ/>)A?>;;PB(#78Y+IQ6=[:H\LVM!5>
M<C5W:Z&K,S+Y&9A;,$<Z64]VM9TRA4V<JVXJ&XQFK=)UK#6J'*3\S,,[U-Y>
M'TRC4^!?ZPD4T(M!,9'6Q" [V#SN+U9P@Z!"G30Y&S:I\W9D?ZFJU9FEQ&PU
MMNKGO/O\8F#58*J\:,2VSYR;<>;51M+,Q+P@WK5@J(F:";*L\^::L^95!,>G
MX.:ZD[:9YC?,THWOCDG9S=U:2C*3*(I%RUEPNY;G%8IR,EO*C2>^0OOQDKCJ
M,#3KXBV\28&?IXJ&  #S\ 7WZ1(NG7_@\ [?UXEJ+PV ^@M\QJ&*@RON#MFU
MJ^7KL:M\D><!:R_OC]-T]84&?[I].2)EY:F:@QIM43$%66E\OS.9PV/Z&H?*
M;B^$2)]QV+W9-ZUR<M"#A_USCC0N_+BX1#=US!-ONB(V3YZ:75@"W[;]"3,9
M=J<%TOJ$N4.<IW*4F**F(#$QM]]+NWWP;+QO\\$GZR9L1:1#3K$0M>23!=+Q
M.70S1V5+Z:9@BPC *1%O#,&4 O]O45 .R^FSG4E$U6]G&6$-TC$N?1RI*:>'
M5:8:D\=($)NO>/8,DJ$:FJ29Y8_GU)DT:A\%RQT,4SF52W1%40X3  ;<T5HK
M/=NL4;TI]DX2E)3IK>"S5T%%-7AG3_>< R'7$-_%(3GF?[RK\[C-]JLS?%5]
MJJ_97@)\:JMHS>AJ*IU(]=559<P$;A5QT5E3$ZAG=G3H'=%/-V#S!W-1LYT)
M%OHLH&1R"V*%U&2CG%@]PY--]V71"/'3(Z-5KV;$HE6>'F1N*1T.7S92NI^<
M@;^C$I=A4%0>6-5LG^@.HWC3U[4\93&O_OCB)4STR7WI_V(YC3?_*50,TIH_
MGWL2T]R8:3XR\LZ_^QZ'E 7QYT?=1>/WM"GDF.Q8B@XWE#:Y!H'VW\OMM5)1
M$S)B,%0NM_3.S%D:M60*S7#)K%E:]ERDO\XGYTS7NN:6[O-N&8-F!.B_D51D
MQOEI%5,_W'UDISCV\.7^6"G?Y,Z88Y#;MZ<.M\<*/Q3?DGEQR?C>,_6.S:J/
M9?[>!_P+XZRQ<(1AF(6SU(?JA>N#H +S&RPZ'8D?+P<S]<(UZT4M(X#[52G,
M3 -WWH5S0-GUP.X;N>QR1YL,<@\6\-8?UDI<O)3<&B3T9GAV=+=XDJ%/'<I0
MP]Y9,U_SF$8@#[(6B6ZH"8&'6Y4S2B]%-(ZH8!N-"Q'Y&<,+(O+'E>E.]DD:
MC5X):]0%1&22V5%/I[;P;+\J'2,W@6'"/Q(N3TPY<7=%L0%5OEU> OQA:?/D
M!HOZ!O,:YMQ&K5PMNO8I1HY6.,3V;;V^W4 4X]^<Z@?'R$?D6$GE%:+^7U>!
MLNT&<9D%P]X_H@+T$D2TR;,")__<2YBKX&WTNP8F<%ME:XPW6$S!$#':D]O6
MPO@%K4N'Z$C#LGN+TVE-#"6. 4XR"E3HD,<;3,;S2(R,]6%<U)QU%"A>S@4Z
M316%IFA1Z;-.R=]O>YLEH7KN].1)-R6)I*RP;9W 6P@C0FP4/>UN"$"N9%,0
M,S<NHG55J)3Q2RQ+DHT^K%Z^8DU.6%4]KY=N'QF_*.W3!KPBGD/AVB#4FC4-
MTP%@&*7&_U+4^**-YBLY"^U^H%AO'Z\N;*X7OV\]\BF>8 W(.RG9/D0I.0-Y
M,%X+^"7U,9ULRH<WMC@N2WMV=:!E4E2U:/;#FX3D3]O"2#/$<( Q3#]>B(O;
MB9 9?,GD[3RU1\6N(H$*8:/B?\KU4;20*%;C70]NN0^ >P2UQ%A7^95$[H=E
M!J_(XD>J-Z=C67-AQ2N)>(EQ!^HQ)+B*DH0'>Y^+$^<P3&2ZX^K$>0;9H?4H
M18F8JX4%YF<!F/83*23(#9$MHF63>9\1R"J'*,Q%T("X)GP$3LO9:<6AJ9'4
M"F8YK>&<^+8%!%5(!CO/0'HZ]5;'@,!^C;&13LQCP-(XP#(?9D4S5X1GZNVR
M=*.G9="DKQ?8'E#79B*_:!@:21:<<\'G+/?W9C5YS(JBXGXFMS;,8^J\LUMM
M![>-Q4$C:93&I%C) A:W^,RACYF.&W2V&B1]@9>DB<N8K"TA:SV8 :4Z,(7N
M(AD*Y>GXZ;CS9$%[PK?P;3M6=5I<'!G_(BVNI00 Q;QE1IKNCNI=.!IQ/>I'
MHLX+JPAL0%8:!)!W,3NKL-0/J<Z4XLET=^0US"Q.[3V/?YD$R1(-!P.HMR/I
M!TPZE%$P0%B4BS/D$V ;P(:>*DK\>,8W:OM*K5QP92'T=W$;?8**Q]8;N?L6
MQ9UV7H-%@K6W _8-IHUN*K19&LV7GU6\%M>QYIDFN3ST7FMVMGZJ$9[HQ&<X
MS^9[J"''5.7W4^X*!Y$)<]0F!*85C.$MG9:9GN5)4/07ANKKW0I)WI5\'KS.
M]];V=M#V&T)R@L#BAGAQ^>7>WE&O>J(!O*[16W/^8D2PYCY8&'ROEV8OH*A*
MEI(NX9+X"'P+$O^F;9*DECL8WMY@67NP]4HN0Y[MM%/LG]D38KI)1W5Q0O\/
MKGK^PG,*MTQ-O5EBPP*O][J#B@=->R@S(S36LDY@1\+B?I%%:?QB[5,]$0E%
M:Q3KL%1P\,Q*WTQR:\'.S2M*$BT5ZDI9BB4"FYP$W?L_,9X2SQ"HAUT8X5MQ
MLJ/H;Z*Z$_::S/Y<S!L\[05A]ND#L:()?IROUJFK,M8SG8^ZSCB3U3!(DIJX
M+>'(U>WB [?5TY5-XY)GQ?=E'SQ[; ^'3GQBT^!4*(E++*3B 2TG< JBNX?[
MQ/"2_>;0T5!X?L\K-BEMV/Q,&7YQ$H2:0VY/_P @*/V27N'3QBH*!V%>_:9.
M9F*WQ]>WC[.4AF<PXKWQ,]M_/97[:'@>/L@&D6:/U$:]P?<:8[J>Y_9X&:X4
MC_<8WZ(W\!/!YG 1G9=>SY3I3T8&>Z%TYJ'34!UZMH(;;51*/ \@ZEI@H?F0
MXVD\#T6/G4H##>5%XZ93;'V[%M-\RG-!N%FJ>W94S#%8.-&(_";^J"$SA#M.
M.-'6<V]";:IZP5\P;XRQ?GC9_.]0@!"7V4] M/:!_HX4WYN-@=F4\S6S[*DX
MH&4^OSH)=U4$#Y9+H3S$\O7_,&VPRLOPMZQ/Z[)_?QFQ9'7S@%*GMUZ_/U4/
M;$BRN./!N.(S7;:89%$2/OG.:GL?YF1X9B^3-N$53I^ZHLLR^9=[QCW_ R:*
MP3ON;W<@O9C=W6KYLUT.>A=$X;I_ZYV;=$AYF5U,;)OC!SV,]7>B.!1!EI.-
MJ*84<\A\% U A=QTI!B^"]:WI,B?<H9V[ 3R9NN J\!=5P5F,6":5MKW;R'1
M(XSX.V2%N>M;VO)R2]?IE:#&@>QC2!7I[T0@CO0(ZMQ6C4O[3DJ-9D(# (45
MB&KX#;8!9&(FDST 0.O,5S/'_=@]_K9\2%"(T> BSU,HK^NPX>"<0G"!BQ22
MMXN2,#EHI&-CW.@2U+)UJ7JHP,4PBCRO4,J.8J>G^&5VRMRMT'W&:7 =CL&;
M/6"B@-8W,;M6TCD)('0 0'@!/PWA!+327L. #@A8^Z=7@MPYW\ ]:EV0*)BS
MSF,^4R6%X@&N%Q3U(@A?UFP81<G,L.W*;#F3.A;T)42(/Y0O%P]5A,M-CUO]
M)@B_C;.<BD).B5N @G3L:TS'V$VO[T9XH"*P62C KMA[<<F+J/!92.K7O6O+
MP:)B>:#L>9]/[]#L<'SZ)II3"^\?EW[+BNY)[7V.6=]:U_L903;%&%']3+GH
M+7OY;5T#A$QLX%6MT^OA.P^?TP;MN#J^ZXE2Q5,FNG0&7-EE-@(_U<IXN5\Z
M"BM#"T_OM.KJZLHQL63&SGM*D^@,^)4>$B?L?7("*S@$)^[<8@Z*59FSR?)P
MU"MTO99C$+5Q&X]C#W>Q5Q>)I?V5)3!H/SQ S-*YLLP!9!B%GH0 0X,H:_1P
MI6Y[GH)<+N'8X5 8CT%0BIP"$NE!]E)BS&6R.0<LT3 ?C^;;9D/0ZT$"NT[
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MPE:! A^^FP6*!OJ*%0Z]_;;\Y#T>E[.RE7"U<_[?I,/*B1BS79JM:]I/)3-
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M::^(76&WYB!6## <#_)"RI'4 <;B1T*\JY"E' 1BM7!(CN]P2*ZX8$<:25)
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M//)RSO$6GC[T8")=*-B1_#+,,<,<328_V,R?>>>59X2#.?,,7WII_'!   \
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MO2=QJ M&$<=[1%@8I8\@^(^M.*Y/<+1+G=(L@?(I3PAOIW J!Z+'CB(-8B
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M]ME],Y9ZB&D!23A_37!<]4%'DX&&H:FVO@V5!@Y^<0284O2%R4WB_'<9'*6
M'H4D3FAOLX6FD(X-<V7.K!JJFZZ#-B@3/C,&MH4C",(G-!4-SY G):)*RS8)
M:<QLA7A3,F@_:ZY_BN(A>LK(=9I(J\4I_UE*!Z\2+6<(:<5:A&#HZ9(LCXGB
M(WK"XCA;&4*F9W*($B1!&"IWD15;'U95!M+ ;EIW#"*;N\6@:EE<<U=5+T,5
M!R!8&?I\$@P=!Y)[&,(H#0A-W5H7!\3@#62"&"2A<C6U:A'=-! 1DZMV*F1B
M988A## =:S=UC$H[U>DH8TC#T*NXLG35M;GF-0VI.BZ+TZ!C%8NW-</&TTY/
MLR)I%&L=;/0K)5^T0- #O)*[Y":DS(OO0LG9G3T\8&&DVO^FF#[G0@QJO 7R
MDW:O&%L"/*GQ>SS\N50+>QHDM;;'3"IL7[WOP<K7F0)J?'UK<L!//9R"W0)Z
M_0YT']N/0/-[8O\5%. GMMTRIU/F/;P^'/BB-3M#7<VOZ60#)W!X]I^0+R6N
M*[5"6MLR3$8FA*C[#\2RL<&>MT&F*<(%ZIH;3")Q5L&EAT-"15UDGB?F],:<
M^"?K&"J?S&B)6,S&6MTD(0!P0 W>:@:A):1N( >@[JW&VH*0TJSO[(>+>(6@
M9::R^GR6(B3 4(SS^"G#>FP)XBAB2!F0#E9TRFZ%KJ9T2BH-PFQUI:?'#*YK
M#"/0<(;T1TN%XB=D@NY @1$BH6KUW#3@7 9R0!/R81ZV0 ;$8&7FH1>J5B]C
M( =<#<XS%?(/X,[W(0RT0-)Q( 9\0!,D$VLY>QX8H70A/PS&X(0600O_5$"*
M]1*S%RV.YJ%U]U(ODQX.\&X8MB!3=UQ2-5G5@;_2K@(V6;LW;]OR(@LWQ8-X
M@[67_^B11/$WCO4'?#=KN,;4?KN_.'A_TRTGGABZLDE!9@\8DZUTQN2[? ^[
MO2?V.#CV!O# BT3!UZ0IS U/8(^6*!1^[=F6*/@: 6+?LFCTED&K%VV9OH'+
ME"4TV#!A-(?*!!Z<*'#9/H<#'=:#6$\9,4UITL"! P2.&B,J3ZJ!8^1ERY,I
M9:9L&=,E39PS4;Y)DTF3,H3*- XL*-%@/6A&(3*=F' H1'J9@B9D6E&9IDQO
M)DT2>I4AU(X0R4Z$R)&I6*-9E:'1M%#B4J/1_X@*I/=0[<.%',DR9<HW;\2/
M#Y,NQ$N7(31BH(1J&JE5628Q7T$M"V4Y\S)0Q3)O4O8Y%&AEH$1CWOPY=&;3
MRD)I6B9TT@T98^*TWKSL<R8T,G[ #G7YMB;-F3N;+MV:-.[7G#&'ZAP\%#'I
MIYUG&O-&D_8TPS>WYFR9^>;CXZ>#AIW)Y";+P(6B+VDRTR;,Q42#&EER4G9-
MQZ>#WVQ<<J?Q]YUJXWW7F59I3 )455TMN& FQ P3E"9H\!)&#&E$LT^'T.Q3
MCS[#1(( #G EHX4,.$2CSR09BH'&)&B(D88RR4B2(1<P<@<-/5O$H"(:C0@U
MCQ@QY, B/;S$< .-:/_,*,9CPH@! PXX,*@)AQWNDZ0D3.*0QHPO9DF/)(S$
M$ .-7VFT99MNO@EGG'+.26>==MZ)9YYWZN.FEII,\@,00 0J**$5&!&H$8,6
MNJB@@A;Q:*,51$HHH8PJ6JFCC0(Q*1"06A#H#Y@R"H2BCH;:J!H_Y#!&#LH4
M1=A (6V$D$9_9C)1K7TQ91=#'$GD$50A)?5414<IY9%2O":$F$!9U74L4QM!
MM)>L!R%;5WJ9%(/566-1I)!BM3Z%%V+AAIM54T]]5"RUOB8TUT9U!6ML6=Z"
M>Y:SP$;36!HKO<02P +OQ%)-.[D4,$P#PX33OR?ED,FKLD)5%$$-973611K_
M%24O44LI$T8  2Q#\D:D&0E RF+ P:VL?24D4%VY8C3Q4 DM=!!%P (UE;=H
MF:445'C]NG%=RU9LU$)L"9WK4^\.I99 7'+)H4B3O<'8>)UM\EMKXB'G7&OF
M&5B:?] 1*%HF-P# W6;\=9U)&& .IYU0ZP$'2FC,43?:>L;Y=UQ]GGV'6W@*
M9K<98T6!1W;@_^T=7MP!.,!?8WBGAX,!*1]@(M>8O:H)#@%L+L,DKI6-VVG(
MZ7T@WZ*EYG7AL-UWGW:*$P/AGV_LAN&14]<S]3[)+ )D&OHDLP5M+$KR(ZX=
M:E+,/OKHPXL8,F0Y-3UA_)C&EM',8R4.&NDS9H<3_Q'#H8@I;N@]GQW2X^,*
M8X#R?B\&Q/!#1?IH'X/S>OX/P  *<( $M)/[MB29'R3J!Q8PE:50A:A2+0I5
MF_)4H2S *%!MJE,1M&"F.FA!1G&@4:A*5*%&-2@%IF$@AQD+6C92%??\A63&
MNA=!X 48DNGE5T,C"M#VM2MWS3 J8R'BQL(E&(8P!"_:JF&OZI61HRE%B30+
MBQ4Y0A1A!6L90],71])BEF3=L&BUBLL6EU(/8J3G#3I92<,4II.3Q"1@<U1)
MPG+2$C?*Q"5  0M(K-B1*J(%B, J$P "@(-00$,9^E#&,,1P S@,)Q-;,%%'
M<MBMHCA-+4.TEQ*GM9BW(/^%(7R)&6)F=C&2S<MB>J'67'3FE*4I$9/+R&)9
M:,A%F:7G,:\CW&J2LY[?C ULX0'0ZH@#G&&@804&.( S8X"#NVTF$S 060P.
M$ /L;"(:KB&-@'[)&M45!VR@,0W?0E.4[0B%..BD3]YB1\P#%>,3(UG; 7)
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M:E<WVY%E8689;AB<WR2'9L,>:+-X#7%D.&"(RO )F: "E/.'E[%X:"!>6X8
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MB+NA#V%S02%Z9>I\)$^_83- _R#RD$%&=%P%.8]!!LK$&.B&W,N5*)?[(Z
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M:E=[[;$KR31EIZ=IV,'::+?#G#<,,7XB"S$N]98^7/T*?S5"7'$C!RMS%\F
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M 4TX!0,1!DOKG_^X+@^1OW>+Q\4Y%300%G992J9D(:9\2JA\RJ6(RA9BRJ5
M/#[KLZB<2JU\RI!I2CZ;2JYDRJ1$O+&D2J@,F2UQ"_T!D@')I1&!D$]Y-S1K
MB,;Z0R5BBR@TC"3J,JX+0V;A*PN:H<""BL$@3 _:C$MC-800@\9J-5S+HUHS
M#MFX1<O21<S,S%P[B+8QI+(IFVE[FF<$&VGTFNT3C_.X&F?D/B H)&=;F["Y
MCMWBK;5AEV'X'_.B+O/KM_7R$>2*R6#J1FO_ DK/03>*6AR-'*]A^A!W_$W6
MF9W@/*@KS$(3>[  ,JE<2L !/,D$K+]D,CE2BA)B8"$+Q+AP^L 1S,#=44\.
M-$\"\RX4W"YP=#&B!)+(J9$*F<O1&)U4&CDDZ9/,,4?SN;]<(J6&2HCT@1QV
M+)P*\0\ T1LGS)ZU.)!(N+QHN)QX*M!20IP).:_:2TH<.#PQ$-&D'-$2/5$3
M3=&R'%$?*-%)?-&D-#P1%0,?4"H075$4/3P<B%$:)5$7]8%)M$9KK-$:18,B
MW5$Q^ $Q& -K1-(0W5$H38,GU5$Q"%&S/)P'A2[,V9OE04+].0A4\8N>\HAP
M@3L+ZK(V] BU4PFH_VH]P8P@+)N,I9 $-M*$B)K$59N]F\2-6K0UG=$CVI"L
MU)"-.YI,S3Q41"T.8.E%1.J^2;JMZ6/-YX.V[@A-U+*.M4DD]H@M^3@^UIHD
M\."MTM(^YE@(CRP5!%J\\JD2_E3.<-01A8,FA"I. ET\R-$44UD_DLP$25@@
M!>V5!IQ'=4M.>)-+#O4;6[TH)%0O'0FFX02W@<Q0N4F(GA@P='K($L1 ;+56
M-PG!;/6O.A&_ [P?^\HN!341CE(1G3.<UX 0^ N1ZTHX?U,W6 V@4\K5))P$
M(/D36+D0C**24O*HM\*!!*F'"HT4O5DW\R-'(N$56"V0) 0N2(R5.HS#0/\<
M1(J-E= ++LG(EF_Q6)#%%D\<69(=6:=<,3C8+Z9:6?!A*O !G\F @TQXV4JL
M64V 65]3GBBQ.L:CU86:G;Z92X% -,EXJ3-$"8#9%IKJ")OZ-)* J:U+#*XJ
MEH:@"(3@LY)I#,;24YN1C3F:1<\!#H_4GSX5CIOI&=]@C9JIC41M6[<=#A(I
MOK%)I-VZ&MV*QE ]/N<SOJ<Y1F"DMFO##MH:S6>D32!@EW<B(/M<'98LQ^/L
MG&':T'!+)I*D$??)D.-L,%2J)M+ID^[Z+H4ZI?B#3EA2K_H:3L1!/Y)"+MUD
M+^V2,'3S%(1*)I1,KV&HDS3H5@1+IXDLGFTM,'3_@D@RJ4B#\[92D25_'"\<
MP<;[[)\.);EC(C=D59]KXE(;28A]^T$5-#'5=0N/F@0 R($TN- # 8, . #T
M78$;H!N2DM[)]2<Y-3QB",> K%_\N]]::1<Q9:#"&*$ODZJ\"D.)J)B$R$2<
M/6";Q=F:A5GP 07,PY8"UA!OI!\#2<?[@M<F^1 -Z:9,R!:\PT0;9 B\?!9\
M 8F*T2)FV2$3]J)X28Q,! M@J8S6D)F3J8=A")8;B($1%9G> !I).#Q-Z*/1
M*(UAJ%(/,@T.J3U0@)&W;6(G#HXDW-O O8[8A"1->D:_M5MJ QM,8BVH\6)G
MV^+J<*1&O3;Z2)X709"!_TQ5;$(<'T$@7:FY>#0_(4FH8BHQ(V.P]=,W@)P<
MC_O!;+K'FBL@'N1!Y)JG[:3.;V.W?MM7NSG7\2O*>-K@I<"=-<DXWSV3$NRO
M]>S6]>36#3S!_JDE<=O< H(2H<S"%L'@D?I(Q5E69%K)5[40W71EA5J9W%2O
M 82N'R$K,0@#'% #&).$,6!2$=VTCL@H5^'/JH.5-9*,97V0ASK*NM&FY4$1
M";F22U,&PD0*MO@++(O3-$VB#]HIHDA3EL"/FW5@38B#=KY9>*99.X!G.P"?
M.TB*. "%?"88M<#=3# _CPPO:2*=% E %Q%=%8DH._DS&8&,3% #R+M+,E4)
MKO_B%@LBHFAQBJW[WQ'BPV'PV,F0!,=2C2&^29O(R1]K(A>*&]^(A+I2@UDL
M#4,=#GW0!R:*@?FEK RKL318VR?^:: 6$!P0S>F().A8S6&,5-5\#@X0#^PS
MS4AUK;F%CF%C#^YPS6!COMY"K?O(@<4@2KYIV 0\75EYI58:0&@8AH!ZB2&:
M'P(9!C1XN;;F)0:;G7AM-_(!"Q<"Z),<:.M:/V7698"S.4GFE>-*XQ/I1F9J
M9+(^0,,93V_BW73R0'4*,'*J./?$Y N$ ^\",;,>P/5;V /D$074CWOM-\6E
M76OJ5U,V96BHU:$<$&6(G_M#'(6SD4/>D4RX 170X4G_V 0!HA&4H:L & ,?
M7!)<$4^%$!F%K6/!3L=4 M"W3$)468N+,(F.00IT88M-F+-B$8SOI@FZNYUV
MUF?SU@0[V(3T7F_UWH1^#@6"<6#U]A9W3F_P81=U%2!3XA6#:UC'/;+^L=.L
M7,JQQ$JQS 0G.\6\\HJ1B*%WF9=-J""V\PJ0X=7DB0R<B0TYJJ(:&]$P&-$.
MGVG,6 0=#A\_*@U,X((8> @\(@UE$ L8@ /+#&H:;]MU20-#<AMA@T;8ZO&Y
M/1M+O;9IHP^T"4;N\P[X("WC*_*I9@ZLNY!]O*7*/4?X*DYYZI PH+R7T('Y
MHH<LU_(<6+C9T9/G>9TK=T?I_V*<]2O>\2)=/0["1=#RET@ ]N'"@PKL!>R?
M/ \IA)I6=ODO30:3 V//ASR"B!.3.%BG3AZP=G+0F Q6#)'R"^Y'5M&;1CP2
MZ3YH^L4FUGWERSVH%=$?8E@Q/V'!\E(0?V40:)!F3(@!!!"#4. 0SAD4=\B$
M'H.#Z=J<Y7*1*PD6QMJ?52I>8&?L7+].?])?KE,BD3@]OWH7Z_YF[,Z(9_$F
M]([G=Z99;-?GF_T(@IGG]O;V>:;$#OG-9&I$].$?6CT1]J.FX4:<J4OC&.3%
ME?*J%,*7IX@7HX!:GMJ64% RCWV#I%R*290$8IAQTA@&L8B!A9A%97"TGIZU
M.]H%'?^& \BJ:827@9Q6C2?<@B#^&9JI<9#7S"A^3?8HFV0SFT<B\M521KUU
MCM34V^R83>UC1DQE&J/V1>EC*_%EB@%RG>N:)18DOZHSLGV-<[(0GV$  YW
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M-2]0\<.FV%\!'OZ_4F&+V!*F6@S&6K$7G1%E&(94T0W6^'SOV8+^0+HT@F&
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M1=E)5Q(F%H@9DI!]W$I9(+;'H7R,)QL3RQJ)0I:-20=3OCG-9#J3RUFF<V4
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M$4W'D41:"$1?2$XJ15EH#N;(617_6-W&M2)&O9Z +6J 6DA;10-CJ*)LDF)
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ME41>36D>O;(K>+XK>/_>U#/.3Y^@#_K(CTQ-35X\'0*C##%@ F)Q(EG%Z+B
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M\B]E0A@ P(VD@7UJY3H) R_<3B*^Q67'C*!-;"8H'H)RRJE09IX9S1CU!4$
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M@-"(P &M?606"42.8J0R&#5'"IMDB8&E3=:(:(@^U-H6_T0Q$JW 8@W1KSD
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M3^CW\*Q1W5HU*8?]*-51GNK.'EI5Q-V(9Y.M%PY_@7.7#:IG';@:MQ@X7WL
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M?<M::3"]U%ILE'768FJ>UC0=:?$&1_!NNITK4R9OI&&@?_+%X=]["O(7H(9
MQ/&>R0F"'*$:'#8X7W\ ;KA?@2R??'-^,+NG\\P:PDR?@T3W#++.\:5!C$[^
MLMBO<C9=/)--,7X;%$^75K9,)FC_3*)3:> MI8\8!^! Z7+0T$,VE"Q-$D8
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M:+F$-CO7H,$'(Z-B3%O[J<Z#G1,9GA.<P=O)3=RS%,KP!F- JSK0%X?1%SE
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M&[K>/M'CM,=1H8W9NR25)03;XD$OM_/%+Z)7"P9 "*1 PJ?4T$'EMR&91JQ
M"J\IK:TI"'OFL[$,&LUO,AJ[.1HR012+I,A]/7-^.46[/Z2)./0?;V[GU=VO
M=RR[L.B)3&0R5"0O$27P6@I,?VBL7M5[7<4U=%6 !>O/)73972XE W87'=.]
M#/AGA_40YHMIFB )"%#L==*F,<"9@G, ") D5\TW@"7+>U._O=DY;\!(E@0
M#J &^HLZ#,$U * "CA,?#9$)GR &CA0'#'$1IF4F%TY+:ZTY!-DEG!CBA\H
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MEJ=$ZUS54U8+,<\^_Z*Q#Q#3&9%]K#A4I:.PD)HY)D=2>&D0@Y2N.KS@S<R
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M2:XY"IA8$Y^3B*" %T&3B:5H"B)2E#V[C8LP"ZALST-%U$1MNJZX$BDITLZ
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MT(PSWXY<6;WMS84S7[9]^C+IX9T35[8/_?3A[I>YGY0F:2AEH4 M Y4_%#$
M-M1??_\ILPDHQ?"G"8$++J/)?_SYIY]^ 4J8'QQC*$21)A!I@I!!&A5D1_^'
M&9&HR1T?5@3')BABI**'&('BXD @)B3B1;^)M2.//?KX(Y!!"CDDD44:>61/
M^NQ4#TG$P'%66JGY5=M;D>$UFV.(V7597W@I9IN7:NPF99A_W;4&7Y E]IE;
M.*@   1[I14'EW"89AE;>H4AVI=JO>D9F(O%]IIL?$DIF9:#X5;8:KP9ZMB3
MOT$'S7K=.1>?>>V1!]YT[Q6GS&^99-H<>N1!)YQY]6AZJ:F?*E=<JLE)%]T;
MP"TH8( 6%J@?A <>*.&N^ST887\*"IB@?PXF6! :$*JEHD$1L?CB0!2!& <H
M RG4D8<'093M0P,-=-%&"":4(D;VT8,DN^VZ^R[_O/'*.R^]];(4S8Z:I)$8
MFG+%4=>_<]*%IL!J!='7:XIFEEB>?]5UZ%Z!Z29HF8X%AA=DCJ4!   Z/&9F
MEW^:*1AEH]TEF!HVP%GE7%92N69:8K:F6&)J;DF:;9!&IL8;S<H'JS[&+1-T
M/4$_5]QS0Z=**;[%94))J=,AM\S4WWDJG7#/H;=>T.5M>C1XY$FWCWV]1ABA
M@@WVMXE^M_IZ;(&Z7MCV@\'.^-&+%$%DK8O>)D3N0B$^=..*!#E$(KCC%I1B
M0AB9!9R]D4L^.>656WXYYI+CJ^0^T622QKX?WQ8H76Q*]C <A,+1;^FJ#;9;
MPZAW&>BA6GX&QP\B<]EP_UIW>MPP''L* $29;W &:,N"(IHF82,?\269$=L\
M<6T*W_[&&&_0]UZEWVF2R21BH($=?^W5(U0FXHOQVWW$<+]I<=O!.O]PL#)=
M*GWP<U<_=,<9EXFMXI8?MOV'01 *$-TFM!]C22AMR$(0 >4F( I1XBPAFA;@
M7L2BQ#FK(0,AT8U.=*X2(:A&%\F61$"(HTF\P2J9>R$,8RC#&=*PAI.C!RA8
MR)B<O0PWR8L9;#"V/.#5QG:E ^)G8)8;PJPA,KGK3!!'AA?.( !C+;N3[-*@
M CQYR8@.8\O! E6E+*E.>7[1"\T6=<:]I($83(..,J"A#$G(X :3^-PD;C &
M./_$1Q^2$,/Z/B>)&,1 #9KX!#&PPA2B:"*1B1S&5R+I2*Q\CQB.'$[2WO,^
MI;FG?N[YG*CP<R%06 @J22E(02")RE4R996H7*0K7^G*3*#A/C*Z2$*P%0>*
M<"A%'%F(1#X$+A=Q:"*-(Q&)7H.0A.B-1:"T(32C*<UI4K.:UMP',4!'Q!W.
M+HJI6<Q;M%0HY=$)9\PKDZ+4PKIT*M$(6H1BE"33/#2\"0)(U,L;M@BHMU!F
M>(RRHI<84['5K"E1:3D"\&:&&8">+#=I>(,FJB._X\Q1!CA@X230$ :/Y4\?
MDV $#GZ3T2V$-"F9& 8IMZ*)9'0(I5TAQB=.R5*H(/+_D$P1RJ62%C_N0,=3
MR_A<A]Z&K%VQK2 S\DHC*PF*3"SU>TN=9%,1"1Q(0A(XE 2.),[RK0^24%J#
M ]%$"/)+<!$N1CB*%@H1,J..9&(,F5C7->,JU[G2M:YVS8D^0/6#+,'F2_'T
MX@Z!5R>#_A-FN)'=7)Y7*,9L#)YANA)<@( #  C@8XB1"V4"D .]9':O?$6+
MZGC',IS5Q76?;9G,&E4PG1'L2<.@#G3"0X],W"  ##I/&&0@ _XH)0PQ& -Q
M]$&,,*Q@?8^[XT= B='D@J]6[ ,?= '((%-1BE)*4\YVJ.:Y.])'@<J"RD?,
M\H8WJ & M:+$1RB1B?)28A)P_W@#'-8K7YZ5Y2R_@0,+\6L6T&4"(2V:%K8P
M8BZ)7,27:OV@1@:"PHIH!$0D!%>*(,+@)[GOKA:^,(8SK.$9XBLD/P6=8Z9'
M);N4%K5?O-GJS#2SNUR,KU.:G1+YR;$9TYBRE\%+/CM3%^"]ES,U[AAJ1N8P
M.(3QQ7@ILA1/V\V<92QCLXG-6< S4>;,,0PYF%0],"$# &Q"CL-0 0[B\"EH
M# ,&,OB!5:'[O>\!L,VUBFZ; 7C'C*:A?N>#HZPF%1U0$E _!/1/5](P!M 1
MFM"#)O0/$&WH1!=:T(4>-*,+G>C \3*7'E*<6O_F(<9AI)@CE)8'NZ5!%8%0
M$OAB4O^'-ZSJ5;.ZU:[FD7#.0EYN0BS(@K4+S1K3O#5E[#94BA[M&*66/?UX
MQ@(HTV2/+3K2L.4'H:G,9G$]IUXG62\[%K9IB<AL=LI3GI'A+WLRY1ZK;*(X
MIQC:( $0!V@D0Q@ 2$,HJ#.==L1 #.5.SM&BPYQ]-Z=SR^GWI[CKTZZ=SU3S
M*;@F[CC _22P("#&-:3\<A:UP/>]CK-+Q=]+\341.B.Y=-:, KP1 7]+K3(B
MH1TZ$JX7=7J#(BIYNK+SZIG3O.8VOSF30@+7A#\4B&@LG<X,6[,?FB[;0O8K
M;0X;N^9!O.E,ATMLK 0I:9>8-C@3+;:C;CIP_MQEL\,26_1TU<+JGHH>0TE.
MIH2! ]L*Y\LY8-![E#&/&)PE&M$XC[CS)Q^]T\<X\CF?OD0EO^%D*FEO+#PH
MT39 7H'J/FA1PXUYAI>)RZGRO9$3>2N?^<R#N$-]$W!$Q"4C;!WS11Y*B-]P
MM#==.J0L\/W0B704DE3?O/;_MK\][N/Z/?O>3$N'BGHY4U=KUG2;>F9*#9K0
M@E 87_TQ0E<3],64Q+^PA76F"S**;9>H%'>3B7 IH]9-G,2 +2^)V!-5_E1E
MW7V<)VA"$0,.9) ?I<  !Y0(A1SG6$AQ[[1S\VG:O]D==31->X#/<"Q'=;P/
M>K2'3]4#^,!!@$1(5_0'5'Q.Z'B)\F3,$N7&-RU4UJD%H]T2,!'$MT#+5W5$
M"9'5MEC+"/U2I#R4Q<57&JP+[>6>#=X@#N8@Y8#7Q!74Z;Q8KA'96I!?]!!6
MSA2&:3417R4?V*E3\5T6UX',$1J&M^4:;M1)HW0@9!E!\CE&&$V?:2E4I C>
MG27'_]]EC3), @R\'7'(D220E,P-PP&( 7]LQW: #72X7Z9X1WO0QYUQ5Z:T
M"B;%"G<@1^#]1WXT$G\P'$;T7//QD/(0WQ(%E&)X2:)!E%%UB()U2(L@CHCL
MDK,L$XB0".,T!(EPR&N\R*$YVBK664APC@[&HBS.(BT&B9/ H)-95N^5W])!
M71D9%&3E6@]-'\CHQ<&46#H9D0\]BF)@7SS-C!$*66LTRJ,PQL]978BQA:R!
M#C'TWW!T#:7T%@#46[G%QSX,PR =P H8P#BF07M8EW=067)43?^UH7!DDR;
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MUD9*>$;",LK%U.)=#(9W%*W!XHE9',F*C&"1,@8X<I#)QHRCHK 0?>M3RD@
MN^W"*J^VR*C;-D^-C+#SZ(8-#?&TSD8ET"3>6M S,B$'($=U-L9T3&CX[L04
MB8_WIBOJ!$ZN,)!2EBUA$@(ERBSP<"D3J*K.$- P?F\&,W &&6)/%J*8<L42
M+_$8@4I)$.OR'!'GLDU*F'#0NBD::XM_-$]P>JO<D+'!#*8H .\V- $-M'!T
MML91:NS@KLXCM*-,?LG_=8(C4<SC-\HDK9X%R3#%HDX+&C^IG!QL&32G4M3
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MZI7JN*BN2BUV 9N6Z4M@0J8I\S DI1C.4@_Q2'M<*JN;F:NC.*Q=<Z&"J5"
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MN3C[>%MYB%(AS9\$^CZ)(/($ESLPCT"?D\@3Q,^26"QKY4<Q,XD.A[!BI^U
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M)/0@*>;V]C<5'GLRVYH=0V;"U @9&=_131*LX^J4!@N@== >E@/(G_A7E"9
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M*!90]YA"B3KZS<(41IAX:1*GE$16G;\MQY\;(S;B0RT_V"G0UBU= *T#T$H
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MP<A4/AC^ 5P_=![,EX$)YF.B%6+PO#A:+2Y$\L1",O3.DZTQ%ZK>7WXNO=7
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M:O8A#;3UIF[$N1*2^[HOOUTI=]FZ6(H@9:K^$ P#7]4>2@*8!3&!B5"9U)G
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M0+G"2"/C82<^$)A*L@ _RCV#;JY7&>;(33'7AI%.\YC!^1]2]W0&6FF@M5Z
MK=[JG*?1?#X/@67@UCP>ABDCOV;P4-A'D8T_3>?"T$:48-HXMO&A/ B$FV#(
M88[53VU\WD>RRF^U9&]4\NP793"Q_^:X7&91@)'O"<BC+(2(A@%,8]69*DTR
MZB/L,6;E7#T[XMRL@$Y@L)-X :3,ZC5OI 9*;#MOZWG<S3RN3M$<>44^"J3<
MM!&NO; +#2.X^;9VYWLUAL>E__7\H)/Z8(TQV/?#FE\X..%S?<_?KZM*[;*:
M@B&;O+AM:Z5)DI,4)VDQ___(>],FQW$L2_2OP&R>36>9"35<0!*8_N2Q58=9
M5'IT1&25S:L/,JSN[)9+WEHBT^O7#\!%HFL%2(#.?F^L)\O#72+N/9 .+G O
MSN450<Y1)%0:*0H12B5$-(L@CN,4"AKSC-,XPPEVN[_E:('+=VF<NUR5;6 I
MMYJ,C"OU@0C?.])6%9FHQ.Q8=AO1NRVXZW05>81BA@M(""40"99!+')I?A(T
M05G$1.&R< 2<K)&*R,P$_6(<^%,]3P<?P,&)*L($]<16CH2=);ME)B#V@1<=
M_[#WN2C<!SS/5X>=3!C[,G$??,Y<+^[UF)X*5)4(@OQ27V2NBQR:VRUS%5&$
M:<$U\Q4Y1#*+(58I@YF@.1:*4)HZZ6Q>&6MZ+%>;!_2>>J"J\#6$[5C+$VZ!
M&:JQLM4%WB/86.I11^HV'%YUI*X,-ZZ.U&V_3W2D+-[2<\.]7G$IQ:8ME]K<
MJW>[3;DTTK]*52D*>;<4^F5B5TFV526KFWDFXHR0',,HU<2"4EI AO,8*HPH
ME0S%4CFIVO6T8VI\T[I1K^R5>EV5(F2-+V!C?'/<F_><(LL=>WC@0^_C7V%>
M^6!RMZT7,[#WHYJ*@R=UQ;U'^8.!6'K=]/<T9=RC@&%XG1P0#'Q</P;]*^6/
M>HSUJSQM4Z:H0RN.<L5@DF=*[S1Y!#&/%33M8U!69*8[A M+7AEK:DQXJ)<Q
M7[K/R^KLN,IM?'_9;.63(PE>0]F.Z#QA%YC,]E8>E9;YKP.UP,,G(5T;;E32
ML?#[F%ALWC)0./A>-3)V=-&YC?EUM2CYRSR7+"-93B JI#EN5 *:/KN0QI0F
M3*4RC9SZ[5J-.C5"J41N?U9-[-IKC*X[."NP+?=ROB$,O:L[M #4L='>Y.Z-
M]QFHK0;_:/[7IHBQOWJP#7!!=(2O#OPVBL(V6%S4%K9Z<\_8IERNUIUK,^V-
M5!-A?9-"-EWYYIJ-(IYB"E.6%1#%!$&*,P33"*%,_Y/',N[1 <MR>*NOV?@]
MK[[2]=9\Q5K-&=>(QQ+[.*%%9'2<)56)QEX0R!#+8$1SF26%RN*4NBF1AH-]
MK-2XIKCEZZN#;9NQ0)-@&8)Z!/:-+V"VIM>;[H[QP!3.=^;A\TW@W2-7-QB]
M1K&60X\;T;KA<1+=.KZ]?_N?U;*J'*H%<^YWV\U6;W+TYVJ>)4F>"BYAK-^K
M]\D%@9CD,<QSE.0D3PLNG+O]7!IL:G%M;2O8&&-G30TO6!WL=2_MM8(\QA)S
M7N0PYHG2&XN8ZV6#$JA(89+A*BE(,G^N:KJ^;_5*-B[PQP,'+%F0#^5R:7!^
M1Q=5XB,,WEF*$9%YJ@&.]1Z.$;U]4T) $4E9D)R*/$D;O#\N+1=JOVBWPP8\
M$ZH_T&&!MEN*?4$7>/UMR.%[30ZUI3/0L=5O0ZI;B/CN/W5QO-';3=WR_%QW
MJ9OO&5*']H/^<:8A6R[U5DH5"N),KY&(1A+2/"E@EO (Y7&N*<9*H-=BK*FM
MDTWEC%%*<FO-Y@RR'8-X@BXP@?1&K6=9T54\_)<0G1_N#<J%KOI]OC3H^EMZ
MW-S[^+[ME!(G$3ET33E(4"W%O^_HHE0OFJ7:7BH'&XXN"S."8XZ0C@LI$1"E
M,H(8%4)'YAA%&<Z2-(JM;^KYM6UJW*3= ZU/,Q G,"(ST&UA=%!_,VF=@Z/[
MWD:=;Z?#U2W/,WZ=^-YX'@,3I=<I;%I069V@!Y]5APMX;S>[8UVX\SK+QY/L
M2Z8]S#1<NU#G><3Q+M"%@>K5A;E 0_00#/KK]R^EDOJOLJE\H*1 6- <TH)5
MAS@8$I3G,"Z0*O1N ,6YU66XLT^?VB*K#02MA0ZB*B>@W5[E!D$1>)WJHG"[
M*L0"#@=-F"&PC*7ATH''E^+*);>O*:2<O&<\19-+YKY2(+GXHGYG%M_DS]7B
MIZ:_]VLIRNTG:M1-MB_-1TQEE L:IU"2C$)$LDCO*9B /"H83C,ETSQS.;6X
M.MKD:*LU%E1?6:,J5%GM=EYQ'6#*(DI27, B31A$/$:0,)1#+C(9%QIF15*W
MJXC>(![GXN$!Y-I>T!KL$V6[<R%OR(5>2"Y!%J#6T H3GZ=#UP<<]7S(RO?C
M$R*[-PUM'?Z7U4K\7BX6=6MIE"%,6(IAPK)$DPC*(,Z)@A(S%3/,8B5[M@9_
M-<[4^+F[^VL-'=K3^S6P=KSA :[01R1]D!K0;/LL#F&::;\>ZHV:99_U]W(S
M[/,O[]N395V:Q^POEU4-)SM[V/UI4L(H)DIED!4$0Y1$>LL9,1,"%PE)8EQ$
MV*E4PWKDJ?%&:WCGAJ0QW?E>J3WT=CP2!-# S'(!RY?71ZHARI&=T?+; <5V
M\)%;GSAB<MKSQ/4![H=A]^L'NBS_61TG'(0PZ].XKWK0]JBA4QU=M=2MBJ,/
MIGS1>[+/YCK2G":2)%FL]U!%7NCP)^&0&9$0P:)4$:E$E%N+9?LV;FK<U_5O
M!EYYV-RQ//CX^K[!P<U7WVWC*:A<=3C+\OX1N'TR^)83&YB#NZX=3>G=\93>
M_[>94OO3S;><VI$.1U]-,3_YUCX??6O5?HHWARD6>T\]':^&POW*Z:SW(4<[
MW T%5O=L.-@8H639WDG3OG!?5",W'__8KJD>0YNW?JEL.-\K:"[3(DN52&&:
M" E1RA-(L2G*S3+&<D[UYT;,MZLM7=AM9@+:ZA0"["T.7EAV1>"-5:ZV2G!;
MXZQO[;#^,V^WEYK(? 9>^6TUR=H9/=04RKHG\KDK0F/JE0V>A'&US?J;.S$=
MM,&XNVNF#1^RWRKT42E9:8;LA_ZFE[RC1@ZF=_*=^(_=9ENMA7.5Q1%CE$"L
ML+D6FT<0LT)_8C))"YSFF21._33[&#&YK:.QSVT=Z(6]'<&'1C0P<^_-[W R
M,!Z UR[,FF[V'2\J@4E^K565,U$/ =,G _>R8U1J'8+4,6<.>E;/#&)?#?FF
MJ7SGKLS?9?GPN)7B[J=F^ ?Y\0_]H2PW\NNZY').!9*:*BGD69I#%"4,LCQ+
MH2RR3%8=B1%WOZ,XDO4N-#'>=<>.\8!N=437WG[4^_T7HW?^RV_?/_369![K
M@R&1HE(4.9019V;?IB".<J(_'2S"^@^X0)GK9<K)?BS"W\L\^E#(I3 ?AWKT
M_QX?",L4^_2F.'3*?GB#F<;W5[=.9Z#U'S0 @!8!4$'@L1Q@W#GS6EXPDNGC
MEBN,.Q\GY0\C#]];[.)Y+1^U>?NXK-9CJO][2.G'44JYD @R%"%3&<OU7C$3
M4!$L$.%I)F3B*'QA-? D=X7@E?7M>53MA;- @!W^=NM&"%0#$_]K*&N;QQ%X
M<P7+LZ: W=ACZPLX(7)&:\#M_>[5%'N=7/Y?NW)3-JF?K69)S9\F"52*Y@3N
MF_PIESOYD:Z7J]VVZ?&'.#=*;P+F""N(..&0XEA D@@2IP6+<TYM:R>&F3(U
M8C/&06U=E6[=6PZ>FQCKV;%9X\!YNEW@,![Z@0FP=01T/ $'5\ K7T#C#&B\
M<6ZB.7!>[*L4QIN?D6H2]O-$._/$#_/T^GNS;N9)ME^K^@ODJ13!#[A7"@\&
M#C!:F8$?(+I%!9Z>Z$E[[FZW?5RMRW]*,4_CC*82QS")&8.HT$$%H9Q"&L4J
M9DF&4R('2<\=QIK:VG16>8[NS?6HS]7!VSKB]H%B^"#[1)T+'"P-J,UU"D=0
M::[.<&^KS'7J]TUAKC-OZ<<B9RBL2:'1!R,'L-IVTLWUJ];Z T]$QI0@"L9Y
M3"#2G&+NZ#.8%1'+1(X%(;G;W<Q^AKA\;\:YM%D;VA&5U7SS7#OB6"G4<VKL
MN"@\W&\0"N_3O^;LUNB>O)Z+YK5KGR0V#$>?_-;3DE&I;QA:QZPX\&D>>HL9
M0F[.8-N35C&7LJ %DP5,I-$NQRB")-94*12F120SI;A;,^];(TXM!*N,!-0<
M4 /9&+FIBK%7U8EH%7Z!<K/9&<74S<STUAW0/>SL)-BQH%=H Q/>44>P"N/&
MW'V>RB.Q64,3K,'7V4'?KI77-0RN-NVZ^L;>)*1CBNW+5_T)V7;[]_QEO=IL
MYGE:,$Y5#(N""X@$RB$1DD.495AE49;F>>)2 7Y]."?Z&:&(N[5V!IZ-O17Q
MR-;B&7@P-L] 98DSZUQ#W9IR/&$9GF\:&+_N8?QX@+$RURO=6,#BF6NNC3@V
MT5AX?X9E;-[5^X;*NLH]TT6S^ZPWGMOMNF2[;27_MCK-2A]RUILYCT6BDB2!
M2N5&P"?%$!=I :OF+CREB2J<%)*&FS2U2.E.QT!/4ICK)*UG[9%5M<I7IU@5
MC6WZ'UQYF$D[:AMW?@+37\<9T!Z)-6=A'7_T,@(^E(M=5:Y<%ZV:C>?9RJ..
MGU[OD7C"W/-UD:%6C7TKQ!.*9RY_^'IR/Q[_()5<ZVWO)VER$8M]/773:?N=
M7$I5;N<)C4FJ> 8Y-CI)*6.0(5' *,ME3/,H39435]L-.S4^;JQUXU=+A.TX
MU#]N@7FR-1@T%G<O;31&@U\:LR\O7,Z\YX:33VZS''E4_G)#XYBC'-_=0];$
M'/M\KSYRFY5J<J&M4FLJ:,)% A-DNDE+CB%E!$'"XY3&C&.BK 7YKXPS-:9Q
MN#%V"\'KQ.(1E\!,4I=+-F::**JM7W$7!+[Z@;,7S_ #VU@Z&/79Z@&^MJSD
MER>ZI$U5O)+-26S[QVJ;H=]9E:G2Y<N_F#_S<K&@ZQ>PD>N?)6_>85IY;.5#
MR?5NI=R:*U@_]5;$EU[&;:BO25]<>?=X*A:W77@E2&'Q\KZR=ZV$^V*Q^KTZ
M8K];BF_2S*;<_- /O?NCW,P9+U2*60:37!80932"5.H5+Z4BY4K0-.5.RIAV
MPTZ-AP^M$0YF5Q_WUG!@+'<5O[.: +N T#^L@6G\;#<*.YC!/XPO7H7P7,#S
MJX)G-?+($G@N:)SJWSF]NQ]WM?*?^LF?]8JY?"CU!OENLY';3?NGIJ-]01@G
M6&./!,80<;UK94F$8,$R10JF"HZ<2MRL1YX:@[76N7&4/=!V-!4$OL!,M9?[
M-41TL!K49L_V<L#C7#%Q1M G7=D//BIC.6-R3%KN#QB0+:$;V;:9_KS\^/2\
M6+U(^4TNJB;Q)65&[;R4FWF$\QA+&4,9T00BE N((\QA)(LD2O.4JL*)NEP&
MGQI[W7&^WDD!>/<>K_D^LOK4P5U=RWX>'+(: = =(W]AVM7_TAK^)U.*V-H.
M&N-!QWK/60E'S+SG'VS''S_3X(C,V9R"ZS.&Z!3NE1 /+7MC%*L\Y2:ABR!2
M10HQQCDLB)04T2BAB=/F\<(X4V.KYFQ[;^? 3KVGN%I3TE"TPK./,U ]-?0N
MPN!?_^YTJ#?0KKOH[WG=N<LO[]&,=]^FP>P!>2.8>B%?<-2PD_*,I6F"89'&
MFC&2 D&<HAPJ5J"<2,3U-LZZ\6Y_.Z;&*-WV(P=GS+]ZY=&\3MGMQ,)($Q'Z
MQ*J=@_M7<W!_?0Z&M<,=,"T.K6_'F9ZQVMP&GR:WAK;#P;W6O'; T\=K5#L<
M@E=-:3T\KE^8JW>ANZ==%3M7>9DSXA1M4T*><53@#.;8%%2KQ&C;Z/]$7#(9
M$99GV&GO;CWRU!:NCN'-M0[^2IVE4<C^96'T;MR"8_O9L N7@V <>$VZNW__
M^:32\"M=5[&T]U:&S@CYC*WM!Q\UVG;&Y#C^=G] ;_(R1VB?EYO=VJ1EWN_6
MYF,R3](LSU.9:]Q182IK!"2BT*15***PB 2-G.ZA71AG:L2TMZ^N6I +!<O#
MKXP/=.%XJG@)86OZ&8I;:+)I#F'W)LY 8Z17BKF&@F=".3O4V/1QS=\S9''U
MY4.[HGZ7#R9$_R:?5^OZ6JQ:K9^J$.O=2_/'NK&G2(J49%D"LR+/(1),0J)_
M ZEBB@I!E:)6&_4!-DR-4KJ;],9.L/<"=-R85;*CS2L&MENUGS$[&@H\#V/M
MT;U.P8 ^KLX@ANGQ:F_&&_5_=<;I<F]8]T?Y[!O[=5T^T?5+O?WDI?ZQV83@
M7,@<%S$L,J:CJU06D$94PI2E<<YQRHABPYO'7AI^:EQYJ>OI##0>@(X+/IK*
M7IP7.UH,AW9@1G0".L">L1]PX3O-7K1@ NUF;Z%CUW/VYE-Z"LK1S>/7]>IG
M*:1X]_+;QD2C38^BY<.=Z<91991-,[RZAY'>U^Y;&,U%@2A!N822<@Q1SA/(
M*,V@BD7$BDPA5@@GR;DAUDR-%'^56\"U0^"Y\<@$*:O6&[TK;=VIZ_%%QZE.
M\SE'O;I!TVE'GJ--4F N-7Z KYVY^<7X LKEG\#>'7#P9P:Z'G6:R7D4Q_.!
MK%?YO$$&C2NPYP.[$PD^+P_M6X53T_]76HIY@5@L$!(PECB"B&41)%@)*#/*
M"Y)D+%).^_/NPZ?&FS?[+MZ&RX[(^H(0F)?VH9VQ:V;RG(M=U=#F/7TNMW11
M*9H>I 8/7%57-/_4OWW-7#Z+;TX1\UMQTWG^R&4VIYZ=UM:<>8V7$KMW=&'.
M_[X_2FDT7>Z$J(3MZ.+0A'CS[D7_XWFUH8N_K%>[Y\W^<W&>?>I3(I;(#*>*
M0ISG5/.&()!('L.<H904288B9"5G/[+=4Z.DU@-0N]#]4EX("OH=!([UL;#E
MQ\E-=F#J#3#/0PL<0Z,>L& RF.EO68 9>CYN%'0&'[[?>J9#XWOU40<>3]K.
MS3RCF$1QE$#.C!IJPC@TU9Y0)2I3,954$B=AF=>/G]KJH*TS&0K9VN?&^4?0
MV5%S?T ",VB#Q=ZT<:[1G8?#)[4=C3 J YWW[I@H+KRJ9WG)BI=[VOAJ,B^K
MY6OYJO.]R9M3^"+'.%8:12I,V$DQ@D2(&,:$)SC+$QDIY%2%,LB<J?'%K2JZ
MNGRN*:9S+%H9-F^6M2VCS4;H$AA3;W<(\1I73BKP7GMS2+T$*,GS@JS7LIIA
M%HU;?>,%O9,B'3]/'7).\(/^T?3^V+Y\6#W1<CG/BPBQ2#$848X@BO6>GB2X
M@*R(HH2@'(NBQ\;^=*"I<6>GZG]O:9\]]AE(73;%PX *?H!XBA'X1VVF]XWJ
M923\[RS/C/4&6\'+'I_?NUUYO1LI;-;;N6DPI@-I88*'*C%<RDTE+)1*7$C.
M(DBX";FB(H,T40(2&G$=<44XSZTR!-<&F1H9=.T$K:&W](3L(;U."+Z "IWE
M[(.1-1?8@'"%!_3;.QR@_W7\_;_Z_%&^^S8>MM][J]<.RP9^T\]]3Y^;>#UA
M:41SP6%&I(X"1)1 2E,,"\T!29X(E1+5)RWX:I2I?>OW\;>1)@2</@/ZL)8W
M-+8=0'5+'O:&:JPLHC'0I X#;%>N8A B+_AZH#=)$)[U]5*F\/R+^S>U?K]Z
M8N627NDYVFF+M6D:CVX:??'-O*!)RIE,S8FLN8Z/)<0(<XBQXIRFG.."S)?R
MH9(3N?HM\&>4U5>&U%^9KFGAOCFM97IVVMY5<KM=N!",QSF[SD8CS\/(7?XZ
M'EUN>-UUJNUZO6D;,(P_7^X-L,>;M[$;88><OU[ML/U ;=$6>^! H[?']@/,
MN3;9GI[<LV5:\Y@?JZ81Y,7N27-<Y#16%,$\3IB1JDDA+:2 %!<)BG@BD(KL
MUD;WP:>W!K9YY4I3_+FQ^W53-<<V:BXS060J4 IS*G240G@5H$20JXA'% D5
MJ=RIE:;?>1AQIU.)7^B)V%6]H70X,O),V.V$PN ;.,;8!WG;5=L@&!PUOYN]
M[G[GL>V=,V!>6^#9CSYN.SQG5$Y:X[D_8<@!K*;'SUOYM&G2!P5BB,I8U94N
MB* $XE@I6"B64$)HG@JKFI=K@TR-H%[9"2I#^YR['B'I<N[:'Y_1SEWWT'C,
MP=B X._<]>CY;W#N>M[#\^>N%U[;+X+\LEH^_)#KIP^2;0]J;&;V(Q(AR!&2
M$-&D@)@K B6+31L-IG#D=._M["A3^[(;(Z&Q$A@SW8*.\S#:Q1>#P0G\3:]P
MV;:X@'\$J7"["H+/\.#\0*-& E=]/5[TK[^XWY?>?N_:BBZ_S!.1Y$R*&"*4
M4HA2DD,JT@C&BLDH+RC-23K_*==L94L*/:QP^59T;0FZ#+;'/E+O[:'>W(,5
M6Y0/?6ZW]ID7.XX)C/4;')C.+IZXS?;R[Y<K9YSY:0" /MFKCQFC<ML G(Z9
M;\BC>AZG7=I/[:7,.2G2@C "4V:4,@DWIVB40862)".()1([%?[>''%J0=+1
M&<+K(X3>RO&W@;<\JO$)9^@3FJ%(NI_+V*+C]3CFYJ#CGL+88G!R^&+]QB&5
ML%]6F\TG;;1Y^O;EKW+[N!+UE><Z^T9R%"=Z]P5S;%I4\%Q"@A*F<<>YY!Q3
M50BW4WRK<:=W@%\;"LJ]C>"7^C[!GX"Y7="G9/86]G'!,8DB!45FJ@LH2B")
M(P:+@J99S J6*.Y>DNP#^3&/[$]Q[W^;PPYW.^KWCF9@^F^*F'_Y4J%7*>0T
MV-96@X[9OFN:+5'R7^!\:^ WJ':VQ.)\Z;/MF_LM"97 <J?MT>$*[.&(*<D)
M4ZF44&_#<[TMYQ'$.@J%5$>J3,J$Q,1).,5BS*E14MTCVJ;E5V^4[2C(,W:!
M">@$-G"P-] AGP- /KG'9MA1F<<!AV/><7FKCT"TWG'O]*;[<*'^G52KM=Q?
M_I";OY;+ZO9'6Q9:-::T6=K3%#&:90+&*8XU>PD&L: )E#)/J,Q$1!29;U=;
MNN@34@6UW8D%]QZ,&D\<_.\*>K *@<O!QJS3><;<;[]P.W0&?ABOA@1\83];
M?<+&R7QBQ@\^@WY80@6PH\Q7N# XK/EO&$R/,B_70_)Q3!C6$/[STS,MUU)T
M!!/J7YE!C GS@BN,8E3H!3)2$,4L@R02%$8H(3(O2,Q0[';>8SWV],Y\NKH2
MY=Y6P!_I^L$UZK>? KMUQ"^LX[:*UR3>6#T#78P/AH,OU\[4>G>%MP8K1%?X
MVX._25=X:TPN=86W?T _\M([#OKPL)8/32N[;_*G7.YD+;S'XT2).-,$E<41
M1$J3%E6Q@%R*G G3(#5S:AMP;;"IG4.\MM44EC?6]M-*O(JS'2GY0B\P#_4'
MSIEY;!#Q2397QQN57VP\/Z84J_?T8Y%?5UMI;L&81U5G&LW/F^:2,J),,*42
MF% I(,(R@32G$L992E@6);(03I<D;HPW-2[IW!GJEA-52>+ZSN;2. 2>:R_<
MF.46]G;DXA'1P/Q260H:\V:@/OALK0UP;=P2&9\\<VO(4:G&TO]CMK%]VX!D
MRIENE28BJO>%WR1?T,VF5"5OA4/_F N&4Y(0 27AB:E]%)!F(H6,9)J84,X2
M9GFE?)@AT]N-?9/-3JP^ -K2/WKD7=PGQ"$5$P;D,;,SKSP KT_MFJ.Y$S]F
MYBS.<\ZF-Y+>TSCNEHR?V>F-UMED3_^G]2/*^LCKN^2[=95A^O3SUW*>IP)G
M+&9Z(T<81%FEQ(<3R/(("1PS+@OB$HZ=&V1J,5ASZ+W9&SD#G_X&?_WL1G/G
MX:0BE3A7,(YBHK?)10P)BREDM)!%H?3G7W&W8OJA@(Y3+=\Y0M7K1G7#]Q7"
M'J"U6Q^&PA68_9N/WG?KCYXSK5\#P"=IGQUG5$J^YNDQX5Y][;"S_N;*KOB@
M'[U\^"K7Y4K,.8EIKG>T,,^-CCQ-",0%1C"F,L:",,7RU(56KPTV-7KMRF+T
M.[L_"ZG;<?U0H$8[H6\-!;6EH#;5_Y'\-4!"G,*?'>]-#MZO>7[IK/WJ>_KQ
MQ;_OZ%I__18OG\HE7?*2+CH=@0\5:9G@E(HXA3++=$#&"QT\Y+& :2)XDBI<
MQ")Q80Z[8:?&(=_E0G*S"=V;#_;V@P]T2\$ONR7=B5*_YD]N)&,Y#W9TXQ_=
MP,1S#L^.R8'J ]U@\DE'EB./2DQN:!Q3E..[>ZNVZD]-R1;R;K.1V[.ULS')
M:8QD 2,AN(YQ,LU4A')(DC1/*<^ER)RT!"S&G!I-'4QV%W"]B:\= WE&+3#]
M'*P%M;GA:Y,= /*L_'ISV+%U8&UQ.*,*:_W6?GSSG3]*L5O(>_5C34V_BL-6
M[6XIJN.RY@^U!5_*I:RT4N9Y(A&-<@15$1E%$Y1"EG()N:FCDCC!*';*)_:V
M9&K<5&EZM'=/SYTY@'\8VVN%'\<2AO[394=JHTQ"8*KSA+\SWPW&SB<+]C=F
M5&X<C-DQ8PY_H&>A@]\V4NT67THEYU(1D:&(P%@9F<HBPA GE$"""$L2216-
MI!>I@\.84^/&PQ7]5WJ48%=9#!;E3]> S@9X.^[S#&=@EKLJ=C #M<W &#V"
MW,$I0J,('G2&G8;DP2D.UJ('9][JKOK_?O7T5-;9(/WLO;8+?W6M[1 31 FC
MI* %9#)5$(F40A*CJOUJ+I.\D#*S:@GF/O34>*EC/=#F@U?VO]HJ.8=N/>;E
M.E^%13LP;4T+:'OI_7" CR2QWP7>K!7\%?!B[\.?_>CG]\/KBDZ^XP-'T\/O
MYVA7][[G$X8E3P_?@31G*,>)A'&>IZ8010>D-.$PR_0RD*4JD471)V,Z6:YO
M#1RP#3]%43&<TR3&,*?F-(3P"+*TB(V66<(++A%SK3\9A.,XQ2?[9-%_[9,;
M:I_<* ^'X_][*+IN*>@IKGMN'[K>R>:@9PJG@[Q)6OGF&<#E%_94=):;C91?
M)-W(#W+#U^5S+9'8?CHE5C$G(H)Q+'48C91FT+1J1!$+%C.>ILR)06^,-S4^
MK<V=@<K@&>B8/(!A;V%NQP@>D0S,#T-!=)>'MH/&JU#TC2''E8RV\_]$/-KR
M;?V8YA,MUW^CBYT\!'Z;O6"GP(2G>8H@)D+3#)?FSH0DD&&6QTBR/)%.%</7
M!IL:QQA;065L9X^XZ:V.>A5G.VKQA5Y@7ND/G#.CV"#BDTZNCC<JE]AX?DPD
M5N_IF=.E"ZEWDA5),<K_\\>:+C?ZL9JH_D++I;GK\*O<SA$7B:2,PS@B!*)"
MI1";B^:%J:#-19RHU*G@S6[8J3&+L;HZ$-G;#3J&SX QO;D@- /:?L=\K=U4
M6"9GO0,<F'R\8>N>BW6"RFOBU6[D<;.L3FB<I%3=WCVT#N7[(UW+=WHL8>YI
M23V4&:GZ[>9NMWU<K<M_2O';4C_[^W;%__.^BL!,/F7S[N7C'W+-RXW\NBZY
M_*8_BXVZ@R)"ATB80DH3'3L1'$.2H02JF&$IXSA5PNE:0%AS)\>1QAO(C)-M
MFU5PMUX;>^ML8^W4#+3^@,HA4'G43ZLC\.?!DG G,\NAB3KH! ^HI F)>YAR
MFR 6OU%-3DCT+Q?N!!VUW^KT3>K O#1'W>_IYM%D:?3_F-3]3[TV&FG,+,X*
MBJ(4FA72J#112$21PT@E.4TSQ47L5-IS:\"IK1 '>P'7ENZK>QISW;C_)MIV
M[.T3P\#\VX'O?0M?]<-'"PR=Z=46&)\$>7/,42G.%H%CDK)^7\\@>,<V\J'*
M!)\VI[S[H]S,14$CLS^'>:K)!B4\ABPO)"QHD3)*>"K<DK4W1YP:T70,!KU[
MR=KC;1DG^D0Q=*AW'4#P#V.OSUC.%ANOX=C-0<>-J&PQ. F*K-\X,-^@-_ ?
MY%K3V+;\6=\UV7> ^ZO>]^_64MPOOYE2:G,M5P=GY>:WY4H;M_YIPJO/R^?=
M5O]9PZ'?4U^(J_99E*:$HY3 A)A+M0G/(<%(PBA+(R8R@I/,:=\=VN"IT=WA
M^+XZ( ,'G^MK7."7O=M_ JWC0'^9]ZZ#RO<9Z'H/*O?!:__[[=.#?X(<LS$3
M^%R,EM%Y^X]$_QQ1X'D*DF<*9?/;Y*H"S\#%?%?H<7N&WMHDN;E7GY>B_%F*
M'5TL7CX_/5%-\B5=M(U3NPHKC;1G*O*4<ZD_.#E+(.*)WOGG2O^',BYH1BG&
M3CO_OH9,;>6J_3#2PV7'$U#N70&L[4%,>^O6])XUR[A^A+D('>[OIZ'K!#AX
M ?:MH+M^!-!P'0JFU_U!7UO&W38,1.QD-S'T>6%2>W=<KP2:_2L:/Z@PI"DO
MI*!ZPR!0!%&6Q= TX(.Y2%)4$)%QY*1RT<^,R='J3D_8^L5\H;]OZ797?;7O
M?J=KL0'5D3BHSL1AY1[H^E?=$ZSO?MP]K*6\W@?3YTSZ2;8-GY^W3J*U'C1A
M-0BBNC$,QC%S8A<LF52NZSI:KCFL&T]SO^_9:;STY7"K4R98Q9&$D2C,-7/%
M(8E3!7/$LX(6/*4<V=[J/#? U"BQVR^MY[7!LSA>IRT?Z 0FI%# V-^:' K0
M2'<CW8%RN@MY#84K-Q[/OFVT>XW7C.[>7KSZ.G=&,^(MWV1SBVSY\+[N1#;G
M#%,>IP(JQ3E$24HA3:C2[$:C+,LSC+C5+OOR$%-CM4K%YGDMG^M(8@;6!Y.K
M(&XMA7RJ;X@X]6N[@O)MQAN.76#.JV#K6 C>>\+&GO2&8S02[1U]Q%Y]PDX_
M7?I7=7N*[0H(\\ZGE=BKY)M=R&*U?(#ZJ_%4_=G3/?+K8%YASPMO'(T_KQO>
M9= ;K^S=4ZZY57"ONB%HTV/D_6JSW51!:K5?:;8KASLPN,A$QC($HTJJ*.,)
MI#1F4$E*2%SD"BDG<;=AYDR-FV_L]'I?2QHX:7;[[/&FXFWWVT'N./D!SW,_
MO"$6C=TQSP-Z9WKJ^7BJ&\]NUMOYH21#BH_+;24R]V'U1,OE/*49HSF-8(HP
MA0AQ DE28!A+:?H,9SFBW(8_KP\S-5[L6@I:4\$_:F,MN? &L-<YSA]<@;FK
M)U+6?&4'Q!4>T@_H<)#^US'_W!AA%%ZQ\[+E"\M7]VR&5[=$7SY4UZ3V&>WW
MN_5:L\V<\%SD!8D@8TCS@< ,8A9EIDA<\X2,%$ZM^,!NN,GQ0FT6>%ZMV\W"
MJG4 +(P'8-&XX-RRZ ;P=C&1/S@#\\;>T%8H8F_K##36>FQ49X6*UX9TUT<<
MM_&<E?<G#>;LWM5/VM%<;:$+'<&LUFTA0T)H1D4<P3Q.C JWZ:89$P8C)C.$
M%<^0M&H/?GF(R9')WDI0F^FF#G@&P]O'7L.1"1Y/'(%RNX##%ATWC<1A*(VH
MA?@:K7()'B5=;!^YWB>8BJ6=WAV\>-1"O(S+#<W#,V\<5=OPLN''&H977CFT
M<.1<;<J[E\Z_]JJ)6Q/AE:(BX6Y7(8HC18T@GZ Z[$(1RB&6N>9)27F:Q(6.
MR*RD;@/8-C6"/:H!UL':^T=SJ%)]2P[.@(]TO83WNRVX/[13[UM/,GR"[0*]
M-YJVT"=AC5=FKLZ7\[&7[K]GW6E\Y=U(I2G>P ]3KS+<O#<J8O&&Z^7*%G]#
M#%T4#E7DGY=ZM:X"ATVK2/)Y:<KCJH/@>[5OV/55KBM14@WK@3GRB!1%A#$D
M/-%+ RL22"*:0AYE&6-%KD31L]#0DX536R ^*B7YMBDJU@/*S19\TZZ [[_3
MY^;N\K.'(D-?$^RZ-+S!M 7/BN_O"'5<>B7 -!+S>\8V#/_[,O*-5@'/&%]>
M"WP/U&]%:%<DO0=A>I@Z]<-7#TLC$_)9Z/%+5=)]#[6VPZR1M#H<.NJ_:?-%
M<TY3OW+.HXC1O! 0*=-,FIN&/9%,8:YW#HF(>4I5Y";J'<Q6%[(91QR\/?2E
ME7UN:T"X*;5;"R8Q38'7A/U&H>/D#!S<!%T_VZ:1^Z;9E:K?P5?0.+L_A6[>
MX&\)"3XE/I>2<,:.NJ0$Q_QX:0D_H+\K3$TA077WIJ-#M3&77.MJ?V-'_;NC
M"S$YDY3A+(,Q)[&I9LTAQAF'B?X]QTR1>/C5IO[F36V[T;GR]'=9/CR:E/F=
M7L/H@P1[;^K[ZQ[N,PV85M=]QMB3->(IU-G:+./=K+Z?U@@*ZBW(808[/HY^
M0VKX!(2^.37 PC>_434<79N;5AY&Z5EK:XIW9=6Y:5VR7:M&^/'I>;%ZD>N_
MTBU_-(6]W;]+_:4S&Z/JCW,4YRF/]<ZB2/.J;PB&+$[U/V.4)!G-99Q&3N6V
M0RV:VAK06@Z>&M.K_F6M[3/P7%MOJ*=ZA6/=[> )M*/^4:<E^)%2Y0OH&EM=
M,9Z!_62U#KUZT0Q\/4S67Z].EGMYKB^ O5;H#C9JW")=7QB>U.EZ>W!?FKYR
M6O5E?[N1X306'!$H$H(A2@L$&9<$)CQ7,>=,9-@I4VPW[-0(U^K$^$O?[DZ6
M4V'+JKX!GL)IO VV/?C1!2J_)&@U\LA,YX+&*9TYO;LO9['MX?&:!4TO^Y</
M=-OM/C4OHB1-C?R40%$$$5,QI'&N8\@,HSQ&C.:14R<7JU&GQUAL"\J]U3,3
M"%9V U/M/0/B8+HK6=G,@2U7>48V.%5I4#]W0&U-!A\J4#]8@-J#I1Q \DM2
M-@./S%$.6)Q2E,N;@]1C7,@"KNI:D;TH8$?VJ;HAI:='"9% 1)727"8(Y%*F
M3.%,Y)E507,@^Z;'>N=B":\5%\Y3Z*7>(N3$C'@0>GY^3"7EWCWSLKV#H/5P
M!CJM^]ZP-J/O/(Q8F>%LXI3J,OKBZUB5T7L8?XU,#P01)XK&5.:0(:/F@JF"
M1 C3=YZ1-"DPCB*GVW!71YL:8Q^^UIO7W_S>_'T=;#LV]@9A8&Z]U,\T"#5:
M@1*ZI>D;T9:5[S9-37WHW/VZ,]=)[M57NMXN]7?TL7S>S#DIDI@G&D1.!$0Y
MPY F&,$,$4PX8E&>"[OJK$M#3*^HJK82W!_J_%VDC<["F B%3)<J'6LGFHRS
MG$"611)2'.=90D5!D+5<X% 0Q^#?!D)-O<\=*P>">)UD?4 3F%</'ZRO_E"Q
MOSHX%)V1+@Z>1PEL'^D6U!<'^6(GI##Q_?915NV[MB]Z9?\I-]LZ\M=KCGQ8
M>;M;> VX*S<+S[YMM'N%UXSNWBJ\^KI^@>D=YZN=GH=ODLNR:BC07'/E$2.2
M< 4Y30T7\AS2**(PCXN(2)J)K,A<8M)+ TV-#EL[P<%0M^CS(J)V@:</G )S
MXQF( NCCWP+"9YQY<:Q10\Q;'A]'ES=?WW.O6B[+K?RB]\OBLUY!E@_EOL#T
MFS32,.7RX>[)2)?\DS9)Z7(EXCDE22X+QJ#D1&G&P#&DU#0"B56<813+B#GU
MXNMIQ]0(I78#5GZ @R--0;BI,&]\ 5UG0.V-X\:WY\Q9;HG#ST?HS7*0J7#?
M1@\#TNL&NZ<IXVZ]A^%ULBD?^+AA@=:OJZW<F +]%5UVF'N?()_GA"92JDQO
M./,(HA0KB&61PYCD0N_CJ5)NM8^V T^--UN[9Z"R? 8JPZN+-I_VLKS=".1+
MW^H;ZZEQB^!\ CY21.<5Z]X1GRUP(2+ FV._241HB\BE"-'Z_3U$/W=/NT65
M7:FOP==L>:_NQ*I*I]^)_]C5>_VV05P6%4*)#!:)T/PF.3()[13F1,0B0SS/
M.+&6 G4<?&H<=[ ?U [,FF"CZF+4.#$#!S<<-$-=Y^4ZN85&.S#!.0/M<4,[
M!+K!BJ2NXXZG4]H3D5?JI7V?T3.$$Z+*#AM1KU+'CN_I<[FE"Z/UM5I6-VSF
M48X$3W($F: 2HDQ%$&=2P5S2B"1*96GJI!-_>\BI4=K!8O"L38;E$O#::,>@
M[#;8EN&85PA#!V('](RUE<)8;:_1J#(6U_<%/09=UO!X#;=NCSINH&6-PDF(
M9?_.OB7/SVO):_&Y[K94AW,ZO%M+\_.O<CNG6 J6X1AF:28@XCR#&&41S#)1
M2,KR5!*GUO*6XTZ-?[IF5QL8VK'=M=#9#GD['@J 9V RZEH\>WTD5G7-;*VN
M^J[[+'=V LIOP;/=T".7/#OA<5KT[/9VQVH46<X_&N'XEV_RH30M));;7_5G
M:IXH&=,BR6&11ABB6&:0%;B 1<$$*7*FHLQJFW=I@*GQ3FTC.!@)C)66!0.7
M0+S.+#Z@"4PACJC8I_ION'X@A4W+"AO)__RP^OF_]%MK0M _'// Q<>.4PIP
MPZE]*<"MU_6\N;!C&_E?.[U;^OA3_^>'?DK39(06/*&I(C!/"FFZMT20DDQO
M<@J:2L83%!5.H<7%D:;VI3X8"BI+@3'5L8'+;7CMX@<OH 7^NO?$R[U&_Q86
M7JOM+PXV;MW\+9]/*N!OOF&8OF!'X_:0(LGR#"$FL-Z%F$9Y)%.02AY#%=,(
M10Q)$6,7JK@VV-38XIS4]("TU%6<[3C#%WJ!::,_<+UE\ZXA$D+Y[NQX;R)>
M=\WS2_IS5]_3\S"U2KB?*9#?MV\L9!%%$2\@SD@*$48Q)!SG4*I$95(I'B&G
M6]PW1YP:G]R0C.P)J^6IJ4^P0A^:-N4[9^_"!&E[:8V.US/3FX..>V1JB\')
MB:GU&_LQRZ&GG:$KS5X_'NGR[X^KQ>+E_O>E%"8N*D5)UR]?J5'$-+^L:JE;
M\?9&S_U>-7T^?I7;P\(;120NN)(P$IEFI:R@D(FT@ DF<8HQCZFT.M<8Q=JI
M,=HK9V? N&LN"RQ![3"H/ 8'EV>@=AKLO=XK[,] 1W:_<;TZB!P0<87]Y-@1
M[V0^#Z$S\I/Y*#BS_RA3Y'/E"&OPJ*O.*-@?KUCC#.JCT6HK"-SH 9NUU12
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M:;(/-T>=KI%"T<.T[<RT/1^F;:6 ,M/VLYJV<@ED/6WZ]YMJVO0/_/77S%-
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M1"+5X/EQ:=GOTP>:[6#AL/Q8%[W[ M+R%&(0-*%/'SK&_4MSA^=$B?DK->J
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MH[++3P.>,-0*R;5KHRDT<YM5_WHO<O;P2,I_M567?!%)GB8^9+HK%@J0!VE
ME%$2,)+X4<@9,PH?-AUP?C9*3UZ@!08;B0<6P#J+N:DMXP[)T4V;2T <8.J8
M(>/6\CDSYL2&D!D"^W:1X7T#SZ3+0FUD>*73YYND^3_$ZD$??7=.D8_9<\9%
MSJN;\F-6-?WH-,W=BM6ZS&]DRX*ZR:>?J-<.*G/*@P@)#Z8B"6 2)#&+HX#&
MS,I5ZDRRN?'7*UF;,A;M&?9CK> %1]G.)M.,[]YDBD8FQDZG9F+:HB*-6CU'
M;MT$:Z../F'2^F@3K]7(X>&X:Y"='IT[$V[:@W77F.X=NSL?8+ Q617+C#=%
MN+OR*)E0H]8^\)[O>WNIX+5O35WU3?V O2R"-(A2M0.$,I I1''"8,K3 (8\
M\'U! TP#2S>8 ZGF1NO'"@=:6Z(.)LS87)UV&L:W:;?Z7(&^1NJC <VQ7$^I
MNL'A1BW0Z74%&LW 7^V?H_3#<@J^8[/9@6!3V];NL#Q@@#M\^. *5+J.5>UI
M^(?([A_4 -?/HB3WHA^4WT9%+ +.@I!Q J.$((@$(9 &:J9%*KF'D,=#815B
M93?\W(BYE1XLM?A7X$>K ""-!J_39:YT]^V3W4I<3) 9/X\'^\A$W"'^>X-X
M)SMHA7^=HC9"?YAAP#DN064CP=2EIP:@<Z#DU)"G7!"EI4^(LH9HKW]FU2*@
M!(52FZ$,(9WAXT'B80_&BN\\CP4H]'WKV*R=0>;&98T-TQ-R0!S6+HYF9'0I
M.B-3SAXPX"\MH>LXJR, .(^NVAUG^IBJ(YH>C*0Z=NW />N25-6-O-,I-^OR
MI3X2;LIQH #)R,?*KI%1!!'E F*/)-"3/(T#[$4>M_KBCXXTM\^^%E1[ESI1
MNY@$F_(GY_$UW#:Z0&WLK>! P.RW<>? <+HU.SK8M-NM<SKO;:'.WC"P%)TV
M/AZ*)?_R^%06SZ(?4TQYX(<4"V4=2 P1%A%4YH+Z3Q#C)$EI:ME:\\18<V.+
MC:B@+ZMEX;@3T)K1A"/ 1B:*PUB-$.QE (?3XFXGAINVDMMYO??*MAG<,J!:
M$5EEZD'?1?F<,5%]6%>KXE';+COGJ^U++H. >IQ(&":80Q2(&)(P\J!@1.+
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MK_F]0UM-5*OJ.N==Y/-F)8Y%%# _U(5YA0<13R.(*><P]OV$IE[*D9UW]=A
M<V.;FTUM"=%*VM2O>""E,HDL39ZCZ!H>W#G ;.PCMJ:PB$*H$W(4B^8<$FY;
M*1P9:^+N"*<UWF]X<.;Z@2'%:UHUB1.]/@EJ&:XMH;;-GD#*0@F%#R.BG7/(
M]R%FOH(V%5B2F*.4&Q7=LQAS;JS1$QF\DKFQ\BU#APTP-R,0QTB.S"5G0!RA
MP:$%/D[#>@V&G3:.UQR'O<!=BUOM(W5?^8R*1_&[LGB.=^>J%DF2Q"E-% '%
M,H(HC1A,4>I#PCTL F6S$.2;I^):CF[T*4V;Q]#4W=BV)FSSK:YT[I5YC*GM
M+)PFI[&0G<@/_\K5KG/7M.S@\ZF^@Q9ATK90FT?UC@CY5,&]#UD%U(;H$93B
M23VX7BA6#Z*-WOV/"CR5Q5/C4M816'7 0AWPJR]Z:F*X"EG_:YWSKG_?P4Q$
M=9E.X6V^'*%^W"7YKK5?:-M^K.JW*]-F\#^+3+T:STJDM8Z6T <N/QXR=6\M
MZ*N.H6H,PNJ>*[5K5=U?%[OCOX+O]6!-*K+"49?"JV,VY%(P;6YOC^Q E3UF
M.N)9C:,>6@GPJ(.5LUQA(9Y(V13)ZPNL9JG;]&>;LZ+^$]63Q%(]M<:P=OCJ
MG2?)7\"](O-&2PV2[KFF_ZXCJ!\UZO]6O)))K86:AC*KNP3IVW@FI=!'  )0
ML?HA1)/]7-^LYD&4RY=ZO]6153T=1 W0M%_7P&WF@:SJ?VM=ZCG:O+".PJX'
M?B4GHJ]MGSA9$/9 5?NQV$,?<7&,P5>QVC[W-_5:ZI$O.&P.0\&I'Q HD Z_
M]@,,B8@H]!*/48\A+T96&=GCB3JWG<]6-U )MB[K]GF# PE<SZMU$,$;SM;8
MALO-AR]7H!]&H-4#[[2"OUPUI8Z^;V907?E,U,*B-(1J!84568I^K/.;!!&,
M-#DC!1"XEO:M@@=&0OU$X,!8(PY;=KKR4M^UY72=\]_5*[MLUKL[\K/UM[UO
MBKXLTA3':1*'4$3<@\A+,:2ISR%-<)2F<2*3P.K SF;PN2T-M<QV2X$5UF;D
M/A:"(]/UI@9=+7=M*]>2=[M.)7OG<@?O6O&/QV9;L^X0U%SRJ-7XDS+C$&1V
MN6[0,P9VVRKR^SM1/NKU_0^R:I?W6[4WK*LJ5#?R6U>2_4O^7X*4G[-GL4@3
M% 8L"J'D4O<B#@-(?)Q /XUDQ&4D_019]>$:(L7<^$R]JI%E/ZY!X)OQVNB0
MCDQP6GZH%:A-SRO0ZO!R!;2P0$OKL(_7)6 Y[? U2)!I>W]=@M5>5["+'F9'
M>56Y6MS\R!43/&1/[3E9DB2$!FHGC^NJ1A(+B 6.8,Q2(9E@D9<8)0X<>/;<
MZ&DCWOF#LK.PG::@"\$8F5@L<##FD1,:GV '=5>/&=2_=EGAT&,G^=9/Z--]
MP:<N&9SPV?,1-JE(:[5;N]FTBGDO9%&*C2$D] &BVL9E;)%BF>*0^Y#Q2.AD
M3P8QP3%,98R\)(PC+HRZ.SF096[??2>7=6+FX,DP,U F@GAD-FFW6XV;K Y[
M!UM5P%870&ME>MLS[40[.S=#LB\O1=5QYN5@<:;.NKP4MP,9EQ<_TCXDHJF)
MVE0?6OY6%NNGUM?M,8IHO6=CE$/D$0))0CA,D1<P3GQ?HGCQ+$I:F)0K.S:,
MS:?9'VQ$_OOC-P#KBD_-# C>:SYF?O)^%-?ST0PNL!K;G41 74JW%1+44@[H
M2WH4)?- !!=H311QT-8?[KK1W6MA'1TTGT/AQ(GRT5LG.SH^)WS_C/CLM<.,
M246G3<&2=L>2QIAXH1=#%B6Z@%;LZ28,",8XCG'"8^2'5AZKG>?/S>C3[M^V
M*I'=;N\8?F8VW06HC$QP-H!8&UU'U'9I2.T.,:EQ=$2_78/GV&7#ON#N8.\F
M_TYT.;^F!&S^O8NH>KDI]^-(A%@$! ON)112+]()NAQ!0M(()E)RQG#**<9=
MC.>=^0<_4!RC3^!UT.?=!/S0.]L'10X^9EK:3,>DV='$T$DRHY,Q,9^&=O9P
MKIZ*JDE4+"2H]=$1;5N-U"=R,$Y4./1V7PBK2UH;*LJD]'<A7KLT>>GC+BC^
M_U LU1U5\_@A$1,+'G NPR"&@E$"4<H"F&(2P$B(,(EXS.-8V!0B=2.6E?DU
M08'1.SU&&[$ZH"^ @VGBJ8<BAG656$^9NT3H15!")CF/2!+$7D 73<CS]Q4I
M5W.=K%T1QYNR]^(^RW7S#4#)4K>(>Y-Y$YAS'R<(,AJKSRO$*<2^0%"D:4)E
MBF3*PG;>/N4V'3?>8-8Z <>;,S7"6T^8F2$S_12,;-?T%?J/UF#IQW]:%I=R
MW)C#&=+.FW5<+MGT#3R<H7FPJ8>[IU]<9T4]4;WCF1KKNLXNN6[25FHG8AMT
M]57\7-W]$,MG\8>2Y*%:)$@MLR+E:J%-4ZB[(D$<)#Z,* ]9)..$8ZLVPY>)
M,S<WE/H4_,%E6(9,AQD=3P?RR#3\JG3+5A50ZW)5!X#6)<O[6K4!5#>YPQVE
M&T!'JO0R1**WJ@%S 7HGJL-<\M1AK'HKGD6^%M4"I2+ %*4P#0F"B/$$$BXH
M9&DJA0S\Q&.QS7ZQ>_ \=WQE*YT=YVW HEQR%@@!@Y KL*((PS11FVO/%[XR
M_Q/,B56EC$%@37$ZX0(L,ZH? L'(I'U[3F]K^MU5TB61;IX]*27N:K1+;GN_
M'T9371'\ZZ8&_M>U/GF\D4W)ZT/%L!=";<QI$DGHXSJ!!WLP33F',DT]3XH@
M5G_8-<2TEF' D<+(W[-M+X'!73/MY\N,)<:9@VGH9 -^*SQHI*_/%VKYKPX7
M_G='/X/1<\E3]D),2FB#,=IEON$/&D:1W\J""<'K&+;>,>&-?+^NLESH.@^+
M($J('\01#'@20H1E"DDH0ABP. EC$H=):A5]:S#FW$R:3N0F!%2G0^L/4,>>
M\>PYJY2A;<=T)K";<9MC,$=FL]<X]N35<&XE=D=>%O"XI"N382<E* L<=BG)
MYM:!J0&/3R0K=43?C=S=S'[ZV?H,?RL*_B-;+A?*/$N8KC7(O$1"),-$EVCW
MH(RQC)2-%N DL4H&L!E];L2T%5Y_0;L^(F6+;30 G0JV/9RL)L>,M$:#?&3Z
M<HJV??#_$-2<AOM;"3!M@/\0;/9"^@<]9!CG-7V[;F2_L=Y-?E$+O\WQ2A.'
MU,;;JCL^]J+CM^D)BU PY!,=W<'] *)(>)"PE,(X]%.*?2XDYC9$^O8JS8V=
MM\W91-<=M-3U'%C;8J,8KQ?MVT^&X5KP]H+.:('9OC"OV\FJ%\59.]OM,7X'
M3YL/HN_L(]3+;W.WB,UGNEVNC#/0:M+E=@;Z'EG#9R39T()3=/4E5Z+4*4Y=
M78R/2HT%YG[, R[U\9I:L)D@$(>40<H1P7&8RMBSZLIP?*BY+:1U?;JMJ-MZ
M(>#C@"I31P$V6['<P#;R2C(0L0&EHLZ!X;8PU-'1)BX#=4[K_:)/9^\8N)$@
MI8YKU0V\:R]QW1E8\(4(,$]Y(" )8JF;IE)(@X!"/PSC0/"8,63EM3TRSNR8
MHA'K55'G+ ?KBNL:T,VYE*4'Y!C"-(E)%- 8,ID@B# .(&9$P!#[$4H3W88\
ML E^<('P!+$0!Q#>(+O71[S-H55+Z*^CS8/A/N-R=,<V_EL)=29C<[AW!5HI
M'=K?IV%P:A0?&6I:2_6TOGOFXYG+AW'TWTF9Z2^B"VK]5)>L_SW+1=TH8Q%$
M"*4H$I"'F$+DJ_^D:=U#AS/,XH2ES(JKSXPW-\[NQ-T6$FX$MJ.'<R";T81#
MZ$:FBV.H@;^TM$W7'(=9T(; N"20<T-.2B2&^N\2BNEMPXCECRPORCJROGGZ
M]FWW,4I)D,90QA&#*$@2F ;8@P(+P23A,?(\&THY.M+<R.1H;7*3K\(29#-*
M<0+=R&1R$6K67'(6$9<L<GRP2?GCK,Z[S''^!OOR4=]*\9BM'[^5&=/UAPOV
MK^]BM5JV?[]^>BH%RVHWUJV.0ZK:\CXD%9)B+X%A3+BR3[@/:2C5=H>C-(V%
M#+@7FY#)<!'FQC*M%N"I5@-46G98-8HT_ZH[X72J@++6Q;S2TL").DU(T\ _
M,E-UR#<:-$468*M#6W*AKP5HU!A0[&K@%)B7PAI_*B8JE#5P2AI]'%74N@S,
M$_6V!CYXLFI<ERG>K]5UX9/L5Z/O(L^*LFX[(_@'];]L]9FP;%E7B>[J&B9$
M> 2IK3%B*41"KSJQ1Z&4(DYE'-*4&VV-#<>;VSK3B Q:F4$C--A*;4YG)F"?
M7SX<0SCR6G$.O0&K@@F,YDN 8S@GXOL6UJJ%E36PRHW@CBC= IP3_&WRE,G(
MVD*E/C/;W#:P?A![$'RMZQ6]/JBJ[L3/U7LE_K\6OB<%QX%NITLCB+"@$(>^
M!Q4E)Z$71<@+K,+%S@\Y-S*NFU:LNJ85E@5)S@-LYDUP"]O8!-P*JR.:7J/7
M.YM6-'Q7.S*U!J!6P667;V.\G)8#.3_JM*4^C%'8*^-A?J>E!2BR1>,-O>9<
MO715^X?V<_@+E/HI"BF!J:^L/811 C%1E!-+%/HR22DA1JW43HXR-X)I'?BM
MB%?=7T#MA#M5TL$"V#,VGBNXQCXK'8J4N05B@L26,JJ.,Y15].M]\?R?ZOZ&
M+M1?=EGB]+.GL49,U-O8($87CY:!^%6L;J0.RFM^+_B"4Q%S@3E$/-5YVB&&
MF,<4AI1*+OT@$':-%H<(,3?R,,RMNP)*$_VC.C*X4\9Y^N+^G)F9-V//Q.C>
MR3$F88RTQZ,H3IP'N2_'W!(CCR(U(%/R^+.&L6=];O?X)%;B^KX4HC;,NJ[F
M/B(QE0SZ..;:<^;#E"LS*N42*^N*I4$2V7#D\:'FQH0;29M2S&0CKAW+G<#6
MC,O<(#;%R6\M)-A*.4(G[_-@N"2>$Z--2B_GM=XE$8,[ANZS/CV*\EZG,);%
MC]7#!S4*R5\6:9@2BAE5/"$)1"1-(54_T[6%_3B(_20PRZ<^,\[<2*+=072R
M@D98T$IKN],Z#*WI7NMBP*;9;=EB-6"O=1*)BW=;AY\^\7[KI(K[.Z[3EP_M
MQ<B%/%Y \$#-!3\*:)"$D' B=:HPA43Z&#+*1)A(Z@L[WZ^M ',CCZW\<%E7
MYUQF3-=9M+0PK.?!S.X8$]V1F68/V,F++ S$SFU;14L9)NZE. RA_0:* Y\S
MC/.Z/=@U^^]UUC1IJ=2&[7-1/I*VWN!"$H_3.")0!'X*49IR2*-(;9YHB&42
M<!28.9TMQIP;LRGQ@-3R@=4%93Q-P#;C,L<0CDQ?G;2@)^X5T)C6 H-68G=T
M90&/2X8R&7924K+ 89>';&X=FM(M15EJBFM;P;95F=^+7#'@:N%%J21)X,,X
MTIX:KC9?E/J*A<(@2#EF*+2SKLZ,-S?*Z<3ML@E7NE>N;4[W:83-N,8A;B/S
MS :R;<-IT H+WK7B.C2*#(%QF^E]>LB)T[V-]-_/^3:[;:#K5ZRV/:C/MM90
M8@CQJ/]YI-5-BGV?^@F&"'.UQ:,IA:D?Q#"-F40)1CB*K*J3NQ5O;ISU=9/\
M;.E3=CMIAG[H-YN*L7W78M4Q8-.%T;!)T5;%\5L6C0.^4U^Y6PFG]:^/@NZ>
M3WZ<4>PCYC]GN>Z%]KL@E6B/HEA*_##E*?0BKHQ'R93Q*(($2H]% 9-A2HA1
MBZ+#CY\;[S82ZB^U%M(\;OL <CQ19C?"6/<.)A %(H*8>0SR- @2'[$@1M[B
M692T&!^[_C!CHR<<8'?F9.-B/$9>.%X!,2 +X-#;9!ST?QDR$\7X6R)D%=A_
M'( 3<?P';IHL;/^XP/TH_1-7N6]>Q]1;L%[J[A_]=D^+0."8Z3)/6/JZ/3KQ
M8$JD!V,9\$0D)(T]:M? Q%X(H[=YT@XFOVN7'-E*"TA/7'<=[([,B9F1/A+.
M,^A4I\-S>]A?FV#OM$?=:?BFZDMW1(K9]*([C9)-_[DS3[(CPZI<+?X@/[/'
M]6.[T@8XY$$22!ACICT5$8$X);H9MOHK8XE4-&=B\>X]>6[&;BN<&4'MXW2:
M=R[2?F0Z:>5R:'8<U?;$UZ_NZ7WYZE^[7_W^0R?YF(_JTGVCQR\8&J+?.C*;
MI/"Z%]'U>O50E-F_!5\D,DBIVGA"@82 :M^D:TYRG;23DBCQL"^IE>?P]'!S
M^T@WTC9E/ZZZ+FAD(_'PAFAG@#<S+-S!.?)7OT7R>X-D(RO8"NLR0-X$%+>A
M\"='G#CHW43[_?!VH[N&<8R.B?]6%L\9%_S]RY^5-BN^Y'4,?7Y_S5;9<YWL
M?*35 $\8\1,90P^S4%&0@C_U!(61)Y%@3$:)M#I!O4B:N3&4]I+7#2;657W(
MJOZ_U43MB3I5FH05WB__7YPO_S_"5)J1VF03-#+GU?D_G2* OH!W?S:3] O8
MJ .V^ER-WZ#!";(NB?,R@2;E52?8[=*NFX=>D%ZT=X#1[B^$D-CC5$(>AHIT
MDYA"]1 )%=_2$(DHD+Y5U=I3@\V.4XL<]L\-LU;:"N3%"E1K^D_=QV55@*?U
M"CSIV:OLB?0D^H9'OXXP'?L@]UCYR7'2D,X XCP1Z=AXTZ<BG='\8#+2N7OL
MCS%O5@^B5,]N+0S]9'VZVH;'?"N6&7O9UD4A:4@D]T.(D]17/,,0)#&C,!;"
M)VG$2"@"TQ-.JY'G1CJU\%9A)_9@GS_8&PW"D3FF0:\O>!<[TD7.-;*#OTSJ
MT%P(L_EIX6AP3W20V,">]V'O^G*(1H=?KL!3K8:CNF&#$#MQ\FCWO,D.)0>I
MV3^O'/: @2Y$\E)GLMY(9:<V\3+:'KHKKJ7,EAE9B6HA9,2\Q(\A14SHDN7J
M;S[F4/I1FG@^Q2)([,XN#4:=WV'E*U&U"9F_-HXVIJ:E+]%@!@P=BHY0G<BK
MV$I;-VS?A78KL4/7HCD\3OV+!L-.ZV0TQV'/TVAQZR7M=[-GL8G-UHT"/S0;
M:/65]1Q2'D$DQ@E3M.3%$*'0@UB& OJ($Y_C-!0\LFKS9#RTE?TY0>>GC>0Z
M1:/N9#ND)ZT1Z&9,- Z4(Q/2%L5>\D;=Y?56Z$^K?L&;O#&AALP=QB+;X^6^
M2:K1Z&_0S-0&E<--1ZV><&F9UOKXY3VI!-<E 93!5C__NBQUT].:/-^_;*]I
M"?7Z!REY76MS$<?8$VF(8"A) I'$(212*'Y3FVD4Q7[@^U:]1)U)-K=-=[^$
M:2TVI%INT%<.]+737OS^A:V&H%:Q+75JV8'&W;2;\>J;3.;(M#OQ/%Y0I]81
MYN.4L[U4N#>J>NL(T^/%<5T-,*2GS[;JW*W0#6GTN5!7.^HF;\N&Z^J]"\3B
ME!,O@FF"%>OSA.MD$0&#5%<X$*%DW*@FG.6X<^/T395&+3O8"+\M@ 9N\DW7
M /-:W[:S<=[7.A+&8V^YYP&O32>>46">K/V.*[@M.^Y8@W:RS8[YTR;LK6.M
MXNN&.O:W#RWHI>,!]%/OU ,^J,W'O8[*JE^\]KPX3@,OY F"A"<,(J%/Z[TH
M@:$0-""8B3 P*O-G/N3<6'\KL769KK/HFMG5;C$;F<5[<(&_/A:/),L=FKOF
M4+BMK'5VU(EK:9FBL%\]R_A.>Y/R[\5RK9:M\J6I8$&6W]2;H=T9G2NVCDDB
M+\5Z]4V46<&OI?J O^0\>\[XFBRK6['*RIKE/BK)%C&BU!,I@4C9F1 E80Q)
M0F*(F$R$]'D:Q\8YRHYEFQM);=0#G7Y *PCZ&C95PQL=0:,DJ+4$/37!5D_P
MT=A5.\;LGS=SWW!.1R;1_X73:6Y6O^&T3F1ZCS:]CD(A1IJ!$W:\ZQ$GL_5'
M@JJ_'QAK"/L%7F\Y-J4TKO-Z"W(KN'A\JL4HJE6UB-32+$B20!(R#%% I-XP
MI) A+V6)2%E*-ZGD=V9KM\&P ^(Q[B:I44=78%M\1,G>=#';2@]J\<UIV60*
MSJ^<KA"=JFS=6Z!HOF Y1G.B1>AB5*V6% N,3BP3)D^9C/HM5.K3N<UM]BT;
M[DJBBTQ]?WFDQ7(1)J$4/O<A#[$/$?803(F7PE2]'#B0$0Z%9]JDX=63Y[;_
M:84#C73F;1A>PW6&."\!862*--3?JK7"05TO:*;P^GF3M4\XJ$:_8<+A"X9Y
M5/\A=(]SP:^?14GNQ=>U=JFTQWS5S7I5K4BN!_N8+=?J,IU]M2RJ=2F^K,1C
M=4VK54G8:D%BE$;$IS!&0001\@)( Q3!"(4)0B2@.#'R?+@5:VX??:<5:-4"
MC5Z;H_H*]%3;"9,"?W5:6095.)IA,\_O]/,V,D^-/676#F6W"+MT.CN2;%+'
MM%LT=YW7CI\^C.%[98KJ3 @=MU&*!Y%7FT ^7>ZSB9N2)$@4E0<0I3K7%8D0
M4I_&, A2QFB2)AZSJG%B,_C<V+I?S*O)[GDE_>N*O,,"WJSFQHR!QT)\9)YU
M"[8UJPY!S25W6HT_*4,.06:7!P<]8V /BJQZ*BJR_*TLUD\?EJ2J,IFQ>CEN
MSG87<8@]3M(0<AQPB)@?0<)276"-<2_%R*.^49JM\8ASX[5.8%!+#%Z+?/X(
M?"#L9NSE%,RQO7R7X6C?G<(4&Z?]*<X..FV'"E,,]GI4&-\X,&/A7%SLL;#8
M3_^]SE8O7W)EZZV;9##-D'</)+^I_6M].W''GKP56G#U\_IL15F*:[*\$^5C
MM2#8#^. Z_"#&$$4,@IQ$#%ERR5AD(8<<\*LLA[FI-W<^+2_ 20K('*N=X=/
M]<F69?[#G& VS:&8D\PS6AU,<B].IEY<@08AT(.H-8U7"B30HG35=T!<@3U_
MQ08KT ,+U&@Y3.J8XTO@-#%D5@I.FUPR*]6/):C,4DC[@(7O(L^*\FNQ$M5G
M147?BBQ??<]^WOTH/JNM4ILH^W$M[GZH/U_N'K)R];(I%XWBD'$$PP3'$'$A
M=2&A /H)#^.$Q#'WD6GPX7 QYK8X-YJ 6A6 ?HV#Z/\#?"U X(6>^?'[!=-R
M/K9A&K#'7N[Z.&LU0*T'4(H I0G0JG2)WD I QIM0*/.@-8D%TR)>:#$-%,S
M4?S$95/D*%+O<D1/1%M<\/#)@C N!Z ?F^'@:0,+B]3KYA]B]5#P;8Q^4T>O
M*I89U\Z^YA="U&MJMTP1GWN^GT+&8@^BE$408TE@%'*1(IQX/C9*S;Q4D+DM
M5*VQ_U@KTI8N;FS^+&]+(VW4 ;3MY6O;/W;PK)GM!:>8BY'7L78:&AW 5HDK
ML*,&Z/2X:C=E[FMX7@JGTZ(F0V69ML3)A8CM%3RY]'G#R+5MQ_TESU8965X_
M/2U;5V43+OVA.4Q1!-\49+E3NYRFH7=S4,ABFC":>#!B(M1];AE,&<4P20D1
MC(34CZP*%E\FSMR(MM5&MU"M]0$]A;J\A:U*H-$);)4"[SZ*%<F6ECTN+IQ3
M,P*>;J9&IN&+)\GY";$;:%U2\H4234K,;M#;I6='3QU&TC7=?U_GO'SY/2,T
M6];EZ3^LRU(M$8J#4<*EGC3.] E,R"%-PT1-H^?Q0,J$X]"&@T^.-C>*K86U
MH\?3:)JQGS.,1B:WQEYL! 4]2:] *ZL[UC*"Q"4IG1YP4LXQTGV74LQN&L@8
MY3W)V]SU#QL#4ONI<_Y-O6"="^A&MND69/E=_:0IJ[0)Q$U9PF+%(%#1B4XR
MIS'$*670QTD:L@2)V+.J:.=$JMDQ4$^I*_!*+4!R#OJ*Z=/:C6I@J]O@B&LW
M\VS(>5//WMC<.-'$V3.I2Z"=,JX3P:9E9I=8[C&XTX</K5/4Q33JFDB'"J2^
M%[(HMW54M?NV%-E]OD@Y%E3($"8HQ!"E!$$:,Q^F5,HX%2%/A6]7OVBH*'/C
M]+HM2U[+3 PSYAS,AQD-3X/RR-S[.L:Z;I2WU:37A W06I=>76=MN[;ZN"R=
M="FF;DLJ#99FXE)+EZ*V7X+IXB?:IP5_4J.L7KX_B.521W20_&61I#AD-/%A
MXG%=8DF$,(UB!$F:TD1*+TU3H]R4PX^?&]LU$H):1-#*:)XF? "^,X$(%X,R
M]L&,#1Y6:</'U;X@=_C 0R=+(#ZN4#^+^,15 T.@Q;VVH6[%4U$V;784*SS6
M#/%[EC<Y;3I1.*)>C&%"4P&1QP1,61#!* ["4*1!2'V[R&2#0>?V:;<R@XW0
MH"<U^$O+#6K!;<NGFTR F3WC&M:1R<$!HO8QKQ80.0U%-1EWV@A1"R3V C=M
M[AW&2Y])5OZ=+-?B#T%T<FV]T;O5-6E+-6 7$^9QX3',8<P$A8CZRJX0J80$
MB812RBGUK<K&F@PZ-U[2,H-:Z"O0%_L*; 2W(R0CY,T(R36>(Q-2'\J-E".$
MB-C XI*$C,:=E(1LD-@E(:M[!Y)0[6L2OZL!1'>P\-+U__JX%O\E2'GWHUAX
M41@3(04D.%8\%(<^I B%,%9/)11['D56"?B&X\Z-BM1K%UARC2' AG3C'K:Q
M&:>1&-0B7VV.%5^N=/\_*L WDO$KH.76P;X.&<@.*:<D9#CTM#QDA\<>%5G>
M/E*VZM$N+FU6S*>?3UGK_/G21EOL9,=\^BE*EE7B6YDQL0A#%/I^F$ JTP2B
MP*<0XT1M )6YY:<1]TG"G2:D.E9@;OQ8BR\X>/?G]X\ZU1146EG+D+3)WP+#
MO>>,YW;L?>S%#;NNMGFA/1AT#'D#Q($,T0X,4*,Q85+H2/,X:=ZG:QWFE=HY
MT@Q99V^.)<?0<XEO:[K,V.=E05:+-$Y2CA(?HDC&$,F40N*'!"(/)2'#'L91
M:G<LT7OZ[-:=Q@O?2 AJ$6T/)?K8F9Y)#$1DFB,)(S &G$@<4/KB XG^,R<^
MCSB@SOYQQ*&+[+.HKSG/FC"!EBONBKL'\7[](LI;49>AJG^@;>UEKT^5^M$W
M]6X\D,Y>27R9"(YC&,>"0<1"#M,(!]#W.>%>B+$GC9R"#F6:&R%LU=K8(7<%
M4%*#6C70ZM;]L%;O=<<V_>-.Q3,FR&@3?8:'WF;Z1F:O_QTS9Y[+_08S.%%B
M]Z0S:97M[1CS$ZG?KD::+ _<,33]I'#7C[:WDC^V+[[NV;9(19KX/!*0I_K(
M7R"L5E%$(6,!0B0.TH 9!:SO/GAN2V$G&]#"F5O%K[ Z;Q /16#DU<1,>2LK
M^)"F%QC KQXWF>U[2(F^V7OP]_86;]-1*>.?B_*;/D@O\F^E>,Z*=;5\N15R
MG7/!V_/6-(B)C!""7DC5Y\@\#DF,8BA9A.-4"D:$<9T@\V'G]K&VS<HRKN-6
M02L\V$H/.O'-31J+.3AO;XZ#[,@D8 SJ@'H_%NB:VX3CH#R1V?<:[>O'8JV=
MPX/0MC+J[$$[8;=9/&PRT\Q>P;[U->!N>P/K"Y/E]5J9>45YO5J)JGG7/B_)
M_<+'<9RRD$%)L0=1(A'$7% HI:^;L] D9<;^R./#S(W/OWSX? M:44%/5J"%
M-3?&3N!ZWC1S@];('#T,*"O#[3P.%YAQ)QX^F5%W7L&^B6=P]045"+X6>=$D
M8NC@29V!\>FG/D+19^Z<QE$@(/;C1(<T4F7H*5X(0QD@3]#4\ZW.W$\/-S="
M:)+LLUK$*Y +PW,*0VPI8XA+'$-/D  BA!FD5&UL<12D2+#$IS%:/(N2%M.C
MVQ]V&GR=0FL6). .KI'YML&I+^FFETDK[/&HC6'E'LZBXKS>P_$1IR_X<%;[
M@Q4?SM\U<5N ]F#[-W7A:G.F_5M95-4"^9*1. XA27VL3YTEI,R+(:,R\84R
MKB6V"E4?0<:Y+0:UB#I<*LN;2*G*=:C4@'GT68I3["60QSI< *>^6D/4:A(E
M:93$6,0I]NW6D#>>R6D6GN^K@OT+D*>G4K"VSQ[1.E3@OIGEMY]9LR7LC6=K
MY'7/0?^#321;HVD_B*W6=@;]"\Y/Q2RZ$)P0<UX!9\-Q=M81P&"H8;; 75EG
ME[S4!-;T@+P5*QW&N^!1BE @*$R%5-N) %-(@]2#/DF)K]Z%6*9DD8O[^NS.
M?&4_/J(14>"&*/;&'8\T&NEJ#B@D6+7B@ZJF_,&+]PG@S9CZ0ARGZJC=HE5+
M>=6VI]7I9[6D[LCR/!HN.>_$:)-2UWFM=QG(X [[@[X_!,^8>E3+6+?JR_Q4
MK0A=9M6#X(K35F2U7HF;\E;<U\4OB_QS4>JC_<87?2-[=U;:3_W^1?WVMT(9
M;[G^N?IU42XP18SB6,(8QQ%$+ X@%IA 0G4=(DY9%,2FAX33B#RW+4>G]<:H
MT=*#GN+@_0MH50<W.DBG4[X^SJDC<MH#M!OYZB%5<^CS_J6^: L#J'$P/U&;
MZ%4Z?]8YOQ=D9*K^?^]&^VZ8G]3.[QV9Z)1W=N^*U5GQM--VXIQY(D$F.Z.>
M%MC^^?;$(SO8:[5A(5)&7IC*""8!\75O^UAML@(*"1=1X$4)3HE5:OV!,>9F
MA-R]VD%=L&NRJM5Q(3"3[I-&J,EQ0OW1-D9O47'CA)XGMT).ZFEL2K:^;ULA
MM86$JNN?6;5(>)(D<:R]ZJ':OH2"PS3P&42>GR),"(T"NW3S4Z/-[:/O9 -_
M:>EL:XB=Q-70L>T*K;%=U(9 V;N330!PZA@^.>"T+EX3W?><M48W#6,*7=BG
M\?TNE\4/75RCNL[YK:A$^2RJIOG[0L0!\KTH@"GBGK(-? %I%#-(0LZYS\,X
M95:V@<F@<^.-C<Q@*W1=<[T3VXY)C' W(Q37:([-*Y\^@.],&</KI;@"?@ ]
M? 7.H@O^:A1QR$,VN+FD(Z-Q)V4E&R1VR<GJWF$<]4WD5597J*^C4;X5U:K<
M'(6\%[F0V:KZF%5L6>CZ9'?BY^J]4N]?B[C.H/(C*),0*=X*"4QQ@*$?"*DH
M*TH];E4M?J@@<^.R3X]/R^)%"-#*#+ZI7UL2V.!),2.U*: >F>AZQW6=P. O
M+2BH)77(9)>"Y9+=!LLR*>-=BM@N"U[\//NSKN]KW=%-)ZU2[2KJAOY:Y'<E
MX>)6,)$]ZTYN5>N>0(0&:L>'(:98;?827:^!1APF7H#]Q!=QXGNFIU:V@\^-
M 3OY0=DH4-L:>9'#E19?_70COT7/==L).7_V,R;,8YMY'<*M[$ )#S;AOJ"6
M'_04&-+DWA9PB];V(P(_54-[YQ-@U\I^((*G&MC;/G*ZMO4#E7W5K'[H,P:Z
M"-LMV(V\9JQI!2J:$75$6"D>](KV++;M3>JNH%LSSH]$2 (L(9.Z)+B0&!(O
MH3 F:C&A$0UH:F5;7RC/W!:8#P\ZDJZ.RFR^N5=:=%V$O@Q($+ETX@R]E---
MQ]@+4:N)CIGKZ7)P6E[W>&JZ)(-13'9'^#IUDUXHTK2.5#?X[;E:'3WV@I3%
M P/]F9>"++-_"_X;R7(][$W^491J.=#MFZOK,JNR_/[C6M=C;R)ROXK5C;PC
M/Q=1(HEB:@2Q(#K-,2:0TC2$/J58!!*3.+'KA^I<Q+DQ]U83\$[MUBJAF.!>
MZ63I'QEA+LV8^VUG:&0R/TO:5Z W?UK1CLR5R=O3%K3J@D;?3>:$4EFO$TII
MQVF'HTR(\U1%MU).G]XX"LH'4R+'&>G"%CY?\J?UJOI=/(MEV&YY"1(>"22'
M"?$)1"%C,$VD@(Q%U&.2I83C09U[]L>:&Y%_S^[S3&:,Y"NPS@NJ3R1J@RZK
M15?$H(4'H66^Q"FTS1C:$88C4VV_24\CZ!5H$1NS5<]Q3$;IT'-@N+=IS'-<
M[Z/]>$[<,L"=W+4:>Q;Y6M"7/\@_B[(.-MST7(\X\SE!'%(/*RXAJ0_3L,:6
M!"P-&8Y3X[2'\\/-CDXV7?1JD75V9BUT$Q!LTE5]".8&/F*G2(Z]&7\3$"W\
MOD[!G,K3>S&H=IY=8XQ.^7+//V0Z[ZVQ0J_\M>9W#3/K?A=J\]GT.JJ^%<N,
MO6R=>$&<A %1FWF91ABB-):0: -/""_!*,"(!\3&K#LQUMQXN!'2SF8[!:69
MS>8(H)'IM9'RJFES5H&_&DG'\6 :(.+28CLUW*06FX'>NQ:;R2T#.:+([^]$
M^=B5IE;;TL=LI7GI UF)^Z)\N9&Z2VSW>]Y&%@8H#'%$ IC&>EL8>2G$'I(0
M>21E0<J#U+,ZO1DHQ^RX1:D!U4"/VWKO6TVN0*>+=A%I;3976595&3IKAE0U
M_ER,36-#IV&$*-$+T71*@0-%F98>+\-KCSHO?-PP6MVZ[:X5<Z^JA4@IEIZ4
M,$(\@D@$&*9)P"#CDB2I+^+ [AAE=X"Y$>&77(TBJA4H=3XM(T^ =*T0+$VO
M/2C-2.P2@$9FIZUHH);-'=<<4]HEB>R-,2D['--P][,_>MVP[_E+SG2.G?@H
MFC^_Y%ULC>YBK5[JKIEL)JJ%1Q(988]!Z24<HB0)(*:!@"24*$J)YT=F'3F&
M##XW'FC.VY:;]7BY%=6.!JQFP(PBQL)U9/KHQ ;O.L%_V48);84'OQM ;<TP
M0S!SR3Y6XT_*3$.0V66M0<\8:J%(H1[)FZ/'._*S]^BO8K6@+& XB00,B)]
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M-2/*J69J9.K4:D"M!]"*U+-0Z] [.JF[@UZ!GA[CI&\X -1I'-PE\DP;#N<
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MOC$?#>R)-N4#0'=4OG$0<B=VXG;/FVP7/DC-_@Y\V ,&M6,L'O4._M-/741
MO!>YD-FJ[8.'$^I+E*300[Y:"E@B(::QA%+**)*8A-PWJJA^=J2Y4?^M:(ZU
MLUIH[8@%M)$7O!.-_(9U8,Z#?)[;G4$W,I<W<M9V:RLI:$4=UJ#Q!&A6'1K=
M@#==B\;NE6O?M.[5<T3!1H"<[LYXXOXIVS.>5V.G/Z/!#<-<"9MG*P.>9'R1
M> GAGF101@A!%*<4$JQL:)KX$?$Y29&P:BZT\_RYT>7VG14VYXO'T#/;X5^
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MW+O.IC[,$,-I'H+TAL,Z4H329GC+9GC+3D&8W;(^QSY=H"C]:/D?1_%, XW
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M(N??5XO%IYJCY@$3 @=Q &-$N*H#3V#&?0S#V/,();$?>%:1Y9;RI\8LF^[
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M;X4A99#JI5&<A3!EW(,D"5"08)'XS"CC9"R%IT9U6YMW_>7::G GVH2MK>%
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MVO0^>S*^$^(]7JC@ZM\>.:\^Y4OY<[Y\Z*3)EG.*!$]C06'D<011D""8I5S
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MXID',U\D,(YHDB+$?.I9->"SD#TU^FI4!XWN>I=X5D_B8*NYG7MD,Q1F7M)
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MR XFEYQD*'E4;K)#8Y^C+.^V/XWXP 67?*<:4]8AG=LNVN6<"A[A!"'(/1%
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MQ13ZT@N#"*4Q3+TH@!GV:10++GAHM=MU0L[4Z&Y[1MSJV?/\? ].,]9R -+
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MU_)Y'U6M\:9V7^#C@' L8!;(-1C*X@#BE&/HA4&4!8B*U*XA[%$I4R.)K9)
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MZ#V#Q@QU2F1:#0'\J<T!@S3X=(&KTT7^-?J,NWYW@-S!TMS%,_N1LG*)ZXV
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M471W]<*+362,R%B0LC"&?L1#B%(60T(C#T9,,"P8(RDS"Z#=?_+4UC5:.>N
MHT/ +DQ#U\ P\&1BC(!=\=UCUEY3?7?G>>.5WSUFQD[]W:,7]#LH4P=OJNM3
M$Z:+4.*CB%.8!5$,491ZD(1A"-,T3$+,,AHPJ_.PW<=/[4/4Y4;L6]'M869V
M=M4?B8&_Q0T(#BM9G3?:Y8'3GH11SY6.6[=_?'3BJIX)NUSD2W52OCV&^B9'
M\^/3\V+URHM?<44?Y12]\^]UA/(\3*,@3"F%B/FIVE&,5,H<@BEEB"99EH29
M;Y7%VUN5J=% JS)X:G0&M*/T;!.IOQ* UY?R\I_ 0[$J2_ #/YPYNG4]AF94
M,\[(#$Q+C1$[9^9 F3$#F_%J+=FY:+;)>E']+[?C]5<]7M_PZ6K#]JG%5P/M
M--^XOS;C)B%?C=I!9O+U3^Q+QT7^@NL6FM(=TROX\J\X7ZK:#.]?_Y6S!RGW
M.U_4#9<>\^?WKW49#=TC7EW^955W8WK_>NQAW_/R;SK!>LY#RE(L73'.Y<((
M(?E3%J%4TG? 4T%3F@BKS([Q5)\:W6^5!1W39T 9WU0W:0H26(93C_@VF$X$
M4QSCP2>.ZX>WQTPP-M)N9X[1M!]YIAE[5 YGIM$UZ!E4O^D*78NO6P9N:N%_
MD'^454YOENR3_'W^L-]AG06"9A0AB%,A(")) (F<KV"*&"8^#R).C%IF.=)G
M:G-.MR=[4T>KMJC3E]UV'7'MD)G-(2,.Q, 3PY$Q(/MC, .M0;K.=V/2H/6)
M' 'L-(G@2I7&S39P@]]!6H*CQ_:CX^]<'<#02BYJ</DHA:@_U#G-"UZH*>3X
M;YL-R206**&>!V,F_X=X1&'*@@#ZJ@\U0HCYH=%!B@MEID;$NHF7^K3U#QUU
M>Z907C509@P\%OQ#G_GT1]Z:4UU YI)0K])G5#9U@=P^E3IYIGU,UC;,JU1/
M7RU5L2B^5$T\MAGJ]7(ZR/PLCD0&$YT[FA$"4T$P%)Y ?AJ1(#!L^&HE=G+<
MN-4<W"SKK=>-[CN%&VQV1RR'XL*A]F  #W[B/0%LS2.@AL%XI""G+M9JPJ$[
M6+.-_H[B;NVQ.A.@9/&PT6*0[ WLAAGUN+MG+^%U64FOO.CNIK2>5L2")%35
M^*) !!#%.(8I(BGTHL!#(1(X]*Q<XC.R)L?JC:I@1U?+]K]GH#5S8AT!-C1+
M'\5J@, ( SB<=O ](V[<GKV7[3[HTFMP2T_"4#JK@J'JL6HC]?WK>TE,CT^X
M^)MN*>M'81RRC$,1DPRBR ]A&B8)%"&F(N0>"D*K#KV7!$Z..KKZ J4PV.A[
MJ2=M/\0-R<0ACH/[??TAM&<50UR<4LLEF>/RBR$"!R1C>E_?LN8Z[:BL-K&[
ML1""JR8*02Q4?F? 8!IX A(4T4C2"XZH5>.4 PE3XY)M?>T%K]/ARNI?; N4
M[Z-H1A=783,P/S3%QI5V@]1#/&F[V]+B^T)&KB1^PL;#PN&G+NSW6=>G >HH
M]U.=-%&O--><-6^[]%:^\NI.J&[BG>8X]ZOO_%DUS5D^?)0W5*_SE&9!&LE5
MB1<(7]*![\,L9!A&-)7KE"@CDA!LZ,"99E.C$=6(Z-U"!W'4W9CJO"76L1"L
M-B;:\8N[X8R('],0!3!#B61WG$8PBU@,8Y_@!&6AB#B=O_""K"8]H%T-!PS8
MF=;8F<TI;S(> \]%.PV^-OF V['96C8#ZCM<B?K(?+_OUS=<<)<=%9UC[7+N
M<Z?<J'.F<TSWYUKW OHN\DN]\=C4="SGTK]F<NT>0.2S!,K)E<*4J$(K+,Y\
M$64AB9!-?\=] 58SY@A='N^5C)97I?O=% 9MML8?<6&=P'  J>FJO3]0@Z_2
MR^:LH%7.Y:+\N-EN%^%[,D9>=!^W\'"1?>*ZOEVFFPC).G]950]=+?4Q@]I)
MDE^X"'W$I/>51/(S3PDD/ AA$."$"-_+(A':]98^(VUJ7G*M(]@JV6NW[CS
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MX['02 =FM5W+AD;^FV;'#30J@$:';9IHK8:)E_^]N<#CDO@:''VRWB Y1N7
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MIDYYO %*2P]^-.T.F_ZY]2^&[K7UV,!UW\P/KN/M@=TV@!JQN_Z13=_<VUY
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M-L[U,C;/8YGRO(AY9.N5A1)R:LQD HWDMG_4NE.U"6,R?3=>]Z[OPF,KL%R
MRB@,OC<: UFK7,>K-3K;.SK!WHC+/N44[!R86XV)VQ9A]PILM01&3?"P!*\5
M!5M-P?T"U+J"5EG0:.M,S^/9V]XKGH+=1W*I>^W_T\/R+^??@.7%-\"/ Q[:
M&CW>>["A1W/]0X.WOVX(/M:P14>]@<YH)<7[Y9-)4:P_J=N5%O&QSM]X][*[
M1"]VS(]N?Z<KL:TH<UM5FZ<ZSJDR28Y\+<6#7#W%LT2F"$?:J2M(FNM%BRP@
MS1&%#&>4Y(0EB>)N-8/#">M"/N-4&N[$ _IU>');^ 2TJ=W":1IV"NP<U!K
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M@T\[EI7&\GC;#VAKJ+;>^?.>H=:[K^>_6T,]-6IYJO7B!=0^3_FJYX_G1_N
MX967[>6!PWQPTX3B;E&M5_5;W%57^TK7<C_S>X:XBI2V%<19RK4'S@0D29;
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MK/93KY9D:E2QKTS=A:)1IRXXL%Q_ERNP+I]D]V,'+^XZ>UWVQ4>S0F!F>F6
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M'GYN/(*R-8AC=M@%S'&<DUPI4T'%E."C<099SK7'C%2.&"E4ECM-$1X0'_,
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M_Y!S\;#\E:XW=<[$]M!YQA.*DUQRR-.$0ZRDTDLDD<.<%&D4219GPBE(^-Q
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M.55A8!2D 21)'BN69"'$0:X 3M. $HPPXT9\.43XU%BTUQW\TFO_![VXO#$
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MDNI6*!:-T2^P5(J!$V-;<H6'0^0Q@H9I3U03,KV(?F@_&S6 \GB%0NS8&6E
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MW,3@8,.+RQ[C349)4A@9R)@20=<@$R,-AAW:)INJU%0^1=2P*;(>0=2;Y!M
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ME,'<SZ]6(BEUSW!1;&_I^EM.]&<3_+/SZ^&>:PZ]\@*BYL2YZ(@TY1A54D_
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M+%Y(9R-GMGO"XMGQE?WIJ $(WDKUKRZ(GUXN%TL_+<7/(P^<)V8X8;DT0H#
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M9;D8A%\$3=RXD)R@5?H3[$%K:VF_@2QL#XIL%ZO=@GR$P]),UEJG":C@B&2
MCA5/)=4)V5(*5-A*[2Y?2FIK.;QA[&H/:FSG^.3FFED9-;J]<4W'<+C/\"=
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M3$[&4K@>,5,(3X$6>$XA/#>.U[LB3+2:T',DI7VY=6?AY!3'[F2E=8#*G9[
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MP&7THA01T+3IZO0<5>.F["]I6(=33@](V]"^G28DG)"F>DF&U?Z:1B.@DH*
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M':?JH5.8'JV_UXE2^NY$N)2D#C4D]!F4]0R<T!Q883Y2=)B3:S*AXS1RQRF
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M>OU$*.T-Y5KK]?6=H-=#M6&;3)WSMO8UF!=O1G7L2:9R!KE5%%H:+VHE.8?
M/ .K'"],R^1DDR+-"Y^1_SJ=462]^GZ3[MWL2\RC#A0. R?7F-::('<Y98J$
M@R%XH="2-2G*W$G-ZSH!/P8WCPWD^<KH8/?>+;"-EWSK-&_^1=ZD!PMZ8U*1
MH!TY0"J2/X2E1FC9BT)>4 ZLR:'/T92.B\0!T'%0U=I0JGIM6-Q&A:EXS3);
MQVLUL6@]8%A?$):^%!$2PR9Y_1-H[=$R#H:><[!Z@BI?&UK7#M4VS^!D$%XG
M"5;4/<>Q!($B2+ L*I6TM*S-V+=3"7Y%N#T%2><@]U2U]M!'9KW&LW91B>"
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M@!8IUZO+T;$FR?DS:.XWW7E.I'(I)79@)V]8W?J_^U:A-4(*'24D)>KHP^S
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M_Y&_XO?U?=[WY78!_3+[C23[\<]\]2W_.I^M/B\GQL<D6&&00KWDBUD!JE1
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MQ:5*7%N?O.CU6G*_KV\%5(?J?GY<132 -=6/1>[PS]JK3;/624TQ;3&J=%T
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M>)P+Z&',H0DDM+_$Z55*T_5;M^D,K?YB'19V?5P'=JT]]<D#-ZCU9J+NTNX
MPC@N)-$!;5E**/F0Y(0#-9"YPD ZU_$1-99VWWVNMHZZE#:&&:^)<BH2Z5FY
MX<P2SX/L/0_)V%HO41_0,O9Y?C "GGX>N+N\&PA!BTVN-C99;MJ[JR>IF(A"
M9 ))2X)A.2/.IDR,\F647S945CDYMQ$S/F@.TO"6/80'B;M!R&QN)$I3N G4
M$>'+)"2DFGB1RPID;X!1E:VI,O=G.SGCPN9P-3^#FSUDWLC$_]?L:G2QA>""
M4*3L8L%$)0/QH!3*Q 6KK?/:I&=BEVV?VY;B]]'3EAG_>PFM%85O2-=:)Y4
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MJ_94_Q6YO7?;5OXD7$":0,Q..L%)BB!*%2!A7BQ0JC(P(2B/F1VA<KP[X?U
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MSIEQI[R)56:R/$)/4XYA%\UO=0P'RKN!R//L.RQ\>9#XO*.#C%Z4\4  .,9
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MF.1\V4!.="P/+P0O%Q+:HALW.3!NP*LJ+Z=V)71LR.T/BR=KJ@-KJ &'=?M
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MQ1-8*HT1O.<<S^(0@[;(B=$U$/4$36//8AL:34.)OZ$==:]BO+RX/"_5E[>
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M:Z4!J#UTZ:]_E5^[J^,W?@5?YXLI+-?M.&A\20E!$O.:2!H%.GENB/!*&9<
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M6B690%:Y--J3WO'6 Q\I#SZ&'IN&ZR-,7L7^G 6G4*!>%X$Z&]$G1R#94W#
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MU4"*[X6G/;0P<F!_]AUFO_O%/V%U-4YB^3N4'J%)H"89BWX[*Z#E,7PBUNM
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M3N0'!5DP8H]F'D+ML<R$#<72,FULTU;C29)&O@H;1.1[X.@(_G> I+4O4R<
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M["!\]'OM9F@\*1WB5!%?KM)<W^^V4IW;AY])@>Y:RDAJM"@>Z"G$,E$J=NK
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M^_5M]WP=)([&!XA\/6!<*_"E9(@E\F"LB24UJ84ZB,I.5.> ,-E'>PXBLYX
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MP_"*.$LR>]!K^%8*DQ(=;4.L4W5YG4H@. 1,'')5[Y'5@K8F&O$(6L<];UM
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MESF1P=M46V-:C\2SC $<R@09E?!<"UONBLG/:YP]H'-<2VT8<!QLK!TOJ>Z
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M  !D=F$M,3(S,3(P97@R,S$N:'1M4$L! A0#%     @ ZX!,4B_L';WS!P
M@20  !<              ( !#20  &1V82TQ,C,Q,C!E>#,Q,3$P>&LN:'1M
M4$L! A0#%     @ ZX!,4M'D0)'1!P  Y2(  !<              ( !-2P
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M2P$"% ,4    " #L@$Q2X0KL=#4G  "0JP$ $               @ $** 8
M9'9A+3(P,C Q,C,Q+GAS9%!+ 0(4 Q0    ( .R 3%+F%(P+44$  *;. @ 4
M              "  6U/!@!D=F$M,C R,#$R,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( .R 3%+E9_AZ!>X  -=K"@ 4              "  ?"0!@!D=F$M,C R
M,#$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( .R 3%(AI_&9\L@  /7(   3
M          "  2=_!P!D=F$M,C R,#$R,S%?9S$N9VEF4$L! A0#%     @
M[(!,4@8H54G^?0  T9X  !,              ( !2D@( &1V82TR,#(P,3(S
M,5]G,BYJ<&=02P$"% ,4    " #L@$Q233>RK5ED @!69 ( $P
M    @ %YQ@@ 9'9A+3(P,C Q,C,Q7V<S+F=I9E!+ 0(4 Q0    ( .R 3%+-
M^T7(C 0" $I!%0 4              "  0,K"P!D=F$M,C R,#$R,S%?;&%B
M+GAM;%!+ 0(4 Q0    ( .R 3%(]=N99G3P! !2+#@ 4              "
M <$O#0!D=F$M,C R,#$R,S%?<')E+GAM;%!+!08     #P / -T#  "0; X
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
